<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38864162</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>332</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>27</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Prolonged vs Intermittent Infusions of &#x3b2;-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>638</StartPage><EndPage>648</EndPage><MedlinePgn>638-648</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2024.9803</ELocationID><Abstract><AbstractText Label="IMPORTANCE">There is uncertainty about whether prolonged infusions of &#x3b2;-lactam antibiotics improve clinically important outcomes in critically ill adults with sepsis or septic shock.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether prolonged &#x3b2;-lactam antibiotic infusions are associated with a reduced risk of death in critically ill adults with sepsis or septic shock compared with intermittent infusions.</AbstractText><AbstractText Label="DATA SOURCES">The primary search was conducted with MEDLINE (via PubMed), CINAHL, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov from inception to May 2, 2024.</AbstractText><AbstractText Label="STUDY SELECTION">Randomized clinical trials comparing prolonged (continuous or extended) and intermittent infusions of &#x3b2;-lactam antibiotics in critically ill adults with sepsis or septic shock.</AbstractText><AbstractText Label="DATA EXTRACTION AND SYNTHESIS">Data extraction and risk of bias were assessed independently by 2 reviewers. Certainty of evidence was evaluated with the Grading of Recommendations Assessment, Development and Evaluation approach. A bayesian framework was used as the primary analysis approach and a frequentist framework as the secondary approach.</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was all-cause 90-day mortality. Secondary outcomes included intensive care unit (ICU) mortality and clinical cure.</AbstractText><AbstractText Label="RESULTS">From 18 eligible randomized clinical trials that included 9108 critically ill adults with sepsis or septic shock (median age, 54 years; IQR, 48-57; 5961 men [65%]), 17 trials (9014 participants) contributed data to the primary outcome. The pooled estimated risk ratio for all-cause 90-day mortality for prolonged infusions of &#x3b2;-lactam antibiotics compared with intermittent infusions was 0.86 (95% credible interval, 0.72-0.98; I2&#x2009;=&#x2009;21.5%; high certainty), with a 99.1% posterior probability that prolonged infusions were associated with lower 90-day mortality. Prolonged infusion of &#x3b2;-lactam antibiotics was associated with a reduced risk of intensive care unit mortality (risk ratio, 0.84; 95% credible interval, 0.70-0.97; high certainty) and an increase in clinical cure (risk ratio, 1.16; 95% credible interval, 1.07-1.31; moderate certainty).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults in the intensive care unit who had sepsis or septic shock, the use of prolonged &#x3b2;-lactam antibiotic infusions was associated with a reduced risk of 90-day mortality compared with intermittent infusions. The current evidence presents a high degree of certainty for clinicians to consider prolonged infusions as a standard of care in the management of sepsis and septic shock.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO Identifier: CRD42023399434.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdul-Aziz</LastName><ForeName>Mohd H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Naomi E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotta</LastName><ForeName>Menino O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devaux</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Tanna</LastName><ForeName>Gian Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Business Economics, Health and Social Care, University of Applied Sciences and Arts of Southern Switzerland, Manno, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Research, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dulhunty</LastName><ForeName>Joel M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Redcliffe Hospital, Redcliffe, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elkady</LastName><ForeName>Hatem</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Westmead Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>UQ Library, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>M Shahnaz</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Ayesha Bibi</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Division of Critical Care, University of Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Jamieson Trauma Institute, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Emergency and Pain Medicine, N&#xee;mes University Hospital, University of Montpellier, N&#xee;mes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xiaoqiu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Statistics Division, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Population Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Myburgh</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, St George Hospital, Kogarah, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Novy</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service d'anesth&#xe9;sie-r&#xe9;animation et m&#xe9;dicine p&#xe9;ri-op&#xe9;ratoire Brabois adulte, CHRU de Nancy, Nancy, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universit&#xe9; de Lorraine, SIMPA, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omar</LastName><ForeName>Shahed</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Critical Care, University of Witwatersrand, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajbhandari</LastName><ForeName>Dorrilyn</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roger</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>D&#xe9;partement d'anesth&#xe9;sie et r&#xe9;animation, douleur et m&#xe9;decine d'urgence, CHU Car&#xe9;meau, N&#xee;mes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UR UM 103IMAGINE, Facult&#xe9; de M&#xe9;decine, Montpellier Universit&#xe9;, N&#xee;mes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaghi</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Diagnostic and Experimental Medicine, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health and University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roberts</LastName><ForeName>Jason A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>University of Queensland Centre for Clinical Research (UQCCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anesthesiology Critical Care Emergency and Pain Medicine, N&#xee;mes University Hospital, University of Montpellier, N&#xee;mes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Herston Infectious Diseases Institute (HeIDI), Metro North Health, Brisbane, Queensland, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000097902">beta Lactam Antibiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2024 Aug 27;332(8):623-625. doi: 10.1001/jama.2024.10168.</RefSource><PMID Version="1">38864160</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097902" MajorTopicYN="Y">beta Lactam Antibiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Abdul-Aziz reported being a writing committee member of the BLISS trial, which is included in this meta-analysis. Dr Hammond reported being a writing committee member of the BLING III trial, which is included in this meta-analysis. Dr Brett reported a consultancy payment to his university from GSK for work on an analysis of sotrovimab in COVID-19 infection outside the submitted work; and reported being a writing committee member of the BLING III trial. Dr De Waele reported receiving honoraria from Pfizer, Menarini, and MSD paid to his institution; and consultancy fees from Viatris paid to his institution outside the submitted work. Dr Dulhunty reported being a writing committee member of the BLING I, BLING II, and BLING III trials, which are included in this meta-analysis. Dr Khan reported receiving grants from the Critical Care Society of Southern Africa outside the submitted work. Dr Liu reported being a writing committee member of the BLING III trial. Dr Monti reported receiving honoraria and consultancy fees from AOP Health, InfectoFos, and Pfizer outside the submitted work; and being a writing committee member of the MERCY trial, which is included in this meta-analysis. Dr Myburgh reported being a writing committee member of the BLING I, BLING II, and BLING III trials. Dr Omar reported receiving honoraria from Jafron Biomedical Co for lectures given on the removal of toxins using hemoadsorption therapy in poisoned patients outside the submitted work. Ms Rajbhandari reported being a writing committee member of the BLING III trial. Dr Roger reported receiving honoraria and consultancy fees from Shionogi, bioM&#xe9;rieux, Advanz Pharma, MSD, AOP Orphan, Viatris, Pfizer, and Fresenius outside the submitted work. Dr Zangrillo reported being a writing committee member of the MERCY trial. Dr Roberts reported receiving consulting fees from Qpex Biopharma, Gilead, Advanz Pharma, Pfizer, Sandoz, MSD, Cipla, and bioM&#xe9;rieux; receiving grants from Qpex Biopharma, the British Society for Antimicrobial Chemotherapy, Pfizer, and bioM&#xe9;rieux outside the submitted work; and being a writing committee member of the BLING I, BLING II, and BLING III trials. Dr Roberts reported being a writing committee member of the BLING I, BLING II, and BLING III trials and of the BLISS trial. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>27</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38864162</ArticleId><ArticleId IdType="pmc">PMC11170459</ArticleId><ArticleId IdType="doi">10.1001/jama.2024.9803</ArticleId><ArticleId IdType="pii">2819970</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Roberts JA, Paul SK, Akova M, et al. ; DALI Study . DALI: defining antibiotic levels in intensive care unit patients: are current &#x3b2;-lactam antibiotic doses sufficient for critically ill patients? Clin Infect Dis. 2014;58(8):1072-1083. doi: 10.1093/cid/ciu027</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu027</ArticleId><ArticleId IdType="pubmed">24429437</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Joynt GM, Lee A, et al. ; SMARRT Study Collaborators and the ANZICS Clinical Trials Group . The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the Multinational Sampling Antibiotics in Renal Replacement Therapy study. Clin Infect Dis. 2021;72(8):1369-1378. doi: 10.1093/cid/ciaa224</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa224</ArticleId><ArticleId IdType="pubmed">32150603</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekar K, Abdul-Aziz MH, Cheng V, et al. Antimicrobial exposures in critically ill patients receiving extracorporeal membrane oxygenation. Am J Respir Crit Care Med. 2023;207(6):704-720. doi: 10.1164/rccm.202207-1393OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202207-1393OC</ArticleId><ArticleId IdType="pubmed">36215036</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998;26(1):1-10. doi: 10.1086/516284</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/516284</ArticleId><ArticleId IdType="pubmed">9455502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouton JW, Vinks AA. Is continuous infusion of beta-lactam antibiotics worthwhile? efficacy and pharmacokinetic considerations. J Antimicrob Chemother. 1996;38(1):5-15. doi: 10.1093/jac/38.1.5</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/38.1.5</ArticleId><ArticleId IdType="pubmed">8858451</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Portunato F, Roberts JA. Prolonged infusion of beta-lactam antibiotics for gram-negative infections: rationale and evidence base. Curr Opin Infect Dis. 2020;33(6):501-510. doi: 10.1097/QCO.0000000000000681</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000681</ArticleId><ArticleId IdType="pubmed">33009140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhaese S, Heffernan A, Liu D, et al. Prolonged versus intermittent infusion of &#x3b2;-lactam antibiotics: a systematic review and meta-regression of bacterial killing in preclinical infection models. Clin Pharmacokinet. 2020;59(10):1237-1250. doi: 10.1007/s40262-020-00919-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40262-020-00919-6</ArticleId><ArticleId IdType="pubmed">32710435</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Webb S, Paterson D, Ho KM, Lipman J. A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics. Crit Care Med. 2009;37(6):2071-2078. doi: 10.1097/CCM.0b013e3181a0054d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a0054d</ArticleId><ArticleId IdType="pubmed">19384201</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Abdul-Aziz MH, Davis JS, et al. Continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis: a meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med. 2016;194(6):681-691. doi: 10.1164/rccm.201601-0024OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201601-0024OC</ArticleId><ArticleId IdType="pubmed">26974879</ArticleId></ArticleIdList></Reference><Reference><Citation>Vardakas KZ, Voulgaris GL, Maliaros A, Samonis G, Falagas ME. Prolonged versus short-term intravenous infusion of antipseudomonal &#x3b2;-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials. Lancet Infect Dis. 2018;18(1):108-120. doi: 10.1016/S1473-3099(17)30615-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(17)30615-1</ArticleId><ArticleId IdType="pubmed">29102324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo Y, Ota K, Imura H, Hara N, Shime N. Prolonged versus intermittent &#x3b2;-lactam antibiotics intravenous infusion strategy in sepsis or septic shock patients: a systematic review with meta-analysis and trial sequential analysis of randomized trials. J Intensive Care. 2020;8:77. doi: 10.1186/s40560-020-00490-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-020-00490-z</ArticleId><ArticleId IdType="pmc">PMC7541232</ArticleId><ArticleId IdType="pubmed">33042550</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Long Y, Wu G, et al. Prolonged vs intermittent intravenous infusion of &#x3b2;-lactam antibiotics for patients with sepsis: a systematic review of randomized clinical trials with meta-analysis and trial sequential analysis. Ann Intensive Care. 2023;13(1):121. doi: 10.1186/s13613-023-01222-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-023-01222-w</ArticleId><ArticleId IdType="pmc">PMC10697919</ArticleId><ArticleId IdType="pubmed">38051467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokhandwala A, Patel P, Isaak AK, et al. Comparison of the effectiveness of prolonged infusion and intermittent infusion of meropenem in patients with sepsis: a meta-analysis. Cureus. 2023;15(10):e46990. doi: 10.7759/cureus.46990</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.46990</ArticleId><ArticleId IdType="pmc">PMC10640903</ArticleId><ArticleId IdType="pubmed">38022273</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti G, Bradic N, Marzaroli M, et al. ; MERCY Investigators . Continuous vs intermittent meropenem administration in critically ill patients with sepsis: the MERCY randomized clinical trial. JAMA. 2023;330(2):141-151. doi: 10.1001/jama.2023.10598</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.10598</ArticleId><ArticleId IdType="pmc">PMC10276329</ArticleId><ArticleId IdType="pubmed">37326473</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Brett SJ, De Waele J, et al. Continuous vs intermittent &#x3b2;-lactam antibiotic infusions in critically ill patients with sepsis: the BLING III randomized clinical trial. JAMA. Published online June 12, 2024. doi: 10.1001/jama.2024.9779</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2024.9779</ArticleId><ArticleId IdType="pmc">PMC11170452</ArticleId><ArticleId IdType="pubmed">38864155</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Hammond NE, Brett SJ, et al. Prolonged infusion versus intermittent infusion dosing of beta-lactam antibiotics in critically ill patients with sepsis: a protocol for a systematic review and meta-analysis of randomised controlled trials. Preprint posted online May 16, 2023. medRxiv 2023.05.15.23289889. doi: 10.1101/2023.05.15.23289889</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.15.23289889</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71):n71. doi: 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008;34(1):17-60. doi: 10.1007/s00134-007-0934-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-007-0934-2</ArticleId><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. ; International Sepsis Definitions Conference . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530-538. doi: 10.1007/s00134-003-1662-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. ; The ACCP/SCCM Consensus Conference Committee; American College of Chest Physicians/Society of Critical Care Medicine . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655. doi: 10.1378/chest.101.6.1644</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan AB, Omar S. Continuous vs intermittent beta-lactam dosing in critically ill patients with sepsis: a randomized controlled trial. World Health Organization. Accessed May 2, 2024. https://trialsearch.who.int/Trial2.aspx?TrialID=PACTR202009811610400</Citation></Reference><Reference><Citation>Schandelmaier S, Briel M, Varadhan R, et al. Development of the Instrument to Assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses. CMAJ. 2020;192(32):E901-E906. doi: 10.1503/cmaj.200077</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.200077</ArticleId><ArticleId IdType="pmc">PMC7829020</ArticleId><ArticleId IdType="pubmed">32778601</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. doi: 10.1186/1471-2288-14-135</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner RM, Jackson D, Wei Y, Thompson SG, Higgins JP. Predictive distributions for between-study heterogeneity and simple methods for their application in bayesian meta-analysis. Stat Med. 2015;34(6):984-998. doi: 10.1002/sim.6381</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6381</ArticleId><ArticleId IdType="pmc">PMC4383649</ArticleId><ArticleId IdType="pubmed">25475839</ArticleId></ArticleIdList></Reference><Reference><Citation>IntHout J, Ioannidis JPA, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method. BMC Med Res Methodol. 2014;14:25. doi: 10.1186/1471-2288-14-25</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-25</ArticleId><ArticleId IdType="pmc">PMC4015721</ArticleId><ArticleId IdType="pubmed">24548571</ArticleId></ArticleIdList></Reference><Reference><Citation>Doleman B, Freeman SC, Lund JN, Williams JP, Sutton AJ. Funnel plots may show asymmetry in the absence of publication bias with continuous outcomes dependent on baseline risk: presentation of a new publication bias test. Res Synth Methods. 2020;11(4):522-534. doi: 10.1002/jrsm.1414</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1414</ArticleId><ArticleId IdType="pubmed">32362052</ArticleId></ArticleIdList></Reference><Reference><Citation>Doleman B, Mathiesen O, Jakobsen JC, et al. Methodologies for systematic reviews with meta-analysis of randomised clinical trials in pain, anaesthesia, and perioperative medicine. Br J Anaesth. 2021;126(4):903-911. doi: 10.1016/j.bja.2021.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2021.01.004</ArticleId><ArticleId IdType="pubmed">33558052</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xf6;ver C. Bayesian random-effects meta-analysis using the bayesmeta R package. J Stat Softw. 2020;93(6):1-51. doi: 10.18637/jss.v093.i06</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v093.i06</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36(3):1-48. doi: 10.18637/jss.v036.i03</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. ; GRADE Working Group . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926. doi: 10.1136/bmj.39489.470347.AD</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines, 1: introduction&#x2014;GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383-394. doi: 10.1016/j.jclinepi.2010.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Georges B, Conil JM, Cougot P, et al. Cefepime in critically ill patients: continuous infusion vs an intermittent dosing regimen. Int J Clin Pharmacol Ther. 2005;43(8):360-369. doi: 10.5414/CPP43360</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CPP43360</ArticleId><ArticleId IdType="pubmed">16119511</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafati MR, Rouini MR, Mojtahedzadeh M, et al. Clinical efficacy of continuous infusion of piperacillin compared with intermittent dosing in septic critically ill patients. Int J Antimicrob Agents. 2006;28(2):122-127. doi: 10.1016/j.ijantimicag.2006.02.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2006.02.020</ArticleId><ArticleId IdType="pubmed">16815689</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Boots R, Rickard CM, et al. Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? a randomized controlled pilot study. J Antimicrob Chemother. 2007;59(2):285-291. doi: 10.1093/jac/dkl478</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkl478</ArticleId><ArticleId IdType="pubmed">17135183</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Kirkpatrick CM, Roberts MS, Robertson TA, Dalley AJ, Lipman J. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. J Antimicrob Chemother. 2009;64(1):142-150. doi: 10.1093/jac/dkp139</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkp139</ArticleId><ArticleId IdType="pubmed">19398460</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts JA, Kirkpatrick CM, Roberts MS, Dalley AJ, Lipman J. First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis. Int J Antimicrob Agents. 2010;35(2):156-163. doi: 10.1016/j.ijantimicag.2009.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2009.10.008</ArticleId><ArticleId IdType="pubmed">20018492</ArticleId></ArticleIdList></Reference><Reference><Citation>Chytra I, Stepan M, Benes J, et al. Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial. Crit Care. 2012;16(3):R113. doi: 10.1186/cc11405</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11405</ArticleId><ArticleId IdType="pmc">PMC3580671</ArticleId><ArticleId IdType="pubmed">22742765</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Roberts JA, Davis JS, et al. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis. 2013;56(2):236-244. doi: 10.1093/cid/cis856</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cis856</ArticleId><ArticleId IdType="pubmed">23074313</ArticleId></ArticleIdList></Reference><Reference><Citation>Dulhunty JM, Roberts JA, Davis JS, et al. ; BLING II Investigators for the ANZICS Clinical Trials Group . A multicenter randomized trial of continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis. Am J Respir Crit Care Med. 2015;192(11):1298-1305. doi: 10.1164/rccm.201505-0857OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201505-0857OC</ArticleId><ArticleId IdType="pubmed">26200166</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal JA, Mat-Nor MB, Mohamad-Nor FS, et al. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;45(1):41-45. doi: 10.1016/j.ijantimicag.2014.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2014.09.009</ArticleId><ArticleId IdType="pubmed">25455853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal JA, Roberts DM, Udy AA, et al. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration. Int J Antimicrob Agents. 2015;46(1):39-44. doi: 10.1016/j.ijantimicag.2015.02.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2015.02.014</ArticleId><ArticleId IdType="pubmed">25881872</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, et al. Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis. Intensive Care Med. 2016;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4188-0</ArticleId><ArticleId IdType="pubmed">26754759</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao HY, Gu J, Lyu J, et al. Pharmacokinetic and pharmacodynamic efficacies of continuous versus intermittent administration of meropenem in patients with severe sepsis and septic shock: a prospective randomized pilot study. Chin Med J (Engl). 2017;130(10):1139-1145. doi: 10.4103/0366-6999.205859</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0366-6999.205859</ArticleId><ArticleId IdType="pmc">PMC5443018</ArticleId><ArticleId IdType="pubmed">28485312</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirjalili M, Zand F, Karimzadeh I, et al. The clinical and paraclinical effectiveness of four-hour infusion vs half-hour infusion of high-dose ampicillin-sulbactam in treatment of critically ill patients with sepsis or septic shock: an assessor-blinded randomized clinical trial. J Crit Care. 2023;73:154170. doi: 10.1016/j.jcrc.2022.154170</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2022.154170</ArticleId><ArticleId IdType="pubmed">36272277</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad SI, Aglan BM, Shaboob EA, Abdelghany HH. Continuous versus intermittent use of meropenem in septic critically ill patients: a randomized controlled trail. Benha Med J. 2024;41(2):38-48. doi: 10.21608/bmfj.2023.247556.1949</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/bmfj.2023.247556.1949</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-Moreno CA, Nocua-B&#xe1;ez LC, Ortiz G, et al. Efficacy of continuous vs intermittent administration of cefepime in adult ICU patients with gram-negative bacilli bacteremia: a randomized double-blind clinical study. Antibiotics (Basel). 2024;13(3):229. doi: 10.3390/antibiotics13030229</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics13030229</ArticleId><ArticleId IdType="pmc">PMC10967321</ArticleId><ArticleId IdType="pubmed">38534664</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Aziz MH, Dulhunty JM, Bellomo R, Lipman J, Roberts JA. Continuous beta-lactam infusion in critically ill patients: the clinical evidence. Ann Intensive Care. 2012;2(1):37. doi: 10.1186/2110-5820-2-37</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-2-37</ArticleId><ArticleId IdType="pmc">PMC3475088</ArticleId><ArticleId IdType="pubmed">22898246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29726345</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>391</Volume><Issue>10131</Issue><PubDate><Year>2018</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1693</StartPage><EndPage>1705</EndPage><MedlinePgn>1693-1705</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(18)30479-3</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(18)30479-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Supplemental oxygen is often administered liberally to acutely ill adults, but the credibility of the evidence for this practice is unclear. We systematically reviewed the efficacy and safety of liberal versus conservative oxygen therapy in acutely ill adults.</AbstractText><AbstractText Label="METHODS">In the Improving Oxygen Therapy in Acute-illness (IOTA) systematic review and meta-analysis, we searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, HealthSTAR, LILACS, PapersFirst, and the WHO International Clinical Trials Registry from inception to Oct 25, 2017, for randomised controlled trials comparing liberal and conservative oxygen therapy in acutely ill adults (aged &#x2265;18 years). Studies limited to patients with chronic respiratory diseases or psychiatric disease, patients on extracorporeal life support, or patients treated with hyperbaric oxygen therapy or elective surgery were excluded. We screened studies and extracted summary estimates independently and in duplicate. We also extracted individual patient-level data from survival curves. The main outcomes were mortality (in-hospital, at 30 days, and at longest follow-up) and morbidity (disability at longest follow-up, risk of hospital-acquired pneumonia, any hospital-acquired infection, and length of hospital stay) assessed by random-effects meta-analyses. We assessed quality of evidence using the grading of recommendations assessment, development, and evaluation approach. This study is registered with PROSPERO, number CRD42017065697.</AbstractText><AbstractText Label="FINDINGS">25 randomised controlled trials enrolled 16&#x2008;037 patients with sepsis, critical illness, stroke, trauma, myocardial infarction, or cardiac arrest, and patients who had emergency surgery. Compared with a conservative oxygen strategy, a liberal oxygen strategy (median baseline saturation of peripheral oxygen [SpO<sub>2</sub>] across trials, 96% [range 94-99%, IQR 96-98]) increased mortality in-hospital (relative risk [RR] 1&#xb7;21, 95% CI 1&#xb7;03-1&#xb7;43, I<sup>2</sup>=0%, high quality), at 30 days (RR 1&#xb7;14, 95% CI 1&#xb7;01-1&#xb7;29, I<sup>2</sup>=0%, high quality), and at longest follow-up (RR 1&#xb7;10, 95% CI 1&#xb7;00-1&#xb7;20, I<sup>2</sup>=0%, high quality). Morbidity outcomes were similar between groups. Findings were robust to trial sequential, subgroup, and sensitivity analyses.</AbstractText><AbstractText Label="INTERPRETATION">In acutely ill adults, high-quality evidence shows that liberal oxygen therapy increases mortality without improving other patient-important outcomes. Supplemental oxygen might become unfavourable above an SpO<sub>2</sub> range of 94-96%. These results support the conservative administration of oxygen therapy.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Derek K</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Lisa H-Y</ForeName><Initials>LH</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand; Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zamiri</LastName><ForeName>Nima</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almenawer</LastName><ForeName>Saleh A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Division of Neurosurgery, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaeschke</LastName><ForeName>Roman</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xfc;nemann</LastName><ForeName>Holger J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neary</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alhazzani</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Medicine, McMaster University, Hamilton, ON, Canada; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada. Electronic address: alhazzaw@mcmaster.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Apr 28;391(10131):1640-1642. doi: 10.1016/S0140-6736(18)30546-4.</RefSource><PMID Version="1">29726326</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Arch Dis Child. 2019 Feb;104(2):106-107. doi: 10.1136/archdischild-2018-315437.</RefSource><PMID Version="1">30213801</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2018 Sep 18;169(6):JC29. doi: 10.7326/ACPJC-2018-169-6-029.</RefSource><PMID Version="1">30242402</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ Evid Based Med. 2019 Jun;24(3):113-114. doi: 10.1136/bmjebm-2018-111054.</RefSource><PMID Version="1">30266723</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Dtsch Arztebl Int. 2018 Oct 12;115(41):685-686. doi: 10.3238/arztebl.2018.0685b.</RefSource><PMID Version="1">30406753</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2436. doi: 10.1016/S0140-6736(18)32219-0.</RefSource><PMID Version="1">30527412</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2436-2437. doi: 10.1016/S0140-6736(18)32201-3.</RefSource><PMID Version="1">30527413</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2018 Dec 8;392(10163):2437. doi: 10.1016/S0140-6736(18)32194-9.</RefSource><PMID Version="1">30527415</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am Fam Physician. 2019 Jan 1;99(1):Online.</RefSource><PMID Version="1">30600981</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>CJEM. 2019 Mar;21(2):296-298. doi: 10.1017/cem.2018.482.</RefSource><PMID Version="1">30651153</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2019 Apr 18;23(1):132. doi: 10.1186/s13054-018-2165-z.</RefSource><PMID Version="1">30999939</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 Feb 15;201(4):478-480. doi: 10.1164/rccm.201905-1029RR.</RefSource><PMID Version="1">31816250</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007049" MajorTopicYN="N">Iatrogenic Disease</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000600" MajorTopicYN="N">supply &amp; distribution</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010102" MajorTopicYN="N">Oxygen Inhalation Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29726345</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(18)30479-3</ArticleId><ArticleId IdType="pii">S0140-6736(18)30479-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39297945</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Landiolol for heart rate control in patients with septic shock and persistent tachycardia. A multicenter randomized clinical trial (Landi-SEP).</ArticleTitle><Pagination><StartPage>1622</StartPage><EndPage>1634</EndPage><MedlinePgn>1622-1634</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-024-07587-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Excessive tachycardia in resuscitated septic shock patients can impair hemodynamics and worsen patient outcome. We investigated whether heart rate (HR) control can be achieved without increased vasopressor requirements using the titratable highly selective, ultra-short-acting &#x3b2;1-blocker landiolol.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This randomized, open-label, controlled trial was conducted at 20 sites in 7 European countries from 2018 to 2022 and investigated the efficacy and safety of landiolol in adult patients with septic shock and persistent tachycardia. Patients were randomly assigned to receive either landiolol along with standard treatment (n&#x2009;=&#x2009;99) or standard treatment alone (n&#x2009;=&#x2009;101). The combined primary endpoint was HR response (i.e., HR within the range of 80-94 beats per minute) and its maintenance without increasing vasopressor requirements during the first 24&#xa0;h after treatment start. Key secondary endpoints were 28-day mortality and adverse events.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Out of 196 included septic shock patients, 98 received standard treatment combined with landiolol and 98 standard treatment alone. A significantly larger proportion of patients met the combined primary endpoint in the landiolol group than in the control group (39.8% [39/98] vs. 23.5% [23/98]), with a between-group difference of 16.5% (95% confidence interval [CI]: 3.4-28.8%; p&#x2009;=&#x2009;0.013). There were no statistically significant differences between study groups in tested secondary outcomes and adverse events.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The ultra-short-acting beta-blocker landiolol was effective in reducing and maintaining HR without increasing vasopressor requirements after 24&#xa0;h in patients with septic shock and persistent tachycardia. There were no differences in adverse events and clinical outcomes such as 28-day mortality vs. standard of care. The results of this study, in the context of previous trials, do not support a treatment strategy of stringent HR reduction (&lt;&#x2009;95&#xa0;bpm) in an unselected septic shock population with persistent tachycardia. Further investigations are needed to identify septic shock patient phenotypes that benefit clinically from HR control.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5835-7083</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Bielefeld, Germany. Sebastian.Rehberg@uni-bielefeld.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#x10c;ern&#xfd;</LastName><ForeName>Vladim&#xed;r</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Charles University, 3rd Medical Faculty and University Hospital Kr&#xe1;lovsk&#xe9; Vinohrady, Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology, Perioperative Medicine and Intensive Care, Masaryk Hospital, &#xda;st&#xed; Nad Labem, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kr&#xe1;lov&#xe9;, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia, Pain Management and Perioperative Medicine, Dalhousie University, Halifax, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hradec Kr&#xe1;lov&#xe9;, Hradec Kr&#xe1;lov&#xe9;, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cihl&#xe1;&#x159;</LastName><ForeName>Radek</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Hospital &#x10c;esk&#xe9; Bud&#x11b;jovice, &#x10c;esk&#xe9; Bud&#x11b;jovice, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borgstedt</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency Medicine, Transfusion Medicine and Pain Therapy, University Hospital of Bielefeld, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biancofiore</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Transplant Intensive Care Unit, University School of Medicine Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular Anaesthesiology and Intensive Care, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schober</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Klinik Floridsdorf &amp; Karl Landsteiner Institute for Cardiovascular and Critical Care Research C/O Klinik Floridsdorf, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trimmel</LastName><ForeName>Helmut</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency Medicine and General Intensive Care, State Hospital Wiener Neustadt, Wiener Neustadt, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernerstorfer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Ordensklinikum Linz GmbH, Barmherzige Schwestern, Linz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siebers</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Hospital of Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dost&#xe1;l</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Charles University, Faculty of Medicine in Hradec Kralove, Hradec Kr&#xe1;lov&#xe9;, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University Hospital Hradec Kr&#xe1;lov&#xe9;, Hradec Kr&#xe1;lov&#xe9;, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, University of Rome, "La Sapienza", Policlinico Umberto Primo, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine and Intensive Care, Department Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretsch</LastName><ForeName>Ingrid</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine II, Division of Cardiology and Intensive Care, Paracelsus Medical University of Salzburg, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, University Hospital Greifswald, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahmel</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Knappschaftskrankenhaus Bochum, Bochum, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podbregar</LastName><ForeName>Matej</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Intensive Care Department, General Hospital Celje, Celje, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duliczki</LastName><ForeName>&#xc9;va</ForeName><Initials>&#xc9;</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Unit, Szabolcs-Szatm&#xe1;r-Bereg County Hospitals and University Teaching Hospital J&#xf3;sa Andr&#xe1;s Teaching Hospital, Ny&#xed;regyh&#xe1;za, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamme</LastName><ForeName>Kadri</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Clinic of Anaesthesiology and Intensive Care, 1St. Intensive Care Unit, Tartu University Hospital, Tartu, Estonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unger</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AOP Orphan Pharmaceuticals GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sus</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>AOP Orphan Pharmaceuticals GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klade</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>AOP Orphan Pharmaceuticals GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krejcy</LastName><ForeName>Kurt</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>AOP Orphan Pharmaceuticals GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirchbaumer-Baroian</LastName><ForeName>Nairi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>AOP Orphan Pharmaceuticals GmbH, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krumpl</LastName><ForeName>G&#xfc;nther</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AOP Health International Management AG, Ruggell, Liechtenstein.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Du&#x161;ka</LastName><ForeName>Franti&#x161;ek</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Charles University, 3rd Medical Faculty and University Hospital Kr&#xe1;lovsk&#xe9; Vinohrady, Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>LANDI-SEP Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009025">Morpholines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="Y">Urea</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013610" MajorTopicYN="Y">Tachycardia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006339" MajorTopicYN="Y">Heart Rate</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009025" MajorTopicYN="Y">Morpholines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Heart rate control</Keyword><Keyword MajorTopicYN="N">Landiolol</Keyword><Keyword MajorTopicYN="N">Persistent tachycardia</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Ultra-short-acting beta-blocker</Keyword></KeywordList><CoiStatement>All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. MU, JS, CK, KK, NKB are employees of AOP Orphan Pharmaceuticals GmbH. GK is a Board Director of AOP Health International Management AG.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Brujevic</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heinz</LastName><ForeName>Gottfried</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spies</LastName><ForeName>Claudia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pratesi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Markota</LastName><ForeName>Andrej</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kekstas</LastName><ForeName>Gintautas</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Csom&#xf3;s</LastName><ForeName>&#xc1;kos</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kecsk&#xe9;s</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sarkany</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>F&#xfc;lesdi</LastName><ForeName>Bela</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wojtowicz</LastName><ForeName>Rafal</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>21</Day><Hour>13</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>19</Day><Hour>11</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39297945</ArticleId><ArticleId IdType="pmc">PMC11447033</ArticleId><ArticleId IdType="doi">10.1007/s00134-024-07587-1</ArticleId><ArticleId IdType="pii">10.1007/s00134-024-07587-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bhagat K, Hingorani AD, Palacios M, Charles IG, Vallance P (1999) Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS. Cardiovasc Res 41:754&#x2013;764</Citation><ArticleIdList><ArticleId IdType="pubmed">10435048</ArticleId></ArticleIdList></Reference><Reference><Citation>Marx G, Vangerow B, Burczyk C, Gratz KF, Maassen N, Cobas Meyer M, Leuwer M, Kuse E, Rueckholdt H (2000) Evaluation of noninvasive determinants for capillary leakage syndrome in septic shock patients. Intensive Care Med 26:1252&#x2013;1258</Citation><ArticleIdList><ArticleId IdType="pubmed">11089750</ArticleId></ArticleIdList></Reference><Reference><Citation>Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471&#x2013;1477</Citation><ArticleIdList><ArticleId IdType="pubmed">8479467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lescroart M, Pequignot B, Kimmoun A, Klein T, Levy B (2022) Beta-blockers in septic shock: what is new? J Intensive Med 2:150&#x2013;155</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923987</ArticleId><ArticleId IdType="pubmed">36789018</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47:1181&#x2013;1247</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486&#x2013;552</Citation><ArticleIdList><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunser MW, Hasibeder WR (2009) Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress. J Intensive Care Med 24:293&#x2013;316</Citation><ArticleIdList><ArticleId IdType="pubmed">19703817</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibovici L, Gafter-Gvili A, Paul M, Almanasreh N, Tacconelli E, Andreassen S, Nielsen AD, Frank U, Cauda R, Group TS (2007) Relative tachycardia in patients with sepsis: an independent risk factor for mortality. QJM. 100:629&#x2013;634</Citation><ArticleIdList><ArticleId IdType="pubmed">17846061</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D&#x2019;Egidio A, D&#x2019;Ippoliti F, Raffone C, Venditti M, Guarracino F, Girardis M, Tritapepe L, Pietropaoli P, Mebazaa A, Singer M (2013) Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 310:1683&#x2013;1691</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiger A, Singer M (2013) The heart in sepsis: from basic mechanisms to clinical management. Curr Vasc Pharmacol 11:187&#x2013;195</Citation><ArticleIdList><ArticleId IdType="pubmed">23506497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander O, Welters ID, Foex P, Sear JW (2005) Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 33:81&#x2013;88</Citation><ArticleIdList><ArticleId IdType="pubmed">15644652</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H, Muller-Werdan U, Hoffmann T, Francis DP, Piepoli MF, Rauchhaus M, Prondzinsky R, Loppnow H, Buerke M, Hoyer D, Werdan K (2005) Autonomic dysfunction predicts mortality in patients with multiple organ dysfunction syndrome of different age groups. Crit Care Med 33:1994&#x2013;2002</Citation><ArticleIdList><ArticleId IdType="pubmed">16148471</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, Torgersen C, Luckner G, Schroder DC, Lorenz I, Dunser MW (2012) Adverse cardiac events during catecholamine vasopressor therapy: a prospective observational study. Intensive Care Med 38:950&#x2013;958</Citation><ArticleIdList><ArticleId IdType="pubmed">22527060</ArticleId></ArticleIdList></Reference><Reference><Citation>Werdan K, Schmidt H, Ebelt H, Zorn-Pauly K, Koidl B, Hoke RS, Heinroth K, Muller-Werdan U (2009) Impaired regulation of cardiac function in sepsis, SIRS, and MODS. Can J Physiol Pharmacol 87:266&#x2013;274</Citation><ArticleIdList><ArticleId IdType="pubmed">19370080</ArticleId></ArticleIdList></Reference><Reference><Citation>Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M (1996) Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 27:270&#x2013;276</Citation><ArticleIdList><ArticleId IdType="pubmed">8557893</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz A, Bourassa MG, Guertin MC, Tardif JC (2005) Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 26:967&#x2013;974</Citation><ArticleIdList><ArticleId IdType="pubmed">15774493</ArticleId></ArticleIdList></Reference><Reference><Citation>Disegni E, Goldbourt U, Reicher-Reiss H, Kaplinsky E, Zion M, Boyko V, Behar S (1995) The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT study group. Secondary prevention reinfarction Israeli Nifedipine trial. J Clin Epidemiol 48:1197&#x2013;1205</Citation><ArticleIdList><ArticleId IdType="pubmed">7561981</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M, Schoenberger JA, Lindberg HA (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736&#x2013;749</Citation><ArticleIdList><ArticleId IdType="pubmed">7457467</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Schupp E, Bunnell E, Ali A, Milcarek B, Parrillo JE (2008) Cardiovascular response to dobutamine stress predicts outcome in severe sepsis and septic shock. Crit Care 12:R35</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2447556</ArticleId><ArticleId IdType="pubmed">18318900</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Donati A, Ertmer C, Rehberg S, Kampmeier T, Orecchioni A, D&#x2019;Egidio A, Cecchini V, Landoni G, Pietropaoli P, Westphal M, Venditti M, Mebazaa A, Singer M (2013) Microvascular effects of heart rate control with esmolol in patients with septic shock: a pilot study. Crit Care Med 41:2162&#x2013;2168</Citation><ArticleIdList><ArticleId IdType="pubmed">23873274</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang X, Wang K, Xu J, Gong S, Ye Y, Chen K, Lian F, Chen W, Yu R (2016) The effect of esmolol on tissue perfusion and clinical prognosis of patients with severe sepsis: a prospective cohort study. Biomed Res Int 2016:1038034</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5019858</ArticleId><ArticleId IdType="pubmed">27652257</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Y, Jingyi W, Xiaogan J, Weihua L, Xiaoju J (2015) Effect of esmolol on fluid responsiveness and hemodynamic parameters in patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27:885&#x2013;889</Citation><ArticleIdList><ArticleId IdType="pubmed">27132454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Li M, Duan J, Yi L, Huang X, Chen D, Li G (2017) Effect of esmolol on hemodynamics and clinical outcomes in patients with septic shock. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 29:390&#x2013;395</Citation><ArticleIdList><ArticleId IdType="pubmed">28524025</ArticleId></ArticleIdList></Reference><Reference><Citation>Aboab J, Sebille V, Jourdain M, Mangalaboyi J, Gharbi M, Mansart A, Annane D (2011) Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med 37:1344&#x2013;1351</Citation><ArticleIdList><ArticleId IdType="pubmed">21567116</ArticleId></ArticleIdList></Reference><Reference><Citation>Balik M, Rulisek J, Leden P, Zakharchenko M, Otahal M, Bartakova H, Korinek J (2012) Concomitant use of beta-1 adrenoreceptor blocker and norepinephrine in patients with septic shock. Wien Klin Wochenschr 124:552&#x2013;556</Citation><ArticleIdList><ArticleId IdType="pubmed">22815003</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JX, Sun J, Liu YY, Jia BH (2013) Effects of adrenergic beta-1 antagonists on hemodynamics of severe septic patients. Zhonghua Yi Xue Za Zhi 93:1243&#x2013;1246</Citation><ArticleIdList><ArticleId IdType="pubmed">23902616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimmoun A, Louis H, Al Kattani N, Delemazure J, Dessales N, Wei C, Marie PY, Issa K, Levy B (2015) beta1-adrenergic inhibition improves cardiac and vascular function in experimental septic shock. Crit Care Med 43:e332-340</Citation><ArticleIdList><ArticleId IdType="pubmed">25962080</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki T, Morisaki H, Serita R, Yamamoto M, Kotake Y, Ishizaka A, Takeda J (2005) Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 33:2294&#x2013;2301</Citation><ArticleIdList><ArticleId IdType="pubmed">16215384</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Wu Q, Nie X, Guo J, Yang C (2015) Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial. Clin Drug Investig 35:707&#x2013;716</Citation><ArticleIdList><ArticleId IdType="pubmed">26387030</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, Louis H, Schmitt M, Albuisson E, Orlowski S, Levy B, Kimmoun A (2016) Effects of low doses of esmolol on cardiac and vascular function in experimental septic shock. Crit Care 20:407</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5175382</ArticleId><ArticleId IdType="pubmed">27998289</ArticleId></ArticleIdList></Reference><Reference><Citation>Xinqiang L, Weiping H, Miaoyun W, Wenxin Z, Wenqiang J, Shenglong C, Juhao Z, Hongki Z (2015) Esmolol improves clinical outcome and tissue oxygen metabolism in patients with septic shock through controlling heart rate. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 27:759&#x2013;763</Citation><ArticleIdList><ArticleId IdType="pubmed">26955704</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Liu Z, Yang W, Zhang G, Hou B, Liu J, Shi Q (2014) Effects of the beta-blockers on cardiac protection and hemodynamics in patients with septic shock: a prospective study. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26:714&#x2013;717</Citation><ArticleIdList><ArticleId IdType="pubmed">25315942</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuding S, Schroder J, Presek P, Wienke A, Muller-Werdan U, Ebelt H, Werdan K (2018) Reducing elevated heart rates in patients with multiple organ dysfunction syndrome with the if (funny channel current) inhibitor ivabradine. Shock 49:402&#x2013;411</Citation><ArticleIdList><ArticleId IdType="pubmed">28930912</ArticleId></ArticleIdList></Reference><Reference><Citation>Khataminia M, Najmeddin F, Najafi A, Sharifnia H, Ahmadi A, Sahebnasagh A, Mojtahedzadeh M (2021) Effect of heart rate control with amiodarone infusion on hemodynamic and clinical outcomes in septic shock patients with tachycardia: a prospective, single-arm clinical study. J Pharm Health Care Sci 7:37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8504122</ArticleId><ArticleId IdType="pubmed">34629112</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Evans SR, Winter MR, Benjamin EJ (2016) Practice patterns and outcomes of treatments for atrial fibrillation during sepsis: a propensity-matched cohort study. Chest 149:74&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944768</ArticleId><ArticleId IdType="pubmed">26270396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo MJ, Chou RH, Lu YW, Guo JY, Tsai YL, Wu CH, Huang PH, Lin SJ (2021) Premorbid beta1-selective (but not non-selective) beta-blocker exposure reduces intensive care unit mortality among septic patients. J Intensive Care 9:40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8116825</ArticleId><ArticleId IdType="pubmed">33985572</ArticleId></ArticleIdList></Reference><Reference><Citation>Summary of Product Characteristics (2022) Rapibloc 300 mg powder for solution for infusion. AOP Orphan Ltd. Available at https://www.medicines.org.uk/emc/. Last updated on 23 Jun 2022</Citation></Reference><Reference><Citation>Summary of Product Characteristics (2010) Esmolol hydrochloride 2500 Mg powder for concentrate for solution for infusion. AOP Orphan Ltd. Available at https://www.medicines.org.uk/emc/. Last updated on 30 Sep 2019</Citation></Reference><Reference><Citation>Ikeshita K, Nishikawa K, Toriyama S, Yamashita T, Tani Y, Yamada T, Asada A (2008) Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts. J Anesth 22:361&#x2013;366</Citation><ArticleIdList><ArticleId IdType="pubmed">19011773</ArticleId></ArticleIdList></Reference><Reference><Citation>Muraki K, Nakagawa H, Nagano N, Henmi S, Kawasumi H, Nakanishi T, Imaizumi K, Tokuno T, Atsuki K, Imaizumi Y, Watanabe M (1996) Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther 278:555&#x2013;563</Citation><ArticleIdList><ArticleId IdType="pubmed">8768704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama A, Takahara A, Hashimoto K (1999) Electrophysiologic, cardiohemodynamic and beta-blocking actions of a new ultra-short-acting beta-blocker, ONO-1101, assessed by the in vivo canine model in comparison with esmolol. J Cardiovasc Pharmacol 34:70&#x2013;77</Citation><ArticleIdList><ArticleId IdType="pubmed">10413070</ArticleId></ArticleIdList></Reference><Reference><Citation>Plosker GL (2013) Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias. Drugs 73:959&#x2013;977</Citation><ArticleIdList><ArticleId IdType="pubmed">23760735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakihana Y, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Morishima E, Matsuda N, Group JLSS (2020) Efficacy and safety of landiolol, an ultra-short-acting beta1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial. Lancet Respir Med. 8:863&#x2013;872</Citation><ArticleIdList><ArticleId IdType="pubmed">32243865</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitehouse T, Hossain A, Perkins GD, Gordon AC, Bion J, Young D, McAuley D, Singer M, Lord J, Gates S, Veenith T, MacCallum NS, Yeung J, Innes R, Welters I, Boota N, Skilton E, Ghuman B, Hill M, Regan SE, Mistry D, Lall R, Collaborators S-L (2023) Landiolol and organ failure in patients with septic shock: the STRESS-L randomized clinical trial. JAMA 330:1641&#x2013;1652</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10600724</ArticleId><ArticleId IdType="pubmed">37877587</ArticleId></ArticleIdList></Reference><Reference><Citation>Unger M, Morelli A, Singer M, Radermacher P, Rehberg S, Trimmel H, Joannidis M, Heinz G, Cerny V, Dostal P, Siebers C, Guarracino F, Pratesi F, Biancofiore G, Girardis M, Kadlecova P, Bouvet O, Zorer M, Grohmann-Izay B, Krejcy K, Klade C, Krumpl G (2018) Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized-controlled trial. Trials 19:637</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245811</ArticleId><ArticleId IdType="pubmed">30454042</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudiger A, Singer M (2016) Decatecholaminisation during sepsis. Crit Care 20:309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5048664</ArticleId><ArticleId IdType="pubmed">27716402</ArticleId></ArticleIdList></Reference><Reference><Citation>Goradia S, Sardaneh AA, Narayan SW, Penm J, Patanwala AE (2021) Vasopressor dose equivalence: a scoping review and suggested formula. J Crit Care 61:233&#x2013;240</Citation><ArticleIdList><ArticleId IdType="pubmed">33220576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantzarlis K, Vazgiourakis V, Makris D (2024) Use of landiolol for patients with septic shock and organ failure. JAMA 331:705</Citation><ArticleIdList><ArticleId IdType="pubmed">38411653</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, Angus DC, Rubenfeld GD, Singer M, Sepsis Definitions Task F (2016) Developing a new definition and assessing new clinical criteria for septic shock: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:775&#x2013;787</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D (2020) Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care 24:239</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda N, Nishida O, Taniguchi T, Okajima M, Morimatsu H, Ogura H, Yamada Y, Nagano T, Ichikawa A, Kakihana Y, Group JLSS (2020) Impact of patient characteristics on the efficacy and safety of landiolol in patients with sepsis-related tachyarrhythmia: Subanalysis of the J-Land 3S randomised controlled study. EClinicalMedicine 28:100571</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7700908</ArticleId><ArticleId IdType="pubmed">33294804</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs C, Wauschkuhn S, Scheer C, Vollmer M, Meissner K, Kuhn SO, Hahnenkamp K, Morelli A, Grundling M, Rehberg S (2017) Continuing chronic beta-blockade in the acute phase of severe sepsis and septic shock is associated with decreased mortality rates up to 90 days. Br J Anaesth 119:616&#x2013;625</Citation><ArticleIdList><ArticleId IdType="pubmed">29121280</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Romano SM, Sanfilippo F, Santonocito C, Frati G, Chiostri M, Agro FE, Ertmer C, Rehberg SW, Vieillard-Baron A (2020) Systolic-dicrotic notch pressure difference can identify tachycardic patients with septic shock at risk of cardiovascular decompensation following pharmacological heart rate reduction. Br J Anaesth 125:1018&#x2013;1024</Citation><ArticleIdList><ArticleId IdType="pubmed">32690246</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30365341</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>13</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>199</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial.</ArticleTitle><Pagination><StartPage>980</StartPage><EndPage>986</EndPage><MedlinePgn>980-986</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201807-1419OC</ELocationID><Abstract><AbstractText Label="RATIONALE">There remains uncertainty about the role of corticosteroids in sepsis with clear beneficial effects on shock duration, but conflicting survival effects. Two transcriptomic sepsis response signatures (SRSs) have been identified. SRS1 is relatively immunosuppressed, whereas SRS2 is relatively immunocompetent.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to categorize patients based on SRS endotypes to determine if these profiles influenced response to either norepinephrine or vasopressin, or to corticosteroids in septic shock.</AbstractText><AbstractText Label="METHODS">A post hoc analysis was performed of a double-blind, randomized clinical trial in septic shock (VANISH [Vasopressin vs. Norepinephrine as Initial Therapy in Septic Shock]). Patients were included within 6 hours of onset of shock and were randomized to receive norepinephrine or vasopressin followed by hydrocortisone or placebo. Genome-wide gene expression profiling was performed and SRS endotype was determined by a previously established model using seven discriminant genes.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Samples were available from 176 patients: 83 SRS1 and 93 SRS2. There was no significant interaction between SRS group and vasopressor assignment (P&#x2009;=&#x2009;0.50). However, there was an interaction between assignment to hydrocortisone or placebo, and SRS endotype (P&#x2009;=&#x2009;0.02). Hydrocortisone use was associated with increased mortality in those with an SRS2 phenotype (odds ratio&#x2009;=&#x2009;7.9; 95% confidence interval&#x2009;=&#x2009;1.6-39.9).</AbstractText><AbstractText Label="CONCLUSIONS">Transcriptomic profile at onset of septic shock was associated with response to corticosteroids. Those with the immunocompetent SRS2 endotype had significantly higher mortality when given corticosteroids compared with placebo. Clinical trial registered with www.clinicaltrials.gov (ISRCTN 20769191).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antcliffe</LastName><ForeName>David B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0002-1846-9160</Identifier><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burnham</LastName><ForeName>Katie L</ForeName><Initials>KL</Initials><Identifier Source="ORCID">0000-0001-8680-2933</Identifier><AffiliationInfo><Affiliation>3 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Beidh</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santhakumaran</LastName><ForeName>Shalini</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0988-9339</Identifier><AffiliationInfo><Affiliation>4 Imperial Clinical Trials Unit, Faculty of Medicine, Imperial College London, London, United Kingdom; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0003-4545-8413</Identifier><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hinds</LastName><ForeName>Charles J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>5 Intensive Care Unit, Barts and the London, Queen Mary School of Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashby</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-3146-7466</Identifier><AffiliationInfo><Affiliation>4 Imperial Clinical Trials Unit, Faculty of Medicine, Imperial College London, London, United Kingdom; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Julian C</ForeName><Initials>JC</Initials><Identifier Source="ORCID">0000-0002-0377-5536</Identifier><AffiliationInfo><Affiliation>3 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0002-0419-547X</Identifier><AffiliationInfo><Affiliation>1 Section of Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>2 Centre for Perioperative and Critical Care Research, Imperial College Healthcare National Health Service Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR/CS/009/007</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204969/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>090532/Z/09/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2019 Apr 15;199(8):936-938. doi: 10.1164/rccm.201811-2148ED.</RefSource><PMID Version="1">30540491</PMID></CommentsCorrections><CommentsCorrections RefType="ErratumIn"><RefSource>Am J Respir Crit Care Med. 2022 Dec 15;206(12):1572-1573. doi: 10.1164/rccm.v206erratum10.</RefSource><PMID Version="1">36519797</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="Y">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007121" MajorTopicYN="N">Immunocompetence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">corticosteroids</Keyword><Keyword MajorTopicYN="N">norepinephrine</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30365341</ArticleId><ArticleId IdType="pmc">PMC6467319</ArticleId><ArticleId IdType="doi">10.1164/rccm.201807-1419OC</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al. ADRENAL Trial Investigators and the Australian&#x2013;New Zealand Intensive Care Society Clinical Trials Group. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378:797&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">29347874</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot J-P, Siami S, et al. CRICS-TRIGGERSEP Network. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378:809&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId></ArticleIdList></Reference><Reference><Citation>Davenport EE, Burnham KL, Radhakrishnan J, Humburg P, Hutton P, Mills TC, et al. Genomic landscape of the individual host response and outcomes in sepsis: a prospective cohort study. Lancet Respir Med. 2016;4:259&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4820667</ArticleId><ArticleId IdType="pubmed">26917434</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnham KL, Davenport EE, Radhakrishnan J, Humburg P, Gordon AC, Hutton P, et al. Shared and distinct aspects of the sepsis transcriptomic response to fecal peritonitis and pneumonia. Am J Respir Crit Care Med. 2017;196:328&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5549866</ArticleId><ArticleId IdType="pubmed">28036233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. VANISH Investigators. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Ashby D, Brett SJ. Protocol for a randomised controlled trial of vasopressin versus noradrenaline as initial therapy in septic shock (VANISH) BMJ Open. 2014;4:e005866.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4091463</ArticleId><ArticleId IdType="pubmed">24993769</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, et al. CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR, Snell EJ. Analysis of binary data. 2nd ed. London: Chapman &amp; Hall; 1989.</Citation></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42:1325&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Tulzo Y, Pangault C, Amiot L, Guilloux V, Tribut O, Arvieux C, et al. Monocyte human leukocyte antigen-DR transcriptional downregulation by cortisol during septic shock. Am J Respir Crit Care Med. 2004;169:1144&#x2013;1151.</Citation><ArticleIdList><ArticleId IdType="pubmed">15028560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim TK, Chen GH, McDonald RA, Toews GB. Granulocyte-macrophage colony&#x2013;stimulating factor overrides the immunosuppressive function of corticosteroids on rat pulmonary dendritic cells. Stem Cells. 1996;14:292&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">8724695</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Garde MDB, Martinez FO, Melgert BN, Hylkema MN, Jonkers RE, Hamann J. Chronic exposure to glucocorticoids shapes gene expression and modulates innate and adaptive activation pathways in macrophages with distinct changes in leukocyte attraction. J Immunol. 2014;192:1196&#x2013;1208.</Citation><ArticleIdList><ArticleId IdType="pubmed">24395918</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung DYM, Bloom JW. Update on glucocorticoid action and resistance. J Allergy Clin Immunol. 2003;111:3&#x2013;22, quiz 23.</Citation><ArticleIdList><ArticleId IdType="pubmed">12532089</ArticleId></ArticleIdList></Reference><Reference><Citation>Olnes MJ, Kotliarov Y, Biancotto A, Cheung F, Chen J, Shi R, et al. CHI Consortium. Corrigendum: effects of systemically administered hydrocortisone on the human immunome. Sci Rep. 2016;6:25215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855172</ArticleId><ArticleId IdType="pubmed">27141995</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway Morris A, Datta D, Shankar-Hari M, Stephen J, Weir CJ, Rennie J, et al. Cell-surface signatures of immune dysfunction risk-stratify critically ill patients: INFECT study. Intensive Care Med. 2018;44:627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6006236</ArticleId><ArticleId IdType="pubmed">29915941</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong HR, Cvijanovich NZ, Anas N, Allen GL, Thomas NJ, Bigham MT, et al. Developing a clinically feasible personalized medicine approach to pediatric septic shock. Am J Respir Crit Care Med. 2015;191:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4351580</ArticleId><ArticleId IdType="pubmed">25489881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Azad TD, Donato M, Haynes WA, Perumal TM, Henao R, et al. Unsupervised analysis of transcriptomics in bacterial sepsis across multiple datasets reveals three robust clusters. Crit Care Med. 2018;46:915&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953807</ArticleId><ArticleId IdType="pubmed">29537985</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21982521</PMID><DateCompleted><Year>2011</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>378</Volume><Issue>9800</Issue><PubDate><Year>2011</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>1396</StartPage><EndPage>1407</EndPage><MedlinePgn>1396-407</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(11)61381-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Preoperative anaemia is associated with adverse outcomes after cardiac surgery but outcomes after non-cardiac surgery are not well established. We aimed to assess the effect of preoperative anaemia on 30-day postoperative morbidity and mortality in patients undergoing major non-cardiac surgery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analysed data for patients undergoing major non-cardiac surgery in 2008 from The American College of Surgeons' National Surgical Quality Improvement Program database (a prospective validated outcomes registry from 211 hospitals worldwide in 2008). We obtained anonymised data for 30-day mortality and morbidity (cardiac, respiratory, CNS, urinary tract, wound, sepsis, and venous thromboembolism outcomes), demographics, and preoperative and perioperative risk factors. We used multivariate logistic regression to assess the adjusted and modified (nine predefined risk factor subgroups) effect of anaemia, which was defined as mild (haematocrit concentration &gt;29-&lt;39% in men and &gt;29-&lt;36% in women) or moderate-to-severe (&#x2264;29% in men and women) on postoperative outcomes.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We obtained data for 227,425 patients, of whom 69,229 (30&#xb7;44%) had preoperative anaemia. After adjustment, postoperative mortality at 30 days was higher in patients with anaemia than in those without anaemia (odds ratio [OR] 1&#xb7;42, 95% CI 1&#xb7;31-1&#xb7;54); this difference was consistent in mild anaemia (1&#xb7;41, 1&#xb7;30-1&#xb7;53) and moderate-to-severe anaemia (1&#xb7;44, 1&#xb7;29-1&#xb7;60). Composite postoperative morbidity at 30 days was also higher in patients with anaemia than in those without anaemia (adjusted OR 1&#xb7;35, 1&#xb7;30-1&#xb7;40), again consistent in patients with mild anaemia (1&#xb7;31, 1&#xb7;26-1&#xb7;36) and moderate-to-severe anaemia (1&#xb7;56, 1&#xb7;47-1&#xb7;66). When compared with patients without anaemia or a defined risk factor, patients with anaemia and most risk factors had a higher adjusted OR for 30-day mortality and morbidity than did patients with either anaemia or the risk factor alone.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Preoperative anaemia, even to a mild degree, is independently associated with an increased risk of 30-day morbidity and mortality in patients undergoing major non-cardiac surgery.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Vifor Pharma.</AbstractText><CopyrightInformation>Copyright &#xa9; 2011 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Musallam</LastName><ForeName>Khaled M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamim</LastName><ForeName>Hani M</ForeName><Initials>HM</Initials></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Toby</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Spahn</LastName><ForeName>Donat R</ForeName><Initials>DR</Initials></Author><Author ValidYN="Y"><LastName>Rosendaal</LastName><ForeName>Frits R</ForeName><Initials>FR</Initials></Author><Author ValidYN="Y"><LastName>Habbal</LastName><ForeName>Aida</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Khreiss</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dahdaleh</LastName><ForeName>Fadi S</ForeName><Initials>FS</Initials></Author><Author ValidYN="Y"><LastName>Khavandi</LastName><ForeName>Kaivan</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Sfeir</LastName><ForeName>Pierre M</ForeName><Initials>PM</Initials></Author><Author ValidYN="Y"><LastName>Soweid</LastName><ForeName>Assaad</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Hoballah</LastName><ForeName>Jamal J</ForeName><Initials>JJ</Initials></Author><Author ValidYN="Y"><LastName>Taher</LastName><ForeName>Ali T</ForeName><Initials>AT</Initials></Author><Author ValidYN="Y"><LastName>Jamali</LastName><ForeName>Faek R</ForeName><Initials>FR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2011 Oct 15;378(9800):1362-3. doi: 10.1016/S0140-6736(11)61552-3.</RefSource><PMID Version="1">21982518</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2012 Apr 7;379(9823):1298-9; author reply 1299-300. doi: 10.1016/S0140-6736(12)60554-6.</RefSource><PMID Version="1">22483028</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2012 Apr 7;379(9823):1299; author reply 1299-300. doi: 10.1016/S0140-6736(12)60555-8.</RefSource><PMID Version="1">22483030</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006400" MajorTopicYN="N">Hematocrit</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>10</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21982521</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(11)61381-0</ArticleId><ArticleId IdType="pii">S0140-6736(11)61381-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28577069</PMID><DateCompleted><Year>2018</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.</ArticleTitle><Pagination><StartPage>730</StartPage><EndPage>749</EndPage><MedlinePgn>730-749</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-017-4832-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute kidney injury (AKI) in the intensive care unit is associated with significant mortality and morbidity.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine and update previous recommendations for the prevention of AKI, specifically the role of fluids, diuretics, inotropes, vasopressors/vasodilators, hormonal and nutritional interventions, sedatives, statins, remote ischaemic preconditioning and care bundles.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A systematic search of the literature was performed for studies published between 1966 and March 2017 using these potential protective strategies in adult patients at risk of AKI. The following clinical conditions were considered: major surgery, critical illness, sepsis, shock, exposure to potentially nephrotoxic drugs and radiocontrast. Clinical endpoints included incidence or grade of AKI, the need for renal replacement therapy and mortality. Studies were graded according to the international GRADE system.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We formulated 12 recommendations, 13 suggestions and seven best practice statements. The few strong recommendations with high-level evidence are mostly against the intervention in question (starches, low-dose dopamine, statins in cardiac surgery). Strong recommendations with lower-level evidence include controlled fluid resuscitation with crystalloids, avoiding fluid overload, titration of norepinephrine to a target MAP of 65-70&#xa0;mmHg (unless chronic hypertension) and not using diuretics or levosimendan for kidney protection solely.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of recent randomised controlled trials have allowed the formulation of new recommendations and/or increase the strength of previous recommendations. On the other hand, in many domains the available evidence remains insufficient, resulting from the limited quality of the clinical trials and the poor reporting of kidney outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6996-0881</Identifier><AffiliationInfo><Affiliation>Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Anichstasse 35, 6020, Innsbruck, Austria. michael.joannidis@i-med.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Druml</LastName><ForeName>W</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, University Hospital Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forni</LastName><ForeName>L G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, University of Surrey and Surrey Perioperative Anaesthesia and Critical Care Collaborative Research Group (SPACeR), Intensive Care Unit, Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, GU2 7XX, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Groeneveld</LastName><ForeName>A B J</ForeName><Initials>ABJ</Initials></Author><Author ValidYN="Y"><LastName>Honore</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoste</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Critical Care and Nephrology, Guy's and St Thomas' Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oudemans-van Straaten</LastName><ForeName>H M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Adult Intensive Care, VU University Medical Centre, De Boelelaan 1118, 1081 HZ, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schetz</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Department and Laboratory of Intensive Care Medicine, Division of Cellular and Molecular Medicine, KU Leuven University, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005060" MajorTopicYN="N">Europe</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Prevention</Keyword><Keyword MajorTopicYN="N">Recommendations</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Vasopressors</Keyword><Keyword MajorTopicYN="N">Volume expansion</Keyword></KeywordList><CoiStatement>MJ has received honoraria or research support from Baxter Healthcare Corp, AM-Pharma, CLS Behring, Fresenius and Astute Medical. WD declares no conflicts of interest. LF has received honoraria and research support from Astute Medical, Fresenius, Baxter Gambro Renal and Orthoclinical Diagnostics. PH had received research grants from Baxter, AM Pharma, Bellco, and Pfizer EH received speaker&#x2019;s fees from Alexion and Astute Medical, and a research grant from Bellco. MO has received honoraria and research funding from Fresenius Medical Care and Baxter Gambro. HO has financial congress support from Dirinco (Netherlands) and speaker&#x2019;s honoraria from Fresenius and Gambro/Baxter. MS declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28577069</ArticleId><ArticleId IdType="pmc">PMC5487598</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-4832-y</ArticleId><ArticleId IdType="pii">10.1007/s00134-017-4832-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chertow GM, Burdick E, Honour M. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365&#x2013;3370. doi: 10.1681/ASN.2004090740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2004090740</ArticleId><ArticleId IdType="pubmed">16177006</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1&#x2013;138. doi: 10.1038/kisup.2012.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/kisup.2012.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane-Gill SL, Sileanu FE, Murugan R, Trietley GS, Handler SM, Kellum JA. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis. 2015;65:860&#x2013;869. doi: 10.1053/j.ajkd.2014.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.10.018</ArticleId><ArticleId IdType="pmc">PMC4442750</ArticleId><ArticleId IdType="pubmed">25488106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan CJ, Blunden MJ, Dobbie H, James A, Nedungadi A, Prowle JR. Critically ill patients requiring acute renal replacement therapy are at an increased risk of long-term renal dysfunction, but rarely receive specialist nephrology follow-up. Nephron. 2015;129:164&#x2013;170. doi: 10.1159/000371448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371448</ArticleId><ArticleId IdType="pubmed">25765730</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Metnitz B, Bauer P, Schusterschitz N, Moreno R, Druml W, Metnitz PG. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med. 2009;35:1692&#x2013;1702. doi: 10.1007/s00134-009-1530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1530-4</ArticleId><ArticleId IdType="pubmed">19547955</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;1423. doi: 10.1007/s00134-015-3934-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3934-7</ArticleId><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccinni P, Cruz DN, Gramaticopolo S, Garzotto F, Dal Santo M, Aneloni G, Rocco M, Alessandri E, Giunta F, Michetti V, Iannuzzi M, Belluomo Anello C, Brienza N, Carlini M, Pelaia P, Gabbanelli V, Ronco C, Investigators N. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT) Minerva Anestesiol. 2011;77:1072&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">21597441</ArticleId></ArticleIdList></Reference><Reference><Citation>Srisawat N, Sileanu FE, Murugan R, Bellomod R, Calzavacca P, Cartin-Ceba R, Cruz D, Finn J, Hoste EE, Kashani K, Ronco C, Webb S, Kellum JA, Acute Kidney Injury-6 Study Group Variation in risk and mortality of acute kidney injury in critically ill patients: a multicenter study. Am J Nephrol. 2015;41:81&#x2013;88. doi: 10.1159/000371748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000371748</ArticleId><ArticleId IdType="pubmed">25677982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell S, Dekker FW, Vadiveloo T, Marwick C, Deshmukh H, Donnan PT, Van Diepen M. Risk of postoperative acute kidney injury in patients undergoing orthopaedic surgery&#x2013;development and validation of a risk score and effect of acute kidney injury on survival: observational cohort study. BMJ. 2015;351:h5639. doi: 10.1136/bmj.h5639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.h5639</ArticleId><ArticleId IdType="pmc">PMC4641433</ArticleId><ArticleId IdType="pubmed">26561522</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Druml W, Forni LG, Groeneveld AB, Honore P, Oudemans-van Straaten HM, Ronco C, Schetz MR, Woittiez AJ, Critical Care Nephrology Working Group of the European Society of Intensive Care Medicine Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med. 2010;36:392&#x2013;411. doi: 10.1007/s00134-009-1678-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1678-y</ArticleId><ArticleId IdType="pubmed">19921152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichai C, Vinsonneau C, Souweine B, Armando F, Canet E, Clec&#x2019;h C, Constantin JM, Darmon M, Duranteau J, Gaillot T, Garnier A, Jacob L, Joannes-Boyau O, Juillard L, Journois D, Lautrette A, Muller L, Legrand M, Lerolle N, Rimmele T, Rondeau E, Tamion F, Walrave Y, Velly L, Soci&#xe9;t&#xe9; fran&#xe7;aise d&#x2019;anesth&#xe9;sie et de r&#xe9;animation (Sfar) Soci&#xe9;t&#xe9; de r&#xe9;animation de langue fran&#xe7;aise (SRLF) Groupe francophone de r&#xe9;animation et urgences p&#xe9;diatriques (GFRUP) Soci&#xe9;t&#xe9; fran&#xe7;aise de n&#xe9;phrologie (SFN) Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies) Ann Intensive Care. 2016;6:48. doi: 10.1186/s13613-016-0145-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-016-0145-5</ArticleId><ArticleId IdType="pmc">PMC4882312</ArticleId><ArticleId IdType="pubmed">27230984</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schunemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;926. doi: 10.1136/bmj.39489.470347.AD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, Alderson P, Glasziou P, Falck-Ytter Y, Schunemann HJ. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64:395&#x2013;400. doi: 10.1016/j.jclinepi.2010.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.09.012</ArticleId><ArticleId IdType="pubmed">21194891</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Schunemann HJ, Djulbegovic B, Akl EA. Guideline panels should not GRADE good practice statements. J Clin Epidemiol. 2015;68:597&#x2013;600. doi: 10.1016/j.jclinepi.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2014.12.011</ArticleId><ArticleId IdType="pubmed">25660962</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M, Takala J, Sprung C, Cantraine F. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med. 2000;26:915&#x2013;921. doi: 10.1007/s001340051281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051281</ArticleId><ArticleId IdType="pubmed">10990106</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerin C, Girard R, Selli JM, Perdrix JP, Ayzac L. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Rhone-Alpes Area Study Group on Acute Renal Failure. Am J Respir Crit Care Med. 2000;161:872&#x2013;879. doi: 10.1164/ajrccm.161.3.9809066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.3.9809066</ArticleId><ArticleId IdType="pubmed">10712336</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwilk B, Wiedeck H, Stein B, Reinelt H, Treiber H, Bothner U. Epidemiology of acute renal failure and outcome of haemodiafiltration in intensive care. Intensive Care Med. 1997;23:1204&#x2013;1211. doi: 10.1007/s001340050487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050487</ArticleId><ArticleId IdType="pubmed">9470074</ArticleId></ArticleIdList></Reference><Reference><Citation>Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D&#x2019;Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol. 2008;3:962&#x2013;967. doi: 10.2215/CJN.04971107.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.04971107</ArticleId><ArticleId IdType="pmc">PMC2440262</ArticleId><ArticleId IdType="pubmed">18354074</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M. Drug-induced renal failure in the ICU. Int J Artif Organs. 2004;27:1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">15645613</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304&#x2013;377. doi: 10.1007/s00134-017-4683-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37&#x2013;47. doi: 10.1038/nrneph.2013.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2013.232</ArticleId><ArticleId IdType="pubmed">24217464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostermann M, Straaten HM, Forni LG. Fluid overload and acute kidney injury: cause or consequence? Crit Care. 2015;19:443. doi: 10.1186/s13054-015-1163-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1163-7</ArticleId><ArticleId IdType="pmc">PMC4699346</ArticleId><ArticleId IdType="pubmed">26707872</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC, ProCESS and ProGReSS-AKI Investigators The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281&#x2013;287. doi: 10.1164/rccm.201505-0995OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201505-0995OC</ArticleId><ArticleId IdType="pmc">PMC4803059</ArticleId><ArticleId IdType="pubmed">26398704</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and Plasma-lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18&#x2013;24. doi: 10.1097/SLA.0b013e318256be72.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318256be72</ArticleId><ArticleId IdType="pubmed">22580944</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkes NJ, Woolf R, Mutch M, Mallett SV, Peachey T, Stephens R, Mythen MG. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg. 2001;93:811&#x2013;816. doi: 10.1097/00000539-200110000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000539-200110000-00003</ArticleId><ArticleId IdType="pubmed">11574338</ArticleId></ArticleIdList></Reference><Reference><Citation>Alphonsus CS, Rodseth RN. The endothelial glycocalyx: a review of the vascular barrier. Anaesthesia. 2014;69:777&#x2013;784. doi: 10.1111/anae.12661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.12661</ArticleId><ArticleId IdType="pubmed">24773303</ArticleId></ArticleIdList></Reference><Reference><Citation>Chappell D, Jacob M. Role of the glycocalyx in fluid management: small things matter. Best Pract Res Clin Anaesthesiol. 2014;28:227&#x2013;234. doi: 10.1016/j.bpa.2014.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2014.06.003</ArticleId><ArticleId IdType="pubmed">25208958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Prowle JR, Joannidis M, Young P, Hjortrup PB, Pettil&#xe4; V (2017) Fluid management in acute kidney injury. Intensive Care Med. doi:10.1007/s00134-017-4817-x</Citation><ArticleIdList><ArticleId IdType="pubmed">28470347</ArticleId></ArticleIdList></Reference><Reference><Citation>Horgan KJ, Ottaviano YL, Watson AJ. Acute renal-failure due to mannitol intoxication. Am J Nephrol. 1989;9:106&#x2013;109. doi: 10.1159/000167946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000167946</ArticleId><ArticleId IdType="pubmed">2500855</ArticleId></ArticleIdList></Reference><Reference><Citation>Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med. 1989;87:359&#x2013;360. doi: 10.1016/S0002-9343(89)80171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(89)80171-8</ArticleId><ArticleId IdType="pubmed">2773975</ArticleId></ArticleIdList></Reference><Reference><Citation>Legendre C, Thervet E, Page B, Percheron A, Noel LH, Kreis H. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248&#x2013;249. doi: 10.1016/0140-6736(93)92345-T.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)92345-T</ArticleId><ArticleId IdType="pubmed">7686994</ArticleId></ArticleIdList></Reference><Reference><Citation>Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet. 1996;348:1620&#x2013;1622. doi: 10.1016/S0140-6736(96)07588-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(96)07588-5</ArticleId><ArticleId IdType="pubmed">8961992</ArticleId></ArticleIdList></Reference><Reference><Citation>Skinsnes OK. Gelatin nephrosis; renal tissue changes in man resulting from the intravenous administration of gelatin. Surg Gynecol Obstetri. 1947;85:563&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">20266769</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer R, Harmening U, Rittmeyer O, Zielmann S, Mielck F, Kazmaier S, Kettler D. Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery. Brit J Anaesth. 1997;78:44&#x2013;50. doi: 10.1093/bja/78.1.44.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/78.1.44</ArticleId><ArticleId IdType="pubmed">9059203</ArticleId></ArticleIdList></Reference><Reference><Citation>Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911&#x2013;916. doi: 10.1016/S0140-6736(00)04211-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04211-2</ArticleId><ArticleId IdType="pubmed">11289347</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardel SN, Saunders FM, Allen H, Menezes G, Edwards CM, Ollerenshaw L, Baddeley D, Kennedy A, Ibbotson RM. Reduced quality of clot formation with gelatin-based plasma substitutes. Br J Anaesth. 1998;80:204&#x2013;207. doi: 10.1093/bja/80.2.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/80.2.204</ArticleId><ArticleId IdType="pubmed">9602586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabuchi N, deHaan J, Huet RCGG, Boonstra PW, vanOeveren W. Gelatin use impairs platelet adhesion during cardiac surgery. Thromb Haemostasis. 1995;74:1447&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pubmed">8772218</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurnik BR, Singer F, Groh WC. Case report: dextran-induced acute anuric renal failure. Am J Med Sci. 1991;302:28&#x2013;30. doi: 10.1097/00000441-199107000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-199107000-00007</ArticleId><ArticleId IdType="pubmed">1712152</ArticleId></ArticleIdList></Reference><Reference><Citation>Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanim. 1994;13:301&#x2013;310. doi: 10.1016/S0750-7658(94)80038-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0750-7658(94)80038-3</ArticleId><ArticleId IdType="pubmed">7992937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mailloux L, Swartz CD, Capizzi R, Kim KE, Onesti G, Ramirez O, Brest AN. Acute renal failure after administration of low-molecular weight dextran. N Engl J Med. 1967;277:1113&#x2013;1118. doi: 10.1056/NEJM196711232772103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM196711232772103</ArticleId><ArticleId IdType="pubmed">6054998</ArticleId></ArticleIdList></Reference><Reference><Citation>Messmer KFW. The use of plasma substitutes with special attention to their side-effects. World J Surg. 1987;11:69&#x2013;74. doi: 10.1007/BF01658463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01658463</ArticleId><ArticleId IdType="pubmed">3544523</ArticleId></ArticleIdList></Reference><Reference><Citation>Fliser D, Zurbruggen I, Mutschler E, Bischoff I, Nussberger J, Franek E, Ritz E. Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int. 1999;55:629&#x2013;634. doi: 10.1046/j.1523-1755.1999.00298.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.1999.00298.x</ArticleId><ArticleId IdType="pubmed">9987087</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue M, Okajima K, Itoh K, Ando Y, Watanabe N, Yasaka T, Nagase S, Morino Y. Mechanism of furosemide resistance in analbuminemic rats and hypoalbuminemic patients. Kidney Int. 1987;32(2):198&#x2013;203. doi: 10.1038/ki.1987.192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1987.192</ArticleId><ArticleId IdType="pubmed">3656933</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Dunzendorfer S, Gaioni LU, Zaraca F, Joannidis M. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care. 2010;14:R191. doi: 10.1186/cc9308.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9308</ArticleId><ArticleId IdType="pmc">PMC3219298</ArticleId><ArticleId IdType="pubmed">21029460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Nephroprotective potential of human albumin infusion: a narrative review. Gastroenterol Res Pract. 2015;2015:912839. doi: 10.1155/2015/912839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/912839</ArticleId><ArticleId IdType="pmc">PMC4475554</ArticleId><ArticleId IdType="pubmed">26136776</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247&#x2013;2256. doi: 10.1056/NEJMoa040232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa040232</ArticleId><ArticleId IdType="pubmed">15163774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano AB, Candela-Toha AM, Zamora J, Vera J, Muriel A, Del Rey JM, Liano F. Preoperative hydration with 0.9% normal saline to prevent acute kidney injury after major elective open abdominal surgery: a randomised controlled trial. Eur J Anaesthesiol. 2016;33:436&#x2013;443. doi: 10.1097/EJA.0000000000000421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000421</ArticleId><ArticleId IdType="pubmed">26825017</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group. Scandinavian Critical Care Trials Group Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566&#x2013;1572. doi: 10.1001/jama.2012.13356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.13356</ArticleId><ArticleId IdType="pubmed">23073953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR. Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med. 2014;40:1897&#x2013;1905. doi: 10.1007/s00134-014-3505-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3505-3</ArticleId><ArticleId IdType="pmc">PMC4239799</ArticleId><ArticleId IdType="pubmed">25293535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1) Crit Care. 2013;17:204. doi: 10.1186/cc11454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314:1701&#x2013;1710. doi: 10.1001/jama.2015.12334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.12334</ArticleId><ArticleId IdType="pubmed">26444692</ArticleId></ArticleIdList></Reference><Reference><Citation>Joannidis M, Forni LG. Acute kidney injury: buffered crystalloids or saline in the ICU&#x2014;a SPLIT decision. Nat Rev Nephrol. 2016;12:6&#x2013;8. doi: 10.1038/nrneph.2015.190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.190</ArticleId><ArticleId IdType="pubmed">26592191</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SALT Investigators and the Pragmatic Critical Care Research Group (2017) Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. doi: 10.1164/rccm.201607-1345OC</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443900</ArticleId><ArticleId IdType="pubmed">27749094</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Bellomo R, Devarajan P, Story D, Matalanis G, Reade MC, Bagshaw SM, Seevanayagam N, Seevanayagam S, Doolan L, Buxton B, Dragun D. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: a pilot double-blind, randomized controlled trial. Crit Care Med. 2009;37:39&#x2013;47. doi: 10.1097/CCM.0b013e318193216f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318193216f</ArticleId><ArticleId IdType="pubmed">19112278</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness SP, Parke RL, Bellomo R, Van Haren FM, Bailey M. Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med. 2013;41:1599&#x2013;1607. doi: 10.1097/CCM.0b013e31828a3f99.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828a3f99</ArticleId><ArticleId IdType="pubmed">23685640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristeller JL, Zavorsky GS, Prior JE, Keating DA, Brady MA, Romaldini TA, Hickman TL, Stahl RF. Lack of effectiveness of sodium bicarbonate in preventing kidney injury in patients undergoing cardiac surgery: a randomized controlled trial. Pharmacotherapy. 2013;33:710&#x2013;717. doi: 10.1002/phar.1262.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.1262</ArticleId><ArticleId IdType="pubmed">23553549</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase M, Haase-Fielitz A, Plass M, Kuppe H, Hetzer R, Hannon C, Murray PT, Bailey MJ, Bellomo R, Bagshaw SM. Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial. PLoS Med. 2013;10:e1001426. doi: 10.1371/journal.pmed.1001426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001426</ArticleId><ArticleId IdType="pmc">PMC3627643</ArticleId><ArticleId IdType="pubmed">23610561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Luo MJ, Zhang M, Wu QC, Wan JY. Sodium bicarbonate in the prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis. Crit Care. 2014;18:517. doi: 10.1186/s13054-014-0517-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0517-x</ArticleId><ArticleId IdType="pmc">PMC4177432</ArticleId><ArticleId IdType="pubmed">25212718</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian ML, Hu Y, Yuan J, Zha Y. Efficacy and safety of perioperative sodium bicarbonate therapy for cardiac surgery-associated acute kidney injury: a meta-analysis. J Cardiovasc Pharmacol. 2015;65:130&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pubmed">25264756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Kim HJ, Kim JY, Ahn H, Ahn IM, Choe WJ, Lim CH. Meta-analysis of sodium bicarbonate therapy for prevention of cardiac surgery-associated acute kidney injury. J Cardiothorac Vasc Anesth. 2015;29:1248&#x2013;1256. doi: 10.1053/j.jvca.2015.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.007</ArticleId><ArticleId IdType="pubmed">26119410</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey M, McGuinness S, Haase M, Haase-Fielitz A, Parke R, Hodgson CL, Forbes A, Bagshaw SM, Bellomo R. Sodium bicarbonate and renal function after cardiac surgery: a prospectively planned individual patient meta-analysis. Anesthesiology. 2015;122:294&#x2013;306. doi: 10.1097/ALN.0000000000000547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000547</ArticleId><ArticleId IdType="pubmed">25501691</ArticleId></ArticleIdList></Reference><Reference><Citation>Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA, CHEST Investigators. Australian and New Zealand Intensive Care Society Clinical Trials Group Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367:1901&#x2013;1911. doi: 10.1056/NEJMoa1209759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1209759</ArticleId><ArticleId IdType="pubmed">23075127</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125&#x2013;139. doi: 10.1056/NEJMoa070716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa070716</ArticleId><ArticleId IdType="pubmed">18184958</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group. Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124&#x2013;134. doi: 10.1056/NEJMoa1204242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204242</ArticleId><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S, CHEST Management Committee Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med. 2013;39:558&#x2013;568. doi: 10.1007/s00134-013-2840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2840-0</ArticleId><ArticleId IdType="pubmed">23407978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarychanski R, Abou-Setta AM, Turgeon AF, Houston BL, McIntyre L, Marshall JC, Fergusson DA. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309:678&#x2013;688. doi: 10.1001/jama.2013.430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.430</ArticleId><ArticleId IdType="pubmed">23423413</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochwerg B, Alhazzani W, Gibson A, Ribic CM, Sindi A, Heels-Ansdell D, Thabane L, Fox-Robichaud A, Mbuagbaw L, Szczeklik W, Alshamsi F, Altayyar S, Ip W, Li G, Wang M, Wludarczyk A, Zhou Q, Annane D, Cook DJ, Jaeschke R, Guyatt GH. Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis. Intensive Care Med. 2015;41:1561&#x2013;1571. doi: 10.1007/s00134-015-3794-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3794-1</ArticleId><ArticleId IdType="pubmed">25904181</ArticleId></ArticleIdList></Reference><Reference><Citation>Haase N, Perner A, Hennings LI, Siegemund M, Lauridsen B, Wetterslev M, Wetterslev J. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ. 2013;346:f839. doi: 10.1136/bmj.f839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f839</ArticleId><ArticleId IdType="pmc">PMC3573769</ArticleId><ArticleId IdType="pubmed">23418281</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutter TC, Ruth CA, Dart AB (2013) Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 7:CD007594. doi:10.1002/14651858.CD007594.pub3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11561698</ArticleId><ArticleId IdType="pubmed">23881659</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Perner A, Sprung CL, Jaeschke R, Schortgen F, Johan Groeneveld AB, Beale R, Hartog CS, European Society of Intensive Care Medicine Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients. Intensive Care Med. 2012;38:368&#x2013;383. doi: 10.1007/s00134-012-2472-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2472-9</ArticleId><ArticleId IdType="pubmed">22323076</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeller C, Fleischmann C, Thomas-Rueddel D, Vlasakov V, Rochwerg B, Theurer P, Gattinoni L, Reinhart K, Hartog CS. How safe is gelatin? A systematic review and meta-analysis of gelatin-containing plasma expanders vs crystalloids and albumin. J Crit Care. 2016;35:75&#x2013;83. doi: 10.1016/j.jcrc.2016.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.04.011</ArticleId><ArticleId IdType="pubmed">27481739</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Iapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412&#x2013;1421. doi: 10.1056/NEJMoa1305727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois MJ, Orellana-Jimenez C, Melot C, De Backer D, Berre J, Leeman M, Brimioulle S, Appoloni O, Creteur J, Vincent JL. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med. 2006;34:2536&#x2013;2540. doi: 10.1097/01.CCM.0000239119.57544.0C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000239119.57544.0C</ArticleId><ArticleId IdType="pubmed">16915107</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedermann CJ, Joannidis M. Albumin replacement in severe sepsis or septic shock. N Engl J Med. 2014;371:83. doi: 10.1056/NEJMc1405675.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc1405675</ArticleId><ArticleId IdType="pubmed">24988572</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A, Laffan MA, Waheed U, Brett SJ. Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality. BMJ. 2014;349:g4561. doi: 10.1136/bmj.g4561.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.g4561</ArticleId><ArticleId IdType="pmc">PMC4106199</ArticleId><ArticleId IdType="pubmed">25099709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee EH, Kim WJ, Kim JY, Chin JH, Choi DK, Sim JY, Choo SJ, Chung CH, Lee JW, Choi IC. Effect of exogenous albumin on the incidence of postoperative acute kidney injury in patients undergoing off-pump coronary artery bypass surgery with a preoperative albumin level of less than 4.0&#xa0;g/dl. Anesthesiology. 2016;124:1001&#x2013;1011. doi: 10.1097/ALN.0000000000001051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001051</ArticleId><ArticleId IdType="pubmed">26891150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36:S216&#x2013;223. doi: 10.1097/CCM.0b013e318168e375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168e375</ArticleId><ArticleId IdType="pubmed">18382197</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA, Luciano RL. Review of select causes of drug-induced AKI. Expert Rev Clin Pharmacol. 2015;8(4):367&#x2013;371. doi: 10.1586/17512433.2015.1045489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/17512433.2015.1045489</ArticleId><ArticleId IdType="pubmed">26109096</ArticleId></ArticleIdList></Reference><Reference><Citation>Branch RA. Prevention of amphotericin-B induced renal impairment. A review on the use of sodium supplementation. Arch Intern Med. 1988;148:2389&#x2013;2394. doi: 10.1001/archinte.1988.00380110049010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.1988.00380110049010</ArticleId><ArticleId IdType="pubmed">3056312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung TW, Jayaweera DT, Pearce D, Benson P, Nahass R, Olson C, Wool GM. Safety of oral versus intravenous hydration during induction therapy with intravenous foscarnet in AIDS patients with cytomegalovirus infections. Int J STD AIDS. 2000;11:640&#x2013;647. doi: 10.1258/0956462001914995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/0956462001914995</ArticleId><ArticleId IdType="pubmed">11057934</ArticleId></ArticleIdList></Reference><Reference><Citation>Safrin S, Cherrington J, Jaffe HS. Cidofovir. Review of current and potential clinical uses. Adv Exp Med Biol. 1999;458:111&#x2013;120. doi: 10.1007/978-1-4615-4743-3_10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4615-4743-3_10</ArticleId><ArticleId IdType="pubmed">10549383</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazella MA. Crystal-induced acute renal failure. Am J Med. 1999;106:459&#x2013;465. doi: 10.1016/S0002-9343(99)00041-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(99)00041-8</ArticleId><ArticleId IdType="pubmed">10225250</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon R, Werner C, Mann D, D&#x2019;Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416&#x2013;1420. doi: 10.1056/NEJM199411243312104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199411243312104</ArticleId><ArticleId IdType="pubmed">7969280</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329&#x2013;336. doi: 10.1001/archinte.162.3.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.3.329</ArticleId><ArticleId IdType="pubmed">11822926</ArticleId></ArticleIdList></Reference><Reference><Citation>Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA, 3rd, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004;291:2328&#x2013;2334. doi: 10.1001/jama.291.19.2328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.291.19.2328</ArticleId><ArticleId IdType="pubmed">15150204</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcan EE, Guneri S, Akdeniz B, Akyildiz IZ, Senaslan O, Baris N, Aslan O, Badak O. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J. 2007;154:539&#x2013;544. doi: 10.1016/j.ahj.2007.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2007.05.012</ArticleId><ArticleId IdType="pubmed">17719303</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M, Yamada T, Mine T, Morita T, Tamaki S, Tsukamoto Y, Okuda K, Iwasaki Y, Hori M, Fukunami M. Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. Am J Cardiol. 2007;100:781&#x2013;786. doi: 10.1016/j.amjcard.2007.03.098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2007.03.098</ArticleId><ArticleId IdType="pubmed">17719320</ArticleId></ArticleIdList></Reference><Reference><Citation>Briguori C, Airoldi F, D&#x2019;Andrea D, Bonizzoni E, Morici N, Focaccio A, Michev I, Montorfano M, Carlino M, Cosgrave J, Ricciardelli B, Colombo A. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007;115:1211&#x2013;1217.</Citation><ArticleIdList><ArticleId IdType="pubmed">17309916</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, Ommen VV, Wildberger JE. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet. 2017;389:1312&#x2013;1322. doi: 10.1016/S0140-6736(17)30057-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)30057-0</ArticleId><ArticleId IdType="pubmed">28233565</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. AJR Am J Roentgenol. 2008;191:376&#x2013;382. doi: 10.2214/AJR.07.3280.</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.07.3280</ArticleId><ArticleId IdType="pubmed">18647905</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk of radiocontrast-associated nephropathy. J Am Soc Nephrol. 2017;28:653&#x2013;659. doi: 10.1681/ASN.2016010021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2016010021</ArticleId><ArticleId IdType="pmc">PMC5280012</ArticleId><ArticleId IdType="pubmed">27688297</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med. 2011;37:1921&#x2013;1931. doi: 10.1007/s00134-011-2389-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2389-8</ArticleId><ArticleId IdType="pubmed">22048719</ArticleId></ArticleIdList></Reference><Reference><Citation>Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care. 2012;16:R67. doi: 10.1186/cc11317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11317</ArticleId><ArticleId IdType="pmc">PMC3681396</ArticleId><ArticleId IdType="pubmed">22534554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Badin J, Savath L, Pajot O, Garot D, Pham T, Capdevila X, Perrotin D, Lakhal K. Acute kidney injury in the critically ill: is iodinated contrast medium really harmful? Crit Care Med. 2013;41:1017&#x2013;1026. doi: 10.1097/CCM.0b013e318275871a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318275871a</ArticleId><ArticleId IdType="pubmed">23324952</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald JS, McDonald RJ, Williamson EE, Kallmes DF, Kashani K (2017) Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study. Intensive Care Med. doi:10.1007/s00134-017-4699-y</Citation><ArticleIdList><ArticleId IdType="pubmed">28213620</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, Klein EY (2017) Risk of acute kidney injury after intravenous contrast media administration. Ann Emerg Med 69:577&#x2013;586.e4</Citation><ArticleIdList><ArticleId IdType="pubmed">28131489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS (2017) Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis. Intensive Care Med. doi:10.1007/s00134-017-4700-9</Citation><ArticleIdList><ArticleId IdType="pubmed">28197679</ArticleId></ArticleIdList></Reference><Reference><Citation>Valette X, Desmeulles I, Savary B, Masson R, Seguin A, Sauneuf B, Brunet J, Verrier P, Pottier V, Orabona M, Samba D, Viquesnel G, Lermuzeaux M, Hazera P, Dutheil JJ, Hanouz JL, Parienti JJ, du Cheyron D. Sodium bicarbonate versus sodium chloride for preventing contrast-associated acute kidney injury in critically ill patients: a randomized controlled trial. Crit Care Med. 2017;45:637&#x2013;644. doi: 10.1097/CCM.0000000000002267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002267</ArticleId><ArticleId IdType="pubmed">28181941</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Li H, Chen S, Chen J, Tan N, Zhou Y, Liu Y, Ye P, Ran P, Duan C, Chen P (2016) Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc. doi:10.1161/JAHA.115.003171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4937263</ArticleId><ArticleId IdType="pubmed">27233298</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236&#x2013;249. doi: 10.1159/000102089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000102089</ArticleId><ArticleId IdType="pubmed">17464133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-ischaemic acute renal failure in the rat. Acta Physiol Scand. 1990;139:271&#x2013;279. doi: 10.1111/j.1748-1716.1990.tb08924.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1748-1716.1990.tb08924.x</ArticleId><ArticleId IdType="pubmed">2368616</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyman SN, Rosen S, Epstein FH, Spokes K, Brezis ML. Loop diuretics reduce hypoxic damage to proximal tubules of the isolated perfused rat kidney. Kidney Int. 1994;45:981&#x2013;985. doi: 10.1038/ki.1994.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1994.132</ArticleId><ArticleId IdType="pubmed">8007601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer HJ, Schuurmann J, Wassermann C, Dusing R. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats. Kidney Int. 1980;17:455&#x2013;464. doi: 10.1038/ki.1980.53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.1980.53</ArticleId><ArticleId IdType="pubmed">7392420</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Dupuis C, Simon C, Gayat E, Mateo J, Lukaszewicz AC, Payen D. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care. 2013;17:R278. doi: 10.1186/cc13133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13133</ArticleId><ArticleId IdType="pmc">PMC4056656</ArticleId><ArticleId IdType="pubmed">24289206</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen KP, Cavender S, Lee J, Feng M, Mark RG, Celi LA, Mukamal KJ, Danziger J. Peripheral edema, central venous pressure, and risk of AKI in critical illness. Clinic J Am Soc Nephrol. 2016;11:602&#x2013;608. doi: 10.2215/CJN.08080715.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.08080715</ArticleId><ArticleId IdType="pmc">PMC4822669</ArticleId><ArticleId IdType="pubmed">26787777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YF, Zheng YP, Zhang N, Liu H, Zheng QX, Yang FT, Wu YF. Study on the correlation between the changes in intra-abdominal pressure and renal functional in the patients with abdominal compartment syndrome. Eur Rev Med Pharmacol Sci. 2015;19:3682&#x2013;3687.</Citation><ArticleIdList><ArticleId IdType="pubmed">26502858</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordemans C, De Laet I, Van Regenmortel N, Schoonheydt K, Dits H, Huber W, Malbrain ML. Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. Ann Intensive Care. 2012;2:S1. doi: 10.1186/2110-5820-2-S1-S1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-2-S1-S1</ArticleId><ArticleId IdType="pmc">PMC3390304</ArticleId><ArticleId IdType="pubmed">22873410</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207. doi: 10.1186/cc13015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13015</ArticleId><ArticleId IdType="pmc">PMC4057505</ArticleId><ArticleId IdType="pubmed">24053972</ArticleId></ArticleIdList></Reference><Reference><Citation>National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF, Jr, Hite RD, Harabin AL. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564&#x2013;2575. doi: 10.1056/NEJMoa062200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa062200</ArticleId><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">10616845</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">7011622</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Power BM. Benefits and risks of furosemide in acute kidney injury. Anaesthesia. 2010;65:283&#x2013;293. doi: 10.1111/j.1365-2044.2009.06228.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2044.2009.06228.x</ArticleId><ArticleId IdType="pubmed">20085566</ArticleId></ArticleIdList></Reference><Reference><Citation>Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, Chen HH, Givertz MM, Semigran MJ, Bart BA, Mascette AM, Braunwald E, O&#x2019;Connor CM, NHLBI Heart Failure Clinical Research Network Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011;364:797&#x2013;805. doi: 10.1056/NEJMoa1005419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1005419</ArticleId><ArticleId IdType="pmc">PMC3412356</ArticleId><ArticleId IdType="pubmed">21366472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cotter G, Weissgarten J, Metzkor E, Moshkovitz Y, Litinski I, Tavori U, Perry C, Zaidenstein R, Golik A. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure. Clin Pharmacol Ther. 1997;62:187&#x2013;193. doi: 10.1016/S0009-9236(97)90067-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0009-9236(97)90067-9</ArticleId><ArticleId IdType="pubmed">9284855</ArticleId></ArticleIdList></Reference><Reference><Citation>Hager B, Betschart M, Krapf R. Effect of postoperative intravenous loop diuretic on renal function after major surgery. Schweiz Med Wochenschr. 1996;126:666&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pubmed">8658094</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Voort PHJ, Boerma EC, Koopmans M, Zandberg M, de Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37:533&#x2013;538. doi: 10.1097/CCM.0b013e318195424d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318195424d</ArticleId><ArticleId IdType="pubmed">19114909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahsan N, Palmer BF, Wheeler D, Greenlee RG, Jr, Toto RD. Intravenous immunoglobulin-induced osmotic nephrosis. Arch Intern Med. 1994;154:1985&#x2013;1987. doi: 10.1001/archinte.154.17.1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.154.17.1985</ArticleId><ArticleId IdType="pubmed">8074604</ArticleId></ArticleIdList></Reference><Reference><Citation>Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592&#x2013;2596. doi: 10.1093/ndt/12.12.2592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/12.12.2592</ArticleId><ArticleId IdType="pubmed">9430857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirivella S, Gielchinsky I, Parsonnet V. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery. Ann Thorac Surg. 2000;69:501&#x2013;506. doi: 10.1016/S0003-4975(99)01298-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-4975(99)01298-9</ArticleId><ArticleId IdType="pubmed">10735688</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333:420. doi: 10.1136/bmj.38902.605347.7C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38902.605347.7C</ArticleId><ArticleId IdType="pmc">PMC1553510</ArticleId><ArticleId IdType="pubmed">16861256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007;9:60&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">17352669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampath S, Moran JL, Graham PL, Rockliff S, Bersten AD, Abrams KR. The efficacy of loop diuretics in acute renal failure: assessment using Bayesian evidence synthesis techniques. Crit Care Med. 2007;35:2516&#x2013;2524. doi: 10.1097/01.CCM.0000284503.88148.6F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000284503.88148.6F</ArticleId><ArticleId IdType="pubmed">18084840</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, Mira JP, Dequin PF, Gergaud S, Weiss N, Legay F, Le Tulzo Y, Conrad M, Robert R, Gonzalez F, Guitton C, Tamion F, Tonnelier JM, Guezennec P, Van Der Linden T, Vieillard-Baron A, Mariotte E, Pradel G, Lesieur O, Ricard JD, Herve F, du Cheyron D, Guerin C, Mercat A, Teboul JL, Radermacher P, Investigators S. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;1593. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi AI, Palesch YY, Suarez JI. Intensive blood-pressure lowering in cerebral hemorrhage. N Eng J Med. 2016;375:e48. doi: 10.1056/NEJMoa1603460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603460</ArticleId><ArticleId IdType="pubmed">27959682</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II Investigators Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779&#x2013;789. doi: 10.1056/NEJMoa0907118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0907118</ArticleId><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>Serpa Neto A, Nassar AP, Cardoso SO, Manetta JA, Pereira VG, Esposito DC, Damasceno MC, Russell JA. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials. Crit Care. 2012;16:R154. doi: 10.1186/cc11469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11469</ArticleId><ArticleId IdType="pmc">PMC3580743</ArticleId><ArticleId IdType="pubmed">22889256</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragadottir G, Redfors B, Nygren A, Sellgren J, Ricksten SE. Low-dose vasopressin increases glomerular filtration rate, but impairs renal oxygenation in post-cardiac surgery patients. Acta Anaesthesiol Scand. 2009;53:1052&#x2013;1059. doi: 10.1111/j.1399-6576.2009.02037.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2009.02037.x</ArticleId><ArticleId IdType="pubmed">19572935</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;887. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hebert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ. The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med. 2010;36:83&#x2013;91. doi: 10.1007/s00134-009-1687-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1687-x</ArticleId><ArticleId IdType="pubmed">19841897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ, VANISH Investigators Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518. doi: 10.1001/jama.2016.10485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10485</ArticleId><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, Rhodes A, Landoni G, Osawa EA, Melo RR, Sundin MR, Grande SM, Gaiotto FA, Pomerantzeff PM, Dallan LO, Franco RA, Nakamura RE, Lisboa LA, de Almeida JP, Gerent AM, Souza DH, Gaiane MA, Fukushima JT, Park CL, Zambolim C, Rocha Ferreira GS, Strabelli TM, Fernandes FL, Camara L, Zeferino S, Santos VG, Piccioni MA, Jatene FB, Costa Auler JO, Jr, Filho RK. Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS randomized controlled trial. Anesthesiology. 2017;126:85&#x2013;93. doi: 10.1097/ALN.0000000000001434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001434</ArticleId><ArticleId IdType="pubmed">27841822</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramaswamy D, Corrigan G, Polhemus C, Boothroyd D, Scandling J, Sommer FG, Alfrey E, Higgins J, Deen WM, Olshen R, Myers BD. Maintenance and recovery stages of postischemic acute renal failure in humans. Am J Physiol Renal Physiol. 2002;282:F271&#x2013;F280. doi: 10.1152/ajprenal.0068.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.0068.2001</ArticleId><ArticleId IdType="pubmed">11788441</ArticleId></ArticleIdList></Reference><Reference><Citation>Conger J, Robinette J, Villar A, Raij L, Shultz P. Increased nitric oxide synthase activity despite lack of response to endothelium-dependent vasodilators in postischemic acute renal failure in rats. J Clin Invest. 1995;96:631&#x2013;638. doi: 10.1172/JCI118078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118078</ArticleId><ArticleId IdType="pmc">PMC185238</ArticleId><ArticleId IdType="pubmed">7542287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L, Bagshaw SM, Langenberg C, Saotome T, May C, Bellomo R. Pathophysiology of septic acute kidney injury: what do we really know? Crit Care Med. 2008;36:S198&#x2013;S203. doi: 10.1097/CCM.0b013e318168ccd5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318168ccd5</ArticleId><ArticleId IdType="pubmed">18382194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, May CN, Gobe G, Langenberg C, Bellomo R. Pathophysiology of septic acute kidney injury: a different view of tubular injury. Contrib Nephrol. 2010;165:18&#x2013;27. doi: 10.1159/000313740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000313740</ArticleId><ArticleId IdType="pubmed">20427951</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Bezemer R, Kandil A, Demirci C, Payen D, Ince C. The role of renal hypoperfusion in development of renal microcirculatory dysfunction in endotoxemic rats. Intensive Care Med. 2011;37:1534&#x2013;1542. doi: 10.1007/s00134-011-2267-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2267-4</ArticleId><ArticleId IdType="pmc">PMC3155675</ArticleId><ArticleId IdType="pubmed">21695476</ArticleId></ArticleIdList></Reference><Reference><Citation>Molitoris BA, Sutton TA. Endothelial injury and dysfunction: role in the extension phase of acute renal failure. Kidney Int. 2004;66:496&#x2013;499. doi: 10.1111/j.1523-1755.2004.761_5.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.761_5.x</ArticleId><ArticleId IdType="pubmed">15253696</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauschke A, Teichgraber UKM, Frei U, Eckardt KU. &#x2018;Low-dose&#x2019; dopamine worsens renal perfusion in patients with acute renal failure. Kidney Int. 2006;69:1669&#x2013;1674. doi: 10.1038/sj.ki.5000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5000310</ArticleId><ArticleId IdType="pubmed">16572117</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari N, Herridge MS, Beyene J. Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death. Ann Intern Med. 2005;142:510&#x2013;524. doi: 10.7326/0003-4819-142-7-200504050-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-7-200504050-00010</ArticleId><ArticleId IdType="pubmed">15809463</ArticleId></ArticleIdList></Reference><Reference><Citation>Karthik S, Lisbon A. Low-dose dopamine in the intensive care unit. Semin Dial. 2006;19:465&#x2013;471. doi: 10.1111/j.1525-139X.2006.00208.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2006.00208.x</ArticleId><ArticleId IdType="pubmed">17150046</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest. 2003;123:1266&#x2013;1275. doi: 10.1378/chest.123.4.1266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.4.1266</ArticleId><ArticleId IdType="pubmed">12684320</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Biondi-Zoccai GG, Tumlin JA, Bove T, De Luca M, Calabro MG, Ranucci M, Zangrillo A. Beneficial impact of fenoldopam in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Am J Kidney Dis. 2007;49:56&#x2013;68. doi: 10.1053/j.ajkd.2006.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2006.10.013</ArticleId><ArticleId IdType="pubmed">17185146</ArticleId></ArticleIdList></Reference><Reference><Citation>Zangrillo A, Biondi-Zoccai GG, Frati E, Covello RD, Cabrini L, Guarracino F, Ruggeri L, Bove T, Bignami E, Landoni G. Fenoldopam and acute renal failure in cardiac surgery: a meta-analysis of randomized placebo-controlled trials. J Cardiothorac Vasc Anesth. 2012;26:407&#x2013;413. doi: 10.1053/j.jvca.2012.01.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2012.01.038</ArticleId><ArticleId IdType="pubmed">22459931</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillies MA, Kakar V, Parker RJ, Honore PM, Ostermann M. Fenoldopam to prevent acute kidney injury after major surgery-a systematic review and meta-analysis. Crit Care. 2015;19:449. doi: 10.1186/s13054-015-1166-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1166-4</ArticleId><ArticleId IdType="pmc">PMC4699343</ArticleId><ArticleId IdType="pubmed">26703329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Zangrillo A, Guarracino F, Alvaro G, Persi B, Maglioni E, Galdieri N, Comis M, Caramelli F, Pasero DC, Pala G, Renzini M, Conte M, Paternoster G, Martinez B, Pinelli F, Frontini M, Zucchetti MC, Pappalardo F, Amantea B, Camata A, Pisano A, Verdecchia C, Dal CE, Cariello C, Faita L, Baldassarri R, Scandroglio AM, Saleh O, Lembo R, Calabro MG, Bellomo R, Landoni G. Effect of fenoldopam on use of renal replacement therapy among patients with acute kidney injury after cardiac surgery: a randomized clinical trial. JAMA. 2014;312:2244&#x2013;2253. doi: 10.1001/jama.2014.13573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.13573</ArticleId><ArticleId IdType="pubmed">25265449</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valson F, Ricksten SE. Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand. 2001;45:536&#x2013;542. doi: 10.1034/j.1399-6576.2001.045005536.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1399-6576.2001.045005536.x</ArticleId><ArticleId IdType="pubmed">11309000</ArticleId></ArticleIdList></Reference><Reference><Citation>Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med. 2005;31:79&#x2013;85. doi: 10.1007/s00134-004-2490-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-004-2490-3</ArticleId><ArticleId IdType="pubmed">15565364</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben AJ, van der Zander K, de Leeuw PW. Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005;19:411&#x2013;419. doi: 10.1111/j.1472-8206.2005.00336.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1472-8206.2005.00336.x</ArticleId><ArticleId IdType="pubmed">16011727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol. 2012;166:522&#x2013;531. doi: 10.1111/j.1476-5381.2012.01827.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.2012.01827.x</ArticleId><ArticleId IdType="pmc">PMC3417485</ArticleId><ArticleId IdType="pubmed">22220582</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C, Kudo T, Haraguchi G, Tomita M. Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis. Crit Care. 2011;15:R258. doi: 10.1186/cc10519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10519</ArticleId><ArticleId IdType="pmc">PMC3334809</ArticleId><ArticleId IdType="pubmed">22032777</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel NN, Rogers CA, Angelini GD, Murphy GJ. Pharmacological therapies for the prevention of acute kidney injury following cardiac surgery: a systematic review. Heart Fail Rev. 2011;16:553&#x2013;567. doi: 10.1007/s10741-011-9235-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10741-011-9235-5</ArticleId><ArticleId IdType="pubmed">21400231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK (2009) Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev CD006028. doi:10.1002/14651858.CD006028.pub2</Citation><ArticleIdList><ArticleId IdType="pubmed">19821351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sezai A, Nakata K, Iida M, Yoshitake I, Wakui S, Hata H, Shiono M. Results of low-dose carperitide infusion in high-risk patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2013;96:119&#x2013;126. doi: 10.1016/j.athoracsur.2013.03.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.03.090</ArticleId><ArticleId IdType="pubmed">23702231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori Y, Kamada T, Ochiai R. Reduction in the incidence of acute kidney injury after aortic arch surgery with low-dose atrial natriuretic peptide: a randomised controlled trial. Eur J Anaesthesiol. 2014;31:381&#x2013;387. doi: 10.1097/EJA.0000000000000035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000035</ArticleId><ArticleId IdType="pubmed">24384584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong B, Wang C, Yao Y, Huang Y, Tan J, Cao Y, Zou Y, Huang J. The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2015;10:e0131326. doi: 10.1371/journal.pone.0131326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0131326</ArticleId><ArticleId IdType="pmc">PMC4479574</ArticleId><ArticleId IdType="pubmed">26107522</ArticleId></ArticleIdList></Reference><Reference><Citation>Papp Z, Edes I, Fruhwald S, De Hert SG, Salmenpera M, Leppikangas H, Mebazaa A, Landoni G, Grossini E, Caimmi P, Morelli A, Guarracino F, Schwinger RH, Meyer S, Algotsson L, Wikstrom BG, Jorgensen K, Filippatos G, Parissis JT, Gonzalez MJ, Parkhomenko A, Yilmaz MB, Kivikko M, Pollesello P, Follath F. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012;159:82&#x2013;87. doi: 10.1016/j.ijcard.2011.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.07.022</ArticleId><ArticleId IdType="pubmed">21784540</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasslacher J, Bijuklic K, Bertocchi C, Kountchev J, Bellmann R, Dunzendorfer S, Joannidis M. Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study. Crit Care. 2011;15:R166. doi: 10.1186/cc10307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10307</ArticleId><ArticleId IdType="pmc">PMC3387603</ArticleId><ArticleId IdType="pubmed">21749676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bove T, Matteazzi A, Belletti A, Paternoster G, Saleh O, Taddeo D, Dossi R, Greco T, Bradic N, Husedzinovic I, Nigro Neto C, Lomivorotov VV, Calabro MG. Beneficial impact of levosimendan in critically ill patients with or at risk for acute renal failure: a meta-analysis of randomized clinical trials. Heart Lung Vessel. 2015;7:35&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4381821</ArticleId><ArticleId IdType="pubmed">25861589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Gong J, Chen D, Wang W, Liu M, Liu B. Levosimendan for prevention of acute kidney injury after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2016;67:408&#x2013;416. doi: 10.1053/j.ajkd.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.09.015</ArticleId><ArticleId IdType="pubmed">26518388</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Perkins GD, Singer M, McAuley DF, Orme RM, Santhakumaran S, Mason AJ, Cross M, Al-Beidh F, Best-Lane J, Brealey D, Nutt CL, McNamee JJ, Reschreiter H, Breen A, Liu KD, Ashby D. Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med. 2016;375:1638&#x2013;1648. doi: 10.1056/NEJMoa1609409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1609409</ArticleId><ArticleId IdType="pubmed">27705084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, Marcel R, Kalavrouziotis D, Nagpal D, Bozinovski J, Toller W, Heringlake M, Goodman SG, Levy JH, Harrington RA, Anstrom KJ, Alexander JH, LEVO-CTS Investigators (2017) Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616218</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Landoni G, Lomivorotov VV, Alvaro G, Lobreglio R, Pisano A, Guarracino F, Calabro MG, Grigoryev EV, Likhvantsev VV, Salgado-Filho MF, Bianchi A, Pasyuga VV, Baiocchi M, Pappalardo F, Monaco F, Boboshko VA, Abubakirov MN, Amantea B, Lembo R, Brazzi L, Verniero L, Bertini P, Scandroglio AM, Bove T, Belletti A, Michienzi MG, Shukevich DL, Zabelina TS, Bellomo R, Zangrillo A, CHEETAH Study Group (2017) Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. doi:10.1056/NEJMoa1616325</Citation><ArticleIdList><ArticleId IdType="pubmed">28320259</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo C, Yuan D, Li X, Yao W, Luo G, Chi X, Li H, Irwin MG, Xia Z, Hei Z. Propofol attenuated acute kidney injury after orthotopic liver transplantation via inhibiting gap junction composed of connexin 32. Anesthesiology. 2015;122:72&#x2013;86. doi: 10.1097/ALN.0000000000000448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000448</ArticleId><ArticleId IdType="pubmed">25254904</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Chou W, Wang JJ, Chen HW, Yeh CH. Propofol increases bone morphogenetic protein-7 and decreases oxidative stress in sepsis-induced acute kidney injury. Nephrol Dial Transplant. 2011;26:1162&#x2013;1172. doi: 10.1093/ndt/gfq572.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfq572</ArticleId><ArticleId IdType="pubmed">20864551</ArticleId></ArticleIdList></Reference><Reference><Citation>Villela NR, Nascimento Junior P, Carvalho LR, Teixeira A. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. 2005;55:429&#x2013;440. doi: 10.1590/S0034-70942005000400007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-70942005000400007</ArticleId><ArticleId IdType="pubmed">19468631</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Chen SW, Kim M, Park SW, Song JH, Wang S, Herman J, D&#x2019;Agati V, Lee HT. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295:F741&#x2013;748. doi: 10.1152/ajprenal.90244.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.90244.2008</ArticleId><ArticleId IdType="pubmed">18579700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsing CH, Lin CF, So E, Sun DP, Chen TC, Li CF, Yeh CH. alpha2-Adrenoceptor agonist dexmedetomidine protects septic acute kidney injury through increasing BMP-7 and inhibiting HDAC2 and HDAC5. Am J Physiol Renal Physiol. 2012;303:F1443&#x2013;F1453. doi: 10.1152/ajprenal.00143.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.00143.2012</ArticleId><ArticleId IdType="pubmed">22933299</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan F, Chen Y, Yuan D, Gong C, Li X, Zhou S. Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats. Biomed Rep. 2015;3:365&#x2013;370.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467244</ArticleId><ArticleId IdType="pubmed">26137237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H, Chi X, Jin Y, Wang Y, Huang P, Wu S, Xia Z, Cai J. Dexmedetomidine inhibits TLR4/NF-kappaB activation and reduces acute kidney injury after orthotopic autologous liver transplantation in rats. Sci Rep. 2015;5:16849. doi: 10.1038/srep16849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16849</ArticleId><ArticleId IdType="pmc">PMC4653646</ArticleId><ArticleId IdType="pubmed">26585410</ArticleId></ArticleIdList></Reference><Reference><Citation>Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370:444&#x2013;454. doi: 10.1056/NEJMra1208705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208705</ArticleId><ArticleId IdType="pubmed">24476433</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirrakhimov AE, Voore P, Halytskyy O, Khan M, Ali AM. Propofol infusion syndrome in adults: a clinical update. Crit Care Res Pract. 2015;2015:260385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4410753</ArticleId><ArticleId IdType="pubmed">25954513</ArticleId></ArticleIdList></Reference><Reference><Citation>Krajcova A, Waldauf P, Andel M, Duska F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care. 2015;19:398. doi: 10.1186/s13054-015-1112-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1112-5</ArticleId><ArticleId IdType="pmc">PMC4642662</ArticleId><ArticleId IdType="pubmed">26558513</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremer OL, Moons KG, Bouman EA, Kruijswijk JE, de Smet AM, Kalkman CJ. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357:117&#x2013;118. doi: 10.1016/S0140-6736(00)03547-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)03547-9</ArticleId><ArticleId IdType="pubmed">11197401</ArticleId></ArticleIdList></Reference><Reference><Citation>Leite TT, Macedo E, Martins Ida S, Neves FM, Liborio AB. Renal outcomes in critically ill patients receiving propofol or midazolam. Clin J Am Soc Nephrol. 2015;10:1937&#x2013;1945. doi: 10.2215/CJN.02330315.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02330315</ArticleId><ArticleId IdType="pmc">PMC4633782</ArticleId><ArticleId IdType="pubmed">26342046</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Song Y, Yang SY, Kwak YL. Anesthetics influence the incidence of acute kidney injury following valvular heart surgery. Kidney Int. 2014;86:414&#x2013;422. doi: 10.1038/ki.2013.532.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2013.532</ArticleId><ArticleId IdType="pubmed">24429400</ArticleId></ArticleIdList></Reference><Reference><Citation>Menting TP, Wever KE, Ozdemir-van Brunschot DM, Van der Vliet DJ, Rovers MM, Warle MC. Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury. Cochrane Database Syst Rev. 2017;3:Cd010777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6464274</ArticleId><ArticleId IdType="pubmed">28258686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichot C, Longrois D, Ghignone M, Quintin L. Dexmedetomidine and clonidine: a review of their pharmacodynamy to define their role for sedation in intensive care patients. Ann Fr Anesth Reanim. 2012;31:876&#x2013;896. doi: 10.1016/j.annfar.2012.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2012.07.018</ArticleId><ArticleId IdType="pubmed">23089375</ArticleId></ArticleIdList></Reference><Reference><Citation>Leino K, Hynynen M, Jalonen J, Salmenpera M, Scheinin H, Aantaa R, Dexmedetomidine in Cardiac Surgery Study Group Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study. BMC Anesthesiol. 2011;11:9. doi: 10.1186/1471-2253-11-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-11-9</ArticleId><ArticleId IdType="pmc">PMC3123640</ArticleId><ArticleId IdType="pubmed">21605394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji F, Li Z, Young JN, Yeranossian A, Liu H. Post-bypass dexmedetomidine use and postoperative acute kidney injury in patients undergoing cardiac surgery with cardiopulmonary bypass. PLoS One. 2013;8:e77446. doi: 10.1371/journal.pone.0077446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077446</ArticleId><ArticleId IdType="pmc">PMC3795046</ArticleId><ArticleId IdType="pubmed">24130886</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon T, Tsai JY, Vachhani S, Peng SP, Feng L, Vaporciyan AA, Cata JP. The use of intraoperative dexmedetomidine is not associated with a reduction in acute kidney injury after lung cancer surgery. J Cardiothorac Vasc Anesth. 2016;30:51&#x2013;55. doi: 10.1053/j.jvca.2015.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2015.03.025</ArticleId><ArticleId IdType="pubmed">26260907</ArticleId></ArticleIdList></Reference><Reference><Citation>Balkanay OO, Goksedef D, Omeroglu SN, Ipek G. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg. 2015;20:209&#x2013;214. doi: 10.1093/icvts/ivu367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivu367</ArticleId><ArticleId IdType="pubmed">25392341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JS, Shim JK, Soh S, Kim MK, Kwak YL. Perioperative dexmedetomidine reduces the incidence and severity of acute kidney injury following valvular heart surgery. Kidney Int. 2016;89:693&#x2013;700. doi: 10.1038/ki.2015.306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2015.306</ArticleId><ArticleId IdType="pubmed">26444030</ArticleId></ArticleIdList></Reference><Reference><Citation>Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978&#x2013;982. doi: 10.1210/jcem.87.3.8341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jcem.87.3.8341</ArticleId><ArticleId IdType="pubmed">11889147</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471&#x2013;1478. doi: 10.4065/78.12.1471.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/78.12.1471</ArticleId><ArticleId IdType="pubmed">14661676</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359&#x2013;1367. doi: 10.1056/NEJMoa011300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa011300</ArticleId><ArticleId IdType="pubmed">11794168</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449&#x2013;461. doi: 10.1056/NEJMoa052521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa052521</ArticleId><ArticleId IdType="pubmed">16452557</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetz M, Vanhorebeek I, Wouters PJ, Wilmer A, van den Berghe G (2008) Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 19: 571&#x2013;578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2391044</ArticleId><ArticleId IdType="pubmed">18235100</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190&#x2013;3197. doi: 10.1097/CCM.0b013e31818f21aa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31818f21aa</ArticleId><ArticleId IdType="pubmed">18936702</ArticleId></ArticleIdList></Reference><Reference><Citation>Investigators N-SS, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283&#x2013;1297. doi: 10.1056/NEJMoa0810625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810625</ArticleId><ArticleId IdType="pubmed">19318384</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009;35:1738&#x2013;1748. doi: 10.1007/s00134-009-1585-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1585-2</ArticleId><ArticleId IdType="pubmed">19636533</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH, Kahoul SH, Brits R. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. Am J Clin Nutr. 2011;93:569&#x2013;577. doi: 10.3945/ajcn.110.005074.</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/ajcn.110.005074</ArticleId><ArticleId IdType="pubmed">21270385</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Rosa GC, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE, Bedoya M, Toro JM, Velasquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care. 2008;12:R120. doi: 10.1186/cc7017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7017</ArticleId><ArticleId IdType="pmc">PMC2592751</ArticleId><ArticleId IdType="pubmed">18799004</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Schetz M, Vlasselaers D, Hermans G, Wilmer A, Bouillon R, Mesotten D. Clinical review: intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94:3163&#x2013;3170. doi: 10.1210/jc.2009-0663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2009-0663</ArticleId><ArticleId IdType="pubmed">19531590</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Intern Med. 2012;23:564&#x2013;574. doi: 10.1016/j.ejim.2012.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2012.02.013</ArticleId><ArticleId IdType="pubmed">22863436</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson RN, Hamilton LA, Connor KA, Maish GO, 3rd, Croce MA, Minard G, Brown RO. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support. Nutrition. 2011;27:766&#x2013;772. doi: 10.1016/j.nut.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2010.08.009</ArticleId><ArticleId IdType="pubmed">20971617</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA. 2009;301:1556&#x2013;1564. doi: 10.1001/jama.2009.496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.496</ArticleId><ArticleId IdType="pubmed">19366775</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowery NT, Guillamondegui OD, Gunter OL, Diaz JJ, Jr, Collier BR, Dossett LA, Dortch MJ, May AK. Severe hypoglycemia while on intensive insulin therapy is not an independent predictor of death after trauma. J Trauma. 2010;68:342&#x2013;347. doi: 10.1097/TA.0b013e3181c825f2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181c825f2</ArticleId><ArticleId IdType="pubmed">20154546</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE-SUGAR Study Investigators. Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108&#x2013;1118. doi: 10.1056/NEJMoa1204942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1204942</ArticleId><ArticleId IdType="pubmed">22992074</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, Inzucchi SE, Ismail-Beigi F, Kirkman MS, Umpierrez GE. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. EndocrPract. 2009;15:353&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">19454396</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G (2013) What&#x2019;s new in glucose control in the ICU? Intensive Care Med 39:823&#x2013;825</Citation><ArticleIdList><ArticleId IdType="pubmed">23460140</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieleman JM, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, Schepp RM, Boer C, Moons KG, van Herwerden LA, Tijssen JG, Numan SC, Kalkman CJ, van Dijk D, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012;308:1761&#x2013;1767. doi: 10.1001/jama.2012.14144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.14144</ArticleId><ArticleId IdType="pubmed">23117776</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob KA, Leaf DE, Dieleman JM, van Dijk D, Nierich AP, Rosseel PM, van der Maaten JM, Hofland J, Diephuis JC, de Lange F, Boer C, Kluin J, Waikar SS, Dexamethasone for Cardiac Surgery Study Group Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol. 2015;26:2947&#x2013;2951. doi: 10.1681/ASN.2014080840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2014080840</ArticleId><ArticleId IdType="pmc">PMC4657835</ArticleId><ArticleId IdType="pubmed">25952257</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitlock RP, Devereaux PJ, Teoh KH, Lamy A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G, Villar JC, Zuo Y, Avezum A, Quantz M, Tagarakis GI, Shah PJ, Abbasi SH, Zheng H, Pettit S, Chrolavicius S, Yusuf S. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015;386:1243&#x2013;1253. doi: 10.1016/S0140-6736(15)00273-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)00273-1</ArticleId><ArticleId IdType="pubmed">26460660</ArticleId></ArticleIdList></Reference><Reference><Citation>Song YR, Lee T, You SJ, Chin HJ, Chae DW, Lim C, Park KH, Han S, Kim JH, Na KY. Prevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot study. Am J Nephrol. 2009;30:253&#x2013;260. doi: 10.1159/000223229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000223229</ArticleId><ArticleId IdType="pubmed">19494484</ArticleId></ArticleIdList></Reference><Reference><Citation>de Seigneux S, Ponte B, Weiss L, Pugin J, Romand JA, Martin PY, Saudan P. Epoetin administrated after cardiac surgery: effects on renal function and inflammation in a randomized controlled study. BMC Nephrol. 2012;13:132. doi: 10.1186/1471-2369-13-132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-13-132</ArticleId><ArticleId IdType="pmc">PMC3506492</ArticleId><ArticleId IdType="pubmed">23033926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo YC, Shim JK, Kim JC, Jo YY, Lee JH, Kwak YL. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology. 2011;115:929&#x2013;937. doi: 10.1097/ALN.0b013e318232004b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318232004b</ArticleId><ArticleId IdType="pubmed">22027622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Shim JK, Song JW, Song Y, Kim HB, Kwak YL. Effect of erythropoietin on the incidence of acute kidney injury following complex valvular heart surgery: a double blind, randomized clinical trial of efficacy and safety. Crit Care. 2013;17:R254. doi: 10.1186/cc13081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13081</ArticleId><ArticleId IdType="pmc">PMC4056185</ArticleId><ArticleId IdType="pubmed">24156702</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasanarong A, Duangchana S, Sumransurp S, Homvises B, Satdhabudha O. Prophylaxis with erythropoietin versus placebo reduces acute kidney injury and neutrophil gelatinase-associated lipocalin in patients undergoing cardiac surgery: a randomized, double-blind controlled trial. BMC Nephrol. 2013;14:136. doi: 10.1186/1471-2369-14-136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2369-14-136</ArticleId><ArticleId IdType="pmc">PMC3704968</ArticleId><ArticleId IdType="pubmed">23829828</ArticleId></ArticleIdList></Reference><Reference><Citation>Tie HT, Luo MZ, Lin D, Zhang M, Wan JY, Wu QC. Erythropoietin administration for prevention of cardiac surgery-associated acute kidney injury: a meta-analysis of randomized controlled trials. Eur J Cardiothorac Surg. 2015;48:32&#x2013;39. doi: 10.1093/ejcts/ezu378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezu378</ArticleId><ArticleId IdType="pubmed">25312524</ArticleId></ArticleIdList></Reference><Reference><Citation>Penny-Dimri JC, Cochrane AD, Perry LA, Smith JA. Characterising the role of perioperative erythropoietin for preventing acute kidney injury after cardiac surgery: systematic review and meta-analysis. Heart Lung Circ. 2016;25:1067&#x2013;1076. doi: 10.1016/j.hlc.2016.04.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2016.04.016</ArticleId><ArticleId IdType="pubmed">27523464</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardashti A, Ederoth P, Algotsson L, Bronden B, Grins E, Larsson M, Nozohoor S, Zinko G, Bjursten H. Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial) Anesthesiology. 2014;121:582&#x2013;590. doi: 10.1097/ALN.0000000000000321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000321</ArticleId><ArticleId IdType="pubmed">25225746</ArticleId></ArticleIdList></Reference><Reference><Citation>Endre ZH, Walker RJ, Pickering JW, Shaw GM, Frampton CM, Henderson SJ, Hutchison R, Mehrtens JE, Robinson JM, Schollum JB, Westhuyzen J, Celi LA, McGinley RJ, Campbell IJ, George PM. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial) Kidney Int. 2010;77:1020&#x2013;1030. doi: 10.1038/ki.2010.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2010.25</ArticleId><ArticleId IdType="pubmed">20164823</ArticleId></ArticleIdList></Reference><Reference><Citation>Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Shapiro MJ, Corwin MJ, Colton T, EPO Critical Care Trials Group Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 2002;288:2827&#x2013;2835. doi: 10.1001/jama.288.22.2827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.288.22.2827</ArticleId><ArticleId IdType="pubmed">12472324</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C, Lin Z, Luo Q, Xia X, Yu X, Huang F. Efficacy and safety of erythropoietin to prevent acute kidney injury in patients with critical illness or perioperative care: a systematic review and meta-analysis of randomized controlled trials. J Cardiovasc Pharmacol. 2015;65:593&#x2013;600. doi: 10.1097/FJC.0000000000000229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000229</ArticleId><ArticleId IdType="pmc">PMC4461384</ArticleId><ArticleId IdType="pubmed">26065644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JE, Song SW, Kim JY, Lee HJ, Chung KH, Shim YH. Effect of a single bolus of erythropoietin on renoprotection in patients undergoing thoracic aortic surgery with moderate hypothermic circulatory arrest. Ann Thorac Surg. 2016;101:690&#x2013;696. doi: 10.1016/j.athoracsur.2015.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2015.08.007</ArticleId><ArticleId IdType="pubmed">26576750</ArticleId></ArticleIdList></Reference><Reference><Citation>Shema-Didi L, Kristal B, Eizenberg S, Marzuq N, Sussan M, Feldman-Idov Y, Ofir P, Atar S. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: a randomized controlled trial. Nephrology (Carlton) 2016;21:295&#x2013;300. doi: 10.1111/nep.12609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12609</ArticleId><ArticleId IdType="pubmed">26370061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons M, Plante I, LeBrun M, Gourde P, Simard M, Grenier L, Thibault L, Labrecque G, Beauchamp D. Protein-rich diet attenuates cyclosporin a-induced renal tubular damage in rats. J Ren Nutr. 2003;13:84&#x2013;92. doi: 10.1053/jren.2003.50027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jren.2003.50027</ArticleId><ArticleId IdType="pubmed">12671830</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts PR, Black KW, Zaloga GP. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat. Am J Respir Crit Care Med. 1997;156:1265&#x2013;1269. doi: 10.1164/ajrccm.156.4.9607003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.156.4.9607003</ArticleId><ArticleId IdType="pubmed">9351632</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouser JF, Hak EB, Kuhl DA, Dickerson RN, Gaber LW, Hak LJ. Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition. Crit Care Med. 1997;25:1748&#x2013;1754. doi: 10.1097/00003246-199710000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199710000-00028</ArticleId><ArticleId IdType="pubmed">9377893</ArticleId></ArticleIdList></Reference><Reference><Citation>Zager RA. Amino acid hyperalimentation in acute renal failure: a potential therapeutic paradox. Kidney Int Suppl. 1987;22:S72&#x2013;S75.</Citation><ArticleIdList><ArticleId IdType="pubmed">3123764</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Elke G, Cook D, Berger MM, Wischmeyer PE, Albert M, Muscedere J, Jones G, Day AG. Glutamine and antioxidants in the critically ill patient: a post hoc analysis of a large-scale randomized trial. JPEN J Parenter Enteral Nutr. 2015;39:401&#x2013;409. doi: 10.1177/0148607114529994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607114529994</ArticleId><ArticleId IdType="pmc">PMC6800175</ArticleId><ArticleId IdType="pubmed">24803474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, Chu T, Forrer F, Muller C, de Jong M, van IJcken W, IJzermans JN, Hoeijmakers JH, de Bruin RW (2010) Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell 9:40&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412229</ArticleId><ArticleId IdType="pubmed">19878145</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel RM, Beck CH, Jr, Abbott WM, Ryan JA, Jr, Barnett GO, Fischer JE. Improved survival from acute renal failure after treatment with intravenous essential l-amino acids and glucose. Results of a prospective, double-blind study. N Engl J Med. 1973;288:695&#x2013;699. doi: 10.1056/NEJM197304052881401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197304052881401</ArticleId><ArticleId IdType="pubmed">4631743</ArticleId></ArticleIdList></Reference><Reference><Citation>Doig GS, Simpson F, Bellomo R, Heighes PT, Sweetman EA, Chesher D, Pollock C, Davies A, Botha J, Harrigan P, Reade MC. Intravenous amino acid therapy for kidney function in critically ill patients: a randomized controlled trial. Intensive Care Med. 2015;41:1197&#x2013;1208. doi: 10.1007/s00134-015-3827-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3827-9</ArticleId><ArticleId IdType="pubmed">25925203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunst J, Vanhorebeek I, Casaer MP, Hermans G, Wouters PJ, Dubois J, Claes K, Schetz M, Van den Berghe G. Impact of early parenteral nutrition on metabolism and kidney injury. J Am Soc Nephrol. 2013;24:995&#x2013;1005. doi: 10.1681/ASN.2012070732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2012070732</ArticleId><ArticleId IdType="pmc">PMC3665391</ArticleId><ArticleId IdType="pubmed">23539756</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Dorzi HM, Albarrak A, Ferwana M, Murad MH, Arabi YM. Lower versus higher dose of enteral caloric intake in adult critically ill patients: a systematic review and meta-analysis. Crit Care. 2016;20:358. doi: 10.1186/s13054-016-1539-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1539-3</ArticleId><ArticleId IdType="pmc">PMC5097427</ArticleId><ArticleId IdType="pubmed">27814776</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Med. 2007;5:32. doi: 10.1186/1741-7015-5-32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-5-32</ArticleId><ArticleId IdType="pmc">PMC2200657</ArticleId><ArticleId IdType="pubmed">18001477</ArticleId></ArticleIdList></Reference><Reference><Citation>Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J. 2006;151:140&#x2013;145. doi: 10.1016/j.ahj.2005.01.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2005.01.055</ArticleId><ArticleId IdType="pubmed">16368307</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong MH, MacKenzie TA, Malenka DJ. N-acetylcysteine prophylaxis significantly reduces the risk of radiocontrast-induced nephropathy: comprehensive meta-analysis. Catheter Cardiovasc Interv. 2005;64:471&#x2013;479. doi: 10.1002/ccd.20342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.20342</ArticleId><ArticleId IdType="pubmed">15789388</ArticleId></ArticleIdList></Reference><Reference><Citation>Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366&#x2013;1374. doi: 10.1111/j.1523-1755.2004.00516.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00516.x</ArticleId><ArticleId IdType="pubmed">15086476</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso A, Lau J, Jaber BL, Weintraub A, Sarnak MJ. Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. Am J Kidney Dis. 2004;43:1&#x2013;9. doi: 10.1053/j.ajkd.2003.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2003.09.009</ArticleId><ArticleId IdType="pubmed">14712421</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med. 2008;148:284&#x2013;294. doi: 10.7326/0003-4819-148-4-200802190-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-148-4-200802190-00007</ArticleId><ArticleId IdType="pubmed">18283206</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao SJ, Zhong ZS, Qi GX, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. Int J Cardiol. 2016;221:251&#x2013;259. doi: 10.1016/j.ijcard.2016.07.086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.086</ArticleId><ArticleId IdType="pubmed">27404685</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang N, Qian P, Kumar S, Yan TD, Phan K. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: a systematic review and trial sequential analysis. Int J Cardiol. 2016;209:319&#x2013;327. doi: 10.1016/j.ijcard.2016.02.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.02.083</ArticleId><ArticleId IdType="pubmed">26922293</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang X, Hu DY, Li CB, Ai ZS, Peng A. N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with pre-existing renal insufficiency or diabetes: a systematic review and meta-analysis. Ren Fail. 2015;37(10):297&#x2013;303. doi: 10.3109/0886022X.2015.1012985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/0886022X.2015.1012985</ArticleId><ArticleId IdType="pubmed">26458505</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Fu Q, Cao L, Jin W, Cheng L, Li Z (2013) Intravenous N-acetylcysteine for prevention of contrast-induced nephropathy: a meta-analysis of randomized, controlled trials. PLoS One 8:e55124</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3559541</ArticleId><ArticleId IdType="pubmed">23383076</ArticleId></ArticleIdList></Reference><Reference><Citation>ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation. 2011;124:1250&#x2013;1259. doi: 10.1161/CIRCULATIONAHA.111.038943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.111.038943</ArticleId><ArticleId IdType="pubmed">21859972</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns KE, Chu MW, Novick RJ, Fox SA, Gallo K, Martin CM, Stitt LW, Heidenheim AP, Myers ML, Moist L. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA. 2005;294:342&#x2013;350. doi: 10.1001/jama.294.3.342.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.294.3.342</ArticleId><ArticleId IdType="pubmed">16030279</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E, Abdulkader R, Castro I, Sobrinho AC, Yu L, Vieira JM., Jr Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial. Nephrol Dial Transplant. 2006;21:1863&#x2013;1869. doi: 10.1093/ndt/gfl079.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfl079</ArticleId><ArticleId IdType="pubmed">16522657</ArticleId></ArticleIdList></Reference><Reference><Citation>Komisarof JA, Gilkey GM, Peters DM, Koudelka CW, Meyer MM, Smith SM. N-acetylcysteine for patients with prolonged hypotension as prophylaxis for acute renal failure (NEPHRON) Crit Care Med. 2007;35:435&#x2013;441. doi: 10.1097/01.CCM.0000253816.83011.DB.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000253816.83011.DB</ArticleId><ArticleId IdType="pubmed">17205018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisillo E, Ceriani R, Bortone F, Juliano G, Salvi L, Veglia F, Fiorentini C, Marenzi G. N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: a prospective, randomized, clinical trial. Crit Care Med. 2008;36:81&#x2013;86. doi: 10.1097/01.CCM.0000295305.22281.1D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000295305.22281.1D</ArticleId><ArticleId IdType="pubmed">18090169</ArticleId></ArticleIdList></Reference><Reference><Citation>Adabag AS, Ishani A, Koneswaran S, Johnson DJ, Kelly RF, Ward HB, McFalls EO, Bloomfield HE, Chandrashekhar Y. Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: a randomized controlled trial. Am Heart J. 2008;155:1143&#x2013;1149. doi: 10.1016/j.ahj.2008.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2008.01.013</ArticleId><ArticleId IdType="pubmed">18513531</ArticleId></ArticleIdList></Reference><Reference><Citation>Song JW, Shim JK, Soh S, Jang J, Kwak YL. Double-blinded, randomized controlled trial of N-acetylcysteine for prevention of acute kidney injury in high risk patients undergoing off-pump coronary artery bypass. Nephrology (Carlton) 2015;20:96&#x2013;102. doi: 10.1111/nep.12361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nep.12361</ArticleId><ArticleId IdType="pubmed">25384603</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency. Can J Anaesth. 2007;54:872&#x2013;881. doi: 10.1007/BF03026790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03026790</ArticleId><ArticleId IdType="pubmed">17975231</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009;47:81&#x2013;88. doi: 10.1080/15563650802665587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15563650802665587</ArticleId><ArticleId IdType="pubmed">19280424</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar Z, Shearer E, Lowe D. N-Acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med. 1999;27:1100&#x2013;1104. doi: 10.1097/00003246-199906000-00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199906000-00028</ArticleId><ArticleId IdType="pubmed">10397212</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Moran JL, Leppard PI. N-acetyl-l-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med. 1996;24:1302&#x2013;1310. doi: 10.1097/00003246-199608000-00006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199608000-00006</ArticleId><ArticleId IdType="pubmed">8706483</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R. Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med. 1999;27:1807&#x2013;1813. doi: 10.1097/00003246-199909000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199909000-00017</ArticleId><ArticleId IdType="pubmed">10507602</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A. Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr. 2007;26:41&#x2013;50. doi: 10.1016/j.clnu.2006.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2006.10.003</ArticleId><ArticleId IdType="pubmed">17174015</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schuttler J, Gartner R. Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35:118&#x2013;126. doi: 10.1097/01.CCM.0000251124.83436.0E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000251124.83436.0E</ArticleId><ArticleId IdType="pubmed">17095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Trips E, Nierhaus A, Briegel J, Heyland DK, Jaschinski U, Moerer O, Weyland A, Marx G, Grundling M, Kluge S, Kaufmann I, Ott K, Quintel M, Jelschen F, Meybohm P, Rademacher S, Meier-Hellmann A, Utzolino S, Kaisers UX, Putensen C, Elke G, Ragaller M, Gerlach H, Ludewig K, Kiehntopf M, Bogatsch H, Engel C, Brunkhorst FM, Loeffler M, Reinhart K, for SepNet Critical Care Trials G (2016) Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: a randomized clinical trial. JAMA intern med 176: 1266-1276</Citation><ArticleIdList><ArticleId IdType="pubmed">27428731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavalipati N, Shah J, Ramakrishan A, Vasnawala H. Pleiotropic effects of statins. Indian J Endocrinol Metab. 2015;19:554&#x2013;562. doi: 10.4103/2230-8210.163106.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2230-8210.163106</ArticleId><ArticleId IdType="pmc">PMC4566334</ArticleId><ArticleId IdType="pubmed">26425463</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease. J Am Coll Cardiol. 2014;63:62&#x2013;70. doi: 10.1016/j.jacc.2013.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.09.017</ArticleId><ArticleId IdType="pubmed">24076297</ArticleId></ArticleIdList></Reference><Reference><Citation>Leoncini M, Toso A, Maioli M, Tropeano F, Villani S, Bellandi F. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective EFFECT of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome) J Am Coll Cardiol. 2014;63:71&#x2013;79. doi: 10.1016/j.jacc.2013.04.105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.04.105</ArticleId><ArticleId IdType="pubmed">24076283</ArticleId></ArticleIdList></Reference><Reference><Citation>Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B, Ricciardelli B, Donnarumma E, Bianco A, Zabatta MA, Troncone G, Colombo A, Briguori C, Condorelli G. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation. 2012;126:3008&#x2013;3016. doi: 10.1161/CIRCULATIONAHA.112.103317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.112.103317</ArticleId><ArticleId IdType="pubmed">23147173</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehata M, Hamza M. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial. Cardiovasc Ther. 2015;33:35&#x2013;41. doi: 10.1111/1755-5922.12108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1755-5922.12108</ArticleId><ArticleId IdType="pubmed">25677920</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Li Y, Xu B, Jia G, Guo T, Wang D, Xu K, Deng J, Han Y. Short-term rosuvastatin therapy prevents contrast-induced acute kidney injury in female patients with diabetes and chronic kidney disease: a subgroup analysis of the TRACK-D study. J Thorac Dis. 2016;8:1000&#x2013;1006. doi: 10.21037/jtd.2016.03.26.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2016.03.26</ArticleId><ArticleId IdType="pmc">PMC4842819</ArticleId><ArticleId IdType="pubmed">27162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbieri L, Verdoia M, Schaffer A, Nardin M, Marino P, De Luca G. The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials. J Thromb Thrombolysis. 2014;38:493&#x2013;502. doi: 10.1007/s11239-014-1076-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-014-1076-3</ArticleId><ArticleId IdType="pubmed">24705677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JM, Park J, Jeon KH, Jung JH, Lee SE, Han JK, Kim HL, Yang HM, Park KW, Kang HJ, Koo BK, Jo SH, Kim HS. Efficacy of short-term high-dose statin pretreatment in prevention of contrast-induced acute kidney injury: updated study-level meta-analysis of 13 randomized controlled trials. PLoS One. 2014;9:e111397. doi: 10.1371/journal.pone.0111397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0111397</ArticleId><ArticleId IdType="pmc">PMC4219719</ArticleId><ArticleId IdType="pubmed">25369120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ukaigwe A, Karmacharya P, Mahmood M, Pathak R, Aryal MR, Jalota L, Donato AA. Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography. Am J Cardiol. 2014;114:1295&#x2013;1302. doi: 10.1016/j.amjcard.2014.07.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2014.07.059</ArticleId><ArticleId IdType="pubmed">25239829</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N, Lee JZ, Huang JJ, Low SW, Howe C, Pandit A, Suryanarayana P, Lee KS. Benefit of statin pretreatment in prevention of contrast-induced nephropathy in different adult patient population: systematic review and meta-analysis. Open Heart. 2014;1:e000127. doi: 10.1136/openhrt-2014-000127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2014-000127</ArticleId><ArticleId IdType="pmc">PMC4189228</ArticleId><ArticleId IdType="pubmed">25332824</ArticleId></ArticleIdList></Reference><Reference><Citation>Marenzi G, Cosentino N, Werba JP, Tedesco CC, Veglia F, Bartorelli AL. A meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromes. Int J Cardiol. 2015;183:47&#x2013;53. doi: 10.1016/j.ijcard.2015.01.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2015.01.046</ArticleId><ArticleId IdType="pubmed">25662053</ArticleId></ArticleIdList></Reference><Reference><Citation>Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dorge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients. Eur Heart J. 2008;29:1548&#x2013;1559. doi: 10.1093/eurheartj/ehn198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehn198</ArticleId><ArticleId IdType="pubmed">18506053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Gu C, Gao M, Yu W, Yu Y. Preoperative statin therapy and renal outcomes after cardiac surgery: a meta-analysis and meta-regression of 59,771 patients. Can J Cardiol. 2015;31:1051&#x2013;1060. doi: 10.1016/j.cjca.2015.02.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2015.02.034</ArticleId><ArticleId IdType="pubmed">26081692</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewicki M, Ng I, Schneider AG. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass. Cochrane Database Syst Rev. 2015;3:CD010480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10788137</ArticleId><ArticleId IdType="pubmed">25758322</ArticleId></ArticleIdList></Reference><Reference><Citation>Billings FT, Hendricks PA, Schildcrout JS, Shi Y, Petracek MR, Byrne JG, Brown NJ. High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: a randomized clinical trial. JAMA. 2016;315:877&#x2013;888. doi: 10.1001/jama.2016.0548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0548</ArticleId><ArticleId IdType="pmc">PMC4843765</ArticleId><ArticleId IdType="pubmed">26906014</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JH, Shim JK, Song JW, Soh S, Kwak YL. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial. Intensive Care Med. 2016;42:1398&#x2013;1407. doi: 10.1007/s00134-016-4358-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4358-8</ArticleId><ArticleId IdType="pubmed">27120082</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, Du J, Guarguagli S, Hill M, Chen Z, Collins R, Casadei B. Perioperative rosuvastatin in cardiac surgery. N Engl J Med. 2016;374:1744&#x2013;1753. doi: 10.1056/NEJMoa1507750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1507750</ArticleId><ArticleId IdType="pubmed">27144849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, Wempe C, Martens S, Zahn PK, Wolf B, Goebel U, Schwer CI, Rosenberger P, Haeberle H, Gorlich D, Kellum JA, Meersch M, Renal RI. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;2141. doi: 10.1001/jama.2015.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.4189</ArticleId><ArticleId IdType="pubmed">26024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman RF, Ezeanuna PU, Kane JC, Cleland CD, Kempananjappa TJ, Lucas FL, Kramer RS. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011;80:861&#x2013;867. doi: 10.1038/ki.2011.156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2011.156</ArticleId><ArticleId IdType="pubmed">21677633</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim TK, Min JJ, Cho YJ, Hausenloy DJ, Ahn H, Kim KH, Hwang HY, Hong DM, Jeon Y. Effects of delayed remote ischemic preconditioning on peri-operative myocardial injury in patients undergoing cardiac surgery&#x2014;a randomized controlled trial. Int J Cardiol. 2017;227:511&#x2013;515. doi: 10.1016/j.ijcard.2016.10.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.10.111</ArticleId><ArticleId IdType="pubmed">27839807</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Bein B, Brosteanu O, Cremer J, Gruenewald M, Stoppe C, Coburn M, Schaelte G, Boning A, Niemann B, Roesner J, Kletzin F, Strouhal U, Reyher C, Laufenberg-Feldmann R, Ferner M, Brandes IF, Bauer M, Stehr SN, Kortgen A, Wittmann M, Baumgarten G, Meyer-Treschan T, Kienbaum P, Heringlake M, Schon J, Sander M, Treskatsch S, Smul T, Wolwender E, Schilling T, Fuernau G, Hasenclever D, Zacharowski K. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med. 2015;373:1397&#x2013;1407. doi: 10.1056/NEJMoa1413579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413579</ArticleId><ArticleId IdType="pubmed">26436208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong DM, Lee EH, Kim HJ, Min JJ, Chin JH, Choi DK, Bahk JH, Sim JY, Choi IC, Jeon Y. Does remote ischaemic preconditioning with postconditioning improve clinical outcomes of patients undergoing cardiac surgery? Remote Ischaemic Preconditioning with Postconditioning Outcome Trial. Eur Heart J. 2014;35:176&#x2013;183. doi: 10.1093/eurheartj/eht346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/eht346</ArticleId><ArticleId IdType="pubmed">24014392</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy DJ, Candilio L, Evans R, Ariti C, Jenkins DP, Kolvekar S, Knight R, Kunst G, Laing C, Nicholas J, Pepper J, Robertson S, Xenou M, Clayton T, Yellon DM, ERICCA Trial Investigators Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408&#x2013;1417. doi: 10.1056/NEJMoa1413534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1413534</ArticleId><ArticleId IdType="pubmed">26436207</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh M, Whitlock R, Garg AX, Legare JF, Duncan AE, Zimmerman R, Miller S, Fremes S, Kieser T, Karthikeyan G, Chan M, Ho A, Nasr V, Vincent J, Ali I, Lavi R, Sessler DI, Kramer R, Gardner J, Syed S, VanHelder T, Guyatt G, Rao-Melacini P, Thabane L, Devereaux PJ, Remote IMPACT Investigators Effects of remote ischemic preconditioning in high-risk patients undergoing cardiac surgery (Remote IMPACT): a randomized controlled trial. CMAJ. 2016;188:329&#x2013;336. doi: 10.1503/cmaj.150632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.150632</ArticleId><ArticleId IdType="pmc">PMC4786386</ArticleId><ArticleId IdType="pubmed">26668200</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Diao Y, Chen G, Tanaka A, Eastwood GM, Bellomo R. Remote ischemic conditioning for kidney protection: a meta-analysis. J Crit Care. 2016;33:224&#x2013;232. doi: 10.1016/j.jcrc.2016.01.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.01.026</ArticleId><ArticleId IdType="pubmed">26936039</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Jeon Y, Meybohm P, Zarbock A, Young PJ, Li L, Hausenloy DJ. Renoprotection by remote ischemic conditioning during elective coronary revascularization: a systematic review and meta-analysis of randomized controlled trials. Int J Cardiol. 2016;222:295&#x2013;302. doi: 10.1016/j.ijcard.2016.07.176.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2016.07.176</ArticleId><ArticleId IdType="pubmed">27498373</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Lang XB, Zhang P, Lv R, Wang YF, Chen JH. Remote ischemic preconditioning for prevention of acute kidney injury: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2014;64:574&#x2013;583. doi: 10.1053/j.ajkd.2014.04.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2014.04.029</ArticleId><ArticleId IdType="pubmed">24954246</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Lang X, Cao L, Wang Y, Lu Y, Feng S, Yang Y, Chen J, Jiang H. Effect of remote ischemic preconditioning on postoperative acute kidney injury among patients undergoing cardiac and vascular interventions: a meta-analysis. J Nephrol. 2017;30:19&#x2013;33. doi: 10.1007/s40620-016-0301-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40620-016-0301-x</ArticleId><ArticleId IdType="pmc">PMC5316401</ArticleId><ArticleId IdType="pubmed">27091767</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, Chen R, Ding X. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care. 2016;20:111. doi: 10.1186/s13054-016-1272-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1272-y</ArticleId><ArticleId IdType="pmc">PMC4837562</ArticleId><ArticleId IdType="pubmed">27095379</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce B, Bole I, Patel V, Brown DL (2017) Clinical outcomes of remote ischemic preconditioning prior to cardiac surgery: a meta-analysis of randomized controlled trials. J Am Heart Assoc. doi:10.1161/JAHA.116.004666</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5523764</ArticleId><ArticleId IdType="pubmed">28219918</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi B, Chen X, Shi H, Lin T, Lin H, Xu Y, Rong J (2017) Remote ischaemic preconditioning reduces acute kidney injury in adult patients undergoing cardiac surgery with cardiopulmonary bypass: a meta-analysis. Eur J Cardiothorac Surg 51:616&#x2013;623</Citation><ArticleIdList><ArticleId IdType="pubmed">28329336</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Bulluck H, Fang N, Li L, Hausenloy DJ. Age and surgical complexity impact on renoprotection by remote ischemic preconditioning during adult cardiac surgery: a meta analysis. Sci Rep. 2017;7:215. doi: 10.1038/s41598-017-00308-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-00308-3</ArticleId><ArticleId IdType="pmc">PMC5428278</ArticleId><ArticleId IdType="pubmed">28303021</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang X, Chi D, Wang S, Wei H, Yu H, Li Q, Liu B. Remote ischemic preconditioning for prevention of acute kidney injury in patients undergoing on-pump cardiac surgery: a systematic review and meta-analysis. Medicine. 2016;95:e3465. doi: 10.1097/MD.0000000000003465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000003465</ArticleId><ArticleId IdType="pmc">PMC5402542</ArticleId><ArticleId IdType="pubmed">27631199</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei H, Wu Y, Wei Y, Yang Y, Teng S, Zhang H. Remote ischemic preconditioning reduces perioperative cardiac and renal events in patients undergoing elective coronary intervention: a meta-analysis of 11 randomized trials. PLoS One. 2014;9:e115500. doi: 10.1371/journal.pone.0115500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0115500</ArticleId><ArticleId IdType="pmc">PMC4281209</ArticleId><ArticleId IdType="pubmed">25551671</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Li G, Yu C, Li Y. The role of remote ischemic preconditioning on postoperative kidney injury in patients undergoing cardiac and vascular interventions: a meta-analysis. J Cardiothorac Surg. 2013;8:43. doi: 10.1186/1749-8090-8-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1749-8090-8-43</ArticleId><ArticleId IdType="pmc">PMC3639828</ArticleId><ArticleId IdType="pubmed">23497625</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukkar L, Hong D, Wong MG, Badve SV, Rogers K, Perkovic V, Walsh M, Yu X, Hillis GS, Gallagher M, Jardine M. Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis. BMJ. 2016;355:i5599. doi: 10.1136/bmj.i5599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i5599</ArticleId><ArticleId IdType="pmc">PMC5098417</ArticleId><ArticleId IdType="pubmed">27821641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou CC, Ge YZ, Yao WT, Wu R, Xin H, Lu TZ, Li MH, Song KW, Wang M, Zhu YP, Zhu M, Geng LG, Gao XF, Zhou LH, Zhang SL, Zhu JG, Jia RP. Limited clinical utility of remote ischemic conditioning in renal transplantation: a meta-analysis of randomized controlled trials. PLoS One. 2017;12:e0170729. doi: 10.1371/journal.pone.0170729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170729</ArticleId><ArticleId IdType="pmc">PMC5271340</ArticleId><ArticleId IdType="pubmed">28129389</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolhe NV, Reilly T, Leung J, Fluck RJ, Swinscoe KE, Selby NM, Taal MW. A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study. Nephrol Dial Transplant. 2016;31:1846&#x2013;1854. doi: 10.1093/ndt/gfw087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfw087</ArticleId><ArticleId IdType="pubmed">27190331</ArticleId></ArticleIdList></Reference><Reference><Citation>Joslin J, Wilson H, Zubli D, Gauge N, Kinirons M, Hopper A, Pile T, Ostermann M. Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clinic Med (Lond) 2015;15:431&#x2013;436. doi: 10.7861/clinmedicine.15-5-431.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.15-5-431</ArticleId><ArticleId IdType="pmc">PMC4953226</ArticleId><ArticleId IdType="pubmed">26430180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagwanani A, Carpenter R, Yusuf A (2014) Improving the management of acute kidney injury in a district general hospital: introduction of the DONUT bundle. BMJ Qual Improv Rep. doi:10.1136/bmjquality.u202650.w1235</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4663825</ArticleId><ArticleId IdType="pubmed">26734238</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, Schmidt C, Hoffmeier A, Van Aken H, Wempe C, Gerss J, Zarbock A (2017) Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med. doi:10.1007/s00134-016-4670-3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5633630</ArticleId><ArticleId IdType="pubmed">28110412</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Barnato AE, Bell D, Bellomo R, Chong CR, Coats TJ, Davies A, Delaney A, Harrison DA, Holdgate A, Howe B, Huang DT, Iwashyna T, Kellum JA, Peake SL, Pike F, Reade MC, Rowan KM, Singer M, Webb SA, Weissfeld LA, Yealy DM, Young JD. A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe investigators. Intensive Care Med. 2015;41:1549&#x2013;1560. doi: 10.1007/s00134-015-3822-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3822-1</ArticleId><ArticleId IdType="pubmed">25952825</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup Acute renal failure&#x2014;definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204&#x2013;R212. doi: 10.1186/cc2872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2872</ArticleId><ArticleId IdType="pmc">PMC522841</ArticleId><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32828186</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>396</Volume><Issue>10250</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Venoarterial extracorporeal membrane oxygenation to rescue sepsis-induced cardiogenic shock: a retrospective, multicentre, international cohort study.</ArticleTitle><Pagination><StartPage>545</StartPage><EndPage>552</EndPage><MedlinePgn>545-552</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S0140-6736(20)30733-9</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0140-6736(20)30733-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with sepsis-induced cardiomyopathy with cardiogenic shock have a high mortality. This study assessed venoarterial extracorporeal membrane oxygenation (VA-ECMO) support for sepsis-induced cardiogenic shock refractory to conventional treatments.</AbstractText><AbstractText Label="METHODS">In this retrospective, multicentre, international cohort study, we compared outcomes of 82 patients (aged &#x2265;18 years) with septic shock who received VA-ECMO at five academic ECMO centres, with 130 controls (not receiving ECMO) obtained from three large databases of septic shock. All patients had severe myocardial dysfunction (cardiac index 3 L/min per m<sup>2</sup> or less or left ventricular ejection fraction [LVEF] 35% or less) and severe haemodynamic compromise (inotrope score at least 75 &#x3bc;g/kg per min or lactic acidaemia at least 4 mmol/L) at time of inclusion. The primary endpoint was survival at 90 days. A propensity score-weighted analysis was done to control for confounders.</AbstractText><AbstractText Label="FINDINGS">At baseline, patients treated with VA-ECMO had more severe myocardial dysfunction (mean cardiac index 1&#xb7;5 L/min per m<sup>2</sup>vs 2&#xb7;2 L/min per m<sup>2</sup>, LVEF 17% vs 27%), more severe haemodynamic impairment (inotrope score 279 &#x3bc;g/kg per min vs 145 &#x3bc;g/kg per min, lactataemia 8&#xb7;9 mmol/L vs 6&#xb7;5 mmol/L), and more severe organ failure (Sequential Organ Failure Assessment score 17 vs 13) than did controls, with p&lt;0&#xb7;0001 for each comparison. Survival at 90 days for patients treated with VA-ECMO was significantly higher than for controls (60% vs 25%, risk ratio [RR] for mortality 0&#xb7;54, 95% CI [0&#xb7;40-0&#xb7;70]; p&lt;0&#xb7;0001). After propensity score weighting, ECMO remained associated with improved survival (51% vs 14%, adjusted RR for mortality 0&#xb7;57, 95% CI [0&#xb7;35-0&#xb7;93]; p=0&#xb7;0029). Lactate and catecholamine clearance were also significantly enhanced in patients treated with ECMO. Among the 49 survivors treated with ECMO, 32 who had been treated at the largest centre reported satisfactory Short Form-36 evaluated health-related quality of life at 1-year follow-up.</AbstractText><AbstractText Label="INTERPRETATION">Patients with severe sepsis-induced cardiogenic shock treated with VA-ECMO had a large and significant improvement in survival compared with controls not receiving ECMO. However, despite the careful propensity-weighted analysis, we cannot rule out unmeasured confounders.</AbstractText><AbstractText Label="FUNDING">None.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Br&#xe9;chot</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Coll&#xe8;ge de France, Centre of Interdisciplinary Research in Biology, CNRS UMR7241, INSERM U1050, Paris, France. Electronic address: nicolas.brechot@aphp.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hajage</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, INSERM, Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, AP-HP, H&#xf4;pitaux Universitaires Piti&#xe9; Salp&#xea;tri&#xe8;re-Charles Foix, D&#xe9;partement Biostatistique Sant&#xe9; Publique et Information M&#xe9;dicale, Centre de Pharmaco&#xe9;pid&#xe9;miologie (Cephepi), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimmoun</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Centre Hospitalier Universitaire de Nancy and INSERM U1116, Universit&#xe9; de Lorraine, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demiselle</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Centre Hospitalier Universitaire Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agerstrand</LastName><ForeName>Cara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Centre, and New York-Presbyterian Hospital, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero</LastName><ForeName>Santiago</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Acute Cardiovascular Care Unit, Cardiology, Hospital Germans Trias i Pujol, Barcelona, Spain; Departament de Medicina, Universitat Aut&#xf2;noma de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Sorbonne Universit&#xe9; INSERM-UMRS 1166, Institute of Cardiometabolism and Nutrition, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luyt</LastName><ForeName>Charles-Edouard</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Sorbonne Universit&#xe9; INSERM-UMRS 1166, Institute of Cardiometabolism and Nutrition, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebreton</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Chirurgie Cardiaque et Cardiovasculaire, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Sorbonne Universit&#xe9; INSERM-UMRS 1166, Institute of Cardiometabolism and Nutrition, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe9;kimian</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flecher</LastName><ForeName>Erwan</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Service de Chirurgie Cardiaque, Centre Hospitalier Universitaire de Rennes, Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zogheib</LastName><ForeName>Elie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Critical Care Department, Amiens University Hospital, Picardy Jules Verne University, Amiens, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Centre Hospitalier Universitaire de Nancy and INSERM U1116, Universit&#xe9; de Lorraine, Nancy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slutsky</LastName><ForeName>Arthur S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Interdepartmental Division of Critical Care Medicine, Departments of Medicine, Surgery and Biomedical Engineering, University of Toronto, Toronto, ON, Canada; Keenan Research Centre, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brodie</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Medical Centre, and New York-Presbyterian Hospital, Columbia University, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asfar</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Centre Hospitalier Universitaire Angers, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Combes</LastName><ForeName>Alain</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Intensive-R&#xe9;animation, Institut de Cardiologie, Assistance Publique-H&#xf4;pitaux de Paris, H&#xf4;pital Piti&#xe9;-Salp&#xea;tri&#xe8;re, Paris, France; Sorbonne Universit&#xe9; INSERM-UMRS 1166, Institute of Cardiometabolism and Nutrition, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International ECMO Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Lancet. 2020 Aug 22;396(10250):515-517. doi: 10.1016/S0140-6736(20)30762-5.</RefSource><PMID Version="1">32828179</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Nat Rev Cardiol. 2020 Nov;17(11):680. doi: 10.1038/s41569-020-00450-y.</RefSource><PMID Version="1">32913307</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Anaesthesist. 2021 Oct;70(10):888-894. doi: 10.1007/s00101-021-00976-x.</RefSource><PMID Version="1">34324037</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2023 Jul 15;208(2):196-198. doi: 10.1164/rccm.202206-1165RR.</RefSource><PMID Version="1">37141107</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012770" MajorTopicYN="N">Shock, Cardiogenic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32828186</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(20)30733-9</ArticleId><ArticleId IdType="pii">S0140-6736(20)30733-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31454263</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1535-4970</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>15</Day></PubDate></JournalIssue><Title>American journal of respiratory and critical care medicine</Title><ISOAbbreviation>Am J Respir Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Balanced Crystalloids versus Saline in Sepsis. A Secondary Analysis of the SMART Clinical Trial.</ArticleTitle><Pagination><StartPage>1487</StartPage><EndPage>1495</EndPage><MedlinePgn>1487-1495</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1164/rccm.201903-0557OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Administration of intravenous crystalloid solutions is a fundamental therapy for sepsis, but the effect of crystalloid composition on patient outcomes remains unknown.<b>Objectives:</b> To compare the effect of balanced crystalloids versus saline on 30-day in-hospital mortality among critically ill adults with sepsis.<b>Methods:</b> Secondary analysis of patients from SMART (Isotonic Solutions and Major Adverse Renal Events Trial) admitted to the medical ICU with an <i>International Classification of Diseases, 10th Edition, Clinical Modification System</i> code for sepsis, using multivariable regression to control for potential confounders.<b>Measurements and Main Results:</b> Of 15,802 patients enrolled in SMART, 1,641 patients were admitted to the medical ICU with a diagnosis of sepsis. A total of 217 patients (26.3%) in the balanced crystalloids group experienced 30-day in-hospital morality compared with 255 patients (31.2%) in the saline group (adjusted odds ratio [aOR], 0.74; 95% confidence interval [CI], 0.59-0.93; <i>P</i>&#x2009;=&#x2009;0.01). Patients in the balanced group experienced a lower incidence of major adverse kidney events within 30 days (35.4% vs. 40.1%; aOR, 0.78; 95% CI, 0.63-0.97) and a greater number of vasopressor-free days (20&#x2009;&#xb1;&#x2009;12 vs. 19&#x2009;&#xb1;&#x2009;13; aOR, 1.25; 95% CI, 1.02-1.54) and renal replacement therapy-free days (20&#x2009;&#xb1;&#x2009;12 vs. 19&#x2009;&#xb1;&#x2009;13; aOR, 1.35; 95% CI, 1.08-1.69) compared with the saline group.<b>Conclusions:</b> Among patients with sepsis in a large randomized trial, use of balanced crystalloids was associated with a lower 30-day in-hospital mortality compared with use of saline.Clinical trial registered with www.clinicaltrials.gov (NCT02444988).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials><Identifier Source="ORCID">0000-0002-8778-026X</Identifier><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Biostatistics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coston</LastName><ForeName>Taylor D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Nathan I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Department of Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casey</LastName><ForeName>Jonathan D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanderer</LastName><ForeName>Jonathan P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ehrenfeld</LastName><ForeName>Jesse M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Informatics.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Daniel W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Biostatistics.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stollings</LastName><ForeName>Joanna L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Services.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siew</LastName><ForeName>Edward D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Vanderbilt Center for Kidney Disease and Integrated Program for Acute Kidney Injury Research, Division of Nephrology and Hypertension, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Gordon R</ForeName><Initials>GR</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Self</LastName><ForeName>Wesley H</ForeName><Initials>WH</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semler</LastName><ForeName>Matthew W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Division of Allergy, Pulmonary, and Critical Care Medicine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02444988</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000445</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 HL143053</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R34 HL105869</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM110469</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL087738</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR002243</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K12 HL133117</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D065007">Pragmatic Clinical Trial</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Respir Crit Care Med</MedlineTA><NlmUniqueID>9421642</NlmUniqueID><ISSNLinking>1073-449X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077324">Crystalloid Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2019 Dec 15;200(12):1456-1458. doi: 10.1164/rccm.201908-1669ED.</RefSource><PMID Version="1">31513748</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 May 1;201(9):1162-1163. doi: 10.1164/rccm.202001-0077LE.</RefSource><PMID Version="1">31972095</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 May 1;201(9):1161-1162. doi: 10.1164/rccm.201912-2479LE.</RefSource><PMID Version="1">31972097</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2020 May 1;201(9):1163-1164. doi: 10.1164/rccm.202001-0073LE.</RefSource><PMID Version="1">31972099</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077324" MajorTopicYN="N">Crystalloid Solutions</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">balanced crystalloids</Keyword><Keyword MajorTopicYN="N">lactated Ringer&#x2019;s</Keyword><Keyword MajorTopicYN="N">saline</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31454263</ArticleId><ArticleId IdType="pmc">PMC6909845</ArticleId><ArticleId IdType="doi">10.1164/rccm.201903-0557OC</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. CDC Prevention Epicenter Program. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017;318:1241&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowan KM, Angus DC, Bailey M, Barnato AE, Bellomo R, Canter RR, et al. PRISM Investigators. Early, goal-directed therapy for septic shock: a patient-level meta-analysis. N Engl J Med. 2017;376:2223&#x2013;2234.</Citation><ArticleIdList><ArticleId IdType="pubmed">28320242</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. 2016. Crit Care Med. 2017;45:486&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr. 2008;27:179&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313809</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond NE, Taylor C, Finfer S, Machado FR, An Y, Billot L, et al. Fluid-TRIPS and Fluidos Investigators; George Institute for Global Health, The ANZICS Clinical Trials Group, BRICNet, and the REVA research Network. Patterns of intravenous fluid resuscitation use in adult intensive care patients between 2007 and 2014: an international cross-sectional study. PLoS One. 2017;12:e0176292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428917</ArticleId><ArticleId IdType="pubmed">28498856</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury AH, Cox EF, Francis ST, Lobo DNA. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte&#xae; 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg. 2012;256:18&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">22580944</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg. 2012;255:821&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pubmed">22470070</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, et al. SALT Investigators * and the Pragmatic Critical Care Research Group; SALT Investigators. Balanced crystalloids versus saline in the intensive care unit: the SALT randomized trial. Am J Respir Crit Care Med. 2017;195:1362&#x2013;1372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5443900</ArticleId><ArticleId IdType="pubmed">27749094</ArticleId></ArticleIdList></Reference><Reference><Citation>Volta CA, Trentini A, Farabegoli L, Manfrinato MC, Alvisi V, Dallocchio F, et al. Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. J Inflamm (Lond) 2013;10:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4015738</ArticleId><ArticleId IdType="pubmed">24059479</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams EL, Hildebrand KL, McCormick SA, Bedel MJ. The effect of intravenous lactated Ringer&#x2019;s solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth Analg. 1999;88:999&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">10320158</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasman H, Cinar O, Uzun A, Cevik E, Jay L, Comert B. A randomized clinical trial comparing the effect of rapidly infused crystalloids on acid-base status in dehydrated patients in the emergency department. Int J Med Sci. 2012;9:59&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3245412</ArticleId><ArticleId IdType="pubmed">22211091</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Bellomo R, Kramer DJ, Pinsky MR. Etiology of metabolic acidosis during saline resuscitation in endotoxemia. Shock. 1998;9:364&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">9617887</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline. Crit Care Med. 2002;30:300&#x2013;305.</Citation><ArticleIdList><ArticleId IdType="pubmed">11889298</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters JH, Gottlieb A, Schoenwald P, Popovich MJ, Sprung J, Nelson DR. Normal saline versus lactated Ringer&#x2019;s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg. 2001;93:817&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">11574339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Song M, Almasri E. Hyperchloremic acidosis increases circulating inflammatory molecules in experimental sepsis. Chest. 2006;130:962&#x2013;967.</Citation><ArticleIdList><ArticleId IdType="pubmed">17035425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Song M, Venkataraman R. Effects of hyperchloremic acidosis on arterial pressure and circulating inflammatory molecules in experimental sepsis. Chest. 2004;125:243&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pubmed">14718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Orbegozo D, Su F, Santacruz C, He X, Hosokawa K, Creteur J, et al. Effects of different crystalloid solutions on hemodynamics, peripheral perfusion, and the microcirculation in experimental abdominal sepsis. Anesthesiology. 2016;125:744&#x2013;754.</Citation><ArticleIdList><ArticleId IdType="pubmed">27655180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308:1566&#x2013;1572.</Citation><ArticleIdList><ArticleId IdType="pubmed">23073953</ArticleId></ArticleIdList></Reference><Reference><Citation>Raghunathan K, Shaw A, Nathanson B, St&#xfc;rmer T, Brookhart A, Stefan MS, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med. 2014;42:1585&#x2013;1591.</Citation><ArticleIdList><ArticleId IdType="pubmed">24674927</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler MW, Self WH, Wanderer JP, Ehrenfeld JM, Wang L, Byrne DW, et al. SMART Investigators and the Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in critically ill adults. N Engl J Med. 2018;378:829&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5846085</ArticleId><ArticleId IdType="pubmed">29485925</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RM, Wanderer JP, Ehrenfeld JM, Stollings JL, McKown AC, Bernard GR, et al. SALT Investigators; Pragmatic Critical Care Research Group. Balanced crystalloids versus saline for adults with sepsis or septic shock [abstract] Am J Respir Crit Care Med. 2018;197:A6188.</Citation></Reference><Reference><Citation>Semler MW, Self WH, Wang L, Byrne DW, Wanderer JP, Ehrenfeld JM, et al. Isotonic Solutions and Major Adverse Renal Events Trial (SMART) Investigators; Pragmatic Critical Care Research Group. Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial. Trials. 2017;18:129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5356286</ArticleId><ArticleId IdType="pubmed">28302179</ArticleId></ArticleIdList></Reference><Reference><Citation>ICD-10-CM official guidelines for coding and reporting [accessed 2018 May 3]  Available from:  https://www.cdc.gov/nchs/data/icd/10cmguidelines_2017_final.pdf.</Citation></Reference><Reference><Citation>Centers for Medicare and Medicaid Services (CMS), National Center for Health Statistics (NCHS) Hospital inpatient quality reporting program measures: International Classification of Diseases, 10th Edition, Clinical Modification System (ICD-10-CM) draft code sets [accessed 2018 May 3]  Available from:  https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Downloads/HIQR-ICD9-to-ICD10-Tables.pdf.</Citation></Reference><Reference><Citation>Semler MW, Rice TW, Shaw AD, Siew ED, Self WH, Kumar AB, et al. Identification of major adverse kidney events within the electronic health record. J Med Syst. 2016;40:167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5791539</ArticleId><ArticleId IdType="pubmed">27234478</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw A. Models of preventable disease: contrast-induced nephropathy and cardiac surgery-associated acute kidney injury. Contrib Nephrol. 2011;174:156&#x2013;162.</Citation><ArticleIdList><ArticleId IdType="pubmed">21921620</ArticleId></ArticleIdList></Reference><Reference><Citation>Palevsky PM, Molitoris BA, Okusa MD, Levin A, Waikar SS, Wald R, et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012;7:844&#x2013;850.</Citation><ArticleIdList><ArticleId IdType="pubmed">22442182</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17:R25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Zarbock A, Nadim MK. What endpoints should be used for clinical studies in acute kidney injury? Intensive Care Med. 2017;43:901&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">28255614</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;c184.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure: on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber PJ. The behavior of maximum likelihood estimates under nonstandard conditions. In: Fifth Berkeley Symposium on Mathematical Statistics and Probability. Vol. 1: Statistics. Berkeley, CA: University of California Press; 1967. pp. 221&#x2013;233.</Citation></Reference><Reference><Citation>White H. A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity. Econometrica. 1980;48:817&#x2013;838.</Citation></Reference><Reference><Citation>Raghunathan K, Bonavia A, Nathanson BH, Beadles CA, Shaw AD, Brookhart MA, et al. Association between initial fluid choice and subsequent in-hospital mortality during the resuscitation of adults with septic shock. Anesthesiology. 2015;123:1385&#x2013;1393.</Citation><ArticleIdList><ArticleId IdType="pubmed">26414499</ArticleId></ArticleIdList></Reference><Reference><Citation>Filis C, Vasileiadis I, Koutsoukou A. Hyperchloraemia in sepsis. Ann Intensive Care. 2018;8:43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869346</ArticleId><ArticleId IdType="pubmed">29589205</ArticleId></ArticleIdList></Reference><Reference><Citation>Potura E, Lindner G, Biesenbach P, Funk G-C, Reiterer C, Kabon B, et al. An acetate-buffered balanced crystalloid versus 0.9% saline in patients with end-stage renal disease undergoing cadaveric renal transplantation: a prospective randomized controlled trial. Anesth Analg. 2015;120:123&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pubmed">25185593</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfortmueller CA, Funk G-C, Reiterer C, Schrott A, Zotti O, Kabon B, et al. Normal saline versus a balanced crystalloid for goal-directed perioperative fluid therapy in major abdominal surgery: a double-blind randomised controlled study. Br J Anaesth. 2018;120:274&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pubmed">29406176</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunatchik A, Semler MW, Rice TW, Casey JD Pragmatic Critical Care Research Group. Accuracy of the Centers for Medicare and Medicaid Services ICD-10-CM codes in identifying sepsis among critically ill adults [abstract] Am J Respir Crit Care Med. 2017;195:A5016.</Citation></Reference><Reference><Citation>Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">9431328</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, III, Feldman HI, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2763564</ArticleId><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. 2012;2:8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38178170</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>12</StartPage><MedlinePgn>12</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">12</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-023-04795-x</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The impact of therapeutic plasma exchange (TPE) on short-term mortality in adult patients with sepsis-induced organ dysfunction remains uncertain. The objective of the study is to assess the effect of adjunct TPE in this setting through a comprehensive literature review.</AbstractText><AbstractText Label="METHODS">The National Library of Medicine's Medline, Ovid (Embase), the Cochrane Library database and clinicaltrial.gov from January 01, 1966, until October 01, 2022, were searched for terms: therapeutic plasma exchange, plasmapheresis, sepsis, and septic shock. We reviewed, selected and extracted data from relevant randomized clinical trials (RCTs) and matched cohort studies (MCSs) comparing short-term mortality in critically ill adult septic patients treated with standard therapy versus those receiving adjunct TPE. Risk of bias was assessed in the RCTs using Cochrane Collaboration tool and in MCSs using ROBINS-I tool. Summary statistics, risk ratios (RRs), and confidence intervals (CIs) were calculated using random effects model.</AbstractText><AbstractText Label="RESULTS">This systematic review included 937 adult critically ill septic patients from five RCTs (n&#x2009;=&#x2009;367) and fifteen MCSs (n&#x2009;=&#x2009;570). Of these total, 543 received treatment with TPE in addition to standard care. The meta-analysis includes all five RCTs and only six MCSs (n&#x2009;=&#x2009;627). The adjunct TPE treatment (n&#x2009;=&#x2009;300) showed a significant reduction in short-term mortality (RR 0.59, 95% CI 0.47-0.74, I2 3%) compared to standard therapy alone (n&#x2009;=&#x2009;327). The systematic review of all 20 trials revealed that adding TPE to the standard therapy of critically ill septic patients resulted in faster clinical and/or laboratory recovery.</AbstractText><AbstractText Label="CONCLUSIONS">Our comprehensive and up-to-date review demonstrates that adjunct TPE may provide potential survival benefits when compared to standard care for critically ill adult patients with sepsis-induced organ dysfunction. While results of this meta-analysis are encouraging, large well-designed randomized trials are required to identify the optimal patient population and TPE procedure characteristics prior to widespread adoption into practice.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kuklin</LastName><ForeName>Vladimir</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Ahus University Hospital, Sykehusveien, 25, 1478, Lorenskog, Norway. vkuklin@me.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sovershaev</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>F&#xfc;rst Medical Laboratory, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bjerner</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>F&#xfc;rst Medical Laboratory, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keith</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Critical Care Medicine, Lexington Medical Center, West Columbia, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>L Keith</ForeName><Initials>LK</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Louisiana State University Health Sciences Center, Shreveport, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Owen Matthew Truscott</ForeName><Initials>OMT</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Ahus University Hospital, Lorenskog, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szpirt</LastName><ForeName>Wladimir</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rock</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>University of Ottawa, Ottawa, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stegmayr</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Public Health and Clinical Medicine, Umea University, Umea, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010951" MajorTopicYN="N">Plasma Exchange</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38178170</ArticleId><ArticleId IdType="pmc">PMC10768220</ArticleId><ArticleId IdType="doi">10.1186/s13054-023-04795-x</ArticleId><ArticleId IdType="pii">10.1186/s13054-023-04795-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Arina P, Singer M. Pathophysiology of sepsis. Curr Opin Anaesthesiol. 2021;34(2):77&#x2013;84. doi: 10.1097/ACO.0000000000000963.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0000000000000963</ArticleId><ArticleId IdType="pubmed">33652454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;-Carvajal AJ, Sol&#xe0; I, Lathyris D, Cardona AF. Human recombinant activated protein C for severe sepsis. Cochrane Database Syst Rev. 2011 doi: 10.1002/14651858.CD004388.pub.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004388.pub</ArticleId><ArticleId IdType="pubmed">21491390</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, Lemeshow S, Osborn T, Terry KM, Levy MM. Time to treatment and mortality during mandated emergency care for sepsis. N Engl J Med. 2017;376(23):2235&#x2013;2244. doi: 10.1056/NEJMoa1703058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1703058</ArticleId><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharfman WB, Tillotson JR, Taft EG, Wright E. Plasmapheresis for meningococcemia with disseminated intravascular coagulation. N Engl J Med. 1979;300(22):1277&#x2013;1278. doi: 10.1056/NEJM197905313002220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197905313002220</ArticleId><ArticleId IdType="pubmed">431695</ArticleId></ArticleIdList></Reference><Reference><Citation>Vain NE, Mazlumian JR, Swarner OW, Cha CC. Role of exchange transfusion in the treatment of severe septicemia. Pediatrics. 1980;66(5):693&#x2013;697. doi: 10.1542/peds.66.5.693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.66.5.693</ArticleId><ArticleId IdType="pubmed">7432874</ArticleId></ArticleIdList></Reference><Reference><Citation>Norska-Borowka I, Grzywna W, Monsiol A, Karczewska K, Godula-Stuglik U. Usefulness of exchange transfusions in the treatment of septicemia complicated by intravascular coagulation in newborn infants. Pediatr Pol. 1980;55:943&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">7001329</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjorvatn B, Bjertnaes L, Fadnes HO, Flaegstad T, Gutteberg TJ, Kristiansen BE, Pape J, Rekvig OP, Osterud B, Aanderud L. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J. 1984;288(6415):439&#x2013;441. doi: 10.1136/bmj.288.6415.439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.288.6415.439</ArticleId><ArticleId IdType="pmc">PMC1444687</ArticleId><ArticleId IdType="pubmed">6419956</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost. 1983;49(1):5&#x2013;7. doi: 10.1055/s-0038-1657303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0038-1657303</ArticleId><ArticleId IdType="pubmed">6845273</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandtzaeg P, Sirnes K, Folsland B, et al. Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients. Scand J Clin Lab Invest. 1985;178:53&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">3867122</ArticleId></ArticleIdList></Reference><Reference><Citation>Ender LA, Lobakov AI, Lipats AA, Vatazin AV, Filizhanko VN. Plasmapheresis in the complex treatment of suppurative-septic complications of acute surgical diseases of the abdominal organs. Klin Med. 1985;63:98&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">4046544</ArticleId></ArticleIdList></Reference><Reference><Citation>Drapkin MS, Wisch JS, Gelfand JA, Cannon JG, Dinarello CA. Plasmapheresis for fulminant meningococcemia. Pediatr Infect Dis J. 1989;8(6):399&#x2013;400. doi: 10.1097/00006454-198906000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198906000-00015</ArticleId><ArticleId IdType="pubmed">2501752</ArticleId></ArticleIdList></Reference><Reference><Citation>McClelland P, Williams PS, Yaqoob M, et al. Multiple organ failure&#x2014;a role for plasma exchange? Intensive Care Med. 1990;16:100&#x2013;103. doi: 10.1007/BF02575302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02575302</ArticleId><ArticleId IdType="pubmed">2332535</ArticleId></ArticleIdList></Reference><Reference><Citation>Janbon B, Vuillez JP, Carpentier F, Barnoud D, Andr&#xe9;-Poyaud P, Barbe G, Guignier M. Removal of circulating tumor necrosis factor. Its role in septic shock treatment. Ann Med Interne. 1992;143(Suppl 1):13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">1300881</ArticleId></ArticleIdList></Reference><Reference><Citation>Westendorp RG, Brand A, Haanen J, van Hinsbergh VW, Thompson J, van Furth R, Meinders EA. Leukaplasmapheresis in meningococcal septic shock. Am J Med. 1992;92(5):577&#x2013;578. doi: 10.1016/0002-9343(92)90761-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9343(92)90761-y</ArticleId><ArticleId IdType="pubmed">1580309</ArticleId></ArticleIdList></Reference><Reference><Citation>van Deuren M, Santman FW, van Dalen R, Sauerwein RW, Span LF, van der Meer JW. Plasma and whole blood exchange in meningococcal sepsis. Clin Infect Dis. 1992;15(3):424&#x2013;430. doi: 10.1093/clind/15.3.424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clind/15.3.424</ArticleId><ArticleId IdType="pubmed">1520788</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdlund B, Sj&#xf6;lin J, Nilsson A, Roll M, Wickerts CJ, Wikstr&#xf6;m B, Wretlind B. Plasmapheresis in the treatment of primary septic shock in humans. Scand J Infect Dis. 1993;25(6):757&#x2013;761. doi: 10.3109/00365549309008575.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365549309008575</ArticleId><ArticleId IdType="pubmed">8052817</ArticleId></ArticleIdList></Reference><Reference><Citation>Churchwell KB, McManus ML, Kent P, Gorlin J, Galacki D, Humphreys D, Kevy SV. Intensive blood and plasma exchange for treatment of coagulopathy in meningococcemia. J Clin Apher. 1995;10(4):171&#x2013;177. doi: 10.1002/jca.2920100403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.2920100403</ArticleId><ArticleId IdType="pubmed">8770708</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe5;rdlund B, Sj&#xf6;lin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 1995;172(1):296&#x2013;301. doi: 10.1093/infdis/172.1.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/172.1.296</ArticleId><ArticleId IdType="pubmed">7797935</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;tt U, Bj&#xf6;rsell-Ostling E. Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia. Can J Anaesth. 1995;42(1):64&#x2013;68. doi: 10.1007/BF03010573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03010573</ArticleId><ArticleId IdType="pubmed">7889586</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt W, Fritzsche H, Hohenberger W, Zirngibl H. Selective cytokine release induced by serum and separated plasma from septic patients. Eur J Surg. 1996;162(10):769&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">8934105</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med. 1996;22(3):259&#x2013;263. doi: 10.1007/BF01712247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01712247</ArticleId><ArticleId IdType="pubmed">8727442</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell WN, Joshi M, Sileo D. Osteonecrosis following meningococcemia and disseminated intravascular coagulation in an adult: case report and review. Clin Infect Dis. 1997;24(3):452&#x2013;455. doi: 10.1093/clinids/24.3.452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/24.3.452</ArticleId><ArticleId IdType="pubmed">9114199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Kanagasundaram NS, Collyns TA, Davison AM. Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis. Nephrol Dial Transplant. 1998;13(2):484&#x2013;487. doi: 10.1093/oxfordjournals.ndt.a027853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.ndt.a027853</ArticleId><ArticleId IdType="pubmed">9509469</ArticleId></ArticleIdList></Reference><Reference><Citation>Darmon M, Azoulay E, Thiery G, Ciroldi M, Galicier L, Parquet N, Veyradier A, Le Gall JR, Oksenhendler E, Schlemmer B. Time course of organ dysfunction in thrombotic microangiopathy patients receiving either plasma perfusion or plasma exchange. Crit Care Med. 2006;34(8):2127&#x2013;2133. doi: 10.1097/01.CCM.0000227659.14644.3E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000227659.14644.3E</ArticleId><ArticleId IdType="pubmed">16763519</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, Orr RA, Janosky J, Carcillo JA. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008;36(10):2878&#x2013;2887. doi: 10.1097/CCM.0b013e318186aa49.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318186aa49</ArticleId><ArticleId IdType="pmc">PMC2772176</ArticleId><ArticleId IdType="pubmed">18828196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevketoglu E, Yildizdas D, Horoz OO, Kihtir HS, Kendirli T, Bayraktar S, Carcillo JA. Use of therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure in the Turkish thrombocytopenia-associated multiple organ failure network. Pediatr Crit Care Med. 2014;15(8):e354&#x2013;359. doi: 10.1097/PCC.0000000000000227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000227</ArticleId><ArticleId IdType="pmc">PMC5287151</ArticleId><ArticleId IdType="pubmed">25068251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadem J, Hafer C, Schneider AS, Wiesner O, Beutel G, Fuehner T, Welte T, Hoeper MM, Kielstein JT. Therapeutic plasma exchange as rescue therapy in severe sepsis and septic shock: retrospective observational single-centre study of 23 patients. BMC Anesthesiol. 2014;14:24. doi: 10.1186/1471-2253-14-24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-14-24</ArticleId><ArticleId IdType="pmc">PMC3986467</ArticleId><ArticleId IdType="pubmed">24708653</ArticleId></ArticleIdList></Reference><Reference><Citation>De Simone N, Racsa L, Bevan S, Matevosyan K, Valley T, Girod C, Sarode R. Therapeutic plasma exchange in the management of sepsis and multiple organ dysfunction syndrome: a report of three cases. J Clin Apher. 2014;29(2):127&#x2013;131. doi: 10.1002/jca.21296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.21296</ArticleId><ArticleId IdType="pubmed">24000124</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai Y, Cornell TT, Cooley EG, Beckman CN, Baldridge PK, Mottes TA, Luckritz KE, Plomaritas KS, Meade JM, Odetola FO, Han YY, Blatt NB, Annich GM. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med. 2015;16(4):366&#x2013;374. doi: 10.1097/PCC.0000000000000351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000351</ArticleId><ArticleId IdType="pmc">PMC4424057</ArticleId><ArticleId IdType="pubmed">25599148</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Plasmapheresis in severe sepsis or septic shock. Blood Purif. 1996;14(1):94&#x2013;101. doi: 10.1159/000170250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000170250</ArticleId><ArticleId IdType="pubmed">8718572</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Apheresis as therapy for patients with severe sepsis and multiorgan dysfunction syndrome. Ther Apher. 2001;5(2):123&#x2013;127. doi: 10.1046/j.1526-0968.2001.005002123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-0968.2001.005002123.x</ArticleId><ArticleId IdType="pubmed">11354296</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr B. Apheresis in patients with severe sepsis and multi organ dysfunction syndrome. Transfus Apher Sci. 2008;38(3):203&#x2013;208. doi: 10.1016/j.transci.2008.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2008.03.009</ArticleId><ArticleId IdType="pubmed">18492616</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbero E, Livigni S, Ferrari F, Finazzi S, Langer M, Malacarne P, Meca MCC, Mosca S, Olivieri C, Pozzato M, Rossi C, Tavola M, Terzitta M, Viaggi B, Bertolini G. GiViTI High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial. Intensive Care Med. 2021;47(11):1303&#x2013;1311. doi: 10.1007/s00134-021-06501-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06501-3</ArticleId><ArticleId IdType="pubmed">34601619</ArticleId></ArticleIdList></Reference><Reference><Citation>Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med. 1999;27(10):2096&#x2013;2104. doi: 10.1097/00003246-199910000-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199910000-00003</ArticleId><ArticleId IdType="pubmed">10548188</ArticleId></ArticleIdList></Reference><Reference><Citation>Busund R, Koukline V, Utrobin U, Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial. Intensive Care Med. 2002;28(10):1434&#x2013;1439. doi: 10.1007/s00134-002-1410-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1410-7</ArticleId><ArticleId IdType="pubmed">12373468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2209&#x2013;2220. doi: 10.1097/CCM.0b013e31828cf412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828cf412</ArticleId><ArticleId IdType="pmc">PMC3758418</ArticleId><ArticleId IdType="pubmed">23860248</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmer E, Houston BL, Kumar A, Abou-Setta AM, Friesen C, Marshall JC, Rock G, Turgeon AF, Cook DJ, Houston DS, Zarychanski R. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care. 2014;18(6):699. doi: 10.1186/s13054-014-0699-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0699-2</ArticleId><ArticleId IdType="pmc">PMC4318234</ArticleId><ArticleId IdType="pubmed">25527094</ArticleId></ArticleIdList></Reference><Reference><Citation>Putzu A, Schorer R, Lopez-Delgado JC, Cassina T, Landoni G. Blood purification and mortality in sepsis and septic shock: a systematic review and meta-analysis of randomized trials. Anesthesiology. 2019;131(3):580&#x2013;593. doi: 10.1097/ALN.0000000000002820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000002820</ArticleId><ArticleId IdType="pubmed">31246600</ArticleId></ArticleIdList></Reference><Reference><Citation>Snow TAC, Littlewood S, Corredor C, Singer M, Arulkumaran N. Effect of extracorporeal blood purification on mortality in sepsis: a meta-analysis and trial sequential analysis. Blood Purif. 2021;50(4&#x2013;5):462&#x2013;472. doi: 10.1159/000510982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510982</ArticleId><ArticleId IdType="pubmed">33113533</ArticleId></ArticleIdList></Reference><Reference><Citation>Prakash S, Sahu A, Routray SS, Maiti R, Mitra JK, Mukherjee S. Efficacy of therapeutic plasma exchange in severe COVID-19 disease: a meta-analysis. Vox Sang. 2023;118(1):49&#x2013;58. doi: 10.1111/vox.13367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/vox.13367</ArticleId><ArticleId IdType="pmc">PMC9874931</ArticleId><ArticleId IdType="pubmed">36254849</ArticleId></ArticleIdList></Reference><Reference><Citation>Connelly-Smith L, Alquist CR, Aqui N, Hofmann J, Klingel R, Onwuemene O, Patriquin C, Pham H, Sanchez A, Schneiderman J, Witt V, Zantek N, Dunbar N. Guidelines on the use of therapeutic apheresis in clinical practice&#x2013;evidence-based approach from the writing committee of the American society for apheresis: the ninth special issue. J Clin Apher. 2023;38(2):77&#x2013;278. doi: 10.1002/jca.22043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jca.22043</ArticleId><ArticleId IdType="pubmed">37017433</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr&#xf3;bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:71. doi: 10.1136/bmj.n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, G&#xf8;tzsche PC, J&#xfc;ni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group. Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC, Savovi&#x107; J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hr&#xf3;bjartsson A, Kirkham J, J&#xfc;ni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Sch&#xfc;nemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JP. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi: 10.1136/bmj.i4919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team (2023). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, https://www.R-project.org/.</Citation></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;160. doi: 10.1136/ebmental-2019-300117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pmc">PMC10231495</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId></ArticleIdList></Reference><Reference><Citation>McGuinness, LA robvis: An R package and web application for visualising risk-of-bias assessments. 2019, https://github.com/mcguinlu/robvis</Citation><ArticleIdList><ArticleId IdType="pubmed">32336025</ArticleId></ArticleIdList></Reference><Reference><Citation>Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, Tamim H, Alqahtani SA, Kutsogiannis DJ, Brindley PG, Karakitsos D, Memish ZA. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents. 2021;57(5):106334. doi: 10.1016/j.ijantimicag.2021.106334.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106334</ArticleId><ArticleId IdType="pmc">PMC8024223</ArticleId><ArticleId IdType="pubmed">33838224</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J, Chen M, Fang D, Liu D, Guo R, Yang S. Therapeutic plasma exchange protects patients with sepsis-associated disseminated intravascular coagulation by improving endothelial function. Clin Appl Thromb Hemost. 2021 doi: 10.1177/10760296211053313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211053313</ArticleId><ArticleId IdType="pmc">PMC8597066</ArticleId><ArticleId IdType="pubmed">34775801</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K, Wand P, Seeliger B, Wendel-Garcia PD, Schmidt JJ, Schmidt BMW, Sauer A, Lehmann F, Budde U, Busch M, Wiesner O, Welte T, Haller H, Wedemeyer H, Putensen C, Hoeper MM, Bode C, David S. Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial. Crit Care. 2022;26(1):134. doi: 10.1186/s13054-022-04003-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04003-2</ArticleId><ArticleId IdType="pmc">PMC9097091</ArticleId><ArticleId IdType="pubmed">35551628</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG, Jakobson S, Rydvall A, Bj&#xf6;rsell-Ostling E. Plasma exchange in patients with acute renal failure in the course of multiorgan failure. Int J Artif Organs. 1995;18(1):45&#x2013;52. doi: 10.1177/039139889501800110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039139889501800110</ArticleId><ArticleId IdType="pubmed">7607758</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG. Plasma exchange in patients with septic shock including acute renal failure. Blood Purif. 1996;14(1):102&#x2013;108. doi: 10.1159/000170251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000170251</ArticleId><ArticleId IdType="pubmed">8718573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorth V, Stenlund G. Plasmapheresis as part of the treatment for septic shock. Scand J Infect Dis. 2000;32(5):511&#x2013;514. doi: 10.1080/003655400458794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/003655400458794</ArticleId><ArticleId IdType="pubmed">11055656</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt J, Mann S, Mohr VD, Lampert R, Firla U, Zirngibl H. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med. 2000;26(5):532&#x2013;537. doi: 10.1007/s001340051200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340051200</ArticleId><ArticleId IdType="pubmed">10923726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ataman K, Jehmlich M, Kock S, Neumann S, Leischik M, Filipovic Z, Hopf HB. Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock. Intensive Care Med. 2002;28(8):1164&#x2013;1167. doi: 10.1007/s00134-002-1375-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-002-1375-6</ArticleId><ArticleId IdType="pubmed">12185443</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T. Plasma exchange as rescue therapy in multiple organ failure including acute renal failure. Crit Care Med. 2003;31(6):1730&#x2013;1736. doi: 10.1097/01.CCM.0000064742.00981.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000064742.00981.14</ArticleId><ArticleId IdType="pubmed">12794412</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaup H, Stahl K, Schmidt BMW, Idowu TO, Busch M, Wiesner O, Welte T, Haller H, Kielstein JT, Hoeper MM, David S. Early therapeutic plasma exchange in septic shock: a prospective open-label nonrandomized pilot study focusing on safety, hemodynamics, vascular barrier function, and biologic markers. Crit Care. 2018;22(1):285. doi: 10.1186/s13054-018-2220-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2220-9</ArticleId><ArticleId IdType="pmc">PMC6206942</ArticleId><ArticleId IdType="pubmed">30373638</ArticleId></ArticleIdList></Reference><Reference><Citation>Keith PD, Wells AH, Hodges J, Fast SH, Adams A, Scott LK. The therapeutic efficacy of adjunct therapeutic plasma exchange for septic shock with multiple organ failure: a single-center experience. Crit Care. 2020;24(1):518. doi: 10.1186/s13054-020-03241-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03241-6</ArticleId><ArticleId IdType="pmc">PMC7443810</ArticleId><ArticleId IdType="pubmed">32831133</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed RM, Soliman AR, Yousry A, Marzouk K, Faris F. Efficacy of 4-hour rescue therapeutic plasma exchange in severe septic shock patients. Rom J Intern Med. 2020;58(2):75&#x2013;80. doi: 10.2478/rjim-2019-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjim-2019-0026</ArticleId><ArticleId IdType="pubmed">31955149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gucyetmez B, Atalan HK, Sertdemir I, Cakir U, Telci L, COVID-19 Study Group Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study. Crit Care. 2020;24(1):492. doi: 10.1186/s13054-020-03215-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03215-8</ArticleId><ArticleId IdType="pmc">PMC7414262</ArticleId><ArticleId IdType="pubmed">32771054</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamis F, Al-Zakwani I, Al Hashmi S, Al Dowaiki S, Al Bahrani M, Pandak N, Al Khalili H, Memish Z. Therapeutic plasma exchange in adults with severe COVID-19 infection. Int J Infect Dis. 2020;99:214&#x2013;218. doi: 10.1016/j.ijid.2020.06.064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.064</ArticleId><ArticleId IdType="pmc">PMC7308750</ArticleId><ArticleId IdType="pubmed">32585284</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamran SM, Mirza ZE, Naseem A, Liaqat J, Fazal I, Alamgir W, Saeed F, Saleem S, Nisar S, Yousaf MA, Khan AZ, Hussain M, Azam R, Hussain M, Khan KA, Jamal Y, Iftikhar R. Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study. PLoS ONE. 2021;16(1):e0244853. doi: 10.1371/journal.pone.0244853.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244853</ArticleId><ArticleId IdType="pmc">PMC7790281</ArticleId><ArticleId IdType="pubmed">33411791</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal V, Nasa P, Raouf M, Gupta M, Dewedar H, Mohammad H, Al Rais Z, Ali Baqer M, Alsabbah A, Ibrahim Y, Salem M, Shammass D, Marashi M. Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19-An exploratory study. Int J Infect Dis. 2021;102:332&#x2013;334. doi: 10.1016/j.ijid.2020.10.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.085</ArticleId><ArticleId IdType="pmc">PMC7607263</ArticleId><ArticleId IdType="pubmed">33157287</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676&#x2013;680. doi: 10.1001/jama.295.6.676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.6.676</ArticleId><ArticleId IdType="pubmed">16467236</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee OPE, Kanesan N, Leow EH, Sultana R, Chor YK, Gan CS, Lee JH. Survival benefits of therapeutic plasma exchange in severe sepsis and septic shock: a systematic review and meta-analysis. J Intensive Care Med. 2023;38(7):598&#x2013;611. doi: 10.1177/08850666231170775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/08850666231170775</ArticleId><ArticleId IdType="pubmed">37097910</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. 2020;18:1324&#x2013;1329. doi: 10.1111/jth.14859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14859</ArticleId><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ, Lai PC, Lee TH, Huang YT. Blood purification for adult patients with severe infection or sepsis/septic shock: a network meta-analysis of randomized controlled trials. Crit Care Med. 2023 doi: 10.1097/CCM.0000000000005991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005991</ArticleId><ArticleId IdType="pmc">PMC10645104</ArticleId><ArticleId IdType="pubmed">37470680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan D, Yao R, Xie X, Fu X, Pei S, Wang Y, Xu D, Li N. The therapeutic efficacy of plasmapheresis for sepsis with multiple organ failure: a propensity score-matched analysis based on the MIMIC-IV database. Shock. 2023 doi: 10.1097/SHK.0000000000002254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000002254</ArticleId><ArticleId IdType="pubmed">37988068</ArticleId></ArticleIdList></Reference><Reference><Citation>Rock G, Weber V, Stegmayr B. Therapeutic plasma exchange (TPE) as a plausible rescue therapy in severe vaccine-induced immune thrombotic thrombocytopenia. Transfus Apher Sci. 2021;60(4):103174. doi: 10.1016/j.transci.2021.103174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.transci.2021.103174</ArticleId><ArticleId IdType="pubmed">34088601</ArticleId></ArticleIdList></Reference><Reference><Citation>Momen-Heravi F. Isolation of extracellular vesicles by ultracentrifugation. Methods Mol Biol. 2017;1660:25&#x2013;32. doi: 10.1007/978-1-4939-7253-1_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-7253-1_3</ArticleId><ArticleId IdType="pubmed">28828645</ArticleId></ArticleIdList></Reference><Reference><Citation>Stegmayr B, Abdel-Rahman EM, Balogun RA. Septic shock with multiorgan failure: from conventional apheresis to adsorption therapies. Semin Dial. 2012;25:171&#x2013;175. doi: 10.1111/j.1525-139X.2011.01029.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-139X.2011.01029.x</ArticleId><ArticleId IdType="pubmed">22329732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura Y, Holland LZ. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm. Int J Hematol. 2022;115(4):457&#x2013;469. doi: 10.1007/s12185-022-03324-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-022-03324-w</ArticleId><ArticleId IdType="pmc">PMC8938647</ArticleId><ArticleId IdType="pubmed">35316498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedeva C, Menassa J, Puthalakath H. Sepsis: inflammation is a necessary evil. Front Cell Dev Biol. 2019;7:108. doi: 10.3389/fcell.2019.00108.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2019.00108</ArticleId><ArticleId IdType="pmc">PMC6596337</ArticleId><ArticleId IdType="pubmed">31281814</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, Merdji H, Clere-Jehl R, Schenck M, Fagot Gandet F, Fafi-Kremer S, Castelain V, Schneider F, Grunebaum L, Angl&#xe9;s-Cano E, Sattler L, Mertes PM, Meziani F, CRICS TRIGGERSEP Group High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46:1089&#x2013;1098. doi: 10.1007/s00134-020-06062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06062-x</ArticleId><ArticleId IdType="pmc">PMC7197634</ArticleId><ArticleId IdType="pubmed">32367170</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30028362</PMID><DateCompleted><Year>2019</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Effect of Thiamine Administration on Lactate Clearance and Mortality in Patients With Septic Shock.</ArticleTitle><Pagination><StartPage>1747</StartPage><EndPage>1752</EndPage><MedlinePgn>1747-1752</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000003311</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Mounting evidence has shown that critically ill patients are commonly thiamine deficient. We sought to test the hypothesis that critically ill patients with septic shock exposed to thiamine would demonstrate improved lactate clearance and more favorable clinical outcomes compared with those not receiving thiamine.</AbstractText><AbstractText Label="DESIGN">Retrospective, single-center, matched cohort study.</AbstractText><AbstractText Label="SETTING">Tertiary care academic medical center.</AbstractText><AbstractText Label="PATIENTS">Adult patients admitted with an International Classification of Diseases, 9th Edition, or International Classification of Diseases, 10th Edition, diagnosis code of septic shock to either the medicine or surgery ICU.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Patients who received IV thiamine supplementation within 24 hours of hospital admission were identified and compared with a matched cohort of patients not receiving thiamine. The primary objective was to determine if thiamine administration was associated with a reduced time to lactate clearance in septic shock. Secondary outcomes included 28-day mortality, acute kidney injury, and need for renal replacement therapy, and vasopressor and mechanical ventilation-free days. Two-thousand two-hundred seventy-two patients were screened, of whom 1,049 were eligible. The study consisted of 123 thiamine-treated patients matched with 246 patients who did not receive thiamine. Based on the Fine-Gray survival model, treatment with thiamine was associated with an improved likelihood of lactate clearance (subdistribution hazard ratio, 1.307; 95% CI, 1.002-1.704). Thiamine administration was also associated with a reduction in 28-day mortality (hazard ratio, 0.666; 95% CI, 0.490-0.905). There were no differences in any secondary outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">Thiamine administration within 24 hours of admission in patients presenting with septic shock was associated with improved lactate clearance and a reduction in 28-day mortality compared with matched controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Woolum</LastName><ForeName>Jordan A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abner</LastName><ForeName>Erin L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>University of Kentucky College of Public Health, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Health Services Research, University of Kentucky HealthCare, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson Bastin</LastName><ForeName>Melissa L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine, Lexington, KY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flannery</LastName><ForeName>Alexander H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Science, University of Kentucky College of Pharmacy, Lexington, KY.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020011">Protective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>12001-76-2</RegistryNumber><NameOfSubstance UI="D014803">Vitamin B Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>X66NSO3N35</RegistryNumber><NameOfSubstance UI="D013831">Thiamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2018 Nov;46(11):1869-1870. doi: 10.1097/CCM.0000000000003336.</RefSource><PMID Version="1">30312231</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2019 Feb;47(2):e153-e154. doi: 10.1097/CCM.0000000000003450.</RefSource><PMID Version="1">30653069</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2019 Feb;47(2):e154. doi: 10.1097/CCM.0000000000003533.</RefSource><PMID Version="1">30653070</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2019 May;47(5):e434-e435. doi: 10.1097/CCM.0000000000003684.</RefSource><PMID Version="1">30985471</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2019 May;47(5):e435-e436. doi: 10.1097/CCM.0000000000003706.</RefSource><PMID Version="1">30985472</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020011" MajorTopicYN="N">Protective Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013831" MajorTopicYN="N">Thiamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014803" MajorTopicYN="N">Vitamin B Complex</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30028362</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000003311</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27695824</PMID><DateCompleted><Year>2016</Year><Month>12</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>316</Volume><Issue>17</Issue><PubDate><Year>2016</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial.</ArticleTitle><Pagination><StartPage>1775</StartPage><EndPage>1785</EndPage><MedlinePgn>1775-1785</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2016.14799</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Adjunctive hydrocortisone therapy is suggested by the Surviving Sepsis Campaign in refractory septic shock only. The efficacy of hydrocortisone in patients with severe sepsis without shock remains controversial.</AbstractText><AbstractText Label="OBJECTIVE">To determine whether hydrocortisone therapy in patients with severe sepsis prevents the development of septic shock.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Double-blind, randomized clinical trial conducted from January 13, 2009, to August 27, 2013, with a follow-up of 180 days until February 23, 2014. The trial was performed in 34 intermediate or intensive care units of university and community hospitals in Germany, and it included 380 adult patients with severe sepsis who were not in septic shock.</AbstractText><AbstractText Label="INTERVENTIONS">Patients were randomly allocated 1:1 either to receive a continuous infusion of 200 mg of hydrocortisone for 5 days followed by dose tapering until day 11 (n&#x2009;=&#x2009;190) or to receive placebo (n&#x2009;=&#x2009;190).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome was development of septic shock within 14 days. Secondary outcomes were time until septic shock, mortality in the intensive care unit or hospital, survival up to 180 days, and assessment of secondary infections, weaning failure, muscle weakness, and hyperglycemia (blood glucose level &gt;150 mg/dL [to convert to millimoles per liter, multiply by 0.0555]).</AbstractText><AbstractText Label="RESULTS">The intention-to-treat population consisted of 353 patients (64.9% male; mean [SD] age, 65.0 [14.4] years). Septic shock occurred in 36 of 170 patients (21.2%) in the hydrocortisone group and 39 of 170 patients (22.9%) in the placebo group (difference, -1.8%; 95% CI, -10.7% to 7.2%; P&#x2009;=&#x2009;.70). No significant differences were observed between the hydrocortisone and placebo groups for time until septic shock; mortality in the intensive care unit or in the hospital; or mortality at 28 days (15 of 171 patients [8.8%] vs 14 of 170 patients [8.2%], respectively; difference, 0.5%; 95% CI, -5.6% to 6.7%; P&#x2009;=&#x2009;.86), 90 days (34 of 171 patients [19.9%] vs 28 of 168 patients [16.7%]; difference, 3.2%; 95% CI, -5.1% to 11.4%; P&#x2009;=&#x2009;.44), and 180 days (45 of 168 patients [26.8%] vs 37 of 167 patients [22.2%], respectively; difference, 4.6%; 95% CI, -4.6% to 13.7%; P&#x2009;=&#x2009;.32). In the hydrocortisone vs placebo groups, 21.5% vs 16.9% had secondary infections, 8.6% vs 8.5% had weaning failure, 30.7% vs 23.8% had muscle weakness, and 90.9% vs 81.5% had hyperglycemia.</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults with severe sepsis not in septic shock, use of hydrocortisone compared with placebo did not reduce the risk of septic shock within 14 days. These findings do not support the use of hydrocortisone in these patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION">clinicaltrials.gov Identifier: NCT00670254.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Keh</LastName><ForeName>Didier</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trips</LastName><ForeName>Evelyn</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clinical Trial Centre Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marx</LastName><ForeName>Gernot</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wirtz</LastName><ForeName>Stefan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Bad Saarow, Bad Saarow, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abduljawwad</LastName><ForeName>Emad</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Bad Saarow, Bad Saarow, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bercker</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogatsch</LastName><ForeName>Holger</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Trial Centre Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Briegel</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Klinikum der Ludwig-Maximilians-Universit&#xe4;t, M&#xfc;nchen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engel</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerlach</LastName><ForeName>Herwig</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Management, Vivantes-Klinikum Neuk&#xf6;lln, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldmann</LastName><ForeName>Anton</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Sven-Olaf</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Ernst Moritz Arndt University, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xfc;ter</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Zentralklinik Bad Berka, Bad Berka, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier-Hellmann</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Management, HELIOS Hospital Erfurt, Erfurt, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nierhaus</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kluge</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehmke</LastName><ForeName>Josefa</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology and Intensive Care Medicine, Vivantes Humboldt Klinikum, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oppert</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care Medicine, Klinikum Ernst von Bergmann, Potsdam, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Resener</LastName><ForeName>Kerstin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, HELIOS Hospital Berlin-Buch, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;dler</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schuerholz</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care and Intermediate Care, University Hospital RWTH Aachen, Aachen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiler</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Center Schleswig Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weyland</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care Medicine, Emergency Medicine and Pain Management, Klinikum Oldenburg Medical Campus Carl von Ossietzky Universit&#xe4;t, Oldenburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reinhart</LastName><ForeName>Konrad</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunkhorst</LastName><ForeName>Frank M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Center for Clinical Studies, Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SepNet&#x2013;Critical Care Trials Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00670254</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2016 Nov 1;316(17):1769-1771. doi: 10.1001/jama.2016.13904.</RefSource><PMID Version="1">27695850</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Ann Intern Med. 2017 Jan 17;166(2):JC10. doi: 10.7326/ACPJC-2017-166-2-010.</RefSource><PMID Version="1">28114466</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Am J Respir Crit Care Med. 2017 Dec 1;196(11):1473-1475. doi: 10.1164/rccm.201701-0245RR.</RefSource><PMID Version="1">29043839</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057194" MajorTopicYN="N">Intention to Treat Analysis</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27695824</ArticleId><ArticleId IdType="doi">10.1001/jama.2016.14799</ArticleId><ArticleId IdType="pii">2565176</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39197514</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>167</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Mortality in Patients With Sepsis Treated With Esmolol or Landiolol: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>121</StartPage><EndPage>138</EndPage><MedlinePgn>121-138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2024.08.020</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(24)05061-X</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The latest meta-analysis indicated potential survival benefits from ultra-short-acting &#x3b2;-blockers in patients with sepsis with persistent tachycardia. However, subsequent multicenter randomized controlled trials (RCTs) have reported conflicting findings, prompting the need for an updated meta-analysis to incorporate these newly published RCTs.</AbstractText><AbstractText Label="RESEARCH QUESTION" NlmCategory="OBJECTIVE">Does the use of ultra-short-acting &#x3b2;-blockers (esmolol or landiolol) in patients with sepsis with persistent tachycardia improve mortality?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">We conducted an updated systematic search through April 2, 2024, exploring the MEDLINE, Cochrane Central Register of Controlled Trials, and Embase databases for RCTs reporting mortality in adult patients with sepsis treated with esmolol or landiolol as compared with those treated with neither of these or receiving placebo and published in English. Meta-analyses were conducted with the random effects model. The primary outcome was mortality at the longest follow-up, with subgroup analysis separating single-center RCTS from large multicenter RCTs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eight RCTs (885 patients) were included in the primary analysis. Ultra-short-acting &#x3b2;-blockers did not improve mortality significantly at the longest follow-up (risk ratio, 0.84; 95%&#xa0;CI, 0.68-1.02; P&#xa0;= .08; I<sup>2</sup>&#xa0;= 51%; very low certainty of the evidence) and 28-day mortality (risk ratio, 0.77; 95%&#xa0;CI, 0.59-1.00; P&#xa0;= .05; I<sup>2</sup>&#xa0;= 62%). Subgroup analyses of mortality outcomes pointed toward different results between single-center and multicenter RCTs. Trial sequence analyses showed that both mortality outcomes were not robust. The sensitivity analyses suggested a significant reduction in mortality by adding RCTs published in non-English languages.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">In this updated meta-analysis, the use of esmolol or landiolol did not reduce mortality in patients with sepsis with persistent tachycardia. However, results were not robust and outcomes differed between single-center and multicenter RCTs. Moreover, sensitivity analyses showed the fragility of the primary outcome. Further studies regarding ultra-short-acting &#x3b2;-blockers with advanced cardiac monitoring or serial echocardiography are warranted.</AbstractText><AbstractText Label="TRIAL REGISTRY" NlmCategory="BACKGROUND">International Prospective Register of Systematic Reviews; No.: CRD42024503570; URL: https://www.crd.york.ac.uk/prospero/.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Medicine, The Queen's Medical Center, Honolulu, HI. Electronic address: st051035@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Messina</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy; School of Anesthesia and Intensive Care, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasegawa</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santonocito</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scimonello</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>School of Anesthesia and Intensive Care, University Magna Graecia, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department Clinical Internal, Anesthesiological and Cardiovascular Sciences, University of Rome, "La Sapienza," Policlinico Umberto Primo, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugar</LastName><ForeName>Siddharth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Respiratory Institute, Cleveland Clinic, Cleveland, OH; Cleveland Clinic Lerner College of Medicine, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, A.O.U. Policlinico-San Marco, Site "Policlinico G. Rodolico", Catania, Italy; Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>62NWQ924LH</RegistryNumber><NameOfSubstance UI="C077049">landiolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>MDY902UXSR</RegistryNumber><NameOfSubstance UI="C036604">esmolol</NameOfSubstance></Chemical><Chemical><RegistryNumber>8W8T17847W</RegistryNumber><NameOfSubstance UI="D014508">Urea</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009025">Morpholines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000319">Adrenergic beta-Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011412">Propanolamines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014508" MajorTopicYN="Y">Urea</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009025" MajorTopicYN="Y">Morpholines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000319" MajorTopicYN="Y">Adrenergic beta-Antagonists</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011412" MajorTopicYN="Y">Propanolamines</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013610" MajorTopicYN="Y">Tachycardia</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">esmolol</Keyword><Keyword MajorTopicYN="N">landiolol</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">tachycardia</Keyword><Keyword MajorTopicYN="N">&#x3b2;-blockers</Keyword></KeywordList><CoiStatement>Financial/Nonfinancial Disclosures None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>11</Day><Hour>14</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39197514</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2024.08.020</ArticleId><ArticleId IdType="pii">S0012-3692(24)05061-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38598125</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial.</ArticleTitle><Pagination><StartPage>678</StartPage><EndPage>686</EndPage><MedlinePgn>678-686</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-024-07385-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to examine the effects of intravenous (IV) fluid restriction on time to resolution of hyperlactatemia in septic shock. Hyperlactatemia in sepsis is associated with worse outcome. Sepsis guidelines suggest targeting lactate clearance to guide fluid therapy despite the complexity of hyperlactatemia and the potential harm of fluid overload.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a post hoc analysis of serial plasma lactate concentrations in a sub-cohort of 777 patients from the international multicenter clinical CLASSIC trial (restriction of intravenous fluids in intensive care unit (ICU) patients with septic shock). Adult ICU patients with septic shock had been randomized to restrictive (n&#x2009;=&#x2009;385) or standard (n&#x2009;=&#x2009;392) intravenous fluid therapy. The primary outcome, time to resolution of hyperlactatemia, was analyzed with a competing-risks regression model. Death and discharge were competing outcomes, and administrative censoring was imposed 72 h after randomization if hyperlactatemia persisted. The regression analysis was adjusted for the same stratification variables and covariates as in the original CLASSIC trial analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The hazard ratios (HRs) for the cumulative probability of resolution of hyperlactatemia, in the restrictive vs the standard group, in the unadjusted analysis, with time split, were 0.94 (confidence interval (CI) 0.78-1.14) at day 1 and 1.21 (0.89-1.65) at day 2-3. The adjusted analyses were consistent with the unadjusted results.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this post hoc retrospective analysis of a multicenter randomized controlled trial (RCT), a restrictive intravenous fluid strategy did not seem to affect the time to resolution of hyperlactatemia in adult ICU patients with septic shock.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ahlstedt</LastName><ForeName>Christian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0009-0005-8206-0801</Identifier><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark. christian.ahlstedt@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Praleene</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kriz</LastName><ForeName>Miroslav</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, First Department of Internal Medicine, Faculty of Medicine, Teaching Hospital and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobson</LastName><ForeName>Gustaf</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sylvest Meyhoff</LastName><ForeName>Tine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skov Kaas-Hansen</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Manne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollenberg</LastName><ForeName>Jacob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Science and Education, Karolinska Institutet, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalos</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Intensive Care Unit, First Department of Internal Medicine, Faculty of Medicine, Teaching Hospital and Biomedical Center in Pilsen, Charles University, Pilsen, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Perioperative and Intensive Care Medicine, Masaryk Hospital, Jan Evangelista Purkyn&#x4d7; University, &#xda;sti Nad Labem, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rooijackers</LastName><ForeName>Olav</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hylander M&#xf8;ller</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science and Education, Karolinska Institutet, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grip</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care (PMI), K32, Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065906" MajorTopicYN="Y">Hyperlactatemia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Hyperlactatemia</Keyword><Keyword MajorTopicYN="N">Lactate</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>8</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38598125</ArticleId><ArticleId IdType="pmc">PMC11078841</ArticleId><ArticleId IdType="doi">10.1007/s00134-024-07385-9</ArticleId><ArticleId IdType="pii">10.1007/s00134-024-07385-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, Liu VX, Deutschman CS, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):775&#x2013;787. doi: 10.1001/jama.2016.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Bellomo R, Bakker J. The ten pitfalls of lactate clearance in sepsis. Intensive Care Med. 2019;45(1):82&#x2013;85. doi: 10.1007/s00134-018-5213-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5213-x</ArticleId><ArticleId IdType="pmc">PMC6334727</ArticleId><ArticleId IdType="pubmed">29754310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker J, de Backer D, Hernandez G. Lactate-guided resuscitation saves lives: we are not sure. Intensive Care Med. 2016;42(3):472&#x2013;474. doi: 10.1007/s00134-016-4220-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4220-z</ArticleId><ArticleId IdType="pubmed">26831675</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49(11):e1063&#x2013;e1143. doi: 10.1097/CCM.0000000000005337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005337</ArticleId><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushimoto S, Akaishi S, Sato T, Nomura R, Fujita M, Kudo D, et al. Lactate, a useful marker for disease mortality and severity but an unreliable marker of tissue hypoxia/hypoperfusion in critically ill patients. Acute Med Surg. 2016;3(4):293&#x2013;297. doi: 10.1002/ams2.207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.207</ArticleId><ArticleId IdType="pmc">PMC5667335</ArticleId><ArticleId IdType="pubmed">29123802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloos F, Zhang Z, Boulain T. Lactate-guided resuscitation saves lives: yes. Intensive Care Med. 2016;42(3):466&#x2013;469. doi: 10.1007/s00134-015-4196-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-4196-0</ArticleId><ArticleId IdType="pubmed">26831674</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnet X, Delaney A, Barnato A. Lactate-guided resuscitation saves lives: no. Intensive Care Med. 2016;42(3):470&#x2013;471. doi: 10.1007/s00134-016-4235-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4235-5</ArticleId><ArticleId IdType="pubmed">26831673</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259&#x2013;265. doi: 10.1097/CCM.0b013e3181feeb15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181feeb15</ArticleId><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Haijin L, An Y, Wei X, Yi X, Yi H. Early lactate levels for prediction of mortality in patients with sepsis or septic shock: a meta-analysis. Int J Clin Exp Med. 2017;10:37&#x2013;47.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, M&#xf8;ller MH, Wetterslev J, Lange T, Kjaer MN, et al. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan. Acta Anaesthesiol Scand. 2019;63(9):1262&#x2013;1271. doi: 10.1111/aas.13434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13434</ArticleId><ArticleId IdType="pubmed">31276193</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386(26):2459&#x2013;2470. doi: 10.1056/NEJMoa2202707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202707</ArticleId><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;r MN, Meyhoff TS, Sivapalan P, Granholm A, Hjortrup PB, Madsen MB, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023;49(7):820&#x2013;830. doi: 10.1007/s00134-023-07114-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07114-8</ArticleId><ArticleId IdType="pmc">PMC10354110</ArticleId><ArticleId IdType="pubmed">37330928</ArticleId></ArticleIdList></Reference><Reference><Citation>Granholm A, Perner A, Krag M, Hjortrup PB, Haase N, Holst LB, et al. Simplified Mortality Score for the Intensive Care Unit (SMS-ICU): protocol for the development and validation of a bedside clinical prediction rule. BMJ Open. 2017;7(3):e015339. doi: 10.1136/bmjopen-2016-015339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015339</ArticleId><ArticleId IdType="pmc">PMC5353313</ArticleId><ArticleId IdType="pubmed">28279999</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller B, Schmidt G, Ulm K. Applying competing risks regression models: an overview. Lifetime Data Anal. 2013;19(1):33&#x2013;58. doi: 10.1007/s10985-012-9230-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10985-012-9230-8</ArticleId><ArticleId IdType="pubmed">23010807</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradburn MJ, Clark TG, Love SB, Altman DG. Survival analysis Part III: multivariate data analysis&#x2014;choosing a model and assessing its adequacy and fit. Br J Cancer. 2003;89(4):605&#x2013;611. doi: 10.1038/sj.bjc.6601120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6601120</ArticleId><ArticleId IdType="pmc">PMC2376927</ArticleId><ArticleId IdType="pubmed">12915864</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Wetterslev J, Lange T, Bundgaard H, Rasmussen BS, et al. Effects of fluid restriction on measures of circulatory efficacy in adults with septic shock. Acta Anaesthesiol Scand. 2017;61(4):390&#x2013;398. doi: 10.1111/aas.12862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12862</ArticleId><ArticleId IdType="pubmed">28150304</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettil&#xe4; V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Rivers EP, Knoblich BP, Jacobsen G, Muzzin A, Ressler JA, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637&#x2013;1642. doi: 10.1097/01.CCM.0000132904.35713.A7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000132904.35713.A7</ArticleId><ArticleId IdType="pubmed">15286537</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold RC, Shapiro NI, Jones AE, Schorr C, Pope J, Casner E, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35&#x2013;39. doi: 10.1097/SHK.0b013e3181971d47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181971d47</ArticleId><ArticleId IdType="pubmed">19533847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chertoff J, Chisum M, Garcia B, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J Intensive Care. 2015;3:39. doi: 10.1186/s40560-015-0105-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-015-0105-4</ArticleId><ArticleId IdType="pmc">PMC4594907</ArticleId><ArticleId IdType="pubmed">26445673</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan E, Hern&#xe1;ndez G, Ospina-Tasc&#xf3;n G, Valenzuela ED, Bakker J, Castro R. A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study. Ann Intensive Care. 2020;10(1):114. doi: 10.1186/s13613-020-00732-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00732-1</ArticleId><ArticleId IdType="pmc">PMC7450018</ArticleId><ArticleId IdType="pubmed">32845407</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez G, Ospina-Tasc&#xf3;n GA, Damiani LP, Estenssoro E, Dubin A, Hurtado J, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock: the ANDROMEDA-SHOCK randomized clinical trial. JAMA. 2019;321(7):654&#x2013;664. doi: 10.1001/jama.2019.0071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.0071</ArticleId><ArticleId IdType="pmc">PMC6439620</ArticleId><ArticleId IdType="pubmed">30772908</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739&#x2013;746. doi: 10.1001/jama.2010.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.158</ArticleId><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Schoonderbeek FJ, Sleeswijk Visser SJ, van der Klooster JM, Lima AP, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752&#x2013;761. doi: 10.1164/rccm.200912-1918OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200912-1918OC</ArticleId><ArticleId IdType="pubmed">20463176</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan E, Bakker J, Estenssoro E, Ospina-Tasc&#xf3;n GA, Cavalcanti AB, Backer D, et al. Hemodynamic phenotype-based, capillary refill time-targeted resuscitation in early septic shock: The ANDROMEDA-SHOCK-2 Randomized Clinical Trial study protocol. Rev Bras Ter Intensiva. 2022;34(1):96&#x2013;106. doi: 10.5935/0103-507X.20220004-en.</Citation><ArticleIdList><ArticleId IdType="doi">10.5935/0103-507X.20220004-en</ArticleId><ArticleId IdType="pmc">PMC9345585</ArticleId><ArticleId IdType="pubmed">35766659</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40439536</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>53</Volume><Issue>8</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>A Multinational Randomized Trial of Mega-Dose Esomeprazole as Anti-Inflammatory Agent in Sepsis.</ArticleTitle><Pagination><StartPage>e1554</StartPage><EndPage>e1566</EndPage><MedlinePgn>e1554-e1566</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000006720</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Proton pump inhibitors have dose-dependent immunomodulatory effects. We tested the hypothesis that mega-dose esomeprazole therapy would reduce organ dysfunction in patients with sepsis or septic shock.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A multinational, randomized, double-blind, placebo-controlled clinical trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Seventeen ICUs or emergency departments in three countries.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adult patients with sepsis or septic shock.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Mega-dose (1024&#x2009;mg) esomeprazole or placebo over a 72-hour period.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">The primary outcome was mean daily Sequential Organ Failure Assessment (SOFA) score to day 10. Secondary outcomes included antibiotics-free days, ICU-free days at day 28, and all-cause mortality. We also conducted a mechanistic study of the in vitro effects of esomeprazole in sepsis. We randomized 307 patients and assigned 148 to esomeprazole and 159 to placebo. Mean age was 71 years; 166 patients (54%) had septic shock and median SOFA score at randomization was 7. The median mean daily SOFA score in the first 10 days post-randomization was 5 (interquartile range [IQR], 3-9) in the esomeprazole group and 5 (IQR, 3-8) in the placebo group (risk difference, 0.1; 95% CI, -0.8 to 1.0; p &gt; 0.99). No differences were observed in secondary outcomes. Monocytes isolated from patients' peripheral blood and activated with a toll-like receptor agonist exhibited a pro-inflammatory phenotype, which was not affected by esomeprazole therapy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients with sepsis or septic shock, mega-dose esomeprazole did not reduce organ dysfunction or other patient-related or biological secondary outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Monti</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carta</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UO Medicina Nucleare, IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruni</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkayeva</LastName><ForeName>Maiya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Astana Medical University, National Scientific Center of Traumatology and Orthopedics named after N. Batpenov, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guarracino</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yakovlev</LastName><ForeName>Aleksey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Centre of Resuscitation and Rehabilitation, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucciolini</LastName><ForeName>Giada</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shemetova</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Moscow State Budgetary Healthcare Institution, "Moscow City Oncological Hospital No.1, Moscow Healthcare Department," Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scapol</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Momesso</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave (VE), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garofalo</LastName><ForeName>Eugenio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brizzi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baldassarri</LastName><ForeName>Rubia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajello</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isirdi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meroi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baiardo Redaelli</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boffa</LastName><ForeName>Nicoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave (VE), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Votta</LastName><ForeName>Carmine Domenico</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Department, Anesthesia and Intensive Care Unit, Maggiore Hospital, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borghi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montrucchio</LastName><ForeName>Giorgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Intensive Care and Emergency, "Citt&#xe0; della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rauch</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano (SABES-ASDAA), Merano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Filippo</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pace</LastName><ForeName>Maria Caterina</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Women, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paternoster</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, School of Medicine, University of Basilicata; Anaesthesia and ICU, San Calo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitale</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>UO Medicina Nucleare, IRCCS Ospedale Policlinico San Martino, Genova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giardina</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labanca</LastName><ForeName>Rosa</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lembo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marmiere</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzaroli</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakhnoukh</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plumari</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scandroglio</LastName><ForeName>Anna Mara</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scquizzato</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sordoni</LastName><ForeName>Stella</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valsecchi</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emergency Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agr&#xf2;</LastName><ForeName>Felice Eugenio</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finco</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine (DMED), University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corradi</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Likhvantsev</LastName><ForeName>Valery</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>First Moscow State Medical University (Sechenov University), Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Longhini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Unit, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkayev</LastName><ForeName>Aidos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Astana Medical University, National Scientific Center of Traumatology and Orthopedics named after N. Batpenov, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8594-5980</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care, The University of Melbourne, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PPI-SEPSIS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03452865</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>N3PA6559FT</RegistryNumber><NameOfSubstance UI="D064098">Esomeprazole</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054328">Proton Pump Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064098" MajorTopicYN="Y">Esomeprazole</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054328" MajorTopicYN="Y">Proton Pump Inhibitors</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="Y">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">esomeprazole</Keyword><Keyword MajorTopicYN="N">proton pump inhibitors</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>Dr. Guarracino received funding from Abbott, Chiesi, Edwards, Masimo, Orion, Orphan, Viatris, and Vygon. Drs. Isirdi, Meroi, Corradi, and Bellomo disclosed off-label use of Esomeprazole. Drs. Borghi&#x2019;s, Marmiere&#x2019;s, and Landoni&#x2019;s institutions received funding from the Italian Ministry of Health. Dr. Montrucchio received funding from 3M and Thermofisher. Dr. Vitale received support for article research from the National Institutes of Health. Drs. Marmiere and Landoni received support for article research from the Italian Ministry of Health. Dr. Sordoni received support for article research from the Italian Ministry of Health (Progetto di Ricerca Finalizzata Ordinaria, GR-2016- 02363630). The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Monaco</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Nuzzi</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Oriani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Panozzo</LastName><ForeName>Gloria</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pasculli</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pieri</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pontillo</LastName><ForeName>Domenico</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Turi</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Calabr&#xf2;</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Fominskiy</LastName><ForeName>Evgeny</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ortalda</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sacchi</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pazzanese</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Peveri</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Furlan</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pruna</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sgobba</LastName><ForeName>Stefano Pietro</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Maltese</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IRCCSs San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Neri</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Corea</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bosco</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Anesthesia and ICU, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bertini</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Amitrano</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Doroni</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Villano</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and ICU, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taddei</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Taddei</LastName><ForeName>Erika</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Bologna</LastName><ForeName>Maria Lidia</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brizzi</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical, Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Orso</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sartori</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Brussa</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency "Santa Maria della Misericordia", Azienda Sanitaria Universitaria Friuli Centrale [ASUFC], Udine University Hospital, Udine, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Guarino</LastName><ForeName>Maria Carmen</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave [VE], Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Salvini</LastName><ForeName>Adelasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>UOC Anestesia e Rianimazione, AULSS 4 Veneto Orientale, San Don&#xe0; di Piave [VE], Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kadantseva</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>V. Negovsky Reanimatology Research Institute FRCC RR, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Redkin</LastName><ForeName>Ivan</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Federal Research and Clinical Center of Resuscitation and Rehabilitation, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Banova</LastName><ForeName>Zhanna</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Moscow State Budgetary Healthcare Institution, "Moscow City Oncological Hospital No.1, Moscow Healthcare Department," Moscow, Russia.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Formicola</LastName><ForeName>Giuseppe Luca</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Department, Anaesthesia and Intensive Care Unit, Maggiore Hospital, ASST Lodi, Lodi, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>De Cesaris</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Emergency, "Citt&#xe0; della Salute e della Scienza" Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Mattei</LastName><ForeName>Alessia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Campus Bio-Medico di Roma, Rome, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Seraglio</LastName><ForeName>Paolo Mario Enrico</ForeName><Initials>PME</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano [SABES-ASDAA], Merano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Leggieri</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Hospital of Merano [SABES-ASDAA], Merano, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Kadralinova</LastName><ForeName>Asiya</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Zhanarystan</LastName><ForeName>Nazerke</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Abdirakhym</LastName><ForeName>Gaziza</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Astana Medical University, Astana, Kazakhstan.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Sardo</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Pota</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Universit&#xe0; della Campania "Luigi Vanvitelli," Napoli, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Vignale</LastName><ForeName>Rosaria</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Anesthesia and ICU, San Calo Hospital, Potenza, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Greco</LastName><ForeName>Massimiliano</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Humanitas University, Milan, Italy; IRCCS Humanitas Research Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Ajello</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anesthesia and Intensive Care, Hospital Tor Vergata Roma, Rome, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Benedetto</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>University of G. d'Annunzio Chieti and Pescara, Chieti, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>D'Ascenzo</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>University of Turin, Turin, Italy; Citt&#xe0; Della Salute e Della Scienza Hospital, Turin, Italy.</Affiliation></AffiliationInfo></Investigator><Investigator ValidYN="Y"><LastName>Yavorovsky</LastName><ForeName>Andrey</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>IM Sechenov First Moscow State Medical University, Ministry of Public Health of Russia, Moscow, Russia.</Affiliation></AffiliationInfo></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>5</Day><Hour>12</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>13</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40439536</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000006720</ArticleId><ArticleId IdType="pii">00003246-990000000-00532</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 2016; 315:801&#x2013;810</Citation></Reference><Reference><Citation>Fleischmann-Struzek C, Mellhammar L, Rose N, et al.: Incidence and mortality of hospital- and ICU-treated sepsis: Results from an updated and expanded systematic review and meta-analysis. Intensive Care Med 2020; 46:1552&#x2013;1562</Citation></Reference><Reference><Citation>Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840&#x2013;851</Citation></Reference><Reference><Citation>Chousterman BG, Swirski FK, Weber GF: Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 2017; 39:517&#x2013;528</Citation></Reference><Reference><Citation>Neumann I, Letelier LM, Rada G, et al.: Comparison of different regimens of proton pump inhibitors for acute peptic ulcer bleeding. Cochrane Database Syst Rev 2013; 2013:CD007999</Citation></Reference><Reference><Citation>Strand DS, Kim D, Peura DA: 25 years of proton pump inhibitors: A comprehensive review. Gut Liver 2017; 11:27&#x2013;37</Citation></Reference><Reference><Citation>Sachs G, Shin JM, Howden CW: Review article: The clinical pharmacology of proton pump inhibitors. Aliment Pharmacol Ther 2006; 23:2&#x2013;8</Citation></Reference><Reference><Citation>Chopra YM, Choundary J, Justice R : Pharmacology/Toxicology Review and Evaluation: NDA 21-689. U.S. Food and Drug Administration. 2004. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021689s000_PharmR.pdf . Accessed November 1, 2024</Citation></Reference><Reference><Citation>Parikh N, Howden CW: The safety of drugs used in acid-related disorders and functional gastrointestinal disorders. Gastroenterol Clin North Am 2010; 39:529&#x2013;542</Citation></Reference><Reference><Citation>Garc&#xed;a Rodr&#xed;guez LA, Ruig&#xf3;mez A, Pan&#xe9;s J: Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol 2007; 5:1418&#x2013;1423</Citation></Reference><Reference><Citation>Norgard NB, Mathews KD, Wall GC: Drug&#x2013;drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 2009; 43:1266&#x2013;1274</Citation></Reference><Reference><Citation>Laine L, Hennekens C: Proton pump inhibitor and clopidogrel interaction: Fact or fiction? Am J Gastroenterol 2010; 105:34&#x2013;41</Citation></Reference><Reference><Citation>Wolfe MM, Sachs G: Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology 2000; 118:S9&#x2013;31</Citation></Reference><Reference><Citation>Barkun AN, Almadi M, Kuipers EJ, et al.: Management of nonvariceal upper gastrointestinal bleeding: Guideline recommendations from the International Consensus Group. Ann Intern Med 2019; 171:805&#x2013;822</Citation></Reference><Reference><Citation>Balza E, Piccioli P, Carta S, et al.: Proton pump inhibitors protect mice from acute systemic inflammation and induce long-term cross-tolerance. Cell Death Dis 2016; 7:e2304&#x2013;e2304</Citation></Reference><Reference><Citation>Monti G, Konkayev A, Carta S, et al.; Collaborators: High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial. Contemp Clin Trials 2023; 133:107319</Citation></Reference><Reference><Citation>Bi&#xe7;ak&#xe7;i U, Tander B, Arit&#xfc;rk E, et al.: Effects of omeprazole and gentamicin on the biochemical and histopathological alterations of the hypoxia/reoxygenation induced intestinal injury in newborn rats. Pediatr Surg Int 2005; 21:800&#x2013;805</Citation></Reference><Reference><Citation>Kotsuka M, Hashimoto Y, Nakatake R, et al.: Omeprazole increases survival through the inhibition of inflammatory mediaters in two rat sepsis models. Shock 2022; 57:444&#x2013;456</Citation></Reference><Reference><Citation>Evans CE, Peng Y, Zhu MM, et al.: Rabeprazole promotes vascular repair and resolution of sepsis-induced inflammatory lung injury through HIF-1&#x3b1;. Cells 2022; 11:1425</Citation></Reference><Reference><Citation>Le Gall J-R, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993; 270:2957&#x2013;2963</Citation></Reference><Reference><Citation>Levy MM, Evans LE, Rhodes A: The Surviving Sepsis Campaign bundle: 2018 update. Intensive Care Med 2018; 44:925&#x2013;928</Citation></Reference><Reference><Citation>International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use: ICH harmonized tripartite guideline: Guideline for good clinical practice. J Postgrad Med 2001; 47:45&#x2013;50</Citation></Reference><Reference><Citation>Gordon AC, Perkins GD, Singer M, et al.: Levosimendan for the prevention of acute organ dysfunction in sepsis. N Engl J Med 2016; 375:1638&#x2013;1648</Citation></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, et al.: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286:1754&#x2013;1758</Citation></Reference><Reference><Citation>De Milito A, Canese R, Marino ML, et al.: pH&#x2010;dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer 2010; 127:207&#x2013;219</Citation></Reference><Reference><Citation>de Grooth H-J, Geenen IL, Girbes AR, et al.: SOFA and mortality endpoints in randomized controlled trials: A systematic review and meta-regression analysis. Crit Care 2017; 21:38</Citation></Reference><Reference><Citation>Thabane L, Mbuagbaw L, Zhang S, et al.: A tutorial on sensitivity analyses in clinical trials: The what, why, when and how. BMC Med Res Methodol 2013; 13:92</Citation></Reference><Reference><Citation>Reilly JP: Safety profile of the proton-pump inhibitors. Am J Health Syst Pharm 1999; 56:S11&#x2013;S17</Citation></Reference><Reference><Citation>Cavaillon J, Singer M, Skirecki T: Sepsis therapies: Learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med 2020; 12:e10128</Citation></Reference><Reference><Citation>Steger-Hartmann T, Raschke M: Translating in vitro to in vivo and animal to human. Curr Opin Toxicol 2020; 23&#x2013;24:6&#x2013;10</Citation></Reference><Reference><Citation>Mak IW, Evaniew N, Ghert M: Lost in translation: Animal models and clinical trials in cancer treatment. Am J Transl Res 2014; 6:114&#x2013;118</Citation></Reference><Reference><Citation>Leenaars CHC, Kouwenaar C, Stafleu FR, et al.: Animal to human translation: A systematic scoping review of reported concordance rates. J Transl Med 2019; 17:223</Citation></Reference><Reference><Citation>Zschaler J, Schlorke D, Arnhold J: Differences in innate immune response between man and mouse. Crit Rev Immunol 2014; 34:433&#x2013;454</Citation></Reference><Reference><Citation>Baillie TA, Rettie AE: Role of biotransformation in drug-induced toxicity: Influence of intra- and inter-species differences in drug metabolism. Drug Metab Pharmacokinet 2011; 26:15&#x2013;29</Citation></Reference><Reference><Citation>Wang N, Lu Y, Zheng J, et al.: Of mice and men: Laboratory murine models for recapitulating the immunosuppression of human sepsis. Front Immunol 2022; 13:956448</Citation></Reference><Reference><Citation>Arrazuria R, Kerscher B, Huber KE, et al.: Variability of murine bacterial pneumonia models used to evaluate antimicrobial agents. Front Microbiol 2022; 13:988728</Citation></Reference><Reference><Citation>Roberts JA, Abdul-Aziz M-H, Davis JS, et al.: Continuous versus intermittent &#x3b2;-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials. Am J Respir Crit Care Med 2016; 194:681&#x2013;691</Citation></Reference><Reference><Citation>Kayambankadzanja RK, Schell CO, Gerdin W&#xe4;rnberg M, et al.: Towards definitions of critical illness and critical care using concept analysis. BMJ Open 2022; 12:e060972</Citation></Reference><Reference><Citation>Rice TW, Wheeler AP, Bernard GR, et al.: A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis. Crit Care Med 2010; 38:1685&#x2013;1694</Citation></Reference><Reference><Citation>Zygun DA, Laupland KB, Fick GH, et al.: Neuroanesthesia and intensive care limited ability of SOFA and MOD scores to discriminate outcome: A prospective evaluation in 1,436 patients. Can J Anaesth 2005; 52:302&#x2013;308</Citation></Reference><Reference><Citation>Marmiere M, D&#x2019;Amico F, Monti G, et al.: Mastering the Sequential Organ Failure Assessment score: Critical choices of score statistic, timing, imputations, and competing risk handling in major trials&#x2014;a systematic review. Crit Care Med 2024; 53:e1116&#x2013;e1124</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38904693</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>141</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Dexamethasone for Cardiac Surgery: A Practice Preference-Randomized Consent Comparative Effectiveness Trial.</ArticleTitle><Pagination><StartPage>859</StartPage><EndPage>869</EndPage><MedlinePgn>859-869</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000005127</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High-dose corticosteroids have been used to attenuate the inflammatory response to cardiac surgery and cardiopulmonary bypass, but patient outcome benefits remain unclear. The primary aim was to determine whether using dexamethasone was superior to not using dexamethasone to increase the number of home days in the first 30 days after cardiac surgery. The secondary aim was to evaluate efficiency, value, and impact of the novel trial design.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This pragmatic, international trial incorporating a prerandomized consent design favoring local practice enrolled patients undergoing cardiac surgery across seven hospitals in Australia and The Netherlands. Patients were randomly assigned to dexamethasone 1&#x2009;mg/kg or not (control). The primary outcome was the number of days alive and at home up to 30 days after surgery ("home days"). Secondary outcomes included prolonged mechanical ventilation (more than 48&#x2009;h), sepsis, renal failure, myocardial infarction, stroke, and death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 2,562 patients assessed for eligibility, 1,951 were randomized (median age, 63 yr; 80% male). The median number of home days was 23.0 (interquartile range, 20.1 to 24.1) in the no dexamethasone group and 23.1 (interquartile range, 20.1 to 24.6) in the dexamethasone group (median difference, 0.1; 95% CI, -0.3 to 0.5; P = 0.66). The rates of prolonged mechanical ventilation (risk ratio, 0.72; 95% CI, 0.48 to 1.08), sepsis (risk ratio, 1.02; 95% CI, 0.57 to 1.82), renal failure (risk ratio, 0.94; 95% CI, 0.80 to 1.12), myocardial infarction (risk ratio, 1.20; 95% CI, 0.30 to 4.82), stroke (risk ratio, 1.06; 95% CI, 0.54 to 2.08), and death (risk ratio, 0.72; 95% CI, 0.22 to 2.35) were comparable between groups (all P &gt; 0.10). Dexamethasone reduced intensive care unit stay (median, 29&#x2009;h; interquartile range, 22 to 50&#x2009;h vs. median, 43&#x2009;h; interquartile range, 24 to 72&#x2009;h; P = 0.004). The authors' novel trial design was highly efficient (89.3% enrollment).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients undergoing cardiac surgery, high-dose dexamethasone decreased intensive care unit stay but did not increase the number of home days after surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 American Society of Anesthesiologists. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Myles</LastName><ForeName>Paul S</ForeName><Initials>PS</Initials><Identifier Source="ORCID">0000-0002-3324-5456</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieleman</LastName><ForeName>Jan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Westmead Hospital, Western Sydney University, Penrith, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munting</LastName><ForeName>Karin E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, University Medical Center, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forbes</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Biostatistics Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Julian A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, and Department of Surgery, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGiffin</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Surgery, Alfred Hospital, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verheijen</LastName><ForeName>Lieke P J</ForeName><Initials>LPJ</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, University Medical Center, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallace</LastName><ForeName>Sophie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Perioperative Medicine, Alfred Hospital and Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>DECS-II Investigators and the ANZCA Clinical Trials Network
</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="Y">Dexamethasone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001315" MajorTopicYN="N" Type="Geographic">Australia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057186" MajorTopicYN="N">Comparative Effectiveness Research</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007258" MajorTopicYN="N">Informed Consent</DescriptorName></MeshHeading></MeshHeadingList><InvestigatorList><Investigator ValidYN="Y"><LastName>Myles</LastName><ForeName>P S</ForeName><Initials>PS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wallace</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ueoka</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dutton</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Robertshaw</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clarris</LastName><ForeName>M</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neylan</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smith</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hulley</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Warwarek</LastName><ForeName>S</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Painter</LastName><ForeName>T</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Heyman</LastName><ForeName>K</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Falland</LastName><ForeName>R-L</ForeName><Initials>RL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pieterse</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fiddes</LastName><ForeName>R</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marriott</LastName><ForeName>A</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieleman</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cope</LastName><ForeName>J</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clark-Mackay</LastName><ForeName>E</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Munting</LastName><ForeName>K E</ForeName><Initials>KE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Verheijen</LastName><ForeName>L P J</ForeName><Initials>LPJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Dijk</LastName><ForeName>D</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wietsma</LastName><ForeName>N E</ForeName><Initials>NE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Monteiro de Olivieira</LastName><ForeName>N P</ForeName><Initials>NP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oey</LastName><ForeName>L W L</ForeName><Initials>LWL</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38904693</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000005127</ArticleId><ArticleId IdType="pii">141590</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33825296</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1463-1318</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland</Title><ISOAbbreviation>Colorectal Dis</ISOAbbreviation></Journal><ArticleTitle>Ileal pouch-anal anastomosis in the elderly: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2062</StartPage><EndPage>2074</EndPage><MedlinePgn>2062-2074</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/codi.15665</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Despite good overall outcomes in most patients undergoing ileal pouch-anal anastomosis (IPAA), there is still hesitation about performing an IPAA in older patients due to the comorbidity burden and concern about incontinence. The aim of this work was to identify short- and long-term outcomes in older patinets undergoing IPAA to determine the perioperative safety and long-term functional success of IPAA in older patients.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A literature search was performed for all publications on IPAA in adults aged &#x2265;50&#xa0;years that reported short- and long-term outcomes. Data extraction included demographics, 30-day outcomes, long-term functional outcomes and pouch failure. Data were further separated by age group (50-65 and &#x2265;65&#xa0;years). Outcomes were compared between age groups. Study quality and risk of bias was assessed using the Newcastle-Ottawa Scale.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 1053 publications reviewed, 13 full papers were included in the analysis. The overall 30-day morbidity and mortality rates were 47.3% and 1.3%, respectively. Thirty-day postoperative rates of small bowel obstruction and pelvic sepsis were 7.6% and 9.9%, respectively. After a median follow-up time of 62&#xa0;months, rates of pouchitis, incontinence and pouch failure were 13.9%, 17.5% and 7.5%, respectively. There was no statically significant difference in rates of short- or long-term functional outcomes based on age 50-65 versus &#x2265;65&#xa0;years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Increasing age did not increase the rate of short- or long-term outcomes, including pouch failure. These data suggest that the decision for IPAA construction should not be based on age alone.</AbstractText><CopyrightInformation>&#xa9; 2021 The Association of Coloproctology of Great Britain and Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Karina E</ForeName><Initials>KE</Initials><Identifier Source="ORCID">0000-0002-2210-5298</Identifier><AffiliationInfo><Affiliation>College of Medicine, Northeast Ohio Medical University, Rootstown, OH, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Qualitative Health Science, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holubar</LastName><ForeName>Stefan D</ForeName><Initials>SD</Initials><Identifier Source="ORCID">0000-0002-2549-9042</Identifier><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steele</LastName><ForeName>Scott R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lightner</LastName><ForeName>Amy L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Digestive Disease Surgical Institute, Cleveland Clinic, Cleveland, OH, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Colorectal Dis</MedlineTA><NlmUniqueID>100883611</NlmUniqueID><ISSNLinking>1462-8910</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003093" MajorTopicYN="Y">Colitis, Ulcerative</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039021" MajorTopicYN="Y">Colonic Pouches</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019449" MajorTopicYN="Y">Pouchitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016737" MajorTopicYN="Y">Proctocolectomy, Restorative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">familial adenomatous polyposis</Keyword><Keyword MajorTopicYN="N">functional outcomes</Keyword><Keyword MajorTopicYN="N">ileal pouch anal anastomosis</Keyword><Keyword MajorTopicYN="N">ulcerative colitis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33825296</ArticleId><ArticleId IdType="doi">10.1111/codi.15665</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Mark-Christensen A, Kjaer MD, Ganesalingam S, Qvist N, Thorlacius-Ussing O, Rosenberg J, et al. Increasing incidence of pelvic sepsis following ileal pouch-anal anastomosis for ulcerative colitis in Denmark: a nationwide cohort study. Dis Colon Rectum. 2019;62(8):965-71.</Citation></Reference><Reference><Citation>Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther. 2014;39(5):459-77.</Citation></Reference><Reference><Citation>Chang S, Shen B, Remzi F. When not to pouch: important considerations for patient selection for ileal pouch-anal anastomosis. Gastroenterol Hepatol. 2017;13(8):466-75.</Citation></Reference><Reference><Citation>Delaney CP, Fazio VW, Remzi FH, Hammel J, Church JM, Hull TL, et al. Prospective, age-related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg. 2003;238(2):221-8.</Citation></Reference><Reference><Citation>Cohan JN, Bacchetti P, Varma MG, Finlayson E. Outcomes after ileoanal pouch surgery in frail and older adults. J Surg Res. 2015;198(2):327-33.</Citation></Reference><Reference><Citation>Pellino G, Sciaudone G, Candilio G, Camerlingo A, Marcellinaro R, Rocco F, et al. Complications and functional outcomes of restorative proctocolectomy for ulcerative colitis in the elderly. BMC Surg. 2013;13(Suppl 2):S9.</Citation></Reference><Reference><Citation>Chapman JR, Larson DW, Wolff BG, Dozois EJ, Cima RR, Pemberton JH, et al. Ileal pouch-anal anastomosis: does age at the time of surgery affect outcome? Arch Surg. 2005;140(6):539-40.</Citation></Reference><Reference><Citation>Cohen JL, Strong SA, Hyman NH, Buie DW, Dunn GD, Ko CY, et al. Practice parameters for the surgical treatment of ulcerative colitis. Dis Colon Rectum. 2005;48(11):1997-2009.</Citation></Reference><Reference><Citation>Farouk R, Pemberton JH, Wolff BG, Dozois RR, Browning S, Larson D. Functional outcomes after ileal pouch-anal anastomosis for chronic ulcerative colitis. Ann Surg. 2000;231(6):919-26.</Citation></Reference><Reference><Citation>Jota G, Karad&#x17e;ov Z, Panovski M, Joksimovi&#x107; N, Kartalov A, Gelevski R, et al. Functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis in elderly patients. Acta Fac Med Naissensis. 2012;29(1):482-487.</Citation></Reference><Reference><Citation>Colombo F, Sahami S, de Buck Van Overstraeten A, Tulchinsky H, Mege D, Dotan I, et al. Restorative proctocolectomy in elderly IBD patients: a multicentre comparative study on safety and efficacy. J Crohns Colitis. 2017;11(6):671-9.</Citation></Reference><Reference><Citation>Bharucha AE, Dunivan G, Goode PS, Lukacz ES, Markland AD, Matthews CA, et al. Epidemiology, pathophysiology, and classification of fecal incontinence: state of the science summary for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop. Am J Gastroenterol. 2015;110(1):127-36.</Citation></Reference><Reference><Citation>Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods. 2016;7(1):55-79.</Citation></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.</Citation></Reference><Reference><Citation>Bauer JJ, Gorfine SR, Gelernt IM, Harris MT, Kreel I. Restorative proctocolectomy in patients older than fifty years. Dis Colon Rectum. 1997;40(5):562-5.</Citation></Reference><Reference><Citation>Dayton MT, Larsen KR. Should older patients undergo ileal pouch-anal anastomosis? Am J Surg. 1996;172(5):444-8.</Citation></Reference><Reference><Citation>Delaney CP, Dadvand B, Remzi FH, Church JM, Fazio VW. Functional outcome, quality of life, and complications after ileal pouch-anal anastomosis in selected septuagenarians. Dis Colon Rectum. 2002;45(7):890-4.Discussion 894.</Citation></Reference><Reference><Citation>Ho KS, Chang CC, Baig MK, B&#xf6;rjesson L, Nogueras JJ, Efron J, et al. Ileal pouch anal anastomosis for ulcerative colitis is feasible for septuagenarians. Colorectal Dis. 2006;8(3):235-8.</Citation></Reference><Reference><Citation>Kiran RP, El-Gazzaz G, Remzi FH, Church JM, Lavery IC, Hammel J, et al. Influence of age at ileoanal pouch creation on long-term changes in functional outcomes. Colorectal Dis. 2011;13(2):184-90.</Citation></Reference><Reference><Citation>McKenna NP, Mathis KL, Pemberton JH, Lightner AL. The impact of age at time of ileal pouch anal anastomosis on short and long-term outcomes in adults. Inflamm Bowel Dis. 2018;24(8):1857-65.</Citation></Reference><Reference><Citation>Pinto RA, Canedo J, Murad-Regadas S, Regadas SF, Weiss EG, Wexner SD. Ileal pouch-anal anastomosis in elderly patients: is there a difference in morbidity compared with younger patients? Colorectal Dis. 2011;13(2):177-83.</Citation></Reference><Reference><Citation>Tan HT, Connolly AB, Morton D, Keighley MR. Results of restorative proctocolectomy in the elderly. Int J Colorectal Dis. 1997;12(6):319-22.</Citation></Reference><Reference><Citation>Fazio VW, Tekkis PP, Remzi F, Lavery IC, Manilich E, Connor J, et al. Quantification of risk for pouch failure after ileal pouch anal anastomosis surgery. Ann Surg. 2003;238(4):605-17.</Citation></Reference><Reference><Citation>Heuschen UA, Allemeyer EH, Hinz U, Lucas M, Herfarth C, Heuschen G. Outcome after septic complications in J pouch procedures. Br J Surg. 2002;89(2):194-200.</Citation></Reference><Reference><Citation>Sagap I, Remzi FH, Hammel JP, Fazio VW. Factors associated with failure in managing pelvic sepsis after ileal pouch-anal anastomosis (IPAA)-a multivariate analysis. Surgery. 2006;140(4):691-704.</Citation></Reference><Reference><Citation>Al-Sanea N, Alfaifi J, Homoud SA, Abduljabbar A, Hibbert D, Ashari L. Outcome after ileal pouch-anal anastomosis for familial adenomatous polyposis compared to mucosal ulcerative colitis in a Middle Eastern population. Ann Saudi Med. 2013;33(3):268-72.</Citation></Reference><Reference><Citation>Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJ. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg. 2005;22(1-2):69-79.</Citation></Reference><Reference><Citation>Krausz MM, Duek SD. Restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis and familial adenomatous polyposis: twenty years follow-up in 174 patients. Isr Med Assoc J. 2005;7(1):23-7.</Citation></Reference><Reference><Citation>Fazio VW, Ziv Y, Church JM, Oakley JR, Lavery IC, Milsom JW, et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg. 1995;222(2):120-7.</Citation></Reference><Reference><Citation>Lee GC, Deery SE, Kunitake H, Hicks CW, Olariu AG, Savitt LR, et al. Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis. Int J Colorectal Dis. 2019;34(3):491-9.</Citation></Reference><Reference><Citation>Mikkola K, Luukkonen P, Jarvinen HJ. Long-term results of restorative proctocolectomy for ulcerative colitis. Int J Colorectal Dis. 1995;10(1):10-4.</Citation></Reference><Reference><Citation>Sahami S, Bartels SA, D'Hoore A, Fadok TY, Tanis PJ, Lindeboom R, et al. A multicentre evaluation of risk factors for anastomotic leakage after restorative proctocolectomy with ileal pouch-anal anastomosis for inflammatory bowel disease. J Crohns Colitis. 2016;10(7):773-8.</Citation></Reference><Reference><Citation>Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT, et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Ann Surg. 2013;257(4):679-85.</Citation></Reference><Reference><Citation>McIntyre PB, Pemberton JH, Wolff BG, Beart RW, Dozois RR. Comparing functional results one year and ten years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Dis Colon Rectum. 1994;37(4):303-7.</Citation></Reference><Reference><Citation>Michelassi F, Lee J, Rubin M, Fichera A, Kasza K, Karrison T, et al. Long-term functional results after ileal pouch anal restorative proctocolectomy for ulcerative colitis: a prospective observational study. Ann Surg. 2003;238(3):433-45.</Citation></Reference><Reference><Citation>Erkek AB, Church JM, Remzi FH. Age-related analysis of functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis. J Gastroenterol Hepatol. 2007;22(5):710-4.</Citation></Reference><Reference><Citation>Lightner AL, Mathis KL, Dozois EJ, Hahnsloser D, Loftus EV, Raffals LE, et al. Results at up to 30 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Inflamm Bowel Dis. 2017;23(5):781-90.</Citation></Reference><Reference><Citation>Nyam DC, Brillant PT, Dozois RR, Kelly KA, Pemberton JH, Wolff BG. Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results. Ann Surg. 1997;226(4):514-21.</Citation></Reference><Reference><Citation>Hahnloser D, Pemberton JH, Wolff BG, Larson DR, Crownhart BS, Dozois RR. Results at up to 20 years after ileal pouch-anal anastomosis for chronic ulcerative colitis. Br J Surg. 2007;94(3):333-40.</Citation></Reference><Reference><Citation>Takao Y, Gilliland R, Nogueras JJ, Weiss EG, Wexner SD. Is age relevant to functional outcome after restorative proctocolectomy for ulcerative colitis? Prospective assessment of 122 cases. Ann Surg. 1998;227(2):187-94.</Citation></Reference><Reference><Citation>Ramage L, Qiu S, Georgiou P, Tekkis P, Tan E. Functional outcomes following ileal pouch-anal anastomosis (IPAA) in older patients: a systematic review. Int J Colorectal Dis. 2016;31(3):481-92.</Citation></Reference><Reference><Citation>Rezvan A, Jakus-Waldman S, Abbas MA, Yazdany T, Nguyen J. Review of the diagnosis, management and treatment of fecal incontinence. Female Pelvic Med Reconstr Surg. 2015;21(1):8-17.</Citation></Reference><Reference><Citation>Brandsborg S, Chen TY, Nicholls RJ, Laurberg S. Difference between patients&#x2019; and clinicians&#x2019; perception of pouch dysfunction and its impact on quality of life following restorative proctocolectomy. Colorectal Dis. 2015;17(6):O136-140.</Citation></Reference><Reference><Citation>Gemlo BT, Wong WD, Rothenberger DA, Goldberg SM. Ileal pouch-anal anastomosis. Patterns of failure. Arch Surg. 1992;127(7):784-6.discussion 787.</Citation></Reference><Reference><Citation>Yu CS, Pemberton JH, Larson D. Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results. Dis Colon Rectum. 2000;43(11):1487-96.</Citation></Reference><Reference><Citation>Mark-Christensen A, Erichsen R, Brandsborg S, Pachler FR, N&#xf8;rager CB, Johansen N, et al. Pouch failures following ileal pouch-anal anastomosis for ulcerative colitis. Colorectal Dis. 2018;20(1):44-52.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38864230</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>280</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Persistence and Sexual Dimorphism of Gut Dysbiosis and Pathobiome after Sepsis and Trauma.</ArticleTitle><Pagination><StartPage>491</StartPage><EndPage>503</EndPage><MedlinePgn>491-503</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000006385</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the persistence of intestinal microbiome dysbiosis and gut-plasma metabolomic perturbations following severe trauma or sepsis weeks after admission in patients experiencing chronic critical illness (CCI).</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">Trauma and sepsis can lead to gut dysbiosis and alterations in the plasma and fecal metabolome. However, the impact of these perturbations and correlations between gut dysbiosis and the plasma metabolome in chronic critical illness have not been studied.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A prospective observational cohort study was performed with healthy subjects, severe trauma patients, and patients with sepsis residing in an intensive care unit for 2 to 3 weeks. A high-throughput multi-omics approach was utilized to evaluate the gut microbial and gut-plasma metabolite responses in critically ill trauma and sepsis patients 14 to 21 days after intensive care unit admission.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients in the sepsis and trauma cohorts demonstrated strikingly depleted gut microbiome diversity, with significant alterations and specific pathobiome patterns in the microbiota composition compared to healthy subjects. Further subgroup analyses based on sex revealed resistance to changes in microbiome diversity among female trauma patients compared to healthy counterparts. Sex--specific changes in fecal metabolites were also observed after trauma and sepsis, while plasma metabolite changes were similar in both males and females.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Dysbiosis induced by trauma and sepsis persists up to 14 to 21 days after onset and is sex-specific, underscoring the implication of pathobiome and entero-septic microbial-metabolite perturbations in post-sepsis and posttrauma chronic critical illness. This indicates resilience to infection or injury in females' microbiome and should inform and facilitate future precision/personalized medicine strategies in the intensive care unit.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Munley</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Gwoncheol</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health, Nutrition and Food Sciences, The Gut Biome Lab, Florida State University, Tallahassee, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Lauren S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kannan</LastName><ForeName>Kolenkode B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mankowski</LastName><ForeName>Robert T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Division of Gerontology, Geriatrics and Palliative Care, Department of Medicine, University of Alabama, Birmingham, AL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casadesus</LastName><ForeName>Gemma</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakrabarty</LastName><ForeName>Paramita</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wallet</LastName><ForeName>Shannon M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Oral Biology, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maile</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bible</LastName><ForeName>Letitia E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biomedical and Chemical Engineering and Sciences, Florida Institute of Technology, Melbourne, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moldawer</LastName><ForeName>Lyle L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Alicia M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagpal</LastName><ForeName>Ravinder</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Health, Nutrition and Food Sciences, The Gut Biome Lab, Florida State University, Tallahassee, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efron</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Surgery and Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM140806</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008721</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="Y">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>J.A.M. and L.S.K. are supported by a postgraduate training grant NIH NIGMS T32 GM-008721. R.N. acknowledges funding from the Florida Department of Health (FL DOH #23A02 and #24A05), the United States Department of Agriculture (USDA-ARS #440658), the Infectious Diseases Society of America (IDSA), the Florida State University Council on Research &amp; Creativity (FSU-CRC), and the FSU College of Education, Health, and Human Sciences (FSU-CEHHS). The remaining authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>12</Day><Hour>13</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>12</Day><Hour>5</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38864230</ArticleId><ArticleId IdType="mid">NIHMS2007715</ArticleId><ArticleId IdType="pmc">PMC11392637</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000006385</ArticleId><ArticleId IdType="pii">00000658-202409000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Takiishi T, Fenero CIM, Camara NOS. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers 2017; 5(4):e1373208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788425</ArticleId><ArticleId IdType="pubmed">28956703</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu X, Liu Z, Zhu C, et al. Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria. Crit Rev Food Sci Nutr 2019; 59(sup1):S130&#x2013;S152.</Citation><ArticleIdList><ArticleId IdType="pubmed">30580556</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthess J, Pandey S, Capitani M, et al. The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity 2019; 50(2):432&#x2013;445 e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6382411</ArticleId><ArticleId IdType="pubmed">30683619</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol 2017; 17(4):219&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pubmed">28260787</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller WD, Keskey R, Alverdy JC. Sepsis and the Microbiome: A Vicious Cycle. J Infect Dis 2021; 223(12 Suppl 2):S264&#x2013;S269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206800</ArticleId><ArticleId IdType="pubmed">33330900</ArticleId></ArticleIdList></Reference><Reference><Citation>Marascio N, Scarlata GGM, Romeo F, et al. The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives. Int J Mol Sci 2023; 24(11).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10252956</ArticleId><ArticleId IdType="pubmed">37298258</ArticleId></ArticleIdList></Reference><Reference><Citation>Munley JA, Kirkpatrick SL, Gillies GS, et al. The Intestinal Microbiome after Traumatic Injury. Microorganisms 2023; 11(8).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10459834</ArticleId><ArticleId IdType="pubmed">37630549</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauermeister A, Mannochio-Russo H, Costa-Lotufo LV, et al. Mass spectrometry-based metabolomics in microbiome investigations. Nat Rev Microbiol 2022; 20(3):143&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9578303</ArticleId><ArticleId IdType="pubmed">34552265</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa M, Asahara T, Henzan N, et al. Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci 2011; 56(8):2361&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">21384123</ArticleId></ArticleIdList></Reference><Reference><Citation>Burmeister DM, Johnson TR, Lai Z, et al. The gut microbiome distinguishes mortality in trauma patients upon admission to the emergency department. J Trauma Acute Care Surg 2020; 88(5):579&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905995</ArticleId><ArticleId IdType="pubmed">32039976</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson SE, Burmeister DM, Johnson TR, et al. A prospective study in severely injured patients reveals an altered gut microbiome is associated with transfusion volume. J Trauma Acute Care Surg 2019; 86(4):573&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433524</ArticleId><ArticleId IdType="pubmed">30633104</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard BM, Kornblith LZ, Christie SA, et al. Characterizing the gut microbiome in trauma: significant changes in microbial diversity occur early after severe injury. Trauma Surg Acute Care Open 2017; 2(1):e000108.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5877916</ArticleId><ArticleId IdType="pubmed">29766103</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyr A, Zhong Y, Reis SE, et al. Analysis of the Plasma Metabolome after Trauma, Novel Circulating Sphingolipid Signatures, and In-Hospital Outcomes. J Am Coll Surg 2021; 232(3):276&#x2013;287 e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11875205</ArticleId><ArticleId IdType="pubmed">33453380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusczek ER, Muratore SL, Dubick MA, et al. Assessment of key plasma metabolites in combat casualties. J Trauma Acute Care Surg 2017; 82(2):309&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">27787435</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng K, Dai W, Liu L, et al. Identification of biomarkers and the mechanisms of multiple trauma complicated with sepsis using metabolomics. Front Public Health 2022; 10:923170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9387941</ArticleId><ArticleId IdType="pubmed">35991069</ArticleId></ArticleIdList></Reference><Reference><Citation>Peltz ED, D'Alessandro A, Moore EE, et al. Pathologic metabolism: an exploratory study of the plasma metabolome of critical injury. J Trauma Acute Care Surg 2015; 78(4):742&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4375785</ArticleId><ArticleId IdType="pubmed">25807403</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SR, Moheimani H, Herzig B, et al. High-dimensional proteomics identifies organ injury patterns associated with outcomes in human trauma. J Trauma Acute Care Surg 2023; 94(6):803&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10205666</ArticleId><ArticleId IdType="pubmed">36787435</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusczek ER, Myers C, Popovsky K, et al. Plasma metabolomics pilot study suggests age and sex-based differences in the metabolic response to traumatic injury. Injury 2018; 49(12):2178&#x2013;2185.</Citation><ArticleIdList><ArticleId IdType="pubmed">30266291</ArticleId></ArticleIdList></Reference><Reference><Citation>Parent BA, Seaton M, Sood RF, et al. Use of Metabolomics to Trend Recovery and Therapy After Injury in Critically Ill Trauma Patients. JAMA Surg 2016; 151(7):e160853.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6874889</ArticleId><ArticleId IdType="pubmed">27223119</ArticleId></ArticleIdList></Reference><Reference><Citation>Agudelo-Ochoa GM, Valdes-Duque BE, Giraldo-Giraldo NA, et al. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis. Gut Microbes 2020; 12(1):1707610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7524144</ArticleId><ArticleId IdType="pubmed">31924126</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald D, Ackermann G, Khailova L, et al. Extreme Dysbiosis of the Microbiome in Critical Illness. mSphere 2016; 1(4).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5007431</ArticleId><ArticleId IdType="pubmed">27602409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabizadeh E, Sadeghi J, Rezaee MA, et al. The profile of key gut microbiota members and short-chain fatty acids in patients with sepsis. Heliyon 2023; 9(7):e17880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10395291</ArticleId><ArticleId IdType="pubmed">37539246</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Shimizu K, Ogura H, et al. Rapid and Sustained Long-Term Decrease of Fecal Short-Chain Fatty Acids in Critically Ill Patients With Systemic Inflammatory Response Syndrome. JPEN J Parenter Enteral Nutr 2015; 39(5):569&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">24711120</ArticleId></ArticleIdList></Reference><Reference><Citation>Darden DB, Brakenridge SC, Efron PA, et al. Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis. Ann Surg 2021; 274(4):664&#x2013;673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592255</ArticleId><ArticleId IdType="pubmed">34506322</ArticleId></ArticleIdList></Reference><Reference><Citation>Park G, Munley JA, Kelly LS, et al. Gut mycobiome dysbiosis after sepsis and trauma. Crit Care 2024; 28(1):18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10785534</ArticleId><ArticleId IdType="pubmed">38212826</ArticleId></ArticleIdList></Reference><Reference><Citation>Munley JA, Kelly LS, Park G, et al. Multicompartmental Traumatic Injury Induces Sex-Specific Alterations in the Gut Microbiome. J Trauma Acute Care Surg 2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10293079</ArticleId><ArticleId IdType="pubmed">36872509</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolyen E, Rideout JR, Dillon MR, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol 2019; 37(8):852&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015180</ArticleId><ArticleId IdType="pubmed">31341288</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods 2016; 13(7):581&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927377</ArticleId><ArticleId IdType="pubmed">27214047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bokulich NA, Kaehler BD, Rideout JR, et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2's q2-feature-classifier plugin. Microbiome 2018; 6(1):90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5956843</ArticleId><ArticleId IdType="pubmed">29773078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B, Maldonado-Devincci AM, Jiang L. Evaluating line-broadening factors on a reference spectrum as a bucketing method for NMR based metabolomics. Anal Biochem 2020; 606:113872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484314</ArticleId><ArticleId IdType="pubmed">32738215</ArticleId></ArticleIdList></Reference><Reference><Citation>Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12(6):R60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3218848</ArticleId><ArticleId IdType="pubmed">21702898</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello MGD, Knight R, Gilbert JA, et al. Preserving microbial diversity. Science 2018; 362(6410):33&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">30287652</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang MQ, Macala KF, Fox-Robichaud A, et al. Sex- and Gender-Dependent Differences in Clinical and Preclinical Sepsis. Shock 2021; 56(2):178&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">33399356</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Afflitto M, Upadhyaya A, Green A, et al. Association Between Sex Hormone Levels and Gut Microbiota Composition and Diversity-A Systematic Review. J Clin Gastroenterol 2022; 56(5):384&#x2013;392.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612624</ArticleId><ArticleId IdType="pubmed">35283442</ArticleId></ArticleIdList></Reference><Reference><Citation>Agus A, Planchais J, Sokol H. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. Cell Host Microbe 2018; 23(6):716&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pubmed">29902437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan YD, Zhu RX, Wu ZQ, et al. Gut Microbiota Disruption in Septic Shock Patients: A Pilot Study. Med Sci Monit 2018; 24:8639&#x2013;8646.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6282651</ArticleId><ArticleId IdType="pubmed">30488879</ArticleId></ArticleIdList></Reference><Reference><Citation>Lankelma JM, van Vught LA, Belzer C, et al. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study. Intensive Care Med 2017; 43(1):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5203863</ArticleId><ArticleId IdType="pubmed">27837233</ArticleId></ArticleIdList></Reference><Reference><Citation>Bu Y, Wang H, Ma X, et al. Untargeted Metabolomic Profiling of the Correlation Between Prognosis Differences and PD-1 Expression in Sepsis: A Preliminary Study. Front Immunol 2021; 12:594270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8046931</ArticleId><ArticleId IdType="pubmed">33868224</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers AJ, McGeachie M, Baron RM, et al. Metabolomic derangements are associated with mortality in critically ill adult patients. PLoS One 2014; 9(1):e87538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3907548</ArticleId><ArticleId IdType="pubmed">24498130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario M, Cambiaghi A, Brunelli L, et al. Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach. Sci Rep 2016; 6:20391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742912</ArticleId><ArticleId IdType="pubmed">26847922</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh P, Manning SD. Impact of age and sex on the composition and abundance of the intestinal microbiota in individuals with and without enteric infections. Ann Epidemiol 2016; 26(5):380&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494358</ArticleId><ArticleId IdType="pubmed">27118420</ArticleId></ArticleIdList></Reference><Reference><Citation>Steegenga WT, Mischke M, Lute C, et al. Sexually dimorphic characteristics of the small intestine and colon of prepubescent C57BL/6 mice. Biol Sex Differ 2014; 5:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169057</ArticleId><ArticleId IdType="pubmed">25243059</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores R, Shi J, Fuhrman B, et al. Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med 2012; 10:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3552825</ArticleId><ArticleId IdType="pubmed">23259758</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoferl MW, Angele MK, Diodato MD, et al. Female sex hormones regulate macrophage function after trauma-hemorrhage and prevent increased death rate from subsequent sepsis. Ann Surg 2002; 235(1):105&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422402</ArticleId><ArticleId IdType="pubmed">11753049</ArticleId></ArticleIdList></Reference><Reference><Citation>Efron PA, Darden DB, Li EC, et al. Sex Differences Associate with Late Microbiome Alterations after Murine Surgical Sepsis. J Trauma Acute Care Surg 2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9323556</ArticleId><ArticleId IdType="pubmed">35324554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer M, Mendez-Garcia C, Rojo D, et al. Antibiotic use and microbiome function. Biochem Pharmacol 2017; 134:114&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">27641814</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeming ER, Johnson AJ, Spector TD, et al. Effect of Diet on the Gut Microbiota: Rethinking Intervention Duration. Nutrients 2019; 11(12).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6950569</ArticleId><ArticleId IdType="pubmed">31766592</ArticleId></ArticleIdList></Reference><Reference><Citation>Serbanescu MA, Mathena RP, Xu J, et al. General Anesthesia Alters the Diversity and Composition of the Intestinal Microbiota in Mice. Anesth Analg 2019; 129(4):e126&#x2013;e129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9717490</ArticleId><ArticleId IdType="pubmed">30489316</ArticleId></ArticleIdList></Reference><Reference><Citation>Martino C, Dilmore AH, Burcham ZM, et al. Microbiota succession throughout life from the cradle to the grave. Nat Rev Microbiol 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">35906422</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28841633</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>11</Issue><PubDate><Year>2017</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Extracorporeal Circulatory Support in Acute Coronary Syndromes: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>e1173</StartPage><EndPage>e1183</EndPage><MedlinePgn>e1173-e1183</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000002692</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Extracorporeal circulatory support is a life-saving technique, and its use is increasing in acute coronary syndromes. A meta-analysis on pooled event rate of short-term mortality and complications of acute coronary syndrome patients treated with extracorporeal circulatory support was performed.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Articles were searched in MEDLINE, Cochrane Library, Google Scholar, and Biomed Central.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Inclusion criteria were observational studies on acute coronary syndrome patients treated with extracorporeal circulatory support. Primary outcome was short-term mortality. Secondary outcomes were extracorporeal circulatory support-related complications, causes of death, long-term mortality, and bridge therapy.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Sixteen articles were selected. Data about clinical characteristics, acute coronary syndrome diagnosis and treatment, extracorporeal circulatory support setting, outcome definitions, and event rate were retrieved from the articles. Random effect meta-analytic pooling was performed reporting results as a summary point estimate and 95% CI.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">A total of 739 patients were included (mean age, 59.8&#x2009;&#xb1;&#x2009;2.9). The event rate of short-term mortality was 58% (95% CI, 51-64%), 6-month mortality was affecting 24% (95% CI, 5-63%) of 1-month survivors, and 1-year mortality 17% (95% CI, 6-40%) of 6-month survivors. The event rates of extracorporeal circulatory support-related complications were acute renal failure 41%, bleeding 25%, neurologic damage in survivors 21%, sepsis/infections 21%, and leg ischemia 12%. Between causes of death, multiple organ failure and brain death affected respectively 40% and 27% of patients. Bridge to ventricular assistance device was offered to 14% of patients, and 7% received a transplant.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is still a high rate of short-term mortality and complications in acute coronary syndrome patients treated with extracorporeal circulatory support. New studies are needed to optimize and standardize extracorporeal circulatory support.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pavasini</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>1Cardiology Unit, Azienda Ospedaliero-Universitaria di Ferrara, Cona (FE), Italy. 2Dipartimento di Scienze Cardiotoraciche, II universit&#xe0; degli Studi di Napoli, Neaples, Italy. 3Hospital Universitario de Santa Maria, CHLN, CAML, CCUL, Facultade de Medicina, Universitade de Lisboa, Lisbon, Portugal. 4Maria Cecilia Hospital, GVM Care &amp; Research, Cotignola (RA), Italy. 5Anaesthetics, Pain Medicine &amp; Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College, London, United Kingdom. 6Adult Intensive Care Unit, Royal Brompton Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cirillo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Campo</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Nobre Menezes</LastName><ForeName>Miguel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Biscaglia</LastName><ForeName>Simone</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tonet</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Ferrari</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Brijesh V</ForeName><Initials>BV</Initials></Author><Author ValidYN="Y"><LastName>Price</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2018 Aug;46(8):e822-e823. doi: 10.1097/CCM.0000000000003188.</RefSource><PMID Version="1">30004985</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2018 Aug;46(8):e823. doi: 10.1097/CCM.0000000000003242.</RefSource><PMID Version="1">30004986</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D054058" MajorTopicYN="N">Acute Coronary Syndrome</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="N">Extracorporeal Membrane Oxygenation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28841633</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000002692</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38973502</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1537-2995</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Transfusion</Title><ISOAbbreviation>Transfusion</ISOAbbreviation></Journal><ArticleTitle>Plasma as endothelial rescue in septic shock: A randomized, phase 2a pilot trial.</ArticleTitle><Pagination><StartPage>1653</StartPage><EndPage>1661</EndPage><MedlinePgn>1653-1661</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/trf.17939</ELocationID><Abstract><AbstractText Label="BACKGROUND">Septic shock is associated with high morbidity and mortality, the endothelium plays an important role. Crystalloids is standard of care to maintain intravascular volume. Plasma is associated with improved endothelial integrity and restoration of the glycocalyx layer. We evaluated the efficacy and safety aspects of cell-free and pathogen inactivated pooled plasma (OctaplasLG&#xae;) as resuscitation in septic shock patients.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">This randomized, investigator-initiated phase IIa trial ran at a Danish single center intensive care unit, from 2017 to 2019. Patients were 18&#x2009;years of age or older with septic shock and randomized to fluid optimization with OctaplasLG&#xae; or Ringer-acetate in the first 24&#x2009;h. The primary endpoints were changes in biomarkers indicative of endothelial activation, damage, and microvascular perfusion from baseline to 24&#x2009;h. Safety events and mortality were assessed during 90&#x2009;days.</AbstractText><AbstractText Label="RESULTS">Forty-four patients were randomized, 20 to OctaplasLG versus 24 to Ringer-acetate. The median age was 69, and 55% were men. Median Sequential Organ Failure Assessment score was 13. Baseline differences favoring the Ringer-acetate group were observed. The OctaplasLG&#xae; group was resuscitated with 740&#x2009;mL plasma and the Ringer-acetate group with 841&#x2009;mL crystalloids. There was no significant change in the microvascular perfusion or five biomarkers except VEGFR1 change, which was higher in patients receiving OctaplasLG&#xae; 0.12(SD 0.37) versus Ringer-acetate -0.24 (SD 0.39), with mean difference 0.36 (95% CI, 0.13-0.59, p&#x2009;=&#x2009;.003) in favor of Ringer-acetate.</AbstractText><AbstractText Label="DISCUSSION">This study found that fluid resuscitation with OctaplasLG&#xae; in critically ill septic shock patients is feasible. Baseline confounding prevented assessment of the potential effect of OctaplasLG&#xae;.</AbstractText><CopyrightInformation>&#xa9; 2024 AABB.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clausen</LastName><ForeName>Niels E</ForeName><Initials>NE</Initials><Identifier Source="ORCID">0000-0002-4370-859X</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Copenhagen University Hospital -Bispebjerg and Frederiksberg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Copenhagen University Hospital -Bispebjerg and Frederiksberg, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriksen</LastName><ForeName>Hanne H</ForeName><Initials>HH</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindhardt</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pott</LastName><ForeName>Frank C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Copenhagen University Hospital -Bispebjerg and Frederiksberg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunen</LastName><ForeName>Thomas Bech</ForeName><Initials>TB</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gybel-Brask</LastName><ForeName>Mikkel</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5716-5899</Identifier><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Theis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>P&#xe4;r I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stensballe</LastName><ForeName>Jakob</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Trauma Center, Centre of Head and Orthopedics, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Octapharma AG</Agency><Country/></Grant><Grant><Agency>OctaplasLG&#xae;&#xae;</Agency><Country/></Grant><Grant><Agency>Copenhagen University Hospital, Rigshospitalet</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017427">Clinical Trial, Phase II</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Transfusion</MedlineTA><NlmUniqueID>0417360</NlmUniqueID><ISSNLinking>0041-1132</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C028570">Ringer's acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007552">Isotonic Solutions</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010949" MajorTopicYN="N">Plasma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007552" MajorTopicYN="N">Isotonic Solutions</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">crystalloids</Keyword><Keyword MajorTopicYN="N">endothelium</Keyword><Keyword MajorTopicYN="N">glycocalyx</Keyword><Keyword MajorTopicYN="N">plasma</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>23</Day><Hour>22</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38973502</ArticleId><ArticleId IdType="doi">10.1111/trf.17939</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Vincent J, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta&#x2010;analysis. Critical Care. 2019;23:1&#x2013;11.</Citation></Reference><Reference><Citation>Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371(15):1381&#x2013;1391.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour C, Shankar&#x2010;Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis&#x2010;3). JAMA &#x2013; J Am Med Assoc. 2016;315(8):801&#x2013;810.</Citation></Reference><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392(10141):75&#x2013;87.</Citation></Reference><Reference><Citation>Guidet B, Aegerter P, Gauzit R, Meshaka P, Dreyfuss D. Incidence and impact of organ dysfunctions associated with sepsis. Chest. 2005;127(3):942&#x2013;951.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304&#x2013;377.</Citation></Reference><Reference><Citation>Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med. 2006;48(1):54.e1.</Citation></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, &#xc5;neman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med. 2012;367(2):124&#x2013;134.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386(26):2459&#x2013;2470.</Citation></Reference><Reference><Citation>Martin L, Koczera P, Zechendorf E, Schuerholz T. The endothelial glycocalyx: new diagnostic and therapeutic approaches in sepsis. Biomed Res Int. 2016;2016(1):3758278.</Citation></Reference><Reference><Citation>Rehm M, Bruegger D, Christ F, Conzen P, Thiel M, Jacob M, et al. Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation. 2007;116(17):1896&#x2013;1906.</Citation></Reference><Reference><Citation>Murphy LS, Wickersham N, McNeil JB, Shaver CM, May AK, Bastarache JA, et al. Endothelial glycocalyx degradation is more severe in patients with non&#x2010;pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction. Ann Intensive Care. 2017;7(1):102.</Citation></Reference><Reference><Citation>Wu X, Hu Z, Yuan H, Chen L, Li Y, Zhao C. Fluid resuscitation and markers of glycocalyx degradation in severe sepsis. Open Med. 2017;12(1):409&#x2013;416.</Citation></Reference><Reference><Citation>Johansen M, Johansson P, Ostrowski S, Bestle M, Hein L, Jensen A, et al. Profound endothelial damage predicts impending organ failure and death in sepsis. Semin Thromb Hemost. 2015;41(1):16&#x2013;25.</Citation></Reference><Reference><Citation>Kozar RA, Peng Z, Zhang R, Holcomb JB, Pati S, Park P, et al. Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock. Anesth Analg. 2011;112(6):1289&#x2013;1295.</Citation></Reference><Reference><Citation>Straat M, M&#xfc;ller MCA, Meijers JCM, Arbous MS, Spoelstra&#x2010;de Man AME, Beurskens CJP, et al. Effect of transfusion of fresh frozen plasma on parameters of endothelial condition and inflammatory status in non&#x2010;bleeding critically ill patients: a prospective substudy of a randomized trial. Crit Care. 2015;19(1):1&#x2013;7.</Citation></Reference><Reference><Citation>Deng X, Cao Y, Huby MP, Duan C, Baer L, Peng Z, et al. Adiponectin in fresh frozen plasma contributes to restoration of vascular barrier function after hemorrhagic shock. Shock. 2016;45(1):50&#x2013;54.</Citation></Reference><Reference><Citation>Sinnott P, Bodger S, Gupta A, Brophy M. Presence of HLA antibodies in single&#x2010;donor&#x2010;derived fresh frozen plasma compared with pooled, solvent detergent&#x2010;treated plasma (OctaplasR). Eur J Immunogenet. 2004;31(6):271&#x2013;274.</Citation></Reference><Reference><Citation>Neisser&#x2010;Svae A, Seghatchian J. The state of the art of removal of prion proteins in SD&#x2010;FFP, by specific prion affinity chromatography and its impact on the hemostatic characteristics of the product. Transfus Apher Sci. 2015;52(2):237&#x2013;239.</Citation></Reference><Reference><Citation>Stensballe J, Ulrich AG, Nilsson JC, Henriksen HH, Olsen PS, Ostrowski SR, et al. Resuscitation of endotheliopathy and bleeding in thoracic aortic dissections. Anesth Analg. 2018;127(4):920&#x2013;927.</Citation></Reference><Reference><Citation>Combes A, Berneau J&#x2010;B, Luyt C&#x2010;E, Trouillet J&#x2010;L. Estimation of left ventricular systolic function by single transpulmonary thermodilution. Intensive Care Med. 2004;30(7):1377&#x2013;1383.</Citation></Reference><Reference><Citation>De Backer D, Aissaoui N, Cecconi M, Chew MS, Denault A, Hajjar L, et al. How can assessing hemodynamics help to assess volume status? Intensive Care Med. 2022;48(10):1482&#x2013;1494.</Citation></Reference><Reference><Citation>De Backer D. Is microcirculatory assessment ready for regular use in clinical practice? Curr Opin Crit Care. 2019;25(3):280&#x2013;284.</Citation></Reference><Reference><Citation>Ince C, Boerma EC, Cecconi M, De Backer D, Shapiro NI, Duranteau J, et al. Second consensus on the assessment of sublingual microcirculation in critically ill patients: results from a task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2018;44(3):281&#x2013;299.</Citation></Reference><Reference><Citation>Berthelsen RE, Ostrowski SR, Bestle MH, Johansson PI. Co&#x2010;administration of iloprost and eptifibatide in septic shock (CO&#x2010;ILEPSS)&#x2010;a randomised, controlled, double&#x2010;blind investigator&#x2010;initiated trial investigating safety and efficacy. Crit Care. 2019;23(1):301.</Citation></Reference><Reference><Citation>Holcomb JB, Pati S. Optimal trauma resuscitation with plasma as the primary resuscitative fluid: the surgeon's perspective. Hematol Am Soc Hematol Educ Progr. 2013;2013:656&#x2013;659.</Citation></Reference><Reference><Citation>van den Brink DP, Kleinveld DJB, Sloos PH, Thomas KA, Stensballe J, Johansson PI, et al. Plasma as a resuscitation fluid for volume&#x2010;depleted shock: potential benefits and risks. Transfusion. 2021;61(S1):S301&#x2013;S312.</Citation></Reference><Reference><Citation>Greco M, Palumbo C, Sicuro F, Lobreglio G. Soluble Fms&#x2010;like tyrosine kinase&#x2010;1 is a marker of endothelial dysfunction during sepsis. J Clin Med Res. 2018;10(9):700&#x2013;706.</Citation></Reference><Reference><Citation>Jenkins DH, Rappold JF, Badloe JF, Bers&#xe9;us O, Blackbourne L, Brohi KH, et al. Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps. Shock. 2014;41(Suppl 1):3&#x2013;12.</Citation></Reference><Reference><Citation>White NJ, Ward KR, Pati S, Strandenes G, Cap AP. Hemorrhagic blood failure: oxygen debt, coagulopathy, and endothelial damage. J Trauma Acute Care Surg. 2017;82(6S Suppl 1):S41&#x2013;S49.</Citation></Reference><Reference><Citation>Naumann DN, Hazeldine J, Davies DJ, Bishop J, Midwinter MJ, Belli A, et al. Endotheliopathy of trauma is an on&#x2010;scene phenomenon, and is associated with multiple organ dysfunction syndrome: a prospective observational study. Shock. 2018;49(4):420&#x2013;428.</Citation></Reference><Reference><Citation>Gaudry S, Hajage D, Schortgen F, Martin&#x2010;Lefevre L, Pons B, Boulet E, et al. Initiation strategies for renal&#x2010;replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122&#x2013;133.</Citation></Reference><Reference><Citation>Bagshaw SM, Wald R, Adhikari NK, Bellomo R, Da Costa BR, Dreyfuss D, et al. Timing of initiation of renal&#x2010;replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240&#x2013;251.</Citation></Reference><Reference><Citation>Barbar SD, Clere&#x2010;Jehl R, Bourredjem A, Hernu R, Montini F, Bruy&#xe8;re R, et al. Timing of renal&#x2010;replacement therapy in patients with acute kidney injury and sepsis. N Engl J Med. 2018;379(15):1431&#x2013;1442.</Citation></Reference><Reference><Citation>Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenst&#xe4;dt H, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury. JAMA. 2016;315(20):2190&#x2013;2199.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34301988</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jul</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Nationwide case-control study of risk factors and outcomes for community-acquired sepsis.</ArticleTitle><Pagination><StartPage>15118</StartPage><MedlinePgn>15118</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">15118</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-94558-x</ELocationID><Abstract><AbstractText>Sepsis is the main cause of death in the intensive care units (ICU) and increasing incidences of ICU admissions for sepsis are reported. Identification of patients at risk for sepsis and poor outcome is therefore of outmost importance. We performed a nation-wide case-control study aiming at identifying and quantifying the association between co-morbidity and socio-economic factors with intensive care admission for community-acquired sepsis. We also explored 30-day mortality. All adult patients (n&#x2009;=&#x2009;10,072) with sepsis admitted from an emergency department to an intensive care unit in Sweden between 2008 and 2017 and a control population (n&#x2009;=&#x2009;50,322), matched on age, sex and county were included. In the sepsis group, 69% had a co-morbid condition at ICU admission, compared to 31% in the control group. Multivariable conditional logistic regression analysis was performed and there was a large variation in the influence of different risk factors associated with ICU-admission, renal disease, liver disease, metastatic malignancy, substance abuse, and congestive heart failure showed the strongest associations. Low&#xa0;income and&#xa0;low&#xa0;education&#xa0;level&#xa0;were more common in&#xa0;sepsis&#xa0;patients&#xa0;compared to&#xa0;controls.&#xa0;The adjusted OR for 30-day mortality for sepsis patients was 132 (95% CI 110-159) compared to controls.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lindstr&#xf6;m</LastName><ForeName>Ann-Charlotte</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden. ann-charlotte.l.lindstrom@sll.se.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. ann-charlotte.l.lindstrom@sll.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>Mikael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Operation and Intensive Care, Uppsala University Hospital, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe5;rtensson</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oldner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Emma</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Anaesthesiology and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34301988</ArticleId><ArticleId IdType="pmc">PMC8302728</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-94558-x</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-94558-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kumar G, et al. Nationwide trends of severe sepsis in the 21st century (2000&#x2013;2007) Chest. 2011;140:1223&#x2013;1231. doi: 10.1378/chest.11-0352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.11-0352</ArticleId><ArticleId IdType="pubmed">21852297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: Comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br. J. Anaesth. 2017;119:626&#x2013;636. doi: 10.1093/bja/aex234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex234</ArticleId><ArticleId IdType="pubmed">29121281</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003;348:1546&#x2013;1554. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles J, et al. Trends in the incidence and mortality of patients with community-acquired septic shock 2003&#x2013;2016. J. Crit. Care. 2019;53:46&#x2013;52. doi: 10.1016/j.jcrc.2019.05.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2019.05.025</ArticleId><ArticleId IdType="pubmed">31195155</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubens M, et al. Increasing sepsis rates in the United States: Results from national inpatient sample, 2005 to 2014. J. Intensive Care Med. 2020;35:858&#x2013;868. doi: 10.1177/0885066618794136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066618794136</ArticleId><ArticleId IdType="pubmed">30175649</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Klompas M. Sepsis trends: Increasing incidence and decreasing mortality, or changing denominator? J. Thorac. Dis. 2020;12:S89&#x2013;s100. doi: 10.21037/jtd.2019.12.51.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd.2019.12.51</ArticleId><ArticleId IdType="pmc">PMC7024753</ArticleId><ArticleId IdType="pubmed">32148931</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am. J. Respir. Crit. Care Med. 2016;193:259&#x2013;272. doi: 10.1164/rccm.201504-0781OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201504-0781OC</ArticleId><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014;311:1308&#x2013;1316. doi: 10.1001/jama.2014.2637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>Strandberg G, Walther S, Agvald &#xd6;hman C, Lipcsey M. Mortality after severe sepsis and septic shock in Swedish intensive care units 2008&#x2013;2016-A nationwide observational study. Acta Anaesthesiol. Scand. 2020;64:967&#x2013;975. doi: 10.1111/aas.13587.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.13587</ArticleId><ArticleId IdType="pubmed">32232853</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri SS, et al. Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest. 2017;151:278&#x2013;285. doi: 10.1016/j.chest.2016.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.07.010</ArticleId><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. 2017;318:1241&#x2013;1249. doi: 10.1001/jama.2017.13836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilhelms SB, Walther SM, Huss F, Sj&#xf6;berg F. Severe sepsis in the ICU is often missing in hospital discharge codes. Acta Anaesthesiol. Scand. 2017;61:186&#x2013;193. doi: 10.1111/aas.12814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12814</ArticleId><ArticleId IdType="pubmed">27699759</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch CA, Harrison DA, Hutchings A, Rowan K. The association between deprivation and hospital mortality for admissions to critical care units in England. J. Crit. Care. 2010;25:382&#x2013;390. doi: 10.1016/j.jcrc.2009.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2009.11.003</ArticleId><ArticleId IdType="pubmed">20074907</ArticleId></ArticleIdList></Reference><Reference><Citation>Rush B, et al. Association of household income level and in-hospital mortality in patients with sepsis: A nationwide retrospective cohort analysis. J. Intensive Care Med. 2018;33:551&#x2013;556. doi: 10.1177/0885066617703338.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066617703338</ArticleId><ArticleId IdType="pmc">PMC5680141</ArticleId><ArticleId IdType="pubmed">28385107</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Int. J. Surg. 2014;12:1495&#x2013;1499. doi: 10.1016/j.ijsu.2014.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2014.07.013</ArticleId><ArticleId IdType="pubmed">25046131</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur. J. Epidemiol. 2009;24:659&#x2013;667. doi: 10.1007/s10654-009-9350-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-009-9350-y</ArticleId><ArticleId IdType="pmc">PMC2773709</ArticleId><ArticleId IdType="pubmed">19504049</ArticleId></ArticleIdList></Reference><Reference><Citation>Svenska Intensivv&#xe5;rdsregistret (SIR), https://www.icuregswe.org/.</Citation></Reference><Reference><Citation>Nationella kvalitetsregister, Swedish National Quality Registries., https://kvalitetsregister.se/index.html.</Citation></Reference><Reference><Citation>SCB. Statistics Sweden, https://www.scb.se/en/.</Citation></Reference><Reference><Citation>Socialstyrelsen. Patientregistret, https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/patientregistret/ (2018).</Citation></Reference><Reference><Citation>Quan H, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care. 2005;43:1130&#x2013;1139. doi: 10.1097/01.mlr.0000182534.19832.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweden, S. Longitudinal integrated database for health insurance and labour market studies (LISA), https://www.scb.se/en/services/guidance-for-researchers-and-universities/vilka-mikrodata-finns/longitudinella-register/longitudinal-integrated-database-for-health-insurance-and-labour-market-studies-lisa/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6451717</ArticleId><ArticleId IdType="pubmed">30929112</ArticleId></ArticleIdList></Reference><Reference><Citation>Socialstyrelsen, T. S. b. o. h. a. w. D&#xf6;dsorsaksregistret, Cause of death register, https://www.socialstyrelsen.se/statistik-och-data/register/alla-register/dodsorsaksregistret/ (2018).</Citation></Reference><Reference><Citation>Henriksen DP, et al. Risk factors for hospitalization due to community-acquired sepsis&#x2014;A population-based case-control study. PLoS ONE. 2015;10:e0124838. doi: 10.1371/journal.pone.0124838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0124838</ArticleId><ArticleId IdType="pmc">PMC4405362</ArticleId><ArticleId IdType="pubmed">25898024</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, et al. Chronic medical conditions and risk of sepsis. PLoS ONE. 2012;7:e48307. doi: 10.1371/journal.pone.0048307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0048307</ArticleId><ArticleId IdType="pmc">PMC3485139</ArticleId><ArticleId IdType="pubmed">23118977</ArticleId></ArticleIdList></Reference><Reference><Citation>Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: Risk, recurrence, and ruination. Front. Endocrinol. (Lausanne) 2017;8:271. doi: 10.3389/fendo.2017.00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00271</ArticleId><ArticleId IdType="pmc">PMC5670360</ArticleId><ArticleId IdType="pubmed">29163354</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AMN, et al. Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J. Am. Heart Assoc. 2018;7:e009684. doi: 10.1161/jaha.118.009684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.118.009684</ArticleId><ArticleId IdType="pmc">PMC6474963</ArticleId><ArticleId IdType="pubmed">30371261</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J, Li S, Li S. The role of the liver in sepsis. Int. Rev. Immunol. 2014;33:498&#x2013;510. doi: 10.3109/08830185.2014.889129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08830185.2014.889129</ArticleId><ArticleId IdType="pmc">PMC4160418</ArticleId><ArticleId IdType="pubmed">24611785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunchorntavakul C, Chamroonkul N, Chavalitdhamrong D. Bacterial infections in cirrhosis: A critical review and practical guidance. World J. Hepatol. 2016;8:307&#x2013;321. doi: 10.4254/wjh.v8.i6.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.4254/wjh.v8.i6.307</ArticleId><ArticleId IdType="pmc">PMC4766259</ArticleId><ArticleId IdType="pubmed">26962397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758&#x2013;1764. doi: 10.1111/j.1523-1755.2000.00337.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2000.00337.x</ArticleId><ArticleId IdType="pubmed">11012910</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Martin JF, Mart&#xed;n-Fernandez M, L&#xf3;pez-Mestanza C, Duque P, Almansa R. Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease) J. Clin. Med. 2018 doi: 10.3390/jcm7110400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7110400</ArticleId><ArticleId IdType="pmc">PMC6262336</ArticleId><ArticleId IdType="pubmed">30380785</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss M. Epidemiology of sepsis: race, sex, and chronic alcohol abuse. Clin. Infect. Dis. 2005;41(Suppl 7):S490&#x2013;497. doi: 10.1086/432003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/432003</ArticleId><ArticleId IdType="pubmed">16237652</ArticleId></ArticleIdList></Reference><Reference><Citation>Trevejo-Nunez G, Kolls JK, de Wit M. Alcohol use as a risk factor in infections and healing: A clinician&#x2019;s perspective. Alcohol Res. 2015;37:177&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4590615</ArticleId><ArticleId IdType="pubmed">26695743</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenstein TK. The role of opioid receptors in immune system function. Front. Immunol. 2019;10:2904. doi: 10.3389/fimmu.2019.02904.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02904</ArticleId><ArticleId IdType="pmc">PMC6934131</ArticleId><ArticleId IdType="pubmed">31921165</ArticleId></ArticleIdList></Reference><Reference><Citation>Alrawashdeh M, Klompas M, Kimmel S, et al. 56: Epidemiology, outcomes, and trends of sepsis in patients with opioid use disorders in U.S. hospitals. Crit. Care Med. 2020;48(1):28. doi: 10.1097/01.ccm.0000618724.61285.b0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000618724.61285.b0</ArticleId><ArticleId IdType="pmc">PMC8602712</ArticleId><ArticleId IdType="pubmed">34314131</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch K, S&#xf8;gaard M, N&#xf8;rgaard M, Thomsen RW, Sch&#xf8;nheyder HC. Socioeconomic inequalities in risk of hospitalization for community-acquired bacteremia: A Danish population-based case-control study. Am. J. Epidemiol. 2014;179:1096&#x2013;1106. doi: 10.1093/aje/kwu032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwu032</ArticleId><ArticleId IdType="pubmed">24682527</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnegelsberg A, et al. Impact of socioeconomic status on mortality and unplanned readmission in septic intensive care unit patients. Acta Anaesthesiol. Scand. 2016;60:465&#x2013;475. doi: 10.1111/aas.12644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aas.12644</ArticleId><ArticleId IdType="pubmed">26490972</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40319710</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>89</Volume><PubDate><Year>2025</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Sepsis on dementia risk: A population-based cohort study with dose-dependent analysis.</ArticleTitle><Pagination><StartPage>155100</StartPage><MedlinePgn>155100</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2025.155100</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(25)00087-5</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Emerging evidence links sepsis-related inflammation to dementia risk, but the dose-dependent effects of recurrent sepsis episodes remain unclear. This study assessed whether sepsis increases dementia risk and explored a potential dose-response relationship between sepsis frequency and dementia.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study using Taiwan's National Health Insurance Research Database (2005-2022), enrolling patients aged &#x2265;18&#xa0;years hospitalized with sepsis. An index period (2008-2013) was used to identify patients without prior dementia. A fixed 12-month landmark period (calendar year 2014) was applied to assess the number of sepsis episodes. Patients who died during the landmark period were excluded. Propensity score matching was performed to generate well-balanced sepsis and non-sepsis groups. Follow-up for dementia and mortality began after the landmark period and continued for up to 64&#xa0;months. Cox and Fine-Gray models were used to account for competing risks of death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sepsis was associated with a significantly increased risk of all-cause dementia (HR 1.59; 95&#xa0;% CI, 1.47-1.72; P&#xa0;&lt;&#xa0;0.0001). A dose-response relationship was observed: patients with multiple sepsis episodes had the highest dementia risk (sHR 1.63; 95&#xa0;% CI, 1.39-1.91). Vascular dementia showed the strongest association, with a higher incidence in the sepsis group (1.2&#xa0;% vs. 0.6&#xa0;%, P&#xa0;=&#xa0;0.0003).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our findings provide robust evidence of a dose-dependent association between sepsis and increased dementia risk, particularly vascular dementia, even after adjusting for competing mortality risks.</AbstractText><AbstractText Label="SUMMARY" NlmCategory="CONCLUSIONS">This study addresses the limitations of previous research by not only employing propensity score matching (PSM) to balance confounding factors between the sepsis and non-sepsis groups but also using an index period and landmark period design to better explore potential causal relationships. These periods ensure that dementia onset occurred after sepsis and allow for the examination of dose-response relationship between sepsis episode frequency and dementia. Furthermore, this is the largest study to date involving sepsis patients, providing more robust evidence than prior studies, which were often smaller and lacked adjustments for competing risks of death.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Mengrong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zhongyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China; Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wan-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan; Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan; Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan; Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan; Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan; Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan; Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address: szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, Zhengzhou, Henan, China. Electronic address: zhangjiq@zzu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>05</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Neuroinflammation. Dose-response relationship</Keyword><Keyword MajorTopicYN="N">Population-based cohort study</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors have no potential conflicts of interest to declare. The datasets supporting the study conclusions are included within the manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>8</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>4</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40319710</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2025.155100</ArticleId><ArticleId IdType="pii">S0883-9441(25)00087-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34750650</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.</ArticleTitle><Pagination><StartPage>16</StartPage><EndPage>24</EndPage><MedlinePgn>16-24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-021-06558-0</ELocationID><Abstract><AbstractText>We aimed to compare the effects of vitamin C, glucocorticoids, vitamin B1, combinations of these drugs, and placebo or usual care on longer-term mortality in adults with sepsis or septic shock. MEDLINE, Embase, CENTRAL, ClinicalTrials.gov and WHO-ICTRP were searched. The final search was carried out on September 3rd, 2021. Multiple reviewers independently selected randomized controlled trials (RCTs) comparing very-high-dose vitamin C (&#x2265;&#x2009;12&#xa0;g/day), high-dose vitamin C (&lt;&#x2009;12,&#x2009;&#x2265;&#x2009;6&#xa0;g/day), vitamin C (&lt;&#x2009;6&#xa0;g/day), glucocorticoid (&lt;&#x2009;400&#xa0;mg/day of hydrocortisone), vitamin B1, combinations of these drugs, and placebo/usual care. We performed random-effects network meta-analysis and, where applicable, a random-effects component network meta-analysis. We used the Confidence in Network Meta-Analysis framework to assess the degree of treatment effect certainty. The primary outcome was longer-term mortality (90-days to 1-year). Secondary outcomes were severity of organ dysfunction over 72&#xa0;h, time to cessation of vasopressor therapy, and length of stay in intensive care unit (ICU). Forty-three RCTs (10,257 patients) were eligible. There were no significant differences in longer-term mortality between treatments and placebo/usual care or between treatments (10 RCTs, 7,096 patients, moderate to very-low-certainty). We did not find any evidence that vitamin C or B1 affect organ dysfunction or ICU length of stay. Adding glucocorticoid to other treatments shortened duration of vasopressor therapy (incremental mean difference, -&#x2009;29.8&#xa0;h [95% CI -&#x2009;44.1 to -&#x2009;15.5]) and ICU stay (incremental mean difference, -&#x2009;1.3&#xa0;days [95% CI -&#x2009;2.2 to -&#x2009;0.3]). Metabolic resuscitation with vitamin C, glucocorticoids, vitamin B1, or combinations of these drugs was not significantly associated with a decrease in longer-term mortality.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3854-4081</Identifier><AffiliationInfo><Affiliation>Intensive Care Unit, Jikei University Hospital, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan. tofujii-tky@umin.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. tofujii-tky@umin.net.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan. tofujii-tky@umin.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salanti</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belletti</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bellomo</LastName><ForeName>Rinaldo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Austin Hospital, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carr</LastName><ForeName>Anitra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Toshi A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luethi</LastName><ForeName>Nora</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Inselspital University Hospital Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anesthesiology, Department of Acute Medicine, Geneva University Hospitals, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartini</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsujimoto</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behaviour, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udy</LastName><ForeName>Andrew A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, The Alfred, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanase</LastName><ForeName>Fumitaka</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Austin Hospital, Heidelberg, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Paul J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Australian and New Zealand Intensive Care Research Centre, Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Melbourne, Parkville, VIC, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Unit, Wellington Regional Hospital, Wellington, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Research Institute of New Zealand, Wellington, New Zealand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000099094">Network Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>X66NSO3N35</RegistryNumber><NameOfSubstance UI="D013831">Thiamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Intensive Care Med. 2022 Nov;48(11):1621-1624. doi: 10.1007/s00134-022-06822-x.</RefSource><PMID Version="1">35960273</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="N">Ascorbic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013831" MajorTopicYN="N">Thiamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hydrocortisone</Keyword><Keyword MajorTopicYN="N">Network meta-analysis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword><Keyword MajorTopicYN="N">Thiamine</Keyword><Keyword MajorTopicYN="N">Vitamin C</Keyword></KeywordList><CoiStatement>None to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34750650</ArticleId><ArticleId IdType="pmc">PMC8724116</ArticleId><ArticleId IdType="doi">10.1007/s00134-021-06558-0</ArticleId><ArticleId IdType="pii">10.1007/s00134-021-06558-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sevransky JE, Rothman RE, Hager DN, Bernard GR, Brown SM, Buchman TG, Busse LW, Coopersmith CM, DeWilde C, Ely EW, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325(8):742&#x2013;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903252</ArticleId><ArticleId IdType="pubmed">33620405</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR, 2nd, Natarajan R, Brophy DF, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322(13):1261&#x2013;1270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6777268</ArticleId><ArticleId IdType="pubmed">31573637</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskowitz A, Huang DT, Hou PC, Gong J, Doshi PB, Grossestreuer AV, Andersen LW, Ngo L, Sherwin RL, Berg KM, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324(7):642&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435341</ArticleId><ArticleId IdType="pubmed">32809003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Luethi N, Young PJ, Frei DR, Eastwood GM, French CJ, Deane AM, Shehabi Y, Hajjar LA, Oliveira G, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323(5):423&#x2013;431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029761</ArticleId><ArticleId IdType="pubmed">31950979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Deane AM, Nair P. Metabolic support in sepsis: corticosteroids and vitamins: the why, the when, the how. Curr Opin Crit Care. 2020;26(4):363&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">32487845</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J, Shaw GM. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care. 2017;21(1):300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5725835</ArticleId><ArticleId IdType="pubmed">29228951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Syed AA, Knowlson S, Sculthorpe R, Farthing D, DeWilde C, Farthing CA, Larus TL, Martin E, Brophy DF, et al. Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis. J Transl Med. 2014;12:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3937164</ArticleId><ArticleId IdType="pubmed">24484547</ArticleId></ArticleIdList></Reference><Reference><Citation>Rygard SL, Butler E, Granholm A, Moller MH, Cohen J, Finfer S, Perner A, Myburgh J, Venkatesh B, Delaney A. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44(7):1003&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pubmed">29761216</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl J Med. 2018;378(9):809&#x2013;818.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490185</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, Billot L, Correa M, Glass P, Harward M, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">29347874</ArticleId></ArticleIdList></Reference><Reference><Citation>van Snippenburg W, Reijnders MGJ, Hofhuis JGM, de Vos R, Kamphuis S, Spronk PE. Thiamine levels during intensive insulin therapy in critically ill patients. J Intensive Care Med. 2017;32(9):559&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">27440134</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Carney E, Cocchi MN, Barbash I, Chase M, Joyce N, Chou PP, Ngo L. Thiamine deficiency in critically ill patients with sepsis. J Crit Care. 2010;25(4):576&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pubmed">20646908</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Andersen LW, Chase M, Berg KM, Tidswell M, Giberson T, Wolfe R, Moskowitz A, Smithline H, Ngo L, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44(2):360&#x2013;367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754670</ArticleId><ArticleId IdType="pubmed">26771781</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr AC. Vitamin C administration in the critically ill: a summary of recent meta-analyses. Crit Care. 2019;23(1):265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6664573</ArticleId><ArticleId IdType="pubmed">31362775</ArticleId></ArticleIdList></Reference><Reference><Citation>Welton NJ, Caldwell DM, Adamopoulos E, Vedhara K. Mixed treatment comparison meta-analysis of complex interventions: psychological interventions in coronary heart disease. Am J Epidemiol. 2009;169(9):1158&#x2013;1165.</Citation><ArticleIdList><ArticleId IdType="pubmed">19258485</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Belletti A, Carr A, Furukawa TA, Luethi N, Putzu A, Sartini C, Salanti G, Tsujimoto Y, Udy AA, et al. Vitamin C therapy for patients with sepsis or septic shock: a protocol for a systematic review and a network meta-analysis. BMJ Open. 2019;9(11):e033458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6858173</ArticleId><ArticleId IdType="pubmed">31722954</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, Ioannidis JP, Straus S, Thorlund K, Jansen JP, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162(11):777&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">26030634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner AK, Ghita GL, Wang Z, Ozrazgat-Baslanti T, Raymond SL, Mankowski RT, Brumback BA, Efron PA, Bihorac A, Moore FA, et al. The development of chronic critical illness determines physical function, quality of life, and long-term survival among early survivors of sepsis in surgical ICUs. Crit Care Med. 2019;47(4):566&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6422682</ArticleId><ArticleId IdType="pubmed">30664526</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP (2011) GS: Cochrane handbook for systematic reviews of interventions, Version 5.1.0</Citation></Reference><Reference><Citation>Bakbergenuly I, Hoaglin DC, Kulinskaya E. Pitfalls of using the risk ratio in meta-analysis. Res Synth Methods. 2019;10(3):398&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6767076</ArticleId><ArticleId IdType="pubmed">30854785</ArticleId></ArticleIdList></Reference><Reference><Citation>Salanti G, Del Giovane C, Chaimani A, Caldwell DM, Higgins JP. Evaluating the quality of evidence from a network meta-analysis. PLoS ONE. 2014;9(7):e99682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4084629</ArticleId><ArticleId IdType="pubmed">24992266</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaimani A, Caldwell D, Li T, Higgins J, Salanti G (2021) Chapter 11: undertaking network meta-analyses. In: Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, Welch V (eds) Cochrane handbook for systematic reviews of interventions. Version 6.2 (updated February 2021) edn</Citation></Reference><Reference><Citation>Friedrich JO, Adhikari NK, Beyene J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol. 2008;8:32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430201</ArticleId><ArticleId IdType="pubmed">18492289</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedrich JO, Adhikari NK, Beyene J. Ratio of means for analyzing continuous outcomes in meta-analysis performed as well as mean difference methods. J Clin Epidemiol. 2011;64(5):556&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pubmed">21447428</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;cker G et al. (2018) netmeta: network meta-analysis using frequentist methods. In: R package version 0.9-8</Citation></Reference><Reference><Citation>Nikolakopoulou A, Higgins JPT, Papakonstantinou T, Chaimani A, Del Giovane C, Egger M, Salanti G. CINeMA: an approach for assessing confidence in the results of a network meta-analysis. PLOS Mede. 2020;17(4):e1003082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7122720</ArticleId><ArticleId IdType="pubmed">32243458</ArticleId></ArticleIdList></Reference><Reference><Citation>Papakonstantinou T, Nikolakopoulou A, Higgins JPT, Egger M, Salanti G (2020) CINeMA: software for semiautomated assessment of the confidence in the results of network meta&#x2010;analysis. Campbell Syst Rev 16(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8356302</ArticleId><ArticleId IdType="pubmed">37131978</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirea L, Ungureanu R, Pavelescu D, Grintescu IC, Mirea D, Tiganiuc L, Dumitrache C, Grintescu I. PP007-MON: discontinuous corticosteroids administration increase the risk of hyperglycaemia in septic shock. Clin Nutr. 2014;33:S132.</Citation></Reference><Reference><Citation>Jiang XYD, Zhao H, Yang F, Yuan Z, Lu P, Tian H. Early low-dose glucocorticoid therapy effectively suppresses serum pro-inflammatory factors such as IL-6 and inhibits apoptosis of CD4+ cells in septic shock patients. Int J Clin Exp Med. 2019;12(1):718&#x2013;723.</Citation></Reference><Reference><Citation>Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">12186604</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184957</ArticleId></ArticleIdList></Reference><Reference><Citation>Keh D, Trips E, Marx G, Wirtz SP, Abduljawwad E, Bercker S, Bogatsch H, Briegel J, Engel C, Gerlach H, et al. Effect of hydrocortisone on development of shock among patients with severe sepsis: the HYPRESS randomized clinical trial. JAMA. 2016;316(17):1775&#x2013;1785.</Citation><ArticleIdList><ArticleId IdType="pubmed">27695824</ArticleId></ArticleIdList></Reference><Reference><Citation>Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care. 2016;20(1):329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065699</ArticleId><ArticleId IdType="pubmed">27741949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv QQ, Gu XH, Chen QH, Yu JQ, Zheng RQ. Early initiation of low-dose hydrocortisone treatment for septic shock in adults: a randomized clinical trial. Am J Emerg Med. 2017;35(12):1810&#x2013;1814.</Citation><ArticleIdList><ArticleId IdType="pubmed">28615145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang SY, Ryoo SM, Park JE, Jo YH, Jang DH, Suh GJ, Kim T, Kim YJ, Kim S, Cho H, et al. Combination therapy of vitamin C and thiamine for septic shock: a multi-centre, double-blinded randomized, controlled study. Intensive Care Med. 2020;46(11):2015&#x2013;2025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417779</ArticleId><ArticleId IdType="pubmed">32780166</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkatesh B, Finfer S, Myburgh J, Cohen J, Billot L. Long-term outcomes of the ADRENAL trial. N Engl J Med. 2018;378(18):1744&#x2013;1745.</Citation><ArticleIdList><ArticleId IdType="pubmed">29694789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani SJ, Mufti SA, Jan RA, Shah SU, Qadri SM, Khan UH, Bagdadi F, Mehfooz N, Koul PA. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis (Lond) 2020;52(4):271&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">31990246</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Aljumah A, Dabbagh O, Tamim HM, Rishu AH, Al-Abdulkareem A, Knawy BA, Hajeer AH, Tamimi W, Cherfan A. Low-dose hydrocortisone in patients with cirrhosis and septic shock: a randomized controlled trial. CMAJ. 2010;182(18):1971&#x2013;1977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001503</ArticleId><ArticleId IdType="pubmed">21059778</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998;26(4):645&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559600</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Perkins GD, Stotz M, Terblanche M, Ashby D, Brett SJ. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit Care Med. 2014;42(6):1325&#x2013;1333.</Citation><ArticleIdList><ArticleId IdType="pubmed">24557425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316(5):509&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Gu C, Zhang S, Lian R, Zhang G. Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock. Chin Crit Care Med. 2016;28(9):780&#x2013;784.</Citation></Reference><Reference><Citation>Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33(11):2457&#x2013;2464.</Citation><ArticleIdList><ArticleId IdType="pubmed">16276166</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutuu A. Physiological-dose steroid therapy in sepsis [ISRCTN36253388] Crit Care. 2002;6(3):251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125315</ArticleId><ArticleId IdType="pubmed">12133187</ArticleId></ArticleIdList></Reference><Reference><Citation>Yildiz O, Tanriverdi F, Simsek S, Aygen B, Kelestimur F. The effects of moderate-dose steroid therapy in sepsis: a placebo-controlled, randomized study. J Res Med Sci. 2011;16(11):1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430057</ArticleId><ArticleId IdType="pubmed">22973341</ArticleId></ArticleIdList></Reference><Reference><Citation>Zabet MH, Mohammadi M, Ramezani M, Khalili H. Effect of high-dose ascorbic acid on vasopressor's requirement in septic shock. J Res Pharm Pract. 2016;5(2):94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4843590</ArticleId><ArticleId IdType="pubmed">27162802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P, Liao Y, Guan J, Guo Y, Zhao M, Hu J, Zhou J, Wang H, Cen Z, Tang Y, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: a randomized controlled trial. Chest. 2020;158(1):174&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243943</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv SJ, Zhang GH, Xia JM, Yu H, Zhao F. Early use of high-dose vitamin C is beneficial in treatment of sepsis. Ir J Med Sci. 2020;190:1183&#x2013;1188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33094466</ArticleId></ArticleIdList></Reference><Reference><Citation>Petsakul S, Morakul S, Tangsujaritvijit V, Kunawut P, Singhatas P, Sanguanwit P. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial. BMC Anesthesiol. 2020;20(1):280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650202</ArticleId><ArticleId IdType="pubmed">33167911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AA, Sabry NA, Abdalla MS, Farid SF. A prospective, randomised clinical study comparing triple therapy regimen to hydrocortisone monotherapy in reducing mortality in septic shock patients. Int J Clin Pract. 2021;75(9):e14376.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003568</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferron-Celma I, Mansilla A, Hassan L, Garcia-Navarro A, Comino AM, Bueno P, Ferron JA. Effect of vitamin C administration on neutrophil apoptosis in septic patients after abdominal surgery. J Surg Res. 2009;153(2):224&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">18952228</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Golden E, Umberger R. Prospective double-blind randomized clinical trial on the effects of low-dose hydrocortisone infusion in patients with severe sepsis. Chest. 2009;136(4):45S.</Citation></Reference><Reference><Citation>Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest. 2020;158(1):164&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pubmed">32194058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed ZU, Prasannan P, Moni M, Edathadathil F, Prasanna P, Menon A, Nair S, Greeshma CR, Sathyapalan DT, Menon V, et al. Vitamin C therapy for routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020;24(8):653&#x2013;661.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519616</ArticleId><ArticleId IdType="pubmed">33024370</ArticleId></ArticleIdList></Reference><Reference><Citation>Harun NF, Cheah SK, Yusof AM, Lau CL, Masdar A, Mahdi SNM, Yahya N, Mohamad N, Rahman RA. Intravenous thiamine as an adjuvant therapy for hyperlactatemia in septic shock patients. Crit Care Shock. 2019;22(6):288&#x2013;298.</Citation></Reference><Reference><Citation>Rahardjo TM, Redjeki I, Maskoen T. Effect of vitamin C 1000 mg IV therapy to lactate level, base deficit and Svo2 in septic patient. Crit Care Med. 2013;41:A283.</Citation></Reference><Reference><Citation>Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med. 2006;34(9):2334&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pubmed">16850006</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Fowler R, Vincent JL. Vitamin C and thiamine for sepsis: time to go back to fundamental principles. Intensive Care Med. 2020;46(11):2061&#x2013;2063.</Citation><ArticleIdList><ArticleId IdType="pubmed">32945934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Li JG, Liang H, Zhou Q, Yu Z, Li L, Luo Y, Liu C, Gan Q. The effect of low-dose hydrocortisone on requirement of norepinephrine and lactate clearance in patients with refractory septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2009;21(9):529&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pubmed">19751560</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanase F, Fujii T, Naorungroj T, Belletti A, Luethi N, Carr AC, Young PJ, Bellomo R. Harm of IV high-dose vitamin C therapy in adult patients: a scoping review. Crit Care Med. 2020;48(7):e620&#x2013;e628.</Citation><ArticleIdList><ArticleId IdType="pubmed">32404636</ArticleId></ArticleIdList></Reference><Reference><Citation>Young PJ. Hydrocortisone in septic shock: is it worth it? Crit Care Resusc. 2020;22(3):189&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10692505</ArticleId><ArticleId IdType="pubmed">32900324</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler AA, 3rd, Fisher BJ, Kashiouris MG. Vitamin C for sepsis and acute respiratory failure-reply. JAMA. 2020;323(8):792&#x2013;793.</Citation><ArticleIdList><ArticleId IdType="pubmed">32096845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39696003</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>19</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Ramelteon exposure and survival of critically Ill sepsis patients: a retrospective study from MIMIC-IV.</ArticleTitle><Pagination><StartPage>454</StartPage><MedlinePgn>454</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">454</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02851-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The effect of ramelteon, a melatonin receptor agonist, on survival in septic patients remains unknown. The purpose of this retrospective cohort study was to explore the relationship between ramelteon exposure and survival outcomes in septic patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from septic patients admitted to the intensive care unit (ICU) were extracted from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, with patients categorized into ramelteon exposure and non-exposure groups based on the use of ramelteon. The primary outcome was 30-day mortality, and secondary outcomes included 90-day mortality, in-hospital mortality, length of ICU stay, and hospital stay. Propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) were employed to address confounding variables. Kaplan-Meier (K-M) analysis and Cox proportional hazards regression models for stepwise regression were utilized to assess the impact of ramelteon exposure on survival.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">This study included 22,152 unexposed patients and 2,708 exposed patients, resulting in 2,607 matched pairs after PSM. Following PSM, ramelteon exposure was associated with significantly lower in-hospital mortality (11.6% vs.19.7%, p&#x2009;&lt;&#x2009;0.001), 30-day mortality (13.4% vs. 23.2%, p&#x2009;&lt;&#x2009;0.001), and 90-day mortality (22.1% vs. 30%, p&#x2009;&lt;&#x2009;0.001).K-M curves demonstrated a significant difference in 30-day and 90-day mortality between the two groups (P&#x2009;&lt;&#x2009;0.001), irrespective of PSM application. Both PSM (hazard ratio [HR]&#x2009;=&#x2009;0.53, 95% confidence intervals [CIs] 0.47-0.61, p&#x2009;&lt;&#x2009;0.001) and IPTW models (HR&#x2009;=&#x2009;0.59, 95% CI 0.50-0.70, p&#x2009;&lt;&#x2009;0.001) indicated a significant positive effect of ramelteon usage on 30-day mortality among septic patients compared to the non-exposure group.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This exploratory, retrospective study suggests an association between ramelteon exposure and reduced 30-day and 90-day mortality in septic patients compared with the non-exposure group. Considering the limitations of the retrospective design and the potential for unmeasured confounding, well-designed prospective studies and randomized controlled trials will be needed to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Han</LastName><ForeName>Yun-Yang</ForeName><Initials>YY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tian</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Zhujiang Hospital of Southern Medical University, Guangzhou, 510280, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhao</LastName><ForeName>Bing-Cheng</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Ke-Xuan</ForeName><Initials>KX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Guangdong Provincial Key Laboratory of Precision Anaesthesia and Perioperative Organ Protection, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China. liukexuan705@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>901AS54I69</RegistryNumber><NameOfSubstance UI="C495910">ramelteon</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007192">Indenes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007192" MajorTopicYN="Y">Indenes</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">MIMIC-IV</Keyword><Keyword MajorTopicYN="N">Melatonin</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Ramelteon</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: Authorization for this investigation was granted by the Massachusetts Institute of Technology (MIT) and Beth Israel Deaconess Medical Center (BIDMC) institutional review boards, with informed consent waived. Database access was granted to a researcher (HYY) who completed the Collaborative Institutional Training Initiative test (name ID: 10112186, record ID: 42408105). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>19</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>12</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39696003</ArticleId><ArticleId IdType="pmc">PMC11653545</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02851-9</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02851-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA-J AM MED ASSOC. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. CRIT CARE. 2020;24(1):239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YC, Yao Y, Yu MM, Gao YL, Qi AL, Jiang TY, Chen ZS, Shou ST, Chai YF. Frequency and mortality of sepsis and septic shock in China: a systematic review and meta-analysis. BMC INFECT DIS. 2022;22(1):564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210671</ArticleId><ArticleId IdType="pubmed">35729526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AD, MacCallum NS, Harris S, Brealey DA, Palmer E, Hetherington J, Shi S, Perez-Suarez D, Ercole A, Watkinson PJ et al: Descriptors of Sepsis Using the Sepsis-3 Criteria: A Cohort Study in Critical Care Units Within the U.K. National Institute for Health Research Critical Care Health Informatics Collaborative. CRIT CARE MED 2021, 49(11):1883&#x2013;1894.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8508729</ArticleId><ArticleId IdType="pubmed">34259454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J CLIN SLEEP MED. 2017;13(2):307&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5263087</ArticleId><ArticleId IdType="pubmed">27998379</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox ME, Burry L, Englesakis M, Coman B, Daou M, van Haren FM, Ely EW, Bosma KJ, Knauert MP. Intensive care unit interventions to promote sleep and circadian biology in reducing incident delirium: a scoping review. Thorax. 2024;79(10):988&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">38350730</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatta K, Kishi Y, Wada K, Takeuchi T, Odawara T, Usui C, Nakamura H. Preventive effects of ramelteon on delirium: a randomized placebo-controlled trial. JAMA PSYCHIAT. 2014;71(4):397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">24554232</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto M. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders. CNS NEUROSCI THER. 2009;15(1):32&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2871175</ArticleId><ArticleId IdType="pubmed">19228178</ArticleId></ArticleIdList></Reference><Reference><Citation>Harpsoe NG, Andersen LP, Gogenur I, Rosenberg J. Clinical pharmacokinetics of melatonin: a systematic review. EUR J CLIN PHARMACOL. 2015;71(8):901&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26008214</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Tolbert D, Cao C. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia. J CLIN PHARMACOL. 2006;46(2):140&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16432265</ArticleId></ArticleIdList></Reference><Reference><Citation>He F, Wu X, Zhang Q, Li Y, Ye Y, Li P, Chen S, Peng Y, Hardeland R, Xia Y. Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights. FRONT IMMUNOL. 2021;12: 683879.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8201398</ArticleId><ArticleId IdType="pubmed">34135911</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Luo X, Li J, Lei Y, Zeng F, Huang X, Lan Y, Yang F. Melatonin: A window into the organ-protective effects of sepsis. BIOMED PHARMACOTHER. 2022;154: 113556.</Citation><ArticleIdList><ArticleId IdType="pubmed">35994818</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang L, Du N, Yin X, Shao H, Yang L. Ramelteon Ameliorates LPS-Induced Hyperpermeability of the Blood-Brain Barrier (BBB) by Activating Nrf2. Inflammation. 2021;44(5):1750&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">33876343</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Wang J, Wang D, Guo L, Yu D. Melatonin Receptor Agonist Ramelteon Suppresses LPS-Induced Neuroinflammation in Astrocytes. ACS CHEM NEUROSCI. 2021;12(9):1498&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">33877803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Zhang Y, Lu D, Huang T, Yan K, Wang W, Gao J. Ramelteon protects against human pulmonary microvascular endothelial cell injury induced by lipopolysaccharide (LPS) via activating nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway. Bioengineered. 2022;13(1):1518&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8805948</ArticleId><ArticleId IdType="pubmed">34986734</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutton SS, Magagnoli J, Cummings TH, Hardin JW. Melatonin use and the risk of 30-day mortality among US veterans with sepsis: A retrospective study. J PINEAL RES. 2022;73(2): e12811.</Citation><ArticleIdList><ArticleId IdType="pubmed">35652450</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink T, Glas M, Wolf A, Kleber A, Reus E, Wolff M, Kiefer D, Wolf B, Rensing H, Volk T, et al. Melatonin receptors mediate improvements of survival in a model of polymicrobial sepsis. CRIT CARE MED. 2014;42(1):e22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">24145838</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikimi M, Numaguchi A, Takahashi K, Miyagawa Y, Matsui K, Higashi M, Makishi G, Matsui S, Matsuda N. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial. CRIT CARE MED. 2018;46(7):1099&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6012040</ArticleId><ArticleId IdType="pubmed">29595562</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen AB, Mikkelsen EM, Cronin-Fenton D, Kristensen NR, Pham TM, Pedersen L, Petersen I. Missing data and multiple imputation in clinical epidemiological research. CLIN EPIDEMIOL. 2017;9:157&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5358992</ArticleId><ArticleId IdType="pubmed">28352203</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kim HJ, Lonjon G, Zhu Y. Balance diagnostics after propensity score matching. ANN TRANSL MED. 2019;7(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351359</ArticleId><ArticleId IdType="pubmed">30788363</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrillo-Vico A, Lardone PJ, Naji L, Fernandez-Santos JM, Martin-Lacave I, Guerrero JM, Calvo JR. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J PINEAL RES. 2005;39(4):400&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16207296</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Wang L, Xie W, Hu S, Zhou H, Zhu P, Zhu H. Melatonin attenuates ER stress and mitochondrial damage in septic cardiomyopathy: A new mechanism involving BAP31 upregulation and MAPK-ERK pathway. J CELL PHYSIOL. 2020;235(3):2847&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">31535369</ArticleId></ArticleIdList></Reference><Reference><Citation>Font MD, Thyagarajan B, Khanna AK. Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. MED CLIN N AM. 2020;104(4):573&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32505253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi SM, Nabavi SF, Sureda A, Xiao J, Dehpour AR, Shirooie S, Silva AS, Baldi A, Khan H, Daglia M. Anti-inflammatory effects of Melatonin: A mechanistic review. CRIT REV FOOD SCI. 2019;59(sup1):S4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">29902071</ArticleId></ArticleIdList></Reference><Reference><Citation>Galano A, Reiter RJ. Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection. J PINEAL RES. 2018;65(1): e12514.</Citation><ArticleIdList><ArticleId IdType="pubmed">29888508</ArticleId></ArticleIdList></Reference><Reference><Citation>Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler TW, Biswal S. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J CLIN INVEST. 2006;116(4):984&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421348</ArticleId><ArticleId IdType="pubmed">16585964</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecon E, Izabelle C, Poder SL, Real F, Zhu A, Tu L, Ghigna MR, Klonjkowski B, Bomsel M, Jockers R, et al. Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2. J PINEAL RES. 2022;72(1): e12772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646885</ArticleId><ArticleId IdType="pubmed">34586649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ameri A, Frouz AM, Ziaei A, Vatankhah M, Safa O, Kamali M, Fathalipour M, Mahmoodi M, Hassanipour S. Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial. Inflammopharmacology. 2023;31(1):265&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9676876</ArticleId><ArticleId IdType="pubmed">36401728</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang PY, Wu JY, Liu TH, Tsai YW, Chen PT, Liao CT, Toh HS. The clinical efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. FRONT MED-LAUSANNE. 2023;10:1171294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10166833</ArticleId><ArticleId IdType="pubmed">37181363</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai S, Kadomura S, Miyai T, Kashiwagi H, Sato Y, Sugawara M, Takekuma Y. Using Japanese big data to investigate novel factors and their high-risk combinations that affect vancomycin-induced nephrotoxicity. BRIT J CLIN PHARMACO. 2022;88(7):3241&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">35106797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingren MS, Starr ME, Saito H. Divergent Sepsis Pathophysiology in Older Adults. ANTIOXID REDOX SIGN. 2021;35(16):1358&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8905233</ArticleId><ArticleId IdType="pubmed">34210173</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu C, Wang F, Zhang YT, Wei SZ, Liu JY, Sun HY, Wang GH, Liu CF. Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming. Aging Cell. 2021;20(6): e13375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8208780</ArticleId><ArticleId IdType="pubmed">33964119</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu GC, Peng CK, Liao WI, Pao HP, Huang KL, Chu SJ. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. RESP RES. 2020;21(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7059294</ArticleId><ArticleId IdType="pubmed">32143642</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathes AM, Kubulus D, Waibel L, Weiler J, Heymann P, Wolf B, Rensing H. Selective activation of melatonin receptors with ramelteon improves liver function and hepatic perfusion after hemorrhagic shock in rat. CRIT CARE MED. 2008;36(10):2863&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18766086</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, Heinen A, Hollmann MW, Mathes A, Huhn R. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels. J CARDIOVASC PHARM. 2018;72(2):106&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">29787401</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33187869</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-460X</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of diabetes and its complications</Title><ISOAbbreviation>J Diabetes Complications</ISOAbbreviation></Journal><ArticleTitle>Diabetes on sepsis outcomes in non-ICU patients: A cohort study and review of the literature.</ArticleTitle><Pagination><StartPage>107765</StartPage><MedlinePgn>107765</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jdiacomp.2020.107765</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1056-8727(20)30546-8</ELocationID><Abstract><AbstractText Label="AIMS">We sought to determine whether primary outcomes differ between non-ICU septic patients with and without type 2 diabetes (T2D).</AbstractText><AbstractText Label="METHODS">This study utilized the Hellenic Sepsis Study Group Registry, collecting nationwide data for sepsis patients since 2006, and classified patients upon presence or absence of T2D. Patients were perfectly matched for a) Sepsis 3 definition criteria (including septic shock) b) gender, c) age, d) APACHE II score and e) Charlson's comorbidity index (CCI). Independent sample t-test and chi-square t-test was used to compare prognostic indices and primary outcomes.</AbstractText><AbstractText Label="RESULTS">Of 4320 initially included non-ICU sepsis patients, 812 were finally analysed, following match on criteria. Baseline characteristics were age 76 [&#xb1;10.3] years, 46% male, APACHE II 15.5 [&#xb1;6], CCI 5.1 [&#xb1;1.8], 24% infection, 63.8% sepsis and 12.2% septic shock. No significant difference was noted between two groups in qSOFA, SOFA, or suPAR1 levels (p&#x202f;=&#x202f;0.7, 0.1 &amp; 0.3) respectively. Primary sepsis syndrome resolved in 70.9% of cases (p&#x202f;=&#x202f;0.9), while mortality was 24% in 28-days time. Cause of death was similar between patients with and without T2D (sepsis 17.8% vs 15.8%, heart event 3.7% vs 3.2%, CNS event 0.5% vs 0.5%, malignancy 0.7% vs 2% respectively, p&#x202f;=&#x202f;0.6).</AbstractText><AbstractText Label="CONCLUSIONS">DM does not appear to negatively affect outcomes in septic patients not requiring ICU.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Akinosoglou</LastName><ForeName>Karolina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine and Infectious Diseases, University Hospital of Patras, Greece. Electronic address: akin@upatras.gr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kapsokosta</LastName><ForeName>Georgia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Nafpaktos Primary Care Unit, Nafpaktos, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouktaroudi</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>4th Dept of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovina</LastName><ForeName>Nikoletta</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>1st Dept of Pulmonary Medicine and Intensive Care Unit, National and Kapodistrian University of Athens, Medical School, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaldis</LastName><ForeName>Vassileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Dept of Surgery, Tripoli General Hospital, Tripoli, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefos</LastName><ForeName>Aggelos</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine, Larissa University General Hospital, University of Thessaly, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kontogiorgi</LastName><ForeName>Marina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>2nd Dept of Critical Care Medicine, National and Kapodistrian University of Athens, Medical School, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giamarellos-Bourboulis</LastName><ForeName>Evangelos</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>4th Dept of Internal Medicine, National and Kapodistrian University of Athens, Medical School, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gogos</LastName><ForeName>Charalambos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Dept of Internal Medicine and Infectious Diseases, University Hospital of Patras, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Hellenic Sepsis Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Diabetes Complications</MedlineTA><NlmUniqueID>9204583</NlmUniqueID><ISSNLinking>1056-8727</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Diabetes</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>14</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33187869</ArticleId><ArticleId IdType="doi">10.1016/j.jdiacomp.2020.107765</ArticleId><ArticleId IdType="pii">S1056-8727(20)30546-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26165470</PMID><DateCompleted><Year>2016</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>9</Issue><PubDate><Year>2015</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Association between sepsis and dementia.</ArticleTitle><Pagination><StartPage>1430</StartPage><EndPage>1433</EndPage><MedlinePgn>1430-3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2015.02.035</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0967-5868(15)00171-X</ELocationID><Abstract><AbstractText>In this study, we explored the association between sepsis and dementia using a population-based dataset in Taiwan and a case-control design. The relationship between severe systemic infections and dementia is still unclear. Data for this case-control study were taken from the Taiwan Longitudinal Health Insurance Database 2000. This study included 5955 patients with dementia and 5955 sex and age-matched healthy controls. We performed conditional logistic regressions to examine the association of dementia with previously diagnosed sepsis. We found that 168 (1.41%) of the sampled people had been hospitalized for treatment of sepsis before the index date, 122 patients (2.05%) and 46 controls (0.77%; p&lt;0.001). The conditional logistic regression indicated that patients with dementia were more likely to have been previously diagnosed with sepsis than controls after adjusting for monthly income, urbanization level, hyperlipidemia, and diabetes (odds ratio [OR] 2.60; 95% confidence interval [CI] 1.84-3.66). We also found that dementia was associated with prior sepsis regardless of sex (males: adjusted OR 3.17; 95% CI 1.76-5.68; females: adjusted OR 2.27; 95% CI 1.48-3.47). We concluded that patients with dementia had a higher odds of previous sepsis compared to the control group.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Li-Ting</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan; Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sheu</LastName><ForeName>Jau-Jiuan</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Taipei Medical University Hospital, Taipei, Taiwan; Department of Neurology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Herng-Ching</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>School of Health Care Administration, Taipei Medical University, 250 Wu-Hsin Street, Taipei 110, Taiwan; Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan. Electronic address: henry11111@tmu.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ming-Chieh</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>School of Health Care Administration, Taipei Medical University, 250 Wu-Hsin Street, Taipei 110, Taiwan; Division of Gastroenterology, Department of Internal Medicine, General Cathay Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Shiu-Dong</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Sleep Research Center, Taipei Medical University Hospital, Taipei, Taiwan; Division of Urology, Department of Surgery, Far Eastern Memorial Hospital, New Taipei City, Taiwan. Electronic address: chungshiudong@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N">Taiwan</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Case-control study</Keyword><Keyword MajorTopicYN="N">Dementia</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26165470</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2015.02.035</ArticleId><ArticleId IdType="pii">S0967-5868(15)00171-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39559702</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Development and validation of a model for predicting in-hospital mortality in patients with sepsis-associated kidney injury receiving renal replacement therapy: a retrospective cohort study based on the MIMIC-IV database.</ArticleTitle><Pagination><StartPage>1488505</StartPage><MedlinePgn>1488505</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1488505</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2024.1488505</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">SAKI is a common and serious complication of sepsis, contributing significantly to high morbidity and mortality, especially in patients requiring RRT. Early identification of high-risk patients enables timely interventions and improvement in clinical outcomes. The objective of this study was to develop and validate a predictive model for in-hospital mortality in patients with SAKI receiving RRT.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with SAKI receiving RRT from the MIMIC-IV database were retrospectively enrolled and randomly assigned to either the training cohort or the testing cohort in a 7:3 ratio. LASSO regression and Boruta algorithm were utilized for feature selection. Subsequently, three machine learning models-CART, SVM and LR-were constructed, and their predictive efficacy was assessed using a comprehensive set of performance indicators. Feature importance analysis was performed to determine the contribution of each feature to a model's predictions. Finally, DCA was employed to evaluate the clinical utility of the prediction models. Additionally, a clinical nomogram was developed to facilitate the interpretation and visualization of the LR model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 1663 adults were ultimately enrolled and randomly allocated into the training cohort (n = 1164) or the testing cohort (n = 499). Twenty-eight variables were evaluated for feature selection, with eight ultimately retained in the final model: age, MAP, RR, lactate, Cr, PT-INR, TBIL and CVP. The LR model demonstrated commendable performance, exhibiting robust discrimination in both the training cohort (AUROC: 0.73 (95% CI 0.70-0.76); AUPRC: 0.75 (95% CI 0.72-0.79); accuracy: 0.66 (95% CI 0.63-0.68)) and the testing cohort (AUROC: 0.72 (95% CI 0.68-0.76); AUPRC: 0.73 (95% CI 0.67-0.79); accuracy: 0.65 (95% CI 0.61-0.69)). Furthermore, there was good concordance between predicted and observed values in both the training cohort (&#x3c7;2 = 4.41, p = 0.82) and the testing cohort (&#x3c7;2 = 4.16, p = 0.84). The results of the DCA revealed that the LR model provided a greater net benefit compared to other prediction models.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The LR model exhibited superior performance in predicting in-hospital mortality in patients with SAKI receiving RRT, suggesting its potential utility in identifying high-risk patients and guiding clinical decision-making.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Li, Zhao, Ren, Chen, Zhang, Wang and Xie.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Caifeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Advertising Center, Tianjin Daily, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Tianjin Medical University General Hospital Airport Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Guolin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Keliang</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D023361">Validation Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049451" MajorTopicYN="N">Nomograms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">in-hospital mortality</Keyword><Keyword MajorTopicYN="N">microbial infection</Keyword><Keyword MajorTopicYN="N">predictive model</Keyword><Keyword MajorTopicYN="N">renal replacement therapy</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>15</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>15</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>4</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39559702</ArticleId><ArticleId IdType="pmc">PMC11570588</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2024.1488505</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angeli P., Gin&#xe8;s P., Wong F., Bernardi M., Boyer T. D., Gerbes A., et al. . (2015). Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J. hepatology 62, 968&#x2013;974. doi:&#xa0;10.1016/j.jhep.2014.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2014.12.029</ArticleId><ArticleId IdType="pubmed">25638527</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R., Kellum J. A., Ronco C., Wald R., Martensson J., Maiden M., et al. . (2017). Acute kidney injury in sepsis. Intensive Care Med 43, 816&#x2013;828. doi:&#xa0;10.1007/s00134-017-4755-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4755-7</ArticleId><ArticleId IdType="pubmed">28364303</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerd&#xe1; J., Cerd&#xe1; M., Kilcullen P., Prendergast J. (2007). In severe acute kidney injury, a higher serum creatinine is paradoxically associated with better patient survival. Nephrology dialysis transplantation: Off. Publ. Eur. Dialysis Transplant. Assoc. - Eur. Renal Assoc 22, 2781&#x2013;2784.</Citation><ArticleIdList><ArticleId IdType="pubmed">17597091</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C. T., Tsai H. B., Wu C. Y., Lin Y. F., Hsu N. C., Chen J. S., et al. . (2015). The severity of initial acute kidney injury at admission of geriatric patients significantly correlates with subsequent in-hospital complications. Sci. Rep 5, 13925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4564739</ArticleId><ArticleId IdType="pubmed">26355041</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins G. S., Ogundimu E. O., Altman D. G. (2016). Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat Med 35, 214&#x2013;226. doi:&#xa0;10.1002/sim.6787</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6787</ArticleId><ArticleId IdType="pmc">PMC4738418</ArticleId><ArticleId IdType="pubmed">26553135</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins G. S., Reitsma J. B., Altman D. G., Moons K. G. (2015). Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement. BMC Med 13, 1. doi:&#xa0;10.1186/s12916-014-0241-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-014-0241-z</ArticleId><ArticleId IdType="pmc">PMC4284921</ArticleId><ArticleId IdType="pubmed">25563062</ArticleId></ArticleIdList></Reference><Reference><Citation>da Hora Passos R., Ramos J. G., Mendon&#xe7;a E. J., Miranda E. A., Dutra F. R., Coelho M. F., et al. . (2017). A clinical score to predict mortality in septic acute kidney injury patients requiring continuous renal replacement therapy: the HELENICC score. BMC anesthesiology 17, 21. doi:&#xa0;10.1186/s12871-017-0312-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-017-0312-8</ArticleId><ArticleId IdType="pmc">PMC5297177</ArticleId><ArticleId IdType="pubmed">28173756</ArticleId></ArticleIdList></Reference><Reference><Citation>Darden D. B., Moore F. A., Brakenridge S. C., Navarro E. B., Anton S. D., Leeuwenburgh C., et al. . (2021). The effect of aging physiology on critical care. Crit. Care clinics 37, 135&#x2013;150. doi:&#xa0;10.1016/j.ccc.2020.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2020.08.006</ArticleId><ArticleId IdType="pmc">PMC8194285</ArticleId><ArticleId IdType="pubmed">33190766</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirjian S., Chertow G. M., Zhang J. H., O'Connor T. Z., Vitale J., Paganini E. P., et al. . (2011). Model to predict mortality in critically ill adults with acute kidney injury. Clin. J. Am. Soc. Nephrology: CJASN 6, 2114&#x2013;2120. doi:&#xa0;10.2215/CJN.02900311</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.02900311</ArticleId><ArticleId IdType="pmc">PMC3359007</ArticleId><ArticleId IdType="pubmed">21896828</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabbian F., Savri&#xe8; C., De Giorgi A., Cappadona R., Di Simone E., Boari B., et al. . (2019). Acute kidney injury and in-hospital mortality: A retrospective analysis of a nationwide administrative database of elderly subjects in Italy. J. Clin. Med 8(9):1371. doi:&#xa0;10.3390/jcm8091371</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8091371</ArticleId><ArticleId IdType="pmc">PMC6781256</ArticleId><ArticleId IdType="pubmed">31480750</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo M., Gao Y., Wang L., Zhang H., Liu X., Zhang H. (2020). Early acute kidney injury associated with liver transplantation: A retrospective case-control study. Med. Sci. monitor: Int. Med. J. Exp. Clin. Res 26, e923864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387046</ArticleId><ArticleId IdType="pubmed">32681793</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T., Lv H., Jiang Y. (2021). The association between four scoring systems and 30-day mortality among intensive care patients with sepsis: a cohort study. Sci. Rep 11, 11214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8159970</ArticleId><ArticleId IdType="pubmed">34045645</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang A., Liao L., Pan L., Pinhu L. (2021). Association between the central venous pressure and all-cause mortality in critically ill patients with acute kidney injury. Int. J. Gen. Med 14, 8019&#x2013;8027. doi:&#xa0;10.2147/IJGM.S331686</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S331686</ArticleId><ArticleId IdType="pmc">PMC8590983</ArticleId><ArticleId IdType="pubmed">34785944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishani A., Xue J. L., Himmelfarb J., Eggers P. W., Kimmel P. L., Molitoris B. A., et al. . (2009). Acute kidney injury increases risk of ESRD among elderly. J. Am. Soc. Nephrology: JASN 20, 223&#x2013;228. doi:&#xa0;10.1681/ASN.2007080837</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2007080837</ArticleId><ArticleId IdType="pmc">PMC2615732</ArticleId><ArticleId IdType="pubmed">19020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson A., Bulgarelli L., Shen L., Gayles A., Shammout A., Horng S., et al. . (2023). MIMIC-IV, a freely accessible electronic health record dataset. Scientific data 10 (1). doi:&#xa0;10.1038/s41597-023-01945-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41597-023-01945-2</ArticleId><ArticleId IdType="pmc">PMC9810617</ArticleId><ArticleId IdType="pubmed">36596836</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum J. A., Lameire N. (2013). Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit. Care (London England) 17, 204. doi:&#xa0;10.1186/cc11454</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11454</ArticleId><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M. A. M., Awan S., Azmat R., Khalil M. A. U., Naseer N., Tan J. (2018). Factors affecting inpatient mortality in elderly people with acute kidney injury. TheScientificWorldJournal 2018, 2142519. doi:&#xa0;10.1155/2018/2142519</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2142519</ArticleId><ArticleId IdType="pmc">PMC5960515</ArticleId><ArticleId IdType="pubmed">29853800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambden S., Laterre P. F., Levy M. M., Francois B. (2019). The SOFA score-development, utility and challenges of accurate assessment in clinical trials. Crit. Care (London England) 23, 374. doi:&#xa0;10.1186/s13054-019-2663-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2663-7</ArticleId><ArticleId IdType="pmc">PMC6880479</ArticleId><ArticleId IdType="pubmed">31775846</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall J. R., Lemeshow S., Saulnier F. (1993). A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. Jama 270, 2957&#x2013;2963. doi:&#xa0;10.1001/jama.1993.03510240069035</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1993.03510240069035</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Macedo E., Bouchard J., Soroko S. H., Chertow G. M., Himmelfarb J., Ikizler T. A., et al. . (2010). Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit. Care (London England) 14, R82. doi:&#xa0;10.1186/cc9004</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9004</ArticleId><ArticleId IdType="pmc">PMC2911707</ArticleId><ArticleId IdType="pubmed">20459609</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh H. J., Lee M. J., Kim C. H., Kim D. Y., Lee H. S., Park J. T., et al. . (2014). The benefit of specialized team approaches in patients with acute kidney injury undergoing continuous renal replacement therapy: propensity score matched analysis. Crit. Care (London England) 18, 454. doi:&#xa0;10.1186/s13054-014-0454-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-014-0454-8</ArticleId><ArticleId IdType="pmc">PMC4145553</ArticleId><ArticleId IdType="pubmed">25116900</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh H. J., Park J. T., Kim J. K., Yoo D. E., Kim S. J., Han S. H., et al. . (2012). Red blood cell distribution width is an independent predictor of mortality in acute kidney injury patients treated with continuous renal replacement therapy. Nephrology dialysis transplantation: Off. Publ. Eur. Dialysis Transplant. Assoc. - Eur. Renal Assoc 27, 589&#x2013;594.</Citation><ArticleIdList><ArticleId IdType="pubmed">21712489</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohnuma T., Uchino S., Toki N., Takeda K., Namba Y., Katayama S., et al. . (2015). External validation for acute kidney injury severity scores: A multicenter retrospective study in 14 Japanese ICUs. Am. J. nephrology 42, 57&#x2013;64. doi:&#xa0;10.1159/000439118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000439118</ArticleId><ArticleId IdType="pubmed">26337793</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos R. D. H., Ramos J. G. R., Gobatto A., Mendon&#xe7;a E. J. B., Miranda E. A., Dutra F. R. D., et al. . (2016). Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: A cohort study. Medicine 95, e5112. doi:&#xa0;10.1097/MD.0000000000005112</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000005112</ArticleId><ArticleId IdType="pmc">PMC5059097</ArticleId><ArticleId IdType="pubmed">27749594</ArticleId></ArticleIdList></Reference><Reference><Citation>Peerapornratana S., Manrique-Caballero C. L., G&#xf3;mez H., Kellum J. A. (2019). Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96, 1083&#x2013;1099. doi:&#xa0;10.1016/j.kint.2019.05.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2019.05.026</ArticleId><ArticleId IdType="pmc">PMC6920048</ArticleId><ArticleId IdType="pubmed">31443997</ArticleId></ArticleIdList></Reference><Reference><Citation>Poston J. T., Koyner J. L. (2019). Sepsis associated acute kidney injury. BMJ (Clinical Res. ed) 364, k4891. doi:&#xa0;10.1136/bmj.k4891</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k4891</ArticleId><ArticleId IdType="pmc">PMC6890472</ArticleId><ArticleId IdType="pubmed">30626586</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee H., Jang K. S., Park J. M., Kang J. S., Hwang N. K., Kim I. Y., et al. . (2016). Short- and long-term mortality rates of elderly acute kidney injury patients who underwent continuous renal replacement therapy. PloS One 11, e0167067. doi:&#xa0;10.1371/journal.pone.0167067</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0167067</ArticleId><ArticleId IdType="pmc">PMC5119822</ArticleId><ArticleId IdType="pubmed">27875571</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley R. D., Ensor J., Snell K. I. E., Harrell F. E., Jr., Martin G. P., Reitsma J. B., et al. . (2020). Calculating the sample size required for developing a clinical prediction model. BMJ (Clinical Res. ed) 368, m441. doi:&#xa0;10.1136/bmj.m441</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m441</ArticleId><ArticleId IdType="pubmed">32188600</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner M. H. (2013). Acute kidney injury in the elderly. Clinics geriatric Med 29, 565&#x2013;578. doi:&#xa0;10.1016/j.cger.2013.05.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2013.05.001</ArticleId><ArticleId IdType="pubmed">23849008</ArticleId></ArticleIdList></Reference><Reference><Citation>See E. J., Jayasinghe K., Glassford N., Bailey M., Johnson D. W., Polkinghorne K. R., et al. . (2019). Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int 95, 160&#x2013;172. doi:&#xa0;10.1016/j.kint.2018.08.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2018.08.036</ArticleId><ArticleId IdType="pubmed">30473140</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Y., Yu J., Zhou F., Yan J., Yang J., Guo Y., et al. . (2022). The predictive performance of the lactate clearance rate combined with the APACHE II score in the prediction of sepsis-associated acute kidney injury in 7 days. Trans. andrology urology 11, 543&#x2013;553. doi:&#xa0;10.21037/tau</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/tau</ArticleId><ArticleId IdType="pmc">PMC9085935</ArticleId><ArticleId IdType="pubmed">35558275</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C. S., Seymour C. W., Shankar-Hari M., Annane D., Bauer M., et al. . (2016). The third international consensus definitions for sepsis and septic shock (Sepsis-3). Jama 315, 801&#x2013;810. doi:&#xa0;10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A. D., Crippa A., Woodcock J., Brage S. (2016). Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetologia 59, 2527&#x2013;2545. doi:&#xa0;10.1007/s00125-016-4079-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-016-4079-0</ArticleId><ArticleId IdType="pmc">PMC6207340</ArticleId><ArticleId IdType="pubmed">27747395</ArticleId></ArticleIdList></Reference><Reference><Citation>Speiser J. L., Miller M. E., Tooze J., Ip E. (2019). A Comparison of Random Forest Variable Selection Methods for Classification Prediction Modeling. Expert systems with applications 134, 93&#x2013;101. doi:&#xa0;10.1016/j.eswa.2019.05.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eswa.2019.05.028</ArticleId><ArticleId IdType="pmc">PMC7508310</ArticleId><ArticleId IdType="pubmed">32968335</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasquez M. M., Hu C., Roe D. J., Chen Z., Halonen M., Guerra S. (2016). Least absolute shrinkage and selection operator type methods for the identification of serum biomarkers of overweight and obesity: simulation and application. BMC Med. Res. methodology 16, 154. doi:&#xa0;10.1186/s12874-016-0254-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-016-0254-8</ArticleId><ArticleId IdType="pmc">PMC5109787</ArticleId><ArticleId IdType="pubmed">27842498</ArticleId></ArticleIdList></Reference><Reference><Citation>Vickers A. J., Van Calster B., Steyerberg E. W. (2016). Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests. BMJ (Clinical Res. ed) 352, i6. doi:&#xa0;10.1136/bmj.i6</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i6</ArticleId><ArticleId IdType="pmc">PMC4724785</ArticleId><ArticleId IdType="pubmed">26810254</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Ou Y., Fan T., Zhao J., Kang M., Dong R., et al. . (2021). Development and internal validation of a nomogram to predict mortality during the ICU stay of thoracic fracture patients without neurological compromise: an analysis of the MIMIC-III clinical database. Front. Public Health 9, 818439. doi:&#xa0;10.3389/fpubh.2021.818439</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.818439</ArticleId><ArticleId IdType="pmc">PMC8727460</ArticleId><ArticleId IdType="pubmed">35004604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38760833</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>17</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE): a randomized multicentre feasibility trial.</ArticleTitle><Pagination><StartPage>166</StartPage><MedlinePgn>166</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">166</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-04952-w</ELocationID><Abstract><AbstractText Label="BACKGROUND/PURPOSE">Non-resuscitation fluids constitute the majority of fluid administered for septic shock patients in the intensive care unit (ICU). This multicentre, randomized, feasibility trial was conducted to test the hypothesis that a restrictive protocol targeting non-resuscitation fluids reduces the overall volume administered compared with usual care.</AbstractText><AbstractText Label="METHODS">Adults with septic shock in six Swedish ICUs were randomized within 12&#xa0;h of ICU admission to receive either protocolized reduction of non-resuscitation fluids or usual care. The primary outcome was the total volume of fluid administered within three days of inclusion.</AbstractText><AbstractText Label="RESULTS">Median (IQR) total volume of fluid in the first three days, was 6008&#xa0;ml (interquartile range [IQR] 3960-8123) in the restrictive fluid group (n&#x2009;=&#x2009;44), and 9765&#xa0;ml (IQR 6804-12,401) in the control group (n&#x2009;=&#x2009;48); corresponding to a Hodges-Lehmann median difference of 3560&#xa0;ml [95% confidence interval 1614-5302]; p&#x2009;&lt;&#x2009;0.001). Outcome data on all-cause mortality, days alive and free of mechanical ventilation and acute kidney injury or ischemic events in the ICU within 90&#xa0;days of inclusion were recorded in 98/98 (100%), 95/98 (98%) and 95/98 (98%) of participants respectively. Cognition and health-related quality of life at six months were recorded in 39/52 (75%) and 41/52 (79%) of surviving participants, respectively. Ninety out of 134 patients (67%) of eligible patients were randomized, and 15/98 (15%) of the participants experienced at least one protocol violation.</AbstractText><AbstractText Label="CONCLUSION">Protocolized reduction of non-resuscitation fluids in patients with septic shock resulted in a large decrease in fluid administration compared with usual care. A trial using this design to test if reducing non-resuscitation fluids improves outcomes is feasible.</AbstractText><AbstractText Label="TRIAL REGISTRATION">Clinicaltrials.gov, NCT05249088, 18 February 2022. https://clinicaltrials.gov/ct2/show/NCT05249088.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lind&#xe9;n</LastName><ForeName>Anja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. anja.linden.icu@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhl&#xe9;ns Gata 10, 252 23, Helsingborg, Sweden. anja.linden.icu@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sp&#xe5;ngfors</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Kristianstad Hospital, Kristianstad, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olsen</LastName><ForeName>M H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre for Clinical Intervention Research, The Capital Region, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroanaesthesiology, The Neuroscience Centre, Copenhagen University Hospital -Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lilja</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Department, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Skane University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jungner</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Skane University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lengquist</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Skane University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kander</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Skane University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samuelsson</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, &#xd6;stersund Hospital, &#xd6;stersund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, &#xd6;stersund Hospital, &#xd6;stersund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmn&#xe4;s</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Und&#xe9;n</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oras</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Clinical Sciences, Danderyd Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Link&#xf6;ping University Hospital, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linder</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Infectious Diseases, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipcsey</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hedenstierna Laboratory, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhl&#xe9;ns Gata 10, 252 23, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakobsen</LastName><ForeName>J C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Kristianstad Hospital, Kristianstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Regional Health Research, The Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bentzer</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Helsingborg Hospital, Charlotte Yhl&#xe9;ns Gata 10, 252 23, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>REDUSE Trial Group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05249088</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>ALF 86626</GrantID><Agency>Swedish National Health Service</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2024 Jul 8;28(1):223. doi: 10.1186/s13054-024-04977-1.</RefSource><PMID Version="1">38978092</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="Y">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Feasibility</Keyword><Keyword MajorTopicYN="N">Fluid therapy</Keyword><Keyword MajorTopicYN="N">Non-resuscitation fluids</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors declare no competing interests. The authors have no competing interests to declare.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Fisher</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nelderup</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hassel</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Johnsson</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Claesson</LastName><ForeName>Camilla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lybeck</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schrey</LastName><ForeName>Susann</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andersson</LastName><ForeName>Linda K</ForeName><Initials>LK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Holmstr&#xf6;m</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larsson</LastName><ForeName>Marina</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bramell</LastName><ForeName>Katarina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aspholm</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Olne</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Larsson</LastName><ForeName>Hanna</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipscey</LastName><ForeName>Miklos</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sk&#xe5;ne</LastName><ForeName>Region</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Niklas</ForeName><Initials>N</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>18</Day><Hour>19</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>18</Day><Hour>4</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>17</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38760833</ArticleId><ArticleId IdType="pmc">PMC11100208</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-04952-w</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-04952-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lind&#xe9;n-S&#xf8;nders&#xf8; A, Jungner M, Sp&#xe5;ngfors M, et al. Survey of non-resuscitation fluids administered during septic shock: a multicenter prospective observational study. Ann Intensive Care. 2019 doi: 10.1186/s13613-019-0607-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-019-0607-7</ArticleId><ArticleId IdType="pmc">PMC6881490</ArticleId><ArticleId IdType="pubmed">31776712</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011 doi: 10.1097/CCM.0b013e3181feeb15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181feeb15</ArticleId><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Rubatto Birri PN, Kotfis K, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2017 doi: 10.1097/CCM.0000000000002189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002189</ArticleId><ArticleId IdType="pubmed">27922878</ArticleId></ArticleIdList></Reference><Reference><Citation>Silversides JA, Fitzgerald E, Manickavasagam US, et al. Deresuscitation of patients with iatrogenic fluid overload is associated with reduced mortality in critical illness. Crit Care Med. 2018 doi: 10.1097/CCM.0000000000003276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003276</ArticleId><ArticleId IdType="pubmed">29985214</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, de Pont AC, Sakr Y, et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12:R74. doi: 10.1186/cc6916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc6916</ArticleId><ArticleId IdType="pmc">PMC2481469</ArticleId><ArticleId IdType="pubmed">18533029</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivapalan P, Ellekjaer KL, Jessen MK, et al. Lower vs higher fluid volumes in adult patients with sepsis: an updated systematic review with meta-analysis and trial sequential analysis. Chest. 2023 doi: 10.1016/j.chest.2023.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.04.036</ArticleId><ArticleId IdType="pmc">PMC10567931</ArticleId><ArticleId IdType="pubmed">37142091</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016 doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind&#xe9;n A, Fisher J, Lilja G, et al. Protocolized reduction of non-resuscitation fluids in septic shock&#x2014;A protocol for a multicentre feasibility trial. BMJ Open. 2023 doi: 10.1136/bmjopen-2022-065392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-065392</ArticleId><ArticleId IdType="pmc">PMC9980317</ArticleId><ArticleId IdType="pubmed">36854601</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen M, Lind&#xe9;n A, Lilja G et al. Protocolised REDUction of non-resuscitation fluids versus usual care in SEptic shock patients (REDUSE) - a statistical analysis plan for a multicentre feasibility trial. 2022. https://zenodo.org/records/7392132#.ZGXJVnZBx3g. Accessed 9 November 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016 doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>DeBacker D, Cecconi M, Chew MS, et al. A plea for personalization of hemodynamic management of septic shock. Crit Care. 2022 doi: 10.1186/s13054-022-04255-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04255-y</ArticleId><ArticleId IdType="pmc">PMC9714237</ArticleId><ArticleId IdType="pubmed">36457089</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intens Care Med. 2021 doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group (2013) Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 10.1186/cc11454</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057151</ArticleId><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Collingridge DS, Wilson EL, et al. Preliminary validation of the Montreal cognitive assessment tool among sepsis survivors: a prospective pilot study. Ann Am Thorac Soc. 2018 doi: 10.1513/AnnalsATS.201804-233OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201804-233OC</ArticleId><ArticleId IdType="pubmed">30168744</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of eq-5d (eq-5d-5l) Quality Life Res. 2011;20:1727&#x2013;1736. doi: 10.1007/s11136-011-9903-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">PMC3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. Neurotrauma. 1998;15(8):573&#x2013;585. doi: 10.1089/neu.1998.15.573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.1998.15.573</ArticleId><ArticleId IdType="pubmed">9726257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann EL. Nonparametrics.&#x202f;Statistical Methods Based on Ranks, Revised. Prentice Hall 1998. p. 76&#x2013;81. ISBN:13997735X, 9780139977350.</Citation></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, et al. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022 doi: 10.1056/NEJMoa2202707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2202707</ArticleId><ArticleId IdType="pubmed">36053521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;r MBN, Meyhoff TS, Sivapalan P, et al. Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock. Intensive Care Med. 2023 doi: 10.1007/s00134-023-07114-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-023-07114-8</ArticleId><ArticleId IdType="pmc">PMC10354110</ArticleId><ArticleId IdType="pubmed">37330928</ArticleId></ArticleIdList></Reference><Reference><Citation>Dankiewicz J, Cronberg T, Lilja G, Jakobsen JC, et al. Hypothermia vs normothermia after out-of-hospital cardiac arrest. N Engl J Med. 2021 doi: 10.1056/NEJMoa2100591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2100591</ArticleId><ArticleId IdType="pubmed">34133859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond NE, Finfer SR, Li Q, Taylor C, et al. Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial. Intensive Care Med. 2020 doi: 10.1007/s00134-020-06169-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-06169-1</ArticleId><ArticleId IdType="pubmed">32676679</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcox ME, Ely EW. Challenges in conducting long-term outcomes studies in critical care. Curr Opin Crit Care. 2019 doi: 10.1097/MCC.0000000000000650.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000650</ArticleId><ArticleId IdType="pmc">PMC7141412</ArticleId><ArticleId IdType="pubmed">31356238</ArticleId></ArticleIdList></Reference><Reference><Citation>Baigent C, Harrell FE, Buyse M, Emberson JR, Altman DG. Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials. 2008 doi: 10.1177/1740774507087554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1740774507087554</ArticleId><ArticleId IdType="pubmed">18283080</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. Clinical Guideline174. 2017. www.nice.org.uk/guidance/cg174. Accessed 9 November 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">32101393</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Regenmortel N, Verbrugghe W, Roelant E. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018 doi: 10.1007/s00134-018-5147-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5147-3</ArticleId><ArticleId IdType="pmc">PMC5924672</ArticleId><ArticleId IdType="pubmed">29589054</ArticleId></ArticleIdList></Reference><Reference><Citation>Danish Society of Anaesthesiology and Intensive care medicine. Nutrition for the critically ill (in danish). https://dasaim.dk/guides/pdf-nbv-ernaering-til-kritisk-syge-2019. Accessed 9 November 2023.</Citation></Reference><Reference><Citation>Singer P, Blaser AR, Berger MM, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutrit. 2018 doi: 10.1016/j.clnu.2018.08.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2018.08.037</ArticleId><ArticleId IdType="pubmed">30348463</ArticleId></ArticleIdList></Reference><Reference><Citation>McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: society of critical care medicine (SCCM) and American society for parenteral and enteral nutrition (A.S.P.E.N.) Crit Care Med. 2016 doi: 10.1177/0148607115621863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607115621863</ArticleId><ArticleId IdType="pubmed">26771786</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39614357</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>29</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Differential effects of thiamine and ascorbic acid in clusters of septic patients identified by latent variable analysis.</ArticleTitle><Pagination><StartPage>396</StartPage><MedlinePgn>396</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">396</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05188-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">Thiamine and ascorbic acid have been proposed to mitigate the devastating consequences of sepsis and septic shock. To date, randomized controlled trials have failed to demonstrate a benefit of these therapies and heterogeneity of treatment effect is suspected. In this study, we aimed at assessing the heterogeneity of treatment effect of thiamine (B1) and the combination of B1 plus ascorbic acid (AA&#x2009;+&#x2009;B1) in critically ill patients with sepsis.</AbstractText><AbstractText Label="METHODS">We conducted a bi-centric retrospective cohort study. All adult patients admitted to the ICU with sepsis or septic shock between January 2012 and August 2022 were included. Patient clusters were identified using latent variable analysis based on demographics and physiological variables obtained within 24&#xa0;h of admission. Within each cluster and using inverse probability weighted Cox models, we compared in-hospital mortality between patients who received standard treatment (control), standard treatment plus B1 (B1 group), and standard treatment plus a combination of thiamine and ascorbic acid (AA&#x2009;+&#x2009;B1 group).</AbstractText><AbstractText Label="RESULTS">A total of 3465 septic patients were included, 2183, 1054 and 228 in the standard, B1 and AA&#x2009;+&#x2009;B1 groups respectively. Five clusters of patients were identified in an unsupervised manner. The "Cluster Severe" included the most severely ill patients, the "Cluster Resp" patients presented with predominantly respiratory failure, the "Cluster Old" included elderly patients with multiple comorbidities, the "Cluster Fit" patients were young, healthy with low severity indices and "Cluster Liver" included patients with predominant liver failure. B1 treatment was associated with different outcomes across the five clusters. It was associated with a lower in-hospital mortality in the "Cluster Severe" and "Cluster Resp". On the other hand, the combination of thiamine and ascorbic acid was not associated with reduced mortality in any cluster but an increased mortality in"Cluster Old".</AbstractText><AbstractText Label="CONCLUSIONS">These results reinforce the lack of efficacy of the combination of AA&#x2009;+&#x2009;B1 reported in recent trials and even raise concerns about potential harm in older patients with comorbidities. On the contrary, we reported improved ICU survival associated with B1 supplementation in the most severe patients and those with predominant respiratory failure, supporting the need for further trials in this specific population.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Legouis</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Anesthesiology, Pharmacology, Critical Care and Emergency Medicine, University Hospital of Geneva, 1205, Geneva, Switzerland. David.legouis@unige.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Nephrology, Department of Physiology and Cell Metabolism, University of Geneva, 1205, Geneva, Switzerland. David.legouis@unige.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monard</LastName><ForeName>C&#xe9;line</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Health Systems, Quantitative Research, Center for Primary Care and Public Health (Unisant&#xe9;), University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ourahmoune</LastName><ForeName>Aimad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical and Quality Directorate, University Hospital and University of Geneva, 1205, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sgardello</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Centre Hospitalier du Valais Romand, 1951, Sion, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintard</LastName><ForeName>Herv&#xe9;</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Anesthesiology, Pharmacology, Critical Care and Emergency Medicine, University Hospital of Geneva, 1205, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criton</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Geneva School of Economics and Management, University of Geneva, 1205, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sangla</LastName><ForeName>Frederic</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Anesthesiology, Pharmacology, Critical Care and Emergency Medicine, University Hospital of Geneva, 1205, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schneider</LastName><ForeName>Antoine</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Adult Intensive Care Unit, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology and Health Systems, Quantitative Research, Center for Primary Care and Public Health (Unisant&#xe9;), University of Lausanne (UNIL), Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PRD 5-2020-I</GrantID><Agency>Geneva University Hospitals</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X66NSO3N35</RegistryNumber><NameOfSubstance UI="D013831">Thiamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>PQ6CK8PD0R</RegistryNumber><NameOfSubstance UI="D001205">Ascorbic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013831" MajorTopicYN="Y">Thiamine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001205" MajorTopicYN="Y">Ascorbic Acid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016000" MajorTopicYN="N">Cluster Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ascorbic acid</Keyword><Keyword MajorTopicYN="N">HAT therapy</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Thiamine</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The study was approved by the local ethical committee for human studies of Geneva, Switzerland (CCER 2023-00147, Commission Cantonale d&#x2019;Ethique de la Recherche). The study was performed according to the Declaration of Helsinki principles. Consent for publication: All authors have approved the manuscript for submission. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>30</Day><Hour>12</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>30</Day><Hour>11</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>29</Day><Hour>23</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39614357</ArticleId><ArticleId IdType="pmc">PMC11606082</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05188-4</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05188-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">31804299</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24740011</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Jaschinski U, Wittebole X, et al. Sepsis in intensive care unit patients: worldwide data from the intensive care over nations audit. Open Forum Infect Dis. 2018;5(12):ofy313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289022</ArticleId><ArticleId IdType="pubmed">30555852</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NKJ, et al. Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med. 2015;193(3):259&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen K-M, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372(17):150319144911000.</Citation><ArticleIdList><ArticleId IdType="pubmed">25776936</ArticleId></ArticleIdList></Reference><Reference><Citation>Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414736</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Mellhammar L, Rose N, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381468</ArticleId><ArticleId IdType="pubmed">32572531</ArticleId></ArticleIdList></Reference><Reference><Citation>Howell MD, Davis AM. Management of sepsis and septic shock. JAMA. 2017;317(8):847.</Citation><ArticleIdList><ArticleId IdType="pubmed">28114603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Mohr NM, Shapiro NI, Venkatesh A, Jones AE, Self WH. Early care of adults with suspected sepsis in the emergency department and out-of-hospital environment: a consensus-based task force report. Ann Emerg Med. 2021;78(1):1&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33840511</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Marik PE, Khangoora V, Rivera R, Hooper MH, Catravas J. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest. 2017;151(6):1229&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">27940189</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii T, Luethi N, Young PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA. 2020;323(5):423&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7029761</ArticleId><ArticleId IdType="pubmed">31950979</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias J, Vassallo AV, Patel VV, Sullivan JB, Cavanaugh J, Elbaga Y. Outcomes of metabolic resuscitation using ascorbic acid, thiamine, and glucocorticoids in the early treatment of sepsis: the ORANGES trial. Chest. 2020;158(1):164&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">32194058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed ZU, Prasannan P, Moni M, et al. Vitamin c therapy for routine care in septic shock (ViCTOR) trial: effect of intravenous vitamin C, thiamine, and hydrocortisone administration on inpatient mortality among patients with septic shock. Indian J Crit Care Med. 2020;24(8):653&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519616</ArticleId><ArticleId IdType="pubmed">33024370</ArticleId></ArticleIdList></Reference><Reference><Citation>Moskowitz A, Huang DT, Hou PC, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA. 2020;324(7):642&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435341</ArticleId><ArticleId IdType="pubmed">32809003</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy PR, Samavedam S, Aluru N, Yelle S, Rajyalakshmi B. Metabolic resuscitation using hydrocortisone, ascorbic acid, and thiamine: do individual components influence reversal of shock independently? Indian J Crit Care Med. 2020;24(8):649&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519600</ArticleId><ArticleId IdType="pubmed">33024369</ArticleId></ArticleIdList></Reference><Reference><Citation>Wani SJ, Mufti SA, Jan RA, et al. Combination of vitamin C, thiamine and hydrocortisone added to standard treatment in the management of sepsis: results from an open label randomised controlled clinical trial and a review of the literature. Infect Dis (Lond). 2020;52(4):271&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31990246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang P, Liao Y, Guan J, et al. Combined treatment with hydrocortisone, vitamin C, and thiamine for sepsis and septic shock: a randomized controlled trial. Chest. 2020;158(1):174&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243943</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevransky JE, Rothman RE, Hager DN, et al. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021;325(8):742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903252</ArticleId><ArticleId IdType="pubmed">33620405</ArticleId></ArticleIdList></Reference><Reference><Citation>Assouline B, Faivre A, Verissimo T, et al. Thiamine, ascorbic acid, and hydrocortisone as a metabolic resuscitation cocktail in sepsis: a meta-analysis of randomized controlled trials with trial sequential analysis. Crit Care Med. 2021;49(12):2112&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">34582409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu Q-Q, Zheng R-Q, Chen Q-H, Yu J-Q, Shao J, Gu X-H. Early administration of hydrocortisone, vitamin C, and thiamine in adult patients with septic shock: a randomized controlled clinical trial. Crit Care. 2022;26(1):295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9520942</ArticleId><ArticleId IdType="pubmed">36171582</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussein AA, Sabry NA, Abdalla MS, Farid SF. A prospective, randomised clinical study comparing triple therapy regimen to hydrocortisone monotherapy in reducing mortality in septic shock patients. Int J Clin Pract. 2021;75(9):e14376.</Citation><ArticleIdList><ArticleId IdType="pubmed">34003568</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Burke JF, Sussman JB, Prescott HC, Hayward RA, Angus DC. Implications of heterogeneity of treatment effect for reporting and analysis of randomized trials in critical care. Am J Respir Crit Care Med. 2015;192(9):1045&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642199</ArticleId><ArticleId IdType="pubmed">26177009</ArticleId></ArticleIdList></Reference><Reference><Citation>Leisch F. FlexMix: A General Framework for Finite Mixture Models and Latent Class Regression in R. J Stat Soft, 2004, 11(8). Available from: http://www.jstatsoft.org/v11/i08/</Citation></Reference><Reference><Citation>Stekhoven DJ, B&#xfc;hlmann P. MissForest&#x2013;non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28(1):112&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22039212</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart EA, Lee BK, Leacy FP. Prognostic score&#x2013;based balance measures for propensity score methods in comparative effectiveness research. J Clinic Epidemiol. 2013;66(80):S84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3713509</ArticleId><ArticleId IdType="pubmed">23849158</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Kim HJ, Lonjon G, Zhu Y. Group written on behalf of AB-DCTC. Balance diagnostics after propensity score matching. Annal Translat Med. 2019;7(1):16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6351359</ArticleId><ArticleId IdType="pubmed">30788363</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC. Double propensity-score adjustment: a solution to design bias or bias due to incomplete matching. Stat Methods Med Res. 2014;26(1):201&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5302082</ArticleId><ArticleId IdType="pubmed">25038071</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T-L, Collins GS, Spence J, et al. Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol. 2017;17(1):78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5408373</ArticleId><ArticleId IdType="pubmed">28454568</ArticleId></ArticleIdList></Reference><Reference><Citation>Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515&#x2013;26.</Citation></Reference><Reference><Citation>Nandhini N, Malviya D, Parashar S, Pandey C, Nath SS, Tripathi M. Comparison of the effects of vitamin C and thiamine on refractory hypotension in patients with sepsis: a randomized controlled trial. Int J Crit Illn Inj Sci. 2022;12(3):138&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9728072</ArticleId><ArticleId IdType="pubmed">36506923</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnino MW, Andersen LW, Chase M, et al. Randomized, double-blind, placebo-controlled trial of thiamine as a metabolic resuscitator in septic shock: a pilot study. Crit Care Med. 2016;44(2):360&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4754670</ArticleId><ArticleId IdType="pubmed">26771781</ArticleId></ArticleIdList></Reference><Reference><Citation>Petsakul S, Morakul S, Tangsujaritvijit V, Kunawut P, Singhatas P, Sanguanwit P. Effects of thiamine on vasopressor requirements in patients with septic shock: a prospective randomized controlled trial. BMC Anesthesiol. 2020;20(1):280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7650202</ArticleId><ArticleId IdType="pubmed">33167911</ArticleId></ArticleIdList></Reference><Reference><Citation>Depeint F, Bruce WR, Shangari N, Mehta R, O&#x2019;Brien PJ. Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways. Chem Biol Interact. 2006;163(1&#x2013;2):113&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">16814759</ArticleId></ArticleIdList></Reference><Reference><Citation>Legouis D, Ricksten S-E, Faivre A, et al. Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality. Nat Metab. 2020;2(8):732&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">32694833</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank AM, Telfer AB, Shenkin A. Thiamine deficiency in the critically ill. Intensive Care Med. 1988;14(4):384&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3136196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangla F, Verissimo T, Faivre A, et al. Thiamine as a metabolic resuscitator in septic shock: a meta-analysis of randomized controlled trials with trial sequential analysis. Front Med (Lausanne). 2023;10:1223862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10533915</ArticleId><ArticleId IdType="pubmed">37780556</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Masse M-H, Menard J, et al. Intravenous vitamin C in adults with sepsis in the intensive care unit. N Engl J Med. 2022;386(25):2387&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">35704292</ArticleId></ArticleIdList></Reference><Reference><Citation>LOVIT-COVID Investigators, on behalf of the Canadian critical care trials group, and the REMAP-CAP investigators, Adhikari NKJ, Hashmi M, et al. intravenous vitamin C for patients hospitalized with COVID-19: two harmonized randomized clinical trials. JAMA 2023; 330(18):1745&#x2013;1759</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10600726</ArticleId><ArticleId IdType="pubmed">37877585</ArticleId></ArticleIdList></Reference><Reference><Citation>Castela Forte J, Perner A, van der Horst ICC. The use of clustering algorithms in critical care research to unravel patient heterogeneity. Intensive Care Med. 2019;45(7):1025&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31062051</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38769373</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5578</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>12</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Molecular psychiatry</Title><ISOAbbreviation>Mol Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Severe mental illness and mortality in sepsis and septic shock: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>3857</StartPage><EndPage>3864</EndPage><MedlinePgn>3857-3864</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41380-024-02603-8</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There have been conflicting reports regarding the case-fatality outcomes associated with sepsis and septic shock in patients with severe mental illness (SMI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched Medline&#xae;, Web of Science&#xae; and the Cochrane Library&#xae; databases (from inception to 4-July-2023) for papers reporting outcomes associated with sepsis and septic shock in adult with (cases) vs. without SMI (controls). The main study outcome was the unadjusted case-fatality rate at hospital discharge, or 30 days if unavailable. Secondary outcomes included the rates of adjusted case-fatality at hospital discharge.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of six studies were included in the systematic review, of which four provided data for meta-analysis involving 2,124,072 patients. Compared to controls, patients with SMI were younger and more frequently women. Unadjusted analyses showed that SMI patients had a lower case-fatality rate associated with sepsis and septic shock than their non-SMI counterparts (OR 0.61, 95% CI [0.58-0.65], PI 95% CI [0.49-0.77], I<sup>2</sup>&#x2009;=&#x2009;91%). Meta-regression and subgroup analyses showed that the denominator of the study population (i.e. septic shock or sepsis) was associated with the outcome with an R<sup>2</sup> of 59.7%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In conclusion, our study reveals a survival advantage of SMI patients over their non-SMI counterparts. Further research is needed to fully elucidate the mechanisms involved and to develop targeted interventions that can improve the prognosis of both SMI and non-SMI patients facing sepsis.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lakbar</LastName><ForeName>Ines</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-0049-6248</Identifier><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France. ines.lakbar@chu-montpellier.fr.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care; Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, 1, 80 Avenue Augustin Fliche, Montpellier Cedex 5, Montpellier, France. ines.lakbar@chu-montpellier.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maakaron</LastName><ForeName>Eloise</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>APHM, service de psychiatrie universitaire, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leone</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Aix-Marseille University, AP-HM, North Hospital, Department of Anesthesia and Intensive Care Medicine, Marseille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delamarre</LastName><ForeName>Louis</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Anesthesiology and Intensive Care; Anesthesia and Critical Care Department C, Gui de Chauliac Teaching Hospital, 80 Avenue Augustin Fliche, Montpellier Cedex 5, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yon</LastName><ForeName>Dong Keon</ForeName><Initials>DK</Initials><Identifier Source="ORCID">0000-0003-1628-9948</Identifier><AffiliationInfo><Affiliation>Center for Digital Health, Medical Science Research Institute, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Kyung Hee University Medical Center, Kyung Hee University College of Medicine, Seoul, South Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tran</LastName><ForeName>Bach</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boyer</LastName><ForeName>Laurent</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1229-6622</Identifier><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FondaMental Fondation, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fond</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>AP-HM, Aix-Marseille Univ, CEReSS, Health Service Research and Quality of Life Centre, School of Medicine - La Timone Medical, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>APHM, service de psychiatrie universitaire, Marseille, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>FondaMental Fondation, Cr&#xe9;teil, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Psychiatry</MedlineTA><NlmUniqueID>9607835</NlmUniqueID><ISSNLinking>1359-4184</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>2</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>20</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38769373</ArticleId><ArticleId IdType="doi">10.1038/s41380-024-02603-8</ArticleId><ArticleId IdType="pii">10.1038/s41380-024-02603-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lakbar I, Leone M, Pauly V, Orleans V, Srougbo K, Diao S, et al. Association of severe mental illness and septic shock case fatality rate in patients admitted to the intensive care unit: A national population-based cohort study. PLOS Med. 2023;20:e1004202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1004202</ArticleId><ArticleId IdType="pubmed">36913434</ArticleId><ArticleId IdType="pmc">10042353</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Lakbar I, Vincent J-L. Sepsis: Actual numbers and uncertainties. Revue d&#x2019;&#xc9;pid&#xe9;miologie. et de St&#xe9; Publique. 2023;71:102176.</Citation></Reference><Reference><Citation>Ishida T, Nakamura K, Miyazaki K, Yukawa T, Yamagishi T, Sugiyama K, et al. Mortality from sepsis among patients with schizophrenia and mood disorders in an intensive care unit: A chart review. Psychiatry Res. 2019;279:372&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2018.12.061</ArticleId><ArticleId IdType="pubmed">30558820</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubani AO, Sharma A, Soubani O, Mishra T. Septic Shock Short-Term Outcomes in Hospitalized Patients With Major Psychiatric Disorders: Analysis From the National Inpatient Sample Database. J Acad Consult Liaison Psychiatry. 2023. https://doi.org/10.1016/j.jaclp.2023.03.003 .</Citation></Reference><Reference><Citation>Nilsson NH, Bendix M, &#xd6;hlund L, Widerstr&#xf6;m M, Werneke U, Maripuu M. Increased Risks of Death and Hospitalization in Influenza/Pneumonia and Sepsis for Individuals Affected by Psychotic Disorders, Bipolar Disorders, and Single Manic Episodes: A Retrospective Cross-Sectional Study. J Clin Med. 2021;10:4411.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10194411</ArticleId><ArticleId IdType="pubmed">34640430</ArticleId><ArticleId IdType="pmc">8509221</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Bege T, Orleans V, Braunstein D, Leone M, et al. Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database. Br J Psychiatry. 2020;217:568&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2019.139</ArticleId><ArticleId IdType="pubmed">31217045</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Leone M, Llorca P-M, Orleans V, Loundou A, et al. Disparities in Intensive Care Unit Admission and Mortality Among Patients With Schizophrenia and COVID-19: A National Cohort Study. Schizophr Bull. 2021;47:624&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/schbul/sbaa158</ArticleId><ArticleId IdType="pubmed">33089862</ArticleId></ArticleIdList></Reference><Reference><Citation>Fond G, Pauly V, Leone M, Orleans V, Garosi A, Lancon C, et al. Mortality among inpatients with bipolar disorders and COVID-19: a propensity score matching analysis in a national French cohort study. Psychol Med. 2023;53:1979&#x2013;88.</Citation></Reference><Reference><Citation>Davydow DS, Ribe AR, Pedersen HS, Vestergaard M, Fenger-Gr&#xf8;n M. The association of unipolar depression with thirty-day mortality after hospitalization for infection: A population-based cohort study in Denmark. J Psychosom Res. 2016;89:32&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2016.08.006</ArticleId><ArticleId IdType="pubmed">27663108</ArticleId></ArticleIdList></Reference><Reference><Citation>Correll CU, Solmi M, Croatto G, Schneider LK, Rohani&#x2010;Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta&#x2010;analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21:248&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wps.20994</ArticleId><ArticleId IdType="pubmed">35524619</ArticleId><ArticleId IdType="pmc">9077617</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmi M, Fiedorowicz J, Poddighe L, Delogu M, Miola A, H&#xf8;ye A, et al. Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies. AJP. 2021;178:793&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.2021.21010031</ArticleId></ArticleIdList></Reference><Reference><Citation>PRISMA-P Group, Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">4320440</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 13 November 2023.</Citation></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId><ArticleId IdType="pmc">2335261</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J, Deeks J. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021), Cochrane. 2021. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Deeks J, Higgins J, Altman D. Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021), Cochrane. 2021. Available from www.training.cochrane.org/handbook .</Citation></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. vol. 77. Chichester, UK: John Wiley&amp;Sons; 2011.</Citation></Reference><Reference><Citation>R&#xfc;cker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med. 2008;27:746&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2971</ArticleId><ArticleId IdType="pubmed">17592831</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters JL. Comparison of Two Methods to Detect Publication Bias in Meta-analysis. JAMA. 2006;295:676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.295.6.676</ArticleId><ArticleId IdType="pubmed">16467236</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2380</ArticleId><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId><ArticleId IdType="pmc">2127453</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Sutton AJ, Ioannidis JPA, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002&#x2013;d4002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Balduzzi S, R&#xfc;cker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22:153&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300117</ArticleId><ArticleId IdType="pubmed">31563865</ArticleId><ArticleId IdType="pmc">10231495</ArticleId></ArticleIdList></Reference><Reference><Citation>Oud L, Garza J. Impact of history of mental disorders on short-term mortality among hospitalized patients with sepsis: A population-based cohort study. PLoS One. 2022;17:e0265240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265240</ArticleId><ArticleId IdType="pubmed">35271683</ArticleId><ArticleId IdType="pmc">8912146</ArticleId></ArticleIdList></Reference><Reference><Citation>Arsenovi&#x107; S, Trajkovi&#x107; G, Pekmezovi&#x107; T, Gazibara T. Association of health literacy with physical and mental health in people with chronic diseases. Rev Epidemiol Sante Publique. 2023;71:101419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.respe.2022.101419</ArticleId><ArticleId IdType="pubmed">36563616</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmi L-R, Saillour-Gl&#xe9;nisson F, Alla F, Boussat B. Evaluation and research on public health interventions. Rev Epidemiol Sante Publique. 2023;71:101836.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.respe.2023.101836</ArticleId><ArticleId IdType="pubmed">36965306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonkat N, Fellendorf FT, Dalkner N, Reininghaus EZ. Severe mental disorders and vaccinations &#x2013; a systematic review. World J Biol Psychiatry. 2022;23:501&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15622975.2021.2013095</ArticleId><ArticleId IdType="pubmed">35014937</ArticleId></ArticleIdList></Reference><Reference><Citation>Steiner J, Jacobs R, Panteli B, Brauner M, Schiltz K, Bahn S, et al. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. Eur Arch Psychiatry Clin Neurosci. 2010;260:509&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-010-0098-x</ArticleId><ArticleId IdType="pubmed">20107825</ArticleId></ArticleIdList></Reference><Reference><Citation>Tynan RJ, Weidenhofer J, Hinwood M, Cairns MJ, Day TA, Walker FR. A comparative examination of the anti-inflammatory effects of SSRI and SNRI antidepressants on LPS stimulated microglia. Brain Behav Immun. 2012;26:469&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2011.12.011</ArticleId><ArticleId IdType="pubmed">22251606</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.3</ArticleId><ArticleId IdType="pubmed">26903267</ArticleId><ArticleId IdType="pmc">6056174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheth PM, Douchant K, Uyanwune Y, Larocque M, Anantharajah A, Borgundvaag E, et al. Evidence of transmission of Clostridium difficile in asymptomatic patients following admission screening in a tertiary care hospital. PLOS One. 2019;14:e0207138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0207138</ArticleId><ArticleId IdType="pubmed">30742636</ArticleId><ArticleId IdType="pmc">6370182</ArticleId></ArticleIdList></Reference><Reference><Citation>Land&#xe9;n M, Larsson H, Lichtenstein P, Westin J, Song J. Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder. Int J Bipolar Disord. 2021;9:4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40345-020-00208-y</ArticleId><ArticleId IdType="pubmed">33521836</ArticleId><ArticleId IdType="pmc">7847747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoertel N, S&#xe1;nchez-Rico M, Vernet R, Beeker N, Jannot A-S, Neuraz A, et al. Association between antidepressant use and reduced risk of intubation or death in hospitalized patients with COVID-19: results from an observational study. Mol Psychiatry. 2021;26:5199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01021-4</ArticleId><ArticleId IdType="pubmed">33536545</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32226310</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1449-2288</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2020</Year></PubDate></JournalIssue><Title>International journal of biological sciences</Title><ISOAbbreviation>Int J Biol Sci</ISOAbbreviation></Journal><ArticleTitle>Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1658</StartPage><EndPage>1675</EndPage><MedlinePgn>1658-1675</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7150/ijbs.43447</ELocationID><Abstract><AbstractText><b>Background:</b> The monitoring and management of blood glucose concentration are standard practices in critical settings as hyperglycaemia has been shown close association with poorer outcomes. Several meta-analyses have revealed that intensive glucose control has no benefit in decreasing short-term mortality among critically ill patients, while the studies these meta-analyses have incorporated have been largely divergent. We aim to perform a more comprehensive meta-analysis addressing this problem to provide stronger evidence. <b>Methods</b>: We conducted comprehensive searches for relevant randomized controlled studies in online databases, including the Cochrane Library, EMBASE, and PubMed databases, up to September 1, 2018. The clinical data, which included all-cause mortality, severe hypoglycemia, need for RRT, infection resulting in sepsis, ICU mortality, 90-day mortality, 180-day mortality, and hospital and ICU lengths of stay, were screened and analyzed after data extraction. We applied odds ratios (ORs) to analyze dichotomous outcomes and mean differences for continuous outcomes with a random effects model. <b>Results:</b> A total of 57 RCTs involving a total of 21840 patients were finally included. Patients admitted to the ICU who underwent intensive glucose control showed significantly reduced all-cause mortality (OR: 0.89; 95% CI: 0.80-1.00; <i>P</i>=0.04; I<sup>2</sup>=32%), reduced infection rate (OR: 0.65, 95% CI: 0.51-0.82, P=0.0002; I<sup>2</sup>=47%), a lower occurrence of acquired sepsis (OR: 0.80, 95% CI: 0.65-0.99, P=0.04; I<sup>2</sup>=0%) and shortened length of ICU stay (MD: -0.70, 95% CI: -1.21--0.19, P=0.007, I<sup>2</sup>=70%) when compared to the same parameters as those treated with the usual care strategy. However, patients in the intensive glucose control group presented with a significantly higher risk of severe hypoglycemia (OR: 5.63, 95% CI: 4.02-7.87, <i>P</i>&lt;0.00001; I<sup>2</sup>=67%). <b>Conclusions:</b> Critically ill patients undergoing intensive glucose control showed significantly reduced all-cause mortality, length of ICU stay and incidence of acquired infection and sepsis compared to the same parameters in patients treated with the usual care strategy, while the intensive glucose control strategy was associated with higher occurrence of severe hypoglycemic events.</AbstractText><CopyrightInformation>&#xa9; The author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Ren-Qi</ForeName><Initials>RQ</Initials><AffiliationInfo><Affiliation>Trauma Research Center, Fourth Medical Center of the Chinese PLA General Hospital, Beijing 100048, People's Republic of China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Burn Surgery, Changhai Hospital, the Second Military Medical University, Shanghai 200433, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Chao</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Trauma Research Center, Fourth Medical Center of the Chinese PLA General Hospital, Beijing 100048, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Guo-Sheng</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Burn Surgery, Changhai Hospital, the Second Military Medical University, Shanghai 200433, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yi-Bing</ForeName><Initials>YB</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University, Beijing 100038, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Zhao-Fan</ForeName><Initials>ZF</Initials><AffiliationInfo><Affiliation>Department of Burn Surgery, Changhai Hospital, the Second Military Medical University, Shanghai 200433, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yong-Ming</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Trauma Research Center, Fourth Medical Center of the Chinese PLA General Hospital, Beijing 100048, People's Republic of China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Int J Biol Sci</MedlineTA><NlmUniqueID>101235568</NlmUniqueID><ISSNLinking>1449-2288</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007003" MajorTopicYN="N">Hypoglycemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="N">Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">intensive glucose control</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>Competing Interests: The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32226310</ArticleId><ArticleId IdType="pmc">PMC7097913</ArticleId><ArticleId IdType="doi">10.7150/ijbs.43447</ArticleId><ArticleId IdType="pii">ijbsv16p1658</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32(10):2426&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">11588337</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic control is associated with increased mortality in critically ill trauma patients. The American surgeon. 2007;73(5):454&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17520998</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clinic proceedings. 2003;78(12):1471&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14661676</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung J, Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. The Journal of trauma. 2005;59(1):80&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">16096543</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson BT. Glucose control in sepsis. Clinics in chest medicine. 2008;29(4):713&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">18954705</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcomb BW, Pradhan EK, Pittas AG, Roghmann MC, Perencevich EN. Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations. Critical care medicine. 2005;33(12):2772&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16352959</ArticleId></ArticleIdList></Reference><Reference><Citation>Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3144755</ArticleId><ArticleId IdType="pubmed">19465235</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Finfer S, Bellomo R. Glycemic control in the ICU. Chest. 2011;140(1):212&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">21729892</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M. et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345(19):1359&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794168</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hooijdonk RT, Mesotten D, Krinsley JS, Schultz MJ. Sweet Spot: Glucose Control in the Intensive Care Unit. Seminars in respiratory and critical care medicine. 2016;37(1):57&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">26820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N. et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">18184958</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V. et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">19318384</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalfon P, Giraudeau B, Ichai C, Guerrini A, Brechot N, Cinotti R. et al. Tight computerized versus conventional glucose control in the ICU: a randomized controlled trial. Intensive care medicine. 2014;40(2):171&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">24420499</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I. et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">16452557</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley J, Schultz MJ, Spronk PE, van Braam Houckgeest F, van der Sluijs JP, Melot C. et al. Mild hypoglycemia is strongly associated with increased intensive care unit length of stay. Annals of intensive care. 2011;1:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3273438</ArticleId><ArticleId IdType="pubmed">22115519</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G. et al. Hypoglycemia and outcome in critically ill patients. Mayo Clinic proceedings. 2010;85(3):217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843109</ArticleId><ArticleId IdType="pubmed">20176928</ArticleId></ArticleIdList></Reference><Reference><Citation>Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C. et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367(12):1108&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">22992074</ArticleId></ArticleIdList></Reference><Reference><Citation>Krinsley JS, Egi M, Kiss A, Devendra AN, Schuetz P, Maurer PM. et al. Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Critical care. 2013;17(2):R37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3733432</ArticleId><ArticleId IdType="pubmed">23452622</ArticleId></ArticleIdList></Reference><Reference><Citation>Duning T, van den Heuvel I, Dickmann A, Volkert T, Wempe C, Reinholz J. et al. Hypoglycemia aggravates critical illness-induced neurocognitive dysfunction. Diabetes care. 2010;33(3):639&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2827523</ArticleId><ArticleId IdType="pubmed">20032274</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D. et al. Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA. 2012;308(16):1641&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">23101118</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer MP, Deane AM. Dysglycemia and Glucose Control During Sepsis. Clinics in chest medicine. 2016;37(2):309&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">27229647</ArticleId></ArticleIdList></Reference><Reference><Citation>Vriesendorp TM, DeVries JH, van Santen S, Moeniralam HS, de Jonge E, Roos YB. et al. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Critical care medicine. 2006;34(11):2714&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943734</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes Care in the Hospital. Standards of Medical Care in Diabetes-2018. Diabetes care. 2018;41(Suppl 1):144&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">29222385</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R. et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Griesdale DE, de Souza RJ, van Dam RM, Heyland DK, Cook DJ, Malhotra A. et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665940</ArticleId><ArticleId IdType="pubmed">19318387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y, Li X, Gao X. Intensive versus conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. European journal of internal medicine. 2012;23(6):564&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">22863436</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18728267</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T, Shojima N, Noma H, Yamauchi T, Kadowaki T. Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials. Intensive care medicine. 2017;43(1):1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637719</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatabe T, Inoue S, Sakaguchi M, Egi M. The optimal target for acute glycemic control in critically ill patients: a network meta-analysis. Intensive care medicine. 2017;43(1):16&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">27686353</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Zhong LJ, Han L, Xie GH, Xiao C, Zhao B. et al. Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials. BioMed research international. 2014;2014:698265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086473</ArticleId><ArticleId IdType="pubmed">25136614</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001;29(7):1303&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JH, Beilman GJ. Hyperglycemia in the intensive care unit: no longer just a marker of illness severity. Surgical infections. 2005;6(2):233&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">16128630</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonidou L, Michalaki M, Leonardou A, Polyzogopoulou E, Fouka K, Gerolymos M. et al. Stress-induced hyperglycemia in patients with severe sepsis: a compromising factor for survival. The American journal of the medical sciences. 2008;336(6):467&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">19092319</ArticleId></ArticleIdList></Reference><Reference><Citation>Godoy DA, Di Napoli M, Rabinstein AA. Treating hyperglycemia in neurocritical patients: benefits and perils. Neurocrit Care. 2010;13(3):425&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Critical care. 2012;16(5):R203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3682305</ArticleId><ArticleId IdType="pubmed">23082798</ArticleId></ArticleIdList></Reference><Reference><Citation>Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clinic proceedings. 2005;80(12):1558&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">16342648</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C. et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Critical care medicine. 2008;36(8):2249&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18664780</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Preiser JC, Sprung CL, Moreno R, Sakr Y. Insulin-treated diabetes is not associated with increased mortality in critically ill patients. Critical care. 2010;14(1):R12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875526</ArticleId><ArticleId IdType="pubmed">20132545</ArticleId></ArticleIdList></Reference><Reference><Citation>Falciglia M, Freyberg RW, Almenoff PL, D'Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Critical care medicine. 2009;37(12):3001&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2905804</ArticleId><ArticleId IdType="pubmed">19661802</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, Wilmer A, Milants I, Wouters PJ, Bouckaert B, Bruyninckx F. et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes. 2006;55(11):3151&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17065355</ArticleId></ArticleIdList></Reference><Reference><Citation>Stecher A, Steblaj S, Kremzar B, Ivanova E. The influence of normoglycemia on ventilator-associated pneumonia in trauma patients. Paper presented at: European Trauma Congress; May 24-26. 2006. Ljubljana, Slovenia.</Citation></Reference><Reference><Citation>Annane D, Cariou A, Maxime V, Azoulay E, D'Honneur G, Timsit JF. et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303(4):341&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20103758</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH. et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Critical care medicine. 2008;36(12):3190&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18936702</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Tamim HM, Dhar GS, Al-Dawood A, Al-Sultan M, Sakkijha MH. et al. Permissive underfeeding and intensive insulin therapy in critically ill patients: a randomized controlled trial. The American journal of clinical nutrition. 2011;93(3):569&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">21270385</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V. et al. Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocritical care. 2008;9(2):159&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">18373223</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Caramia R, Paoloni FP, Delfini R, Rosa G. Safety and efficacy of intensive insulin therapy in critical neurosurgical patients. Anesthesiology. 2009;110(3):611&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. Journal of neurosurgical anesthesiology. 2007;19(3):156&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">17592345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland DK, Fankhanel Y, Langford E, Lee M, Lee SW, Maloney C. et al. Intensive versus modified conventional control of blood glucose level in medical intensive care patients: a pilot study. American journal of critical care. 2005;14(5):370&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">16120888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ. et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008;39(2):384&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18096840</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao SG, Ren JA, Shen B, Chen D, Zhou YB, Li JS. Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomized controlled trial. World journal of surgery. 2011;35(1):85&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">20878324</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappi SB, Noritomi DT, Velasco IT, Curi R, Loureiro TC, Soriano FG. Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis. Intensive care medicine. 2012;38(4):634&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">22297666</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan RP, Galas FR, Hajjar LA, Bello CN, Piccioni MA, Auler JO. Intensive perioperative glucose control does not improve outcomes of patients submitted to open-heart surgery: a randomized controlled trial. Clinics. 2009;64(1):51&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671976</ArticleId><ArticleId IdType="pubmed">19142552</ArticleId></ArticleIdList></Reference><Reference><Citation>Coester A, Neumann CR, Schmidt MI. Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma. 2010;68(4):904&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">20032790</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies RR, Newton RW, McNeill GP, Fisher BM, Kesson CM, Pearson D. Metabolic control in diabetic subjects following myocardial infarction: difficulties in improving blood glucose levels by intravenous insulin infusion. Scott Med J. 1991;36(3):74&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">1925506</ArticleId></ArticleIdList></Reference><Reference><Citation>de Azevedo JR, de Araujo LO, da Silva WS, de Azevedo RP. A carbohydrate-restrictive strategy is safer and as efficient as intensive insulin therapy in critically ill patients. Journal of critical care. 2010;25(1):84&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19327317</ArticleId></ArticleIdList></Reference><Reference><Citation>De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, Gonzalez LG, Saldarriaga NE. et al. Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Critical care. 2008;12(5):R120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592751</ArticleId><ArticleId IdType="pubmed">18799004</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai SP, Henry LL, Holmes SD, Hunt SL, Martin CT, Hebsur S. et al. Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. The Journal of thoracic and cardiovascular surgery. 2012;143(2):318&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">22137804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong SM, Qin YJ, Gao YF. The influence of intensive insulin therapy on hemodynamics in patients with septic shock. Zhongguo wei zhong bing ji jiu yi xue. 2009;21(5):290&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">19439117</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah R, Samokhvalov A, Zviebel F, Makhoul N. Insulin therapy of hyperglycemia in intensive care. Isr Med Assoc J. 2007;9(3):140&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">17402320</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandhi GY, Nuttall GA, Abel MD, Mullany CJ, Schaff HV, O'Brien PC. et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med. 2007;146(4):233&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">17310047</ArticleId></ArticleIdList></Reference><Reference><Citation>Giakoumidakis K, Eltheni R, Patelarou E, Theologou S, Patris V, Michopanou N. et al. Effects of intensive glycemic control on outcomes of cardiac surgery. Heart lung. 2013;42(2):146&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23453011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray CS, Hildreth AJ, Sandercock PA, O'Connell JE, Johnston DE, Cartlidge NE. et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) Lancet Neurol. 2007;6(5):397&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">17434094</ArticleId></ArticleIdList></Reference><Reference><Citation>Green DM, O'Phelan KH, Bassin SL, Chang CW, Stern TS, Asai SM. Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocritical care. 2010;13(3):299&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">20697836</ArticleId></ArticleIdList></Reference><Reference><Citation>Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocrine practice. 2004;10(Suppl 2):46&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">15251640</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Zhang TY, Zhou H, Li T, Zhao JY, Zhao D. et al. Impact of intensive insulin therapy on surgical critically ill patients. Zhonghua wai ke za zhi. 2007;45(15):1052&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">18005588</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson WR, Dhingra V, Chittock D, Foster D, Hebert P, Cook D. et al. The efficacy and safety of glucose control algorithms in intensive care: a pilot study of the Survival Using Glucose Algorithm Regulation (SUGAR) trial. Polskie Archiwum Medycyny Wewnetrznej. 2009;119(7-8):439&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">19776683</ArticleId></ArticleIdList></Reference><Reference><Citation>Iapichino G, Albicini M, Umbrello M, Sacconi F, Fermo I, Pavlovich R. et al. Tight glycemic control does not affect asymmetric-dimethylarginine in septic patients. Intensive care medicine. 2008;34(10):1843&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">18504551</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IM, Ingle S, Underwood C, Blunt M. Glycaemic control and outcome in general intensive care. Proc Am Thorac Soc. 2005;2:A295.</Citation></Reference><Reference><Citation>Jin. Y, Guolong. C. A multicentre study on intensive insulin therapy of severe sepsis and septic shock patients in ICU collaborative study group on IIT in Zhejiang province, china. Intensive Care Med. 2009;35(Suppl 1):86S.</Citation></Reference><Reference><Citation>Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR. Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke. 2009;40(12):3804&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2790382</ArticleId><ArticleId IdType="pubmed">19834016</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreisel SH, Berschin UM, Hammes HP, Leweling H, Bertsch T, Hennerici MG. et al. Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovascular diseases. 2009;27(2):167&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">19092238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar HL, McDonnell MM, Chipkin S, Fitzgerald C, Bliss C, Cabral H. Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients. Annals of surgery. 2011;254(3):458&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">21865944</ArticleId></ArticleIdList></Reference><Reference><Citation>M. K, J. B, KR. B. The effects of strict glycemic control in the critically ill general and vascular surgical patient. 91st Annual Clinical Congress of the American College of Surgeons; October 16-20; San Francisco, California2005.</Citation></Reference><Reference><Citation>Mahmoodpoor A, Ali-Asgharzadeh A, Parish M, Amir-Aslanzadeh Z, Abedini N. A comparative study of efficacy of intensive insulin therapy versus conventional method on mortality and morbidity of critically ill patients. Pakistan journal of medical sciences. 2011;27(3):496&#x2013;9.</Citation></Reference><Reference><Citation>McMullin J, Brozek J, McDonald E, Clarke F, Jaeschke R, Heels-Ansdell D. et al. Lowering of glucose in critical care: a randomized pilot trial. Journal of critical care. 2007;22(2):112&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17548021</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda MP, Crespo JC, Secoli SR. Insulin infusion in intensive care: randomized controlled trial. Rev Esc Enferm USP. 2013;47(3):615&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">24601137</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell I, Knight E, Gissane J, Tamhane R, Kolli R, Leditschke IA. et al. A phase II randomised controlled trial of intensive insulin therapy in general intensive care patients. Critical care and resuscitation. 2006;8(4):289&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17227263</ArticleId></ArticleIdList></Reference><Reference><Citation>Okabayashi T, Shima Y, Sumiyoshi T, Kozuki A, Tokumaru T, Iiyama T. et al. Intensive versus intermediate glucose control in surgical intensive care unit patients. Diabetes care. 2014;37(6):1516&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">24623024</ArticleId></ArticleIdList></Reference><Reference><Citation>Oksanen T, Skrifvars MB, Varpula T, Kuitunen A, Pettil&#xe4; V, Nurmi J. et al. Strict versus moderate glucose control after resuscitation from ventricular fibrillation. Intensive care medicine. 2007;33(12):2093&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">17928994</ArticleId></ArticleIdList></Reference><Reference><Citation>Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J. et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive care medicine. 2009;35(10):1738&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">19636533</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez R, Boque M, Galera A, Rodriguez-Cintron W. Insulin: effect on mortality and renal failure in medical intensive care unit patients. Proc Am Thorac Soc. 2005;2:A37.</Citation></Reference><Reference><Citation>Rosso C, Corvol JC, Pires C, Crozier S, Attal Y, Jacqueminet S. et al. Intensive versus subcutaneous insulin in patients with hyperacute stroke: results from the randomized INSULINFARCT trial. Stroke. 2012;43(9):2343&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22700528</ArticleId></ArticleIdList></Reference><Reference><Citation>Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P. et al. Tight glycemic control may favor fibrinolysis in patients with sepsis. Critical care medicine. 2009;37(2):424&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114908</ArticleId></ArticleIdList></Reference><Reference><Citation>Staszewski J, Brodacki B, Kotowicz J, Stepien A. Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. Journal of stroke and cerebrovascular diseases. 2011;20(2):150&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">20621520</ArticleId></ArticleIdList></Reference><Reference><Citation>Taslimi R, Azizkhani R, Talebian MH, Abtahi HR, Jalili M, Nejati A. et al. The efficacy of intensive glucose management on hospitalized critically ill patients associated mortality rate in intensive care unit. Daru. 2009;17(3):157&#x2013;62.</Citation></Reference><Reference><Citation>Walters MR, Weir CJ, Lees KR. A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients. Cerebrovascular diseases. 2006;22(2-3):116&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16685123</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LC, Lei S, Wu YC, Wu JN, Wang LF, Guan TR. et al. Intensive insulin therapy in critically ill patients. Zhongguo wei zhong bing ji jiu yi xue. 2006;18(12):748&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17166358</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li JP, Song YL, Zhao QH. Intensive insulin therapy for preventing postoperative infection in patients with traumatic brain injury: a randomized controlled trial. Medicine. 2017;96:e6458.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5380263</ArticleId><ArticleId IdType="pubmed">28353579</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Guo Q, Zhang X, Sun S, Wang Y, Zhao L. et al. Intensive insulin therapy on infection rate, days in NICU, in-hospital mortality and neurological outcome in severe traumatic brain injury patients: a randomized controlled trial. International journal of nursing studies. 2009;46(6):753&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">19232615</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZL, Liu WD, Ding Y, Liu XY, Zhang YY, Niu HY. Comatose stroke patients complicated with hyperglycemia: A study of realtime insulin titration model. Chinese Journal of Cerebrovascular Diseases. 2009;6:113&#x2013;8.</Citation></Reference><Reference><Citation>Yu WK, Li WQ, Wang XD, Yan XW, Qi XP, Li N. et al. Influence and mechanism of a tight control of blood glucose by intensive insulin therapy on human sepsis. Zhonghua wai ke za zhi. 2005;43(1):29&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">15774170</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang RL, He W, Li T, Zhou H, Wang C, Gao S. et al. Evaluation of optimal goal of glucose control in critically ill patients. Chinese journal of clinical nutrition. 2008;16(4):204&#x2013;8.</Citation></Reference><Reference><Citation>Waeschle RM, Moerer O, Hilgers R, Herrmann P, Neumann P, Quintel M. The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability. Critical care. 2008;12(5):R129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2592768</ArticleId><ArticleId IdType="pubmed">18939991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali NA, O'Brien JM Jr, Dungan K, Phillips G, Marsh CB, Lemeshow S. et al. Glucose variability and mortality in patients with sepsis. Critical care medicine. 2008;36(8):2316&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3176449</ArticleId><ArticleId IdType="pubmed">18596625</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirasawa H, Oda S, Nakamura M. Blood glucose control in patients with severe sepsis and septic shock. World journal of gastroenterology. 2009;15(33):4132&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2738808</ArticleId><ArticleId IdType="pubmed">19725146</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP. et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16609090</ArticleId></ArticleIdList></Reference><Reference><Citation>Clement S, Braithwaite SS, Magee MF, Ahmann A, Smith EP, Schafer RG. et al. Management of diabetes and hyperglycemia in hospitals. Diabetes care. 2004;27(2):553&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">14747243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwoun MO, Ling PR, Lydon E, Imrich A, Qu Z, Palombo J. et al. Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN. 1997;21(2):91&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9084011</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A, Novials A, Ortega E, La Sala L, Pujadas G, Testa R. et al. Evidence that hyperglycemia after recovery from hypoglycemia worsens endothelial function and increases oxidative stress and inflammation in healthy control subjects and subjects with type 1 diabetes. Diabetes. 2012;61(11):2993&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3478543</ArticleId><ArticleId IdType="pubmed">22891214</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceriello A, Novials A, Ortega E, Pujadas G, La Sala L, Testa R. et al. Hyperglycemia following recovery from hypoglycemia worsens endothelial damage and thrombosis activation in type 1 diabetes and in healthy controls. Nutrition, metabolism, and cardiovascular diseases: NMCD. 2014;24(2):116&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">24094827</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh SW, Gum ET, Hamby AM, Chan PH, Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. The Journal of clinical investigation. 2007;117(4):910&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1838937</ArticleId><ArticleId IdType="pubmed">17404617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38632681</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2362</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of clinical investigation</Title><ISOAbbreviation>Eur J Clin Invest</ISOAbbreviation></Journal><ArticleTitle>Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e14225</StartPage><MedlinePgn>e14225</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/eci.14225</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Midregional-proAdrenomedullin (MR-proADM) has been recently proposed as a tool in patients with sepsis and septic shock. Our aim was to evaluate the prognostic role of MR-proADM in hospitalized patients with sepsis and septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">PRISMA guideline was followed. MEDLINE and EMBASE were searched up to June 2023. Primary outcome was mean difference in MR-proADM among survivors and nonsurvivors, secondary outcome mean difference in MR-proADM according to infection severity and type. Risk of bias was evaluated using Newcastle-Ottawa scale for observational studies and Cochrane tool for randomized trials. Pooled mean differences (MD) with corresponding 95% confidence intervals (CIs) were calculated in a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four studies included 6730 adult patients (1208 nonsurvivors and 5522 survivors) and three studies included 195 paediatric patients (30 nonsurvivors and 165 survivors). A total of 10, 4 and 13 studies included, respectively, patients with sepsis (3602 patients), septic shock (386 patients) and a mixed population (2937 patients). Twenty-one studies included patients with different source of infection, three with pneumonia and one with a catheter-related infection. Most studies (n&#x2009;=&#x2009;12) had a follow-up of 28&#x2009;days. In adult cohort, pooled mean difference between nonsurvivors and survivors of MR-proADM was 2.55&#x2009;mmol/L (95% CI: 1.95-3.15) with higher values in patients with septic shock (4.25&#x2009;mmol/L; 95% CI, 2.23-6.26&#x2009;mmol/L) than in patients with sepsis (1.77&#x2009;mmol/L; 95% CI: 1.11-2.44&#x2009;mmol/L). In paediatric cohort, pooled mean difference was 3.11&#x2009;mmol/L (95% CI: -0.02-6.24&#x2009;mmol/L).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Higher values of MR-proADM are detectable in nonsurvivors adult and paediatric-hospitalized patients with sepsis or septic shock.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. European Journal of Clinical Investigation published by John Wiley &amp; Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Valeriani</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-9729-3214</Identifier><AffiliationInfo><Affiliation>Department of General Surgery and Surgical Specialty, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious disease, Umberto I Hospital, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falletta</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastori</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-6357-5213</Identifier><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porfidia</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Universit&#xe0; Cattolica del Sacro Cuore, Largo Agostino Gemelli, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroianni</LastName><ForeName>Claudio Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Bari</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motta</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pignatelli</LastName><ForeName>Pasquale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oliva</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0832-7975</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Clin Invest</MedlineTA><NlmUniqueID>0245331</NlmUniqueID><ISSNLinking>0014-2972</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>148498-78-6</RegistryNumber><NameOfSubstance UI="D053607">Adrenomedullin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C088633">proadrenomedullin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053607" MajorTopicYN="Y">Adrenomedullin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="Y">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adrenomedullin</Keyword><Keyword MajorTopicYN="N">infections</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>18</Day><Hour>0</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38632681</ArticleId><ArticleId IdType="doi">10.1111/eci.14225</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Evans L , Rhodes A , Alhazzani W , et&#xa0;al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2010;1247.</Citation></Reference><Reference><Citation>WHO. Sepsis [Internet]. 2018. Available from: https://www.who.int/newsroom/fact&#x2010;sheets/detail/sepsis. Accessed June 20, 2023.</Citation></Reference><Reference><Citation>Bauer M , Gerlach H , Vogelmann T , Preissing F , Stiefel J , Adam D . Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019&#x2010; results from a systematic review and meta&#x2010;analysis. Crit Care. 2020;24(1):239.</Citation></Reference><Reference><Citation>Nargis W , Ibrahim M , Ahamed BU . Procalcitonin versus C&#x2010;reactive protein: usefulness as biomarker of sepsis in ICU patient. Int J Crit Illn Inj Sci. 2014;4(3):195&#x2010;199.</Citation></Reference><Reference><Citation>Paudel R , Dogra P , Montgomery&#x2010;Yates AA , Coz Yataco A . Procalcitonin: a promising tool or just another overhyped test? Int J Med Sci. 2020;17(3):332&#x2010;337.</Citation></Reference><Reference><Citation>Suberviola B , Castellanos&#x2010;Ortega A , Llorca J , Ortiz F , Iglesias D , Prieto B . Prognostic value of proadrenomedullin in severe sepsis and septic shock patients with community&#x2010;acquired pneumonia. Swiss Med Wkly. 2012;142:w13542.</Citation></Reference><Reference><Citation>Lundberg OHM , Rosenqvist M , Bronton K , Schulte J , Friberg H , Melander O . Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care. PLoS One. 2022;17(4):e0267497.</Citation></Reference><Reference><Citation>Christ&#x2010;Crain M , Morgenthaler NG , Struck J , Harbarth S , Bergmann A , Muller B . Mid&#x2010;regional pro&#x2010;adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care. 2005;9(6):R816&#x2010;R824.</Citation></Reference><Reference><Citation>Li P , Wang C , Pang S . The diagnostic accuracy of mid&#x2010;regional pro&#x2010;adrenomedullin for sepsis: a systematic review and meta&#x2010;analysis. Minerva Anestesiol. 2021;87(10):1117&#x2010;1127.</Citation></Reference><Reference><Citation>Page MJ , Moher D , Bossuyt PM , et&#xa0;al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.</Citation></Reference><Reference><Citation>Wells GA , Shea B , O'Connel D , Peterson J , Welch V , Losos M . The Newcastle&#x2010;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#x2010;Analyses. 2012. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed January 10, 2023).</Citation></Reference><Reference><Citation>Deeks JJ , Higgins JPT , AltmaN DG . Analysing data and undertaking meta&#x2010;analyses. In: Higgins JPT , Thomas J , Chandler J , Cumpston M , Li T , Page MJ , Welch VA , (Eds.). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (Updated August 2023). Cochrane, 2023. Available from https://www.training.cochrane.org/handbook. Accessed January 2023.</Citation></Reference><Reference><Citation>Luo D , Wan X , Liu J , Tong T . Optimally estimating the sample mean from the sample size, median, mid&#x2010;range, and/or mid&#x2010;quartile range. Stat Methods Med Res. 2018;27(6):1785&#x2010;1805.</Citation></Reference><Reference><Citation>Akpinar S , Rollas K , Alagoz A , Segmen F , Sipit T . Performance evaluation of MR&#x2010;proadrenomedullin and other scoring systems in severe sepsis with pneumonia. J Thorac Dis. 2014;6(7):921&#x2010;929.</Citation></Reference><Reference><Citation>Andaluz&#x2010;Ojeda D , Nguyen HB , Meunier&#x2010;Beillard N , et&#xa0;al. Superior accuracy of mid&#x2010;regional proadrenomedullin for mortality prediction in sepsis with varying levels of illness severity. Ann Intensive Care. 2017;7(1):15.</Citation></Reference><Reference><Citation>Badia Tejero AM , Martinez Sagasti F , Domingo Mar&#x131;n S , et&#xa0;al. Superior accuracy of mid&#x2010;regional proadrenomedullin over C reactive protein, procalcitonin and lactate for ICU mortality prediction in septic patients. Infection. 2017;45(1):S58&#x2010;S59.</Citation></Reference><Reference><Citation>Baldira J , Ruiz&#x2010;Rodriguez JC , Wilson DC , et&#xa0;al. Biomarkers and clinical scores to aid the identification of disease severity and intensive care requirement following activation of an in&#x2010;hospital sepsis code. Ann Intensive Care. 2020;10(1):7.</Citation></Reference><Reference><Citation>Bernal&#x2010;Morell E , Garcia&#x2010;Villalba E , Vera MDC , et&#xa0;al. Usefulness of midregional pro&#x2010;adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis. J Infect. 2018;76(3):249&#x2010;257.</Citation></Reference><Reference><Citation>Charles PE , Peju E , Dantec A , et&#xa0;al. Mr&#x2010;Proadm elevation upon Icu admission predicts the outcome of septic patients and is correlated with upcoming fluid overload. Shock. 2017;48(4):418&#x2010;426.</Citation></Reference><Reference><Citation>Christ&#x2010;Crain M , Morgenthaler NG , Stolz D , et&#xa0;al. Pro&#x2010;adrenomedullin to predict severity and outcome in community&#x2010;acquired pneumonia [ISRCTN04176397]. Crit Care. 2006;10(3):R96.</Citation></Reference><Reference><Citation>De La Torre&#x2010;Prados MV , Garcia&#x2010;De La Torre A , Enguix A , Mayor&#x2010;Reyes M , Nieto&#x2010;Gonzalez M , Garcia&#x2010;Alcantara A . Mid&#x2010;regional pro&#x2010;adrenomedullin as prognostic biomarker in septic shock. Minerva Anestesiol. 2016;82(7):760&#x2010;766.</Citation></Reference><Reference><Citation>Elke G , Bloos F , Wilson DC , et&#xa0;al. The use of mid&#x2010;regional proadrenomedullin to identify disease severity and treatment response to sepsis &#x2010; a secondary analysis of a large randomised controlled trial. Crit Care. 2018;22(1):79.</Citation></Reference><Reference><Citation>Fahmy AA , Azab MM , Amr GE , Matar HM . Sediq AM . al. eMid&#x2010;regional proadrenomedullin is a good prognostic marker for patients in the intensive care unit with sepsis. Crit Care Shock. 2022;25:309&#x2010;316.</Citation></Reference><Reference><Citation>Haag E , Gregoriano C , Molitor A , et&#xa0;al. Does mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proADM) improve the sequential organ failure assessment&#x2010;score (SOFA score) for mortality&#x2010;prediction in patients with acute infections? Results of a prospective observational study. Clin Chem Lab Med. 2021;59(6):1165&#x2010;1176.</Citation></Reference><Reference><Citation>Hoeboer SH , Alberts E , van den Hul I , Tacx AN , Debets&#x2010;Ossenkopp YJ , Groeneveld AB . Old and new biomarkers for predicting high and low risk microbial infection in critically ill patients with new onset fever: a case for procalcitonin. J Infect. 2012;64(5):484&#x2010;493.</Citation></Reference><Reference><Citation>Julian&#x2010;Jimenez A , Yanez MC , Gonzalez&#x2010;Del Castillo J , et&#xa0;al. Prognostic power of biomarkers for short&#x2010;term mortality in the elderly patients seen in emergency departments due to infections. Enferm Infecc Microbiol Clin (Engl ed). 2019;37(1):11&#x2010;18.</Citation></Reference><Reference><Citation>Lundberg OH , Bergenzaun L , Ryden J , Rosenqvist M , Melander O , Chew MS . Adrenomedullin and endothelin&#x2010;1 are associated with myocardial injury and death in septic shock patients. Crit Care. 2016;20(1):178.</Citation></Reference><Reference><Citation>Mearelli F , Barbati G , Casarsa C , et&#xa0;al. The integration of qSOFA with clinical variables and serum biomarkers improves the prognostic value of qSOFA alone in patients with suspected or confirmed sepsis at ED admission. J Clin Med. 2020;9(4):1205.</Citation></Reference><Reference><Citation>Ni J , Sun Y , Qu H , Wang A , Cao Y , Li X . Prognostic value of serum proadrenomedullin in catheter&#x2010;related bloodstream infection in the intensive care unit: a prospective observational study. Medicine (Baltimore). 2018;97(42):e12821.</Citation></Reference><Reference><Citation>Saeed K , Wilson DC , Bloos F , et&#xa0;al. The early identification of disease progression in patients with suspected infection presenting to the emergency department: a multi&#x2010;centre derivation and validation study. Crit Care. 2019;23(1):40.</Citation></Reference><Reference><Citation>Schuetz P , Christ&#x2010;Crain M , Morgenthaler NG , Struck J , Bergmann A , Muller B . Circulating precursor levels of endothelin&#x2010;1 and adrenomedullin, two endothelium&#x2010;derived, counteracting substances, in sepsis. Endothelium. 2007;14(6):345&#x2010;351.</Citation></Reference><Reference><Citation>Serano AMN , Alonso JV , Pinero GR , Camacho AR , Benet JS , Vaquero M . Biomarkers in shock patients and their value as a prognostic tool; a prospective multi&#x2010;center cohort study. Bull Emerg Trauma. 2019;7(3):232&#x2010;239.</Citation></Reference><Reference><Citation>Suberviola B , Castellanos&#x2010;Ortega A , Ruiz Ruiz A , Lopez&#x2010;Hoyos M , Santibanez M . Hospital mortality prognostication in sepsis using the new biomarkers suPAR and proADM in a single determination on ICU admission. Intensive Care Med. 2013;39(11):1945&#x2010;1952.</Citation></Reference><Reference><Citation>Valenzuela&#x2010;Sanchez F , Valenzuela&#x2010;Mendez B , Bohollo de Austria R , et&#xa0;al. Plasma levels of mid&#x2010;regional pro&#x2010;adrenomedullin in sepsis are associated with risk of death. Minerva Anestesiol. 2019;85(4):366&#x2010;375.</Citation></Reference><Reference><Citation>Bima P , Montrucchio G , Caramello V , et&#xa0;al. Prognostic value of mid&#x2010;regional Proadrenomedullin sampled at presentation and after 72 hours in septic patients presenting to the emergency department: an observational two&#x2010;center study. Biomedicine. 2022;10(3):719.</Citation></Reference><Reference><Citation>Helan M , Malaska J , Tomandl J , et&#xa0;al. Kinetics of biomarkers of oxidative stress in septic shock: a pilot study. Antioxidants (Basel). 2022;11(4):640.</Citation></Reference><Reference><Citation>Fahmey SS , Mostafa H , Elhafeez NA , Hussain H . Diagnostic and prognostic value of proadrenomedullin in neonatal sepsis. Korean J Pediatr. 2018;61(5):156&#x2010;159.</Citation></Reference><Reference><Citation>Hagag AA , Elmahdy HS , Ezzat AA . Prognostic value of plasma pro&#x2010;adrenomedullin and antithrombin levels in neonatal sepsis. Indian Pediatr. 2011;48(6):471&#x2010;473.</Citation></Reference><Reference><Citation>Jordan I , Corniero P , Balaguer M , et&#xa0;al. Adrenomedullin is a useful biomarker for the prognosis of critically ill septic children. Biomark Med. 2014;8(9):1065&#x2010;1072.</Citation></Reference><Reference><Citation>Struck J , Tao C , Morgenthaler NG , Bergmann A . Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides. 2004;25(8):1369&#x2010;1372.</Citation></Reference><Reference><Citation>Liang J , Cai Y , Shao Y . Comparison of presepsin and mid&#x2010;regional pro&#x2010;adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta&#x2010;analysis. BMC Infect Dis. 2023;23(1):288.</Citation></Reference><Reference><Citation>Liu D , Xie L , Zhao H , Liu X , Cao J . Prognostic value of mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proADM) in patients with community&#x2010;acquired pneumonia: a systematic review and meta&#x2010;analysis. BMC Infect Dis. 2016;16:232.</Citation></Reference><Reference><Citation>Garcia de Guadiana&#x2010;Romualdo L , Calvo Nieves MD , Rodriguez Mulero MD , et&#xa0;al. MR&#x2010;proADM as marker of endotheliitis predicts COVID&#x2010;19 severity. Eur J Clin Invest. 2021;51(5):e13511.</Citation></Reference><Reference><Citation>Spoto S , Fogolari M , De Florio L , et&#xa0;al. Procalcitonin and MR&#x2010;proAdrenomedullin combination in the etiological diagnosis and prognosis of sepsis and septic shock. Microb Pathog. 2019;137:103763.</Citation></Reference><Reference><Citation>Corr MP , Fairley D , McKenna JP , Shields MD , Waterfield T . Diagnostic value of mid&#x2010;regional pro&#x2010;adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review. BMC Pediatr. 2022;22(1):176.</Citation></Reference><Reference><Citation>Hupf J , Mustroph J , Hanses F , Evert K , Maier LS , Jungbauer CG . RNA&#x2010;expression of adrenomedullin is increased in patients with severe COVID&#x2010;19. Crit Care. 2020;24(1):527.</Citation></Reference><Reference><Citation>Michels M , Djamiatun K , Faradz SM , Koenders MM , de Mast Q , van der Ven AJ . High plasma mid&#x2010;regional pro&#x2010;adrenomedullin levels in children with severe dengue virus infections. J Clin Virol. 2011;50(1):8&#x2010;12.</Citation></Reference><Reference><Citation>Fialek B , De Roquetaillade C , Pruc M , et&#xa0;al. Systematic review with meta&#x2010;analysis of mid&#x2010;regional pro&#x2010;adrenomedullin (MR&#x2010;proadm) as a prognostic marker in Covid&#x2010;19&#x2010;hospitalized patients. Ann Med. 2023;55(1):379&#x2010;387.</Citation></Reference><Reference><Citation>Montrucchio G , Sales G , Balzani E , et&#xa0;al. Effectiveness of mid&#x2010;regional pro&#x2010;adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID&#x2010;19 critically ill patients: new evidence from a 15&#x2010;month observational prospective study. Front Med (Lausanne). 2023;10:1122367.</Citation></Reference><Reference><Citation>Sozio E , Moore NA , Fabris M , et&#xa0;al. Identification of COVID&#x2010;19 patients at risk of hospital admission and mortality: a European multicentre retrospective analysis of mid&#x2010;regional pro&#x2010;adrenomedullin. Respir Res. 2022;23(1):221.</Citation></Reference><Reference><Citation>Lampsas S , Tsaplaris P , Pantelidis P , et&#xa0;al. The role of endothelial related circulating biomarkers in COVID&#x2010;19. A systematic review and meta&#x2010;analysis. Curr Med Chem. 2022;29(21):3790&#x2010;3805.</Citation></Reference><Reference><Citation>Zaninotto M , Mion MM , Marchioro L , Padoan A , Plebani M . Endothelial dysfunction and mid&#x2010;regional proAdrenomedullin: what role in SARS&#x2010;CoV&#x2010;2 infected patients? Clin Chim Acta. 2021;523:185&#x2010;190.</Citation></Reference><Reference><Citation>Sozio E , Tascini C , Fabris M , et&#xa0;al. MR&#x2010;proADM as prognostic factor of outcome in COVID&#x2010;19 patients. Sci Rep. 2021;11(1):5121.</Citation></Reference><Reference><Citation>Andres C , Andaluz&#x2010;Ojeda D , Cicuendez R , et&#xa0;al. MR&#x2010; proADM to detect specific types of organ failure in infection. Eur J Clin Invest. 2020;50(6):e13246.</Citation></Reference><Reference><Citation>Falkentoft AC , Rorth R , Iversen K , et&#xa0;al. MR&#x2010;proADM as a prognostic marker in patients with ST&#x2010;segment&#x2010;elevation myocardial infarction&#x2010;DANAMI&#x2010;3 (a Danish study of optimal acute treatment of patients with STEMI) substudy. J Am Heart Assoc. 2018;7(11):e008123.</Citation></Reference><Reference><Citation>Potocki M , Ziller R , Mueller C . Mid&#x2010;regional pro&#x2010;adrenomedullin in acute heart failure: a better biomarker or just another biomarker? Curr Heart Fail Rep. 2012;9(3):244&#x2010;251.</Citation></Reference><Reference><Citation>Myhre PL , Liu Y , Kulac IJ , et&#xa0;al. Changes in mid&#x2010;regional pro&#x2010;adrenomedullin during treatment with sacubitril/valsartan. Eur J Heart Fail. 2023;25(8):1396&#x2010;1405.</Citation></Reference><Reference><Citation>Nunez J , de la Espriella R , Rossignol P , et&#xa0;al. Congestion in heart failure: a circulating biomarker&#x2010;based perspective. A review from the biomarkers working Group of the Heart Failure Association, European Society of Cardiology. Eur J Heart Fail. 2022;24(10):1751&#x2010;1766.</Citation></Reference><Reference><Citation>Spinarova M , Spinar J , Spinarova L , et&#xa0;al. Relation between mid&#x2010;regional pro&#x2010;adrenomedullin in patients with chronic heart failure and the dose of diuretics in 2&#x2010;year follow&#x2010;up&#x2014;Data from FAR NHL registry. Medicina (Kaunas). 2022;58(10):1477.</Citation></Reference><Reference><Citation>Sabatine MS , Morrow DA , de Lemos JA , et&#xa0;al. Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease. Circulation. 2012;125(2):233&#x2010;240.</Citation></Reference><Reference><Citation>von Haehling S , Filippatos GS , Papassotiriou J , et&#xa0;al. Mid&#x2010;regional pro&#x2010;adrenomedullin as a novel predictor of mortality in patients with chronic heart failure. Eur J Heart Fail. 2010;12(5):484&#x2010;491.</Citation></Reference><Reference><Citation>Dieplinger B , Mueller T , Kollerits B , et&#xa0;al. Pro&#x2010;A&#x2010;type natriuretic peptide and pro&#x2010;adrenomedullin predict progression of chronic kidney disease: the MMKD study. Kidney Int. 2009;75(4):408&#x2010;414.</Citation></Reference><Reference><Citation>Yan H , Jin S , Liang L , Du J , Aithal GP , Li L . Pro&#x2010;adrenomedullin in acute decompensation of liver cirrhosis: relationship with acute&#x2010;on&#x2010;chronic liver failure and short&#x2010;term survival. Scand J Gastroenterol. 2020;55(5):606&#x2010;614.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30261898</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Septic shock-3 vs 2: an analysis of the ALBIOS study.</ArticleTitle><Pagination><StartPage>237</StartPage><MedlinePgn>237</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">237</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-018-2169-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">A reanalysis of the ALBIOS trial suggested that patients with septic shock - defined by vasopressor-dependent hypotension in the presence of severe sepsis (Shock-2) - had a survival benefit when treated with albumin. The new septic shock definition (Shock-3) added the criterion of a lactate threshold of 2&#xa0;mmol/L. We investigated how the populations defined according to Shock-2 and Shock-3 differed and whether the albumin benefit would be confirmed.</AbstractText><AbstractText Label="METHODS">This is a retrospective analysis of the ALBIOS study, a randomized controlled study conducted between 2008 and 2012 in 100 intensive care units in Italy comparing the administration of 20% albumin and crystalloids versus crystalloids alone in patients with severe sepsis or septic shock. We analyzed data from 1741 patients from ALBIOS with serum lactate measurement available at baseline. We compared group size, physiological variables and 90-day mortality between patients defined by Shock-2 and Shock-3 and between the albumin and crystalloid treatment groups.</AbstractText><AbstractText Label="RESULTS">We compared the Shock-2 and the Shock-3 definitions and the albumin and crystalloid treatment groups in terms of group size and physiological, laboratory and outcome variables. The Shock-3 definition reduced the population with shock by 34%. The Shock-3 group had higher lactate (p&#x2009;&lt;&#x2009;0.001), greater resuscitation-fluid requirement (p&#x2009;=&#x2009;0.014), higher Simplified Acute Physiology Score II (p&#x2009;&lt;&#x2009;0.001) and Sepsis-related Organ Failure Assessment scores (p&#x2009;=&#x2009;0.022), lower platelet count (p&#x2009;=&#x2009;0.002) and higher 90-day mortality (46.7% vs 51.9%; p&#x2009;=&#x2009;0.031). Albumin decreased mortality in Shock-2 patients compared to crystalloids (43.5% vs 49.9%; 12.6% relative risk reduction; p&#x2009;=&#x2009;0.04). In patients defined by Shock-3 a similar benefit was observed for albumin with a 11.3% relative risk reduction (48.7% vs 54.9%; 11.3% relative risk reduction; p&#x2009;=&#x2009;0.22).</AbstractText><AbstractText Label="CONCLUSIONS">The Sepsis-3 definition reduced the size of the population with shock and showed a similar effect size in the benefits of albumin. The Shock-3 criteria will markedly slow patients' recruitment rates, in view of testing albumin in septic shock.</AbstractText><AbstractText Label="TRIAL REGISTRATION">ClinicalTrials.gov, number NCT00707122 . Registered on 30 June 2008.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vasques</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duscio</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romitti</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasticci</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caironi</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, Azienda-Ospedaliero Universitaria S. Luigi Gonzaga, Orbassano, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Oncologia, Universit&#xe0; degli Studi di Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meessen</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Research, IRCCS - Istituto di Ricerche Farmacologiche "Mario Negri", Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cressoni</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Dipartimento di Scienze della Salute, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporota</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Adult Critical Care, Guy's and St Thomas' NHS Foundation Trust, King's Health Partners, and Division of Asthma, Allergy and Lung Biology, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pesenti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit&#xe0; degli Studi di Milano, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Dipartimento di Anestesia, Rianimazione ed Emergenza Urgenza, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Milan-Bicocca, School of Medicine and Surgery, Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quintel</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gattinoni</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Emergency and Intensive Care Medicine, University of G&#xf6;ttingen, Robert-Koch-Stra&#xdf;e, 40, 37075, G&#xf6;ttingen, Germany. gattinoniluciano@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00707122</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>ZIF514RVZR</RegistryNumber><NameOfSubstance UI="D000075462">Serum Albumin, Human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075462" MajorTopicYN="N">Serum Albumin, Human</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALBIOS</Keyword><Keyword MajorTopicYN="N">Albumin</Keyword><Keyword MajorTopicYN="N">Crystalloids</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Shock-3</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: The ALBIOS study was approved by the ethical commission. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30261898</ArticleId><ArticleId IdType="pmc">PMC6161337</ArticleId><ArticleId IdType="doi">10.1186/s13054-018-2169-8</ArticleId><ArticleId IdType="pii">10.1186/s13054-018-2169-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caironi P, Tognoni G, Masson S, Fumagalli R, et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370:1412&#x2013;21. doi: 10.1056/NEJMoa1305727.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1305727</ArticleId><ArticleId IdType="pubmed">24635772</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644&#x2013;55. doi: 10.1378/chest.101.6.1644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Int Care Med. 1996;22:707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Ranieri VM, Pesenti A. Sepsis: needs for defining severity. Int Care Med. 2015;41:551&#x2013;2. doi: 10.1007/s00134-014-3598-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3598-8</ArticleId><ArticleId IdType="pubmed">25518952</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst LB, Haase N, Wetterslev J, Wernerman J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381&#x2013;1391. doi: 10.1056/NEJMoa1406617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1406617</ArticleId><ArticleId IdType="pubmed">25270275</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;93. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Yealy DM, Kellum JA, Huang DT, Barnato AE, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683&#x2013;93. doi: 10.1056/NEJMoa1401602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>Peake SL, Delaney A, Bailey M, Bellomo R, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496&#x2013;506. doi: 10.1056/NEJMoa1404380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;10. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Howell MD, Talmor D, Nathanson LA, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45:524&#x2013;8. doi: 10.1016/j.annemergmed.2004.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2004.12.006</ArticleId><ArticleId IdType="pubmed">15855951</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Lee T, Singer J, Boyd JH, et al. The septic shock 3.0 definition and trials: a vasopressin and septic shock trial experience. Crit Care Med. 2017;45:940&#x2013;8. doi: 10.1097/CCM.0000000000002323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002323</ArticleId><ArticleId IdType="pubmed">28333757</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;87. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, Seymour CW, et al. Developing a new definition and assessing new clinical criteria for septic shock: for the third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:775&#x2013;87. doi: 10.1001/jama.2016.0289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345:1368&#x2013;77. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24612945</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><PubDate><Year>2014</Year><Month>Mar</Month><Day>10</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Local versus general anesthesia for transcatheter aortic valve implantation (TAVR)--systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>41</StartPage><MedlinePgn>41</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/1741-7015-12-41</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The hypothesis of this study was that local anesthesia with monitored anesthesia care (MAC) is not harmful in comparison to general anesthesia (GA) for patients undergoing Transcatheter Aortic Valve Implantation (TAVR).TAVR is a rapidly spreading treatment option for severe aortic valve stenosis. Traditionally, in most centers, this procedure is done under GA, but more recently procedures with MAC have been reported.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a systematic review and meta-analysis comparing MAC versus GA in patients undergoing transfemoral TAVR. Trials were identified through a literature search covering publications from 1 January 2005 through 31 January 2013. The main outcomes of interest of this literature meta-analysis were 30-day overall mortality, cardiac-/procedure-related mortality, stroke, myocardial infarction, sepsis, acute kidney injury, procedure time and duration of hospital stay. A random effects model was used to calculate the pooled relative risks (RR) with 95% confidence intervals.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seven observational studies and a total of 1,542 patients were included in this analysis. None of the studies were randomized. Compared to GA, MAC was associated with a shorter hospital stay (-3.0 days (-5.0 to -1.0); P = 0.004) and a shorter procedure time (MD -36.3 minutes (-58.0 to -15.0 minutes); P &lt;0.001). Overall 30-day mortality was not significantly different between MAC and GA (RR 0.77 (0.38 to 1.56); P = 0.460), also cardiac- and procedure-related mortality was similar between both groups (RR 0.90 (0.34 to 2.39); P = 0.830).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These data did not show a significant difference in short-term outcomes for MAC or GA in TAVR. MAC may be associated with reduced procedural time and shorter hospital stay. Now randomized trials are needed for further evaluation of MAC in the setting of TAVR.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fr&#xf6;hlich</LastName><ForeName>Georg M</ForeName><Initials>GM</Initials></Author><Author ValidYN="Y"><LastName>Lansky</LastName><ForeName>Alexandra J</ForeName><Initials>AJ</Initials></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Roffi</LastName><ForeName>Marco</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Toggweiler</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Reinthaler</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Duolao</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Hutchinson</LastName><ForeName>Nevil</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Wendler</LastName><ForeName>Olaf</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Hildick-Smith</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Heart Hospital, University College London Hospitals, London, UK. pascalmeier74@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000772" MajorTopicYN="Y">Anesthesia, Local</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="N">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="N">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24612945</ArticleId><ArticleId IdType="pmc">PMC4022332</ArticleId><ArticleId IdType="doi">10.1186/1741-7015-12-41</ArticleId><ArticleId IdType="pii">1741-7015-12-41</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;1607. doi: 10.1056/NEJMoa1008232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1008232</ArticleId><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pi&#xe9;rard LA, Maurer G. ESC Working Group on Valvular Heart Disease Position Paper - heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597&#x2013;1606. doi: 10.1093/eurheartj/ehs443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs443</ArticleId><ArticleId IdType="pubmed">23293304</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Himbert D, Tchetche D, Carri&#xe9; D, Albat B, Cribier A, Rioufol G, Sudre A, Blanchard D, Collet F, Dos Santos P, Meneveau N, Tirouvanziam A, Caussin C, Guyon P, Boschat J, Le Breton H, Collart F, Houel R. et al.Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med. 2012;366:1705&#x2013;1715. doi: 10.1056/NEJMoa1114705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1114705</ArticleId><ArticleId IdType="pubmed">22551129</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiles S.  TAVR in-Hospital Death, Stroke Rates Stay Low Even as Use Climbs: GARY. Munich: European Society of Cardiology ESC 2012; 2012.   http://www.medscape.com/viewarticle/769866.</Citation></Reference><Reference><Citation>Linke A, Bosmans J, Gerckens U, Wenaweser P, Tamburino C, Brecker S, Bauernschmitt R. Local vs. General Anaesthesia: Impact on the outcomes of transcatheter aortic valve implantation: insights from the multicentre ADVANCE study. Munich: European Society of Cardiology ESC; 2012.</Citation></Reference><Reference><Citation>Motloch LJ, Rottlaender D, Reda S, Larbig R, Bruns M, M&#xfc;ller-Ehmsen J, Strauch J, Madershahian N, Erdmann E, Wahlers T, Hoppe UC. Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol. 2012;101:45&#x2013;53. doi: 10.1007/s00392-011-0362-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0362-8</ArticleId><ArticleId IdType="pubmed">21931964</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Meguro K, Mouillet G, Bergoend E, Monin JL, Lim P, Dubois-Rande JL, Teiger E. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol. 2013;111:94&#x2013;99. doi: 10.1016/j.amjcard.2012.08.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2012.08.053</ArticleId><ArticleId IdType="pubmed">23068861</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruppert V, Leurs LJ, Rieger J, Steckmeier B, Buth J, Umscheid T. EUROSTAR Collaborators. Risk-adapted outcome after endovascular aortic aneurysm repair: analysis of anesthesia types based on EUROSTAR data. J Endovasc Ther. 2007;14:12&#x2013;22. doi: 10.1583/06-1957.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1583/06-1957.1</ArticleId><ArticleId IdType="pubmed">17291150</ArticleId></ArticleIdList></Reference><Reference><Citation>Kilpatrick B, Slinger P. Lung protective strategies in anaesthesia. Br J Anaesth. 2010;105:i108&#x2013;i116. doi: 10.1093/bja/aeq299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aeq299</ArticleId><ArticleId IdType="pmc">PMC9149602</ArticleId><ArticleId IdType="pubmed">21148650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim T, Kim HJ, Lee JM, Kim JH, Hong DM, Jeon Y, Roh YJ, Lim YJ, Bahk JH. The head-down tilt position decreases vasopressor requirement during hypotension following induction of anaesthesia in patients undergoing elective coronary artery bypass graft and valvular heart surgeries. Eur J Anaesthesiol. 2011;28:45&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">21088595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K. EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.b2535</ArticleId><ArticleId IdType="pmc">PMC2714657</ArticleId><ArticleId IdType="pubmed">19622551</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Straus SE, Moher D. How can we improve the interpretation of systematic reviews? BMC Med. 2011;9:31. doi: 10.1186/1741-7015-9-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-31</ArticleId><ArticleId IdType="pmc">PMC3072347</ArticleId><ArticleId IdType="pubmed">21450084</ArticleId></ArticleIdList></Reference><Reference><Citation>tctmd. The Source for Interventional Cardiovascular News and Education.   http://www.tctmd.com.</Citation></Reference><Reference><Citation>The Heart Org. Medscape Cardiology.   http://www.theheart.org.</Citation></Reference><Reference><Citation>EuroPCR:   http://www.europcronline.com.</Citation></Reference><Reference><Citation>American College of Cardiology. CardioSource.   http://www.cardiosource.com.</Citation></Reference><Reference><Citation>CRTonline.   http://www.crtonline.org.</Citation></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177&#x2013;188. doi: 10.1016/0197-2456(86)90046-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137&#x2013;159. doi: 10.1111/j.1467-985X.2008.00552.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2008.00552.x</ArticleId><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankey SS, Weissfeld LA, Fine MJ, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat. 1996;25:1031&#x2013;1056.</Citation></Reference><Reference><Citation>Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539&#x2013;1558. doi: 10.1002/sim.1186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.1186</ArticleId><ArticleId IdType="pubmed">12111919</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32:138.</Citation></Reference><Reference><Citation>Behan M, Haworth P, Hutchinson N, Trivedi U, Laborde JC, Hildick-Smith D. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv. 2008;72:1012&#x2013;1015. doi: 10.1002/ccd.21777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ccd.21777</ArticleId><ArticleId IdType="pubmed">19021273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Dor I, Looser PM, Maluenda G, Weddington TC, Kambouris NG, Barbash IM, Hauville C, Okubagzi P, Corso PJ, Satler LF, Pichard AD, Waksman R. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med. 2012;13:207&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">22818531</ArticleId></ArticleIdList></Reference><Reference><Citation>Covello RD, Ruggeri L, Landoni G, Guarracino F, Bignami E, Gonfalini M, Virzo I, Michev I, Colombo A, Zangrillo A. Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol. 2010;76:100&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">20150850</ArticleId></ArticleIdList></Reference><Reference><Citation>Deh&#xe9;din B, Guinot PG, Ibrahim H, Allou N, Provench&#xe8;re S, Dilly MP, Vahanian A, Himbert D, Brochet E, Radu C, Nataf P, Montravers P, Longrois D, Depoix JP. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth. 2011;25:1036&#x2013;1043. doi: 10.1053/j.jvca.2011.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2011.05.008</ArticleId><ArticleId IdType="pubmed">21803602</ArticleId></ArticleIdList></Reference><Reference><Citation>Gulur P, Nishimori M, Ballantyne JC. Regional anaesthesia versus general anaesthesia, morbidity and mortality. Best Pract Res Clin Anaesthesiol. 2006;20:249&#x2013;263. doi: 10.1016/j.bpa.2005.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2005.10.002</ArticleId><ArticleId IdType="pubmed">16850776</ArticleId></ArticleIdList></Reference><Reference><Citation>Bainbridge D, Martin J, Arango M, Cheng D. for the Evidence-based Peri-operative Clinical Outcomes Research (EpiCOR) Group. Evidence-based peri-operative clinical outcomes research, perioperative and anaesthetic-related mortality in developed and developing countries: a systematic review and meta-analysis. Lancet. 2012;380:1075&#x2013;1081. doi: 10.1016/S0140-6736(12)60990-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)60990-8</ArticleId><ArticleId IdType="pubmed">22998717</ArticleId></ArticleIdList></Reference><Reference><Citation>Cioni M, Taramasso M, Giacomini A, Montorfano M, Latib A, Colombo A, Alfieri O, Maisano F. Transaxillary approach: short- and mid-term results in a single-center experience. Innovations (Phila) 2011;6:361&#x2013;365. doi: 10.1097/IMI.0b013e318248e9ed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/IMI.0b013e318248e9ed</ArticleId><ArticleId IdType="pubmed">22436770</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips D. Aortic stenosis: a review. AANA J. 2006;74:309&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">16918123</ArticleId></ArticleIdList></Reference><Reference><Citation>Gripari P, Ewe SH, Fusini L, Muratori M, Ng AC, Cefal&#xf9; C, Delgado V, Schalij MJ, Bax JJ, Marsan NA, Tamborini G, Pepi M. Intraoperative 2D and 3D transoesophageal echocardiographic predictors of aortic regurgitation after transcatheter aortic valve implantation. Heart. 2012;98:1229&#x2013;1236. doi: 10.1136/heartjnl-2012-301998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2012-301998</ArticleId><ArticleId IdType="pubmed">22826560</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold M, Achenbach S, Pfeiffer I, Ensminger S, Marwan M, Einhaus F, Pflederer T, Ropers D, Schuhbaeck A, Anders K, Lell M, Uder M, Ludwig J, Weyand M, Daniel WG, Feyrer R. A method to determine suitable fluoroscopic projections for transcatheter aortic valve implantation by computed tomography. J Cardiovasc Comput Tomogr. 2012;6:422&#x2013;428. doi: 10.1016/j.jcct.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2012.10.008</ArticleId><ArticleId IdType="pubmed">23217463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar S, Ling LH, Halloran K, Morton JB, Spence SJ, Joseph S, Kistler PM, Sparks PB, Kalman JM. Esophageal hematoma after atrial fibrillation ablation: incidence, clinical features, and sequelae of esophageal injury of a different sort. Circ Arrhythm Electrophysiol. 2012;5:701&#x2013;705. doi: 10.1161/CIRCEP.112.970624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.112.970624</ArticleId><ArticleId IdType="pubmed">22544279</ArticleId></ArticleIdList></Reference><Reference><Citation>Association of Anaesthetists of Great Britain and Ireland. Day case and short stay surgery: 2. Anaesthesia. 2011;66:417&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">21418041</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 2001;7:174&#x2013;177. doi: 10.3201/eid0702.010203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0702.010203</ArticleId><ArticleId IdType="pmc">PMC2631709</ArticleId><ArticleId IdType="pubmed">11294700</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan M, Kavanagh BP. Perioperative modifications of respiratory function. Best Pract Res Clin Anaesthesiol. 2010;24:145&#x2013;155. doi: 10.1016/j.bpa.2009.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpa.2009.12.001</ArticleId><ArticleId IdType="pubmed">20608553</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Guerrero ML, Verdejo C, Azofra J, de G&#xf3;rgolas M. Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis. 1995;20:16&#x2013;23. doi: 10.1093/clinids/20.1.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/20.1.16</ArticleId><ArticleId IdType="pubmed">7727642</ArticleId></ArticleIdList></Reference><Reference><Citation>Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2:e001032.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3358616</ArticleId><ArticleId IdType="pubmed">22561354</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasta JF, McLaughlin TP, Mody SH, Piech CT. Daily cost of an intensive care unit day: the contribution of mechanical ventilation. Crit Care Med. 2005;33:1266&#x2013;1271. doi: 10.1097/01.CCM.0000164543.14619.00.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000164543.14619.00</ArticleId><ArticleId IdType="pubmed">15942342</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini G, Gasparetto V, Napodano M, Fraccaro C, Gerosa G, Isabella G. Valvular leak after transcatheter aortic valve implantation: a clinician update on epidemiology, pathophysiology and clinical implications. Am J Cardiovasc Dis. 2011;1:312&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253519</ArticleId><ArticleId IdType="pubmed">22254207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32861869</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-6809</ISSN><JournalIssue CitedMedium="Internet"><Volume>73</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of vascular surgery</Title><ISOAbbreviation>J Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Cannabis use disorder and perioperative outcomes in vascular surgery.</ArticleTitle><Pagination><StartPage>1376</StartPage><EndPage>1387.e3</EndPage><MedlinePgn>1376-1387.e3</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jvs.2020.07.094</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0741-5214(20)31890-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Heavy cannabis use is known to have an adverse impact on cardiovascular and cerebrovascular outcomes in the general population and in patients presenting for surgery. However, there have been no studies that have focused on patients undergoing vascular surgical procedures. The objective of this study was to determine the perioperative risk of cannabis use disorder (CUD), primarily cardiovascular risk, in perioperative vascular surgery patients.</AbstractText><AbstractText Label="METHODS">Using the National Inpatient Sample from 2006 to 2015, we conducted a retrospective cohort study involving those undergoing one of six elective and emergent vascular surgical procedures (carotid endarterectomy [CEA], infrainguinal bypasses, open abdominal aortic aneurysm repair, aortobifemoral bypass, endovascular aortic aneurysm repair, or peripheral arterial endovascular procedures). Patients with CUD identified by the International Classification of Diseases, 9th edition, were matched with patients without CUD in a 1:1 ratio using propensity scores. The primary outcome was perioperative myocardial infarction (MI). Secondary outcomes include stroke, sepsis, deep vein thrombosis, pulmonary embolus, acute kidney injury requiring dialysis, respiratory failure, in-hospital mortality, total cost, and length of stay.</AbstractText><AbstractText Label="RESULTS">We identified a total cohort of 510,007 patients. Over the study period, the recorded prevalence of CUD increased from 1.3/1000 to 10.3/1000 admissions (P&#xa0;&lt; .001). After propensity score matching the cohort consisted of 4684 patients. Those with CUD had a higher incidence of perioperative MI (3.3% vs 2.1%; odds ratio [OR], 1.56; 95% confidence interval [CI], 1.09-2.24; P&#xa0;= .016) and perioperative stroke (5.5% vs 3.5%; OR, 1.59; 95% CI, 1.20-2.12; P&#xa0;= .0013) than patients without CUD. In a sensitivity analysis, where the risk was evaluated separately by type of procedure, the higher incidence of perioperative stroke was primarily seen among those undergoing CEA. Patients with CUD had a lower incidence of sepsis (3.3% vs 5.1%; OR, 0.64; 95% CI, 0.47-0.85; P&#xa0;= .0024). We obtained similar results in a sensitivity analysis that included all patients in the complete unmatched cohort and adjusted for confounding using logistic regression models accounting for the survey design, although the findings of sepsis and stroke failed to reach statistical significance after correcting for multiple testing (MI P&#xa0;= .001; stroke P&#xa0;= .031; sepsis P&#xa0;= .009).</AbstractText><AbstractText Label="CONCLUSIONS">CUD was associated with a significantly higher incidence of perioperative MI in vascular surgery patients. Those with CUD had a greater incidence of diagnosis of acute perioperative stroke when undergoing CEA. Owing to limitations in administrative data, it is unclear if this represents a true effect or selection bias. These findings warrant further investigation in a prospective cohort.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McGuinness</LastName><ForeName>Brandon</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada; Harvard T.H. Chan School of Public Health, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goel</LastName><ForeName>Akash</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, Mass; Department of Anesthesiology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Fadi</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rapanos</LastName><ForeName>Theodore</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Vascular Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittleman</LastName><ForeName>Murray A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, Mass; Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladha</LastName><ForeName>Karim S</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada. Electronic address: karim.ladha@mail.utoronto.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Vasc Surg</MedlineTA><NlmUniqueID>8407742</NlmUniqueID><ISSNLinking>0741-5214</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007297" MajorTopicYN="N">Inpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002189" MajorTopicYN="N">Marijuana Abuse</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008385" MajorTopicYN="N">Marijuana Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014656" MajorTopicYN="N">Vascular Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Carotid endarterectomy</Keyword><Keyword MajorTopicYN="N">Marijuana</Keyword><Keyword MajorTopicYN="N">Myocardial infarction</Keyword><Keyword MajorTopicYN="N">Stroke</Keyword><Keyword MajorTopicYN="N">Vascular surgical procedures</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32861869</ArticleId><ArticleId IdType="doi">10.1016/j.jvs.2020.07.094</ArticleId><ArticleId IdType="pii">S0741-5214(20)31890-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39581988</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>24</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of sepsis-associated acute kidney injury in critically ill patients: a multicenter, prospective, observational cohort study in South Korea.</ArticleTitle><Pagination><StartPage>383</StartPage><MedlinePgn>383</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">383</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-024-05167-9</ELocationID><Abstract><AbstractText Label="BACKGROUND">Despite the clinical importance of sepsis-associated acute kidney injury (SA-AKI), little is known about its epidemiology. We aimed to investigate the incidence and outcomes of SA-AKI, as well as the risk factors for mortality among patients with severe SA-AKI in critically ill patients.</AbstractText><AbstractText Label="METHODS">This secondary multicenter, observational, prospective cohort analysis of sepsis in South Korea evaluated patients aged&#x2009;&#x2265;&#x2009;19&#xa0;years admitted to intensive care units with a diagnosis of sepsis. The primary outcome was the incidence of SA-AKI, defined using the new consensus definition of the Acute Disease Quality Initiative 28 Workgroup. Secondary outcomes were in-hospital mortality and risk factors for in-hospital mortality.</AbstractText><AbstractText Label="RESULTS">Between September 2019 and December 2022, 5100 patients were admitted to intensive care units with a diagnosis of sepsis, and 3177 (62.3%) developed SA-AKI. A total of 613 (19.3%), 721 (22.7%), and 1843 (58.0%) patients had stage 1, 2, and 3 SA-AKI, respectively. Severe SA-AKI (stages 2 and 3 combined) was associated with an increased risk of in-hospital mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle was associated with a decreased risk of in-hospital mortality in severe SA-AKI (adjusted odds ratio, 0.62; 95% confidence interval, 0.48-0.79; P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Of the patients admitted to the intensive care unit for sepsis, 62.3% developed SA-AKI. Severe SA-AKI was associated with an increased risk of mortality. Adherence to the fluid resuscitation component of the one-hour sepsis bundle can potentially improve outcomes in these patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Myung Jin</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si , 13620, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jang</LastName><ForeName>Yeonhoon</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Office of Hospital Information, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Care, Division of Critical Care Medicine, University of California, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Sunghoon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pulmonary, Allergy and Critical Care Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>RyoungEun</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suh</LastName><ForeName>Gee Young</ForeName><Initials>GY</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Dong Kyu</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Su Yeon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Mi Hyeon</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Chae-Man</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Se Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Office of Hospital Information, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea. syjung@snubh.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Family Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea. syjung@snubh.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Sung Yoon</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, 82 Gumi-ro, Bundang-gu, Seongnam-si , 13620, Republic of Korea. nucleon727@snu.ac.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Korean Sepsis Alliance (KSA) investigator</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM151494</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>06-2022-0139</GrantID><Agency>Seoul National University Bundang Hospital</Agency><Country/></Grant><Grant><GrantID>R01-GM151494-01</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Kidney</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Availability of data and materials: No datasets were generated or analysed during the current study. The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request. Ethics approval and consent to participate: This study was approved by the institutional review boards of each participating hospital, including the Seoul National University Bundang Hospital (IRB number: B-1810-500-402). The requirement for informed consent was waived because of the noninterventional, observational nature of the study. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>25</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>24</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39581988</ArticleId><ArticleId IdType="pmc">PMC11587587</ArticleId><ArticleId IdType="doi">10.1186/s13054-024-05167-9</ArticleId><ArticleId IdType="pii">10.1186/s13054-024-05167-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S, Fleischmann-Struzek C, Machado FR, Reinhart KK, Rowan K, Seymour CW, Watson RS, West TE, Marinho F, Hay SI, Lozano R, Lopez AD, Angus DC, Murray CJL, Naghavi M. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. 2020;395:200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294:813&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16106006</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honor&#xe9; PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">26162677</ArticleId></ArticleIdList></Reference><Reference><Citation>Peerapornratana S, Manrique-Caballero CL, G&#xf3;mez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96:1083&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6920048</ArticleId><ArticleId IdType="pubmed">31443997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia HM, Jiang YJ, Zheng X, Li W, Wang MP, Xi XM, Li WX. The attributable mortality of sepsis for acute kidney injury: a propensity-matched analysis based on multicenter prospective cohort study. Ren Fail. 2023;45:2162415.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9848315</ArticleId><ArticleId IdType="pubmed">36637012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuwabara S, Goggins E, Okusa MD. The pathophysiology of sepsis-associated AKI. Clin J Am Soc Nephrol. 2022;17:1050&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9269625</ArticleId><ArticleId IdType="pubmed">35764395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Nadim MK, Pickkers P, Gomez H, Bell S, Joannidis M, Kashani K, Koyner JL, Pannu N, Meersch M, Reis T, Rimmel&#xe9; T, Bagshaw SM, Bellomo R, Cantaluppi V, Deep A, De Rosa S, Perez-Fernandez X, Husain-Syed F, Kane-Gill SL, Kelly Y, Mehta RL, Murray PT, Ostermann M, Prowle J, Ricci Z, See EJ, Schneider A, Soranno DE, Tolwani A, Villa G, Ronco C, Forni LG. Sepsis-associated acute kidney injury: consensus report of the 28th acute disease quality initiative workgroup. Nat Rev Nephrol. 2023;19:401&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">36823168</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Bouchard J, Soroko SB, Ikizler TA, Paganini EP, Chertow GM, Himmelfarb J. Sepsis as a cause and consequence of acute kidney injury: program to improve care in acute renal disease. Intensive Care Med. 2011;37:241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3028102</ArticleId><ArticleId IdType="pubmed">21152901</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Xie H, Ye Z, Li F, Wang L. Rates, predictors, and mortality of sepsis-associated acute kidney injury: a systematic review and meta-analysis. BMC Nephrol. 2020;21:318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7393862</ArticleId><ArticleId IdType="pubmed">32736541</ArticleId></ArticleIdList></Reference><Reference><Citation>Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko RE, Kang D, Cho J, Na SJ, Chung CR, Lim SY, Lee YJ, Park S, Oh DK, Lee SY, Park MH, Lee H, Lim CM, Suh GY. Influence of gender on age-associated in-hospital mortality in patients with sepsis and septic shock: a prospective nationwide multicenter cohort study. Crit Care. 2023;27:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10257805</ArticleId><ArticleId IdType="pubmed">37303037</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. BMJ. 2007;335:806&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xe1;vada J, Hoste E, Cartin-Ceba R, Calzavacca P, Gajic O, Clermont G, Bellomo R, Kellum JA. A comparison of three methods to estimate baseline creatinine for RIFLE classification. Nephrol Dial Transplant. 2010;25:3911&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20100732</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlo J, Chaix B, Ohlsson H, Beckman A, Johnell K, Hjerpe P, R&#xe5;stam L, Larsen K. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Community Health. 2006;60:290&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2566165</ArticleId><ArticleId IdType="pubmed">16537344</ArticleId></ArticleIdList></Reference><Reference><Citation>Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc. 1996. 10.1111/j.2517-6161.1996.tb02080.x.</Citation></Reference><Reference><Citation>White KC, Serpa-Neto A, Hurford R, Clement P, Laupland KB, See E, McCullough J, White H, Shekar K, Tabah A, Ramanan M, Garrett P, Attokaran AG, Luke S, Senthuran S, McIlroy P, Bellomo R. Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study. Intensive Care Med. 2023. 10.1007/s00134-023-07138-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10499944</ArticleId><ArticleId IdType="pubmed">37432520</ArticleId></ArticleIdList></Reference><Reference><Citation>Federspiel CK, Itenov TS, Mehta K, Hsu RK, Bestle MH, Liu KD. Duration of acute kidney injury in critically ill patients. Ann Intensive Care. 2018;8:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5823799</ArticleId><ArticleId IdType="pubmed">29473104</ArticleId></ArticleIdList></Reference><Reference><Citation>Khader A, Zelnick LR, Sathe NA, Kestenbaum BR, Himmelfarb J, Johnson NJ, Shapiro NI, Douglas IS, Hough CL, Bhatraju PK. The interaction of acute kidney injury with resuscitation strategy in sepsis: a secondary analysis of a multicenter, phase 3, randomized clinical trial (CLOVERS). Am J Respir Crit Care Med. 2023;208:1335&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10765399</ArticleId><ArticleId IdType="pubmed">37870416</ArticleId></ArticleIdList></Reference><Reference><Citation>Legrand M, Payen D. Understanding urine output in critically ill patients. Ann Intensive Care. 2011;1:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3224471</ArticleId><ArticleId IdType="pubmed">21906341</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallarico RT, McCoy IE, D&#xe9;pret F, Legrand M. Meaning and management of perioperative oliguria. Anesthesiology. 2024;140:304&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10843636</ArticleId><ArticleId IdType="pubmed">37812766</ArticleId></ArticleIdList></Reference><Reference><Citation>Priyanka P, Zarbock A, Izawa J, Gleason TG, Renfurm RW, Kellum JA. The impact of acute kidney injury by serum creatinine or urine output criteria on major adverse kidney events in cardiac surgery patients. J Thorac Cardiovasc Surg. 2021;162:143&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">32033818</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G. Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol. 2015;26:2231&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552117</ArticleId><ArticleId IdType="pubmed">25568178</ArticleId></ArticleIdList></Reference><Reference><Citation>Leedahl DD, Frazee EN, Schramm GE, Dierkhising RA, Bergstralh EJ, Chawla LS, Kashani KB. Derivation of urine output thresholds that identify a very high risk of AKI in patients with septic shock. Clin J Am Soc Nephrol. 2014;9:1168&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4078959</ArticleId><ArticleId IdType="pubmed">24789551</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL, Yealy DM, Huang DT, Angus DC. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193:281&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4803059</ArticleId><ArticleId IdType="pubmed">26398704</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood MM, Shafer LA, Ho J, Reslerova M, Martinka G, Keenan S, Dial S, Wood G, Rigatto C, Kumar A. Early reversible acute kidney injury is associated with improved survival in septic shock. J Crit Care. 2014;29:711&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">24927984</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhel F, Peters-Sengers H, Falahi F, Scicluna BP, van Vught LA, Bonten MJ, Cremer OL, Schultz MJ, van der Poll T. Mortality and host response aberrations associated with transient and persistent acute kidney injury in critically ill patients with sepsis: a prospective cohort study. Intensive Care Med. 2020;46:1576&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381452</ArticleId><ArticleId IdType="pubmed">32514599</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez ML, Ferrer R, Torrents E, Guillamat-Prats R, Gom&#xe0; G, Su&#xe1;rez D, &#xc1;lvarez-Rocha L, Pozo Laderas JC, Mart&#xed;n-Loeches I, Levy MM, Artigas A. Impact of source control in patients with severe sepsis and septic shock. Crit Care Med. 2017;45:11&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27611975</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Ogura H, Kushimoto S, Shiraishi A, Sugiyama T, Deshpande GA, Uchida M, Nagata I, Saitoh D, Fujishima S, Mayumi T, Hifumi T, Shiino Y, Nakada TA, Tarui T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Yamakawa K, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S. Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J Intensive Care. 2019;7:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6500015</ArticleId><ArticleId IdType="pubmed">31073407</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189:1204&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. 2004;351:159&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">15247356</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff TS, Hjortrup PB, Wetterslev J, Sivapalan P, Laake JH, Cronhjort M, Jakob SM, Cecconi M, Nalos M, Ostermann M, Malbrain M, Pettil&#xe4; V, M&#xf8;ller MH, Kj&#xe6;r MN, Lange T, Overgaard-Steensen C, Brand BA, Winther-Olesen M, White JO, Quist L, Westergaard B, Jonsson AB, Hjorts&#xf8; CJS, Meier N, Jensen TS, Engstr&#xf8;m J, Nebrich L, Andersen-Ranberg NC, Jensen JV, Joseph NA, Poulsen LM, Herl&#xf8;v LS, S&#xf8;lling CG, Pedersen SK, Knudsen KK, Straarup TS, Vang ML, Bundgaard H, Rasmussen BS, Aagaard SR, Hildebrandt T, Russell L, Bestle MH, Sch&#xf8;nemann-Lund M, Br&#xf8;chner AC, Elvander CF, Hoffmann SKL, Rasmussen ML, Martin YK, Friberg FF, Seter H, Aslam TN, &#xc5;dn&#xf8;y S, Seidel P, Strand K, Johnstad B, Joelsson-Alm E, Christensen J, Ahlstedt C, Pfortmueller CA, Siegemund M, Greco M, Rad&#x11b;j J, K&#x159;&#xed;&#x17e; M, Gould DW, Rowan KM, Mouncey PR, Perner A. Restriction of intravenous fluid in ICU patients with septic shock. N Engl J Med. 2022;386:2459&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Douglas IS, Brower RG, Brown SM, Exline MC, Ginde AA, Gong MN, Grissom CK, Hayden D, Hough CL, Huang W, Iwashyna TJ, Jones AE, Khan A, Lai P, Liu KD, Miller CD, Oldmixon K, Park PK, Rice TW, Ringwood N, Semler MW, Steingrub JS, Talmor D, Thompson BT, Yealy DM, Self WH. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388:499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39478504</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6963</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>31</Day></PubDate></JournalIssue><Title>BMC health services research</Title><ISOAbbreviation>BMC Health Serv Res</ISOAbbreviation></Journal><ArticleTitle>Timely empirical antibiotic therapy against sepsis in a rural Norwegian ambulance service: a prospective cohort study.</ArticleTitle><Pagination><StartPage>1320</StartPage><MedlinePgn>1320</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12913-024-11827-x</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early diagnosis and antibiotic therapy in patients with sepsis reduce morbidity and mortality, thus pre-hospital management is likely to affect patient outcomes. Pre-hospital administration may increase the risk of unnecessary use of broad-spectrum antibiotics, but identification of an infectious focus enables more targeted antibiotic therapy. The aim of this study was to investigate how paramedics, with or without the assistance of general practitioners, can administer empiric intravenous antibiotic treatment against sepsis in a timely manner.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cohort study of patients with suspected sepsis that received pre-hospital intravenous antibiotics and were transported to hospital. The setting was mainly rural with long average distance to hospital. Patients received targeted antibiotic treatment after an assessment based on clinical work-up supported by scoring systems. Patients were prospectively included from May 2018 to August 2022. Results are presented as median or absolute values, and chi-square tests were used to compare categorical data.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 328 patients. Median age was 76&#xa0;years (IQR 64, 83) and 48.5% of patients were female. 30-days all-cause mortality was 10.4%. In cases where a suspected infectious focus was determined, the hospital discharge papers confirmed the pre-hospital diagnosis focus in 195 cases (79.3%). The presence of a general practitioner during the pre-hospital assessment increased the rate of correctly identified infectious focus from 72.6% to 86.1% (p&#x2009;=&#x2009;0.009). Concordance between pre-hospital identification of a tentative focus and discharge diagnosis was highest for lower respiratory tract (p&#x2009;=&#x2009;0.02) and urinary tract infections (p&#x2009;=&#x2009;0.03). Antibiotic treatment was initiated 44&#xa0;min (median) after arrival of ambulance, and median transportation time to hospital was 69&#xa0;min. Antibiotic therapy was started 76&#xa0;min (median) before arrival at hospital.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pre-hospital identification of infectious focus in suspected sepsis was feasible, and collaboration with primary care physicians increased level of diagnostic accuracy. This allowed initiation of intravenous focus-directed antibiotics more than one hour before arrival in hospital in a rural setting. The effect of pre-hospital therapy on timing was much stronger than in previous studies from more urban areas.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andersson</LastName><ForeName>Lars-J&#xf8;ran</ForeName><Initials>LJ</Initials><Identifier Source="ORCID">0009-0002-4778-3156</Identifier><AffiliationInfo><Affiliation>Anaesthesia and Critical Care Research Group, Faculty of Health Sciences, UiT - The Arctic University of Norway, Troms&#xf8;, Norway. lan073@uit.no.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Emergency Medical Services, University Hospital of North Norway, Troms&#xf8;, Norway. lan073@uit.no.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simonsen</LastName><ForeName>Gunnar Skov</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0003-0043-7045</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Infection Control, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Group for Host-Microbe Interaction, Faculty of Health Sciences, UiT - The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sollig&#xe5;rd</LastName><ForeName>Erik</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6173-3580</Identifier><AffiliationInfo><Affiliation>Department of Research, Innovation, Education and Health Service Development, M&#xf8;re og Romsdal Hospital Trust, &#xc5;lesund, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Circulation and Medical Imaging, Gemini Centre for Sepsis Research, Norwegian University of Science and Technology, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fredriksen</LastName><ForeName>Knut</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-9281-8007</Identifier><AffiliationInfo><Affiliation>Anaesthesia and Critical Care Research Group, Faculty of Health Sciences, UiT - The Arctic University of Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Emergency Medical Services, University Hospital of North Norway, Troms&#xf8;, Norway.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Health Serv Res</MedlineTA><NlmUniqueID>101088677</NlmUniqueID><ISSNLinking>1472-6963</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009664" MajorTopicYN="N" Type="Geographic">Norway</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000552" MajorTopicYN="Y">Ambulances</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ambulance</Keyword><Keyword MajorTopicYN="N">Anti-Bacterial Agents</Keyword><Keyword MajorTopicYN="N">Emergency Medical Services</Keyword><Keyword MajorTopicYN="N">Emergency Medical Technicians</Keyword><Keyword MajorTopicYN="N">General practitioners</Keyword><Keyword MajorTopicYN="N">Paramedics</Keyword><Keyword MajorTopicYN="N">Primary Care Physicians</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>31</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39478504</ArticleId><ArticleId IdType="pmc">PMC11526532</ArticleId><ArticleId IdType="doi">10.1186/s12913-024-11827-x</ArticleId><ArticleId IdType="pii">10.1186/s12913-024-11827-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Skei NV, Nilsen TIL, Knoop ST, Prescott H, Lydersen S, Mohus RM, et al. Long-term temporal trends in incidence rate and case fatality of sepsis and COVID-19-related sepsis in Norwegian hospitals, 2008&#x2013;2021: a nationwide registry study. BMJ Open. 2023;13(8):e071846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10401253</ArticleId><ArticleId IdType="pubmed">37532480</ArticleId></ArticleIdList></Reference><Reference><Citation>Skei NV, Nilsen TIL, Mohus RM, Prescott HC, Lydersen S, Sollig&#xe5;rd E, et al. Trends in mortality after a sepsis hospitalization: a nationwide prospective registry study from 2008 to 2021. Infection. 2023;51(6):1773&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10665235</ArticleId><ArticleId IdType="pubmed">37572240</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels R. Surviving the first hours in sepsis: getting the basics right (an intensivist&#x2019;s perspective). J Antimicrob Chemother. 2011;66(Suppl 2):ii11-23.</Citation><ArticleIdList><ArticleId IdType="pubmed">21398303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Martin-Loeches I, Phillips G, Osborn TM, Townsend S, Dellinger RP, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">24717459</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Gesten F, Prescott HC, Friedrich ME, Iwashyna TJ, Phillips GS, et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. N Engl J Med. 2017;376(23):2235&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5538258</ArticleId><ArticleId IdType="pubmed">28528569</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockey D. International EMS systems: Geographical lottery and diversity but many common challenges. Resuscitation. 2009;80(7):722.</Citation><ArticleIdList><ArticleId IdType="pubmed">19427091</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam N, Oskam E, Stassen PM, Exter PV, van de Ven PM, Haak HR, et al. Prehospital antibiotics in the ambulance for sepsis: a multicentre, open label, randomised trial. Lancet Respir Med. 2018;6(1):40&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29196046</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones J, Allen S, Davies J, Driscoll T, Ellis G, Fegan G, et al. Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe). Sci Rep. 2021;11(1):18586.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452688</ArticleId><ArticleId IdType="pubmed">34545117</ArticleId></ArticleIdList></Reference><Reference><Citation>Walchok JG, Pirrallo RG, Furmanek D, Lutz M, Shope C, Giles B, et al. Paramedic-initiated CMS sepsis core measure bundle prior to hospital arrival: a stepwise approach. Prehosp Emerg Care. 2017;21(3):291&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">27918869</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunningham CT, Sanseverino A, Reznek M, Borges E, Beth Urhoy M, Gross K, et al. A pilot study of prehospital antibiotics for severe sepsis. Acad Emerg Med. 2022;29(2):231&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">34480817</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics Norway: https://www.ssb.no Accessed 2024&#x2013;06&#x2013;20</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486&#x2013;552.</Citation><ArticleIdList><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J Acute Cardiovasc Care. 2023;13(1):55&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">37740496</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Kahn JM, Martin-Gill C, Callaway CW, Yealy DM, Scales D, Angus DC. Delays From First Medical Contact to Antibiotic Administration for Sepsis. Crit Care Med. 2017;45(5):759&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065262</ArticleId><ArticleId IdType="pubmed">28234754</ArticleId></ArticleIdList></Reference><Reference><Citation>The Norwegian Directorate of Health https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-primaerhelsetjenesten (In Norwegian) Accessed 2024&#x2013;06&#x2013;20</Citation></Reference><Reference><Citation>The Norwegian Directorate of Health https://www.helsedirektoratet.no/retningslinjer/antibiotika-i-sykehus (In Norwegian) Accessed 2024&#x2013;06&#x2013;20</Citation></Reference><Reference><Citation>NORM/NORM-VET 2022. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Troms&#xf8; / Oslo 2023. ISSN:1502&#x2013;2307 (print) / 1890&#x2013;9965 (electronic) Available at http://www.antibiotikaresistens.no.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36142893</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>18</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: Computational and Experimental Approaches.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10982</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms231810982</ELocationID><Abstract><AbstractText>Toll-like receptors (TLR) play an eminent role in the regulation of immune responses to invading pathogens during sepsis. TLR genetic variants might influence individual susceptibility to developing sepsis. The current study aimed to investigate the association of genetic polymorphisms of the <i>TLR2</i> and <i>TLR4</i> with the risk of developing sepsis with both a pilot study and in silico tools. Different in silico tools were used to predict the impact of our SNPs on protein structure, stability, and function. Furthermore, in our prospective study, all patients matching the inclusion criteria in the intensive care units (ICU) were included and followed up, and DNA samples were genotyped using real-time polymerase chain reaction (RT-PCR) technology. There was a significant association between <i>TLR2</i> Arg753Gln polymorphisms and sepsis under the over-dominant model (<i>p</i> = 0.043). In contrast, we did not find a significant difference with the <i>TLR4</i> Asp299Gly polymorphism with sepsis. However, there was a significant association between <i>TLR4</i> Asp299Gly polymorphisms and <i>Acinetobacter baumannii</i> infection which is quite a virulent organism in ICU (<i>p</i> = 0.001) and post-surgical cohorts (<i>p</i> = 0.033). Our results conclude that the <i>TLR2</i> genotype may be a risk factor for sepsis in adult patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Behairy</LastName><ForeName>Mohammed Y</ForeName><Initials>MY</Initials><Identifier Source="ORCID">0000-0001-8415-2914</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, University of Sadat City, Sadat City 32958, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdelrahman</LastName><ForeName>Ali A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toraih</LastName><ForeName>Eman A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0001-9267-3787</Identifier><AffiliationInfo><Affiliation>Department of Surgery, School of Medicine, Tulane University, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genetics Unit, Department of Histology &amp; Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Emad El-Deen A</ForeName><Initials>EEA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care and Pain Management, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azab</LastName><ForeName>Marwa M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sayed</LastName><ForeName>Anwar A</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-2243-0971</Identifier><AffiliationInfo><Affiliation>Department of Medical Microbiology and Immunology, Taibah University, Madinah 42353, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London SW7 2BX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashem</LastName><ForeName>Hany R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Fayoum University, Fayoum 63514, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495342">TLR2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C495345">TLR4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051195">Toll-Like Receptor 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051197">Toll-Like Receptor 4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051193">Toll-Like Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051195" MajorTopicYN="Y">Toll-Like Receptor 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051197" MajorTopicYN="N">Toll-Like Receptor 4</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051193" MajorTopicYN="N">Toll-Like Receptors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TLR</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">polymorphism</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36142893</ArticleId><ArticleId IdType="pmc">PMC9504743</ArticleId><ArticleId IdType="doi">10.3390/ijms231810982</ArticleId><ArticleId IdType="pii">ijms231810982</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Black R.E., Morris S.S., Bryce J. Where and why are 10 million children dying every year? Lancet. 2003;361:2226&#x2013;2234. doi: 10.1016/S0140-6736(03)13779-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)13779-8</ArticleId><ArticleId IdType="pubmed">12842379</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.-L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D., Moreno R., Lipman J., Gomersall C., Sakr Y., et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302:2323&#x2013;2329. doi: 10.1001/jama.2009.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.1754</ArticleId><ArticleId IdType="pubmed">19952319</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachtigall I., Tamarkin A., Tafelski S., Weimann A., Rothbart A., Heim S., Wernecke K.D., Spies C. Polymorphisms of the toll-like receptor 2 and 4 genes are associated with faster progression and a more severe course of sepsis in critically ill patients. J. Int. Med. Res. 2014;42:93&#x2013;110. doi: 10.1177/0300060513504358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060513504358</ArticleId><ArticleId IdType="pubmed">24366499</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., Bellomo R., Bernard G.R., Chiche J.-D., Coopersmith C.M., et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Frodsham A.J., Hill A.V.S. Genetics of infectious diseases. Hum. Mol. Genet. 2004;13:R187&#x2013;R194. doi: 10.1093/hmg/ddh225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddh225</ArticleId><ArticleId IdType="pubmed">15358724</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng B., Mao Z., Pang K., Zhang S., Li L. Association of tumor necrosis factor &#x3b1; -308G/A and interleukin-6 -174G/C gene polymorphism with pneumonia-induced sepsis. J. Crit. Care. 2015;30:920&#x2013;923. doi: 10.1016/j.jcrc.2015.04.123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.04.123</ArticleId><ArticleId IdType="pubmed">26025100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomade O., Spies-Weisshart B., Glaser A., Schnetzke U., Hochhaus A., Scholl S. Impact of NOD2 polymorphisms on infectious complications following chemotherapy in patients with acute myeloid leukaemia. Ann. Hematol. 2013;92:1071&#x2013;1077. doi: 10.1007/s00277-013-1734-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00277-013-1734-0</ArticleId><ArticleId IdType="pubmed">23558906</ArticleId></ArticleIdList></Reference><Reference><Citation>Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 2011;109:87&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">21569913</ArticleId></ArticleIdList></Reference><Reference><Citation>Noreen M., Arshad M. Association of TLR1, TLR2, TLR4, TLR6, and TIRAP polymorphisms with disease susceptibility. Immunol. Res. 2015;62:234&#x2013;252. doi: 10.1007/s12026-015-8640-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-015-8640-6</ArticleId><ArticleId IdType="pubmed">25784622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sameer A.S., Nissar S. Toll-Like Receptors (TLRs): Structure, Functions, Signaling, and Role of Their Polymorphisms in Colorectal Cancer Susceptibility. Biomed. Res. Int. 2021;2021:1157023. doi: 10.1155/2021/1157023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/1157023</ArticleId><ArticleId IdType="pmc">PMC8452412</ArticleId><ArticleId IdType="pubmed">34552981</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Karmakar S., Babu S.P.S. TLR2 and TLR4 mediated host immune responses in major infectious diseases: A review. Braz. J. Infect. Dis. 2016;20:193&#x2013;204. doi: 10.1016/j.bjid.2015.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2015.10.011</ArticleId><ArticleId IdType="pmc">PMC9427569</ArticleId><ArticleId IdType="pubmed">26775799</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee S., Huda S., Sinha Babu S.P. Toll-like receptor polymorphism in host immune response to infectious diseases: A review. Scand. J. Immunol. 2019;90:e12771. doi: 10.1111/sji.12771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12771</ArticleId><ArticleId IdType="pubmed">31054156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G., Li C., Cao Z., Corbet E.F., Jin L. Toll-like receptors 2 and 4 gene polymorphisms in a Chinese population with periodontitis. Quintessence Int. 2008;39:217&#x2013;226.</Citation><ArticleIdList><ArticleId IdType="pubmed">18618036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohto U., Yamakawa N., Akashi-Takamura S., Miyake K., Shimizu T. Structural analyses of human Toll-like receptor 4 polymorphisms D299G and T399I. J. Biol. Chem. 2012;287:40611&#x2013;40617. doi: 10.1074/jbc.M112.404608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.404608</ArticleId><ArticleId IdType="pmc">PMC3504774</ArticleId><ArticleId IdType="pubmed">23055527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Song C., Snyder G.A., Sundberg E.J., Medvedev A.E. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J. Biol. Chem. 2012;287:38327&#x2013;38337. doi: 10.1074/jbc.M112.375493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.375493</ArticleId><ArticleId IdType="pmc">PMC3488101</ArticleId><ArticleId IdType="pubmed">22992740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferwerda B., McCall M.B.B., Alonso S., Giamarellos-Bourboulis E.J., Mouktaroudi M., Izagirre N., Syafruddin D., Kibiki G., Cristea T., Hijmans A., et al. TLR4 polymorphisms, infectious diseases, and evolutionary pressure during migration of modern humans. Proc. Natl. Acad. Sci. USA. 2007;104:16645&#x2013;16650. doi: 10.1073/pnas.0704828104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0704828104</ArticleId><ArticleId IdType="pmc">PMC2034238</ArticleId><ArticleId IdType="pubmed">17925445</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioana M., Ferwerda B., Plantinga T.S., Stappers M., Oosting M., McCall M., Cimpoeru A., Burada F., Panduru N., Sauerwein R., et al. Different patterns of Toll-like receptor 2 polymorphisms in populations of various ethnic and geographic origins. Infect. Immun. 2012;80:1917&#x2013;1922. doi: 10.1128/IAI.00121-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00121-12</ArticleId><ArticleId IdType="pmc">PMC3347449</ArticleId><ArticleId IdType="pubmed">22354034</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz E., Mira J.P., Frees K.L., Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch. Intern. Med. 2002;162:1028&#x2013;1032. doi: 10.1001/archinte.162.9.1028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.162.9.1028</ArticleId><ArticleId IdType="pubmed">11996613</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumpf O., Giamarellos-Bourboulis E.J., Koch A., Hamann L., Mouktaroudi M., Oh D.-Y., Latz E., Lorenz E., A Schwartz D., Ferwerda B., et al. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: An observational study in three cohorts. Crit. Care. 2010;14:R103. doi: 10.1186/cc9047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9047</ArticleId><ArticleId IdType="pmc">PMC2911747</ArticleId><ArticleId IdType="pubmed">20525286</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Zhang A., Wang X., Li Z., Yang J., Zeng L., Gu W., Jiang J.-X. Association between the TLR2 Arg753Gln polymorphism and the risk of sepsis: A meta-analysis. Crit. Care. 2015;19:416. doi: 10.1186/s13054-015-1130-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1130-3</ArticleId><ArticleId IdType="pmc">PMC4663740</ArticleId><ArticleId IdType="pubmed">26616674</ArticleId></ArticleIdList></Reference><Reference><Citation>Hossain M.S., Roy A.S., Islam M.S. In silico analysis predicting effects of deleterious SNPs of human RASSF5 gene on its structure and functions. Sci. Rep. 2020;10:14542. doi: 10.1038/s41598-020-71457-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71457-1</ArticleId><ArticleId IdType="pmc">PMC7471297</ArticleId><ArticleId IdType="pubmed">32884013</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Abdelrahman A.l.A., Abdallah H.Y., Ibrahim E.E.-D.A., Sayed A.A., Azab M.M. In silico analysis of missense variants of the C1qA gene related to infection and autoimmune diseases.  [(accessed on 4 August 2022)];J. Taibah. Univ. Med. Sci. 2022  Available online:  https://www.sciencedirect.com/science/article/pii/S1658361222000890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519598</ArticleId><ArticleId IdType="pubmed">36212588</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Soltan M.A., Adam M.S., Refaat A.M., Ezz E.M., Albogami S., Fayad E., Althobaiti F., Gouda A.M., Sileem A.E., et al.  Computational Analysis of Deleterious SNPs in NRAS to Assess Their Potential Correlation with Carcinogenesis.  [(accessed on 19 August 2022)];Front. Genet. 2022 13:872845. Available online:  https://www.frontiersin.org/articles/10.3389/fgene.2022.872845.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2022.872845</ArticleId><ArticleId IdType="pmc">PMC9424727</ArticleId><ArticleId IdType="pubmed">36051694</ArticleId></ArticleIdList></Reference><Reference><Citation>Behairy M.Y., Abdelrahman A.A., Abdallah H.Y., Ibrahim E.E.-D.A., Hashem H.R., Sayed A.A., Azab M.M. Role of MBL2 Polymorphisms in Sepsis and Survival: A Pilot Study and In Silico Analysis. Diagnostics. 2022;12:460. doi: 10.3390/diagnostics12020460.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020460</ArticleId><ArticleId IdType="pmc">PMC8871458</ArticleId><ArticleId IdType="pubmed">35204551</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Akira S. TLR signaling pathways. Semin. Immunol. 2004;16:3&#x2013;9. doi: 10.1016/j.smim.2003.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2003.10.003</ArticleId><ArticleId IdType="pubmed">14751757</ArticleId></ArticleIdList></Reference><Reference><Citation>Deller M.C., Kong L., Rupp B. Protein stability: A crystallographer&#x2019;s perspective. Pt 2Acta Cryst. Sect. F Struct. Biol. Commun. 2016;72:72&#x2013;95. doi: 10.1107/S2053230X15024619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S2053230X15024619</ArticleId><ArticleId IdType="pmc">PMC4741188</ArticleId><ArticleId IdType="pubmed">26841758</ArticleId></ArticleIdList></Reference><Reference><Citation>Berezin C., Glaser F., Rosenberg J., Paz I., Pupko T., Fariselli P., Casadio R., Ben-Tal N. ConSeq: The identification of functionally and structurally important residues in protein sequences. Bioinformatics. 2004;20:1322&#x2013;1324. doi: 10.1093/bioinformatics/bth070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bth070</ArticleId><ArticleId IdType="pubmed">14871869</ArticleId></ArticleIdList></Reference><Reference><Citation>Saleh M.A., Ramadan M.M., Arram E.O. Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis. APMIS. 2017;125:558&#x2013;564. doi: 10.1111/apm.12680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12680</ArticleId><ArticleId IdType="pubmed">28332241</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu F., Lu W., Qian Q., Qi W., Hu J., Feng B. Frequency of TLR 2, 4, and 9 gene polymorphisms in Chinese population and their susceptibility to type 2 diabetes and coronary artery disease. J. Biomed. Biotechnol. 2012;2012:373945. doi: 10.1155/2012/373945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/373945</ArticleId><ArticleId IdType="pmc">PMC3469311</ArticleId><ArticleId IdType="pubmed">23091345</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan X., Wu Y., Ye J., Ding Z., Qian C., Zhou A. Gene polymorphisms of Toll-like receptors in Chinese Han children with sepsis in Wenzhou. Zhonghua Er Ke Za Zhi = Chin. J. Pediatr. 2010;48:15&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">20441696</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzy M.S., Hussein M.H., Abdelaziz E.Z., Yamany H.A., Ismail H.M., Toraih E.A. Association of MicroRNA-196a2 Variant with Response to Short-Acting &#x3b2;2-Agonist in COPD: An Egyptian Pilot Study. PLoS ONE. 2016;11:e0152834. doi: 10.1371/journal.pone.0152834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152834</ArticleId><ArticleId IdType="pmc">PMC4820109</ArticleId><ArticleId IdType="pubmed">27043015</ArticleId></ArticleIdList></Reference><Reference><Citation>Tumangger H., Jamil K.F. Contribution of genes polymorphism to susceptibility and outcome of sepsis. Egypt. J. Med. Hum. Genet. 2010;11:97&#x2013;103. doi: 10.1016/j.ejmhg.2010.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmhg.2010.10.001</ArticleId></ArticleIdList></Reference><Reference><Citation>David V.L., Ercisli M.F., Rogobete A.F., Boia E.S., Horhat R., Nitu R., Diaconu M.M., Pirtea L., Ciuca I., Horhat D.I., et al. Early Prediction of Sepsis Incidence in Critically Ill Patients Using Specific Genetic Polymorphisms. Biochem. Genet. 2017;55:193&#x2013;203. doi: 10.1007/s10528-016-9785-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10528-016-9785-2</ArticleId><ArticleId IdType="pubmed">27943002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatzi M., Papanikolaou J., Makris D., Papathanasiou I., Tsezou A., Karvouniaris M., Zakynthinos E. Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece. J. Crit. Care. 2018;47:1&#x2013;8. doi: 10.1016/j.jcrc.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2018.05.012</ArticleId><ArticleId IdType="pubmed">29860039</ArticleId></ArticleIdList></Reference><Reference><Citation>March C., Regueiro V., Llobet E., Moranta D., Morey P., Garmendia J., Bengoechea J.A. Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS ONE. 2010;5:e10033. doi: 10.1371/journal.pone.0010033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0010033</ArticleId><ArticleId IdType="pmc">PMC2850920</ArticleId><ArticleId IdType="pubmed">20383325</ArticleId></ArticleIdList></Reference><Reference><Citation>Knapp S., Wieland C.W., Florquin S., Pantophlet R., Dijkshoorn L., Tshimbalanga N., Akira S., van der Poll T. Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia. Am. J. Respir. Crit. Care Med. 2006;173:122&#x2013;129. doi: 10.1164/rccm.200505-730OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200505-730OC</ArticleId><ArticleId IdType="pubmed">16210672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C.-H., Jeong Y.-J., Lee J., Jeon S.-J., Park S.-R., Kang M.-J., Park J.-H., Park J.-H. Essential role of toll-like receptor 4 in Acinetobacter baumannii-induced immune responses in immune cells. Microb. Pathog. 2013;54:20&#x2013;25. doi: 10.1016/j.micpath.2012.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2012.08.008</ArticleId><ArticleId IdType="pubmed">22982140</ArticleId></ArticleIdList></Reference><Reference><Citation>Erridge C., Moncayo-Nieto O.L., Morgan R., Young M., Poxton I.R. Acinetobacter baumannii lipopolysaccharides are potent stimulators of human monocyte activation via Toll-like receptor 4 signalling. J. Med. Microbiol. 2007;56 Pt 2:165&#x2013;171. doi: 10.1099/jmm.0.46823-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.46823-0</ArticleId><ArticleId IdType="pubmed">17244795</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch A., Hamann L., Schott M., Boehm O., Grotemeyer D., Kurt M., Schwenke C., Schumann R.R., Bornstein S.R., Zacharowski K. Genetic variation of TLR4 influences immunoendocrine stress response: An observational study in cardiac surgical patients. Crit. Care. 2011;15:R109. doi: 10.1186/cc10130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10130</ArticleId><ArticleId IdType="pmc">PMC3219387</ArticleId><ArticleId IdType="pubmed">21466684</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayr F.B., Yende S., Angus D.C. Epidemiology of severe sepsis. Virulence. 2014;5:4&#x2013;11. doi: 10.4161/viru.27372.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27372</ArticleId><ArticleId IdType="pmc">PMC3916382</ArticleId><ArticleId IdType="pubmed">24335434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong D.T., Gomez M., McGuire G.P., Kavanagh B. Utilization of intensive care unit days in a Canadian medical-surgical intensive care unit. Crit. Care Med. 1999;27:1319&#x2013;1324. doi: 10.1097/00003246-199907000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199907000-00020</ArticleId><ArticleId IdType="pubmed">10446826</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelha F.J., Castro M.A., Landeiro N.M., Neves A.M., Santos C.C. Mortality and length of stay in a surgical intensive care unit. Rev. Bras. Anestesiol. 2006;56:34&#x2013;45. doi: 10.1590/S0034-70942006000100005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0034-70942006000100005</ArticleId><ArticleId IdType="pubmed">19468548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim N.L., Kumar P., Hu J., Henikoff S., Schneider G., Ng P.C. SIFT web server: Predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40:W452&#x2013;W457. doi: 10.1093/nar/gks539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks539</ArticleId><ArticleId IdType="pmc">PMC3394338</ArticleId><ArticleId IdType="pubmed">22689647</ArticleId></ArticleIdList></Reference><Reference><Citation>Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods. 2010;7:248&#x2013;249. doi: 10.1038/nmeth0410-248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth0410-248</ArticleId><ArticleId IdType="pmc">PMC2855889</ArticleId><ArticleId IdType="pubmed">20354512</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang H., Thomas P.D. PANTHER-PSEP: Predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics. 2016;32:2230&#x2013;2232. doi: 10.1093/bioinformatics/btw222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw222</ArticleId><ArticleId IdType="pubmed">27193693</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y., Chan A.P. PROVEAN web server: A tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745&#x2013;2747. doi: 10.1093/bioinformatics/btv195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btv195</ArticleId><ArticleId IdType="pmc">PMC4528627</ArticleId><ArticleId IdType="pubmed">25851949</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E., Calabrese R., Fariselli P., Martelli P.L., Altman R.B., Casadio R. WS-SNPs&amp;GO: A web server for predicting the deleterious effect of human protein variants using functional annotation. BMC Genom. 2013;14((Suppl. S3)):S6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3665478</ArticleId><ArticleId IdType="pubmed">23819482</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum M., Chang H.Y., Chuguransky S., Grego T., Kandasaamy S., Mitchell A., Nuka G., Paysan-Lafosse T., Qureshi M., Raj S., et al. The InterPro protein families and domains database: 20 years on. Nucleic Acids Res. 2021;49:D344&#x2013;D354. doi: 10.1093/nar/gkaa977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa977</ArticleId><ArticleId IdType="pmc">PMC7778928</ArticleId><ArticleId IdType="pubmed">33156333</ArticleId></ArticleIdList></Reference><Reference><Citation>Capriotti E., Fariselli P., Casadio R. I-Mutant2.0: Predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33:W306&#x2013;W310. doi: 10.1093/nar/gki375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki375</ArticleId><ArticleId IdType="pmc">PMC1160136</ArticleId><ArticleId IdType="pubmed">15980478</ArticleId></ArticleIdList></Reference><Reference><Citation>Bava K.A., Gromiha M.M., Uedaira H., Kitajima K., Sarai A. ProTherm, version 4.0: Thermodynamic database for proteins and mutants. Nucleic Acids Res. 2004;32:D120&#x2013;D121. doi: 10.1093/nar/gkh082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkh082</ArticleId><ArticleId IdType="pmc">PMC308816</ArticleId><ArticleId IdType="pubmed">14681373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazy H., Abadi S., Martz E., Chay O., Mayrose I., Pupko T., Ben-Tal N. ConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 2016;44:W344&#x2013;W350. doi: 10.1093/nar/gkw408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw408</ArticleId><ArticleId IdType="pmc">PMC4987940</ArticleId><ArticleId IdType="pubmed">27166375</ArticleId></ArticleIdList></Reference><Reference><Citation>Venselaar H., Te Beek T.A., Kuipers R.K., Hekkelman M.L., Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinform. 2010;11:548. doi: 10.1186/1471-2105-11-548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-11-548</ArticleId><ArticleId IdType="pmc">PMC2992548</ArticleId><ArticleId IdType="pubmed">21059217</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31950146</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>22</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1442-2050</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>4</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus</Title><ISOAbbreviation>Dis Esophagus</ISOAbbreviation></Journal><ArticleTitle>Perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy: the first meta-analysis of randomized clinical trials.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">doz111</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/dote/doz111</ELocationID><Abstract><AbstractText>Although several randomized controlled trials have been published in recent years, the effect of perioperative immunonutrition in esophageal cancer (EC) patients remains unclear. This initial meta-analysis was conducted to assess whether perioperative enteral immunonutrition reduces postoperative complications in patients undergoing esophagectomy for EC. Relevant randomized controlled trials published before 1st September 2019 were retrieved from the Cochrane Library, PubMed, and EMBASE databases. After the literature was screened, two researchers extracted the information and data from eligible studies according to predefined selection criteria. Obtained data were pooled and analyzed by RevMan 5.3 software. The results were presented as risk ratios (RRs) with 95% confidence intervals (CIs). The heterogeneity among studies was tested by I2 test. Seven high-quality randomized controlled trials were included, with a total of 606 patients, 311 of whom received immunonutrition before and after surgery, while 295 received perioperative standard nutrition. No significant difference was observed between the two groups in the incidence of postoperative infection complications, including total infection complications (RR&#x2009;=&#x2009;0.97, CI: 0.78-1.20, P&#x2009;=&#xa0;0.76), pneumonia (RR&#x2009;=&#x2009;0.97, CI: 0.71-1.33, P&#x2009;=&#xa0;0.84), wound infection (RR&#x2009;=&#x2009;0.80, CI: 0.46-1.40, P&#x2009;=&#xa0;0.44), sepsis (RR&#x2009;=&#x2009;1.35, CI: 0.67-2.71, P&#x2009;=&#xa0;0.40), and urinary tract infection (RR&#x2009;=&#x2009;0.87, CI: 0.54-1.40, P&#x2009;=&#xa0;0.56). The prevalence of anastomotic leakage in the two groups was 9.4 and 5.4%, but the difference was not statistically significant (RR&#x2009;=&#x2009;0.59, CI: 0.33-1.04, P&#x2009;=&#xa0;0.07). Perioperative enteral immunonutrition provided no benefit in terms of the incidence of infection complications and anastomotic leakage in EC patients undergoing esophagectomy. Further large-scale randomized controlled trials are needed to confirm this conclusion.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mingliang</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>General Surgery Department, The First Affiliation Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhangyan</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Geriatric Medicine Department, The First Affiliation Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fangfang</LastName><ForeName>Fan</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Center for sleep and circadian neurobiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huizhen</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>General Surgery Department, The First Affiliation Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yongxiang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>General Surgery Department, The First Affiliation Hospital of Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Esophagus</MedlineTA><NlmUniqueID>8809160</NlmUniqueID><ISSNLinking>1120-8694</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004750" MajorTopicYN="N">Enteral Nutrition</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="N">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anastomotic leakage</Keyword><Keyword MajorTopicYN="N">esophageal cancer</Keyword><Keyword MajorTopicYN="N">esophagectomy</Keyword><Keyword MajorTopicYN="N">immunonutrition</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31950146</ArticleId><ArticleId IdType="doi">10.1093/dote/doz111</ArticleId><ArticleId IdType="pii">5707342</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28545914</PMID><DateCompleted><Year>2018</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1409</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2017</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Burns : journal of the International Society for Burn Injuries</Title><ISOAbbreviation>Burns</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and outcome analysis of sepsis and organ dysfunction/failure after burns.</ArticleTitle><Pagination><StartPage>1335</StartPage><EndPage>1347</EndPage><MedlinePgn>1335-1347</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.burns.2017.02.017</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0305-4179(17)30136-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The aim of this prospective study in adult population is to give frequency data (prevalence, incidence) of burn wound sepsis and its consequences (organ dysfunction/failure); to analyze the evolution of the SOFA cumulative score during the disease and relationship between the SOFA score in the 3rd, 7th, 14th and 21th day after burn with mortality.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A prospective cohort study was performed among adult patients (age &#x2265;20 years) admitted in the ICU, with major and moderate burns. Sepsis, organ dysfunction, organ failure and mortality were calculated as Cumulative Incidence (CI) and as Incidence rate (IR). Data from patients with sepsis were compared with those without sepsis. Evaluation of SOFA evolution was done with delta score and the influence of the SOFA score in mortality was calculated with AUC of the ROC curve.</AbstractText><AbstractText Label="RESULTS AND CONCLUSIONS" NlmCategory="CONCLUSIONS">Period prevalence of sepsis in our adult burned population was 26%. Incidence proportion as CI was 0.3 or 30 patients per 100 adults. Incidence rate (IR) was 6 patients with sepsis per 100 patient-years. Overall morbidity was 88.1% while overall mortality was 11.9%. Mortality in patients with sepsis was 34.4%. Incidence of MOD was 63% while incidence of MOF was 37%. Respective mortality as CI was 7% and 81% while mortality rate as IR was 1.4 per 100 patient-years in patients with MOD and 16.2 per 100 patient-years in patients with MOF. SOFA-3 should be considered a "reliable indicator" at separating survivors from non survivors and SOFA 7, 14, and 21 should be considered excellent in predicting mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Ltd and ISBI. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belba</LastName><ForeName>Monika Kristaq</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Surgery, Service of Burns and Plastic Surgery, Service of Anesthesiology, University Hospital Center "Mother Teresa", Tirana, Albania. Electronic address: piet_amy@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrela</LastName><ForeName>Elizana Ylber</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Public Health, Faculty of Medicine, University Hospital Center "Mother Teresa", Tirana, Albania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belba</LastName><ForeName>Amy Gjergji</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, KU Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Burns</MedlineTA><NlmUniqueID>8913178</NlmUniqueID><ISSNLinking>0305-4179</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burns</Keyword><Keyword MajorTopicYN="N">SOFA score</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28545914</ArticleId><ArticleId IdType="doi">10.1016/j.burns.2017.02.017</ArticleId><ArticleId IdType="pii">S0305-4179(17)30136-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38615549</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>298</Volume><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Sepsis and Septic Shock in Patients Undergoing Thyroidectomy: Incidence, Risk Factors, and Outcomes.</ArticleTitle><Pagination><StartPage>160</StartPage><EndPage>168</EndPage><MedlinePgn>160-168</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2024.03.021</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(24)00132-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Postoperative sepsis represents a rare complication following thyroidectomy. We aimed to explore the incidence, risk factors, sources, and outcomes of postoperative sepsis and septic shock among adult patients undergoing thyroidectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from the American College of Surgeons National Surgical Quality Improvement Program were used in this retrospective cohort study. Patients aged &#x2265;18&#xa0;y who underwent elective thyroidectomy between 2005 and 2019 were included. Multivariable binary logistic regression models were computed to explore risk factors and outcomes of 30-d sepsis and septic shock.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among the 180,373 included patients, 0.1% developed sepsis or septic shock. Male gender, low body mass index, American Society of Anesthesiologists classes 3-5, functional dependence, smoking, diabetes mellitus, pulmonary disease, inpatient surgery, malignant indication, clean-contaminated wound classification, and operation time &#x2265;150&#xa0;min were significant risk factors for development of sepsis or septic shock. Common infectious sources of sepsis included surgical site infections (29.6%), pneumonia (18.6%), urinary tract infections (16.2%), and multiple infections (6.9%). Patients with postoperative sepsis or septic shock were significantly more likely to develop complications, including wound disruption, stroke, cardiac and renal complications, thromboembolism, prolonged length of stay, unplanned reoperation, and mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Sepsis is rare following thyroidectomy. Our study provides insight into risk factors and procedural characteristics which may contribute to the development of postoperative sepsis or septic shock in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Waqar</LastName><ForeName>Usama</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan; Research Fellow, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio. Electronic address: usama.waqar@scholar.aku.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aziz</LastName><ForeName>Namrah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudhry</LastName><ForeName>Ahmad Areeb</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Medical College, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iftikhar</LastName><ForeName>Haissan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Epidemiology and Biostatistics, Fellow Rhinology and Skull Base, University Hospitals Birmingham, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jivani</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Surgical Clinical Reviewer, Department of Infection Prevention and Hospital Epidemiology, Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbas</LastName><ForeName>Syed Akbar</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Assistant Professor, Section of Otolaryngology, Head and Neck Surgery, Department of Surgery, Aga Khan University Hospital, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013965" MajorTopicYN="Y">Thyroidectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Thyroid</Keyword><Keyword MajorTopicYN="N">Thyroid surgery</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>2</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>14</Day><Hour>18</Hour><Minute>8</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38615549</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2024.03.021</ArticleId><ArticleId IdType="pii">S0022-4804(24)00132-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39214800</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Analysis of Perioperative Factors Leading to Postoperative Pulmonary Complications, Graft Injury and Increased Postoperative Mortality in Lung Transplantation.</ArticleTitle><Pagination><StartPage>2712</StartPage><EndPage>2721</EndPage><MedlinePgn>2712-2721</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2024.08.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(24)00521-4</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Postoperative complications such as postoperative pulmonary complications (PPCs) and other organ complications are associated with increased morbidity and mortality after successful lung transplantation and have a detrimental effect on patient recovery. The aim of this study was to investigate perioperative risk factors for in-hospital mortality and postoperative complications with a focus on PPC and graft injury in patients undergoing lung transplantation DESIGN: Single-center retrospective cohort study of 173 patients undergoing lung transplantation SETTING: University Hospital, Medical Center Freiburg.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">In the stepwise multivariate regression analysis, donor age &gt;60 years (odds ratio [OR], 1.85; 95% confidence interval [CI], 1.27-2.81), intraoperative extracorporeal membrane oxygenation (OR, 2.4; 95% CI, 1.7-3.3), transfusion of &gt;4 red blood cell concentrates (OR, 3.1; 95% CI, 1.82-5.1), mean pulmonary artery pressure of &gt;30 mmHg at the end of surgery (OR, 3.5; 95% CI, 2-6.3), the occurrence of postoperative graft injury (OR, 4.1; 95% CI, 2.8-5.9), PPCs (OR, 2.1; 95% CI, 1.7-2.6), sepsis (OR, 4.5; 95% CI, 2.8-7.3), and Kidney disease Improving Outcome grading system stage 3 acute renal failure (OR, 4.3; 95% CI, 2.4-7.7) were associated with increased in hospital mortality, whereas patients with chronic obstructive pulmonary disease had a lower in-hospital mortality (OR, 1.6; 95% CI, 1.4-1.9). The frequency and number of PPCs correlated with postoperative mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Clinical management and risk stratification focusing on the underlying identified factors that could help to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Axel</LastName><ForeName>Semmelmann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany. Electronic address: axel.semmelmann@uniklinik-freiburg.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moneke</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Autenrieth</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baar</LastName><ForeName>Wolfgang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loop</LastName><ForeName>Torsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care, Medical Center - University of Freiburg, Faculty of Medicine, Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016040" MajorTopicYN="Y">Lung Transplantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="N">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lung transplantation</Keyword><Keyword MajorTopicYN="N">anesthesia</Keyword><Keyword MajorTopicYN="N">anesthesia for lung transplantation</Keyword><Keyword MajorTopicYN="N">perioperative medicine</Keyword><Keyword MajorTopicYN="N">postoperative pulmonary complications</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>18</Day><Hour>0</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>30</Day><Hour>22</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39214800</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2024.08.002</ArticleId><ArticleId IdType="pii">S1053-0770(24)00521-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29217448</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1615-5947</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><PubDate><Year>2018</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of vascular surgery</Title><ISOAbbreviation>Ann Vasc Surg</ISOAbbreviation></Journal><ArticleTitle>Perioperative Outcomes after Regional Versus General Anesthesia for Above the Knee Amputations.</ArticleTitle><Pagination><StartPage>53</StartPage><EndPage>66</EndPage><MedlinePgn>53-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.avsg.2017.10.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0890-5096(17)31122-6</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nontraumatic lower extremity amputation (LEA) remains a common procedure among patients who frequently have significant comorbidities. Patients undergoing above knee amputation (AKA) have the highest rates of mortality in this cohort, yet there is little evidence to support selection between peripheral nerve block or neuraxial regional anesthesia (RA) versus general anesthesia (GA) techniques. The objective of this study was to determine whether RA (neuraxial or peripheral nerve block) techniques were associated with more favorable outcomes versus general anesthesia among patients undergoing AKA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study using propensity-matched groups. Patients undergoing AKA were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) data set and grouped according to anesthetic type as either RA or GA. Patients undergoing AKA with RA were propensity matched to similar patients who had GA. Primary outcome was 30-day mortality. Secondary outcomes were numerous and included cardiac, pulmonary, infectious, and bleeding complications, as well as length of stay. Among a subset of patients for whom readmission data were available, rate of readmission was compared as a secondary outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine thousand nine hundred ninety-nine patients were identified in the ACS-NSQIP database. One thousand three hundred twelve received a regional anesthetic, and the remainder had a general anesthetic. Factors significantly associated with GA included younger age (70 vs. 75&#xa0;years; P&#xa0;&lt;&#xa0;0.001), higher body mass index (26.5 vs. 25.4; P&#xa0;&lt;&#xa0;0.001), and ethnically white (62.4% vs. 57%; P&#xa0;&lt;&#xa0;0.001). Before matching, patients receiving RA were less likely to be smokers (22% vs. 29%; P&#xa0;&lt;&#xa0;0.001), have a bleeding disorder (15% vs 30%; P&#xa0;&lt;&#xa0;0.001), or have a diagnosis of sepsis (26% vs 34%; P&#xa0;&lt;&#xa0;0.001). Propensity score matching produced a cohort composed of 1,916 patients equally divided between RA and GA. We found no difference with respect to the primary end point of 30-day mortality (11.7% vs 11.7%; odds ratio [OR] 1.01; P&#xa0;=&#xa0;0.943) nor was there any difference with respect to secondary outcomes. Among patients for whom readmission data were available, there was no statistically significant difference between rates of readmission between the groups (15.6% for RA vs. 12.7% for GA; OR 1.26, confidence interval 0.87-1.828, P&#xa0;=&#xa0;0.221).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present investigation did not detect any difference between regional and general anesthetic with respect to morbidity or mortality among patients undergoing AKA. This data set did not allow us to address other relevant markers including pain control or phantom limb syndrome.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pisansky</LastName><ForeName>Andrew J B</ForeName><Initials>AJB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brovman</LastName><ForeName>Ethan Y</ForeName><Initials>EY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuo</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaye</LastName><ForeName>Alan D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Louisiana State University Health Sciences Center, New Orleans, LA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urman</LastName><ForeName>Richard D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Center for Perioperative Research, Brigham and Women's Hospital, Boston, MA. Electronic address: rurman@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Ann Vasc Surg</MedlineTA><NlmUniqueID>8703941</NlmUniqueID><ISSNLinking>0890-5096</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Ann Vasc Surg. 2018 Aug;51:330. doi: 10.1016/j.avsg.2018.02.043.</RefSource><PMID Version="1">29772333</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="Y">Amputation, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009407" MajorTopicYN="Y">Nerve Block</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058729" MajorTopicYN="N">Peripheral Arterial Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29217448</ArticleId><ArticleId IdType="doi">10.1016/j.avsg.2017.10.014</ArticleId><ArticleId IdType="pii">S0890-5096(17)31122-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21314352</PMID><DateCompleted><Year>2011</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1545-1550</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists</Title><ISOAbbreviation>J Endovasc Ther</ISOAbbreviation></Journal><ArticleTitle>Endovascular management of arterioenteric fistulas: a systemic review and meta-analysis of the literature.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>77</EndPage><MedlinePgn>66-77</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1583/10-3229.1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To present a systemic review and meta-analysis investigating the outcomes of endovascular management of arterioenteric fistula (AEF).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Literature review on AEF management with endovascular surgery using MEDLINE search, including two cases managed by the authors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-nine patients (50 men; mean age 68 years, range 23-90) were identified. AEF was successfully managed in 55 (93%) patients and 30-day mortality was 8.5% (5/59). During follow-up, 10 (19%) patients developed recurrent bleeding, which occurred more often in AEFs due to cancer. The freedom from recurrence rate at 12 and 24 months was 71.5%. Seventeen (32%) patients developed sepsis, which was managed conservatively in 8 (7 successful). Freedom from sepsis at 12 and 24 months was 64%, while the freedom from combined recurrence and sepsis at 12 and 24 months was 59%. Patients who did not have intestinal repair had a higher rate of combined recurrence and sepsis compared to patients who did; the freedom from combined recurrence and sepsis at 12 months was 52% for patients not having intestinal repair versus 100% in patients who did (p = 0.022). Total AEF-related mortality rates at 12 and 24 months were 15% and 19%, respectively, significantly worse when AEF recurred (p = 0.001). Overall survival rates at 12 and 24 months were 68% and 52%; prognosis was worse in patients with perioperative sepsis, large bowel fistulization, tube graft placement, no intestinal repair, and recurrent AEF.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Endovascular management of AEF can achieve satisfactory short and midterm results, better than those historically reported for open surgery, despite the high rate of recurrent bleeding and sepsis. Further investigation of the role played by intestinal repair is warranted.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kakkos</LastName><ForeName>Stavros K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Vascular Surgery, University Hospital of Patras, Rio, Patras Greece. kakkos@upatras.gr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadoulas</LastName><ForeName>Spyros</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Tsolakis</LastName><ForeName>Ioannis A</ForeName><Initials>IA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endovasc Ther</MedlineTA><NlmUniqueID>100896915</NlmUniqueID><ISSNLinking>1526-6028</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001018" MajorTopicYN="N">Aortic Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019917" MajorTopicYN="Y">Blood Vessel Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016009" MajorTopicYN="N">Chi-Square Distribution</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057510" MajorTopicYN="Y">Endovascular Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007412" MajorTopicYN="N">Intestinal Fistula</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016157" MajorTopicYN="N">Vascular Fistula</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21314352</ArticleId><ArticleId IdType="doi">10.1583/10-3229.1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36774318</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-7361</ISSN><JournalIssue CitedMedium="Internet"><Volume>173</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Surgery</Title><ISOAbbreviation>Surgery</ISOAbbreviation></Journal><ArticleTitle>Comparisons of coagulation characteristics between elderly and non-elderly patients with sepsis: A prospective study.</ArticleTitle><Pagination><StartPage>1303</StartPage><EndPage>1310</EndPage><MedlinePgn>1303-1310</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.surg.2023.01.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0039-6060(23)00002-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">A blunt host defense response in older patients may contribute to different coagulation responses during sepsis. We aimed to investigate the differences in coagulation parameters between elderly and non-elderly patients with sepsis.</AbstractText><AbstractText Label="METHODS">Adult patients diagnosed with sepsis within 24 hours after admission to the intensive care unit between September 2018 and December 2020 were prospectively enrolled. Patients were categorized into the adult (18-64 years) and elderly (age &#x2265;65 years) groups. Conventional coagulation parameters and inflammatory markers were measured on intensive care unit admission and on Days 3 and 7. Thromboelastography was performed on intensive care unit admission. The differences in the coagulation parameters between the 2 groups were evaluated. The adult and elderly patients were matched to adjust for baseline characteristics. Correlations between inflammatory markers and coagulation-related parameters were also analyzed.</AbstractText><AbstractText Label="RESULTS">Of the 567 patients, 303 (53.4%) were elderly. Compared with adult patients, elderly patients had lower prothrombin time elevation, lower fibrinogen, D-dimer, and fibrin/Fib degradation product levels, and lower proportion of disseminated intravascular coagulation on intensive care unit admission; and, they had lower dynamic platelet, lower fibrinogen, and D-dimer levels during the first week in the intensive care unit. Thromboelastography parameters were generally within the normal range, although elderly patients had lower R and K values and a higher alpha angle. Comparisons of coagulation parameters between the 2 groups revealed similar results in the matched cohort. The inflammatory markers correlated with prothrombin time, activated partial thromboplastin time, and antithrombin III.</AbstractText><AbstractText Label="CONCLUSION">Elderly patients had milder coagulation activation, accompanied by a decreased inflammatory response during sepsis, compared to non-elderly patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Chengrui</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Zhenzhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgical Intensive Care Unit, Beijing Chaoyang Hospital Affiliated to Capital Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Ran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Baosen</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yini</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhiliang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ding</LastName><ForeName>Renyu</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Zhenggang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Yingjian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Liang</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Xiaochun</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning Province, China. Electronic address: maxc_cmu@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Surgery</MedlineTA><NlmUniqueID>0417347</NlmUniqueID><ISSNLinking>0039-6060</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9001-32-5</RegistryNumber><NameOfSubstance UI="D005340">Fibrinogen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001780" MajorTopicYN="N">Blood Coagulation Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="Y">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005340" MajorTopicYN="N">Fibrinogen</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>11</Day><Hour>22</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36774318</ArticleId><ArticleId IdType="doi">10.1016/j.surg.2023.01.002</ArticleId><ArticleId IdType="pii">S0039-6060(23)00002-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38037809</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1437-4331</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>25</Day></PubDate></JournalIssue><Title>Clinical chemistry and laboratory medicine</Title><ISOAbbreviation>Clin Chem Lab Med</ISOAbbreviation></Journal><ArticleTitle>Thrombopoietin levels in sepsis and septic shock&#xa0;-&#xa0;a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>999</StartPage><EndPage>1010</EndPage><MedlinePgn>999-1010</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2023-0792</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Sepsis is a life-threatening condition implicating an inadequate activation of the immune system. Platelets act as modulators and contributors to immune processes. Indeed, altered platelet turnover, thrombotic events, and changes in thrombopoietin levels in systemic inflammation have been reported, but thrombopoietin-levels in sepsis and septic-shock have not yet been systematically evaluated. We therefore performed a meta-analysis of thrombopoietin (TPO)-levels in patients with sepsis.</AbstractText><AbstractText Label="METHODS">Two independent reviewers screened records and full-text articles for inclusion. Scientific databases were searched for studies examining thrombopoietin levels in adult sepsis and septic-shock patients until August 1st 2022.</AbstractText><AbstractText Label="RESULTS">Of 95 items screened, six studies met the inclusion criteria, including 598 subjects. Both sepsis and severe sepsis were associated with increased levels of thrombopoietin (sepsis vs. control: standardized mean difference 3.06, 95&#x202f;% CI 1.35-4.77; Z=3.50, p=0.0005) (sepsis vs. severe sepsis: standardized mean difference&#xa0;-1.67, 95&#x202f;% CI&#xa0;-2.46 to&#xa0;-0.88; Z=4.14, p&lt;0.0001). TPO-levels did not show significant differences between severe sepsis and septic shock patients but&#xa0;differed between sepsis and inflammation-associated non-septic controls. Overall, high heterogeneity and low sample size could be noted.</AbstractText><AbstractText Label="CONCLUSIONS">Concluding, increased levels of thrombopoietin appear to be present both in sepsis and severe sepsis with high heterogeneity but thrombopoietin does not allow to differentiate between severe sepsis and septic-shock. TPO may potentially serve to differentiate sepsis from non-septic trauma and/or tissue damage related (systemic) inflammation. Usage of different assays and high heterogeneity demand standardization of methods and further large multicenter trials.</AbstractText><CopyrightInformation>&#xa9; 2023 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, P.R. China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;rlich</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biostatistics and Clinical Research, University of M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowell</LastName><ForeName>Clifford A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Italiano</LastName><ForeName>Joseph E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Harvard Medical School and Vascular Biology Program, Boston Children's Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossaint</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bender</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Experimental Biomedicine&#xa0;- Chair I, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarbock</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margraf</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-6539-6478</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Biochemical Pharmacology, William Harvey Research Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Chem Lab Med</MedlineTA><NlmUniqueID>9806306</NlmUniqueID><ISSNLinking>1434-6621</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9014-42-0</RegistryNumber><NameOfSubstance UI="D013926">Thrombopoietin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013926" MajorTopicYN="N">Thrombopoietin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">thrombopoietin</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>1</Day><Hour>5</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38037809</ArticleId><ArticleId IdType="doi">10.1515/cclm-2023-0792</ArticleId><ArticleId IdType="pii">cclm-2023-0792</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Margraf, A, Ludwig, N, Zarbock, A, Rossaint, J. Systemic inflammatory response syndrome after surgery: mechanisms and protection. Anesth Analg 2020;131:1693&#x2013;707. https://doi.org/10.1213/ane.0000000000005175 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0000000000005175</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, L, Rhodes, A, Alhazzani, W, Antonelli, M, Coopersmith, CM, French, C, et al.. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47:1181&#x2013;247. https://doi.org/10.1007/s00134-021-06506-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Zarbock, A. Platelets in inflammation and resolution. J&#xa0;Immunol 2019;203:2357&#x2013;67. https://doi.org/10.4049/jimmunol.1900899 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900899</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Lowell, CA, Zarbock, A. Neutrophils in acute inflammation: current concepts and translational implications. Blood 2022;139:2130&#x2013;44. https://doi.org/10.1182/blood.2021012295 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2021012295</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaertner, F, Ahmad, Z, Rosenberger, G, Fan, S, Nicolai, L, Busch, B, et al.. Migrating platelets are mechano-scavengers that collect and bundle bacteria. Cell 2017;171:1368&#x2013;82 e23. https://doi.org/10.1016/j.cell.2017.11.001 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuchtriegel, G, Uhl, B, Puhr-Westerheide, D, Pornbacher, M, Lauber, K, Krombach, F, et al.. Platelets guide leukocytes to their sites of extravasation. PLoS Biol 2016;14:e1002459. https://doi.org/10.1371/journal.pbio.1002459 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1002459</ArticleId></ArticleIdList></Reference><Reference><Citation>Margraf, A, Zarbock, A. Platelets in inflammation and resolution. J&#xa0;Immunol 2019;203:2357&#x2013;67. https://doi.org/10.4049/jimmunol.1900899 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900899</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiery-Antier, N, Binquet, C, Vinault, S, Meziani, F, Boisrame-Helms, J, Quenot, JP, et al.. Is thrombocytopenia an early prognostic marker in septic shock? Crit Care Med 2016;44:764&#x2013;72. https://doi.org/10.1097/ccm.0000000000001520 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ccm.0000000000001520</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint, J, Kuhne, K, Skupski, J, Van Aken, H, Looney, MR, Hidalgo, A, et al.. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun 2016;7:13464. https://doi.org/10.1038/ncomms13464 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms13464</ArticleId></ArticleIdList></Reference><Reference><Citation>de Stoppelaar, SF, van&#x2019;t Veer, C, Claushuis, TA, Albersen, BJ, Roelofs, JJ, van der Poll, T. Thrombocytopenia impairs host defense in Gram-negative pneumonia-derived sepsis in mice. Blood 2014;124:3781&#x2013;90. https://doi.org/10.1182/blood-2014-05-573915 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-05-573915</ArticleId></ArticleIdList></Reference><Reference><Citation>Claushuis, TA, van Vught, LA, Scicluna, BP, Wiewel, MA, Klein Klouwenberg, PM, Hoogendijk, AJ, et al.. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 2016;127:3062&#x2013;72. https://doi.org/10.1182/blood-2015-11-680744 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2015-11-680744</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyama, K, Katayama, S, Muronoi, T, Tonai, K, Goto, Y, Koinuma, T, et al.. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PLoS One 2018;13:e0192064. https://doi.org/10.1371/journal.pone.0192064 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192064</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakey, S, Karamanos, E, Louwers, L, Kolbe, N, Killu, K, Horst, H, et al.. Thrombocytosis vs. thrombocytopenia as risk factor for increased mortality in sepsis. Crit Care Med 2013;41:A263. https://doi.org/10.1097/01.ccm.0000440283.47246.33 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000440283.47246.33</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, JZ, Xia, YP, Kuter, DJ. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia. Br J Haematol 2000;111:943&#x2013;53. https://doi.org/10.1046/j.1365-2141.2000.02430.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.2000.02430.x</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sauvage, FJ, Carver-Moore, K, Luoh, SM, Ryan, A, Dowd, M, Eaton, DL, et al.. Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med 1996;183:651&#x2013;6. https://doi.org/10.1084/jem.183.2.651 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.183.2.651</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney, AL, Carver-Moore, K, de Sauvage, FJ, Moore, MW. Thrombocytopenia in c-mpl-deficient mice. Science 1994;265:1445&#x2013;7. https://doi.org/10.1126/science.8073287 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8073287</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel, SR, Hartwig, JH, Italiano, JEJr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005;115:3348&#x2013;54. https://doi.org/10.1172/jci26891 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci26891</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballmaier, M, Holter, W, Germeshausen, M. Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias. Haematologica 2015;100:e341&#x2013;4. https://doi.org/10.3324/haematol.2015.125963 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3324/haematol.2015.125963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura, S, Nagasaki, M, Kunishima, S, Sawaguchi, A, Sakata, A, Sakaguchi, H, et al.. IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs. J Cell Biol 2015;209:453&#x2013;66. https://doi.org/10.1083/jcb.201410052 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201410052</ArticleId></ArticleIdList></Reference><Reference><Citation>Valet, C, Magnen, M, Qiu, L, Cleary, SJ, Wang, KM, Ranucci, S, et al.. Sepsis promotes splenic production of a protective platelet pool with high CD40 ligand expression. J Clin Invest 2022;132:e153920. https://doi.org/10.1172/jci153920 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci153920</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuccurullo, A, Greco, E, Lupia, E, De Giuli, P, Bosco, O, Martin-Conte, E, et al.. Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis. PLoS One 2016;11:e0151088. https://doi.org/10.1371/journal.pone.0151088 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151088</ArticleId></ArticleIdList></Reference><Reference><Citation>Barichello, T, Generoso, JS, Singer, M, Dal-Pizzol, F. Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review. Crit Care 2022;26:14. https://doi.org/10.1186/s13054-021-03862-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03862-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hozo, SP, Djulbegovic, B, Hozo, I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13. https://doi.org/10.1186/1471-2288-5-13 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins, JPT, Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions , 2nd ed. Hoboken, NJ: Wiley-Blackwell; 2020:pages cm.</Citation></Reference><Reference><Citation>Rossaint, J, Margraf, A, Zarbock, A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol 2018;9:2712. https://doi.org/10.3389/fimmu.2018.02712 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02712</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreeramkumar, V, Adrover, JM, Ballesteros, I, Cuartero, MI, Rossaint, J, Bilbao, I, et al.. Neutrophils scan for activated platelets to initiate inflammation. Science 2014;346:1234&#x2013;8. https://doi.org/10.1126/science.1256478 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256478</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmons, RV, Reid, DM, Cohen, RL, Meng, G, Young, NS, Dunbar, CE, et al.. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 1996;87:4068&#x2013;71. https://doi.org/10.1182/blood.v87.10.4068.bloodjournal87104068 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v87.10.4068.bloodjournal87104068</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmeister, KM. TPO-logy accepted. Blood 2018;132:555&#x2013;7. https://doi.org/10.1182/blood-2018-06-854935 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2018-06-854935</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, M, Li, J, Neves, MAD, Zhu, G, Carrim, N, Yu, R, et al.. GPIbalpha is required for platelet-mediated hepatic thrombopoietin generation. Blood 2018;132:622&#x2013;34. https://doi.org/10.1182/blood-2017-12-820779 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-12-820779</ArticleId></ArticleIdList></Reference><Reference><Citation>Baaten, C, Swieringa, F, Misztal, T, Mastenbroek, TG, Feijge, MAH, Bock, PE, et al.. Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects. Blood Adv 2018;2:2320&#x2013;31. https://doi.org/10.1182/bloodadvances.2017011544 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2017011544</ArticleId></ArticleIdList></Reference><Reference><Citation>Folman, CC, Linthorst, GE, van Mourik, J, van Willigen, G, de Jonge, E, Levi, M, et al.. Platelets release thrombopoietin (TPO) upon activation: another regulatory loop in thrombocytopoiesis? Thromb Haemostasis 2000;83:923&#x2013;30. https://doi.org/10.1055/s-0037-1613944 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1613944</ArticleId></ArticleIdList></Reference><Reference><Citation>Makar, RS, Zhukov, OS, Sahud, MA, Kuter, DJ. Thrombopoietin levels in patients with disorders of platelet production: diagnostic potential and utility in predicting response to TPO receptor agonists. Am J Hematol 2013;88:1041&#x2013;4. https://doi.org/10.1002/ajh.23562 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23562</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllister, SK, Bland, LA, Arduino, MJ, Aguero, SM, Wenger, PN, Jarvis, WR. Patient cytokine response in transfusion-associated sepsis. Infect Immun 1994;62:2126&#x2013;8. https://doi.org/10.1128/iai.62.5.2126-2128.1994 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.62.5.2126-2128.1994</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L, Zhao, H, Wang, D. Inflammatory cytokine expression in patients with sepsis at an intensive care unit. Exp Ther Med 2018;16:2126&#x2013;31. https://doi.org/10.3892/etm.2018.6376 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2018.6376</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderoff, RI, Kontor, KM, Heffernan, JK, Clarke, HJ, Garrison, LK, Kreilgaard, L, et al.. Aqueous stability of recombinant human thrombopoietin as a function of processing schemes. J Pharmaceut Sci 1996;85:749&#x2013;52. https://doi.org/10.1021/js950377g .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/js950377g</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato, T, Oda, A, Inagaki, Y, Ohashi, H, Matsumoto, A, Ozaki, K, et al.. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669&#x2013;74. https://doi.org/10.1073/pnas.94.9.4669 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.9.4669</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J, Xia, Y, Kuter, DJ. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Br J Haematol 1999;106:345&#x2013;56. https://doi.org/10.1046/j.1365-2141.1999.01571.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.1999.01571.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikawa, Y, Nishida, S, Kuroda, K, Kashiwagi, H, Tomiyama, Y, Kuwana, M. Development of an automated chemiluminescent enzyme immunoassay for measuring thrombopoietin in human plasma. Diagnostics 2022;12:313. https://doi.org/10.3390/diagnostics12020313 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12020313</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Bosco, O, Bergerone, S, Dondi, AE, Goffi, A, Oliaro, E, et al.. Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina. J Am Coll Cardiol 2006;48:2195&#x2013;203. https://doi.org/10.1016/j.jacc.2006.04.106 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2006.04.106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota, Y, Arai, T, Tanaka, T, Yamaoka, G, Kiuchi, H, Kajikawa, T, et al.. Thrombopoietin modulates platelet activation in&#xa0;vitro through protein-tyrosine phosphorylation. Stem Cells 1996;14:439&#x2013;44. https://doi.org/10.1002/stem.140439 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.140439</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Bosco, O, Mariano, F, Dondi, AE, Goffi, A, Spatola, T, et al.. Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation. J Thromb Haemostasis 2009;7:1000&#x2013;8. https://doi.org/10.1111/j.1538-7836.2009.03348.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03348.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorup, CV, Christensen, S, Hvas, AM. Immature platelets as a predictor of disease severity and mortality in sepsis and septic shock: a systematic review. Semin Thromb Hemost 2020;46:320&#x2013;7. https://doi.org/10.1055/s-0039-3400256 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-3400256</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss, LJ, Manukjan, G, Pflug, A, Winter, N, Weigel, M, Nagler, N, et al.. Acquired platelet GPVI receptor dysfunction in critically ill patients with sepsis. Blood 2021;137:3105&#x2013;15. https://doi.org/10.1182/blood.2020009774 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020009774</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceresa, IF, Noris, P, Ambaglio, C, Pecci, A, Balduini, CL. Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders. Platelets 2007;18:579&#x2013;82. https://doi.org/10.1080/09537100701593601 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537100701593601</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupia, E, Pigozzi, L, Pivetta, E, Bosco, O, Vizio, B, Loiacono, M, et al.. Thrombopoietin as early biomarker of disease severity in patients with acute pancreatitis. Pancreas 2017;46:164&#x2013;9. https://doi.org/10.1097/mpa.0000000000000752 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mpa.0000000000000752</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Z, Feng, T, Xie, Y, Huang, P, Xie, H, Tian, R, et al.. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial). BMC Infect Dis 2019;19:780. https://doi.org/10.1186/s12879-019-4388-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-019-4388-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakynthinos, SG, Papanikolaou, S, Theodoridis, T, Zakynthinos, EG, Christopoulou-Kokkinou, V, Katsaris, G, et al.. Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients. Crit Care Med 2004;32:1004&#x2013;10. https://doi.org/10.1097/01.ccm.0000121433.61546.a0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000121433.61546.a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Segre, E, Pigozzi, L, Lison, D, Pivetta, E, Bosco, O, Vizio, B, et al.. May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? Clin Chem Lab Med 2014;52:1479&#x2013;83. https://doi.org/10.1515/cclm-2014-0219 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2014-0219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu, M, Konishi, A, Nomura, S. Examination of biomarker expressions in sepsis-related DIC patients. Int J Gen Med 2018;11:353&#x2013;61. https://doi.org/10.2147/ijgm.s173684 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/ijgm.s173684</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, WH, Mo, LC, Shi, MH, Rao, H, Zhan, XY, Yang, M. Correlation between thrombopoietin and inflammatory factors, platelet indices, and thrombosis in patients with sepsis: a retrospective study. World J Clin Cases 2022;10:4072&#x2013;83. https://doi.org/10.12998/wjcc.v10.i13.4072 .</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i13.4072</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavranou, GA, Mentzelopoulos, S, Katsaounou, P, Siempos, I, Kalomenidis, I, Geranaki, A, et al.. Can coagulation system disorders and cytokine and inflammatory marker levels predict the temporary clinical deterioration or improvement of septic patients on ICU admission? J&#xa0;Clin Med 2021;10:1548. https://doi.org/10.3390/jcm10081548 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081548</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31679669</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1542-2224</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons</Title><ISOAbbreviation>J Foot Ankle Surg</ISOAbbreviation></Journal><ArticleTitle>Revision After Total Transmetatarsal Amputation.</ArticleTitle><Pagination><StartPage>1171</StartPage><EndPage>1176</EndPage><MedlinePgn>1171-1176</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jfas.2019.03.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1067-2516(19)30105-X</ELocationID><Abstract><AbstractText>Total transmetatarsal amputation (TMA) can be an option for foot salvage in gangrene, sepsis, or infected necrosis. However, the literature concerning predictive outcome factors and bacterial sampling is scarce. To identify potential associations between revision surgery and underlying bacteria or other preoperative selection criteria, we reviewed all patients with TMA who were treated at our institution. We compared the patients with remissions with surgical revisions. Among 96 adult patients with TMA (105 amputations), 42 required a revision surgery (40%), 18 had a further minor proximal surgical reamputation (17%) and 18 had a major proximal surgical reamputation (14%). In group comparisons, a previous infection with Staphylococcus aureus was protective with a lower revision risk (4/26 with revision surgery vs 22/26 without revisions; p&#x202f;=&#x202f;.03). This was the opposite for postoperative persistent soft tissue or bone infections (p &lt; .01) and delayed wound healing (p &lt; .01), which were positively associated with a revision risk. The American Society of Anesthesiologists Score, sex, age, body mass index, diabetes, polyneuropathy, chronic renal failure, dialysis, peripheral arterial disease, smoking status, and antibiotic regimen did not influence this revision risk. These results must be interpreted cautiously because no multiple variable calculations could be conducted as a result of the paucity of cases and confounding could not be evaluated sufficiently. TMA is an option to prevent major amputations, but it may be associated with a subsequent revision risk of 40% in adult patients. In our cohort study, persistent postamputation infection and delayed wound healing were associated with revision. However, no preoperative selection criteria were found that lead to revision surgery except for an infection with Staphylococcus aureus, which protected against revision surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 the American College of Foot and Ankle Surgeons. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Resident, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland. Electronic address: peter.kaiser@balgrist.ch.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xe4;ller</LastName><ForeName>Thomas Vincent</ForeName><Initials>TV</Initials><AffiliationInfo><Affiliation>Resident, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>U&#xe7;kay</LastName><ForeName>Ilker</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Head of Infectiology, Unit for Clinical and Applied Research, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Dominik</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Surgeon, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berli</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Surgeon, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xf6;ni</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Surgeon and Head of Technical Orthopedics, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waibel</LastName><ForeName>Felix</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Surgeon, Orthopedic Department, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Foot Ankle Surg</MedlineTA><NlmUniqueID>9308427</NlmUniqueID><ISSNLinking>1067-2516</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="Y">Amputation, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017719" MajorTopicYN="N">Diabetic Foot</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005528" MajorTopicYN="N">Foot</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016523" MajorTopicYN="N">Foot Ulcer</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005734" MajorTopicYN="N">Gangrene</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008682" MajorTopicYN="N">Metatarsal Bones</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010019" MajorTopicYN="N">Osteomyelitis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018461" MajorTopicYN="N">Soft Tissue Infections</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">antibiotic therapy</Keyword><Keyword MajorTopicYN="N">failure</Keyword><Keyword MajorTopicYN="N">forefoot amputation</Keyword><Keyword MajorTopicYN="N">outcome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>3</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31679669</ArticleId><ArticleId IdType="doi">10.1053/j.jfas.2019.03.015</ArticleId><ArticleId IdType="pii">S1067-2516(19)30105-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38211902</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Long-term survivability of surgical and nonsurgical management of spinal epidural abscess.</ArticleTitle><Pagination><StartPage>748</StartPage><EndPage>758</EndPage><MedlinePgn>748-758</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2023.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(24)00002-0</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Spinal epidural abscess (SEA) is a rare and life-threatening infection within the epidural space with significant functional impairment and morbidity. Active debate remains over whether to operate for SEAs, with limited existing data comparing the long-term survivability after surgical versus nonsurgical management.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aims to determine the long-term survival of patients who underwent surgical and nonsurgical management for SEA.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">A total of 250 consecutive SEA patients.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">Survival and mortality rates, complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All patients treated at a tertiary medical center for a primary SEA from January 2000 to June 2020 are identified. Data collection is by retrospective chart review. Cox proportional hazards regression models are used for all survival analyses while controlling for potential confounding variables and with multiple testing corrections.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 35 out of 250 patients died with an overall all-cause mortality of 14%. More than half of all deaths occurred within 90 days after treatment. The 90-day, 3-year, and 5-year survival rates are 92.8%, 89.2%, and 86.4%, respectively. Among surgery patients, the all-cause mortality was 13.07%, compared to 16.22% for medically-managed patients. Surgical treatment (decompression, fusion, debridement) significantly reduced the risk of death by 62.4% compared to medical therapy (p=.03), but surgery patients experienced a significantly longer mean length of stay (p=.01). Risk factors of short-term mortality included hypoalbuminemia (&lt;3.5 g/dL), American Society of Anesthesiologists (ASA) 4+, and cardiac arrest. Risk factors of long-term mortality were immunocompromised state, elevated WBC count &gt;12,000, sepsis, septic shock, ASA 4+, and cardiac arrest (p&lt;.05). In terms of complications, surgically-managed patients experienced a higher proportion of deep vein thrombosis (p&lt;.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The overall long-term survivability of SEA treatment is relatively high at (86% at 5-year) in this study. The following SEA mortality risk factors were identified: hypoalbuminemia (short-term), immunocompromised state (long-term), leukocytosis (long-term), sepsis and septic shock (long-term), ASA 4+ and cardiac arrest (overall). For primary SEA patients, surgical management may reduce mortality risk compared to nonsurgical management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Mingda</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA. Electronic address: Mingda.Chen@case.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baumann</LastName><ForeName>Anthony N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Northeast Ohio Medical University, 4209 State Route 44. Rootstown, OH 44272, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraiman</LastName><ForeName>Elad T</ForeName><Initials>ET</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheng</LastName><ForeName>Christina W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA; Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furey</LastName><ForeName>Christopher G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>School of Medicine, Case Western Reserve University, 9501 Euclid Ave, Cleveland, OH 44106, USA; Department of Orthopaedic Surgery, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="Y">Epidural Abscess</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Decompression</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Long-term</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Non-surgical</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Spinal epidural abscess</Keyword><Keyword MajorTopicYN="N">Surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38211902</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2023.12.008</ArticleId><ArticleId IdType="pii">S1529-9430(24)00002-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34120808</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Major head and neck surgeries in the elderly population, a match-control study.</ArticleTitle><Pagination><StartPage>1947</StartPage><EndPage>1952</EndPage><MedlinePgn>1947-1952</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2021.06.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(21)00571-0</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">To investigate complication rates in elderly cancer patients undergoing major head and neck surgeries.</AbstractText><AbstractText Label="METHODS">A retrospective, matched-control, analysis. For each elderly (&#x2265;70 years) patient, a younger, (&lt;70 years) patients were matched based on sex, tumor location, disease stage, and operation time. Post-operative complication and survival analyses were performed.</AbstractText><AbstractText Label="RESULTS">Of 225 patients, 75 (33.3%) were elderly (mean age 76.2 (70-88) years) and compared with a match control group (53.2 (23-69) years). A higher rate of cardio-vascular comorbidity was noted in the elderly group (70.6% vs. 34%, respectively, P&#xa0;&lt;&#xa0;0.001). The majority (62.7%) of elderly patients required reconstruction with 24% receiving vascularized flap reconstruction. Total postoperative complication rate was 49.9% in the study versus 42.3% in the control group, with a major complication rate of 22.5% in the elderly versus 11.9% in the control group (P&#xa0;=&#xa0;0.154). Mean follow-up was 41 (0-144) months. Five-year disease-specific (67.1% vs. 80.7%, P&#xa0;&lt;&#xa0;0.001) and overall survival rates (48.6% vs. 75.4%, P&#xa0;&lt;&#xa0;0.001) were significantly lower among elderly patients.</AbstractText><AbstractText Label="CONCLUSIONS">Major head and neck surgery in the elderly population does not entail higher complication rate, compared with younger patients, and should be allowed when curative intent is feasible and patient's general condition allows.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tzelnick</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: tzelnicksharon@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mizrachi</LastName><ForeName>Aviram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shavit</LastName><ForeName>Sagit Stern</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ben-Ner</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reuven</LastName><ForeName>Yonathan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Bshara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shpitzer</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachar</LastName><ForeName>Gideon</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Head and Neck Surgery, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017577" MajorTopicYN="N">Cutaneous Fistula</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006258" MajorTopicYN="N">Head and Neck Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007511" MajorTopicYN="N">Ischemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007822" MajorTopicYN="N">Laryngeal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007825" MajorTopicYN="N">Laryngectomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009026" MajorTopicYN="Y">Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009062" MajorTopicYN="N">Mouth Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D037981" MajorTopicYN="Y">Neck Dissection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013517" MajorTopicYN="Y">Otorhinolaryngologic Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010608" MajorTopicYN="N">Pharyngeal Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010996" MajorTopicYN="N">Pleural Effusion</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019651" MajorTopicYN="Y">Plastic Surgery Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013524" MajorTopicYN="Y">Surgical Flaps</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Head and neck surgery</Keyword><Keyword MajorTopicYN="N">Survival</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34120808</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2021.06.009</ArticleId><ArticleId IdType="pii">S0748-7983(21)00571-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38730089</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2025</Year><Month>01</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1433-8726</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>10</Day></PubDate></JournalIssue><Title>World journal of urology</Title><ISOAbbreviation>World J Urol</ISOAbbreviation></Journal><ArticleTitle>Urosepsis 30-day mortality, morbidity, and their risk factors: SERPENS study, a prospective, observational multi-center study.</ArticleTitle><Pagination><StartPage>314</StartPage><MedlinePgn>314</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">314</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00345-024-04979-2</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To provide a descriptive report of mortality and morbidity in the first 30 days of diagnosis of urosepsis. Secondary aim is to identify risk factors of unfavourable outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Prospective observational multicentre cohort study conducted from September 2014 to November 2018 in European hospitals. Adult patients (&#x2265;&#x2009;18 years) diagnosed with acute urosepsis according to Sepsis-2 criteria with confirmed microbiological infection were included. Outcomes were classified in one of four health states: death, multiple organ failure, single organ failure, and recovery at day 30 from onset of urosepsis. Descriptive statistics and ordinal logistic regression analysis was performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three hundred and fifty four patients were recruited, and 30-day mortality rate was 2.8%, rising to 4.6% for severe sepsis. All patients who died had a SOFA score of&#x2009;&#x2265;&#x2009;2 at diagnosis. Upon initial diagnosis, 79% (n&#x2009;=&#x2009;281) of patients presented with OF. Within 30 days, an additional 5% developed OF, resulting in a total of 84% affected. Charlson score (OR 1.14 CI 1.01-1.28), patients with respiratory failure at baseline (OR 2.35, CI 1.32-4.21), ICU admission within the past 12 months (OR 2.05, CI 1.00-4.19), obstruction causative of urosepsis (OR 1.76, CI 1.02-3.05), urosepsis with multi-drug-resistant(MDR) pathogens (OR 2.01, CI 1.15-3.53), and SOFA baseline score&#x2009;&#x2265;&#x2009;2 (OR 2.74, CI 1.49-5.07) are significantly associated with day 30 outcomes (OF and death).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Impact of comorbidities and MDR pathogens on outcomes highlights the existence of a distinct group of patients who are prone to mortality and morbidity. These findings underscore the need for the development of pragmatic classifications to better assess the severity of UTIs and guide management strategies.</AbstractText><AbstractText Label="STUDY REGISTRATION" NlmCategory="BACKGROUND">Clinicaltrials.gov registration number NCT02380170.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tandogdu</LastName><ForeName>Zafer</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0002-5309-3656</Identifier><AffiliationInfo><Affiliation>University College London Hospitals, London, UK. drzafer@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Surgery and Interventional Science, University College London, Charles Bell Housr, London, UK. drzafer@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koves</LastName><ForeName>Bela</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>South Pest Teaching Hospital, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ristovski</LastName><ForeName>Slobodan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Clinic for Surgical Diseases "St. Naum Ohridski" Skopje, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balci</LastName><ForeName>Mustafa Bahadir Can</ForeName><Initials>MBC</Initials><AffiliationInfo><Affiliation>Gaziosmanpasa Taksim Teaching Hospital, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rennesund</LastName><ForeName>Kristin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Urology Department, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gravas</LastName><ForeName>Stavros</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nale</LastName><ForeName>DjordJe</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinic of Urology, University Clinical Center of Serbia, Faculty of Medicine, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina-Polo</LastName><ForeName>Jos&#xe9;</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario, 12 de Octubre imas12, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garab&#xe1;&#x161;ov&#xe1;</LastName><ForeName>M&#xe1;ria Kopilec</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Teaching Hospital Tren&#x10d;&#xed;n, Tren&#x10d;&#xed;n, Slovakia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costantini</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Ospedale Santa Maria della Misericordia di Perugia, Perigia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cano-Valasco</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital General Universitario Gregorio Mara&#xf1;&#xf3;n, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Glavinova</LastName><ForeName>Maja Sofronievska</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Surgical Clinic St. Naum Ohridski, Skopje, Republic of North Macedonia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruyere</LastName><ForeName>Franck</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Urology, CHRU Bretonneau, Tours, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perepanova</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>S.R. Institute of Urology, Moscow, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulchavenya</LastName><ForeName>Ekaterina</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Novosibirsk Research Institute of Tuberculosis, Novosibirsk, Russian Federation.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cek</LastName><ForeName>Mete</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Trakya University Medical School, Edirne, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wagenlehner</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Justus Liebig University, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Johansen</LastName><ForeName>Truls Erik Bjerklund</ForeName><Initials>TEB</Initials><AffiliationInfo><Affiliation>University of Oslo, Oslo, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Clinical Medicine, University of Aarhus, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>SERPENS Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02380170</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>World J Urol</MedlineTA><NlmUniqueID>8307716</NlmUniqueID><ISSNLinking>0724-4983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>World J Urol. 2024 Jun 19;42(1):380. doi: 10.1007/s00345-024-05093-z.</RefSource><PMID Version="1">38896145</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="Y">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotic resistance</Keyword><Keyword MajorTopicYN="N">Severe UTI</Keyword><Keyword MajorTopicYN="N">Urosepsis</Keyword></KeywordList><CoiStatement>Authors declare that they have no conflict of interest in keeping with the current research and manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>11</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>11</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>10</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38730089</ArticleId><ArticleId IdType="pmc">PMC11087335</ArticleId><ArticleId IdType="doi">10.1007/s00345-024-04979-2</ArticleId><ArticleId IdType="pii">10.1007/s00345-024-04979-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, Colombara DV, Ikuta KS, Kissoon N, Finfer S et al (2020) Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. The Lancet 395(10219):200&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A (2014) Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med 189(10):1204&#x2013;1213</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu V, Escobar GJ, Greene JD, Soule J, Whippy A, Angus DC, Iwashyna TJ (2014) Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312(1):90&#x2013;92</Citation><ArticleIdList><ArticleId IdType="pubmed">24838355</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49(11):e1063&#x2013;e1143</Citation><ArticleIdList><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE (2016) Sepsis: recognition, diagnosis and early management NG51. In: NICE (ed). UK: National Institute for Health and Care Excellence</Citation><ArticleIdList><ArticleId IdType="pubmed">32011837</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiani E, Donati A, Serafini G, Rinaldi L, Adrario E, Pelaia P, Busani S, Girardis M (2015) Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS ONE 10(5):e0125827</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422717</ArticleId><ArticleId IdType="pubmed">25946168</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC (2021) Antibiotic resistance threats in the United States, 2019. In: Prevention (ed). CfDCa</Citation></Reference><Reference><Citation>Madrazo M, L&#xf3;pez-Cruz I, Piles L, Vi&#xf1;ola S, Alberola J, Eiros JM, Artero A (2023) Risk factors and the impact of multidrug-resistant bacteria on community-acquired urinary sepsis. Microorganisms 11(5):1278</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10221993</ArticleId><ArticleId IdType="pubmed">37317252</ArticleId></ArticleIdList></Reference><Reference><Citation>Busani S, Serafini G, Mantovani E, Venturelli C, Giannella M, Viale P, Mussini C, Cossarizza A, Girardis M (2019) Mortality in patients with septic shock by multidrug resistant bacteria: risk factors and impact of sepsis treatments. J Intensive Care Med 34(1):48&#x2013;54</Citation><ArticleIdList><ArticleId IdType="pubmed">28100110</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, K&#xf6;ves B, Naber K, Perepanova T, Tenke P et al (2016) The global prevalence of infections in urology study: a long-term, worldwide surveillance study on urological infections. Pathogens (Basel, Switzerland) 5(1):10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4810131</ArticleId><ArticleId IdType="pubmed">26797640</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29(4):530&#x2013;538</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphries RM, Ambler J, Mitchell SL, Castanheira M, Dingle T, Hindler JA, Koeth L, Sei K, Development CM, Standardization Working Group of the Subcommittee on Antimicrobial Susceptibility T (2018) CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests. J Clin Microbiol 56(4):e01934-e11917</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5869819</ArticleId><ArticleId IdType="pubmed">29367292</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, MacGowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM et al (2013) EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 19(2):141&#x2013;160</Citation><ArticleIdList><ArticleId IdType="pubmed">22117544</ArticleId></ArticleIdList></Reference><Reference><Citation>Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268&#x2013;281</Citation><ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmbom M, Andersson M, Grabe M, Peeker R, Saudi A, Styrke J, Aljabery F (2022) Community-onset urosepsis: incidence and risk factors for 30-day mortality&#x2014;a retrospective cohort study. Scand J Urol 56(5&#x2013;6):414&#x2013;420</Citation><ArticleIdList><ArticleId IdType="pubmed">36127849</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuttevaer R, Boogers W, Brink A, Dijk WV, Steenwinkel JD, Schuit S, Verbon A, Lingsma H, Alsma J (2022) Predictive performance of comorbidity for 30-day and 1-year mortality in patients with bloodstream infection visiting the emergency department: a retrospective cohort study. BMJ Open 12(4):e057196</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8987751</ArticleId><ArticleId IdType="pubmed">35387824</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozyrakis D, Kratiras Z, Soukias G, Chatzistamou SE, Zarkadas A, Perikleous S, Kateris D, Katsaros I, Skriapas K, Karagiannis D (2020) Clinical outcome and prognostic factors of sepsis, septic shock and prolonged hospitalization, of patients presented with acute obstructive pyelonephritis. J Endourol 34(4):516&#x2013;522</Citation><ArticleIdList><ArticleId IdType="pubmed">32000528</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinel I, Dellinger RP (2007) Advances in pathogenesis and management of sepsis. Curr Opin Infect Dis 20(4):345&#x2013;352</Citation><ArticleIdList><ArticleId IdType="pubmed">17609592</ArticleId></ArticleIdList></Reference><Reference><Citation>REMAP-CAP Investigators (2021) Interleukin-6 receptor antagonists in critically ill patients with Covid-19. N Engl J Med 384(16):1491&#x2013;1502</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7953461</ArticleId><ArticleId IdType="pubmed">33631065</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">37369141</PMID><DateRevised><Year>2023</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2325-6621</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Annals of the American Thoracic Society</Title><ISOAbbreviation>Ann Am Thorac Soc</ISOAbbreviation></Journal><ArticleTitle>Impact of Vasodilator Administration on Survival in Patients with Sepsis: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1345</StartPage><EndPage>1352</EndPage><MedlinePgn>1345-1352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1513/AnnalsATS.202303-205OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Sepsis and septic shock are associated with microcirculatory dysfunction, which is believed to contribute to sepsis-induced organ failure. Vasodilators have been proposed to improve tissue perfusion in sepsis, but the overall survival impact of this strategy is unclear. <b>Objectives:</b> To evaluate the impact of systemic vasodilator administration in patients with sepsis and septic shock on mortality. <b>Methods:</b> We conducted a meta-analysis using a random effects model. Published and unpublished randomized trials in adult patients with sepsis and septic shock were included when comparing the use of systemic vasodilators against no vasodilators. The primary outcome was 28-30-day mortality, and secondary outcomes were organ function and resource use measures. <b>Results:</b> We included eight randomized trials (1,076 patients). In patients randomized to vasodilator arms compared with those randomized to treatment without vasodilators, the 28-30-day mortality risk ratio was 0.74 (95% confidence interval, 0.54-1.01). In a chronological cumulative meta-analysis, the association between vasodilators and survival improved over time. In a prespecified subgroup analysis in 104 patients in two randomized trials, prostacyclin analogues were associated with a decreased rate of 28-30-day mortality among patients with sepsis and septic shock (risk ratio, 0.46; 95% confidence interval, 0.25-0.85). <b>Conclusions:</b> In patients with sepsis and septic shock, administration of vasodilators is not associated with decreased 28-30-day mortality, but the confidence interval suggests potential benefit, and the meta-analysis might lack power. Prostacyclin appears the most promising. The results of this meta-analysis should encourage randomized trials evaluating the impact of vasodilators on mortality in sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mavrothalassitis</LastName><ForeName>Orestes Y</ForeName><Initials>OY</Initials><Identifier Source="ORCID">0000-0002-2301-9682</Identifier><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Isabel E</ForeName><Initials>IE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lazzareschi</LastName><ForeName>Daniel V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahir</LastName><ForeName>Peggy</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>UCSF Library, University of California, San Francisco, San Francisco, California; and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Legrand</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9788-5316</Identifier><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Anesthesia and Perioperative Care.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT) Network, Nancy, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Am Thorac Soc</MedlineTA><NlmUniqueID>101600811</NlmUniqueID><ISSNLinking>2325-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dobutamine</Keyword><Keyword MajorTopicYN="N">microcirculation</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prostacyclin</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>19</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>27</Day><Hour>17</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37369141</ArticleId><ArticleId IdType="doi">10.1513/AnnalsATS.202303-205OC</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34184576</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1489</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of intensive care medicine</Title><ISOAbbreviation>J Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Early Lactate-Guided Resuscitation of Elderly Septic Patients.</ArticleTitle><Pagination><StartPage>686</StartPage><EndPage>692</EndPage><MedlinePgn>686-692</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/08850666211023347</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early lactate-guided resuscitation was endorsed in the guidelines of the Surviving Sepsis Campaign as a key strategy to decrease the mortality of patients admitted to the ICU department with septic shock. However, its effectiveness in elderly Asian patients is uncertain.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We conducted a single-center trial to test the effectiveness of the early lactate-guided resuscitation of older Asian patients at the Second Hospital of Hebei Medical University. Eligible septic shock patients who consented to participation in the study were randomly assigned to receive early lactate-guided treatment or regular treatment as controls.</AbstractText><AbstractText Label="RESULT" NlmCategory="RESULTS">A total of 82 patients met the hyperlactatemia criteria and participated in the trial. Forty-two patients received early lactate-guided treatment (lactate group) and 40 received regular treatment (control group). The lactate group received more fluids at initial 6 hours (3.3 &#xb1; 1.4 vs 2.4 &#xb1; 1.7 L, <i>P</i> = 0.01), but similar proportions of patients in both groups required the use of vasopressors and vasodilators. Patients in the lactate group showed significantly reduced ICU needs compared to the control group, which were weaned from mechanical ventilation more quickly (median 7, IQR 4 to 14 vs median 9, IQR 4.3 to 17.8, <i>P</i> = 0.02) and transferred out of the ICU earlier (median 4.5, IQR 2.8 to 7.3 vs median 6, IQR 3.2 to 8, <i>P</i> = 0.01). However, the hospital mortality (35.7% vs 42.5%, <i>P</i> = 0.35) and ICU mortality (31.0% vs 37.5%, <i>P</i> = 0.38) for both groups were not reduced.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">For critically ill patients (elderly Asian patients) admitted to the ICU department with hyperlactatemia, early lactate-guided treatment reduced ICU needs but did not reduce mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, 71213The Second Hospital of Hebei Medical University, Hebei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Jiangqing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, 71213The Second Hospital of Hebei Medical University, Hebei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Unit, 71213The Second Hospital of Hebei Medical University, Hebei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yaxuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Urology Surgery, 71213The Second Hospital of Hebei Medical University, Hebei Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tong</LastName><ForeName>Fei</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-2394-0009</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care Unit, 71213The Second Hospital of Hebei Medical University, Hebei Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Intensive Care Med</MedlineTA><NlmUniqueID>8610344</NlmUniqueID><ISSNLinking>0885-0666</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065906" MajorTopicYN="Y">Hyperlactatemia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Asian</Keyword><Keyword MajorTopicYN="N">lactate</Keyword><Keyword MajorTopicYN="N">older</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>29</Day><Hour>8</Hour><Minute>47</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34184576</ArticleId><ArticleId IdType="doi">10.1177/08850666211023347</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37399014</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>JAMA network open</Title><ISOAbbreviation>JAMA Netw Open</ISOAbbreviation></Journal><ArticleTitle>Frailty and Outcomes Following Cardiopulmonary Resuscitation for Perioperative Cardiac Arrest.</ArticleTitle><Pagination><StartPage>e2321465</StartPage><MedlinePgn>e2321465</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2321465</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2023.21465</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Frailty is associated with mortality following surgery and cardiopulmonary resuscitation (CPR) for in-hospital cardiac arrest. Despite the growing focus on frailty as a basis for preoperative risk stratification and concern that CPR in patients with frailty may border on futility, the association between frailty and outcomes following perioperative CPR is unknown.</AbstractText><AbstractText Label="OBJECTIVE">To determine the association between frailty and outcomes following perioperative CPR.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This longitudinal cohort study of patients used the American College of Surgeons National Surgical Quality Improvement Program, including more than 700 participating hospitals in the US, from January 1, 2015, through December 31, 2020. Follow-up duration was 30 days. Patients 50 years or older undergoing noncardiac surgery who received CPR on postoperative day 0 were included; patients were excluded if data required to determine frailty, establish outcome, or perform multivariable analyses were missing. Data were analyzed from September 1, 2022, through January 30, 2023.</AbstractText><AbstractText Label="EXPOSURES">Frailty defined as Risk Analysis Index (RAI) of 40 or greater vs less than 40.</AbstractText><AbstractText Label="OUTCOMES AND MEASURES">Thirty-day mortality and nonhome discharge.</AbstractText><AbstractText Label="RESULTS">Among the 3149 patients included in the analysis, the median age was 71 (IQR, 63-79) years, 1709 (55.9%) were men, and 2117 (69.2%) were White. Mean (SD) RAI was 37.73 (6.18), and 792 patients (25.9%) had an RAI of 40 or greater, of whom 534 (67.4%) died within 30 days of surgery. Multivariable logistic regression adjusting for race, American Society of Anesthesiologists physical status, sepsis, and emergency surgery demonstrated a positive association between frailty and mortality (adjusted odds ratio [AOR], 1.35 [95% CI, 1.11-1.65]; P&#x2009;=&#x2009;.003). Spline regression analysis demonstrated steadily increasing probability of mortality and nonhome discharge with increasing RAI above 37 and 36, respectively. Association between frailty and mortality following CPR varied by procedure urgency (AOR for nonemergent procedures, 1.55 [95% CI, 1.23-1.97]; AOR for emergent procedures, 0.97 [95% CI, 0.68-1.37]; P&#x2009;=&#x2009;.03 for interaction). An RAI of 40 or greater was associated with increased odds of nonhome discharge compared with an RAI of less than 40 (AOR, 1.85 [95% CI, 1.31-2.62]; P&#x2009;&lt;&#x2009;.001).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">The findings of this cohort study suggest that although roughly 1 in 3 patients with an RAI of 40 or greater survived at least 30 days following perioperative CPR, higher frailty burden was associated with increased mortality and greater risk of nonhome discharge among survivors. Identifying patients who are undergoing surgery and have frailty may inform primary prevention strategies, guide shared decision-making regarding perioperative CPR, and promote goal-concordant surgical care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Allen</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orkaby</LastName><ForeName>Ariela R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>New England Geriatric Research, Education, and Clinical Center (GRECC), Veterans Affairs Boston Healthcare System, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Aging, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Justice</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Equity Research and Promotion, Veteran Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>GRECC, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Frances Y</ForeName><Initials>FY</Initials><AffiliationInfo><Affiliation>Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cooper</LastName><ForeName>Zara</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bernacki</LastName><ForeName>Rachelle E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bader</LastName><ForeName>Angela M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA Netw Open</MedlineTA><NlmUniqueID>101729235</NlmUniqueID><ISSNLinking>2574-3805</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="Y">Heart Arrest</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="Y">Cardiopulmonary Resuscitation</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Orkaby reported receiving grant funding from the US Department of Veterans Affairs and National Institutes of Health (NIH), unrelated to this work, and a consulting relationship with Anthos Therapeutics. Dr Hall reported receiving grant funding from the NIH and the Veterans Health Administration Office of Research and Development and consulting for FutureAssure LLC, outside the submitted work. No other disclosures were reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>13</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>3</Day><Hour>11</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37399014</ArticleId><ArticleId IdType="pmc">PMC10318473</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.21465</ArticleId><ArticleId IdType="pii">2806836</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Etzioni DA, Liu JH, Maggard MA, Ko CY. The aging population and its impact on the surgery workforce. Ann Surg. 2003;238(2):170-177. doi:10.1097/01.SLA.0000081085.98792.3d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.SLA.0000081085.98792.3d</ArticleId><ArticleId IdType="pmc">PMC1422682</ArticleId><ArticleId IdType="pubmed">12894008</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons . Geriatric surgery verification program. Accessed April 3, 2021. http://www.facs.org/quality-programs/accreditation-and-verification/geriatric-surgery-verification/</Citation><ArticleIdList><ArticleId IdType="pubmed">33184851</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow WB, Rosenthal RA, Merkow RP, Ko CY, Esnaola NF; American College of Surgeons National Surgical Quality Improvement Program; American Geriatrics Society . Optimal preoperative assessment of the geriatric surgical patient: a best practices guideline from the American College of Surgeons National Surgical Quality Improvement Program and the American Geriatrics Society. J Am Coll Surg. 2012;215(4):453-466. doi:10.1016/j.jamcollsurg.2012.06.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2012.06.017</ArticleId><ArticleId IdType="pubmed">22917646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty S, Rosenthal RA, Russell MM, Neuman MD, Ko CY, Esnaola NF. Optimal perioperative management of the geriatric patient: a best practices guideline from the American College of Surgeons NSQIP and the American Geriatrics Society. J Am Coll Surg. 2016;222(5):930-947. doi:10.1016/j.jamcollsurg.2015.12.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2015.12.026</ArticleId><ArticleId IdType="pubmed">27049783</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunnally ME, O&#x2019;Connor MF, Kordylewski H, Westlake B, Dutton RP. The incidence and risk factors for perioperative cardiac arrest observed in the National Anesthesia Clinical Outcomes Registry. Anesth Analg. 2015;120(2):364-370. doi:10.1213/ANE.0000000000000527</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000527</ArticleId><ArticleId IdType="pubmed">25390278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, O&#x2019;Reilly M, Englesbe MJ, et al. . Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology. 2009;110(1):58-66. doi:10.1097/ALN.0b013e318190b6dc</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318190b6dc</ArticleId><ArticleId IdType="pubmed">19104171</ArticleId></ArticleIdList></Reference><Reference><Citation>Goswami S, Brady JE, Jordan DA, Li G. Intraoperative cardiac arrests in adults undergoing noncardiac surgery: incidence, risk factors, and survival outcome. Anesthesiology. 2012;117(5):1018-1026. doi:10.1097/ALN.0b013e31827005e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e31827005e9</ArticleId><ArticleId IdType="pubmed">23042223</ArticleId></ArticleIdList></Reference><Reference><Citation>Fielding-Singh V, Willingham MD, Fischer MA, Grogan T, Benharash P, Neelankavil JP. A population-based analysis of intraoperative cardiac arrest in the United States. Anesth Analg. 2020;130(3):627-634. doi:10.1213/ANE.0000000000004477</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000004477</ArticleId><ArticleId IdType="pubmed">31651456</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JC, Braz JR, Oliveira TS, de Carvalho LR, Castiglia YM, Braz LG. Intraoperative and anesthesia-related cardiac arrest and its mortality in older patients: a 15-year survey in a tertiary teaching hospital. PLoS One. 2014;9(8):e104041. doi:10.1371/journal.pone.0104041</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0104041</ArticleId><ArticleId IdType="pmc">PMC4130522</ArticleId><ArticleId IdType="pubmed">25117481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalkman S, Hooft L, Meijerman JM, Knape JT, van Delden JJ. Survival after perioperative cardiopulmonary resuscitation: providing an evidence base for ethical management of do-not-resuscitate orders. Anesthesiology. 2016;124(3):723-729. doi:10.1097/ALN.0000000000000873</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000873</ArticleId><ArticleId IdType="pubmed">26418698</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen LW, Holmberg MJ, Berg KM, Donnino MW, Granfeldt A. In-hospital cardiac arrest: a review. JAMA. 2019;321(12):1200-1210. doi:10.1001/jama.2019.1696</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.1696</ArticleId><ArticleId IdType="pmc">PMC6482460</ArticleId><ArticleId IdType="pubmed">30912843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran SK, Mhyre J, Kheterpal S, et al. ; American Heart Association&#x2019;s Get With The Guidelines-Resuscitation Investigators . Predictors of survival from perioperative cardiopulmonary arrests: a retrospective analysis of 2524 events from the Get With The Guidelines-Resuscitation registry. Anesthesiology. 2013;119(6):1322-1339. doi:10.1097/ALN.0b013e318289bafe</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e318289bafe</ArticleId><ArticleId IdType="pmc">PMC3797152</ArticleId><ArticleId IdType="pubmed">23838723</ArticleId></ArticleIdList></Reference><Reference><Citation>Constant AL, Montlahuc C, Grimaldi D, et al. . Predictors of functional outcome after intraoperative cardiac arrest. Anesthesiology. 2014;121(3):482-491. doi:10.1097/ALN.0000000000000313</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000000313</ArticleId><ArticleId IdType="pubmed">24841698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser HA, Saied NN, Kokoefer AS, Saffour L, Zoller JK, Helwani MA. Incidence and prediction of intraoperative and postoperative cardiac arrest requiring cardiopulmonary resuscitation and 30-day mortality in non-cardiac surgical patients. PLoS One. 2020;15(1):e0225939. doi:10.1371/journal.pone.0225939</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0225939</ArticleId><ArticleId IdType="pmc">PMC6975552</ArticleId><ArticleId IdType="pubmed">31967987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazaure HS, Roman SA, Rosenthal RA, Sosa JA. Cardiac arrest among surgical patients: an analysis of incidence, patient characteristics, and outcomes in ACS-NSQIP. JAMA Surg. 2013;148(1):14-21. doi:10.1001/jamasurg.2013.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2013.671</ArticleId><ArticleId IdType="pubmed">23324834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, et al. ; Cardiovascular Health Study Collaborative Research Group . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156. doi:10.1093/gerona/56.3.M146</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/56.3.M146</ArticleId><ArticleId IdType="pubmed">11253156</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Ferrucci L, Darer J, Williamson JD, Anderson G. Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. J Gerontol A Biol Sci Med Sci. 2004;59(3):255-263. doi:10.1093/gerona/59.3.M255</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/59.3.M255</ArticleId><ArticleId IdType="pubmed">15031310</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Mitnitski A. Frailty defined by deficit accumulation and geriatric medicine defined by frailty. Clin Geriatr Med. 2011;27(1):17-26. doi:10.1016/j.cger.2010.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2010.08.008</ArticleId><ArticleId IdType="pubmed">21093719</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Bryson GL, van Walraven C. Association of frailty and 1-year postoperative mortality following major elective noncardiac surgery: a population-based cohort study. JAMA Surg. 2016;151(6):538-545. doi:10.1001/jamasurg.2015.5085</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2015.5085</ArticleId><ArticleId IdType="pubmed">26791334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall DE, Arya S, Schmid KK, et al. . Association of a frailty screening initiative with postoperative survival at 30, 180, and 365 days. JAMA Surg. 2017;152(3):233-240. doi:10.1001/jamasurg.2016.4219</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4219</ArticleId><ArticleId IdType="pmc">PMC7180387</ArticleId><ArticleId IdType="pubmed">27902826</ArticleId></ArticleIdList></Reference><Reference><Citation>Seib CD, Rochefort H, Chomsky-Higgins K, et al. . Association of patient frailty with increased morbidity after common ambulatory general surgery operations. JAMA Surg. 2018;153(2):160-168. doi:10.1001/jamasurg.2017.4007</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.4007</ArticleId><ArticleId IdType="pmc">PMC5838594</ArticleId><ArticleId IdType="pubmed">29049457</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R, Attwood K, Arya S, et al. . Association of frailty with failure to rescue after low-risk and high-risk inpatient surgery. JAMA Surg. 2018;153(5):e180214. doi:10.1001/jamasurg.2018.0214</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2018.0214</ArticleId><ArticleId IdType="pmc">PMC5875343</ArticleId><ArticleId IdType="pubmed">29562073</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Taljaard M, Bryson GL, et al. . Frailty as a predictor of death or new disability after surgery: a prospective cohort study. Ann Surg. 2020;271(2):283-289. doi:10.1097/SLA.0000000000002967</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002967</ArticleId><ArticleId IdType="pubmed">30048320</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinall MC Jr, Arya S, Youk A, et al. . Association of preoperative patient frailty and operative stress with postoperative mortality. JAMA Surg. 2020;155(1):e194620. doi:10.1001/jamasurg.2019.4620</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.4620</ArticleId><ArticleId IdType="pmc">PMC6865246</ArticleId><ArticleId IdType="pubmed">31721994</ArticleId></ArticleIdList></Reference><Reference><Citation>George EL, Hall DE, Youk A, et al. . Association between patient frailty and postoperative mortality across multiple noncardiac surgical specialties. JAMA Surg. 2021;156(1):e205152. doi:10.1001/jamasurg.2020.5152</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2020.5152</ArticleId><ArticleId IdType="pmc">PMC7675216</ArticleId><ArticleId IdType="pubmed">33206156</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Angeles M, Cooper Z, Jarman MP, Sturgeon D, Salim A, Havens JM. Association of frailty with morbidity and mortality in emergency general surgery by procedural risk level. JAMA Surg. 2021;156(1):68-74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7689563</ArticleId><ArticleId IdType="pubmed">33237323</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill TM, Vander Wyk B, Leo-Summers L, Murphy TE, Becher RD. Population-based estimates of 1-year mortality after major surgery among community-living older US adults. JAMA Surg. 2022;157(12):e225155. doi:10.1001/jamasurg.2022.5155</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2022.5155</ArticleId><ArticleId IdType="pmc">PMC9582971</ArticleId><ArticleId IdType="pubmed">36260323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mowbray FI, Manlongat D, Correia RH, et al. . Prognostic association of frailty with post-arrest outcomes following cardiac arrest: a systematic review and meta-analysis. Resuscitation. 2021;167:242-250. doi:10.1016/j.resuscitation.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2021.06.009</ArticleId><ArticleId IdType="pubmed">34166743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamlyn J, Lowry C, Jackson TA, Welch C. Outcomes in adults living with frailty receiving cardiopulmonary resuscitation: a systematic review and meta-analysis. Resusc Plus. 2022;11:100266. doi:10.1016/j.resplu.2022.100266</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resplu.2022.100266</ArticleId><ArticleId IdType="pmc">PMC9256816</ArticleId><ArticleId IdType="pubmed">35812717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibitoye SE, Rawlinson S, Cavanagh A, Phillips V, Shipway DJH. Frailty status predicts futility of cardiopulmonary resuscitation in older adults. Age Ageing. 2021;50(1):147-152. doi:10.1093/ageing/afaa104</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afaa104</ArticleId><ArticleId IdType="pubmed">32500916</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu FY, Streiter S, O&#x2019;Mara L, et al. . Frailty and survival after in-hospital cardiopulmonary resuscitation. J Gen Intern Med. 2022;37(14):3554-3561. doi:10.1007/s11606-021-07199-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07199-1</ArticleId><ArticleId IdType="pmc">PMC9585129</ArticleId><ArticleId IdType="pubmed">34981346</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper L, Abbett SK, Feng A, et al. . Launching a geriatric surgery center: recommendations from the Society for Perioperative Assessment and Quality Improvement. J Am Geriatr Soc. 2020;68(9):1941-1946. doi:10.1111/jgs.16681</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16681</ArticleId><ArticleId IdType="pubmed">32662064</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucoin SD, Hao M, Sohi R, et al. . Accuracy and feasibility of clinically applied frailty instruments before surgery: a systematic review and meta-analysis. Anesthesiology. 2020;133(1):78-95. doi:10.1097/ALN.0000000000003257</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003257</ArticleId><ArticleId IdType="pubmed">32243326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dj&#xe4;rv T. Should we resuscitate the frail? Resuscitation. 2019;143:225-227. doi:10.1016/j.resuscitation.2019.08.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2019.08.019</ArticleId><ArticleId IdType="pubmed">31446155</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried TR, Bradley EH, Towle VR, Allore H. Understanding the treatment preferences of seriously ill patients. N Engl J Med. 2002;346(14):1061-1066. doi:10.1056/NEJMsa012528</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsa012528</ArticleId><ArticleId IdType="pubmed">11932474</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen MB, Bernacki RE, Gewertz BL, et al. . Beyond the do-not-resuscitate order: an expanded approach to decision-making regarding cardiopulmonary resuscitation in older surgical patients. Anesthesiology. 2021;135(5):781-787. doi:10.1097/ALN.0000000000003937</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000003937</ArticleId><ArticleId IdType="pubmed">34499085</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons National Surgical Quality Improvement Program . Accessed May 4, 2022. https://www.facs.org/quality-programs/data-and-registries/acs-nsqip/</Citation></Reference><Reference><Citation>Hall DE, Arya S, Schmid KK, et al. . Development and initial validation of the Risk Analysis Index for measuring frailty in surgical populations. JAMA Surg. 2017;152(2):175-182. doi:10.1001/jamasurg.2016.4202</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.4202</ArticleId><ArticleId IdType="pmc">PMC7140150</ArticleId><ArticleId IdType="pubmed">27893030</ArticleId></ArticleIdList></Reference><Reference><Citation>Arya S, Varley P, Youk A, et al. . Recalibration and external validation of the Risk Analysis Index: a surgical frailty assessment tool. Ann Surg. 2020;272(6):996-1005. doi:10.1097/SLA.0000000000003276</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003276</ArticleId><ArticleId IdType="pmc">PMC8785437</ArticleId><ArticleId IdType="pubmed">30907757</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg KA, George EL, Trickey AW, et al. . Assessment of the Risk Analysis Index for prediction of mortality, major complications, and length of stay in patients who underwent vascular surgery. Ann Vasc Surg. 2020;66:442-453. doi:10.1016/j.avsg.2020.01.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.avsg.2020.01.015</ArticleId><ArticleId IdType="pmc">PMC7608558</ArticleId><ArticleId IdType="pubmed">31935435</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan Q, Kim J, Hall DE, et al. . Association of frailty and the expanded Operative Stress Score with preoperative acute serious conditions, complications and mortality in males compared to females: a retrospective observational study. Ann Surg. 2023;277(2):e294-e304. doi:10.1097/SLA.0000000000005027</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000005027</ArticleId><ArticleId IdType="pmc">PMC8709872</ArticleId><ArticleId IdType="pubmed">34183515</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam S, Aalberg JJ, Soriano RP, Divino CM. New 5-factor modified Frailty Index Using American College of Surgeons NSQIP Data. J Am Coll Surg. 2018;226(2):173-181.e8. doi:10.1016/j.jamcollsurg.2017.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2017.11.005</ArticleId><ArticleId IdType="pubmed">29155268</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrell FE Jr. rms: Regression modeling strategies. R package version 6.7-0. May 8, 2023. Accessed May 10, 2023. https://cran.r-project.org/web/packages/rms/index.html</Citation></Reference><Reference><Citation>Reitz KM, Hall DE, Shinall MC Jr, Shireman PK, Silverstein JC. Using the Unified Medical Language system to expand the Operative Stress Score&#x2014;first use case. J Surg Res. 2021;268:552-561. doi:10.1016/j.jss.2021.07.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2021.07.030</ArticleId><ArticleId IdType="pmc">PMC8678140</ArticleId><ArticleId IdType="pubmed">34464893</ArticleId></ArticleIdList></Reference><Reference><Citation>Wharton C, King E, MacDuff A. Frailty is associated with adverse outcome from in-hospital cardiopulmonary resuscitation. Resuscitation. 2019;143:208-211. doi:10.1016/j.resuscitation.2019.07.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2019.07.021</ArticleId><ArticleId IdType="pubmed">31369792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando SM, McIsaac DI, Rochwerg B, et al. . Frailty and associated outcomes and resource utilization following in-hospital cardiac arrest. Resuscitation. 2020;146:138-144. doi:10.1016/j.resuscitation.2019.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resuscitation.2019.11.011</ArticleId><ArticleId IdType="pubmed">31785373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ernst KF, Hall DE, Schmid KK, et al. . Surgical palliative care consultations over time in relationship to systemwide frailty screening. JAMA Surg. 2014;149(11):1121-1126. doi:10.1001/jamasurg.2014.1393</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2014.1393</ArticleId><ArticleId IdType="pmc">PMC4603652</ArticleId><ArticleId IdType="pubmed">25207603</ArticleId></ArticleIdList></Reference><Reference><Citation>Yefimova M, Aslakson RA, Yang L, et al. . Palliative care and end-of-life outcomes following high-risk surgery. JAMA Surg. 2020;155(2):138-146. doi:10.1001/jamasurg.2019.5083</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2019.5083</ArticleId><ArticleId IdType="pmc">PMC6990868</ArticleId><ArticleId IdType="pubmed">31895424</ArticleId></ArticleIdList></Reference><Reference><Citation>Koike M, Yoshimura M, Mio Y, Uezono S. The effects of a preoperative multidisciplinary conference on outcomes for high-risk patients with challenging surgical treatment options: a retrospective study. BMC Anesthesiol. 2021;21(1):39. doi:10.1186/s12871-021-01257-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-021-01257-1</ArticleId><ArticleId IdType="pmc">PMC7865098</ArticleId><ArticleId IdType="pubmed">33549032</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones TS, Jones EL, Barnett CC Jr, et al. . A multidisciplinary high-risk surgery committee may improve perioperative decision making for patients and physicians. J Palliat Med. 2021;24(12):1863-1866. doi:10.1089/jpm.2021.0141</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jpm.2021.0141</ArticleId><ArticleId IdType="pubmed">34851187</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Huang A, Wong CA, Wijeysundera DN, Bryson GL, van Walraven C. Effect of preoperative geriatric evaluation on outcomes after elective surgery: a population-based study. J Am Geriatr Soc. 2017;65(12):2665-2672. doi:10.1111/jgs.15100</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15100</ArticleId><ArticleId IdType="pubmed">28971482</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryant EA, Tulebaev S, Castillo-Angeles M, et al. . Frailty identification and care pathway: an interdisciplinary approach to care for older trauma patients. J Am Coll Surg. 2019;228(6):852-859.e1. doi:10.1016/j.jamcollsurg.2019.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2019.02.052</ArticleId><ArticleId IdType="pubmed">30959106</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinall MC Jr, Youk A, Massarweh NN, et al. . Association of preoperative frailty and operative stress with mortality after elective vs emergency surgery. JAMA Netw Open. 2020;3(7):e2010358. doi:10.1001/jamanetworkopen.2020.10358</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.10358</ArticleId><ArticleId IdType="pmc">PMC7358909</ArticleId><ArticleId IdType="pubmed">32658284</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarze ML, Brasel KJ, Mosenthal AC. Beyond 30-day mortality: aligning surgical quality with outcomes that patients value. JAMA Surg. 2014;149(7):631-632. doi:10.1001/jamasurg.2013.5143</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2013.5143</ArticleId><ArticleId IdType="pmc">PMC4295201</ArticleId><ArticleId IdType="pubmed">24897945</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor LJ, Nabozny MJ, Steffens NM, et al. . A framework to improve surgeon communication in high-stakes surgical decisions: best case/worst case. JAMA Surg. 2017;152(6):531-538. doi:10.1001/jamasurg.2016.5674</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2016.5674</ArticleId><ArticleId IdType="pmc">PMC5479749</ArticleId><ArticleId IdType="pubmed">28146230</ArticleId></ArticleIdList></Reference><Reference><Citation>McIsaac DI, Aucoin SD, van Walraven C. A bayesian comparison of frailty instruments in noncardiac surgery: a cohort study. Anesth Analg. 2021;133(2):366-373. doi:10.1213/ANE.0000000000005290</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005290</ArticleId><ArticleId IdType="pubmed">33264118</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkadri J, Hage D, Nickerson LH, et al. . A systematic review and meta-analysis of preoperative frailty instruments derived from electronic health data. Anesth Analg. 2021;133(5):1094-1106. doi:10.1213/ANE.0000000000005595</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005595</ArticleId><ArticleId IdType="pubmed">33999880</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29174966</PMID><DateCompleted><Year>2019</Year><Month>07</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2742</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of infection</Title><ISOAbbreviation>J Infect</ISOAbbreviation></Journal><ArticleTitle>Pentraxin-3 as a marker of sepsis severity and predictor of mortality outcomes: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jinf.2017.10.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0163-4453(17)30351-1</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Pentraxin-3 (PTX-3) is a multi-functional pattern recognition molecule produced by various cell types of peripheral tissues in different infections. It is raised in sepsis, but its values in predicting disease severity or mortality outcomes have been controversial. Therefore, we conducted a systematic review and meta-analysis of these associations.</AbstractText><AbstractText Label="METHODS">PubMed and Embase were searched until July 18, 2017 for studies that evaluated the relationship between PTX-3 levels and disease severity or mortality in sepsis.</AbstractText><AbstractText Label="RESULTS">A total of 23 and 10 entries were retrieved from both databases, respectively, of which 16 studies were included in the final meta-analysis. A total of 3001 patients (56% male, mean age 63&#xa0;&#xb1;&#xa0;15 years; mean follow-up duration of 207 days) were analysed. PTX-3 was significantly higher in patients with more severe sepsis compared to those with less severe sepsis (standard mean difference&#xa0;=&#xa0;18.5&#xa0;ng/mL, standard error: 4.5&#xa0;ng/mL, P&#xa0;&lt;&#xa0;0.0001) and higher in non-survivors compared to survivors (standard mean difference&#xa0;=&#xa0;40.3&#xa0;ng/mL, standard error: 6.8&#xa0;ng/mL, P&#xa0;&lt;&#xa0;0.0001). Elevated PTX-3 levels significantly increased the risk of all-cause mortality (hazard ratio: 1.91, 95% CI: 1.53 to 2.46, P&#xa0;&lt;&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">PTX-3 significantly predicts disease severity and mortality in sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Yee Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Mengqi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chau</LastName><ForeName>Alex</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University of British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wing Tak</ForeName><Initials>WT</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Chinese University of Hong Kong, Hong Kong, SAR, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazoukis</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Sunny Hei</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lampropoulos</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Second Department of Cardiology, Laboratory of Cardiac Electrophysiology, Evangelismos General Hospital of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xia</LastName><ForeName>Yunlong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cardiology, First Affiliated Hospital of Dalian Medical University, Dalian, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guangping</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Martin C S</ForeName><Initials>MCS</Initials><AffiliationInfo><Affiliation>The Jockey Club School of Public Health and Primary Care, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; State Key Laboratory of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>William K K</ForeName><Initials>WKK</Initials><AffiliationInfo><Affiliation>Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Department of Anaesthesia and Intensive Care, State Key Laboratory of Digestive Disease, LKS Institute of Health Sciences, Chinese University of Hong Kong, Hong Kong, SAR, China. Electronic address: wukakei@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tse</LastName><ForeName>Gary</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Therapeutics, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong, China. Electronic address: tseg@cuhk.edu.hk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>International Heath Informatics Study (IHIS) Network</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>11</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Infect</MedlineTA><NlmUniqueID>7908424</NlmUniqueID><ISSNLinking>0163-4453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000683">Serum Amyloid P-Component</NameOfSubstance></Chemical><Chemical><RegistryNumber>148591-49-5</RegistryNumber><NameOfSubstance UI="C077657">PTX3 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2018 Apr;76(4):426-428. doi: 10.1016/j.jinf.2018.01.004.</RefSource><PMID Version="1">29360521</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Infect. 2018 Jul;77(1):75-81. doi: 10.1016/j.jinf.2018.04.014.</RefSource><PMID Version="1">29778629</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000683" MajorTopicYN="N">Serum Amyloid P-Component</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Pentraxin-3</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>7</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29174966</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2017.10.016</ArticleId><ArticleId IdType="pii">S0163-4453(17)30351-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28197792</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>11</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1128-045X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Techniques in coloproctology</Title><ISOAbbreviation>Tech Coloproctol</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic lavage versus surgical resection for acute diverticulitis with generalised peritonitis: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>93</StartPage><EndPage>110</EndPage><MedlinePgn>93-110</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10151-017-1585-0</ELocationID><Abstract><AbstractText>This systematic review and meta-analysis investigates current evidence on the therapeutic role of laparoscopic lavage in the management of diverticular peritonitis. A systematic review of the literature was performed on PubMed until June 2016, according to preferred reporting items for systematic reviews and meta-analyses guidelines. All randomised controlled trials comparing laparoscopic lavage with surgical resection, irrespective of anastomosis or stoma formation, were analysed. After assessment of titles and full text, 3 randomised trials fulfilled the inclusion criteria. Overall the quality of evidence was low because of serious concerns regarding the risk of bias and imprecision. In the laparoscopic lavage group, there was a statistically significant higher rate of postoperative intra-abdominal abscess (RR 2.54, 95% CI 1.34-4.83), a lower rate of postoperative wound infection (RR 0.10, 95% CI 0.02-0.51), and a shorter length of postoperative hospital stay during index admission (WMD&#xa0;=&#xa0;-2.03, 95% CI -2.59 to -1.47). There were no statistically significant differences in terms of postoperative mortality at index admission or within 30&#xa0;days from intervention in all Hinchey stages and in Hinchey stage III, postoperative mortality at 12&#xa0;months, surgical reintervention at index admission or within 30-90&#xa0;days from index intervention, stoma rate at 12&#xa0;months, or adverse events within 90&#xa0;days of any Clavien-Dindo grade. The surgical reintervention rate at 12&#xa0;months from index intervention was significantly lower in the laparoscopic lavage group (RR 0.57, 95% CI 0.38-0.86), but these data included emergency reintervention and planned intervention (stoma reversal). This systematic review and meta-analysis did not demonstrate any significant difference between laparoscopic peritoneal lavage and traditional surgical resection in patients with peritonitis from perforated diverticular disease, in terms of postoperative mortality and early reoperation rate. Laparoscopic lavage was associated with a lower rate of stoma formation. However, the finding of a significantly higher rate of postoperative intra-abdominal abscess in patients who underwent laparoscopic lavage compared to those who underwent surgical resection is of concern. Since the aim of surgery in patients with peritonitis is to treat the sepsis, if one technique is associated with more postoperative abscesses, then the technique is ineffective. Even so, laparoscopic lavage does not appear fundamentally inferior to traditional surgical resection and this technique may achieve reasonable outcomes with minimal invasiveness.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cirocchi</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of General Surgery and Surgical Oncology, Hospital of Terni, University of Perugia, Terni, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Saverio</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General (Colorectal), Emergency and Trauma Surgery Service, Maggiore Hospital Regional Emergency Surgery and Trauma Center - Bologna Local Health District, Bologna, Italy. salo75@inwind.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>D G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Royal Perth Hospital, The University of Western Australia, Perth, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The University of Newcastle, Newcastle, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabo&#x142;a</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Gastrointestinal and General Surgery, Medical University of Wroc&#x142;aw, Wroc&#x142;aw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abraha</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Health Planning Service, Department of Epidemiology, Regional Health Authority of Umbria, Perugia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Randolph</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Tift College of Education, Mercer University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arezzo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Binda</LastName><ForeName>G A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Galliera Hospital, Genoa, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Tech Coloproctol</MedlineTA><NlmUniqueID>9613614</NlmUniqueID><ISSNLinking>1123-6337</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018784" MajorTopicYN="N">Abdominal Abscess</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004238" MajorTopicYN="N">Diverticulitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007416" MajorTopicYN="N">Intestinal Perforation</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007422" MajorTopicYN="N">Intestines</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010533" MajorTopicYN="N">Peritoneal Lavage</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010538" MajorTopicYN="N">Peritonitis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054047" MajorTopicYN="N">Surgical Stomas</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Abdominal sepsis</Keyword><Keyword MajorTopicYN="N">Acute diverticulitis</Keyword><Keyword MajorTopicYN="N">Colostomy</Keyword><Keyword MajorTopicYN="N">Hartmann resection</Keyword><Keyword MajorTopicYN="N">Hinchey classification</Keyword><Keyword MajorTopicYN="N">Intra-abdominal infections</Keyword><Keyword MajorTopicYN="N">Laparoscopic lavage</Keyword><Keyword MajorTopicYN="N">Laparoscopy</Keyword><Keyword MajorTopicYN="N">Peritonitis</Keyword><Keyword MajorTopicYN="N">Sigmoid resection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28197792</ArticleId><ArticleId IdType="doi">10.1007/s10151-017-1585-0</ArticleId><ArticleId IdType="pii">10.1007/s10151-017-1585-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>BMJ. 2015 May 27;350:h2445</Citation><ArticleIdList><ArticleId IdType="pubmed">26016488</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2014 Nov;93(25):e184</Citation><ArticleIdList><ArticleId IdType="pubmed">25437034</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2000 Jun;10(3):135-8; discussion 139-41</Citation><ArticleIdList><ArticleId IdType="pubmed">10872974</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1996 Apr;171(4):432-4</Citation><ArticleIdList><ArticleId IdType="pubmed">8604837</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2008 Jan;95(1):97-101</Citation><ArticleIdList><ArticleId IdType="pubmed">18076019</ArticleId></ArticleIdList></Reference><Reference><Citation>Health Technol Assess. 2012 Sep;16(35):1-82</Citation><ArticleIdList><ArticleId IdType="pubmed">22989478</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2016 Dec;36(Pt A):118-120</Citation><ArticleIdList><ArticleId IdType="pubmed">27751913</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2017 Apr;265(4):670-676</Citation><ArticleIdList><ArticleId IdType="pubmed">27631772</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2004 May 26;291(20):2457-65</Citation><ArticleIdList><ArticleId IdType="pubmed">15161896</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2013 Jun;74(6):1385-91; quiz 1610</Citation><ArticleIdList><ArticleId IdType="pubmed">23694862</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2005 Sep;7(5):454-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16108881</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2017 Feb;32(2):163-169</Citation><ArticleIdList><ArticleId IdType="pubmed">27567926</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2015 Sep 26;386(10000):1269-77</Citation><ArticleIdList><ArticleId IdType="pubmed">26209030</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2017 Jan;32(1):159</Citation><ArticleIdList><ArticleId IdType="pubmed">27714519</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2010 Oct 18;10:29</Citation><ArticleIdList><ArticleId IdType="pubmed">20955571</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2015 Nov;210(5):838-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26116319</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2015 Oct 6;314(13):1364-75</Citation><ArticleIdList><ArticleId IdType="pubmed">26441181</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2013 Apr;28(4):447-57</Citation><ArticleIdList><ArticleId IdType="pubmed">23242271</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZ J Surg. 2005 Jun;75(6):436-40</Citation><ArticleIdList><ArticleId IdType="pubmed">15943733</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2016 Aug 30;11(1):42</Citation><ArticleIdList><ArticleId IdType="pubmed">27582782</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2008 Apr;206(4):654-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18387470</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2012 Jun;14(6):671-83</Citation><ArticleIdList><ArticleId IdType="pubmed">21689339</ArticleId></ArticleIdList></Reference><Reference><Citation>Medicine (Baltimore). 2015 Jan;94(1):e334</Citation><ArticleIdList><ArticleId IdType="pubmed">25569649</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 Aug 18;151(4):264-9, W64</Citation><ArticleIdList><ArticleId IdType="pubmed">19622511</ArticleId></ArticleIdList></Reference><Reference><Citation>J Trauma Acute Care Surg. 2012 Apr;72(4):807-14; quiz 1124</Citation><ArticleIdList><ArticleId IdType="pubmed">22491590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tech Coloproctol. 2015 Feb;19(2):105-10</Citation><ArticleIdList><ArticleId IdType="pubmed">25550116</ArticleId></ArticleIdList></Reference><Reference><Citation>Colorectal Dis. 2016 Oct;18(10 ):937-938</Citation><ArticleIdList><ArticleId IdType="pubmed">27248855</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Colorectal Dis. 2011 Mar;26(3):377-84</Citation><ArticleIdList><ArticleId IdType="pubmed">20949274</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Med Res Methodol. 2005 Apr 20;5:13</Citation><ArticleIdList><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2016 Feb 2;164(3):137-45</Citation><ArticleIdList><ArticleId IdType="pubmed">26784672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2016 Jan;263(1):117-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25489672</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2008 Jul;32(7):1507-11</Citation><ArticleIdList><ArticleId IdType="pubmed">18259803</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2011 Aug 01;12:186</Citation><ArticleIdList><ArticleId IdType="pubmed">21806795</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28717843</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-5195</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>International orthopaedics</Title><ISOAbbreviation>Int Orthop</ISOAbbreviation></Journal><ArticleTitle>Septic arthritis associated with systemic sepsis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>7</EndPage><MedlinePgn>1-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00264-017-3565-4</ELocationID><Abstract><AbstractText Label="PURPOSE">Septic arthritis presents with good joint function, but sometimes leads to poor outcomes. Concurrent systemic sepsis has been regarded as the poor outcome, and the exact cause remains unclear. This paper was performed to identify factors associated with concurrent systemic sepsis and to research results to predict poor outcomes in patients with septic arthritis.</AbstractText><AbstractText Label="METHODS">Laboratory and medical data were reviewed for 137 adults with acute septic arthritis who underwent open or arthroscopic surgical debridement at our institution between January 2005 and December 2014. The patients were divided according to whether they had septic arthritis alone (Group A) or in combination with systemic sepsis (Group B). Systemic sepsis was defined as two more systemic inflammatory signs in response to an infectious process. Patient characteristics, laboratory findings, synovial fluid findings and cultures, and surgical results were compared between two groups.</AbstractText><AbstractText Label="RESULTS">Of the 137 patients, 41 (29.9%) had initial systemic sepsis at the diagnosis of septic arthritis. Independent t test revealed that duration of prodromal symptom (p&#xa0;=&#xa0;0.012), serum neutrophil percent (p&#xa0;=&#xa0;0.008), C-reactive protein (p&#xa0;=&#xa0;0.001), Charlson comorbidity index (p&#xa0;=&#xa0;0.001), positive culture in synovial fluid (p&#xa0;=&#xa0;0.001), and methicillin-sensitive Staphylococcus aureus (MSSA) isolate in synovial fluid (p&#xa0;=&#xa0;0.001) had significant correlations with the group B. Repeated debridement was performed for those who had recurrence of infection, and this procedure was more often in group B (23 versus 21 joints, 23.9 versus 51.2%, p&#xa0;=&#xa0;0.012). Progression of arthritis occurred more often in group B (16 versus 17 joints, 16.7 versus 41.5%, p&#xa0;=&#xa0;0.001).</AbstractText><AbstractText Label="CONCLUSION">Septic arthritis combined with systemic sepsis was related to duration of prodromal symptom, serum neutrophil percent, C-reactive protein, Charlson comorbidity index, positive culture in synovial fluid, and a MSSA isolate in synovial fluid. Concurrent systemic sepsis led to poor outcomes in patients with septic arthritis in terms of recurrence of infection and progression of arthritis.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">III Case control study.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Sung-Weon</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea. can1204@hanmail.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Dong-Hee</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shin</LastName><ForeName>Sung-Jin</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Byoung-Youl</ForeName><Initials>BY</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eho</LastName><ForeName>Yil-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Seong-Wook</ForeName><Initials>SW</Initials><AffiliationInfo><Affiliation>Department of Orthopedic Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, 50, Hapsung 2-Dong, Changwon-si, Gyeongsangnam-do, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int Orthop</MedlineTA><NlmUniqueID>7705431</NlmUniqueID><ISSNLinking>0341-2695</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001170" MajorTopicYN="N">Arthritis, Infectious</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001182" MajorTopicYN="N">Arthroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003646" MajorTopicYN="N">Debridement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013582" MajorTopicYN="N">Synovial Fluid</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Osteoarthritis</Keyword><Keyword MajorTopicYN="N">Recurrence</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic arthritis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28717843</ArticleId><ArticleId IdType="doi">10.1007/s00264-017-3565-4</ArticleId><ArticleId IdType="pii">10.1007/s00264-017-3565-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arthritis Rheum. 2006 Aug;54(8):2368-76</Citation><ArticleIdList><ArticleId IdType="pubmed">16868999</ArticleId></ArticleIdList></Reference><Reference><Citation>Int Orthop. 2001;25(4):239-41</Citation><ArticleIdList><ArticleId IdType="pubmed">11561499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Bone Joint Surg Am. 2015 Apr 1;97(7):558-64</Citation><ArticleIdList><ArticleId IdType="pubmed">25834080</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2006 May 17;295(19):2275-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16705109</ArticleId></ArticleIdList></Reference><Reference><Citation>J Foot Surg. 1982 Fall;21(3):229-33</Citation><ArticleIdList><ArticleId IdType="pubmed">6749955</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2001 Jan;40(1):24-30</Citation><ArticleIdList><ArticleId IdType="pubmed">11157138</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Orthop Traumatol Turc. 2011;45(2):94-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21610307</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Orthop Trauma Surg. 2001 Oct;121(9):521-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11599755</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Surg. 2015 Mar;7(1):110-9</Citation><ArticleIdList><ArticleId IdType="pubmed">25729527</ArticleId></ArticleIdList></Reference><Reference><Citation>Knee Surg Sports Traumatol Arthrosc. 2000;8(5):270-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11061294</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2007 Oct 15;57(7):1151-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17907232</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Rev. 2002 Oct;15(4):527-44</Citation><ArticleIdList><ArticleId IdType="pubmed">12364368</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Rheum Dis. 1999 Apr;58(4):214-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10364899</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Orthop Relat Res. 1990 Feb;(251):241-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2295180</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1992 Jun;20(6):864-74</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1985 Mar;33(3):170-4</Citation><ArticleIdList><ArticleId IdType="pubmed">3973335</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1976 Mar;60(3):369-77</Citation><ArticleIdList><ArticleId IdType="pubmed">769545</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Lab Sci. 2009 Summer;22(3):131-5</Citation><ArticleIdList><ArticleId IdType="pubmed">19827405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39011965</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-397X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Adipocyte</Title><ISOAbbreviation>Adipocyte</ISOAbbreviation></Journal><ArticleTitle>Association between the triglyceride glucose index and short-term mortality in septic patients with or without obesity: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>2379867</StartPage><MedlinePgn>2379867</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2379867</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1080/21623945.2024.2379867</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Sepsis is a significant contributor to both intensive care unit (ICU) admissions and mortality among patients in ICU, with a rising prevalence of obesity. There is a lack of extensive research on the correlation between TyGI and findings in patients with sepsis, especially in obese patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This study used a retrospective cohort design and included patients with sepsis (&#x2265;18&#x2009;years) from the Medical Information Mart for Intensive Care IV database. The association between TyGI and outcome was examined using multivariable logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">8,840 patients with sepsis were included in the analysis. The in-ICU mortality rate was 9.7%. Non-survivors exhibited significantly greater TyGI levels than survivors [9.19(8.76-9.71) vs. 9.10(8.67-9.54), <i>p</i>&#x2009;&lt;&#x2009;0.001]. The adjusted multivariate regression model showed that elevated TyGI values were linked to a greater likelihood of death in ICU (odds ratio [OR] range 1.072-1.793, <i>p</i>&#x2009;&lt;&#x2009;0.001) and hospital (OR range 1.068-1.445, <i>p</i>&#x2009;=&#x2009;0.005). Restricted Cubic Spline analysis revealed a nonlinear association between TyGI and in-ICU and in-hospital mortality risks within specified ranges. Subgroup analysis revealed interaction effects in the general obesity, abdominal obesity, and impaired fasting glucose subgroups (<i>p</i>&#x2009;=&#x2009;0.014, 0.016, and&#x2009;&lt;&#x2009;0.001, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">TyGI was associated with an increased sepsis-related short-term mortality risk and adverse outcomes after ICU admission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lv</LastName><ForeName>Zhou</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-2571-0693</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Juntao</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The affiliated Hospital of Qingdao University, Qingdao, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Minglu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Liuyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Saie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Surgical Intensive Care Unit, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chunmei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adipocyte</MedlineTA><NlmUniqueID>101567863</NlmUniqueID><ISSNLinking>2162-3945</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014280">Triglycerides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="Y">Obesity</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014280" MajorTopicYN="Y">Triglycerides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001786" MajorTopicYN="Y">Blood Glucose</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Triglyceride-glucose index</Keyword><Keyword MajorTopicYN="N">metabolic syndrome</Keyword><Keyword MajorTopicYN="N">obesity paradox</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">short-term mortality</Keyword></KeywordList><CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>16</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>16</Day><Hour>7</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39011965</ArticleId><ArticleId IdType="pmc">PMC11253880</ArticleId><ArticleId IdType="doi">10.1080/21623945.2024.2379867</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801&#x2013;12. doi: 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Wang H, Kang Y, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209&#x2013;e218. doi: 10.1097/CCM.0000000000004155</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004155</ArticleId><ArticleId IdType="pubmed">31804299</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care. 2020;24(1):239. doi: 10.1186/s13054-020-02950-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02950-2</ArticleId><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200&#x2013;211. doi: 10.1016/S0140-6736(19)32989-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Collaborators GBDO, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477817</ArticleId><ArticleId IdType="pubmed">28604169</ArticleId></ArticleIdList></Reference><Reference><Citation>Chooi YC, Ding C, Magkos F.. The epidemiology of obesity. Metabolism. 2019;92:6&#x2013;10. doi: 10.1016/j.metabol.2018.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2018.09.005</ArticleId><ArticleId IdType="pubmed">30253139</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang M, Zhao Z, et al. Geographic variation in prevalence of adult obesity in China: results from the 2013-2014 National chronic disease and risk factor surveillance. Ann Intern Med. 2020;172(4):291&#x2013;293. doi: 10.7326/M19-0477</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M19-0477</ArticleId><ArticleId IdType="pubmed">31658469</ArticleId></ArticleIdList></Reference><Reference><Citation>Schetz M, De Jong A, Deane AM, et al. Obesity in the critically ill: a narrative review. Intensive Care Med. 2019;45(6):757&#x2013;769. doi: 10.1007/s00134-019-05594-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05594-1</ArticleId><ArticleId IdType="pubmed">30888440</ArticleId></ArticleIdList></Reference><Reference><Citation>Gbdrf C. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1923&#x2013;1994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6227755</ArticleId><ArticleId IdType="pubmed">30496105</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong B, Jayabaskaran J, Kong G, et al. Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the global burden of disease study 2019. EClinicalMedicine. 2023;57:101850. doi: 10.1016/j.eclinm.2023.101850</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101850</ArticleId><ArticleId IdType="pmc">PMC9971264</ArticleId><ArticleId IdType="pubmed">36864983</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo HJ, Kim TH, Jang JH, et al. Obesity paradox and functional outcomes in sepsis: a multicenter prospective study. Crit Care Med. 2023;51(6):742&#x2013;752. doi: 10.1097/CCM.0000000000005801</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005801</ArticleId><ArticleId IdType="pmc">PMC10187629</ArticleId><ArticleId IdType="pubmed">36762918</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepper DJ, Demirkale CY, Sun J, et al. Does obesity protect against death in sepsis? A retrospective cohort study of 55,038 adult patients. Crit Care Med. 2019;47(5):643&#x2013;650. doi: 10.1097/CCM.0000000000003692</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003692</ArticleId><ArticleId IdType="pmc">PMC6465121</ArticleId><ArticleId IdType="pubmed">30789403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Wang C, Lin Q, et al. The obesity paradox for survivors of critically ill patients. Crit Care. 2022;26(1):198. doi: 10.1186/s13054-022-04074-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-022-04074-1</ArticleId><ArticleId IdType="pmc">PMC9251913</ArticleId><ArticleId IdType="pubmed">35781349</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Obesity and overweight fact sheet. WHO media centre. Cited February 16. 2018.  [cited 2021 Oct
15]. Available from:
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight</Citation></Reference><Reference><Citation>Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104&#x2013;108. doi: 10.1016/j.mce.2009.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2009.07.008</ArticleId><ArticleId IdType="pubmed">19628019</ArticleId></ArticleIdList></Reference><Reference><Citation>Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). In: And treatment of high blood cholesterol in adults (adult treatment panel III). Vol. 285(19): 2001. p. 2486&#x2013;2497 doi:10.1001/jama.285.19.2486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.285.19.2486</ArticleId><ArticleId IdType="pubmed">11368702</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeland IJ, Poirier P, Despres JP. Cardiovascular and metabolic heterogeneity of obesity: clinical challenges and implications for management. Circulation. 2018;137(13):1391&#x2013;1406. doi: 10.1161/CIRCULATIONAHA.117.029617</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.029617</ArticleId><ArticleId IdType="pmc">PMC5875734</ArticleId><ArticleId IdType="pubmed">29581366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Gao Z, Dai Y, et al. Association of general and abdominal obesity and their changes with stroke in Chinese adults: results from an 11.8-year follow-up study. Nutr Metab Cardiovasc Dis. 2020;30(11):2001&#x2013;2007. doi: 10.1016/j.numecd.2020.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2020.06.011</ArticleId><ArticleId IdType="pubmed">32807634</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng L, Fan J, Yu C, et al. Body-mass index and long-term risk of sepsis-related mortality: a population-based cohort study of 0.5 million Chinese adults. Crit Care. 2020;24(1):534. doi: 10.1186/s13054-020-03229-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03229-2</ArticleId><ArticleId IdType="pmc">PMC7457784</ArticleId><ArticleId IdType="pubmed">32867859</ArticleId></ArticleIdList></Reference><Reference><Citation>Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299&#x2013;304. doi: 10.1089/met.2008.0034</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/met.2008.0034</ArticleId><ArticleId IdType="pubmed">19067533</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan SH, Sobia F, Niazi NK, et al. Metabolic clustering of risk factors: evaluation of triglyceride-glucose index (TyG index) for evaluation of insulin resistance. Diabetol Metab Syndr. 2018;10(1):74. doi: 10.1186/s13098-018-0376-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13098-018-0376-8</ArticleId><ArticleId IdType="pmc">PMC6173832</ArticleId><ArticleId IdType="pubmed">30323862</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui H, Liu Q, Wu Y, et al. Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study. Cardiovasc Diabetol. 2022;21(1):22. doi: 10.1186/s12933-022-01456-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01456-1</ArticleId><ArticleId IdType="pmc">PMC8830002</ArticleId><ArticleId IdType="pubmed">35144621</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao LC, Xu JN, Wang TT, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. doi: 10.1186/s12933-022-01511-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01511-x</ArticleId><ArticleId IdType="pmc">PMC9078015</ArticleId><ArticleId IdType="pubmed">35524263</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue Y, Xu J, Li M, et al. Potential screening indicators for early diagnosis of NAFLD/MAFLD and liver fibrosis: triglyceride glucose index-related parameters. Front Endocrinol (Lausanne). 2022;13:951689. doi: 10.3389/fendo.2022.951689</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.951689</ArticleId><ArticleId IdType="pmc">PMC9478620</ArticleId><ArticleId IdType="pubmed">36120429</ArticleId></ArticleIdList></Reference><Reference><Citation>Huo RR, Zhai L, Liao Q, et al. Changes in the triglyceride glucose-body mass index estimate the risk of stroke in middle-aged and older Chinese adults: a nationwide prospective cohort study. Cardiovasc Diabetol. 2023;22(1):254. doi: 10.1186/s12933-023-01983-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01983-5</ArticleId><ArticleId IdType="pmc">PMC10505325</ArticleId><ArticleId IdType="pubmed">37716947</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu T, Li Y, et al. Triglyceride-glucose index, symptomatic intracranial artery stenosis and recurrence risk in minor stroke patients with hypertension. Cardiovasc Diabetol. 2023;22(1):90. doi: 10.1186/s12933-023-01823-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01823-6</ArticleId><ArticleId IdType="pmc">PMC10114394</ArticleId><ArticleId IdType="pubmed">37076850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z, An S, Gao Y, et al. Association between the triglyceride glucose index and in-hospital and 1-year mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit. Cardiovasc Diabetol. 2023;22(1):110. doi: 10.1186/s12933-023-01843-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01843-2</ArticleId><ArticleId IdType="pmc">PMC10183125</ArticleId><ArticleId IdType="pubmed">37179310</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Gong H, Kan F, et al. Association between the triglyceride glucose (TyG) index and the risk of acute kidney injury in critically ill patients with heart failure: analysis of the MIMIC-IV database. Cardiovasc Diabetol. 2023;22(1):232. doi: 10.1186/s12933-023-01971-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01971-9</ArticleId><ArticleId IdType="pmc">PMC10472684</ArticleId><ArticleId IdType="pubmed">37653418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim YM, Kim JH, Park JS, et al. Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer. 2022;25(1):33&#x2013;41. doi: 10.1007/s10120-021-01222-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10120-021-01222-4</ArticleId><ArticleId IdType="pubmed">34355281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritz J, Brozek W, Concin H, et al. The triglyceride-glucose index and obesity-related risk of end-stage kidney disease in Austrian adults. JAMA Netw Open. 2021;4(3):e212612. doi: 10.1001/jamanetworkopen.2021.2612</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.2612</ArticleId><ArticleId IdType="pmc">PMC8013829</ArticleId><ArticleId IdType="pubmed">33787913</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Zhang R, Shi S, et al. Triglyceride-glucose index linked to all-cause mortality in critically ill patients: a cohort of 3026 patients. Cardiovasc Diabetol. 2022;21(1):128. doi: 10.1186/s12933-022-01563-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01563-z</ArticleId><ArticleId IdType="pmc">PMC9270811</ArticleId><ArticleId IdType="pubmed">35804386</ArticleId></ArticleIdList></Reference><Reference><Citation>Alistair Johnson LB, Pollard T, Horng S, et al.Version:available in Jan. 6, 2023(ht tps://d oi.org/1 0.5281/zenodo.10900938. cited 2023 Jul 25].</Citation></Reference><Reference><Citation>Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015;314(18):1966&#x2013;1967. doi: 10.1001/jama.2015.15281</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.15281</ArticleId><ArticleId IdType="pmc">PMC4638176</ArticleId><ArticleId IdType="pubmed">26547468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang R, Shi S, Chen W, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):10. doi: 10.1186/s12933-023-01737-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-023-01737-3</ArticleId><ArticleId IdType="pmc">PMC9838037</ArticleId><ArticleId IdType="pubmed">36639637</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Liu L, Ruan H, et al. Triglyceride-glucose index linked to hospital mortality in critically Ill stroke: an observational multicentre study on eICU database. Front Med (Lausanne). 2020;7:591036. doi: 10.3389/fmed.2020.591036</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.591036</ArticleId><ArticleId IdType="pmc">PMC7655911</ArticleId><ArticleId IdType="pubmed">33195355</ArticleId></ArticleIdList></Reference><Reference><Citation>Holst J. Global health - emergence, hegemonic trends and biomedical reductionism. Global Health. 2020;16(1):42. doi: 10.1186/s12992-020-00573-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12992-020-00573-4</ArticleId><ArticleId IdType="pmc">PMC7201392</ArticleId><ArticleId IdType="pubmed">32375801</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukhopadhyay A, Kowitlawakul Y, Henry J, et al. Higher BMI is associated with reduced mortality but longer hospital stays following ICU discharge in critically ill Asian patients. Clin Nutr ESPEN. 2018;28:165&#x2013;170. doi: 10.1016/j.clnesp.2018.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnesp.2018.08.009</ArticleId><ArticleId IdType="pubmed">30390876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagan N, Morrow LE, Walters RW, et al. Sepsis and the obesity paradox: size matters in more than one way. Crit Care Med. 2020;48(9):e776&#x2013;e782. doi: 10.1097/CCM.0000000000004459</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004459</ArticleId><ArticleId IdType="pubmed">32590388</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah RV, Abbasi SA, Yamal JM, et al. Group ACR: impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich). 2014;16(6):451&#x2013;458. doi: 10.1111/jch.12325</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jch.12325</ArticleId><ArticleId IdType="pmc">PMC4091725</ArticleId><ArticleId IdType="pubmed">24779706</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis ED, Williams HC, Bruno MEC, et al. Exploring the obesity paradox in a murine Model of sepsis: improved survival despite increased organ injury in obese mice. Shock. 2022;57(1):151&#x2013;159. doi: 10.1097/SHK.0000000000001856</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001856</ArticleId><ArticleId IdType="pmc">PMC8678195</ArticleId><ArticleId IdType="pubmed">34482320</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Z, Zhang J, Hong J, et al. Development of a nomogram to predict 28-day mortality of patients with sepsis-induced coagulopathy: an analysis of the MIMIC-III database. Front Med (Lausanne). 2021;8:661710. doi: 10.3389/fmed.2021.661710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.661710</ArticleId><ArticleId IdType="pmc">PMC8056034</ArticleId><ArticleId IdType="pubmed">33889591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y, Zhang L, Xu F, et al. Risk factor analysis and nomogram for predicting in-hospital mortality in ICU patients with sepsis and lung infection. BMC Pulm Med. 2022;22(1):17. doi: 10.1186/s12890-021-01809-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01809-8</ArticleId><ArticleId IdType="pmc">PMC8739695</ArticleId><ArticleId IdType="pubmed">34991569</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29246418</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5727</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>7</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Assessment of adrenomedullin and proadrenomedullin as predictors of mortality in septic patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>416</StartPage><EndPage>424</EndPage><MedlinePgn>416-424</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2017.10.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(17)30309-1</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To ascertain the ability of adrenomedullin (ADM) and proadrenomedullin (proADM) to predict mortality in sepsis patients.</AbstractText><AbstractText Label="DESIGN">A systematic literature search was made of the PubMed, EMBASE, Cochrane and China National Knowledge Infrastructure (CNKI) databases before May 2017, supplemented by manual searches of references. A meta-analysis of high-quality clinical studies was subsequently performed to assess the association between ADM/proADM and mortality risk among patients with sepsis.</AbstractText><AbstractText Label="PATIENTS">Thirteen studies involving 2556 patients were included in the study.</AbstractText><AbstractText Label="INTERVENTIONS">Two reviewers independently identified articles, extracted data, assessed quality and cross-checked the results. The predictive values of ADM and proADM referred to mortality were assessed by relative risk (RR). The overall diagnostic accuracy of ADM and proADM in application to sepsis was pooled according to a bivariate model. Publication bias was assessed using Deek's funnel plot asymmetry test.</AbstractText><AbstractText Label="RESULTS">Elevated ADM or proADM levels were associated with increased mortality (pooled RR=3.31; 95%CI 2.31-4.75). Subgroup analyses indicated the pooled RRs were 3.12 (95%CI 1.75-5.56) and 3.43 (95%CI 2.21-5.31) for ADM and proADM, respectively. The pooled sensitivity and specificity were 0.72 (95%CI 0.64-0.78) and 0.77 (95%CI 0.69-0.83), respectively. The overall area under the summary receiver operating characteristic (SROC) curve was 0.80 (95%CI 0.77-0.84). Publication bias was not statistically significant.</AbstractText><AbstractText Label="CONCLUSIONS">Both ADM and proADM might serve as useful markers for predicting the prognosis of sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Espa&#xf1;a, S.L.U. y SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Q</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>B S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>L B</ForeName><Initials>LB</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>3rd Department of General Surgery, First Hospital of Lanzhou University, Lanzhou 730000, China. Electronic address: chasechai@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva (Engl Ed)</MedlineTA><NlmUniqueID>101717568</NlmUniqueID><ISSNLinking>2173-5727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507862">ADM protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C088633">proadrenomedullin</NameOfSubstance></Chemical><Chemical><RegistryNumber>148498-78-6</RegistryNumber><NameOfSubstance UI="D053607">Adrenomedullin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D053607" MajorTopicYN="N">Adrenomedullin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adrenomedulina</Keyword><Keyword MajorTopicYN="N">Adrenomedullin</Keyword><Keyword MajorTopicYN="N">Mortalidad</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Proadrenomedulina</Keyword><Keyword MajorTopicYN="N">Proadrenomedullin</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>10</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29246418</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2017.10.013</ArticleId><ArticleId IdType="pii">S0210-5691(17)30309-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27238923</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-2990</ISSN><JournalIssue CitedMedium="Internet"><Volume>351</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The American journal of the medical sciences</Title><ISOAbbreviation>Am J Med Sci</ISOAbbreviation></Journal><ArticleTitle>Risk Factors and Outcomes in Patients With Hypernatremia and Sepsis.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>605</EndPage><MedlinePgn>601-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjms.2016.01.027</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9629(16)30210-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hypernatremia is an uncommon but important electrolyte abnormality in intensive care unit patients. Sepsis is one of the most common causes of intensive care unit admission, but few studies about the role of hypernatremia in sepsis has been published yet. In this study, we aimed to explore the risk factors for developing hypernatremia in patients with sepsis, and the prognosis of patients with sepsis with or without hypernatremia was also assessed.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">In this retrospective cohort study of 51 septic intensive care unit patients at a single center, we examined the risk factors for the development of hypernatremia and the association of hypernatremia with clinical outcomes using univariate and multivariable analyses. Clinical outcomes such as mortality and hospital duration of patients with or without hypernatremia were also compared.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Acute Physiology and Chronic Health Evaluation II score (odds ratio = 1.15; 95% CI: 1.022-1.294) was found to be the only independent risk factor for hypernatremia in patients with sepsis. Moreover, patients developing hypernatremia during hospitalization showed significantly higher morbidity and mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Acute Physiology and Chronic Health Evaluation II score may be an independent risk factor for hypernatremia in patients with sepsis. Moreover, hypernatremia is strongly associated with worse outcome in sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Hai-Bin</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China. Electronic address: nihaibingicu@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Xing-Xing</ForeName><Initials>XX</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiao-Fei</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ke-Qin</ForeName><Initials>KQ</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chen-Bin</ForeName><Initials>CB</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiao-Meng</ForeName><Initials>XM</Initials><AffiliationInfo><Affiliation>Department of Emergency, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ke</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu Province, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Med Sci</MedlineTA><NlmUniqueID>0370506</NlmUniqueID><ISSNLinking>0002-9629</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Am J Med Sci. 2016 Jun;351(6):606. doi: 10.1016/j.amjms.2016.03.015.</RefSource><PMID Version="1">27238924</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006955" MajorTopicYN="N">Hypernatremia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypernatremia</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Risk factors</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>11</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>1</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27238923</ArticleId><ArticleId IdType="doi">10.1016/j.amjms.2016.01.027</ArticleId><ArticleId IdType="pii">S0002-9629(16)30210-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31246600</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>131</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Blood Purification and Mortality in Sepsis and Septic Shock: A Systematic Review and Meta-analysis of Randomized Trials.</ArticleTitle><Pagination><StartPage>580</StartPage><EndPage>593</EndPage><MedlinePgn>580-593</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000002820</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis and septic shock are severe inflammatory conditions related to high morbidity and mortality. We performed a systematic review with meta-analysis of randomized trials to assess whether extracorporeal blood purification reduces mortality in this setting.</AbstractText><AbstractText Label="METHODS">Electronic databases were searched for pertinent studies up to January 2019. We included randomized controlled trials on the use of hemoperfusion, hemofiltration without a renal replacement purpose, and plasmapheresis as a blood purification technique in comparison to conventional therapy in adult patients with sepsis and septic shock. The primary outcome was mortality at the longest follow-up available. We calculated relative risks and 95% CIs. The grading of recommendations assessment, development and evaluation methodology for the certainty of evidence was used.</AbstractText><AbstractText Label="RESULTS">Thirty-seven trials with 2,499 patients were included in the meta-analysis. Hemoperfusion was associated with lower mortality compared to conventional therapy (relative risk = 0.88 [95% CI, 0.78 to 0.98], P = 0.02, very low certainty evidence). Low risk of bias trials on polymyxin B immobilized filter hemoperfusion showed no mortality difference versus control (relative risk = 1.14 [95% CI, 0.96 to 1.36], P = 0.12, moderate certainty evidence), while recent trials found an increased mortality (relative risk = 1.22 [95% CI, 1.03 to 1.45], P = 0.02, low certainty evidence); trials performed in the United States and Europe had no significant difference in mortality (relative risk = 1.13 [95% CI, 0.96 to 1.34], P = 0.15), while trials performed in Asia had a positive treatment effect (relative risk = 0.57 [95% CI, 0.47 to 0.69], P &lt; 0.001). Hemofiltration (relative risk = 0.79 [95% CI, 0.63 to 1.00], P = 0.05, very low certainty evidence) and plasmapheresis (relative risk = 0.63 [95% CI, 0.42 to 0.96], P = 0.03, very low certainty evidence) were associated with a lower mortality.</AbstractText><AbstractText Label="CONCLUSIONS">Very low-quality randomized evidence demonstrates that the use of hemoperfusion, hemofiltration, or plasmapheresis may reduce mortality in sepsis or septic shock. Existing evidence of moderate quality and certainty does not provide any support for a difference in mortality using polymyxin B hemoperfusion. Further high-quality randomized trials are needed before systematic implementation of these therapies in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Putzu</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the Division of Anesthesiology, Department of Anesthesiology, Pharmacology, Intensive Care, and Emergency Medicine, Geneva University Hospitals, Geneva, Switzerland (A.P., R.S.) the Hospital Universitari de Bellvitge, Intensive Care Department, and the Biomedical Investigation Institute of Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain (J.C.L.-D.) the Department of Cardiovascular Anesthesia and Intensive Care, Cardiocentro Ticino, Lugano, Switzerland (T.C.) the Department of Anaesthesia and Intensive Care, San Raffaele Scientific Institute, Milan, Italy (G.L.) Vita-Salute San Raffaele University, Milan, Italy (G.L.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schorer</LastName><ForeName>Raoul</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Lopez-Delgado</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Cassina</LastName><ForeName>Tiziano</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006440" MajorTopicYN="N">Hemofiltration</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31246600</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000002820</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38871280</PMID><DateCompleted><Year>2024</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Resilience, Survival, and Functional Independence in Older Adults Facing Critical Illness.</ArticleTitle><Pagination><StartPage>1431</StartPage><EndPage>1441</EndPage><MedlinePgn>1431-1441</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2024.04.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(24)00700-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Older adults surviving critical illness often experience new or worsening functional impairments. Modifiable positive psychological constructs such as resilience may mitigate post-intensive care morbidity.</AbstractText><AbstractText Label="RESEARCH QUESTION" NlmCategory="OBJECTIVE">Is pre-ICU resilience associated with: (1) post-ICU survival; (2) the drop in functional independence during the ICU stay; or (3) the trend in predicted independence before vs&#xa0;after the ICU stay?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="METHODS">This retrospective cohort study was performed by using Medicare-linked Health and Retirement Study surveys from 2006 to 2018. Older adults aged&#xa0;&#x2265; 65 years admitted to an ICU were included. Resilience was calculated prior to ICU admission. The resilience measure was defined from the Simplified Resilience Score, which was previously adapted and validated for the Health and Retirement Study. Resilience was scored by using the Leave-Behind survey normalized to a scale from 0 (lowest resilience) to 12 (highest resilience). Outcomes were survival and probability of functional independence. Survival was modeled by using Gompertz models and independence using joint survival models adjusting for sociodemographic and clinical variables. Average marginal effects were estimated to determine independence probabilities.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Across 3,409 patients&#xa0;aged &#x2265; 65 years old admitted to ICUs, preexisting frailty (30.5%) and cognitive impairment (24.3%) were common. Most patients were previously independent (82.7%). Mechanical ventilation occurred in 14.8%&#xa0;and sepsis in 43.2%. Those in the highest resilience group (vs&#xa0;lowest resilience) had a lower risk of post-ICU mortality (adjusted hazard ratio, 0.81; 95%&#xa0;CI, 0.70-0.94). Higher resilience was associated with greater likelihood of post-ICU functional independence (estimated probability of functional independence 5 years after ICU discharge in highest-to-lowest resilience groups (adjusted hazard ratio [95%&#xa0;CI]): 0.53 (0.33-0.74), 0.47 (0.26-0.68), 0.49 (0.28-0.70), and 0.36 (0.17-0.55); P&#xa0;&lt; .01. Resilience was not associated with a difference in the drop in independence during the ICU stay or a difference in the pre-ICU vs post-ICU trend in predicted independence .</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">ICU survivors with higher resilience had increased rates of survival and functional independence, although the slope of functional decline before vs after the ICU stay did not differ according to resilience group.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cobert</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Anesthesia Service, San Francisco VA Health Care System, San Francisco, CA; Department of Anesthesiology, University of California San Francisco, San Francisco, CA. Electronic address: Julien.cobert@ucsf.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Sun Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Geriatrics, Palliative, and Extended Care, Veterans Affairs Medical Center, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boscardin</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA; Geriatrics, Palliative, and Extended Care, Veterans Affairs Medical Center, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chapman</LastName><ForeName>Allyson C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Critical Care and Palliative Medicine, Department of Internal Medicine, University of California San Francisco, San Francisco, CA; Department of Surgery, University of California San Francisco, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Espejo</LastName><ForeName>Edie</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA; Geriatrics, Palliative, and Extended Care, Veterans Affairs Medical Center, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maley</LastName><ForeName>Jason H</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Sei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Geriatrics, Palliative, and Extended Care, Veterans Affairs Medical Center, San Francisco, CA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Alexander K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Division of Geriatrics, Department of Medicine, University of California San Francisco, San Francisco, CA; Geriatrics, Palliative, and Extended Care, Veterans Affairs Medical Center, San Francisco, CA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055500" MajorTopicYN="Y">Resilience, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085542" MajorTopicYN="N">Functional Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">recovery of function</Keyword><Keyword MajorTopicYN="N">resilience</Keyword></KeywordList><CoiStatement>Financial/Nonfinancial Disclosures None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>12</Month><Day>12</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>14</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>19</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38871280</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2024.04.039</ArticleId><ArticleId IdType="pii">S0012-3692(24)00700-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27684877</PMID><DateCompleted><Year>2017</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>39</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Prevalence and risk factors of sepsis-induced cardiomyopathy: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>e5031</StartPage><MedlinePgn>e5031</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e5031</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000005031</ELocationID><Abstract><AbstractText>The aim of the study is to evaluate the epidemiology and clinical features of sepsis-induced cardiomyopathy (SICM).A retrospective cohort study was conducted.A total of 210 adult patients with sepsis or septic shock admitted to a Japanese tertiary care hospital from January 1, 2013, to December 31, 2015, who underwent transthoracic echocardiography (TTE) on admission.The definition of SICM was ejection fraction (EF)&#x200a;&lt;&#x200a;50% and a &#x2265;10% decrease compared to the baseline EF which recovered within 2 weeks, in sepsis or septic shock patients.Our primary outcome was the incidence rate of SICM. Our secondary outcomes were the in-hospital mortality rate and length of intensive care unit (ICU) stay according to the presence or absence of SICM. In total, 29 patients (13.8%) were diagnosed with SICM. The prevalence rate of SICM was significantly higher in male than in female (P = 0.02). Multivariate logistic regression analyses revealed that the incidence of SICM was associated with younger age (odds ratio [OR], 0.97; 95% confidence interval [CI], 0.95-0.99), higher lactate level on admission (OR, 1.18; 95% CI, 1.05-1.32) and history of heart failure (HF) (OR, 3.77; 95% CI, 1.37-10.40). There were no significant differences in the in-hospital and 30-day mortality between patients with and without SICM (24.1% vs 12.7%, P = 0.15; 20.7% vs 12.1%, P = 0.23). Lengths of hospital and ICU stay were significantly longer in patients with SICM than in those without SICM (median, 43 vs 26 days, P = 0.04; 9 vs 5 days, P&#x200a;&lt;&#x200a;0.01).SICM developed in 13.8% of patients with sepsis and septic shock. A younger age, higher lactate levels on admission and history of HF were risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Ryota</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>aDepartment of Emergency and Critical Care Medicine, Urasoe General Hospital bDepartment of General Medicine, Kurashiki Central Hospital cDepartment of Anesthesia, Urasoe General Hospital, Okinawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuriyama</LastName><ForeName>Akira</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Takada</LastName><ForeName>Tadaaki</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Nasu</LastName><ForeName>Michitaka</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Luthe</LastName><ForeName>Sarah Kyuragi</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding and conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27684877</ArticleId><ArticleId IdType="pmc">PMC5265970</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000005031</ArticleId><ArticleId IdType="pii">00005792-201609270-00087</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 1984; 100:483&#x2013;490.</Citation><ArticleIdList><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R, Nasu M. A review of sepsis-induced cardiomyopathy. J Intensive care 2015; 3:48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4642671</ArticleId><ArticleId IdType="pubmed">26566443</ArticleId></ArticleIdList></Reference><Reference><Citation>Flesch M, Kilter H, Cremers B, et al. Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite. J Am Coll Cardiol 1999; 33:1062&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">10091837</ArticleId></ArticleIdList></Reference><Reference><Citation>Natanson C, Eichenholz Pw Fau - Danner RL, Danner Rl Fau-Eichacker PQ, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989; 169:823&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189288</ArticleId><ArticleId IdType="pubmed">2647895</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Thota V, Fau - Dee L, et al. Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med 1996; 183:949&#x2013;958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2192364</ArticleId><ArticleId IdType="pubmed">8642298</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315:801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardin F, Brun-Ney D, Auvert B, et al. Sepsis-related cardiogenic shock. Crit Care Med 1990; 18:1055&#x2013;1060.</Citation><ArticleIdList><ArticleId IdType="pubmed">2209030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard Baron A, Schmitt JM, Beauchet A, et al. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology 2001; 94:400&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">11374597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med 2009; 37:441&#x2013;447.</Citation><ArticleIdList><ArticleId IdType="pubmed">19114917</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A, Caille V, Charron C, et al. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med 2008; 36:1701&#x2013;1706.</Citation><ArticleIdList><ArticleId IdType="pubmed">18496368</ArticleId></ArticleIdList></Reference><Reference><Citation>Etchecopar-Chevreuil C, Francois B, Clavel M, et al. Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study. Intensive Care Med 2008; 34:250&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004543</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Repesse X, Fau-Charron C, Charron C, et al. Evaluation of left ventricular systolic function revisited in septic shock. Crit Care (London, England) 2013; 17:164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3706940</ArticleId><ArticleId IdType="pubmed">23826739</ArticleId></ArticleIdList></Reference><Reference><Citation>Gattinoni L, Brazzi L, Pelosi P, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 1995; 333:1025&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">7675044</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Timmins AC, Yau EH, et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717&#x2013;1722.</Citation><ArticleIdList><ArticleId IdType="pubmed">7993413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez G, Bruhn A, Luengo C, et al. Effects of dobutamine on systemic, regional and microcirculatory perfusion parameters in septic shock: a randomized, placebo-controlled, double-blind, crossover study. Intensive Care Med 2013; 39:1435&#x2013;1443.</Citation><ArticleIdList><ArticleId IdType="pubmed">23740284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyte M, Freestone PP, Neal CP, et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet (London, England) 2003; 361:130&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531580</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkman E, Kaukonen KM, Pettila V, et al. Association between inotrope treatment and 90-day mortality in patients with septic shock. Acta Anaesthesiologica Scandinavica 2013; 57:431&#x2013;442.</Citation><ArticleIdList><ArticleId IdType="pubmed">23298252</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA 2013; 310:1683&#x2013;1691.</Citation><ArticleIdList><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care (London, England) 2013; 17:R96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056117</ArticleId><ArticleId IdType="pubmed">23706109</ArticleId></ArticleIdList></Reference><Reference><Citation>Robotham JL, Takata M, Fau-Berman M, et al. Ejection fraction revisited. Anesthesiology 1991; 74:172&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">1986643</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, et al. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA 2014; 311:1308&#x2013;1316.</Citation><ArticleIdList><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23372722</PMID><DateCompleted><Year>2013</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2013</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>e54431</StartPage><MedlinePgn>e54431</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e54431</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0054431</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">It is currently unclear whether parenteral selenium supplementation should be recommended in the management of critically ill patients. Here we conducted a systematic review and meta-analysis to assess the efficacy of parenteral selenium supplementation on clinical outcomes.</AbstractText><AbstractText Label="METHODS/PRINCIPAL FINDINGS" NlmCategory="RESULTS">Randomized trials investigating parenteral selenium supplementation administered in addition to standard of care to critically ill patients were included. CENTRAL, Medline, EMBASE, the Science Citation Index, and CINAHL were searched with complementary manual searches. The primary outcome was all-cause mortality. Trials published in any language were included. Two authors independently extracted data and assessed trial quality. A third author was consulted to resolve disagreements and for quality assurance. Twelve trials were included and meta-analysis was performed on nine trials that recruited critically ill septic patients. These comprised 965 participants in total. Of these, 148 patients (30.7%) in the treatment groups, and 180 patients (37.3%) in control groups died. Parenteral selenium treatment significantly reduced all-cause mortality in critically ill patients with sepsis (relative risk [RR] 0.83, 95% CI 0.70-0.99, p&#x200a;=&#x200a;0.04, I(2)&#x200a;=&#x200a;0%). Subgroup analyses demonstrated that the administration schedule employing longer duration (RR 0.77, 95% CI 0.63-0.94, p&#x200a;=&#x200a;0.01, I(2)&#x200a;=&#x200a;0%), loading boluses (RR 0.73, 95% CI 0.58-0.94, p&#x200a;=&#x200a;0.01, I(2)&#x200a;=&#x200a;0%) or high-dose selenium treatment (RR 0.77, 95% CI 0.61-0.99, p&#x200a;=&#x200a;0.04, I(2)&#x200a;=&#x200a;0%) might be associated with a lower mortality risk. There was no evidence of adverse events.</AbstractText><AbstractText Label="CONCLUSIONS/SIGNIFICANCE" NlmCategory="CONCLUSIONS">Parenteral selenium supplementation reduces risk of mortality among critically ill patients with sepsis. Owing to the varied methodological quality of the studies, future high-quality randomized trials that directly focus on the effect of adequate-duration of parenteral selenium supplementation for severe septic patients are needed to confirm our results. Clinicians should consider these findings when treating this high-risk population.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="BACKGROUND">PROSPERO 2011; CRD42011001768.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Ting-Shuo</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Keelung Branch, Keelung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shyu</LastName><ForeName>Yu-Chiau</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Huang-Yang</ForeName><Initials>HY</Initials></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Li-Mei</ForeName><Initials>LM</Initials></Author><Author ValidYN="Y"><LastName>Lo</LastName><ForeName>Chia-Ying</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Shin-Sheng</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Pei-Jer</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>H6241UJ22B</RegistryNumber><NameOfSubstance UI="D012643">Selenium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007263" MajorTopicYN="N">Infusions, Parenteral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012643" MajorTopicYN="N">Selenium</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000178" MajorTopicYN="Y">diet therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>7</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2013</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23372722</ArticleId><ArticleId IdType="pmc">PMC3555933</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0054431</ArticleId><ArticleId IdType="pii">PONE-D-12-28370</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mann EA, Baun MM, Meininger JC, Wade CE (2012) Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock 37: 4&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">21941222</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Aegerter P, Jars-Guincestre MC, Guidet B (2003) Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 168: 165&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">12851245</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348: 1546&#x2013;1554.</Citation><ArticleIdList><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Suffredini AF, Munford RS (2011) Novel therapies for septic shock over the past 4 decades. JAMA 306: 194&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">21750297</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA (2006) Management of sepsis. N Engl J Med 355: 1699&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pubmed">17050894</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL (2004) Evidence-based medicine in the ICU: important advances and limitations. Chest 126: 592&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">15302748</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones NE, Heyland DK (2008) Pharmaconutrition: a new emerging paradigm. Curr Opin Gastroenterol 24: 215&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pubmed">18301274</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupertuis YM, Meguid MM, Pichard C (2009) Advancing from immunonutrition to a pharmaconutrition: a gigantic challenge. Curr Opin Clin Nutr Metab Care 12: 398&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">19474715</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy G, Manzanares W (2011) Pharmaconutrition: how has this concept evolved in the last two decades? Nutrition 27: 1090&#x2013;1092.</Citation><ArticleIdList><ArticleId IdType="pubmed">21684119</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayman MP (2012) Selenium and human health. Lancet 379: 1256&#x2013;1268.</Citation><ArticleIdList><ArticleId IdType="pubmed">22381456</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Rose AH, Hoffmann PR (2012) The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 16: 705&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277928</ArticleId><ArticleId IdType="pubmed">21955027</ArticleId></ArticleIdList></Reference><Reference><Citation>Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, et al. (1998) Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 26: 1536&#x2013;1544.</Citation><ArticleIdList><ArticleId IdType="pubmed">9751590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Reinhart K, Bloos F, Marx G, Russwurm S, et al. (2007) Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 98: 775&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">17478454</ArticleId></ArticleIdList></Reference><Reference><Citation>McClave SA, Martindale RG, Vanek VW, McCarthy M, Roberts P, et al. (2009) Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr 33: 277&#x2013;316.</Citation><ArticleIdList><ArticleId IdType="pubmed">19398613</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, et al. (2009) ESPEN Guidelines on Parenteral Nutrition: intensive care. Clin Nutr 28: 387&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">19505748</ArticleId></ArticleIdList></Reference><Reference><Citation>Avenell A, Noble DW, Barr J, Engelhardt T (2004) Selenium supplementation for critically ill adults. Cochrane Database Syst Rev CD003703.</Citation><ArticleIdList><ArticleId IdType="pubmed">15495061</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenta J, Brodska H, Drabek T, Hendl J, Kazda A (2011) High-dose selenium substitution in sepsis: a prospective randomized clinical trial. Intensive Care Med 37: 808&#x2013;815.</Citation><ArticleIdList><ArticleId IdType="pubmed">21347869</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzanares W, Biestro A, Torre MH, Galusso F, Facchin G, et al. (2011) High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation. Intensive Care Med 37: 1120&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">21445641</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews PJ, Avenell A, Noble DW, Campbell MK, Croal BL, et al. (2011) Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 342: d1542.</Citation><ArticleIdList><ArticleId IdType="pubmed">21415104</ArticleId></ArticleIdList></Reference><Reference><Citation>
Huang TS, Lin LM, Lo CY, Shih JN, Chen HY, et al. (2011) Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis of randomized controlled trials. PROSPERO
2011: CRD42011001768
Available from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42011001768 Accessed 1 January 2013.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3555933</ArticleId><ArticleId IdType="pubmed">23372722</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley RD, Higgins JP, Deeks JJ (2011) Interpretation of random effects meta-analyses. BMJ 342: d549.</Citation><ArticleIdList><ArticleId IdType="pubmed">21310794</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335: 914&#x2013;916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2048840</ArticleId><ArticleId IdType="pubmed">17974687</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher J (2007) What is heterogeneity and is it important? BMJ 334: 94&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1767262</ArticleId><ArticleId IdType="pubmed">17218716</ArticleId></ArticleIdList></Reference><Reference><Citation>Petitti DB (2001) Approaches to heterogeneity in meta-analysis. Stat Med 20: 3625&#x2013;3633.</Citation><ArticleIdList><ArticleId IdType="pubmed">11746342</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559&#x2013;1573.</Citation><ArticleIdList><ArticleId IdType="pubmed">12111920</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuklinski B, Buchner M, Schweder R, Nagel R (1991) [Acute pancreatitis&#x2013;a free radical disease. Decrease in fatality with sodium selenite (Na2SeO3) therapy]. Z Gesamte Inn Med 46: 145&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">1648849</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann T, Albrecht S, Kuhne H, Vogelsang U, Grutzmann R, et al. (1997) [Selenium administration in patients with sepsis syndrome. A prospective randomized study]. Med Klin (Munich) 92 Suppl 3: 3&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">9417494</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Schottdorf J, Schopohl J, Gaertner R (1999) Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 27: 1807&#x2013;1813.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507602</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger MM, Reymond MJ, Shenkin A, Rey F, Wardle C, et al. (2001) Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 27: 91&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">11280679</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Lindner J, Baumann G, Dawczynski H, Bauch K (2004) [Investigation of antioxidant therapy with sodium selenite in acute pancreatitis. A prospective randomized blind trial]. Med Klin (Munich) 99: 708&#x2013;712.</Citation><ArticleIdList><ArticleId IdType="pubmed">15599680</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, et al. (2007) Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 35: 118&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pubmed">17095947</ArticleId></ArticleIdList></Reference><Reference><Citation>Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, et al. (2007) Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care 11: R73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2206523</ArticleId><ArticleId IdType="pubmed">17617901</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, et al. (2007) Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 26: 41&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17174015</ArticleId></ArticleIdList></Reference><Reference><Citation>Forceville X (2007) Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study&#x2013;selenium and sepsis. J Trace Elem Med Biol 21 Suppl 1: 62&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">18039501</ArticleId></ArticleIdList></Reference><Reference><Citation>
Montoya GCHL, Villalobos SJA, Olvera GC, Aguirre SJ, Franco GJ (2009) Anti-inflammatory effect of selenium in septic patients. Rev Asoc Mex Med Crit y Ter Int
23: 199&#x2013;205
Available from http://new.medigraphic.com/cgi-bin/informacion.cgi?IDREVISTA=20 Accessed 1 January 2013.
</Citation></Reference><Reference><Citation>Rayman MP (2000) The importance of selenium to human health. Lancet 356: 233&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">10963212</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzanares W, Hardy G (2009) Selenium supplementation in the critically ill: posology and pharmacokinetics. Curr Opin Clin Nutr Metab Care 12: 273&#x2013;280.</Citation><ArticleIdList><ArticleId IdType="pubmed">19333120</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA (2009) The sepsis seesaw: tilting toward immunosuppression. Nat Med 15: 496&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3786779</ArticleId><ArticleId IdType="pubmed">19424209</ArticleId></ArticleIdList></Reference><Reference><Citation>Limaye AP, Kirby KA, Rubenfeld GD, Leisenring WM, Bulger EM, et al. (2008) Cytomegalovirus reactivation in critically ill immunocompetent patients. JAMA 300: 413&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2774501</ArticleId><ArticleId IdType="pubmed">18647984</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt CE, Combes A, Deback C, Aubriot-Lorton MH, Nieszkowska A, et al. (2007) Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med 175: 935&#x2013;942.</Citation><ArticleIdList><ArticleId IdType="pubmed">17234903</ArticleId></ArticleIdList></Reference><Reference><Citation>Boomer JS, To K, Chang KC, Takasu O, Osborne DF, et al. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594&#x2013;2605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3361243</ArticleId><ArticleId IdType="pubmed">22187279</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy G, Hardy I, Manzanares W (2012) Selenium supplementation in the critically ill. Nutr Clin Pract 27: 21&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">22307489</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzanares W, Dhaliwal R, Jiang X, Murch L, Heyland DK (2012) Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care 16: R66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3681395</ArticleId><ArticleId IdType="pubmed">22534505</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25489947</PMID><DateCompleted><Year>2015</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>12</Issue><PubDate><Year>2014</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Spontaneous neutrophil migration patterns during sepsis after major burns.</ArticleTitle><Pagination><StartPage>e114509</StartPage><MedlinePgn>e114509</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e114509</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0114509</ELocationID><Abstract><AbstractText>Finely tuned to respond quickly to infections, neutrophils have amazing abilities to migrate fast and efficiently towards sites of infection and inflammation. Although neutrophils ability to migrate is perturbed in patients after major burns, no correlations have yet been demonstrated between altered migration and higher rate of infections and sepsis in these patients when compared to healthy individuals. To probe if such correlations exist, we designed microfluidic devices to quantify the neutrophil migration phenotype with high precision. Inside these devices, moving neutrophils are confined in channels smaller than the neutrophils and forced to make directional decisions at bifurcations and around posts. We employed these devices to quantify neutrophil migration across 18 independent parameters in 74 blood samples from 13 patients with major burns and 3 healthy subjects. Blinded, retrospective analysis of clinical data and neutrophil migration parameters revealed that neutrophils isolated from blood samples collected during sepsis migrate spontaneously inside the microfluidic channels. The spontaneous neutrophil migration is a unique phenotype, typical for patients with major burns during sepsis and often observed one or two days before the diagnosis of sepsis is confirmed. The spontaneous neutrophil migration phenotype is rare in patients with major burns in the absence of sepsis, and is not encountered in healthy individuals. Our findings warrant further studies of neutrophils and their utility for early diagnosing and monitoring sepsis in patients after major burns.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Caroline N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Boston, Massachusetts, United States of America; Shriners Hospital for Children, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Molly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimisko</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alexander</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibrahim</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Shriners Hospital for Children, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassell</LastName><ForeName>Bryan A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warren</LastName><ForeName>H Shaw</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Shriners Hospital for Children, Boston, Massachusetts, United States of America; Departments of Pediatrics and Medicine, Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tompkins</LastName><ForeName>Ronald G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fagan</LastName><ForeName>Shawn P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irimia</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Surgery Department, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; BioMEMS Resource Center, Center for Engineering in Medicine and Surgical Services, Boston, Massachusetts, United States of America; Shriners Hospital for Children, Boston, Massachusetts, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>U54 GM062119</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007035</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM007035</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R24 GM102656</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM092804</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>GM092804</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>EB002503</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P41 EB002503</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C563515">Neutrophil Chemotactic Response, Abnormal</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007154" MajorTopicYN="N">Immune System Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007960" MajorTopicYN="N">Leukocyte Disorders</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046210" MajorTopicYN="N">Microfluidic Analytical Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>11</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25489947</ArticleId><ArticleId IdType="pmc">PMC4260850</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0114509</ArticleId><ArticleId IdType="pii">PONE-D-14-33885</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D'Avignon LC, Hogan BK, Murray CK, Loo FL, Hospenthal DR, et al. (2010) Contribution of bacterial and viral infections to attributable mortality in patients with severe burns: An autopsy series. Burns 36:773&#x2013;779.</Citation><ArticleIdList><ArticleId IdType="pubmed">20074860</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, et al. (2009) The leading causes of death after burn injury in a single pediatric burn center. Crit Care 13:R183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811947</ArticleId><ArticleId IdType="pubmed">19919684</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Ellis P, Arabi Y, Roberts D, Light B, et al. (2009) Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest 136:1237&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pubmed">19696123</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier PE, Drancourt M, Colson P, Rolain JM, La SB, et al. (2013) Modern clinical microbiology: new challenges and solutions. NatRevMicrobiol 11:574&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097238</ArticleId><ArticleId IdType="pubmed">24020074</ArticleId></ArticleIdList></Reference><Reference><Citation>Seng P, Rolain JM, Fournier PE, La SB, Drancourt M, et al. (2010) MALDI-TOF-mass spectrometry applications in clinical microbiology. FutureMicrobiol 5:1733&#x2013;1754.</Citation><ArticleIdList><ArticleId IdType="pubmed">21133692</ArticleId></ArticleIdList></Reference><Reference><Citation>Branski LK, Al-Mousawi A, Rivero H, Jeschke MG, Sanford AP, et al. (2009) Emerging infections in burns. SurgInfect(Larchmt) 10:389&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2956561</ArticleId><ArticleId IdType="pubmed">19810827</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard GR, Vincent JL, Laterre PF, Larosa SP, Dhainaut JF, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. NEnglJMed 344:699&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">11236773</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Finnerty CC, Kulp GA, Kraft R, Herndon DN (2013) Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients? IntJBurns Trauma 3:137&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712409</ArticleId><ArticleId IdType="pubmed">23875119</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitrolaki DM, Dimitriou H, Kalmanti M, Briassoulis G (2013) CD64-Neutrophil expression and stress metabolic patterns in early sepsis and severe traumatic brain injury in children. BMCPediatr 13:31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3599547</ArticleId><ArticleId IdType="pubmed">23452299</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjaertoft G, Hakansson LD, Pauksens K, Sisask G, Venge P (2007) Neutrophil CD64 (FcgammaRI) expression is a specific marker of bacterial infection: a study on the kinetics and the impact of major surgery. ScandJInfectDis 39:525&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577814</ArticleId></ArticleIdList></Reference><Reference><Citation>Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin&#x2013;a new indicator of the systemic response to severe infections. Infection 25:329&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102374</ArticleId><ArticleId IdType="pubmed">9427049</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberhoffer M, Karzai W, Meier-Hellmann A, Bogel D, Fassbinder J, et al. (1999) Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis. Crit Care Med 27:1814&#x2013;1818.</Citation><ArticleIdList><ArticleId IdType="pubmed">10507603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual C, Karzai W, Meier-Hellmann A, Oberhoffer M, Horn A, et al. (1998) Total plasma antioxidant capacity is not always decreased in sepsis. Crit Care Med 26:705&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559608</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-Murta BM, Zaparoli M, Ferreira RB, Silva-Vergara ML, Oliveira CH, et al. (2002) Failure of neutrophil chemotactic function in septic patients. Crit Care Med 30:1056&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">12006803</ArticleId></ArticleIdList></Reference><Reference><Citation>Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA (2008) Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. ClinExpImmunol 154:87&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2561092</ArticleId><ArticleId IdType="pubmed">18727624</ArticleId></ArticleIdList></Reference><Reference><Citation>Parihar A, Parihar MS, Milner S, Bhat S (2008) Oxidative stress and anti-oxidative mobilization in burn injury. Burns 34:6&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">17905515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasten KR, Muenzer JT, Caldwell CC (2010) Neutrophils are significant producers of IL-10 during sepsis. BiochemBiophysResCommun 393:28&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2830356</ArticleId><ArticleId IdType="pubmed">20097159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjerknes R, Vindenes H (1989) Neutrophil dysfunction after thermal injury: alteration of phagolysosomal acidification in patients with large burns. Burns 15:77&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">2736052</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyden S (1962) The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med 115:453&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2137509</ArticleId><ArticleId IdType="pubmed">13872176</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Jeon N, Baskaran H, Dertinger SK, Whitesides GM, Van de Water L, et al. (2002) Neutrophil chemotaxis in linear and complex gradients of interleukin-8 formed in a microfabricated device. Nat Biotechnol 20:826&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">12091913</ArticleId></ArticleIdList></Reference><Reference><Citation>Abhyankar VV, Lokuta MA, Huttenlocher A, Beebe DJ (2006) Characterization of a membrane-based gradient generator for use in cell-signaling studies. Lab Chip 6:389&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">16511622</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia D, Liu SY, Tharp WG, Samadani A, Toner M, et al. (2006) Microfluidic system for measuring neutrophil migratory responses to fast switches of chemical gradients. Lab Chip 6:191&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3763904</ArticleId><ArticleId IdType="pubmed">16450027</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenan TM, Folch A (2008) Biomolecular gradients in cell culture systems. Lab Chip 8:34&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848882</ArticleId><ArticleId IdType="pubmed">18094760</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, et al. (2005) Neutrophil migration in opposing chemoattractant gradients using microfluidic chemotaxis devices. Ann Biomed Eng 33:475&#x2013;482.</Citation><ArticleIdList><ArticleId IdType="pubmed">15909653</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadi W, Rhee SW, Lin F, Vahidi B, Chung BG, et al. (2007) Generation of stable concentration gradients in 2D and 3D environments using a microfluidic ladder chamber. Biomed Microdevices 9:627&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pubmed">17530414</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia D, Balazsi G, Agrawal N, Toner M (2009) Adaptive-control model for neutrophil orientation in the direction of chemical gradients. Biophys J 96:3897&#x2013;3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2712156</ArticleId><ArticleId IdType="pubmed">19450463</ArticleId></ArticleIdList></Reference><Reference><Citation>Sackmann EK, Berthier E, Young EW, Shelef MA, Wernimont SA, et al. (2012) Microfluidic kit-on-a-lid: a versatile platform for neutrophil chemotaxis assays. Blood 120:e45&#x2013;e53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3466974</ArticleId><ArticleId IdType="pubmed">22915642</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambravaneswaran V, Wong IY, Aranyosi AJ, Toner M, Irimia D (2010) Directional decisions during neutrophil chemotaxis inside bifurcating channels. Integr Biol (Camb) 2:639&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001269</ArticleId><ArticleId IdType="pubmed">20676444</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia D, Charras G, Agrawal N, Mitchison T, Toner M (2007) Polar stimulation and constrained cell migration in microfluidic channels. Lab Chip 7:1783&#x2013;1790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3001245</ArticleId><ArticleId IdType="pubmed">18030401</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler KL, Ambravaneswaran V, Agrawal N, Bilodeau M, Toner M, et al. (2010) Burn injury reduces neutrophil directional migration speed in microfluidic devices. PLoS One 5:e11921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912851</ArticleId><ArticleId IdType="pubmed">20689600</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjerknes R, Vindenes H, Laerum OD (1990) Altered neutrophil functions in patients with large burns. Blood Cells 16:127&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">2190644</ArticleId></ArticleIdList></Reference><Reference><Citation>de Chalain TM, Bracher M, Linley W, Gerneke D, Hickman R (1994) Cytoskeletal actin: the influence of major burns on neutrophil structure and function. Burns 20:416&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pubmed">7999269</ArticleId></ArticleIdList></Reference><Reference><Citation>Hietbrink F, Koenderman L, Althuizen M, Pillay J, Kamp V, et al. (2013) Kinetics of the innate immune response after trauma: implications for the development of late onset sepsis. Shock 40:21&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">23603769</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y, Goldstein E, Lippert W, Brofeldt T, Donovan R (1989) Polymorphonuclear leucocyte motility in patients with severe burns. Burns 15:93&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">2736054</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomkin JS, Nelson RD, Chenoweth DE, Solem LD, Simmons RL (1984) Regulation of neutrophil migratory function in burn injury by complement activation products. Ann Surg 200:742&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1250592</ArticleId><ArticleId IdType="pubmed">6508405</ArticleId></ArticleIdList></Reference><Reference><Citation>Warden GD, Mason AD Jr, Pruitt BA Jr. (1975) Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Ann Surg 181:363&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1343862</ArticleId><ArticleId IdType="pubmed">1093487</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurihara T, Jones CN, Yu YM, Fischman AJ, Watada S, et al. (2013) Resolvin D2 restores neutrophil directionality and improves survival after burns. Faseb J 27:2270&#x2013;2281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3659356</ArticleId><ArticleId IdType="pubmed">23430978</ArticleId></ArticleIdList></Reference><Reference><Citation>Warden GD, Mason AD Jr., Pruitt BA Jr. (1974) Evaluation of leukocyte chemotaxis in vitro in thermally injured patients. J Clin Invest 54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC301642</ArticleId><ArticleId IdType="pubmed">4430710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza B, Wong E, Patel S, Cho H, Martel J, et al. (2014) Retrotaxis of human neutrophils during mechanical confinement inside microfluidic channels. IntegrBiol(Camb) 6:175&#x2013;183.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928968</ArticleId><ArticleId IdType="pubmed">24419464</ArticleId></ArticleIdList></Reference><Reference><Citation>Irimia D (2010) Microfluidic technologies for temporal perturbations of chemotaxis. Annu Rev Biomed Eng 12:259&#x2013;284.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3153854</ArticleId><ArticleId IdType="pubmed">20450351</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand D, Das S, Bhargava S, Srivastava LM, Garg A, et al.. (2014) Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: A prospective, observational, cohort study. J Crit Care.</Citation><ArticleIdList><ArticleId IdType="pubmed">25263339</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan H, Zhao Y, Zhu JH, Song FC (2014) Urine neutrophil gelatinase-associated lipocalin in septic patients with and without acute kidney injury. Ren Fail 36:1399&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pubmed">25088407</ArticleId></ArticleIdList></Reference><Reference><Citation>Heit B, Robbins SM, Downey CM, Guan Z, Colarusso P, et al. (2008) PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils. NatImmunol 9:743&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pubmed">18536720</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, et al. (2010) Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464:104&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843437</ArticleId><ArticleId IdType="pubmed">20203610</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolaczkowska E, Kubes P (2013) Neutrophil recruitment and function in health and inflammation. NatRevImmunol 13:159&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">23435331</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, et al. (2001) Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. AmJRespirCrit Care Med 164:396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">11500339</ArticleId></ArticleIdList></Reference><Reference><Citation>Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, et al. (2000) Protection from septic shock by neutralization of macrophage migration inhibitory factor. NatMed 6:164&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">10655104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuster H, Weiss M, Willeitner AE, Detlefsen S, Jeremias I, et al. (1998) Interleukin-1 receptor antagonist and interleukin-6 for early diagnosis of neonatal sepsis 2 days before clinical manifestation. Lancet 352:1271&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">9788457</ArticleId></ArticleIdList></Reference><Reference><Citation>Martensson J, Bell M, Oldner A, Xu S, Venge P, et al. (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">20397003</ArticleId></ArticleIdList></Reference><Reference><Citation>Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, et al. (2014) Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns 40:402&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pubmed">23972824</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25218723</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0736-4679</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of emergency medicine</Title><ISOAbbreviation>J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Septic shock and adequacy of early empiric antibiotics in the emergency department.</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>607</EndPage><MedlinePgn>601-7</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jemermed.2014.06.037</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0736-4679(14)00737-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Antibiotic resistance is an increasing concern for Emergency Physicians.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To examine whether empiric antibiotic therapy achieved appropriate antimicrobial coverage in emergency department (ED) septic shock patients and evaluate reasons for inadequate coverage.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective review was performed of all adult septic shock patients presenting to the ED of a tertiary care center from December 2007 to September 2008. Inclusion criteria were: 1) Suspected or confirmed infection; 2) &#x2265; 2 Systemic Inflammatory Response Syndrome criteria; 3) Treatment with one antimicrobial agent; 4) Hypotension requiring vasopressors. Patients were dichotomized by presentation from a community or health care setting.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Eighty-five patients with septic shock were identified. The average age was 68 &#xb1; 15.8 years. Forty-seven (55.3%) patients presented from a health care setting. Pneumonia was the predominant clinically suspected infection (n = 38, 45%), followed by urinary tract (n = 16, 19%), intra-abdominal (n = 13, 15%), and other infections (n = 18, 21%). Thirty-nine patients (46%) had an organism identified by positive culture, of which initial empiric antibiotic therapy administered in the ED adequately covered the infectious organism in 35 (90%). The 4 patients who received inadequate therapy all had urinary tract infections (UTI) and were from a health care setting.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this population of ED patients with septic shock, empiric antibiotic coverage was inadequate in a small group of uroseptic patients with recent health care exposure. Current guidelines for UTI treatment do not consider health care setting exposure. A larger, prospective study is needed to further define this risk category and determine optimal empiric antibiotic therapy for patients.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Flaherty</LastName><ForeName>Sarah K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chase</LastName><ForeName>Maureen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dugas</LastName><ForeName>Andrea F</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Johns Hopkins Medicine, Baltimore, MD.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graver</LastName><ForeName>Amanda M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salciccioli</LastName><ForeName>Justin D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocchi</LastName><ForeName>Michael N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesia Critical Care, Division of Critical Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donnino</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Division of Pulmonary/Critical and Critical Care, Beth Israel Deaconess Medical Center, Boston, Massachusetts.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K02 HL107447</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21AT005119-01</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1K02HL107447-01A1</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 GM101463</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AT005119</GrantID><Acronym>AT</Acronym><Agency>NCCIH NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Emerg Med</MedlineTA><NlmUniqueID>8412174</NlmUniqueID><ISSNLinking>0736-4679</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2015 Apr;193(4):1263-4. doi: 10.1016/j.juro.2015.01.025.</RefSource><PMID Version="1">25890515</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Emerg Med. 2016 Sep;51(3):e63-4. doi: 10.1016/j.jemermed.2015.03.049.</RefSource><PMID Version="1">27156494</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059413" MajorTopicYN="N">Intraabdominal Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="N">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018410" MajorTopicYN="N">Pneumonia, Bacterial</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="N">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antibiotics</Keyword><Keyword MajorTopicYN="N">critical care</Keyword><Keyword MajorTopicYN="N">nosocomial</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">urinary tract infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25218723</ArticleId><ArticleId IdType="mid">NIHMS627833</ArticleId><ArticleId IdType="pmc">PMC4254037</ArticleId><ArticleId IdType="doi">10.1016/j.jemermed.2014.06.037</ArticleId><ArticleId IdType="pii">S0736-4679(14)00737-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spellberg Brad. Rising Plague: The global threat from deadly bacteria and our dwindling arsenal to fight them. Promethus; New York: 2009.</Citation></Reference><Reference><Citation>World Health Organization . WHO Global strategy for containment of antibiotic resistance. Geneva: p. 2001.</Citation></Reference><Reference><Citation>Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010 Mar 1;50(5):625&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pubmed">20175247</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999 Oct;29(4):745&#x2013;758.</Citation><ArticleIdList><ArticleId IdType="pubmed">10589881</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005 Mar 1;40(5):643&#x2013;654.</Citation><ArticleIdList><ArticleId IdType="pubmed">15714408</ArticleId></ArticleIdList></Reference><Reference><Citation>Naber KG, Bergman B, Bishop MC, et al. EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). Eur Urol. 2001 Nov;40(5):576&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">11752870</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(Suppl 2):S27&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107997</ArticleId><ArticleId IdType="pubmed">17278083</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005 Feb 15;171(4):388&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699079</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine. 2001 Jul;29(7):1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A. Optimizing antimicrobial therapy in sepsis and septic shock. Crit Care Clin. 2009 Oct;25(4):733&#x2013;751, viii.</Citation><ArticleIdList><ArticleId IdType="pubmed">19892250</ArticleId></ArticleIdList></Reference><Reference><Citation>Talan DA, Moran GJ, Abrahamian FM. Severe sepsis and septic shock in the emergency department. Infect Dis Clin North Am. 2008 Mar;22(1):1&#x2013;31, v.</Citation><ArticleIdList><ArticleId IdType="pubmed">18295681</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a five fold reduction of survival in human septic shock. Chest. 2009 Nov;136(5):1237&#x2013;1248.</Citation><ArticleIdList><ArticleId IdType="pubmed">19696123</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive care medicine. 2008 Jan;34(1):17&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2249616</ArticleId><ArticleId IdType="pubmed">18058085</ArticleId></ArticleIdList></Reference><Reference><Citation>Glickman SW, Cairns CB, Otero RM, et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Acad Emerg Med. 2010 Apr;17(4):383&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283798</ArticleId><ArticleId IdType="pubmed">20370777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenlehner FM, Weidner W, Naber KG. Optimal management of urosepsis from the urological perspective. Int J Antimicrob Agents. 2007 Nov;30(5):390&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">17728107</ArticleId></ArticleIdList></Reference><Reference><Citation>Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R. Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep. 2004 Mar 26;53(RR-3):1&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15048056</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract. 2002 Aug;51(8):709&#x2013;716.</Citation><ArticleIdList><ArticleId IdType="pubmed">12184969</ArticleId></ArticleIdList></Reference><Reference><Citation>Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit Care Med. 1996 May;153(5):1711&#x2013;1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">8630626</ArticleId></ArticleIdList></Reference><Reference><Citation>Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis. 2002 Nov 15;35(10):1205&#x2013;1211.</Citation><ArticleIdList><ArticleId IdType="pubmed">12410480</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkey PM. The growing burden of antimicrobial resistance. J Antimicrob Chemother. 2008 Sep;62(Suppl 1):i1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18684701</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas AF, Mackenhauer J, Salciccioli JD, Cocchi MN, Gautam S, Donnino MW. Prevalence and characteristics of nonlactate and lactate expressors in septic shock. J Crit Care. 2012 Aug;27(4):344&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3727145</ArticleId><ArticleId IdType="pubmed">22440322</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Official Statement of the American Thoracic Society and the Infectious Disease Society of America. Am J Respir Crit Care Med. 2005;171:388&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">15699079</ArticleId></ArticleIdList></Reference><Reference><Citation>Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodr&#xed;guez-Ba&#xf1;o J. ITUBRAS group. Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect. Oct. 2013;19(10):962&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23279375</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack A. Rising Threat of Infections Unfazed by Antibiotics. New York Times; 2010.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37142091</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Lower vs&#xa0;Higher Fluid Volumes in Adult Patients With Sepsis: An Updated Systematic Review With Meta-Analysis and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>892</StartPage><EndPage>912</EndPage><MedlinePgn>892-912</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2023.04.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(23)00637-2</ELocationID><Abstract><AbstractText Label="BACKGROUND">IV fluids are recommended for adults with sepsis. However, the optimal strategy for IV fluid management in sepsis is unknown, and clinical equipoise exists.</AbstractText><AbstractText Label="RESEARCH QUESTION">Do lower vs&#xa0;higher fluid volumes improve patient-important outcomes in adult patients with sepsis?</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS">We updated a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials assessing lower vs&#xa0;higher IV fluid volumes in adult patients with sepsis. The coprimary outcomes were all-cause mortality, serious adverse events, and health-related quality of life. We followed the recommendations from the Cochrane Handbook and used the Grading of Recommendations Assessment, Development and Evaluation approach. Primary conclusions were based on trials with low risk of bias if available.</AbstractText><AbstractText Label="RESULTS">We included 13 trials (N&#xa0;= 4,006) with four trials (n&#xa0;= 3,385) added to this update. The meta-analysis of all-cause mortality in eight trials with low risk of bias showed a relative risk of 0.99 (97%&#xa0;CI, 0.89-1.10; moderate certainty evidence). Six trials with predefined definitions of serious adverse events showed a relative risk of 0.95 (97%&#xa0;CI, 0.83-1.07; low certainty evidence). Health-related quality of life was not reported.</AbstractText><AbstractText Label="INTERPRETATION">Among adult patients with sepsis, lower IV fluid volumes probably result in little to no difference in all-cause mortality compared with higher IV fluid volumes, but the interpretation is limited by imprecision in the estimate, which does not exclude potential benefit or harm. Similarly, the evidence suggests lower IV fluid volumes result in little to no difference in serious adverse events. No trials reported on health-related quality of life.</AbstractText><AbstractText Label="TRIAL REGISTRATION">PROSPERO; No.: CRD42022312572; URL: https://www.crd.york.ac.uk/prospero/.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sivapalan</LastName><ForeName>Praleene</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark. Electronic address: praleene.sivapalan.01@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ellekjaer</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jessen</LastName><ForeName>Marie K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Research Center for Emergency Medicine, Aarhus University and University Hospital, Aarhus N, Denmark; Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Clinical Science and Education, S&#xf6;dersjukhuset, Section of Anaesthesia and Intensive Care, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark; Department of Cardiothoracic Anaesthesia and Intensive Care, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Private Office, Tuborg Sundpark, Hellerup, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Collaboration for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2023 Oct;164(4):812-813. doi: 10.1016/j.chest.2023.05.027.</RefSource><PMID Version="1">37805236</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="Y">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>5</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>4</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37142091</ArticleId><ArticleId IdType="pmc">PMC10567931</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2023.04.036</ArticleId><ArticleId IdType="pii">S0012-3692(23)00637-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans L., Rhodes A., Alhazzani W., et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd J.H., Forbes J., Nakada T.A., Walley K.R., Russell J.A. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39(2):259&#x2013;265.</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy C.V., Schramm G.E., Doherty J.A., et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest. 2009;136(1):102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19318675</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheampong A., Vincent J.L. A&#xa0;positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4479078</ArticleId><ArticleId IdType="pubmed">26073560</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.H., Perner A. Higher vs. lower fluid volume for septic shock: clinical characteristics and outcome in unselected patients in a prospective, multicenter cohort. Crit Care. 2012;16(3):R76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3580618</ArticleId><ArticleId IdType="pubmed">22568926</ArticleId></ArticleIdList></Reference><Reference><Citation>Maitland K., Kiguli S., Opoka R.O., et al. Mortality after fluid bolus in African children with severe infection. N&#xa0;Engl J Med. 2011;364(26):2483&#x2013;2495.</Citation><ArticleIdList><ArticleId IdType="pubmed">21615299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann H.P., Wheeler A.P., Bernard G.R., et al. Comparison of two fluid-management strategies in acute lung injury. N&#xa0;Engl J Med. 2006;354(24):2564&#x2013;2575.</Citation><ArticleIdList><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronhjort M., Hjortrup P.B., Holst L.B., et al. Association between fluid balance and mortality in patients with septic shock: a post hoc analysis of the TRISS trial. Acta Anaesthesiol Scand. 2016;60(7):925&#x2013;933.</Citation><ArticleIdList><ArticleId IdType="pubmed">27030514</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., M&#xf8;ller M.H., Hjortrup P.B., Cronhjort M., Perner A., Wetterslev J. Lower vs&#xa0;higher fluid volumes during initial management of sepsis: a systematic review with meta-analysis and trial sequential analysis. Chest. 2020;157(6):1478&#x2013;1496.</Citation><ArticleIdList><ArticleId IdType="pubmed">31982391</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro N.I., Douglas I.S., et al. National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network. Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med. 2023;388(6):499&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10685906</ArticleId><ArticleId IdType="pubmed">36688507</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas I.S., Alapat P.M., Corl K.A., et al. Fluid response evaluation in sepsis hypotension and shock: a randomized clinical trial. Chest. 2020;158(4):1431&#x2013;1445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9490557</ArticleId><ArticleId IdType="pubmed">32353418</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., Hjortrup P.B., Wetterslev J., et al. Restriction of intravenous fluid in ICU patients with septic shock. N&#xa0;Engl J Med. 2022;386(26):2459&#x2013;2470.</Citation><ArticleIdList><ArticleId IdType="pubmed">35709019</ArticleId></ArticleIdList></Reference><Reference><Citation>Jessen M.K., Andersen L.W., Thomsen M.H., et al. Restrictive Fluids Versus Standard Care in Adults with Sepsis in the Emergency Department (REFACED): a multicenter, randomized feasibility trial. Acad Emerg Med. 2022;29(10):1172&#x2013;1184.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9804491</ArticleId><ArticleId IdType="pubmed">35652491</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyhoff T.S., M&#xf8;ller M.H., Hjortrup P.B., Cronhjort M., Perner A., Wetterslev J. Lower vs. higher fluid volumes in sepsis&#x2014;protocol for a systematic review with meta-analysis. Acta Anaesthesiol Scand. 2017;61(8):942&#x2013;951.</Citation><ArticleIdList><ArticleId IdType="pubmed">28782112</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., Welch V.A., editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022) Cochrane; 2022. www.training.cochrane.org/handbook Available from.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>H Sch&#xfc;nemann, J Bro&#x17c;ek, G Guyatt and A Oxman, Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Accessed May 25, 2023. GRADEPro GDT website. https://www.guidelinedevelopment.org/handbook</Citation></Reference><Reference><Citation>Page M.J., McKenzie J.E., Bossuyt P.M., et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021:372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Guideine: Integrated Addendum To ICH E6 (R1): Guideline for Good Clinical Practice. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf</Citation></Reference><Reference><Citation>Chen C., Kollef M.H. Targeted fluid minimization following initial resuscitation in septic shock a pilot study. Chest. 2015;148(6):1462&#x2013;1469.</Citation><ArticleIdList><ArticleId IdType="pubmed">26291900</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup P.B., Haase N., Bundgaard H., et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42(11):1695&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Corl K.A., Prodromou M., Merchant R.C., et al. The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): a randomized pilot study. Crit Care Med. 2019;47(7):951&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6579683</ArticleId><ArticleId IdType="pubmed">30985449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cronhjort M., Bergman M., Joelsson-Alm E., et al. Fluid responsiveness assessment using passive leg raising test to reduce fluid administration and weight gain in patients with septic shock. J Anesth Perioper Med. 2017;4 doi: 10.24015/JAPM.2016.0049.</Citation><ArticleIdList><ArticleId IdType="doi">10.24015/JAPM.2016.0049</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald S.P.J., Keijzers G., Taylor D.M.D., et al. Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med. 2018;44(12):2070&#x2013;2078.</Citation><ArticleIdList><ArticleId IdType="pubmed">30382308</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa M.J., Burk R.E., Wilson E.L., Hirshberg E.L., Grissom C.K., Brown S.M. Echocardiogram-guided resuscitation versus early goal-directed therapy in the treatment of septic shock: a randomized, controlled, feasibility trial. J Intensive Care. 2018;6(1):50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6090604</ArticleId><ArticleId IdType="pubmed">30123511</ArticleId></ArticleIdList></Reference><Reference><Citation>Semler M., Janz D.R., Casey J.D., Self W.H., Rice T.W. Conservative fluid management after sepsis resuscitation: a pilot randomized trial. J&#xa0;Intensive Care Med. 2020;35(12):1374&#x2013;1382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620161</ArticleId><ArticleId IdType="pubmed">30630380</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard J.C., Bayle F., Bourdin G., et al. Preload dependence indices to titrate volume expansion during septic shock: a randomized controlled trial. Crit Care. 2015;19(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310180</ArticleId><ArticleId IdType="pubmed">25572383</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne J.A.C., Savovi&#x107; J., Page M.J., et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter B., Gelman A., Hoffman M.D., et al. Stan: a probabilistic programming language. J Stat Softw. 2017;76(1):1. doi: 10.18637/jss.v076.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v076.i01</ArticleId><ArticleId IdType="pmc">PMC9788645</ArticleId><ArticleId IdType="pubmed">36568334</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xfc;rkner P.C. brms: an R package for Bayesian multilevel models using Stan. J Stat Softw. 2017;80(1) doi: 10.18637/jss.v080.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v080.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Jakobsen J.C., Wetterslev J., Winkel P., Lange T., Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14(1):1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4251848</ArticleId><ArticleId IdType="pubmed">25416419</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetterslev J., Thorlund K., Brok J., Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2809074</ArticleId><ArticleId IdType="pubmed">20042080</ArticleId></ArticleIdList></Reference><Reference><Citation>Harbord R.M., Egger M., Sterne J.A.C. A&#xa0;modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443&#x2013;3457.</Citation><ArticleIdList><ArticleId IdType="pubmed">16345038</ArticleId></ArticleIdList></Reference><Reference><Citation>Silversides J.A., Major E., Ferguson A.J., et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43(2):155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">27734109</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkins D., Best D., Briss P.A., et al. Grading quality of evidence and strength of recommendations. BMJ. 2004;328(7454):1490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC428525</ArticleId><ArticleId IdType="pubmed">15205295</ArticleId></ArticleIdList></Reference><Reference><Citation>van Genderen M.E., Engels N., van der Valk R.J.P., et al. Early peripheral perfusion&#x2013;guided fluid therapy in patients with septic shock. Am J Respir Crit Care Med. 2015;191(4):477&#x2013;480.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679107</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed M.F.H., Malewicz N.M., Zehry H.I., et al. Fluid administration in emergency room limited by lung ultrasound in patients with sepsis: protocol for a prospective phase II multicenter randomized controlled trial. JMIR Res Protoc. 2020;9(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7481877</ArticleId><ArticleId IdType="pubmed">32657759</ArticleId></ArticleIdList></Reference><Reference><Citation>Controlled fluid resuscitation in sepsis  . 2023. ClinicalTrials.gov identifier: NCT03214913. Updated July 12, 2017. Accessed August 17,https://classic.clinicaltrials.gov/ct2/show/NCT03214913</Citation></Reference><Reference><Citation>Protocolized reduction of non-resuscitation fluids vs usual care in septic shock  . 2023. ClinicalTrials.gove identifier: NCT05249088. Updated September 29, 2022. Accessed August 17,https://clinicaltrials.gov/study/NCT05249088</Citation></Reference><Reference><Citation>Australian and New Zealand Intensive Care Research Centre. Australasian Resuscitation In Sepsis Evaluation: FLUid or Vasopressors In Emergency Department Sepsis (ARISE FLUIDS). NCT04569942. ClinicalTrials.gov. National Institutes of Health; 2020. Updated July 8, 2022. https://clinicaltrials.gov/show/NCT04569942</Citation></Reference><Reference><Citation>Pontificia Universidad Catolica de Chile. Hemodynamic phenotype and capillary refill time-targeted resuscitation strategy. NCT05057611. ClinicalTrials.gov. National Institutes of Health; 2021. Updated September 14, 2022. https://clinicaltrials.gov/show/NCT05057611</Citation></Reference><Reference><Citation>Lei C. Effects of different fluid resuscitation strategies on intestinal barrier function in patients with septic shock: a pilot, prospective, randomized, controlled trial, Chinese Clinical Trial Register, 2100043734.</Citation></Reference><Reference><Citation>Centre Hospitalier Universitaire de N&#x12b;mes  . National Institutes of Health; 2021. OPTImized Restrictive Strategy Targeting Non-Resuscitative FLUIDs in Septic Shock: pilot study. (OPTIFLUID). NCT04947904. ClinicalTrials.gov.https://clinicaltrials.gov/ct2/show/NCT04947904 Updated April 14, 2023.</Citation></Reference><Reference><Citation>Singer M., Deutschman C.S., Seymour C., et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530&#x2013;538.</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS Greater Glasgow and Clyde. Early Vasopressors in Sepsis (EVIS). NCT05179499. ClinicalTrials.gov. National Institutes of Health; 2022. Updated February 13, 2023. https://www.clinicaltrials.gov/ct2/show/NCT05179499</Citation></Reference><Reference><Citation>Driessen R.G.H., van de Poll M.C.G., Mol M.F., van Mook W.N.K.A., Schnabel R.M. The influence of a change in septic shock definitions on intensive care epidemiology and outcome: comparison of sepsis-2 and sepsis-3 definitions. Infect Dis (Auckl) 2018;50(3):207&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="pubmed">28950786</ArticleId></ArticleIdList></Reference><Reference><Citation>Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer&#x2019;s acetate in severe sepsis. N&#xa0;Engl J Med. 2012;367(2):124&#x2013;134.</Citation><ArticleIdList><ArticleId IdType="pubmed">22738085</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30278945</PMID><DateCompleted><Year>2019</Year><Month>04</Month><Day>22</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>231</Volume><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Mortality after pancreaticoduodenectomy: assessing early and late causes of patient death.</ArticleTitle><Pagination><StartPage>304</StartPage><EndPage>308</EndPage><MedlinePgn>304-308</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2018.05.075</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(18)30375-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Safety of pancreaticoduodenectomy has improved significantly in the past 3&#xa0;decades. Current inpatient and 30-d mortality rates are low. However, incidence and causes of 90-d and 1-y mortality are poorly defined and largely unexplored.</AbstractText><AbstractText Label="METHODS">All patients who had pancreaticoduodenectomy between 2007 and 2016 were included in this single institution, retrospective cohort study. Distributions of pancreaticoduodenectomy-specific morbidity and cause-specific mortality were compared between early (within 90&#xa0;d) and late (91-365&#xa0;d) postoperative recovery periods.</AbstractText><AbstractText Label="RESULTS">A total of 551 pancreaticoduodenectomies were performed during the study period. Of these, 6 (1.1%), 20 (3.6%), and 91 (16.5%) patients died within 30, 90, and 365&#xa0;d after pancreaticoduodenectomy, respectively. Causes of early and late mortality varied significantly (all P&#xa0;&#x2264;&#xa0;0.032). The most common cause of death within 90&#xa0;d was due to multisystem organ failure from sepsis or aspiration in 9 (45%) patients, followed by post-pancreatectomy hemorrhage in 5 (25%) patients, and cardiopulmonary arrest from myocardial infarction or pulmonary embolus in 3 (15%) patients. In contrast, recurrent cancer was the most common cause of death in 46 (65%) patients during the late postoperative period between 91 and 365&#xa0;d. Mortality from failure to thrive and debility was similar between early and late postoperative periods (15% versus 19.7%, P&#xa0;=&#xa0;0.76).</AbstractText><AbstractText Label="CONCLUSIONS">Most quality improvement initiatives in patients selected for pancreaticoduodenectomy have focused on reduction of technical complications and improvement of early postoperative mortality. Further reduction in postoperative mortality after pancreaticoduodenectomy can be achieved by improving patient selection, mitigating postoperative malnutrition, and optimizing preoperative cancer staging and management strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Narayanan</LastName><ForeName>Sowmya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Allison N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turrentine</LastName><ForeName>Florence E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia; Surgery Outcomes Research Center, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bauer</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia; Division of Surgical Oncology, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adams</LastName><ForeName>Reid B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia; Division of Surgical Oncology, University of Virginia, Charlottesville, Virginia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaydfudim</LastName><ForeName>Victor M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Virginia, Charlottesville, Virginia; Surgery Outcomes Research Center, University of Virginia, Charlottesville, Virginia; Division of Surgical Oncology, University of Virginia, Charlottesville, Virginia. Electronic address: vz8h@virginia.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>L30 CA220861</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA163177</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>06</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="N">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Outcomes</Keyword><Keyword MajorTopicYN="N">Pancreaticoduodenectomy</Keyword><Keyword MajorTopicYN="N">Quality improvement</Keyword><Keyword MajorTopicYN="N">Whipple</Keyword></KeywordList><CoiStatement>Disclosure. None of the authors have any personal, financial, or other conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>2</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>5</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30278945</ArticleId><ArticleId IdType="mid">NIHMS1589421</ArticleId><ArticleId IdType="pmc">PMC8246070</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2018.05.075</ArticleId><ArticleId IdType="pii">S0022-4804(18)30375-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg. 1987;206:358&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1493175</ArticleId><ArticleId IdType="pubmed">3632096</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire WP. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986;151:141&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">3946745</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassour I, Wang SC, Christie A, et al. Minimally invasive versus open pancreaticoduodenectomy: a propensity-matched study from a national cohort of patients. Ann Surg. 2018;268:151&#x2013;157.</Citation><ArticleIdList><ArticleId IdType="pubmed">28486387</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleeson EM, Shaikh MF, Shewokis PA, et al. WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database. Surgery. 2016;160:1279&#x2013;1287.</Citation><ArticleIdList><ArticleId IdType="pubmed">27544541</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;ttner FJ, Fitzmaurice C, Schwarzer G, et al. Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev. 2016;2:CD006053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255094</ArticleId><ArticleId IdType="pubmed">26905229</ArticleId></ArticleIdList></Reference><Reference><Citation>Newhook TE, LaPar DJ, Lindberg JM, Bauer TW, Adams RB, Zaydfudim VM. Morbidity and mortality of pancreaticoduodenectomy for benign and premalignant pancreatic neoplasms. J Gastrointest Surg. 2015;19:1072&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">25801594</ArticleId></ArticleIdList></Reference><Reference><Citation>McPhee JT, Hill JS, Whalen GF, et al. Perioperative mortality for pancreatectomy: a national perspective. Ann Surg. 2007;246:246&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1933570</ArticleId><ArticleId IdType="pubmed">17667503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy EP, Rosato EL, Sauter PK, et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institutionethe first step in multidisciplinary team building. J Am Coll Surg. 2007;204:917&#x2013;923 [discussion 923&#x2013;924].</Citation><ArticleIdList><ArticleId IdType="pubmed">17481510</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch M, Garden OJ, Padbury R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International study group of liver surgery. Surgery. 2011;149:680&#x2013;688.</Citation><ArticleIdList><ArticleId IdType="pubmed">21316725</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee GC, Fong ZV, Ferrone CR, et al. High performing Whipple patients: factors associated with short length of stay after open pancreaticoduodenectomy. J Gastrointest Surg. 2014;18:1760&#x2013;1769.</Citation><ArticleIdList><ArticleId IdType="pubmed">25091843</ArticleId></ArticleIdList></Reference><Reference><Citation>House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">18060467</ArticleId></ArticleIdList></Reference><Reference><Citation>Venkat R, Puhan MA, Schulick RD, et al. Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg. 2011;146:1277&#x2013;1284.</Citation><ArticleIdList><ArticleId IdType="pubmed">22106320</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson RS, Pezzi CM, Mallin K, Loomis AM, Winchester DP. The 90-day mortality after pancreatectomy for cancer is double the 30-day mortality: more than 20,000 resections from the national cancer data base. Ann Surg Oncol. 2014;21:4059&#x2013;4067.</Citation><ArticleIdList><ArticleId IdType="pubmed">25190121</ArticleId></ArticleIdList></Reference><Reference><Citation>Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pubmed">17981197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery. 2017;161:584&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">28040257</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart RA, Relles D, Pineda DM, et al. Defining treatment and outcomes of hepaticojejunostomy failure following pancreaticoduodenectomy. J Gastrointest Surg. 2013;17:451&#x2013;460.</Citation><ArticleIdList><ArticleId IdType="pubmed">23292459</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnoss JC, Ulrich AB, Harnoss JM, Diener MK, B&#xfc;chler MW, Welsch T. Use and results of consensus definitions in pancreatic surgery: a systematic review. Surgery. 2014;155:47&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">24694359</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JS, Hwang HK, Kim JK, et al. Clinical validation and risk factors for delayed gastric emptying based on the International Study Group of Pancreatic Surgery (ISGPS) classification. Surgery. 2009;146:882&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">19744455</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsch T, Borm M, Degrate L, Hinz U, B&#xfc;chler MW, Wente MN. Evaluation of the International Study Group of Pancreatic Surgery definition of delayed gastric emptying after pancreatoduodenectomy in a high-volume centre. Br J Surg. 2010;97:1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pubmed">20632270</ArticleId></ArticleIdList></Reference><Reference><Citation>Malleo G, Crippa S, Butturini G, et al. Delayed gastric emptying after pylorus-preserving pancreaticoduodenectomy: validation of International Study Group of Pancreatic Surgery classification and analysis of risk factors. HPB (Oxford). 2010;12:610&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2999788</ArticleId><ArticleId IdType="pubmed">20961369</ArticleId></ArticleIdList></Reference><Reference><Citation>McMillan MT, Allegrini V, Asbun HJ, et al. Incorporation of procedure-specific risk into the ACS-NSQIP surgical risk calculator improves the prediction of morbidity and mortality after pancreatoduodenectomy. Ann Surg. 2017;265:978&#x2013;986.</Citation><ArticleIdList><ArticleId IdType="pubmed">27232260</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu HG, Sharma G, Brovman E, et al. Risk factors of reoperation after pancreatic resection. Dig Dis Sci. 2017;62:1666&#x2013;1675.</Citation><ArticleIdList><ArticleId IdType="pubmed">28341868</ArticleId></ArticleIdList></Reference><Reference><Citation>Varley PR, Geller DA, Tsung A. Factors influencing failure to rescue after pancreaticoduodenectomy: a national surgical quality improvement project perspective. J Surg Res. 2017;214:131&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">28624034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10:511&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pubmed">16627216</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberan-Garcia A, Ubr&#xe9; M, Roca J, et al. Personalised prehabilitation in high-risk patients undergoing elective major abdominal surgery: a randomized blinded controlled trial. Ann Surg. 2018;267:50&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">28489682</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzola M, Bertoglio C, Boniardi M, et al. Frailty in major oncologic surgery of upper gastrointestinal tract: how to improve postoperative outcomes. Eur J Surg Oncol. 2017;43:1566&#x2013;1571.</Citation><ArticleIdList><ArticleId IdType="pubmed">28669651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolshinsky V, Li MH-G, Ismail H, Burbury K, Riedel B, Heriot A. Multimodal prehabilitation programs as a bundle of care in gastrointestinal cancer surgery: a systematic review. Dis Colon Rectum. 2018;61:124&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">29219922</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26253455</PMID><DateCompleted><Year>2016</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jan</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Effects of terlipressin on patients with sepsis via improving tissue blood flow.</ArticleTitle><Pagination><StartPage>274</StartPage><EndPage>282</EndPage><MedlinePgn>274-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2015.07.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(15)00797-0</ELocationID><Abstract><AbstractText>Terlipressin (TP), an analog of arginine vasopressin, was reported beneficial in sepsis patients when combined use with norepinephrine (NE), but the undetermined action, mechanism, and safety limited it to become the first-line vasopressor for sepsis patients. With 32 septic shock patients, we investigated the effects of a small dose of TP (1.3&#xa0;&#x3bc;g/kg/h) on hemodynamic, tissue blood flow, vital organ function, acid-base balance, and coagulation function to systemically know the beneficial effect and side effects of TP on septic shock. The results showed that as compared with the single use of NE group (17 patients), a small dose of TP (1.3&#xa0;&#x3bc;g/kg/h) in combination with NE continuous infusion, except for decreasing the mortality and NE requirement, could better improve and stabilize the hemodynamics, improve the tissue blood flow, increase the blood oxygen saturation and urine volume, and decrease the lactate level and complication rate (47% versus 82.3% in NE group). Meanwhile, TP + NE did not induce blood bilirubin increase and platelet count decrease and hyponatremia that vasopressin has. The results show that low dose of TP continuous infusion can help NE achieve the good resuscitation effect by improving tissue blood flow, stabilizing hemodynamics, and protecting organ function in septic shock patients while did not induce the side effects that high dose or bonus of TP or vasopressin induced. Low dose of TP may be recommended as the first-line vasopressor for refractory hypotension after severe sepsis or septic shock.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Xudong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yaoli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Jian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Dongpo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Liangming</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Trauma, Burns and Combined Injury, Second Department of Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China. Electronic address: lt200132@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ChiCTR</DataBankName><AccessionNumberList><AccessionNumber>CHICTR-TRC-11,001,583</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>50-57-7</RegistryNumber><NameOfSubstance UI="D008236">Lypressin</NameOfSubstance></Chemical><Chemical><RegistryNumber>7Z5X49W53P</RegistryNumber><NameOfSubstance UI="D000077585">Terlipressin</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000136" MajorTopicYN="N">Acid-Base Equilibrium</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008236" MajorTopicYN="N">Lypressin</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012039" MajorTopicYN="N">Regional Blood Flow</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077585" MajorTopicYN="N">Terlipressin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Early resuscitation goal</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Side effect</Keyword><Keyword MajorTopicYN="N">Terlipressin</Keyword><Keyword MajorTopicYN="N">Vascular reactivity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>6</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>5</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26253455</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2015.07.016</ArticleId><ArticleId IdType="pii">S0022-4804(15)00797-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34303572</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1409</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Burns : journal of the International Society for Burn Injuries</Title><ISOAbbreviation>Burns</ISOAbbreviation></Journal><ArticleTitle>Systematic review of excision and grafting in burns: Comparing outcomes of early and late surgery in low and high-income countries.</ArticleTitle><Pagination><StartPage>1705</StartPage><EndPage>1713</EndPage><MedlinePgn>1705-1713</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.burns.2021.07.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0305-4179(21)00170-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION">While the benefits of early excision in burn surgery are clear, the advantages may be lost in low income countries with limited resources. It is important to identify the right timing of excision in different groups of patients, particularly those in low-income countries (LIC), as the burden of disease contributes to the highest global mortality and has the least resources. This systematic review and meta-analysis aims to determine the timing of excision in LICs and the outcomes associated with surgery: (1) mortality, (2) sepsis and (3) length of stay (LOS) compared to high income countries (HICs).</AbstractText><AbstractText Label="METHODOLOGY">The PRISMA guidelines and MOOSE checklist were followed for this review. Publications in English from year 1990 to 2017 that included data on the timing and type of burn surgery and outcomes were included. Searches were done using Web of Science, Cochrane collaboration and Pubmed using keywords "Burn and surgery", "Burn and excision", "Burn and excision and grafting" and "burn and skin grafting". Trial quality was evaluated using the Newcastle-Ottawa scale. Outcomes compared for early and late excisions were length of stay (LOS), sepsis and mortality between LICs and HICs.</AbstractText><AbstractText Label="RESULTS">From 278 citations, we selected 41 for full text evaluation, and identified 16 eligible trials. LOS is shorter in early excision compared to late excision in both LICs and HICs. Mortality is lower in late excision compared to early excision in both LICs and HICs. Further subgroup analysis of elderly patients in HICs confirmed that mortality is lower in late excision and unchanged if the elderly are excluded. Early excision reduces sepsis in both LIC and HIC.</AbstractText><AbstractText Label="DISCUSSION">The variable definitions of age, timing of excision, variable nature of % TBSA comparison, mixed inclusion of inhalation injury, co-morbidities and unquantified access to resources make the data difficult to interpret and it is not possible to draw accurate conclusions on the role of early excision for burns in low-middle income countries. A prospective study is needed in order to answer this question.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Ltd and ISBI. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Lingwei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Trauma Sciences, Queen Mary University of London, Mile End Rd, Bethnal Green, London E1 4NS, United Kingdom. Electronic address: lingwei.borissov@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajandram</LastName><ForeName>Retnagowri</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia. Electronic address: retnagowri@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allorto</LastName><ForeName>Nikki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Surgery, Pietermaritzburg Metropolitan Complex, University of Kwa-zulu Natal, South Africa. Electronic address: nikkiallorto@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Burns</MedlineTA><NlmUniqueID>8913178</NlmUniqueID><ISSNLinking>0305-4179</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="Y">Burns</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019049" MajorTopicYN="N">Developed Countries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058028" MajorTopicYN="N">Research Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016038" MajorTopicYN="N">Skin Transplantation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burns</Keyword><Keyword MajorTopicYN="N">Early excision</Keyword><Keyword MajorTopicYN="N">High-income countries</Keyword><Keyword MajorTopicYN="N">Late excision</Keyword><Keyword MajorTopicYN="N">Low-income countries</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>25</Day><Hour>20</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34303572</ArticleId><ArticleId IdType="doi">10.1016/j.burns.2021.07.001</ArticleId><ArticleId IdType="pii">S0305-4179(21)00170-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34772325</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2374-4243</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Infectious diseases (London, England)</Title><ISOAbbreviation>Infect Dis (Lond)</ISOAbbreviation></Journal><ArticleTitle>Short- versus prolonged-course antibiotic therapy for sepsis or infectious diseases in critically ill adults: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>223</EndPage><MedlinePgn>213-223</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/23744235.2021.2001046</ELocationID><Abstract><AbstractText Label="BACKGROUND">The 2016 International Guidelines for the Management of Sepsis and Septic Shock recommend antibiotic therapy for 7-10&#xa0;days for most patients with sepsis. However, evidence on critically ill patients is limited. Thus, we conducted the first systematic review and meta-analysis comparing the effectiveness and adverse events of shorter- (&#x2264;1&#xa0;week) with longer-course antibiotics in adults with critical infections including sepsis.</AbstractText><AbstractText Label="METHODS">We searched the MEDLINE, Cochrane Central Register of Controlled Trials, and Igaku Chuo Zasshi databases for randomised controlled trials (RCTs) and observational studies (OSs) from inception to 31 March 2021.</AbstractText><AbstractText Label="RESULTS">We included 6 of 3,766 identified articles, incorporating data from 4 RCTs and 2 OSs (1,721 patients) in meta-analyses. Three RCTs and one OS focussed on ventilator-associated pneumonia, and one RCT and one OS investigated intra-abdominal infections. The severity score levels were similar to that of sepsis, but no study comprehensively focussing on sepsis was found. There were no significant differences in mortality at a maximum follow-up of 30&#xa0;days (RR 1.08, 95%CI 0.80-1.46); 28-day mortality, clinical cure, the occurrence of new events, and the emergence of resistant organisms between the groups in the RCTs. The OSs findings were consistent. The quality of evidence was assessed as very low to moderate using the GRADE approach, with no uniform description of severity scores, sepsis, or adverse events.</AbstractText><AbstractText Label="CONCLUSIONS">Shorter, fixed-duration antibiotic therapy for clinically heterogeneous sepsis or severe infections was not associated with poorer outcomes, but the overall quality of evidence was poor.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kubo</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-3765-736X</Identifier><AffiliationInfo><Affiliation>Department of Emergency Medicine and Department of Infectious Diseases, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Juntendo University Urayasu Hospital, Urayasu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshimura</LastName><ForeName>Jumpei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kikutani</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shime</LastName><ForeName>Nobuaki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis (Lond)</MedlineTA><NlmUniqueID>101650235</NlmUniqueID><ISSNLinking>2374-4243</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="Y">Communicable Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053717" MajorTopicYN="Y">Pneumonia, Ventilator-Associated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">critical illness</Keyword><Keyword MajorTopicYN="N">fixed duration antibiotic therapy</Keyword><Keyword MajorTopicYN="N">meta-analysis</Keyword><Keyword MajorTopicYN="N">severity</Keyword><Keyword MajorTopicYN="N">short-course</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34772325</ArticleId><ArticleId IdType="doi">10.1080/23744235.2021.2001046</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">40023700</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8422</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>Journal of cardiothoracic and vascular anesthesia</Title><ISOAbbreviation>J Cardiothorac Vasc Anesth</ISOAbbreviation></Journal><ArticleTitle>Copeptin Levels During Cardiac Surgery.</ArticleTitle><Pagination><StartPage>1197</StartPage><EndPage>1204</EndPage><MedlinePgn>1197-1204</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.jvca.2025.02.014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1053-0770(25)00126-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To investigate copeptin levels during the full perioperative course in open, adult cardiac surgery with cardiopulmonary bypass (CPB).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">A single-center study conducted in a tertiary care hospital.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">We included 61 patients undergoing various cardiac surgical procedures. In the final analysis, 57 patients were evaluated. Patients were divided into 2 subgroups based on preoperative copeptin levels, either above or below the reference level of 10 pmol/L.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">No intervention.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Copeptin levels were measured at multiple time points preoperatively, perioperatively, and postoperatively. Copeptin levels significantly increased from a preoperative median of 6.6 pmol/L (interquartile range [IQR], 3.9-11.0) to 27 pmol/L (IQR, 15.0-66.0 pmol/L) after sternotomy (p &#x2264; 0.001). Peak levels occurred 60 minutes after CPB initiation, reaching 286 pmol/L (IQR, 163-446 pmol/L). After this, the copeptin levels did not drop significantly until CPB termination at 179.5 pmol/L (IQR, 136.0-346.0 pmol/L) (p &#x2264; 0.001). Subsequent decreases were observed upon arrival in the intensive care unit and throughout the postoperative period. However, at 4 days postoperatively, copeptin levels remained significantly higher (11.5 pmol/L; IQR,7.2-19.0 pmol/L; p &#x2264; 0.001), than preoperative levels.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study describes copeptin levels during the perioperative course in adult cardiac surgery. The elevated levels during CPB suggest a strong activation of the arginine vasopressin system, with peak levels exceeding those seen in septic shock. This knowledge will enable further targeted clinical studies on copeptin as a prognostic marker in the field of cardiac surgery.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Samuelsson</LastName><ForeName>Selma</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Link&#xf6;ping University Hospital and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Link&#xf6;ping University, Link&#xf6;ping, Sweden. Electronic address: Selma.Samuelsson@liu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engerstr&#xf6;m</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Anesthesiology and Intensive Care, Link&#xf6;ping University Hospital, Department of Anesthesia and Intensive Care, Norrk&#xf6;ping Hospital and Department of Biomedical and Clinical Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holm</LastName><ForeName>Jonas</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Link&#xf6;ping University Hospital and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiothorac Vasc Anesth</MedlineTA><NlmUniqueID>9110208</NlmUniqueID><ISSNLinking>1053-0770</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006020">Glycopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C048197">copeptins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006020" MajorTopicYN="Y">Glycopeptides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006348" MajorTopicYN="Y">Cardiac Surgical Procedures</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AVP</Keyword><Keyword MajorTopicYN="N">arginine vasopressin</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">cardiopulmonary bypass</Keyword><Keyword MajorTopicYN="N">copeptin</Keyword><Keyword MajorTopicYN="N">heart&#x2013;lung machine</Keyword><Keyword MajorTopicYN="N">vasopressin</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors have no conflict of interest to disclose regarding this work. Dr Holm is an external consultant to Intertek Medical Notified Body AB.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>13</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>3</Month><Day>1</Day><Hour>21</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40023700</ArticleId><ArticleId IdType="doi">10.1053/j.jvca.2025.02.014</ArticleId><ArticleId IdType="pii">S1053-0770(25)00126-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39179637</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Simultaneous removal of endotoxins, inflammatory mediators and uremic toxins in ICU patients with septic shock: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>19645</StartPage><MedlinePgn>19645</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">19645</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-70522-3</ELocationID><Abstract><AbstractText>Sepsis, one of the leading causes of death, is still lacking specific treatment. OXIRIS (BAXTER, Deerfield, IL, USA) is the first device allowing combined removal of endotoxins, inflammatory mediators and uremic toxins, alongside fluid balance control. Available data is very limited. This retrospective propensity score-matched cohort study of adult patients with septic shock aimed to evaluate septic shock duration and mortality in patients treated with either standard of care renal replacement therapy (RRT) or RRT with combined hemoadsorption, who were admitted to the interdisciplinary surgical intensive care unit at Heidelberg University Hospital during the years 2018 through 2021. Main outcomes were duration of shock, thirty-day mortality and plasma interleukin-6 levels before and after initiation of hemoadsorption. Included were 117 patients (female, 33%; male 67%); median age: 67 (16) years. After matching: 42 patients (female, 33%; male, 67%); mean age: 59.1&#x2009;&#xb1;&#x2009;13.8&#xa0;years. There was no statistically significant difference in septic shock duration (p&#x2009;=&#x2009;0.94; hazard ratio (HR) 0.97 (95% CI, 0.48-1.97)). Thirty-day survival analysis showed a non-statistically significant survival difference. (p&#x2009;=&#x2009;0.063; HR 0.43 (95% CI, 0.17-1.09)). A post-hoc 90-day survival analysis revealed statistically significant longer survival and lower death hazard ratio in patients treated with RRT&#x2009;+&#x2009;HA (p&#x2009;=&#x2009;0.037; HR&#x2009;=&#x2009;0.42 (95% CI, 0.18-0.99). In conclusion, RRT with combined hemoadsorption of endotoxins, inflammatory mediators and uremic toxins is a modality worth further investigation.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Theisen</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenstern</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nusshag</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Nephrology, Heidelberg University, Im Neuenheimer Feld 162, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Pediatrics, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>H&#xf6;lle</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigand</LastName><ForeName>Markus A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Kalenka</LastName><ForeName>Armin</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kreiskrankenhaus Bergstra&#xdf;e, Viernheimer Str. 2, 64646, Heppenheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fiedler-Kalenka</LastName><ForeName>Mascha O</ForeName><Initials>MO</Initials><AffiliationInfo><Affiliation>Medical Faculty Heidelberg, Department of Anesthesiology, Heidelberg University, Im Neuenheimer Feld 420, 69120, Heidelberg, Germany. mascha.fiedler-kalenka@med.uni-heidelberg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004731">Endotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018836">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000087527">Uremic Toxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004731" MajorTopicYN="Y">Endotoxins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018836" MajorTopicYN="Y">Inflammation Mediators</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087527" MajorTopicYN="Y">Uremic Toxins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017582" MajorTopicYN="Y">Renal Replacement Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Endotoxins</Keyword><Keyword MajorTopicYN="N">Hemoadsorption</Keyword><Keyword MajorTopicYN="N">Inflammatory mediators</Keyword><Keyword MajorTopicYN="N">Renal replacement therapy</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>24</Day><Hour>16</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>23</Day><Hour>23</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39179637</ArticleId><ArticleId IdType="pmc">PMC11344040</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-70522-3</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-70522-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA315, 801&#x2013;810. 10.1001/jama.2016.0287 (2016). 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwindenhammer, V. et al. oXiris(R) use in septic shock: Experience of two french centres. Blood Purif.47(Suppl 3), 1&#x2013;7. 10.1159/000499510 (2019). 10.1159/000499510</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499510</ArticleId><ArticleId IdType="pubmed">30982028</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger, R. P. et al. Effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: The EUPHRATES randomized clinical trial. JAMA320, 1455&#x2013;1463. 10.1001/jama.2018.14618 (2018). 10.1001/jama.2018.14618</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2018.14618</ArticleId><ArticleId IdType="pmc">PMC6233793</ArticleId><ArticleId IdType="pubmed">30304428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz, D. N. et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: The EUPHAS randomized controlled trial. JAMA301, 2445&#x2013;2452. 10.1001/jama.2009.856 (2009). 10.1001/jama.2009.856</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2009.856</ArticleId><ArticleId IdType="pubmed">19531784</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, Y., Peng, J. Y. &amp; Peng, Z. Blood purification in sepsis and systemic inflammation. Curr. Opin. Crit. Care27, 582&#x2013;586. 10.1097/MCC.0000000000000890 (2021). 10.1097/MCC.0000000000000890</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000890</ArticleId><ArticleId IdType="pubmed">34581298</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerlach, H. Agents to reduce cytokine storm. F1000Res5, 2909. 10.12688/f1000research.9092.1 (2016). 10.12688/f1000research.9092.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.9092.1</ArticleId><ArticleId IdType="pmc">PMC5224679</ArticleId><ArticleId IdType="pubmed">28105327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss, R. S. &amp; Opal, S. Immunotherapy for sepsis&#x2013;a new approach against an ancient foe. N. Engl. J. Med.363, 87&#x2013;89. 10.1056/NEJMcibr1004371 (2010). 10.1056/NEJMcibr1004371</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr1004371</ArticleId><ArticleId IdType="pmc">PMC4136660</ArticleId><ArticleId IdType="pubmed">20592301</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, F., Peng, Z., Murugan, R. &amp; Kellum, J. A. Blood purification and mortality in sepsis: A meta-analysis of randomized trials. Crit. Care Med.41, 2209&#x2013;2220. 10.1097/CCM.0b013e31828cf412 (2013). 10.1097/CCM.0b013e31828cf412</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31828cf412</ArticleId><ArticleId IdType="pmc">PMC3758418</ArticleId><ArticleId IdType="pubmed">23860248</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. Lancet395, 497&#x2013;506. 10.1016/S0140-6736(20)30183-5 (2020). 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan China. JAMA323, 1061&#x2013;1069. 10.1001/jama.2020.1585 (2020). 10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Monard, C., Rimmele, T. &amp; Ronco, C. Extracorporeal blood purification therapies for sepsis. Blood Purif.47(Suppl 3), 1&#x2013;14. 10.1159/000499520 (2019). 10.1159/000499520</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499520</ArticleId><ArticleId IdType="pubmed">30974444</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamik, B., Zielinski, S., Smiechowicz, J. &amp; Kubler, A. Endotoxin elimination in patients with septic shock: An observation study. Arch. Immunol. Ther. Exp. (Warsz)63, 475&#x2013;483. 10.1007/s00005-015-0348-8 (2015). 10.1007/s00005-015-0348-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-015-0348-8</ArticleId><ArticleId IdType="pmc">PMC4633444</ArticleId><ArticleId IdType="pubmed">26093653</ArticleId></ArticleIdList></Reference><Reference><Citation>Turani, F., Barchetta, R., Falco, M., Busatti, S. &amp; Weltert, L. Continuous renal replacement therapy with the adsorbing filter oXiris in septic patients: A case series. Blood Purif.47(Suppl 3), 1&#x2013;5. 10.1159/000499589 (2019). 10.1159/000499589</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499589</ArticleId><ArticleId IdType="pubmed">30982024</ArticleId></ArticleIdList></Reference><Reference><Citation>Malard, B., Lambert, C. &amp; Kellum, J. A. In vitro comparison of the adsorption of inflammatory mediators by blood purification devices. Intensive Care Med. Exp.6, 12. 10.1186/s40635-018-0177-2 (2018). 10.1186/s40635-018-0177-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-018-0177-2</ArticleId><ArticleId IdType="pmc">PMC5935601</ArticleId><ArticleId IdType="pubmed">29728790</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickkers, P. et al. Sepsis management with a blood purification membrane: european experience. Blood Purif.47(Suppl 3), 1&#x2013;9. 10.1159/000499355 (2019). 10.1159/000499355</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499355</ArticleId><ArticleId IdType="pubmed">30982031</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock: A single-centre experience in China. Front. Public Health10, 1012998. 10.3389/fpubh.2022.1012998 (2022). 10.3389/fpubh.2022.1012998</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1012998</ArticleId><ArticleId IdType="pmc">PMC9557776</ArticleId><ArticleId IdType="pubmed">36249210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellum, J. A. &amp; Dishart, M. K. Effect of hemofiltration filter adsorption on circulating IL-6 levels in septic rats. Crit. Care6, 429&#x2013;433. 10.1186/cc1528 (2002). 10.1186/cc1528</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc1528</ArticleId><ArticleId IdType="pmc">PMC130143</ArticleId><ArticleId IdType="pubmed">12398783</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman, M. E., Hansson, F., Vincent, J. L. &amp; Bodelsson, M. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study. PLoS One14, e0220444. 10.1371/journal.pone.0220444 (2019). 10.1371/journal.pone.0220444</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0220444</ArticleId><ArticleId IdType="pmc">PMC6675097</ArticleId><ArticleId IdType="pubmed">31369593</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang, S., Chen, Q., Zhang, Y., Xu, L. &amp; Chen, J. Comparison of the clinical effectiveness of AN69-oXiris versus AN69-ST filter in septic patients: A single-centre study. Blood Purif.51, 617&#x2013;629. 10.1159/000519166 (2022). 10.1159/000519166</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000519166</ArticleId><ArticleId IdType="pubmed">34610595</ArticleId></ArticleIdList></Reference><Reference><Citation>Premuzic, V. et al. Extracorporeal blood purification is associated with improvement in biochemical and clinical variables in the critically-ill COVID-19 patients. Ther. Apher. Dial26, 316&#x2013;329. 10.1111/1744-9987.13730 (2022). 10.1111/1744-9987.13730</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1744-9987.13730</ArticleId><ArticleId IdType="pmc">PMC8652436</ArticleId><ArticleId IdType="pubmed">34486793</ArticleId></ArticleIdList></Reference><Reference><Citation>Copaescu, A., Smibert, O., Gibson, A., Phillips, E. J. &amp; Trubiano, J. A. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J. Allergy Clin. Immunol.146(518&#x2013;534), e511. 10.1016/j.jaci.2020.07.001 (2020).10.1016/j.jaci.2020.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.07.001</ArticleId><ArticleId IdType="pmc">PMC7471766</ArticleId><ArticleId IdType="pubmed">32896310</ArticleId></ArticleIdList></Reference><Reference><Citation>Abasiyanik, M. F. et al. Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes. Nat. Commun.11, 2607. 10.1038/s41467-020-16124-9 (2020). 10.1038/s41467-020-16124-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16124-9</ArticleId><ArticleId IdType="pmc">PMC7248118</ArticleId><ArticleId IdType="pubmed">32451375</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl, K., Bode, C. &amp; David, S. Letter to the Editor: Innovative future concepts of extracorporeal strategies in sepsis and septic shock. Crit. Care27, 121. 10.1186/s13054-023-04408-7 (2023). 10.1186/s13054-023-04408-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04408-7</ArticleId><ArticleId IdType="pmc">PMC10031856</ArticleId><ArticleId IdType="pubmed">36949529</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmele, T. et al. Hemofiltration with the Cascade system in an experimental porcine model of septic shock. Ther. Apher. Dial13, 63&#x2013;70. 10.1111/j.1744-9987.2009.00655.x (2009). 10.1111/j.1744-9987.2009.00655.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1744-9987.2009.00655.x</ArticleId><ArticleId IdType="pubmed">19379172</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, J. et al. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial. Int. J. Artif. Organs45, 801&#x2013;808. 10.1177/03913988221107947 (2022). 10.1177/03913988221107947</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/03913988221107947</ArticleId><ArticleId IdType="pubmed">35864718</ArticleId></ArticleIdList></Reference><Reference><Citation>Shum, H. P., Chan, K. C., Kwan, M. C. &amp; Yan, W. W. Application of endotoxin and cytokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med. J.19, 491&#x2013;497. 10.12809/hkmj133910 (2013). 10.12809/hkmj133910</Citation><ArticleIdList><ArticleId IdType="doi">10.12809/hkmj133910</ArticleId><ArticleId IdType="pubmed">23650198</ArticleId></ArticleIdList></Reference><Reference><Citation>Broman, M. E. &amp; Bodelsson, M. Analysis of endotoxin adsorption in two swedish patients with septic shock. Blood Purif.47(Suppl 3), 1&#x2013;3. 10.1159/000499546 (2019). 10.1159/000499546</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499546</ArticleId><ArticleId IdType="pubmed">30982027</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan, H. K. et al. Augmented adsorptive blood purification during continuous veno-venous haemodiafiltration in a severe septic, acute kidney injury patient: Use of oXiris(R): A single centre case report. Blood Purif.47(Suppl 3), 1&#x2013;6. 10.1159/000499633 (2019). 10.1159/000499633</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499633</ArticleId><ArticleId IdType="pubmed">30982048</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. Hemofilter with adsorptive capacities: Case report series. Blood Purif.47(Suppl 3), 1&#x2013;6. 10.1159/000499357 (2019). 10.1159/000499357</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000499357</ArticleId><ArticleId IdType="pubmed">30982026</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, J., Xiao, W. &amp; Lin, J. Effect of oXiris-CVVH on the clinical outcomes of patients with septic shock: An inverse probability of treatment-weighted analysis. Blood Purif.51, 972&#x2013;989. 10.1159/000524088 (2022). 10.1159/000524088</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000524088</ArticleId><ArticleId IdType="pubmed">35649340</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Zhou, L., Yang, L. &amp; Yuan, F. Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: A case report and literature review. J. Int. Med. Res.48, 300060520940439. 10.1177/0300060520940439 (2020). 10.1177/0300060520940439</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300060520940439</ArticleId><ArticleId IdType="pmc">PMC7372632</ArticleId><ArticleId IdType="pubmed">32686965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, T. et al. Early use of endotoxin absorption by oXiris in abdominal septic shock: A case report. Med. (Baltimore)99, e19632. 10.1097/MD.0000000000019632 (2020).10.1097/MD.0000000000019632</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000019632</ArticleId><ArticleId IdType="pmc">PMC7360291</ArticleId><ArticleId IdType="pubmed">32664051</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan, M. et al. Continuous renal replacement therapy with adsorbing filter oXiris in acute kidney injury with septic shock: A retrospective observational study. Front. Med. (Lausanne)9, 789623. 10.3389/fmed.2022.789623 (2022). 10.3389/fmed.2022.789623</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.789623</ArticleId><ArticleId IdType="pmc">PMC9024201</ArticleId><ArticleId IdType="pubmed">35463014</ArticleId></ArticleIdList></Reference><Reference><Citation>Lumlertgul, N. &amp; Srisawat, N. The haemodynamic effects of oXiris haemofilter in septic shock patients requiring renal support: A single-centre experience. Int. J. Artif. Organs44, 17&#x2013;24. 10.1177/0391398820917150 (2021). 10.1177/0391398820917150</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0391398820917150</ArticleId><ArticleId IdType="pubmed">32393096</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med.47, 1181&#x2013;1247. 10.1007/s00134-021-06506-y (2021). 10.1007/s00134-021-06506-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunkhorst, F. M. et al. S3 Guideline Sepsis-prevention, diagnosis, therapy, and aftercare&#x202f;: Long version. Med. Klin. Intensivmed. Notfmed.115, 37&#x2013;109. 10.1007/s00063-020-00685-0 (2020). 10.1007/s00063-020-00685-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00063-020-00685-0</ArticleId><ArticleId IdType="pubmed">32356041</ArticleId></ArticleIdList></Reference><Reference><Citation>Boer, P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am. J. Physiol.247, F632-636. 10.1152/ajprenal.1984.247.4.F632 (1984). 10.1152/ajprenal.1984.247.4.F632</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajprenal.1984.247.4.F632</ArticleId><ArticleId IdType="pubmed">6496691</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm, E. et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet370, 1453&#x2013;1457. 10.1016/S0140-6736(07)61602-X (2007). 10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, T. A. &amp; Altman, D. G. Basic statistical reporting for articles published in biomedical journals: The &#x201c;Statistical analyses and methods in the published literature&#x201d; or the SAMPL Guidelines. Int. J. Nurs. Stud.52, 5&#x2013;9. 10.1016/j.ijnurstu.2014.09.006 (2015). 10.1016/j.ijnurstu.2014.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2014.09.006</ArticleId><ArticleId IdType="pubmed">25441757</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen, J. Statistical power analysis for the behavioral sciences 2nd edn. (Lawrence Erlbaum Associates Publishers, Mahwah, 1988).</Citation></Reference><Reference><Citation>Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med.28, 3083&#x2013;3107. 10.1002/sim.3697 (2009). 10.1002/sim.3697</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.3697</ArticleId><ArticleId IdType="pmc">PMC3472075</ArticleId><ArticleId IdType="pubmed">19757444</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin, P. C. An Introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav. Res.46, 399&#x2013;424. 10.1080/00273171.2011.568786 (2011). 10.1080/00273171.2011.568786</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00273171.2011.568786</ArticleId><ArticleId IdType="pmc">PMC3144483</ArticleId><ArticleId IdType="pubmed">21818162</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin, P. C. A comparison of 12 algorithms for matching on the propensity score. Stat. Med.33, 1057&#x2013;1069. 10.1002/sim.6004 (2014). 10.1002/sim.6004</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.6004</ArticleId><ArticleId IdType="pmc">PMC4285163</ArticleId><ArticleId IdType="pubmed">24123228</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbaum, P. R. &amp; Rubin, D. B. The central role of the propensity score in observational studies for causal effects. Biometrika70, 41&#x2013;55. 10.1093/biomet/70.1.41 (1983).10.1093/biomet/70.1.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/70.1.41</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart, E. A. Matching methods for causal inference: A review and a look forward. Stat. Sci.25, 1&#x2013;21. 10.1214/09-STS313 (2010). 10.1214/09-STS313</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/09-STS313</ArticleId><ArticleId IdType="pmc">PMC2943670</ArticleId><ArticleId IdType="pubmed">20871802</ArticleId></ArticleIdList></Reference><Reference><Citation>Staffa, S. J. &amp; Zurakowski, D. Five steps to successfully implement and evaluate propensity score matching in clinical research studies. Anesth. Analg.127, 1066&#x2013;1073. 10.1213/ANE.0000000000002787 (2018). 10.1213/ANE.0000000000002787</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002787</ArticleId><ArticleId IdType="pubmed">29324498</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan, E. L. &amp; Meier, P. Nonparametric-estimation from incomplete observations. J. Am. Stat. Assoc.53, 457&#x2013;481. 10.2307/2281868 (1958).10.2307/2281868</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2281868</ArticleId></ArticleIdList></Reference><Reference><Citation>Bland, J. M. &amp; Altman, D. G. The logrank test. BMJ328, 1073. 10.1136/bmj.328.7447.1073 (2004). 10.1136/bmj.328.7447.1073</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.328.7447.1073</ArticleId><ArticleId IdType="pmc">PMC403858</ArticleId><ArticleId IdType="pubmed">15117797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B34, 187+ (1972).10.1111/j.2517-6161.1972.tb00899.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1972.tb00899.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin, P. C. The use of propensity score methods with survival or time-to-event outcomes: Reporting measures of effect similar to those used in randomized experiments. Stat. Med.33, 1242&#x2013;1258. 10.1002/sim.5984 (2014). 10.1002/sim.5984</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.5984</ArticleId><ArticleId IdType="pmc">PMC4285179</ArticleId><ArticleId IdType="pubmed">24122911</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin, P. C., Mamdani, M. M., Stukel, T. A., Anderson, G. M. &amp; Tu, J. V. The use of the propensity score for estimating treatment effects: Administrative versus clinical data. Stat. Med.24, 1563&#x2013;1578. 10.1002/sim.2053 (2005). 10.1002/sim.2053</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.2053</ArticleId><ArticleId IdType="pubmed">15706581</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer, M. et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit. Care24, 239. 10.1186/s13054-020-02950-2 (2020). 10.1186/s13054-020-02950-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02950-2</ArticleId><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari, M. et al. Developing a New definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA315, 775&#x2013;787. 10.1001/jama.2016.0289 (2016). 10.1001/jama.2016.0289</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0289</ArticleId><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, J. L., Jones, G., David, S., Olariu, E. &amp; Cadwell, K. K. Frequency and mortality of septic shock in Europe and North America: A systematic review and meta-analysis. Crit. Care23, 196. 10.1186/s13054-019-2478-6 (2019). 10.1186/s13054-019-2478-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2478-6</ArticleId><ArticleId IdType="pmc">PMC6545004</ArticleId><ArticleId IdType="pubmed">31151462</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, G. et al. Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: A systematic review and meta-analysis. Crit. Care27, 275. 10.1186/s13054-023-04555-x (2023). 10.1186/s13054-023-04555-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04555-x</ArticleId><ArticleId IdType="pmc">PMC10331993</ArticleId><ArticleId IdType="pubmed">37424026</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, X., Zhang, F. &amp; Zhong, Y. Comment on: Continuous renal replacement therapy with the adsorptive oXiris filter may be associated with the lower 28-day mortality in sepsis: A systematic review and meta-analysis. Crit. Care27, 305. 10.1186/s13054-023-04588-2 (2023). 10.1186/s13054-023-04588-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04588-2</ArticleId><ArticleId IdType="pmc">PMC10399000</ArticleId><ArticleId IdType="pubmed">37537672</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J. J., Lai, P. C., Huang, Y. T. &amp; Lai, C. H. Bias and potential premature conclusions regarding the clinical benefits of oXiris in septic adult patients. Crit. Care27, 314. 10.1186/s13054-023-04594-4 (2023). 10.1186/s13054-023-04594-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04594-4</ArticleId><ArticleId IdType="pmc">PMC10422721</ArticleId><ArticleId IdType="pubmed">37568185</ArticleId></ArticleIdList></Reference><Reference><Citation>Supady, A. et al. Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): A single centre, open-label, randomised, controlled trial. Lancet Respir. Med.9, 755&#x2013;762. 10.1016/S2213-2600(21)00177-6 (2021). 10.1016/S2213-2600(21)00177-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00177-6</ArticleId><ArticleId IdType="pmc">PMC8121541</ArticleId><ArticleId IdType="pubmed">34000236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L. et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: A meta-analysis. Am. J. Kidney Dis.66, 322&#x2013;330. 10.1053/j.ajkd.2015.02.328 (2015). 10.1053/j.ajkd.2015.02.328</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.ajkd.2015.02.328</ArticleId><ArticleId IdType="pubmed">25843704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nash, D. M., Przech, S., Wald, R. &amp; O&#x2019;Reilly, D. Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit. J. Crit. Care41, 138&#x2013;144. 10.1016/j.jcrc.2017.05.002 (2017). 10.1016/j.jcrc.2017.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.05.002</ArticleId><ArticleId IdType="pubmed">28525779</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujimoto, H. et al. Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy. Cochrane Database Syst. Rev.3, CD012467. 10.1002/14651858.CD012467.pub2 (2020). 10.1002/14651858.CD012467.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD012467.pub2</ArticleId><ArticleId IdType="pmc">PMC7067597</ArticleId><ArticleId IdType="pubmed">32164041</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour, C. W. et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA321, 2003&#x2013;2017. 10.1001/jama.2019.5791 (2019). 10.1001/jama.2019.5791</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMerle, K. M. et al. Identification of a hyperinflammatory sepsis phenotype using protein biomarker and clinical data in the ProCESS randomized trial. Sci. Rep.14, 6234. 10.1038/s41598-024-55667-5 (2024). 10.1038/s41598-024-55667-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-55667-5</ArticleId><ArticleId IdType="pmc">PMC10940677</ArticleId><ArticleId IdType="pubmed">38485953</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">40720942</PMID><DateRevised><Year>2025</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1421-9735</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2025</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Blood purification</Title><ISOAbbreviation>Blood Purif</ISOAbbreviation></Journal><ArticleTitle>Interleukin-6 Removal and Clinical Effects of Oxiris: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>10</EndPage><MedlinePgn>1-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1159/000547587</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sepsis is a life-threatening condition associated with high mortality due to an unregulated host immune response. Extracorporeal blood purification (EBP) therapies have been proposed as adjunctive treatments to immunomodulate patients; however, none have been consistently shown to be effective in reducing mortality. In several observational studies, Oxiris has been associated with cytokine reduction and a potential benefit in influencing inflammatory diseases. This meta-analysis explores the association between cytokine removal and clinical efficacy of the Oxiris membrane using interleukin-6 (IL-6) as a biomarker.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This review includes articles on EBP with Oxiris membranes in adult patients with sepsis/septic shock or COVID-19. No time or language restrictions were applied to the systematic literature search. Data extraction and statistical analysis were limited to the cytokines and clinical data reported in the included articles. The most representative cytokine was IL-6 and the selected outcomes included Vasoactive-Inotropic Score (VIS), SOFA score, procalcitonin (PCT) and C-reactive protein (CRP). The review used meta-analysis and unpaired t test to estimate differences between groups of patients treated with or without Oxiris.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The study found no significant differences in demographics between the intervention and control groups at baseline. Intervention group showed a significant reduction in vasoactive inotropic score, norepinephrine dose, SOFA score, PCT, and CRP.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We reviewed 8 studies in which IL-6 was significantly reduced in the Oxiris group compared to the control. This meta-analysis found that the use of the Oxiris membrane resulted in significant clinical improvement during treatment.</AbstractText><CopyrightInformation>&#xa9; 2025 S. Karger AG, Basel.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ulsamer</LastName><ForeName>Arnau</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institut d'Investigaci&#xf3; Biom&#xe8;dica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pomar&#xe8; Montin</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bocciero</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parra Morales</LastName><ForeName>Tania Julieth</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Departamento de ortopedia y traumatolog&#xed;a, Universidad El Bosque, Bogota, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tofani</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Statistics, Informatics, Applications, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>di Girolamo</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Anesthesia and Intensive Care, IRCCS Polyclinic San Donato, San Donato M.se, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romagnoli</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villa</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Section of Oncological Anesthesia and Intensive Care, AOU Careggi, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecchi</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Sciences, Section of Anesthesiology and Intensive Care, University of Florence, Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Blood Purif</MedlineTA><NlmUniqueID>8402040</NlmUniqueID><ISSNLinking>0253-5068</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AN69</Keyword><Keyword MajorTopicYN="N">Extracorporeal blood purification</Keyword><Keyword MajorTopicYN="N">Interleukin-6</Keyword><Keyword MajorTopicYN="N">Oxiris</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>29</Day><Hour>0</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>28</Day><Hour>18</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40720942</ArticleId><ArticleId IdType="doi">10.1159/000547587</ArticleId><ArticleId IdType="pii">000547587</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28045915</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>21</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Alkalosis in Critically Ill Patients with Severe Sepsis and Septic Shock.</ArticleTitle><Pagination><StartPage>e0168563</StartPage><MedlinePgn>e0168563</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0168563</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0168563</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Although metabolic alkalosis is a common occurrence in intensive care units (ICUs), no study has evaluated its prevalence or outcomes in patients with severe sepsis or septic shock.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective cohort study of critically ill patients suffering from severe sepsis and septic shock admitted to the ICUs of Halmstad and Varberg County hospitals. From 910 patient records, 627 patients met the inclusion criteria. We investigated the relationship between metabolic alkalosis and mortality. Further, we studied the relationship between metabolic alkalosis and ICU length of stay (LOS).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Metabolic alkalosis was associated with decreased 30-day and 12-month mortalities. This effect was however lost when a multivariate analysis was conducted, correcting for age, gender, pH on admission, base excess (BE) on admission, Simplified Acute Physiology Score III (SAPS III) and acute kidney injury (AKI). We then analyzed for any dose-response effect between the severity of metabolic alkalosis and mortality and found no relationship. Bivariate analysis showed that metabolic alkalosis had a significant effect on the length of ICU stay. When adjusting for age, sex, pH at admission, BE at admission, SAPS III and AKI in a multivariate analysis, metabolic alkalosis significantly contributed to prolonged ICU length of stay. In two separate sensitivity analyses pure metabolic alkalosis and late metabolic alkalosis (time of onset &gt;48 hours) were the only significant predictor of increased ICU length of stay.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Metabolic alkalosis did not have any effect on 30-day and 12-month mortalities after adjusting for age, sex, SAPS III-score, pH and BE on admission and AKI in a multivariate analysis. The presence of metabolic alkalosis was independently associated with an increased ICU length of stay.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kre&#xfc;</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6888-6173</Identifier><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, &#xd6;rebro University Hospital, &#xd6;rebro, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jazrawi</LastName><ForeName>Allan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General Surgery, V&#xe4;stmanland County Hospital, V&#xe4;ster&#xe5;s, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baigi</LastName><ForeName>Amir</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Institute of Medicine, General Medicine and Public Health, Gothenburg University, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute for Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Link&#xf6;ping University Hospital, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2017 Apr 5;12(4):e0175530. doi: 10.1371/journal.pone.0175530.</RefSource><PMID Version="1">28380074</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000471" MajorTopicYN="N">Alkalosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>1</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>1</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28045915</ArticleId><ArticleId IdType="pmc">PMC5207677</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0168563</ArticleId><ArticleId IdType="pii">PONE-D-16-24355</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Webster NR, Kulkarni V. Metabolic Alkalosis in the Critically Ill. Rev Clin Lab Sci. 1999;36(5):497&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pubmed">10560889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lib&#xf3;rio AB, Noritomi DT, Leite TT, de Melo Bezerra CT, de Faria ER, Kellum JA. Increased serum bicarbonate in critically ill patients: a retrospective analysis. Intensive Care Med 2015;41(3):572 10.1007/s00134-015-3682-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3682-8</ArticleId><ArticleId IdType="pubmed">25672278</ArticleId></ArticleIdList></Reference><Reference><Citation>Raphael KL, Murphy RA, Shlipak MG, Satterfield S, Huston HK, Sebastian A, et al. Bicarbonate concentration, acid-base status, and mortality in the health, aging and body composition study. CJASN. 2016;11(2):308&#x2013;31 10.2215/CJN.06200615</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.06200615</ArticleId><ArticleId IdType="pmc">PMC4741040</ArticleId><ArticleId IdType="pubmed">26769766</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards SH. Pathophysiology of acid base balance: The theory practice relationship. Intensive Crit Care Nurs. 2008;24(1):28&#x2013;38 10.1016/j.iccn.2007.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.iccn.2007.05.003</ArticleId><ArticleId IdType="pubmed">17689248</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer BF, Alpern RJ. Metabolic Alkalosis. J Am Soc Nephrol. 1997;8(9):1462&#x2013;9</Citation><ArticleIdList><ArticleId IdType="pubmed">9294840</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med 1980: 8:725&#x2013;728</Citation><ArticleIdList><ArticleId IdType="pubmed">6778655</ArticleId></ArticleIdList></Reference><Reference><Citation>Maehle K, Haug B, Flaaten H, Nielsen EW. Metabolic alkalosis is the most common acid-base disorder in ICU patients. Crit Care 2014;18:420 10.1186/cc13802</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13802</ArticleId><ArticleId IdType="pmc">PMC4056091</ArticleId><ArticleId IdType="pubmed">25001067</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubin A, Menises MM, Masevicius FD, Moseinco MC, Kutscherauer DO, Ventrice E,et al. Comparison of three different methods of evaluation of metabolic acid-base disorders. Crit Care Med. 2007; 35:1264&#x2013;1269. 10.1097/01.CCM.0000259536.11943.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000259536.11943.90</ArticleId><ArticleId IdType="pubmed">17334252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37674453</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1972-6007</ISSN><JournalIssue CitedMedium="Internet"><Volume>174</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>La Clinica terapeutica</Title><ISOAbbreviation>Clin Ter</ISOAbbreviation></Journal><ArticleTitle>Evaluation of procalcitonin in hemorrhagic shock: a pilot study.</ArticleTitle><Pagination><StartPage>432</StartPage><EndPage>435</EndPage><MedlinePgn>432-435</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.7417/CT.2023.2461</ELocationID><Abstract><AbstractText>An increased secretion of procalcitonin (PCT) is primarily due to systemic inflammation of bacterial origin, as PCT is used to diagnose and manage sepsis. However, other conditions can induce high plasma levels of PCT, and hemorrhagic shock may be one of these as we found in clinical practice. The aim of this pilot, observational and prospective study was to investigate the role of PCT in hemorrhagic shock and if it could help in distinguishing between different types of shock. We enrolled 15 patients who entered the shock room of our Emergency Department (ED) with a diagnosis of hemodynamic shock, defined as hypotension (systolic blood pressure &lt; 90 mmHg, or medial arterial pressure &lt; 65 mmHg), and/or elevated lactate level (&gt; 2 mmol/L), with one or more signs of cerebral or systemic hypoperfusion. For all the patients we dosed PCT at the time of admission, and we collected them into three different groups - septic, hemorrhagic and mixed shock - based on clinical presentation and laboratory and instrumental examination. First results did not show a significant increase of PCT in patients with hemorrhagic shock alone (average 0.12 &#xb1; 0.07 ng/mL), while PCT levels were similarly high in those with septic and mixed shock (17.63 &#xb1; 32.16 and 24.62 &#xb1; 33.02 respectively). PCT is not a marker of bleeding shock and does not help in distinguishing if bleeding or sepsis have the major impact on hemodynamics in those with mixed shock. However, patients with sepsis usually access the ED a few days after the initial infectious and inflammatory process has begun, while those with a major bleeding ask for intervention at the very first beginning. Thus, it may be helpful to see is PCT levels rise after some time from the bleeding start, or to investigate a different biomarker that rises earlier in course of systemic disfunction, such as presepsin. Finally, we also aimed at investigating if PCT levels would show any correlation with age of patients, regardless of the type of shock: results provided an higher PCT in individuals &#x2265; 80 years old, than in those &lt; 80 years old.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Piccioni</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valletta</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franza</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosa</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manca</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zanza</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Foundation "Ospedale Alba-Bra Onlus", Department of Emergency Medicine, Anesthesia and Critical Care Medicine, Michele and Pietro Ferrero Hospital, Verduno Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Savioli</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Surgery, IRCCS Fondanzione Policlinico San Matteo, Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasbarrini</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Covino</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franceschi</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facolt&#xe0; di Medicina e Chirurgia, Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Clin Ter</MedlineTA><NlmUniqueID>0372604</NlmUniqueID><ISSNLinking>0009-9074</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000594167">presepsin protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012771" MajorTopicYN="Y">Shock, Hemorrhagic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="N">Lipopolysaccharide Receptors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hemorrhagic shock</Keyword><Keyword MajorTopicYN="N">procalcitonin</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37674453</ArticleId><ArticleId IdType="doi">10.7417/CT.2023.2461</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32824268</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>15</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Effects of both Pro- and Synbiotics in Liver Surgery and Transplantation with Special Focus on the Gut-Liver Axis-A Systematic Review and Meta-Analysis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2461</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu12082461</ELocationID><Abstract><AbstractText>The gut-liver axis is of upmost importance for the development of infections after surgery. Further bacterial translocation due to surgery-related dysbiosis is associated with limited detoxification function of the liver compromising outcome of surgical therapy. After liver surgery, about 30% of patients develop a bacterial infection, with the risk of bacteremia or even sepsis-associated liver failure and mortality in &gt;40%. The potential benefit of pro-/synbiotics given before surgery is still under debate. Thus, a systematic literature search on trials comparing patients with or without supplementation and outcome after liver resection or transplantation was performed. Our search strategy revealed 12 relevant studies on perioperative administration of pro-/synbiotics in liver surgery. The pro-/synbiotic combinations and concentrations as well as administration timeframes differed between studies. Five studies were performed in liver transplantation and 7 in liver resection. All studies but one reported lower infection rates (pooled RR: 0.46, 95% CI: 0.31-0.67) with pro-/synbiotics. Liver function was assessed after LT/LR in 3 and 5 studies, respectively. Pro-/synbiotics improved function in 1/3 and 2/5 studies, respectively. Concluding, perioperative pro-/synbiotics clearly reduce infection after liver surgery. However, standard protocols with both well-defined probiotic strain preparations and administration timeframes are pending.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kahn</LastName><ForeName>Judith</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pregartner</LastName><ForeName>Gudrun</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schemmer</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>General, Visceral, and Transplant Surgery, Department of Surgery, Medical University of Graz, 8036 Graz, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056692">Prebiotics</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056692" MajorTopicYN="N">Prebiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058616" MajorTopicYN="N">Synbiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">gut&#x2013;liver axis</Keyword><Keyword MajorTopicYN="N">liver surgery</Keyword><Keyword MajorTopicYN="N">liver transplantation</Keyword><Keyword MajorTopicYN="N">pro-/synbiotic</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32824268</ArticleId><ArticleId IdType="pmc">PMC7468972</ArticleId><ArticleId IdType="doi">10.3390/nu12082461</ArticleId><ArticleId IdType="pii">nu12082461</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rayes N., Schutz T., Lochs H. Probiotika, Prabiotika und Synbiotika in der Chirurgie und bei kritisch Kranken auf der Intensivstation. Leberresektion, Transplantation. In: Bischoff S.C., editor. Probiotika, Pr&#xe4;biotika and Synbiotika. 1st ed. Georg Thieme Verlag KG; Stuttgart, Germany: 2009. p. 296.</Citation></Reference><Reference><Citation>Rahbari N.N., Wente M., Schemmer P., Diener M.K., Hoffmann K., Motschall E., Schmidt J., Weitz J., B&#xfc;chler M.W. Systematic review and meta-analysis of the effect of portal triad clamping on outcome after hepatic resection. Br. J. Surg. 2008;95:424&#x2013;432. doi: 10.1002/bjs.6141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.6141</ArticleId><ArticleId IdType="pubmed">18314921</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbari N.N., Elbers H., Koch M., Vogler P., Striebel F., Bruckner T., Mehrabi A., Schemmer P., B&#xfc;chler M.W., Weitz J. Randomized clinical trial of stapler versus clamp-crushing transection in elective liver resection. Br. J. Surg. 2014;101:200&#x2013;207. doi: 10.1002/bjs.9387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.9387</ArticleId><ArticleId IdType="pubmed">24402888</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K., M&#xfc;ller-B&#xfc;tow V., Franz C., Hinz U., Longerich T., B&#xfc;chler M.W., Schemmer P. Factors predictive of survival after stapler hepatectomy of hepatocellular carcinoma: A multivariate, single-center analysis. Anticancer Res. 2014;34:767&#x2013;776.</Citation><ArticleIdList><ArticleId IdType="pubmed">24511011</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruns H., Lozanovski V.J., Schultze D., Hillebrand N., Hinz U., B&#xfc;chler M.W., Schemmer P. Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: A multivariate analysis. PLoS ONE. 2014;9:e98782. doi: 10.1371/journal.pone.0098782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0098782</ArticleId><ArticleId IdType="pmc">PMC4048202</ArticleId><ArticleId IdType="pubmed">24905210</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann K., Unsinn M., Hinz U., Weiss K.H., Waldburger N., Longerich T., Radeleff B., Schirmacher P., B&#xfc;chler M.W., Schemmer P. Outcome after a liver resection of benign lesions. HPB (Oxford) 2015;17:994&#x2013;1000. doi: 10.1111/hpb.12496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hpb.12496</ArticleId><ArticleId IdType="pmc">PMC4605338</ArticleId><ArticleId IdType="pubmed">26456947</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Friess H., B&#xfc;chler M.W. Recent advances in surgical therapy for primary and metastatic liver cancer. Ann. Surg. Hepatol. 2002;7:124&#x2013;133.</Citation></Reference><Reference><Citation>Nickkholgh A., Weitz J., Encke J., Sauer P., Mehrabi A., B&#xfc;chler M.W., Schmidt J., Schemmer P. Utilization of extended donor criteria in liver transplantation: A comprehensive review of the literature. Nephrol. Dial. Transplant. 2007;22:viii29&#x2013;viii36. doi: 10.1093/ndt/gfm654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfm654</ArticleId><ArticleId IdType="pubmed">17890260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Friess H., Dervenis C., Schmidt J., Weitz J., Uhl W., B&#xfc;chler M.W. The use of endo GIA vascular staplers in liver surgery and their potential benefit: A review. Dig. Surg. 2007;24:300&#x2013;305. doi: 10.1159/000103662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000103662</ArticleId><ArticleId IdType="pubmed">17657156</ArticleId></ArticleIdList></Reference><Reference><Citation>Schemmer P., Bruns H., Weitz J., Schmidt J., B&#xfc;chler M.W. Liver transection using vascular stapler: A review. HPB (Oxford) 2008;10:249&#x2013;252. doi: 10.1080/13651820802166930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13651820802166930</ArticleId><ArticleId IdType="pmc">PMC2518299</ArticleId><ArticleId IdType="pubmed">18773103</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S., Hoffmann K., Schemmer P. Treatment of hepatocellular carcinoma: A systematic review. Liver Cancer. 2012;1:144&#x2013;158. doi: 10.1159/000343828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000343828</ArticleId><ArticleId IdType="pmc">PMC3760458</ArticleId><ArticleId IdType="pubmed">24159579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotthardt D.N., Weiss K.H., Rupp C., Bode K., Eckerle I., Rudolph G., Bergemann J., Kloeters-Plachky P., Chahoud F., B&#xfc;chler M.W., et al. Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation. Endoscopy. 2013;45:890&#x2013;896. doi: 10.1055/s-0033-1344713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0033-1344713</ArticleId><ArticleId IdType="pubmed">24165814</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishman J.A. Infection in solid-organ transplant recipients. N. Engl. J. Med. 2007;357:2601&#x2013;2614. doi: 10.1056/NEJMra064928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra064928</ArticleId><ArticleId IdType="pubmed">18094380</ArticleId></ArticleIdList></Reference><Reference><Citation>Xourafas D., Pawlik T.M., Cloyd J.M. Early Morbidity and Mortality after Minimally Invasive Liver Resection for Hepatocellular Carcinoma: A Propensity-Score Matched Comparison with Open Resection. J. Gastrointest. Surg. 2019;23:1435&#x2013;1442. doi: 10.1007/s11605-018-4016-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11605-018-4016-2</ArticleId><ArticleId IdType="pubmed">30377911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan Y., Su S., Li B., Fang C. Efficacy of probiotics and prebiotics in prevention of infectious complications following hepatic resections: Systematic review and meta-analysis. J. Gastrointest. Liver Dis. 2019;28:205&#x2013;211. doi: 10.15403/jgld-182.</Citation><ArticleIdList><ArticleId IdType="doi">10.15403/jgld-182</ArticleId><ArticleId IdType="pubmed">31204407</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001;29:1303&#x2013;1310. doi: 10.1097/00003246-200107000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaido T., Mori A., Oike F., Mizumoto M., Ogura Y., Hata K., Yoshizawa A., Iida T., Uemoto S. Impact of pretransplant nutritional sta- tus in patients undergoing liver transplantation. Hepatogastroenterology. 2010;57:1489&#x2013;1492.</Citation><ArticleIdList><ArticleId IdType="pubmed">21443108</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N., Paterson D.L., Gayowski T., Wagener M.M., Marino I.R. Predicting bacteremia and bacteremic mortality in liver transplant recipients. Liver Transplant. 2000;6:54&#x2013;61. doi: 10.1002/lt.500060112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.500060112</ArticleId><ArticleId IdType="pubmed">10648578</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin G.S., Mannino D.M., Eaton S., Moss M. The epidemiology of sepsis in the United States from through 2000. N. Engl. J. Med. 2003;348:1546&#x2013;1554. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman B.T., Schmidt U., Berman M.F., Bittner E.A. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: A large, nationwide sample. Anesthesiology. 2010;112:917&#x2013;925. doi: 10.1097/ALN.0b013e3181cea3d0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181cea3d0</ArticleId><ArticleId IdType="pubmed">20357565</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore L.J., Moore F.A., Todd S.R., Jones S.L., Turner K.L., Bass B.L. Sepsis in general surgery: The 2005&#x2014;National surgical quality improvement program perspective. Arch. Surg. 2010;145:695&#x2013;700. doi: 10.1001/archsurg.2010.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2010.107</ArticleId><ArticleId IdType="pubmed">20644134</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel T.R., Dombrovskiy V.Y., Carson J.L., Graham A.M., Lowry S.F. Postoperative sepsis in the United States. Ann. Surg. 2010;252:1065&#x2013;1071. doi: 10.1097/SLA.0b013e3181dcf36e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181dcf36e</ArticleId><ArticleId IdType="pmc">PMC2951484</ArticleId><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen S.J., Martinez E.G., Gregorio G.V., Dans L.F. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010;2010:CD003048. doi: 10.1002/14651858.CD003048.pub3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD003048.pub3</ArticleId><ArticleId IdType="pmc">PMC6532699</ArticleId><ArticleId IdType="pubmed">21069673</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J.S., Bousvaros A., Lee J.W., Diaz A., Davidson E.J. Efficacy of probiotic use in acute diarrhea in children: A meta-analysis. Dig. Dis. Sci. 2002;47:2625&#x2013;2634. doi: 10.1023/A:1020501202369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1020501202369</ArticleId><ArticleId IdType="pubmed">12452406</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Mrukowicz J.Z. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: A systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr. 2001;33(Suppl. S2):17&#x2013;25. doi: 10.1097/00005176-200110002-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005176-200110002-00004</ArticleId><ArticleId IdType="pubmed">11698781</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Niel C.W., Feudtner C., Garrison M.M., Christakis D.A. Lactobacillus therapy for acute infectious diarrhea in children: A meta-analysis. Pediatrics. 2002;109:678&#x2013;684. doi: 10.1542/peds.109.4.678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.4.678</ArticleId><ArticleId IdType="pubmed">11927715</ArticleId></ArticleIdList></Reference><Reference><Citation>McFarland L.V. Meta-analysis of probiotics for the prevention of traveler&#x2019;s diarrhea. Travel Med. Infect. Dis. 2007;5:97&#x2013;105. doi: 10.1016/j.tmaid.2005.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmaid.2005.10.003</ArticleId><ArticleId IdType="pubmed">17298915</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston B.C., Supina A.L., Ospina M., Vohra S. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev. 2007;2007:CD004827.</Citation><ArticleIdList><ArticleId IdType="pubmed">17443557</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston B.C., Supina A.L., Ospina M., Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: A meta-analysis of randomized placebo-controlled trials. CMAJ. 2006;175:377&#x2013;383. doi: 10.1503/cmaj.051603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.051603</ArticleId><ArticleId IdType="pmc">PMC1534112</ArticleId><ArticleId IdType="pubmed">16908901</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Ruszczy&#x144;ski M., Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: A meta-analysis of randomized controlled trials. J. Pediatr. 2006;149:367&#x2013;372. doi: 10.1016/j.jpeds.2006.04.053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpeds.2006.04.053</ArticleId><ArticleId IdType="pubmed">16939749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cremonini F., Di Caro S., Nista E.C., Bartolozzi F., Capelli G., Gasbarrini G., Gasbarrini A. Meta-analysis: The effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2002;16:1461&#x2013;1467. doi: 10.1046/j.1365-2036.2002.01318.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2036.2002.01318.x</ArticleId><ArticleId IdType="pubmed">12182746</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza A.L., Rajkumar C., Cooke J., Bulpitt C.J. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ. 2002;324:1361. doi: 10.1136/bmj.324.7350.1361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.324.7350.1361</ArticleId><ArticleId IdType="pmc">PMC115209</ArticleId><ArticleId IdType="pubmed">12052801</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrelak J.A., Whitten D.L., Myers S.P. Is Lactobacillus rhamnosus GG effec- tive in preventing the onset of antibiotic-associated diarrhoea: A systematic review. Digestion. 2005;72:51&#x2013;56. doi: 10.1159/000087637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000087637</ArticleId><ArticleId IdType="pubmed">16113542</ArticleId></ArticleIdList></Reference><Reference><Citation>Szajewska H., Mrukowicz J. Meta-analysis: Non-pathogenic yeast Saccharo- myces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2005;22:365&#x2013;372. doi: 10.1111/j.1365-2036.2005.02624.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2036.2005.02624.x</ArticleId><ArticleId IdType="pubmed">16128673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng S.C., Hart A.L., Kamm M.A., Stagg A.J., Knight S.C. Mechanisms of action of probiotics: Recent advances. Inflamm. Bowel Dis. 2009;15:300&#x2013;310. doi: 10.1002/ibd.20602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ibd.20602</ArticleId><ArticleId IdType="pubmed">18626975</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen T.D., Pyrsopoulos N., Rustgi V.K. Microbiota and the liver. Liver Transplant. 2018;24:539&#x2013;550. doi: 10.1002/lt.25008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lt.25008</ArticleId><ArticleId IdType="pubmed">29316191</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins J.P., Altman D.G., G&#xf8;tzsche P.C., J&#xfc;ni P., Moher D., Oxman A.D., Savovic J., Schulz K.F., Weeks L., Sterne J.A. Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration&#x2019;s tool for assessing risk of bias in dandomised trials. BMJ. 2011;343:d5928. doi: 10.1136/bmj.d5928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d5928</ArticleId><ArticleId IdType="pmc">PMC3196245</ArticleId><ArticleId IdType="pubmed">22008217</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G.A., Shea B., O&#x2019;Connell D. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Non-Randomised Studies in Meta-Analyses.  [(accessed on 27 October 2017)]; Available online:  http://www.ahri.a/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>Gr&#x105;t M., Wronka K.M., Lewandowski Z., Gr&#x105;t K., Krasnod&#x119;bski M., Stypu&#x142;kowski J., Ho&#x142;&#xf3;wko W., Masior &#x141;., Kosi&#x144;ska I., Wasilewicz M., et al. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo- controlled trial. Clin. Nutr. 2017;36:1530&#x2013;1539. doi: 10.1016/j.clnu.2017.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.04.021</ArticleId><ArticleId IdType="pubmed">28506447</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Seehofer D., Hansen S., Boucsein K., M&#xfc;ller A.R., Serke S., Bengmark S., Neuhaus P. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation. 2002;74:123&#x2013;127. doi: 10.1097/00007890-200207150-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007890-200207150-00021</ArticleId><ArticleId IdType="pubmed">12134110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Seehofer D., Theruvath T., Schiller R.A., Langrehr J.M., Jonas S., Bengmark S., Neuhaus P. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation&#x2014;A randomized, double-blind trial. Am. J. Transplant. 2005;5:125&#x2013;130. doi: 10.1111/j.1600-6143.2004.00649.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2004.00649.x</ArticleId><ArticleId IdType="pubmed">15636620</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi S., Takatsuki M., Hidaka M., Soyama A., Ichikawa T., Kanematsu T. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study. Am. J. Surg. 2011;201:498&#x2013;502. doi: 10.1016/j.amjsurg.2010.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.02.013</ArticleId><ArticleId IdType="pubmed">20619394</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen J., Wu J., Chalson H., Merigan L., Mitchell A. Probiotic use in preventing postoperative infection in liver transplant patients. Hepatobiliary Surg. Nutr. 2013;2:142&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3924667</ArticleId><ArticleId IdType="pubmed">24570932</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., Asahara T., Nomoto K., Tanaka R., Nimura Y. Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch. Surg. 2005;390:104&#x2013;113. doi: 10.1007/s00423-004-0536-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-004-0536-1</ArticleId><ArticleId IdType="pubmed">15711820</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Li C., Huang M., Tong C., Zhang X., Wang L., Peng H., Lan P., Zhang P., Huang N., et al. Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: A double-center and double-blind randomized clinical trial. BMC Gastroenterol. 2015;15:34. doi: 10.1186/s12876-015-0260-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12876-015-0260-z</ArticleId><ArticleId IdType="pmc">PMC4374379</ArticleId><ArticleId IdType="pubmed">25881090</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifatbegovic Z., Mesic D., Ljuca F., Zildzic M., Avdagic M., Grbic K., Agic M., Hadziefendic B. Effect of probiotics on liver function after surgery resection for malignancy in the liver cirrhotic. Med. Arch. 2010;64:208&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">21246916</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayes N., Pilarski T., Stockmann M., Bengmark S., Neuhaus P., Seehofer D. Effect of pre- and probiotics on liver regeneration after resection: A randomised, double-blind pilot study. Benef. Microbes. 2012;3:237&#x2013;244. doi: 10.3920/BM2012.0006.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2012.0006</ArticleId><ArticleId IdType="pubmed">22968413</ArticleId></ArticleIdList></Reference><Reference><Citation>Usami M., Miyoshi M., Kanbara Y., Aoyama M., Sakaki H., Shuno K., Hirata K., Takahashi M., Ueno K., Tabata S., et al. Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J. Parenter. Enter. Nutr. 2011;35:317&#x2013;328. doi: 10.1177/0148607110379813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607110379813</ArticleId><ArticleId IdType="pubmed">21527594</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugawara G., Nagino M., Nishio H., Ebata T., Takagi K., Asahara T., Nomoto K., Nimura Y. Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer Surgery: A Randomized Controlled Trial. Ann. Surg. 2006;244:706&#x2013;714. doi: 10.1097/01.sla.0000219039.20924.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000219039.20924.88</ArticleId><ArticleId IdType="pmc">PMC1856608</ArticleId><ArticleId IdType="pubmed">17060763</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida H., Sasaki M., Maehira H., Mori H., Yasukawa D., Takebayashi K., Kurihara M., Bamba S., Tani M. The effect of preoperative synbiotic treatment to prevent surgical-site infection in hepatic resection. J. Clin. Biochem. Nutr. 2020;66:67&#x2013;73. doi: 10.3164/jcbn.19-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.3164/jcbn.19-46</ArticleId><ArticleId IdType="pmc">PMC6983438</ArticleId><ArticleId IdType="pubmed">32001959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawas T., Al Halabi S., Hernaez R., Carey W.D., Cho W.K. Patients Receiving Prebiotics and Probiotics Before Liver Transplantation Develop Fewer Infections Than Controls: A Systematic Review and Meta-Analysis. Clin. Gastroenterol. Hepatol. 2015;13:1567&#x2013;1574. doi: 10.1016/j.cgh.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2015.05.027</ArticleId><ArticleId IdType="pubmed">26044318</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 1999;274:10689&#x2013;10692. doi: 10.1074/jbc.274.16.10689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.274.16.10689</ArticleId><ArticleId IdType="pubmed">10196138</ArticleId></ArticleIdList></Reference><Reference><Citation>Faure E., Equils O., Sieling P.A., Thomas L., Zhang F.X., Kirschning C.J., Polentarutti N., Muzio M., Arditi M. Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-and TLR-in endothelial cells. J. Biol. Chem. 2000;275:11058&#x2013;11063. doi: 10.1074/jbc.275.15.11058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.275.15.11058</ArticleId><ArticleId IdType="pubmed">10753909</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseaux C., Thuru X., Gelot A., Barnich N., Neut C., Dubuqoy L., Dubuquoy C., Merour E., Geboes K., Chamaillard M., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat. Med. 2007;13:35&#x2013;37. doi: 10.1038/nm1521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1521</ArticleId><ArticleId IdType="pubmed">17159985</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerty C.C., Mabvuure N.T., Ali A., Kozar R.A., Herndon D.N. The surgically induced stress response. JPEN J. Parenter. Enter. Nutr. 2013;37(Suppl. S5):21S&#x2013;29S. doi: 10.1177/0148607113496117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607113496117</ArticleId><ArticleId IdType="pmc">PMC3920901</ArticleId><ArticleId IdType="pubmed">24009246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chowdhury A.H., Adiamah A., Kushairi A., Varadhan K.K., Krznaric Z., Kulkarni A.D., Neal K.R., Lobo D.N. Perioperative Probiotics or Synbiotics in Adults Undergoing Elective Abdominal Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Ann. Surg. 2020;271:1036&#x2013;1047. doi: 10.1097/SLA.0000000000003581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003581</ArticleId><ArticleId IdType="pubmed">31469748</ArticleId></ArticleIdList></Reference><Reference><Citation>Skonieczna-&#x17b;ydecka K., Kaczmarczyk M., &#x141;oniewski I., Lara L.F., Koulaouzidis A., Misera A., Maciejewska D., Marlicz W. A Systematic Review, Meta-Analysis, and Meta-Regression Evaluating the Efficacy and Mechanisms of Action of Probiotics and Synbiotics in the Prevention of Surgical Site Infections and Surgery-Related Complications. J. Clin. Med. 2018;7:556. doi: 10.3390/jcm7120556.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120556</ArticleId><ArticleId IdType="pmc">PMC6307089</ArticleId><ArticleId IdType="pubmed">30558358</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran C.P., Musa S.A., Rahman T.M. The use of probiotics in the surgical patient. Eur. Surg. 2011;44:91&#x2013;98. doi: 10.1007/s10353-011-0613-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10353-011-0613-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda T., Shirabe K., Yoshiya S., Matono R., Morita K., Hashimoto N., Ikegami T., Yoshizumi T., Baba H., Maehara Y. Nutrition Support and Infections Associated With Hepatic Resection and Liver Transplantation in Patients With Chronic Liver Disease. J. Parenter. Enter. Nutr. 2012;37:318&#x2013;326. doi: 10.1177/0148607112456041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0148607112456041</ArticleId><ArticleId IdType="pubmed">22898793</ArticleId></ArticleIdList></Reference><Reference><Citation>Schnabl B., Brenner D.A. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513&#x2013;1524. doi: 10.1053/j.gastro.2014.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2014.01.020</ArticleId><ArticleId IdType="pmc">PMC3996054</ArticleId><ArticleId IdType="pubmed">24440671</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Duan Z.P., Ha D.K., Bengmark S., Kurtovic J., Riordan S.M. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology. 2004;39:1441&#x2013;1449. doi: 10.1002/hep.20194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.20194</ArticleId><ArticleId IdType="pubmed">15122774</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath A., Leber B., Schmerboeck B., Tawdrous M., Zettel G., Hartl A., Madl T., Stryeck S., Fuchs D., Lemesch S., et al. Randomised clinical trial: The effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment. Pharmacol. Ther. 2016;44:926&#x2013;935. doi: 10.1111/apt.13788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.13788</ArticleId><ArticleId IdType="pmc">PMC5053220</ArticleId><ArticleId IdType="pubmed">27593544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh D.C., Wu C.C., Ho W.M., Cheng S.B., Lu I.Y., Liu T.J., P&#x2019;eng F.K. Bacterial translocation after cirrhotic liver resection: A clinical investigation of patients. J. Surg. Res. 2003;111:209&#x2013;214. doi: 10.1016/S0022-4804(03)00112-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-4804(03)00112-4</ArticleId><ArticleId IdType="pubmed">12850464</ArticleId></ArticleIdList></Reference><Reference><Citation>Viehman J.A., Clancy C.J., Clarke L., Shields R.K., Silveira F.P., Kwak E.J., Vergidis P., Hughes C., Humar A., Nguyen M.H. Surgical site infections after liver transplantation: Emergence of multidrug-resistant bacteria and implications for prophylaxis and treatment strategies. Transplantation. 2016;100:2107&#x2013;2114. doi: 10.1097/TP.0000000000001356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000001356</ArticleId><ArticleId IdType="pubmed">27479167</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorgenson M.R., Descourouez J.L., Siodlak M., Tjugum S., Rice J.P., Fernandez L.A. Efficacy and Safety of Probiotics and Synbiotics in Liver Transplantation. Pharmacotherapy. 2018;38:758&#x2013;768. doi: 10.1002/phar.2130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/phar.2130</ArticleId><ArticleId IdType="pubmed">29804307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39672206</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Management of severe pyogenic spinal infections: the 2SICK study by the EANS spine section.</ArticleTitle><Pagination><StartPage>876</StartPage><EndPage>885</EndPage><MedlinePgn>876-885</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2024.12.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(24)01196-3</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Spondylodiscitis management presents significant clinical challenges, particularly in critically ill patients, where the risks and benefits of surgical intervention must be carefully balanced. The optimal timing of surgery in this context remains a subject of debate.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This study aims to evaluate the effectiveness of early surgery versus delayed surgery or conservative management in critically ill patients with de novo pyogenic spondylodiscitis.</AbstractText><AbstractText Label="STUDY DESIGN/SETTING" NlmCategory="METHODS">This is an international, multicenter retrospective cohort study involving 24 centers, primarily in Europe.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">The study included 192 critically ill patients (65.63% male) with a median age of 69 years, all severely affected by pyogenic spondylodiscitis characterized by an initial CRP level &gt;200 mg/l or the presence of two out of four Systemic Inflammatory Response Syndrome criteria upon admission.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">The primary outcome was 30-day mortality. Secondary outcomes included length of ICU stay, length of hospital stay, and relapse rates of spondylodiscitis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients were divided into three groups: early surgery (within three days of admission), delayed surgery (after three days of admission), and conservative therapy. Propensity score matching and multivariate regression analyses were performed to adjust for baseline differences and assess the impact of treatment modalities on mortality and other clinical outcomes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Delayed surgery was associated with significantly lower 30-day mortality (4.05%) compared to early surgery (27.85%) and conservative therapy (27.78%) (p&lt;.001). Delayed surgery also resulted in shorter hospital stays (42.76 days) compared to conservative therapy (55.53 days) and early surgery (26.33 days) (p&lt;.001), and shorter ICU stays (4.52 days) compared to conservative therapy (16.48 days) and early surgery (7.92 days) (p&lt;.001). The optimal window for surgery, minimizing mortality, was identified as ten to fourteen days postadmission (p=.02). Risk factors for increased mortality included age (p&lt;.05), multiple organ failure (p&lt;.05), and vertebral body destruction (p&lt;.05), whereas delayed surgery (p&lt;.05) and the presence of an epidural abscess were associated with reduced mortality (p&lt;.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Delayed surgery, optimally between 10 to 14 days postadmission, was associated with lower mortality in critically ill spondylodiscitis patients. These findings highlight the potential benefits of considering surgical timing to improve patient outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kramer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany. Electronic address: andreas.kramer@unimedizin-mainz.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thavarajasingam</LastName><ForeName>Santhosh G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany; Imperial Brain &amp; Spine Initiative, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuhoff</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Spinal Surgery and Neurotraumatology, Berufsgenossenschaftliche Unfallklinik Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Felipa</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ponniah</LastName><ForeName>Hariharan Subbiah</ForeName><Initials>HS</Initials><AffiliationInfo><Affiliation>Imperial Brain &amp; Spine Initiative, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lener</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thom&#xe9;</LastName><ForeName>Claudius</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stengel</LastName><ForeName>Felix C</ForeName><Initials>FC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery and Spine Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery and Spine Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hostettler</LastName><ForeName>Isabel C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery and Spine Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stienen</LastName><ForeName>Martin N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery and Spine Center of Eastern Switzerland, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jemna</LastName><ForeName>Maxim</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, St Marien Hospital L&#xfc;nen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gousias</LastName><ForeName>Konstantinos</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Athens Medical Center, University of M&#xfc;nster Medical School, European University of Cyprus Medical School, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nedeljkovic</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grujicic</LastName><ForeName>Danica</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nedeljkovic</LastName><ForeName>Zarko</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poluga</LastName><ForeName>Jasmina</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinic for Infectious and Tropical Diseases, University Clinical Center of Serbia, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xe4;r</LastName><ForeName>Ralph T</ForeName><Initials>RT</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Urbanski</LastName><ForeName>Wiktor</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Wroclaw University Hospital, Wroclaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurosurgery, Hospital Garcia de Orta, Almada, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casimiro</LastName><ForeName>Carlos Daniel Oliveira</ForeName><Initials>CDO</Initials><AffiliationInfo><Affiliation>Neurosurgery, Hospital Garcia de Orta, Almada, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmer</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital St. Poelten, St Polten, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladisich</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital St. Poelten, St Polten, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matt</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Bethel Clinic University of Bielefeld Medical Center, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simon</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Bethel Clinic University of Bielefeld Medical Center, Bielefeld, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pai</LastName><ForeName>Delin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doenitz</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital Regensburg, Regensburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mongardi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurosurgery Division - Department of Neuroscience, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lofrese</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neurosurgery Division - Department of Neuroscience, Cesena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchta</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassner</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Christian Doppler Clinic, Paracelsus Medical University, Salzburg, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tr&#xe1;vn&#xed;&#x10d;ek</LastName><ForeName>Pavel</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hossz&#xfa;</LastName><ForeName>Tom&#xe1;&#x161;</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Faculty of Medicine in Hradec Kralove, University Hospital Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wissels</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery Jessa Hospital, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamps</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery Jessa Hospital, Hasselt, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamouda</LastName><ForeName>Waeel</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Cairo University Medical School and Teaching Hospitals, Cairo, Egypt; Security Forces Hospital Dammam, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panico</LastName><ForeName>Flavio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neurosurgery Unit, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garbossa</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurosurgery Unit, Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbato</LastName><ForeName>Marcello</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurosurgery Unit, Azienda Ospedaliera dei Colli, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbarisi</LastName><ForeName>Manlio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurosurgery Unit, Azienda Ospedaliera dei Colli, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantel</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gempt</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasula</LastName><ForeName>Tharaka Sai</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Valley Baptist Medical Center, Harlingen, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Desai</LastName><ForeName>Sohum</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Valley Baptist Medical Center, Harlingen, Texas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitowanu</LastName><ForeName>Julius Mautin</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Neurological Surgery, Lagos State University Teaching Hospital, Ikeja, Lagos State, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rov&#x10d;anin</LastName><ForeName>Bekir</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omerhodzic</LastName><ForeName>Ibrahim</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Clinical Center University of Sarajevo, Sarajevo, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demetriades</LastName><ForeName>Andreas K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, Royal Infirmary Edinburgh, NHS Lothian, Edinburgh, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davies</LastName><ForeName>Benjamin</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Academic Neurosurgery, Addenbroke's Hospital, Cambridge University Hospital NHS Healthcare Trust, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiban</LastName><ForeName>Ehab</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Hospital of Lausitz, Cottbus, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ringel</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University Medical Center Mainz, Mainz, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015299" MajorTopicYN="Y">Discitis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="N">Conservative Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Conservative stabilization</Keyword><Keyword MajorTopicYN="N">Mortality rates</Keyword><Keyword MajorTopicYN="N">Pyogenic spondylodiscitis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Severe spinal infection</Keyword><Keyword MajorTopicYN="N">Surgical timing</Keyword></KeywordList><CoiStatement>Declaration of competing interest One or more of the authors declare financial or professional relationships on ICMJE-TSJ disclosure forms.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>17</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>14</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>13</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39672206</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2024.12.018</ArticleId><ArticleId IdType="pii">S1529-9430(24)01196-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36519396</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1757-7861</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Orthopaedic surgery</Title><ISOAbbreviation>Orthop Surg</ISOAbbreviation></Journal><ArticleTitle>What are Risk Factors of Postoperative Pneumonia in Geriatric Individuals after Hip Fracture Surgery: A Systematic Review and Meta-Analysis.</ArticleTitle><Pagination><StartPage>38</StartPage><EndPage>52</EndPage><MedlinePgn>38-52</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/os.13631</ELocationID><Abstract><AbstractText>Postoperative pneumonia (POP) is a common postoperative complication. Negative consequences associated with POP included prolonged hospital length of stay, more frequent intensive care unit (ICU) stays, and a higher rate of sepsis, readmission, and mortality. This meta-analysis aimed to assess the incidence and risk factors associated with POP after hip fracture surgery in elderly patients. PubMed, Web of Science, and Cochrane Library were searched (up to March 31, 2022). All studies on the risk factors for POP after hip fracture surgery in elderly patients, published in English, were reviewed. The qualities of the included studies were assessed using the Newcastle-Ottawa Scale. Data were pooled, and a meta-analysis was performed. Ten studies, including 12,084 geriatric patients undergoing hip fracture surgery, were included. Of these 12,084 patients, POP occurred in 809 patients. The results indicated that age (mean difference [MD]&#xa0;=&#xa0;4.95, 95% confidence interval [CI]: 3.22-6.69), male (odds ratio [OR]&#xa0;=&#xa0;1.41, 95% CI: 1.02-1.93), the American Society of Anaesthesiologists classification &#x2265;3 (OR&#xa0;=&#xa0;3.48, 95% CI: 1.87-6.47), dependent functional status (OR&#xa0;=&#xa0;5.23, 95% CI: 2.18-12.54, P&#xa0;=&#xa0;0.0002), smoking (OR&#xa0;=&#xa0;1.33, 95% CI: 1.07-1.65), chronic obstructive pulmonary disease (OR&#xa0;=&#xa0;3.76, 95% CI: 2.07-6.81), diabetes mellitus (OR&#xa0;=&#xa0;1.19, 95% CI: 1.01-1.40), coronary heart disease (OR&#xa0;=&#xa0;1.74, 95% CI: 1.23-2.46), arrhythmia (OR&#xa0;=&#xa0;1.47, 95% CI: 1.01-2.14), cerebrovascular disease (OR&#xa0;=&#xa0;1.88, 95% CI: 1.56-2.27), dementia (OR&#xa0;=&#xa0;2.36, 95% CI: 1.04-5.36), chronic renal failure (OR&#xa0;=&#xa0;1.85, 95% CI: 1.29-2.67), hip arthroplasty (OR&#xa0;=&#xa0;1.30, 95% CI: 1.08-1.56), delayed surgery (OR&#xa0;=&#xa0;6.40, 95% CI: 3.00-13.68), preoperative creatinine (MD&#xa0;=&#xa0;5.32, 95% CI: 0.55-10.08), and preoperative serum albumin (MD&#xa0;=&#xa0;-3.01, 95% CI: -4.21 - -1.80) were risk factors for POP. Related prophylactic measures should be provided in geriatric patients with the above-mentioned risk factors to prevent POP after hip fracture surgery.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley &amp; Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Yu-Cheng</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-0337-9285</Identifier><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuan-Wei</ForeName><Initials>YW</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Wang</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying-Juan</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Geriatrics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rui</LastName><ForeName>Yun-Feng</ForeName><Initials>YF</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Team (MDT) for Geriatric Hip Fracture Management, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Orthopaedic Trauma Institute (OTI), Southeast University, Nanjing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Trauma Center, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>YL20220525</GrantID><Agency>Winfast Charity Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>Orthop Surg</MedlineTA><NlmUniqueID>101501666</NlmUniqueID><ISSNLinking>1757-7853</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="Y">Hip Fractures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Hip Fracture</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Postoperative Pneumonia</Keyword><Keyword MajorTopicYN="N">Risk Factors</Keyword></KeywordList><CoiStatement>On behalf of all authors, the corresponding author states that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>15</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36519396</ArticleId><ArticleId IdType="pmc">PMC9837248</ArticleId><ArticleId IdType="doi">10.1111/os.13631</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Xu B, Yan S, Low LL, Vasanwala FF, Low SG. Predictors of poor functional outcomes and mortality in patients with hip fracture: a systematic review. BMC Musculoskelet Disord. 2019;20:568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6882152</ArticleId><ArticleId IdType="pubmed">31775693</ArticleId></ArticleIdList></Reference><Reference><Citation>Loggers SAI, Van Lieshout EMM, Joosse P, Verhofstad MHJ, Willems HC. Prognosis of nonoperative treatment in elderly patients with a hip fracture: a systematic review and meta&#x2010;analysis. Injury. 2020;51:2407&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">32907702</ArticleId></ArticleIdList></Reference><Reference><Citation>Belmont PJ Jr, Garcia EJ, Romano D, Bader JO, Nelson KJ, Schoenfeld AJ. Risk factors for complications and in&#x2010;hospital mortality following hip fractures: a study using the National Trauma Data Bank. Arch Orthop Trauma Surg. 2014;134:597&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">24570142</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H, Yin P, Long A, Gao Y, Zhao Z, Li J, et al. Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study. Osteoporos Int. 2016;27:3001&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27241669</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin KH, Kim JJ, Son SW, Hwang KS, Han SB. Early postoperative hypoalbuminaemia as a risk factor for postoperative pneumonia following hip fracture surgery. Clin Interv Aging. 2020;15:1907&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547765</ArticleId><ArticleId IdType="pubmed">33116445</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Zhu Y, Zhang K, Tian M, Qin S, Li X, et al. Incidence and risk factors for postoperative pneumonia following surgically treated hip fracture in geriatric patients: a retrospective cohort study. J Orthop Surg Res. 2022;17:179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8944015</ArticleId><ArticleId IdType="pubmed">35331285</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Zhang J, Li J, Guo J, Meng H, Zhu Y, et al. In&#x2010;hospital postoperative pneumonia following geriatric intertrochanteric fracture surgery: incidence and risk factors. Clin Interv Aging. 2020;15:1599&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489945</ArticleId><ArticleId IdType="pubmed">32982195</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang G, Dong X, Xu T, Feng Y, He Z, Ke C, et al. A nomogram for prediction of postoperative pneumonia risk in elderly hip fracture patients. Risk Manag Healthc Policy. 2020;13:1603&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502327</ArticleId><ArticleId IdType="pubmed">32982518</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y, Li X, Wang Y, Cheng L, Tian H, Li N, et al. Partial pressure of oxygen level at admission as a predictor of postoperative pneumonia after hip fracture surgery in a geriatric population: a retrospective cohort study. BMJ Open. 2021;11:e048272.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8552163</ArticleId><ArticleId IdType="pubmed">34706948</ArticleId></ArticleIdList></Reference><Reference><Citation>Salarbaks AM, Lindeboom R, Nijmeijer W. Pneumonia in hospitalized elderly hip fracture patients: the effects on length of hospital&#x2010;stay, in&#x2010;hospital and thirty&#x2010;day mortality and a search for potential predictors. Injury. 2020;51:1846&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">32482422</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Shen ZL, Duan XZ, Zhou QR, Fan JF, Shen J, et al. Postoperative pneumonia in geriatric patients with a hip fracture: incidence, risk factors and a predictive nomogram. Geriatr Orthop Surg Rehabil. 2022;13:21514593221083824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8949772</ArticleId><ArticleId IdType="pubmed">35340623</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Li X, Ji Y, Tian H, Liang X, Li N, et al. Preoperative serum albumin level as a predictor of postoperative pneumonia after femoral neck fracture surgery in a geriatric population. Clin Interv Aging. 2019;14:2007&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6859085</ArticleId><ArticleId IdType="pubmed">32009780</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun SE, Shon HC, Kim JW, et al. Risk factors and prognostic implications of aspiration pneumonia in older hip fracture patients: a multicenter retrospective analysis. Geriatr Gerontol Int. 2019;19:119&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">30556343</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin CT, Gao Y, Pugely AJ. Incidence and risk factors for 30&#x2010;day readmissions after hip fracture surgery. Iowa Orthop J. 2016;36:155&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910810</ArticleId><ArticleId IdType="pubmed">27528853</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjorholt KE, Kristensen NR, Prieto&#x2010;Alhambra D, Johnsen SP, Pedersen AB. Increased risk of mortality after postoperative infection in hip fracture patients. Bone. 2019;127:563&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">31340186</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Iantorno SE, Saltzman BM, Tetreault MW, Darrith B, Della Valle CJ. Sepsis within 30&#x2009;days of geriatric hip fracture surgery. J Arthroplasty. 2017;32:3114&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">28634098</ArticleId></ArticleIdList></Reference><Reference><Citation>Marseu K, Slinger P. Peri&#x2010;operative pulmonary dysfunction and protection. Anaesthesia. 2016;71(Suppl 1):46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">26620146</ArticleId></ArticleIdList></Reference><Reference><Citation>Stang A. Critical evaluation of the Newcastle&#x2010;Ottawa scale for the assessment of the quality of nonrandomized studies in meta&#x2010;analyses. Eur J Epidemiol. 2010;25:603&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">20652370</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang G, Xie L, Chen Z, Hao S, Fu C, Wu Q, et al. Clinical risk factors for mortality of hospitalized patients with COVID&#x2010;19: systematic review and meta&#x2010;analysis. Ann Palliat Med. 2021;10:2723&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">33549005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang MT, Li S, Liu X, Huang X, Zhang DY, Lei MX. Early detection of pneumonia with the help of dementia in geriatric hip fracture patients. Orthop Surg. 2022;14:129&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755876</ArticleId><ArticleId IdType="pubmed">35023317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Q, Mei Y, Wang X, Feng J, Cai J, Sun Y, et al. Study on the risk factors of postoperative hypoxemia in patients undergoing coronary artery bypass grafting. Circ J. 2008;72:1975&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931449</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukui K, Fujioka M, Yamasaki K, Yamakawa S, Matsuo H, Noguchi M. Risk factors for postoperative complications among the elderly after plastic surgery procedures performed under general anesthesia. Plast Surg Int. 2018;2018:7053839&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6077609</ArticleId><ArticleId IdType="pubmed">30112200</ArticleId></ArticleIdList></Reference><Reference><Citation>Beverly A, Brovman EY, Urman RD. Comparison of postoperative outcomes in elderly patients with a do&#x2010;not&#x2010;resuscitate order undergoing elective and nonelective hip surgery. Geriatr Orthop Surg Rehabil. 2017;8:78&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5431406</ArticleId><ArticleId IdType="pubmed">28540112</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Saltzman BM, Sershon RA, Darrith B, Della Valle CJ. Incidence, risk factors, and clinical implications of pneumonia after surgery for geriatric hip fracture. J Arthroplasty. 2017;32(1991&#x2013;95):e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">29289445</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Sershon RA, Saltzman BM, Darrith B, Della Valle CJ. Incidence, risk factors, and clinical implications of pneumonia after surgery for geriatric hip fracture. J Arthroplasty. 2018;33:1552&#x2013;1556.e1.</Citation><ArticleIdList><ArticleId IdType="pubmed">29289445</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49:1458&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">29699731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekstrom W, Samuelsson B, Ponzer S, Cederholm T, Thorngren K&#x2010;G, Hedstr&#xf6;m M. Sex effects on short&#x2010;term complications after hip fracture: a prospective cohort study. Clin Interv Aging. 2015;10:1259&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4531035</ArticleId><ArticleId IdType="pubmed">26347328</ArticleId></ArticleIdList></Reference><Reference><Citation>Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smoking&#x2010;induced pneumonia. Am J Respir Crit Care Med. 2019;199:250&#x2013;1.</Citation><ArticleIdList><ArticleId IdType="pubmed">30290125</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Mascha EJ, Roberman D, Turner PL, You J, Kurz A, et al. Smoking and perioperative outcomes. Anesthesiology. 2011;114:837&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">21372682</ArticleId></ArticleIdList></Reference><Reference><Citation>Solbakken SM, Meyer HE, Stigum H, S&#xf8;gaard AJ, Holvik K, Magnus JH, et al. Excess mortality following hip fracture: impact of self&#x2010;perceived health, smoking, and body mass index. A NOREPOS study. Osteoporos Int. 2017;28:881&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">27714442</ArticleId></ArticleIdList></Reference><Reference><Citation>Ally SA, Foy M, Sood A, Gonzalez M. Preoperative risk factors for postoperative pneumonia following primary Total Hip and Knee Arthroplasty. J Orthop. 2021;27:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8379351</ArticleId><ArticleId IdType="pubmed">34456526</ArticleId></ArticleIdList></Reference><Reference><Citation>Leer&#x2010;Salvesen S, Enges&#xe6;ter LB, Dybvik E, Furnes O, Kristensen TB, Gjertsen JE. Does time from fracture to surgery affect mortality and intraoperative medical complications for hip fracture patients? An observational study of 73 557 patients reported to the Norwegian Hip Fracture Register. Bone Joint J. 2019;101&#x2010;B(9):1129&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">31474142</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasui H, Inui N, Karayama M, Mori K, Hozumi H, Suzuki Y, et al. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three&#x2010;dimensional CT in patients with chronic obstructive pulmonary disease. Respir Med. 2019;146:76&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">30665522</ArticleId></ArticleIdList></Reference><Reference><Citation>Yakubek GA, Curtis GL, Sodhi N, Faour M, Klika AK, Mont MA, et al. Chronic obstructive pulmonary disease is associated with short&#x2010;term complications following total hip arthroplasty. J Arthroplasty. 2018;33:1926&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29402713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma CM, Liu Q, Li ML, Ji MJ, Zhang JD, Zhang BH, et al. The effects of type 2 diabetes and postoperative pneumonia on the mortality in inpatients with surgery. Diabetes Metab Syndr Obes. 2019;12:2507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6890188</ArticleId><ArticleId IdType="pubmed">31819576</ArticleId></ArticleIdList></Reference><Reference><Citation>He K, Hemmila MR, Cain&#x2010;Nielsen AH, Machado&#x2010;Aranda DA, Frydrych LM, Delano MJ. Complications and resource utilization in trauma patients with diabetes. PloS One. 2019;14:e0221414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713394</ArticleId><ArticleId IdType="pubmed">31461502</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C&#x2010;reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">11466099</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh JJ, Lin CL, Kao CH. Relationship between pneumonia and cardiovascular diseases: a retrospective cohort study of the general population. Eur J Intern Med. 2019;59:39&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">30098854</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramalho SHR, Shah AM. Lung function and cardiovascular disease: a link. Trends Cardiovasc Med. 2021;31:93&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332411</ArticleId><ArticleId IdType="pubmed">31932098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee R, Lee D, Gowda NB, Probasco WV, Ibrahim G, Falk DP, et al. Surgical complications associated with congestive heart failure in elderly patients following primary hip hemiarthroplasty for femoral neck fractures. Eur J Orthop Surg Traumatol. 2019;29:1253&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">31041543</ArticleId></ArticleIdList></Reference><Reference><Citation>Teramoto S, Yoshida K, Hizawa N. Update on the pathogenesis and management of pneumonia in the elderly&#x2010;roles of aspiration pneumonia. Respir Investig. 2015;53:178&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26344607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannawi Y, Hannawi B, Rao CP, Suarez JI, Bershad EM. Stroke&#x2010;associated pneumonia: major advances and obstacles. Cerebrovasc Dis. 2013;35:430&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">23735757</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyashita N, Yamauchi Y. Bacterial pneumonia in elderly Japanese populations. Jpn Clin Med. 2018;9:1179670717751433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5804998</ArticleId><ArticleId IdType="pubmed">29434484</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkocak OF, Yoo JY, Restrepo C, Maltenfort MG, Parvizi J. Incidence of infection and inhospital mortality in patients with chronic renal failure after total joint arthroplasty. J Arthroplasty. 2016;31:2437&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">27341974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23:437&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6435626</ArticleId><ArticleId IdType="pubmed">30178234</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer AC, Eklund H, Hedstrom M, Modig K. The ASA score predicts infections, cardiovascular complications, and hospital readmissions after hip fracture &#x2010; a nationwide cohort study. Osteoporos Int. 2021;32:2185&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8563539</ArticleId><ArticleId IdType="pubmed">34013459</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Shen Y, Hou L, Yang B, Dong B, Hao Q. Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults. BMC Geriatr. 2021;21:541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8507107</ArticleId><ArticleId IdType="pubmed">34641805</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldebeyan S, Nooh A, Aoude A, Weber MH, Harvey EJ. Hypoalbuminaemia&#x2010;a marker of malnutrition and predictor of postoperative complications and mortality after hip fractures. Injury. 2017;48:436&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">28040258</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Daly BJ, Walsh JC, Quinlan JF, Falk GA, Stapleton R, Quinlan WR, et al. Serum albumin and total lymphocyte count as predictors of outcome in hip fractures. Clin Nutr. 2010;29:89&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19674819</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubner M, Mantziari S, Demartines N, Pralong F, Coti&#x2010;Bertrand P, Sch&#xe4;fer M. Postoperative albumin drop is a marker for surgical stress and a predictor for clinical outcome: a pilot study. Gastroenterol Res Pract. 2016;2016:8743187&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736779</ArticleId><ArticleId IdType="pubmed">26880899</ArticleId></ArticleIdList></Reference><Reference><Citation>Pincus D, Ravi B, Wasserstein D, Huang A, Paterson JM, Nathens AB, et al. Association between wait time and 30&#x2010;day mortality in adults undergoing hip fracture surgery. JAMA. 2017;318:1994&#x2013;2003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5820694</ArticleId><ArticleId IdType="pubmed">29183076</ArticleId></ArticleIdList></Reference><Reference><Citation>Glassou EN, Kjorholt KK, Hansen TB, Pedersen AB. Delay in surgery, risk of hospital&#x2010;treated infections and the prognostic impact of comorbidity in hip fracture patients. A Danish nationwide cohort study, 2005&#x2013;2016. Clin Epidemiol. 2019;11:383&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6519337</ArticleId><ArticleId IdType="pubmed">31191031</ArticleId></ArticleIdList></Reference><Reference><Citation>Klestil T, Roder C, Stotter C, Winkler B, Nehrer S, Lutz M, et al. Impact of timing of surgery in elderly hip fracture patients: a systematic review and meta&#x2010;analysis. Sci Rep. 2018;8:13933.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6141544</ArticleId><ArticleId IdType="pubmed">30224765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Zhang X, Tian S, Wu Y. Minimally invasive versus conventional dynamic hip screw for the treatment of intertrochanteric fractures in older patients. Orthopedics. 2012;35:e244&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22310413</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Donnell CM, McLoughlin L, Patterson CC, Clarke M, McCourt KC, McBrien ME, et al. Perioperative outcomes in the context of mode of anaesthesia for patients undergoing hip fracture surgery: systematic review and meta&#x2010;analysis. Br J Anaesth. 2018;120:37&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">29397135</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26649579</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>264</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Impaired Immune Response in Elderly Burn Patients: New Insights Into the Immune-senescence Phenotype.</ArticleTitle><Pagination><StartPage>195</StartPage><EndPage>202</EndPage><MedlinePgn>195-202</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000001408</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Comparing the inflammatory and immunological trajectories in burned adults versus burned elderly patients to gain novel insights and better understanding why elderly have poor outcomes.</AbstractText><AbstractText Label="SUMMARY BACKGROUND DATA">Despite receiving the same treatment and clinical consideration as all other burn patients, elderly patients continue to have substantially poorer outcomes compared with adults. In light of an aging population, gaining a better understanding of their susceptibility to complications and creating new treatment strategies is imperative.</AbstractText><AbstractText Label="METHODS">We included 130 burn patients (94 adults: &lt;65 years old and 36 elderly: &#x2265;65 years old) and 10 healthy controls in this study. Immune activity and expression was assessed using bioplex at various time points. Clinical outcomes such as infection, sepsis, and mortality were prospectively collected.</AbstractText><AbstractText Label="RESULTS">Elderly burn patients had significantly lower burn size but significantly higher Baux scores. Morbidity and mortality was significantly increased in the elderly cohort. Immune biomarkers indicated that elderly are immune compromised and unable to respond with the expected inflammatory response during the early phase after injury. This trajectory changes to a hyperinflammatory pattern during the later phase after burn. These findings are even more pronounced when comparing sepsis versus nonsepsis patients as well as survivors versus nonsurvivors in the elderly.</AbstractText><AbstractText Label="CONCLUSIONS">Elderly burned patients mount a delayed immune and dampened inflammatory response early after burn injury that changes to an augmented response at later time points. Late-onset sepsis and nonsurvivors had an immune exhaustion phenotype, which may represent one of the main mediators responsible for the striking mortality in elderly.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stanojcic</LastName><ForeName>Mile</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>*Sunnybrook Research Institute, University of Toronto, Toronto, Canada&#x2020;Department of Surgery, Division of Plastic Surgery, University of Toronto, Toronto, Canada&#x2021;Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Xiu</LastName><ForeName>Fangming</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Jeschke</LastName><ForeName>Marc G</ForeName><Initials>MG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM087285</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency>CIHR</Agency><Country>Canada</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018925">Chemokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000375" MajorTopicYN="Y">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001830" MajorTopicYN="N">Body Surface Area</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018925" MajorTopicYN="N">Chemokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="Y">Geriatric Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014945" MajorTopicYN="N">Wound Healing</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>12</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26649579</ArticleId><ArticleId IdType="mid">NIHMS708508</ArticleId><ArticleId IdType="pmc">PMC4899096</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000001408</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Milan A. Age and sex structure: Canada, provinces and territories, 2010. 2011 Retrieved from  http://www.statcan.gc.ca.</Citation></Reference><Reference><Citation>Barillo DJ, Goode R. Fire fatality study: demographics of fire victims. Burns. 1996;22:85&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">8634135</ArticleId></ArticleIdList></Reference><Reference><Citation>Pham TN, Kramer CB, Wang J, et al. Epidemiology and outcomes of older adults with burn injury: an analysis of the National Burn Repository. J Burn Care Res. 2009;30:30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3042349</ArticleId><ArticleId IdType="pubmed">19060727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gauglitz GG, Song J, Herndon DN, et al. Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock. 2008;30:503&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7863568</ArticleId><ArticleId IdType="pubmed">18391855</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One. 2011;6:e21245.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3138751</ArticleId><ArticleId IdType="pubmed">21789167</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyhlen K, Gautam C, Andersson R, et al. Modulation of cytokine-induced production of IL-8 in vitro by interferons and glucocorticosteroids. Inflammation. 2004;28:77&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">15379213</ArticleId></ArticleIdList></Reference><Reference><Citation>de Bandt JP, Chollet-Martin S, Hernvann A, et al. Cytokine response to burn injury: relationship with protein metabolism. J Trauma. 1994;36:624&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">8189461</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo S, Inada K, Kikuchi M, et al. Are plasma endotoxin levels related to burn size and prognosis? Burns. 1992;18:486&#x2013;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">1489498</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueyama M, Maruyama I, Osame M, et al. Marked increase in plasma interleukin-6 in burn patients. J Lab Clin Med. 1992;120:693&#x2013;698.</Citation><ArticleIdList><ArticleId IdType="pubmed">1385556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Chinkes DL, Finnerty CC, et al. Pathophysiologic response to severe burn injury. Ann Surg. 2008;248:387&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3905467</ArticleId><ArticleId IdType="pubmed">18791359</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Gauglitz GG, Finnerty CC, Kraft R, Mlcak RP, Herndon DN. Survivors versus nonsurvivors postburn: differences in inflammatory and hypermetabolic trajectories. Ann Surg. 2014;259:814&#x2013;823.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3732513</ArticleId><ArticleId IdType="pubmed">23579577</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Herndon DN. Burns in children: standard and new treatments. Lancet. 2014;383:1168&#x2013;1178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859869</ArticleId><ArticleId IdType="pubmed">24034453</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Berghe G, de Zegher F, Veldhuis JD, et al. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin. Endocrinol. Metab. 1997;82:590&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pubmed">9024260</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C, Bonafe M, Valensin S, et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000;908:244&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomellini V, Gomez CR, Gamelli RL, et al. Aging and animal models of systemic insult: trauma, burn, and sepsis. Shock. 2009;31:11&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2907874</ArticleId><ArticleId IdType="pubmed">18636047</ArticleId></ArticleIdList></Reference><Reference><Citation>Masud D, Norton S, Smailes S, et al. The use of a frailty scoring system for burns in the elderly. Burns. 2013;39:30&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">22575336</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz CR, Villegas J, Sylvester M, et al. Burns are more aggressive in the elderly: proportion of deep burn area/total burn area might have a role in mortality. Burns. 2011;37:1058&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">21571438</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimble RF. Inflammatory response in the elderly. Curr Opin Clin Nutr Metab Care. 2003;6:21&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">12496677</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren RS, Kramer CB, Rivara FP, et al. Influence of comorbidities and age on outcome following burn injury in older adults. J Burn Care Res. 2009;30:307&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3045667</ArticleId><ArticleId IdType="pubmed">19165104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rani M, Schwacha MG. Aging and the pathogenic response to burn. Aging Dis. 2012;3:171&#x2013;180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3377829</ArticleId><ArticleId IdType="pubmed">22724078</ArticleId></ArticleIdList></Reference><Reference><Citation>Solana R, Tarazona R, Gayoso I, et al. Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol. 2012;24:331&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pubmed">22560929</ArticleId></ArticleIdList></Reference><Reference><Citation>Wasiak J, Lee SJ, Paul E, et al. Predictors of health status and age-related quality of life 12 months after severe burn. Burns. 2014;40:568&#x2013;574.</Citation><ArticleIdList><ArticleId IdType="pubmed">24582756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerby JD, McGwin G, Jr, George RL, et al. Sex differences in mortality after burn injury: results of analysis of the National Burn Repository of the American Burn Association. J Burn Care Res. 2006;27:452&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">16819347</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Barrow RE, Mlcak RP, et al. Endogenous anabolic hormones and hypermetabolism: effect of trauma and gender differences. Ann Surg. 2005;241:759&#x2013;767.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1357130</ArticleId><ArticleId IdType="pubmed">15849511</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, Mlcak RP, Finnerty CC, et al. Gender differences in pediatric burn patients: does it make a difference. Ann Surg. 2008;248:126&#x2013;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7863567</ArticleId><ArticleId IdType="pubmed">18580216</ArticleId></ArticleIdList></Reference><Reference><Citation>Wohltmann CD, Franklin GA, Boaz PW, et al. A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg. 2001;181:297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">11438262</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa G, Huynh T, Sing RF, et al. Gender-related outcomes in trauma. J Trauma. 2002;53:340&#x2013;434.</Citation><ArticleIdList><ArticleId IdType="pubmed">12352476</ArticleId></ArticleIdList></Reference><Reference><Citation>McGwin G, George RL, Cross JM, et al. Gender differences in mortality following burn injury. Shock. 2002;18:311&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">12392273</ArticleId></ArticleIdList></Reference><Reference><Citation>Silver GM, Klein MB, Herndon DN, et al. Standard operating procedures for the clinical management of patients enrolled in a prospective study of inflammation and the host response to thermal injury. J Burn Care Res. 2007;28:222&#x2013;230.</Citation><ArticleIdList><ArticleId IdType="pubmed">17351437</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein MB, Goverman J, Hayden DL, et al. Benchmarking outcomes in critically injured burn patients. Ann Surg. 2014;259:833&#x2013;841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4283803</ArticleId><ArticleId IdType="pubmed">24722222</ArticleId></ArticleIdList></Reference><Reference><Citation>Janzekovic Z. A new concept in the early excision and immediate grafting of burns. J Trauma. 1970;10:1103&#x2013;1109.</Citation><ArticleIdList><ArticleId IdType="pubmed">4921723</ArticleId></ArticleIdList></Reference><Reference><Citation>Herndon DN, Park DH. Comparison of serial debridement and autografting and early massive excision with cadaver skin overlay in the treatment of large burns in children. J Trauma. 1986;26:149&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">3511266</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso C, Lio D, Cavallone L, et al. Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci. 2004;1028:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">15915584</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan TE, Wong AM, Finch CE. Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol. 2007;35:83&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">17063034</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med. 2006;34:15&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">16374151</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerty CC, Jeschke MG, Herndon DN, et al. Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med. 2008;14:553&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2424320</ArticleId><ArticleId IdType="pubmed">18548133</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojcic M, Chen P, Harrison RA, et al. Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med. 2014;42:1357&#x2013;1364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4166573</ArticleId><ArticleId IdType="pubmed">24584061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritz T, Weinberger B, Grubeck-Loebenstein B. The aging bone marrow and its impact on immune responses in old age. Immunol Lett. 2014;162:310&#x2013;315.</Citation><ArticleIdList><ArticleId IdType="pubmed">25014741</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson JW, Otto AM, Gibran NS, et al. Trajectories to death in patients with burn injury. J Trauma Acute Care Surg. 2013;74:282&#x2013;288.</Citation><ArticleIdList><ArticleId IdType="pubmed">23271104</ArticleId></ArticleIdList></Reference><Reference><Citation>Rymkiewicz PD, Heng YX, Vasudev A, et al. The immune system in the aging human. J Immunol Res. 2012;53:235&#x2013;250.</Citation><ArticleIdList><ArticleId IdType="pubmed">22477521</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerty CC, Herndon DN, Chinkes DL, et al. Serum cytokine differences in severely burned children with and without sepsis. Shock. 2007;27:4&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17172973</ArticleId></ArticleIdList></Reference><Reference><Citation>Faist E, Ertel W, Salmen B, et al. The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery. Arch Surg. 1988;123:1449&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">3056331</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga M, Costantini E, Di Francesco A, et al. Impact of thymopentin on the incidence and severity of postoperative infection: a randomized controlled trial. Br J Surg. 1994;81:205&#x2013;208.</Citation><ArticleIdList><ArticleId IdType="pubmed">8156337</ArticleId></ArticleIdList></Reference><Reference><Citation>Haupt W, Zirngibl H, Riese J, et al. Depression of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 production: a reaction to the initial systemic hyperactivation in septic shock. J Invest Surg. 1997;10:349&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">9654391</ArticleId></ArticleIdList></Reference><Reference><Citation>Keck M, Lumenta DB, Andel H, et al. Burn treatment in elderly. Burns. 2009;35:1071&#x2013;1079.</Citation><ArticleIdList><ArticleId IdType="pubmed">19520515</ArticleId></ArticleIdList></Reference><Reference><Citation>Khadim MF, Rashid A, Fogarty B, et al. Mortality estimates in the elderly burned patients: the Northern Ireland experience. Burns. 2009;35:7&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">18687531</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993;23:2375&#x2013;2378.</Citation><ArticleIdList><ArticleId IdType="pubmed">8370415</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsey RJ, Thompson JM, Ernerudh J, et al. Plasma cytokine levels in elderly humans. Mech Ageing Dev. 2003;124:487&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">12714257</ArticleId></ArticleIdList></Reference><Reference><Citation>Stowe RP, Peek MK, Cutchin MP, et al. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci. 2010;65:429&#x2013;433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844059</ArticleId><ArticleId IdType="pubmed">20018825</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29204670</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>2</Issue><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.</ArticleTitle><Pagination><StartPage>167</StartPage><EndPage>178</EndPage><MedlinePgn>167-178</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-017-5004-9</ELocationID><Abstract><AbstractText Label="PURPOSE">Polymyxin B-immobilized hemoperfusion (PMX-HP) is an adjuvant therapy for sepsis or septic shock that clears circulating endotoxin. Prior trials have shown that PMX-HP improves surrogate endpoints. We aimed to conduct an evidence synthesis to evaluate the efficacy and safety of PMX-HP in critically ill adult patients with sepsis or septic shock.</AbstractText><AbstractText Label="METHODS">We searched for randomized controlled trials (RCTs) in MEDLINE, EMBASE, the Cochrane Library, the Health Technology Assessment Database, CINAHL, "Igaku Chuo Zasshi", the National Institute of Health Clinical Trials Register, the World Health Organization International Clinical Trials Registry Platform, the University Hospital Medical Information Network Clinical Trials Registry, the reference lists of retrieved articles, and publications by manufacturers of PMX-HP. The primary outcomes were 28-day all-cause mortality, the number of patients with at least one serious adverse event, and organ dysfunction scores. The GRADE methodology for the certainty of evidence was used.</AbstractText><AbstractText Label="RESULTS">Six trials (857 participants; weighted mean age 62.5&#xa0;years) proved eligible. Patient-oriented primary outcomes were assessed. The pooled risk ratio (RR) for 28-day mortality associated with PMX-HP was 1.03 [95% confidence interval (CI) 0.78-1.36; I <sup>2</sup>&#xa0;=&#xa0;25%; n&#xa0;=&#xa0;797]. The pooled RR for adverse events was 2.17 (95% CI 0.68-6.94; I <sup>2</sup>&#xa0;=&#xa0;0%; n&#xa0;=&#xa0;717). Organ dysfunction scores over 24-72&#xa0;h after PMX-HP treatment did not change significantly (standardized mean difference - 0.26; 95% CI - 0.64 to 0.12; I <sup>2</sup>&#xa0;=&#xa0;78%; n&#xa0;=&#xa0;797). The certainty of the body of evidence was judged as low for both benefit and harm using the GRADE methodology.</AbstractText><AbstractText Label="CONCLUSIONS">There is currently insufficient evidence to support the routine use of PMX-HP to treat patients with sepsis or septic shock.</AbstractText><AbstractText Label="REGISTRATION">PROSPERO International Prospective Register of Systematic Reviews (CRD42016038356).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fujii</LastName><ForeName>Tomoko</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-3854-4081</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Preventive Medicine, Kyoto University Graduate School of Medicine, Yoshida Hon-machi, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Japan Society for the Promotion of Science, 5-3-1 Kojimachi, Chiyoda-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganeko</LastName><ForeName>Riki</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, Kyoto University Hospital, 54 Kawaharacho, Syogoin, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kataoka</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Hyogo Prefectural Amagasaki General Medical Center, Higashi-Naniwa-Cho 2-17-77, Amagasaki, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furukawa</LastName><ForeName>Toshi A</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine, Yoshida Konoe-cho, Sakyo-Ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Featherstone</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Alberta Research Center for Health Evidence (ARCHE), University of Alberta, 11405-87 Avenue Edmonton, Alberta, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doi</LastName><ForeName>Kent</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vincent</LastName><ForeName>Jean-Louis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Erasme University Hospital, Unversit&#xe9; Libre de Bruxelles, Route de Lennik 808, 1070, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasero</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, San Giovanni Battista Hospital, University of Turin, Via Giuseppe Verdi, 8, 10124, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robert</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Service de R&#xe9;animation M&#xe9;dicale, CHU-Poitiers, University of Poitiers, 86000, Poitiers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ronco</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Nephrology Dialysis and Transplantation, International Renal Research Institute of Vicenza (IRRIV), San Bortolo Hospital, Viale Rodolfi 37, 36100, Vicenza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bagshaw</LastName><ForeName>Sean M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Faculty of Medicine and Dentistry, University of Alberta, 2-124 Clinical Sciences Building, 8440-112 ST NW, Edmonton, Canada, T6G 2B7. bagshaw@ualberta.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP16J10320</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J2VZ07J96K</RegistryNumber><NameOfSubstance UI="D011112">Polymyxin B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Intensive Care Med. 2018 Feb;44(2):279-280. doi: 10.1007/s00134-018-5055-6.</RefSource><PMID Version="1">29340720</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="Y">Hemoperfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011112" MajorTopicYN="Y">Polymyxin B</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Polymyxin B-immobilized hemoperfusion</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29204670</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-5004-9</ArticleId><ArticleId IdType="pii">10.1007/s00134-017-5004-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nephron. 2000 Oct;86(2):210</Citation><ArticleIdList><ArticleId IdType="pubmed">11015003</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2008 Sep;34(9):1638-45</Citation><ArticleIdList><ArticleId IdType="pubmed">18463848</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 May;38(5):1360-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20308884</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2009 Jun 17;301(23):2445-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19531784</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2005 May;23(5):400-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15834304</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Apher Dial. 2003 Feb;7(1):108-14</Citation><ArticleIdList><ArticleId IdType="pubmed">12921125</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2011 Jul 13;306(2):194-9</Citation><ArticleIdList><ArticleId IdType="pubmed">21750297</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock. 2017 Jan;47(1):93-99</Citation><ArticleIdList><ArticleId IdType="pubmed">27984535</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2013 Apr 25;17(2):R65</Citation><ArticleIdList><ArticleId IdType="pubmed">23561510</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hosp Infect. 2003 Jan;53(1):58-63</Citation><ArticleIdList><ArticleId IdType="pubmed">12495686</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2008 Jul 3;359(1):7-20</Citation><ArticleIdList><ArticleId IdType="pubmed">18492867</ArticleId></ArticleIdList></Reference><Reference><Citation>Control Clin Trials. 1986 Sep;7(3):177-88</Citation><ArticleIdList><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>BMJ Open. 2016 Nov 21;6(11):e012908</Citation><ArticleIdList><ArticleId IdType="pubmed">27872122</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 1998 Nov;26(11):1793-800</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2013 Aug;66(8):847-55</Citation><ArticleIdList><ArticleId IdType="pubmed">23747228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ther Apher. 1998 Feb;2(1):3-12</Citation><ArticleIdList><ArticleId IdType="pubmed">10227782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nephron Clin Pract. 2003;94(2):c33-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12845235</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2003 Apr;29(4):530-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2001 Nov;29(11):2046-50</Citation><ArticleIdList><ArticleId IdType="pubmed">11700393</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2002 May-Jun;48(3):244-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12058997</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2014 May 15;189(10):1204-13</Citation><ArticleIdList><ArticleId IdType="pubmed">24635548</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1991 Jan;99(1):169-75</Citation><ArticleIdList><ArticleId IdType="pubmed">1984950</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 1993 Oct 15;119(8):771-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8379598</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2015 Jun;41(6):975-84</Citation><ArticleIdList><ArticleId IdType="pubmed">25862039</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2014 Jun 11;15:218</Citation><ArticleIdList><ArticleId IdType="pubmed">24916483</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2004 Mar;32(3):858-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Crit Care Med. 2000 May;161(5):1429-36</Citation><ArticleIdList><ArticleId IdType="pubmed">10806135</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2004 Aug 1;190(3):527-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15243928</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2004 Sep;30(9):1838-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15197430</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Purif. 2001;19(4):361-8; discussion 368-9</Citation><ArticleIdList><ArticleId IdType="pubmed">11574732</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2000 Nov;28(11):3581-7</Citation><ArticleIdList><ArticleId IdType="pubmed">11098957</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2009 Mar;37(3):803-10</Citation><ArticleIdList><ArticleId IdType="pubmed">19237881</ArticleId></ArticleIdList></Reference><Reference><Citation>ASAIO J. 2002 Jan-Feb;48(1):41-4</Citation><ArticleIdList><ArticleId IdType="pubmed">11814097</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2017 Aug;45(8):e858-e864</Citation><ArticleIdList><ArticleId IdType="pubmed">28445237</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 22;361(17):1627-38</Citation><ArticleIdList><ArticleId IdType="pubmed">19846848</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2011 Apr;64(4):383-94</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2014 Apr 2;311(13):1308-16</Citation><ArticleIdList><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2007;11(2):R47</Citation><ArticleIdList><ArticleId IdType="pubmed">17448226</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2013 Sep;41(9):2209-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23860248</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Epidemiol. 2009 Sep;62(9):944-52</Citation><ArticleIdList><ArticleId IdType="pubmed">19230612</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2013 Feb;41(2):580-637</Citation><ArticleIdList><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood Purif. 2011;32(4):331-40</Citation><ArticleIdList><ArticleId IdType="pubmed">22086346</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2006 May;32(5):713-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16550372</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2009 Jul 21;6(7):e1000097</Citation><ArticleIdList><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31522785</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-1983</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical nutrition (Edinburgh, Scotland)</Title><ISOAbbreviation>Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>A randomized-controlled trial of arginine infusion in severe sepsis on microcirculation and metabolism.</ArticleTitle><Pagination><StartPage>1764</StartPage><EndPage>1773</EndPage><MedlinePgn>1764-1773</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.clnu.2019.08.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0261-5614(19)33025-0</ELocationID><Abstract><AbstractText Label="BACKGROUND &amp; AIMS">Sepsis is hypothesized as an arginine deficient state, with lack of nitric oxide (NO) for adequate microcirculation and local perfusion. This study aimed to investigate if prolonged (72-h) intravenous l-arginine administration in sepsis patients improves microcirculation. Secondly, effects on arginine and protein metabolism, and organ function were studied.</AbstractText><AbstractText Label="METHODS">Critically ill patients with a diagnosis of septic shock participated in a long-term (72&#xa0;h) randomized double-blind placebo-controlled parallel-group study. l-arginine-HCl (1.2&#xa0;&#x3bc;mol&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>; n&#xa0;=&#xa0;9) or l-alanine (isocaloric control: 2.4&#xa0;&#x3bc;mol&#xa0;kg<sup>-1</sup>&#xa0;min<sup>-1</sup>; n&#xa0;=&#xa0;9) was continuously infused. Primary study outcome was microcirculation, assessed as gastric mucosal perfusion by gastric tonometry (P<sub>r-a</sub>CO<sub>2</sub> gap) and skin perfusion by Laser Doppler flowmetry. Secondary endpoints were whole body (WB) arginine and protein metabolism, organ function and clinical outcomes. We measured global hemodynamics continuously for safety monitoring. Statistical analyses were performed by mixed model for repeated measures with treatment by time interaction as estimate for between-group difference.</AbstractText><AbstractText Label="RESULTS">P<sub>r-a</sub>CO<sub>2</sub> increased only in the l-arginine group (p&#xa0;=&#xa0;0.006), without a significant between-group difference (p&#xa0;=&#xa0;0.17). We found no significant differences in skin perfusion parameters. l-arginine infusion resulted in a larger increase of plasma arginine and ornithine concentrations (p&#xa0;&lt;&#xa0;0.01), WB (endogenous) arginine appearance (p&#xa0;&lt;&#xa0;0.001), WB NO synthesis (p&#xa0;=&#xa0;0.027) and WB arginine to urea conversion (p&#xa0;&lt;&#xa0;0.001) than infusion of l-alanine. We found no effect on global hemodynamics, and protein metabolism by l-arginine infusion. Organ function parameters were unaffected, except for a significant difference between groups in intra-abdominal pressure over time (p&#xa0;=&#xa0;0.029).</AbstractText><AbstractText Label="CONCLUSIONS">Prolonged intravenous l-arginine administration does not improve local perfusion and organ function despite an increase in WB NO synthesis. Administration is safe with regard to global hemodynamics, but the observed increase in P<sub>r-a</sub>CO<sub>2</sub> and intra-abdominal pressure warrants careful application of l-arginine infusion and further research, especially in the early stage of septic shock.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Luiking</LastName><ForeName>Yvette C</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center+, Department of Surgery and Intensive Care Medicine, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands; NUTRIM School for Nutrition and Translational Research in Metabolism, P.O. Box 616, 6200 MD Maastricht, the Netherlands. Electronic address: yc.luiking@ctral.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poeze</LastName><ForeName>Martijn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Maastricht University Medical Center+, Department of Surgery and Intensive Care Medicine, P.O. Box 5800, 6202 AZ Maastricht, the Netherlands; NUTRIM School for Nutrition and Translational Research in Metabolism, P.O. Box 616, 6200 MD Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deutz</LastName><ForeName>Nicolaas E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>NUTRIM School for Nutrition and Translational Research in Metabolism, P.O. Box 616, 6200 MD Maastricht, the Netherlands; Maastricht University, Department of Surgery, Maastricht P.O. Box 616, 6200 MD Maastricht, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Nutr</MedlineTA><NlmUniqueID>8309603</NlmUniqueID><ISSNLinking>0261-5614</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>31C4KY9ESH</RegistryNumber><NameOfSubstance UI="D009569">Nitric Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>94ZLA3W45F</RegistryNumber><NameOfSubstance UI="D001120">Arginine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001120" MajorTopicYN="N">Arginine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005753" MajorTopicYN="N">Gastric Mucosa</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007262" MajorTopicYN="N">Infusions, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="N">Microcirculation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009569" MajorTopicYN="N">Nitric Oxide</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000098" MajorTopicYN="Y">blood supply</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arginine</Keyword><Keyword MajorTopicYN="N">Hemodynamics</Keyword><Keyword MajorTopicYN="N">Laser Doppler flowmetry</Keyword><Keyword MajorTopicYN="N">Nitric oxide</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Tonometry</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31522785</ArticleId><ArticleId IdType="doi">10.1016/j.clnu.2019.08.013</ArticleId><ArticleId IdType="pii">S0261-5614(19)33025-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39718689</PMID><DateCompleted><Year>2025</Year><Month>03</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2038-3312</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Updates in surgery</Title><ISOAbbreviation>Updates Surg</ISOAbbreviation></Journal><ArticleTitle>Esophagectomy in patients with liver cirrhosis: systematic review and meta-analysis of short-term outcomes.</ArticleTitle><Pagination><StartPage>143</StartPage><EndPage>152</EndPage><MedlinePgn>143-152</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s13304-024-02060-6</ELocationID><Abstract><AbstractText>Patients with esophageal cancer and concomitant liver cirrhosis (LC) pose a surgical challenge because of the increased risk of postoperative complications and mortality. Purpose of this study was to review the existing literature and estimate perioperative short-term outcomes of esophagectomy in this patient population. Systematic review and meta-analysis. PubMed, MEDLINE, Scopus, Web of Science, Cochrane Central Library, and ClinicalTrials.gov were queried. The search was last updated on July 30th, 2024. Primary outcomes were anastomotic leak (AL) and 90&#xa0;day mortality. Ten observational studies were included for a total of 387 patients with LC. The age of the included patients ranged from 35 to 85&#xa0;years, 91.2% were males. The main causes of liver cirrhosis were alcoholic (75%) and viral hepatitis (20.4%). Esophageal squamous cell carcinoma was diagnosed in 58.7% of patients. Ivor-Lewis esophagectomy with intrathoracic anastomosis was reported in 69.9% of patients, while McKeown esophagectomy with cervical anastomosis was reported in 30.1% of patients. The estimated pooled prevalence of AL and 90-day mortality were 13% (95% CI&#x2009;=&#x2009;6-24%; I<sup>2</sup>&#x2009;=&#x2009;72%) and 17% (95% CI&#x2009;=&#x2009;10-27%; I<sup>2</sup>&#x2009;=&#x2009;72%), respectively. The estimated pooled prevalence of postoperative pulmonary complication, sepsis, and liver failure were 52% (95% CI&#x2009;=&#x2009;39-65%), 30% (95% CI&#x2009;=&#x2009;14-52%), and 9% (95% CI&#x2009;=&#x2009;4-17%), respectively. Esophagectomy can be performed in properly selected patients with LC and concomitant esophageal cancer. Foregut surgeons should be aware of the not negligible postoperative complications rates and mortality. Risk stratification and attentive perioperative care are essential to minimize serious adverse events.</AbstractText><CopyrightInformation>&#xa9; 2024. Italian Society of Surgery (SIC).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sozzi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Istitituto Clinico Sant'Ambrogio, Via C. Belgioioso, 173, 20157, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aiolfi</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7764-6075</Identifier><AffiliationInfo><Affiliation>I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Istitituto Clinico Sant'Ambrogio, Via C. Belgioioso, 173, 20157, Milan, Italy. alberto.aiolfi86@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonitta</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Istitituto Clinico Sant'Ambrogio, Via C. Belgioioso, 173, 20157, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bona</LastName><ForeName>Davide</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>I.R.C.C.S. Ospedale Galeazzi - Sant'Ambrogio, Division of General Surgery, Department of Biomedical Science for Health, University of Milan, Istitituto Clinico Sant'Ambrogio, Via C. Belgioioso, 173, 20157, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonavina</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Division of General and Foregut Surgery, Department of Biomedical Sciences for Health, University of Milan, IRCCS Policlinico San Donato, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OGSA Group for Esophagogastric Surgery</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Updates Surg</MedlineTA><NlmUniqueID>101539818</NlmUniqueID><ISSNLinking>2038-131X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Updates Surg. 2025 Jun 25. doi: 10.1007/s13304-025-02223-z.</RefSource><PMID Version="1">40563067</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="Y">Esophagectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008103" MajorTopicYN="Y">Liver Cirrhosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004938" MajorTopicYN="Y">Esophageal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057868" MajorTopicYN="N">Anastomotic Leak</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Esophageal cancer</Keyword><Keyword MajorTopicYN="N">Esophagectomy</Keyword><Keyword MajorTopicYN="N">Liver cirrhosis</Keyword><Keyword MajorTopicYN="N">Postoperative complications</Keyword></KeywordList><CoiStatement>Declarations. Conflict of interest: All the authors declare no conflict of interest. Ethical approval: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent: Informed consent does not apply. Research involving human participants and/or animals: This project does not involve any new studies with human participants or animals conducted by any of the authors.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Biondi</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rausa</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simi&#x107;</LastName><ForeName>Aleksandar</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Skrobic</LastName><ForeName>Ognjan</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Popa</LastName><ForeName>Calin</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schlanger</LastName><ForeName>Diana</ForeName><Initials>D</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>3</Month><Day>3</Day><Hour>17</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>24</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>24</Day><Hour>11</Hour><Minute>27</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39718689</ArticleId><ArticleId IdType="doi">10.1007/s13304-024-02060-6</ArticleId><ArticleId IdType="pii">10.1007/s13304-024-02060-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumors, Eighth edition. John Wiley &amp; Sons, Inc, Chichester, West Sussex, UK&#x202f;; Hoboken, NJ</Citation></Reference><Reference><Citation>Edge SB, Compton CC (2010) The American joint committee on cancer: the 7<sup>th</sup> edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471&#x2013;1474. https://doi.org/10.1245/s10434-010-0985-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-010-0985-4</ArticleId><ArticleId IdType="pubmed">20180029</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeng K-S, Chang C-F, Sheen I-S et al (2022) Upper gastrointestinal cancer and liver cirrhosis. Cancers 14:2269. https://doi.org/10.3390/cancers14092269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers14092269</ArticleId><ArticleId IdType="pubmed">35565397</ArticleId><ArticleId IdType="pmc">9105927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta M, Kuwano H, Hashizume M et al (1995) Development of esophageal cancer after endoscopic injection sclerotherapy for esophageal varices: three case reports. Endoscopy 27:455&#x2013;458. https://doi.org/10.1055/s-2007-1005742</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1005742</ArticleId><ArticleId IdType="pubmed">8549446</ArticleId></ArticleIdList></Reference><Reference><Citation>Sengupta S, Wroblewski K, Aronsohn A et al (2015) Screening for zinc deficiency in patients with cirrhosis: when should we start? Dig Dis Sci 60:3130&#x2013;3135. https://doi.org/10.1007/s10620-015-3613-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10620-015-3613-0</ArticleId><ArticleId IdType="pubmed">25742912</ArticleId></ArticleIdList></Reference><Reference><Citation>Schizas D, Giannopoulos S, Vailas M et al (2020) The impact of cirrhosis on esophageal cancer surgery: an up-to-date meta-analysis. Am J Surgery 220:865&#x2013;872. https://doi.org/10.1016/j.amjsurg.2020.02.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2020.02.035</ArticleId></ArticleIdList></Reference><Reference><Citation>Berzigotti A, Abraldes JG (2013) Impact of obesity and insulin-resistance on cirrhosis and portal hypertension. Gastroenterol Hepatol 36:527&#x2013;533. https://doi.org/10.1016/j.gastrohep.2013.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gastrohep.2013.03.005</ArticleId><ArticleId IdType="pubmed">23731977</ArticleId></ArticleIdList></Reference><Reference><Citation>Haldar D, Kern B, Hodson J et al (2019) Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European liver transplant registry study. J Hepatol 71:313&#x2013;322. https://doi.org/10.1016/j.jhep.2019.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2019.04.011</ArticleId><ArticleId IdType="pubmed">31071367</ArticleId><ArticleId IdType="pmc">6656693</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran S, Zou B, Lee K et al (2024) Updates in characteristics and survival rates of cirrhosis in a nationwide cohort of real-world U.S. patients, 2003&#x2013;2021. Aliment Pharmacol Ther 60:212&#x2013;223. https://doi.org/10.1111/apt.18024</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apt.18024</ArticleId><ArticleId IdType="pubmed">38693757</ArticleId></ArticleIdList></Reference><Reference><Citation>Asti E, Sozzi M, Bonitta G et al (2018) Esophagectomy in patients with liver cirrhosis: a systematic review and Bayesian meta-analysis. J Visc Surg 155:453&#x2013;464. https://doi.org/10.1016/j.jviscsurg.2018.03.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviscsurg.2018.03.014</ArticleId><ArticleId IdType="pubmed">29653854</ArticleId></ArticleIdList></Reference><Reference><Citation>Peracchia A, Bardini R, Ruol A et al (1988) Esophagovisceral anastomotic leak. J Thorac Cardiovasc Surg 95:685&#x2013;691. https://doi.org/10.1016/s0022-5223(19)35737-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-5223(19)35737-x</ArticleId><ArticleId IdType="pubmed">3280882</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooke BS, Schwartz TA, Pawlik TM (2021) MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg 156:787&#x2013;788. https://doi.org/10.1001/jamasurg.2021.0522</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2021.0522</ArticleId><ArticleId IdType="pubmed">33825847</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId><ArticleId IdType="pmc">8005924</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A, Clarke M, Dooley G et al (2012) The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev 1:2. https://doi.org/10.1186/2046-4053-1-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-1-2</ArticleId><ArticleId IdType="pubmed">22587842</ArticleId><ArticleId IdType="pmc">3348673</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hern&#xe1;n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ. https://doi.org/10.1136/bmj.i4919</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pubmed">27737834</ArticleId><ArticleId IdType="pmc">5063034</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakbergenuly I, Kulinskaya E (2018) Meta-analysis of binary outcomes via generalized linear mixed models: a simulation study. BMC Med Res Methodol 18:70. https://doi.org/10.1186/s12874-018-0531-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0531-9</ArticleId><ArticleId IdType="pubmed">29973146</ArticleId><ArticleId IdType="pmc">6032567</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Chu H (2020) Meta-analysis of proportions using generalized linear mixed models. Epidemiology 31:713&#x2013;717. https://doi.org/10.1097/EDE.0000000000001232</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000001232</ArticleId><ArticleId IdType="pubmed">32657954</ArticleId><ArticleId IdType="pmc">7398826</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzer G, Chemaitelly H, Abu-Raddad LJ, R&#xfc;cker G (2019) Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions. Res Synth Methods 10:476&#x2013;483. https://doi.org/10.1002/jrsm.1348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1348</ArticleId><ArticleId IdType="pubmed">30945438</ArticleId><ArticleId IdType="pmc">6767151</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177&#x2013;188. https://doi.org/10.1016/0197-2456(86)90046-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-2456(86)90046-2</ArticleId><ArticleId IdType="pubmed">3802833</ArticleId></ArticleIdList></Reference><Reference><Citation>Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404&#x2013;413. https://doi.org/10.1093/biomet/26.4.404</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomet/26.4.404</ArticleId></ArticleIdList></Reference><Reference><Citation>E., Rausa M. A., Zappa M. E., Kelly L., Turati A., Russo A., Aiolfi G., Bonitta L. G., Sgroi (2019) A standardized use of intraoperative anastomotic testing in colorectal surgery in the new millennium: is technology taking over? A systematic review and network meta-analysis Techniques in Coloproctology 23(7) 625&#x2013;631. https://doi.org/10.1007/s10151-019-02034-6 .</Citation></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2010) A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Method 1:97&#x2013;111. https://doi.org/10.1002/jrsm.12</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId></ArticleIdList></Reference><Reference><Citation>Core Team R (2018) R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria</Citation></Reference><Reference><Citation>Belghiti J, Cherqui D, Langonnet F, F&#xe9;k&#xe9;t&#xe9; F (1990) Esophagogastrectomy for carcinoma in cirrhotic patients. Hepatogastroenterology 37:388&#x2013;391</Citation><ArticleIdList><ArticleId IdType="pubmed">2210605</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachibana M, Kotoh T, Kinugasa S et al (2000) Esophageal cancer with cirrhosis of the liver: results of esophagectomy in 18 consecutive patients. Ann Surg Oncol 7:758&#x2013;763. https://doi.org/10.1007/s10434-000-0758-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10434-000-0758-6</ArticleId><ArticleId IdType="pubmed">11129424</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M-S (2005) Is it safe to perform esophagectomy in esophageal cancer patients combined with liver cirrhosis? Interact Cardiovasc Thorac Surg 4:423&#x2013;425. https://doi.org/10.1510/icvts.2005.110387</Citation><ArticleIdList><ArticleId IdType="doi">10.1510/icvts.2005.110387</ArticleId><ArticleId IdType="pubmed">17670448</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda M, Saeki H, Nakashima Y et al (2015) Treatment results of two-stage operation for the patients with esophageal cancer concomitant with liver dysfunction. J Med Invest 62:149&#x2013;153. https://doi.org/10.2152/jmi.62.149</Citation><ArticleIdList><ArticleId IdType="doi">10.2152/jmi.62.149</ArticleId><ArticleId IdType="pubmed">26399339</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozzi M, Siboni S, Asti E et al (2017) Short-term outcomes of minimally invasive esophagectomy for carcinoma in patients with liver cirrhosis. J Laparoendosc Adv Surg Tech 27:592&#x2013;596. https://doi.org/10.1089/lap.2017.0115</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/lap.2017.0115</ArticleId></ArticleIdList></Reference><Reference><Citation>Valmasoni M, Pierobon ES, De Pasqual CA et al (2017) Esophageal cancer surgery for patients with concomitant liver cirrhosis: a single-center matched-cohort study. Ann Surg Oncol 24:763&#x2013;769. https://doi.org/10.1245/s10434-016-5610-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-016-5610-8</ArticleId><ArticleId IdType="pubmed">27704371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z-Q, Deng H-Y, Yang Y-S et al (2017) Can oesophagectomy be performed for patients with oesophageal carcinoma and concomitant liver cirrhosis? A retrospective study based on a propensity-matched cohort. Interact Cardiovasc Thorac Surg 25:442&#x2013;447. https://doi.org/10.1093/icvts/ivx132</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/icvts/ivx132</ArticleId><ArticleId IdType="pubmed">28520878</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng C, Wen Y-W, Tsai C-Y, Chao Y-K (2021) Impact of Child-Pugh class A liver cirrhosis on perioperative outcomes of patients with oesophageal cancer: a propensity score-matched analysis. Eur J Cardiothorac Surg 59:395&#x2013;402. https://doi.org/10.1093/ejcts/ezaa334</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejcts/ezaa334</ArticleId></ArticleIdList></Reference><Reference><Citation>Grass JK, K&#xfc;sters N, Kemper M et al (2022) Risk stratification of cirrhotic patients undergoing esophagectomy for esophageal cancer: a single-center experience. PLoS One 17:e0265093. https://doi.org/10.1371/journal.pone.0265093</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0265093</ArticleId><ArticleId IdType="pubmed">35263385</ArticleId><ArticleId IdType="pmc">8906633</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SY, Shin J, Jeon YJ et al (2024) Surgical outcomes and survival following esophagectomy for squamous cell carcinoma with or without liver cirrhosis: retrospective cohort study. Int J Surg. https://doi.org/10.1097/js9.0000000000001179</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/js9.0000000000001179</ArticleId><ArticleId IdType="pubmed">39806746</ArticleId><ArticleId IdType="pmc">11634098</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. The Lancet 383:1749&#x2013;1761. https://doi.org/10.1016/s0140-6736(14)60121-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(14)60121-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefton HB, Rosa A, Cohen M (2009) Diagnosis and epidemiology of cirrhosis. Med Clin North Am 93(787&#x2013;799):vii. https://doi.org/10.1016/j.mcna.2009.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcna.2009.03.002</ArticleId><ArticleId IdType="pubmed">19577114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundling F, Seidl H, Schmidtler F et al (2011) Nonhepatic cancer in liver cirrhosis: a retrospective study of prevalence, complication rate after specific oncological treatment, follow-up and prognostic predictors of outcome in 354 patients with cirrhosis. Anticancer Res 31:2931&#x2013;2938</Citation><ArticleIdList><ArticleId IdType="pubmed">21868541</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang Z, Li Y, Zhu C et al (2021) Gastrointestinal cancers and liver cirrhosis: implications on treatments and prognosis. Front Oncol. https://doi.org/10.3389/fonc.2021.766069</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2021.766069</ArticleId><ArticleId IdType="pubmed">35127526</ArticleId><ArticleId IdType="pmc">8733586</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbagh C, Fuks D, Regimbeau J-M (2014) Non-hepatic gastrointestinal surgery in patients with cirrhosis. J Visc Surg 151:203&#x2013;211. https://doi.org/10.1016/j.jviscsurg.2014.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviscsurg.2014.04.004</ArticleId><ArticleId IdType="pubmed">24810712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariette C (2008) Is there a place for esogastric cancer surgery in cirrhotic patients? Ann Surg Oncol 15:680&#x2013;682. https://doi.org/10.1245/s10434-007-9765-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-007-9765-1</ArticleId><ArticleId IdType="pubmed">18172733</ArticleId><ArticleId IdType="pmc">2234446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pati S, Irfan W, Jameel A et al (2023) Obesity and cancer: a current overview of epidemiology, pathogenesis, outcomes, and management. Cancers 15:485. https://doi.org/10.3390/cancers15020485</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15020485</ArticleId><ArticleId IdType="pubmed">36672434</ArticleId><ArticleId IdType="pmc">9857053</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiolfi A, Sozzi A, Bonitta G et al (2022) Linear- versus circular-stapled esophagogastric anastomosis during esophagectomy: systematic review and meta-analysis. Langenbecks Arch Surg 407:3297&#x2013;3309. https://doi.org/10.1007/s00423-022-02706-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-022-02706-2</ArticleId><ArticleId IdType="pubmed">36242619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagens ERC, Anderegg MCJ, Van Berge Henegouwen MI, Gisbertz SS (2018) International survey on the management of anastomotic leakage after esophageal resection. Ann Thorac Surg 106:1702&#x2013;1708. https://doi.org/10.1016/j.athoracsur.2018.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2018.05.009</ArticleId><ArticleId IdType="pubmed">29883644</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE, Alderson D, Cecconello I et al (2015) International consensus on standardization of data collection for complications associated with esophagectomy: esophagectomy complications consensus group (ECCG). Ann Surg 262:286&#x2013;294. https://doi.org/10.1097/SLA.0000000000001098</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000001098</ArticleId><ArticleId IdType="pubmed">25607756</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassis ES, Kosinski AS, Ross P et al (2013) Predictors of anastomotic leak after esophagectomy: an analysis of the society of thoracic surgeons general thoracic database. Ann Thorac Surg 96:1919&#x2013;1926. https://doi.org/10.1016/j.athoracsur.2013.07.119</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.athoracsur.2013.07.119</ArticleId><ArticleId IdType="pubmed">24075499</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberto, Aiolfi Emanuele, Asti Emanuele, Rausa Giulia, Bonavina Gianluca, Bonitta Luigi, Bonavina (2018) Use of C-reactive protein for the early prediction of anastomotic leak after esophagectomy: Systematic review and Bayesian meta-analysis PLOS ONE 13(12) e0209272-10.1371/journal.pone.0209272</Citation></Reference><Reference><Citation>Deng H-Y, Zheng X, Zha P et al (2019) Can we perform esophagectomy for esophageal cancer patients with concomitant liver cirrhosis? A comprehensive systematic review and meta-analysis. Diseases Esophagus. https://doi.org/10.1093/dote/doz003</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/dote/doz003</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberto, Aiolfi Davide, Bona Gianluca, Bonitta Luigi, Bonavina Luigi, Cayre Guglielmo, Guerrazzi Christian A., Gutschow John, Lipham Michele, Manara C&#x103;lin, Popa Emanuele, Rausa Diana, Schlanger Sebastian, Schoppmann Aleksandar, Simi&#x107; Andrea, Sozzi Joerg, Zehetner Short-term Outcomes of Different Techniques for Gastric Ischemic Pre-Conditioning Before Esophagectomy Annals of Surgery 10.1097/SLA.0000000000006124</Citation></Reference><Reference><Citation>Alberto, Aiolfi Gianluca, Bonitta Giampiero, Campanelli Davide, Bona Francesca, Lombardo Marta, Cavalli Michele, Manara Juxhin, Guraj Guglielmo, Guerrazzi (2023) Impact of postoperative NSAIDs administration on anastomotic leak after esophago-gastric surgery: systematic review and meta-analysis Updates in Surgery 75(4) 817&#x2013;824. https://doi.org/10.1007/s13304-023-01515-6 .</Citation></Reference><Reference><Citation>Traub J, Reiss L, Aliwa B, Stadlbauer V (2021) Malnutrition in patients with liver cirrhosis. Nutrients 13:540. https://doi.org/10.3390/nu13020540</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13020540</ArticleId><ArticleId IdType="pubmed">33562292</ArticleId><ArticleId IdType="pmc">7915767</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipeki N (2014) Immune dysfunction in cirrhosis. WJG 20:2564. https://doi.org/10.3748/wjg.v20.i10.2564</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v20.i10.2564</ArticleId><ArticleId IdType="pubmed">24627592</ArticleId><ArticleId IdType="pmc">3949265</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Qi X, Guo X (2016) Child-pugh versus MELD Score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine 95:e2877. https://doi.org/10.1097/md.0000000000002877</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/md.0000000000002877</ArticleId><ArticleId IdType="pubmed">26937922</ArticleId><ArticleId IdType="pmc">4779019</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoris A, Marlar CA (2024) Use Of The Child Pugh Score In Liver Disease. In: StatPearls. StatPearls Publishing, Treasure Island (FL)</Citation></Reference><Reference><Citation>Fekete F, Belghiti J, Cherqui D et al (1987) Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients. Ann Surg 206:74&#x2013;78. https://doi.org/10.1097/00000658-198707000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198707000-00012</ArticleId><ArticleId IdType="pubmed">3606234</ArticleId><ArticleId IdType="pmc">1492920</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi D, Stanley AJ, Hayes PC et al (2020) Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension. Gut 69:1173&#x2013;1192. https://doi.org/10.1136/gutjnl-2019-320221</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2019-320221</ArticleId><ArticleId IdType="pubmed">32114503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj R, Vaziri H, Gautam A et al (2018) Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Translational Hepatol 6:1&#x2013;9. https://doi.org/10.14218/JCTH.2017.00035</Citation><ArticleIdList><ArticleId IdType="doi">10.14218/JCTH.2017.00035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatnagar M, Fisher A, Ramsaroop S et al (2024) Chylothorax: pathophysiology, diagnosis, and management&#x2014;a comprehensive review. J Thorac Dis 16:1645&#x2013;1661. https://doi.org/10.21037/jtd-23-1636</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-23-1636</ArticleId><ArticleId IdType="pubmed">38505027</ArticleId><ArticleId IdType="pmc">10944732</ArticleId></ArticleIdList></Reference><Reference><Citation>Blendis L, Wong F (2001) The hyperdynamic circulation in cirrhosis. Pharmacol Ther 89:221&#x2013;231. https://doi.org/10.1016/S0163-7258(01)00124-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-7258(01)00124-3</ArticleId><ArticleId IdType="pubmed">11516477</ArticleId></ArticleIdList></Reference><Reference><Citation>Licata A, Mazzola A, Ingrassia D et al (2014) Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med 25:795&#x2013;802. https://doi.org/10.1016/j.ejim.2014.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2014.09.004</ArticleId><ArticleId IdType="pubmed">25245607</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara N, Sato H, Miyawaki Y et al (2020) Effect of azygos arch preservation during thoracoscopic esophagectomy on facilitation of postoperative refilling. Langenbecks Arch Surg 405:1079&#x2013;1089. https://doi.org/10.1007/s00423-020-01994-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-020-01994-w</ArticleId><ArticleId IdType="pubmed">32986133</ArticleId></ArticleIdList></Reference><Reference><Citation>Puccetti F, Cinelli L, Barbieri LA et al (2024) The near-infrared visualization and pre-emptive ligation of the thoracic duct effectively reduce the chyle leak incidence after minimally invasive esophagectomy. Ann Surg. https://doi.org/10.1097/SLA.0000000000006490</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000006490</ArticleId><ArticleId IdType="pubmed">39140608</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Singh H, Kalia S et al (2015) Chylothorax after esophagectomy for esophageal cancer: risk factors and management. Indian J Gastroenterol 34:240&#x2013;244. https://doi.org/10.1007/s12664-015-0571-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12664-015-0571-6</ArticleId><ArticleId IdType="pubmed">26027841</ArticleId></ArticleIdList></Reference><Reference><Citation>Low DE, Kuppusamy MK, Alderson D et al (2019) Benchmarking complications associated with esophagectomy. Ann Surg 269:291&#x2013;298. https://doi.org/10.1097/SLA.0000000000002611</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002611</ArticleId><ArticleId IdType="pubmed">29206677</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Yang Z, Tan H (2014) Perioperative nutritional support and fluid therapy in patients with liver diseases. Hepatobiliary Surg Nutr 3:140&#x2013;148. https://doi.org/10.3978/j.issn.2304-3881.2014.04.05</Citation><ArticleIdList><ArticleId IdType="doi">10.3978/j.issn.2304-3881.2014.04.05</ArticleId><ArticleId IdType="pubmed">25019075</ArticleId><ArticleId IdType="pmc">4073320</ArticleId></ArticleIdList></Reference><Reference><Citation>Manara M, Bona D, Bonavina L et al (2024) Impact of pulmonary complications following esophagectomy on long-term survival: multivariate meta-analysis and restricted mean survival time assessment. Updates Surg 76:757&#x2013;767. https://doi.org/10.1007/s13304-024-01761-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13304-024-01761-2</ArticleId><ArticleId IdType="pubmed">38319522</ArticleId><ArticleId IdType="pmc">11129973</ArticleId></ArticleIdList></Reference><Reference><Citation>Haberl J, Zollner G, Fickert P, Stadlbauer V (2018) To salt or not to salt?&#x2014;That is the question in cirrhosis. Liver Int 38:1148&#x2013;1159. https://doi.org/10.1111/liv.13750</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.13750</ArticleId><ArticleId IdType="pubmed">29608812</ArticleId></ArticleIdList></Reference><Reference><Citation>The Korean Association for the Study of the Liver (KASL) (2018) KASL clinical practice guidelines for liver cirrhosis: ascites and related complications. Clin Mol Hepatol 24:230&#x2013;277. https://doi.org/10.3350/cmh.2018.1005</Citation><ArticleIdList><ArticleId IdType="doi">10.3350/cmh.2018.1005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonavina L (2021) Progress in the esophagogastric anastomosis and the challenges of minimally invasive thoracoscopic surgery. Ann Transl Med 9:907&#x2013;907. https://doi.org/10.21037/atm.2020.03.66</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.03.66</ArticleId><ArticleId IdType="pubmed">34164541</ArticleId><ArticleId IdType="pmc">8184442</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiolfi A, Griffiths EA, Sozzi A et al (2023) Effect of anastomotic leak on long-term survival after esophagectomy: multivariate meta-analysis and restricted mean survival times examination. Ann Surg Oncol 30:5564&#x2013;5572. https://doi.org/10.1245/s10434-023-13670-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1245/s10434-023-13670-6</ArticleId><ArticleId IdType="pubmed">37210447</ArticleId></ArticleIdList></Reference><Reference><Citation>de Franchis R, Bosch J, Garcia-Tsao G et al (2022) Baveno VII - renewing consensus in portal hypertension. J Hepatol 76:959&#x2013;974. https://doi.org/10.1016/j.jhep.2021.12.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhep.2021.12.022</ArticleId><ArticleId IdType="pubmed">35120736</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhindsa BS, Tun KM, Fiedler A et al (2024) Endoscopic ultrasound-guided portal pressure gradient measurement: a systematic review and meta-analysis. Ann Gastroenterol 37:356&#x2013;361. https://doi.org/10.20524/aog.2024.0882</Citation><ArticleIdList><ArticleId IdType="doi">10.20524/aog.2024.0882</ArticleId><ArticleId IdType="pubmed">38779643</ArticleId><ArticleId IdType="pmc">11107402</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman KL, Johnson KM, Cornia PB et al (2020) Perioperative evaluation and management of patients with cirrhosis: risk assessment, surgical outcomes, and future directions. Clin Gastroenterol Hepatol 18:2398-2414.e3. https://doi.org/10.1016/j.cgh.2019.07.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2019.07.051</ArticleId><ArticleId IdType="pubmed">31376494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahat E, Lim C, Bhangui P et al (2018) Transjugular intrahepatic portosystemic shunt as a bridge to non-hepatic surgery in cirrhotic patients with severe portal hypertension: a systematic review. HPB (Oxford) 20:101&#x2013;109. https://doi.org/10.1016/j.hpb.2017.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hpb.2017.09.006</ArticleId><ArticleId IdType="pubmed">29110990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30475159</PMID><DateCompleted><Year>2020</Year><Month>01</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2153-7933</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Therapeutic hypothermia and temperature management</Title><ISOAbbreviation>Ther Hypothermia Temp Manag</ISOAbbreviation></Journal><ArticleTitle>Therapeutic Hypothermia and Targeted Temperature Management for Traumatic Arrest and Surgical Patients.</ArticleTitle><Pagination><StartPage>156</StartPage><EndPage>158</EndPage><MedlinePgn>156-158</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/ther.2018.0022</ELocationID><Abstract><AbstractText>Therapeutic hypothermia (TH) and targeted temperature management (TTM) have been shown to improve outcomes in survivors of cardiac arrest, but prior research has excluded trauma and postoperative patients. We sought to determine whether TH/TTM is safe in trauma and surgical patients. A retrospective cohort study was conducted at a single level I trauma center reviewing adults presenting as a traumatic arrest or cardiac arrest in the postoperative period with a Glasgow Coma Scale &lt;8 after return of circulation who were treated with either TH or TTM. Neurological recovery is considered favorable if a patient was discharged following commands. A total of 32 cardiac arrest patients were included in the study, 14 of whom were treated with TH and 18 with TTM protocols, with goal temperatures of 33&#xb0;C and 36&#xb0;C, respectively. Mean age of the cohort was 60&#x2009;&#xb1;&#x2009;13, with 26 (81%) men. There were 18 trauma patients and 14 postoperative patients. Complications included pneumonia (13%), sepsis (6%), bleeding requiring transfusion (22%), arrhythmias (6%), and seizures (9%), which are similar to prior published series. Overall survival to discharge was 41% (<i>n</i>&#x2009;=&#x2009;13), and all survivors had favorable neurological recovery. Traumatic arrest and perioperative cardiac arrest patients previously excluded from TH/TTM studies appear to have an acceptable incidence of complications compared with standard TH/TTM patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cragun</LastName><ForeName>Benjamin N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>1 Department of Trauma Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hite Philp</LastName><ForeName>Frances</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>1 Department of Trauma Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Neill</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>2 Department of Emergency Medicine, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noorbakhsh</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>1 Department of Trauma Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tindall</LastName><ForeName>Rachel P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>3 Department of Transplant Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philp</LastName><ForeName>Allan S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>1 Department of Trauma Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ditillo</LastName><ForeName>Michael F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>1 Department of Trauma Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ther Hypothermia Temp Manag</MedlineTA><NlmUniqueID>101543518</NlmUniqueID><ISSNLinking>2153-7658</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001833" MajorTopicYN="Y">Body Temperature Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015600" MajorTopicYN="N">Glasgow Coma Scale</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="Y">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="N">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020127" MajorTopicYN="N">Recovery of Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cardiac arrest</Keyword><Keyword MajorTopicYN="N">resuscitation</Keyword><Keyword MajorTopicYN="N">targeted temperature management</Keyword><Keyword MajorTopicYN="N">therapeutic hypothermia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30475159</ArticleId><ArticleId IdType="doi">10.1089/ther.2018.0022</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39915868</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Postoperative sepsis and its sequential impact on dementia.</ArticleTitle><Pagination><StartPage>66</StartPage><MedlinePgn>66</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">66</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-025-05276-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative sepsis is a severe complication associated with increased mortality and potential long-term cognitive decline, including dementia. However, the relationship between postoperative sepsis and dementia remains poorly understood.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective cohort study used data from the National Database in Taiwan, covering the period from January 1, 2005, to December 31, 2022. The index period for surgeries was set between January 1, 2008, and December 31, 2013, allowing the identification of patients without prior dementia. A landmark period of 12&#xa0;months following surgery was defined to capture the number of postoperative sepsis events, which were then analyzed for their impact on dementia risk. After 1:4 propensity score matching (PSM), dementia and mortality were evaluated using Cox proportional hazards and Fine-Gray competing risk models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Following PSM, 778 patients were in the postoperative sepsis group and 3,112 in the non-postoperative sepsis group. Dementia incidence was higher in the postoperative sepsis group (26%) compared to the non- postoperative sepsis group (13.6%), with a hazard ratio (HR) of 1.25 (95% CI, 1.03-1.52). A dose-response relationship was observed, with dementia rates of 24.5% for one postoperative sepsis event and 34.9% for two or more events, the latter showing an HR of 1.77 (95% CI, 1.17-2.66). Mortality was also elevated in the postoperative sepsis group (40.5% vs. 31.6%; HR 1.45, 95% CI, 1.28-1.65).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Postoperative sepsis is significantly associated with increased dementia risk in a dose-dependent manner. These findings highlight the importance of enhancing perioperative infection control to reduce both immediate and long-term cognitive complications.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Mingyang</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Fangfang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yangyang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miao</LastName><ForeName>Mengrong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Zhongyuan</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academy of Medical Sciences of Zhengzhou University, Zhengzhou, Henan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wan-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Graduate Institute of Business Administration, College of Management, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Artificial Intelligence Development Center, Fu Jen Catholic University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yuan</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Big Data Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, No. 83, Nanchang St., Luodong Township, Yilan County, 265, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Radiation Oncology, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Healthcare Administration, College of Medical and Health Science, Asia University, Taichung, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cancer Center, Lo-Hsu Medical Foundation, Lotung Poh-Ai Hospital, Yilan, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centers for Regional Anesthesia and Pain Medicine, Taipei Municipal Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Nutrition and Health Biotechnology, College of Medical and Health Science, Asia University, Taichung, Taiwan. szuyuanwu5399@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jiaqiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, People's Hospital of Zhengzhou University, Henan Provincial People's Hospital, 7 Weiwu Rd, Zhengzhou, Henan, China. zhangjiq@zzu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="Y">Dementia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Dementia risk</Keyword><Keyword MajorTopicYN="N">Perioperative infection control</Keyword><Keyword MajorTopicYN="N">Postoperative sepsis</Keyword><Keyword MajorTopicYN="N">Propensity score matching</Keyword><Keyword MajorTopicYN="N">Real-world database analysis</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: This study was conducted using de-identified data from the National Health Insurance Research Database (NHIRD), a publicly available database in Taiwan. Since the data are fully anonymized and do not contain identifiable personal information, the study does not involve human participants directly. As such, ethical approval and informed consent were not required. This complies with the relevant guidelines and regulations for the use of anonymized secondary data in research. Conflict of interest: The authors declare no competing interests related to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>7</Day><Hour>11</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>7</Day><Hour>0</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>6</Day><Hour>23</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39915868</ArticleId><ArticleId IdType="pmc">PMC11800527</ArticleId><ArticleId IdType="doi">10.1186/s13054-025-05276-z</ArticleId><ArticleId IdType="pii">10.1186/s13054-025-05276-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):E105&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810394</ArticleId><ArticleId IdType="pubmed">34998485</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimo A, Seeher K, Cataldi R, Cyhlarova E, Dielemann JL, Frisell O, Guerchet M, Jonsson L, Malaha AK, Nichols E, et al. The worldwide costs of dementia in 2019. Alzheimers Dement. 2023;19(7):2865&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10842637</ArticleId><ArticleId IdType="pubmed">36617519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhou Y, Fang X, Qu G. Care burden on family caregivers of patients with dementia and affecting factors in China: a systematic review. Front Psychiatr. 2022;13:1004552.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9760850</ArticleId><ArticleId IdType="pubmed">36545040</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke CE, Morgan S, Solomkin JS, Mazuski JE, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg. 2017;152(8):784&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28467526</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen NS, Bock JM, May AK. Sepsis and postoperative surgical site infections. Surgery. 2023;174(2):403&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">36775759</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaeke P, De Man JG, Coenen S, Jorens PG, De Winter BY, Hubens G. Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients. Surg Today. 2020;50(5):427&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pubmed">31172283</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Cao M, Tao H, Fei Z, Huang X, Liang P, Liu B, Liu J, Lu X, Ma P, et al. Evidence-based guideline for the prevention and management of perioperative infection. J Evid Based Med. 2023;16(1):50&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">36852502</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhole S, Mahakalkar C, Kshirsagar S, Bhargava A. Antibiotic prophylaxis in surgery: current insights and future directions for surgical site infection prevention. Cureus. 2023;15(10): e47858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10680052</ArticleId><ArticleId IdType="pubmed">38021553</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R, Bhaskaran K, Smeeth L, Brayne C, Chaturvedi N, Warren-Gash C. Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study. Lancet Healthy Longev. 2021;2(7):e426&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8245326</ArticleId><ArticleId IdType="pubmed">34240064</ArticleId></ArticleIdList></Reference><Reference><Citation>van Ton AMP, Meijer-van Leijsen EM, Bergkamp MI, Bronkhorst EM, Pickkers P, De Leeuw FE, Tuladhar AM, Abdo WF. Dementia risk and structural brain changes following nonneurological infections during 9-year follow-up. Crit Care Med. 2022;50(4):554&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">34432713</ArticleId></ArticleIdList></Reference><Reference><Citation>Janbek J, Laursen TM, Frimodt-M&#xf8;ller N, Magyari M, Haas JG, Lathe R, Waldemar G. Hospital-diagnosed infections, autoimmune diseases, and subsequent dementia incidence. JAMA Netw Open. 2023;6(9): e2332635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10485730</ArticleId><ArticleId IdType="pubmed">37676660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei S, Li X, Zhao H, Feng Z, Chun L, Xie Y, Li J. Dementia risk or cognitive impairment in sepsis survivals: a systematic review and meta-analysis. Front Aging Neurosci. 2022;14: 839472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959917</ArticleId><ArticleId IdType="pubmed">35356300</ArticleId></ArticleIdList></Reference><Reference><Citation>Raz L, Knoefel J, Bhaskar K. The neuropathology and cerebrovascular mechanisms of dementia. J Cereb Blood Flow Metab. 2016;36(1):172&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4758551</ArticleId><ArticleId IdType="pubmed">26174330</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie J, Van Hoecke L, Vandenbroucke RE. The impact of systemic inflammation on alzheimer&#x2019;s disease pathology. Front Immunol. 2021;12: 796867.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8770958</ArticleId><ArticleId IdType="pubmed">35069578</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad MA, Kareem O, Khushtar M, Akbar M, Haque MR, Iqubal A, Haider MF, Pottoo FH, Abdulla FS, Al-Haidar MB, et al. Neuroinflammation: a potential risk for dementia. Int J Mol Sci. 2022;23(2):616.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8775769</ArticleId><ArticleId IdType="pubmed">35054805</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzambi R, Bhaskaran K, Brayne C, Davidson JA, Smeeth L, Warren-Gash C. Common bacterial infections and dementia risk or cognitive decline: a systematic review. J Alzheimers Dis. 2020;76(4):1609&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7504996</ArticleId><ArticleId IdType="pubmed">32651320</ArticleId></ArticleIdList></Reference><Reference><Citation>Asby D, Boche D, Allan S, Love S, Miners JS. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer&#x2019;s disease. Brain. 2021;144(6):1869&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320299</ArticleId><ArticleId IdType="pubmed">33723589</ArticleId></ArticleIdList></Reference><Reference><Citation>Basak JM, Ferreiro A, Cohen LS, Sheehan PW, Nadarajah CJ, Kanan MF, Sukhum KV, Dantas G, Musiek ES. Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer&#x2019;s disease. Neurobiol Dis. 2021;152: 105292.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8057119</ArticleId><ArticleId IdType="pubmed">33556539</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Heneka MT. Long-term cerebral consequences of sepsis. Lancet Neurol. 2014;13(6):630&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">24849863</ArticleId></ArticleIdList></Reference><Reference><Citation>Semmler A, Widmann CN, Okulla T, Urbach H, Kaiser M, Widman G, Mormann F, Weide J, Fliessbach K, Hoeft A, et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J Neurol Neurosurg Psychiatr. 2013;84(1):62&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23134661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fritze T, Doblhammer G, Widmann CN, Heneka MT. Time course of dementia following sepsis in German health claims data. Neurol Neuroimmunol Neuroinflamm. 2021. 10.1212/NXI.0000000000000911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7803331</ArticleId><ArticleId IdType="pubmed">33293458</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao LT, Sheu JJ, Lin HC, Tsai MC, Chung SD. Association between sepsis and dementia. J Clin Neurosci. 2015;22(9):1430&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">26165470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernainy P, Cohen AA, Murray E, Losina E, Lamontagne F, Sourial N. Rethinking the pros and cons of randomized controlled trials and observational studies in the era of big data and advanced methods: a panel discussion. BMC Proc. 2024;18(Suppl 2):1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10795211</ArticleId><ArticleId IdType="pubmed">38233894</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk after major elective surgery based on the route of anaesthesia: a propensity score-matched population-based cohort study. EClinicalMedicine. 2023;55: 101727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9641180</ArticleId><ArticleId IdType="pubmed">36386032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Dementia risk amongst older adults with hip fracture receiving general anaesthesia or regional anaesthesia: a propensity-score-matched population-based cohort study. Br J Anaesth. 2023;130(3):305&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">36593163</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Long-term opioid use and dementia risk in patients with chronic pain. J Am Med Dir Assoc. 2023;24(9):1420-1426.e1422.</Citation><ArticleIdList><ArticleId IdType="pubmed">37545051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun M, Chen WM, Wu SY, Zhang J. Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction. Brain. 2023;147:1474&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">37878862</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa R, Sposato K, Abbo LM. Preventing surgical site infections: implementing strategies throughout the perioperative continuum. AORN J. 2023;117(5):300&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">37102746</ArticleId></ArticleIdList></Reference><Reference><Citation>Osagwu M, Okobi E, Ekor E. Postoperative infections: risk factors, prevention, and management strategies. Int J Med Sci Dent Res. 2024;7:52&#x2013;76.</Citation></Reference><Reference><Citation>Li Y, Ji M, Yang J. Current understanding of long-term cognitive impairment after sepsis. Front Immunol. 2022;13: 855006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9120941</ArticleId><ArticleId IdType="pubmed">35603184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon EH, Ward DD, Xiong H, Berkovsky S, Hubbard RE. Delirium and incident dementia in hospital patients in New South Wales, Australia: retrospective cohort study. BMJ. 2024;384: e077634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10966895</ArticleId><ArticleId IdType="pubmed">38537951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling L, Mui OOY, Laupland KB, Lefrant JY, Roberts JA, Gopalan PD, Lipman J, Joynt GM. CaBo OMi: scoping review on diagnostic criteria and investigative approach in sepsis of unknown origin in critically ill patients. J Intensive Care. 2022;10(1):44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9465866</ArticleId><ArticleId IdType="pubmed">36089642</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki RF, Golde TE, Heneka MT, Readhead B. Do infections have a role in the pathogenesis of Alzheimer disease? Nat Rev Neurol. 2020;16(4):193&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32152461</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler L, Walker KA. The role of chronic infection in Alzheimer&#x2019;s disease: instigators, co-conspirators, or bystanders? Curr Clin Microbiol Rep. 2021;8(4):199&#x2013;212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8849576</ArticleId><ArticleId IdType="pubmed">35186664</ArticleId></ArticleIdList></Reference><Reference><Citation>Richmond-Rakerd LS, Iyer MT, D&#x2019;Souza S, Khalifeh L, Caspi A, Moffitt TE, Milne BJ. Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis. Nat Aging. 2024;4(6):783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">38714911</ArticleId></ArticleIdList></Reference><Reference><Citation>Sipil&#xe4; PN, Heikkil&#xe4; N, Lindbohm JV, Hakulinen C, Vahtera J, Elovainio M, Suominen S, V&#xe4;&#xe4;n&#xe4;nen A, Koskinen A, Nyberg ST, et al. Hospital-treated infectious diseases and the dementia risk: a large, multicohort, observational study with a replication cohort. Lancet Infect Dis. 2021;21(11):1557&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8592915</ArticleId><ArticleId IdType="pubmed">34166620</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue Y, Shue F, Bu G, Kanekiyo T. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer&#x2019;s disease. Molecular Neurodegener. 2023. 10.1186/s13024-023-00640-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10334598</ArticleId><ArticleId IdType="pubmed">37434208</ArticleId></ArticleIdList></Reference><Reference><Citation>Manabe T, Heneka MT. Cerebral dysfunctions caused by sepsis during ageing. Nat Rev Immunol. 2022;22(7):444&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8582341</ArticleId><ArticleId IdType="pubmed">34764472</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendeln A-C, Degenhardt K, Kaurani L, Gertig M, Ulas T, Jain G, Wagner J, Haesler LM, Wild K, Skodras A, et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature. 2018;556(7701):332&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6038912</ArticleId><ArticleId IdType="pubmed">29643512</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sousa VL, Ara&#xfa;jo SB, Antonio LM, Silva-Queiroz M, Colodeti LC, Soares C, Barros-Arag&#xe3;o F, Mota-Araujo HP, Alves VS, Coutinho-Silva R, et al. Innate immune memory mediates increased susceptibility to Alzheimer&#x2019;s disease-like pathology in sepsis surviving mice. Brain Behav Immun. 2021;95:287&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">33838250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippensteel JA, Anderson BJ, Orfila JE, McMurtry SA, Dietz RM, Su G, Ford JA, Oshima K, Yang Y, Zhang F, et al. Circulating heparan sulfate fragments mediate septic cognitive dysfunction. J Clin Invest. 2019;129(4):1779&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6436867</ArticleId><ArticleId IdType="pubmed">30720464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozben T, Ozben S. Neuro-inflammation and anti-inflammatory treatment options for Alzheimer&#x2019;s disease. Clin Biochem. 2019;72:87&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30954437</ArticleId></ArticleIdList></Reference><Reference><Citation>Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-brain barrier dysfunction in normal aging and neurodegeneration: mechanisms, impact, and treatments. Stroke. 2023;54(3):661&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9993074</ArticleId><ArticleId IdType="pubmed">36848419</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda S, Sato N, Morishita R. Systemic inflammation, blood-brain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front Aging Neurosci. 2014;6:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114193</ArticleId><ArticleId IdType="pubmed">25120476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ehlenbach WJ, Sonnen JA, Montine TJ, Larson EB. Association between sepsis and microvascular brain injury. Crit Care Med. 2019;47(11):1531&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">31389836</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23876943</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>30</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-6749</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>5</Issue><PubDate><Year>2014</Year><Season>Jun-Jul</Season></PubDate></JournalIssue><Title>Medicina intensiva</Title><ISOAbbreviation>Med Intensiva</ISOAbbreviation></Journal><ArticleTitle>Protein C zymogen in adults with severe sepsis or septic shock.</ArticleTitle><Pagination><StartPage>278</StartPage><EndPage>282</EndPage><MedlinePgn>278-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medin.2013.04.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0210-5691(13)00106-X</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Activated protein C is associated with a risk of bleeding and its effects on survival in septic shock patients are questionable. Protein C zymogen has no risk of bleeding and improves the outcome of patients with septic shock. We hereby describe the largest published case series of adult patients receiving protein C zymogen.</AbstractText><AbstractText Label="DESIGN, SETTING AND PARTICIPANTS" NlmCategory="METHODS">A prospective study on 23 adult patients with severe sepsis or septic shock, two or more organ failures and at high risk for bleeding, treated with protein C zymogen (50IU/kg bolus followed by continuous infusion of 3IU/kg/h for 72h).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The Z-test evidenced a significant reduction between the expected mortality (53%) and the observed mortality 30% (Z value=1.99, p=0.046) in our sample population. Protein C levels increased from 34&#xb1;18% to 66&#xb1;22% at 6h after PC bolus (p&lt;0.001), and kept on increasing during 72h of administration (p&lt;0.001 to baseline). Sequential Organ Failure Assessment (SOFA), score of organ dysfunction, decreased from baseline to 7 days after administration of protein C from 14&#xb1;2 to 7&#xb1;4 (p&lt;0.001). No adverse event drug related was noted.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Protein C zymogen administration is safe and its use in septic patients should be investigated through a randomized controlled trial.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Espa&#xf1;a, S.L. and SEMICYUC. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Crivellari</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvetti</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerli</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy. Electronic address: landoni.giovanni@hsr.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franco</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bove</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappalardo</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zangrillo</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, San Raffaele Scientific Institute, Milano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>07</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Intensiva</MedlineTA><NlmUniqueID>9207689</NlmUniqueID><ISSNLinking>0210-5691</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004792">Enzyme Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011486">Protein C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004792" MajorTopicYN="N">Enzyme Precursors</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011486" MajorTopicYN="N">Protein C</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bleeding</Keyword><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Cuidados cr&#xed;ticos</Keyword><Keyword MajorTopicYN="N">Cuidados intensivos</Keyword><Keyword MajorTopicYN="N">Hemorragia</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Protein C zymogen</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Zim&#xf3;geno de prote&#xed;na C</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>11</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2013</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2013</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>7</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23876943</ArticleId><ArticleId IdType="doi">10.1016/j.medin.2013.04.005</ArticleId><ArticleId IdType="pii">S0210-5691(13)00106-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31679383</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1735-3947</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>7</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Archives of Iranian medicine</Title><ISOAbbreviation>Arch Iran Med</ISOAbbreviation></Journal><ArticleTitle>Impact on Efficacy and Safety of Hydrocortisone in Sepsis and Septic Shock - A Systematic Literature Review and Meta-analysis.</ArticleTitle><Pagination><StartPage>394</StartPage><EndPage>402</EndPage><MedlinePgn>394-402</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">Sepsis and septic shock are major causes of morbidity and mortality worldwide, associated with a high economic and social burden on healthcare systems and communities, yet with few definite treatment modalities. The efficacy of steroids in the management of sepsis or septic shock remains a controversy and subject of investigation due to their theoretical beneficial effects.</AbstractText><AbstractText Label="METHODS">This was a systematic literature review and meta-analysis on randomized controlled trials of hydrocortisone usage in sepsis or septic shock as of 2000, following the GRADE methodology, considering a primary outcome of 28 day all-cause mortality.</AbstractText><AbstractText Label="RESULTS">Ten randomized control trials were included in the review, 9 of which reported 28 day mortality either as a primary or secondary outcome. Relative risk of dying at 28 days was 0.93 in favor of hydrocortisone (95% CI: 0.86-1.01; P = 0.056). Other secondary outcomes of the review were similarly statistically insignificant. The quality of evidence was graded as very low to low.</AbstractText><AbstractText Label="CONCLUSION">Hydrocortisone, when used in sepsis or septic shock, in critically ill adult patients showed a statistically insignificant trend towards decreasing 28 day all-cause mortality. This warrants consideration of clinical significance for each patient individually.</AbstractText><CopyrightInformation>&#xa9; 2019 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Aletreby</LastName><ForeName>Waleed Tharwat</ForeName><Initials>WT</Initials><Identifier Source="ORCID">0000-0001-8387-1829</Identifier><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alharthy</LastName><ForeName>Abdulrahman Mishaal</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madi</LastName><ForeName>Ahmed Fouad</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Ibrahim Refaat</ForeName><Initials>IR</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamido</LastName><ForeName>Hend Mohammed</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Omar Elsayed</ForeName><Initials>OE</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesia Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzayer</LastName><ForeName>Wasim</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huwait</LastName><ForeName>Basim Mohammed</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alodat</LastName><ForeName>Mohammed Ali</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mumtaz</LastName><ForeName>Shahzad Ahmed</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mahmood</LastName><ForeName>Nasir Nasim</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Kurdi</LastName><ForeName>Mahmoud Hussien</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farrag</LastName><ForeName>Hazem Abdulgaffar</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karakitsos</LastName><ForeName>Dimitrios</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Keck Medical School, USC, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><MedlineTA>Arch Iran Med</MedlineTA><NlmUniqueID>100889644</NlmUniqueID><ISSNLinking>1029-2977</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Efficacy</Keyword><Keyword MajorTopicYN="N">Hydrocortisone</Keyword><Keyword MajorTopicYN="N">Safety</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31679383</ArticleId><ArticleId IdType="pii">S1029-2977-22(07)394-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31982391</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-3543</ISSN><JournalIssue CitedMedium="Internet"><Volume>157</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Chest</Title><ISOAbbreviation>Chest</ISOAbbreviation></Journal><ArticleTitle>Lower vs&#xa0;Higher Fluid Volumes During Initial Management of Sepsis: A Systematic Review With Meta-Analysis and Trial Sequential Analysis.</ArticleTitle><Pagination><StartPage>1478</StartPage><EndPage>1496</EndPage><MedlinePgn>1478-1496</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.chest.2019.11.050</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0012-3692(20)30123-9</ELocationID><Abstract><AbstractText Label="OBJECTIVE">IV fluids are recommended during the initial management of sepsis, but the quality of evidence is low, and clinical equipoise exists. We aimed to assess patient-important benefits and harms of lower vs&#xa0;higher fluid volumes in adult patients with sepsis.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) of randomized clinical trials of IV fluid volume separation in adult patients with sepsis. We adhered to our published protocol; the Cochrane handbook; the Preferred Reporting Items for Systematic Reviews and Meta-Analyses; and the Grading of Recommendations Assessment, Development and Evaluation statements. The primary outcomes were all-cause mortality, serious adverse events (SAEs), and quality of life.</AbstractText><AbstractText Label="RESULTS">We included nine trials (n&#xa0;= 637); all were published after 2015 and had an overall high risk of bias. We found no statistically significant difference between lower vs&#xa0;higher fluid volumes in all-cause mortality (relative risk [RR], 0.87; 95%&#xa0;CI, 0.69-1.10; I<sup>2</sup>&#xa0;= 0%; TSA-adjusted CI, 0.34-2.22) or SAEs (RR, 0.91; 95%&#xa0;CI, 0.78-1.05; I<sup>2</sup>&#xa0;= 0%; TSA-adjusted CI, 0.68-1.21). No trials reported on quality of life. We did not find differences in the secondary or exploratory outcomes. The quality of evidence was very low across all outcomes.</AbstractText><AbstractText Label="CONCLUSIONS">In this systematic review, we found very low quantity and quality of evidence supporting the decision on the volumes of IV fluid therapy in adults with sepsis.</AbstractText><AbstractText Label="TRIAL REGISTRY">ClinicalTrials.gov; No.: NCT03668236; URL: www.clinicaltrials.gov.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine Sylvest</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark. Electronic address: tine.sylvest.meyhoff@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter Buhl</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Karolinska Institutet, Department of Clinical Science and Education, S&#xf6;dersjukhuset, Section of Anaesthesia and Intensive Care, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; Collaboration for Research in Intensive Care, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03668236</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>01</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Chest</MedlineTA><NlmUniqueID>0231335</NlmUniqueID><ISSNLinking>0012-3692</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jun;157(6):1403-1404. doi: 10.1016/j.chest.2020.01.015.</RefSource><PMID Version="1">32505300</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jul;158(1):427-428. doi: 10.1016/j.chest.2020.02.030.</RefSource><PMID Version="1">32654720</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Chest. 2020 Jul;158(1):428. doi: 10.1016/j.chest.2020.02.031.</RefSource><PMID Version="1">32654721</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D002986" MajorTopicYN="Y">Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">fluid therapy</Keyword><Keyword MajorTopicYN="N">intensive care</Keyword><Keyword MajorTopicYN="N">resuscitation</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31982391</ArticleId><ArticleId IdType="doi">10.1016/j.chest.2019.11.050</ArticleId><ArticleId IdType="pii">S0012-3692(20)30123-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29241382</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1489</ISSN><JournalIssue CitedMedium="Internet"><Volume>35</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of intensive care medicine</Title><ISOAbbreviation>J Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Causes of Mortality in ICU-Acquired Weakness.</ArticleTitle><Pagination><StartPage>293</StartPage><EndPage>296</EndPage><MedlinePgn>293-296</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0885066617745818</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intensive care unit-acquired weakness (ICU-AW) is a common complication of critical illness and is associated with increased mortality, longer mechanical ventilation and longer hospital stay. Little is known about the causes of mortality in patients with ICU-AW. In this study, we aimed to give an overview of the causes of death in a population diagnosed with ICU-AW during hospital admission.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from a prospective cohort study in the mixed medical-surgical ICU of the Academic Medical Center in Amsterdam were used. Patients were included when mechanically ventilated for more than 48 hours. Intensive care unit-acquired weakness was defined as a mean medical research council score &lt;4. Baseline data and data on the time of death were collected.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-three patients were included. Irreversible shock with multiple organ failure (MOF) was the most common cause of death (28/53 of patients; 26 patients with septic shock and 2 patients with hypovolemic shock). Most common site of sepsis was abdominal (38.5%) and pulmonary (19.2%). On admission to the ICU, 53% had a do-not-resuscitate code. In 74% of the patients, further treatment limitations were implemented during their ICU stay.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In this cohort of patients with ICU-AW, most patients died of irreversible shock with MOF, caused by sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>van Wagenberg</LastName><ForeName>Linda</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witteveen</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wieske</LastName><ForeName>Luuk</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Janneke</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D023362">Evaluation Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Intensive Care Med</MedlineTA><NlmUniqueID>8610344</NlmUniqueID><ISSNLinking>0885-0666</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="Y">Cause of Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="N">Frailty</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009102" MajorTopicYN="N">Multiple Organ Failure</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU-acquired weakness</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">weakness</Keyword></KeywordList><CoiStatement><b>Declaration of Conflicting Interests:</b> The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29241382</ArticleId><ArticleId IdType="pmc">PMC6993133</ArticleId><ArticleId IdType="doi">10.1177/0885066617745818</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stevens RD, Dowdy DW, Michaels RK, Mendez-Tellez PA, Pronovost PJ, Needham DM. Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med. 2007;33(11):1876&#x2013;1891.</Citation><ArticleIdList><ArticleId IdType="pubmed">17639340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wieske L, Dettling-Ihnenfeldt DS, Verhamme C, et al. Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up study. Crit Care. 2015;19:196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4427976</ArticleId><ArticleId IdType="pubmed">25928709</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharshar T, Bastuji-Garin S, Stevens RD, et al. Presence and severity of intensive care unit-acquired paresis at time of awakening are associated with increased intensive care unit and hospital mortality. Crit Care Med. 2009;37(12):3047&#x2013;3053.</Citation><ArticleIdList><ArticleId IdType="pubmed">19770751</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnacho-Montero J, Madrazo-Osuna J, Garc&#xed;a-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001;27(8):1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">11511941</ArticleId></ArticleIdList></Reference><Reference><Citation>van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">3363593</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan E, Cheek F, Chlan L, et al. An official American Thoracic Society clinical practice guideline: the diagnosis of intensive care unit-acquired weakness in adults. Am J Respir Crit Care Med. 2014;190(12):1437&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pubmed">25496103</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahhan T, Jamil M, Al-Tarifi A, Abouchala N, Kherallah M. Validation of the APACHE IV scoring system in patients with severe sepsis and comparison with the APACHE II system. Crit Care. 2009;13(suppl 1):P511.</Citation></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, M&#xe9;lot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286(14):1754&#x2013;1758.</Citation><ArticleIdList><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644&#x2013;1655</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton CF, Brown JD, Sibbald WJ. The electrophysiologic investigation of respiratory paralysis in critically ill patients. Neurology. 1983;33:186.</Citation></Reference><Reference><Citation>Jolley SE, Bunnell AE, Hough CL. ICU-acquired weakness. Chest. 2016;150(5):1129&#x2013;1140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5103015</ArticleId><ArticleId IdType="pubmed">27063347</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermans G, Van Mechelen H, Clerckx B, et al. Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis. Am J Respir Crit Care Med. 2014;190(4):410&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pubmed">24825371</ArticleId></ArticleIdList></Reference><Reference><Citation>van Vught LA, Klein Klouwenberg PM, Spitoni C, et al. Incidence, risk factors and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469&#x2013;1479.</Citation><ArticleIdList><ArticleId IdType="pubmed">26975785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemphill JC, Newman J, Zhao S, Johnston SC. JC. Hemphill Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35(5):1130&#x2013;1134.</Citation><ArticleIdList><ArticleId IdType="pubmed">15044768</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CT, Chuang YC, Tsai YJ, Ko WJ, Yu CJ. High mortality in severe sepsis and septic shock patients with do-not-resuscitate orders in East Asia. PLos One. 2016;11(7):e0159501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4944975</ArticleId><ArticleId IdType="pubmed">27416064</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Weinberg J, Wiener RS, Cooke CR, Lindenauer PK. Hospital variation in utilization of life-sustaining treatments among patients with do not resuscitate orders. Health Serv Res. 2017. doi: 10.1111/1475-6773.1265.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5980340</ArticleId><ArticleId IdType="pubmed">28097649</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns JP, Edwards J, Johnson J, Cassem NH, Truog RD. Do-not-resuscitate order after 25 years. Crit Care Med. 2003;31(5):1543&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pubmed">12771631</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34644242</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2325-6621</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of the American Thoracic Society</Title><ISOAbbreviation>Ann Am Thorac Soc</ISOAbbreviation></Journal><ArticleTitle>The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis.</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>632</EndPage><MedlinePgn>625-632</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1513/AnnalsATS.202105-547OC</ELocationID><Abstract><AbstractText><b>Rationale:</b> Extremity threat and amputation after sepsis is a well-publicized and devastating event. However, there is a paucity of data about the epidemiology of extremity threat after sepsis onset. <b>Objectives:</b> To estimate the incidence of extremity threat with or without surgical amputation in community sepsis. <b>Methods:</b> Retrospective cohort study of adults with Sepsis-3 hospitalized at 14 academic and community sites from 2013 to 2017. Vasopressor-dependent sepsis was identified by administration of epinephrine, norepinephrine, phenylephrine, vasopressin, or dopamine for more than 1 hour during the 48 hours before to 24 hours after sepsis onset. Outcomes included the incidence of extremity threat, defined as acute onset ischemia, with or without amputation, in the 90 days after sepsis onset. The association between extremity threat, demographics, comorbid conditions, and time-varying sepsis treatments was evaluated using a Cox proportional hazards model. <b>Results:</b> Among 24,365 adults with sepsis, 12,060 (54%) were vasopressor dependent (mean&#x2009;&#xb1;&#x2009;standard deviation age, 64&#x2009;&#xb1;&#x2009;16 years; male, 6,548 [54%]; sequential organ failure assessment [SOFA], 10&#x2009;&#xb1;&#x2009;4). Of these, 231 (2%) patients had a threatened extremity with 26 undergoing 37 amputations, a risk of 2.2 (95% confidence interval [CI], 1.4-3.2) per 1,000, and 205 not undergoing amputation, a risk of 17.0 (95% CI, 14.8-19.5) per 1,000. Most amputations occurred in lower extremities (95%), a median (interquartile range) of 16 (6-40) days after sepsis onset. Compared with patients with no extremity threat, patients with threat had a higher SOFA score (11&#x2009;&#xb1;&#x2009;4 vs. 10&#x2009;&#xb1;&#x2009;4; <i>P</i>&#x2009;&lt;&#x2009;0.001), serum lactate (4.6 mmol/L [2.4-8.7] vs. 3.1 [1.7-6.0]; <i>P</i>&#x2009;&lt;&#x2009;0.001), and more bacteremia (<i>n</i>&#x2009;=&#x2009;37 [37%] vs. <i>n</i>&#x2009;=&#x2009;2,087 [26%]; <i>P</i>&#x2009;&lt;&#x2009;0.001) at sepsis onset. Peripheral vascular disease, congestive heart failure, SOFA score, and norepinephrine equivalents were significantly associated with extremity threat. <b>Conclusions:</b> The evaluation of a threatened extremity resulting in surgical amputation occurred in 2 per 1,000 patients with vasopressor-dependent sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Reitz</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0002-9397-321X</Identifier><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kennedy</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rieser</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hlavin</LastName><ForeName>Callie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gershengorn</LastName><ForeName>Hayley B</ForeName><Initials>HB</Initials><Identifier Source="ORCID">0000-0002-7360-2489</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care, and Sleep Medicine, Miller School of Medicine, University of Miami, Miami, Florida.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Albert Einstein College of Medicine, Bronx, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neal</LastName><ForeName>Matthew D</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bensen</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linstrum</LastName><ForeName>Kelsey</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prescott</LastName><ForeName>Hallie C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rosengart</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talisa</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hall</LastName><ForeName>Daniel E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Pittsburgh Healthcare System, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Health Equity Research and Promotion, Veterans Affairs, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tzeng</LastName><ForeName>Edith</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Vascular Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Pittsburgh Healthcare System, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wunsch</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Sunnybrook Health Science Centre, Toronto, Ontario, Canada; and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesia and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Ontario, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yende</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6596-8034</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wolff Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angus</LastName><ForeName>Derek C</ForeName><Initials>DC</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seymour</LastName><ForeName>Christopher W</ForeName><Initials>CW</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, and.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, and.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>T32 HL098036</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119526</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 AG064730</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 CA113263</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM119519</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Am Thorac Soc</MedlineTA><NlmUniqueID>101600811</NlmUniqueID><ISSNLinking>2325-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000671" MajorTopicYN="Y">Amputation, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amputation</Keyword><Keyword MajorTopicYN="N">peripheral ischemia</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">symmetric peripheral gangrene</Keyword><Keyword MajorTopicYN="N">vasopressor</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>17</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34644242</ArticleId><ArticleId IdType="pmc">PMC8996267</ArticleId><ArticleId IdType="doi">10.1513/AnnalsATS.202105-547OC</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA . 2016;315:762&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, et al. International Forum of Acute Care Trialists Assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med . 2016;193:259&#x2013;272.</Citation><ArticleIdList><ArticleId IdType="pubmed">26414292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri SS, Rhee C, Strich JR, Morales MK, Hohmann S, Menchaca J, et al. Estimating ten-year trends in septic shock&#xa0;incidence and mortality in United States academic medical centers&#xa0;using clinical data. Chest . 2017;151:278&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth . 2017;119:626&#x2013;636.</Citation><ArticleIdList><ArticleId IdType="pubmed">29121281</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA . 2018;319:62&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5839473</ArticleId><ArticleId IdType="pubmed">29297082</ArticleId></ArticleIdList></Reference><Reference><Citation>Huchinson J. Notes of uncommon cases: severe symmetrical gangrene of the extremities. BMJ . 1891;2:8&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2272897</ArticleId><ArticleId IdType="pubmed">20753362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira AC, Fernandes V. Symmetrical peripheral gangrene. Eur J Vasc Endovasc Surg . 2018;55:391.</Citation><ArticleIdList><ArticleId IdType="pubmed">28867472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffin N, Vasa CV, Breakstone S, Axman W. Symmetrical peripheral gangrene of bilateral feet and unilateral hand after administration of vasopressors during septic shock. BMJ Case Rep 2018.  [accessed 2018 Nov 19]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836706/pdf/bcr-2017-223602.pdf</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836706</ArticleId><ArticleId IdType="pubmed">29437714</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JY, Kanzler M, Swetter SM. Dopamine-associated symmetric peripheral gangrene. Arch Dermatol . 1997;133:247&#x2013;249.</Citation><ArticleIdList><ArticleId IdType="pubmed">9041849</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong J, Zhang L, Rao G, Zhao X. Complicating symmetric peripheral gangrene after dopamine therapy to patients with septic shock. J Forensic Sci . 2015;60:1644&#x2013;1646.</Citation><ArticleIdList><ArticleId IdType="pubmed">26223832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayes MA, Yau EH, Hinds CJ, Watson JD. Symmetrical peripheral gangrene: association with noradrenaline administration. Intensive Care Med . 1992;18:433&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">1469185</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung KJ, Nho JH, Cho HK, Hong S, Won SH, Chun DI, et al. Amputation of multiple limbs caused by use of inotropics: case report, a report of 4 cases. Medicine (Baltimore) . 2018;97:e9800.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5805451</ArticleId><ArticleId IdType="pubmed">29384879</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med . 2010;362:779&#x2013;789.</Citation><ArticleIdList><ArticleId IdType="pubmed">20200382</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown SM, Lanspa MJ, Jones JP, Kuttler KG, Li Y, Carlson R, et al. Survival after shock requiring high-dose vasopressor therapy. Chest . 2013;143:664&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590882</ArticleId><ArticleId IdType="pubmed">22911566</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L, Sheng Y, Feng X, Wu J. The effects and safety of vasopressin receptor agonists in patients with septic shock: a meta-analysis and trial sequential analysis. Crit Care . 2019;23:91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6419432</ArticleId><ArticleId IdType="pubmed">30871607</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al. VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med . 2008;358:877&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, et al. CATS Study Group Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet . 2007;370:676&#x2013;684.</Citation><ArticleIdList><ArticleId IdType="pubmed">17720019</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimbo K, Yokota K, Miyamoto J, Okuhara Y, Ochi M. Symmetrical peripheral gangrene caused by septic shock. Case Reports Plast Surg Hand Surg . 2015;2:53&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793794</ArticleId><ArticleId IdType="pubmed">27252971</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips V. Acute meningococcemia with symmetric peripheral gangrene: report of a case with recovery. Ann Intern Med. . 1958;48:864&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">13521612</ArticleId></ArticleIdList></Reference><Reference><Citation>Modak D, Guha SK. Symmetrical peripheral gangrene: a rare complication of dengue fever. Indian J Med Sci . 2012;66:292&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">23897526</ArticleId></ArticleIdList></Reference><Reference><Citation>Patial T, Sharma K, Jaswal AS, Thakur V, Negi S. Symmetrical peripheral gangrene and tuberculosis: a rare kinship. Int J Mycobacteriol . 2017;6:407&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pubmed">29171458</ArticleId></ArticleIdList></Reference><Reference><Citation>Molos MA, Hall JC. Symmetrical peripheral gangrene and disseminated intravascular coagulation. Arch Dermatol . 1985;121:1057&#x2013;1061.</Citation><ArticleIdList><ArticleId IdType="pubmed">3896158</ArticleId></ArticleIdList></Reference><Reference><Citation>Berrey MM, van Burik J-A. Images in clinical medicine. Symmetric peripheral gangrene. N Engl J Med . 2001;344:1593.</Citation><ArticleIdList><ArticleId IdType="pubmed">11372011</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamatsu S, Kojima A, Tanaka A, Hayashi K, Hashimoto T. Images in anesthesiology: symmetric peripheral gangrene. Anesthesiology . 2013;118:1455.</Citation><ArticleIdList><ArticleId IdType="pubmed">23059450</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP, STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg . 2014;12:1495&#x2013;1499.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol . 2014;64:1373&#x2013;1384.</Citation><ArticleIdList><ArticleId IdType="pubmed">25103073</ArticleId></ArticleIdList></Reference><Reference><Citation>Wozniak K, Sleszycka J, Safianowska A, Wiechno W, Domagala-Kulawik J. Systemic inflammation in peripheral arterial disease with or without coexistent chronic obstructive pulmonary disease: analysis of selected markers. Arch Med Sci . 2012;8:477&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3400913</ArticleId><ArticleId IdType="pubmed">22852003</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care . 2005;43:1130&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. Intensive Care Med . 1996;22:707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill ME, Rosenwaike I. The Social Security Administration&#x2019;s death master file: the completeness of death reporting at older ages. Soc Secur Bull . 2001;64:45&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">12428517</ArticleId></ArticleIdList></Reference><Reference><Citation>Navar AM, Peterson ED, Steen DL, Wojdyla DM, Sanchez RJ, Khan I, et al. Evaluation of mortality data from the Social Security Administration death master file for clinical research. JAMA Cardiol . 2019;4:375&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484792</ArticleId><ArticleId IdType="pubmed">30840023</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitz KM, Marroquin OC, Zenati MS, Kennedy J, Korytkowski M, Tzeng E, et al. Association between preoperative metformin exposure and postoperative outcomes in adults with type 2 diabetes. JAMA Surg . 2020;155:e200416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7142798</ArticleId><ArticleId IdType="pubmed">32267474</ArticleId></ArticleIdList></Reference><Reference><Citation>Therneau T, Grambsch P. Modeling survival data: extending the Cox model. New York: Springer; 2000.</Citation></Reference><Reference><Citation>Therneau T. A Package for Survival Analysis in R. The R Foundation; 2020.  [accessed 2020 Jun 1]. Available from: https://cran.r-project.org/web/packages/survival/index.html</Citation></Reference><Reference><Citation>Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA . 2019;321:2003&#x2013;2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States-an analysis based on timing of diagnosis and severity level. Crit Care Med . 2018;46:1889&#x2013;1897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6250243</ArticleId><ArticleId IdType="pubmed">30048332</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, et al. Ischemic limb necrosis in septic shock: what is the role of high-dose vasopressor therapy? J Thromb Haemost . 2019;17:1973&#x2013;1978.</Citation><ArticleIdList><ArticleId IdType="pubmed">31334603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gando S, Levi M, Toh C-H. Disseminated intravascular coagulation. Nat Rev Dis Primers . 2016;2:16037.</Citation><ArticleIdList><ArticleId IdType="pubmed">27250996</ArticleId></ArticleIdList></Reference><Reference><Citation>Saito S, Uchino S, Hayakawa M, Yamakawa K, Kudo D, Iizuka Y, et al. Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) Study Group Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care . 2019;50:23&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30471557</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis MDP, Dy KM, Nelson S. Presentation and outcome of purpura fulminans associated with peripheral gangrene in 12 patients at Mayo Clinic. J Am Acad Dermatol . 2007;57:944&#x2013;956.</Citation><ArticleIdList><ArticleId IdType="pubmed">17719676</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation . 2018;137:e67&#x2013;e492.</Citation><ArticleIdList><ArticleId IdType="pubmed">29386200</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30318583</PMID><DateCompleted><Year>2020</Year><Month>03</Month><Day>23</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2019</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>No association with cardiac death after sepsis: A nationwide observational cohort study.</ArticleTitle><Pagination><StartPage>344</StartPage><EndPage>351</EndPage><MedlinePgn>344-351</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13280</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cardiac dysfunction is a well-known complication of sepsis, but its long-term consequences and implications for patients remain unclear. The aim of this study was to investigate cardiac outcome in sepsis by assessing causes of death up to 2&#xa0;years after treatment in an Intensive Care Unit (ICU) in a nationwide register-based cohort collected from the Swedish Intensive Care Registry.</AbstractText><AbstractText Label="METHODS">A cohort of 13&#xa0;669 sepsis and septic shock ICU patients from 2008 to 2014 was collected together with a non-septic control group, matched regarding age, sex and severity of illness (n&#xa0;=&#xa0;6582), and all without preceding severe cardiac disease. For a large proportion of the severe sepsis and septic shock patients (n&#xa0;=&#xa0;7087), no matches were found. Information on causes of death up to 2&#xa0;years after ICU admission was sought in the Swedish National Board of Health and Welfare's Cause of Death Registry.</AbstractText><AbstractText Label="RESULTS">Intensive Care Unit mortality was nearly identical in a matched comparison of sepsis patients to controls (24% in both groups) but higher in more severely ill sepsis patients for whom no matches were found (33% vs 24%, P&#xa0;&lt;&#xa0;0.001). There was no association of sepsis to cardiac deaths in the first month (OR 1.03, 95%CI 0.87 to 1.20, P&#xa0;=&#xa0;0.76) nor up to 2&#xa0;years after ICU admission (OR 1.01, 95%CI 0.82 to 1.25, P&#xa0;=&#xa0;0.94) in an adjusted between-group comparison.</AbstractText><AbstractText Label="CONCLUSIONS">There was no association with an increased risk of death related to cardiac disease in patients with severe sepsis or septic shock when compared to other ICU patients with similar severity of illness.</AbstractText><CopyrightInformation>&#xa9; 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>De Geer</LastName><ForeName>Lina</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9201-5282</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oscarsson Tibblin</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fredrikson</LastName><ForeName>Mats</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Occupational and Environmental Medicine, Department of Clinical and Experimental Medicine and Forum &#xd6;sterg&#xf6;tland, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walther</LastName><ForeName>Sten M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Thoracic and Vascular Surgery, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003643" MajorTopicYN="Y">Death</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>3</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30318583</ArticleId><ArticleId IdType="doi">10.1111/aas.13280</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25466837</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>17</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-2472</ISSN><JournalIssue CitedMedium="Internet"><Volume>135</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Thrombosis research</Title><ISOAbbreviation>Thromb Res</ISOAbbreviation></Journal><ArticleTitle>Mild induced hypothermia: effects on sepsis-related coagulopathy--results from a randomized controlled trial.</ArticleTitle><Pagination><StartPage>175</StartPage><EndPage>182</EndPage><MedlinePgn>175-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.thromres.2014.10.028</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0049-3848(14)00585-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Coagulopathy associates with poor outcome in sepsis. Mild induced hypothermia has been proposed as treatment in sepsis but it is not known whether this intervention worsens functional coagulopathy.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Interim analysis data from an ongoing randomized controlled trial; The Cooling And Surviving Septic shock (CASS) study. Patients suffering severe sepsis/septic shock are allocated to either mild induced hypothermia (cooling to 32-34&#xb0;C for 24hours) or control (uncontrolled temperature).</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT01455116. Thrombelastography (TEG) is performed three times during the first day after study enrollment in all patients. Reaction time (R), maximum amplitude (MA) and patients' characteristics are here reported.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred patients (control n=50 and intervention n=50; male n=59; median age 68years) with complete TEG during follow-up were included. At enrollment, 3%, 38%, and 59% had a hypocoagulable, normocoagulable, and hypercoagulable TEG clot strength (MA), respectively. In the hypothermia group, functional coagulopathy improved during the hypothermia phase, measured by R and MA, in patients with hypercoagulation as well as in patients with hypocoagulation (correlation between &#x394;R and initial R: rho=-0.60, p&lt;0.0001 and correlation between &#x394;MA and initial MA: rho=-0.50, p=0.0002). Similar results were not observed in the control group neither for R (rho=-0.03, p=0.8247) nor MA (rho=-0.15, p=0.3115).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Mild induced hypothermia did seem to improve functional coagulopathy in septic patients. This improvement of functional coagulopathy parameters during the hypothermia intervention persisted after rewarming. Randomized trials are warranted to determine whether the positive effect on sepsis-related coagulopathy can be transformed to improved survival.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johansen</LastName><ForeName>Maria E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark. Electronic address: Maria.Egede.Johansen@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Jens-Ulrik</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bestle</LastName><ForeName>Morten H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Nordsjaellands hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostrowski</LastName><ForeName>Sisse R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thormar</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Bispebjerg Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Henrik</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Henrik Planck</ForeName><Initials>HP</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Roskilde, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poulsen</LastName><ForeName>Lone</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, University Hospital Gentofte, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kj&#xe6;r</LastName><ForeName>Jesper</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cozzi-Lepri</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark; Department of Virology, Royal Free and University College Medical School London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Neurointensive Care Unit 2093, Department of Neuroanaesthesiology, University Hospital Rigshospitalet, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>T&#xf8;nnesen</LastName><ForeName>Else</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Aarhus University Hospital, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lundgren</LastName><ForeName>Jens D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Centre for Health and Infectious Diseases Research (CHIP), Department of Infectious Diseases and Reumathology, Rigshospitalet,University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johansson</LastName><ForeName>P&#xe4;r I</ForeName><Initials>PI</Initials><AffiliationInfo><Affiliation>Section for Transfusion Medicine, Capital Region Blood Bank, Rigshospitalet, Denmark; Department of Surgery, University of Texas Medical School at Houston, TX, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01455116</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Thromb Res</MedlineTA><NlmUniqueID>0326377</NlmUniqueID><ISSNLinking>0049-3848</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="N">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001778" MajorTopicYN="N">Blood Coagulation Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004548" MajorTopicYN="N">Elasticity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013696" MajorTopicYN="N">Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019851" MajorTopicYN="N">Thrombophilia</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014783" MajorTopicYN="N">Viscosity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coagulopathy</Keyword><Keyword MajorTopicYN="N">Mild induced hypothermia</Keyword><Keyword MajorTopicYN="N">Randomized controlled trial</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Thrombelastography</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>10</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25466837</ArticleId><ArticleId IdType="doi">10.1016/j.thromres.2014.10.028</ArticleId><ArticleId IdType="pii">S0049-3848(14)00585-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31453837</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2380-0194</ISSN><JournalIssue CitedMedium="Internet"><Volume>33</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Clinical spine surgery</Title><ISOAbbreviation>Clin Spine Surg</ISOAbbreviation></Journal><ArticleTitle>Postoperative Complications Associated With Metabolic Syndrome Following Adult Spinal Deformity Surgery.</ArticleTitle><Pagination><StartPage>E87</StartPage><EndPage>E91</EndPage><MedlinePgn>E87-E91</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BSD.0000000000000859</ELocationID><Abstract><AbstractText Label="STUDY DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE">The objective of this study was to examine the effect of metabolic syndrome on 30-day postoperative complications following corrective surgery for the adult spinal deformity (ASD).</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA">Metabolic syndrome has been shown to increase the risk of cardiovascular morbidity and mortality. Few studies have examined the effect of metabolic syndrome on patients with ASD undergoing surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS">We performed a retrospective cohort study of patients who underwent spinal fusion for ASD. Patients were divided into 2 groups based on the presence or absence of metabolic syndrome, which was defined as a combination of hypertension, diabetes mellitus, and obesity. Baseline patient characteristics and operative variables were compared between the 2 groups. We also compared the incidence of 30-day postoperative complications between the 2 groups. A multivariable regression analysis was then performed to identify 30-day postoperative complications that were independently associated with metabolic syndrome.</AbstractText><AbstractText Label="RESULTS">A total of 6696 patients were included with 8.3% (n=553) having metabolic syndrome. Patients with metabolic syndrome were more likely to have renal comorbidity (P=0.042), bleeding disorder (P=0.011), American Society of Anesthesiology classification &#x2265;3 (P&lt;0.001), and undergo a long fusion (P=0.009). Patients with metabolic syndrome had higher rates of 30-day mortality (P=0.042), superficial surgical site infection (P=0.006), sepsis (P=0.003), cardiac complications (P&lt;0.001), pulmonary complications (P=0.003), pulmonary embolism (P=0.050), prolonged hospitalization (P=0.010), nonhome discharge (P=0.007), and reoperation (P=0.003). Metabolic syndrome was an independent risk factor for cardiac complications [odds ratio (OR)=4.2; 95% confidence interval (CI): 1.7-10.2; P=0.001], superficial surgical site infection (OR=2.8; 95% CI: 1.4-5.7; P=0.004), sepsis (OR=2.2, 95% CI: 1.2-3.9; P=0.009), reoperation (OR=1.7; 95% CI: 1.2-2.5; P=0.006), pulmonary complications (OR=1.7; 95% CI: 1.1-2.5; P=0.017), and prolonged hospitalization (OR=1.4; 95% CI: 1.0-1.9; P=0.039).</AbstractText><AbstractText Label="CONCLUSIONS">Recognition and awareness of the relationship between metabolic syndrome and postoperative complications following ASD surgery is important for preoperative optimization and perioperative care.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Ivan B</ForeName><Initials>IB</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Ray</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>John T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Zoe B</ForeName><Initials>ZB</Initials></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Samuel K</ForeName><Initials>SK</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Spine Surg</MedlineTA><NlmUniqueID>101675083</NlmUniqueID><ISSNLinking>2380-0186</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="N">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000002" MajorTopicYN="Y">abnormalities</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31453837</ArticleId><ArticleId IdType="doi">10.1097/BSD.0000000000000859</ArticleId><ArticleId IdType="pii">01933606-202003000-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kaur J. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014;2014:943162.</Citation></Reference><Reference><Citation>Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003&#x2013;2012. JAMA. 2015;313:1973&#x2013;1974.</Citation></Reference><Reference><Citation>Alberti G, Zimmet P, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome [International Diabetes Federation]; 2006. Available at: www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html. Accessed January 1, 2019.</Citation></Reference><Reference><Citation>Pollex RL, Hegele RA. Genetic determinants of the metabolic syndrome. Nat Clin Pract Cardiovasc Med. 2006;3:482&#x2013;489.</Citation></Reference><Reference><Citation>Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683&#x2013;689.</Citation></Reference><Reference><Citation>Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709&#x2013;2716.</Citation></Reference><Reference><Citation>Memtsoudis SG, Kirksey M, Ma Y, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine. 2012;37:989&#x2013;995.</Citation></Reference><Reference><Citation>Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108:506&#x2013;523.</Citation></Reference><Reference><Citation>Tzimas P, Petrou A, Laou E, et al. Impact of metabolic syndrome in surgical patients: should we bother? Br J Anaesth. 2015;115:194&#x2013;202.</Citation></Reference><Reference><Citation>Youssef JA, Orndorff DO, Patty CA, et al. Current status of adult spinal deformity. Global Spine J. 2013;3:51&#x2013;62.</Citation></Reference><Reference><Citation>Cowman JA Jr, Dimick JB, Wainess R, et al. Changes in the utilization of spinal fusion in the United States. Neurosurgery. 2006;59:15&#x2013;20.</Citation></Reference><Reference><Citation>Memtsoudis SG, Hughes A, Ma Y, et al. Increased in-hospital complications after primary posterior versus primary anterior cervical fusion. Clin Orthop Relat Res. 2011;469:649&#x2013;657.</Citation></Reference><Reference><Citation>Chung AS, Campbell D, Waldrop R, et al. Metabolic syndrome and 30-day outcomes in elective lumbar spinal fusion. Spine. 2018;43:661&#x2013;666.</Citation></Reference><Reference><Citation>Di Capua J, Somani S, Kim JS, et al. Hospital-acquired conditions in adult spinal deformity surgery: predictors for hospital-acquired conditions and other 30-day postoperative outcomes. Spine. 2017;42:595&#x2013;602.</Citation></Reference><Reference><Citation>Gierach M, Gierach J, Ewertowska M, et al. Correlation between body mass index and waist circumference in patients with metabolic syndrome. ISRN Endocrinol. 2014;2014:514589.</Citation></Reference><Reference><Citation>Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119:812&#x2013;819.</Citation></Reference><Reference><Citation>Ford ES, Li C. Metabolic syndrome and health-related quality of life among U.S. adults. Ann Epidemiol. 2008;18:165&#x2013;171.</Citation></Reference><Reference><Citation>Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut. 2010;59:1410&#x2013;1415.</Citation></Reference><Reference><Citation>Yilmaz H, Ozcan KS, Sayar N, et al. Metabolic syndrome is associated with atrial electrical and mechanical dysfunction. Med Princ Pract. 2015;24:147&#x2013;152.</Citation></Reference><Reference><Citation>Glance LG, Wissler R, Mukamel DB, et al. Perioperative outcomes among patients with modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology. 2010;113:859&#x2013;872.</Citation></Reference><Reference><Citation>Murphy AB, Menendez ME, Watson SL, et al. Metabolic syndrome and shoulder arthroplasty: epidemiology and perioperative outcomes. Int Orthop. 2016;40:1927&#x2013;1933.</Citation></Reference><Reference><Citation>Bhayani NH, Hyder O, Frederick W, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012;152:218&#x2013;226.</Citation></Reference><Reference><Citation>Cichos KH, Churchill JL, Phillips SG, et al. Metabolic syndrome and hip fracture: epidemiology and perioperative outcomes. Injury. 2018;49:2036&#x2013;2041.</Citation></Reference><Reference><Citation>Ljungqvist O, Soop M, Hedstrom M. Why metabolism matters in elective orthopedic surgery: a review. Acta Orthop. 2007;78:610&#x2013;615.</Citation></Reference><Reference><Citation>Hedstrom M, Ljungqvist O, Cederholm T. Metabolism and catabolism in hip fracture patients: nutritional and anabolic intervention&#x2013;a review. Acta Orthop. 2006;77:741&#x2013;747.</Citation></Reference><Reference><Citation>Jacobsson G, Dashti S, Wahlberg T, et al. The epidemiology of and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis. 2007;39:6&#x2013;13.</Citation></Reference><Reference><Citation>Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592&#x2013;598.</Citation></Reference><Reference><Citation>Befus M, Low FD, Miko BA, et al. Obesity as a determinant of Staphylococcus aureus colonization among inmates in maximum-security prisons in New York state. Am J Epidemiol. 2015;182:494&#x2013;502.</Citation></Reference><Reference><Citation>Scully IL, McNeil LK, Pathirana S, et al. Neutrophil killing of Staphylococcus aurues in diabetes, obesity, and metabolic syndrome: a prospective cellular surveillance study. Diabetol Metab Syndr. 2017;9:76.</Citation></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;851.</Citation></Reference><Reference><Citation>Abbasi J. In treating sepsis, questions about timing and mandates. JAMA. 2017;318:506&#x2013;508.</Citation></Reference><Reference><Citation>Shahreyar M, Fahhoum R, Akinseye O, et al. Severe sepsis and cardiac arrhythmias. Ann Transl Med. 2018;6:6.</Citation></Reference><Reference><Citation>Meydan C, Bekenstein U, Soreq H. Molecular regulatory pathways link sepsis with metabolic syndrome: non-coding RNA elements underlying the sepsis/metabolic cross-talk. Front Mol Neurosci. 2018;11:189.</Citation></Reference><Reference><Citation>Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric surgery. Curr Opin Anaesthesiol. 2016;29:421&#x2013;429.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22172797</PMID><DateCompleted><Year>2012</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2012</Year><Month>03</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>2</Issue><PubDate><Year>2012</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Incidence and risk factors for sepsis in surgical patients: a cohort study.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>166</EndPage><MedlinePgn>159-66</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2011.08.001</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of the study was to evaluate risk factors for infection and sepsis in surgical patients admitted to the intensive care unit (ICU).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Data were prospectively collected from a cohort of surgical patients from January 2005 to December 2007. We analyzed the incidence of infection and sepsis and certain other variables from the pre-, intra-, and postoperative periods as risk factors for infection and sepsis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We studied 625 surgical patients. The mortality rate was 18.2%, and the mean age of the subjects was 53.1 &#xb1; 18.8 years. The incidences of severe sepsis and septic shock were 5% and 11.5%, respectively. A multivariate analysis showed that the following variables were associated with sepsis in the postoperative period: urgent surgery (odds ratio, 2.63; 95% confidence interval [CI], 1.50-4.63), fluid resuscitation (odds ratio, 1.90; 95% CI, 1.18-3.05), vasoactive drugs (odds ratio, 2.58; 95% CI, 1.61-4.14), and mechanical ventilation (odds ratio, 5.51; 95% CI, 3.07-9.89). A Sequential Organ Failure Assessment was associated with infection or sepsis upon ICU admission (area under the curve, 0.737 &#xb1; 0.019; 95% CI, 0.748-0.825).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study showed that sepsis has high incidence and mortality in surgical patients admitted to the ICU. Urgent surgeries, mechanical ventilation, fluid resuscitation, and vasoactive drugs in the postoperative period and Sequential Organ Failure Assessment at ICU admission were risk factors for sepsis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elias</LastName><ForeName>Adriana Cristina Galbiati Parminondi</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>University Hospital of Londrina, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Tiemi</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Grion</LastName><ForeName>Cintia Magalh&#xe3;es Carvalho</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Cardoso</LastName><ForeName>Lucienne Tibery Queiroz</ForeName><Initials>LT</Initials></Author><Author ValidYN="Y"><LastName>Verri</LastName><ForeName>Paulo Henrique</ForeName><Initials>PH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>12</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2011</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2011</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2012</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22172797</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2011.08.001</ArticleId><ArticleId IdType="pii">S0883-9441(11)00377-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">33863237</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1745-2422</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>Expert review of medical devices</Title><ISOAbbreviation>Expert Rev Med Devices</ISOAbbreviation></Journal><ArticleTitle>Antimicrobial and resource utilization with T2 magnetic resonance for rapid diagnosis of bloodstream infections: systematic review with meta-analysis of controlled studies.</ArticleTitle><Pagination><StartPage>473</StartPage><EndPage>482</EndPage><MedlinePgn>473-482</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/17434440.2021.1919508</ELocationID><Abstract><AbstractText><b>Objectives:</b> To compare antimicrobial and resource utilization with T2 Magnetic Resonance (T2MR) versus blood culture (BC) in patients with suspected bloodstream infection.<b>Methods:</b> We systematically searched MEDLINE, EMBASE, and CENTRAL for randomized trials or observational controlled studies of patients with suspected bloodstream infection receiving a diagnosis with T2MR or BC. Using an inverse variance meta-analysis model, we reported mortality using the risk ratio (RR) and the remaining outcomes as the mean difference (MD).<b>Results:</b> Fourteen studies were included in the meta-analysis. Time to detection (MD&#xa0;=&#xa0;-81&#xa0;hours; p &lt;&#xa0;0.001) and time to species identification (MD&#xa0;=&#xa0;-77&#xa0;hours; p &lt;&#xa0;0.001) were faster with T2MR. Patients testing positive on T2MR received targeted antimicrobial therapy faster (-42&#xa0;hours; p &lt;&#xa0;0.001) and patients testing negative on T2MR were de-escalated from empirical therapy faster (-7&#xa0;hours; p =&#xa0;0.02) vs. BC. Length of intensive care unit stay (MD&#xa0;=&#xa0;-5.0&#xa0;days; p =&#xa0;0.03) and hospital stay (MD&#xa0;=&#xa0;-4.8&#xa0;days; p =&#xa0;0.03) were shorter with T2MR. Mortality rates were comparable between T2MR and BC (28.9% vs. 29.9%, RR&#xa0;=&#xa0;1.02, p =&#xa0;0.86).<b>Conclusion:</b> Utilization of T2MR for identification of bloodstream pathogens provides faster time to detection, faster transition to targeted microbial therapy, faster de-escalation of empirical therapy, shorter ICU and hospital stay, and with comparable mortality rate versus BC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Giannella</LastName><ForeName>Maddalena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Polyclinic, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankey</LastName><ForeName>George A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Infectious Disease Translational Research, Ochsner Clinic Foundation, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascale</LastName><ForeName>Renato</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Medical and Surgical Sciences, Sant'Orsola-Malpighi Polyclinic, University of Bologna, Bologna, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Valerie M</ForeName><Initials>VM</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Miller Scientific, Johnson City, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Larry E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, Miller Scientific, Johnson City, TN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seitz</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, Clinic Favoriten, Vienna Healthcare Group, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Rev Med Devices</MedlineTA><NlmUniqueID>101230445</NlmUniqueID><ISSNLinking>1743-4440</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018849" MajorTopicYN="Y">Controlled Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017594" MajorTopicYN="N">Publication Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bacteremia</Keyword><Keyword MajorTopicYN="N">T2Dx</Keyword><Keyword MajorTopicYN="N">blood culture</Keyword><Keyword MajorTopicYN="N">candida</Keyword><Keyword MajorTopicYN="N">magnetic resonance</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>17</Day><Hour>5</Hour><Minute>19</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33863237</ArticleId><ArticleId IdType="doi">10.1080/17434440.2021.1919508</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30075792</PMID><DateCompleted><Year>2019</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Left ventricular systolic function evaluated by strain echocardiography and relationship with mortality in patients with severe sepsis or septic shock: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>183</StartPage><MedlinePgn>183</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">183</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-018-2113-y</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis-induced myocardial dysfunction is associated with poor outcomes, but traditional measurements of systolic function such as left ventricular ejection fraction (LVEF) do not directly correlate with prognosis. Global longitudinal strain (GLS) utilizing speckle-tracking echocardiography (STE) could be a better marker of intrinsic left ventricular (LV) function, reflecting myocardial deformation rather than displacement and volume changes. We sought to investigate the prognostic value of GLS in patients with sepsis and/or septic shock.</AbstractText><AbstractText Label="METHODS">We conducted a systematic review (PubMed and Embase up to 26 October 2017) and meta-analysis to investigate the association between GLS and mortality at longest follow up in patients with severe sepsis and/or septic shock. In the primary analysis, we included studies reporting transthoracic echocardiography data on GLS according to mortality. A secondary analysis evaluated the association between LVEF and mortality including data from studies reporting GLS.</AbstractText><AbstractText Label="RESULTS">We included eight studies in the primary analysis with a total of 794 patients (survival 68%, n&#x2009;=&#x2009;540). We found a significant association between worse LV function and GLS values and mortality: standard mean difference (SMD) -&#x2009;0.26; 95% confidence interval (CI) -&#x2009;0.47, -&#x2009;0.04; p&#x2009;=&#x2009;0.02 (low heterogeneity, I<sup>2</sup>&#xa0;=&#x2009;43%). No significant association was found between LVEF and mortality in the same population of patients (eight studies; SMD, 0.02; 95% CI -&#x2009;0.14, 0.17; p&#x2009;=&#x2009;0.83; no heterogeneity, I<sup>2</sup>&#xa0;=&#x2009;3%).</AbstractText><AbstractText Label="CONCLUSIONS">Worse GLS (less negative)&#xa0;values are associated with higher mortality in patients with severe sepsis or septic shock, while such association is not valid for LVEF. More critical care research is warranted to confirm the better ability of STE in demonstrating underlying intrinsic myocardial disease compared to LVEF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sanfilippo</LastName><ForeName>F</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5144-0776</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127, Palermo, Italy. filipposanfi@yahoo.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corredor</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine, Bart's Heart Centre St. Bartholomew's Hospital, W. Smithfield, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, St Georges University Hospitals NHS Trust, Blackshaw Road, London, SW170QT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tritapepe</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anaesthetic and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorini</LastName><ForeName>F L</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Papa Giovanni XXIII Hospital, Bergamo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcadipane</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad alta specializzazione), Via Tricomi 5, 90127, Palermo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieillard-Baron</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-Hopitaux de Paris, University Hospital Ambroise Par&#xe9;, Intensive Care Unit, Section Thorax-Vascular Disease-Abdomen-Metabolism, 92100, Boulogne-Billancourt, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>INSERM U-1018, CESP, Team 5 (EpReC, Renal and Cardiovascular Epidemiology), Universite' Versailles Saint Quentin en Yvelines, 94807, Villejuif, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Humanitas Clinical and Research Center, Via A. Manzoni 56, 20089, Rozzano - Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Humanitas University, Department of Biomedical Sciences, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele - Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care. 2019 Feb 8;23(1):38. doi: 10.1186/s13054-019-2312-1.</RefSource><PMID Version="1">30736846</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D025401" MajorTopicYN="N">Echocardiography, Stress</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016277" MajorTopicYN="N">Ventricular Function, Left</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Global longitudinal strain</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Left ventricular ejection fraction</Keyword><Keyword MajorTopicYN="N">Speckle tracking</Keyword><Keyword MajorTopicYN="N">Systolic dysfunction</Keyword></KeywordList><CoiStatement>Not applicable. Not applicable. The authors declare that they have no competing interests. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>7</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30075792</ArticleId><ArticleId IdType="pmc">PMC6091069</ArticleId><ArticleId IdType="doi">10.1186/s13054-018-2113-y</ArticleId><ArticleId IdType="pii">10.1186/s13054-018-2113-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, et al. Year in review in intensive care medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation. Intensive Care Med. 2012;38(3):345&#x2013;358. doi: 10.1007/s00134-012-2467-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2467-6</ArticleId><ArticleId IdType="pmc">PMC3291826</ArticleId><ArticleId IdType="pubmed">22270471</ArticleId></ArticleIdList></Reference><Reference><Citation>Gullo A, Foti A, Murabito P, Li Volti G, Astuto M, Stissi C, Rubulotta F, Sanfilippo F, Santonocito C, Sganga G, et al. Spectrum of sepsis, mediators, source control and management of bundles. Front Biosci (Elite Ed) 2010;2:906&#x2013;911. doi: 10.2741/e150.</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e150</ArticleId><ArticleId IdType="pubmed">20515762</ArticleId></ArticleIdList></Reference><Reference><Citation>Beesley SJ, Weber G, Sarge T, Nikravan S, Grissom CK, Lanspa MJ, Shahul S, Brown SM. Septic cardiomyopathy. Crit Care Med. 2018;46(4):625&#x2013;634. doi: 10.1097/CCM.0000000000002851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002851</ArticleId><ArticleId IdType="pubmed">29227368</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter JD, Doddi M. Sepsis and the heart. Br J Anaesth. 2010;104(1):3&#x2013;11. doi: 10.1093/bja/aep339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aep339</ArticleId><ArticleId IdType="pubmed">19939836</ArticleId></ArticleIdList></Reference><Reference><Citation>Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesth Analg. 2009;108(6):1841&#x2013;1847. doi: 10.1213/ane.0b013e318195e11d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e318195e11d</ArticleId><ArticleId IdType="pubmed">19448210</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965&#x2013;969. doi: 10.1007/s001340100920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340100920</ArticleId><ArticleId IdType="pubmed">11497154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Corredor C, Fletcher N, Landesberg G, Benedetto U, Foex P, Cecconi M. Diastolic dysfunction and mortality in septic patients: a systematic review and meta-analysis. Intensive Care Med. 2015;41(6):1004&#x2013;13. 10.1007/s00134-015-3748-7. Epub 2015 Mar 24.</Citation><ArticleIdList><ArticleId IdType="pubmed">25800584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Corredor C, Arcadipane A, Landesberg G, Vieillard-Baron A, Cecconi M, Fletcher N. Tissue Doppler assessment of diastolic function and relationship with mortality in critically ill septic patients: a systematic review and meta-analysis. Br J Anaesth. 2017;119(4):583&#x2013;594. doi: 10.1093/bja/aex254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex254</ArticleId><ArticleId IdType="pubmed">29121301</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker MM, Shelhamer JH, Bacharach SL, Green MV, Natanson C, Frederick TM, Damske BA, Parrillo JE. Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med. 1984;100(4):483&#x2013;490. doi: 10.7326/0003-4819-100-4-483.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-100-4-483</ArticleId><ArticleId IdType="pubmed">6703540</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A, Caille V, Charron C, Belliard G, Page B, Jardin F. Actual incidence of global left ventricular hypokinesia in adult septic shock. Crit Care Med. 2008;36(6):1701&#x2013;1706. doi: 10.1097/CCM.0b013e318174db05.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318174db05</ArticleId><ArticleId IdType="pubmed">18496368</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care. 2013;17(3):R96. doi: 10.1186/cc12741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12741</ArticleId><ArticleId IdType="pmc">PMC4056117</ArticleId><ArticleId IdType="pubmed">23706109</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014;40(12):1795&#x2013;1815. doi: 10.1007/s00134-014-3525-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-014-3525-z</ArticleId><ArticleId IdType="pmc">PMC4239778</ArticleId><ArticleId IdType="pubmed">25392034</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard-Baron A. Septic cardiomyopathy. Ann Intensive Care. 2011;1(1):6. doi: 10.1186/2110-5820-1-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-1-6</ArticleId><ArticleId IdType="pmc">PMC3159902</ArticleId><ArticleId IdType="pubmed">21906334</ArticleId></ArticleIdList></Reference><Reference><Citation>Vignon P, Huang SJ. Global longitudinal strain in septic cardiomyopathy: the hidden part of the iceberg? Intensive Care Med. 2015;41(10):1851&#x2013;1853. doi: 10.1007/s00134-015-3962-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3962-3</ArticleId><ArticleId IdType="pubmed">26183488</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M, Kaluski E, Krakover R, Vered Z. Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004;17(10):1021&#x2013;1029. doi: 10.1016/j.echo.2004.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2004.06.019</ArticleId><ArticleId IdType="pubmed">15452466</ArticleId></ArticleIdList></Reference><Reference><Citation>Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G, Galderisi M, Marwick T, Nagueh SF, Sengupta PP, et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr. 2011;12(3):167&#x2013;205. doi: 10.1093/ejechocard/jer021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jer021</ArticleId><ArticleId IdType="pubmed">21385887</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62(10):e1&#x2013;34. doi: 10.1016/j.jclinepi.2009.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2009.06.006</ArticleId><ArticleId IdType="pubmed">19631507</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228. doi: 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 10 Jan 2018.</Citation></Reference><Reference><Citation>Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13. doi: 10.1186/1471-2288-5-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-5-13</ArticleId><ArticleId IdType="pmc">PMC1097734</ArticleId><ArticleId IdType="pubmed">15840177</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557&#x2013;560. doi: 10.1136/bmj.327.7414.557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.327.7414.557</ArticleId><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri V, Innocenti F, Guzzo A, Guerrini E, Vignaroli D, Pini R. Left ventricular systolic longitudinal function as predictor of outcome in patients with sepsis. Circ Cardiovasc Imaging. 2015;8(11):e003865.</Citation><ArticleIdList><ArticleId IdType="pubmed">26546483</ArticleId></ArticleIdList></Reference><Reference><Citation>Innocenti F, Palmieri V, Guzzo A, Stefanone VT, Donnini C, Pini R. SOFA score and left ventricular systolic function as predictors of short-term outcome in patients with sepsis. Intern Emerg Med. 2018;13(1):51&#x2013;58. 10.1007/s11739-016-1579-3. Epub 2016 Dec 1.</Citation><ArticleIdList><ArticleId IdType="pubmed">27909859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang WT, Lee WH, Lee WT, Chen PS, Su YR, Liu PY, Liu YW, Tsai WC. Left ventricular global longitudinal strain is independently associated with mortality in septic shock patients. Intensive Care Med. 2015;41(10):1791&#x2013;1799. doi: 10.1007/s00134-015-3970-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-015-3970-3</ArticleId><ArticleId IdType="pubmed">26183489</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, Beeri R, Weissman C, Sprung CL, Landesberg A. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014;42(4):790&#x2013;800. doi: 10.1097/CCM.0000000000000107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000107</ArticleId><ArticleId IdType="pubmed">24365861</ArticleId></ArticleIdList></Reference><Reference><Citation>De Geer L, Engvall J, Oscarsson A. Strain echocardiography in septic shock - a comparison with systolic and diastolic function parameters, cardiac biomarkers and outcome. Crit Care. 2015;19:122. doi: 10.1186/s13054-015-0857-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0857-1</ArticleId><ArticleId IdType="pmc">PMC4374340</ArticleId><ArticleId IdType="pubmed">25882600</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa MJ, Shahul S, Hersh A, Wilson EL, Olsen TD, Hirshberg EL, Grissom CK, Brown SM. Associations among left ventricular systolic function, tachycardia, and cardiac preload in septic patients. Ann Intensive Care. 2017;7(1):17. doi: 10.1186/s13613-017-0240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0240-2</ArticleId><ArticleId IdType="pmc">PMC5315651</ArticleId><ArticleId IdType="pubmed">28213737</ArticleId></ArticleIdList></Reference><Reference><Citation>Orde SR, Pulido JN, Masaki M, Gillespie S, Spoon JN, Kane GC, Oh JK. Outcome prediction in sepsis: speckle tracking echocardiography based assessment of myocardial function. Crit Care. 2014;18(4):R149. doi: 10.1186/cc13987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc13987</ArticleId><ArticleId IdType="pmc">PMC4227017</ArticleId><ArticleId IdType="pubmed">25015102</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahul S, Gulati G, Hacker MR, Mahmood F, Canelli R, Nizamuddin J, Mahmood B, Mueller A, Simon BA, Novack V, et al. Detection of myocardial dysfunction in septic shock: a speckle-tracking echocardiography study. Anesth Analg. 2015;121(6):1547&#x2013;1554. doi: 10.1213/ANE.0000000000000943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000943</ArticleId><ArticleId IdType="pubmed">26397444</ArticleId></ArticleIdList></Reference><Reference><Citation>Boissier F, Razazi K, Seemann A, Bedet A, Thille AW, de Prost N, Lim P, Brun-Buisson C, Mekontso Dessap A. Left ventricular systolic dysfunction during septic shock: the role of loading conditions. Intensive Care Med. 2017;43(5):633&#x2013;642. doi: 10.1007/s00134-017-4698-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4698-z</ArticleId><ArticleId IdType="pubmed">28204860</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaky A, Gill EA, Lin CP, Bendjelid K, Treggiari MM. Characteristics of sepsis-induced cardiac dysfunction using speckle-tracking echocardiography: a feasibility study. Anaesth Intensive Care. 2016;44(1):65&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5050013</ArticleId><ArticleId IdType="pubmed">26673591</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla K, Hallman C, Bech-Hanssen O, Haney M, Ricksten SE. Strain echocardiography identifies impaired longitudinal systolic function in patients with septic shock and preserved ejection fraction. Cardiovasc Ultrasound. 2015;13:30. doi: 10.1186/s12947-015-0025-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12947-015-0025-4</ArticleId><ArticleId IdType="pmc">PMC4487964</ArticleId><ArticleId IdType="pubmed">26134971</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng PY, Sin WC, Ng AK, Chan WM. Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS) Crit Care. 2016;20(1):145. doi: 10.1186/s13054-016-1327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1327-0</ArticleId><ArticleId IdType="pmc">PMC4867983</ArticleId><ArticleId IdType="pubmed">27177587</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Liu JJ, Du WH, Wang X, Chen ZQ, Zhang LC. 2D speckle tracking imaging to assess sepsis induced early systolic myocardial dysfunction and its underlying mechanisms. Eur Rev Med Pharmacol Sci. 2014;18(20):3105&#x2013;3114.</Citation><ArticleIdList><ArticleId IdType="pubmed">25392112</ArticleId></ArticleIdList></Reference><Reference><Citation>Hestenes SM, Halvorsen PS, Skulstad H, Remme EW, Espinoza A, Hyler S, Bugge JF, Fosse E, Nielsen EW, Edvardsen T. Advantages of strain echocardiography in assessment of myocardial function in severe sepsis: an experimental study. Crit Care Med. 2014;42(6):e432&#x2013;e440. doi: 10.1097/CCM.0000000000000310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000310</ArticleId><ArticleId IdType="pubmed">24633187</ArticleId></ArticleIdList></Reference><Reference><Citation>Mignot A, Donal E, Zaroui A, Reant P, Salem A, Hamon C, Monzy S, Roudaut R, Habib G, Lafitte S. Global longitudinal strain as a major predictor of cardiac events in patients with depressed left ventricular function: a multicenter study. J Am Soc Echocardiogr. 2010;23(10):1019&#x2013;1024. doi: 10.1016/j.echo.2010.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.07.019</ArticleId><ArticleId IdType="pubmed">20810243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho E, Brown A, Barrett P, Morgan RB, King G, Kennedy MJ, Murphy RT. Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart. 2010;96(9):701&#x2013;707. doi: 10.1136/hrt.2009.173997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2009.173997</ArticleId><ArticleId IdType="pubmed">20424152</ArticleId></ArticleIdList></Reference><Reference><Citation>Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N. Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol. 2012;158(3):423&#x2013;432. doi: 10.1016/j.ijcard.2011.01.096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.01.096</ArticleId><ArticleId IdType="pubmed">21354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahul S, Rhee J, Hacker MR, Gulati G, Mitchell JD, Hess P, Mahmood F, Arany Z, Rana S, Talmor D. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging. 2012;5(6):734&#x2013;739. doi: 10.1161/CIRCIMAGING.112.973818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.112.973818</ArticleId><ArticleId IdType="pmc">PMC3871635</ArticleId><ArticleId IdType="pubmed">22891044</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellavia D, Abraham TP, Pellikka PA, Al-Zahrani GB, Dispenzieri A, Oh JK, Bailey KR, Wood CM, Novo S, Miyazaki C, et al. Detection of left ventricular systolic dysfunction in cardiac amyloidosis with strain rate echocardiography. J Am Soc Echocardiogr. 2007;20(10):1194&#x2013;1202. doi: 10.1016/j.echo.2007.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2007.02.025</ArticleId><ArticleId IdType="pubmed">17596912</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YW, Su CT, Sung JM, Wang SP, Su YR, Yang CS, Tsai LM, Chen JH, Tsai WC. Association of left ventricular longitudinal strain with mortality among stable hemodialysis patients with preserved left ventricular ejection fraction. Clin J Am Soc Nephrol. 2013;8(9):1564&#x2013;1574. doi: 10.2215/CJN.10671012.</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.10671012</ArticleId><ArticleId IdType="pmc">PMC3805079</ArticleId><ArticleId IdType="pubmed">23704303</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100(21):1673&#x2013;1680. doi: 10.1136/heartjnl-2014-305538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-305538</ArticleId><ArticleId IdType="pubmed">24860005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1&#x2013;39.e14. doi: 10.1016/j.echo.2014.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsalinos KE, Daraban AM, Unlu S, Thomas JD, Badano LP, Voigt JU. Head-to-head comparison of global longitudinal strain measurements among nine different vendors: the EACVI/ASE inter-vendor comparison study. J Am Soc Echocardiogr. 2015;28(10):1171&#x2013;1181. doi: 10.1016/j.echo.2015.06.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2015.06.011</ArticleId><ArticleId IdType="pubmed">26209911</ArticleId></ArticleIdList></Reference><Reference><Citation>Barraud D, Faivre V, Damy T, Welschbillig S, Gayat E, Heymes C, Payen D, Shah AM, Mebazaa A. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med. 2007;35(5):1376&#x2013;1382. doi: 10.1097/01.CCM.0000261889.18102.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000261889.18102.84</ArticleId><ArticleId IdType="pubmed">17414729</ArticleId></ArticleIdList></Reference><Reference><Citation>Jianhui L, Rosenblatt-Velin N, Loukili N, Pacher P, Feihl F, Waeber B, Liaudet L. Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism. Am J Phys Heart Circ Phys. 2010;299(2):H492&#x2013;H501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2930391</ArticleId><ArticleId IdType="pubmed">20525873</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinsky MR, Rico P. Cardiac contractility is not depressed in early canine endotoxic shock. Am J Respir Crit Care Med. 2000;161(4 Pt 1):1087&#x2013;1093. doi: 10.1164/ajrccm.161.4.9904033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.161.4.9904033</ArticleId><ArticleId IdType="pubmed">10764295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Santonocito C, Panarello G, Arcadipane A. The role of speckle tracking echocardiography for prognostication in patients with severe sepsis or septic shock. Crit Care. 2016;20:284. doi: 10.1186/s13054-016-1451-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1451-x</ArticleId><ArticleId IdType="pmc">PMC5018936</ArticleId><ArticleId IdType="pubmed">27616201</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymanski C, Levy F, Tribouilloy C. Should LVEF be replaced by global longitudinal strain? Heart. 2014;100(21):1655&#x2013;1656. doi: 10.1136/heartjnl-2014-306186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2014-306186</ArticleId><ArticleId IdType="pubmed">25049321</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieillard Baron A, Schmitt JM, Beauchet A, Augarde R, Prin S, Page B, Jardin F. Early preload adaptation in septic shock? A transesophageal echocardiographic study. Anesthesiology. 2001;94(3):400&#x2013;406. doi: 10.1097/00000542-200103000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000542-200103000-00007</ArticleId><ArticleId IdType="pubmed">11374597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jardin F, Fourme T, Page B, Loubieres Y, Vieillard-Baron A, Beauchet A, Bourdarias JP. Persistent preload defect in severe sepsis despite fluid loading: a longitudinal echocardiographic study in patients with septic shock. Chest. 1999;116(5):1354&#x2013;1359. doi: 10.1378/chest.116.5.1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.116.5.1354</ArticleId><ArticleId IdType="pubmed">10559099</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu S, Frank LH, Fenton KE, Sable CA, Levy RJ, Berger JT. Two-dimensional speckle tracking imaging detects impaired myocardial performance in children with septic shock, not recognized by conventional echocardiography. Pediatr Crit Care Med. 2012;13(3):259&#x2013;264. doi: 10.1097/PCC.0b013e3182288445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3182288445</ArticleId><ArticleId IdType="pubmed">21760563</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YW, Tsai WC, Su CT, Lin CC, Chen JH. Evidence of left ventricular systolic dysfunction detected by automated function imaging in patients with heart failure and preserved left ventricular ejection fraction. J Card Fail. 2009;15(9):782&#x2013;789. doi: 10.1016/j.cardfail.2009.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardfail.2009.05.006</ArticleId><ArticleId IdType="pubmed">19879465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner A, Bijnens B, Hansen M, How OJ, Aarsaether E, Muller S, Sutherland GR, Myrmel T. Left ventricular size determines tissue Doppler-derived longitudinal strain and strain rate. Eur J Echocardiogr. 2009;10(2):271&#x2013;277. doi: 10.1093/ejechocard/jen230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jen230</ArticleId><ArticleId IdType="pubmed">18827033</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns AT, La Gerche A, D'Hooge J, MacIsaac AI, Prior DL. Left ventricular strain and strain rate: characterization of the effect of load in human subjects. Eur J Echocardiogr. 2010;11(3):283&#x2013;289. doi: 10.1093/ejechocard/jep214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jep214</ArticleId><ArticleId IdType="pubmed">20026455</ArticleId></ArticleIdList></Reference><Reference><Citation>Aissaoui N, Guerot E, Combes A, Delouche A, Chastre J, Leprince P, Leger P, Diehl JL, Fagon JY, Diebold B. Two-dimensional strain rate and Doppler tissue myocardial velocities: analysis by echocardiography of hemodynamic and functional changes of the failed left ventricle during different degrees of extracorporeal life support. J Am Soc Echocardiogr. 2012;25(6):632&#x2013;640. doi: 10.1016/j.echo.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2012.02.009</ArticleId><ArticleId IdType="pubmed">22421027</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi JO, Shin DH, Cho SW, Song YB, Kim JH, Kim YG, Lee SC, Park SW. Effect of preload on left ventricular longitudinal strain by 2D speckle tracking. Echocardiography (Mount Kisco, NY) 2008;25(8):873&#x2013;879. doi: 10.1111/j.1540-8175.2008.00707.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8175.2008.00707.x</ArticleId><ArticleId IdType="pubmed">18986415</ArticleId></ArticleIdList></Reference><Reference><Citation>Park HE, Chang SA, Kim HK, Shin DH, Kim JH, Seo MK, Kim YJ, Cho GY, Sohn DW, Oh BH, et al. Impact of loading condition on the 2D speckle tracking-derived left ventricular dyssynchrony index in nonischemic dilated cardiomyopathy. Circ Cardiovasc Imaging. 2010;3(3):272&#x2013;281. doi: 10.1161/CIRCIMAGING.109.890848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.109.890848</ArticleId><ArticleId IdType="pubmed">20190282</ArticleId></ArticleIdList></Reference><Reference><Citation>Nafati C, Gardette M, Leone M, Reydellet L, Blasco V, Lannelongue A, Sayagh F, Wiramus S, Antonini F, Albanese J, et al. Use of speckle-tracking strain in preload-dependent patients, need for cautious interpretation! Ann Intensive Care. 2018;8(1):29. doi: 10.1186/s13613-018-0376-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-018-0376-8</ArticleId><ArticleId IdType="pmc">PMC5821613</ArticleId><ArticleId IdType="pubmed">29468335</ArticleId></ArticleIdList></Reference><Reference><Citation>Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Reisner SA, Rakowski H, Bolotin G, Agmon Y. Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J. 2009;158(4):540&#x2013;545. doi: 10.1016/j.ahj.2009.07.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ahj.2009.07.008</ArticleId><ArticleId IdType="pubmed">19781412</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki S, Daimon M, Miyazaki T, Onishi Y, Koiso Y, Nishizaki Y, Ichikawa R, Chiang SJ, Makinae H, Suzuki H, et al. Global longitudinal strain in relation to the severity of aortic stenosis: a two-dimensional speckle-tracking study. Echocardiography (Mount Kisco, NY) 2011;28(7):703&#x2013;708. doi: 10.1111/j.1540-8175.2011.01419.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8175.2011.01419.x</ArticleId><ArticleId IdType="pubmed">21564277</ArticleId></ArticleIdList></Reference><Reference><Citation>Paonessa JR, Brennan T, Pimentel M, Steinhaus D, Feng M, Celi LA. Hyperdynamic left ventricular ejection fraction in the intensive care unit. Crit Care. 2015;19:288. doi: 10.1186/s13054-015-1012-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1012-8</ArticleId><ArticleId IdType="pmc">PMC4528812</ArticleId><ArticleId IdType="pubmed">26250903</ArticleId></ArticleIdList></Reference><Reference><Citation>Negishi K, Negishi T, Haluska BA, Hare JL, Plana JC, Marwick TH. Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging. 2014;15(3):324&#x2013;331. doi: 10.1093/ehjci/jet159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jet159</ArticleId><ArticleId IdType="pubmed">24057661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesbitt GC, Mankad S, Oh JK. Strain imaging in echocardiography: methods and clinical applications. Int J Cardiovasc Imaging. 2009;25(Suppl 1):9&#x2013;22. doi: 10.1007/s10554-008-9414-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-008-9414-1</ArticleId><ArticleId IdType="pubmed">19145475</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokke TM, Hasselberg NE, Smedsrud MK, Sarvari SI, Haugaa KH, Smiseth OA, Edvardsen T, Remme EW. Geometry as a confounder when assessing ventricular systolic function: comparison between ejection fraction and strain. J Am Coll Cardiol. 2017;70(8):942&#x2013;954. doi: 10.1016/j.jacc.2017.06.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.06.046</ArticleId><ArticleId IdType="pubmed">28818204</ArticleId></ArticleIdList></Reference><Reference><Citation>van Melle JP, van der Vleuten PA, Hummel YM, Nijveldt R, Tio RA, Voors AA, Zijlstra F. Predictive value of tissue Doppler imaging for left ventricular ejection fraction, remodelling, and infarct size after percutaneous coronary intervention for acute myocardial infarction. Eur J Echocardiogr. 2010;11(7):596&#x2013;601. doi: 10.1093/ejechocard/jeq023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ejechocard/jeq023</ArticleId><ArticleId IdType="pubmed">20211849</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer H, Caracciolo G, Abe H, Wilansky S, Carerj S, Gentile F, Nesser HJ, Khandheria B, Narula J, Sengupta PP. Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr. 2010;23(4):351&#x2013;369. doi: 10.1016/j.echo.2010.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2010.02.015</ArticleId><ArticleId IdType="pubmed">20362924</ArticleId></ArticleIdList></Reference><Reference><Citation>Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E, Stoylen A, Ihlen H, Lima JA, Smiseth OA, et al. Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol. 2006;47(4):789&#x2013;793. doi: 10.1016/j.jacc.2005.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2005.10.040</ArticleId><ArticleId IdType="pubmed">16487846</ArticleId></ArticleIdList></Reference><Reference><Citation>Buss SJ, Mereles D, Emami M, Korosoglou G, Riffel JH, Bertel D, Schonland SO, Hegenbart U, Katus HA, Hardt SE. Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus. Clin Res Cardiol. 2012;101(4):273&#x2013;280. doi: 10.1007/s00392-011-0389-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00392-011-0389-x</ArticleId><ArticleId IdType="pubmed">22139127</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Ting I, Huang AM, Slama M, McLean AS. Longitudinal wall fractional shortening: an M-mode index based on mitral annular plane systolic excursion (MAPSE) that correlates and predicts left ventricular longitudinal strain (LVLS) in intensive care patients. Crit Care. 2017;21(1):292. doi: 10.1186/s13054-017-1876-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-017-1876-x</ArticleId><ArticleId IdType="pmc">PMC5702151</ArticleId><ArticleId IdType="pubmed">29178915</ArticleId></ArticleIdList></Reference><Reference><Citation>Sander O, Welters ID, Foex P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med. 2005;33(1):81&#x2013;88. doi: 10.1097/01.CCM.0000150028.64264.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000150028.64264.14</ArticleId><ArticleId IdType="pubmed">15644652</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli A, Ertmer C, Westphal M, Rehberg S, Kampmeier T, Ligges S, Orecchioni A, D'Egidio A, D'Ippoliti F, Raffone C, et al. Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial. JAMA. 2013;310(16):1683&#x2013;1691. doi: 10.1001/jama.2013.278477.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.278477</ArticleId><ArticleId IdType="pubmed">24108526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanfilippo F, Santonocito C, Morelli A, Foex P. Beta-blocker use in severe sepsis and septic shock: a systematic review. Curr Med Res Opin. 2015;31(10):1817&#x2013;1825. doi: 10.1185/03007995.2015.1062357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1185/03007995.2015.1062357</ArticleId><ArticleId IdType="pubmed">26121122</ArticleId></ArticleIdList></Reference><Reference><Citation>Rushmer RF, Crystal DK. Changes in configuration of the ventricular chambers during the cardiac cycle. Circulation. 1951;4(2):211&#x2013;218. doi: 10.1161/01.CIR.4.2.211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.4.2.211</ArticleId><ArticleId IdType="pubmed">14859397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Hsiao JF, Maalouf JF, Ammash NM, McCully RB, Miller FA, Pellikka PA, et al. Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest. 2011;139(6):1299&#x2013;1309. doi: 10.1378/chest.10-2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-2015</ArticleId><ArticleId IdType="pubmed">21148241</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckberg G, Hoffman JI, Mahajan A, Saleh S, Coghlan C. Cardiac mechanics revisited: the relationship of cardiac architecture to ventricular function. Circulation. 2008;118(24):2571&#x2013;2587. doi: 10.1161/CIRCULATIONAHA.107.754424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.754424</ArticleId><ArticleId IdType="pubmed">19064692</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;nl&#xfc; S, Mirea O, Duchenne J, Pagourelias ED, B&#xe9;zy S, Thomas JD, Badano LP, Voigt J-U. Comparison of feasibility, accuracy, and reproducibility of layer-specific global longitudinal strain measurements among five different vendors: a report from the EACVI-ASE strain standardization task force. J Am Soc Echocardiogr. 2018;31(3):374&#x2013;380. doi: 10.1016/j.echo.2017.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2017.11.008</ArticleId><ArticleId IdType="pubmed">29246512</ArticleId></ArticleIdList></Reference><Reference><Citation>Yingchoncharoen T, Agarwal S, Popovic ZB, Marwick TH. Normal ranges of left ventricular strain: a meta-analysis. J Am Soc Echocardiogr. 2013;26(2):185&#x2013;191. doi: 10.1016/j.echo.2012.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2012.10.008</ArticleId><ArticleId IdType="pubmed">23218891</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmittinger CA, Dunser MW, Torgersen C, Luckner G, Lorenz I, Schmid S, Joannidis M, Moser P, Hasibeder WR, Halabi M, et al. Histologic pathologies of the myocardium in septic shock: a prospective observational study. Shock. 2013;39(4):329&#x2013;335. doi: 10.1097/SHK.0b013e318289376b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318289376b</ArticleId><ArticleId IdType="pubmed">23376953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang HY, Bassel-Duby R, Maass DL, Johnston WE, Horton JW, Tao W. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Phys Heart Circ Phys. 2007;292(5):H2408&#x2013;H2416.</Citation><ArticleIdList><ArticleId IdType="pubmed">17220181</ArticleId></ArticleIdList></Reference><Reference><Citation>Celes MR, Torres-Duenas D, Prado CM, Campos EC, Moreira JE, Cunha FQ, Rossi MA. Increased sarcolemmal permeability as an early event in experimental septic cardiomyopathy: a potential role for oxidative damage to lipids and proteins. Shock. 2010;33(3):322&#x2013;331. doi: 10.1097/SHK.0b013e3181b38ef6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181b38ef6</ArticleId><ArticleId IdType="pubmed">20160610</ArticleId></ArticleIdList></Reference><Reference><Citation>Supinski GS, Callahan LA. Hemin prevents cardiac and diaphragm mitochondrial dysfunction in sepsis. Free Radic Biol Med. 2006;40(1):127&#x2013;137. doi: 10.1016/j.freeradbiomed.2005.09.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.09.025</ArticleId><ArticleId IdType="pubmed">16337886</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang QS, Martinez B, Yao X, Maass DL, Ma L, Wolf SE, Minei JP. Sepsis-induced cardiac mitochondrial dysfunction involves altered mitochondrial-localization of tyrosine kinase Src and tyrosine phosphatase SHP2. PLoS One. 2012;7(8):e43424. doi: 10.1371/journal.pone.0043424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0043424</ArticleId><ArticleId IdType="pmc">PMC3428365</ArticleId><ArticleId IdType="pubmed">22952679</ArticleId></ArticleIdList></Reference><Reference><Citation>Ersboll M, Valeur N, Mogensen UM, Andersen MJ, Moller JE, Velazquez EJ, Hassager C, Sogaard P, Kober L. Prediction of all-cause mortality and heart failure admissions from global left ventricular longitudinal strain in patients with acute myocardial infarction and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2013;61(23):2365&#x2013;2373. doi: 10.1016/j.jacc.2013.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2013.02.061</ArticleId><ArticleId IdType="pubmed">23563128</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, Kane GC. Outcome prediction by quantitative right ventricular function assessment in 575 subjects evaluated for pulmonary hypertension. Circ Cardiovasc Imaging. 2013;6(5):711&#x2013;721. doi: 10.1161/CIRCIMAGING.113.000640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCIMAGING.113.000640</ArticleId><ArticleId IdType="pubmed">23811750</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30291379</PMID><DateCompleted><Year>2019</Year><Month>11</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>11</Issue><PubDate><Year>2018</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Early PREdiction of sepsis using leukocyte surface biomarkers: the ExPRES-sepsis cohort study.</ArticleTitle><Pagination><StartPage>1836</StartPage><EndPage>1848</EndPage><MedlinePgn>1836-1848</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-018-5389-0</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Reliable biomarkers for predicting subsequent sepsis among patients with suspected acute infection are lacking. In patients presenting to emergency departments (EDs) with suspected acute infection, we aimed to evaluate the reliability and discriminant ability of 47 leukocyte biomarkers as predictors of sepsis (Sequential Organ Failure Assessment score&#x2009;&#x2265;&#x2009;2 at 24&#xa0;h and/or 72&#xa0;h following ED presentation).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a multi-centre cohort study in four EDs and intensive care units (ICUs), we standardised flow-cytometric leukocyte biomarker measurement and compared patients with suspected acute infection (cohort-1) with two comparator cohorts: ICU patients with established sepsis (cohort-2), and ED patients without infection or systemic inflammation but requiring hospitalization (cohort-3).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Between January 2014 and February 2016, we recruited 272, 59 and 75 patients to cohorts 1, 2, and 3, respectively. Of 47 leukocyte biomarkers, 14 were non-reliable, and 17 did not discriminate between the three cohorts. Discriminant analyses for predicting sepsis within cohort-1 were undertaken for eight neutrophil (cluster of differentiation antigens (CD) CD15; CD24; CD35; CD64; CD312; CD11b; CD274; CD279), seven monocyte (CD35; CD64; CD312; CD11b; HLA-DR; CD274; CD279) and a CD8 T-lymphocyte biomarker (CD279). Individually, only higher neutrophil CD279 [OR 1.78 (95% CI 1.23-2.57); P&#x2009;=&#x2009;0.002], higher monocyte CD279 [1.32 (1.03-1.70); P&#x2009;=&#x2009;0.03], and lower monocyte HLA-DR [0.73 (0.55-0.97); P&#x2009;=&#x2009;0.03] expression were associated with subsequent sepsis. With logistic regression the optimum biomarker combination was increased neutrophil CD24 and neutrophil CD279, and reduced monocyte HLA-DR expression, but no combination had clinically relevant predictive validity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">From a large panel of leukocyte biomarkers, immunosuppression biomarkers were associated with subsequent sepsis in ED patients with suspected acute infection.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">NCT02188992.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shankar-Hari</LastName><ForeName>Manu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5338-2538</Identifier><AffiliationInfo><Affiliation>School of Immunology &amp; Microbial Sciences, Kings College, London, UK. manu.shankar-hari@kcl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guy's and St Thomas' NHS Foundation Trust, London, SE17EH, UK. manu.shankar-hari@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Datta</LastName><ForeName>Deepankar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Julie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Immunology &amp; Microbial Sciences, Kings College, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guy's and St Thomas' NHS Foundation Trust, London, SE17EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assi</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stephen</LastName><ForeName>Jacqueline</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weir</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rennie</LastName><ForeName>Jillian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bateman</LastName><ForeName>Anthony</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Critical Care &amp; Pain Medicine, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felton</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warner</LastName><ForeName>Noel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Judge</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keenan</LastName><ForeName>Jim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burpee</LastName><ForeName>Tony</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Alun K</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Guy's and St Thomas' NHS Foundation Trust, London, SE17EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lewis</LastName><ForeName>Sion M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Guy's and St Thomas' NHS Foundation Trust, London, SE17EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mare</LastName><ForeName>Tracey</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Guy's and St Thomas' NHS Foundation Trust, London, SE17EH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Alistair I</ForeName><Initials>AI</Initials><AffiliationInfo><Affiliation>Becton-Dickinson Bioscience, Franklin Lakes, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Emergency Department, Royal Victoria Infirmary, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulme</LastName><ForeName>Gillian</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Flow Cytometry Core Facility Laboratory, Faculty of Medical Sciences, Centre for Life, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimmick</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Flow Cytometry Core Facility Laboratory, Faculty of Medical Sciences, Centre for Life, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Alasdair</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Emergency Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rossi</LastName><ForeName>Adriano G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>A John</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conway Morris</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>University Division of Anesthesia, Department of Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Timothy S</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>MRC Centre for Inflammation Research, University of Edinburgh, 47 Little France Crescent, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Population Health Sciences, Usher Institute, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02188992</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>G0601481</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>EME/16/33/01</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G0901697</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>205214/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>Sepsis 2: 101193</GrantID><Agency>Innovate UK</Agency><Country/></Grant><Grant><GrantID>16/33/01</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CS-2016-16-011</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/K013386/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CS-2016-16-011</GrantID><Agency>Research Trainees Coordinating Centre</Agency><Country/></Grant><Grant><GrantID>WT 2055214/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006684">HLA-DR Antigens</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006684" MajorTopicYN="N">HLA-DR Antigens</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker, risk prediction</Keyword><Keyword MajorTopicYN="N">Cohort study</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>11</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30291379</ArticleId><ArticleId IdType="doi">10.1007/s00134-018-5389-0</ArticleId><ArticleId IdType="pii">10.1007/s00134-018-5389-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JCI Insight. 2018 Mar 8;3(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">29515037</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28886074</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>18</Day></DateCompleted><DateRevised><Year>2020</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2017</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Unique transcriptomic response to sepsis is observed among patients of different age groups.</ArticleTitle><Pagination><StartPage>e0184159</StartPage><MedlinePgn>e0184159</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0184159</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0184159</ELocationID><Abstract><AbstractText>Sepsis is a major cause of morbidity and mortality, especially at the extremes of age. To understand the human age-specific transcriptomic response to sepsis, a multi-cohort, pooled analysis was conducted on adults, children, infants, and neonates with and without sepsis. Nine public whole-blood gene expression datasets (636 patients) were employed. Age impacted the transcriptomic host response to sepsis. Gene expression from septic neonates and adults was more dissimilar whereas infants and children were more similar. Neonates showed reductions in inflammatory recognition and signaling pathways compared to all other age groups. Likewise, adults demonstrated decreased pathogen sensing, inflammation, and myeloid cell function, as compared to children. This may help to explain the increased incidence of sepsis-related organ failure and death in adults. The number of dysregulated genes in septic patients was proportional to age and significantly differed among septic adults, children, infants, and neonates. Overall, children manifested a greater transcriptomic intensity to sepsis as compared to the other age groups. The transcriptomic magnitude for adults and neonates was dramatically reduced as compared to children and infants. These findings suggest that the transcriptomic response to sepsis is age-dependent, and diagnostic and therapeutic efforts to identify and treat sepsis will have to consider age as an important variable.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Raymond</LastName><ForeName>Steven L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez</LastName><ForeName>Mar&#xed;a Cecilia</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baker</LastName><ForeName>Henry V</ForeName><Initials>HV</Initials><AffiliationInfo><Affiliation>Department of Molecular Genetics and Microbiology, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Shawn D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efron</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sweeney</LastName><ForeName>Timothy E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine; Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khatri</LastName><ForeName>Purvesh</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Biomedical Informatics Research, Department of Medicine, Stanford University School of Medicine; Stanford, California, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Immunity, Transplantation, and Infection, Stanford University; Stanford, California, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moldawer</LastName><ForeName>Lyle L</ForeName><Initials>LL</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wynn</LastName><ForeName>James L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0001-7052-4836</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathology, Immunology, and Laboratory Medicine, University of Florida College of Medicine; Gainesville, Florida, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K08 GM106143</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM113945</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI057229</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 AI117925</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI109662</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG028740</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM111152</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM097531</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM040586</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="Y">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>Drs. Sweeney and Khatri are co-founders of, and hold stock in, Inflammatix, Inc, which intends to market a transcriptomic diagnostic test for sepsis (sepsis meta score, SMS; Sci Transl Med. 2015;7(287):287ra271.). No funding was provided by Inflammatix for this project and the manuscript does not discuss, test, or endorse the SMS. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The other authors declare no conflicting or competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28886074</ArticleId><ArticleId IdType="pmc">PMC5590890</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0184159</ArticleId><ArticleId IdType="pii">PONE-D-17-15060</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis*. Crit Care Med. 2014;42(3):625&#x2013;31. Epub 2013/11/10. doi: 10.1097/CCM.0000000000000026 ; PubMed Central PMCID: PMCPMC4313930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000026</ArticleId><ArticleId IdType="pmc">PMC4313930</ArticleId><ArticleId IdType="pubmed">24201173</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS data brief. 2011;(62):1&#x2013;8. Epub 2011/12/07. .</Citation><ArticleIdList><ArticleId IdType="pubmed">22142805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermorvant-Duchemin E, Laborie S, Rabilloud M, Lapillonne A, Claris O. Outcome and prognostic factors in neonates with septic shock. Pediatr Crit Care Med. 2008;9(2):186&#x2013;91. Epub 2008/05/15. doi: 10.1097/PCC.0b013e31816689a8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e31816689a8</ArticleId><ArticleId IdType="pubmed">18477932</ArticleId></ArticleIdList></Reference><Reference><Citation>Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics. 1999;103(2):446&#x2013;51. Epub 1999/02/02. .</Citation><ArticleIdList><ArticleId IdType="pubmed">9925839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Wolkowiez M, Moran C, Benjamin DK, Cotten CM, Clark RH, Benjamin DK Jr., et al. Early and late onset sepsis in late preterm infants. The Pediatric infectious disease journal. 2009;28(12):1052&#x2013;6. Epub 2009/12/03. ; PubMed Central PMCID: PMCPMC2798577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2798577</ArticleId><ArticleId IdType="pubmed">19953725</ArticleId></ArticleIdList></Reference><Reference><Citation>Girard TD, Opal SM, Ely EW. Insights into severe sepsis in older patients: from epidemiology to evidence-based management. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2005;40(5):719&#x2013;27. Epub 2005/02/17. doi: 10.1086/427876 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/427876</ArticleId><ArticleId IdType="pubmed">15714419</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Mannino DM, Moss M. The effect of age on the development and outcome of adult sepsis. Critical care medicine. 2006;34(1):15&#x2013;21. Epub 2005/12/24. .</Citation><ArticleIdList><ArticleId IdType="pubmed">16374151</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll BJ, Hansen NI, Bell EF, Shankaran S, Laptook AR, Walsh MC, et al.
Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics. 2010;126(3):443&#x2013;56. Epub 2010/08/25. doi: 10.1542/peds.2009-2959 ; PubMed Central PMCID: PMCPMC2982806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2009-2959</ArticleId><ArticleId IdType="pmc">PMC2982806</ArticleId><ArticleId IdType="pubmed">20732945</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. American journal of respiratory and critical care medicine. 2003;167(5):695&#x2013;701. Epub 2002/11/16. doi: 10.1164/rccm.200207-682OC .</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200207-682OC</ArticleId><ArticleId IdType="pubmed">12433670</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Scumpia PO, Delano MJ, O'Malley KA, Ungaro R, Abouhamze A, et al.
Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock. 2007;28(6):675&#x2013;83. Epub 2007/07/11. doi: 10.1097/SHK.0b013e3180556d09 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3180556d09</ArticleId><ArticleId IdType="pubmed">17621256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, et al.
The influence of developmental age on the early transcriptomic response of children with septic shock. Mol Med. 2011;17(11&#x2013;12):1146&#x2013;56. Epub 2011/07/09. doi: 10.2119/molmed.2011.00169 ; PubMed Central PMCID: PMCPMC3321808.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2011.00169</ArticleId><ArticleId IdType="pmc">PMC3321808</ArticleId><ArticleId IdType="pubmed">21738952</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, Cuenca AG, et al.
Protective immunity and defects in the neonatal and elderly immune response to sepsis. J Immunol. 2014;192(7):3156&#x2013;65. Epub 2014/03/05. doi: 10.4049/jimmunol.1301726 ; PubMed Central PMCID: PMCPMC3967513.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301726</ArticleId><ArticleId IdType="pmc">PMC3967513</ArticleId><ArticleId IdType="pubmed">24591376</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Guthrie SO, Wong HR, Lahni P, Ungaro R, Lopez MC, et al.
Postnatal Age Is a Critical Determinant of the Neonatal Host Response to Sepsis. Mol Med. 2015;21:496&#x2013;504. Epub 2015/06/09. doi: 10.2119/molmed.2015.00064 ; PubMed Central PMCID: PMCPMC4607623.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2015.00064</ArticleId><ArticleId IdType="pmc">PMC4607623</ArticleId><ArticleId IdType="pubmed">26052715</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Wong HR, Khatri P. Robust classification of bacterial and viral infections via integrated host gene expression diagnostics. Sci Transl Med. 2016;8(346):346ra91 Epub 2016/07/08. doi: 10.1126/scitranslmed.aaf7165 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf7165</ArticleId><ArticleId IdType="pmc">PMC5348917</ArticleId><ArticleId IdType="pubmed">27384347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Khatri P. Benchmarking Sepsis Gene Expression Diagnostics Using Public Data. Critical care medicine. 2017;45(1):1&#x2013;10. Epub 2016/09/30. doi: 10.1097/CCM.0000000000002021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002021</ArticleId><ArticleId IdType="pmc">PMC5518756</ArticleId><ArticleId IdType="pubmed">27681387</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy A, Mondry A, Holmes CC, Altman DG. Key issues in conducting a meta-analysis of gene expression microarray datasets. PLoS medicine. 2008;5(9):e184 Epub 2008/09/05. doi: 10.1371/journal.pmed.0050184 ; PubMed Central PMCID: PMCPMC2528050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0050184</ArticleId><ArticleId IdType="pmc">PMC2528050</ArticleId><ArticleId IdType="pubmed">18767902</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon R. Microarray-based expression profiling and informatics. Curr Opin Biotechnol. 2008;19(1):26&#x2013;9. doi: 10.1016/j.copbio.2007.10.008 ; PubMed Central PMCID: PMCPMC2290821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2007.10.008</ArticleId><ArticleId IdType="pmc">PMC2290821</ArticleId><ArticleId IdType="pubmed">18053704</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon R. Analysis of DNA microarray expression data. Best Pract Res Clin Haematol. 2009;22(2):271&#x2013;82. doi: 10.1016/j.beha.2009.07.001 ; PubMed Central PMCID: PMCPMC2757654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2009.07.001</ArticleId><ArticleId IdType="pmc">PMC2757654</ArticleId><ArticleId IdType="pubmed">19698933</ArticleId></ArticleIdList></Reference><Reference><Citation>Tester AM, Cox JH, Connor AR, Starr AE, Dean RA, Puente XS, et al.
LPS responsiveness and neutrophil chemotaxis in vivo require PMN MMP-8 activity. PloS one. 2007;2(3):e312 Epub 2007/03/22. doi: 10.1371/journal.pone.0000312 ; PubMed Central PMCID: PMCPMC1819564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000312</ArticleId><ArticleId IdType="pmc">PMC1819564</ArticleId><ArticleId IdType="pubmed">17375198</ArticleId></ArticleIdList></Reference><Reference><Citation>Krause PJ, Herson VC, Boutin-Lebowitz J, Eisenfeld L, Block C, LoBello T, et al.
Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res. 1986;20(4):296&#x2013;300. Epub 1986/04/01. doi: 10.1203/00006450-198604000-00004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-198604000-00004</ArticleId><ArticleId IdType="pubmed">3703618</ArticleId></ArticleIdList></Reference><Reference><Citation>Bektas S, Goetze B, Speer CP. Decreased adherence, chemotaxis and phagocytic activities of neutrophils from preterm neonates. Acta paediatrica Scandinavica. 1990;79(11):1031&#x2013;8. Epub 1990/11/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">2267919</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CN, Moore M, Dimisko L, Alexander A, Ibrahim A, Hassell BA, et al.
Spontaneous neutrophil migration patterns during sepsis after major burns. PLoS One. 2014;9(12):e114509 Epub 2014/12/10. doi: 10.1371/journal.pone.0114509 ; PubMed Central PMCID: PMCPMC4260850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114509</ArticleId><ArticleId IdType="pmc">PMC4260850</ArticleId><ArticleId IdType="pubmed">25489947</ArticleId></ArticleIdList></Reference><Reference><Citation>Atkinson SJ, Varisco BM, Sandquist M, Daly MN, Klingbeil L, Kuethe JW, et al.
Matrix Metalloproteinase-8 Augments Bacterial Clearance in a Juvenile Sepsis Model. Molecular medicine (Cambridge, Mass). 2016;22 Epub 2016/08/11. doi: 10.2119/molmed.2016.00058 ; PubMed Central PMCID: PMCPMC5072408.</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2016.00058</ArticleId><ArticleId IdType="pmc">PMC5072408</ArticleId><ArticleId IdType="pubmed">27506554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacionales DC, Gentile LF, Vanzant E, Lopez MC, Cuenca A, Cuenca AG, et al.
Aged mice are unable to mount an effective myeloid response to sepsis. Journal of immunology (Baltimore, Md: 1950). 2014;192(2):612&#x2013;22. Epub 2013/12/18. doi: 10.4049/jimmunol.1302109 ; PubMed Central PMCID: PMCPMC3884685.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302109</ArticleId><ArticleId IdType="pmc">PMC3884685</ArticleId><ArticleId IdType="pubmed">24337739</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramchandran R, Mehta D, Vogel SM, Mirza MK, Kouklis P, Malik AB. Critical role of Cdc42 in mediating endothelial barrier protection in vivo. American journal of physiology Lung cellular and molecular physiology. 2008;295(2):L363&#x2013;9. Epub 2008/06/03. doi: 10.1152/ajplung.90241.2008 ; PubMed Central PMCID: PMCPMC2519844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.90241.2008</ArticleId><ArticleId IdType="pmc">PMC2519844</ArticleId><ArticleId IdType="pubmed">18515405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenca AG, Gentile LF, Lopez MC, Ungaro R, Liu H, Xiao W, et al.
Development of a genomic metric that can be rapidly used to predict clinical outcome in severely injured trauma patients. Critical care medicine. 2013;41(5):1175&#x2013;85. Epub 2013/02/08. doi: 10.1097/CCM.0b013e318277131c ; PubMed Central PMCID: PMCPMC3652285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318277131c</ArticleId><ArticleId IdType="pmc">PMC3652285</ArticleId><ArticleId IdType="pubmed">23388514</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CL, Dickinson P, Forster T, Craigon M, Ross A, Khondoker MR, et al.
Identification of a human neonatal immune-metabolic network associated with bacterial infection. Nature communications. 2014;5:4649 Epub 2014/08/15. doi: 10.1038/ncomms5649 ; PubMed Central PMCID: PMCPMC4143936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms5649</ArticleId><ArticleId IdType="pmc">PMC4143936</ArticleId><ArticleId IdType="pubmed">25120092</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahajan P, Kuppermann N, Mejias A, Suarez N, Chaussabel D, Casper TC, et al.
Association of RNA Biosignatures With Bacterial Infections in Febrile Infants Aged 60 Days or Younger. Jama. 2016;316(8):846&#x2013;57. Epub 2016/08/24. doi: 10.1001/jama.2016.9207 ; PubMed Central PMCID: PMCPMC5122927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.9207</ArticleId><ArticleId IdType="pmc">PMC5122927</ArticleId><ArticleId IdType="pubmed">27552618</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Shidham A, Wong HR, Khatri P. A comprehensive time-course-based multicohort analysis of sepsis and sterile inflammation reveals a robust diagnostic gene set. Sci Transl Med. 2015;7(287):287ra71 Epub 2015/05/15. doi: 10.1126/scitranslmed.aaa5993 ; PubMed Central PMCID: PMCPMC4734362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaa5993</ArticleId><ArticleId IdType="pmc">PMC4734362</ArticleId><ArticleId IdType="pubmed">25972003</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu N, Mora-Jensen H, Theilgaard-Monch K, Doornbos-van der Meer B, Huitema MG, Stegeman CA, et al.
Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177. PloS one. 2014;9(6):e99671 Epub 2014/06/14. doi: 10.1371/journal.pone.0099671 ; PubMed Central PMCID: PMCPMC4057222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0099671</ArticleId><ArticleId IdType="pmc">PMC4057222</ArticleId><ArticleId IdType="pubmed">24926686</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemmensen SN, Bohr CT, Rorvig S, Glenthoj A, Mora-Jensen H, Cramer EP, et al.
Olfactomedin 4 defines a subset of human neutrophils. Journal of leukocyte biology. 2012;91(3):495&#x2013;500. Epub 2011/12/22. doi: 10.1189/jlb.0811417 ; PubMed Central PMCID: PMCPMC3289394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0811417</ArticleId><ArticleId IdType="pmc">PMC3289394</ArticleId><ArticleId IdType="pubmed">22187488</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn JL, Wong HR, Shanley TP, Bizzarro MJ, Saiman L, Polin RA. Time for a neonatal-specific consensus definition for sepsis. Pediatric critical care medicine: a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2014;15(6):523&#x2013;8. Epub 2014/04/23. doi: 10.1097/pcc.0000000000000157 ; PubMed Central PMCID: PMCPMC4087075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/pcc.0000000000000157</ArticleId><ArticleId IdType="pmc">PMC4087075</ArticleId><ArticleId IdType="pubmed">24751791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang BM, McLean AS, Dawes IW, Huang SJ, Cowley MJ, Lin RC. Gene-expression profiling of gram-positive and gram-negative sepsis in critically ill patients. Critical care medicine. 2008;36(4):1125&#x2013;8. Epub 2008/04/02. doi: 10.1097/CCM.0b013e3181692c0b .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181692c0b</ArticleId><ArticleId IdType="pubmed">18379237</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Khatri P. Generalizable Biomarkers in Critical Care: Toward Precision Medicine. Critical care medicine. 2017;45(6):934&#x2013;9. Epub 2017/05/17. doi: 10.1097/CCM.0000000000002402 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002402</ArticleId><ArticleId IdType="pmc">PMC5800880</ArticleId><ArticleId IdType="pubmed">28509729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38674300</PMID><DateCompleted><Year>2024</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>19</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>The Predictive Factors Associated with In-Hospital Mortality of Melioidosis: A Cohort Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">654</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60040654</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: Melioidosis is an infectious disease caused by <i>Burkholderia pseudomallei</i>, and it has a wide range of clinical symptoms. It is endemic in tropical areas, including Southeast Asia. Despite the availability of effective treatment, the mortality rate is still high, especially in patients presenting with septic shock. The aim of this study was to determine and explore clinical characteristics, microbiology, treatment outcomes, and factors associated with in-hospital mortality which could predict prognosis and provide a guide for future treatment. <i>Materials and Methods</i>: The population in this retrospective cohort study included all 262 patients with a diagnosis of melioidosis who were hospitalized at Surin Hospital, Surin, Thailand, from April 2014 to March 2017. We included patients older than 15 years with a positive culture for <i>B. pseudomallei.</i> Data regarding the clinical characteristics, microbiology, and treatment outcomes of the patients were collected and analyzed. The patients were divided into two groups dependent on outcome, specifically non-survival and survival. Logistic regression was performed to determine the risk factors associated with in-hospital mortality. <i>Results</i>: Out of the 262 patients with melioidosis during the study period, 117 (44.7%) patients died. The mean age was 57.2 &#xb1; 14.4 years, and 193 (73.7%) patients were male. The most common comorbidity was diabetes (123, 46.9%), followed by chronic kidney disease (35, 13.4%) and chronic liver disease (31, 11.8%). Four risk factors were found to be associated with in-hospital mortality, including age (adjusted odds ratio (aOR) 1.04, 95%CI: 1.01-1.07), respiration rate (aOR 1.18, 95%CI: 1.06-1.32), abnormal chest X-ray finding (aOR 4.79, 95%CI: 1.98-11.59), and bicarbonate levels (CO<sub>2</sub>) (aOR 0.92, 95%CI: 0.85-0.99). <i>Conclusions</i>: Our study identified age, respiration rate, abnormal chest X-ray finding, and CO<sub>2</sub> levels are predictive factors associated with in-hospital mortality in melioidosis patients. Physicians should be aware of these factors, have access to aggressive treatment options, and closely monitor patients with these risk factors.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chayangsu</LastName><ForeName>Sunee</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5563-9501</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Surin Hospital, Surin 32000, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suankratay</LastName><ForeName>Chusana</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Faculty of Medicine, The King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantraworasin</LastName><ForeName>Apichat</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7913-2799</Identifier><AffiliationInfo><Affiliation>Clinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Clinical Epidemiology and Clinical Statistic, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khorana</LastName><ForeName>Jiraporn</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-9023-0923</Identifier><AffiliationInfo><Affiliation>Clinical Surgical Research Center, Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Clinical Epidemiology and Clinical Statistic, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Surgery, Department of Surgery, Faculty of Medicine, Chiang Mai University Hospital, Chiang Mai 50200, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008554" MajorTopicYN="Y">Melioidosis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N" Type="Geographic">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016957" MajorTopicYN="Y">Burkholderia pseudomallei</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Burkholderia pseudomallei</Keyword><Keyword MajorTopicYN="N">melioidosis</Keyword><Keyword MajorTopicYN="N">mortality rate</Keyword><Keyword MajorTopicYN="N">outcome</Keyword><Keyword MajorTopicYN="N">predictive factors</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>9</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>27</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38674300</ArticleId><ArticleId IdType="pmc">PMC11052379</ArticleId><ArticleId IdType="doi">10.3390/medicina60040654</ArticleId><ArticleId IdType="pii">medicina60040654</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Whitmore A.S., Krishnaswami C.S. An Account of the Discovery of a Hitherto un Described Infective Disease Occurring among the Population of Rangoon. Indian Med. Gaz. 1912;47:262&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5168169</ArticleId><ArticleId IdType="pubmed">29005374</ArticleId></ArticleIdList></Reference><Reference><Citation>Molyneux D.H., Savioli L., Engels D. Neglected tropical diseases: Progress towards addressing the chronic pandemic. Lancet. 2017;389:312&#x2013;325. doi: 10.1016/S0140-6736(16)30171-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)30171-4</ArticleId><ArticleId IdType="pubmed">27639954</ArticleId></ArticleIdList></Reference><Reference><Citation>Limmathurotsakul D., Wongratanacheewin S., Day N.P., Teerawattanasook N., Chaowagul W., Chaisuksant S., Chetchotisakd P., Peacock S.J., Wongsuvan G. Increasing incidence of human melioidosis in northeast Thailand. Am. J. Trop. Med. Hyg. 2010;82:1113&#x2013;1117. doi: 10.4269/ajtmh.2010.10-0038.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2010.10-0038</ArticleId><ArticleId IdType="pmc">PMC2877420</ArticleId><ArticleId IdType="pubmed">20519609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinjoy S., Hantrakun V., Kongyu S., Kaewrakmuk J., Wangrangsimakul T., Jitsuronk S., Saengchun W., Bhengsri S., Akarachotpong T., Thamthitiwat S., et al. Melioidosis in Thailand: Present and Future. Trop. Med. Infect. Dis. 2018;3:38. doi: 10.3390/tropicalmed3020038.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed3020038</ArticleId><ArticleId IdType="pmc">PMC5928800</ArticleId><ArticleId IdType="pubmed">29725623</ArticleId></ArticleIdList></Reference><Reference><Citation>Domthong P., Chaisuksant S., Sawanyawisuth K. What clinical factors are associated with mortality in septicemic melioidosis? A report from an endemic area. J. Infect. Dev. Ctries. 2016;10:404&#x2013;409. doi: 10.3855/jidc.6455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3855/jidc.6455</ArticleId><ArticleId IdType="pubmed">27131004</ArticleId></ArticleIdList></Reference><Reference><Citation>Churuangsuk C., Chusri S., Hortiwakul T., Charernmak B., Silpapojakul K. Characteristics, clinical outcomes and factors influencing mortality of patients with melioidosis in southern Thailand: A 10-year retrospective study. Asian Pac. J. Trop. Med. 2016;9:256&#x2013;260. doi: 10.1016/j.apjtm.2016.01.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2016.01.034</ArticleId><ArticleId IdType="pubmed">26972397</ArticleId></ArticleIdList></Reference><Reference><Citation>Zornitzki L., Anuk L., Frydman S., Morag-Koren N., Zahler D., Freund O., Biran R., Liron Y., Tau L., Tchebiner J.Z., et al. Rate and predictors of blood culture positivity after antibiotic administration: A prospective single-center study. Infection. 2023;52:483&#x2013;490. doi: 10.1007/s15010-023-02105-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02105-9</ArticleId><ArticleId IdType="pubmed">37884696</ArticleId></ArticleIdList></Reference><Reference><Citation>Limmathurotsakul D., Peacock S.J. Melioidosis: A clinical overview. Br. Med. Bull. 2011;99:125&#x2013;139. doi: 10.1093/bmb/ldr007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bmb/ldr007</ArticleId><ArticleId IdType="pubmed">21558159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhengsri S., Peruski L.F., Baggett H.C., Tanwisaid K., Jorakate P., Kaewpan A., Salika P., Naorat S., Dejsirilert S., Chantra S., et al. Incidence of bacteremic melioidosis in eastern and northeastern Thailand. Am. J. Trop. Med. Hyg. 2011;85:117&#x2013;120. doi: 10.4269/ajtmh.2011.11-0070.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2011.11-0070</ArticleId><ArticleId IdType="pmc">PMC3122354</ArticleId><ArticleId IdType="pubmed">21734135</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhengsri S., Chierakul W., Tisayaticom K., Thamthitiwat S., Chantra S., Tanwisaid K., Baggett H.C., Lertiendumrong J., Kaewkungwal J. Economic burden of bacteremic melioidosis in eastern and northeastern, Thailand. Am. J. Trop. Med. Hyg. 2013;89:369&#x2013;373. doi: 10.4269/ajtmh.13-0148.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.13-0148</ArticleId><ArticleId IdType="pmc">PMC3741263</ArticleId><ArticleId IdType="pubmed">23798583</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod C., Morris P.S., Bauert P.A., Kilburn C.J., Ward L.M., Baird R.W., Currie B.J. Clinical presentation and medical management of melioidosis in children: A 24-Year Prospective study in the Northern Territory of Australia and review of the literature. Clin. Infect. Dis. 2015;60:21&#x2013;26. doi: 10.1093/cid/ciu733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciu733</ArticleId><ArticleId IdType="pubmed">25228703</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsley P.V., Leader M., Nagodawithana N.S., Tipre M., Sathiakumar N. Melioidosis in Malaysia: A Review of Case Reports. PLoS Neglected Trop. Dis. 2016;10:e0005182. doi: 10.1371/journal.pntd.0005182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005182</ArticleId><ArticleId IdType="pmc">PMC5179056</ArticleId><ArticleId IdType="pubmed">28005910</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie B.J., Jacups S.P., Cheng A.C., Fisher D.A., Anstey N.M., Huffam S.E., Krause V.L. Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop. Med. Int. Health. 2004;9:1167&#x2013;1174. doi: 10.1111/j.1365-3156.2004.01328.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2004.01328.x</ArticleId><ArticleId IdType="pubmed">15548312</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan M.R.A., Pani S.P., Peng N.P., Voralu K., Vijayalakshmi N., Mehanderkar R., Aziz N.A., Michael E. Incidence, risk factors and clinical epidemiology of melioidosis: A complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia. BMC Infect. Dis. 2010;10:302. doi: 10.1186/1471-2334-10-302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-10-302</ArticleId><ArticleId IdType="pmc">PMC2975659</ArticleId><ArticleId IdType="pubmed">20964837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang L., Harris P.N., Seiler R.L., Ooi P.L., Cutter J., Goh K.T., Cook A.R., Fisher D., Chai L.Y.A. Melioidosis, Singapore, 2003&#x2013;2014. Emerg. Infect. Dis. 2018;24:140&#x2013;143. doi: 10.3201/eid2401.161449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2401.161449</ArticleId><ArticleId IdType="pmc">PMC5749452</ArticleId><ArticleId IdType="pubmed">29260679</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J.D., Smith S., Binotto E., McBride W.J., Currie B.J., Hanson J. The epidemiology and clinical features of melioidosis in Far North Queensland: Implications for patient management. PLoS Neglected Trop. Dis. 2017;11:e0005411. doi: 10.1371/journal.pntd.0005411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005411</ArticleId><ArticleId IdType="pmc">PMC5363997</ArticleId><ArticleId IdType="pubmed">28264029</ArticleId></ArticleIdList></Reference><Reference><Citation>Mardhiah K., Wan-Arfah N., Naing N.N., Hassan M.R.A., Chan H.K. The Cox model of predicting mortality among melioidosis patients in Northern Malaysia: A retrospective study. Medicine. 2021;100:E26160. doi: 10.1097/MD.0000000000026160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000026160</ArticleId><ArticleId IdType="pmc">PMC8238369</ArticleId><ArticleId IdType="pubmed">34160382</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw T., Tellapragada C., Kamath A., Eshwara V.K., Mukhopadhyay C. Implications of environmental and pathogen-specific determinants on clinical presentations and disease outcome in melioidosis patients. PLoS Neglected Trop. Dis. 2019;13:e0007312. doi: 10.1371/journal.pntd.0007312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0007312</ArticleId><ArticleId IdType="pmc">PMC6538188</ArticleId><ArticleId IdType="pubmed">31091290</ArticleId></ArticleIdList></Reference><Reference><Citation>Currie B.J. Melioidosis: An important cause of pneumonia in residents of and travellers returned from endemic regions. Eur. Respir. J. 2003;22:542&#x2013;550. doi: 10.1183/09031936.03.00006203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.03.00006203</ArticleId><ArticleId IdType="pubmed">14516149</ArticleId></ArticleIdList></Reference><Reference><Citation>Meumann E.M., Cheng A.C., Ward L., Currie B.J. Clinical features and epidemiology of melioidosis pneumonia: Results from a 21-year study and review of the literature. Clin. Infect. Dis. 2012;54:362&#x2013;369. doi: 10.1093/cid/cir808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cir808</ArticleId><ArticleId IdType="pmc">PMC3258273</ArticleId><ArticleId IdType="pubmed">22057702</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby P., Smith S., Ward L., Hanson J., Currie B.J. Clinical utility of platelet count as a prognostic marker for melioidosis. Am. J. Trop. Med. Hyg. 2019;100:1085&#x2013;1087. doi: 10.4269/ajtmh.18-0698.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.18-0698</ArticleId><ArticleId IdType="pmc">PMC6493933</ArticleId><ArticleId IdType="pubmed">30887945</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31709860</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2374-4243</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>2</Issue><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Infectious diseases (London, England)</Title><ISOAbbreviation>Infect Dis (Lond)</ISOAbbreviation></Journal><ArticleTitle><i>Capnocytophaga canimorsus</i> - a potent pathogen in immunocompetent humans - systematic review and retrospective observational study of case reports.</ArticleTitle><Pagination><StartPage>65</StartPage><EndPage>74</EndPage><MedlinePgn>65-74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/23744235.2019.1687933</ELocationID><Abstract><AbstractText><b>Purpose:</b> Severe and fatal <i>Capnocytophaga canimorsus</i> infection has been described in immunocompromised patients. Data of <i>C. canimorsus</i> infection in immunocompetent and risk factors of severe courses are missing. Our aims were to describe the epidemiology of <i>C. canimorsus</i> infection and to identify potential risk factors of sepsis and fatal outcome.<b>Methods:</b> Observational study and systematic review of all cases reported in immunocompetent subjects between 2002 and 2019.<b>Results:</b> A total of 128 cases of <i>C. canimorsus</i> infection in immunocompetent individuals were reported. Male gender comprised 74.2%, the median age was 58&#xa0;years and 47.7% were admitted with sepsis. Case-fatality rate was 29.7% and especially high in septic patients (55.7%). Transmission by bite (OR = 2.37, 95% CI: 1.05-6.52) and incubation time &#x2264;3&#xa0;d (OR = 7.98; 95% CI: 2.33-27.34) were identified as risk factors of sepsis on admission, and early wound cleansing as protective (OR = 0.42; 95% CI: 0.14-0.96). Sepsis (OR = 23.67; 95% CI: 2.85-197.89) and septic shock (OR = 45.50; 95% CI: 3.08-676.55) were risk factors of fatal outcome, whereas early wound cleansing (OR = 0.05; 95% CI: 0.01-0.72), initial penicillin therapy with beta-lactamase inhibitors (OR = 0.48; 95% CI: 0.16-0.92) and surgical removal of infectious focus (OR = 0.38; 95% CI: 0.06-0.95) were protective factors.<b>Conclusions:</b> Immunocompetent patients with <i>C. canimorsus</i> infection frequently develop sepsis. A shorter incubation period in cases of sepsis might be related to higher infectious dose. Fatal outcome may be prevented by early wound cleansing, initial use of penicillins in combination with beta-lactamase inhibitors and surgical removal of an infectious focus.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mader</LastName><ForeName>Naomi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rotes Kreuz Krankenhaus, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xfc;hrs</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rotes Kreuz Krankenhaus, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langenbeck</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Intensive Care Medicine, Rotes Kreuz Krankenhaus, Bremen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herget-Rosenthal</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine, Rotes Kreuz Krankenhaus, Bremen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Infect Dis (Lond)</MedlineTA><NlmUniqueID>101650235</NlmUniqueID><ISSNLinking>2374-4243</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001733" MajorTopicYN="N">Bites and Stings</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002206" MajorTopicYN="Y">Capnocytophaga</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016905" MajorTopicYN="Y">Gram-Negative Bacterial Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Capnocytophaga canimorsus</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">prevention</Keyword><Keyword MajorTopicYN="N">risk factor</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31709860</ArticleId><ArticleId IdType="doi">10.1080/23744235.2019.1687933</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25946168</PMID><DateCompleted><Year>2016</Year><Month>04</Month><Day>25</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>5</Issue><PubDate><Year>2015</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies.</ArticleTitle><Pagination><StartPage>e0125827</StartPage><MedlinePgn>e0125827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0125827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0125827</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Several reports suggest that implementation of the Surviving Sepsis Campaign (SSC) guidelines is associated with mortality reduction in sepsis. However, adherence to the guideline-based resuscitation and management sepsis bundles is still poor.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To perform a systematic review of studies evaluating the impact of performance improvement programs on compliance with Surviving Sepsis Campaign (SSC) guideline-based bundles and/or mortality.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Medline (PubMed), Scopus and Intercollegiate Studies Institute Web of Knowledge databases from 2004 (first publication of the SSC guidelines) to October 2014.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Studies on adult patients with sepsis, severe sepsis or septic shock that evaluated changes in compliance to individual/combined bundle targets and/or mortality following the implementation of performance improvement programs. Interventions may consist of educational programs, process changes or both.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Data from the included studies were extracted independently by two authors. Unadjusted binary data were collected in order to calculate odds ratios (OR) for compliance to individual/combined bundle targets. Adjusted (if available) or unadjusted data of mortality were collected. Random-effects models were used for the data synthesis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty observational studies were selected. Despite high inconsistency across studies, performance improvement programs were associated with increased compliance with the complete 6-hour bundle (OR = 4.12 [95% confidence interval 2.95-5.76], I(2) = 87.72%, k = 25, N = 50,081) and the complete 24-hour bundle (OR = 2.57 [1.74-3.77], I(2) = 85.22%, k = 11, N = 45,846) and with a reduction in mortality (OR = 0.66 [0.61-0.72], I(2) = 87.93%, k = 48, N = 434,447). Funnel plots showed asymmetry.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Performance improvement programs are associated with increased adherence to resuscitation and management sepsis bundles and with reduced mortality in patients with sepsis, severe sepsis or septic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Damiani</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donati</LastName><ForeName>Abele</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Serafini</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rinaldi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adrario</LastName><ForeName>Erica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelaia</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Anesthesia and Intensive Care Unit, Department of Biomedical Sciences and Public Health, Universit&#xe0; Politecnica delle Marche, Via Tronto 10, 60126 Torrette di Ancona, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busani</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Modena University Hospital, L.go del Pozzo 71, 41100 Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>05</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="Y">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2015</Year><Month>5</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25946168</ArticleId><ArticleId IdType="pmc">PMC4422717</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0125827</ArticleId><ArticleId IdType="pii">PONE-D-14-50776</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. 2014; 5: 4&#x2013;11. 10.4161/viru.27372</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.27372</ArticleId><ArticleId IdType="pmc">PMC3916382</ArticleId><ArticleId IdType="pubmed">24335434</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend SR, Schorr C, Levy MM, Dellinger RP.Reducing mortality in severe sepsis: The Surviving Sepsis Campaign. Clin Chest Med. 2008; 29: 721&#x2013;733. 10.1016/j.ccm.2008.06.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2008.06.011</ArticleId><ArticleId IdType="pubmed">18954706</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for the Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 2013; 41: 580&#x2013;637. 10.1097/CCM.0b013e31827e83af</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Pronovost PJ, Dellinger RP, Townsend S, Resar RK, Clemmer TP, et al. Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med. 2004; 32: S595&#x2013;S597.</Citation><ArticleIdList><ArticleId IdType="pubmed">15542969</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital-mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005; 9: R764&#x2013;R770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414020</ArticleId><ArticleId IdType="pubmed">16356225</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Zanten ARH, Brinkman S, Arbous MS, Abu-Hanna A, Levy MM, de Keizer NF; Netherlands Patient Safety Agency Sepsis Expert Group. Guideline bundles adherence and mortality in severe sepsis and septic shock. Crit Care Med. 2014; 42: 1890&#x2013;1898. 10.1097/CCM.0000000000000297</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000297</ArticleId><ArticleId IdType="pubmed">24670937</ArticleId></ArticleIdList></Reference><Reference><Citation>Djurkovic S, Baracaldo JC, Guerra JA, Sartorius J, Haupt MT. A survey of clinicians addressing the approach to the management of severe sepsis and septic shock in the United States. J Crit Care. 2010; 25: 658.e1&#x2013;658.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20646900</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010; 36: 222&#x2013;231. 10.1007/s00134-009-1738-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1738-3</ArticleId><ArticleId IdType="pmc">PMC2826633</ArticleId><ArticleId IdType="pubmed">20069275</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliano KK, Lecardo M, Staul LA. Impact of Protocol Watch on compliance with the Surviving Sepsis Campaign. Am J Crit Care. 2011; 20: 330&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">21724635</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg GM, Vasquez DG, Hale LDS, Nyberg SM, Moran DA. Evaluation of process variations in noncompliance in implementation of evidence-based sepsis care. J Healthc Qual. 2013; 35: 60&#x2013;69. 10.1111/j.1945-1474.2011.00168.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1945-1474.2011.00168.x</ArticleId><ArticleId IdType="pubmed">22093135</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS sepsis definitions conference. Crit Care Med. 2003; 31: 1250&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med. 2004; 30: 536&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">14997291</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998; 52:377&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1756728</ArticleId><ArticleId IdType="pubmed">9764259</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester, UK: John Wiley and Sons, Ltd; 2009.</Citation></Reference><Reference><Citation>Lipsey MW, Wilson DB, eds. Practical Meta-Analysis. Vol 49 Thousand Oaks, CA: Sage; 2001.</Citation></Reference><Reference><Citation>Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ. 2003; 327: 557&#x2013;560.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC192859</ArticleId><ArticleId IdType="pubmed">12958120</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001; 54: 1046&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pubmed">11576817</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond CM, Djogovic D, Villa-Roel C, Bullard MJ, Meurer DP, Rowe BH. Pilot study comparing sepsis management with and without electronic clinical practice guidelines in an academic emergency department. J Emerg Med. 2013; 44: 698&#x2013;708. 10.1016/j.jemermed.2012.08.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.08.025</ArticleId><ArticleId IdType="pubmed">23137959</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon CM, Holthaus CV, Zubrow MT, Posa P, Gunaga S, Kella V, et al. The GENESIS Project (GENeralized Early Sepsis Intervention Strategies): a multicenter quality improvement collaborative. J Intensive Care Med. 2012; 10.1177/0885066612453025</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066612453025</ArticleId><ArticleId IdType="pubmed">22902347</ArticleId></ArticleIdList></Reference><Reference><Citation>Capuzzo M, Rambaldi M, Pinelli G, Campesato M, Pigna A, Zanello M, et al. Hospital staff education on severe sepsis/septic shock and hospital mortality: an original hypothesis. BMC Anesthesiology. 2012; 12: 28 10.1186/1471-2253-12-28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-12-28</ArticleId><ArticleId IdType="pmc">PMC3524041</ArticleId><ArticleId IdType="pubmed">23167611</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ortega A, Suberviola B, Garcia-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: Results of a three-year follow-up quasi-experimental study. Crit Care Med. 2010; 38: 1036&#x2013;1043. 10.1097/CCM.0b013e3181d455b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181d455b6</ArticleId><ArticleId IdType="pubmed">20154597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Chang SC, Pu C, Tang GJ. The impact of nationwide education program on clinical practice in sepsis care and mortality of severe sepsis: a population-based study in Taiwan. PLoS ONE. 2013; 8: e77414 10.1371/journal.pone.0077414</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0077414</ArticleId><ArticleId IdType="pmc">PMC3790748</ArticleId><ArticleId IdType="pubmed">24124616</ArticleId></ArticleIdList></Reference><Reference><Citation>De Miguel-Yanes JM, Munoz-Gonzalez J, Andueza-Lillo JA, Moyano-Villaseca B, Gonzalez-Ramallo VJ, Bustamante-Fermosel A. Implementation of a bundle of actions to improve adherence to the Surviving Sepsis Campaign guidelines at the ED. Am J Emerg Med. 2009; 27: 668&#x2013;674. 10.1016/j.ajem.2008.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2008.05.010</ArticleId><ArticleId IdType="pubmed">19751623</ArticleId></ArticleIdList></Reference><Reference><Citation>El Solh AA, Akinnusi ME, Alsawalha LN, Pineda LA. Outcome in septic shock in older adults after implementation of the sepsis &#x201c;bundle&#x201d;. JAGS. 2008; 56: 272&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">18047494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Levy MM, Blanco J, Gonzalez-Dias G, Garnacho-Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008; 299: 2294&#x2013;2303. 10.1001/jama.299.19.2294</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.299.19.2294</ArticleId><ArticleId IdType="pubmed">18492971</ArticleId></ArticleIdList></Reference><Reference><Citation>Francis M, Rich T, Williamson T, Peterson D. Effect of an emergency department sepsis protocol on time to antibiotics in severe sepsis. CJEM. 2010; 12: 303&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">20650022</ArticleId></ArticleIdList></Reference><Reference><Citation>Girardis M, Rinaldi L, Donno L, Marietta M, Codeluppi M, Marchegiano P, et al. Effects on management and outcome of severe sepsis and septic shock patients admitted to the intensive care unit after implementation of a sepsis program: a pilot study. Crit Care. 2009; 13: R143 10.1186/cc8029</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8029</ArticleId><ArticleId IdType="pmc">PMC2784353</ArticleId><ArticleId IdType="pubmed">19728879</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurnani PK, Patel GP, Crank CW, Vais D, Lateef O, Akimov S, et al. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: a single-center, before-and-after study. Clinical Therapeutics. 2010; 32: 1285&#x2013;1293. 10.1016/j.clinthera.2010.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2010.07.003</ArticleId><ArticleId IdType="pubmed">20678676</ArticleId></ArticleIdList></Reference><Reference><Citation>Heppner HJ, Singler K, Kwetkat A, Popp S, Esslinger AS, Bahrmann P, et al. Do clinical guidelines improve management of sepsis in critically ill elderly patients? A before-and-after study of the implementation of a sepsis protocol. Wien Klin Wochenschr. 2012; 124: 692&#x2013;698. 10.1007/s00508-012-0229-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00508-012-0229-7</ArticleId><ArticleId IdType="pubmed">22948390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoo WES, Muehlberg K, Ferraro RG, Jumaoas MC. Successes and lessons learned implementing the sepsis bundle. J Healthc Qual. 2009; 31: 9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">19753803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob ST, Banura P, Baeten JM, Moore CC, Meya D, Nakiyingi L, et al. The impact of early monitored management on survival in hospitalized adult Ugandan patients with severe sepsis: a prospective intervention study. Crit Care Med. 2012; 40: 2050&#x2013;2058. 10.1097/CCM.0b013e31824e65d7</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31824e65d7</ArticleId><ArticleId IdType="pmc">PMC3378757</ArticleId><ArticleId IdType="pubmed">22564958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeon K, Shin TG, Sim MS, Suh GY, Lim SY, Song HG, et al. Improvements in compliance with resuscitation bundles and achievement of end points after an educational program on the management of severe sepsis and septic shock. SHOCK. 2012; 37: 463&#x2013;467. 10.1097/SHK.0b013e31824c31d1</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31824c31d1</ArticleId><ArticleId IdType="pubmed">22301605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Troyer JL, Kline JA. Cost-effectiveness of an emergency department based early sepsis resuscitation protocol. Crit Care Med. 2011; 39: 1306&#x2013;1312. 10.1097/CCM.0b013e31821201be</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821201be</ArticleId><ArticleId IdType="pmc">PMC3102146</ArticleId><ArticleId IdType="pubmed">21336115</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan WS, Mahadevan M, Tan JH, Guo J, Ibrahim I. Feasibility of introduction and implementation of the Surviving Sepsis Campaign bundle in a Singapore Emergency Department. Eur J Emerg Med. 2013; 20: 344&#x2013;349. 10.1097/MEJ.0b013e32835c2ba3</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEJ.0b013e32835c2ba3</ArticleId><ArticleId IdType="pubmed">23211272</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguna-P&#xe9;rez A, Chilet-Rosell E, Delgado Lacosta M, Alvarez-Dardet C, Uris Selles J, Munoz-Mendoza CL. Clinical pathway intervention compliance and effectiveness when used in the treatment of patients with severe sepsis and septic shock at an Intensive Care Unit in Spain. Rev Lat Am Enfermagem. 2012; 20: 635&#x2013;643.</Citation><ArticleIdList><ArticleId IdType="pubmed">22990147</ArticleId></ArticleIdList></Reference><Reference><Citation>LaRosa JA, Ahmad N, Feinberg M, Shah M, DiBrienza R, Studer S. The use of an early alert system to improve compliance with sepsis bundles and to assess impact on mortality. Crit Care Res Pract. 2012; 2012: 980369 10.1155/2012/980369</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/980369</ArticleId><ArticleId IdType="pmc">PMC3296210</ArticleId><ArticleId IdType="pubmed">22461981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefrant JY, Muller L, Raillard A, Jung B, Beaudroit L, Favier L, et al. Reduction of the severe sepsis or septic shock associated mortality by reinforcement of the recommendations bundle: a multicenter study. Ann Fr Anesth Reanim. 2010; 29: 621&#x2013;628. 10.1016/j.annfar.2010.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annfar.2010.04.007</ArticleId><ArticleId IdType="pubmed">20634026</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Rhodes A, Phillips GS, Townsend SR, Schorr CA, Beale R, et al. Surviving Sepsis Campaign: Association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. 2014; 43: 3&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">25275252</ArticleId></ArticleIdList></Reference><Reference><Citation>MacRedmond R, Hollohan K, Stenstrom R, Nebre R, Jaswal D, Dodek P. Introduction of a comprehensive management protocol for severe sepsis is associated with sustained improvements in timeliness of care and survival. Qual Saf Health Care. 2010; 19: e46 10.1136/qshc.2009.033407</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2009.033407</ArticleId><ArticleId IdType="pubmed">20671074</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinley BA, Moore LJ, Sucher JF, Todd SR, Turner KL, Valdivia A, et al. Computer protocol facilitates evidence-based Care of sepsis in the surgical intensive care unit. J Trauma. 2011; 70: 1153&#x2013;1167. 10.1097/TA.0b013e31821598e9</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31821598e9</ArticleId><ArticleId IdType="pubmed">21610430</ArticleId></ArticleIdList></Reference><Reference><Citation>Memon JI, Rehmani RS, Alaithan AM, El Gammal A, Lone TM, Ghorab K, et al. Impact of 6-hour sepsis resuscitation bundle compliance on hospital mortality in a Saudi hospital. Crit Care Res Pract. 2012; 2012: 273268 10.1155/2012/273268</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/273268</ArticleId><ArticleId IdType="pmc">PMC3469084</ArticleId><ArticleId IdType="pubmed">23082248</ArticleId></ArticleIdList></Reference><Reference><Citation>Micek ST, Roubinian N, Heuring T, Bode M, Williams J, Harrison C, et al. Before&#x2014;after study of a standardized hospital order set for the management of septic shock. Crit Care Med. 2006; 34: 2707&#x2013;2713.</Citation><ArticleIdList><ArticleId IdType="pubmed">16943733</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RR 3rd, Dong L, Nelson NC, Brown SM, Kuttler KG, Probst DR, et al. Multicenter implementation of a severe sepsis and septic shock treatment bundle. Am J Respir Crit Care Med. 2013; 188: 77&#x2013;82. 10.1164/rccm.201212-2199OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201212-2199OC</ArticleId><ArticleId IdType="pmc">PMC3735248</ArticleId><ArticleId IdType="pubmed">23631750</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore LJ, Jones SL, Kreiner LA, McKinley B, Sucher JF, Todd SR, et al. Validation of a screening tool for the early identification of sepsis. J Trauma. 2009; 66: 1539&#x2013;1547. 10.1097/TA.0b013e3181a3ac4b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181a3ac4b</ArticleId><ArticleId IdType="pubmed">19509612</ArticleId></ArticleIdList></Reference><Reference><Citation>Na S, Kuan WS, Mahadevan M, Li CH, Shrikhande P, Ray S, et al. Implementation of early goal-directed therapy and the surviving sepsis campaign resuscitation bundle in Asia. Int J Qual Health Care. 2012; 24: 452&#x2013;462. 10.1093/intqhc/mzs045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzs045</ArticleId><ArticleId IdType="pubmed">22899698</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007; 35: 1105&#x2013;1112.</Citation><ArticleIdList><ArticleId IdType="pubmed">17334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HM, Schiavoni A, Scott KD, Tanios MA. Implementation of sepsis management guideline in a community-based teaching hospital&#x2014;can education be potentially beneficial for septic patients? Int J Clin Pract. 2012; 66: 705&#x2013;710. 10.1111/j.1742-1241.2012.02939.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-1241.2012.02939.x</ArticleId><ArticleId IdType="pubmed">22698423</ArticleId></ArticleIdList></Reference><Reference><Citation>Noritomi DT, Ranzani OT, Monteiro MB, Ferreira EM, Santos SR, Leibel F, et al. Implementation of a multifaceted sepsis education program in an emerging country setting: clinical outcomes and cost-effectiveness in a long-term follow-up study. Intensive Care Med. 2014; 40: 182&#x2013;191. 10.1007/s00134-013-3131-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-3131-5</ArticleId><ArticleId IdType="pubmed">24146003</ArticleId></ArticleIdList></Reference><Reference><Citation>Palleschi MT, Sirianni S, O&#x2019;Connor N, Dunn D, Hasenau SM. An interprofessional process to improve early identification and treatment for sepsis. J Healthc Qualt. 2014; 36: 23&#x2013;31. 10.1111/jhq.12006</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhq.12006</ArticleId><ArticleId IdType="pubmed">23534854</ArticleId></ArticleIdList></Reference><Reference><Citation>Patocka C, Turner J, Xue X, Segal E. Evaluation of an emergency department triage screening tool for suspected severe sepsis and septic shock. J Healthc Qual. 2014; 36: 52&#x2013;61. 10.1111/jhq.12055</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jhq.12055</ArticleId><ArticleId IdType="pubmed">24372995</ArticleId></ArticleIdList></Reference><Reference><Citation>Plambech MZ, Lurie AI, Ipsen HL. Initial, successful implementation of sepsis guidelines in an emergency department. Dan Med J. 2012; 59: A4545</Citation><ArticleIdList><ArticleId IdType="pubmed">23290285</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer AM, Deal EN, Labelle AJ, Witt C, Thiel SW, Heard K, et al. Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med. 2011; 39: 469&#x2013;473. 10.1097/CCM.0b013e318205df85</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318205df85</ArticleId><ArticleId IdType="pubmed">21169824</ArticleId></ArticleIdList></Reference><Reference><Citation>Schramm GE, Kashyap R, Mullon JJ, Gajic O, Afessa B. Septic shock: a multidisciplinary response team and weekly feedback to clinicians improve the process of care and mortality. Crit Care Med. 2011; 39: 252&#x2013;258. 10.1097/CCM.0b013e3181ffde08</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181ffde08</ArticleId><ArticleId IdType="pubmed">21057312</ArticleId></ArticleIdList></Reference><Reference><Citation>Seoane L, Winterbottom F, Nash T, Behrhorst J, Chacko E, Shum L, et al. Using quality improvement principles to improve the care of patients with severe sepsis and septic shock. Ochsner J. 2013; 13: 359&#x2013;366.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3776511</ArticleId><ArticleId IdType="pubmed">24052765</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, et al. Implementation and outcomes of the Multiple Urgent Sepsis Therapy (MUST) protocol. Crit Care Med. 2006; 34: 1025&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484890</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiramizo SC, Marra AR, Durao MS, Paes AT, Edmond MB, Pavao dos Santos OF. Decreasing mortality in severe sepsis and septic shock patients by implementing a sepsis bundle in a hospital setting. PLoS ONE. 2011; 6: e26790 10.1371/journal.pone.0026790</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026790</ArticleId><ArticleId IdType="pmc">PMC3207817</ArticleId><ArticleId IdType="pubmed">22073193</ArticleId></ArticleIdList></Reference><Reference><Citation>Silverman LZ, Hoesel M, Desai A, Posa P, Purtill MA, Brandt MM. It takes an intensivist. Am J Surg. 2011; 201: 320&#x2013;323. 10.1016/j.amjsurg.2010.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjsurg.2010.09.013</ArticleId><ArticleId IdType="pubmed">21367371</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweet DD, Jaswal D, Fu W, Bouchard M, Sivapalan P, Rachel J, et al. Effect of an emergency department sepsis protocol on the care of septic patients admitted to the intensive care unit. CJEM. 2010; 12: 414&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">20880435</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiel SW, Asghar MF, Micek ST, Reichlay RM, Doherty JA, Kollef MH. Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med. 2009; 37: 819&#x2013;824. 10.1097/CCM.0b013e318196206b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318196206b</ArticleId><ArticleId IdType="pubmed">19237883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tromp M, Hulscher M, Bleeker-Rovers CP, Peters L, van den Berg DTNA, Borm GF, et al. The role of nurses in the recognition and treatment of patients with sepsis in the emergency department: a prospective before-and-after intervention study. Int J Nurs Stud. 2010; 47: 1464&#x2013;1473. 10.1016/j.ijnurstu.2010.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijnurstu.2010.04.007</ArticleId><ArticleId IdType="pubmed">20494356</ArticleId></ArticleIdList></Reference><Reference><Citation>Vall&#xe9;e F, Fourcade O, Marty P, Sanchez P, Samii K, Genestal M. The hemodynamic &#x201c;target&#x201d;: a visual tool of goal-directed therapy for septic patients. Clinics. 2007; 62: 447&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">17823708</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Xiong Y, Schorr C, Dellinger RP. Impact of sepsis bundle strategy on outcomes of patients suffering from severe sepsis and septic shock in China. J Emerg Med. 2013; 44: 735&#x2013;741. 10.1016/j.jemermed.2012.07.084</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.07.084</ArticleId><ArticleId IdType="pubmed">23332802</ArticleId></ArticleIdList></Reference><Reference><Citation>Westphal GA, Koening A, Caldeira Filho M, Feij&#xf2; J, de Oliveira LT, Nunes F, et al. Reduced mortality after the implementation of a protocol for the early detection of severe sepsis. J Crit Care. 2011; 26: 76&#x2013;81. 10.1016/j.jcrc.2010.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2010.08.001</ArticleId><ArticleId IdType="pubmed">21036531</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012; 12: 919&#x2013;924. 10.1016/S1473-3099(12)70239-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(12)70239-6</ArticleId><ArticleId IdType="pubmed">23103175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang MJ, Shin TG, Jo IJ, Jeon K, Suh GY, Sim MS, et al. Factors influencing compliance with early resuscitation bundle in the management of severe sepsis and septic shock. Shock. 2012; 38: 474&#x2013;9. 10.1097/SHK.0b013e31826eea2b</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e31826eea2b</ArticleId><ArticleId IdType="pubmed">23042195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012; 366: 2055&#x2013;2064. 10.1056/NEJMoa1202290</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1202290</ArticleId><ArticleId IdType="pubmed">22616830</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014; 370: 1683&#x2013;1693. 10.1056/NEJMoa1401602</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014; 371: 1496&#x2013;506. 10.1056/NEJMoa1404380</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, Wiener RS, Walkey AJ. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014; 42: 2&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313930</ArticleId><ArticleId IdType="pubmed">24201173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014; 311: 1308&#x2013;1316. 10.1001/jama.2014.2637</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30806696</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3598</ISSN><JournalIssue CitedMedium="Internet"><Volume>321</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>26</Day></PubDate></JournalIssue><Title>JAMA</Title><ISOAbbreviation>JAMA</ISOAbbreviation></Journal><ArticleTitle>Association of Overlapping Surgery With Perioperative Outcomes.</ArticleTitle><Pagination><StartPage>762</StartPage><EndPage>772</EndPage><MedlinePgn>762-772</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1001/jama.2019.0711</ELocationID><Abstract><AbstractText Label="IMPORTANCE">Overlapping surgery, in which more than 1 procedure performed by the same primary surgeon is scheduled so the start time of one procedure overlaps with the end time of another, is of concern because of potential adverse outcomes.</AbstractText><AbstractText Label="OBJECTIVE">To determine the association between overlapping surgery and mortality, complications, and length of surgery.</AbstractText><AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">Retrospective cohort study of 66&#x202f;430 operations in patients aged 18 to 90 years undergoing total knee or hip arthroplasty; spine surgery; coronary artery bypass graft (CABG) surgery; and craniotomy at 8 centers between January 1, 2010, and May 31, 2018. Patients were followed up until discharge.</AbstractText><AbstractText Label="EXPOSURES">Overlapping surgery (&#x2265;2 operations performed by the same surgeon in which &#x2265;1 hour of 1 case, or the entire case for those &lt;1 hour, occurs when another procedure is being performed).</AbstractText><AbstractText Label="MAIN OUTCOMES AND MEASURES">Primary outcomes were in-hospital mortality or complications (major: thromboembolic event, pneumonia, sepsis, stroke, or myocardial infarction; minor: urinary tract or surgical site infection) and surgery duration.</AbstractText><AbstractText Label="RESULTS">The final sample consisted of 66&#x202f;430 operations (mean patient age, 59 [SD, 15] years; 31&#x202f;915 women [48%]), of which 8224 (12%) were overlapping. After adjusting for confounders, overlapping surgery was not associated with a significant difference in in-hospital mortality (1.9% overlapping vs 1.6% nonoverlapping; difference, 0.3% [95% CI, -0.2% to 0.7%]; P&#x2009;=&#x2009;.21) or risk of complications (12.8% overlapping vs 11.8% nonoverlapping; difference, 0.9% [95% CI, -0.1% to 1.9%]; P&#x2009;=&#x2009;.08). Overlapping surgery was associated with increased surgery length (204 vs 173 minutes; difference, 30 minutes [95% CI, 24 to 37 minutes]; P&#x2009;&lt;&#x2009;.001). Overlapping surgery was significantly associated with increased mortality and increased complications among patients having a high preoperative predicted risk for mortality and complications, compared with low-risk patients (mortality: 5.8% vs 4.7%; difference, 1.2% [95% CI, 0.1% to 2.2%]; P&#x2009;=&#x2009;.03; complications: 29.2% vs 27.0%; difference, 2.3% [95% CI, 0.3% to 4.3%]; P&#x2009;=&#x2009;.03).</AbstractText><AbstractText Label="CONCLUSIONS AND RELEVANCE">Among adults undergoing common operations, overlapping surgery was not significantly associated with differences in in-hospital mortality or postoperative complication rates but was significantly associated with increased surgery length. Further research is needed to understand the association of overlapping surgery with these outcomes among specific patient subgroups.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Eric</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mello</LastName><ForeName>Michelle M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Health Research and Policy, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanford Law School, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rishel</LastName><ForeName>Chris A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>Michelle T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kheterpal</LastName><ForeName>Sachin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saager</LastName><ForeName>Leif</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Michigan School of Medicine, Ann Arbor.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleisher</LastName><ForeName>Lee A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Critical Care, University of Pennsylvania Perelman School of Medicine, Philadelphia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damrose</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadry</LastName><ForeName>Bassam</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jena</LastName><ForeName>Anupam B</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Massachusetts General Hospital, Boston.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Bureau of Economic Research, Cambridge, Massachusetts.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Multicenter Perioperative Outcomes Group (MPOG)</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>DP5 OD017897</GrantID><Acronym>OD</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K08 DA042314</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JAMA</MedlineTA><NlmUniqueID>7501160</NlmUniqueID><ISSNLinking>0098-7484</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Feb 26;321(8):772. doi: 10.1001/jama.2019.1123.</RefSource><PMID Version="1">30806675</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2019 Aug;202(2):200. doi: 10.1097/JU.0000000000000322.</RefSource><PMID Version="1">31063071</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Jul 16;322(3):274. doi: 10.1001/jama.2019.6459.</RefSource><PMID Version="1">31310291</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>JAMA. 2019 Jul 16;322(3):274-275. doi: 10.1001/jama.2019.6463.</RefSource><PMID Version="1">31310292</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019644" MajorTopicYN="N">Arthroplasty, Replacement, Hip</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019645" MajorTopicYN="N">Arthroplasty, Replacement, Knee</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001026" MajorTopicYN="N">Coronary Artery Bypass</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003399" MajorTopicYN="N">Craniotomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="Y">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="Y">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of Interest Disclosures:</b> Dr Sun reported receiving consulting fees unrelated to this work from Egalet Inc and the Mission Lisa Foundation and receiving grants from the National Institute on Drug Abuse. Dr Jena reported receiving personal fees from Pfizer, Hill Rom Services, Bristol-Myers Squibb, Novartis, Amgen, Eli Lilly, Vertex Pharmaceuticals, AstraZeneca, Tesaro, Sanofi Aventis, Biogen, Precision Health Economics, and Analysis Group, outside the submitted work. No other authors reported disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>8</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30806696</ArticleId><ArticleId IdType="pmc">PMC6439866</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.0711</ArticleId><ArticleId IdType="pii">2725689</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mello MM, Livingston EH. The evolving story of overlapping surgery. JAMA. 2017;318(3):233-234. doi:10.1001/jama.2017.8061</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.8061</ArticleId><ArticleId IdType="pubmed">28658474</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons (ACS)  Statements on Principles. ACS website. https://www.facs.org/about-acs/statements/stonprin. Revised April 12, 2016. Accessed December 28, 2018.</Citation></Reference><Reference><Citation>Zhang AL. Overlapping surgery&#x2014;perspectives from the other side of the table. JAMA Intern Med. 2018;178(1):83-84. doi:10.1001/jamainternmed.2017.6846</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2017.6846</ArticleId><ArticleId IdType="pubmed">29204596</ArticleId></ArticleIdList></Reference><Reference><Citation>Mello MM, Livingston EH. Managing the risks of concurrent surgeries. JAMA. 2016;315(15):1563-1564. doi:10.1001/jama.2016.2305</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.2305</ArticleId><ArticleId IdType="pubmed">26985632</ArticleId></ArticleIdList></Reference><Reference><Citation>Abelson J, Saltzman J, Kowalczyk L, Allen S Clash in the name of care. Boston Globe October 25, 2015. 
https://apps.bostonglobe.com/spotlight/clash-in-the-name-of-care/story/. Accessed January 28, 2019.</Citation></Reference><Reference><Citation>Sweeny L, Rosenthal EL, Light T, et al. . Effect of overlapping operations on outcomes in microvascular reconstructions of the head and neck. Otolaryngol Head Neck Surg. 2017;156(4):627-635. doi:10.1177/0194599817691746</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599817691746</ArticleId><ArticleId IdType="pubmed">28322117</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan J, Brock AA, Karsy M, et al. . Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases. J Neurosurg. 2017;127(5):1096-1104. doi:10.3171/2016.8.JNS161226</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.8.JNS161226</ArticleId><ArticleId IdType="pubmed">27911238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyder JA, Habermann EB, Cima RR. Length of stay after overlapping surgery. JAMA. 2017;318(21):2140. doi:10.1001/jama.2017.16607</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.16607</ArticleId><ArticleId IdType="pubmed">29209713</ArticleId></ArticleIdList></Reference><Reference><Citation>Zygourakis CC, Keefe M, Lee J, et al. . Comparison of patient outcomes in 3725 overlapping vs 3633 nonoverlapping neurosurgical procedures using a single institution&#x2019;s clinical and administrative database. Neurosurgery. 2017;80(2):257-268. doi:10.1093/neuros/nyw067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyw067</ArticleId><ArticleId IdType="pubmed">28173545</ArticleId></ArticleIdList></Reference><Reference><Citation>Zygourakis CC, Lee J, Barba J, Lobo E, Lawton MT. Performing concurrent operations in academic vascular neurosurgery does not affect patient outcomes. J Neurosurg. 2017;127(5):1089-1095. doi:10.3171/2016.6.JNS16822</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2016.6.JNS16822</ArticleId><ArticleId IdType="pubmed">28106498</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JB, Ban KA, Berian JR, et al. . Concurrent bariatric operations and association with perioperative outcomes: registry based cohort study. BMJ. 2017;358:j4244. doi:10.1136/bmj.j4244</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4244</ArticleId><ArticleId IdType="pmc">PMC5613750</ArticleId><ArticleId IdType="pubmed">28951446</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JB, Berian JR, Ban KA, et al. . Outcomes of concurrent operations: results from the American College of Surgeons&#x2019; National Surgical Quality Improvement Program. Ann Surg. 2017;266(3):411-420. doi:10.1097/SLA.0000000000002358</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000002358</ArticleId><ArticleId IdType="pubmed">28650359</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard BM, Holland CM, Mehta CC, et al. . Association of overlapping surgery with patient outcomes in a large series of neurosurgical cases. JAMA Surg. 2018;153(4):313-321. doi:10.1001/jamasurg.2017.4502</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.4502</ArticleId><ArticleId IdType="pmc">PMC5933391</ArticleId><ArticleId IdType="pubmed">29117312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravi B, Pincus D, Wasserstein D, et al. . Association of overlapping surgery with increased risk for complications following hip surgery: a population-based, matched cohort study. JAMA Intern Med. 2018;178(1):75-83. doi:10.1001/jamainternmed.2017.6835</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2017.6835</ArticleId><ArticleId IdType="pmc">PMC5833499</ArticleId><ArticleId IdType="pubmed">29204597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl MA, Mooney MA, Sheehy JP, et al. . Overlapping surgeries are not associated with worse patient outcomes: retrospective multivariate analysis of 14&#x2009;872 neurosurgical cases performed at a single institution. Neurosurgery. 2018;83(1):53-59. doi:10.1093/neuros/nyx472</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/neuros/nyx472</ArticleId><ArticleId IdType="pubmed">29029182</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee LO, Bateman BT, Kheterpal S, et al. ; Multicenter Perioperative Outcomes Group Investigators . Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients: a report from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2017;126(6):1053-1063. doi:10.1097/ALN.0000000000001630</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001630</ArticleId><ArticleId IdType="pmc">PMC5445642</ArticleId><ArticleId IdType="pubmed">28383323</ArticleId></ArticleIdList></Reference><Reference><Citation>de Graaff JC, Pasma W, van Buuren S, et al. . Reference values for noninvasive blood pressure in children during anesthesia: a multicentered retrospective observational cohort study. Anesthesiology. 2016;125(5):904-913. doi:10.1097/ALN.0000000000001310</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001310</ArticleId><ArticleId IdType="pmc">PMC5259808</ArticleId><ArticleId IdType="pubmed">27606930</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman MF, Iyer N, Freudzon L, et al. ; Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee . Alarm limits for intraoperative drug infusions: a report from the Multicenter Perioperative Outcomes Group. Anesth Analg. 2017;125(4):1203-1211. doi:10.1213/ANE.0000000000002305</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000002305</ArticleId><ArticleId IdType="pubmed">28759483</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz MF, Brambrink AM, Healy DW, et al. . Success of intubation rescue techniques after failed direct laryngoscopy in adults: a retrospective comparative analysis from the Multicenter Perioperative Outcomes Group. Anesthesiology. 2016;125(4):656-666. doi:10.1097/ALN.0000000000001267</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001267</ArticleId><ArticleId IdType="pubmed">27483124</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman BT, Mhyre JM, Ehrenfeld J, et al. . The risk and outcomes of epidural hematomas after perioperative and obstetric epidural catheterization: a report from the Multicenter Perioperative Outcomes Group research consortium. Anesth Analg. 2013;116(6):1380-1385. doi:10.1213/ANE.0b013e318251daed</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0b013e318251daed</ArticleId><ArticleId IdType="pubmed">22504213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kheterpal S, Healy D, Aziz MF, et al. ; Multicenter Perioperative Outcomes Group (MPOG) Perioperative Clinical Research Committee . Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group. Anesthesiology. 2013;119(6):1360-1369. doi:10.1097/ALN.0000435832.39353.20</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000435832.39353.20</ArticleId><ArticleId IdType="pubmed">24071617</ArticleId></ArticleIdList></Reference><Reference><Citation>Bender SP, Paganelli WC, Gerety LP, et al. . Intraoperative lung-protective ventilation trends and practice patterns: a report from the Multicenter Perioperative Outcomes Group. Anesth Analg. 2015;121(5):1231-1239. doi:10.1213/ANE.0000000000000940</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000940</ArticleId><ArticleId IdType="pubmed">26332856</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson EH, Louie R, Zingmond DS, et al. . A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg. 2012;256(6):973-981. doi:10.1097/SLA.0b013e31826b4c4f</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31826b4c4f</ArticleId><ArticleId IdType="pubmed">23095667</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HH, Tejwani R, Zhang H, Wiener JS, Routh JC. Hospital surgical volume and associated postoperative complications of pediatric urological surgery in the United States. J Urol. 2015;194(2):506-511. doi:10.1016/j.juro.2015.01.096</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.juro.2015.01.096</ArticleId><ArticleId IdType="pmc">PMC4509970</ArticleId><ArticleId IdType="pubmed">25640646</ArticleId></ArticleIdList></Reference><Reference><Citation>Fokkema M, Hurks R, Curran T, et al. . The impact of the present on admission indicator on the accuracy of administrative data for carotid endarterectomy and stenting. J Vasc Surg. 2014;59(1):32-38. doi:10.1016/j.jvs.2013.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jvs.2013.07.006</ArticleId><ArticleId IdType="pmc">PMC3874266</ArticleId><ArticleId IdType="pubmed">23993438</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan H, Sundararajan V, Halfon P, et al. . Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-1139. doi:10.1097/01.mlr.0000182534.19832.83</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mlr.0000182534.19832.83</ArticleId><ArticleId IdType="pubmed">16224307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2010.</Citation></Reference><Reference><Citation>Angrist JD, Pischke J-S. Most Harmless Econometrics: An Empiricist&#x2019;s Companion. Princeton, NJ: Princeton University Press; 2009.</Citation></Reference><Reference><Citation>Tsugawa Y, Jena AB, Figueroa JF, Orav EJ, Blumenthal DM, Jha AK. Comparison of hospital mortality and readmission rates for medicare patients treated by male vs female physicians. JAMA Intern Med. 2017;177(2):206-213. doi:10.1001/jamainternmed.2016.7875</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2016.7875</ArticleId><ArticleId IdType="pmc">PMC5558155</ArticleId><ArticleId IdType="pubmed">27992617</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison PD. SAS Global Forum paper 360-2008: convergence failures in logistic regression. Semantic Scholar website. https://pdfs.semanticscholar.org/4f17/1322108dff719da6aa0d354d5f73c9c474de.pdf. 2008. Accessed January 28, 2019.</Citation></Reference><Reference><Citation>Greene W. The behaviour of the maximum likelihood estimator of limited dependent variable models in the presence of fixed effects. Econom J. 2004;7(1):98-119. doi:10.1111/j.1368-423X.2004.00123.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1368-423X.2004.00123.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun EC, Dutton RP, Jena AB. Comparison of anesthesia times and billing patterns by anesthesia practitioners. JAMA Netw Open. 2018;1(7):e184288. doi:10.1001/jamanetworkopen.2018.4288</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2018.4288</ArticleId><ArticleId IdType="pmc">PMC6324364</ArticleId><ArticleId IdType="pubmed">30646351</ArticleId></ArticleIdList></Reference><Reference><Citation>Childers CP, Maggard-Gibbons M. Understanding costs of care in the operating room. JAMA Surg. 2018;153(4):e176233. doi:10.1001/jamasurg.2017.6233</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamasurg.2017.6233</ArticleId><ArticleId IdType="pmc">PMC5875376</ArticleId><ArticleId IdType="pubmed">29490366</ArticleId></ArticleIdList></Reference><Reference><Citation>Macario A. What does one minute of operating room time cost? J Clin Anesth. 2010;22(4):233-236. doi:10.1016/j.jclinane.2010.02.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinane.2010.02.003</ArticleId><ArticleId IdType="pubmed">20522350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawthers AG, McCarthy EP, Davis RB, Peterson LE, Palmer RH, Iezzoni LI. Identification of in-hospital complications from claims data: is it valid? Med Care. 2000;38(8):785-795. doi:10.1097/00005650-200008000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-200008000-00003</ArticleId><ArticleId IdType="pubmed">10929991</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31276193</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial-Protocol and statistical analysis plan.</ArticleTitle><Pagination><StartPage>1262</StartPage><EndPage>1271</EndPage><MedlinePgn>1262-1271</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13434</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Intravenous (IV) fluid is a key intervention in the management of septic shock. The benefits and harms of lower versus higher fluid volumes are unknown and thus clinical equipoise exists. We describe the protocol and detailed statistical analysis plan for the conservative versus liberal approach to fluid therapy of septic shock in the Intensive Care (CLASSIC) trial. The aim of the CLASSIC trial is to assess benefits and harms of IV fluid restriction versus standard care in adult intensive care unit (ICU) patients with septic shock.</AbstractText><AbstractText Label="METHODS">CLASSIC trial is an investigator-initiated, international, randomised, stratified, and analyst-blinded trial. We will allocate 1554 adult patients with septic shock, who are planned to be or are admitted to an ICU, to IV fluid restriction versus standard care. The primary outcome is mortality at day 90. Secondary outcomes are serious adverse events (SAEs), serious adverse reactions (SARs), days alive at day 90 without life support, days alive and out of the hospital at day 90 and mortality, health-related quality of life (HRQoL), and cognitive function at 1 year. We will conduct the statistical analyses according to a pre-defined statistical analysis plan, including three interim analyses. For the primary analysis, we will use logistic regression adjusted for the stratification variables comparing the two interventions in the intention-to-treat (ITT) population.</AbstractText><AbstractText Label="DISCUSSION">The CLASSIC trial results will provide important evidence to guide clinicians' choice regarding the IV fluid therapy in adults with septic shock.</AbstractText><CopyrightInformation>&#xa9; 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>Tine Sylvest</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0002-1840-1596</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjortrup</LastName><ForeName>Peter Buhl</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-6378-9673</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre for Clinical Intervention Research, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Theis</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Public Health, Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kjaer</LastName><ForeName>Maj-Brit N&#xf8;rregaard</ForeName><Initials>MN</Initials><Identifier Source="ORCID">0000-0002-6536-0504</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jonsson</LastName><ForeName>Andreas Bender</ForeName><Initials>AB</Initials><Identifier Source="ORCID">0000-0003-4611-5543</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hjorts&#xf8;</LastName><ForeName>Carl Johan Steensen</ForeName><Initials>CJS</Initials><Identifier Source="ORCID">0000-0003-0413-9715</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronhjort</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Science and Education, Section of Anaesthesia and Intensive Care, Karolinska Institutet, S&#xf6;dersjukhuset, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Laake</LastName><ForeName>Jon Henrik</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0001-6157-5359</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesiology, Division of Emergencies and Critical Care, Rikshospitalet, Oslo University Hospital, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakob</LastName><ForeName>Stephan M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Bern (Inselspital), University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalos</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medical Intensive Care Unit, Interni klinika, Fakultni Nemocnice, Plzen, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pettil&#xe4;</LastName><ForeName>Ville</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-3921-4423</Identifier><AffiliationInfo><Affiliation>Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Horst</LastName><ForeName>Iwan</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3891-8522</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, University Medical Centre Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostermann</LastName><ForeName>Marlies</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St Thomas' Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouncey</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Intensive Care National Audit &amp; Research Centre (ICNARC), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rowan</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Intensive Care National Audit &amp; Research Centre (ICNARC), London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Humanitas Research Hospital, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrer</LastName><ForeName>Ricard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Hospital Vall d'Hebron, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malbrain</LastName><ForeName>Manu L N G</ForeName><Initials>MLNG</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Hospital Brussels (UZB), Jette, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel (VUB), Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahlstedt</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital Huddinge, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoffmann</LastName><ForeName>S&#xf8;ren</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Copenhagen University Hospital, Bispebjerg, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bestle</LastName><ForeName>Morten Heiberg</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Nordsjaellands Hospital, University Hospital of Copenhagen, Hiller&#xf8;d, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nebrich</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Zealand University Hospital, K&#xf8;ge, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Russell</LastName><ForeName>Lene</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-7352-8728</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Zealand University Hospital, Roskilde, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vang</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Randers Hospital, Randers, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Michael Lindhardt</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Herning Hospital, Herning, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xf8;lling</LastName><ForeName>Christoffer</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Viborg Hospital, Viborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Bodil Steen</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Aalborg University Hospital, Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Br&#xf8;chner</LastName><ForeName>Anne Craveiro</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Lillebaelt Hospital, Kolding, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4668-0123</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Research in Intensive Care (CRIC), Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Sofus Friis' foundation</Agency><Country>International</Country></Grant><Grant><GrantID>NNF17OC0028608</GrantID><Agency>Novo Nordisk Foundation</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002985" MajorTopicYN="Y">Clinical Protocols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064792" MajorTopicYN="N">Pragmatic Clinical Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31276193</ArticleId><ArticleId IdType="doi">10.1111/aas.13434</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43:304-377.</Citation></Reference><Reference><Citation>Kollind M, Wickbom F, Wilkman E, et al. Shock treatment in a cohort of Scandinavian intensive care units in 2014. Acta Anaesthesiol Scand. 2016;60:945-957.</Citation></Reference><Reference><Citation>Perner A, Cecconi M, Cronhjort M, et al. Expert statement for the management of hypovolemia in sepsis. Intensive Care Med. 2018;44:791-798.</Citation></Reference><Reference><Citation>Cecconi M, Hofer C, Teboul J-L, et al. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med. 2015;41:1529-1537.</Citation></Reference><Reference><Citation>Bihari S, Prakash S, Bersten AD. Post resusicitation fluid boluses in severe sepsis or septic shock. Shock. 2013;40:28-34.</Citation></Reference><Reference><Citation>Van Regenmortel N, Verbrugghe W, Roelant E, et al. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44:409-417.</Citation></Reference><Reference><Citation>Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259-265.</Citation></Reference><Reference><Citation>Acheampong A, Vincent J-L. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care. 2015;19:251.</Citation></Reference><Reference><Citation>Malbrain M, Marik PE, Witters I, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46:361-380.</Citation></Reference><Reference><Citation>Byrne L, Obonyo NG, Diab SD, et al. Unintended consequences: fluid resuscitation worsens shock in an ovine model of endotoxemia. Am J Respir Crit Care Med. 2018;198:1043-1054.</Citation></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695-1705.</Citation></Reference><Reference><Citation>Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med. 2011;364:2483-2495.</Citation></Reference><Reference><Citation>Heart N, Lung and BIARDS (ARDS) CTN, Wiedemann HP, et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354:2564-2575.</Citation></Reference><Reference><Citation>Andrews B, Muchemwa L, Kelly P, Lakhi S, Heimburger DC, Bernard GR. Simplified severe sepsis protocol: a randomized controlled trial of modified early goal-directed therapy in Zambia. Crit Care Med. 2014;42:2315-2324.</Citation></Reference><Reference><Citation>Andrews B, Semler MW, Muchemwa L, et al. Effect of an early resuscitation protocol on in-hospital mortality among adults with sepsis and hypotension: a randomized clinical trial. JAMA. 2017;318:1233-1240.</Citation></Reference><Reference><Citation>Meyhoff TS, M&#xf8;ller MH, Hjortrup PB, et al. Lower vs. higher fluid volumes in sepsis-protocol for a systematic review with meta-analysis. Acta Anaesthesiol Scand. 2017;61:942-951.</Citation></Reference><Reference><Citation>Chan A-W, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200-207.</Citation></Reference><Reference><Citation>WMA Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. WMA - The World Medical Association; 2013. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed May 2, 2019.</Citation></Reference><Reference><Citation>International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Integrated Addendum To ICH E6 (R1): Guideline for Good Clinical PracticeFed Regist. 1998;63(179):49583-49598.</Citation></Reference><Reference><Citation>G&#xf8;tzsche PC. Blinding during data analysis and writing of manuscripts. Control Clin Trials. 1996;17:285-290.</Citation></Reference><Reference><Citation>J&#xe4;rvinen TLN, Sihvonen R, Bhandari M, et al. Blinded interpretation of study results can feasibly and effectively diminish interpretation bias. J Clin Epidemiol. 2014;67:769-772.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801.</Citation></Reference><Reference><Citation>Wacharasint P, Nakada T, Boyd JH, Russell JA, Walley KR. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock. 2012;38:4-10.</Citation></Reference><Reference><Citation>Ait-Oufella H, Lemoinne S, Boelle PY, et al. Mottling score predicts survival in septic shock. Intensive Care Med. 2011;37:801-807.</Citation></Reference><Reference><Citation>Varpula M, Tallgren M, Saukkonen K, Voipio-Pulkki L-M, Pettil&#xe4; V. Hemodynamic variables related to outcome in septic shock. Intensive Care Med. 2005;31:1066-1071.</Citation></Reference><Reference><Citation>Kellum JA, Lameire N, KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17:204.</Citation></Reference><Reference><Citation>Janssen MF, Pickard AS, Golicki D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res. 2013;22:1717-1727.</Citation></Reference><Reference><Citation>Wong A, Nyenhuis D, Black SE, et al. Montreal cognitive assessment 5-minute protocol is a brief, valid, reliable, and feasible cognitive screen for telephone administration. Stroke. 2015;46:1059-1064.</Citation></Reference><Reference><Citation>Granholm A, Perner A, Krag M, et al. Development and internal validation of the Simplified Mortality Score for the Intensive Care Unit (SMS-ICU). Acta Anaesthesiol Scand. 2018;62:336-346.</Citation></Reference><Reference><Citation>Mallinckrodt CH, Lin Q, Molenberghs M. A structured framework for assessing sensitivity to missing data assumptions in longitudinal clinical trials. Pharm Stat. 2013;12:1-6.</Citation></Reference><Reference><Citation>Little R. A test of missing completely at random for multivariate data with missing values. J Am Stat Assoc. 1988;83:1198-1202.</Citation></Reference><Reference><Citation>Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7:147-177.</Citation></Reference><Reference><Citation>Vickers AJ, Altman DG. Statistics notes: missing outcomes in randomised trials. BMJ. 2013;346:f3438.</Citation></Reference><Reference><Citation>Kahan BC, Morris TP. Improper analysis of trials randomised using stratified blocks or minimisation. Stat Med. 2012;31:328-340.</Citation></Reference><Reference><Citation>Kaukonen K-M, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. 2014;311:1308-1316.</Citation></Reference><Reference><Citation>Ryg&#xe5;rd SL, Butler E, Granholm A, et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 2018;44:1003-1016.</Citation></Reference><Reference><Citation>Andersen PK, Skovgaard LT. Regression with Linear Predictors. Vol. 23. 1st ed. New York: Springer; 2010. Accessed April 23, 2019.</Citation></Reference><Reference><Citation>Jakobsen J, Tamborrino M, Winkel P, et al. Count data analysis in randomised. Clinical trials. J Biom Biostat. 2015;6.227 https://doi.org/10.4172/2155-6180.1000227</Citation></Reference><Reference><Citation>Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus ringer&#x2019;s acetate in severe sepsis. N Engl J Med. 2012;367:124-134.</Citation></Reference><Reference><Citation>Holst LB, Haase N, Wetterslev J, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014;371:1381-1391.</Citation></Reference><Reference><Citation>Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med. 2017;43:155-170.</Citation></Reference><Reference><Citation>Pettil&#xe4; V, Hjortrup PB, Jakob SM, et al. Control groups in recent septic shock trials: a systematic review. Intensive Care Med. 2016;42:1912-1921.</Citation></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:332.</Citation></Reference><Reference><Citation>Lan K, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70:659.</Citation></Reference><Reference><Citation>Self WH, Semler MW, Bellomo R, et al. Liberal versus restrictive intravenous fluid therapy for early septic shock: rationale for a randomized trial. Ann Emerg Med. 2018;72:457-466.</Citation></Reference><Reference><Citation>Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS). Full text view - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03434028. Accessed April 23, 2019.</Citation></Reference><Reference><Citation>Savovi&#x107; J, Jones HE, Altman DG, et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med. 2012;157:429-438.</Citation></Reference><Reference><Citation>Higgins JPT GS. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. Cochrane Collab. 2011. http://handbook-5-1.cochrane.org/.</Citation></Reference><Reference><Citation>Anthon CT, Granholm A, Perner A, Laake JH, M&#xf8;ller MH. No firm evidence that lack of blinding affects estimates of mortality in randomized clinical trials of intensive care interventions: a systematic review and meta-analysis. J Clin Epidemiol. 2018;100:71-81.</Citation></Reference><Reference><Citation>Savovic J, Turner RM, Mawdsley D, et al. Association between risk-of-bias assessments and results of randomized trials in cochrane reviews: The ROBES meta-epidemiologic study. Am J Epidemiol. 2018;187:1113-1122.</Citation></Reference><Reference><Citation>Asfar P, Meziani F, Hamel J-F, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583-1593.</Citation></Reference><Reference><Citation>Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals. www.equator-network.org. Accessed April 3, 2019.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19632847</PMID><DateCompleted><Year>2010</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2010</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2653</ISSN><JournalIssue CitedMedium="Internet"><Volume>17</Volume><Issue>1</Issue><PubDate><Year>2010</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia</Title><ISOAbbreviation>J Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Early detection of spinal sepsis.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>63</EndPage><MedlinePgn>59-63</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jocn.2009.02.005</ELocationID><Abstract><AbstractText>Spinal sepsis (spinal epidural or subdural abscess) is a rare condition, which, if not diagnosed rapidly, can lead to paralysis or death. It is difficult to diagnose in its early stages as the symptoms are as yet non-specific. We aimed to identify predisposing factors and presenting symptoms that might aid in the early diagnosis of spinal sepsis. A case-control study was performed with non-pediatric patients who had been diagnosed with spinal sepsis from 1998 to 2007. Our control group comprised 80 randomly selected patients who had presented to the emergency department with back pain. We identified 72 patients with spinal sepsis. A multivariate analysis revealed that obesity (adjusted odds ratio [aOR] 21.4; 95% confidence interval [CI] 1.8-257.5) and alcoholism (aOR 6.5; 95% CI 1.3-32.8) were important predictive factors for spinal sepsis. To our knowledge, this is the first report that associates obesity and alcoholism with spinal sepsis.</AbstractText><CopyrightInformation>Copyright (c) 2009 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Angsuwat</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kavar</LastName><ForeName>Bhadrakant</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>Adrian J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>07</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>J Clin Neurosci</MedlineTA><NlmUniqueID>9433352</NlmUniqueID><ISSNLinking>0967-5868</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000437" MajorTopicYN="N">Alcoholism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001416" MajorTopicYN="N">Back Pain</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="N">Bacterial Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015984" MajorTopicYN="N">Causality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003951" MajorTopicYN="N">Diagnostic Errors</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013354" MajorTopicYN="N">Empyema, Subdural</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="N">Epidural Abscess</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004824" MajorTopicYN="N">Epidural Space</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013122" MajorTopicYN="N">Spinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013355" MajorTopicYN="N">Subdural Space</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2009</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>7</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>7</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19632847</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2009.02.005</ArticleId><ArticleId IdType="pii">S0967-5868(09)00158-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34049590</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>28</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-6511</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>28</Day></PubDate></JournalIssue><Title>BMC pharmacology &amp; toxicology</Title><ISOAbbreviation>BMC Pharmacol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Association between phosphate disturbances and mortality among critically ill patients with sepsis or septic shock.</ArticleTitle><Pagination><StartPage>30</StartPage><MedlinePgn>30</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">30</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40360-021-00487-w</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The aim of this study is to examine the association of hypophosphatemia and hyperphosphatemia on the first day of ICU admission with mortality in septic critically ill patients.</AbstractText><AbstractText Label="METHODS">In this retrospective cohort study, all adult patients who were admitted to the&#xa0;medical-surgical ICUs between 2014 and 2017 with sepsis or septic shock were categorized as having hypophosphatemia, normophosphatemia and&#xa0;hyperphosphatemia based on day 1 serum phosphate values. We compared the clinical characteristics and outcomes between the three groups. We used multivariate analysis to examine the association of hypophosphatemia and hyperphosphatemia with these outcomes.</AbstractText><AbstractText Label="RESULTS">Of the 1422 patients enrolled in the study, 188 (13%) had hypophosphatemia, 865 (61%) normophosphatemia and 369 (26%) had hyperphosphatemia. The&#xa0;patients in the hyperphosphatemia group had significantly lower GCS, higher APACHE II scores, higher serum creatinine, increased use of vasopressors, and required more&#xa0;mechanical ventilation with lower PaO2/FiO2 ratio compared with the other two groups. In addition,&#xa0;the hyperphosphatemia group showed significantly higher ICU and hospital mortality in comparison with&#xa0;the other two groups.</AbstractText><AbstractText Label="CONCLUSION">Hyperphosphatemia and not hypophosphatemia on the first ICU admission day was associated with an increase in the ICU and hospital mortality in septic critically ill patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Harbi</LastName><ForeName>Shmeylan A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0003-4437-8761</Identifier><AffiliationInfo><Affiliation>Pharmaceutical Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Dorzi</LastName><ForeName>Hasan M</ForeName><Initials>HM</Initials><Identifier Source="ORCID">0000-0002-3772-8949</Identifier><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Meshari</LastName><ForeName>Albatool M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Saudi Food and Drug Authority, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamim</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Biostatistics and Bioinformatics, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine, American University of Beirut- Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdukahil</LastName><ForeName>Sheryl Ann I</ForeName><Initials>SAI</Initials><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadat</LastName><ForeName>Musharaf</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arabi</LastName><ForeName>Yaseen</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-5735-6241</Identifier><AffiliationInfo><Affiliation>King Abdullah International Medical Research Center, Riyadh, Saudi Arabia. arabi@ngha.med.sa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia. arabi@ngha.med.sa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. arabi@ngha.med.sa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Pharmacol Toxicol</MedlineTA><NlmUniqueID>101590449</NlmUniqueID><ISSNLinking>2050-6511</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010710">Phosphates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054559" MajorTopicYN="N">Hyperphosphatemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017674" MajorTopicYN="N">Hypophosphatemia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010710" MajorTopicYN="N">Phosphates</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012529" MajorTopicYN="N" Type="Geographic">Saudi Arabia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critically ill</Keyword><Keyword MajorTopicYN="N">Intensive care</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Phosphate</Keyword><Keyword MajorTopicYN="N">Saudi Arabia</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword></KeywordList><CoiStatement>The authors have no financial or non-financial competing interests to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>29</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>5</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34049590</ArticleId><ArticleId IdType="pmc">PMC8161900</ArticleId><ArticleId IdType="doi">10.1186/s40360-021-00487-w</ArticleId><ArticleId IdType="pii">10.1186/s40360-021-00487-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geerse DA, Bindels AJ, Kuiper MA, Roos AN, Spronk PE, Schultz MJ. Treatment of hypophosphatemia in the intensive care unit: a review. Crit Care. 2010;14(4):R147. doi: 10.1186/cc9215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9215</ArticleId><ArticleId IdType="pmc">PMC2945130</ArticleId><ArticleId IdType="pubmed">20682049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J, Kogan A, Sahar G, Lev S, Vidne B, Singer P. Hypophosphatemia following open heart surgery: incidence and consequences. Eur J Cardiothorac Surg. 2004;26(2):306&#x2013;310. doi: 10.1016/j.ejcts.2004.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcts.2004.03.004</ArticleId><ArticleId IdType="pubmed">15296888</ArticleId></ArticleIdList></Reference><Reference><Citation>Salem RR, Tray K. Hepatic resection-related hypophosphatemia is of renal origin as manifested by isolated hyperphosphaturia. Ann Surg. 2005;241(2):343&#x2013;348. doi: 10.1097/01.sla.0000152093.43468.c0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.sla.0000152093.43468.c0</ArticleId><ArticleId IdType="pmc">PMC1356921</ArticleId><ArticleId IdType="pubmed">15650646</ArticleId></ArticleIdList></Reference><Reference><Citation>Daily WH, Tonnesen AS, Allen SJ. Hypophosphatemia--incidence, etiology, and prevention in the trauma patient. Crit Care Med. 1990;18(11):1210&#x2013;1214. doi: 10.1097/00003246-199011000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199011000-00004</ArticleId><ArticleId IdType="pubmed">2225887</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger MM, Rothen C, Cavadini C, Chiolero RL. Exudative mineral losses after serious burns: a clue to the alterations of magnesium and phosphate metabolism. Am J Clin Nutr. 1997;65(5):1473&#x2013;1481. doi: 10.1093/ajcn/65.5.1473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcn/65.5.1473</ArticleId><ArticleId IdType="pubmed">9129479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010;8(2):72&#x2013;81. doi: 10.5049/EBP.2010.8.2.72.</Citation><ArticleIdList><ArticleId IdType="doi">10.5049/EBP.2010.8.2.72</ArticleId><ArticleId IdType="pmc">PMC3043756</ArticleId><ArticleId IdType="pubmed">21468200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008;336:1495&#x2013;1498. doi: 10.1136/bmj.a301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.a301</ArticleId><ArticleId IdType="pmc">PMC2440847</ArticleId><ArticleId IdType="pubmed">18583681</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor LR, Klein KL, Bethune JE. Hyperphosphatemia in lactic acidosis. N Engl J Med. 1977;297(13):707&#x2013;709. doi: 10.1056/NEJM197709292971307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM197709292971307</ArticleId><ArticleId IdType="pubmed">408683</ArticleId></ArticleIdList></Reference><Reference><Citation>Bech A, Blans M, Raaijmakers M, Mulkens C, Telting D, de Boer H. Hypophosphatemia on the intensive care unit: individualized phosphate replacement based on serum levels and distribution volume. J Crit Care. 2013;28(5):838&#x2013;843. doi: 10.1016/j.jcrc.2013.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2013.03.002</ArticleId><ArticleId IdType="pubmed">23642477</ArticleId></ArticleIdList></Reference><Reference><Citation>Barak V, Schwartz A, Kalickman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: the role of cytokines. Am J Med. 1998;104(1):40&#x2013;47. doi: 10.1016/S0002-9343(97)00275-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(97)00275-1</ArticleId><ArticleId IdType="pubmed">9528718</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S, Egi M, Schneider AG, Bellomo R, Hart GK, Hegarty C. Hypophosphatemia in critically ill patients. J Crit Care. 2013;28:536.e9&#x2013;536.19. doi: 10.1016/j.jcrc.2012.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2012.10.011</ArticleId><ArticleId IdType="pubmed">23265292</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotfain E, Schwartz A, Boniel A, Koyfman L, Boyko M, Kutz R, Klein M. Clinical outcome of critically ill patients with thrombocytopenia and hypophosphatemia in the early stage of sepsis. Anaesthesiol Intensive Ther. 2016;48(5):294&#x2013;299. doi: 10.5603/AIT.a2016.0053.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.a2016.0053</ArticleId><ArticleId IdType="pubmed">27834985</ArticleId></ArticleIdList></Reference><Reference><Citation>Borba MGS, Val FA, Sampaio VS, et al. Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study). medRxiv. 2020; 2020.04.07.20056424.</Citation></Reference><Reference><Citation>Haider DG, Lindner G, Wolzt M, Ahmad SS, Sauter T, Leichtle AB, Fiedler GM, Fuhrmann V, Exadaktylos AK. Hyperphosphatemia is an independent risk factor for mortality in critically ill patients: results from a cross-sectional study. PLoS One. 2015;10(8):e0133426. doi: 10.1371/journal.pone.0133426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0133426</ArticleId><ArticleId IdType="pmc">PMC4529074</ArticleId><ArticleId IdType="pubmed">26252874</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Li Z, Shi Y, et al. Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. Biomed Rep. 2016;4(4):413&#x2013;416. doi: 10.3892/br.2016.605.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2016.605</ArticleId><ArticleId IdType="pmc">PMC4812158</ArticleId><ArticleId IdType="pubmed">27073623</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsumrain MH, Jawad SA, Imran NB, Riar S, DeBari VA, Adelman M. Association of hypophosphatemia with failure-to-wean from mechanical ventilation. Ann Clin Lab Sci. 2010;40(2):144&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">20421625</ArticleId></ArticleIdList></Reference><Reference><Citation>Talakoub R, Bahrami M, Honarmand A, Abbasi S, Gerami H. The predicting ability of serum phosphorus to assess the duration of mechanical ventilation in critically ill patients. Adv Biomed Res. 2017;6(1):51. doi: 10.4103/2277-9175.205192.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2277-9175.205192</ArticleId><ArticleId IdType="pmc">PMC5433651</ArticleId><ArticleId IdType="pubmed">28620595</ArticleId></ArticleIdList></Reference><Reference><Citation>Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, Schold JD, Schreiber MJ. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011;26(11):3508&#x2013;3514. doi: 10.1093/ndt/gfr075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfr075</ArticleId><ArticleId IdType="pubmed">21382993</ArticleId></ArticleIdList></Reference><Reference><Citation>Ognibene A, Ciniglio R, Greifenstein A, et al. Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia. South Med J. 1994;87(1):65&#x2013;69. doi: 10.1097/00007611-199401000-00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-199401000-00014</ArticleId><ArticleId IdType="pubmed">7506845</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi Y, Alshimemeri A, Taher S. Weekend and weeknight admissions have the same outcome of weekday admissions to an intensive care unit with onsite intensivist coverage. Crit Care Med. 2006;34(3):605&#x2013;611. doi: 10.1097/01.CCM.0000203947.60552.DD.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000203947.60552.DD</ArticleId><ArticleId IdType="pubmed">16521254</ArticleId></ArticleIdList></Reference><Reference><Citation>Musher DM, Rueda AM, Kaka AS, Mapara SM. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007;45(2):158&#x2013;165. doi: 10.1086/518849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518849</ArticleId><ArticleId IdType="pubmed">17578773</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228. doi: 10.1007/s00134-012-2769-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818&#x2013;829. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Livingston BM, Mackenzie SJ, MacKirdy FN, Howie JC. Should the pre-sedation Glasgow coma scale value be used when calculating acute physiology and chronic health evaluation scores for sedated patients? Scottish Intensive Care Society Audit Group. Crit Care Med. 2000;28(2):389&#x2013;394. doi: 10.1097/00003246-200002000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200002000-00017</ArticleId><ArticleId IdType="pubmed">10708172</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A, Acute Kidney Injury Network Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31. doi: 10.1186/cc5713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Sin JCK, King L, Ballard E, Llewellyn S, Laupland KB, Tabah A. Hypophosphatemia and outcomes in ICU: a systematic review and meta-analysis. J Intensive Care Med. 2020. 10.1177/0885066620940274.</Citation><ArticleIdList><ArticleId IdType="pubmed">32783487</ArticleId></ArticleIdList></Reference><Reference><Citation>Vervloet MG, van Ballegooijen AJ. Prevention and treatment of hyperphosphatemia in chronic kidney disease. Kidney Int. 2018;93(5):1060&#x2013;1072. doi: 10.1016/j.kint.2017.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.11.036</ArticleId><ArticleId IdType="pubmed">29580635</ArticleId></ArticleIdList></Reference><Reference><Citation>Shor R, Halabe A, Rishver S, Tilis Y, Matas Z, Fux A, Boaz M, Weinstein J. Severe hypophosphatemia in sepsis as a mortality predictor. Ann Clin Lab Sci. 2006;36(1):67&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">16501239</ArticleId></ArticleIdList></Reference><Reference><Citation>Zazzo JF, Troche G, Ruel P, Maintenant J. High incidence of hypophosphatemia in surgical intensive care patients: efficacy of phosphorus therapy on myocardial function. Intensive Care Med. 1995;21(10):826&#x2013;831. doi: 10.1007/BF01700966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01700966</ArticleId><ArticleId IdType="pubmed">8557871</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim C, Tan HK, Kaushik M. Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events. Clin Kidney J. 2017;10(3):341&#x2013;347. doi: 10.1093/ckj/sfw120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ckj/sfw120</ArticleId><ArticleId IdType="pmc">PMC5466083</ArticleId><ArticleId IdType="pubmed">28616212</ArticleId></ArticleIdList></Reference><Reference><Citation>Boot R, Koekkoek K, van Zanten ARH. Refeeding syndrome: relevance for the critically ill patient. Curr Opin Crit Care. 2018;24(4):235&#x2013;240. doi: 10.1097/MCC.0000000000000514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000514</ArticleId><ArticleId IdType="pubmed">29901461</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfagna F, Del Vecchio L, Pontoriero G, Locatelli F. Current and potential treatment options for hyperphosphatemia. Expert Opin Drug Saf. 2018;17(6):597&#x2013;607. doi: 10.1080/14740338.2018.1476487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14740338.2018.1476487</ArticleId><ArticleId IdType="pubmed">29783873</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33687732</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2044</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anaesthesia</Title><ISOAbbreviation>Anaesthesia</ISOAbbreviation></Journal><ArticleTitle>A time-sensitive analysis of the prognostic utility of vasopressor dose in septic shock.</ArticleTitle><Pagination><StartPage>1358</StartPage><EndPage>1366</EndPage><MedlinePgn>1358-1366</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/anae.15453</ELocationID><Abstract><AbstractText>It is unclear whether the association between vasopressor dose and mortality is affected by duration of administration. We examined whether prognostication in septic shock is feasible through the use of daily median vasopressor doses. We undertook a single-centre retrospective cohort study. We included patients with a diagnosis of septic shock admitted to the intensive care unit at Queen Elizabeth Hospital, Birmingham, UK, between April 2016 and July 2019. The primary outcome measure was 90-day mortality. We defined vasopressor dose as the median norepinephrine equivalent dose (equivalent infusion rates of all vasopressors and inotropes) recorded for each day, for the first four&#xa0;days of septic shock. We divided patients into groups by vasopressor dose quintiles and calculated their 90-day mortality rate. We examined area under the receiver operator characteristic curves for prognostic ability. In total, 844 patients were admitted with septic shock and had a 90-day mortality of 43% (n&#xa0;=&#xa0;358). Over the first four&#xa0;days, median vasopressor dose decreased in 93% of survivors and increased in 56% of non-survivors. The mortality rate associated with a given vasopressor dose quintile increased on sequential days of septic shock. The area under the receiver operator characteristic curves of daily median vasopressor dose against mortality increased from day 1 to day 4 (0.67 vs. 0.86, p&#xa0;&lt;&#xa0;0.0001). By day 4, a median daily vasopressor dose &gt;&#xa0;0.05&#xa0;&#x3bc;g.kg<sup>-1</sup> .min<sup>-1</sup> had an 80% sensitivity and specificity for mortality. The prognostic utility of vasopressor dose improved considerably with shock duration. Prolonged administration of small vasopressor doses was associated with a high attributable mortality.</AbstractText><CopyrightInformation>&#xa9; 2021 Association of Anaesthetists.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chotalia</LastName><ForeName>M</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2206-1678</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matthews</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arunkumar</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Informatics, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bangash</LastName><ForeName>M N</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parekh</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Queen Elizabeth Hospital Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Anaesthesia</MedlineTA><NlmUniqueID>0370524</NlmUniqueID><ISSNLinking>0003-2409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">prognostication</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">vasopressor dose</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>9</Day><Hour>12</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33687732</ArticleId><ArticleId IdType="doi">10.1111/anae.15453</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Angus DC, Pereira CA, Silva E. Epidemiology of severe sepsis around the world. Endocrine Metabolic and Immune Disorders - Drug Targets 2006; 6: 207-12.</Citation></Reference><Reference><Citation>Kadri SS, Rhee C, Strich JR, et&#xa0;al. Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers using clinical data. Chest 2017; 151: 278-85.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et&#xa0;al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Journal of the American Medical Association 2016; 315: 801-10.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et&#xa0;al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine 2017; 43: 304-77.</Citation></Reference><Reference><Citation>Auchet T, Regnier MA, Girerd N, Levy B. Outcome of patients with septic shock and high-dose vasopressor therapy. Annals of Intensive Care 2017; 7: 43.</Citation></Reference><Reference><Citation>Sviri S, Hashoul J, Stav I, van Heerden PV. Does high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect? Journal of Critical Care 2014; 29: 157-60.</Citation></Reference><Reference><Citation>Morelli A, Ertmer C, Lange M, et&#xa0;al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: the DOBUPRESS study. British Journal of Anaesthesia 2008; 100: 494-503.</Citation></Reference><Reference><Citation>Martin C, Medam S, Antonini F, et&#xa0;al. Norepinephrine: not too much, too long. Shock 2015; 44: 305-9.</Citation></Reference><Reference><Citation>Leone M, Albanese J, Delmas A, Chaabane W, Garnier F, Martin C. Terlipressin in catecholamine-resistant septic shock patients. Shock 2004; 22: 314-9.</Citation></Reference><Reference><Citation>Katsaragakis S, Kapralou A, Theodorou D, et&#xa0;al. Refractory septic shock: efficacy and safety of very high doses of norepinephrine. Methods and Findings in Experimental and Clinical Pharmacology 2006; 28: 307-13.</Citation></Reference><Reference><Citation>Jenkins CR, Gomersall CD, Leung P, Joynt GM. Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study. Anaesthesia and Intensive Care 2009; 37: 286-9.</Citation></Reference><Reference><Citation>Dunser MW, Mayr AJ, Ulmer H, et&#xa0;al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 2003; 107: 2313-9.</Citation></Reference><Reference><Citation>Dopp-Zemel D, Groeneveld AB. High-dose norepinephrine treatment: determinants of mortality and futility in critically ill patients. American Journal of Critical Care 2013; 22: 22-32.</Citation></Reference><Reference><Citation>Brown SM, Lanspa MJ, Jones JP, et&#xa0;al. Survival after shock requiring high-dose vasopressor therapy. Chest 2013; 143: 664-71.</Citation></Reference><Reference><Citation>Brand DA, Patrick PA, Berger JT, et&#xa0;al. Intensity of vasopressor therapy for septic shock and the risk of in-hospital death. Journal of Pain and Symptom Management 2017; 53: 938-43.</Citation></Reference><Reference><Citation>Benbenishty J, Weissman C, Sprung CL, Brodsky-Israeli M, Weiss Y. Characteristics of patients receiving vasopressors. Heart and Lung 2011; 40: 247-52.</Citation></Reference><Reference><Citation>Kastrup M, Braun J, Kaffarnik M, et&#xa0;al. Catecholamine dosing and survival in adult intensive care unit patients. World Journal of Surgery 2013; 37: 766-73.</Citation></Reference><Reference><Citation>Viglianti EM, Bagshaw SM, Bellomo R, et&#xa0;al. Late vasopressor administration in patients in the ICU: a retrospective cohort study. Chest 2020; 158: 571-8.</Citation></Reference><Reference><Citation>Khanna A, English SW, Wang XS, et&#xa0;al. Angiotensin II for the treatment of vasodilatory shock. New England Journal of Medicine 2017; 377: 419-30.</Citation></Reference><Reference><Citation>Nguyen HB, Rivers EP, Knoblich BP, et&#xa0;al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Critical Care Medicine 2004; 32: 1637-42.</Citation></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Critical Care Medicine 1985; 13: 818-29.</Citation></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et&#xa0;al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Medicine 1996; 22: 707-10.</Citation></Reference><Reference><Citation>Glasheen WP, Cordier T, Gumpina R, Haugh G, Davis J, Renda A. Charlson Comorbidity Index: ICD-9 update and ICD-10 translation. American Health and Drug Benefits 2019; 12: 188-97.</Citation></Reference><Reference><Citation>Roila F, Lupattelli M, Sassi M, et&#xa0;al. Intra and interobserver variability in cancer patients' performance status assessed according to Karnofsky and ECOG scales. Annals of Oncology 1991; 2: 437-9.</Citation></Reference><Reference><Citation>Jentzer JC, Vallabhajosyula S, Khanna AK, Chawla LS, Busse LW, Kashani KB. Management of refractory vasodilatory shock. Chest 2018; 154: 416-26.</Citation></Reference><Reference><Citation>DiRusso SM. Clinical significance of differences in area under the receiver operating characteristic curve: nomograms for predicting nonsentinel axillary lymph node metastasis. Journal of the American College of Surgeons 2009; 209: 152.</Citation></Reference><Reference><Citation>Teja B, Bosch NA, Walkey AJ, Pinto R, Wunsch H. Vasopressor dosing in septic shock clinical trials: a systematic review and ecologic study. Annals of the American Thoracic Society 2020; 17: 773-6.</Citation></Reference><Reference><Citation>Torgersen C, Moser P, Luckner G, et&#xa0;al. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anesthesia and Analgesia 2009; 108: 1841-7.</Citation></Reference><Reference><Citation>Hwang TL, Lau YT, Huang SF, Chen MF, Liu MS. Changes of alpha 1-adrenergic receptors in human liver during intraabdominal sepsis. Hepatology 1994; 20: 638-42.</Citation></Reference><Reference><Citation>Ponzoni CR, Corr&#xea;a TD, Filho RR, Serpa Neto A, Assun&#xe7;&#xe3;o MS, Pardini A, Schettino GP. Readmission to the intensive care unit: incidence, risk factors, resource use, and outcomes. A retrospective cohort study. Annals of the American Thoracic Society 2017; 14: 1312-9.</Citation></Reference><Reference><Citation>Yadav H, Harrison AM, Hanson AC, Gajic O, Kor DJ, Cartin-Ceba R. Improving the accuracy of cardiovascular component of the sequential organ failure assessment score. Critical Care Medicine 2015; 43: 1449-57.</Citation></Reference><Reference><Citation>Vallabhajosyula S, Jentzer JC, Kotecha AA, et&#xa0;al. Development and performance of a novel vasopressor-driven mortality prediction model in septic shock. Annals of Intensive Care 2018; 8: 112.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28755257</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1432-2323</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2018</Year><Month>Jan</Month></PubDate></JournalIssue><Title>World journal of surgery</Title><ISOAbbreviation>World J Surg</ISOAbbreviation></Journal><ArticleTitle>Two-way Interaction Effects of Perioperative Complications on 30-Day Mortality in General Surgery.</ArticleTitle><Pagination><StartPage>2</StartPage><EndPage>11</EndPage><MedlinePgn>2-11</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00268-017-4156-7</ELocationID><Abstract><AbstractText Label="BACKGROUND">Multiple perioperative complications increase mortality risk, and certain complications synergistically increase this risk to a greater degree than might be expected if the complications were independent, but these effects are not well established.</AbstractText><AbstractText Label="METHODS">This is a retrospective cohort study of 422,827 intraabdominal general surgery patients (American College of Surgeons National Surgical Quality Improvement Program 2005-2011). Eight complications were evaluated: acute respiratory failure (ARF), acute kidney injury (AKI), sepsis/septic shock, stroke, cardiac arrest (CA), myocardial infarction (MI), deep vein thrombosis/pulmonary embolus, and transfusion. Each combination of two complications (28 total) was modeled using a Cox model for 30-day mortality, with adjustment for preoperative comorbidities and risk factors. Additive interaction was determined with the relative excess risk due to interaction (RERI). A positive RERI indicates that the mortality risk with both complications is greater than the sum of the individual mortality risks. Bonferroni correction was applied (&#x3b1;&#xa0;=&#xa0;0.05/28&#xa0;=&#xa0;0.0018).</AbstractText><AbstractText Label="RESULTS">Seven combinations demonstrated positive interaction: sepsis-CA (RERI 88.1; p&#xa0;&lt;&#xa0;0.0001), ARF-AKI (RERI 50.5; p&#xa0;&lt;&#xa0;0.0001), AKI-sepsis (RERI 33.9; p&#xa0;&lt;&#xa0;0.0001), sepsis-stroke (RERI 33.9; p&#xa0;&lt;&#xa0;0.0001), ARF-stroke (RERI 32.3; p&#xa0;&lt;&#xa0;0.0001), AKI-MI (RERI 24.5; p&#xa0;=&#xa0;0.0013), and ARF-sepsis (RERI 19.2; p&#xa0;&lt;&#xa0;0.0001). Two combinations demonstrated negative interaction: ARF-CA (RERI -65.1; p&#xa0;=&#xa0;0.0017) and CA-transfusion (RERI -52.0, p&#xa0;&lt;&#xa0;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">Interaction effects exist between certain complications to increase the risk of short-term mortality. ARF, AKI, sepsis, and stroke were most likely to be involved in positive interactions. Further research into the mechanisms for these effects will be necessary to develop strategies to minimize the compounding effects of multiple complications in the perioperative period.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Minjae</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, 622 West 168th Street, PH 5 Suite 505C, New York, NY, 10032, USA. mk2767@cumc.columbia.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA. mk2767@cumc.columbia.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Guohua</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Columbia University Medical Center, 622 West 168th Street, PH 5 Suite 505C, New York, NY, 10032, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Epidemiology, Columbia University Mailman School of Public Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Surg</MedlineTA><NlmUniqueID>7704052</NlmUniqueID><ISSNLinking>0364-2313</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="N">Respiratory Insufficiency</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28755257</ArticleId><ArticleId IdType="doi">10.1007/s00268-017-4156-7</ArticleId><ArticleId IdType="pii">10.1007/s00268-017-4156-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Gen Intern Med. 2006 Feb;21(2):177-80</Citation><ArticleIdList><ArticleId IdType="pubmed">16606377</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266</Citation><ArticleIdList><ArticleId IdType="pubmed">11904577</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2015 Sep;221(3):708-16</Citation><ArticleIdList><ArticleId IdType="pubmed">26228016</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Soc Nephrol. 1999 Feb;10(2):429-32</Citation><ArticleIdList><ArticleId IdType="pubmed">10215345</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 2005;20(7):563-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16119427</ArticleId></ArticleIdList></Reference><Reference><Citation>ISBT Sci Ser. 2015 Apr;10(Suppl 1):188-191</Citation><ArticleIdList><ArticleId IdType="pubmed">26347800</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Public Health. 1998 Jan;88(1):15-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9584027</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2009 May 5;150(9):604-12</Citation><ArticleIdList><ArticleId IdType="pubmed">19414839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1994 Dec;220(6):740-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7986140</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 Feb;39(2):259-65</Citation><ArticleIdList><ArticleId IdType="pubmed">20975548</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Anaesth. 2015 Dec;115 Suppl 2:ii3-14</Citation><ArticleIdList><ArticleId IdType="pubmed">26658199</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin J Am Soc Nephrol. 2010 Apr;5(4):733-9</Citation><ArticleIdList><ArticleId IdType="pubmed">20167687</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1980 Oct;112(4):467-70</Citation><ArticleIdList><ArticleId IdType="pubmed">7424895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerebrovasc Dis. 2012;34(3):175-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22922182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24697967</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Epidemiol. 2004 Dec;33(6):1389-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15319402</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2010 Feb;38(2):438-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19789449</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2015 Dec;121(6):1536-46</Citation><ArticleIdList><ArticleId IdType="pubmed">26273749</ArticleId></ArticleIdList></Reference><Reference><Citation>Circulation. 2009 Jun 9;119(22):2936-44</Citation><ArticleIdList><ArticleId IdType="pubmed">19506125</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Crit Care. 2006 Aug;12(4):325-32</Citation><ArticleIdList><ArticleId IdType="pubmed">16810043</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2011 May;39(5):1050-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21317650</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesth Analg. 2012 Jan;114(1):148-51</Citation><ArticleIdList><ArticleId IdType="pubmed">22052982</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp Neurol. 2015 Oct;272:41-9</Citation><ArticleIdList><ArticleId IdType="pubmed">26054885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2002 Sep;236(3):344-53; discussion 353-4</Citation><ArticleIdList><ArticleId IdType="pubmed">12192321</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2011 Oct;115(4):879-90</Citation><ArticleIdList><ArticleId IdType="pubmed">21862923</ArticleId></ArticleIdList></Reference><Reference><Citation>Anesthesiology. 2014 May;120(5):1168-81</Citation><ArticleIdList><ArticleId IdType="pubmed">24755786</ArticleId></ArticleIdList></Reference><Reference><Citation>Am Heart J. 2005 Aug;150(2):330-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16086939</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Rev Oncol Hematol. 2016 Mar;99:272-85</Citation><ArticleIdList><ArticleId IdType="pubmed">26811138</ArticleId></ArticleIdList></Reference><Reference><Citation>Contrib Nephrol. 2011;174:71-7</Citation><ArticleIdList><ArticleId IdType="pubmed">21921611</ArticleId></ArticleIdList></Reference><Reference><Citation>Chest. 1993 Nov;104(5):1592-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8222829</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroke. 2010 Oct;41(10 Suppl):S3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">20876499</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2009 Oct 1;361(14):1368-75</Citation><ArticleIdList><ArticleId IdType="pubmed">19797283</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Epidemiol. 2005;20(7):575-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16119429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1999 Aug;230(2):251-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10450740</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2010 Dec;252(6):1065-71</Citation><ArticleIdList><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2014 Apr;29(2):241-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24332993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39667298</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1883</ISSN><JournalIssue CitedMedium="Internet"><Volume>240</Volume><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>American journal of surgery</Title><ISOAbbreviation>Am J Surg</ISOAbbreviation></Journal><ArticleTitle>Impact of intraoperative adverse events in general and gastrointestinal surgery: A nationwide study.</ArticleTitle><Pagination><StartPage>116125</StartPage><MedlinePgn>116125</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.amjsurg.2024.116125</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0002-9610(24)00677-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Intraoperative adverse events (iAEs) during general surgery can lead to significant morbidity and healthcare burden, yet their impact remains underexplored. We aimed to estimate the nationwide incidence of iAEs in general surgery and explore their associations with mortality, complications, length of stay, and costs.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective cohort study using the Nationwide Readmissions Database 2019 and included adult patients (aged 18 years and older) who underwent general surgical procedures. Eligible patients were grouped based on the presence of an iAE, defined as an unrecognized abdominopelvic accidental puncture or laceration. The primary outcome was in-hospital mortality, while secondary outcomes included 30-day post-operative complications, length of stay, and total inpatient costs. Multivariable logistic and linear regression models were used to examine the association between the presence of an iAE and post-operative outcomes and costs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 701,866 patients were included. The mean age was 55.1 years, and 60.0&#xa0;&#x200b;% were female. 6350 (0.9&#xa0;&#x200b;%) experienced an iAE. The procedure with the highest incidence of iAE was small bowel resection (2.3&#xa0;&#x200b;%). On univariate analysis, patients who experienced an iAE had higher mortality (3.8&#xa0;&#x200b;% vs. 1.5&#xa0;&#x200b;%, P&#xa0;&#x200b;&lt;&#xa0;&#x200b;0.001), 30-day complications, length of stay, and inpatient costs. After multivariable regression, iAEs were independently associated with an increase in in-hospital mortality, length of stay, unplanned readmission, wound complications, acute kidney injury, sepsis, surgical site infection, ileus, and inpatient costs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite their low incidence, iAEs are associated with heightened rates of complications and healthcare utilization. Incorporating iAEs into surgical quality initiatives and developing iAE reporting standards is warranted.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Proa&#xf1;o-Zamudio</LastName><ForeName>Jefferson A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nzenwa</LastName><ForeName>Ikemsinachi C</ForeName><Initials>IC</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abiad</LastName><ForeName>May</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Argandykov</LastName><ForeName>Dias</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romijn</LastName><ForeName>Anne-Sophie C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagazzi</LastName><ForeName>Emanuele</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafaqat</LastName><ForeName>Wardah</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paranjape</LastName><ForeName>Charudutt N</ForeName><Initials>CN</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Velmahos</LastName><ForeName>George C</ForeName><Initials>GC</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaafarani</LastName><ForeName>Haytham M A</ForeName><Initials>HMA</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwabejire</LastName><ForeName>John O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency Surgery &amp; Surgical Critical Care, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: JHWABEJIRE@PARTNERS.ORG.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>12</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Surg</MedlineTA><NlmUniqueID>0370473</NlmUniqueID><ISSNLinking>0002-9610</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007431" MajorTopicYN="Y">Intraoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="Y">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017721" MajorTopicYN="N">Hospital Costs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>20</Day><Hour>22</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>12</Month><Day>12</Day><Hour>18</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39667298</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2024.116125</ArticleId><ArticleId IdType="pii">S0002-9610(24)00677-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16715031</PMID><DateCompleted><Year>2006</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0090-3493</ISSN><JournalIssue CitedMedium="Print"><Volume>34</Volume><Issue>7</Issue><PubDate><Year>2006</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1996</StartPage><EndPage>2003</EndPage><MedlinePgn>1996-2003</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To quantify the accuracy of serum procalcitonin as a diagnostic test for sepsis, severe sepsis, or septic shock in adults in intensive care units or after surgery or trauma, alone and compared with C-reactive protein. To draw and compare the summary receiver operating characteristics curves for procalcitonin and C-reactive protein from the literature.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">MEDLINE (keywords: procalcitonin, intensive care, sepsis, postoperative sepsis, trauma); screening of the literature.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Meta-analysis of all 49 published studies in medical, surgical, or polyvalent intensive care units or postoperative wards. Children, medical patients, and immunocompromised patients were excluded.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Thirty-three studies fulfilled inclusion criteria (3,943 patients, 1,828 males, 922 females; mean age: 56.1 yrs; 1,825 patients with sepsis, severe sepsis, or septic shock; 1,545 with only systemic inflammatory response syndrome); eight studies could not be analyzed statistically. Global mortality rate was 29.3%.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">Global odds ratios for diagnosis of infection complicated by systemic inflammation were 15.7 for the 25 studies (2,966 patients) using procalcitonin (95% confidence interval, 9.1-27.1) and 5.4 for the 15 studies (1,322 patients) using C-reactive protein (95% confidence interval, 3.2-9.2). The summary receiver operating characteristics curve for procalcitonin was better than for C-reactive protein. In the 15 studies using both markers, the Q* value (intersection of summary receiver operating characteristics curve with the diagonal line where sensitivity equals specificity) was significantly higher for procalcitonin than for C-reactive protein (0.78 vs. 0.71, p = .02), the former test showing better accuracy.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Procalcitonin represents a good biological diagnostic marker for sepsis, severe sepsis, or septic shock, difficult diagnoses in critically ill patients. Procalcitonin is superior to C-reactive protein. Procalcitonin should be included in diagnostic guidelines for sepsis and in clinical practice in intensive care units.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Uzzan</LastName><ForeName>Bernard</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>APHP Laboratoire de Pharmacologie-Hormonologie, H&#xf4;pital Avicenne, Bobigny, France. bernard.uzzan@avc.aphp.fr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cohen</LastName><ForeName>R&#xe9;gis</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Nicolas</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Cucherat</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Perret</LastName><ForeName>G&#xe9;rard-Yves</ForeName><Initials>GY</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606589">CALCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>JHB2QIZ69Z</RegistryNumber><NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2007 Feb;35(2):679; author reply 679-80. doi: 10.1097/01.CCM.0000254967.79846.6A.</RefSource><PMID Version="1">17251741</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>75</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>7</Month><Day>15</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>5</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16715031</ArticleId><ArticleId IdType="doi">10.1097/01.CCM.0000226413.54364.36</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25466352</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>16</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2213-2619</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>12</Issue><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>The Lancet. Respiratory medicine</Title><ISOAbbreviation>Lancet Respir Med</ISOAbbreviation></Journal><ArticleTitle>Incidence of mortality and morbidity related to postoperative lung injury in patients who have undergone abdominal or thoracic surgery: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1007</StartPage><EndPage>1015</EndPage><MedlinePgn>1007-15</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S2213-2600(14)70228-0</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2213-2600(14)70228-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Lung injury is a serious complication of surgery. We did a systematic review and meta-analysis to assess whether incidence, morbidity, and in-hospital mortality associated with postoperative lung injury are affected by type of surgery and whether outcomes are dependent on type of ventilation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched MEDLINE, CINAHL, Web of Science, and Cochrane Central Register of Controlled Trials for observational studies and randomised controlled trials published up to April, 2014, comparing lung-protective mechanical ventilation with conventional mechanical ventilation during abdominal or thoracic surgery in adults. Individual patients' data were assessed. Attributable mortality was calculated by subtracting the in-hospital mortality of patients without postoperative lung injury from that of patients with postoperative lung injury.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We identified 12 investigations involving 3365 patients. The total incidence of postoperative lung injury was similar for abdominal and thoracic surgery (3&#xb7;4% vs 4&#xb7;3%, p=0&#xb7;198). Patients who developed postoperative lung injury were older, had higher American Society of Anesthesiology scores and prevalence of sepsis or pneumonia, more frequently had received blood transfusions during surgery, and received ventilation with higher tidal volumes, lower positive end-expiratory pressure levels, or both, than patients who did not. Patients with postoperative lung injury spent longer in intensive care (8&#xb7;0 [SD 12&#xb7;4] vs 1&#xb7;1 [3&#xb7;7] days, p&lt;0&#xb7;0001) and hospital (20&#xb7;9 [18&#xb7;1] vs 14&#xb7;7 [14&#xb7;3] days, p&lt;0&#xb7;0001) and had higher in-hospital mortality (20&#xb7;3% vs 1&#xb7;4% p&lt;0&#xb7;0001) than those without injury. Overall attributable mortality for postoperative lung injury was 19% (95% CI 18-19), and differed significantly between abdominal and thoracic surgery patients (12&#xb7;2%, 95% CI 12&#xb7;0-12&#xb7;6 vs 26&#xb7;5%, 26&#xb7;2-27&#xb7;0, p=0&#xb7;0008). The risk of in-hospital mortality was independent of ventilation strategy (adjusted HR 0&#xb7;71, 95% CI 0&#xb7;41-1&#xb7;22).</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Postoperative lung injury is associated with increases in in-hospital mortality and durations of stay in intensive care and hospital. Attributable mortality due to postoperative lung injury is higher after thoracic surgery than after abdominal surgery. Lung-protective mechanical ventilation strategies reduce incidence of postoperative lung injury but does not improve mortality.</AbstractText><AbstractText Label="FUNDING" NlmCategory="BACKGROUND">None.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Serpa Neto</LastName><ForeName>Ary</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Medical Intensive Care Unit, ABC Medical School (FMABC), Santo Andr&#xe9;, Brazil; Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil. Electronic address: aryserpa@terra.com.br.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hemmes</LastName><ForeName>Sabrine N T</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Department of Anaesthesiology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barbas</LastName><ForeName>Carmen S V</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Hospital Israelita Albert Einstein, S&#xe3;o Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beiderlinden</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, D&#xfc;sseldorf University Hospital, Heinrich-Heine University, D&#xfc;sseldorf, Germany; Department of Anaesthesiology, Marienhospital Osnabr&#xfc;ck, Osnabr&#xfc;ck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez-Bustamante</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Futier</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Aneasthesiology and Critical Care Medicine, Estaing University Hospital, Clermont-Ferrand, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollmann</LastName><ForeName>Markus W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Samir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine and Anaesthesiology (SAR B), Saint Eloi University Hospital, Montpellier, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kozian</LastName><ForeName>Alf</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Licker</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Pharmacology and Intensive Care, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Wen-Qian</ForeName><Initials>WQ</Initials><AffiliationInfo><Affiliation>State Key Laboratory of Oncology of South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moine</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scavonetto</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Anesthesia Clinical Research Unit, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schilling</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Selmo</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Azienda Ospedaliera Fondazione Macchi, Ospedale di Circolo, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Severgnini</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sprung</LastName><ForeName>Juraj</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Anesthesia Clinical Research Unit, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treschan</LastName><ForeName>Tanja</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, D&#xfc;sseldorf University Hospital, Heinrich-Heine University, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unzueta</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Hospital de Sant Pau, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weingarten</LastName><ForeName>Toby N</ForeName><Initials>TN</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Anesthesia Clinical Research Unit, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolthuis</LastName><ForeName>Esther K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wrigge</LastName><ForeName>Hermann</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department Anaesthesiology and Intensive Care Medicine, University of Leipzig, Leipzig, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gama de Abreu</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University Hospital Carl Gustav Carus, Dresden, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pelosi</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Surgical Sciences and Integrated Diagnostics, IRCCS San Martino IST, University of Genoa, Genoa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Department of Anaesthesiology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands; Laboratory of Experimental Intensive Care and Anaesthesiology, Academic Medical Centre, University of Amsterdam, Amsterdam, Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>PROVE Network investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>11</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet Respir Med</MedlineTA><NlmUniqueID>101605555</NlmUniqueID><ISSNLinking>2213-2600</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet Respir Med. 2014 Dec;2(12):e23</RefSource></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Lancet Respir Med. 2014 Dec;2(12):949-50. doi: 10.1016/S2213-2600(14)70256-5.</RefSource><PMID Version="1">25466340</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="N">Lung Injury</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011175" MajorTopicYN="N">Positive-Pressure Respiration</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019616" MajorTopicYN="N">Thoracic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25466352</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(14)70228-0</ArticleId><ArticleId IdType="pii">S2213-2600(14)70228-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34152632</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1525-1594</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Artificial organs</Title><ISOAbbreviation>Artif Organs</ISOAbbreviation></Journal><ArticleTitle>The effect of perioperative hemadsorption in patients operated for acute infective endocarditis-A randomized controlled study.</ArticleTitle><Pagination><StartPage>1328</StartPage><EndPage>1337</EndPage><MedlinePgn>1328-1337</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aor.14019</ELocationID><Abstract><AbstractText>Patients operated for infective endocarditis (IE) are at high risk of developing an excessive systemic hyperinflammatory state, resulting in systemic inflammatory response syndrome and septic shock. Hemoadsorption (HA) by cytokine adsorbers has been successfully applied to remove inflammatory mediators. This randomized controlled trial investigates the effect of perioperative HA therapy on inflammatory parameters and hemodynamic status in patients operated for IE. A total of 20 patients were randomly assigned to either HA therapy or the control group. HA therapy was initiated intraoperatively and continued for 24&#xa0;hours postoperatively. Cytokine levels (IL-6, IL-1b, TNF-&#x3b1;), leukocytes, C-reactive protein (CRP), and Procalcitonin (PCT) as well as catecholamine support, and volume requirement were compared between both groups. Operative procedures included aortic (n&#xa0;=&#xa0;7), mitral (n&#xa0;=&#xa0;6), and multiple valve surgery (n&#xa0;=&#xa0;7). All patients survived to discharge. No significant differences concerning median cytokine levels (IL-6 and TNF-&#x3b1;) were observed between both groups. CRP and PCT baseline levels were significantly higher in the HA group (59.5 vs. 26.3&#xa0;mg/dL, P&#xa0;=&#xa0;.029 and 0.17 vs. 0.05&#xa0;&#xb5;g/L, P&#xa0;=&#xa0;.015) equalizing after surgery. Patients in the HA group required significantly higher doses of vasopressors (0.093 vs. 0.025&#xa0;&#xb5;g/kg/min norepinephrine, P&#xa0;=&#xa0;.029) at 12&#xa0;hours postoperatively as well as significantly more overall volume replacement (7217 vs. 4185&#xa0;mL at 12&#xa0;hours, P&#xa0;=&#xa0;.015; 12&#xa0;021 vs. 4850&#xa0;mL at 48&#xa0;hours, P&#xa0;=&#xa0;.015). HA therapy did neither result in a reduction of inflammatory parameters nor result in an improvement of hemodynamic parameters in patients operated for IE. For a more targeted use of HA therapy, appropriate selection criteria are required.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Asch</LastName><ForeName>Silke</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0435-3447</Identifier><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiac and Thoracic Surgery, Hospital Fulda, Fulda, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufmann</LastName><ForeName>Tobias Peter</ForeName><Initials>TP</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walter</LastName><ForeName>Michaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leistner</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, University Hospital W&#xfc;rzburg, W&#xfc;rzburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danner</LastName><ForeName>Bernd C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perl</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutschka</LastName><ForeName>Ingo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niehaus</LastName><ForeName>Heidi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Thoracic- and Cardiovascular Surgery, University Hospital, Georg-August-University, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracic, Transplant and Vascular Surgery, Hanover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Artif Organs</MedlineTA><NlmUniqueID>7802778</NlmUniqueID><ISSNLinking>0160-564X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002315" MajorTopicYN="N">Cardiopulmonary Bypass</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="N">Endocarditis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006382" MajorTopicYN="Y">Hemadsorption</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="N">Hemoperfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SIRS</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">endocarditis</Keyword><Keyword MajorTopicYN="N">hemadsorption</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>21</Day><Hour>12</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34152632</ArticleId><ArticleId IdType="doi">10.1111/aor.14019</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG Jr. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059.</Citation></Reference><Reference><Citation>Tr&#xe4;ger K, Skrabal C, Fischer G, Datzmann T, Schroeder J, Fritzler D, et al. Hemoadsorption treatment of patients with acute infective endocarditis during surgery with cardiopulmonary bypass-a case series. Int J Artif Organs. 2017;40:240-9.</Citation></Reference><Reference><Citation>Murdoch DR, Corey GR, Hoen B, Mir&#xf3; JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-73.</Citation></Reference><Reference><Citation>Kang D-H, Kim Y-J, Kim S-H, Sun BJ, Kim D-H, Yun S-C, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med. 2012;366:2466-73.</Citation></Reference><Reference><Citation>Datzmann T, Tr&#xe4;ger K. Extracorporeal membrane oxygenation and cytokine adsorption. J Thorac Dis. 2018;10 Suppl 5:653-60.</Citation></Reference><Reference><Citation>Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.</Citation></Reference><Reference><Citation>Chew M, Brandslund I, Brix-Christensen V, Ravn H, Hjortdal V, Pedersen J, et al. Tissue injury and the inflammatory response to pediatric cardiac surgery with cardiopulmonary bypass: a descriptive study. Anesthesiology. 2001;94:745-53.</Citation></Reference><Reference><Citation>Bernardi MH, Rinoesl H, Dragosits K, Ristl R, Hoffelner F, Opfermann P, et al. Effect of hemoadsorption during cardiopulmonary bypass surgery-a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016;20:96.</Citation></Reference><Reference><Citation>Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operation. Ann Thorac Surg. 1996;61:1714-20.</Citation></Reference><Reference><Citation>Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short term survival in lethal endotoxemia. Crit Care Med. 2004;32:801-5.</Citation></Reference><Reference><Citation>Born F, Pichlmaier M, Peter&#xdf; S, Khaladj N, Hagl C. Systemic inflammatory response syndrome in in heart surgery: new possibilities for treatment through the use of a cytokine adsorber during ECC? Kardiotechnik. 2014;2:1-10.</Citation></Reference><Reference><Citation>Tr&#xe4;ger K, Fritzler D, Fischer G, Schr&#xf6;der J, Skrabal C, Liebold A, et al. Treatment of post-cardiopulmonary bypass SIRS by hemoadsorption: a case series. Int J Artif Organs. 2016;39:141-6.</Citation></Reference><Reference><Citation>Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517-28.</Citation></Reference><Reference><Citation>Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, et al. Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med. 2007;167:1655-63.</Citation></Reference><Reference><Citation>Kruttgen A, Rose-John S. Interleukin-6 in sepsis and capillary leakage syndrome. J Interferon Cytokine Res. 2012;32:60-5.</Citation></Reference><Reference><Citation>Kogelmann K, Jarczak D, Scheller M, Dr&#xfc;ner M. Hemoadsorption by CytoSorb in septic patients: a case series. Crit Care. 2017;21:74.</Citation></Reference><Reference><Citation>Vocelka CR, Jones KM, Mikhova KM, Ebisu RM, Shar A, Kellum JA, et al. Role of cytokine hemoadsorption in cardiopulmonary bypass-induced ventricular dysfunction in a porcine model. J Extra Corpor Technol. 2013;45:220-7.</Citation></Reference><Reference><Citation>Poli EC, Alberio L, Bauer-Doerries A, Marcucci C, Roumy A, Kirsch M, et al. Cytokine clearance with CytoSorb&#xae; during cardiac surgery: a pilot randomized controlled trial. Crit Care. 2019;23:108.</Citation></Reference><Reference><Citation>Garau I, M&#xe4;rz A, Sehner S, Reuter DA, Reichenspurner H, Z&#xf6;llner C, et al. Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor &#x3b1; serum levels in cardiac surgery: a randomized controlled trial. Minerva Anestesiol. 2018;85:715-23.</Citation></Reference><Reference><Citation>Sch&#xe4;dler D, Pausch C, Heise D, Meier-Hellmann A, Brederlau J, Weiler N, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial. PLoS ONE. 2017;12:e0187015.</Citation></Reference><Reference><Citation>Honore PM, Matson JR. Extracorporeal removal for sepsis: acting at the tissue level - the beginning of a new era for this treatment modality in septic shock. Crit Care Med. 2004;32:896-7.</Citation></Reference><Reference><Citation>Diab M, Tasar R, Sponholz C, Lehmann T, Pletz MW, Bauer M, et al. Changes in inflammatory and vasoactive mediator profiles during valvular surgery with or without infective endocarditis: a case control pilot study. PLoS ONE. 2020;15:e0228286.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">22847898</PMID><DateCompleted><Year>2013</Year><Month>04</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-6473</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>11</Issue><PubDate><Year>2012</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</Title><ISOAbbreviation>Liver Transpl</ISOAbbreviation></Journal><ArticleTitle>Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1316</StartPage><EndPage>1323</EndPage><MedlinePgn>1316-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/lt.23521</ELocationID><Abstract><AbstractText>Salvage liver transplantation (SLT), or liver transplantation after liver resection (LR), has been performed after primary LR for many years. However, the true outcomes and risks of SLT versus primary liver transplantation (PLT) remain unclear. We performed a systematic review and meta-analysis to evaluate the survival rate of SLT recipients and the incidence of postoperative complications. Among 2799 screened references, 7 eligible studies were identified. The results of the meta-analysis indicated no statistically significant differences in the overall survival rates of SLT and PLT: the pooled relative risk (RR) was 0.99 [95% confidence interval (CI) = 0.90-1.09, P = 0.87] at 1 year, 0.97 (95% CI = 0.83-1.13, P = 0.68) at 3 years, and 0.96 (95% CI = 0.81-1.13, P = 0.61) at 5 years. As for postoperative complications, there were no statistically significant differences in the incidence of sepsis and biliary complications between SLT and PLT, but there was a significantly higher incidence of bleeding with SLT (RR = 2.84, 95% CI = 1.57-5.13, P = 0.001). In conclusion, the overall survival associated with SLT is similar to that associated with PLT. Because of the limited organ donor pool, SLT might be an acceptable therapy for patients undergoing primary LR for hepatocellular carcinoma.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 American Association for the Study of Liver Diseases.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Zhenhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhiwei</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Sunyi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Shu-Sen</ForeName><Initials>SS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Liver Transpl</MedlineTA><NlmUniqueID>100909185</NlmUniqueID><ISSNLinking>1527-6465</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006528" MajorTopicYN="N">Carcinoma, Hepatocellular</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006498" MajorTopicYN="N">Hepatectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016031" MajorTopicYN="N">Liver Transplantation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016879" MajorTopicYN="N">Salvage Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">22847898</ArticleId><ArticleId IdType="doi">10.1002/lt.23521</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26051976</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-3511</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases</Title><ISOAbbreviation>Int J Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Community- and healthcare-associated infections in critically ill patients: a multicenter cohort study.</ArticleTitle><Pagination><StartPage>80</StartPage><EndPage>85</EndPage><MedlinePgn>80-5</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijid.2015.05.024</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1201-9712(15)00133-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the spectrum of infection, comorbidities, outcomes, and mortality of patients admitted to the intensive care unit (ICU) due to community-acquired or healthcare-associated severe sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This prospective cohort study was conducted in three university medical centers in Lebanon from February 2005 to December 2006. Patients with severe sepsis were included and followed up until hospital discharge or death.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred and twenty patients were included of whom 60% had community-acquired infections (CAI) and 40% had healthcare-associated infections (HAI). The most common infection in both groups was pneumonia. Hematologic malignancies were the only comorbidity more prevalent in HAI than in CAI (p=0.047). Fungal infections and extended-spectrum beta-lactamase (ESBL) organisms were more frequent in HAI than in CAI (p=0.04 and 0.029, respectively). APACHE and SOFA scores were high and did not differ between the two groups, nor did the proportion of septic shock, while mortality was significantly higher in the HAI patients than in the CAI patients (p=0.004). On multivariate analysis for mortality, independent risk factors were the source of infection acquisition (p=0.004), APACHE II score (p=0.006), multidrug-resistant Pseudomonas infections (p=0.043), and fungal infections (p=0.006).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Severe sepsis and septic shock had a high mortality rate, especially in the HAI group. Patients with risk factors for increased mortality should be monitored and aggressive treatment should be administered.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dabar</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hotel Dieu de France Hospital, Pulmonary and Critical Care Division, Saint Joseph University School of Medicine, PO Box 16-6830, Achrafieh Beirut, Lebanon. Electronic address: georges.dabar@usj.edu.lb.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmouche</LastName><ForeName>Carine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Hotel Dieu de France Hospital, Pulmonary and Critical Care Division, Saint Joseph University School of Medicine, PO Box 16-6830, Achrafieh Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salameh</LastName><ForeName>Pascale</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Lebanese University, Faculties of Pharmacy and of Public Health II, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Bertrand L</ForeName><Initials>BL</Initials><AffiliationInfo><Affiliation>Kidney and Dialysis Research Laboratory, Division of Nephrology, Department of Medicine, Saint Elizabeth's Medical Center, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamaleddine</LastName><ForeName>Ghassan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Kings County Hospital Center, Pulmonary and Critical Care Department, Brooklyn, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waked</LastName><ForeName>Mirna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Saint George Hospital, Pulmonary and Critical Care Department, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yazbeck</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hotel Dieu de France Hospital, Anesthesia and Critical Care Division, Saint Joseph University School of Medicine, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>06</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>Int J Infect Dis</MedlineTA><NlmUniqueID>9610933</NlmUniqueID><ISSNLinking>1201-9712</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007861" MajorTopicYN="N">Lebanon</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009181" MajorTopicYN="N">Mycoses</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Community-acquired</Keyword><Keyword MajorTopicYN="N">Comorbidities</Keyword><Keyword MajorTopicYN="N">Healthcare-associated</Keyword><Keyword MajorTopicYN="N">Infection spectrum</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>6</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26051976</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2015.05.024</ArticleId><ArticleId IdType="pii">S1201-9712(15)00133-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30481997</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1827-1596</ISSN><JournalIssue CitedMedium="Internet"><Volume>85</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Minerva anestesiologica</Title><ISOAbbreviation>Minerva Anestesiol</ISOAbbreviation></Journal><ArticleTitle>Levels of circulating microparticles in septic shock and sepsis-related complications: a case-control study.</ArticleTitle><Pagination><StartPage>625</StartPage><EndPage>634</EndPage><MedlinePgn>625-634</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.23736/S0375-9393.18.12782-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Microparticles (MP) have been largely studied as potential biomarkers in septic shock (SS) though their biological and clinical relevance is still unclear. This case-control study describes the trend of various MP subtypes during SS to evaluate their possible association with severity of illness and sepsis-related complications (disseminated intravascular coagulation [DIC] and acute kidney injury [AKI]).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Forty patients admitted to the Intensive Care Unit with SS and 40 matched healthy volunteers were recruited. AnnexinV+, E-selectin+, thrombomodulin (TM+), leukocyte-derived (CD45+, CD36+) and platelet-derived MP (PMP-expressed as PMP/platelets ratio) were measured by flow-cytometry at baseline, on day 1, 3 and 7 after diagnosis. Severity of illness was assessed by Sequential Organ Failure Assessment Score, duration of vasoactive support and mechanical ventilation. Sepsis-related complications were considered.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, septic patients showed higher levels of all MP considered compared to controls. TM+MP were significantly lower in more severe sepsis, while CD36+MP and PMP/platelets ratio were significantly increased in patients requiring longer vasoactive support and mechanical ventilation. As for sepsis-related complications, a higher PMP/platelets ratio in patients who developed DIC and increased E-selectin+MP in subjects who developed AKI were observed. PMP/platelets ratio at baseline was significantly associated with longer vasoactive support (OR=1.59 [1.05-2.42]), longer mechanical ventilation (OR=1.6 [1.06-2.42]) and DIC occurrence (OR=1.45 [1.08-1.96]).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A global response through extra-vesiculation of endothelial cells, leukocytes and platelets during the early stages of SS was confirmed. The cellular activation was detected until day 3 after diagnosis. PMP/platelets ratio at diagnosis may be useful to evaluate SS severity and DIC occurrence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Boscolo</LastName><ForeName>Annalisa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campello</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Thrombotic and Hemorrhagic Diseases, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertini</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spiezia</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Thrombotic and Hemorrhagic Diseases, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucchetta</LastName><ForeName>Vittorio</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piasentini</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radu</LastName><ForeName>Claudia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Unit of Thrombotic and Hemorrhagic Diseases, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manesso</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ori</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unit of Anesthesia and Intensive Care, Department of Medicine (DIMED), University of Padua, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simioni</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Unit of Thrombotic and Hemorrhagic Diseases, Department of Medicine (DIMED), University of Padua, Padua, Italy - paolo.simioni@unipd.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Minerva Anestesiol</MedlineTA><NlmUniqueID>0375272</NlmUniqueID><ISSNLinking>0375-9393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Minerva Anestesiol. 2019 Jun;85(6):571-576. doi: 10.23736/S0375-9393.19.13596-1.</RefSource><PMID Version="1">30947485</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055252" MajorTopicYN="Y">Cell-Derived Microparticles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30481997</ArticleId><ArticleId IdType="doi">10.23736/S0375-9393.18.12782-9</ArticleId><ArticleId IdType="pii">S0375-9393.18.12782-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39557689</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1435-2451</ISSN><JournalIssue CitedMedium="Internet"><Volume>409</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>Langenbeck's archives of surgery</Title><ISOAbbreviation>Langenbecks Arch Surg</ISOAbbreviation></Journal><ArticleTitle>Frailty as a predictor of mortality and morbidity after cholecystectomy: A systematic review and meta-analysis of cohort studies.</ArticleTitle><Pagination><StartPage>352</StartPage><MedlinePgn>352</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00423-024-03537-z</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although cholecystectomy is a common surgery, it carries higher risks of postoperative complications and mortality for older adults. Age alone is not a reliable predictor of postoperative outcomes, whereas frailty may provide a more accurate assessment of a patient's health and functional status. Frailty, characterized by physical deterioration and reduced resilience, has been shown to predict mortality, prolonged recovery, and morbidity after various surgeries, including cholecystectomy. Thus, incorporating frailty evaluations into preoperative assessments can improve patient outcomes by individualizing treatment strategies. This systematic review and meta-analysis aims to evaluate how well frailty predicts postoperative outcomes following cholecystectomy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In accordance with PRISMA guidelines, we searched PubMed, Embase, and Web of Science on August 14th, 2024, without restrictions on publication year or language. The quality of the studies was assessed using the Newcastle-Ottawa scale, and meta-analysis was conducted using odds ratios with 95% confidence intervals as the effect size, employing a random-effects model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nine cohort studies comprising a total of 128,421 participants were included. The pooled results showed significantly higher odds of short-term mortality (OR: 5.54, 95% CI: 1.65-18.60, p&#x2009;=&#x2009;0.006), postoperative morbidity (OR: 2.65, 95% CI: 1.51-4.64, p&#x2009;=&#x2009;0.001), major morbidity (OR: 3.61, 95% CI: 1.52-8.59), and respiratory failure (OR: 3.85, 95% CI: 1.08-13.79) among frail patients. Additionally, frail patients had longer hospital stays (mean difference: 2.98 days, 95% CI: 1.91-4.04) and significantly higher odds of postoperative infection and sepsis. However, no association was evident with reoperation rates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study highlights the value of utilizing frailty assessment tools in preoperative settings for predicting outcomes after cholecystectomy. These tools could improve decision-making in both emergency and elective situations, aiding in the choice between surgical and medical management, as well as between open and laparoscopic procedures tailored to each patient.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Niknami</LastName><ForeName>Mojtaba</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Imam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tahmasbi</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Imam Hossein Medical and Educational Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Firouzabadi</LastName><ForeName>Shahryar Rajai</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran. shahryarrajai@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohammadi</LastName><ForeName>Ida</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mofidi</LastName><ForeName>Seyed Ali</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alinejadfard</LastName><ForeName>Mohammadreza</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aarabi</LastName><ForeName>Aryan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadraei</LastName><ForeName>Samin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Langenbecks Arch Surg</MedlineTA><NlmUniqueID>9808285</NlmUniqueID><ISSNLinking>1435-2443</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002763" MajorTopicYN="Y">Cholecystectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cholecystectomy</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Frailty index</Keyword><Keyword MajorTopicYN="N">Morbidity</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Ethical approval</b> Not applicable. <b>Consent for publication</b> Not applicable. <b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>23</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39557689</ArticleId><ArticleId IdType="doi">10.1007/s00423-024-03537-z</ArticleId><ArticleId IdType="pii">10.1007/s00423-024-03537-z</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Unalp-Arida A, Ruhl CE (2024) Burden of gallstone disease in the United States population: Prepandemic rates and trends. World J Gastrointest Surg 16(4):1130</Citation><ArticleIdList><ArticleId IdType="pubmed">38690054</ArticleId><ArticleId IdType="pmc">11056655</ArticleId><ArticleId IdType="doi">10.4240/wjgs.v16.i4.1130</ArticleId></ArticleIdList></Reference><Reference><Citation>Agresta F, Ansaloni L, Baiocchi GL, Bergamini C, Campanile FC, Carlucci M et al (2012) Laparoscopic approach to acute abdomen from the Consensus Development Conference of the Societ&#xe0; Italiana di Chirurgia Endoscopica e nuove tecnologie (SICE), Associazione Chirurghi Ospedalieri Italiani (ACOI), Societ&#xe0; Italiana di Chirurgia (SIC), Societ&#xe0; Italiana di Chirurgia d&#x2019;Urgenza e del Trauma (SICUT), Societ&#xe0; Italiana di Chirurgia nell&#x2019;Ospedalit&#xe0; Privata (SICOP), and the European Association for Endoscopic Surgery (EAES). Surg Endosc 26:2134&#x2013;2164</Citation><ArticleIdList><ArticleId IdType="pubmed">22736283</ArticleId><ArticleId IdType="doi">10.1007/s00464-012-2331-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu ASY, Menon R, Gunnarsson R, De Costa A (2017) Risk factors for conversion of laparoscopic cholecystectomy to open surgery&#x2013;A systematic literature review of 30 studies. Am J Surg 214(5):920&#x2013;930</Citation><ArticleIdList><ArticleId IdType="pubmed">28739121</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2017.07.029</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain A (2011) Difficult laparoscopic cholecystectomy: current evidence and strategies of management. Surg Laparoscopy Endoscopy Percutaneous Tech 21(4):211&#x2013;217</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLE.0b013e318220f1b1</ArticleId></ArticleIdList></Reference><Reference><Citation>De la Serna S, Ruano A, P&#xe9;rez-Jim&#xe9;nez A, Rojo M, Avellana R, Garc&#xed;a-Botella A et al (2019) Safety and feasibility of cholecystectomy in octogenarians. Analysis of a single center series of 316 patients. Hpb 21(11):1570&#x2013;6</Citation><ArticleIdList><ArticleId IdType="pubmed">31014560</ArticleId><ArticleId IdType="doi">10.1016/j.hpb.2019.03.373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rose JB, Hawkins WG (2017) Diagnosis and management of biliary injuries. Curr Probl Surg 54(8):406&#x2013;435</Citation><ArticleIdList><ArticleId IdType="pubmed">28987473</ArticleId><ArticleId IdType="doi">10.1067/j.cpsurg.2017.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Giraldo C, Venegas-Sanabria LC, Rojas-L&#xf3;pez S, Avenda&#xf1;o-Morales V (2024) Outcomes after laparoscopic cholecystectomy in patients older than 80 years: two-years follow-up. BMC Surg 24(1):87</Citation><ArticleIdList><ArticleId IdType="pubmed">38475792</ArticleId><ArticleId IdType="pmc">10935780</ArticleId><ArticleId IdType="doi">10.1186/s12893-024-02383-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Dua A, Aziz A, Desai SS, McMaster J, Kuy S (2014) National trends in the adoption of laparoscopic cholecystectomy over 7 years in the United States and impact of laparoscopic approaches stratified by age. Minimally Invasive Surgery 2014(1):635461</Citation><ArticleIdList><ArticleId IdType="pubmed">24790759</ArticleId><ArticleId IdType="pmc">3980842</ArticleId></ArticleIdList></Reference><Reference><Citation>Irojah B, Bell T, Grim R, Martin J, Ahuja V (2017) Are They Too Old for Surgery? Safety of Cholecystectomy in Superelderly Patients (&#x2265; Age 90). Perm J 21:16&#x2013;013. https://doi.org/10.7812/TPP/16-013</Citation></Reference><Reference><Citation>Murphy MM, Ng S-C, Simons JP, Csikesz NG, Shah SA, Tseng JF (2010) Predictors of major complications after laparoscopic cholecystectomy: surgeon, hospital, or patient? J Am Coll Surg 211(1):73&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">20610252</ArticleId><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.02.050</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanakala V, Borowski DW, Pellen MG, Dronamraju SS, Woodcock SA, Seymour K et al (2011) Risk factors in laparoscopic cholecystectomy: a multivariate analysis. Int J Surg 9(4):318&#x2013;323</Citation><ArticleIdList><ArticleId IdType="pubmed">21333763</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2011.02.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagenson AM, Powers BD, Zorbas KA, Karhadkar S, Karachristos A, Di Carlo A et al (2021) Frailty Predicts Morbidity and Mortality After Laparoscopic Cholecystectomy for Acute Cholecystitis: An ACS-NSQIP Cohort Analysis. J Gastrointest Surg 25(4):932&#x2013;940</Citation><ArticleIdList><ArticleId IdType="pubmed">32212087</ArticleId><ArticleId IdType="doi">10.1007/s11605-020-04570-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren S, Vella-Azzopardi R, Beckwee D, Habbig A-K, Scafoglieri A, Jansen B et al (2016) Frailty and the prediction of negative health outcomes: a meta-analysis. J Am med Direct Assoc 17(12):1163-e1-e17</Citation></Reference><Reference><Citation>Murphy PB, Savage SA, Zarzaur BL (2020) Impact of patient frailty on morbidity and mortality after common emergency general surgery operations. J Surg Res 247:95&#x2013;102</Citation><ArticleIdList><ArticleId IdType="pubmed">31787316</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2019.10.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Louwers L, Schnickel G, Rubinfeld I (2016) Use of a simplified frailty index to predict Clavien 4 complications and mortality after hepatectomy: analysis of the National Surgical Quality Improvement Project database. Am J Surg 211(6):1071&#x2013;1076</Citation><ArticleIdList><ArticleId IdType="pubmed">26800866</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2015.09.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Obeid NM, Azuh O, Reddy S, Webb S, Reickert C, Velanovich V et al (2012) Predictors of critical care-related complications in colectomy patients using the National Surgical Quality Improvement Program: exploring frailty and aggressive laparoscopic approaches. J Trauma Acute Care Surg 72(4):878&#x2013;883</Citation><ArticleIdList><ArticleId IdType="pubmed">22491599</ArticleId><ArticleId IdType="doi">10.1097/TA.0b013e31824d0f70</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton A, Velanovich V (2011) Preoperative frailty and quality of life as predictors of postoperative complications. Ann Surg 253(6):1223&#x2013;1229</Citation><ArticleIdList><ArticleId IdType="pubmed">21412145</ArticleId><ArticleId IdType="doi">10.1097/SLA.0b013e318214bce7</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasgupta M, Rolfson DB, Stolee P, Borrie MJ, Speechley M (2009) Frailty is associated with postoperative complications in older adults with medical problems. Arch Gerontol Geriatr 48(1):78&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">18068828</ArticleId><ArticleId IdType="doi">10.1016/j.archger.2007.10.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56(3):M146&#x2013;M157</Citation><ArticleIdList><ArticleId IdType="pubmed">11253156</ArticleId><ArticleId IdType="doi">10.1093/gerona/56.3.M146</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K (2005) Frailty and its definition: a worthy challenge. J Am Geriatrics Soc 53(6):1069&#x2013;1070</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53312.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhat JS, Velanovich V, Falvo AJ, Horst HM, Swartz A, Patton JH Jr et al (2012) Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly. J Trauma Acute Care Surg 72(6):1526&#x2013;1531</Citation><ArticleIdList><ArticleId IdType="pubmed">22695416</ArticleId><ArticleId IdType="doi">10.1097/TA.0b013e3182542fab</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards SJ, Frizelle FA, Geddes JA, Eglinton TW, Hampton MB (2018) Frailty in surgical patients. Int J Colorectal Dis 33:1657&#x2013;1666</Citation><ArticleIdList><ArticleId IdType="pubmed">30218144</ArticleId><ArticleId IdType="doi">10.1007/s00384-018-3163-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell CA, Patel MB, Suarez-Rodriguez LC, Miller RS (2019) Frailty and prognostication in geriatric surgery and trauma. Clin Geriatr Med 35(1):13&#x2013;26</Citation><ArticleIdList><ArticleId IdType="pubmed">30390979</ArticleId><ArticleId IdType="doi">10.1016/j.cger.2018.08.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason LJ, Benton EA, Alvarez-Nebreda ML, Weaver MJ, Harris MB, Javedan H (2017) FRAIL questionnaire screening tool and short-term outcomes in geriatric fracture patients. J Am Med Dir Assoc 18(12):1082&#x2013;1086</Citation><ArticleIdList><ArticleId IdType="pubmed">28866353</ArticleId><ArticleId IdType="pmc">6611671</ArticleId><ArticleId IdType="doi">10.1016/j.jamda.2017.07.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CCH, Yang YT, Lai IR, Lin BR, Yang CY, Huang J et al (2019) Three nurse-administered protocols reduce nutritional decline and frailty in older gastrointestinal surgery patients: a cluster randomized trial. J Am Med Direct Assoc 20(5):524&#x2013;93. e3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2018.09.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hogan DB, Maxwell CJ, Afilalo J, Arora RC, Bagshaw SM, Basran J et al (2017) A scoping review of frailty and acute care in middle-aged and older individuals with recommendations for future research. Canadian Geriatrics J 20(1):22</Citation><ArticleIdList><ArticleId IdType="doi">10.5770/cgj.20.240</ArticleId></ArticleIdList></Reference><Reference><Citation>Makary MA, Segev DL, Pronovost PJ, Syin D, Bandeen-Roche K, Patel P et al (2010) Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 210(6):901&#x2013;908</Citation><ArticleIdList><ArticleId IdType="pubmed">20510798</ArticleId><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.01.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewitt J, Long S, Carter B, Bach S, McCarthy K, Clegg A (2018) The prevalence of frailty and its association with clinical outcomes in general surgery: a systematic review and meta-analysis. Age Ageing 47(6):793&#x2013;800</Citation><ArticleIdList><ArticleId IdType="pubmed">30084863</ArticleId><ArticleId IdType="doi">10.1093/ageing/afy110</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeiren S, Vella-Azzopardi R, Beckw&#xe9;e D, Habbig AK, Scafoglieri A, Jansen B et al (2016) Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis. J Am Med Dir Assoc 17(12):1163.e1-e17</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2016.09.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafiee A, Arabzadeh Bahri R, Rajai S, Ahoopai M, Seighali N, Amini MJ (2023) Frailty as a predictor of adverse outcomes in burn patients: a systematic review. BMC Geriatr 23(1):680</Citation><ArticleIdList><ArticleId IdType="pubmed">37858053</ArticleId><ArticleId IdType="pmc">10588052</ArticleId><ArticleId IdType="doi">10.1186/s12877-023-04302-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg 88:105906</Citation><ArticleIdList><ArticleId IdType="pubmed">33789826</ArticleId><ArticleId IdType="doi">10.1016/j.ijsu.2021.105906</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells GA, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al (2000) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</Citation></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J et al (2011) GRADE guidelines: 1. Introduction&#x2014;GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383&#x2013;94</Citation><ArticleIdList><ArticleId IdType="pubmed">21195583</ArticleId><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiner SG, Marcantonio ER, Trivedi S, Inouye SK, Travison TG, Schmitt EM et al (2024) Comparison of the frailty index and frailty phenotype and their associations with postoperative delirium incidence and severity. J Am Geriatr Soc 72(6):1781&#x2013;1792</Citation><ArticleIdList><ArticleId IdType="pubmed">37964474</ArticleId><ArticleId IdType="doi">10.1111/jgs.18677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira AA, Borim FSA, Aprahamian I, Neri AL (2019) Comparison of Two Models of Frailty for the Prediction of Mortality in Brazilian Community-Dwelling Older Adults: The FIBRA Study. J Nutr Health Aging 23(10):1004&#x2013;1010</Citation><ArticleIdList><ArticleId IdType="pubmed">31781731</ArticleId><ArticleId IdType="doi">10.1007/s12603-019-1264-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Ortuno R (2013) An alternative method for Frailty Index cut-off points to define frailty categories. Eur Geriatric Med 4(5):299&#x2013;303</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eurger.2013.06.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Porgo TV, Moore L, Tardif PA (2016) Evidence of data quality in trauma registries: A systematic review. J Trauma Acute Care Surg 80(4):648&#x2013;658</Citation><ArticleIdList><ArticleId IdType="pubmed">26881490</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000000970</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniou SA, Antoniou GA, Koch OO, Pointner R, Granderath FA (2014) Meta-analysis of laparoscopic vs open cholecystectomy in elderly patients. World J Gastroenterol 20(46):17626&#x2013;17634</Citation><ArticleIdList><ArticleId IdType="pubmed">25516678</ArticleId><ArticleId IdType="pmc">4265625</ArticleId><ArticleId IdType="doi">10.3748/wjg.v20.i46.17626</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedgwick P (2013) Meta-analyses: heterogeneity and subgroup analysis. BMJ&#x202f;: British Medical Journal 346:f4040</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f4040</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2024) Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane. Available from:&#xa0; https://www.training.cochrane.org/handbook</Citation></Reference><Reference><Citation>Haddaway NR, Page MJ, Pritchard CC, McGuinness LA (2022) PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis. Campbell Syst Rev 18:e1230. https://doi.org/10.1002/cl2.1230</Citation></Reference><Reference><Citation>Rosa F, Covino M, Russo A, Salini S, Forino R, Della Polla D et al (2023) Frailty assessment as independent prognostic factor for patients?65 years undergoing urgent cholecystectomy for acute cholecystitis. Dig Liver Dis 55(4):505&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">36328898</ArticleId><ArticleId IdType="doi">10.1016/j.dld.2022.10.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasithiotakis K, Petrakis J, Venianaki M, Georgiades G, Koutsomanolis D, Andreou A et al (2013) Frailty predicts outcome of elective laparoscopic cholecystectomy in geriatric patients. Surg Endosc Other Interv Tech 27(4):1144&#x2013;1150</Citation></Reference><Reference><Citation>Kenig J, Walega P, Olszewska U, Konturek A, Nowak W (2016) Geriatric Assessment as a qualification element for elective and emergency cholecystectomy in older patients. World J Emerg Surg 11:36. https://doi.org/10.1186/s13017-016-0094-1</Citation></Reference><Reference><Citation>Mastalerz K, Kenig J, Olszewska U, Michalik C (2018) The Surgical Apgar Score and frailty as outcome predictors in short- and long-term evaluation of fit and frail older patients undergoing elective laparoscopic cholecystectomy - a prospective cohort study. Videosurg Other Miniinvasive Tech 13(3):350&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pubmed">30302148</ArticleId><ArticleId IdType="pmc">6174164</ArticleId><ArticleId IdType="doi">10.5114/wiitm.2018.75878</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DU, Fan GH, Hastie DJ, Addonizio EA, Suh J, Wang E et al (2022) The impact of frailty on the postoperative outcomes of patients undergoing cholecystectomy: propensity score matched analysis of 2011&#x2013;2017 US hospitals. HPB 24(1):130&#x2013;140</Citation><ArticleIdList><ArticleId IdType="pubmed">34219032</ArticleId><ArticleId IdType="doi">10.1016/j.hpb.2021.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzon L, Costa G, Massa G, Frezza B, Stella F, Balducci G (2017) The impact of frailty syndrome and risk scores on emergency cholecystectomy patients. Surg Today 47(1):74&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">27241560</ArticleId><ArticleId IdType="doi">10.1007/s00595-016-1361-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Agathis AZ, Bangla VG, Divino CM (2023) Role of mFI-5 in predicting geriatric outcomes in laparoscopic cholecystectomy. Am J Surg 226(5):697&#x2013;702</Citation><ArticleIdList><ArticleId IdType="pubmed">37633764</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2023.07.039</ArticleId></ArticleIdList></Reference><Reference><Citation>Panayi AC, Orkaby AR, Sakthivel D, Endo Y, Varon D, Roh D et al (2019) Impact of frailty on outcomes in surgical patients: A systematic review and meta-analysis. Am J Surg 218(2):393&#x2013;400</Citation><ArticleIdList><ArticleId IdType="pubmed">30509455</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2018.11.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH et al (2002) Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 162(20):2333&#x2013;2341</Citation><ArticleIdList><ArticleId IdType="pubmed">12418947</ArticleId><ArticleId IdType="doi">10.1001/archinte.162.20.2333</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatic M, von Haehling S, Ebner N (2020) Inflammatory biomarkers of frailty. Exp Gerontol 133:110858</Citation><ArticleIdList><ArticleId IdType="pubmed">32007546</ArticleId><ArticleId IdType="doi">10.1016/j.exger.2020.110858</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15(9):505&#x2013;522</Citation><ArticleIdList><ArticleId IdType="pubmed">30065258</ArticleId><ArticleId IdType="pmc">6146930</ArticleId><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun N, Youle RJ, Finkel T (2016) The Mitochondrial Basis of Aging. Mol Cell 61(5):654&#x2013;666</Citation><ArticleIdList><ArticleId IdType="pubmed">26942670</ArticleId><ArticleId IdType="pmc">4779179</ArticleId><ArticleId IdType="doi">10.1016/j.molcel.2016.01.028</ArticleId></ArticleIdList></Reference><Reference><Citation>Marzetti E, Calvani R, Cesari M, Buford TW, Lorenzi M, Behnke BJ et al (2013) Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials. Int J Biochem Cell Biol 45(10):2288&#x2013;2301</Citation><ArticleIdList><ArticleId IdType="pubmed">23845738</ArticleId><ArticleId IdType="pmc">3759621</ArticleId><ArticleId IdType="doi">10.1016/j.biocel.2013.06.024</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherry AD (2019) Mitochondrial dysfunction in cardiac surgery. Anesthesiol Clin 37(4):769&#x2013;785</Citation><ArticleIdList><ArticleId IdType="pubmed">31677690</ArticleId><ArticleId IdType="pmc">6986803</ArticleId><ArticleId IdType="doi">10.1016/j.anclin.2019.08.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards SJG, Frizelle FA, Geddes JA, Eglinton TW, Hampton MB (2018) Frailty in surgical patients. Int J Colorectal Dis 33(12):1657&#x2013;1666</Citation><ArticleIdList><ArticleId IdType="pubmed">30218144</ArticleId><ArticleId IdType="doi">10.1007/s00384-018-3163-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoo B, Boshier PR, Freethy A, Tharakan G, Saeed S, Hill N et al (2017) Redefining the stress cortisol response to surgery. Clin Endocrinol 87(5):451&#x2013;458</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cen.13439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando SM, McIsaac DI, Rochwerg B, Bagshaw SM, Muscedere J, Munshi L et al (2019) Frailty and invasive mechanical ventilation: association with outcomes, extubation failure, and tracheostomy. Intensive Care Med 45(12):1742&#x2013;1752</Citation><ArticleIdList><ArticleId IdType="pubmed">31595352</ArticleId><ArticleId IdType="doi">10.1007/s00134-019-05795-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahalingam M, Moore JX, Donnelly JP, Safford MM, Wang HE (2019) Frailty Syndrome and Risk of Sepsis in the REasons for Geographic And Racial Differences in Stroke (REGARDS) Cohort. J Intensive Care Med 34(4):292&#x2013;300</Citation><ArticleIdList><ArticleId IdType="pubmed">28675981</ArticleId><ArticleId IdType="doi">10.1177/0885066617715251</ArticleId></ArticleIdList></Reference><Reference><Citation>Muscedere J, Waters B, Varambally A, Bagshaw SM, Boyd JG, Maslove D et al (2017) The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med 43(8):1105&#x2013;1122</Citation><ArticleIdList><ArticleId IdType="pubmed">28676896</ArticleId><ArticleId IdType="pmc">5501903</ArticleId><ArticleId IdType="doi">10.1007/s00134-017-4867-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenig J, Wa&#x142;&#x119;ga P, Olszewska U, Konturek A, Nowak W (2016) Geriatric Assessment as a qualification element for elective and emergency cholecystectomy in older patients. World J Emerg Surg 11:36</Citation><ArticleIdList><ArticleId IdType="pubmed">27478493</ArticleId><ArticleId IdType="pmc">4966740</ArticleId><ArticleId IdType="doi">10.1186/s13017-016-0094-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastalerz K, Kenig J, Olszewska U, Michalik C (2018) The Surgical Apgar Score and frailty as outcome predictors in short- and long-term evaluation of fit and frail older patients undergoing elective laparoscopic cholecystectomy - a prospective cohort study. Wideochir Inne Tech Maloinwazyjne 13(3):350&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pubmed">30302148</ArticleId><ArticleId IdType="pmc">6174164</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin FC, O&#x2019;Halloran AM (2020) Tools for Assessing Frailty in Older People: General Concepts. Adv Exp Med Biol 1216:9&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">31894542</ArticleId><ArticleId IdType="doi">10.1007/978-3-030-33330-0_2</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I et al (2005) A global clinical measure of fitness and frailty in elderly people. CMAJ 173(5):489&#x2013;495</Citation><ArticleIdList><ArticleId IdType="pubmed">16129869</ArticleId><ArticleId IdType="pmc">1188185</ArticleId><ArticleId IdType="doi">10.1503/cmaj.050051</ArticleId></ArticleIdList></Reference><Reference><Citation>Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, H&#xe9;bert R et al (2004) Prevalence, attributes, and outcomes of fitness and frailty in community-dwelling older adults: report from the Canadian study of health and aging. J Gerontol A Biol Sci Med Sci 59(12):1310&#x2013;1317</Citation><ArticleIdList><ArticleId IdType="pubmed">15699531</ArticleId><ArticleId IdType="doi">10.1093/gerona/59.12.1310</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogata T, Sadakari Y, Nakane H, Koikawa K, Kanno H, Kohata R et al (2023) The five-item modified frailty index predicts long-term outcomes in elderly patients undergoing colorectal cancer surgery. World J Surg Oncol 21(1):268</Citation><ArticleIdList><ArticleId IdType="pubmed">37626381</ArticleId><ArticleId IdType="pmc">10463643</ArticleId><ArticleId IdType="doi">10.1186/s12957-023-03150-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D, Song X, Mitnitski A, Rockwood K (2005) Evaluation of a frailty index based on a comprehensive geriatric assessment in a population based study of elderly Canadians. Aging Clin Exp Res 17(6):465&#x2013;471</Citation><ArticleIdList><ArticleId IdType="pubmed">16485864</ArticleId><ArticleId IdType="doi">10.1007/BF03327413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatip &#xdc;nl&#xfc; E, Fatih Do&#x11f;u G, Y&#xfc;cel Y&#xdc; C.E, J&#xfc;lide S.K, Banu &#xc7; E, Kemal Tolga S (2022) Comparison of the modified 5-item frailty index with the american society of anesthesiologists classification and charlson age comorbidity index for predicting postoperative outcomes in geriatric patients: a prospective observational study. T&#xfc;rk Geriatri Dergisi 25(4):611&#x2013;621. https://doi.org/10.31086/tjgeri.2022.320</Citation></Reference><Reference><Citation>Tran DTT, Tu JV, Dupuis JY, Bader Eddeen A, Sun LY (2018) Association of Frailty and Long-Term Survival in Patients Undergoing Coronary Artery Bypass Grafting. J Am Heart Assoc 7(15):e009882</Citation><ArticleIdList><ArticleId IdType="pubmed">30030214</ArticleId><ArticleId IdType="pmc">6201467</ArticleId><ArticleId IdType="doi">10.1161/JAHA.118.009882</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa F, Covino M, Russo A, Salini S, Forino R, Della Polla D et al (2023) Frailty assessment as independent prognostic factor for patients &gt;/=65 years undergoing urgent cholecystectomy for acute cholecystitis. Dig Liver Dis 55(4):505&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">36328898</ArticleId><ArticleId IdType="doi">10.1016/j.dld.2022.10.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucoin SD, Hao M, Sohi R, Shaw J, Bentov I, Walker D et al (2020) Accuracy and Feasibility of Clinically Applied Frailty Instruments before Surgery: A Systematic Review and Meta-analysis. Anesthesiology 133(1):78&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pubmed">32243326</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000003257</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasithiotakis K, Petrakis J, Venianaki M, Georgiades G, Koutsomanolis D, Andreou A et al (2013) Frailty predicts outcome of elective laparoscopic cholecystectomy in geriatric patients. Surg Endosc 27(4):1144&#x2013;1150</Citation><ArticleIdList><ArticleId IdType="pubmed">23052539</ArticleId><ArticleId IdType="doi">10.1007/s00464-012-2565-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuy S, Sosa JA, Roman SA, Desai R, Rosenthal RA (2011) Age matters: a study of clinical and economic outcomes following cholecystectomy in elderly Americans. Am J Surg 201(6):789&#x2013;796</Citation><ArticleIdList><ArticleId IdType="pubmed">21741511</ArticleId><ArticleId IdType="doi">10.1016/j.amjsurg.2010.04.018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa F, Covino M, Russo A, Salini S, Forino R, Della Polla D et al (2023) Frailty assessment as independent prognostic factor for patients&#x2265; 65 years undergoing urgent cholecystectomy for acute cholecystitis. Dig Liver Dis 55(4):505&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">36328898</ArticleId><ArticleId IdType="doi">10.1016/j.dld.2022.10.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastalerz K, Kenig J, Olszewska U, Michalik C (2018) The Surgical Apgar score and frailty as outcome predictors in short-and long-term evaluation of fit and frail older patients undergoing elective laparoscopic cholecystectomy&#x2013;a prospective cohort study. Videosurg Other Miniinvasive Tech 13(3):350&#x2013;357</Citation><ArticleIdList><ArticleId IdType="pubmed">30302148</ArticleId><ArticleId IdType="pmc">6174164</ArticleId><ArticleId IdType="doi">10.5114/wiitm.2018.75878</ArticleId></ArticleIdList></Reference><Reference><Citation>Asmar S, Bible L, Obaid O, Anand T, Chehab M, Ditillo M et al (2021) Frail geriatric patients with acute calculous cholecystitis: Operative versus nonoperative management? J Trauma Acute Care Surg 91(1):219&#x2013;225</Citation><ArticleIdList><ArticleId IdType="pubmed">33605704</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000003115</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen ER, Hendriks T, Natroshvili T, Bremers AJ (2020) Retrospective analysis of non-surgical treatment of acute cholecystitis. Surg Infect 21(5):428&#x2013;432</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2019.261</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay K, Das R (2020) Laparoscopic and open cholecystectomy: a comparative study. Int J Surg Sci 4(1):427&#x2013;430</Citation><ArticleIdList><ArticleId IdType="doi">10.33545/surgery.2020.v4.i1h.375</ArticleId></ArticleIdList></Reference><Reference><Citation>Osei-Bordom D, Hall L, Hodson J, Joshi K, Austen L, Bartlett D et al (2022) Impact of Frailty on Short-Term Outcomes After Laparoscopic and Open Hepatectomy. World J Surg 46(10):1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-022-06648-0</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31569138</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>12</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Incidence and Outcomes of Sepsis in Korea: A Nationwide Cohort Study From 2007 to 2016.</ArticleTitle><Pagination><StartPage>e993</StartPage><EndPage>e998</EndPage><MedlinePgn>e993-e998</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000004041</ELocationID><Abstract><AbstractText Label="OBJECTIVES">This study aimed to estimate the incidence and clinical outcomes of sepsis in Korea from 2007 to 2016.</AbstractText><AbstractText Label="DESIGN">Retrospective observational study.</AbstractText><AbstractText Label="SETTING">Nationwide study with population-based healthcare reimbursement claims database.</AbstractText><AbstractText Label="PATIENTS">Using data from the National Health Insurance Service of Korea, patients who were hospitalized with a diagnosis of sepsis from 2007 to 2016 were analyzed. The incidence of sepsis was calculated using mid-year census population and analyzed according to year, age, and sex. The Elixhauser Comorbidity Index score was calculated to adjust for the impact of comorbidities on clinical outcome. In-hospital mortality, hospital length of stay, ICU admission rates, and risk factors for in-hospital mortality were also analyzed.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The incidence of sepsis increased from 173.8 per 100,000 population in 2007 to 233.6 per 100,000 population in 2016. In-hospital mortality decreased from 30.9% in 2007 to 22.6% in 2016 (p &lt; 0.0001). From 2007 to 2016, hospital length of stay and ICU admission rates associated with sepsis decreased from 26.0&#x2009;&#xb1;&#x2009;33.5 days to 21.3&#x2009;&#xb1;&#x2009;24.4 days (p &lt; 0.0001) and from 16.2% to 12.7% (p &lt; 0.0001), respectively. Male sex, age greater than 50 years, Elixhauser Comorbidity Index greater than 10, and mechanical ventilation were identified as risk factors for in-hospital mortality after adjusting for baseline characteristics.</AbstractText><AbstractText Label="CONCLUSIONS">The incidence of sepsis in Korea increased from 2007 to 2016, while the associated in-hospital mortality, hospital length of stay, and ICU admission rates decreased.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Seung-Young</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Care Center, Seoul National University Hospital, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Songhee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Ga Hee</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>Department of Statistics, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Eun Jin</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Information Statistics, Andong National University, Andong, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Seongmi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Statistics, Kyungpook National University, Daegu, Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Health Insurance Service, Health Insurance Policy Research Institute, Gangwon-do, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryu</LastName><ForeName>Ho Geol</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Seoul National University College of Medicine, Seoul, Korea.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010343" MajorTopicYN="N">Patient Admission</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056910" MajorTopicYN="N" Type="Geographic">Republic of Korea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31569138</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000004041</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31796098</PMID><DateCompleted><Year>2020</Year><Month>05</Month><Day>04</Day></DateCompleted><DateRevised><Year>2020</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Dec</Month><Day>03</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>The prognostic value of serum procalcitonin measurements in critically injured patients: a systematic review.</ArticleTitle><Pagination><StartPage>390</StartPage><MedlinePgn>390</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">390</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-019-2669-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Major trauma is associated with high incidence of septic complications and multiple organ dysfunction (MOD), which markedly influence the outcome of injured patients. Early identification of patients at risk of developing posttraumatic complications is crucial to provide early treatment and improve outcomes. We sought to evaluate the prognostic value of serum procalcitonin (PCT) levels after trauma as related to severity of injury, sepsis, organ dysfunction, and mortality.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We searched PubMed, MEDLINE, EMBASE, the Cochrane Database, and references of included articles. Two investigators independently identified eligible studies and extracted data. We included original studies that assessed the prognostic value of serum PCT levels in predicting severity of injury, sepsis, organ dysfunction, and mortality among critically injured adult patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 2015 citations, 19 studies (17 prospective; 2 retrospective) met inclusion criteria. Methodological quality of included studies was moderate. All studies showed a strong correlation between initial PCT levels and Injury Severity Score (ISS). Twelve out of 16 studies demonstrated significant elevation of initial PCT levels in patients who later developed sepsis after trauma. PCT level appeared a strong predictor of MOD in seven out of nine studies. While two studies did not show association between PCT levels and mortality, four studies demonstrated significant elevation of PCT levels in non-survivors versus survivors. One study reported that the PCT level of &#x2265;&#x2009;5&#x2009;ng/mL was associated with significantly increased mortality (OR 3.65; 95% CI 1.03-12.9; p&#x2009;=&#x2009;0.04).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PCT appears promising as a surrogate biomarker for trauma. Initial peak PCT level may be used as an early predictor of sepsis, MOD, and mortality in trauma population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>AlRawahi</LastName><ForeName>Aziza N</ForeName><Initials>AN</Initials><Identifier Source="ORCID">0000-0003-2914-0931</Identifier><AffiliationInfo><Affiliation>Department of Surgery, University of Calgary and the Foothills Medical Centre, North Tower 10th Floor, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada. aziza.alrawahi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>AlHinai</LastName><ForeName>Fatma A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Calgary and the Foothills Medical Centre, North Tower 10th Floor, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doig</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Calgary, Ground Floor McCaig Tower, 3134 Hospital Drive NW, Calgary, Alberta, T2N 5A1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ball</LastName><ForeName>Chad G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Calgary and the Foothills Medical Centre, North Tower 10th Floor, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Trauma Program, University of Calgary and the Foothills Medical Centre, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dixon</LastName><ForeName>Elijah</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Calgary and the Foothills Medical Centre, North Tower 10th Floor, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Zhengwen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Regional Trauma Program, University of Calgary and the Foothills Medical Centre, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Calgary and the Foothills Medical Centre, North Tower 10th Floor, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Calgary, Ground Floor McCaig Tower, 3134 Hospital Drive NW, Calgary, Alberta, T2N 5A1, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Trauma Program, University of Calgary and the Foothills Medical Centre, 1403-29th St. NW, Calgary, Alberta, T2N 2T9, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>12</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="AssociatedDataset"><RefSource>Crit Care. 2020 Jan 7;24(1):9. doi: 10.1186/s13054-020-2729-6.</RefSource><PMID Version="1">31910884</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="Y">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="N">Wounds and Injuries</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="Y">classification</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Injuries</Keyword><Keyword MajorTopicYN="N">Intensive care unit</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">Trauma</Keyword></KeywordList><CoiStatement>AWK has received funding from Kinetic Concepts Incorporated for a randomized controlled trial comparing the ABThera&#x2122; Open Abdomen Negative Pressure Therapy system and Barker&#x2019;s vacuum pack temporary abdominal closure techniques. He has also received travel funding from LifeCell Corp., Syntheses, and Innovative Trauma Care. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>12</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31796098</ArticleId><ArticleId IdType="pmc">PMC6892215</ArticleId><ArticleId IdType="doi">10.1186/s13054-019-2669-1</ArticleId><ArticleId IdType="pii">10.1186/s13054-019-2669-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rhee P, Joseph B, Pandit V, et al. Increasing trauma deaths in the United States. Ann Surg. 2014;260(1):13&#x2013;21. doi: 10.1097/SLA.0000000000000600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000000600</ArticleId><ArticleId IdType="pubmed">24651132</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention, National Center for Injury Prevention and Control. Web&#x2013;based Injury Statistics Query and Reporting System (WISQARS) [online] [2014] Available from URL: https://www.cdc.gov/injury/wisqars/.</Citation></Reference><Reference><Citation>Trunkey DD. Trauma. Accidental and intentional injuries account for more years of life lost in the U.S. than cancer and heart disease. Among the prescribed remedies are improved preventive efforts, speedier surgery and further research. Sci Am. 1983;249(2):28&#x2013;35. doi: 10.1038/scientificamerican0883-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/scientificamerican0883-28</ArticleId><ArticleId IdType="pubmed">6623052</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker CC, Oppenheimer L, Stephens B, et al. Epidemiology of trauma deaths. Am J Surg. 1980;140(1):144&#x2013;150. doi: 10.1016/0002-9610(80)90431-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9610(80)90431-6</ArticleId><ArticleId IdType="pubmed">7396078</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197&#x2013;2223. doi: 10.1016/S0140-6736(12)61689-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61689-4</ArticleId><ArticleId IdType="pubmed">23245608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095&#x2013;2128. doi: 10.1016/S0140-6736(12)61728-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61728-0</ArticleId><ArticleId IdType="pmc">PMC10790329</ArticleId><ArticleId IdType="pubmed">23245604</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann EA, Baun MM, Meininger JC, et al. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock. 2012;37(1):4&#x2013;16. doi: 10.1097/SHK.0b013e318237d6bf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318237d6bf</ArticleId><ArticleId IdType="pubmed">21941222</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am. 1995;75(2):257&#x2013;277. doi: 10.1016/S0039-6109(16)46587-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0039-6109(16)46587-4</ArticleId><ArticleId IdType="pubmed">7899997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 1996;24(7):1125&#x2013;1128. doi: 10.1097/00003246-199607000-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199607000-00010</ArticleId><ArticleId IdType="pubmed">8674323</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 1996;24(1):163&#x2013;172. doi: 10.1097/00003246-199601000-00026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199601000-00026</ArticleId><ArticleId IdType="pubmed">8565523</ArticleId></ArticleIdList></Reference><Reference><Citation>Talmor M, Hydo L, Barie PS. Relationship of systemic inflammatory response syndrome to organ dysfunction, length of stay, and mortality in critical surgical illness: effect of intensive care unit resuscitation. Arch Surg. 1999;134(1):81&#x2013;87. doi: 10.1001/archsurg.134.1.81.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.134.1.81</ArticleId><ArticleId IdType="pubmed">9927137</ArticleId></ArticleIdList></Reference><Reference><Citation>Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36(6):691&#x2013;709. doi: 10.1016/j.injury.2004.12.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2004.12.037</ArticleId><ArticleId IdType="pubmed">15910820</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeifer R, Tarkin IS, Rocos B, et al. Patterns of mortality and causes of death in polytrauma patients--has anything changed? Injury. 2009;40(9):907&#x2013;911. doi: 10.1016/j.injury.2009.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2009.05.006</ArticleId><ArticleId IdType="pubmed">19540488</ArticleId></ArticleIdList></Reference><Reference><Citation>Balci C, Sungurtekin H, G&#xfc;rses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care. 2003;7(1):85&#x2013;90. doi: 10.1186/cc1843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc1843</ArticleId><ArticleId IdType="pmc">PMC154110</ArticleId><ArticleId IdType="pubmed">12617745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Z, Wilson C, Robertson HL, Roberts DJ, Ball CG, Jenne CN, Kirkpatrick AW. Inflammatory mediators in intra-abdominal sepsis or injury - a scoping review. Crit Care. 2015;19(1):373. doi: 10.1186/s13054-015-1093-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1093-4</ArticleId><ArticleId IdType="pmc">PMC4623902</ArticleId><ArticleId IdType="pubmed">26502877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin H, Liu Z, Xiao Y, et al. Prediction of sepsis in trauma patients. Burns Trauma. 2014;2(3):106&#x2013;113. doi: 10.4103/2321-3868.135479.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2321-3868.135479</ArticleId><ArticleId IdType="pmc">PMC5012019</ArticleId><ArticleId IdType="pubmed">27602370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciriello V, Gudipati S, Stavrou PZ, Kanakaris NK, Bellamy MC, Giannoudis PV. Biomarkers predicting sepsis in polytrauma patients: current evidence. Injury. 2013;44(12):1680&#x2013;1692. doi: 10.1016/j.injury.2013.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2013.09.024</ArticleId><ArticleId IdType="pubmed">24119650</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: a review. Pathology. 2007;39(4):383&#x2013;390. doi: 10.1080/00313020701444564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00313020701444564</ArticleId><ArticleId IdType="pubmed">17676478</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoist JF, Mimoz O, Assicot M, et al. Serum procalcitonin, but not C-reactive protein, identifies sepsis in trauma patients. Clin Chem. 1998;44(8 Pt 1):1778&#x2013;1779.</Citation><ArticleIdList><ArticleId IdType="pubmed">9702980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafetzis DA, Velissariou IM, Nikolaides P, et al. Procalcitonin as a predictor of severe appendicitis in children. Eur J Clin Microbiol Infect Dis. 2005;24:484&#x2013;487. doi: 10.1007/s10096-005-1360-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-005-1360-4</ArticleId><ArticleId IdType="pubmed">15995845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyl&#xe9;n ES, Snider RH, Thompson BS, et al. Pneumonitis-associated hyperprocalcitonemia. Am J Med Sci. 1996;312:12&#x2013;18. doi: 10.1016/S0002-9629(15)41740-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9629(15)41740-9</ArticleId><ArticleId IdType="pubmed">8686724</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisner M, Tschaikowsky K, Hutzler A, et al. Postoperative plasma concentration of procalcitonin after different types of surgery. Intensive Care Med. 1998;24:680&#x2013;684. doi: 10.1007/s001340050644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050644</ArticleId><ArticleId IdType="pubmed">9722037</ArticleId></ArticleIdList></Reference><Reference><Citation>Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515&#x2013;518. doi: 10.1016/0140-6736(93)90277-N.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(93)90277-N</ArticleId><ArticleId IdType="pmc">PMC7141580</ArticleId><ArticleId IdType="pubmed">8094770</ArticleId></ArticleIdList></Reference><Reference><Citation>Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med. 2006;34(7):1996&#x2013;2003. doi: 10.1097/01.CCM.0000226413.54364.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000226413.54364.36</ArticleId><ArticleId IdType="pubmed">16715031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surg Infect. 2013;14(6):489&#x2013;511. doi: 10.1089/sur.2012.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2012.028</ArticleId><ArticleId IdType="pubmed">24274059</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen JU, Hein L, Lundgren B, et al. Procalcitonin And Survival Study (PASS) Group. Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Crit Care Med. 2011;39(9):2048&#x2013;2058. doi: 10.1097/CCM.0b013e31821e8791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31821e8791</ArticleId><ArticleId IdType="pubmed">21572328</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336&#x2013;341. doi: 10.1016/j.ijsu.2010.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2010.02.007</ArticleId><ArticleId IdType="pubmed">20171303</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159&#x2013;174. doi: 10.2307/2529310.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2529310</ArticleId><ArticleId IdType="pubmed">843571</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">1597042</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden JA, C&#xf4;t&#xe9; P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144(6):427&#x2013;437. doi: 10.7326/0003-4819-144-6-200603210-00010.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-144-6-200603210-00010</ArticleId><ArticleId IdType="pubmed">16549855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren B, Zou G, Huang Y, et al. Serum levels of HSP70 and other DAMP proteins can aid in patient diagnosis after traumatic injury. Cell Stress Chaperones. 2016;21(4):677&#x2013;686. doi: 10.1007/s12192-016-0694-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-016-0694-4</ArticleId><ArticleId IdType="pmc">PMC4908000</ArticleId><ArticleId IdType="pubmed">27137634</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojtaszek M, Sta&#x15b;kiewicz G, Torres K, et al. Changes of procalcitonin level in multiple trauma patients. Anaesthesiol Intensive Ther. 2014;46(2):78&#x2013;82. doi: 10.5603/AIT.2014.0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.5603/AIT.2014.0015</ArticleId><ArticleId IdType="pubmed">24858965</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajkumari N, Mathur P, Sharma S, et al. Procalcitonin as a predictor of sepsis and outcome in severe trauma patients: a prospective study. J Lab Physicians. 2013;5(2):100&#x2013;108. doi: 10.4103/0974-2727.119852.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0974-2727.119852</ArticleId><ArticleId IdType="pmc">PMC3968618</ArticleId><ArticleId IdType="pubmed">24701102</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakran JV, Michetti CP, Sheridan MJ, et al. The utility of procalcitonin in critically ill trauma patients. J Trauma Acute Care Surg. 2012;73(2):413&#x2013;418. doi: 10.1097/TA.0b013e31825ff5b7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31825ff5b7</ArticleId><ArticleId IdType="pubmed">22846948</ArticleId></ArticleIdList></Reference><Reference><Citation>Haasper C, Kalmbach M, Dikos GD, et al. Prognostic value of procalcitonin (PCT) and/or interleukin-6 (IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome (MODS) or sepsis. Technol Health Care. 2010;18(2):89&#x2013;100. doi: 10.3233/THC-2010-0571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/THC-2010-0571</ArticleId><ArticleId IdType="pubmed">20495248</ArticleId></ArticleIdList></Reference><Reference><Citation>Keel M, H&#xe4;rter L, Reding T, et al. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med. 2009;37(5):1642&#x2013;1648. doi: 10.1097/CCM.0b013e31819da7d6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31819da7d6</ArticleId><ArticleId IdType="pubmed">19325491</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli GP, Pognani C, Cita M, et al. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med. 2009;37(6):1845&#x2013;1849. doi: 10.1097/CCM.0b013e31819ffd5b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31819ffd5b</ArticleId><ArticleId IdType="pubmed">19384224</ArticleId></ArticleIdList></Reference><Reference><Citation>Billeter A, Turina M, Seifert B, et al. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33(3):558&#x2013;566. doi: 10.1007/s00268-008-9896-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-008-9896-y</ArticleId><ArticleId IdType="pubmed">19148699</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier M, Wutzler S, Lehnert M, et al. Serum procalcitonin levels in patients with multiple injuries including visceral trauma. J Trauma. 2009;66(1):243&#x2013;249. doi: 10.1097/TA.0b013e31817c966f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31817c966f</ArticleId><ArticleId IdType="pubmed">19131834</ArticleId></ArticleIdList></Reference><Reference><Citation>Balci C, Sivaci R, Akbulut G, et al. Procalcitonin levels as an early marker in patients with multiple trauma under intensive care. J Int Med Res. 2009;37(6):1709&#x2013;1717. doi: 10.1177/147323000903700606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/147323000903700606</ArticleId><ArticleId IdType="pubmed">20146868</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli GP, Pognani C, Cita M, et al. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol. 2006;72(1&#x2013;2):69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16407808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ertugrul BM, Yilmabasar A, Ertugrul O, et al. Do C-reactive protein and procalcitonin predict hospital-acquired infection in patients with trauma? Saudi Med J. 2006;27(4):560&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">16598344</ArticleId></ArticleIdList></Reference><Reference><Citation>Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care. 2006;10(1):R1. doi: 10.1186/cc3910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3910</ArticleId><ArticleId IdType="pmc">PMC1550798</ArticleId><ArticleId IdType="pubmed">16356205</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger G, Aigner R, Glasner A, et al. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med. 2004;30(2):331&#x2013;334. doi: 10.1007/s00134-003-2111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-2111-6</ArticleId><ArticleId IdType="pubmed">14727016</ArticleId></ArticleIdList></Reference><Reference><Citation>Hensler T, Sauerland S, Lefering R, et al. The clinical value of procalcitonin and neopterin in predicting sepsis and organ failure after major trauma. Shock. 2003;20(5):420&#x2013;426. doi: 10.1097/01.shk.0000093541.78705.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000093541.78705.38</ArticleId><ArticleId IdType="pubmed">14560105</ArticleId></ArticleIdList></Reference><Reference><Citation>Andermahr J, Greb A, Hensler T, et al. Pneumonia in multiple injured patients: a prospective controlled trial on early prediction using clinical and immunological parameters. Inflamm Res. 2002;51(5):265&#x2013;272. doi: 10.1007/PL00000303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00000303</ArticleId><ArticleId IdType="pubmed">12056515</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberholzer A, Keel M, Zellweger R, et al. Incidence of septic complications and multiple organ failure in severely injured patients is sex specific. J Trauma. 2000;48(5):932&#x2013;937. doi: 10.1097/00005373-200005000-00019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-200005000-00019</ArticleId><ArticleId IdType="pubmed">10823539</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanner GA, Keel M, Steckholzer U, et al. Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med. 2000;28(4):950&#x2013;957. doi: 10.1097/00003246-200004000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200004000-00007</ArticleId><ArticleId IdType="pubmed">10809265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimoz O, Benoist JF, Edouard AR, et al. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998;24(2):185&#x2013;188. doi: 10.1007/s001340050543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s001340050543</ArticleId><ArticleId IdType="pubmed">9539079</ArticleId></ArticleIdList></Reference><Reference><Citation>Civil ID, Schwab CW. The Abbreviated Injury Scale, 1985 revision: a condensed chart for clinical use. J Trauma. 1988;28(1):87&#x2013;90. doi: 10.1097/00005373-198801000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-198801000-00012</ArticleId><ArticleId IdType="pubmed">3339667</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;710. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Goris RJ, te Boekhorst TP, Nuytinck JK, et al. Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg. 1985;120(10):1109&#x2013;1115. doi: 10.1001/archsurg.1985.01390340007001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.1985.01390340007001</ArticleId><ArticleId IdType="pubmed">4038052</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefering R, Goris RJ, van Nieuwenhoven EJ, et al. Revision of the multiple organ failure score. Langenbeck's Arch Surg. 2002;387(1):14&#x2013;20. doi: 10.1007/s00423-001-0269-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-001-0269-3</ArticleId><ArticleId IdType="pubmed">11981679</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367&#x2013;374. doi: 10.1097/CCM.0b013e3181cb0cdc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181cb0cdc</ArticleId><ArticleId IdType="pubmed">20035219</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima A, Yazawa J, Sugiki D, et al. Clinical utility of procalcitonin as a marker of sepsis: a potential predictor of causative pathogens. Intern Med. 2014;53:1497&#x2013;1503. doi: 10.2169/internalmedicine.53.1785.</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.53.1785</ArticleId><ArticleId IdType="pubmed">25030560</ArticleId></ArticleIdList></Reference><Reference><Citation>Castelli GP, Pognani C, Meisner M, et al. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004;8:R234&#x2013;R242. doi: 10.1186/cc2877.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc2877</ArticleId><ArticleId IdType="pmc">PMC522844</ArticleId><ArticleId IdType="pubmed">15312223</ArticleId></ArticleIdList></Reference><Reference><Citation>Meynaar I, Droog W, Batstra M, et al. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011;2011:594&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3113363</ArticleId><ArticleId IdType="pubmed">21687569</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng S, Zhu H, Wang K, et al. Procalcitonin as a marker of sepsis and outcome in patients with neurotrauma: an observation study. BMC Anesthesiol. 2013;13:48&#x2013;51. doi: 10.1186/1471-2253-13-48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2253-13-48</ArticleId><ArticleId IdType="pmc">PMC3932500</ArticleId><ArticleId IdType="pubmed">24330775</ArticleId></ArticleIdList></Reference><Reference><Citation>Nobre V, Harbarth S, Jean-Daniel G, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498&#x2013;505. doi: 10.1164/rccm.200708-1238OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200708-1238OC</ArticleId><ArticleId IdType="pubmed">18096708</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin (PCT)-guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Arch Surg. 2009;394:221&#x2013;226. doi: 10.1007/s00423-008-0432-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00423-008-0432-1</ArticleId><ArticleId IdType="pubmed">19034493</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochreiter M, Kohler T, Schweiger AM, et al. Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care. 2009;13(R83):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2717450</ArticleId><ArticleId IdType="pubmed">19493352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients&#x2019; exposure to antibiotics in intensive care units (PRORATA trial): a multicenter randomized controlled trial. Lancet. 2010;375:463&#x2013;474. doi: 10.1016/S0140-6736(09)61879-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(09)61879-1</ArticleId><ArticleId IdType="pubmed">20097417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351(1&#x2013;2):17&#x2013;29. doi: 10.1016/j.cccn.2004.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cccn.2004.08.018</ArticleId><ArticleId IdType="pubmed">15563869</ArticleId></ArticleIdList></Reference><Reference><Citation>Meynaar IA, Droog W, Batstra M, et al. In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, Il-6, or LBP. Crit Care Res Pract. 2011;2011:594645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3113363</ArticleId><ArticleId IdType="pubmed">21687569</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr JA. Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit. J Intensive Care. 2015;3(1):36. doi: 10.1186/s40560-015-0100-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-015-0100-9</ArticleId><ArticleId IdType="pmc">PMC4523913</ArticleId><ArticleId IdType="pubmed">26244096</ArticleId></ArticleIdList></Reference><Reference><Citation>Osborn TM, Tracy JK, Dunne JR, et al. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med. 2004;32(11):2234&#x2013;2240. doi: 10.1097/01.CCM.0000145586.23276.0F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000145586.23276.0F</ArticleId><ArticleId IdType="pubmed">15640635</ArticleId></ArticleIdList></Reference><Reference><Citation>Plurad DS, Lustenberger T, Kilday P, et al. The association of race and survival from sepsis after injury. Am Surg. 2010;76(1):43Y47.</Citation><ArticleIdList><ArticleId IdType="pubmed">20135938</ArticleId></ArticleIdList></Reference><Reference><Citation>Svoboda P, Kantorov&#xe1; I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery? Hepatogastroenterology. 2007;54(74):359&#x2013;363.</Citation><ArticleIdList><ArticleId IdType="pubmed">17523274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28843067</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><PubDate><Year>2018</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Elevated modified shock index in early sepsis is associated with myocardial dysfunction and mortality.</ArticleTitle><Pagination><StartPage>30</StartPage><EndPage>35</EndPage><MedlinePgn>30-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2017.08.019</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(17)30568-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study was to explore the association of an elevated modified shock index (MSI) in sepsis and myocardial dysfunction.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single center exploratory retrospective cohort study was conducted at Mayo Clinic from 2011 to 2014. It includes adults admitted to the medical intensive care unit with severe sepsis or septic shock. The time MSI&gt;1.3, area under the curve, in the first 6h was assessed using logistic regression for primary outcomes of myocardial dysfunction and depression and secondary outcomes including mortality and SOFA score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall 578 individuals met inclusion criteria, 169 (29%) developed myocardial dysfunction and 23 (4%) myocardial depression. Adjusted for age, gender, Charlson score, and baseline APACHE 3 score, area MSI&gt;1.3 was associated with increased odds of myocardial dysfunction (OR 1.10, 95% CI 1.00-1.21; p=0.058) and depression (OR 1.28, 95% CI 1.07-1.53; p=0.007). Associations were also seen with ICU mortality (OR 1.17, 95% CI 1.04-1.32; p=0.011), hospital mortality (OR 1.13, 95% CI 1.02-1.25; p=0.025) and SOFA score.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Elevated modified shock index during early sepsis is associated with the development of myocardial dysfunction and depression, SOFA score and mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2017 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jayaprakash</LastName><ForeName>Namita</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Division of Pulmonary and Critical Care, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, United States. Electronic address: namita.njayapr1@hfhs.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajic</LastName><ForeName>Ognjen</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Ryan D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Department Biomedical statistics and informatics, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smischney</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesia/Critical Care Division, HEMAIR (HEModynamic and AIRway Management Group), Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009202" MajorTopicYN="N">Cardiomyopathies</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004452" MajorTopicYN="N">Echocardiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiovascular</Keyword><Keyword MajorTopicYN="N">Heart dysfunction</Keyword><Keyword MajorTopicYN="N">Myocardium</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28843067</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2017.08.019</ArticleId><ArticleId IdType="pii">S0883-9441(17)30568-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28457334</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>210</Volume><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Plasma DNA and RNA differentially impact coagulation during abdominal sepsis-an explorative study.</ArticleTitle><Pagination><StartPage>231</StartPage><EndPage>243</EndPage><MedlinePgn>231-243</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2016.11.044</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(16)30523-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Cell-free DNA (cfDNA) and extracellular RNA (exRNA) are both suspected to activate coagulation cascades in sepsis. Therefore, our study investigated the influence of plasmatic nucleic acids on coagulation in septic patients in comparison to patients after major abdominal surgery.</AbstractText><AbstractText Label="MATERIALS AND METHODS">A total of 15 patients with sepsis, 10 postoperative patients, and 10 healthy volunteers were included in this longitudinal study. Blood was collected at sepsis onset and after surgery respectively, as well as after 24, 72 and 168&#xa0;h. Levels of cfDNA and exRNA were measured by quantitative probe-based polymerase chain reaction. In addition, thromboelastography for coagulation as well as thromboaggregometry for platelet function was conducted.</AbstractText><AbstractText Label="RESULTS">Both cfDNA and exRNA were elevated in patients with sepsis compared with postoperative patients and healthy volunteers. While higher exRNA levels correlated with a faster clotting time and more stable clots, cfDNA correlated with a shorter clotting time but also less fibrinolysis. In addition, higher cfDNA seems to be associated with kidney dysfunction as well as with general markers of cell damage (lactate dehydrogenase and lactate).</AbstractText><AbstractText Label="CONCLUSIONS">Both nucleic acid species might be associated with different effects on coagulation during sepsis, with an overall procoagulatory influence. For this reason, individualized therapeutic approaches in patients suffering from coagulation-associated organ dysfunction might be feasible.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schneck</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samara</LastName><ForeName>Omar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Hospital of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecker</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General and Thoracic Surgery, University Hospital of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padberg</LastName><ForeName>Winfried</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of General and Thoracic Surgery, University Hospital of Giessen and Marburg, Giessen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtenstern</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weigand</LastName><ForeName>Markus Alexander</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhle</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany. Electronic address: florian.uhle@med.uni-heidelberg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>11</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001777" MajorTopicYN="Y">Blood Coagulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013916" MajorTopicYN="N">Thrombelastography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">ROTEM</Keyword><Keyword MajorTopicYN="N">Systemic inflammatory response syndrome</Keyword><Keyword MajorTopicYN="N">Thromboelastography</Keyword><Keyword MajorTopicYN="N">cfDNA</Keyword><Keyword MajorTopicYN="N">exRNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28457334</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2016.11.044</ArticleId><ArticleId IdType="pii">S0022-4804(16)30523-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27105616</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>07</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>12</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Impact of intraoperative cholangiography on postoperative morbidity and readmission: analysis of the NSQIP database.</ArticleTitle><Pagination><StartPage>5395</StartPage><EndPage>5403</EndPage><MedlinePgn>5395-5403</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND">The debate regarding the merits of routine use of intraoperative cholangiography (IOC) during laparoscopic cholecystectomy (LC) continues to rage. We aim to analyze the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to identify patterns of utilization of cholangiography during LC as well as its impact on patient outcomes.</AbstractText><AbstractText Label="STUDY DESIGN">This is a retrospective cohort study of patients undergoing LC with or without IOC in the 2012 and 2013 ACS NSQIP database. Only patients without any preoperative biochemical evidence of the CBD stone were included in the analysis. Comparison between two groups and data analysis focused on the following primary outcomes: 30-day mortality, readmission, return to operating room and NSQIP collected morbidity.</AbstractText><AbstractText Label="RESULTS">Twenty-one percentage of patients undergoing LC without any biochemical abnormality are undergoing IOC. There were no statistically significant differences in thirty-day outcomes between two patient populations with regard to mortality, morbidity, cardiac, central nervous system, wound, deep vein thrombosis, sepsis, respiratory and urinary tract complications. Patients undergoing LC plus IOC were found to have statistically significant reduction in the rate of readmission related to the first operation (adjusted odds ratio 0.80, 95&#xa0;% CI 0.70-0.92; P value&#xa0;=&#xa0;0.002). Readmissions related to biliary complications including retained CBD following cholecystectomy were 1.61 times more likely in patients who underwent LC without cholangiography.</AbstractText><AbstractText Label="CONCLUSION">The use of IOC at the time of LC appears to be associated with a statistically significant decrease in re-admission rates, especially readmissions related to biliary complications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Halawani</LastName><ForeName>Hamzeh M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Surgery, American University of Beirut Medical Center, Cairo Street, Riad El Solh, PO Box 11-0236, Beirut, 1107 2020, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tamim</LastName><ForeName>Hani</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalifeh</LastName><ForeName>Farah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Immunology and Microbiology, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mailhac</LastName><ForeName>Aur&#xe9;lie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Clinical Research Institute, American University of Beirut Medical Center, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jamali</LastName><ForeName>Faek R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Department of Surgery, American University of Beirut Medical Center, Cairo Street, Riad El Solh, PO Box 11-0236, Beirut, 1107 2020, Lebanon. fj03@aub.edu.lb.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002758" MajorTopicYN="N">Cholangiography</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017081" MajorTopicYN="Y">Cholecystectomy, Laparoscopic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042882" MajorTopicYN="N">Gallstones</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007430" MajorTopicYN="N">Intraoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010818" MajorTopicYN="N">Practice Patterns, Physicians'</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bile duct injury</Keyword><Keyword MajorTopicYN="N">Common bile duct stones</Keyword><Keyword MajorTopicYN="N">Intraoperative cholangiography</Keyword><Keyword MajorTopicYN="N">Laparoscopic cholecystectomy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27105616</ArticleId><ArticleId IdType="doi">10.1007/s00464-016-4896-8</ArticleId><ArticleId IdType="pii">10.1007/s00464-016-4896-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Surg Endosc. 2010 Oct;24(10):2368-86</Citation><ArticleIdList><ArticleId IdType="pubmed">20706739</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2012 Feb;99(2):160-7</Citation><ArticleIdList><ArticleId IdType="pubmed">22183717</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2004 Apr;187(4):475-81</Citation><ArticleIdList><ArticleId IdType="pubmed">15041494</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2007 Jan;21(1):34-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17111284</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2014 May;101(6):677-84</Citation><ArticleIdList><ArticleId IdType="pubmed">24664658</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Surg. 2015 Aug 13;15:97</Citation><ArticleIdList><ArticleId IdType="pubmed">26268709</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2012 Sep;94(6):375-80</Citation><ArticleIdList><ArticleId IdType="pubmed">22943325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2011 Oct 15;378(9800):1396-407</Citation><ArticleIdList><ArticleId IdType="pubmed">21982521</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 1998 Nov;12(11):1303-10</Citation><ArticleIdList><ArticleId IdType="pubmed">9788852</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2012 Apr;214(4):668-79; discussion 679-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22366491</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2007 Jun;21(6):955-9</Citation><ArticleIdList><ArticleId IdType="pubmed">17285384</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Apr 2;289(13):1639-44</Citation><ArticleIdList><ArticleId IdType="pubmed">12672731</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35460850</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>International journal of antimicrobial agents</Title><ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation></Journal><ArticleTitle>Epidemiology and age-related mortality in critically ill patients with intra-abdominal infection or sepsis: an international cohort study.</ArticleTitle><Pagination><StartPage>106591</StartPage><MedlinePgn>106591</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2022.106591</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0924-8579(22)00095-4</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe epidemiology and age-related mortality in critically ill older adults with intra-abdominal infection.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A secondary analysis was undertaken of a prospective, multi-national, observational study (Abdominal Sepsis Study, ClinicalTrials.gov #NCT03270345) including patients with intra-abdominal infection from 309 intensive care units (ICUs) in 42 countries between January and December 2016. Mortality was considered as ICU mortality, with a minimum of 28 days of observation when patients were discharged earlier. Relationships with mortality were assessed by logistic regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The cohort included 2337 patients. Four age groups were defined: middle-aged patients [reference category; 40-59 years; n=659 (28.2%)], young-old patients [60-69 years; n=622 (26.6%)], middle-old patients [70-79 years; n=667 (28.5%)] and very old patients [&#x2265;80 years; n=389 (16.6%)]. Secondary peritonitis was the predominant infection (68.7%) and was equally prevalent across age groups. Mortality increased with age: 20.9% in middle-aged patients, 30.5% in young-old patients, 31.2% in middle-old patients, and 44.7% in very old patients (P&lt;0.001). Compared with middle-aged patients, young-old age [odds ratio (OR) 1.62, 95% confidence interval (CI) 1.21-2.17], middle-old age (OR 1.80, 95% CI 1.35-2.41) and very old age (OR 3.69, 95% CI 2.66-5.12) were independently associated with mortality. Other independent risk factors for mortality included late-onset hospital-acquired intra-abdominal infection, diffuse peritonitis, sepsis/septic shock, source control failure, liver disease, congestive heart failure, diabetes and malnutrition.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">For ICU patients with intra-abdominal infection, age &gt;60 years was associated with mortality; patients aged &#x2265;80 years had the worst prognosis. Comorbidities and overall disease severity further compromised survival. As all of these factors are non-modifiable, it remains unclear how to improve outcomes.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arvaniti</LastName><ForeName>Kostoula</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Papageorgiou University Affiliated Hospital, Thessalon&#xed;ki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulos</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Critical Care Department, University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology, Intensive Care and Emergency Medicine, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Universit&#xe0; Cattolica del Sacro Cuore, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blot</LastName><ForeName>Koen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creagh-Brown</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Surrey Perioperative Anaesthetic Critical Care Collaborative Research Group, Royal Surrey County Hospital, Guildford, UK; Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deschepper</LastName><ForeName>Mieke</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Strategic Policy Cell, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lange</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dikmen</LastName><ForeName>Yalim</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Reanimation, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eckmann</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of General, Visceral and Thoracic Surgery, Klinikum Hannoversch-Muenden, Goettingen University, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Einav</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Intensive Care Unit, Shaare Zedek Medical Centre, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Francois</LastName><ForeName>Guy</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Scientific Affairs-Research, European Society of Intensive Care Medicine, Brussels, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fjeldsoee-Nielsen</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care, Nykoebing Falster Hospital, Nykoebing Falster, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Girardis</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Anaesthesia and Intensive Care Department, University Hospital of Modena, Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jovanovic</LastName><ForeName>Bojan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Anaesthesia and Resuscitation, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindner</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Intensive Care Medicine, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koulenti</LastName><ForeName>Despoina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Burns, Trauma and Critical Care Research Centre, Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia; 2nd Critical Care Department, Attikon University Hospital, Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labeau</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium; Department of Nursing, Faculty of Education, Health and Social Work, University College Ghent, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipman</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Jamieson Trauma Institute and The University of Queensland, Brisbane, Australia; Nimes University Hospital, University of Montpellier, Nimes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipovestky</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Critical Care Department, Hospital of the Interamerican Open University, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makikado</LastName><ForeName>Luis Daniel Umezawa</ForeName><Initials>LDU</Initials><AffiliationInfo><Affiliation>Unidad de Cuidados Intensivos, Cl&#xed;nica Ricardo Palma, Lima, Per&#xfa;.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maseda</LastName><ForeName>Emilio</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Surgical Critical Care, Department of Anaesthesia, Hospital Universitario La Paz-IdiPaz, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mikstacki</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, Poznan University of Medical Sciences, Poznan, Poland; Department of Anaesthesiology and Intensive Therapy, Regional Hospital in Poznan, Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montravers</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris, NSERM UMR 1152 - ANR10-LABX-17, Paris, France; AP-HP, H&#xf4;pital Bichat, Department of Anaesthesiology and Critical Care Medicine, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paiva</LastName><ForeName>Jos&#xe9; Artur</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Intensive Care Department, Faculty of Medicine, Centro Hospitalar Universitario S. Joao, Faculty of Medicine, University of Porto, Grupo Infec&#xe7;ao e Sepsis, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pereyra</LastName><ForeName>Cecilia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Intensive Care Unit from Hospital Interzonal General de Agudos "Prof Dr Luis Guemes", Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rello</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Ciberes and Vall d'Hebron Institute of Research, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timsit</LastName><ForeName>Jean-Francois</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Universit&#xe9; de Paris, IAME, INSERM, Paris, France; AP-HP and H&#xf4;pital Bichat, Medical and Infection Diseases ICU (MI2), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomescu</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Critical Care, Fundeni Clinical Institute, Bucharest, Romania; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vogelaers</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of General Internal Medicine and Infectious Diseases, AZ Delta, Roeselare, Belgium; Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blot</LastName><ForeName>Stijn</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium. Electronic address: stijn.blot@UGent.be.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Abdominal Sepsis Study (AbSeS) Group on behalf of the Trials Group of the European Society of Intensive Care Medicine</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03270345</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Antimicrob Agents</MedlineTA><NlmUniqueID>9111860</NlmUniqueID><ISSNLinking>0924-8579</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059413" MajorTopicYN="Y">Intraabdominal Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010538" MajorTopicYN="Y">Peritonitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ICU</Keyword><Keyword MajorTopicYN="N">Intra-abdominal infection</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword><Keyword MajorTopicYN="N">Older adults</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>11</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35460850</ArticleId><ArticleId IdType="doi">10.1016/j.ijantimicag.2022.106591</ArticleId><ArticleId IdType="pii">S0924-8579(22)00095-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17992396</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>25</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1516-3180</ISSN><JournalIssue CitedMedium="Print"><Volume>125</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>Sao Paulo medical journal = Revista paulista de medicina</Title><ISOAbbreviation>Sao Paulo Med J</ISOAbbreviation></Journal><ArticleTitle>Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial.</ArticleTitle><Pagination><StartPage>237</StartPage><EndPage>241</EndPage><MedlinePgn>237-41</MedlinePgn></Pagination><Abstract><AbstractText Label="CONTEXT AND OBJECTIVE" NlmCategory="OBJECTIVE">Sepsis and septic shock are very common conditions among critically ill patients that lead to multiple organ dysfunction syndrome (MODS) and death. Our purpose was to investigate the efficacy of early administration of dexamethasone for patients with septic shock, with the aim of halting the progression towards MODS and death.</AbstractText><AbstractText Label="DESIGN AND SETTING" NlmCategory="METHODS">Prospective, randomized, double-blind, single-center study, developed in a surgical intensive care unit at Hospital das Cl&#xed;nicas, Faculdade de Medicina da Universidade de S&#xe3;o Paulo.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study involved 29 patients with septic shock. All eligible patients were prospectively randomized to receive either a dose of 0.2 mg/kg of dexamethasone (group D) or placebo (group P), given three times at intervals of 36 hours. The patients were monitored over a seven-day period by means of the sequential organ failure assessment score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients treated with dexamethasone did not require vasopressor therapy for as much time over the seven-day period as did the placebo group (p = 0.043). Seven-day mortality was 67% in group P (10 out of 15) and 21% in group D (3 out of 14) (relative risk = 0.31, 95% confidence interval 0.11 to 0.88). Dexamethasone enhanced the effects of vasopressor drugs.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Early treatment with dexamethasone reduced the seven-day mortality among septic shock patients and showed a trend towards reduction of 28-day mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cicarelli</LastName><ForeName>Domingos Dias</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hospital das Cl&#xed;nicas, Faculdade de Medicina, Universidade de S&#xe3;o Paulo, Porto, Portugal. dcicarelli@uol.com.br</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vieira</LastName><ForeName>Joaquim Edson</ForeName><Initials>JE</Initials></Author><Author ValidYN="Y"><LastName>Bense&#xf1;or</LastName><ForeName>F&#xe1;bio Ely Martins</ForeName><Initials>FE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Sao Paulo Med J</MedlineTA><NlmUniqueID>100897261</NlmUniqueID><ISSNLinking>1516-3180</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010919">Placebos</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001938" MajorTopicYN="N" Type="Geographic">Brazil</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010919" MajorTopicYN="N">Placebos</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="por"><AbstractText Label="CONTEXTO E OBJETIVO:">Sepse e choque s&#xe9;ptico s&#xe3;o doen&#xe7;as muito comuns em pacientes gravemente enfermos, evoluindo muitas vezes com s&#xed;ndrome de disfun&#xe7;&#xe3;o de m&#xfa;ltiplos &#xf3;rg&#xe3;os (SDMO) e morte. A proposta do trabalho foi investigar a efic&#xe1;cia da administra&#xe7;&#xe3;o precoce de dexametasona a estes pacientes, tentando evitar a progress&#xe3;o do choque s&#xe9;ptico para SDMO e morte.</AbstractText><AbstractText Label="TIPO DE ESTUDO E LOCAL:">Estudo prospectivo, aleat&#xf3;rio, duplamente encoberto, monoc&#xea;ntrico, realizado na Unidade de Terapia Intensiva p&#xf3;s-operat&#xf3;ria do Hospital das Cl&#xed;nicas da Faculdade de Medicina da Universidade de S&#xe3;o Paulo.</AbstractText><AbstractText Label="M&#xc9;TODOS:">Foram estudados 29 pacientes com choque s&#xe9;ptico. Os participantes foram aleatoriamente divididos em dois grupos que receberam 0,2 mg/kg de dexametasona (grupo D) ou placebo (grupo P), repetidas a cada 36 horas. Os pacientes foram acompanhados durante sete dias de interna&#xe7;&#xe3;o na Unidade de Terapia Intensiva atrav&#xe9;s do escore SOFA (Sequential Organ Failure Assessment).</AbstractText><AbstractText Label="RESULTADOS:">Os pacientes que receberam dexametasona necessitaram de menos tempo de tratamento com vasopressores durante o per&#xed;odo de sete dias (p = 0,043). A mortalidade em sete dias no grupo P foi de 67% (10 em 15) e no grupo D foi de 21% (3 em 14) (risco relativo = 0.31, intervalo de confian&#xe7;a 95% 0.11-0.88).</AbstractText><AbstractText Label="CONCLUS&#xc3;O:">O tratamento precoce com dexametasona dos pacientes com choque s&#xe9;ptico reduziu a mortalidade em sete dias de acompanhamento e mostrou tend&#xea;ncia de redu&#xe7;&#xe3;o da mortalidade em 28 dias.</AbstractText></OtherAbstract><CoiStatement><b>Conflicts of interest:</b> Not declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2007</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>11</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>23</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>11</Month><Day>10</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2007</Year><Month>7</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17992396</ArticleId><ArticleId IdType="pmc">PMC11020550</ArticleId><ArticleId IdType="doi">10.1590/s1516-31802007000400009</ArticleId><ArticleId IdType="pii">S1516-31802007000400009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12519925</ArticleId></ArticleIdList></Reference><Reference><Citation>Christman JW, Lancaster LH, Blackwell TS. Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy. Intensive Care Med. 1998;24(11):1131&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094907</ArticleId><ArticleId IdType="pubmed">9876974</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS., Jr Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science. 1995;270(5234):283&#x2013;286.</Citation><ArticleIdList><ArticleId IdType="pubmed">7569975</ArticleId></ArticleIdList></Reference><Reference><Citation>Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med. 1999;27(4):723&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">10321661</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA. 1998;280(2):159&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">9669790</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlet J, International Sepsis Forum Immunological therapy in sepsis: currently available. Intensive Care Med. 2001;27(Suppl 1):S93&#x2013;S103.</Citation><ArticleIdList><ArticleId IdType="pubmed">11307373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicarelli DD, Bense&#xf1;or FE, Vieira JE. Effects of single dose of dexamethasone on patients with systemic inflammatory response. Sao Paulo Med J. 2006;124(2):90&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11060357</ArticleId><ArticleId IdType="pubmed">16878192</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmer BP, Parker KL. Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. pp. 1459&#x2013;1485.</Citation></Reference><Reference><Citation>Reade MC, Young JD. Consent for observational studies in critical care: time to open Pandora's Box. Anaesthesia. 2003;58(1):1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">12492660</ArticleId></ArticleIdList></Reference><Reference><Citation>Cook R, Cook D, Tilley J, Lee K, Marshall J, Canadian Critical Care Trials Group Multiple organ dysfunction: baseline and serial component scores. Crit Care Med. 2001;29(11):2046&#x2013;2050.</Citation><ArticleIdList><ArticleId IdType="pubmed">11700393</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;710.</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendon&#xe7;a A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26(11):1793&#x2013;1800.</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettil&#xe4; V, Pettil&#xe4; M, Sarna S, Voutilainen P, Takkunen O. Comparison of multiple organ dysfunction scores in the prediction of hospital mortality in the critically ill. Crit Care Med. 2002;30(8):1705&#x2013;1711.</Citation><ArticleIdList><ArticleId IdType="pubmed">12163780</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xf3;voa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med. 1998;24(10):1052&#x2013;1056.</Citation><ArticleIdList><ArticleId IdType="pubmed">9840239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hollenberg SM, Ahrens TS, Annane D, et al. Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med. 2004;32(9):1928&#x2013;1948.</Citation><ArticleIdList><ArticleId IdType="pubmed">15343024</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenberg RS, Daniels SR, Flanders WD, Eley JW, Boring JR. Medical epidemiology. 3rd ed. New York: McGraw-Hill; 2001.</Citation></Reference><Reference><Citation>MacLaren R, Jung R. Stress-dose corticosteroids therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults. Pharmacotherapy. 2002;22(9):1140&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pubmed">12222550</ArticleId></ArticleIdList></Reference><Reference><Citation>Manglik S, Flores E, Lubarsky L, Fernandez F, Chhibber VL, Tayek JA. Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial. Crit Care Med. 2003;31(6):1668&#x2013;1675.</Citation><ArticleIdList><ArticleId IdType="pubmed">12794402</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham E, Evans T. Corticosteroids and septic shock. JAMA. 2002;288(7):886&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pubmed">12186608</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, S&#xe9;bille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862&#x2013;871.</Citation><ArticleIdList><ArticleId IdType="pubmed">12186604</ArticleId></ArticleIdList></Reference><Reference><Citation>Matot I, Sprung CL. Corticosteroids in septic shock: resurrection of the last rites? Crit Care Med. 1998;26(4):627&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559592</ArticleId></ArticleIdList></Reference><Reference><Citation>Meduri GU, Kanangat S. Glucocorticoid treatment of sepsis and acute respiratory distress syndrome: time for a critical reappraisal. Crit Care Med. 1998;26(4):630&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">9559593</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson BT. Glucocorticoids and acute lung injury. Crit Care Med. 2003;31(4 Suppl):S253&#x2013;S257.</Citation><ArticleIdList><ArticleId IdType="pubmed">12682449</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin GS, Bernard GR, International Sepsis Forum Airway and lung in sepsis. Intensive Care Med. 2001;27(Suppl 1):S63&#x2013;S79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11307371</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33435881</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month><Day>12</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Risk factors for unplanned reintubation caused by acute airway compromise after general anesthesia: a case-control study.</ArticleTitle><Pagination><StartPage>17</StartPage><MedlinePgn>17</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-021-01238-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">This study aimed to identify the risk factors and evaluate the prognosis of unplanned reintubation caused by acute airway compromise (AAC) after general anesthesia.</AbstractText><AbstractText Label="METHODS">This case-control study included surgical patients who underwent unplanned reintubation in the operating room and postanesthesia care unit after general anesthesia between January 1, 2014, and December 31, 2018. Cases due to AAC were matched 1:4 with randomly selected controls.</AbstractText><AbstractText Label="RESULTS">A total of 123,068 patients were included, and reintubation due to AAC was performed in 36 patients (approximate incidence 0.03%). Univariable analysis revealed that male sex, age&#x2009;&gt;&#x2009;65, ASA physical status 3, sepsis, heart disease history, cerebral infarction history, Cormack Lehane grade, surgery type, fresh frozen plasma infusion, increased intubation duration, white blood cell count, and creatinine clearance rate were related to AAC-caused unplanned reintubation. Multivariable analysis revealed that age&#x2009;&gt;&#x2009;65 (OR&#x2009;=&#x2009;7.50, 95% CI 2.47-22.81, P&#x2009;&lt;&#x2009;0.001), ASA physical status 3 (OR&#x2009;=&#x2009;6.51, 95% CI 1.18-35.92, P&#x2009;=&#x2009;0.032), head-neck surgery (OR&#x2009;=&#x2009;4.94, 95% CI 1.33-18.36, P&#x2009;=&#x2009;0.017) or thoracic surgery (OR&#x2009;=&#x2009;12.56, 95% CI 2.93-53.90, P&#x2009;&lt;&#x2009;0.001) and a high fluid load (OR&#x2009;=&#x2009;3.04, 95% CI 1.16-7.99, P&#x2009;=&#x2009;0.024) were associated with AAC-caused unplanned reintubation. AAC-caused unplanned reintubation patients had longer postoperative hospital (OR&#x2009;=&#x2009;5.26, 95% CI 1.57-8.95, P&#x2009;&lt;&#x2009;0.001) and intensive care unit days (OR&#x2009;=&#x2009;3.94, 95% CI 1.69-6.18, P&#x2009;&lt;&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSIONS">Age&#x2009;&gt;&#x2009;65, ASA physical status 3, head-neck or thoracic surgery and high fluid load were found to be associated with AAC-caused unplanned reintubation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Si</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yuelun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Research Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Che</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Le</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2563-0012</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China. pumchshenle@aliyun.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yuguang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2016-I2M-3-024</GrantID><Agency>Chinese Academy of Medical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060666" MajorTopicYN="N">Airway Extubation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="N">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001826" MajorTopicYN="N">Body Fluids</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007442" MajorTopicYN="N">Intubation, Intratracheal</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Airway</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Extubation</Keyword><Keyword MajorTopicYN="N">General anesthesia</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>13</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>1</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33435881</ArticleId><ArticleId IdType="pmc">PMC7802267</ArticleId><ArticleId IdType="doi">10.1186/s12871-021-01238-4</ArticleId><ArticleId IdType="pii">10.1186/s12871-021-01238-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thille AW, Harrois A, Schortgen F, Brun-Buisson C, Brochard L. Outcomes of extubation failure in medical intensive care unit patients. Crit Care Med. 2011;39(12):2612&#x2013;2618.</Citation><ArticleIdList><ArticleId IdType="pubmed">21765357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran SK, Nafiu OO, Ghaferi AA, Tremper KK, Shanks A, Kheterpal S. Independent predictors and outcomes of unanticipated early postoperative tracheal intubation after nonemergent, noncardiac surgery. Anesthesiology. 2011;115(1):44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">21552116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinachoti T, Poopipatpab S, Buranatrevedhya S, Taratarnkoolwatana K, Werawataganon T, Jantorn P. The Thai anesthesia incident monitoring study (Thai AIMS) of post anesthetic reintubation: an analysis of 184 incident reports. J Med Assoc Thail. 2008;91(11):1706&#x2013;1713.</Citation><ArticleIdList><ArticleId IdType="pubmed">19127793</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaber S, Quintard H, Cinotti R, Asehnoune K, Arnal J, Guitton C, Paugam-Burtz C, Abback P, Dessap AM, Lakhal K, et al. Risk factors and outcomes for airway failure versus non-airway failure in the intensive care unit: a multicenter observational study of 1514 extubation procedures. Crit Care. 2018;22:236.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6151191</ArticleId><ArticleId IdType="pubmed">30243304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii E, Fujino K, Tanaka-Mizuno S, Eguchi Y. Variation of Risk Factors for Cause-Specific Reintubation: A Preliminary Study. Can Respir J. 2018;2018:3654251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6230426</ArticleId><ArticleId IdType="pubmed">30510604</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfeld G, Kahn JM, Shankar-Hari M, Singer M, et al. Assessment of clinical criteria for Sepsis: for the third international consensus definitions for Sepsis and septic shock (Sepsis-3) JAMA. 2016;315(8):762&#x2013;774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin P, Chen C, Chiu H, Tai H, Lee DL, Lai R. Outcomes of unplanned extubation in ordinary ward are similar to those in intensive care unit. Medicine (Baltimore) 2019;98(11):e14841.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6426589</ArticleId><ArticleId IdType="pubmed">30882675</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaallah AF, Vallejo MC, Elzamzamy OM, Mueller MG, Eller WS. Perioperative risk factors for postoperative respiratory failure. J Perioper Pract. 2019;29(3):49&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340782</ArticleId><ArticleId IdType="pubmed">30035690</ArticleId></ArticleIdList></Reference><Reference><Citation>Acheampong D, Guerrier S, Lavarias V, Pechman D, Mills C, Inabnet WB, Leitman IM. Unplanned postoperative reintubation following general and vascular surgical procedures: outcomes and risk factors. Ann Med Surg (Lond) 2019;33:40&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6108072</ArticleId><ArticleId IdType="pubmed">30167302</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng A-C, Cheng K-C, Chen C-M, Hsing S-C, Sung M-Y. The outcome and predictors of failed extubation in intensive care patients&#x2014;the elderly is an important predictor. Int J Gerontol. 2011;5(4):206&#x2013;211.</Citation></Reference><Reference><Citation>Hua M, Brady JE, Li G. A scoring system to predict unplanned intubation in patients having undergone major surgical procedures. Anesth Analg. 2012;115(1):88&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3381852</ArticleId><ArticleId IdType="pubmed">22543066</ArticleId></ArticleIdList></Reference><Reference><Citation>Suraseranivong R, Krairit O, Theerawit P, Sutherasan Y. Association between age-related factors and extubation failure in elderly patients. PLoS One. 2018;13(11):e0207628.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6245685</ArticleId><ArticleId IdType="pubmed">30458035</ArticleId></ArticleIdList></Reference><Reference><Citation>Brovman EY, Steen TL, Urman RD. Associated risk factors and complications in vascular surgery patients requiring unplanned postoperative reintubation. J Cardiothorac and Vasc Anesth. 2017;31(2):554&#x2013;561.</Citation><ArticleIdList><ArticleId IdType="pubmed">28111104</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin HT, Ting PC, Chang WY, Yang MW, Chang CJ, Chou AH. Predictive risk index and prognosis of postoperative reintubation after planned extubation during general anesthesia: a single-center retrospective case-controlled study in Taiwan from 2005 to 2009. Acta Anaesthesiol Taiwanica. 2013;51(1):3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23711598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting PC, Chou AH, Yang MW, Ho AC, Chang CJ, Chang SC. Postoperative reintubation after planned extubation: a review of 137,866 general anesthetics from 2005 to 2007 in a medical Center of Taiwan. Acta Anaesthesiol Taiwanica. 2010;48(4):167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">21195986</ArticleId></ArticleIdList></Reference><Reference><Citation>Rujirojindakul P, Geater A, Mcneil E, Vasinanukorn P, Prathep S, Asim W, Naklongdee J. Risk factors for reintubation in the post-anaesthetic care unit: a case&#x2013;control study. Br J Anaesth. 2012;109(4):636&#x2013;642.</Citation><ArticleIdList><ArticleId IdType="pubmed">22777658</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemaire F, Jeanlouis T, Cinotti L, Giotto G, Abrouk F, Steg G, Macquinmavier I, Zapol WM. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology. 1988;69(2):171&#x2013;179.</Citation><ArticleIdList><ArticleId IdType="pubmed">3044189</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathangi K, Mathews J, Mathangi C. Assessment of perioperative difficult airway among undiagnosed obstructive sleep apnoea patients undergoing elective surgery: a prospective cohort study. Indian J Anaesth. 2018;62(7):538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6053895</ArticleId><ArticleId IdType="pubmed">30078857</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade RG, Lima BL, Lopes DK, Filho RO, Lima LC, Couceiro TC. Difficult laryngoscopy and tracheal intubation: observational study. Braz J Anesthesiol. 2018;68(2):168&#x2013;173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9391704</ArticleId><ArticleId IdType="pubmed">29162293</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Saeed M, Mark RG, Malhotra A, Talmor DS. Risk factors for acute lung injury and acute respiratory distress syndrome in patients mechanically ventilated &gt; 48 hours in the ICU. Crit Care Med. 2006;34.</Citation></Reference><Reference><Citation>Neto AS, Juffermans NP, Hemmes SN, Barbas CS, Beiderlinden M, Fernandezbustamante A, Futier E, Gajic O, Jaber S, Kozian A, et al. Interaction between peri-operative blood transfusion, tidal volume, airway pressure and postoperative ARDS: an individual patient data meta-analysis. Ann Transl Med. 2018;6(2):23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5799143</ArticleId><ArticleId IdType="pubmed">29430440</ArticleId></ArticleIdList></Reference><Reference><Citation>Michetti CP, Griffen MM, Teicher EJ, Rodriguez J, Seoudi H, Liu C, Lita E, Newcomb AB. FRIEND or FOE: a prospective evaluation of risk factors for reintubation in surgical and trauma patients. Am J Surg. 2018;216(6):1056&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pubmed">30017306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn RG. Adverse effects of crystalloid and colloid fluids. Anaesthesiol Intensive Ther. 2017;49(4):303&#x2013;308.</Citation><ArticleIdList><ArticleId IdType="pubmed">28953310</ArticleId></ArticleIdList></Reference><Reference><Citation>Markand ON, Moorthy S, Mahomed Y, King RD, Brown JW. Postoperative phrenic nerve palsy in patients with open-heart surgery. Ann Thorac Surg. 1985;39(1):68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">3966838</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhyieddeen K, Forouzandeh F. Diaphragmatic paralysis after cardiac surgery. J Am Coll Cardiol. 2012;59(18).</Citation><ArticleIdList><ArticleId IdType="pubmed">22538342</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallone LF, Vannucci A. Extubation of the difficult airway and Extubation failure. Anesth Analg. 2013;116(2):368&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">23302983</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31743301</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1540-0514</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Shock (Augusta, Ga.)</Title><ISOAbbreviation>Shock</ISOAbbreviation></Journal><ArticleTitle>The Prognostic Value of Presepsin for Sepsis in Abdominal Surgery: A Prospective Study.</ArticleTitle><Pagination><StartPage>56</StartPage><EndPage>61</EndPage><MedlinePgn>56-61</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SHK.0000000000001479</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Rapid diagnosis accompanied by appropriate treatment is essential in the therapy of sepsis. However, there is no blood marker available, which reliably predicts sepsis and associated mortality. Therefore, the aim of the present study was to evaluate presepsin and endotoxin in comparison with established blood markers in patients undergoing emergency visceral surgery for abdominal infection.</AbstractText><AbstractText Label="PATIENTS AND METHODS">This prospective study included 31 patients with abdominal infection undergoing emergency surgery between March and August 2014. The Sepsis-2 and Sepsis-3 definitions of sepsis were used. Blood markers (presepsin, endotoxin, C-reactive protein, procalcitonin (PCT), interleukin 6 (IL-6), white blood count) were analyzed preoperatively and correlated with the clinical course and mortality. Additionally, a combination of the three markers, which performed best, was tested.</AbstractText><AbstractText Label="RESULTS">Twenty patients (64.5%) in the analyzed cohort developed sepsis from an abdominal focus according to the latest sepsis definition. Out of the analyzed blood markers, presepsin exhibited the highest area under the curve, sensitivity, and specificity for the prediction of the development of sepsis. Moreover, presepsin had the highest predictive value for mortality as opposed to both endotoxin and previously established blood markers (i.e., PCT, IL-6). The multimarker approach, which included PCT, IL-6, and presepsin, showed no additional predictive value over presepsin alone.</AbstractText><AbstractText Label="CONCLUSION">The present study suggests that presepsin is a novel predictor of sepsis and mortality from sepsis in patients undergoing surgery for intra-abdominal infections. The findings of the present study should be validated in a larger cohort.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>B&#xf6;sch</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schallhorn</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miksch</LastName><ForeName>Rainer Christoph</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaudry</LastName><ForeName>Irshad H</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>Center for Surgical Research and Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faist</LastName><ForeName>Eugen</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Werner</LastName><ForeName>Jens</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Angele</LastName><ForeName>Martin K</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pratschke</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General, Visceral, and Transplant Surgery, Ludwig-Maximilians-University Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Shock</MedlineTA><NlmUniqueID>9421564</NlmUniqueID><ISSNLinking>1073-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004731">Endotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018950">Lipopolysaccharide Receptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000594167">presepsin protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="N">Abdomen</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004731" MajorTopicYN="N">Endotoxins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018950" MajorTopicYN="N">Lipopolysaccharide Receptors</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31743301</ArticleId><ArticleId IdType="doi">10.1097/SHK.0000000000001479</ArticleId><ArticleId IdType="pii">00024382-202007000-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, Gruendling M, Huhle G, Jaschinski U, John S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med 33 (4):606&#x2013;618, 2007.</Citation></Reference><Reference><Citation>Farthmann EH, Schoffel U. Epidemiology and pathophysiology of intraabdominal infections (IAI). Infection 26 (5):329&#x2013;334, 1998.</Citation></Reference><Reference><Citation>Stein DM, Jessie EM, Crane S, Kufera JA, Timmons T, Rodriguez CJ, Menaker J, Scalea TM. Hyperacute adrenal insufficiency after hemorrhagic shock exists and is associated with poor outcomes. J Trauma Acute Care Surg 74 (2):363&#x2013;370, 2013.</Citation></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41 (2):580&#x2013;637, 2013.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med 43 (3):304&#x2013;377, 2017.</Citation></Reference><Reference><Citation>Ferrada P, Wolfe L, Duchesne J, Fraga GP, Benjamin E, Alvarez A, Campbell A, Wybourn C, Garcia A, Morales C, et al. Management of duodenal trauma: a retrospective review from the Panamerican Trauma Society. J Trauma Acute Care Surg 86 (3):392&#x2013;396, 2019.</Citation></Reference><Reference><Citation>Patel MS, Malinoski DJ, Zhou L, Neal ML, Hoyt DB. Penetrating oesophageal injury: a contemporary analysis of the National Trauma Data Bank. Injury 44 (1):48&#x2013;55, 2013.</Citation></Reference><Reference><Citation>Wang HE, Devereaux RS, Yealy DM, Safford MM, Howard G. National variation in United States sepsis mortality: a descriptive study. Int J Health Geogr 9:9, 2010.</Citation></Reference><Reference><Citation>Arora S, Singh P, Singh PM, Trikha A. Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis. Shock 43 (3):212&#x2013;221, 2015.</Citation></Reference><Reference><Citation>Kang J, Gong P, Zhang XD, Wang WJ, Li CS. Early differential value of plasma presepsin on infection of trauma patients. Shock 52:362&#x2013;369, 2019.</Citation></Reference><Reference><Citation>Pierrakos C, Vincent JL. Sepsis biomarkers: a review. Crit Care 14 (1):R15, 2010.</Citation></Reference><Reference><Citation>Takahashi W, Nakada TA, Yazaki M, Oda S. Interleukin-6 levels act as a diagnostic marker for infection and a prognostic marker in patients with organ dysfunction in intensive care units. Shock 46 (3):254&#x2013;260, 2016.</Citation></Reference><Reference><Citation>Giannakopoulos K, Hoffmann U, Ansari U, Bertsch T, Borggrefe M, Akin I, Behnes M. The use of biomarkers in sepsis: a systematic review. Curr Pharm Biotechnol 18 (6):499&#x2013;507, 2017.</Citation></Reference><Reference><Citation>Mann EA, Baun MM, Meininger JC, Wade CE. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock 37 (1):4&#x2013;16, 2012.</Citation></Reference><Reference><Citation>Chang R, Holcomb JB. Choice of fluid therapy in the initial management of sepsis, severe sepsis, and septic shock. Shock 46 (1):17&#x2013;26, 2016.</Citation></Reference><Reference><Citation>Xu H, Turnquist HR, Hoffman R, Billiar TR. Role of the IL-33-ST2 axis in sepsis. Mil Med Res 4:3, 2017.</Citation></Reference><Reference><Citation>Namas RA, Vodovotz Y, Almahmoud K, Abdul-Malak O, Zaaqoq A, Namas R, Mi Q, Barclay D, Zuckerbraun B, Peitzman AB, et al. Temporal patterns of circulating inflammation biomarker networks differentiate susceptibility to nosocomial infection following blunt trauma in humans. Ann Surg 263 (1):191&#x2013;198, 2016.</Citation></Reference><Reference><Citation>Kim H, Hur M, Moon HW, Yun YM, Di Somma S, Network G. Multi-marker approach using procalcitonin, presepsin, galectin-3, and soluble suppression of tumorigenicity 2 for the prediction of mortality in sepsis. Ann Intensive Care 7 (1):27, 2017.</Citation></Reference><Reference><Citation>Larsen FF, Petersen JA. Novel biomarkers for sepsis: a narrative review. Eur J Intern Med 45:46&#x2013;50, 2017.</Citation></Reference><Reference><Citation>Lu B, Zhang Y, Li C, Liu C, Yao Y, Su M, Shou S. The utility of presepsin in diagnosis and risk stratification for the emergency patients with sepsis. Am J Emerg Med 36 (8):1341&#x2013;1345, 2018.</Citation></Reference><Reference><Citation>Shimizu T, Obata T, Sonoda H, Akabori H, Miyake T, Yamamoto H, Tabata T, Eguchi Y, Tani T. Diagnostic potential of endotoxin scattering photometry for sepsis and septic shock. Shock 40 (6):504&#x2013;511, 2013.</Citation></Reference><Reference><Citation>Okamura Y, Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin Chim Acta 412 (23&#x2013;24):2157&#x2013;2161, 2011.</Citation></Reference><Reference><Citation>Romaschin AD, Klein DJ, Marshall JC. Bench-to-bedside review: clinical experience with the endotoxin activity assay. Crit Care 16 (6):248, 2012.</Citation></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, et al. 2001&#x200a;SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (4):1250&#x2013;1256, 2003.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315 (8):801&#x2013;810, 2016.</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (5):373&#x2013;383, 1987.</Citation></Reference><Reference><Citation>Liu S, Khemlani LS, Shapiro RA, Johnson ML, Liu K, Geller DA, Watkins SC, Goyert SM, Billiar TR. Expression of CD14 by hepatocytes: upregulation by cytokines during endotoxemia. Infect Immun 66 (11):5089&#x2013;5098, 1998.</Citation></Reference><Reference><Citation>Kondo Y, Umemura Y, Hayashida K, Hara Y, Aihara M, Yamakawa K. Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis. J Intensive Care 15 (7):22, 2019.</Citation></Reference><Reference><Citation>Gupta D, Kirkland TN, Viriyakosol S, Dziarski R. CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 271 (38):23310&#x2013;23316, 1996.</Citation></Reference><Reference><Citation>Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (4975):1431&#x2013;1433, 1990.</Citation></Reference><Reference><Citation>Zou Q, Wen W, Zhang XC. Presepsin as a novel sepsis biomarker. World J Emerg Med 5 (1):16&#x2013;19, 2014.</Citation></Reference><Reference><Citation>Parenica J, Jarkovsky J, Malaska J, Mebazaa A, Gottwaldova J, Helanova K, Litzman J, Dastych M, Tomandl J, Spinar J, et al. Infectious complications and immune/inflammatory response in cardiogenic shock patients: a prospective observational study. Shock 47 (2):165&#x2013;174, 2017.</Citation></Reference><Reference><Citation>Pekkarinen PT, Ristagno G, Wilkman E, Masson S, Latini R, Laurikkala J, Bendel S, Ala-Kokko T, Varpula T, Vaahersalo J, et al. Procalcitonin and presepsin as prognostic markers after out-of-hospital cardiac arrest. Shock 50 (4):395&#x2013;400, 2018.</Citation></Reference><Reference><Citation>Yang HS, Hur M, Yi A, Kim H, Lee S, Kim SN. Prognostic value of presepsin in adult patients with sepsis: systematic review and meta-analysis. PLoS One 13 (1):e0191486, 2018.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">20133891</PMID><DateCompleted><Year>2010</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-8561</ISSN><JournalIssue CitedMedium="Internet"><Volume>56</Volume><Issue>4</Issue><PubDate><Year>2010</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical chemistry</Title><ISOAbbreviation>Clin Chem</ISOAbbreviation></Journal><ArticleTitle>Perioperative gene expression analysis for prediction of postoperative sepsis.</ArticleTitle><Pagination><StartPage>613</StartPage><EndPage>622</EndPage><MedlinePgn>613-22</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1373/clinchem.2009.133876</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative sepsis is one of the main causes of death after major abdominal surgery; however, the immunologic factors contributing to the development of sepsis are not completely understood. In this study, we evaluated gene expression in patients who developed postoperative sepsis and in patients with an uncomplicated postoperative course.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 220 patients in a retrospective matched-pair, case-control pilot study to investigate the perioperative expression of 23 inflammation-related genes regarding their properties for predicting postoperative sepsis. Twenty patients exhibiting symptoms of sepsis in the first 14 days after surgery (case group) were matched with 20 control patients with an uncomplicated postoperative course. Matching criteria were sex, age, main diagnosis, type of surgery, and concomitant diseases. Blood samples were drawn before surgery and on the first and second postoperative days. Relative gene expression was analyzed with real-time reverse-transcription PCR.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Significant differences (P &lt; 0.005) in gene expression between the 2 groups were observed for IL1B (interleukin 1, beta), TNF [tumor necrosis factor (TNF superfamily, member 2)], CD3D [CD3d molecule, delta (CD3-TCR complex)], and PRF1 [perforin 1 (pore forming protein)]. Logistic regression analysis and a subsequent ROC curve analysis revealed that the combination of TNF, IL1B, and CD3D expression had a specificity and specificity of 90% and 85%, respectively, and predicted exclusion of postoperative sepsis with an estimated negative predictive value of 98.1%.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These data suggest that gene expression analysis may be an effective tool for differentiating patients at high and low risk for sepsis after abdominal surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hinrichs</LastName><ForeName>Carl</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Immunology, Charit&#xe9; Universit&#xe4;tsmedizin Berlin, Campus Mitte, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotsch</LastName><ForeName>Katja</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Buchwald</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Habicher</LastName><ForeName>Marit</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Saak</LastName><ForeName>Nicole</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Gerlach</LastName><ForeName>Herwig</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Volk</LastName><ForeName>Hans-Dieter</ForeName><Initials>HD</Initials></Author><Author ValidYN="Y"><LastName>Keh</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>02</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Chem</MedlineTA><NlmUniqueID>9421549</NlmUniqueID><ISSNLinking>0009-9147</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017252">CD3 Complex</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C472562">CD3delta antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508585">IL1B protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C510468">PRF1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D052899">Pore Forming Cytotoxic Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>126465-35-8</RegistryNumber><NameOfSubstance UI="D054353">Perforin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017252" MajorTopicYN="N">CD3 Complex</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054353" MajorTopicYN="N">Perforin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D052899" MajorTopicYN="N">Pore Forming Cytotoxic Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012044" MajorTopicYN="N">Regression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20133891</ArticleId><ArticleId IdType="doi">10.1373/clinchem.2009.133876</ArticleId><ArticleId IdType="pii">clinchem.2009.133876</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36153530</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1745-6215</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>Trials</Title><ISOAbbreviation>Trials</ISOAbbreviation></Journal><ArticleTitle>Optimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial.</ArticleTitle><Pagination><StartPage>799</StartPage><MedlinePgn>799</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">799</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13063-022-06732-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hemodynamic stabilization is a core component in the resuscitation of septic shock. However, the optimal target blood pressure remains debatable. Previous randomized controlled trials suggested that uniformly adopting a target mean arterial pressure (MAP) higher than 65&#x2009;mmHg for all adult septic shock patients would not be beneficial; however, it has also been proposed that higher target MAP may be beneficial for elderly patients, especially those with arteriosclerosis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A multicenter, pragmatic single-blind randomized controlled trial will be conducted to compare target MAP of 80-85&#x2009;mmHg (high-target) and 65-70&#x2009;mmHg (control) in the resuscitation of septic shock patients admitted to 28 hospitals in Japan. Patients with septic shock aged &#x2265;65&#x2009;years are randomly assigned to the high-target or control groups. The target MAP shall be maintained for 72&#x2009;h after randomization or until vasopressors are no longer needed to improve patients' condition. To minimize the adverse effects related to catecholamines, if norepinephrine dose of &#x2265;&#x2009;0.1&#x2009;&#x3bc;g/kg/min is needed to maintain the target MAP, vasopressin will be initiated. Other therapeutic approaches, including fluid administration, hydrocortisone use, and antibiotic choice, will be determined by the physician in charge based on the latest clinical guidelines. The primary outcome is all-cause mortality at 90&#x2009;days after randomization.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">The result of this trial will provide great insight on the resuscitation strategy for septic shock in the era of global aged society. Also, it will provide the better understanding on the importance of individualized treatment strategy in hemodynamic management in critically ill patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">UMIN Clinical Trials Registry; UMIN000041775. Registered 13 September 2020.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Endo</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5967-0776</Identifier><AffiliationInfo><Affiliation>Trauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan. eraeaccm@tmd.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura, Ibaraki, Japan. eraeaccm@tmd.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tagami</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital, 1-396 Kosugimachi, Nakahara-ku, Kawasaki, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umemura</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi, Osaka, 558-8558, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Kyosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Hyogo Prefectural Nishinomiya Hospital, 13-9, Rokutanjicho, Nishinomiya City, Hyogo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nagasawa</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Acute Critical Care Medicine, Shizuoka Hospital, Juntendo University, 1129 Nagaoka, Izunokuni City, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Araki</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kojima</LastName><ForeName>Mitsuaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medicine, Tokyo Women's Medical University Adachi Medical Center, 4-33-1 Kohoku, Adachi-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sera</LastName><ForeName>Toshiki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Critical Care Medical Center, Hiroshima Prefectural Hospital, 1-5-54 Ujinakanda, Minami-ku, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagi</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Medicine and Acute Care Surgery, Matsudo City General Hospital, 993-1 Sendabori, Matsudo-shi, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Ryo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Jiro</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Acute Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakane</LastName><ForeName>Masaki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Yamagata University Hospital, 2-2-2 Iida-nishi, Yamagata, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeda</LastName><ForeName>Chikashi</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Kyoto University Hospital, Shogoin Kawaharacho54, Sakyo-ku, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Narita</LastName><ForeName>Chihiro</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Shizuoka General Hospital, 4-27-1 Kitaando, Aoiku, Shizuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazuma</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okura</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medical Center, Teine Keijinkai Hospital, 1-jo 12-chome, Maeda, Teine-ku, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wada</LastName><ForeName>Takeshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Division of Acute and Critical Care Medicine, Hokkaido University Faculty of Medicine, N15, W7, Kita-ku, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tahara</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Sunagawa City Medical Center, 3-chome1-1 Nishi 4-jo Kita, Sunagawa-shi, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuoka</LastName><ForeName>Ayaka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga City, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masaki</LastName><ForeName>Todani</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency and Trauma Center, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimoyama</LastName><ForeName>Keiichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tokyo Medical University, 6-7-1, Nisi-Shinjuku, Shinjuku-Ku, Tokyo, 160-0023, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yokokawa</LastName><ForeName>Yuta</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryocho, Aoba-ku, Sendai, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Rintaro</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Ibaraki Seinan Medical Center Hospital, 2190 Sakai, Sashima, Ibaraki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sageshima</LastName><ForeName>Hisako</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Sapporo City General Hospital, 13-1-1, Kita-11-jonishi, Chuo-ku, Hokkaido, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanagida</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency, Fukuoka City Hospital, 13-1 Yoshitukahoncho, Hakata-ku, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Kunihiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>M&amp;D Data Science Center, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otomo</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Trauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JP21H03197</GrantID><Agency>Japan Society for the Promotion of Science</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Trials</MedlineTA><NlmUniqueID>101263253</NlmUniqueID><ISSNLinking>1745-6215</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>11000-17-2</RegistryNumber><NameOfSubstance UI="D014667">Vasopressins</NameOfSubstance></Chemical><Chemical><RegistryNumber>WI4X0X7BPJ</RegistryNumber><NameOfSubstance UI="D006854">Hydrocortisone</NameOfSubstance></Chemical><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001794" MajorTopicYN="N">Blood Pressure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006854" MajorTopicYN="N">Hydrocortisone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015337" MajorTopicYN="N">Multicenter Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="N">Norepinephrine</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014667" MajorTopicYN="N">Vasopressins</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arterial pressure</Keyword><Keyword MajorTopicYN="N">Geriatrics</Keyword><Keyword MajorTopicYN="N">Hypotension</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Vasoconstrictor agents</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>23</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36153530</ArticleId><ArticleId IdType="pmc">PMC9509562</ArticleId><ArticleId IdType="doi">10.1186/s13063-022-06732-9</ArticleId><ArticleId IdType="pii">10.1186/s13063-022-06732-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vincent JL, Jones G, David S, Olariu E, Cadwell KK. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis. Crit Care. 2019;23:196. doi: 10.1186/s13054-019-2478-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2478-6</ArticleId><ArticleId IdType="pmc">PMC6545004</ArticleId><ArticleId IdType="pubmed">31151462</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA. Personalized blood pressure targets in shock: what if your normal blood pressure is &#x201c;low&#x201d;? Am J Respir Crit Care Med. 2020;202:10&#x2013;12. doi: 10.1164/rccm.202004-1124ED.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202004-1124ED</ArticleId><ArticleId IdType="pmc">PMC7328338</ArticleId><ArticleId IdType="pubmed">32352319</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, Asfar P, Radermacher P, Vincent JL, Martin C. Optimizing mean arterial pressure in septic shock: a critical reappraisal of the literature. Crit Care. 2015;19:101. doi: 10.1186/s13054-015-0794-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0794-z</ArticleId><ArticleId IdType="pmc">PMC4355573</ArticleId><ArticleId IdType="pubmed">25888071</ArticleId></ArticleIdList></Reference><Reference><Citation>Corr&#xea;a TD, Jakob SM, Takala J. Arterial blood pressure targets in septic shock: is it time to move to an individualized approach? Crit Care. 2015;19:264. doi: 10.1186/s13054-015-0958-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0958-x</ArticleId><ArticleId IdType="pmc">PMC4472269</ArticleId><ArticleId IdType="pubmed">26084781</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorese Coimbra KT, de Freitas FGR, Bafi AT, Pinheiro TT, Nunes NF, de Azevedo LCP, et al. Effect of increasing blood pressure with noradrenaline on the microcirculation of patients with septic shock and previous arterial hypertension. Crit Care Med. 2019;47:1033&#x2013;1040. doi: 10.1097/CCM.0000000000003795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003795</ArticleId><ArticleId IdType="pubmed">31094744</ArticleId></ArticleIdList></Reference><Reference><Citation>Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583&#x2013;1593. doi: 10.1056/NEJMoa1312173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1312173</ArticleId><ArticleId IdType="pubmed">24635770</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Meade MO, H&#xe9;bert PC, Asfar P, Lauzier F, Seely AJE, et al. Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial. Intensive Care Med. 2016;42:542&#x2013;550. doi: 10.1007/s00134-016-4237-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4237-3</ArticleId><ArticleId IdType="pubmed">26891677</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreis DT, Singer M. Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum. Intensive Care Med. 2016;42:1387&#x2013;1397. doi: 10.1007/s00134-016-4249-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4249-z</ArticleId><ArticleId IdType="pubmed">26873833</ArticleId></ArticleIdList></Reference><Reference><Citation>Stolk RF, van der Pasch E, Naumann F, Schouwstra J, Bressers S, van Herwaarden AE, et al. Norepinephrine dysregulates the immune response and compromises host defense during Sepsis. Am J Respir Crit Care Med. 2020;202:830&#x2013;842. doi: 10.1164/rccm.202002-0339OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202002-0339OC</ArticleId><ArticleId IdType="pubmed">32520577</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Richards-Belle A, Thomas K, Harrison DA, Sadique MZ, Grieve RD, et al. Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: a randomized clinical trial. JAMA. 2020;323:938&#x2013;949. doi: 10.1001/jama.2020.0930.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.0930</ArticleId><ArticleId IdType="pmc">PMC7064880</ArticleId><ArticleId IdType="pubmed">32049269</ArticleId></ArticleIdList></Reference><Reference><Citation>Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet. 2002;360:219&#x2013;223. doi: 10.1016/S0140-6736(02)09459-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09459-X</ArticleId><ArticleId IdType="pubmed">12133657</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers EP, Yataco AC, Jaehne AK, Gill J, Disselkamp M. Oxygen extraction and perfusion markers in severe sepsis and septic shock: diagnostic, therapeutic and outcome implications. Curr Opin Crit Care. 2015;21:381&#x2013;387. doi: 10.1097/MCC.0000000000000241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000241</ArticleId><ArticleId IdType="pubmed">26348417</ArticleId></ArticleIdList></Reference><Reference><Citation>Futier E, Lefrant JY, Guinot PG, Godet T, Lorne E, Cuvillon P, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial. JAMA. 2017;318:1346&#x2013;1357. doi: 10.1001/jama.2017.14172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.14172</ArticleId><ArticleId IdType="pmc">PMC5710560</ArticleId><ArticleId IdType="pubmed">28973220</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Singer M, Einav S, Moreno R, Wendon J, Teboul JL, et al. Equilibrating SSC guidelines with individualized care. Crit Care. 2021;25:397. doi: 10.1186/s13054-021-03813-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03813-0</ArticleId><ArticleId IdType="pmc">PMC8596086</ArticleId><ArticleId IdType="pubmed">34789298</ArticleId></ArticleIdList></Reference><Reference><Citation>Japanese Ministry of Health Labour and Welfare: Result of National health and nutrition examination survey. https://www.e-stat.go.jp/stat-search/files?page=1&amp;toukei=00450171&amp;tstat=000001041744. Accessed 6 Sept 2022.</Citation></Reference><Reference><Citation>Beaney T, Schutte AE, Tomaszewski M, Ariti C, Burrell LM, Castillo RR, et al. May measurement month 2017: an analysis of blood pressure screening results worldwide. Lancet Glob Health. 2018;6:e736&#x2013;e743. doi: 10.1016/S2214-109X(18)30259-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(18)30259-6</ArticleId><ArticleId IdType="pubmed">29778399</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettil&#xe4; V, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the classic randomised, parallel-group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695&#x2013;1705. doi: 10.1007/s00134-016-4500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-016-4500-7</ArticleId><ArticleId IdType="pubmed">27686349</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, et al. Higher fluid balance increases the risk of death from sepsis: results from a large international audit. Crit Care Med. 2017;45:386&#x2013;394. doi: 10.1097/CCM.0000000000002189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002189</ArticleId><ArticleId IdType="pubmed">27922878</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne F, Day AG, Meade MO, Cook DJ, Guyatt GH, Hylands M, et al. Pooled analysis of higher versus lower blood pressure targets for vasopressor therapy septic and vasodilatory shock. Intensive Care Med. 2018;44:12&#x2013;21. doi: 10.1007/s00134-017-5016-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-5016-5</ArticleId><ArticleId IdType="pubmed">29260272</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell JA, Walley KR, Singer J, Gordon AC, H&#xe9;bert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358:877&#x2013;887. doi: 10.1056/NEJMoa067373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa067373</ArticleId><ArticleId IdType="pubmed">18305265</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA. 2016;316:509&#x2013;518. doi: 10.1001/jama.2016.10485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.10485</ArticleId><ArticleId IdType="pubmed">27483065</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020) J Intensive Care. 2021;9:53. doi: 10.1186/s40560-021-00555-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-021-00555-7</ArticleId><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019&#x2014;results from a systematic review and meta-analysis. Crit Care. 2020;24:239. doi: 10.1186/s13054-020-02950-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02950-2</ArticleId><ArticleId IdType="pmc">PMC7236499</ArticleId><ArticleId IdType="pubmed">32430052</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33369488</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3792</ISSN><JournalIssue CitedMedium="Internet"><Volume>205</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>May</Month></PubDate></JournalIssue><Title>The Journal of urology</Title><ISOAbbreviation>J Urol</ISOAbbreviation></Journal><ArticleTitle>A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics for Percutaneous Nephrolithotomy in Moderate to High Infectious Risk Population: A Report from the EDGE Consortium.</ArticleTitle><Pagination><StartPage>1379</StartPage><EndPage>1386</EndPage><MedlinePgn>1379-1386</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/JU.0000000000001582</ELocationID><Abstract><AbstractText Label="PURPOSE">Postoperative infectious related complications are not uncommon after percutaneous nephrolithotomy. Previously, we noted that 7 days of antibiotics did not decrease sepsis rates compared to just perioperative antibiotics in a low risk percutaneous nephrolithotomy population. This study aimed to compare the same regimens in individuals at moderate to high risk for sepsis undergoing percutaneous nephrolithotomy.</AbstractText><AbstractText Label="MATERIALS AND METHODS">Patients were prospectively randomized in this multi-institutional study to either 2 days or 7 days of preoperative antibiotics. Enrolled patients had stones requiring percutaneous nephrolithotomy and had either a positive preoperative urine culture or existing indwelling urinary drainage tube. Primary outcome was difference in sepsis rates between the groups. Secondary outcomes included rate of nonseptic bacteriuria, stone-free rate and length of stay.</AbstractText><AbstractText Label="RESULTS">A total of 123 patients at 7 institutions were analyzed. There was no difference in sepsis rates between groups on univariate analysis. Similarly, there were no differences in nonseptic bacteriuria, stone-free rate and length of stay. On multivariate analysis, 2 days of antibiotics increased the risk of sepsis compared to 7 days of antibiotics (OR 3.1, 95% CI 1.1-8.9, p=0.031). Patients receiving antibiotics for 2 days had higher rates of staghorn calculus than the 7-day group (58% vs 32%, p=0.006) but post hoc subanalysis did not demonstrate increased sepsis in the staghorn only group.</AbstractText><AbstractText Label="CONCLUSIONS">Giving 7 days of preoperative antibiotics vs 2 days decreases the risk of sepsis in moderate to high risk percutaneous nephrolithotomy patients. Future guidelines should consider infectious risk stratification for percutaneous nephrolithotomy antibiotic recommendations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sur</LastName><ForeName>Roger L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krambeck</LastName><ForeName>Amy E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Methodist Hospital Indiana University, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Large</LastName><ForeName>Tim</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Methodist Hospital Indiana University, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bechis</LastName><ForeName>Seth K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedlander</LastName><ForeName>David F</ForeName><Initials>DF</Initials><AffiliationInfo><Affiliation>University of North Carolina School of Medicine, Chapel Hill, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monga</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsi</LastName><ForeName>Ryan S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Vanderbilt University Medical Center, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Ben H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Ohio State University, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knudsen</LastName><ForeName>Bodo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Scottsdale, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sourial</LastName><ForeName>Michael W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Ohio State University, Columbus, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Mitchell R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Scottsdale, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Karen L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Mayo Clinic, Scottsdale, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Ojas</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Columbia University Irving Medical Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Joel E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abedi</LastName><ForeName>Garen</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>UC San Diego Health, San Diego, California.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02829060</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Urol</MedlineTA><NlmUniqueID>0376374</NlmUniqueID><ISSNLinking>0022-5347</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2021 May;205(5):1386. doi: 10.1097/JU.0000000000001582.01.</RefSource><PMID Version="1">33739849</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>J Urol. 2023 Oct;210(4):581. doi: 10.1097/JU.0000000000003626.</RefSource><PMID Version="1">37492895</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="Y">Antibiotic Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="N">Kidney Calculi</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="Y">Nephrolithotomy, Percutaneous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-bacterial agents</Keyword><Keyword MajorTopicYN="N">nephrolithiasis</Keyword><Keyword MajorTopicYN="N">nephrolithotomy</Keyword><Keyword MajorTopicYN="N">percutaneous</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">urolithiasis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>12</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>12</Month><Day>28</Day><Hour>13</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33369488</ArticleId><ArticleId IdType="doi">10.1097/JU.0000000000001582</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">27829181</PMID><DateCompleted><Year>2017</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Effect of thoracic epidural block on infection-induced inflammatory response: A randomized controlled trial.</ArticleTitle><Pagination><StartPage>6</StartPage><EndPage>12</EndPage><MedlinePgn>6-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2016.10.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(16)30638-4</ELocationID><Abstract><AbstractText Label="PURPOSE">Epidural block decreases inflammation and oxidative stress in experimental models of sepsis as well as after surgery. There is, however, no clinical evidence evaluating its effect on infection-induced inflammatory process. The present trial evaluated the effect of thoracic epidural block (TEB) on systemic inflammatory response in patients with small intestinal perforation peritonitis. Outcome measures included systemic levels of interleukin (IL)-6, IL-10, procalcitonin, and C-reactive protein and postoperative Sepsis-Related Organ Failure Assessment scores.</AbstractText><AbstractText Label="MATERIAL AND METHODS">Sixty adult patients undergoing emergency abdominal laparotomy without any contraindication to TEB were randomized to receive general anesthesia alone or in combination with the TEB, which was continued for 48 hours postoperatively (n = 30 each).</AbstractText><AbstractText Label="RESULTS">Use of TEB was associated with a statistically insignificant trend of preservation of anti-inflammatory response depicted by higher levels of IL-10 and lack of alteration in proinflammatory IL-6, along with appreciably lower procalcitonin levels, decreased incidence of raised C-reactive protein levels, and better postoperative SOFA score (P &gt; .05). It resulted in significantly better postoperative respiratory function and faster return of bowel motility (P &lt; .05). Although the sample size is too small for conclusive statement, none of the patients developed epidural abscess.</AbstractText><AbstractText Label="CONCLUSION">Thoracic epidural block showed a trend toward better preservation of anti-inflammatory response and clinical recovery that, however, failed to achieve statistical significance (P &gt; .05).</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tyagi</LastName><ForeName>Asha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology &amp; Critical Care, University College of Medical Sciences &amp; GTB Hospital, Delhi 110095, India. Electronic address: drashatyagi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bansal</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology &amp; Critical Care, University College of Medical Sciences &amp; GTB Hospital, Delhi 110095, India. Electronic address: bansal.a.1988@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Das</LastName><ForeName>Shukla</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University College of Medical Sciences &amp; GTB Hospital, Delhi 110095, India. Electronic address: shukladas_123@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sethi</LastName><ForeName>Ashok Kumar</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology &amp; Critical Care, University College of Medical Sciences &amp; GTB Hospital, Delhi 110095, India. Electronic address: newdraksethi@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakkar</LastName><ForeName>Aanchal</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology &amp; Critical Care, University College of Medical Sciences &amp; GTB Hospital, Delhi 110095, India. Electronic address: kakkaraanchal2@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508609">IL10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C508600">IL6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI="D016753">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000767" MajorTopicYN="N">Anesthesia, Epidural</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016753" MajorTopicYN="N">Interleukin-10</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013904" MajorTopicYN="N">Thoracic Vertebrae</DescriptorName><QualifierName UI="Q000294" MajorTopicYN="Y">innervation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cytokines</Keyword><Keyword MajorTopicYN="N">Interleukin</Keyword><Keyword MajorTopicYN="N">Perforation peritonitis</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Thoracic epidural block</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27829181</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2016.10.006</ArticleId><ArticleId IdType="pii">S0883-9441(16)30638-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32301500</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1473-2262</ISSN><JournalIssue CitedMedium="Internet"><Volume>39</Volume><PubDate><Year>2020</Year><Month>Apr</Month><Day>17</Day></PubDate></JournalIssue><Title>European cells &amp; materials</Title><ISOAbbreviation>Eur Cell Mater</ISOAbbreviation></Journal><ArticleTitle>Pathogen-specific antibody profiles in patients with severe systemic infections.</ArticleTitle><Pagination><StartPage>171</StartPage><EndPage>182</EndPage><MedlinePgn>171-182</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22203/eCM.v039a11</ELocationID><Abstract><AbstractText>Infections are often caused by pathobionts, endogenous bacteria that belong to the microbiota. Trauma and surgical intervention can allow bacteria to overcome host defences, ultimately leading to sepsis if left untreated. One of the main defence strategies of the immune system is the production of highly specific antibodies. In the present proof-of-concept study, plasma antibodies against 9 major pathogens were measured in sepsis patients, as an example of severe systemic infections. The binding of plasma antibodies to bacterial extracellular proteins was quantified using a semi-automated immunoblot assay. Comparison of the pathogen-specific antibody levels before and after infection showed an increase in plasma IgG in 20 out of 37 tested patients. This host-directed approach extended the results of pathogen-oriented microbiological and PCR diagnostics: a specific antibody response to additional bacteria was frequently observed, indicating unrecognised poly-microbial invasion. This might explain some cases of failed, seemingly targeted antibiotic treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Normann</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Tietz</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>K&#xfc;hn</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Balau</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Schulz</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Kolata</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Schuerholz</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Petersmann</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Stentzel</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Steil</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>S O</ForeName><Initials>SO</Initials></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>V&#xf6;lker</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Nauck</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Steinmetz</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Raafat</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Gr&#xfc;ndling</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Br&#xf6;ker</LastName><ForeName>B M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Immunology, University Medicine Greifswald, Greifswald, Germany.broeker@uni-greifswald.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Eur Cell Mater</MedlineTA><NlmUniqueID>100973416</NlmUniqueID><ISSNLinking>1473-2262</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000906">Antibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000906" MajorTopicYN="N">Antibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000917" MajorTopicYN="N">Antibody Formation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007700" MajorTopicYN="N">Kinetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32301500</ArticleId><ArticleId IdType="doi">10.22203/eCM.v039a11</ArticleId><ArticleId IdType="pii">vol039a11</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33131081</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>04</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1469-8749</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Developmental medicine and child neurology</Title><ISOAbbreviation>Dev Med Child Neurol</ISOAbbreviation></Journal><ArticleTitle>Adverse outcomes after major surgery in children with intellectual disability.</ArticleTitle><Pagination><StartPage>211</StartPage><EndPage>217</EndPage><MedlinePgn>211-217</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/dmcn.14715</ELocationID><Abstract><AbstractText Label="AIM">To evaluate outcomes after major surgery in children and adolescents with intellectual disability.</AbstractText><AbstractText Label="METHOD">We used 2004 to 2013 claims data from Taiwan's National Health Insurance programme to conduct a nested cohort study, which included 220&#xa0;292 surgical patients aged 6 to 17&#xa0;years. A propensity score matching procedure was used to select 2173 children with intellectual disability and 21&#xa0;730 children without intellectual disability for comparison. Logistic regression was used to calculate the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of the postoperative complications and 30-day mortality associated with intellectual disability.</AbstractText><AbstractText Label="RESULTS">Children with intellectual disability had a higher risk of postoperative pneumonia (OR 2.16, 95% CI 1.48-3.15; p&lt;0.001), sepsis (OR 1.67, 95% CI 1.28-2.18; p&lt;0.001), and 30-day mortality (OR 2.04, 95% CI 1.05-3.93; p=0.013) compared with children without intellectual disability. Children with intellectual disability also had longer lengths of hospital stay (p&lt;0.001) and higher medical expenditure (p&lt;0.001) when compared with children with no intellectual disability.</AbstractText><AbstractText Label="INTERPRETATION">Children with intellectual disability experienced more complications and higher 30-day mortality after surgery when compared with children without intellectual disability. There is an urgent need to revise the protocols for the perioperative care of this specific population.</AbstractText><AbstractText Label="WHAT THIS PAPER ADDS">Surgical patients with intellectual disability are at increased risk of postoperative pneumonia, sepsis, and 30-day mortality. Intellectual disability is associated with higher medical expenditure and increased length of stay in hospital after surgical procedures. The influence of intellectual disability on postoperative outcomes is consistent in both sexes and those aged 10 to 17 years. Low income and a history of fractures significantly impacts postoperative adverse events for patients with intellectual disability.</AbstractText><CopyrightInformation>&#xa9; 2020 Mac Keith Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shih-Yu</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chuen-Chau</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chao-Shun</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chun-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Illinois, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Jui-An</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Regional Anesthesia and Pain Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cherng</LastName><ForeName>Yih-Giun</ForeName><Initials>YG</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ta-Liang</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chien-Chang</ForeName><Initials>CC</Initials><Identifier Source="ORCID">0000-0001-6694-0730</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Regional Anesthesia and Pain Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Big Data and Meta-Analysis, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MOST108-2221-E-038-006</GrantID><Agency>Taiwan's Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>MOST106-2314-B-038-036-MY3</GrantID><Agency>Taiwan's Ministry of Science and Technology</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Dev Med Child Neurol</MedlineTA><NlmUniqueID>0006761</NlmUniqueID><ISSNLinking>0012-1622</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Dev Med Child Neurol. 2021 Feb;63(2):130. doi: 10.1111/dmcn.14742.</RefSource><PMID Version="1">33230853</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005102" MajorTopicYN="N">Health Expenditures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008607" MajorTopicYN="N">Intellectual Disability</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009313" MajorTopicYN="N">National Health Programs</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011203" MajorTopicYN="N">Poverty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>1</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33131081</ArticleId><ArticleId IdType="doi">10.1111/dmcn.14715</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Res Dev Disabil 2011; 32: 419-36.</Citation></Reference><Reference><Citation>Maenner MJ, Blumberg SJ, Kogan MD, Christensen D, Yeargin-Allsopp M, Schieve LA. Prevalence of cerebral palsy and intellectual disability among children identified in two U.S. National Surveys, 2011-2013. Ann Epidemiol 2016; 26: 222-6.</Citation></Reference><Reference><Citation>Cooper SA, McLean G, Guthrie B, et al. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis. BMC Fam Pract 2015; 16: 110.</Citation></Reference><Reference><Citation>Allerton LA, Welch V, Emerson E. Health inequalities experienced by children and young people with intellectual disabilities: a review of literature from the United Kingdom. J Intellect Disabil 2011; 15: 269-78.</Citation></Reference><Reference><Citation>Straetmans JM, van Schrojenstein Lantman-de Valk HM, Schellevis FG. Health problems of people with intellectual disabilities: the impact for general practice. Br J Gen Pract 2007; 57: 64-6.</Citation></Reference><Reference><Citation>Doran CM, Einfeld SL, Madden RH, et al. How much does intellectual disability really cost? First estimates for Australia. J Intellect Dev Disabil 2012; 37: 42-9.</Citation></Reference><Reference><Citation>Tumanyan MR, Filaretova OV, Chechneva VV, Gulasaryan RS, Butrim IV, Bockeria LA. Repair of complete atrioventricular septal defect in infants with down syndrome: outcomes and long-term results. Pediatr Cardiol 2015; 36: 71-5.</Citation></Reference><Reference><Citation>T&#xf3;th R, Sz&#xe1;nt&#xf3; P, Prod&#xe1;n Z, et al. Down syndrome and postoperative complications after paediatric cardiac surgery: a propensity-matched analysis. Interact Cardiovasc Thorac Surg 2013; 17: 691-7.</Citation></Reference><Reference><Citation>Desai AR, Branco RG, Comitis GA, et al. Early postoperative outcomes following surgical repair of complete atrioventricular septal defects: is down syndrome a risk factor? Pediatr Crit Care Med 2014; 15: 35-41.</Citation></Reference><Reference><Citation>Formigari R, Di Donato RM, Gargiulo G, et al. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome. Ann Thorac Surg 2004; 78: 666-72.</Citation></Reference><Reference><Citation>Evans JM, Dharmar M, Meierhenry E, Marcin JP, Raff GW. Association between Down syndrome and in-hospital death among children undergoing surgery for congenital heart disease: a US population-based study. Circ Cardiovasc Qual Outcomes 2014; 7: 445-52.</Citation></Reference><Reference><Citation>Lange R, Guenther T, Busch R, Hess J, Schreiber C. The presence of Down syndrome is not a risk factor in complete atrioventricular septal defect repair. J Thorac Cardiovasc Surg 2007; 134: 304-10.</Citation></Reference><Reference><Citation>Dhiman N, Chi A, Pawlik TM, et al. Increased complications after appendectomy in patients with cerebral palsy: are special needs patients at risk for disparities in outcomes? Surgery 2013; 154: 479-85.</Citation></Reference><Reference><Citation>Lin JA, Liao CC, Chang CC, Chang H, Chen TL. Postoperative adverse outcomes in intellectually disabled surgical patients: a nationwide population-based study. PLoS One 2011; 6: e26977.</Citation></Reference><Reference><Citation>Boylan MR, Kapadia BH, Issa K, Perfetti DC, Maheshwari AV, Mont MA. Down syndrome increases the risk of short-term complications after total hip arthroplasty. J Arthroplasty 2016; 31: 368-72.</Citation></Reference><Reference><Citation>Hsieh CY, Su CC, Shao SC, et al. Taiwan's National Health Insurance Research Database: past and future. Clin Epidemiol 2019; 11: 349-58.</Citation></Reference><Reference><Citation>Liao CC, Shen WW, Chang CC, Chang H, Chen TL. Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg 2013; 257: 433-8.</Citation></Reference><Reference><Citation>Coplan J. Three pitfalls in the early diagnosis of mental retardation. Clin Pediatr 1982; 21: 308-10.</Citation></Reference><Reference><Citation>Bagger JP, Zindrou D, Taylor KM. Postoperative infection with meticillin-resistant Staphylococcus aureus and socioeconomic background. Lancet 2004; 363: 706-8.</Citation></Reference><Reference><Citation>Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg 2010; 252: 1065-71.</Citation></Reference><Reference><Citation>Jin F, Chung F. Minimizing perioperative adverse events in the elderly. Br J Anaesth 2001; 87: 608-24.</Citation></Reference><Reference><Citation>Vartak S, Ward MM, Vaughn TE. Do postoperative complications vary by hospital teaching status? Med Care 2008; 46: 25-32.</Citation></Reference><Reference><Citation>Segal M, Eliasziw M, Phillips S, et al. Intellectual disability is associated with increased risk for obesity in a nationally representative sample of U.S. children. Disabil Health J 2016; 9: 392-8.</Citation></Reference><Reference><Citation>Schupf N, Ortiz M, Kapell D, Kiely M, Rudelli RD. Prevalence of intestinal parasite infections among individuals with mental retardation in New York State. Ment Retard 1995; 33: 84-9.</Citation></Reference><Reference><Citation>Tannenbaum TN, Lipworth L, Baker S. Risk of fractures in an intermediate care facility for persons with mental retardation. Am J Ment Retard 1989; 93: 444-51.</Citation></Reference><Reference><Citation>Schneier AJ, Shields BJ, Hostetler SG, Xiang H, Smith GA. Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States. Pediatrics 2006; 118: 483-92.</Citation></Reference><Reference><Citation>Krahn GL, Hammond L, Turner A. A cascade of disparities: health and health care access for people with intellectual disabilities. Ment Retard Dev Disabil Res Rev 2006; 12: 70-82.</Citation></Reference><Reference><Citation>Baxter H, Lowe K, Houston H, Jones G, Felce D, Kerr M. Previously unidentified morbidity in patients with intellectual disability. Br J Gen Pract 2006; 56: 93-8.</Citation></Reference><Reference><Citation>Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 2011; 164: 9-16.</Citation></Reference><Reference><Citation>Anders PL, Davis EL. Oral health of patients with intellectual disabilities: a systematic review. Spec Care Dentist 2010; 30: 110-7.</Citation></Reference><Reference><Citation>Altun C, Guven G, Akgun OM, Akkurt MD, Basak F, Akbulut E. Oral health status of disabled individuals attending special schools. Eur J Dent 2010; 4: 361-6.</Citation></Reference><Reference><Citation>Lee RL, Leung C, Tong WK, Chen H, Lee PH. Comparative efficacy of a simplified handwashing program for improvement in hand hygiene and reduction of school absenteeism among children with intellectual disability. Am J Infect Control 2015; 43: 907-12.</Citation></Reference><Reference><Citation>Emerson E, Hatton C. Poverty, socio-economic position, social capital and the health of children and adolescents with intellectual disabilities in Britain: a replication. J Intellect Disabil Res 2007; 51: 866-74.</Citation></Reference><Reference><Citation>Emerson E. Mothers of children and adolescents with intellectual disability: social and economic situation, mental health status, and the self-assessed social and psychological impact of the child's difficulties. J Intellect Disabil Res 2003; 47: 385-99.</Citation></Reference><Reference><Citation>Daily DK, Ardinger HH, Holmes GE. Identification and evaluation of mental retardation. Am Fam Physician 2000; 61: 1059-67.</Citation></Reference><Reference><Citation>Dikken JL, Wouters MW, Lemmens VE, et al. Influence of hospital type on outcomes after oesophageal and gastric cancer surgery. Br J Surg 2012; 99: 954-63.</Citation></Reference><Reference><Citation>Schmidt CM, Turrini O, Parikh P, et al. Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg 2010; 145: 634-40.</Citation></Reference><Reference><Citation>Chaudhary K, Bagharwal P, Wadhawan S. Anesthesia for intellectually disabled. J Anaesthesiol Clin Pharmacol 2017; 33: 432-40.</Citation></Reference><Reference><Citation>Glassman P. A review of guidelines for sedation, anesthesia, and alternative interventions for people with special needs. Spec Care Dentist 2009; 29: 9-16.</Citation></Reference><Reference><Citation>Wang YC, Lin IH, Huang CH, et al. Dental anesthesia for patients with special needs. Acta Anaesthesiol Taiwan 2012; 50: 122-5.</Citation></Reference><Reference><Citation>von Ungern-Sternberg BS, Boda K, Chambers NA, et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet 2010; 376: 773-83.</Citation></Reference><Reference><Citation>Tait AR, Malviya S. Anesthesia for the child with an upper respiratory tract infection: still a dilemma? Anesth Analg 2005; 100: 59-65.</Citation></Reference><Reference><Citation>Robertson J, Chadwick D, Baines S, et al. People with intellectual disabilities and dysphagia. Disabil Rehabil 2018; 40: 1345-60.</Citation></Reference><Reference><Citation>Gan TJ, Belani KG, Bergese S, et al. Fourth consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2020; 131: 411-48.</Citation></Reference><Reference><Citation>Ljungqvist O, Scott M, Fearon KC. Enhanced recovery after surgery: a review. JAMA Surg 2017; 152: 292-8.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30311628</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>02</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2737-5935</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Singapore medical journal</Title><ISOAbbreviation>Singapore Med J</ISOAbbreviation></Journal><ArticleTitle>Complicated intra-abdominal infections: a prospective validation study of the WSES Sepsis Severity Score.</ArticleTitle><Pagination><StartPage>317</StartPage><EndPage>321</EndPage><MedlinePgn>317-321</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.11622/smedj.2018120</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The World Society of Emergency Surgery (WSES) recently developed and validated a sepsis severity score for complicated intra-abdominal infections (cIAIs). We aimed to prospectively study the validity of this score in our local setting and compare it with global findings.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a prospective study of 100 consecutive adult patients with cIAIs treated at Al-Ain Hospital, United Arab Emirates, from October 2014 to January 2016, we studied patients' demographics, disease, risk factors, WSES Sepsis Severity Score, management, hospital stay and mortality. Our findings were compared with those from a recent global multicentre prospective study from 53 countries (n = 4,496).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with global data, our patients were more likely to be male (p &lt; 0.0001) and younger (p &lt; 0.0001), with more appendicitis and perforated peptic ulcers (p &lt; 0.0001), significantly lower sepsis severity score (p &lt; 0.0001) and more delays in surgical intervention (p = 0.001). Nevertheless, they had similar adequate source control (p = 0.54) and surgical reinterventions (p = 0.63). Overall, our patients had a significantly lower mortality rate (1.0% vs. 9.3% in global data; p = 0.001). A direct logistic regression model showed that the WSES Sepsis Severity Score significantly predicted mortality (p &lt; 0.0001), but our hospital's setting was not predictive of mortality compared with other hospitals (p = 0.18).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Although our patient demographics and hospital's setting significantly differed from those of other international hospitals, the WSES Sepsis Severity Score was very accurate in predicting mortality among our patients, which supports its generalisability for all patient populations worldwide.</AbstractText><CopyrightInformation>Copyright: &#xa9; Singapore Medical Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Abdel-Kader</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Al-Ain Hospital, Al-Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sartelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Macerata Hospital, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu-Zidan</LastName><ForeName>Fikri M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Department of Surgery, College of Medicine and Health Sciences, UAE University, Al-Ain, United Arab Emirates.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>Singapore Med J</MedlineTA><NlmUniqueID>0404516</NlmUniqueID><ISSNLinking>0037-5675</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059413" MajorTopicYN="N">Intraabdominal Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014479" MajorTopicYN="N" Type="Geographic">United Arab Emirates</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">global</Keyword><Keyword MajorTopicYN="N">intra-abdominal infection</Keyword><Keyword MajorTopicYN="N">scoring</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">severity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>6</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30311628</ArticleId><ArticleId IdType="pmc">PMC6595066</ArticleId><ArticleId IdType="doi">10.11622/smedj.2018120</ArticleId><ArticleId IdType="pii">j60/6/317</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sartelli M, Viale P, Catena F, et al. 2013 WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545734</ArticleId><ArticleId IdType="pubmed">23294512</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazuski JE, Solomkin JS. Intra-abdominal infections. Surg Clin North Am. 2009;89:421&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">19281892</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacelli F, Doglietto GB, Alfieri S, et al. Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. Arch Surg. 1996;131:641&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8645072</ArticleId></ArticleIdList></Reference><Reference><Citation>Koperna T, Schulz F. Prognosis and treatment of peritonitis. Do we need new scoring systems? Arch Surg. 1996;131:180&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8611076</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulari K, Lepp&#xe4;niemi A. Severe secondary peritonitis following gastrointestinal tract perforation. Scand J Surg. 2004;93:204&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15544075</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections in a worldwide context:an observational prospective study (CIAOW Study) World J Emerg Surg. 2013;8:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3538624</ArticleId><ArticleId IdType="pubmed">23286785</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Catena F, Ansaloni L, et al. Complicated intra-abdominal infections worldwide:the definitive data of the CIAOW Study. World J Emerg Surg. 2014;9:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039043</ArticleId><ArticleId IdType="pubmed">24883079</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartelli M, Abu-Zidan FM, Catena F, et al. Global validation of the WSES Sepsis Severity Score for patients with complicated intra-abdominal infections:a prospective multicentre study (WISS Study) World J Emerg Surg. 2015;10:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4681030</ArticleId><ArticleId IdType="pubmed">26677396</ArticleId></ArticleIdList></Reference><Reference><Citation>Grivna M, Aw TC, El-Sadig M, et al. The legal framework and initiatives for promoting safety in the United Arab Emirates. Int J Inj Contr Saf Promot. 2012;19:278&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pubmed">22803840</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry SB. What makes UAE a role model of cohesion. Gulf News 28 May 2016.  [Accessed September 19, 2018].  Available at: https://gulfnews.com/news/uae/society/what-makes-uae-a-role-model-of-cohesion-1.1836341 .</Citation></Reference><Reference><Citation>Al Ain Hospital.  [Accessed September 20, 2018].  Available at: https://www.seha.ae/alain/English/aboutus/Pages/welcome-message.aspx .</Citation></Reference><Reference><Citation>Inter Press Service News Agency. Abu Dhabi population hits 3 million, fertility rate up to 3.7 per citizen-female.  [Accessed September 19, 2018].  Available at: http://www.ipsnews.net/2017/10/abu-dhabi-population-hits-3-million-fertility-rate-3-7-per-citizen-female/ </Citation></Reference><Reference><Citation>Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">18538699</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Torab FC, Amer M, Abu-Zidan FM, Branicki FJ. Perforated peptic ulcer:different ethnic, climatic and fasting risk factors for morbidity in Al-ain medical district, United Arab Emirates. Asian J Surg. 2009;32:95&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">19423456</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlino JI, Malangoni MA, Smith CM, Lange RL. Prospective randomized trials affect the outcomes of intraabdominal infection. Ann Surg. 2001;233:859&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1421330</ArticleId><ArticleId IdType="pubmed">11371744</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi A, Watanabe Y, Doi T, et al. Evaluation of prognostic factors and scoring system in colonic perforation. World J Gastroenterol. 2007;13:3228&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4436609</ArticleId><ArticleId IdType="pubmed">17589902</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19114902</PMID><DateCompleted><Year>2009</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>The vasopressin and copeptin response to infection, severe sepsis, and septic shock.</ArticleTitle><Pagination><StartPage>476</StartPage><EndPage>482</EndPage><MedlinePgn>476-82</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0b013e3181957532</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the course of arginine vasopressin (AVP) and copeptin plasma concentrations between patients with infection, severe sepsis, and septic shock.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective, closed-cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Twelve-bed general and surgical intensive care unit and 33-bed internal medicine ward in a university hospital.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Ten patients with infection, 22 with severe sepsis, and 28 with septic shock.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">Hemodynamic, laboratory and clinical data were recorded daily during the first 7 days after intensive care unit or hospital admission. Parallel thereto, blood was withdrawn to determine plasma AVP (radioimmunoassay) and copeptin (immunoluminometric assay) concentrations. Standard tests, a mixed effects model, and a linear regression analysis were used for statistical analysis. The AVP response was different between the three study groups (p &lt; 0.001) but did not change over time (p = 0.12). Although patients with severe sepsis and septic shock had higher AVP levels than did patients with infection (both p &lt; 0.001), no difference in AVP concentrations was seen between severe sepsis and septic shock patients (p = 0.98). No difference in AVP was observed between survivors and nonsurvivors at day 28 (p = 0.87). In patients with severe sepsis, serum osmolarity (p &lt; 0.001), arterial pH (p = 0.001), lactate (p &lt; 0.001), and Pao2 (p = 0.04) were associated with the course of AVP plasma levels, whereas it was serum osmolarity alone in patients with septic shock (p = 0.03). Plasma AVP concentrations correlated with copeptin (r = .614, p &lt; 0.001), but this correlation was influenced by continuous veno-venous hemofiltration (p = 0.002).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Severe sepsis induced a stronger AVP response than infection without systemic inflammation. However, the lack of a difference in AVP plasma concentrations between patients with and without shock indicates that the AVP system does not function normally in severe sepsis. Our data support the hypothesis that impaired AVP response is at least partially responsible for the failure to restore vascular tone in septic shock.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jochberger</LastName><ForeName>Stefan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xf6;rler</LastName><ForeName>Jakob</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Luckner</LastName><ForeName>G&#xfc;nter</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Mayr</LastName><ForeName>Viktoria D</ForeName><Initials>VD</Initials></Author><Author ValidYN="Y"><LastName>Wenzel</LastName><ForeName>Volker</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ulmer</LastName><ForeName>Hanno</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Morgenthaler</LastName><ForeName>Nils G</ForeName><Initials>NG</Initials></Author><Author ValidYN="Y"><LastName>Hasibeder</LastName><ForeName>Walter R</ForeName><Initials>WR</Initials></Author><Author ValidYN="Y"><LastName>D&#xfc;nser</LastName><ForeName>Martin W</ForeName><Initials>MW</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006020">Glycopeptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C048197">copeptins</NameOfSubstance></Chemical><Chemical><RegistryNumber>113-79-1</RegistryNumber><NameOfSubstance UI="D001127">Arginine Vasopressin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2009 Feb;37(2):749-50. doi: 10.1097/CCM.0b013e318194d117.</RefSource><PMID Version="1">19325368</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001127" MajorTopicYN="N">Arginine Vasopressin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006020" MajorTopicYN="N">Glycopeptides</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>31</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>5</Month><Day>7</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19114902</ArticleId><ArticleId IdType="doi">10.1097/CCM.0b013e3181957532</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26759980</PMID><DateCompleted><Year>2016</Year><Month>06</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-1948</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Medical care</Title><ISOAbbreviation>Med Care</ISOAbbreviation></Journal><ArticleTitle>Outcomes and Resource Use of Sepsis-associated Stays by Presence on Admission, Severity, and Hospital Type.</ArticleTitle><Pagination><StartPage>303</StartPage><EndPage>310</EndPage><MedlinePgn>303-10</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/MLR.0000000000000481</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To establish a baseline for the incidence of sepsis by severity and presence on admission in acute care hospital settings before implementation of a broad sepsis screening and response initiative.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study using hospital discharge abstracts of 5672 patients, aged 18 years and above, with sepsis-associated stays between February 2012 and January 2013 at an academic medical center and 5 community hospitals in Texas.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sepsis was present on admission in almost 85% of cases and acquired in-hospital in the remainder. The overall inpatient death rate was 17.2%, but was higher in hospital-acquired sepsis (38.6%, medical; 29.2%, surgical) and Stages 2 (17.6%) and 3 (36.4%) compared with Stage 1 (5.9%). Patients treated at the academic medical center had a higher death rate (22.5% vs. 15.1%, P&lt;0.001) and were more costly ($68,050&#xb1;184,541 vs. $19,498&#xb1;31,506, P&lt;0.001) versus community hospitals.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Greater emphasis is needed on public awareness of sepsis and the detection of sepsis in the prehospitalization and early hospitalization period. Hospital characteristics and case mix should be accounted for in cross-hospital comparisons of sepsis outcomes and costs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Stephen L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Departments of *Surgery, Center for Outcomes Research &#x2020;Anesthesia-Critical Care, Houston, Methodist Research Institute, Houston Methodist Hospital, Houston, TX.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashton</LastName><ForeName>Carol M</ForeName><Initials>CM</Initials></Author><Author ValidYN="Y"><LastName>Kiehne</LastName><ForeName>Lisa B</ForeName><Initials>LB</Initials></Author><Author ValidYN="Y"><LastName>Nicolas</LastName><ForeName>Juan C</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Rose</LastName><ForeName>Alexis L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Shirkey</LastName><ForeName>Beverly A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Masud</LastName><ForeName>Faisal</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Wray</LastName><ForeName>Nelda P</ForeName><Initials>NP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1C1CMS330975-01-00</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Med Care</MedlineTA><NlmUniqueID>0230027</NlmUniqueID><ISSNLinking>0025-7079</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017714" MajorTopicYN="N">Community-Acquired Infections</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003365" MajorTopicYN="N">Costs and Cost Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003953" MajorTopicYN="N">Diagnosis-Related Groups</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006764" MajorTopicYN="N">Hospitals, Community</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>2</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26759980</ArticleId><ArticleId IdType="pmc">PMC4751740</ArticleId><ArticleId IdType="doi">10.1097/MLR.0000000000000481</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torio CM (AHRQ), Andrews RM (AHRQ). National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. HCUP Statistical Brief #160. August 2013. Agency for Healthcare Research and Quality, Rockville, MD. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb160.pdf. Accessed December 29, 2015.</Citation></Reference><Reference><Citation>Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167&#x2013;1174.</Citation><ArticleIdList><ArticleId IdType="pubmed">23442987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar G, Taneja A, Majumdar T, et al. The association of lacking insurance with outcomes of severe sepsis: retrospective analysis of an administrative database. Crit Care Med. 2014;42:583&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4990450</ArticleId><ArticleId IdType="pubmed">24152590</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med. 2014;42:625&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313930</ArticleId><ArticleId IdType="pubmed">24201173</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Friedman B, Stranges E. Septicemia in US Hospitals, 2009: Statistical Brief #122 Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Health Care Policy and Research (US); 2006.</Citation></Reference><Reference><Citation>Hall MJ, Williams SN, DeFrances CJ, et al. 
Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS Data Brief. 2011;62:1&#x2013;8, Available at: http://www.cdc.gov/nchs/data/databriefs/db62.pdf. Accessed December 29, 2015.</Citation><ArticleIdList><ArticleId IdType="pubmed">22142805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HE, Donnelly JP, Shapiro NI, et al. Hospital variations in severe sepsis mortality. Am J Med Qual. 2015;30:328&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">24814940</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Wiener RS. Hospital case volume and outcomes among patients hospitalized with severe sepsis. Am J Respir Crit Care Med. 2014;189:548&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3977716</ArticleId><ArticleId IdType="pubmed">24400669</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey DE, Jr, Chang K, Bustami RT. Evaluation of hospitalization for infections that are present on admission. Am J Med Qual. 2011;26:468&#x2013;473.</Citation><ArticleIdList><ArticleId IdType="pubmed">21724961</ArticleId></ArticleIdList></Reference><Reference><Citation>Page D, Donnelly J, Wang H. Community-, healthcare-, and hospital-acquired severe sepsis hospitalizations in the university healthsystem consortium. Crit Care Med. 2015;43:1945&#x2013;1951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4537676</ArticleId><ArticleId IdType="pubmed">26110490</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu V, Escobar GJ, Greene JD, et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA. 2014;312:90&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">24838355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SL, Ashton CM, Kiehne L, et al. Reductions in sepsis mortality and costs after design and implementation of a nursing-based early recognition and response program. Jt Comm J Qual Patient Saf. 2015;41:483&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4880050</ArticleId><ArticleId IdType="pubmed">26484679</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SL, Ashton CM, Kiehne L, et al. The Sepsis Early Recognition and Response Initiative (SERRI): field notes from a Centers for Medicare and Medicaid Innovation project. Accepted for publication, Jt. Comm J Qual Patient Saf.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4892845</ArticleId><ArticleId IdType="pubmed">26892701</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray NP, Petersen NJ, Souchek J, et al. The hospital multistay rate as an indicator of quality of care. Health Serv Res. 1999;34:777&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1089037</ArticleId><ArticleId IdType="pubmed">10445902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen K-M, Bailey M, Pilcher D, et al. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372:1629&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pubmed">25776936</ArticleId></ArticleIdList></Reference><Reference><Citation>Horeczko T, Green JP, Panacek EA. Epidemiology of the systemic inflammatory response syndrome (SIRS) in the emergency department. West J Emerg Med. 2014;15:329&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4025532</ArticleId><ArticleId IdType="pubmed">24868313</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR, Arias SA, Camargo CA, Jr, et al. Sepsis visits and antibiotic utilization in US emergency departments. Crit Care Med. 2014;42:528&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">24201179</ArticleId></ArticleIdList></Reference><Reference><Citation>Gress J.
Sepsis Awareness Research 2014. Nielsen Consumer Insights; 2014Available at: http://www.sepsis.org/files/sepsisawareness2014.pdf. Accessed December 29, 2015.</Citation></Reference><Reference><Citation>Muhlstein D.
What types of hospitals have high charge-to-reimbursement ratios?: Health Affairs. 2013. Available at: http://healthaffairs.org/blog/2013/07/15/what-types-of-hospitals-have-high-charge-to-reimbursement-ratios/. Accessed December 29, 2015.</Citation></Reference><Reference><Citation>Prescott HC, Langa KM, Liu V, et al. Increased 1-year healthcare use in survivors of severe sepsis. Am J Respir Crit Care Med. 2014;190:62&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226030</ArticleId><ArticleId IdType="pubmed">24872085</ArticleId></ArticleIdList></Reference><Reference><Citation>Hines AL (Truven Health Analytics), Barrett ML (ML Barrett, Inc), Jiang HJ (AHRQ), and Steiner CA (AHRQ). Conditions With the Largest Number of Adult Hospital Readmissions by Payer, 2011. HCUP Statistical Brief #172. April 2014. Agency for Healthcare Research and Quality: Rockville, MD. Available at: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb172-Conditions-Readmissions-Payer.pdf. Accessed December 29, 2015.</Citation></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23027433</PMID><DateCompleted><Year>2014</Year><Month>01</Month><Day>27</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2193-6323</ISSN><JournalIssue CitedMedium="Internet"><Volume>74</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of neurological surgery. Part A, Central European neurosurgery</Title><ISOAbbreviation>J Neurol Surg A Cent Eur Neurosurg</ISOAbbreviation></Journal><ArticleTitle>Endoscopic endonasal versus open repair of anterior skull base CSF leak, meningocele, and encephalocele: a systematic review of outcomes.</ArticleTitle><Pagination><StartPage>239</StartPage><EndPage>250</EndPage><MedlinePgn>239-50</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/s-0032-1325636</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Repair of anterior skull base cerebrospinal fluid (CSF) leaks, encephaloceles, and meningoceles can prevent meningitis, intracranial abscess, and pneumocephalus. Various surgical techniques have been employed for repair, including open transcranial and transfacial methods. The endoscopic endonasal approach represents a minimal access but equally aggressive alternative. We conducted a systematic review of case series and case reports to assess the role of endoscopy in the management of these lesions.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We performed a MEDLINE search of the literature (1950-2010) to identify open and endoscopic surgical series for repair of anterior skull base CSF leaks, encephaloceles, and meningoceles. Comparisons were made for patient and defect characteristics as well as success of repair, morbidity, and outcome.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Seventy-one studies, involving 1178 patients, were included. There was no significant difference in the rate of successful repair (~90%) between the open and endoscopic cohorts. Compared with open approaches, complications were significantly lower in the endoscopic group, including meningitis (3.9% versus 1.1%, p = 0.034), abscess/wound infection (6.8% versus 0.7%, p &lt; 0.001), and sepsis (3.8% versus 0%, p = 0.003). Perioperative mortality was also lower in the endoscopic group (0%) compared with the open group (1.4%) (p &lt; 0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our systematic review supports the endoscopic endonasal approach as a safe and effective alternative for the treatment of anterior skull base defects, which may be preferable in select patients.</AbstractText><CopyrightInformation>Georg Thieme Verlag KG Stuttgart &#xb7; New York.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Komotar</LastName><ForeName>Ricardo J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starke</LastName><ForeName>Robert M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Raper</LastName><ForeName>Daniel M S</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Anand</LastName><ForeName>Vijay K</ForeName><Initials>VK</Initials></Author><Author ValidYN="Y"><LastName>Schwartz</LastName><ForeName>Theodore H</ForeName><Initials>TH</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2012</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol Surg A Cent Eur Neurosurg</MedlineTA><NlmUniqueID>101580767</NlmUniqueID><ISSNLinking>2193-6315</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065634" MajorTopicYN="N">Cerebrospinal Fluid Leak</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002559" MajorTopicYN="N">Cerebrospinal Fluid Rhinorrhea</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004677" MajorTopicYN="N">Encephalocele</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004724" MajorTopicYN="N">Endoscopy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008588" MajorTopicYN="N">Meningocele</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009296" MajorTopicYN="N">Nasal Cavity</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019291" MajorTopicYN="N">Skull Base</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23027433</ArticleId><ArticleId IdType="doi">10.1055/s-0032-1325636</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25318368</PMID><DateCompleted><Year>2016</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-2218</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Surgical endoscopy</Title><ISOAbbreviation>Surg Endosc</ISOAbbreviation></Journal><ArticleTitle>Laparoscopic versus open surgery for complicated appendicitis: a randomized controlled trial to prove safety.</ArticleTitle><Pagination><StartPage>2027</StartPage><EndPage>2032</EndPage><MedlinePgn>2027-32</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00464-014-3906-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To date, no randomized control trial has been performed comparing open appendectomy (OA) to laparoscopic appendectomy (LA) in complicated appendicitis. A systematic review and meta-analysis in 2010 concluded LA is advantageous to OA with less surgical site sepsis in complicated appendicitis; however, the level of evidence is weak (level 3a). The aim of the study was to determine whether LA is safe in the treatment of complicated appendicitis. Primary outcome included all-cause mortality and procedure-related mortality; secondary outcomes included intra-operative duration, rates of wound sepsis and re-intervention, length of hospital stay and re-admission rates.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">One hundred and fourteen patients were randomized prospectively to either OA or LA using a computer-generated blind method. Patients who were either less than 12&#xa0;years of age, had previous abdominal surgery or were pregnant were excluded. A team of senior surgeons capable of doing both OA and LA performed all procedures.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The intra-operative duration, the rate of wound sepsis, the number of re-operations, the length of hospital stay and the rate of re-admissions between the OA and LA groups did not differ statistically.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Laparoscopic appendectomy is safe in complicated appendicitis. Current Control Trials (ISRCTN92257749).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thomson</LastName><ForeName>John-Edwin</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Surgery, Chris Hani Baragwanath Academic Hospital, Old Potch Road, Moreleta Park, Soweto, Johannesburg, 2013, South Africa, drjohnthomson@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kruger</LastName><ForeName>Deirdr&#xe9;</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Jann-Kruger</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kiss</LastName><ForeName>Akos</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Omoshoro-Jones</LastName><ForeName>J A O</ForeName><Initials>JA</Initials></Author><Author ValidYN="Y"><LastName>Luvhengo</LastName><ForeName>Thifheli</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ISRCTN</DataBankName><AccessionNumberList><AccessionNumber>ISRCTN92257749</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Endosc</MedlineTA><NlmUniqueID>8806653</NlmUniqueID><ISSNLinking>0930-2794</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001062" MajorTopicYN="N">Appendectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001064" MajorTopicYN="N">Appendicitis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010535" MajorTopicYN="N">Laparoscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007813" MajorTopicYN="N">Laparotomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010359" MajorTopicYN="N">Patient Readmission</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012086" MajorTopicYN="N">Reoperation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>10</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25318368</ArticleId><ArticleId IdType="doi">10.1007/s00464-014-3906-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Am J Surg. 1993 Jun;165(6):670-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8506965</ArticleId></ArticleIdList></Reference><Reference><Citation>S Afr J Surg. 2008 Aug;46(3):74-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18807302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1993 Nov;218(5):685-92</Citation><ArticleIdList><ArticleId IdType="pubmed">8239785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1995 Sep;222(3):256-61; discussion 261-2</Citation><ArticleIdList><ArticleId IdType="pubmed">7677456</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1997 Jun;84(6):842-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9189105</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 1997 Jul;132(7):708-11; discussion 712</Citation><ArticleIdList><ArticleId IdType="pubmed">9230853</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 2014 Mar;218(3):e51-65</Citation><ArticleIdList><ArticleId IdType="pubmed">24559968</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1995 Feb;169(2):208-12; discussion 212-3</Citation><ArticleIdList><ArticleId IdType="pubmed">7840381</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2009 Feb;33(2):208-14</Citation><ArticleIdList><ArticleId IdType="pubmed">19067040</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 1998 May;186(5):545-53</Citation><ArticleIdList><ArticleId IdType="pubmed">9583695</ArticleId></ArticleIdList></Reference><Reference><Citation>J Minim Access Surg. 2013 Apr;9(2):55-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23741109</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc. 1991 Mar;1(1):8-13</Citation><ArticleIdList><ArticleId IdType="pubmed">1669379</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Surg. 2009 Jun;7(3):250-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19393776</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Gastroenterol. 2010 Nov 03;10:129</Citation><ArticleIdList><ArticleId IdType="pubmed">21047410</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Epidemiol. 1990 Nov;132(5):910-25</Citation><ArticleIdList><ArticleId IdType="pubmed">2239906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1993 Sep 11;342(8872):633-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8103144</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Laparosc Endosc Percutan Tech. 2011 Jun;21(3):142-5</Citation><ArticleIdList><ArticleId IdType="pubmed">21654295</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 2010 Sep;34(9):2026-40</Citation><ArticleIdList><ArticleId IdType="pubmed">20549210</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 2001 Feb;88(2):200-5</Citation><ArticleIdList><ArticleId IdType="pubmed">11167866</ArticleId></ArticleIdList></Reference><Reference><Citation>South Med J. 1996 Jul;89(7):668-74</Citation><ArticleIdList><ArticleId IdType="pubmed">8685751</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Coll Surg. 1994 Sep;179(3):273-8</Citation><ArticleIdList><ArticleId IdType="pubmed">8069421</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 1996 Mar-Apr;20(3):263-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8661828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1994 Jun;219(6):725-8; discussion 728-31</Citation><ArticleIdList><ArticleId IdType="pubmed">8203983</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 1997 Apr;11(4):336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">9094272</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Dec;24(12):2987-92</Citation><ArticleIdList><ArticleId IdType="pubmed">20552369</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 1998 Oct;12(10):1204-8</Citation><ArticleIdList><ArticleId IdType="pubmed">9745057</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1999 Jan;86(1):48-53</Citation><ArticleIdList><ArticleId IdType="pubmed">10027359</ArticleId></ArticleIdList></Reference><Reference><Citation>S Afr Med J. 2013 Jul 29;103(10):742-5</Citation><ArticleIdList><ArticleId IdType="pubmed">24079626</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1997 Aug;84(8):1045-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9278639</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Surg. 2006;40:1-19</Citation><ArticleIdList><ArticleId IdType="pubmed">17163092</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2001 Jul;15(7):660-2</Citation><ArticleIdList><ArticleId IdType="pubmed">11591963</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 1999 Mar;177(3):250-6</Citation><ArticleIdList><ArticleId IdType="pubmed">10219865</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Surg. 1996 Jan;20(1):17-20; discussion 21</Citation><ArticleIdList><ArticleId IdType="pubmed">8588406</ArticleId></ArticleIdList></Reference><Reference><Citation>Langenbecks Arch Surg. 2013 Jan;398(1):147-52</Citation><ArticleIdList><ArticleId IdType="pubmed">23212182</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Surg. 1993 Dec;80(12):1599-600</Citation><ArticleIdList><ArticleId IdType="pubmed">8298936</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2010 Oct 06;(10):CD001546</Citation><ArticleIdList><ArticleId IdType="pubmed">20927725</ArticleId></ArticleIdList></Reference><Reference><Citation>Endoscopy. 1983 Mar;15(2):59-64</Citation><ArticleIdList><ArticleId IdType="pubmed">6221925</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Endosc. 2010 Feb;24(2):266-9</Citation><ArticleIdList><ArticleId IdType="pubmed">19517167</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 1894 Jul;20(1):38-43</Citation><ArticleIdList><ArticleId IdType="pubmed">17860070</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28701223</PMID><DateCompleted><Year>2018</Year><Month>09</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jul</Month><Day>13</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.</ArticleTitle><Pagination><StartPage>181</StartPage><MedlinePgn>181</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">181</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-017-1764-4</ELocationID><Abstract><AbstractText Label="BACKGROUND">The administration of low-dose intravenous immunoglobulin G (IVIgG) (5&#xa0;g/day for 3&#xa0;days; approximate total 0.3&#xa0;g/kg) is widely used as an adjunctive treatment for patients with sepsis in Japan, but its efficacy in the reduction of mortality has not been evaluated. We investigated whether the administration of low-dose IVIgG is associated with clinically important outcomes including intensive care unit (ICU) and in-hospital mortality.</AbstractText><AbstractText Label="METHODS">This is a post-hoc subgroup analysis of data from a retrospective cohort study, the Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study. The JSEPTIC DIC study was conducted in 42 ICUs in 40 institutions throughout Japan, and it investigated associations between sepsis-related coagulopathy, anticoagulation therapies, and clinical outcomes of 3195 adult patients with sepsis and septic shock admitted to ICUs from January 2011 through December 2013. To investigate associations between low-dose IVIgG administration and mortalities, propensity score-based matching analysis was used.</AbstractText><AbstractText Label="RESULTS">IVIgG was administered to 960 patients (30.8%). Patients who received IVIgG were more severely ill than those who did not (Acute Physiology and Chronic Health Evaluation (APACHE) II score 24.2&#x2009;&#xb1;&#x2009;8.8 vs 22.6&#x2009;&#xb1;&#x2009;8.7, p&#x2009;&lt;&#x2009;0.001). They had higher ICU mortality (22.8% vs 17.4%, p&#x2009;&lt;&#x2009;0.001), but similar in-hospital mortality (34.4% vs 31.0%, p&#x2009;=&#x2009;0.066). In propensity score-matched analysis, 653 pairs were created. Both ICU mortality and in-hospital mortality were similar between the two groups (21.0% vs 18.1%, p&#x2009;=&#x2009;0.185, and 32.9% vs 28.6%, p&#x2009;=&#x2009;0.093, respectively) using generalized estimating equations fitted with logistic regression models adjusted for other therapeutic interventions. The administration of IVIgG was not associated with ICU or in-hospital mortality (odds ratio (OR) 0.883; 95% confidence interval (CI) 0.655-1.192, p&#x2009;=&#x2009;0.417, and OR 0.957, 95% CI, 0.724-1.265, p&#x2009;=&#x2009;0.758, respectively).</AbstractText><AbstractText Label="CONCLUSIONS">In this analysis of a large cohort of patients with sepsis and septic shock, the administration of low-dose IVIgG as an adjunctive therapy was not associated with a decrease in ICU or in-hospital mortality.</AbstractText><AbstractText Label="TRIAL REGISTRATION">University Hospital Medical Information Network Individual Clinical Trials Registry, UMIN-CTR000012543 . Registered on 10 December 2013.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Iizuka</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma, Omiya, Saitatama, Saitama, 330-8503, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Critical Care, Shonan Kamakura General Hospital, Kamakura, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanui</LastName><ForeName>Masamitsu</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0184-0381</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma, Omiya, Saitatama, Saitama, 330-8503, Japan. msanui@mac.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasabuchi</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, University of Tokyo, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lefor</LastName><ForeName>Alan Kawarai</ForeName><Initials>AK</Initials><AffiliationInfo><Affiliation>Department of Surgery, Jichi Medical University, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>Mineji</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Hokkaido University Hospital, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Shinjiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uchino</LastName><ForeName>Shigehiko</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudo</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takimoto</LastName><ForeName>Kohei</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Osaka University Graduate School of Medicine, Suita, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayumi</LastName><ForeName>Toshihiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Occupational and Environmental Health, Kita-Kyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azuhata</LastName><ForeName>Takeo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ito</LastName><ForeName>Fumihito</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Ohta General Hospital Foundation, Ohta Nishinouchi Hospital, Koriyama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshihiro</LastName><ForeName>Shodai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Pharmaceutical Department, JA Hiroshima General Hospital, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayakawa</LastName><ForeName>Katsura</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Saitama Red Cross Hospital, Saitama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakashima</LastName><ForeName>Tsuyoshi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Wakayama Medical University, Wakayama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Takayuki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Critical Care Medicine, Advanced Medical Emergency Department and Critical Care Center, Japan Red Cross Maebashi Hospital, Maebashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noda</LastName><ForeName>Eiichiro</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Kyushu University Hospital, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Yoshihiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekine</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Emergency Department, Ibaraki Prefectural Central Hospital, Kasama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoshikawa</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sekino</LastName><ForeName>Motohiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Intensive Care, Nagasaki University Hospital, Nagasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueno</LastName><ForeName>Keiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tokyo Medical University, Hachioji Medical Center, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okuda</LastName><ForeName>Yuko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Kyoto Daiichi Red-Cross Hospital, Kyoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watanabe</LastName><ForeName>Masayuki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Saiseikai Yokohamasi Tobu Hospital, Yokohama, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tampo</LastName><ForeName>Akihito</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Asahikawa Medical University, Asahikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saito</LastName><ForeName>Nobuyuki</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shock and Trauma Center, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitai</LastName><ForeName>Yuya</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency Medicine, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Suita, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kobayashi</LastName><ForeName>Iwao</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medicine, Asahikawa Red Cross Hospital, Asahikawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kondo</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Graduate School of Medicine, University of the Ryukyu, Nishihara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsunaga</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma, Omiya, Saitatama, Saitama, 330-8503, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nachi</LastName><ForeName>Sho</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Advanced Critical Care Center, Gifu University Hospital, Gifu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miike</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Saga University Hospital, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takahashi</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The Division of Cardiovascular Disease, Steel Memorial Muroran Hospital, Muroran, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takauji</LastName><ForeName>Shuhei</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine and Critical Care, Sapporo City General Hospital, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umakoshi</LastName><ForeName>Kensuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Ehime University Hospital, Toon, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todaka</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Tomishiro Central Hospital, Tomishiro, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodaira</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Akashi City Hospital, Akashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andoh</LastName><ForeName>Kohkichi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care, Sendai City Hospital, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasai</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Emergency Department, Hakodate Municipal Hospital, Hakodate, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwashita</LastName><ForeName>Yoshiaki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Mie University Hospital, Tsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arai</LastName><ForeName>Hideaki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, University of Occupational and Environmental Health, Kita-Kyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murata</LastName><ForeName>Masato</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Gunma University, Maebashi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamane</LastName><ForeName>Masahiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, KKR Sapporo Medical Center, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiga</LastName><ForeName>Kazuhiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Seirei Mikatahara General Hospital, Hamamatsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hori</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Hyogo College of Medicine, Nishinomiya, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>UMIN CTR</DataBankName><AccessionNumberList><AccessionNumber>CTR000012543</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004211" MajorTopicYN="N">Disseminated Intravascular Coagulation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adjunctive therapy</Keyword><Keyword MajorTopicYN="N">IVIG</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Polyclonal intravenous immunoglobulin G</Keyword><Keyword MajorTopicYN="N">Propensity score</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: This study is a post-hoc analysis utilizing the database from a retrospective cohort study, the Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study, which was approved by the institutional review board of each participating hospital (Additional file 1: Table S1). Because of the anonymous and retrospective nature of this study, the board of each hospital waived the need for informed consent. CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER&#x2019;S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>7</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28701223</ArticleId><ArticleId IdType="pmc">PMC5508630</ArticleId><ArticleId IdType="doi">10.1186/s13054-017-1764-4</ArticleId><ArticleId IdType="pii">10.1186/s13054-017-1764-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840&#x2013;51. doi: 10.1056/NEJMra1208623.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1208623</ArticleId><ArticleId IdType="pubmed">23984731</ArticleId></ArticleIdList></Reference><Reference><Citation>The Japanese Society of Intensive Care Medicine Committee of Sepsis Registry 2007 JSICM Sepsis 1st Registry: Management of severe sepsis and septic shock in Japan. J Jpn Soc Intensive Care Med. 2013;20:329&#x2013;34. doi: 10.3918/jsicm.20.329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3918/jsicm.20.329</ArticleId></ArticleIdList></Reference><Reference><Citation>Masaoka T, Hasegawa H, Takaku F, et al. The efficacy of intravenous immunoglobulin in combination therapy with antibiotics for severe infections. Jpn J Chemother. 2000;48:199&#x2013;217.</Citation></Reference><Reference><Citation>Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Ono K, Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost. 2016;115:1157&#x2013;66. doi: 10.1160/TH15-12-0987.</Citation><ArticleIdList><ArticleId IdType="doi">10.1160/TH15-12-0987</ArticleId><ArticleId IdType="pubmed">26939575</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250&#x2013;6. doi: 10.1097/01.CCM.0000050454.01978.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000050454.01978.3B</ArticleId><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami T, Matsui H, Fushimi K, et al. Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study. Clin Infect Dis. 2015;61:385&#x2013;92. doi: 10.1093/cid/civ307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/civ307</ArticleId><ArticleId IdType="pubmed">25882302</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami T, Matsui H, Fushimi K, et al. Intravenous immunoglobulin use in septic shock patients after emergency laparotomy. J Infect. 2015;71:158&#x2013;66. doi: 10.1016/j.jinf.2015.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2015.04.003</ArticleId><ArticleId IdType="pubmed">25869539</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486&#x2013;552. doi: 10.1097/CCM.0000000000002255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002255</ArticleId><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Spencer J, Sewell WA, et al. Bench-to-bedside review: immunoglobulin therapy for sepsis&#x2014;biological plausibility from a critical care perspective. Crit Care. 2012;16:206. doi: 10.1186/cc10597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10597</ArticleId><ArticleId IdType="pmc">PMC3584720</ArticleId><ArticleId IdType="pubmed">22424150</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Rosa R, Pietrosanti M, Luzi G, Salemi S, D'Amelio R. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis? Eur J Intern Med. 2014;25:511&#x2013;6. doi: 10.1016/j.ejim.2014.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2014.05.002</ArticleId><ArticleId IdType="pubmed">24877856</ArticleId></ArticleIdList></Reference><Reference><Citation>Werdan K, Pilz G, Bujdoso O, et al. Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med. 2007;35:2693&#x2013;701. doi: 10.1097/01.CCM.0000295426.37471.79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000295426.37471.79</ArticleId><ArticleId IdType="pubmed">18074471</ArticleId></ArticleIdList></Reference><Reference><Citation>Alejandria MM, Lansang MA, Dans LF, et al. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;9:CD001090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6516813</ArticleId><ArticleId IdType="pubmed">24043371</ArticleId></ArticleIdList></Reference><Reference><Citation>Turgeon AF, Hutton B, Fergusson DA, et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med. 2007;146:193&#x2013;203. doi: 10.7326/0003-4819-146-3-200702060-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-146-3-200702060-00009</ArticleId><ArticleId IdType="pubmed">17283351</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40586833</PMID><DateCompleted><Year>2025</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1496-8975</ISSN><JournalIssue CitedMedium="Internet"><Volume>72</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Canadian journal of anaesthesia = Journal canadien d'anesthesie</Title><ISOAbbreviation>Can J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Prognostic value of perioperative changes in serum primary metabolites in patients after major surgery under general anesthesia: an exploratory secondary analysis of the TAPIR trial.</ArticleTitle><Pagination><StartPage>954</StartPage><EndPage>965</EndPage><MedlinePgn>954-965</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12630-025-02984-6</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Major surgery under general anesthesia substantially alters physiologic homeostasis. Nevertheless, the intricate effects on the metabolome are poorly studied. Metabolic fingerprints may allow the identification of patients at risk for unfavourable outcomes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a secondary, exploratory, targeted metabolomic analysis of 177 high-risk patients undergoing major abdominal surgery under general anesthesia enrolled in the Targeting preoperatively Assessed Personal cardiac Index in major abdominal suRgery patients (TAPIR) randomized controlled trial. We analyzed primary serum metabolites using liquid chromatography coupled with triple quadrupole mass spectrometry before surgery (on preoperative day 0) and on postoperative day 3 (POD3). Our primary aim was to investigate postoperative alterations in primary serum metabolites. Secondary objectives included analyses in different subgroups, including patients with postoperative complications (composite of complication, delirium, acute kidney injury, and infection) up to day 30. We applied regression analyses and calculated false discovery rate-adjusted P values to address multiplicity.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of the 37 metabolites analyzed, 20 were different on POD3 after comparison with before surgery (lower: 4-hydroxyproline, alanine, asparagine, citrulline, cystine, dimethylglycine, glutamine, glutamic acid, glycine, guanosine, histidine, niacinamide, serine, uric acid, and xanthine; higher: isoleucine, leucine, methionine, methionine sulfoxide, pyruvic acid; adjusted P values&#x2009;&lt;&#x2009;0.05). We found no statistically significant preoperative differences between patients with and without postoperative complications (all adjusted P values&#x2009;&#x2265;&#x2009;0.05). Postoperatively, patients with (vs without) delirium within thirty days after surgery (n&#x2009;=&#x2009;13/177) showed lower levels of alanine, asparagine, citrulline, cystine, glutamine, glutamic acid, serine, threonine, and tyrosine after adjusting for preoperative metabolite levels.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Major abdominal surgery under general anesthesia was associated with complex changes in primary metabolites. We identified alterations in certain metabolites that were associated with postoperative delirium. Future research may establish metabolic patterns allowing the identification of patients at risk for unfavourable postoperative outcomes.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Krieg</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Septomics Research Centre, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Baumbach</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Septomics Research Centre, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceanga</LastName><ForeName>Iuliana-Andreea</ForeName><Initials>IA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Septomics Research Centre, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Standke</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Septomics Research Centre, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gr&#xe4;ler</LastName><ForeName>Markus H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Sepsis Control and Care, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Biomedicine (CMB), Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claus</LastName><ForeName>Ralf A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Molecular Biomedicine (CMB), Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicklas</LastName><ForeName>Julia Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center for Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkler</LastName><ForeName>Martin S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, University Medical Centre G&#xf6;ttingen, G&#xf6;ttingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saugel</LastName><ForeName>Bernd</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Center for Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coldewey</LastName><ForeName>Sina M</ForeName><Initials>SM</Initials><Identifier Source="ORCID">0000-0002-7130-0006</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. sina.coldewey@uzh.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Septomics Research Centre, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany. sina.coldewey@uzh.ch.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Anesthesiology and Perioperative Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland. sina.coldewey@uzh.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>03Z22JN12</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>03COV07</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant><Grant><GrantID>03Z22JI2</GrantID><Agency>Bundesministerium f&#xfc;r Bildung und Forschung</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><VernacularTitle>Valeur pronostique des modifications p&#xe9;riop&#xe9;ratoires des m&#xe9;tabolites s&#xe9;riques primaires chez les personnes op&#xe9;r&#xe9;es apr&#xe8;s une intervention chirurgicale majeure sous anesth&#xe9;sie g&#xe9;n&#xe9;rale: une analyse secondaire exploratoire de l&#x2019;&#xe9;tude TAPIR.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Can J Anaesth</MedlineTA><NlmUniqueID>8701709</NlmUniqueID><ISSNLinking>0832-610X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000768" MajorTopicYN="Y">Anesthesia, General</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055432" MajorTopicYN="N">Metabolomics</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000005" MajorTopicYN="Y">Abdomen</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="Y">Metabolome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>R&#xe9;SUM&#xe9;: OBJECTIF: Une intervention chirurgicale majeure sous anesth&#xe9;sie g&#xe9;n&#xe9;rale modifie consid&#xe9;rablement l&#x2019;hom&#xe9;ostasie physiologique. N&#xe9;anmoins, les effets complexes sur le m&#xe9;tabolome sont peu &#xe9;tudi&#xe9;s. Les empreintes m&#xe9;taboliques peuvent permettre d&#x2019;identifier les personnes pr&#xe9;sentant des risques&#xa0;d&#x2019;issues d&#xe9;favorables. M&#xe9;THODE: Nous avons r&#xe9;alis&#xe9; une analyse m&#xe9;tabolomique secondaire, exploratoire et cibl&#xe9;e de 177 patientes et patients &#xe0; haut risque b&#xe9;n&#xe9;ficiant d&#x2019;une chirurgie abdominale majeure sous anesth&#xe9;sie g&#xe9;n&#xe9;rale et inscrits &#xe0; l'&#xe9;tude randomis&#xe9;e contr&#xf4;l&#xe9;e TAPIR (Targeting preoperatively Assessed Personal cardiac Index in major abdominal suRgery patients). Nous avons analys&#xe9; les m&#xe9;tabolites s&#xe9;riques primaires &#xe0; l&#x2019;aide de la chromatographie liquide coupl&#xe9;e &#xe0; la spectrom&#xe9;trie de masse triple quadrip&#xf4;le avant l&#x2019;op&#xe9;ration (au jour pr&#xe9;op&#xe9;ratoire 0) et au jour postop&#xe9;ratoire 3 (POD3). Notre objectif principal &#xe9;tait d&#x2019;&#xe9;tudier les alt&#xe9;rations postop&#xe9;ratoires des m&#xe9;tabolites s&#xe9;riques primaires. Les objectifs secondaires comprenaient des analyses dans diff&#xe9;rents sous-groupes, y compris des personnes pr&#xe9;sentant des complications postop&#xe9;ratoires (composite de complication, de delirium, d&#x2019;insuffisance r&#xe9;nale aigu&#xeb; et d&#x2019;infection) jusqu&#x2019;au 30<sup>e</sup> jour. Nous avons appliqu&#xe9; des analyses de r&#xe9;gression et calcul&#xe9; les valeurs P ajust&#xe9;es au taux de fausses associations pour tenir compte de la multiplicit&#xe9;. R&#xe9;SULTATS: Sur les 37 m&#xe9;tabolites analys&#xe9;s, 20 &#xe9;taient diff&#xe9;rents au POD3 apr&#xe8;s comparaison de leurs valeurs pr&#xe9;-chirurgie (plus bas&#xa0;: 4-hydroxyproline, alanine, asparagine, citrulline, cystine, dim&#xe9;thylglycine, glutamine, acide glutamique, glycine, guanosine, histidine, niacinamide, s&#xe9;rine, acide urique et xanthine; plus &#xe9;lev&#xe9;s&#xa0;: isoleucine, leucine, m&#xe9;thionine, m&#xe9;thionine sulfoxyde, acide pyruvique; valeurs P ajust&#xe9;es&#x2009;&lt;&#x2009;0,05). Nous n&#x2019;avons trouv&#xe9; aucune diff&#xe9;rence pr&#xe9;op&#xe9;ratoire statistiquement significative entre les patientes et patients avec et sans complications postop&#xe9;ratoires (toutes valeurs P ajust&#xe9;es&#x2009;&#x2265;&#x2009;0,05). En postop&#xe9;ratoire, les patientes et patients atteints (vs non atteints) de delirium dans les trente jours suivant la chirurgie (n&#x2009;=&#x2009;13/177) ont montr&#xe9; des taux plus faibles d&#x2019;alanine, d&#x2019;asparagine, de citrulline, de cystine, de glutamine, d&#x2019;acide glutamique, de s&#xe9;rine, de thr&#xe9;onine et de tyrosine apr&#xe8;s ajustement pour tenir compte des taux de m&#xe9;tabolites pr&#xe9;op&#xe9;ratoires. CONCLUSION: Une chirurgie abdominale majeure sous anesth&#xe9;sie g&#xe9;n&#xe9;rale a &#xe9;t&#xe9; associ&#xe9;e &#xe0;&#xa0;des changements complexes dans les m&#xe9;tabolites primaires. Nous avons identifi&#xe9; des alt&#xe9;rations de certains m&#xe9;tabolites associ&#xe9;es au delirium postop&#xe9;ratoire. Des recherches futures pourraient &#xe9;tablir des mod&#xe8;les m&#xe9;taboliques permettant d&#x2019;identifier les personnes &#xe0; risque d&#x2019;issues postop&#xe9;ratoires d&#xe9;favorables.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">acute kidney injury</Keyword><Keyword MajorTopicYN="N">clinical outcomes</Keyword><Keyword MajorTopicYN="N">delirium</Keyword><Keyword MajorTopicYN="N">hemodynamic monitoring</Keyword><Keyword MajorTopicYN="N">major surgery</Keyword><Keyword MajorTopicYN="N">patient-centred anesthesia care</Keyword><Keyword MajorTopicYN="N">primary metabolites</Keyword><Keyword MajorTopicYN="N">targeted metabolomics</Keyword></KeywordList><CoiStatement>Bernd Saugel is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Edwards Lifesciences (Irvine, CA, USA), is a consultant for Philips North America (Cambridge, MA, USA) and has received honoraria for giving lectures from Philips Medizin Systeme B&#xf6;blingen (B&#xf6;blingen, Germany), has received institutional restricted research grants and honoraria for giving lectures from Baxter (Deerfield, IL, USA), is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from GE HealthCare (Chicago, IL, USA), has received institutional restricted research grants and honoraria for giving lectures from CNSystems Medizintechnik (Graz, Austria), is a consultant for Maquet Critical Care (Solna, Sweden), has received honoraria for giving lectures from Getinge (Gothenburg, Sweden), is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Pulsion Medical Systems (Feldkirchen, Germany), is a consultant for and has received institutional restricted research grants and honoraria for giving lectures from Vygon (Aachen, Germany), is a consultant for and has received institutional restricted research grants from Retia Medical (Valhalla, NY, USA), has received institutional restricted research grants from Osypka Medical (Berlin, Germany), was a consultant for and has received institutional restricted research grants from Tensys Medical (San Diego, CA, USA), and is an Editor of the <i>British Journal of Anaesthesia</i>. Julia Y. Nicklas has received refunds of travel expenses from CNSystems Medizintechnik GmbH (Graz, Austria). Martin S. Winkler has received funding from Sartorius AG (G&#xf6;ttingen, Germany), GRIFOLS SA (Barcelona, Spain), Sphingotec (Henningsdorf, Germany), Inflammatix (Sunnyvale, CA, USA), and the German Research Foundation (Bonn, Germany). He is on the advisory board of Amomed (Vienna, Austria) and Gilaed Science Inc. (Foster City, CA, USA). All other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>7</Month><Day>5</Day><Hour>20</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>1</Day><Hour>4</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>30</Day><Hour>11</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40586833</ArticleId><ArticleId IdType="pmc">PMC12228667</ArticleId><ArticleId IdType="doi">10.1007/s12630-025-02984-6</ArticleId><ArticleId IdType="pii">10.1007/s12630-025-02984-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation><i>Omling E, Jarnheimer A, Rose J, Bj&#xf6;rk J, Meara JG, Hagander L.</i> Population-based incidence rate of inpatient and outpatient surgical procedures in a high-income country. Br J Surg 2018; 105: 86&#x2013;95. 10.1002/bjs.10643
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5765448</ArticleId><ArticleId IdType="pubmed">29131303</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Ludbrook GL.</i> The hidden pandemic: the cost of postoperative complications. Curr Anesthesiol Rep 2022; 12: 1&#x2013;9. 10.1007/s40140-021-00493-y
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8558000</ArticleId><ArticleId IdType="pubmed">34744518</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Keller DS, Ho JW, Mercadel AJ, Ogola GO, Steele SR.</i> Are we taking a risk with risk assessment tools? Evaluating the relationship between NSQIP and the ACS risk calculator in colorectal surgery. Am J Surg 2018; 216: 645&#x2013;51. 10.1016/j.amjsurg.2018.07.015
</Citation><ArticleIdList><ArticleId IdType="pubmed">30049434</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Parker T, Brealey D, Dyson A, Singer M.</i> Optimising organ perfusion in the high-risk surgical and critical care patient: a narrative review. Br J Anaesth 2019; 123: 170&#x2013;6. 10.1016/j.bja.2019.03.027
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6676242</ArticleId><ArticleId IdType="pubmed">31054772</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Briesenick L, Schaade A, Bergholz A, et al.</i> Energy expenditure under general anesthesia: an observational study using indirect calorimetry in patients having noncardiac surgery. Anesth Analg 2023; 137: 169&#x2013;75. 10.1213/ane.0000000000006343
</Citation><ArticleIdList><ArticleId IdType="pubmed">36622833</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Stevens JL, Feelisch M, Martin DS.</i> Perioperative oxidative stress: the unseen enemy. Anesth Analg 2019; 129: 1749&#x2013;60. 10.1213/ane.0000000000004455
</Citation><ArticleIdList><ArticleId IdType="pubmed">31743197</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wang Q, Zhou J, Liu T, et al.</i> Predictive value of preoperative profiling of serum metabolites for emergence agitation after general anesthesia in adult patients. Front Mol Biosci 2021; 8: 739227. 10.3389/fmolb.2021.739227
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566542</ArticleId><ArticleId IdType="pubmed">34746231</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Hogarth K, Tarazi D, Maynes JT.</i> The effects of general anesthetics on mitochondrial structure and function in the developing brain. Front Neurol 2023; 14: 1179823.
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10390784</ArticleId><ArticleId IdType="pubmed">37533472</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Castelli FA, Rosati G, Moguet C, et al.</i> Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal Bioanal Chem 2022; 414: 759&#x2013;89. 10.1007/s00216-021-03586-z
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386160</ArticleId><ArticleId IdType="pubmed">34432105</ArticleId></ArticleIdList></Reference><Reference><Citation><i>He M, Zheng J, Liu H, et al.</i> Decreased serum uric acid in patients with traumatic brain injury or after cerebral tumor surgery. Neurosciences (Riyadh) 2021; 26: 36&#x2013;44. 10.17712/nsj.2021.1.20200089
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8015494</ArticleId><ArticleId IdType="pubmed">33530042</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wei XB, Chen WJ, Duan CY, et al.</i> Joint effects of uric acid and lymphocyte count on adverse outcomes in elderly patients with rheumatic heart disease undergoing valve replacement surgery. J Thorac Cardiovasc Surg 2019; 158: 420&#x2013;7. 10.1016/j.jtcvs.2018.10.058
</Citation><ArticleIdList><ArticleId IdType="pubmed">30459109</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Mock-Ohnesorge J, Mock A, Hackert T, et al.</i> Perioperative changes in the plasma metabolome of patients receiving general anesthesia for pancreatic cancer surgery. Oncotarget 2021; 12: 996&#x2013;1010. 10.18632/oncotarget.27956
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8121611</ArticleId><ArticleId IdType="pubmed">34012512</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Zhuang F, Bai X, Shi Y, et al.</i> Metabolomic profiling identifies biomarkers and metabolic impacts of surgery for colorectal cancer. Front Surg 2022; 9: 913967. 10.3389/fsurg.2022.913967
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453208</ArticleId><ArticleId IdType="pubmed">36090329</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Nicklas JY, Diener O, Leistenschneider M, et al.</i> Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial. Br J Anaesth 2020; 125: 122&#x2013;32. 10.1016/j.bja.2020.04.094
</Citation><ArticleIdList><ArticleId IdType="pubmed">32711724</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Jammer I, Wickboldt N, Sander M, et al.</i> Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: a statement from the ESA-ESICM joint taskforce on perioperative outcome measures. Eur J Anaesthesiol 2015; 32: 88&#x2013;105. 10.1097/eja.0000000000000118
</Citation><ArticleIdList><ArticleId IdType="pubmed">25058504</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Khwaja A.</i> KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract 2012; 120: c179&#x2013;84. 10.1159/000339789
</Citation><ArticleIdList><ArticleId IdType="pubmed">22890468</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Cohen J.</i> A power primer. Psychol Bull 1992; 112: 155&#x2013;9. 10.1037/0033-2909.112.1.155
</Citation><ArticleIdList><ArticleId IdType="pubmed">19565683</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Benjamini Y, Hochberg Y.</i> Controlling the false discovery rate&#x2014;a practical and powerful approach to multiple testing. J R Stat Soc B 1995; 57: 289&#x2013;300. 10.1111/j.2517-6161.1995.tb02031.x</Citation></Reference><Reference><Citation><i>R Core Team.</i> R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2020.</Citation></Reference><Reference><Citation><i>Team R.</i> RStudio: Integrated Development Environment for R. 1.4.1717 ed. Boston: RStudio, Inc.; 2021.</Citation></Reference><Reference><Citation><i>Burton D, Nicholson G, Hall G.</i> Endocrine and metabolic response to surgery. BJA Educ 2004; 4: 144&#x2013;7. 10.1093/bjaceaccp/mkh040</Citation></Reference><Reference><Citation><i>Aledo JC.</i> Methionine in proteins: the Cinderella of the proteinogenic amino acids. Protein Sci 2019; 28: 1785&#x2013;96. 10.1002/pro.3698
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6739822</ArticleId><ArticleId IdType="pubmed">31359525</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Parry-Billings M, Baigrie RJ, Lamont PM, Morris PJ, Newsholme EA.</i> Effects of major and minor surgery on plasma glutamine and cytokine levels. Arch Surg 1992; 127: 1237&#x2013;40. 10.1001/archsurg.1992.01420100099017
</Citation><ArticleIdList><ArticleId IdType="pubmed">1358047</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Viggiano E, Passavanti MB, Pace MC, et al.</i> Plasma glutamine decreases immediately after surgery and is related to incisiveness. J Cell Physiol 2012; 227: 1988&#x2013;91. 10.1002/jcp.22928
</Citation><ArticleIdList><ArticleId IdType="pubmed">21751210</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Costa BP, Martins P, Verissimo C, et al.</i> Glutaminemia prognostic significance in critical surgical patients&#x2014;an analysis of plasma aminogram profile. Nutr Hosp 2017; 34: 799&#x2013;807. 10.20960/nh.817
</Citation><ArticleIdList><ArticleId IdType="pubmed">29095001</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Tang G, Pi F, Qiu YH, Wei ZQ.</i> Postoperative parenteral glutamine supplementation improves the short-term outcomes in patients undergoing colorectal cancer surgery: a propensity score matching study. Front Nutr 2023; 10: 1040893. 10.3389/fnut.2023.1040893
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10060866</ArticleId><ArticleId IdType="pubmed">37006941</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wen S, Arakawa H, Tamai I.</i> Uric acid in health and disease: from physiological functions to pathogenic mechanisms. Pharmacol Ther 2024; 256: 108615. 10.1016/j.pharmthera.2024.108615
</Citation><ArticleIdList><ArticleId IdType="pubmed">38382882</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Karaman S, Sivrikaya A, Onmaz DE, Alptekin H.</i> Altered methylarginine levels after surgery in subjects with multinodular goiter. Horm Mol Biol Clin Investig 2021; 42: 291&#x2013;6. 10.1515/hmbci-2020-0093
</Citation><ArticleIdList><ArticleId IdType="pubmed">33607721</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Hy&#x161;pler R, Tich&#xe1; A, Ka&#x161;ka M, et al.</i> Markers of perioperative bowel complications in colorectal surgery patients. Dis Markers 2015; 2015: 428535. 10.1155/2015/428535
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4693001</ArticleId><ArticleId IdType="pubmed">26788017</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Papadia C, Osowska S, Cynober L, Forbes A.</i> Citrulline in health and disease. Review on human studies. Clin Nutr 2018; 37: 1823&#x2013;8. 10.1016/j.clnu.2017.10.009
</Citation><ArticleIdList><ArticleId IdType="pubmed">29107336</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wu G.</i> Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health. Amino Acids 2020; 52: 32960. 10.1007/s00726-020-02823-6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088015</ArticleId><ArticleId IdType="pubmed">32072297</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Correia GD, Wooi Ng K, Wijeyesekera A, et al.</i> Metabolic profiling of children undergoing surgery for congenital heart disease. Crit Care Med 2015; 43: 1467&#x2013;76. 10.1097/ccm.0000000000000982
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467581</ArticleId><ArticleId IdType="pubmed">25844698</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Reisinger AC, Posch F, Hackl G, et al.</i> Branched-chain amino acids can predict mortality in ICU sepsis patients. Nutrients 2021; 13: 3106. 10.3390/nu13093106
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8469152</ArticleId><ArticleId IdType="pubmed">34578983</ArticleId></ArticleIdList></Reference><Reference><Citation><i>De Bandt JP, Cynober L.</i> Therapeutic use of branched-chain amino acids in burn, trauma, and sepsis. J Nutr 2006; 136: 308S&#x2013;13. 10.1093/jn/136.1.308s
</Citation><ArticleIdList><ArticleId IdType="pubmed">16365104</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Heinzmann SS, Merrifield CA, Rezzi S, et al.</i> Stability and robustness of human metabolic phenotypes in response to sequential food challenges. J Proteome Res 2012; 11: 643-55.
</Citation><ArticleIdList><ArticleId IdType="pubmed">21999107</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Walsh MC, Brennan L, Malthouse JP, Roche HM, Gibney MJ.</i> Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans. Am J Clin Nutr 2006; 84: 531&#x2013;9. 10.1093/ajcn/84.3.531
</Citation><ArticleIdList><ArticleId IdType="pubmed">16960166</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Wallace M, Hashim YZ, Wingfield M, et al.</i> Effects of menstrual cycle phase on metabolomic profiles in premenopausal women. Hum Reprod 2010; 25: 949&#x2013;56. 10.1093/humrep/deq011
</Citation><ArticleIdList><ArticleId IdType="pubmed">20150174</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Dallmann R, Viola AU, Tarokh L, Cajochen C, Brown SA.</i> The human circadian metabolome. Proc Natl Acad Sci USA 2012; 109: 2625&#x2013;9. 10.1073/pnas.1114410109
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3289302</ArticleId><ArticleId IdType="pubmed">22308371</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Lu J, Tian Y, Gu J, et al.</i> Comparative study of metabolite changes after antihypertensive therapy with calcium channel blockers or angiotensin type 1 receptor blockers. J Cardiovasc Pharmacol 2021; 77: 228&#x2013;37. 10.1097/fjc.0000000000000958
</Citation><ArticleIdList><ArticleId IdType="pubmed">33235029</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Yin X, Prendiville O, McNamara AE, Brennan L.</i> Targeted metabolomic approach to assess the reproducibility of plasma metabolites over a four month period in a free-living population. J Proteome Res 2022; 21: 683&#x2013;90. 10.1021/acs.jproteome.1c00440
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8902803</ArticleId><ArticleId IdType="pubmed">34978446</ArticleId></ArticleIdList></Reference><Reference><Citation><i>Riekeberg E, Powers R.</i> New frontiers in metabolomics: from measurement to insight. F1000Res 2017; 6: 1148. 10.12688/f1000research.11495.1
</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5521158</ArticleId><ArticleId IdType="pubmed">28781759</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29906382</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2018</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0125-2208</ISSN><JournalIssue CitedMedium="Print"><Volume>99 Suppl 6</Volume><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</Title><ISOAbbreviation>J Med Assoc Thai</ISOAbbreviation></Journal><ArticleTitle>Acute Kidney Injury in Elderly Patients in Thai-Surgical Intensive Care Units (THAI-SICU) Study.</ArticleTitle><Pagination><StartPage>S209</StartPage><EndPage>S218</EndPage><MedlinePgn>S209-S218</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE">To demonstrate prevalence, characteristics and outcomes of the elderly patients who were diagnosed with acute kidney injury (AKI) in surgical intensive care units (ICUs).</AbstractText><AbstractText Label="MATERIAL AND METHOD">AKI data were extracted from multicenter prospective cohort study conducted in 9 university-affiliated surgical ICUs in Thailand (THAI-SICU study) from April 2011 to January 2013. The elderly group was defined as those over 65 years old. Statistical analysis was done comparing baseline characteristics and outcomes between the elderly with AKI and those without.</AbstractText><AbstractText Label="RESULTS">A total of 2,310 elderly patients (49.7%) were identified in our surgical ICUs from a total 4,652 cases. Of this elderly group, AKI was diagnosed in 445 cases (19.3%). The differences in the baseline characteristics of the elderly with AKI group were: older, higher number of males, greater number of smokers, and greater disease severity evaluated with APACHE-II and SOFA score than the elderly without AKI. The ICU mortality and 28-day hospital mortality were higher in the elderly with AKI than those without (28.1% vs. 5.2%, p&lt;0.001 with RR = 5.401, 95% CI 4.231-6.895 and 35.7% vs. 9.4%, p&lt;0.001 with RR = 3.786, 95% CI 3.138-4.569, respectively). Using multivariable logistic regression analysis and after adjustment of covariates, independent potential risk factors of developing AKI in the SICU included: older age, higher APACHE-II and SOFA score, smoking history, emergency surgery, concurrent sepsis, cardiac complications, delirium, and requiring respiratory support during ICU stay.</AbstractText><AbstractText Label="CONCLUSION">Geriatric patients made up almost half of our surgical ICU population and nearly one-fifth of them suffered AKI. Once they had AKI, ICU mortality and 28-day hospital mortality were higher than those without AKI.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Trongtrakul</LastName><ForeName>Konlawij</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Poopipatpab</LastName><ForeName>Sujaree</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Pisitsak</LastName><ForeName>Chawika</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Chittawatanarat</LastName><ForeName>Kaweesak</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Morakul</LastName><ForeName>Sunthiti</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><MedlineTA>J Med Assoc Thai</MedlineTA><NlmUniqueID>7507216</NlmUniqueID><ISSNLinking>0125-2208</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003693" MajorTopicYN="N">Delirium</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004630" MajorTopicYN="N">Emergencies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006785" MajorTopicYN="N">Hospitals, University</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011182" MajorTopicYN="N">Postoperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012907" MajorTopicYN="N">Smoking</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013785" MajorTopicYN="N">Thailand</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29906382</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40462110</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>04</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>03</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Impact of the Japanese clinical practice guidelines for management of sepsis and septic shock (J-SSCG) 2020 on real-world adherence and interhospital variation: a nationwide inpatient database study.</ArticleTitle><Pagination><StartPage>225</StartPage><MedlinePgn>225</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">225</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13054-025-05482-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG) 2020 aimed to standardize sepsis care in Japan. However, the extent of their impact on clinical practice remains uncertain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a nationwide retrospective cohort study using the Japanese Diagnosis Procedure Combination database between April 2018 and December 2021. Of the 118 clinical questions (CQs) in the J-SSCG 2020, we identified 26 recommendations to which adherence could be evaluated using patient-level data. We evaluated adherence trends before and after the guideline's publication using interrupted time series analysis and quantified hospital-level variation using intraclass correlation coefficients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 213,099 patients with sepsis from 791 hospitals were included. Adherence rates varied widely across CQs (range: 0.5-98.7%). Recommendations "against" interventions generally showed high adherence, whereas those "for" interventions exhibited lower and more variable adherence. After guideline publication, adherence increased by &lt;&#x2009;3% points for most CQs. Interrupted time series analysis demonstrated no abrupt or substantial changes, and statistically significant trends were modest (&lt;&#x2009;2% annually). Among the 26 CQs, 14 were consistent with J-SSCG 2016 and 12 were newly introduced in 2020; both groups showed similarly limited changes in adherence. Adjusted intraclass correlation coefficients exceeded 10% for 22 CQs, indicating persistent between-hospital variation, which remained unchanged after the guideline's release.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This nationwide study identified persistent evidence-practice gaps, minimal improvements in adherence after J-SSCG 2020, and substantial interhospital variation that remained unaltered. These findings underscore the challenges of implementing guidelines in practice and highlight the need to better understand contextual barriers to standardized sepsis care in Japan.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohbe</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan. hohbey@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan. hohbey@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, 569-8686, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kudo</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Miyagi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aso</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Services Research, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsui</LastName><ForeName>Hiroki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fushimi</LastName><ForeName>Kiyohide</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Health Policy and Informatics, Institute of Science Tokyo Graduate School, 2-12-1 Ookayama, Meguro-ku, Tokyo, 152-8550, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yasunaga</LastName><ForeName>Hideo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yatabe</LastName><ForeName>Tomoaki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Emergency Department, Nishichita General Hospital, 3-1-1 Nakanoike, Tokai-shi, 477-8522, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egi</LastName><ForeName>Moritoki</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Kyoto University Hospital, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi-ku, Osaka-shi, 558-8558, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nishida</LastName><ForeName>Osamu</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Care Medicine, Fujita Health University, 1-98 Dengakugakubo, Kutsukake, Toyoake, 470-1192, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushimoto</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Miyagi, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Executive Advisor for Emergency Medicine and Intensive Care, Kawasaki Saiwai Hospital, 31-27 Omiya-cho, Saiwai-ku, Kawasaki, 212-0014, Kanagawa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>23AA2003</GrantID><Agency>Ministry of Health, Labour and Welfare</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Population" UI="C000724324">Japanese people</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="Y">Guideline Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="Y">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065186" MajorTopicYN="N">Interrupted Time Series Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000095225" MajorTopicYN="N" AutoHM="Y">East Asian People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adherence</Keyword><Keyword MajorTopicYN="N">Clinical practice guidelines</Keyword><Keyword MajorTopicYN="N">Hospital variation</Keyword><Keyword MajorTopicYN="N">Interrupted time series</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><CoiStatement>Declarations. Consent for publication: Not applicable. Registry and the registration no. of the study/trial: Not applicable. Ethics approval and consent to participate: This study was approved by the Institutional Review Board of the University of Tokyo (approval number 3501-5; May 19, 2021). Given the deidentified nature of the data, the requirement for informed consent was waived. All procedures were conducted in accordance with the ethical standards of the Committee on Human Experimentation and the 1975 Declaration of Helsinki. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>5</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>6</Month><Day>4</Day><Hour>0</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>6</Month><Day>3</Day><Hour>23</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>6</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40462110</ArticleId><ArticleId IdType="pmc">PMC12135573</ArticleId><ArticleId IdType="doi">10.1186/s13054-025-05482-9</ArticleId><ArticleId IdType="pii">10.1186/s13054-025-05482-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and National sepsis incidence and mortality, 1990&#x2013;2017: analysis for the global burden of disease study. Lancet. 2020;395:200&#x2013;11. 10.1016/S0140-6736(19)32989-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021;49:e1063&#x2013;143. 10.1097/CCM.0000000000005337.</Citation><ArticleIdList><ArticleId IdType="pubmed">34605781</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda S, Aibiki M, Ikeda T, Imaizumi H, Endo S, Ochiai R, et al. The Japanese guidelines for the management of sepsis. J Intensive Care. 2014;2:55. 10.1186/s40560-014-0055-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4336273</ArticleId><ArticleId IdType="pubmed">25705413</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016). J Intensive Care. 2018;6:7. 10.1186/s40560-017-0270-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5797365</ArticleId><ArticleId IdType="pubmed">29435330</ArticleId></ArticleIdList></Reference><Reference><Citation>Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9:53. 10.1186/s40560-021-00555-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8384927</ArticleId><ArticleId IdType="pubmed">34433491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shime N, Nakada T-A, Yatabe T, Yamakawa K, Aoki Y, Inoue S, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2024. J Intensive Care. 2025;13:15. 10.1186/s40560-025-00776-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11907869</ArticleId><ArticleId IdType="pubmed">40087807</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8:iii&#x2013;iv. 10.3310/hta8060.</Citation><ArticleIdList><ArticleId IdType="pubmed">14960256</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ. 1999;318:527&#x2013;30. 10.1136/bmj.318.7182.527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1114973</ArticleId><ArticleId IdType="pubmed">10024268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pepi&#xf3; Vilaub&#xed; JM, Orozco-Beltr&#xe1;n D, Gon&#xe7;alves AQ, Rodriguez Cumplido D, Aguilar Martin C, Lopez-Pineda A, et al. Adherence to European clinical practice guidelines for secondary prevention of cardiovascular disease: A cohort study. Int J Environ Res Public Health. 2018;15:1233. 10.3390/ijerph15061233.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6025527</ArticleId><ArticleId IdType="pubmed">29891821</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelmayer WC, Fischer MA, Schneeweiss S, Wang PS, Levin R, Avorn J. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005;46:1080&#x2013;7. 10.1053/j.ajkd.2005.08.018.</Citation><ArticleIdList><ArticleId IdType="pubmed">16310574</ArticleId></ArticleIdList></Reference><Reference><Citation>McBride D, Br&#xfc;ggenj&#xfc;rgen B, Roll S, Willich SN. Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice. J Thromb Thrombolysis. 2007;24:65&#x2013;72. 10.1007/s11239-006-0002-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17260164</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujishima S, Gando S, Saitoh D, Mayumi T, Kushimoto S, Shiraishi S-I, et al. A multicenter, prospective evaluation of quality of care and mortality in Japan based on the surviving Sepsis campaign guidelines. J Infect Chemother. 2014;20:115&#x2013;20. 10.1016/j.jiac.2013.09.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">24462442</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Ogura H, Shiraishi A, Kushimoto S, Saitoh D, Fujishima S, et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in japan: the FORECAST study. Crit Care. 2018;22:322. 10.1186/s13054-018-2186-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6251147</ArticleId><ArticleId IdType="pubmed">30466493</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, Kushimoto S, Tokuda Y, Phillips GS, Rhodes A, Sugiyama T, et al. Implementation of earlier antibiotic administration in patients with severe sepsis and septic shock in japan: a descriptive analysis of a prospective observational study. Crit Care. 2019;23:360. 10.1186/s13054-019-2644-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6862854</ArticleId><ArticleId IdType="pubmed">31744549</ArticleId></ArticleIdList></Reference><Reference><Citation>The Ministry of Health. Labour and Welfare, Japan. Hospital bed function report [Internet]. Accessed 2023 Aug 25. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000055891.html</Citation></Reference><Reference><Citation>Yasunaga H. Updated information on the diagnosis procedure combination data. Annals Clin Epidemiol. 2024;6:106&#x2013;10. 10.37737/ace.24015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11668689</ArticleId><ArticleId IdType="pubmed">39726797</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476&#x2013;82. 10.1016/j.je.2016.09.009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5602797</ArticleId><ArticleId IdType="pubmed">28142051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohbe H, Sasabuchi Y, Doi K, Matsui H, Yasunaga H. Association between levels of intensive care and in-hospital mortality in patients hospitalized for sepsis stratified by sequential organ failure assessment scores. Crit Care Med. 2023;51:1138&#x2013;47. 10.1097/CCM.0000000000005886.</Citation><ArticleIdList><ArticleId IdType="pubmed">37114933</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801&#x2013;10. 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Sch&#xfc;nemann HJ, Djulbegovic B, Akl EA. Guideline panels should not GRADE good practice statements. J Clin Epidemiol. 2015;68:597&#x2013;600. 10.1016/j.jclinepi.2014.12.011.</Citation><ArticleIdList><ArticleId IdType="pubmed">25660962</ArticleId></ArticleIdList></Reference><Reference><Citation>Amrhein V, Greenland S, McShane B. Scientists rise up against statistical significance. Nature. 2019;567:305&#x2013;7. 10.1038/d41586-019-00857-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30894741</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299&#x2013;309. 10.1046/j.1365-2710.2002.00430.x.</Citation><ArticleIdList><ArticleId IdType="pubmed">12174032</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin PC, Merlo J. Intermediate and advanced topics in multilevel logistic regression analysis. Stat Med. 2017;36:3257&#x2013;77. 10.1002/sim.7336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5575471</ArticleId><ArticleId IdType="pubmed">28543517</ArticleId></ArticleIdList></Reference><Reference><Citation>Questionnaire survey group, Guideline committee of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock. 2020. Questionnaire survey on usage and awareness of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020. J Jpn Soc Intensive Care Med. 2022;29:609&#x2013;19.</Citation></Reference><Reference><Citation>Gupta A, Yu Y, Tan Q, Liu S, Masoudi FA, Du X, et al. Quality of care for patients hospitalized for heart failure in China. JAMA Netw Open. 2020;3:e1918619. 10.1001/jamanetworkopen.2019.18619.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6991250</ArticleId><ArticleId IdType="pubmed">31913489</ArticleId></ArticleIdList></Reference><Reference><Citation>Gathara D, English M, van Hensbroek MB, Todd J, Allen E. Exploring sources of variability in adherence to guidelines across hospitals in low-income settings: a multi-level analysis of a cross-sectional survey of 22 hospitals. Implement Sci. 2015;10:60. 10.1186/s13012-015-0245-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4416316</ArticleId><ArticleId IdType="pubmed">25928803</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181&#x2013;247. 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18074465</PMID><DateCompleted><Year>2007</Year><Month>12</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0090-3493</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>12</Issue><PubDate><Year>2007</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>2686</StartPage><EndPage>2692</EndPage><MedlinePgn>2686-92</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To systematically review the literature to assess whether adjunctive therapy with polyclonal intravenous immunoglobulin (ivIg) reduces mortality among critically ill adults with severe sepsis and septic shock.</AbstractText><AbstractText Label="DATA SOURCE" NlmCategory="METHODS">MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials databases; the meta-register of controlled trials; and the Medical Editors Trial Amnesty register.</AbstractText><AbstractText Label="STUDY SELECTION" NlmCategory="METHODS">Prospective randomized clinical trials (RCTs) evaluating ivIg treatment in critically ill adults with severe sepsis or septic shock were included. Two reviewers conducted assessment of suitability for inclusion.</AbstractText><AbstractText Label="DATA EXTRACTION" NlmCategory="METHODS">Two authors independently determined the validity of included studies and extracted data.</AbstractText><AbstractText Label="DATA SYNTHESIS" NlmCategory="RESULTS">The effect of ivIg on all-cause mortality was quantified using a fixed-effect meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fourteen RCTs published between 1988 and 2006 were included. Most were small, used relatively low doses of ivIg, and included predominantly surgical patients with Gram-negative infections. There was a significant reduction in mortality associated with use of ivIg treatment with a pooled odds ratio of 0.66 (95% confidence interval 0.53-0.83; p &lt; .0005). In general, a greater treatment effect was seen among studies of lower methodological quality, studies using higher doses of ivIg, and studies that did not use albumin as a control. There was evidence of between-study heterogeneity (chi-square p = .009), and this was at least moderate as measured by the I2 value (I2 = 53.8%). When only high-quality studies were pooled, the odds ratio for mortality was 0.96 (95% confidence interval 0.71-1.3; p = .78).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This meta-analysis demonstrates an overall reduction in mortality with the use of ivIg for the adjunctive treatment of severe sepsis and septic shock in adults, although significant heterogeneity exists among the included trials and this result was not confirmed when only high-quality studies were analyzed. These data warrant a well-designed, adequately powered, and transparently reported clinical trial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Laupland</LastName><ForeName>Kevin B</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirkpatrick</LastName><ForeName>Andrew W</ForeName><Initials>AW</Initials></Author><Author ValidYN="Y"><LastName>Delaney</LastName><ForeName>Anthony</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016756">Immunoglobulins, Intravenous</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007155">Immunologic Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Crit Care Med. 2007 Dec;35(12):2852-4. doi: 10.1097/01.CCM.0000297164.40980.F0.</RefSource><PMID Version="1">18043202</PMID></CommentsCorrections><CommentsCorrections RefType="CommentOn"><RefSource>Crit Care Med. 2007 Dec;35(12):2855-6. doi: 10.1097/01.CCM.0000295277.26957.65.</RefSource><PMID Version="1">18043203</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016756" MajorTopicYN="N">Immunoglobulins, Intravenous</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007155" MajorTopicYN="N">Immunologic Factors</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>57</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>12</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>12</Month><Day>13</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18074465</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33402282</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-6859</ISSN><JournalIssue CitedMedium="Internet"><Volume>161</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Gynecologic oncology</Title><ISOAbbreviation>Gynecol Oncol</ISOAbbreviation></Journal><ArticleTitle>Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.</ArticleTitle><Pagination><StartPage>39</StartPage><EndPage>45</EndPage><MedlinePgn>39-45</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygyno.2020.12.036</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0090-8258(20)34251-7</ELocationID><Abstract><AbstractText Label="OBJECTIVE">To examine characteristics and short-term perioperative outcomes related to minimally invasive pelvic exenteration for gynecologic malignancy.</AbstractText><AbstractText Label="METHODS">This comparative effectiveness study is a retrospective population-based analysis of the National Inpatient Sample from 10/2008-9/2015. Women with cervical, uterine, vaginal, and vulvar malignancies who underwent pelvic exenteration were evaluated based on the use of laparoscopic or robotic-assisted surgery. Patient demographics and intraoperative/postoperative complications related to a minimally invasive surgical approach were assessed.</AbstractText><AbstractText Label="RESULTS">Among 1376 women who underwent pelvic exenteration, 49 (3.6%) had the procedure performed via a minimally invasive approach. The majority of minimally invasive cases were robotic-assisted (51.0%). Women in the minimally invasive group were more likely to be old, white, have cervical/uterine cancers, and receive urinary diversion, but less frequently received vaginal reconstruction or colostomy when compared to those in the open surgery group (P &lt; 0.05). Overall perioperative complication rates were similar between the minimally invasive and open surgery groups (79.6% versus 77.7%, P = 0.862), but the minimally invasive group had a decreased risk of high-risk complications compared to the open surgery group (adjusted-odds ratio 0.19, 95% confidence interval 0.07-0.51). Specifically, a minimally invasive approach was associated with decreased incidence of sepsis and thromboembolism compared to an open approach (P &lt; 0.05). The minimally invasive group had a shorter length of stay (median, 9 versus 14&#xa0;days) and lower total charge (median, $127,875 versus $208,591) compared to the open surgery group (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION">Laparotomy remains the main surgical approach for pelvic exenteration for gynecologic malignancy and minimally invasive surgery was infrequently utilized during the study period in the United States. Before widely adopting this surgical approach, the utility and role of minimally invasive pelvic exenteration requires further investigation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matsuo</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA. Electronic address: koji.matsuo@med.usc.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsuzaki</LastName><ForeName>Shinya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandelbaum</LastName><ForeName>Rachel S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanao</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Gynecologic Oncology, Cancer Institute Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Erica J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klar</LastName><ForeName>Maximilian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Freiburg, Freiburg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roman</LastName><ForeName>Lynda D</ForeName><Initials>LD</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA, USA; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wright</LastName><ForeName>Jason D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>01</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gynecol Oncol</MedlineTA><NlmUniqueID>0365304</NlmUniqueID><ISSNLinking>0090-8258</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019060" MajorTopicYN="N">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010385" MajorTopicYN="N">Pelvic Exenteration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059035" MajorTopicYN="N">Perioperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complication</Keyword><Keyword MajorTopicYN="N">Laparoscopic</Keyword><Keyword MajorTopicYN="N">Minimally invasive surgery</Keyword><Keyword MajorTopicYN="N">Pelvic exenteration</Keyword><Keyword MajorTopicYN="N">Robotic assisted</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>6</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33402282</ArticleId><ArticleId IdType="doi">10.1016/j.ygyno.2020.12.036</ArticleId><ArticleId IdType="pii">S0090-8258(20)34251-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34760851</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-2360</ISSN><JournalIssue CitedMedium="Print"><Volume>9</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in pediatrics</Title><ISOAbbreviation>Front Pediatr</ISOAbbreviation></Journal><ArticleTitle>Long-Term Functional Outcomes After Sepsis for Adult and Pediatric Critical Care Patients-Protocol for a Systematic Review.</ArticleTitle><Pagination><StartPage>734205</StartPage><MedlinePgn>734205</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">734205</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fped.2021.734205</ELocationID><Abstract><AbstractText><b>Objective:</b> Sepsis is responsible for a massive burden of disease, with a global estimate of 48.9 million cases resulting in approximately 11 million deaths annually. Survivors of sepsis may also experience long-term impairments that can persist for years after hospital discharge. These cognitive, physical and/or psychosocial deficits may contribute to a lower health related quality of life and represent a significant ongoing burden to the individual, the community and the health care system. We aim to systematically review the available evidence on long-term functional and quality of life outcomes after sepsis in children and adults. <b>Data Sources:</b> Medline, EMBASE, and CINAHL will be searched for eligible studies. <b>Study Selection:</b> Studies of adult and pediatric survivors of sepsis who had required admission to intensive care will be included. A minimum 6 month prospective follow up will be required. Accepted outcomes will be any validated measure of health-related quality of life (HRQoL) or functional deficits, using the Post-Intensive Care Syndrome (PICS) framework of cognitive, physical or psychosocial outcomes. <b>Data Extraction:</b> Data extraction will include information related to study characteristics, population characteristics, clinical criteria and outcomes. <b>Data Synthesis:</b> Studies meeting the inclusion criteria will be presented descriptively separated for pediatric and adult age groups. Meta-analysis will be attempted if sufficient primary data from several studies applying the same tests and outcomes are available. The primary outcome is HRQoL after sepsis; secondary outcomes include the functional status at follow-up. <b>Conclusions:</b> This systematic review will define the long-term impact of sepsis survivorship. The data will contribute to informing patient, clinician and stakeholder decisions and guide further research and resource management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Simpson, Long, Fleischmann-Struzek, Minogue, Venkatesh, Hammond, Tian and Schlapbach.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Child Health Research Center, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Healthcare Transformation, Queensland University of Technology, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fleischmann-Struzek</LastName><ForeName>Carolin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Minogue</LastName><ForeName>Jessicah</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Healthcare Transformation, Queensland University of Technology, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>Balasubramanian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>The Wesley and Princess Alexandra Hospitals, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The George Institute for Global Health and University of New South Wales Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Naomi E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>The George Institute for Global Health and University of New South Wales Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Royal North Shore Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Perioperative Medicine, Westmead Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlapbach</LastName><ForeName>Luregn J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Child Health Research Center, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Queensland Children's Hospital, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care and Neonatology, and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Pediatr</MedlineTA><NlmUniqueID>101615492</NlmUniqueID><ISSNLinking>2296-2360</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">adult</Keyword><Keyword MajorTopicYN="N">child</Keyword><Keyword MajorTopicYN="N">long-term outcome</Keyword><Keyword MajorTopicYN="N">quality of life</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">survivorship</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>11</Day><Hour>7</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34760851</ArticleId><ArticleId IdType="pmc">PMC8573219</ArticleId><ArticleId IdType="doi">10.3389/fped.2021.734205</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M., et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801&#x2013;10. 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Kissoon N. Defining pediatric sepsis. JAMA Pediatr. (2018) 172:312&#x2013;4. 10.1001/jamapediatrics.2017.5208</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2017.5208</ArticleId><ArticleId IdType="pubmed">29459982</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. (2020) 395:200&#x2013;11. 10.1016/S0140-6736(19)32989-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Kissoon N, Alhawsawi A, Aljuaid MH, Daniels R, Gorordo-Delsol LA, et al. . World Sepsis Day: a global agenda to target a leading cause of morbidity and mortality. Am J Physiol Lung Cell Mol Physiol. (2020) 319:L518&#x2013;l522. 10.1152/ajplung.00369.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00369.2020</ArticleId><ArticleId IdType="pubmed">32812788</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, Schlapbach LJ, Reinhart K, Kissoon N. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. (2018) 6:223&#x2013;30. 10.1016/S2213-2600(18)30063-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(18)30063-8</ArticleId><ArticleId IdType="pubmed">29508706</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhart K, Daniels R, Kissoon N, Machado FR, Schachter RD, Finfer S. Recognizing sepsis as a global health priority - A WHO resolution. N Engl J Med. (2017) 377:414&#x2013;7. 10.1056/NEJMp1707170</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1707170</ArticleId><ArticleId IdType="pubmed">28658587</ArticleId></ArticleIdList></Reference><Reference><Citation>Kissoon N, Reinhart K, Daniels R, Machado MFR, Schachter RD, Finfer S. Sepsis in children: global implications of the world health assembly resolution on sepsis. Pediatr Crit Care Med. (2017) 18:e625&#x2013;7. 10.1097/PCC.0000000000001340</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001340</ArticleId><ArticleId IdType="pubmed">28914721</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Thompson K, Finfer SR. The WHO resolution on sepsis: what action is needed in Australia? Med J Aust. (2019) 211:395&#x2013;7 e1. 10.5694/mja2.50279</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50279</ArticleId><ArticleId IdType="pubmed">31329300</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012. JAMA. (2014) 311:1308&#x2013;16. 10.1001/jama.2014.2637</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, MacLaren G, Festa M, Alexander J, Erickson S, Beca J, et al. . Australian, O. New Zealand Intensive Care Society Centre for, Resource E, Australian, and G New Zealand Intensive Care Society Paediatric Study, Prediction of pediatric sepsis mortality within 1 h of intensive care admission. Intensive Care Med. (2017) 43:1085&#x2013;96. 10.1007/s00134-017-4701-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4701-8</ArticleId><ArticleId IdType="pubmed">28220227</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ, Straney L, Alexander J, MacLaren G, Festa M, Schibler A, et al. . Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis. (2015) 15:46&#x2013;54. 10.1016/S1473-3099(14)71003-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(14)71003-5</ArticleId><ArticleId IdType="pubmed">25471555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. . Klompas, and C.D.program CPE. Incidence and trends of sepsis in us hospitals using clinical vs claims data, 2009-2014. JAMA. (2017) 318:1241&#x2013;9. 10.1001/jama.2017.13836</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the united states-an analysis based on timing of diagnosis and severity level. Crit Care Med. (2018) 46:1889&#x2013;97. 10.1097/CCM.0000000000003342</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003342</ArticleId><ArticleId IdType="pmc">PMC6250243</ArticleId><ArticleId IdType="pubmed">30048332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, Morandi A, Thompson JL, Pun BT, et al. . Long-term cognitive impairment after critical illness. New England Journal of Medicine. (2013) 369:1306&#x2013;16. 10.1056/NEJMoa1301372</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1301372</ArticleId><ArticleId IdType="pmc">PMC3922401</ArticleId><ArticleId IdType="pubmed">24088092</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai SV, Law TJ, Needham DM. Long-term complications of critical care. Crit Care Med. (2011) 39:371&#x2013;9. 10.1097/CCM.0b013e3181fd66e5</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181fd66e5</ArticleId><ArticleId IdType="pubmed">20959786</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Davidson J, Cohen H, Hopkins RO, Weinert C, Wunsch H, et al. . Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference. Crit Care Med. (2012) 40:502&#x2013;9. 10.1097/CCM.0b013e318232da75</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318232da75</ArticleId><ArticleId IdType="pubmed">21946660</ArticleId></ArticleIdList></Reference><Reference><Citation>Maley JH, Mikkelsen ME. Short-term gains with long-term consequences: the evolving story of sepsis survivorship. Clin Chest Med. (2016) 37:367&#x2013;80. 10.1016/j.ccm.2016.01.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2016.01.017</ArticleId><ArticleId IdType="pubmed">27229651</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Iwashyna TJ, Blackwood B, Calandra T, Chlan LL, Choong K, et al. . Understanding and enhancing sepsis survivorship. Priorities for research and practice. Am J Respir Crit Care Med. (2019) 200:972&#x2013;81. 10.1164/rccm.201812-2383CP</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201812-2383CP</ArticleId><ArticleId IdType="pmc">PMC6794113</ArticleId><ArticleId IdType="pubmed">31161771</ArticleId></ArticleIdList></Reference><Reference><Citation>Prescott HC, Angus DC. Enhancing recovery from sepsis: a review. JAMA. (2018) 319:62&#x2013;75. 10.1001/jama.2017.17687</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.17687</ArticleId><ArticleId IdType="pmc">PMC5839473</ArticleId><ArticleId IdType="pubmed">29297082</ArticleId></ArticleIdList></Reference><Reference><Citation>Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. (2010) 38:1276&#x2013;83. 10.1097/CCM.0b013e3181d8cc1d</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181d8cc1d</ArticleId><ArticleId IdType="pubmed">20308885</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. (2010) 304:1787&#x2013;94. 10.1001/jama.2010.1553</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1553</ArticleId><ArticleId IdType="pmc">PMC3345288</ArticleId><ArticleId IdType="pubmed">20978258</ArticleId></ArticleIdList></Reference><Reference><Citation>Annane D, Sharshar T. Cognitive decline after sepsis. Lancet Respir Med. (2015) 3:61&#x2013;9. 10.1016/S2213-2600(14)70246-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(14)70246-2</ArticleId><ArticleId IdType="pubmed">25434614</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos MC, Davies DC, Moss RF, Tighe D, Bennett ED. Pathophysiology of septic encephalopathy: a review. Crit Care Med. (2000) 28:3019&#x2013;24. 10.1097/00003246-200008000-00057</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200008000-00057</ArticleId><ArticleId IdType="pubmed">10966289</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolley SE, Bunnell AE, Hough CL. ICU-acquired weakness. Chest. (2016) 150:1129&#x2013;40. 10.1016/j.chest.2016.03.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.03.045</ArticleId><ArticleId IdType="pmc">PMC5103015</ArticleId><ArticleId IdType="pubmed">27063347</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlapbach LJ. Paediatric sepsis. Curr Opin Infect Dis. (2019) 32:497&#x2013;504. 10.1097/QCO.0000000000000583</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000583</ArticleId><ArticleId IdType="pubmed">31335441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronner MB, Knoester H, Sol JJ, Bos AP, Heymans HS, Grootenhuis MA. An explorative study on quality of life and psychological and cognitive function in pediatric survivors of septic shock. Pediatr Crit Care Med. (2009) 10:636&#x2013;42. 10.1097/PCC.0b013e3181ae5c1a</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0b013e3181ae5c1a</ArticleId><ArticleId IdType="pubmed">19581821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmerman JJ, Banks R, Berg RA, Zuppa A, Newth CJ, Wessel D, et al. . Life after pediatric sepsis evaluation, trajectory of mortality and health-related quality of life morbidity following community-acquired pediatric septic shock. Crit Care Med. (2020) 48:329&#x2013;37. 10.1097/CCM.0000000000004123</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004123</ArticleId><ArticleId IdType="pmc">PMC7164680</ArticleId><ArticleId IdType="pubmed">32058370</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning JC, Pinto NP, Rennick JE, Colville G, Curley MAQ. Conceptualizing post intensive care syndrome in children-The PICS-p framework. Pediatr Crit Care Med. (2018) 19:298&#x2013;300. 10.1097/PCC.0000000000001476</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000001476</ArticleId><ArticleId IdType="pubmed">29406379</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink EL, Jarvis JM, Maddux AB, Pinto N, Galyean P, Olson LM, et al. . Development of a core outcome set for pediatric critical care outcomes research. Contemp Clin Trials. (2020) 91:105968. 10.1016/j.cct.2020.105968</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2020.105968</ArticleId><ArticleId IdType="pmc">PMC7313715</ArticleId><ArticleId IdType="pubmed">32147572</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink EL, Maddux AB, Pinto N, Sorenson S, Notterman D, Dean JM, et al. . A core outcome set for pediatric critical care. Crit Care Med. (2020) 48:1819&#x2013;28. 10.1097/CCM.0000000000004660</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004660</ArticleId><ArticleId IdType="pmc">PMC7785252</ArticleId><ArticleId IdType="pubmed">33048905</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. (2021) 372:n71. 10.1136/bmj.n71</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. . Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. (2015) 4:1. 10.1186/2046-4053-4-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-4-1</ArticleId><ArticleId IdType="pmc">PMC4320440</ArticleId><ArticleId IdType="pubmed">25554246</ArticleId></ArticleIdList></Reference><Reference><Citation>EuroQol Group. EuroQol&#x2013;a new facility for the measurement of health-related quality of life. Health Policy. (1990) 16:199&#x2013;208. 10.1016/0168-8510(90)90421-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-8510(90)90421-9</ArticleId><ArticleId IdType="pubmed">10109801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) I Conceptual framework and item selection. Med Care. (1992) 30:473&#x2013;83. 10.1097/00005650-199206000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai AD, Zhou C, Stanford S, Haaland W, Varni JW. Mangione-Smith RM. Validity and responsiveness of the pediatric quality of life inventory (PedsQL) 40 generic core scales in the pediatric inpatient setting. JAMA Pediatr. (2014) 168:1114&#x2013;21. 10.1001/jamapediatrics.2014.1600</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2014.1600</ArticleId><ArticleId IdType="pubmed">25347549</ArticleId></ArticleIdList></Reference><Reference><Citation>Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. (2003) 3:329&#x2013;41. 10.1367/1539-4409(2003)003&lt;0329:tpaapp&gt;2.0.co;2</Citation><ArticleIdList><ArticleId IdType="doi">10.1367/1539-4409(2003)003&lt;0329:tpaapp&gt;2.0.co;2</ArticleId><ArticleId IdType="pubmed">14616041</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt K, Worrack S, Von Korff M, Davydow D, Brunkhorst F, Ehlert U, et al. . Effect of a primary care management intervention on mental health&#x2013;related quality of life among survivors of sepsis. JAMA. (2016) 315:2703. 10.1001/jama.2016.7207</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.7207</ArticleId><ArticleId IdType="pmc">PMC5122319</ArticleId><ArticleId IdType="pubmed">27367877</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham DM, Sepulveda KA, Dinglas VD, Chessare CM, Friedman LA, Bingham CO, et al. . Core outcome measures for clinical research in acute respiratory failure survivors. Am J Respir Crit Care Med. (2017) 196:1122&#x2013;30. 10.1164/rccm.201702-0372OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201702-0372OC</ArticleId><ArticleId IdType="pmc">PMC5694837</ArticleId><ArticleId IdType="pubmed">28537429</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir BA, Randolph S. International Consensus Conference on Pediatric, International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. (2005) 6:2&#x2013;8. 10.1097/01.PCC.0000149131.72248.E6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.PCC.0000149131.72248.E6</ArticleId><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. . 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. (2003) 31:1250&#x2013;6. 10.1097/01.CCM.0000050454.01978.3B</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000050454.01978.3B</ArticleId><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. . The Newcastle&#x2013;Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. (2000).</Citation></Reference><Reference><Citation>Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, et al. . Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC Methods Programme. (2006).</Citation></Reference><Reference><Citation>Ara R, Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health. (2008) 11:1131&#x2013;43. 10.1111/j.1524-4733.2008.00352.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1524-4733.2008.00352.x</ArticleId><ArticleId IdType="pubmed">18489495</ArticleId></ArticleIdList></Reference><Reference><Citation>Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. (1994) 50:1088&#x2013;101. 10.2307/2533446</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2533446</ArticleId><ArticleId IdType="pubmed">7786990</ArticleId></ArticleIdList></Reference><Reference><Citation>Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. (1997) 315:629&#x2013;34. 10.1136/bmj.315.7109.629</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.315.7109.629</ArticleId><ArticleId IdType="pmc">PMC2127453</ArticleId><ArticleId IdType="pubmed">9310563</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC. The lingering consequences of sepsis: a hidden public health disaster? JAMA. (2010) 304:1833&#x2013;4. 10.1001/jama.2010.1546</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.1546</ArticleId><ArticleId IdType="pubmed">20978262</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam N, Nannan Panday RS, Heijnen JR, van Galen LS, Kramer MHH, Nanayakkara PWB. Long-term health related quality of life in patients with sepsis after intensive care stay: A systematic review. Acute Med. (2017) 16:164&#x2013;9. 10.52964/AMJA.0678</Citation><ArticleIdList><ArticleId IdType="doi">10.52964/AMJA.0678</ArticleId><ArticleId IdType="pubmed">29300794</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. . Critical Care, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. (2008) 36:296&#x2013;327. 10.1097/01.CCM.0000298158.12101.41</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000298158.12101.41</ArticleId><ArticleId IdType="pubmed">18158437</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38549422</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Empirical carbapenems or piperacillin/tazobactam for infections in intensive care: An international retrospective cohort study.</ArticleTitle><Pagination><StartPage>821</StartPage><EndPage>829</EndPage><MedlinePgn>821-829</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.14419</ELocationID><Abstract><AbstractText Label="BACKGROUND">Critically ill patients in intensive care units (ICU) are frequently administered broad-spectrum antibiotics (e.g., carbapenems or piperacillin/tazobactam) for suspected or confirmed infections. This retrospective cohort study aimed to describe the use of carbapenems and piperacillin/tazobactam in two international, prospectively collected datasets.</AbstractText><AbstractText Label="METHODS">We conducted a post hoc analysis of data from the "Adjunctive Glucocorticoid Therapy in Patients with Septic Shock" (ADRENAL) trial (n&#x2009;=&#x2009;3713) and the "Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure" (DIANA) study (n&#x2009;=&#x2009;1488). The primary outcome was the proportion of patients receiving initial antibiotic treatment with carbapenems and piperacillin/tazobactam. Secondary outcomes included mortality, days alive and out of ICU and ICU length of stay at 28&#x2009;days.</AbstractText><AbstractText Label="RESULTS">In the ADRENAL trial, carbapenems were used in 648 out of 3713 (17%), whereas piperacillin/tazobactam was used in 1804 out of 3713 (49%) participants. In the DIANA study, carbapenems were used in 380 out of 1480 (26%), while piperacillin/tazobactam was used in 433 out of 1488 (29%) participants. Mortality at 28&#x2009;days was 23% for patients receiving carbapenems and 24% for those receiving piperacillin/tazobactam in ADRENAL and 23% and 19%, respectively, in DIANA. We noted variations in secondary outcomes; in DIANA, patients receiving carbapenems had a median of 13&#x2009;days alive and out of ICU compared with 18&#x2009;days among those receiving piperacillin/tazobactam. In ADRENAL, the median hospital length of stay was 27&#x2009;days for patients receiving carbapenems and 21&#x2009;days for those receiving piperacillin/tazobactam.</AbstractText><AbstractText Label="CONCLUSIONS">In this post hoc analysis of ICU patients with infections, we found widespread initial use of carbapenems and piperacillin/tazobactam in international ICUs, with the latter being more frequently used. Randomized clinical trials are needed to assess if the observed variations in outcomes may be drug-related effects or due to confounders.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Meier</LastName><ForeName>Nick</ForeName><Initials>N</Initials><Identifier Source="ORCID">0009-0006-4761-3228</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Munch</LastName><ForeName>Marie Warrer</ForeName><Initials>MW</Initials><Identifier Source="ORCID">0000-0003-1127-9599</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-5799-7655</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hertz</LastName><ForeName>Frederik Bo&#xeb;tius</ForeName><Initials>FB</Initials><Identifier Source="ORCID">0000-0003-0888-4616</Identifier><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunology &amp; Microbiology, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Venkatesh</LastName><ForeName>Balasubramanian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hammond</LastName><ForeName>Naomi E</ForeName><Initials>NE</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Critical Care Program, The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Bus</LastName><ForeName>Liesbet</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Waele</LastName><ForeName>Jan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Internal Medicine and Pediatrics, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kauzonas</LastName><ForeName>Evaldas</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;vall</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0001-5612-0325</Identifier><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>Morten Hylander</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Helleberg</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre of Excellence for Health, Immunity and Infections, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Rigshospitalet</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>157044-21-8</RegistryNumber><NameOfSubstance UI="D000077725">Piperacillin, Tazobactam Drug Combination</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015780">Carbapenems</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077725" MajorTopicYN="Y">Piperacillin, Tazobactam Drug Combination</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015780" MajorTopicYN="Y">Carbapenems</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">empirical antibiotic treatment</Keyword><Keyword MajorTopicYN="N">intensive care unit</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>29</Day><Hour>2</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38549422</ArticleId><ArticleId IdType="doi">10.1111/aas.14419</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Vincent JL. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323&#x2010;2329.</Citation></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2010;1247.</Citation></Reference><Reference><Citation>Yealy DM, Mohr NM, Shapiro NI, Venkatesh A, Jones AE, Self WH. Early care of adults with suspected sepsis in the emergency department and out&#x2010;of&#x2010;hospital environment: a consensus&#x2010;based task force report. Ann Emerg Med. 2021;78(1):1&#x2010;19.</Citation></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR. Global, regional, and national sepsis incidence and mortality, 1990&#x2010;2017: analysis for the global burden of disease study. Lancet. 2020;395(10219):200&#x2010;211.</Citation></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344&#x2010;353.</Citation></Reference><Reference><Citation>Vincent JL, Marshall JC, &#xd1;amendys&#x2010;Silva SA, et al. Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit. Lancet Respir Med. 2014;2(5):380&#x2010;386.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R. Surviving sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486&#x2010;552.</Citation></Reference><Reference><Citation>Ohnuma T, Hayashi Y, Yamashita K, et al. A nationwide survey of intravenous antimicrobial use in intensive care units in Japan. Int J Antimicrob Agents. 2018;51(4):636&#x2010;641.</Citation></Reference><Reference><Citation>Luyt CE, Br&#xe9;chot N, Trouillet JL, Chastre J. Antibiotic stewardship in the intensive care unit. Crit Care. 2014;18(5):480.</Citation></Reference><Reference><Citation>McLaughlin M, Advincula MR, Malczynski M, Qi C, Bolon M, Scheetz MH. Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae. Antimicrob Agents Chemother. 2013;57(10):5131&#x2010;5133.</Citation></Reference><Reference><Citation>Chang HJ, Hsu PC, Yang CC, et al. Risk factors and outcomes of carbapenem&#x2010;nonsusceptible Escherichia coli bacteremia: a matched case&#x2013;control study. J Microbiol Immunol Infect. 2011;44(2):125&#x2010;130.</Citation></Reference><Reference><Citation>Remschmidt C, Schneider S, Meyer E, Schroeren&#x2010;Boersch B, Gastmeier P, Schwab F. Surveillance of antibiotic use and resistance in intensive care units (SARI). Deutsches &#xc4;rzteblatt Int. 2017;114:858&#x2010;865. doi:10.3238/arztebl.2017.0858</Citation></Reference><Reference><Citation>Jacoby TS, Kuchenbecker RS, Dos Santos RP, Magedanz L, Guzatto P, Moreira LB. Impact of hospital&#x2010;wide infection rate, invasive procedures use and antimicrobial consumption on bacterial resistance inside an intensive care unit. J Hosp Infec. 2010;75(1):23&#x2010;27.</Citation></Reference><Reference><Citation>De Bus L, Depuydt P, Steen J, et al. Antimicrobial de&#x2010;escalation in the critically ill patient and assessment of clinical cure: the DIANA study. Intensive Care Med. 2020;46(7):1404&#x2010;1417.</Citation></Reference><Reference><Citation>Bonomo RA, Burd EM, Conly J, et al. Carbapenemase&#x2010;producing organisms: a global scourge. Clin Infect Dis. 2018;66(8):1290&#x2010;1297.</Citation></Reference><Reference><Citation>Zanichelli V, Sharland M, Cappello B, et al. The WHO AWaRe (access, watch, reserve) antibiotic book and prevention of antimicrobial resistance. Bull World Health Org. 2023;101(4):290&#x2010;296.</Citation></Reference><Reference><Citation>Harris PNA, Tambyah PA, Paterson DL. &#x3b2;&#x2010;Lactam and &#x3b2;&#x2010;lactamase inhibitor combinations in the treatment of extended&#x2010;spectrum &#x3b2;&#x2010;lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? Lancet Infect Dis. 2015;15(4):475&#x2010;485.</Citation></Reference><Reference><Citation>Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M. Effect of piperacillin&#x2010;tazobactam vs meropenem on 30&#x2010;day mortality for patients with E. coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA. 2018;320(10):984&#x2010;994.</Citation></Reference><Reference><Citation>Venkatesh B, Finfer S, Cohen J, et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl J Med. 2018;378(9):797&#x2010;808.</Citation></Reference><Reference><Citation>Munch MW, Granholm A, Perner A, Moeller MH, Sj&#xf6;vall F. Empirical piperacillin/tazobactam or carbapenems for infections in the intensive care unit. 2022. https://osf.io/8fves.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344&#x2010;349.</Citation></Reference><Reference><Citation>Granholm A, Kaas&#x2010;Hansen BS, Lange T, et al. Use of days alive without life support and similar count outcomes in randomised clinical trials &#x2013; an overview and comparison of methodological choices and analysis methods. BMC Med Res Methodol. 2023;23(1):139.</Citation></Reference><Reference><Citation>Qian ET, Casey JD, Wright A, et al. Cefepime vs piperacillin&#x2010;tazobactam in adults hospitalized with acute infection: the ACORN randomized clinical trial. JAMA. 2023;330(16):1557&#x2010;1567.</Citation></Reference><Reference><Citation>Munch MW, Granholm A, Jonsson AB, et al. Piperacillin/tazobactam versus carbapenems in patients with severe bacterial infections: a systematic review with meta&#x2010;analysis. Acta Anaesthesiol Scand. 2023;67(7):853&#x2010;868.</Citation></Reference><Reference><Citation>Hemkens LG, Contopoulos&#x2010;Ioannidis DG, Ioannidis JPA. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta&#x2010;epidemiological survey. BMJ. 2016;8:i493.</Citation></Reference><Reference><Citation>Billot L, Venkatesh B, Myburgh J, et al. Statistical analysis plan for the adjunctive corticosteroid treatment in critically ill patients with septic shock (ADRENAL) trial. Crit Care Resusc. 2017;19(2):183&#x2010;191.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29797710</PMID><DateCompleted><Year>2019</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>62</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>The association between pre-operative sepsis and 30-day mortality in hip fracture patients-A cohort study.</ArticleTitle><Pagination><StartPage>1209</StartPage><EndPage>1214</EndPage><MedlinePgn>1209-1214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13160</ELocationID><Abstract><AbstractText Label="BACKGROUND">Post-operative sepsis considerably increases mortality, but the extent of pre-operative sepsis in hip fracture patients and its consequences are sparsely elucidated. The aim of this study was to assess the association between pre-operative sepsis and 30-day mortality after hip fracture surgery.</AbstractText><AbstractText Label="METHODS">We conducted a retrospective analysis of data collected among 1894 patients who underwent hip fracture surgery in the Capital Region of Denmark in 2014 (NCT03201679). Data on vital signs, cultures and laboratory data were obtained. Sepsis was defined as a positive culture of any kind and presence of systemic inflammatory response syndrome within 24&#xa0;hours and was assessed within 72&#xa0;hours before surgery and 30&#xa0;days post-operatively. Primary outcome was 30-day mortality. Secondary outcomes included length of hospital stay and admission to intensive care unit.</AbstractText><AbstractText Label="RESULTS">A total of 144 (7.6%) of the hip fracture patients met the criteria for pre-operative sepsis. The 30-day mortality was 13.9% in patients with pre-operative sepsis as compared to 9.0% in those without (OR 1.69, 95% CI [1.00; 2.85], P&#xa0;=&#xa0;.08). Patients with pre-operative sepsis had longer hospital stays (median 10&#xa0;days vs 9&#xa0;days, mean difference 2.1 [SD 9.4] days, P&#xa0;=&#xa0;.03), and higher frequency of ICU admission (11.1% vs 2.7%, OR 4.15, 95% CI [2.19; 7.87], P&#xa0;&lt;&#xa0;.0001).</AbstractText><AbstractText Label="CONCLUSION">Pre-operative sepsis in hip fracture patients was associated with an increased length of hospital stay and tended to increase mortality. Pre-operative sepsis in hip fracture patients merits more intensive surveillance and increased attention to timely treatment.</AbstractText><CopyrightInformation>&#xa9; 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>M&#xf8;rch</LastName><ForeName>S S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0002-9125-4764</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantholdt-Hansen</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedersen</LastName><ForeName>N E</ForeName><Initials>NE</Initials><Identifier Source="ORCID">0000-0001-9065-4427</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for HR, Capital Region of Denmark, Copenhagen Academy for Medical Education and Simulation, Herlev, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duus</LastName><ForeName>C L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-9893-5573</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petersen</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Day Case Surgery, Amager and Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>C &#xd8;</ForeName><Initials>C&#xd8;</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Amager and Hvidovre Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jarl&#xf8;v</LastName><ForeName>J O</ForeName><Initials>JO</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meyhoff</LastName><ForeName>C S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-4885-4609</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Bispebjerg and Frederiksberg Hospital, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Departmental funding only</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003718" MajorTopicYN="N" Type="Geographic">Denmark</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="Y">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">hip fracture</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">pre-operative sepsis</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>4</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29797710</ArticleId><ArticleId IdType="doi">10.1111/aas.13160</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34118301</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>02</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1523-6838</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>American journal of kidney diseases : the official journal of the National Kidney Foundation</Title><ISOAbbreviation>Am J Kidney Dis</ISOAbbreviation></Journal><ArticleTitle>Arteriovenous Access Type and Risk of Mortality, Hospitalization, and Sepsis Among Elderly Hemodialysis Patients: A Target Trial Emulation Approach.</ArticleTitle><Pagination><StartPage>69</StartPage><EndPage>78</EndPage><MedlinePgn>69-78</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1053/j.ajkd.2021.03.030</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0272-6386(21)00642-9</ELocationID><Abstract><AbstractText Label="RATIONALE &amp; OBJECTIVE">Evidence is mixed regarding the optimal choice of the first permanent vascular access for elderly patients receiving hemodialysis (HD). Lacking data from randomized controlled trials, we used a target trial emulation approach to compare arteriovenous fistula (AVF) versus arteriovenous graft (AVG) creation among elderly patients receiving HD.</AbstractText><AbstractText Label="STUDY DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING &amp; PARTICIPANTS">Elderly patients included in the US Renal Data System who initiated HD with a catheter and had an AVF or AVG created within 6 months of starting HD.</AbstractText><AbstractText Label="EXPOSURE">Creation of an AVF versus an AVG as the incident arteriovenous access.</AbstractText><AbstractText Label="OUTCOMES">All-cause mortality, all-cause and cause-specific hospitalization, and sepsis.</AbstractText><AbstractText Label="ANALYTICAL APPROACH">Target trial emulation approach, high-dimensional propensity score and inverse probability of treatment weighting, and instrumental variable analysis using the proclivity of the operating physician to create a fistula as the instrumental variable.</AbstractText><AbstractText Label="RESULTS">A total of 19,867 patients were included, with 80.1% receiving an AVF and 19.9% an AVG. In unweighted analysis, AVF creation was associated with significantly lower risks of mortality and hospitalization, especially within 6 months after vascular access creation. In inverse probability of treatment weighting analysis, AVF creation was associated with lower incidences of mortality and hospitalization within 6 months after creation (hazard ratios of 0.82 [95% CI, 0.75-0.91] and 0.82 [95% CI, 0.78-0.87] for mortality and all-cause hospitalization, respectively), but not between 6 months and 3 years after access creation. No association between AVF creation and mortality, sepsis, or all-cause, cardiovascular disease-related, or infection-related hospitalization was found in instrumental variable analyses. However, AVF creation was associated with a lower risk of access-related hospitalization not due to infection.</AbstractText><AbstractText Label="LIMITATIONS">Potential for unmeasured confounding, analyses limited to elderly patients, and absence of data on actual access use during follow-up.</AbstractText><AbstractText Label="CONCLUSIONS">Using observational data to emulate a target randomized controlled trial, the type of initial arteriovenous access created was not associated with the risks of mortality, sepsis, or all-cause, cardiovascular disease-related, or infection-related hospitalization among elderly patients who initiated HD with a catheter.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lyu</LastName><ForeName>Beini</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Micah R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin School of Medicine and Public Health Madison, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yevzlin</LastName><ForeName>Alexander S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Michigan, Ann Arbor, Michigan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gardezi</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Wisconsin School of Medicine and Public Health Madison, Wisconsin.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astor</LastName><ForeName>Brad C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin; Department of Medicine, University of Wisconsin School of Medicine and Public Health Madison, Wisconsin. Electronic address: bcastor@medicine.wisc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Kidney Dis</MedlineTA><NlmUniqueID>8110075</NlmUniqueID><ISSNLinking>0272-6386</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001166" MajorTopicYN="Y">Arteriovenous Shunt, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006435" MajorTopicYN="N">Renal Dialysis</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Arteriovenous access</Keyword><Keyword MajorTopicYN="N">HD access</Keyword><Keyword MajorTopicYN="N">arteriovenous fistula (AVF)</Keyword><Keyword MajorTopicYN="N">arteriovenous graft (AVG)</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">end-stage renal disease (ESRD)</Keyword><Keyword MajorTopicYN="N">hemodialysis (HD)</Keyword><Keyword MajorTopicYN="N">hospitalization</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">target trial</Keyword><Keyword MajorTopicYN="N">vascular access</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>12</Day><Hour>20</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34118301</ArticleId><ArticleId IdType="doi">10.1053/j.ajkd.2021.03.030</ArticleId><ArticleId IdType="pii">S0272-6386(21)00642-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36225784</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2296-2565</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in public health</Title><ISOAbbreviation>Front Public Health</ISOAbbreviation></Journal><ArticleTitle>Tree-based, two-stage risk factor analysis for postoperative sepsis based on Sepsis-3 criteria in elderly patients: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>1006955</StartPage><MedlinePgn>1006955</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1006955</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpubh.2022.1006955</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis remains the leading cause of postoperative death in elderly patients and is defined as organ dysfunction with proven or suspected infection according to Sepsis-3 criteria. To better avoid potential non-linear associations between the risk factors, we firstly used a tree-based analytic methods to explore the putative risk factors of geriatric sepsis based on the criteria in the study.</AbstractText><AbstractText Label="METHODS">Data of 7,302 surgical patients aged &#x2265; 65 years at the Third Affiliated Hospital of Sun Yat-sen University from January 2015 to September 2020 were collected. An analytic method that combined tree-based analysis with the method of Mantel-Haenszel and logistic regression was adopted to assess the association between 17 putative risk factors and postoperative sepsis defined by the Sepsis-3 guideline by controlling 16 potential confounding factors.</AbstractText><AbstractText Label="RESULTS">Among the 16 potential covariates, six major confounders were statistically identified by the tree-based model, including cerebrovascular diseases, preoperative infusion of red blood cells, pneumonia, age &#x2265; 75, malignant tumor and diabetes. Our analysis indicated that emergency surgery increases the risk of postoperative sepsis in elderly patients by more than six times. The type of surgery is also a crucial risk factor for sepsis, particularly transplantation and neurosurgery. Other risk factors were duration of surgery &gt; 120 min, administration of steroids, hypoalbuminemia, elevated creatinine, blood urea nitrogen, hematocrit, platelets, glucose, white blood cell count, abnormal neutrophil-to-lymphocyte ratio and elevated hsCRP-to-albumin ratio.</AbstractText><AbstractText Label="CONCLUSIONS">Our study uses an effective method to explore some risk factors for postoperative sepsis in elderly by adjusting many potential confounders and it can provide information for intervention design.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Peng, Chen, Chen, Wang, Yang, Ma, Liu, Zhou and Hei.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chaojin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jingjing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Big Data and Artificial Intelligence Center, The Third Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanlin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Duo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Jieyang People's Hospital, Jieyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Chuzhou</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Shantou Central Hospital, Shantou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zifeng</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Big Data and Artificial Intelligence Center, The Third Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Shaoli</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hei</LastName><ForeName>Ziqing</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Public Health</MedlineTA><NlmUniqueID>101616579</NlmUniqueID><ISSNLinking>2296-2565</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>AYI8EX34EU</RegistryNumber><NameOfSubstance UI="D003404">Creatinine</NameOfSubstance></Chemical><Chemical><RegistryNumber>IY9XDZ35W2</RegistryNumber><NameOfSubstance UI="D005947">Glucose</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="Y">C-Reactive Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003404" MajorTopicYN="N">Creatinine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005163" MajorTopicYN="N">Factor Analysis, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">classification and regression tree</Keyword><Keyword MajorTopicYN="N">elderly</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">tree-based analysis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>2</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36225784</ArticleId><ArticleId IdType="pmc">PMC9550002</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2022.1006955</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801&#x2013;10. 10.1001/jama.2016.0287</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. (2001) 29:1303&#x2013;10. 10.1097/00003246-200107000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200107000-00002</ArticleId><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman BT, Schmidt U, Berman MF, Bittner EA. Temporal trends in the epidemiology of severe postoperative sepsis after elective surgery: a large, nationwide sample. Anesthesiology. (2010) 112:917&#x2013;25. 10.1097/ALN.0b013e3181cea3d0</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181cea3d0</ArticleId><ArticleId IdType="pubmed">20357565</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, et al. . Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009&#x2013;2014. JAMA. (2017) 318:1241&#x2013;9. 10.1001/jama.2017.13836</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2017.13836</ArticleId><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel TR, Dombrovskiy VY, Carson JL, Graham AM, Lowry SF. Postoperative sepsis in the United States. Ann Surg. (2010) 252:1065&#x2013;71. 10.1097/SLA.0b013e3181dcf36e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e3181dcf36e</ArticleId><ArticleId IdType="pmc">PMC2951484</ArticleId><ArticleId IdType="pubmed">20571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Brakenridge SC, Efron PA, Cox MC, Stortz JA, Hawkins RB, Ghita G, et al. . Current epidemiology of surgical sepsis: discordance between inpatient mortality and 1-year outcomes. Ann Surg. (2019) 270:502&#x2013;10. 10.1097/SLA.0000000000003458</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000003458</ArticleId><ArticleId IdType="pmc">PMC6942687</ArticleId><ArticleId IdType="pubmed">31356275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankowski RT, Anton SD, Ghita GL, Brumback B, Cox MC, Mohr AM, et al. . Older sepsis survivors suffer persistent disability burden and poor long-term survival. J Am Geriatr Soc. (2020) 68:1962&#x2013;9. 10.1111/jgs.16435</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.16435</ArticleId><ArticleId IdType="pmc">PMC7654284</ArticleId><ArticleId IdType="pubmed">32294254</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Cooke CR, Wunsch H, Kahn JM. Population burden of long-term survivorship after severe sepsis in older Americans. J Am Geriatr Soc. (2012) 60:1070&#x2013;7. 10.1111/j.1532-5415.2012.03989.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2012.03989.x</ArticleId><ArticleId IdType="pmc">PMC3374893</ArticleId><ArticleId IdType="pubmed">22642542</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Ortega A, Suberviola B, Garc&#xed;a-Astudillo LA, Holanda MS, Ortiz F, Llorca J, et al. . Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit Care Med. (2010) 38:1036&#x2013;43. 10.1097/CCM.0b013e3181d455b6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181d455b6</ArticleId><ArticleId IdType="pubmed">20154597</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Pilcher D, Cooper DJ, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. (2015) 372:1629&#x2013;38. 10.1056/NEJMoa1415236</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1415236</ArticleId><ArticleId IdType="pubmed">25776936</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouza C, L&#xf3;pez-Cuadrado T, Amate-Blanco JM. Characteristics, incidence and temporal trends of sepsis in elderly patients undergoing surgery. Br J Surg. (2016) 103:e73&#x2013;82. 10.1002/bjs.10065</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bjs.10065</ArticleId><ArticleId IdType="pubmed">26670423</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohl DD, Iantorno SE, Saltzman BM, Tetreault MW, Darrith B, Della Valle CJ. Sepsis within 30 days of geriatric hip fracture surgery. J Arthroplasty. (2017) 32:3114&#x2013;9. 10.1016/j.arth.2017.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arth.2017.05.024</ArticleId><ArticleId IdType="pubmed">28634098</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh W-Y. Classification and regression trees. WIREs Data Mining Knowl Discov. (2011) 1:14&#x2013;23. 10.1002/widm.8</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/widm.8</ArticleId></ArticleIdList></Reference><Reference><Citation>Orimo H. [Reviewing the definition of elderly]. Nihon Ronen Igakkai Zasshi. (2006) 43:27&#x2013;34. 10.3143/geriatrics.43.27</Citation><ArticleIdList><ArticleId IdType="doi">10.3143/geriatrics.43.27</ArticleId><ArticleId IdType="pubmed">16521795</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaeke P, De Man JG, Coenen S, Jorens PG, De Winter BY, Hubens G. Clinical- and surgery-specific risk factors for post-operative sepsis: a systematic review and meta-analysis of over 30 million patients. Surg Today. (2020) 50:427&#x2013;39. 10.1007/s00595-019-01827-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00595-019-01827-4</ArticleId><ArticleId IdType="pubmed">31172283</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuckerman SL, Lakomkin N, Smith JS, Shaffrey CI, Devin CJ. Incidence and predictors of all-cause mortality within one year after adult spinal deformity surgery. J Spine Surg. (2018) 4:333&#x2013;41. 10.21037/jss.2018.05.28</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jss.2018.05.28</ArticleId><ArticleId IdType="pmc">PMC6046338</ArticleId><ArticleId IdType="pubmed">30069526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Gu Y, Huang F, Liu D, Zhang Z, Zhou N, et al. . Risk factors for sepsis based on sepsis-3 criteria after orthotopic liver transplantation. Mediators Inflamm. (2018) 2018:8703172. 10.1155/2018/8703172</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/8703172</ArticleId><ArticleId IdType="pmc">PMC6031077</ArticleId><ArticleId IdType="pubmed">30026670</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang S, Li L, Wang L, Liu J, Tan Y, Hu J, et al. . A decision tree model of cerebral palsy based on risk factors. J Matern Fetal Neonatal Med. (2021) 34:3922&#x2013;7. 10.1080/14767058.2019.1702944</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14767058.2019.1702944</ArticleId><ArticleId IdType="pubmed">31842640</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L, He J, Li M, Dai J, Zhou Y, Lai F, et al. . Based on a decision tree model for exploring the risk factors of smartphone addiction among children and adolescents in china during the COVID-19 pandemic. Front Psychiatry. (2021) 12:652356. 10.3389/fpsyt.2021.652356</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.652356</ArticleId><ArticleId IdType="pmc">PMC8217434</ArticleId><ArticleId IdType="pubmed">34168575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, H&#xe4;rtl R. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. J Neurosurg. (2015) 122:202&#x2013;10. 10.3171/2014.10.JNS132545</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/2014.10.JNS132545</ArticleId><ArticleId IdType="pubmed">25380107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno E, Nicoletti A, Quattrocchi G, Filippini G, Colosimo C, Zappia M. Pregabalin for essential tremor. Cochrane Database Syst Rev. (2016) 10:Cd009682. 10.1002/14651858.CD009682.pub2</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD009682.pub2</ArticleId><ArticleId IdType="pmc">PMC6461190</ArticleId><ArticleId IdType="pubmed">27763691</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. . Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. (2017) 43:304&#x2013;77. 10.1007/s00134-017-4683-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. . Global, regional, and national sepsis incidence and mortality, 1990&#x2013;2017: analysis for the Global Burden of Disease Study. Lancet. (2020) 395:200&#x2013;11. 10.1016/S0140-6736(19)32989-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)32989-7</ArticleId><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sood A, Abdollah F, Sammon JD, Arora N, Weeks M, Peabody JO, et al. . Postoperative sepsis prediction in patients undergoing major cancer surgery. J Surg Res. (2017) 209:60&#x2013;9. 10.1016/j.jss.2016.09.059</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2016.09.059</ArticleId><ArticleId IdType="pubmed">28032572</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim M, Brady JE Li G. Interaction effects of acute kidney injury, acute respiratory failure, and sepsis on 30-day postoperative mortality in patients undergoing high-risk intraabdominal general surgical procedures. Anesth Analg. (2015) 121:1536&#x2013;46. 10.1213/ANE.0000000000000915</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000000915</ArticleId><ArticleId IdType="pubmed">26273749</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabriel V, Grigorian A, Nahmias J, Pejcinovska M, Smith M, Sun B, et al. . Risk factors for post-operative sepsis and septic shock in patients undergoing emergency surgery. Surg Infect. (2019) 20:367&#x2013;72. 10.1089/sur.2018.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2018.186</ArticleId><ArticleId IdType="pubmed">30950768</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy KE, Hall MW, Cholette J, Juffermans NP, Nicol K, Doctor A, et al. . Mechanisms of red blood cell transfusion-related immunomodulation. Transfusion. (2018) 58:804&#x2013;15. 10.1111/trf.14488</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.14488</ArticleId><ArticleId IdType="pmc">PMC6592041</ArticleId><ArticleId IdType="pubmed">29383722</ArticleId></ArticleIdList></Reference><Reference><Citation>Upile T, Jerjes W, Mahil J, Upile N, Sudhoff H, Wright A, et al. . An explanation for the worsened prognosis in some cancer patients of perioperative transfusion: the time-dependent release of biologically active growth factors from stored blood products. Eur Arch Otorhinolaryngol. (2011) 268:1789&#x2013;94. 10.1007/s00405-011-1525-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-011-1525-y</ArticleId><ArticleId IdType="pubmed">21347776</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore LJ, Moore FA, Todd SR, Jones SL, Turner KL, Bass BL. Sepsis in general surgery: the 2005-2007 national surgical quality improvement program perspective. Arch Surg. (2010) 145:695&#x2013;700. 10.1001/archsurg.2010.107</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2010.107</ArticleId><ArticleId IdType="pubmed">20644134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ninh A, Wood K, Bui AH, Leitman IM. Risk factors and outcomes for sepsis after appendectomy in adults. Surg Infect. (2019) 20:601&#x2013;6. 10.1089/sur.2019.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/sur.2019.003</ArticleId><ArticleId IdType="pubmed">31009326</ArticleId></ArticleIdList></Reference><Reference><Citation>Howitt SH, Herring M, Malagon I, McCollum CN, Grant SW. Incidence and outcomes of sepsis after cardiac surgery as defined by the Sepsis-3 guidelines. Br J Anaesth. (2018) 120:509&#x2013;16. 10.1016/j.bja.2017.10.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2017.10.018</ArticleId><ArticleId IdType="pmc">PMC6200099</ArticleId><ArticleId IdType="pubmed">29452807</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth. (2017) 119:626&#x2013;36. 10.1093/bja/aex234</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex234</ArticleId><ArticleId IdType="pubmed">29121281</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleuren LM, Klausch TLT, Zwager CL, Schoonmade LJ, Guo T, Roggeveen LF, et al. . Machine learning for the prediction of sepsis: a systematic review and meta-analysis of diagnostic test accuracy. Intensive Care Med. (2020) 46:383&#x2013;400. 10.1007/s00134-019-05872-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-019-05872-y</ArticleId><ArticleId IdType="pmc">PMC7067741</ArticleId><ArticleId IdType="pubmed">31965266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. (2018) 392:75&#x2013;87. 10.1016/S0140-6736(18)30696-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(18)30696-2</ArticleId><ArticleId IdType="pubmed">29937192</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe TA, McKoy JM. Sepsis in older adults. Infect Dis Clin North Am. (2017) 31:731&#x2013;42. 10.1016/j.idc.2017.07.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2017.07.010</ArticleId><ArticleId IdType="pubmed">29079157</ArticleId></ArticleIdList></Reference><Reference><Citation>Glenn DA, Henderson CD, O'Shaughnessy M, Hu Y, Bomback A, Gibson K, et al. . Infection-related acute care events among patients with glomerular disease. Clin J Am Soc Nephrol. (2020) 15:1749&#x2013;61. 10.2215/CJN.05900420</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05900420</ArticleId><ArticleId IdType="pmc">PMC7769021</ArticleId><ArticleId IdType="pubmed">33082200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen AJ, Packiam VT, Nottingham CU, Pariser JJ, Faris SF, Bales GT. Iatrogenic bladder injury: national analysis of 30-day outcomes. Urology. (2016) 97:250&#x2013;6. 10.1016/j.urology.2016.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urology.2016.05.002</ArticleId><ArticleId IdType="pubmed">27181242</ArticleId></ArticleIdList></Reference><Reference><Citation>Duggan EW, Carlson K, Umpierrez GE. Perioperative hyperglycemia management: an update. Anesthesiology. (2017) 126:547&#x2013;60. 10.1097/ALN.0000000000001515</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0000000000001515</ArticleId><ArticleId IdType="pmc">PMC5309204</ArticleId><ArticleId IdType="pubmed">28121636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Koirala J, Khardori R, Khardori N. Infections in diabetes mellitus and hyperglycemia. Infect Dis Clin North Am. (2007) 21:617&#x2013;38. 10.1016/j.idc.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2007.07.003</ArticleId><ArticleId IdType="pubmed">17826615</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu ZD, Lippi G, Montagnana M. Diagnostic and prognostic value of red blood cell distribution width in sepsis: a narrative review. Clin Biochem. (2020) 77:1&#x2013;6. 10.1016/j.clinbiochem.2020.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2020.01.001</ArticleId><ArticleId IdType="pubmed">31935355</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungstr&#xf6;m L, Pernestig AK, Jacobsson G, Andersson R, Usener B, Tilevik D. Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis. PLoS ONE. (2017) 12:e0181704. 10.1371/journal.pone.0181704</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0181704</ArticleId><ArticleId IdType="pmc">PMC5519182</ArticleId><ArticleId IdType="pubmed">28727802</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Z, Fu Z, Huang W, Huang K. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. (2020) 38:641&#x2013;7. 10.1016/j.ajem.2019.10.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2019.10.023</ArticleId><ArticleId IdType="pubmed">31785981</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Chen X, Chen J, Xing J, Hei Z, Zhang Q, et al. . Association between preoperative hs-crp/albumin ratio and postoperative sirs in elderly patients: a retrospective observational cohort study. J Nutr Health Aging. (2022) 26:352&#x2013;9. 10.1007/s12603-022-1761-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12603-022-1761-4</ArticleId><ArticleId IdType="pubmed">35450991</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckart A, Struja T, Kutz A, Baumgartner A, Baumgartner T, Zurfluh S, et al. . Relationship of nutritional status, inflammation, and serum albumin levels during acute illness: a prospective study. Am J Med. (2020) 133:713&#x2013;22.e7. 10.1016/j.amjmed.2019.10.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2019.10.031</ArticleId><ArticleId IdType="pubmed">31751531</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Liu B, Tang Y, Chang P, Yao L, Huang B, et al. . Improvement of sepsis prognosis by ulinastatin: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol. (2019) 10:1370. 10.3389/fphar.2019.01370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01370</ArticleId><ArticleId IdType="pmc">PMC6893897</ArticleId><ArticleId IdType="pubmed">31849646</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27765072</PMID><DateCompleted><Year>2018</Year><Month>01</Month><Day>19</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1466-609X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2016</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>Critical care (London, England)</Title><ISOAbbreviation>Crit Care</ISOAbbreviation></Journal><ArticleTitle>Bioavailable estradiol concentrations are elevated and predict mortality in septic patients: a prospective cohort study.</ArticleTitle><Pagination><StartPage>335</StartPage><MedlinePgn>335</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">335</ELocationID><Abstract><AbstractText Label="BACKGROUND">Experimental studies demonstrate beneficial immunological and hemodynamic effects of estradiol in animal models of sepsis. This raises the question whether estradiol contributes to sex differences in the incidence and outcomes of sepsis in humans. Yet, total estradiol levels are elevated in sepsis patients, particularly nonsurvivors. Bioavailable estradiol concentrations have not previously been reported in septic patients. The bioavailable estradiol concentration accounts for aberrations in estradiol carrier protein concentrations that could produce discrepancies between total and bioavailable estradiol levels. We hypothesized that bioavailable estradiol levels are low in septic patients and sepsis nonsurvivors.</AbstractText><AbstractText Label="METHODS">We conducted a combined case-control and prospective cohort study. Venous blood samples were obtained from 131 critically ill septic patients in the medical and surgical intensive care units at the University of Rochester Medical Center and 51 control subjects without acute illness. Serum bioavailable estradiol concentrations were calculated using measurements of total estradiol, sex hormone-binding globulin, and albumin. Comparisons were made between patients with severe sepsis and control subjects and between hospital survivors and nonsurvivors. Multivariable logistic regression analysis was also performed.</AbstractText><AbstractText Label="RESULTS">Bioavailable estradiol concentrations were significantly higher in sepsis patients than in control subjects (211 [78-675] pM vs. 100 [78-142] pM, p&#x2009;&lt;&#x2009;0.01) and in sepsis nonsurvivors than in survivors (312 [164-918] pM vs. 167 [70-566] pM, p&#x2009;=&#x2009;0.04). After adjustment for age and comorbidities, patients with bioavailable estradiol levels above the median value had significantly higher risk of hospital mortality (OR 4.27, 95 % CI 1.65-11.06, p&#x2009;=&#x2009;0.003). Bioavailable estradiol levels were directly correlated with severity of illness and did not differ between men and women.</AbstractText><AbstractText Label="CONCLUSIONS">Contrary to our hypothesis, bioavailable estradiol levels were elevated in sepsis patients, particularly nonsurvivors, and were independently associated with mortality. Whether estradiol's effects are harmful, beneficial, or neutral in septic patients remains unknown, but our findings raise caution about estradiol's therapeutic potential in this setting. Our findings do not provide an explanation for sex-based differences in sepsis incidence and outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsang</LastName><ForeName>Greg</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Insel</LastName><ForeName>Michael B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weis</LastName><ForeName>Justin M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>Mary Anne M</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gough</LastName><ForeName>Michael S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frasier</LastName><ForeName>Lauren M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mack</LastName><ForeName>Cynthia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doolin</LastName><ForeName>Kathleen P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Department of Nursing, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graves</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>College of Nursing, University of South Florida, MDC22, 12901 Bruce B. Downs Boulevard, Tampa, FL, 33612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apostolakos</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pietropaoli</LastName><ForeName>Anthony P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY, 14642, USA. anthony_pietropaoli@urmc.rochester.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 HL080077</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL066988</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024160</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit Care</MedlineTA><NlmUniqueID>9801902</NlmUniqueID><ISSNLinking>1364-8535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>4TI98Z838E</RegistryNumber><NameOfSubstance UI="D004958">Estradiol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004958" MajorTopicYN="N">Estradiol</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Estradiol</Keyword><Keyword MajorTopicYN="N">Estrogens</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Sex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27765072</ArticleId><ArticleId IdType="pmc">PMC5073735</ArticleId><ArticleId IdType="doi">10.1186/s13054-016-1525-9</ArticleId><ArticleId IdType="pii">10.1186/s13054-016-1525-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546&#x2013;54. doi: 10.1056/NEJMoa022139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022139</ArticleId><ArticleId IdType="pubmed">12700374</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowler RA, Sabur N, Li P, Juurlink DN, Pinto R, Hladunewich MA, et al. Sex- and age-based differences in the delivery and outcomes of critical care. CMAJ. 2007;177(12):1513&#x2013;9. doi: 10.1503/cmaj.071112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.071112</ArticleId><ArticleId IdType="pmc">PMC2096494</ArticleId><ArticleId IdType="pubmed">18003954</ArticleId></ArticleIdList></Reference><Reference><Citation>Pietropaoli AP, Glance LG, Oakes D, Fisher SG. Gender differences in mortality in patients with severe sepsis or septic shock. Gend Med. 2010;7(5):422&#x2013;37. doi: 10.1016/j.genm.2010.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.09.005</ArticleId><ArticleId IdType="pmc">PMC3322379</ArticleId><ArticleId IdType="pubmed">21056869</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentin A, Jordan B, Lang T, Hiesmayr M, Metnitz PGH. Gender-related differences in intensive care: a multiple-center cohort study of therapeutic interventions and outcome in critically ill patients. Crit Care Med. 2003;31(7):1901&#x2013;7. doi: 10.1097/01.CCM.0000069347.78151.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000069347.78151.50</ArticleId><ArticleId IdType="pubmed">12847381</ArticleId></ArticleIdList></Reference><Reference><Citation>Christaki E, Opal SM, Keith JC, Kessinian N, Palardy JE, Parejo NA, et al. Estrogen receptor &#x3b2; agonism increases survival in experimentally induced sepsis and ameliorates the genomic sepsis signature: a pharmacogenomic study. J Infect Dis. 2010;201(8):1250&#x2013;7. doi: 10.1086/651276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/651276</ArticleId><ArticleId IdType="pubmed">20205571</ArticleId></ArticleIdList></Reference><Reference><Citation>Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM, Chaudry IH. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med. 1997;25(1):106&#x2013;10. doi: 10.1097/00003246-199701000-00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199701000-00021</ArticleId><ArticleId IdType="pubmed">8989185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu HP, Shimizu T, Choudhry MA, Hsieh YC, Suzuki T, Bland KI, et al. Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-&#x3b2; agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol. 2006;40(1):185&#x2013;94. doi: 10.1016/j.yjmcc.2005.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2005.10.001</ArticleId><ArticleId IdType="pubmed">16288780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hildebrand F, Hubbard WJ, Choudhry MA, Thobe BM, Pape HC, Chaudry IH. Are the protective effects of 17&#x3b2;-estradiol on splenic macrophages and splenocytes after trauma-hemorrhage mediated via estrogen-receptor (ER)-&#x3b1; or ER-&#x3b2;? J Leukoc Biol. 2006;79(6):1173&#x2013;80. doi: 10.1189/jlb.0106029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0106029</ArticleId><ArticleId IdType="pubmed">16531562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kn&#xf6;ferl MW, Angele MK, Schwacha MG, Anantha Samy TS, Bland KI, Chaudry IH. Immunoprotection in proestrus females following trauma-hemorrhage: the pivotal role of estrogen receptors. Cell Immunol. 2003;222(1):27&#x2013;34. doi: 10.1016/S0008-8749(03)00081-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-8749(03)00081-9</ArticleId><ArticleId IdType="pubmed">12798305</ArticleId></ArticleIdList></Reference><Reference><Citation>Trentzsch H, Stewart D, De Maio A. Genetic background conditions the effect of sex steroids on the inflammatory response during endotoxic shock. Crit Care Med. 2003;31(1):232&#x2013;6. doi: 10.1097/00003246-200301000-00036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-200301000-00036</ArticleId><ArticleId IdType="pubmed">12545021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sener G, Arbak S, Kurtaran P, Gedik N, Ye&#x11f;en BC. Estrogen protects the liver and intestines against sepsis-induced injury in rats. J Surg Res. 2005;128(1):70&#x2013;8. doi: 10.1016/j.jss.2005.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2005.02.019</ArticleId><ArticleId IdType="pubmed">16115495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dossett LA, Swenson BR, Heffernan D, Bonatti H, Metzger R, Sawyer RG, et al. High levels of endogenous estrogens are associated with death in the critically injured adult. J Trauma. 2008;64(3):580&#x2013;5. doi: 10.1097/TA.0b013e31816543dd.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31816543dd</ArticleId><ArticleId IdType="pmc">PMC2654263</ArticleId><ArticleId IdType="pubmed">18332796</ArticleId></ArticleIdList></Reference><Reference><Citation>May AK, Dossett LA, Norris PR, Hansen EN, Dorsett RC, Popovsky KA, et al. Estradiol is associated with mortality in critically ill trauma and surgical patients. Crit Care Med. 2008;36(1):62&#x2013;8. doi: 10.1097/01.CCM.0000292015.16171.6D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000292015.16171.6D</ArticleId><ArticleId IdType="pmc">PMC2654262</ArticleId><ArticleId IdType="pubmed">18090358</ArticleId></ArticleIdList></Reference><Reference><Citation>Angstwurm MWA, Gaertner R, Schopohl J. Outcome in elderly patients with severe infection is influenced by sex hormones but not gender. Crit Care Med. 2005;33(12):2786&#x2013;93. doi: 10.1097/01.CCM.0000190242.24410.17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000190242.24410.17</ArticleId><ArticleId IdType="pubmed">16352961</ArticleId></ArticleIdList></Reference><Reference><Citation>Spratt DI, Morton JR, Kramer RS, Mayo SW, Longcope C, Vary CPH. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab. 2006;291(3):E631&#x2013;8. doi: 10.1152/ajpendo.00467.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00467.2005</ArticleId><ArticleId IdType="pubmed">16670151</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaillon JM, Adib-Conquy M, Fitting C, Adrie C, Payen D. Cytokine cascade in sepsis. Scand J Infect Dis. 2003;35(9):535&#x2013;44. doi: 10.1080/00365540310015935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365540310015935</ArticleId><ArticleId IdType="pubmed">14620132</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA. Sex hormone-binding globulin: anatomy and physiology of a new regulatory system. J Steroid Biochem Mol Biol. 1991;40(4&#x2013;6):813&#x2013;20. doi: 10.1016/0960-0760(91)90307-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0960-0760(91)90307-Q</ArticleId><ArticleId IdType="pubmed">1659894</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascal N, Amouzou EK, Sanni A, Namour F, Abdelmouttaleb I, Vidailhet M, et al. Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus. Am J Clin Nutr. 2002;76(1):239&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">12081841</ArticleId></ArticleIdList></Reference><Reference><Citation>Heyland DK, Dhaliwal R, Jiang X, Day AG. Identifying critically ill patients who benefit the most from nutrition therapy: the development and initial validation of a novel risk assessment tool. Crit Care. 2011;15(6):R268. doi: 10.1186/cc10546.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10546</ArticleId><ArticleId IdType="pmc">PMC3388687</ArticleId><ArticleId IdType="pubmed">22085763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap FHY, Joynt GM, Buckley TA, Wong ELY. Association of serum albumin concentration and mortality risk in critically ill patients. Anaesth Intensive Care. 2002;30(2):202&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12002929</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan MA, Frasier LM, Stewart JC, Mack CM, Gough MS, Graves BT, et al. Artery-to-vein differences in nitric oxide metabolites are diminished in sepsis. Crit Care Med. 2010;38(4):1069&#x2013;77. doi: 10.1097/CCM.0b013e3181d16a3e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181d16a3e</ArticleId><ArticleId IdType="pmc">PMC3322374</ArticleId><ArticleId IdType="pubmed">20081526</ArticleId></ArticleIdList></Reference><Reference><Citation>Gough MS, Morgan MAM, Mack CM, Darling DC, Frasier LM, Doolin KP, et al. The ratio of arginine to dimethylarginines is reduced and predicts outcomes in patients with severe sepsis. Crit Care Med. 2011;39(6):1351&#x2013;8. doi: 10.1097/CCM.0b013e318212097c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318212097c</ArticleId><ArticleId IdType="pmc">PMC3292345</ArticleId><ArticleId IdType="pubmed">21378552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wexler O, Morgan MA, Gough MS, Steinmetz SD, Mack CM, Darling DC, et al. Brachial artery reactivity in patients with severe sepsis: an observational study. Crit Care. 2012;16(2):R38. doi: 10.1186/cc11223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc11223</ArticleId><ArticleId IdType="pmc">PMC3568781</ArticleId><ArticleId IdType="pubmed">22390813</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29(4):530&#x2013;8. doi: 10.1007/s00134-003-1662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf8;rnerem A, Straume B, Midtby M, F&#xf8;nneb&#xf8; V, Sundsfjord J, Svartberg J, et al. Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: the Troms&#xf8; Study. J Clin Endocrinol Metab. 2004;89(12):6039&#x2013;47. doi: 10.1210/jc.2004-0735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2004-0735</ArticleId><ArticleId IdType="pubmed">15579756</ArticleId></ArticleIdList></Reference><Reference><Citation>Endogenous Hormones and Breast Cancer Collaborative Group Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Cancer Epidemiol Biomarkers Prev. 2003;12(12):1457&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">14693737</ArticleId></ArticleIdList></Reference><Reference><Citation>Svartberg J, Midtby M, Bonaa KH, Sundsfjord J, Joakimsen RM, Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Eur J Endocrinol. 2003;149(2):145&#x2013;52. doi: 10.1530/eje.0.1490145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/eje.0.1490145</ArticleId><ArticleId IdType="pubmed">12887292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi S, Geay A, Dechaud H, Biessy C, Zeleniuch-Jacquotte A, Akhmedkhanov A, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers Prev. 2002;11(10 Pt 1):1065&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">12376508</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818&#x2013;29. doi: 10.1097/00003246-198510000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-198510000-00009</ArticleId><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22(7):707&#x2013;10. doi: 10.1007/BF01709751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01709751</ArticleId><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard GR, Wheeler AP, Arons MM, Morris PE, Paz HL, Russell JA, et al. A trial of antioxidants N-acetylcysteine and procysteine in ARDS. Chest. 1997;112(1):164&#x2013;72. doi: 10.1378/chest.112.1.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.112.1.164</ArticleId><ArticleId IdType="pubmed">9228372</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;83. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauffmann RM, Norris PR, Jenkins JM, Dupont WD, Torres RE, Blume JD, et al. Trends in estradiol during critical illness are associated with mortality independent of admission estradiol. J Am Coll Surg. 2011;212(4):703&#x2013;13. doi: 10.1016/j.jamcollsurg.2010.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamcollsurg.2010.12.017</ArticleId><ArticleId IdType="pmc">PMC3073628</ArticleId><ArticleId IdType="pubmed">21463817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourrier F, Jallot A, Leclerc L, Jourdain M, Racdot A, Chagnon JL, et al. Sex steroid hormones in circulatory shock, sepsis syndrome, and septic shock. Circ Shock. 1994;43:171&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7895322</ArticleId></ArticleIdList></Reference><Reference><Citation>Combes A, Luyt CE, Trouillet JL, Nieszkowska A, Chastre J. Gender impact on the outcomes of critically ill patients with nosocomial infections. Crit Care Med. 2009;37:2506&#x2013;11. doi: 10.1097/CCM.0b013e3181a569df.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181a569df</ArticleId><ArticleId IdType="pubmed">19602974</ArticleId></ArticleIdList></Reference><Reference><Citation>Christeff N, Carli A, Benassayag C, Bleichner G, Vaxelaire JF, Nunez EA. Relationship between changes in serum estrone levels and outcome in human males with septic shock. Circ Shock. 1992;36(4):249&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1623570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachtigall I, Tafelski S, Rothbart A, Kaufner L, Schmidt M, Tamarkin A, et al. Gender-related outcome difference is related to course of sepsis on mixed ICUs: a prospective, observational clinical study. Crit Care. 2011;15(3):R151. doi: 10.1186/cc10277.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10277</ArticleId><ArticleId IdType="pmc">PMC3219025</ArticleId><ArticleId IdType="pubmed">21693012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Elia C, Mascia L, Barberis B, Cardellino S, Livigni S, et al. The influence of gender on the epidemiology of and outcome from severe sepsis. Crit Care. 2013;17(2):R50. doi: 10.1186/cc12570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12570</ArticleId><ArticleId IdType="pmc">PMC3733421</ArticleId><ArticleId IdType="pubmed">23506971</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315(8):762&#x2013;74. doi: 10.1001/jama.2016.0288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0288</ArticleId><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA. 2016;315(8):801&#x2013;10. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16360789</PMID><DateCompleted><Year>2006</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2015</Year><Month>06</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1474-547X</ISSN><JournalIssue CitedMedium="Internet"><Volume>366</Volume><Issue>9503</Issue><PubDate><Year>2005</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Lancet (London, England)</Title><ISOAbbreviation>Lancet</ISOAbbreviation></Journal><ArticleTitle>Mitochondrial DNA and survival after sepsis: a prospective study.</ArticleTitle><Pagination><StartPage>2118</StartPage><EndPage>2121</EndPage><MedlinePgn>2118-21</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Human genome evolution has been shaped by infectious disease. Although most genetic studies have focused on the immune system, recovery after sepsis is directly related to physiological reserve that is critically dependent on mitochondrial function. We investigated whether haplogroup H, the most common type of mitochondrial DNA (mtDNA) in Europe, contributes to the subtle genetic variation in survival after sepsis.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a prospective study, we included 150 individuals who were sequentially admitted to the intensive care unit in a hospital in Newcastle upon Tyne, UK. After clinical data were obtained, patients underwent mtDNA haplotyping by analysis with PCR and restriction fragment length polymorphism. As endpoints, we used death during the 6-month period or survival at 6 months.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">Follow-up was complete for all study participants, although the haplotype of two patients could not be reliably determined. On admission to the intensive care unit, the frequency of mtDNA haplogroup H in study patients did not differ between study patients admitted with severe sepsis and 542 age-matched controls from the northeast of England. MtDNA haplogroup H was a strong independent predictor of outcome during severe sepsis, conferring a 2.12-fold (95% CI 1.02-4.43) increased chance of survival at 180 days compared with individuals without the haplogroup H.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Although haplogroup H is the most recent addition to the group of European mtDNA, paradoxically it is also the most common. Increased survival after sepsis provides one explanation for this observation. MtDNA haplotyping offers a new means of risk stratification of patients with severe infections, which suggests new avenues for therapeutic intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baudouin</LastName><ForeName>Simon V</ForeName><Initials>SV</Initials><AffiliationInfo><Affiliation>University Department of Surgical &amp; Reproductive Sciences, University of Newcastle upon Tyne, Newcastle upon Tyne, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>David</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Tiangyou</LastName><ForeName>Watcharee</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Elson</LastName><ForeName>Joanna L</ForeName><Initials>JL</Initials></Author><Author ValidYN="Y"><LastName>Poynter</LastName><ForeName>Jayne</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Pyle</LastName><ForeName>Angela</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Keers</LastName><ForeName>Sharon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Turnbull</LastName><ForeName>Douglass M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Howell</LastName><ForeName>Neil</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Chinnery</LastName><ForeName>Patrick F</ForeName><Initials>PF</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lancet</MedlineTA><NlmUniqueID>2985213R</NlmUniqueID><ISSNLinking>0140-6736</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004272">DNA, Mitochondrial</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Lancet. 2006 May 27;367(9524):1730</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004272" MajorTopicYN="N">DNA, Mitochondrial</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2006</Year><Month>1</Month><Day>5</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>12</Month><Day>20</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16360789</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(05)67890-7</ArticleId><ArticleId IdType="pii">S0140-6736(05)67890-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32076046</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>20</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Characteristics and outcomes of bacteremia among ICU-admitted patients with severe sepsis.</ArticleTitle><Pagination><StartPage>2983</StartPage><MedlinePgn>2983</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2983</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-020-59830-6</ELocationID><Abstract><AbstractText>The clinical implications of bacteremia among septic patients remain unclear, although a vast amount of data have been accumulated on sepsis. We aimed to compare the clinical characteristics and outcomes of severe sepsis patients with and without bacteremia. This secondary analysis of a multicenter, prospective cohort study included 59 intensive care units (ICUs) in Japan between January 2016 and March 2017. The study cohort comprised 1,184 adults (aged &#x2265;&#x2009;16 years) who were admitted to an ICU with severe sepsis and diagnosed according to the Sepsis-2 criteria. Of 1,167 patients included in the analysis, 636 (54.5%) had bacteremia. Those with bacteremia had significantly higher rates of septic shock (66.4% vs. 58.9%, p&#x2009;=&#x2009;0.01) and higher sepsis severity scores, including the Acute Physiology and Chronic Health Evaluation (APACHE) II and the Sequential Organ Failure Assessment (SOFA). No significant difference in in-hospital mortality was seen between patients with and without bacteremia (25.6% vs. 21.0%, p&#x2009;=&#x2009;0.08). In conclusion, half of severe sepsis patients in ICUs have bacteremia. Although patients with bacteremia had more severe state, between-group differences in patient-centered outcomes, such as in-hospital mortality, have not been fully elucidated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Komori</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8548-3707</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Toshikazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University, Tokyo, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Services Research, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan. abetoshi111@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushimoto</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9232-5782</Identifier><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency and Trauma Center, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saitoh</LastName><ForeName>Daizoh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Traumatology, Research Institute, National Defense Medical College, Tokorozawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujishima</LastName><ForeName>Seitaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for General Medicine Education, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayumi</LastName><ForeName>Toshihiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hifumi</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiino</LastName><ForeName>Yasukazu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Acute Medicine, Kawasaki Medical School, Kurashiki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakada</LastName><ForeName>Taka-Aki</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-4480-556X</Identifier><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarui</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Mitaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otomo</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-9674-1369</Identifier><AffiliationInfo><Affiliation>Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Kohji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umemura</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Joji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Disaster and Emergency Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medicine, Saga University Hospital, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Shin-Ichiro</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Aizuwakamatsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takuma</LastName><ForeName>Kiyotsugu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Emergency &amp; Critical Care Center, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuruta</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Advanced Medical Emergency &amp; Critical Care Center, Yamaguchi University Hospital, Ube, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Niizashiki Chuo General Hospital, Niiza, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2999-4021</Identifier><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuno</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeyama</LastName><ForeName>Naoshi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Advanced Critical Care Center, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Norio</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Advanced Emergency Medical Service Center, Kurume University Hospital, Kurume, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Hiroto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Teikyo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueyama</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma, Critical Care Medicine, and Burn Center, Japan Community Healthcare Organization, Chukyo Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gando</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Acute and Critical Care Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>JAAM FORECAST group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010360" MajorTopicYN="N">Patient Transfer</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Tasaki</LastName><ForeName>Osamu</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mizobata</LastName><ForeName>Yasumitsu</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Funakoshi</LastName><ForeName>Hiraku</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okuyama</LastName><ForeName>Toshiro</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Iwao</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kanai</LastName><ForeName>Toshio</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamada</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aibiki</LastName><ForeName>Mayuki</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sato</LastName><ForeName>Keiji</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Susumu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yoshida</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kasaoka</LastName><ForeName>Shunji</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kon</LastName><ForeName>Akihide</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rinka</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kato</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Okudera</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Narimatsu</LastName><ForeName>Eichi</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fujiwara</LastName><ForeName>Toshifumi</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sugita</LastName><ForeName>Manabu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shichinohe</LastName><ForeName>Yasuo</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakae</LastName><ForeName>Hajime</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iiduka</LastName><ForeName>Ryouji</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nakamura</LastName><ForeName>Mitsunobu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Murata</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sato</LastName><ForeName>Yoshitake</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ishikura</LastName><ForeName>Hiroyasu</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Myojo</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsujita</LastName><ForeName>Yasuyuki</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Kosaku</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yamaguchi</LastName><ForeName>Hiroyuki</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sakurai</LastName><ForeName>Toshihiro</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miyatake</LastName><ForeName>Satoru</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Saotome</LastName><ForeName>Takao</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yasuda</LastName><ForeName>Susumu</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mizushima</LastName><ForeName>Yasuaki</ForeName><Initials>Y</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>2</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32076046</ArticleId><ArticleId IdType="pmc">PMC7031517</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-59830-6</ArticleId><ArticleId IdType="pii">10.1038/s41598-020-59830-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kempker JA, Martin GS. The changing epidemiology and definitions of sepsis. Clin. Chest Med. 2016;37:165&#x2013;179. doi: 10.1016/j.ccm.2016.01.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2016.01.002</ArticleId><ArticleId IdType="pmc">PMC4884306</ArticleId><ArticleId IdType="pubmed">27229635</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644&#x2013;1655. doi: 10.1378/chest.101.6.1644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Crit. Care Med. 2017;45:486&#x2013;552. doi: 10.1097/CCM.0000000000002255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002255</ArticleId><ArticleId IdType="pubmed">28098591</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel-Frausto MS, et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273:117&#x2013;123. doi: 10.1001/jama.1995.03520260039030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03520260039030</ArticleId><ArticleId IdType="pubmed">7799491</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeganathan N, et al. The characteristics and impact of source of infection on sepsis-related ICU outcomes. J. Crit. Care. 2017;41:170&#x2013;176. doi: 10.1016/j.jcrc.2017.05.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.05.019</ArticleId><ArticleId IdType="pubmed">28564621</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas-Ruddel DO, et al. Influence of pathogen and focus of infection on procalcitonin values in sepsis patients with bacteremia or candidemia. Crit. Care. 2018;22:128. doi: 10.1186/s13054-018-2050-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2050-9</ArticleId><ArticleId IdType="pmc">PMC5949148</ArticleId><ArticleId IdType="pubmed">29753321</ArticleId></ArticleIdList></Reference><Reference><Citation>Mosevoll KA, et al. Inflammatory mediator profiles differ in sepsis patients with and without bacteremia. Front. Immunol. 2018;9:691. doi: 10.3389/fimmu.2018.00691.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00691</ArticleId><ArticleId IdType="pmc">PMC5897503</ArticleId><ArticleId IdType="pubmed">29681903</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannan Panday RS, Lammers EMJ, Alam N, Nanayakkara PWB. An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit. Care. 2019;23:182. doi: 10.1186/s13054-019-2431-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2431-8</ArticleId><ArticleId IdType="pmc">PMC6530106</ArticleId><ArticleId IdType="pubmed">31113475</ArticleId></ArticleIdList></Reference><Reference><Citation>Kethireddy S, et al. Culture-negative septic shock compared with culture-positive septic shock: a retrospective cohort study. Crit. Care Med. 2018;46:506&#x2013;512. doi: 10.1097/CCM.0000000000002924.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000002924</ArticleId><ArticleId IdType="pubmed">29293143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, et al. Culture-negative severe sepsis: nationwide trends and outcomes. Chest. 2016;150:1251&#x2013;1259. doi: 10.1016/j.chest.2016.08.1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.08.1460</ArticleId><ArticleId IdType="pubmed">27615024</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe T, et al. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit. Care. 2018;22:322. doi: 10.1186/s13054-018-2186-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-018-2186-7</ArticleId><ArticleId IdType="pmc">PMC6251147</ArticleId><ArticleId IdType="pubmed">30466493</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med. 2003;29:530&#x2013;538. doi: 10.1007/s00134-003-1662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda Y. Investigation of the freely available easy-to-use software &#x2018;EZR&#x2019; for medical statistics. Bone Marrow Transplant. 2013;48:452&#x2013;458. doi: 10.1038/bmt.2012.244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2012.244</ArticleId><ArticleId IdType="pmc">PMC3590441</ArticleId><ArticleId IdType="pubmed">23208313</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe R, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than gram-positive bacteremia. Crit. Care. 2010;14:R27. doi: 10.1186/cc8898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8898</ArticleId><ArticleId IdType="pmc">PMC2887127</ArticleId><ArticleId IdType="pubmed">20202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks D, Smith A, Young D, Fulton R, Booth MG. Mortality in intensive care: The impact of bacteremia and the utility of systemic inflammatory response syndrome. Am. J. Infect. Control. 2016;44:1291&#x2013;1295. doi: 10.1016/j.ajic.2016.04.214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2016.04.214</ArticleId><ArticleId IdType="pubmed">27339793</ArticleId></ArticleIdList></Reference><Reference><Citation>Valles J, Rello J, Ochagavia A, Garnacho J, Alcala MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003;123:1615&#x2013;1624. doi: 10.1378/chest.123.5.1615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.123.5.1615</ArticleId><ArticleId IdType="pubmed">12740282</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansur A, et al. Primary bacteraemia is associated with a higher mortality risk compared with pulmonary and intra-abdominal infections in patients with sepsis: a prospective observational cohort study. BMJ Open. 2015;5:e006616. doi: 10.1136/bmjopen-2014-006616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2014-006616</ArticleId><ArticleId IdType="pmc">PMC4289738</ArticleId><ArticleId IdType="pubmed">25564146</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 2004;39:206&#x2013;217. doi: 10.1086/421997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421997</ArticleId><ArticleId IdType="pubmed">15307030</ArticleId></ArticleIdList></Reference><Reference><Citation>Feezor RJ, et al. Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect. Immun. 2003;71:5803&#x2013;5813. doi: 10.1128/IAI.71.10.5803-5813.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.71.10.5803-5813.2003</ArticleId><ArticleId IdType="pmc">PMC201043</ArticleId><ArticleId IdType="pubmed">14500502</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayan AL, Ravindran S, Saikant R, Lakshmi S, Kartik R. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J. Intensive Care. 2017;5:51. doi: 10.1186/s40560-017-0246-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-017-0246-8</ArticleId><ArticleId IdType="pmc">PMC5543591</ArticleId><ArticleId IdType="pubmed">28794881</ArticleId></ArticleIdList></Reference><Reference><Citation>Heredia-Rodriguez M, et al. Procalcitonin cannot be used as a biomarker of infection in heart surgery patients with acute kidney injury. J. Crit. Care. 2016;33:233&#x2013;239. doi: 10.1016/j.jcrc.2016.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2016.01.015</ArticleId><ArticleId IdType="pubmed">26861073</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25199629</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>349</Volume><PubDate><Year>2014</Year><Month>Sep</Month><Day>08</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort study.</ArticleTitle><Pagination><StartPage>g5334</StartPage><MedlinePgn>g5334</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">g5334</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj.g5334</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate the impact of preoperative sepsis on risk of postoperative arterial and venous thromboses.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective cohort study using the National Surgical Quality Improvement Program database of the American College of Surgeons (ACS-NSQIP).</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Inpatient and outpatient procedures in 374 hospitals of all types across the United States, 2005-12.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">2,305,380 adults who underwent surgical procedures.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Arterial thrombosis (myocardial infarction or stroke) and venous thrombosis (deep venous thrombosis or pulmonary embolism) in the 30 days after surgery.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among all surgical procedures, patients with preoperative systemic inflammatory response syndrome or any sepsis had three times the odds of having an arterial or venous postoperative thrombosis (odds ratio 3.1, 95% confidence interval 3.0 to 3.1). The adjusted odds ratios were 2.7 (2.5 to 2.8) for arterial thrombosis and 3.3 (3.2 to 3.4) for venous thrombosis. The adjusted odds ratios for thrombosis were 2.5 (2.4 to 2.6) in patients with systemic inflammatory response syndrome, 3.3 (3.1 to 3.4) in patients with sepsis, and 5.7 (5.4 to 6.1) in patients with severe sepsis, compared with patients without any systemic inflammation. In patients with preoperative sepsis, both emergency and elective surgical procedures had a twofold increased odds of thrombosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Preoperative sepsis represents an important independent risk factor for both arterial and venous thromboses. The risk of thrombosis increases with the severity of the inflammatory response and is higher in both emergent and elective surgical procedures. Suspicion of thrombosis should be higher in patients with sepsis who undergo surgery.</AbstractText><CopyrightInformation>&#xa9; Donz&#xe9; et al 2014.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Donz&#xe9;</LastName><ForeName>Jacques D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine, Bern University Hospital, 3010 Bern, Switzerland Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, 02120 Boston, Massachusetts, USA Harvard Medical School, 02115 Boston, Massachusetts, USA donze.author@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ridker</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Harvard Medical School, 02115 Boston, Massachusetts, USA Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women's Hospital, 02215 Boston, MA Division of Cardiovascular Medicine, Brigham and Women's Hospital, 02215 Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finlayson</LastName><ForeName>Samuel R G</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Utah, 84132 Salt Lake City, UT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>David W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine and Primary Care, Brigham and Women's Hospital, 02120 Boston, Massachusetts, USA Harvard Medical School, 02115 Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Sep 08;349:g5444. doi: 10.1136/bmj.g5444.</RefSource><PMID Version="1">25199797</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6291. doi: 10.1136/bmj.g6291.</RefSource><PMID Version="1">25336047</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6294. doi: 10.1136/bmj.g6294.</RefSource><PMID Version="1">25336428</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>BMJ. 2014 Oct 21;349:g6293. doi: 10.1136/bmj.g6293.</RefSource><PMID Version="1">25336445</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057234" MajorTopicYN="N">Preoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020521" MajorTopicYN="N">Stroke</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018746" MajorTopicYN="N">Systemic Inflammatory Response Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020246" MajorTopicYN="N">Venous Thrombosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; JD does consultancy for Profility and Homeward Health; PR is listed as a co-inventor on patents held by the Brigham and Women&#x2019;s hospital that relate to the use of inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to Siemens and AstraZeneca, has received investigator initiated research grants from the National Institutes of Health, Amgen, Novartis, Pfizer, and AstraZeneca, and has served as a consultant to Vascular Biogenics, ISIS, Aegerion, Lilly, and BostonHeart. DB is a board member of SAE Medical, does consultancy for Zynx, and has received grants from Earlysense and received royalties from Medicalis.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2014</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25199629</ArticleId><ArticleId IdType="pmc">PMC4157562</ArticleId><ArticleId IdType="doi">10.1136/bmj.g5334</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ashton CM, Petersen NJ, Wray NP, Kiefe CI, Dunn JK, Wu L, et al. The incidence of perioperative myocardial infarction in men undergoing noncardiac surgery. Ann Intern Med 1993;118:504-10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8442621</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis. 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141:e227S-77S.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3278061</ArticleId><ArticleId IdType="pubmed">22315263</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Bradley D, Chan MT, Walsh M, Villar JC, Polanczyk CA, et al. An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study. Open Med 2011;5:e193-200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345376</ArticleId><ArticleId IdType="pubmed">22567075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9077376</ArticleId></ArticleIdList></Reference><Reference><Citation>Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature 2011;473:317-25.</Citation><ArticleIdList><ArticleId IdType="pubmed">21593864</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross R. Atherosclerosis&#x2014;an inflammatory disease. N Engl J Med 1999;340:115-26.</Citation><ArticleIdList><ArticleId IdType="pubmed">9887164</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein SE, Zhou YF, Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 1999;100:e20-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">10421626</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet 1997;349:1391-2.</Citation><ArticleIdList><ArticleId IdType="pubmed">9149715</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9259669</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000;163:49-56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1232552</ArticleId><ArticleId IdType="pubmed">10920732</ArticleId></ArticleIdList></Reference><Reference><Citation>American College of Surgeons. ACS NSQIP: Program Overview, 2012. http://site.acsnsqip.org/wp-content/uploads/2012/11/NSQIP-Overview-10.12.pdf.</Citation></Reference><Reference><Citation>Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335:806-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034723</ArticleId><ArticleId IdType="pubmed">17947786</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JW, Donaldson SI. Evaluating interventions with differential attrition: the importance of nonresponse mechanisms and use of follow-up data. J Appl Psychol 1993;78:119-28.</Citation><ArticleIdList><ArticleId IdType="pubmed">8449850</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine RL, LeClerc JR, Bailey JE, Monberg MJ, Sarwat S. Venous and arterial thromboembolism in severe sepsis. Thromb Haemost 2008;99:892-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18449418</ArticleId></ArticleIdList></Reference><Reference><Citation>Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 2005;293:2641-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">15928286</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini-Hill A, Lozano E, Fischberg G, Perez Barreto M, Rajamani K, Ameriso SF, et al. Infection and risk of ischemic stroke: differences among stroke subtypes. Stroke 2003;34:452-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12574559</ArticleId></ArticleIdList></Reference><Reference><Citation>Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">1733381</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet 1998;351:1467-71.</Citation><ArticleIdList><ArticleId IdType="pubmed">9605802</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila KJ, Valtonen VV, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-34.</Citation><ArticleIdList><ArticleId IdType="pubmed">9524851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke 2003;34:2518-32.</Citation><ArticleIdList><ArticleId IdType="pubmed">14500942</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10477528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-207.</Citation><ArticleIdList><ArticleId IdType="pubmed">18997196</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637.</Citation><ArticleIdList><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">7044682</ArticleId></ArticleIdList></Reference><Reference><Citation>Pingleton SK, Bone RC, Pingleton WW, Ruth WE. Prevention of pulmonary emboli in a respiratory intensive care unit: efficacy of low-dose heparin. Chest 1981;79:647-50.</Citation><ArticleIdList><ArticleId IdType="pubmed">6971738</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274:335-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7609264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers SO Jr, Kilaru RK, Hosokawa P, Henderson WG, Zinner MJ, Khuri SF. Multivariable predictors of postoperative venous thromboembolic events after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 2007;204:1211-21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17544079</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost 1991;17 Suppl 3:304-12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1754886</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005;51:70-8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15900257</ArticleId></ArticleIdList></Reference><Reference><Citation>Shorr AF, Williams MD. Venous thromboembolism in critically ill patients. Observations from a randomized trial in sepsis. Thromb Haemost 2009;101:139-44.</Citation><ArticleIdList><ArticleId IdType="pubmed">19132200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group. Lancet 1996;347:1357-61.</Citation><ArticleIdList><ArticleId IdType="pubmed">8637340</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM, Jr., Kastelein JJ, et al. A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 2009;360:1851-61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2710995</ArticleId><ArticleId IdType="pubmed">19329822</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.</Citation><ArticleIdList><ArticleId IdType="pubmed">15843671</ArticleId></ArticleIdList></Reference><Reference><Citation>Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 2013;339:161-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3891792</ArticleId><ArticleId IdType="pubmed">23307733</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23973684</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker PM. Targeting inflammatory pathways for the treatment of cardiovascular disease. Eur Heart J 2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3954097</ArticleId><ArticleId IdType="pubmed">24204011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35841811</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-8673</ISSN><JournalIssue CitedMedium="Internet"><Volume>279</Volume><PubDate><Year>2022</Year><Month>Nov</Month></PubDate></JournalIssue><Title>The Journal of surgical research</Title><ISOAbbreviation>J Surg Res</ISOAbbreviation></Journal><ArticleTitle>Undertriage of Geriatric Trauma Patients in Florida.</ArticleTitle><Pagination><StartPage>427</StartPage><EndPage>435</EndPage><MedlinePgn>427-435</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jss.2022.06.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-4804(22)00362-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Elderly undertriage rates are estimated up to 55% in the United States. This study examined risk factors for undertriage among hospitalized trauma patients in a state with high volumes of geriatric trauma patients.</AbstractText><AbstractText Label="MATERIALS AND METHODS">This is a population-based retrospective cohort study of 62,557 patients admitted to Florida hospitals between 2016 and 2018 from the Agency for Healthcare Administration database. Severely injured trauma patients were defined by American College of Surgeons definitions and an International Classification of Disease Injury Severity Score &lt;0.85. Undertriage was defined as definitive care of these severely injured patients at any Florida hospital other than a state-designated trauma center (TC). Univariate analyses were used to identify risk factors associated with inpatient mortality and undertriage. Multiple variable regression was used to estimate risk-adjusted odds of mortality after admission to either a designated or nondesignated TC.</AbstractText><AbstractText Label="RESULTS">Undertriaged patients were more likely to have isolated traumatic brain injuries, lower International Classification of Disease Injury Severity Scores, multiple comorbidities, and older age. Trauma patients aged 65 and older were more than twice as likely to be undertriaged (34% versus 15.7%, P&#xa0;&lt;&#xa0;0.0001). Undertriaged patients of all ages were also more likely to suffer from pneumonia, urinary tract infection, arrhythmias, and sepsis. After risk adjustment, severely injured trauma patients admitted to non-TC were also more likely to be at risk for mortality (adjusted odds ratio, 1.27; 95% confidence interval, 1.17-1.38).</AbstractText><AbstractText Label="CONCLUSIONS">Age and multiple comorbidities are significant predictors of mortality among undertriage of trauma patients. As a result, trauma triage guidelines should account for high-risk geriatric trauma patients who would benefit from definitive treatment at designated TCs.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Courtney</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millen</LastName><ForeName>Janelle Cheri</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Huazhi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Trauma, Ocala Regional Medical Center, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida; Department of Surgery, University of South Florida, Tampa, Florida; Department of Trauma, Ocala Regional Medical Center, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferber</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida; Department of Surgery, University of South Florida, Tampa, Florida; Department of Trauma, Ocala Regional Medical Center, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richards</LastName><ForeName>Winston</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida; Department of Surgery, University of South Florida, Tampa, Florida; Department of Trauma, Ocala Regional Medical Center, Ocala, Florida.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ang</LastName><ForeName>Darwin</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Central Florida, General Surgery, Ocala, Florida; Department of Surgery, University of South Florida, Tampa, Florida; Department of Trauma, Ocala Regional Medical Center, Ocala, Florida. Electronic address: Darwin.Ang@hcahealthcare.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Surg Res</MedlineTA><NlmUniqueID>0376340</NlmUniqueID><ISSNLinking>0022-4804</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005431" MajorTopicYN="N" Type="Geographic">Florida</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015601" MajorTopicYN="N">Injury Severity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014193" MajorTopicYN="Y">Trauma Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014218" MajorTopicYN="N">Triage</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014947" MajorTopicYN="Y">Wounds and Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Florida geriatric trauma</Keyword><Keyword MajorTopicYN="N">Geriatric trauma</Keyword><Keyword MajorTopicYN="N">Geriatric undertriage</Keyword><Keyword MajorTopicYN="N">Trauma center undertriage</Keyword><Keyword MajorTopicYN="N">Undertriage</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>16</Day><Hour>18</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35841811</ArticleId><ArticleId IdType="doi">10.1016/j.jss.2022.06.006</ArticleId><ArticleId IdType="pii">S0022-4804(22)00362-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39755598</PMID><DateCompleted><Year>2025</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2253</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>1</Issue><PubDate><Year>2025</Year><Month>Jan</Month><Day>04</Day></PubDate></JournalIssue><Title>BMC anesthesiology</Title><ISOAbbreviation>BMC Anesthesiol</ISOAbbreviation></Journal><ArticleTitle>Norepinephrine titration in patients with sepsis-induced encephalopathy: cerebral pulsatility index compared to mean arterial pressure guided protocol: randomized controlled trial.</ArticleTitle><Pagination><StartPage>5</StartPage><MedlinePgn>5</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12871-024-02814-0</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although surviving sepsis campaign (SSC) guidelines are the standard for sepsis and septic shock management, outcomes are still unfavourable. Given that perfusion pressure in sepsis is heterogeneous among patients and within the same patient; we evaluated the impact of individualized hemodynamic management via the transcranial Doppler (TCD) pulsatility index (PI) on mortality and outcomes among sepsis-induced encephalopathy (SIE) patients.</AbstractText><AbstractText Label="METHODS">In this prospective, single-center randomized controlled study, 112 patients with SIE were randomly assigned. Mean arterial pressure (MAP) and norepinephrine (NE) titration were guided via the TCD pulsatility index to achieve a pulsatility index&#x2009;&lt;&#x2009;1.3 in Group I, whereas the SSC guidelines were used in Group II to achieve a MAP&#x2009;&#x2265;&#x2009;65&#xa0;mmHg. The primary outcome was intensive care unit (ICU) mortality and the secondary outcomes were; MAP that was measured invasively and values were recorded; daily in the morning, at the end of NE infusion and the end of ICU stay, duration of ICU stay, cerebral perfusion pressure (CPP), sequential organ failure assessment (SOFA) score, norepinephrine titration and Glasgow coma scale (GCS) score at discharge.</AbstractText><AbstractText Label="RESULTS">ICU mortality percentage wasn`t significantly different between the two groups (p value 0.174). There was a&#xa0;significant increase in the MAP at the end of norepinephrine infusion (mean value of 69.54&#x2009;&#xb1;&#x2009;10.42 and p value 0.002) and in the GCS score at ICU discharge (Median value of 15 and p value 0.014) in the TCD group, and episodes of cerebral hypoperfusion with CPP&#x2009;&lt;&#x2009;60&#xa0;mmHg, were significantly lower in the TCD group (median value of 2 and p value 0.018). Heart rate values, number of episodes of tachycardia or bradycardia, Total norepinephrine dosing, duration of norepinephrine infusion, SOFA score, serum lactate levels, and ICU stay duration weren`t significantly different between the two groups.</AbstractText><AbstractText Label="CONCLUSIONS">Individualizing hemodynamic management via the TCD pulsatility index in SIE patients was not associated with significant mortality reduction. However, it reduces episodes of cerebral hypoperfusion and&#xa0;improves GCS outcome but doesn't significantly affect heart rate values, SOFA score, serum lactate level, length of ICU stay, total NE dosing, and duration of NE infusion.</AbstractText><AbstractText Label="TRIAL REGISTRATION">The clinical trial was registered on clinucaltrials.gov under the identifier NCT05842616 https://clinicaltrials.gov/study/NCT05842616?cond=NCT05842616&amp;rank=1 on 6-May-2023 before the enrolment of the first patient.</AbstractText><CopyrightInformation>&#xa9; 2025. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Salem</LastName><ForeName>Mai Salah</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University Hospitals, Tanta, Gharbya, Egypt. mai.salah@med.tanta.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abosabaa</LastName><ForeName>Motaz Amr</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University Hospitals, Tanta, Gharbya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abd El Ghafar</LastName><ForeName>Mohamed Samir</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University Hospitals, Tanta, Gharbya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ei-Gendy</LastName><ForeName>Hala Mohey Ei-Deen Mohamed</ForeName><Initials>HMEM</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University Hospitals, Tanta, Gharbya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsherif</LastName><ForeName>Salah El-Din Ibrahim</ForeName><Initials>SEI</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Surgical Intensive Care and Pain Medicine, Faculty of Medicine, Tanta University Hospitals, Tanta, Gharbya, Egypt.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05842616</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Anesthesiol</MedlineTA><NlmUniqueID>100968535</NlmUniqueID><ISSNLinking>1471-2253</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>X4W3ENH1CV</RegistryNumber><NameOfSubstance UI="D009638">Norepinephrine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009638" MajorTopicYN="Y">Norepinephrine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062186" MajorTopicYN="Y">Arterial Pressure</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017585" MajorTopicYN="Y">Ultrasonography, Doppler, Transcranial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065166" MajorTopicYN="N">Sepsis-Associated Encephalopathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011673" MajorTopicYN="N">Pulsatile Flow</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002560" MajorTopicYN="N">Cerebrovascular Circulation</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cerebral hypoperfusion</Keyword><Keyword MajorTopicYN="N">ICU mortality</Keyword><Keyword MajorTopicYN="N">Mean arterial pressure</Keyword><Keyword MajorTopicYN="N">Norepinephrine titration</Keyword><Keyword MajorTopicYN="N">Sepsis-induced encephalopathy</Keyword><Keyword MajorTopicYN="N">TCD Pulsatility index</Keyword></KeywordList><CoiStatement>Declarations. Ethics approval and consent to participate: The clinical trial was conducted after approval from the&#xa0;Research Ethical Committee, Faculty of Medicine, Tanta University, code number 35559/6/22. An informed written consent was obtained from all patients relatives. The following study adhered to CONSORT guidelines. Consent for publication: No personal data was involved in this clinical trial. Competing interests: The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>7</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>4</Day><Hour>23</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39755598</ArticleId><ArticleId IdType="pmc">PMC11699758</ArticleId><ArticleId IdType="doi">10.1186/s12871-024-02814-0</ArticleId><ArticleId IdType="pii">10.1186/s12871-024-02814-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Huang Y, Chen R, Jiang L, Li S, Xue Y. Basic research and clinical progress of sepsis associated encephalopathy. J Intensive Med. 2021;1(02):90&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923961</ArticleId><ArticleId IdType="pubmed">36788800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Manohar M, Kaur K, Sharma J. Cerebral Resuscitation in Neurocritical Care. In: Prabhakar H, Singhal V, Zirpe KG, Sapra H, editors. Principles and Practice of Neurocritical Care. Singapore: Springer; 2024. 10.1007/978-981-99-8059-8_40.</Citation></Reference><Reference><Citation>Rosenblatt K, Walker KA, Goodson C, Olson E, Maher D, Brown CH IV, Nyquist P. Cerebral autoregulation&#x2013;guided optimal blood pressure in sepsis-associated encephalopathy: a case series. J Intensive Care Med. 2020;35(12):1453&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6692246</ArticleId><ArticleId IdType="pubmed">30760173</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Ursoleo JDA, Murru CP, Landoni G. Blood pressure management for hypotensive patients in intensive care andperioperative cardiovascular settings. J Cardiothor Vasc Anesth. 2024;38:2089.</Citation><ArticleIdList><ArticleId IdType="pubmed">38918089</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattan E, Castro R, Vera M, Hern&#xe1;ndez G. Optimaltarget in septic shock resuscitation. Ann Transl Med. 2020;8(12):789.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7333135</ArticleId><ArticleId IdType="pubmed">32647714</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouan Y, Seegers V, Meziani F, Grelon F, Megarbane B, Anguel N, et al. Effects of mean arterial pressure on arousal in sedated ventilated patients with septic shock: a SEPSISPAM post hoc exploratory study. Annals Intensive Care. 2019;9:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6509319</ArticleId><ArticleId IdType="pubmed">31073873</ArticleId></ArticleIdList></Reference><Reference><Citation>Robba C, Ball L, Pelosi P. Brain Ultrasound in the Non-neurocritical Care Setting. Annual update in intensive care and emergency medicine. 2019;2019:407&#x2013;21.</Citation></Reference><Reference><Citation>Czempik PF, Pluta MP, Krzych &#x141;J. Sepsis-associatedbrain dysfunction: a review of current literature. Int J Environ Res Public Health. 2020;17(16):5852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460246</ArticleId><ArticleId IdType="pubmed">32806705</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas LE, Termorshuizen F, de Lange DW, van Dijk D, de Keizer NF. Performance of the quick SOFA in very old ICU patients admitted with sepsis. Acta Anaesthesiol Scand. 2020;64(4):508&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">31885070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamath S, Hammad Altaq H, Abdo T. Management of sepsis and septic shock: what have we learned in the last two decades? Microorganisms. 2023;11(9):2231.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10537306</ArticleId><ArticleId IdType="pubmed">37764075</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorican K, Chochola M, Kocik M, Zak A. Diagnostic criteria for the determination of clinically significant internalcarotid artery stenosis using duplex ultrasound. Biomed Papers. 2020;164(3):255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">31219103</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: internationalguidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47(11):1181&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato T, Niijima A, Arai A, Maku T, Motegi H, Takahashi M, et al. Middle cerebral artery pulsatility index correlates with prognosis and diastolic dysfunctions in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2022;31(3):255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">35033988</ArticleId></ArticleIdList></Reference><Reference><Citation>Taibi R, Elhalimi K, Negadi M. P0036/# 2138: Estimation of cerebral perfusion pressure &#x201c;cpp&#x201d; by trans cranial doppler &#x201c;tcd&#x201d; in children with severe trauma brain injury &#x201c;TBI.&#x201d; Pediatric Critical Care Medicine. 2021;22(Supplement 1 3S):53.</Citation></Reference><Reference><Citation>Mount CA, Das JM. Cerebral perfusion pressure.&#xa0; StatPearls: StatPearls Publishing; 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">30725956</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda R, Nakamura K, Takatani Y, Tanaka C, Kondo Y, Ohbe H, et al. Sepsisassociated delirium: a narrative review. J Clin Med. 2023;12(4):1273. 10.3390/jcm12041273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9962483</ArticleId><ArticleId IdType="pubmed">36835809</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q, Ai M, Huang L, Peng Q, Ai Y, Zhang L. Relationship between cerebral hemodynamics, tissue oxygen saturation, and delirium in patients with septic shock: a pilot observational cohort study. Front Med. 2021;8:641104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8660998</ArticleId><ArticleId IdType="pubmed">34901041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrakos C, Attou R, Decorte L, Kolyviras A, Malinverni S, Gottignies P, et al. Transcranial Doppler to assess sepsis-associatedencephalopathy in critically ill patients. BMC Anesthesiol. 2014;14:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4061318</ArticleId><ArticleId IdType="pubmed">24944522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, B&#xf6;gli S, Wildbolz S, Nierobisch N, Keller E, Brandi G. 41st International symposium on intensive care and emergency medicine. Crit Care. 2022;26(1):P001.</Citation></Reference><Reference><Citation>Peng Q, Liu X, Ai M, Huang L, Li L, Liu W, et al. Cerebral autoregulation-directed optimal blood pressure management reducedthe risk of delirium in patients with septic shock. J Intensive Med. 2024;4:376.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11258506</ArticleId><ArticleId IdType="pubmed">39035614</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng H, Liang Z, Zhang S, Yang Y. Optimal targetmean arterial pressure for patients with sepsis-associated encephalopathy: aretrospective cohort study. BMC Infect Dis. 2024;24(1):902.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11367872</ArticleId><ArticleId IdType="pubmed">39223467</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L, Liu B, Wang Y, Wang Z, Xie K, Li Y. New strategies to optimize hemodynamics for sepsis-associated encephalopathy. J Personal Med. 2022;12(12):1967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9784429</ArticleId><ArticleId IdType="pubmed">36556188</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvati S, Ursoleo JDA, Landoni G, Belletti A. In Reply to" Letter to the Editor: The alphabet soup of norepinephrinedoses". J Cardiothor Vasc Anesth. 2024;S1053&#x2013;0770(24):00276&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">38890086</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotani Y, Belletti A, Ursoleo JDA, Salvati S, Landoni G. Norepinephrine dose should be reported as base equivalence in clinical research manuscripts. J Cardiothorac Vasc Anesth. 2023;37:1523&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">37291003</ArticleId></ArticleIdList></Reference><Reference><Citation>Salvati S, Ursoleo JDA, Belletti A, Monti G, Bonizzoni MA, Fazio M, Landoni G. Norepinephrine salt formulations and risk of therapeutic error: results of a national survey. J Cardiothor Vasc Anesth. 2024;38:2624.</Citation><ArticleIdList><ArticleId IdType="pubmed">38908934</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28504993</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1526-7598</ISSN><JournalIssue CitedMedium="Internet"><Volume>125</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Anesthesia and analgesia</Title><ISOAbbreviation>Anesth Analg</ISOAbbreviation></Journal><ArticleTitle>Red Blood Cell Transfusion and Surgical Site Infection After Colon Resection Surgery: A Cohort Study.</ArticleTitle><Pagination><StartPage>1316</StartPage><EndPage>1321</EndPage><MedlinePgn>1316-1321</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1213/ANE.0000000000002099</ELocationID><Abstract><AbstractText Label="BACKGROUND">Surgical site infections (SSIs) after colon surgery remain a critical safety issue. Patients with an SSI have an increased risk of death, prolonged hospitalization, and increased costs of care. Red blood cell (RBC) transfusion is given during the perioperative period to increase blood oxygen delivery, but it is associated with complications, including infection. We hypothesized that RBC transfusion would be associated with increased SSI risk in patients undergoing colon resection surgery.</AbstractText><AbstractText Label="METHODS">A retrospective cohort study was performed using the 2014 National Surgical Quality Improvement Program participant use file. Patients who had colon resection surgery were identified using current procedural terminology codes. The association between perioperative RBC transfusion and superficial and deep incisional SSIs, organ space SSIs, and postoperative septic shock was modeled using logistic regression with propensity score analysis.</AbstractText><AbstractText Label="RESULTS">Of 23,388 patients who had colon resection surgery, 1845 (7.9%) received perioperative RBC transfusion. After controlling for confounders with propensity score analysis and inverse probability of treatment weighting, RBC transfusion had no apparent association with superficial incisional SSI (odds ratio [OR], 1.18; 99% confidence interval [CI], 0.48-2.88) or deep incisional SSI (OR, 1.47; 99% CI, 0.23-9.43). However, RBC transfusion appeared to be associated with increased risk of organ space SSI (OR, 2.93; 99% CI, 1.43-6.01) and septic shock (OR, 9.23; 99% CI, 3.53-24.09).</AbstractText><AbstractText Label="CONCLUSIONS">RBC transfusion has no apparent association with increased risk for incisional SSIs, but may be associated with increased risk for organ space SSI and septic shock after colon resection surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazzeffi</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Kenichi</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Galvagno</LastName><ForeName>Samuel</ForeName><Initials>S</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesth Analg</MedlineTA><NlmUniqueID>1310650</NlmUniqueID><ISSNLinking>0003-2999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Anesth Analg. 2017 Oct;125(4):1092-1094. doi: 10.1213/ANE.0000000000002297.</RefSource><PMID Version="1">28922217</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003106" MajorTopicYN="N">Colon</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013505" MajorTopicYN="N">Digestive System Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017707" MajorTopicYN="N">Erythrocyte Transfusion</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28504993</ArticleId><ArticleId IdType="doi">10.1213/ANE.0000000000002099</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33569597</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2091</ISSN><JournalIssue CitedMedium="Internet"><Volume>76</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>13</Day></PubDate></JournalIssue><Title>The Journal of antimicrobial chemotherapy</Title><ISOAbbreviation>J Antimicrob Chemother</ISOAbbreviation></Journal><ArticleTitle>Impact of extracorporeal membrane oxygenation (ECMO) support on piperacillin exposure in septic patients: a case-control study.</ArticleTitle><Pagination><StartPage>1242</StartPage><EndPage>1249</EndPage><MedlinePgn>1242-1249</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/jac/dkab031</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe the impact of extracorporeal membrane oxygenation (ECMO) devices on piperacillin exposure in ICU patients.</AbstractText><AbstractText Label="METHODS">This observational, prospective, multicentre, case-control study was performed in the ICUs of two tertiary care hospitals in France. ECMO patients with sepsis treated with piperacillin/tazobactam were enrolled. Control patients were matched according to SOFA score and creatinine clearance. The pharmacokinetics of piperacillin were described based on a population pharmacokinetic model, calculating the proportion of time the piperacillin plasma concentration was above 64&#x2009;mg/L (i.e. 4&#xd7; MIC breakpoint for Pseudomonas aeruginosa).</AbstractText><AbstractText Label="RESULTS">Forty-two patients were included. Median (IQR) age was 60&#x2009;years (49-66), SOFA score was 11 (9-14) and creatinine clearance was 47&#x2009;mL/min (5-95). There was no significant difference in the proportion of time piperacillin concentrations were &#x2265;64&#x2009;mg/L in patients treated with ECMO and controls during the first administration (P&#x200a;=&#x200a;0.184) or at steady state (P&#x200a;=&#x200a;0.309). Following the first administration, 36/42 (86%) patients had trough piperacillin concentrations &lt;64&#x2009;mg/L. Trough concentrations at steady state were similar in patients with ECMO and controls (P&#x200a;=&#x200a;0.535). Creatinine clearance &#x2265;40&#x2009;mL/min was independently associated with piperacillin trough concentration &lt;64&#x2009;mg/L at steady state [OR&#x200a;=&#x200a;4.3 (95% CI 1.1-17.7), P&#x200a;=&#x200a;0.043], while ECMO support was not [OR&#x200a;=&#x200a;0.5 (95% CI 0.1-2.1), P&#x200a;=&#x200a;0.378].</AbstractText><AbstractText Label="CONCLUSIONS">ECMO support has no impact on piperacillin exposure. ICU patients with sepsis are frequently underexposed to piperacillin, which suggests that therapeutic drug monitoring should be strongly recommended for severe infections.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fill&#xe2;tre</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>St Brieuc Hospital, R&#xe9;animation Polyvalente, F-22000 St Brieuc, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemaitre</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Univ Rennes, Rennes University Hospital, Inserm, EHESP, Irset (Institut de Recherche en sant&#xe9;, Environnement et Travail) - UMR_S 1085, F-35000 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nesseler</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Service de R&#xe9;animation de Chirurgie Cardiothoracique et de Chirurgie Vasculaire, F-35000 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, CIC 1414, F35000 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Sorbonne Universit&#xe9;, Institute of Cardiometabolism and Nutrition, APHP, Piti&#xe9;-Salp&#xea;tri&#xe8;re Hospital, Medical Intensive Care Unit, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besset</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Louis Mourier Hospital, M&#xe9;decine Intensive-R&#xe9;animation, AP-HP, F92700 Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Launey</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Univ Rennes, Inra, Inserm, Institut NUMECAN - UMR_A 1341, UMR_S 1241, CIC 1414, F35000 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rennes University Hospital, Surgical Critical Care Unit, Department of Anaesthesia, Critical Care and Perioperative Medicine, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maamar</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Facult&#xe9; de M&#xe9;decine, Biosit, F-35043 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daufresne</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Haematology Unit, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flecher</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Department of Thoracic and Cardiovascular Surgery, F-35033 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inserm U1099, Signal and Image Treatment Laboratory (LTSI), F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le Tulzo</LastName><ForeName>Y</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Facult&#xe9; de M&#xe9;decine, Biosit, F-35043 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tadie</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Facult&#xe9; de M&#xe9;decine, Biosit, F-35043 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tattevin</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Rennes University Hospital, Infectious Diseases and Intensive Care Unit, F-35033 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Facult&#xe9; de M&#xe9;decine, Biosit, F-35043 Rennes, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Univ Rennes, Inserm-CIC-1414, IFR 140, F-35033 Rennes, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Antimicrob Chemother</MedlineTA><NlmUniqueID>7513617</NlmUniqueID><ISSNLinking>0305-7453</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>X00B0D5O0E</RegistryNumber><NameOfSubstance UI="D010878">Piperacillin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015199" MajorTopicYN="Y">Extracorporeal Membrane Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010878" MajorTopicYN="N">Piperacillin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>11</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33569597</ArticleId><ArticleId IdType="doi">10.1093/jac/dkab031</ArticleId><ArticleId IdType="pii">6132745</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26230536</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>19</Issue><PubDate><Year>2015</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Timing of Complications After Spinal Fusion Surgery.</ArticleTitle><Pagination><StartPage>1527</StartPage><EndPage>1535</EndPage><MedlinePgn>1527-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000001073</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To characterize the timing of complications after spinal fusion procedures.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">Despite many publications on risk factors for complications after spine surgery, there are few publications on the timing at which such complications occur.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients undergoing anterior cervical decompression and fusion (ACDF) or posterior lumbar fusion (PLF; with or without interbody) procedures during 2011-2013 were identified in the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database. For each of 8 different complications, the median time from surgery until complication was determined, along with the interquartile range and middle 80%.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 12,067 patients undergoing ACDF and 11,807 patients undergoing PLF were identified. For ACDF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-5; 0-15), pneumonia 4 (2-9; 1-14), pulmonary embolism 5 (2-9; 1-10), deep vein thrombosis 10.5 (7-16.5; 5-21), sepsis 10.5 (4-18; 1-23), surgical site infection 13 (8-19; 5-25), and urinary tract infection 17 (8-22; 4-26). For PLF, the median day of diagnosis (and interquartile range; middle 80%) for anemia requiring transfusion was 0 (0-1; 0-2), myocardial infarction 2 (1-4; 1-8), pneumonia 4 (2-9; 1-17), pulmonary embolism 5 (3-11; 2-17), urinary tract infection 7 (4-14; 2-23), deep vein thrombosis 8 (5-16; 3-20), sepsis 9 (4-16; 2-22), and surgical site infection 17 (13-22; 9-27).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These precisely described postoperative time periods enable heightened clinical awareness among spine surgeons. Spine surgeons should have the lowest threshold for testing for each complication during the time period of greatest risk. Authors, reviewers, and surgeons utilizing research on postoperative complications should carefully consider the impact that the duration of follow-up has on study results.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bohl</LastName><ForeName>Daniel D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>*Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL &#x2020;Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, CT; and &#x2021;Departments of Orthopaedic Surgery and Neurological Surgery, Thomas Jefferson University and The Rothman Institute, Philadelphia, PA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Webb</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials></Author><Author ValidYN="Y"><LastName>Lukasiewicz</LastName><ForeName>Adam M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Samuel</LastName><ForeName>Andre M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Basques</LastName><ForeName>Bryce A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Junyoung</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Kern</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Vaccaro</LastName><ForeName>Alexander R</ForeName><Initials>AR</Initials></Author><Author ValidYN="Y"><LastName>Grauer</LastName><ForeName>Jonathan N</ForeName><Initials>JN</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019299" MajorTopicYN="N">Decompression, Surgical</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008159" MajorTopicYN="N">Lumbar Vertebrae</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011655" MajorTopicYN="N">Pulmonary Embolism</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="N">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066231" MajorTopicYN="Y">Surgeons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26230536</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000001073</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35272752</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1221-9118</ISSN><JournalIssue CitedMedium="Print"><Volume>117</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Chirurgia (Bucharest, Romania : 1990)</Title><ISOAbbreviation>Chirurgia (Bucur)</ISOAbbreviation></Journal><ArticleTitle>Significance of Biomarkers in Early Diagnosis of Abdominal Sepsis.</ArticleTitle><Pagination><StartPage>30</StartPage><EndPage>36</EndPage><MedlinePgn>30-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21614/chirurgia.2660</ELocationID><ELocationID EIdType="pii" ValidYN="Y">4</ELocationID><Abstract><AbstractText Label="INTRODUCTION/OBJECTIVE" NlmCategory="OBJECTIVE">Peritonitis is one of the most important sources of abdominal sepsis. Since intra-abdominal infection leads to the activation of the inflammatory response, this suggested that some of these mediators could be used as markers of the severity of newly formed sepsis, but primarily to identify or rule out new-onset sepsis. The aim of this study was to evaluate the sensitivity and specificity of serum markers of inflammation: C-reactive protein, procalcitonin and serum amyloid A in the serum of patients with diffuse secondary peritonitis. <b>Methods:</b> The prospective cohort study was conducted at the Clinic for Emergency Surgery of the Clinical Center of Serbia in Belgrade. The study group consisted of 100 patients aged 18 to 70 years, with signs of acute abdomen due to diffuse secondary peritonitis. <b>Results:</b> CRP and PCT are so far among the most valuable preoperative markers for distinguishing sepsis from SIRS. On the first postoperative day the analysis of the relationship between sensitivity and specificity at the different breakpoints used indicates a greater diagnostic accuracy and greater sensitivity of SAA compared to CRP and PCT. In the remaining postoperative period in our study, the ROC curve mostly coincided with the diagonal line, so CRP, PCT, and SAA had little diagnostic accuracy.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of our study suggest that finding a specific marker for the diagnosis of abdominal sepsis, a marker that would differentiate between SIRS and sepsis, pre- and postoperatively, would be very useful.</AbstractText><CopyrightInformation>Celsius.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arbutina</LastName><ForeName>Dragana D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Milic</LastName><ForeName>Ljiljana</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Cuk</LastName><ForeName>Vladica V</ForeName><Initials>VV</Initials></Author><Author ValidYN="Y"><LastName>Juloski</LastName><ForeName>Jovan T</ForeName><Initials>JT</Initials></Author><Author ValidYN="Y"><LastName>Radulovic</LastName><ForeName>Radosav</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Starcevic</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Karamarkovic</LastName><ForeName>Aleksandar R</ForeName><Initials>AR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Romania</Country><MedlineTA>Chirurgia (Bucur)</MedlineTA><NlmUniqueID>9213031</NlmUniqueID><ISSNLinking>1221-9118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>JHB2QIZ69Z</RegistryNumber><NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042241" MajorTopicYN="N">Early Diagnosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059413" MajorTopicYN="Y">Intraabdominal Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C-reactiveprotein</Keyword><Keyword MajorTopicYN="N">SIRS</Keyword><Keyword MajorTopicYN="N">procalcitonin</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">serumamyloidA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35272752</ArticleId><ArticleId IdType="doi">10.21614/chirurgia.2660</ArticleId><ArticleId IdType="pii">4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">33618037</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-8171</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>The American journal of emergency medicine</Title><ISOAbbreviation>Am J Emerg Med</ISOAbbreviation></Journal><ArticleTitle>Analgesic refractory colic pain: Is prolonged conservative management appropriate?</ArticleTitle><Pagination><StartPage>137</StartPage><EndPage>142</EndPage><MedlinePgn>137-142</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2021.02.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0735-6757(21)00127-3</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To propose a clear definition and management pathway of patients with analgesic refractory colic pain (ARCP).</AbstractText><AbstractText Label="PATIENTS AND METHODS">Prospective cohort study from February 2018 to February 2019 including patients with ARCP defined as ongoing renal colic pain after one dose of IV NSAID, IV paracetamol, and a parenteral opioid, given sequentially in that order. Patients were observed in-hospital under full parenteral analgesic management for 8-12&#xa0;h, whenever patients had minimal or absent pain after conservative management (CM) they were discharged, and followed-up with new imaging within four weeks. If the pain was not controlled after CM, surgical management (double-J stent or ureteroscopy) was performed. We excluded patients with any other indication for urgent intervention or in cases where CM was deemed inappropriate (sepsis, acute renal failure, stones &gt;10&#xa0;mm in size, suspected concomitant urinary tract infection, bilateral ureteral stones, pregnancy, patients with a single kidney, kidney transplant recipients, difficult access to medical care or refusal to undergo CM).</AbstractText><AbstractText Label="RESULTS">Data from 60 patients was collected. The only variable associated with an increased risk of failed CM was a history of previous renal colic (OR 3.98 [95% CI 1.14-13.84], p&#xa0;=&#xa0;0.02). Neither gender, age, stone size, location, or hydronephrosis grade were able to predict CM failure. 41.6% of patients were successfully managed conservatively and only 8% of them required scheduled surgical management at follow-up.</AbstractText><AbstractText Label="CONCLUSION">Our results show that a high proportion of patients with ARCP may be successfully managed conservatively with an extended observation period without complications at follow-up. These results should be replicated in a randomized controlled trial to confirm them.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Padilla</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain; Department of Urology, University Hospital Infanta Sof&#xed;a, Madrid, Spain. Electronic address: danielantonio.gonzalez@salud.madrid.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-D&#xed;az</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Rojo</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abad-L&#xf3;pez</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos-P&#xe9;rez de la Blanca</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hern&#xe1;ndez-Arroyo</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teigell-Tobar</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pe&#xf1;a-Vallejo</LastName><ForeName>Helena</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez-Antol&#xed;n</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera-Meir&#xe1;s</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Urology, University Hospital 12 de Octubre, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Emerg Med</MedlineTA><NlmUniqueID>8309942</NlmUniqueID><ISSNLinking>0735-6757</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000700">Analgesics</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>362O9ITL9D</RegistryNumber><NameOfSubstance UI="D000082">Acetaminophen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000082" MajorTopicYN="N">Acetaminophen</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000700" MajorTopicYN="N">Analgesics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="N">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003085" MajorTopicYN="N">Colic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072700" MajorTopicYN="Y">Conservative Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059408" MajorTopicYN="N">Pain Management</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Analgesic</Keyword><Keyword MajorTopicYN="N">Conservative</Keyword><Keyword MajorTopicYN="N">Pain</Keyword><Keyword MajorTopicYN="N">Refractory</Keyword><Keyword MajorTopicYN="N">Renal colic</Keyword><Keyword MajorTopicYN="N">Surgical</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare no conflicts of interest relevant to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>22</Day><Hour>20</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33618037</ArticleId><ArticleId IdType="doi">10.1016/j.ajem.2021.02.018</ArticleId><ArticleId IdType="pii">S0735-6757(21)00127-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">28153684</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-6500</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>7</Issue><PubDate><Year>2017</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal of shoulder and elbow surgery</Title><ISOAbbreviation>J Shoulder Elbow Surg</ISOAbbreviation></Journal><ArticleTitle>Analysis of complication rates following perioperative transfusion in shoulder arthroplasty.</ArticleTitle><Pagination><StartPage>1203</StartPage><EndPage>1209</EndPage><MedlinePgn>1203-1209</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jse.2016.11.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1058-2746(16)30612-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postoperative anemia requiring a blood transfusion is not uncommon following anatomic total shoulder arthroplasty (TSA) or reverse total shoulder arthroplasty (RTSA). However, the potential complications in patients undergoing transfusion after shoulder arthroplasty remain unclear. The goal of this study was to examine the postoperative outcomes of patients receiving blood transfusions following TSA and RTSA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Using the Medicare Standard Analytic Files database, we identified all patients undergoing TSA or RTSA between 2005 and 2010. Using International Classification of Diseases, Ninth Revision, Clinical Modification and Current Procedural Terminology codes, we identified the procedure, transfusion status, comorbidities, and postoperative complications of interest. Odds ratios and 95% confidence intervals were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 7,794 patients who received a perioperative blood transfusion following TSA or RTSA, as well as 34,293 age- and gender-matched controls, during the study period. Patients who received a perioperative transfusion had statistically significantly higher rates of myocardial infarction, pneumonia, systemic inflammatory response syndrome or sepsis, venous thromboembolic events, and cerebrovascular accidents at all time points in question. Patients who received a blood transfusion also showed an increased incidence of surgical complications, including periprosthetic infection and mechanical complications, up to 2 years postoperatively.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">To our knowledge, this represents the largest study to examine the relationship between the need for perioperative blood transfusion and postoperative medical and surgical outcomes following TSA and RTSA. The results observed in this study highlight the importance of preoperative counseling and medical optimization prior to shoulder arthroplasty, particularly in patients with preoperative anemia or multiple medical comorbidities.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grier</LastName><ForeName>A Jordan</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bala</LastName><ForeName>Abiram</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penrose</LastName><ForeName>Colin T</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seyler</LastName><ForeName>Thorsten M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bolognesi</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garrigues</LastName><ForeName>Grant E</ForeName><Initials>GE</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Duke University Medical Center, Durham, NC, USA. Electronic address: grant.garrigues@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>01</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Shoulder Elbow Surg</MedlineTA><NlmUniqueID>9206499</NlmUniqueID><ISSNLinking>1058-2746</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000740" MajorTopicYN="N">Anemia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072228" MajorTopicYN="Y">Arthroplasty, Replacement, Shoulder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="Y">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009657" MajorTopicYN="N">North Carolina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="Y">Perioperative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Total</Keyword><Keyword MajorTopicYN="N">arthroplasty</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">database</Keyword><Keyword MajorTopicYN="N">replacement</Keyword><Keyword MajorTopicYN="N">reverse</Keyword><Keyword MajorTopicYN="N">shoulder</Keyword><Keyword MajorTopicYN="N">transfusion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>11</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>2</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28153684</ArticleId><ArticleId IdType="doi">10.1016/j.jse.2016.11.039</ArticleId><ArticleId IdType="pii">S1058-2746(16)30612-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39788609</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1743-1328</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Neurological research</Title><ISOAbbreviation>Neurol Res</ISOAbbreviation></Journal><ArticleTitle>Intravenous lidocaine for the treatment of sepsis-associated encephalopathy: a retrospective cohort study.</ArticleTitle><Pagination><StartPage>115</StartPage><EndPage>121</EndPage><MedlinePgn>115-121</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/01616412.2024.2448634</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study aimed to evaluate the efficacy of intraoperative intravenous lidocaine administration in the management of sepsis-associated encephalopathy (SAE).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This retrospective cohort analysis included 165 patients diagnosed with SAE, who were categorized into two groups: the lidocaine group (<i>n</i>&#x2009;=&#x2009;55) and the control group (<i>n</i>&#x2009;=&#x2009;110). The lidocaine group received an intravenous injection of lidocaine at 1.5&#x2009;mg/kg following anesthesia induction, and then received a continuous infusion at 1.5&#x2009;mg/kg/h until the completion of surgery. The control group did not receive lidocaine during surgery. Data collected included patient demographics, medical history, infection site, Acute Physiology and Chronic Health Evaluation (APACHE) II score, Sequential Organ Failure Assessment (SOFA) score, Glasgow Coma Scale (GCS) score, laboratory results, anesthetic agents used, surgery duration, and length of stay in the intensive care unit (ICU). The primary outcome was the in-hospital prognosis of SAE.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Patients in the lidocaine group had a significantly shorter ICU stay and a significantly higher rate of favorable prognosis compared with the control group (<i>p</i>&#x2009;&lt;&#x2009;0.05). Multivariate logistic regression analysis identified age and surgery duration as risk factors for SAE prognosis, whereas intraoperative intravenous lidocaine, GCS score, and intravenous dexmedetomidine emerged as protective factors.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Intraoperative intravenous administration of lidocaine significantly enhanced the prognosis of SAE patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yu-Xuan</ForeName><Initials>YX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yiliaikebaier</LastName><ForeName>Mailipate</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Rui-Xuan</ForeName><Initials>RX</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Gui-Ping</ForeName><Initials>GP</Initials><Identifier Source="ORCID">0000-0002-1645-4918</Identifier><AffiliationInfo><Affiliation>Department of Anesthesiology, People's Hospital of Xinjiang Uygur Autonomous Region, Xinjiang Clinical Research Center for Anesthesia Management, Urumqi, Xinjiang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Neurol Res</MedlineTA><NlmUniqueID>7905298</NlmUniqueID><ISSNLinking>0161-6412</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>98PI200987</RegistryNumber><NameOfSubstance UI="D008012">Lidocaine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000779">Anesthetics, Local</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008012" MajorTopicYN="Y">Lidocaine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065166" MajorTopicYN="Y">Sepsis-Associated Encephalopathy</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000779" MajorTopicYN="Y">Anesthetics, Local</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061605" MajorTopicYN="N">Administration, Intravenous</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lidocaine</Keyword><Keyword MajorTopicYN="N">organ dysfunction</Keyword><Keyword MajorTopicYN="N">prognosis</Keyword><Keyword MajorTopicYN="N">retrospective cohort study</Keyword><Keyword MajorTopicYN="N">sepsis-associated encephalopathy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>1</Month><Day>30</Day><Hour>0</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>1</Month><Day>10</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>1</Month><Day>9</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39788609</ArticleId><ArticleId IdType="doi">10.1080/01616412.2024.2448634</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34259454</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Descriptors of Sepsis Using the Sepsis-3 Criteria: A Cohort Study in Critical Care Units Within the U.K. National Institute for Health Research Critical Care Health Informatics Collaborative.</ArticleTitle><Pagination><StartPage>1883</StartPage><EndPage>1894</EndPage><MedlinePgn>1883-1894</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005169</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe the epidemiology of sepsis in critical care by applying the Sepsis-3 criteria to electronic health records.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study using electronic health records.</AbstractText><AbstractText Label="SETTING">Ten ICUs from four U.K. National Health Service hospital trusts contributing to the National Institute for Health Research Critical Care Health Informatics Collaborative.</AbstractText><AbstractText Label="PATIENTS">A total of 28,456 critical care admissions (14,332 emergency medical, 4,585 emergency surgical, and 9,539 elective surgical).</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">Twenty-nine thousand three hundred forty-three episodes of clinical deterioration were identified with a rise in Sequential Organ Failure Assessment score of at least 2 points, of which 14,869 (50.7%) were associated with antibiotic escalation and thereby met the Sepsis-3 criteria for sepsis. A total of 4,100 episodes of sepsis (27.6%) were associated with vasopressor use and lactate greater than 2.0 mmol/L, and therefore met the Sepsis-3 criteria for septic shock. ICU mortality by source of sepsis was highest for ICU-acquired sepsis (23.7%; 95% CI, 21.9-25.6%), followed by hospital-acquired sepsis (18.6%; 95% CI, 17.5-19.9%), and community-acquired sepsis (12.9%; 95% CI, 12.1-13.6%) (p for comparison less than 0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">We successfully operationalized the Sepsis-3 criteria to an electronic health record dataset to describe the characteristics of critical care patients with sepsis. This may facilitate sepsis research using electronic health record data at scale without relying on human coding.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine and Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Anoop D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Software Development Group, Research IT Services, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>MacCallum</LastName><ForeName>Niall S</ForeName><Initials>NS</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Steve</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brealey</LastName><ForeName>David A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palmer</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hetherington</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research Software Development Group, Research IT Services, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Sinan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perez-Suarez</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Research Software Development Group, Research IT Services, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ercole</LastName><ForeName>Ari</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watkinson</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashworth</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beale</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brett</LastName><ForeName>Stephen J</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Software Development Group, Research IT Services, University College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Statistics, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Intensive Care, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery and Cancer, Imperial College London, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singer</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University College London Hospitals Biomedical Research Centre, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bloomsbury Institute of Intensive Care Medicine, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2021 Nov 1;49(11):1983-1986. doi: 10.1097/CCM.0000000000005223.</RefSource><PMID Version="1">34643579</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="Y">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013222" MajorTopicYN="N">State Medicine</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Drs. Shah&#x2019;s, Watkinson&#x2019;s, and Brett&#x2019;s institutions received funding from the National Institute for Health Research (NIHR). Dr. Shah is supported by a postdoctoral fellowship funded by the Health Foundation's grant to the University of Cambridge for The Healthcare Improvement Studies Institute. Dr. Palmer received funding from the Medical Research Council and The London Clinic. Dr. Hetherington&#x2019;s institution received funding from the United Kingdom Government; he received funding from Turing Institute and the Department of Health and Social Care; he received support for article research from Research Councils UK; he disclosed work for hire. Dr. Shi disclosed work for hire. Dr. Watkinson&#x2019;s institution received funding from Wellcome and Sesnyne Health; he disclosed that he was the Chief Medical Officer for Sesnyne Health. Dr. Ashworth disclosed that he is an employee of Imperial College Healthcare National Health Service (NHS) Trust and the Clinical Director of Critical Care. Dr. Beale&#x2019;s institution received funding from the Philips Medical Systems Medical Advisory Board; he disclosed that he is on the Steering Committee of the Surviving Sepsis Campaign. Dr. Singer&#x2019;s institution received funding from Roche, Deltex, NewB, GE Healthcare, Pfizer, and Biomerieux. The views expressed are those of the authors and are not necessarily those of the NIHR, the NHS, or the United Kingdom Department of Health and Social Care. The remaining authors have disclosed that they do not have any potential conflicts of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34259454</ArticleId><ArticleId IdType="pmc">PMC8508729</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005169</ArticleId><ArticleId IdType="pii">00003246-202111000-00005</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rudd KE, Johnson SC, Agesa KM, et al. . Global, regional, and national sepsis incidence and mortality, 1990-2017: Analysis for the Global Burden of Disease Study. Lancet. 2020; 395:200&#x2013;211</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6970225</ArticleId><ArticleId IdType="pubmed">31954465</ArticleId></ArticleIdList></Reference><Reference><Citation>Filbin MR, Lynch J, Gillingham TD, et al. . Presenting symptoms independently predict mortality in septic shock. Crit Care Med. 2018; 46:1592&#x2013;1599</Citation><ArticleIdList><ArticleId IdType="pubmed">29965833</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. . Surviving sepsis campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017; 43:304&#x2013;377</Citation><ArticleIdList><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992; 101:1644&#x2013;1655</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Phillips GS, Levy ML, et al. ; Sepsis Definitions Task Force. Developing a new definition and assessing new clinical criteria for septic shock: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:775&#x2013;787</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4910392</ArticleId><ArticleId IdType="pubmed">26903336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendon&#xe7;a A, Cantraine F, et al. . Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on &#x201c;sepsis-related problems&#x201d; of the European Society of Intensive Care Medicine. Crit Care Med. 1998; 26:1793&#x2013;1800</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour CW, Liu VX, Iwashyna TJ, et al. . Assessment of clinical criteria for sepsis: For the third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016; 315:762&#x2013;774</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433435</ArticleId><ArticleId IdType="pubmed">26903335</ArticleId></ArticleIdList></Reference><Reference><Citation>Valik JK, Ward L, Tanushi H, et al. . Validation of automated sepsis surveillance based on the Sepsis-3 clinical criteria against physician record review in a general hospital population: Observational study using electronic health records data. BMJ Qual Saf. 2020; 29:735&#x2013;745</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467502</ArticleId><ArticleId IdType="pubmed">32029574</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidswell R, Parker T, Brealey D, et al. . Sepsis - the broken code how accurately is sepsis being diagnosed? J Infect. 2020; 81:e31&#x2013;e32</Citation><ArticleIdList><ArticleId IdType="pubmed">33065173</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Murphy MV, Li L, et al. ; Centers for Disease Control and Prevention Epicenters Program. Comparison of trends in sepsis incidence and coding using administrative claims versus objective clinical data. Clin Infect Dis. 2015; 60:88&#x2013;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4318944</ArticleId><ArticleId IdType="pubmed">25258352</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Murphy MV, Li L, et al. ; Centers for Disease Control and Prevention Epicenters Program. Improving documentation and coding for acute organ dysfunction biases estimates of changing sepsis severity and burden: A retrospective study. Crit Care. 2015; 19:338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4570698</ArticleId><ArticleId IdType="pubmed">26369326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Kadri S, Huang SS, et al. . Objective sepsis surveillance using electronic clinical data. Infect Control Hosp Epidemiol. 2016; 37:163&#x2013;171</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4743875</ArticleId><ArticleId IdType="pubmed">26526737</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadri SS, Rhee C, Strich JR, et al. . Estimating ten-year trends in septic shock incidence and mortality in United States academic medical centers using clinical data. Chest. 2017; 151:278&#x2013;285</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5310115</ArticleId><ArticleId IdType="pubmed">27452768</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer E, Post B, Klapaukh R, et al. . The association between supraphysiologic arterial oxygen levels and mortality in critically ill patients. A multicenter observational cohort study. Am J Respir Crit Care Med. 2019; 200:1373&#x2013;1380</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6884048</ArticleId><ArticleId IdType="pubmed">31513754</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris S, Shi S, Brealey D, et al. . Critical Care Health Informatics Collaborative (CCHIC): Data, tools and methods for reproducible research: A multi-centre UK intensive care database. Int J Med Inform. 2018; 112:82&#x2013;89</Citation><ArticleIdList><ArticleId IdType="pubmed">29500026</ArticleId></ArticleIdList></Reference><Reference><Citation>NIHR Oxford Biomedical Research Center: Metadata Catalogue.  Available at:  https://hic.nihr.ac.uk/metadata. Accessed February 14, 2021.</Citation></Reference><Reference><Citation>Young JD, Goldfrad C, Rowan K. Development and testing of a hierarchical method to code the reason for admission to intensive care units: The ICNARC Coding Method. Intensive Care National Audit &amp; Research Centre. Br J Anaesth. 2001; 87:543&#x2013;548</Citation><ArticleIdList><ArticleId IdType="pubmed">11878722</ArticleId></ArticleIdList></Reference><Reference><Citation>Braykov NP, Morgan DJ, Schweizer ML, et al. . Assessment of empirical antibiotic therapy optimisation in six hospitals: An observational cohort study. Lancet Infect Dis. 2014; 14:1220&#x2013;1227</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5525058</ArticleId><ArticleId IdType="pubmed">25455989</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization: International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Vols. 1&#x2013;3. Fourth Edition. Geneva, Switzerland, World Health Organization, 1992&#x2013;2000. Available at: https://icd.who.int/browse10/2019/en. Accessed February 14, 2021</Citation></Reference><Reference><Citation>R Core Team. R. A Language and Environment for Statistical Computing.
2013. Available at: https://www.r-project.org/. Accessed February 14, 2021</Citation></Reference><Reference><Citation>Rhee C, Jentzsch MS, Kadri SS, et al. . Variation in identifying sepsis and organ dysfunction using administrative versus electronic clinical data and impact on hospital outcome comparisons. Crit Care Med. 2019; 47:493&#x2013;500</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970408</ArticleId><ArticleId IdType="pubmed">30431493</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissot HC, Shah AD, Brealey D, et al. . Natural language processing for mimicking clinical trial recruitment in critical care: A semi-automated simulation based on the LeoPARDS trial. IEEE J Biomed Health Inform. 2020; 24:2950&#x2013;2959</Citation><ArticleIdList><ArticleId IdType="pubmed">32149659</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, et al. . The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996; 22:707&#x2013;710</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldens M, Schout M, Hammond NE, et al. . Sepsis incidence and mortality are underestimated in Australian intensive care unit administrative data. Med J Aust. 2018; 209:255&#x2013;260</Citation><ArticleIdList><ArticleId IdType="pubmed">30176790</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al. . Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017; 318:1241&#x2013;1249</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710396</ArticleId><ArticleId IdType="pubmed">28903154</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohil SK, Cao C, Phelan M, et al. . Impact of policies on the rise in sepsis incidence, 2000-2010. Clin Infect Dis. 2016; 62:695&#x2013;703</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4772840</ArticleId><ArticleId IdType="pubmed">26787173</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein Klouwenberg PM, Cremer OL, van Vught LA, et al. . Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: A cohort study. Crit Care. 2015; 19:319.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4562354</ArticleId><ArticleId IdType="pubmed">26346055</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross AE, Johannes RS, Gupta V, et al. . The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and clostridium difficile risk in 88 US medical centers. Clin Infect Dis. 2017; 65:613&#x2013;618</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11320714</ArticleId><ArticleId IdType="pubmed">28444166</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Sakr Y, Sprung CL, et al. ; Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med. 2006; 34:344&#x2013;353</Citation><ArticleIdList><ArticleId IdType="pubmed">16424713</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J, Ngerng W, See K, et al. . Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013; 17:R202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057416</ArticleId><ArticleId IdType="pubmed">24028771</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C, Kadri SS, Danner RL, et al. . Diagnosing sepsis is subjective and highly variable: A survey of intensivists using case vignettes. Crit Care. 2016; 20:89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822273</ArticleId><ArticleId IdType="pubmed">27048508</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Marshall JC, Namendys-Silva SA, et al. ; ICON investigators. Assessment of the worldwide burden of critical illness: The intensive care over nations (ICON) audit. Lancet Respir Med. 2014; 2:380&#x2013;386</Citation><ArticleIdList><ArticleId IdType="pubmed">24740011</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32349069</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>21</Day></DateCompleted><DateRevised><Year>2020</Year><Month>09</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1175</ISSN><JournalIssue CitedMedium="Internet"><Volume>133</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Anesthesiology</Title><ISOAbbreviation>Anesthesiology</ISOAbbreviation></Journal><ArticleTitle>Risk Factors for Failure to Rescue in Myocardial Infarction after Noncardiac Surgery: A Cohort Study.</ArticleTitle><Pagination><StartPage>96</StartPage><EndPage>108</EndPage><MedlinePgn>96-108</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/ALN.0000000000003330</ELocationID><Abstract><AbstractText Label="BACKGROUND">Compared to other perioperative complications, failure to rescue (i.e., death after suffering a complication) is highest after perioperative myocardial infarction (a myocardial infarction that occurs intraoperatively or within 30 days after surgery). The purpose of this study was to identify patient and surgical risk factors for failure to rescue in patients who have had a perioperative myocardial infarction.</AbstractText><AbstractText Label="METHODS">Individuals who experienced a perioperative myocardial infarction after noncardiac surgery between 2012 and 2016 were identified from the American College of Surgeons (Chicago, Illinois) National Surgical Quality Improvement Program database. Multivariable logistic regression was used to identify risk factors for failure to rescue. Subgroup and sensitivity analyses evaluated the robustness of primary findings.</AbstractText><AbstractText Label="RESULTS">The authors identified 1,307,884 individuals who had intermediate to high-risk noncardiac surgery. A total of 8,923 (0.68%) individuals had a perioperative myocardial infarction, of which 1,726 (19.3%) experienced failure to rescue. Strongest associations (adjusted odds ratio greater than 1.5) were age 85 yr or older (2.52 [95% CI, 2.05 to 3.09] vs. age younger than 65 yr), underweight body mass index (1.53 [95% CI, 1.17 to 2.01] vs. normal body mass index), American Society of Anesthesiologists class IV (1.76 [95% CI, 1.33 to 2.31] vs. class I or II) and class V (3.48 [95% CI, 2.20 to 5.48] vs. class I or II), and presence of: ascites (1.81 [95% CI, 1.15 to 2.87]), disseminated cancer (1.54 [95% CI, 1.18 to 2.00]), systemic inflammatory response syndrome (1.55 [95% CI, 1.26 to 1.90]), sepsis (1.75 [95% CI, 1.39 to 2.20]), septic shock (1.79 [95% CI, 1.34 to 2.37]), and dyspnea at rest (1.94 [95% CI, 1.32 to 2.86]). Patients who had emergency surgery, high-risk procedures, and postoperative complications were at higher risk of failure to rescue.</AbstractText><AbstractText Label="CONCLUSIONS">Routinely identified patient and surgical factors predict risk of failure to rescue after perioperative myocardial infarction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mazzarello</LastName><ForeName>Sasha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the School of Epidemiology and Public Health (S.M., D.I.M., D.A.F.) Faculty of Medicine (S.M., D.I.M., D.A.F., M.M.L.) Department of Cellular and Molecular Medicine (M.M.L.), University of Ottawa, Ottawa, Canada the Clinical Epidemiology Program (S.M., D.I.M., D.A.F., M.M.L.) Blueprint Translational Research Group (S.M., D.A.F., M.M.L.) the Regenerative Medicine Program (M.M.L.), Ottawa Hospital Research Institute, Ottawa, Canada the Department of Anesthesiology and Pain Medicine, The Ottawa Hospital (D.I.M., M.M.L.), University of Ottawa, Ottawa, Canada the R. Fraser Elliot Chair in Cardiac Anesthesia, Department of Anesthesia and Pain Management University Health Network, Peter Munk Cardiac Centre, University of Toronto, Toronto, Canada (W.S.B.).</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIsaac</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Beattie</LastName><ForeName>W Scott</ForeName><Initials>WS</Initials></Author><Author ValidYN="Y"><LastName>Fergusson</LastName><ForeName>Dean A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Lalu</LastName><ForeName>Manoj M</ForeName><Initials>MM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Anesthesiology</MedlineTA><NlmUniqueID>1300217</NlmUniqueID><ISSNLinking>0003-3022</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004632" MajorTopicYN="N">Emergency Medical Services</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013851" MajorTopicYN="N">Thinness</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017211" MajorTopicYN="N">Treatment Failure</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32349069</ArticleId><ArticleId IdType="doi">10.1097/ALN.0000000000003330</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24657218</PMID><DateCompleted><Year>2015</Year><Month>02</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1638-6183</ISSN><JournalIssue CitedMedium="Internet"><Volume>102</Volume><PubDate><Year>2014</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Biochimie</Title><ISOAbbreviation>Biochimie</ISOAbbreviation></Journal><ArticleTitle>Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial.</ArticleTitle><Pagination><StartPage>166</StartPage><EndPage>173</EndPage><MedlinePgn>166-73</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.biochi.2014.03.006</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9084(14)00086-8</ELocationID><Abstract><AbstractText>Mitochondrial dysfunction is key feature of septic shock and contributes to the development of sepsis related organ dysfunction. It is characterized by a variable reduction of the respiratory chain (RC) activities, altered mitochondrial morphology and reactive oxygen species production. Recent data have reported the efficacy of levosimendan, a calcium sensitizer, in improving heart performance and organ perfusion in critically ill patients. Moreover, it has been demonstrated that Levosimendan has antioxidant properties. Nevertheless, the effects of levosimendan on mitochondrial function are not fully elucidated. The objective of this study was therefore to evaluate the effect of levosimendan on mitochondria performance. Five mitochondrial parameters were screened: the redox status; the amount of scavenging enzymes; the activities of the RC complexes; the mitochondrial content; the steady state levels of the RC subunits; the mitochondrial biogenesis. Our results show that patients treated with levosimendan had a significant reduction of glutathionylated proteins and an increase in the amount of the antioxidant enzyme MnSOD, underlining its antioxidant properties. The activities of the RC complexes I, II and III were unchanged in the mitochondria of patients treated with levosimendan compared to controls whereas the mitochondrial content was significantly higher in levosimendan vs. control patients. Finally, evaluation of mitochondrial biogenesis did not show any significant difference in the two groups, although an overall increase in the amount of the RC subunits was observed in the levosimendan group. In conclusion, our study demonstrated that in septic shock patients, Levosimendan exerts antioxidant action by increasing antioxidant defense and lowering oxidative damage.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Torraco</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrozzo</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piemonte</LastName><ForeName>Fiorella</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pastore</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory of Metabolomics and Proteomics, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tozzi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verrigni</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assenza</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department 2, University of Rome, "La Sapienza", Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orecchioni</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, University of Rome, "La Sapienza", Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Egidio</LastName><ForeName>Annalia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, University of Rome, "La Sapienza", Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marraffa</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, University of Rome, "La Sapienza", Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landoni</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care, Universit&#xe0; Vita-Salute San Raffaele, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bertini</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Molecular Medicine for Neuromuscular and Neurodegenerative Diseases, Bambino Ges&#xf9; Children's Hospital, IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, University of Rome, "La Sapienza", Italy. Electronic address: andrea.morelli@uniroma1.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Biochimie</MedlineTA><NlmUniqueID>1264604</NlmUniqueID><ISSNLinking>0300-9084</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006835">Hydrazones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011724">Pyridazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017382">Reactive Oxygen Species</NameOfSubstance></Chemical><Chemical><RegistryNumber>349552KRHK</RegistryNumber><NameOfSubstance UI="D000077464">Simendan</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 7.1.1.2</RegistryNumber><NameOfSubstance UI="D042967">Electron Transport Complex I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042967" MajorTopicYN="N">Electron Transport Complex I</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006835" MajorTopicYN="N">Hydrazones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011724" MajorTopicYN="N">Pyridazines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017382" MajorTopicYN="N">Reactive Oxygen Species</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000077464" MajorTopicYN="N">Simendan</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Glutathione</Keyword><Keyword MajorTopicYN="N">Levosimendan</Keyword><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Oxidative stress</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>2</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24657218</ArticleId><ArticleId IdType="doi">10.1016/j.biochi.2014.03.006</ArticleId><ArticleId IdType="pii">S0300-9084(14)00086-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37879161</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>01</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-2157</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>12</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</Title><ISOAbbreviation>Eur J Surg Oncol</ISOAbbreviation></Journal><ArticleTitle>Pelvic exenteration for chronic fistulating pelvic sepsis after multimodal treatment of pelvic malignancy.</ArticleTitle><Pagination><StartPage>107124</StartPage><MedlinePgn>107124</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ejso.2023.107124</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0748-7983(23)00762-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Chronic fistulating pelvic sepsis is an uncommon complication of multimodal treatment of visceral pelvic tumours. Radical multi-visceral resection is reserved for patients with persistent, debilitating symptoms despite less invasive treatments and for which there is minimal published data. This study aimed to report the rates of morbidity and long-term sepsis control after pelvic exenteration for chronic fistulating pelvic sepsis.</AbstractText><AbstractText Label="METHODS">This retrospective cohort study was conducted at a high-volume pelvic exenteration referral centre. Patients who underwent pelvic exenteration for chronic fistulating pelvic sepsis between September 1994 and January 2023 after previous treatment for pelvic malignancy were included. Data relating to postoperative morbidity, mortality and the rate of recurrent pelvic sepsis or fistulae were retrospectively collected.</AbstractText><AbstractText Label="RESULTS">19 patients who underwent radical resection for chronic fistulating pelvic sepsis after previous pelvic cancer treatment were included. 11 patients were male (58&#xa0;%) and median age was 62 years (range 42-79). Previously treated rectal (8 patients, 42&#xa0;%), prostate (5, 26&#xa0;%) and cervical cancer (5, 26&#xa0;%) were most common. 18 patients (95&#xa0;%) had previously received high-dose pelvic radiotherapy, and 14 (74&#xa0;%) had required surgical resection. Total pelvic exenteration was performed in 47&#xa0;% of patients, total cystectomy in 68&#xa0;% and major pubic bone resection in 37&#xa0;%. There was no intraoperative or postoperative mortality. Major complication rate was 32&#xa0;%. 12-month readmission rate was 42&#xa0;%. At last follow up, 74&#xa0;% had no signs or symptoms of persisting pelvic sepsis.</AbstractText><AbstractText Label="CONCLUSIONS">Pelvic exenteration for refractory pelvic sepsis following treatment of malignancy is safe and effective in selected patients.</AbstractText><CopyrightInformation>&#xa9; 2023 Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Kilian G M</ForeName><Initials>KGM</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risbey</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia. Electronic address: professor.solomon@sydney.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Austin</LastName><ForeName>Kirk K S</ForeName><Initials>KKS</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Byrne</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, Australia; Surgical Outcomes Research Centre (SOuRCe), Royal Prince Alfred Hospital, Sydney, Australia; Institute of Academic Surgery (IAS), Royal Prince Alfred Hospital, Sydney, Australia; Faculty of Medicine and Health, Central Clinical School, The University of Sydney, New South Wales, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Surg Oncol</MedlineTA><NlmUniqueID>8504356</NlmUniqueID><ISSNLinking>0748-7983</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010386" MajorTopicYN="Y">Pelvic Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010385" MajorTopicYN="Y">Pelvic Exenteration</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic pelvic sepsis</Keyword><Keyword MajorTopicYN="N">Pelvic exenteration</Keyword><Keyword MajorTopicYN="N">Radionecrosis</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>4</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>25</Day><Hour>18</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37879161</ArticleId><ArticleId IdType="doi">10.1016/j.ejso.2023.107124</ArticleId><ArticleId IdType="pii">S0748-7983(23)00762-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37276351</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>51</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Epidemiology, Resistance Profiles, and Outcomes of Bloodstream Infections in Community-Onset Sepsis in the United States.</ArticleTitle><Pagination><StartPage>1148</StartPage><EndPage>1158</EndPage><MedlinePgn>1148-1158</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000005870</ELocationID><Abstract><AbstractText Label="OBJECTIVES">To describe frequency of positive blood cultures, patterns of pathogens' characteristics and their resistance profile in patients with blood cultures drawn due to a presumed diagnosis of community-onset sepsis, and to examine the association between blood culture-positive pathogens and hospital mortality.</AbstractText><AbstractText Label="DESIGN">Retrospective cohort study.</AbstractText><AbstractText Label="SETTING">Two hundred one U.S. hospitals from 2016 to 2020 using the Premier Healthcare Database.</AbstractText><AbstractText Label="SUBJECTS">Adult patients presenting with community-onset sepsis who had blood cultures collected within 2 days of hospital admission. We defined sepsis using the U.S. Centers for Disease Control Adult Sepsis Event Surveillance criteria.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">We identified 147,061 patients with community-onset sepsis. The number of blood culture-positive sepsis episodes was 21,167 (14%) and the number of nonblood culture-positive sepsis episodes was 20,326 (14%). Among patients with blood culture-positive sepsis, Gram-negative rods were isolated in 55% of patients, Gram-positive cocci were isolated in 47%. Of those, methicillin-resistant Staphylococcus aureus (MRSA) was 11%, ceftriaxone-resistant Enterobacterales /extended-spectrum &#x3b2;-lactamase was 7%, and carbapenem-resistant Enterobacterales was 1.3%. The crude in-hospital mortality was 17% for culture-negative sepsis, 13% for nonblood culture-positive sepsis, and 17% for blood culture-positive sepsis. In multilevel logistic regression models, compared with culture-negative sepsis, blood culture-positive sepsis (adjusted odds ratio [aOR], 0.89; 95% CI, 0.85-0.94) and nonblood culture-positive sepsis (aOR, 0.82; 95% CI, 0.78-0.87) were associated with lower odds of in-hospital mortality. Acinetobacter species, Pseudomonas aeruginosa , methicillin-sensitive Staphylococcus aureus , and MRSA were associated with higher in-hospital mortality, whereas Escherichia coli , Klebsiella species, Proteus species, and Streptococcus species were associated with lower in-hospital mortality.</AbstractText><AbstractText Label="CONCLUSIONS">In patients hospitalized with community-onset sepsis, the prevalence of blood culture-positive sepsis was 14%. Among positive blood culture sepsis resistant organisms were infrequent. Compared with culture-negative sepsis, blood culture-positive sepsis and nonblood culture-positive sepsis were associated with lower in-hospital mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ohnuma</LastName><ForeName>Tetsu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chihara</LastName><ForeName>Shingo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Infectious Diseases, Department of Internal Medicine, Virginia Mason Medical Center, Seattle, WA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costin</LastName><ForeName>Blair</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Treggiari</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartz</LastName><ForeName>Raquel R</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Perioperative, and Pain Medicine, Brigham and Women's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raghunathan</LastName><ForeName>Karthik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veterans Affairs Anesthesiology Service Division, Durham VA Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krishnamoorthy</LastName><ForeName>Vijay</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Critical Care and Perioperative Population Health Research (CAPER) Unit, Department of Anesthesiology, Duke University Medical Center, Durham, NC.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2023 Sep 1;51(9):1261-1263. doi: 10.1097/CCM.0000000000005918.</RefSource><PMID Version="1">37589517</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="Y">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="Y">Cross Infection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055624" MajorTopicYN="N">Methicillin-Resistant Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013211" MajorTopicYN="N">Staphylococcus aureus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Dr. Treggiari received funding from Edwards Lifesciences. Dr. Bartz received funding from The Difficult Airway. The remaining authors have disclosed that they do not have any potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>19</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>5</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37276351</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000005870</ArticleId><ArticleId IdType="pii">00003246-202309000-00006</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Evans L, Rhodes A, Alhazzani W, et al.: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021; 47:1181&#x2013;1247</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al.: The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315:801&#x2013;810</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention: Sepsis. 2022. Available at: https://www.cdc.gov/sepsis/what-is-sepsis.html . Accessed February 11, 2022</Citation></Reference><Reference><Citation>Kethireddy S, Bilgili B, Sees A, et al.; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group: Culture-negative septic shock compared with culture-positive septic shock: A retrospective cohort study. Crit Care Med. 2018; 46:506&#x2013;512</Citation></Reference><Reference><Citation>Gupta S, Sakhuja A, Kumar G, et al.: Culture-negative severe sepsis: Nationwide trends and outcomes. Chest. 2016; 150:1251&#x2013;1259</Citation></Reference><Reference><Citation>Rhee C, Kadri SS, Dekker JP, et al.; CDC Prevention Epicenters Program: Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open. 2020; 3:e202899</Citation></Reference><Reference><Citation>Rhee C, Wang R, Zhang Z, et al.; CDC Prevention Epicenters Program: Epidemiology of hospital-onset versus community-onset sepsis in U.S. hospitals and association with mortality: A retrospective analysis using electronic clinical data. Crit Care Med. 2019; 47:1169&#x2013;1176</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention: Hospital Toolkit for Adult Sepsis Surveillance. 2018. Available at: https://www.cdc.gov/sepsis/pdfs/Sepsis-Surveillance-Toolkit-Mar-2018_508.pdf . Accessed February 9, 2022</Citation></Reference><Reference><Citation>Rahmel T, Schmitz S, Nowak H, et al.: Long-term mortality and outcome in hospital survivors of septic shock, sepsis, and severe infections: The importance of aftercare. PLoS One. 2020; 15:e0228952</Citation></Reference><Reference><Citation>Moore BJ, White S, Washington R, et al.: Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: The AHRQ elixhauser comorbidity index. Med Care. 2017; 55:698&#x2013;705</Citation></Reference><Reference><Citation>Kadri SS, Lai YL, Warner S, et al.; forming the National Insititutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH-ARORI): Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: A retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. Lancet Infect Dis. 2021; 21:241&#x2013;251</Citation></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al.; CDC Prevention Epicenter Program: Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014. JAMA. 2017; 318:1241&#x2013;1249</Citation></Reference><Reference><Citation>Phua J, Ngerng W, See K, et al.: Characteristics and outcomes of culture-negative versus culture-positive severe sepsis. Crit Care. 2013; 17:R202</Citation></Reference><Reference><Citation>Ljungstrom L, Andersson R, Jacobsson G: Incidences of community onset severe sepsis, sepsis-3 sepsis, and bacteremia in Sweden - a prospective population-based study. PLoS One. 2019; 14:e0225700</Citation></Reference><Reference><Citation>Sigakis MJG, Jewell E, Maile MD, et al.: Culture-negative and culture-positive sepsis: A comparison of characteristics and outcomes. Anesth Analg. 2019; 129:1300&#x2013;1309</Citation></Reference><Reference><Citation>Cheng MP, Stenstrom R, Paquette K, et al.: Blood culture results before and after antimicrobial administration in patients with severe manifestations of sepsis: A diagnostic study. Ann Intern Med. 2019; 171:547&#x2013;554</Citation></Reference><Reference><Citation>Yang L, Lin Y, Wang J, et al.: Comparison of clinical characteristics and outcomes between positive and negative blood culture septic patients: A retrospective cohort study. Infect Drug Resist. 2021; 14:4191&#x2013;4205</Citation></Reference><Reference><Citation>Scheer CS, Fuchs C, Grundling M, et al.: Impact of antibiotic administration on blood culture positivity at the beginning of sepsis: A prospective clinical cohort study. Clin Microbiol Infect. 2019; 25:326&#x2013;331</Citation></Reference><Reference><Citation>Hantrakun V, Somayaji R, Teparrukkul P, et al.: Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis). PLoS One. 2018; 13:e0204509</Citation></Reference><Reference><Citation>Mellhammar L, Kahn F, Whitlow C, et al.: Bacteremic sepsis leads to higher mortality when adjusting for confounders with propensity score matching. Sci Rep. 2021; 11:6972</Citation></Reference><Reference><Citation>Nannan Panday RS, Lammers EMJ, Alam N, et al.: An overview of positive cultures and clinical outcomes in septic patients: A sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit Care. 2019; 23:182</Citation></Reference><Reference><Citation>Chou EH, Mann S, Hsu TC, et al.: Incidence, trends, and outcomes of infection sites among hospitalizations of sepsis: A nationwide study. PLoS One. 2020; 15:e0227752</Citation></Reference><Reference><Citation>Vincent JL, Sakr Y, Singer M, et al.; EPIC III Investigators: Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020; 323:1478&#x2013;1487</Citation></Reference><Reference><Citation>Umemura Y, Ogura H, Takuma K, et al.; Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome Sepsis and Trauma (FORECAST) Study Group: Current spectrum of causative pathogens in sepsis: A prospective nationwide cohort study in Japan. Int J Infect Dis. 2021; 103:343&#x2013;351</Citation></Reference><Reference><Citation>Paquette K, Sweet D, Stenstrom R, et al.: Neither blood culture positivity nor time to positivity is associated with mortality among patients presenting with severe manifestations of sepsis: The FABLED cohort study. Open Forum Infect Dis. 2021; 8:ofab321</Citation></Reference><Reference><Citation>Abe T, Ogura H, Kushimoto S, et al.; JAAM FORECAST group: Variations in infection sites and mortality rates among patients in intensive care units with severe sepsis and septic shock in Japan. J Intensive Care. 2019; 7:28</Citation></Reference><Reference><Citation>Cosgrove SE, Sakoulas G, Perencevich EN, et al.: Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis. 2003; 36:53&#x2013;59</Citation></Reference><Reference><Citation>Timbrook TT, Morton JB, McConeghy KW, et al.: The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: A systematic review and meta-analysis. Clin Infect Dis. 2017; 64:15&#x2013;23</Citation></Reference><Reference><Citation>Tsalik EL, Bonomo RA, Fowler VG Jr: New molecular diagnostic approaches to bacterial infections and antibacterial resistance. Annu Rev Med. 2018; 69:379&#x2013;394</Citation></Reference><Reference><Citation>Pfaller MA, Carvalhaes CG, Smith CJ, et al.: Bacterial and fungal pathogens isolated from patients with bloodstream infection: Frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (2012-2017). Diagn Microbiol Infect Dis. 2020; 97:115016</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34972827</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>31</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Dec</Month><Day>31</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Bedside determination of microcirculatory oxygen delivery and uptake: a prospective observational clinical study for proof of principle.</ArticleTitle><Pagination><StartPage>24516</StartPage><MedlinePgn>24516</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">24516</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-021-03922-4</ELocationID><Abstract><AbstractText>Assessment of microcirculatory functional capacity is considered to be of prime importance for therapy guidance and outcome prediction in critically ill intensive care patients. Here, we show determination of skin microcirculatory oxygen delivery and consumption rates to be a feasible approach at the patient's bedside. Real time laser-doppler flowmetry (LDF) and white light spectrophotometry (WLS) were used for assessment of thenar skin microperfusion, regional Hb and postcapillary venous oxygen saturation before and after forearm ischemia. Adapted Fick's principle equations allowed for calculation of microcirculatory oxygen delivery and uptake. Patient groups with expected different microcirculatory status were compared [control (n&#x2009;=&#x2009;20), sepsis-1/2 definition criteria identified SIRS (n&#x2009;=&#x2009;10) and septic shock patients (n&#x2009;=&#x2009;20), and the latter group further classified according to sepsis-3 definition criteria in sepsis (n&#x2009;=&#x2009;10) and septic shock (n&#x2009;=&#x2009;10)], respectively. In otherwise healthy controls, microcirculatory oxygen delivery and uptake approximately doubled after ischemia with maximum values (mDO2max and mVO2max) significantly lower in SIRS or septic patient groups, respectively. Scatter plots of mVO2max and mDO2max values defined a region of unphysiological low values not observed in control but in critically ill patients with the percentage of dots within this region being highest in septic shock patients. LDF and WLS combined with vasoocclusive testing reveals significant differences in microcirculatory oxygen delivery and uptake capacity between control and critically ill patients. As a clinically feasible technique for bedside determination of microcirculatory oxygen delivery and uptake, LDF and WLS combined with vasoocclusive testing holds promise for monitoring of disease progression and/or guidance of therapy at the microcirculatory level to be tested in further clinical trials.ClinicalTrials.gov: NCT01530932.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sturm</LastName><ForeName>Timo</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TRACC-Group (Translational Research in Anaesthesiology and Critical Care), Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leiblein</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clau&#xdf;</LastName><ForeName>Christoph</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erles</LastName><ForeName>Enno</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TRACC-Group (Translational Research in Anaesthesiology and Critical Care), Mannheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thiel</LastName><ForeName>Manfred</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Medical Faculty Mannheim, Heidelberg University, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. manfred.thiel@medma.uni-heidelberg.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>TRACC-Group (Translational Research in Anaesthesiology and Critical Care), Mannheim, Germany. manfred.thiel@medma.uni-heidelberg.de.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01530932</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001784" MajorTopicYN="N">Blood Gas Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066491" MajorTopicYN="Y">Clinical Decision-Making</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019468" MajorTopicYN="N">Disease Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017078" MajorTopicYN="N">Laser-Doppler Flowmetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008833" MajorTopicYN="Y">Microcirculation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="N">Oximetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000089382" MajorTopicYN="Y">Oxygen Saturation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>1</Day><Hour>5</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>12</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34972827</ArticleId><ArticleId IdType="pmc">PMC8720096</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-03922-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-021-03922-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Caille V, Squara P. Oxygen uptake-to-delivery relationship: A way to assess adequate flow. Crit. Care. 2006;S4:1&#x2013;2. doi: 10.1186/cc4831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc4831</ArticleId><ArticleId IdType="pmc">PMC3226126</ArticleId><ArticleId IdType="pubmed">17164016</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors AF, Jr, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients SUPPORT Investigators. JAMA. 1996;276:889&#x2013;897. doi: 10.1001/jama.276.11.889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.276.11.889</ArticleId><ArticleId IdType="pubmed">8782638</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard C, et al. Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: A randomized controlled trial. JAMA. 2003;290:2713&#x2013;2720. doi: 10.1001/jama.290.20.2713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.290.20.2713</ArticleId><ArticleId IdType="pubmed">14645314</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beest P, Wietasch G, Scheeren T, Spronk P, Kuiper M. Clinical review: Use of venous oxygen saturations as a goal&#x2014;A yet unfinished puzzle. Crit. Care. 2011;15:232. doi: 10.1186/cc10351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10351</ArticleId><ArticleId IdType="pmc">PMC3334733</ArticleId><ArticleId IdType="pubmed">22047813</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Orbegozo Cortes D, Donadello K, Vincent JL. Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock. Virulence. 2014;5:73&#x2013;79. doi: 10.4161/viru.26482.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.26482</ArticleId><ArticleId IdType="pmc">PMC3916386</ArticleId><ArticleId IdType="pubmed">24067428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince C. The microcirculation is the motor of sepsis. Crit. Care. 2005;9(Suppl 4):S13&#x2013;19. doi: 10.1186/cc3753.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc3753</ArticleId><ArticleId IdType="pmc">PMC3226164</ArticleId><ArticleId IdType="pubmed">16168069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A. An alternate pathophysiologic paradigm of sepsis and septic shock: Implications for optimizing antimicrobial therapy. Virulence. 2014;5:80&#x2013;97. doi: 10.4161/viru.26913.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.26913</ArticleId><ArticleId IdType="pmc">PMC3916387</ArticleId><ArticleId IdType="pubmed">24184742</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Oufella H, et al. Mottling score predicts survival in septic shock. Intens. Care Med. 2011;37:801&#x2013;807. doi: 10.1007/s00134-011-2163-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-011-2163-y</ArticleId><ArticleId IdType="pubmed">21373821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima Y, Baudry N, Duranteau J, Vicaut E. Microcirculation in intestinal villi: A comparison between hemorrhagic and endotoxin shock. Am. J. Respir. Crit. Care Med. 2001;164:1526&#x2013;1530. doi: 10.1164/ajrccm.164.8.2009065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.164.8.2009065</ArticleId><ArticleId IdType="pubmed">11704607</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American college of chest physicians/society of critical care medicine. Chest. 1992;101:1644&#x2013;1655. doi: 10.1378/chest.101.6.1644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.101.6.1644</ArticleId><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3) JAMA. 2016;315:801&#x2013;810. doi: 10.1001/jama.2016.0287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2016.0287</ArticleId><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturm T, Leiblein J, Schneider-Lindner V, Kirschning T, Thiel M. Association of microcirculation, macrocirculation, and severity of illness in septic shock: A prospective observational study to identify microcirculatory targets potentially suitable for guidance of hemodynamic therapy. J. Intens. Care Med. 2018;33:256&#x2013;266. doi: 10.1177/0885066616671689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0885066616671689</ArticleId><ArticleId IdType="pubmed">27686326</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner HA, et al. An algorithm for systemic inflammatory response syndrome criteria-based prediction of sepsis in a polytrauma cohort. Crit. Care Med. 2016;44:2199&#x2013;2207. doi: 10.1097/CCM.0000000000001955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000001955</ArticleId><ArticleId IdType="pubmed">27441906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001;286:1754&#x2013;1758. doi: 10.1001/jama.286.14.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.286.14.1754</ArticleId><ArticleId IdType="pubmed">11594901</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Gall JR, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957&#x2013;2963. doi: 10.1001/jama.270.24.2957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.270.24.2957</ArticleId><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakka SG, Reuter DA, Perel A. The transpulmonary thermodilution technique. J. Clin. Monit. Comput. 2012;26:347&#x2013;353. doi: 10.1007/s10877-012-9378-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-012-9378-5</ArticleId><ArticleId IdType="pubmed">22806214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer B, Berschin G, Sommer HM. Microcirculation under an elastic bandage during rest and exercise&#x2014;Preliminary experience with the laser-doppler spectrophotometry system O2C. J. Sports Sci. Med. 2013;12:414&#x2013;421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772583</ArticleId><ArticleId IdType="pubmed">24149146</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, et al. Characterization of buccal microvascular response in patients with septic shock. Eur. J. Anaesthesiol. 2010;27:388&#x2013;394. doi: 10.1097/EJA.0b013e3283349db3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0b013e3283349db3</ArticleId><ArticleId IdType="pubmed">20090537</ArticleId></ArticleIdList></Reference><Reference><Citation>Forst T, et al. Reliability of lightguide spectrophotometry (O2C) for the investigation of skin tissue microvascular blood flow and tissue oxygen supply in diabetic and nondiabetic subjects. J. Diabetes. Sci. Technol. 2008;2:1151&#x2013;1156. doi: 10.1177/193229680800200625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/193229680800200625</ArticleId><ArticleId IdType="pmc">PMC2769807</ArticleId><ArticleId IdType="pubmed">19885305</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen D, et al. Is thenar tissue hemoglobin oxygen saturation in septic shock related to macrohemodynamic variables and outcome? Crit. Care S. 2009;6:1. doi: 10.1186/cc8004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8004</ArticleId><ArticleId IdType="pmc">PMC2786108</ArticleId><ArticleId IdType="pubmed">19951390</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheeren TW, Schober P, Schwarte LA. Monitoring tissue oxygenation by near infrared spectroscopy (NIRS): Background and current applications. J. Clin. Monit. Comput. 2012;26:279&#x2013;287. doi: 10.1007/s10877-012-9348-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-012-9348-y</ArticleId><ArticleId IdType="pmc">PMC3391360</ArticleId><ArticleId IdType="pubmed">22467064</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, et al. The association of near-infrared spectroscopy-derived tissue oxygenation measurements with sepsis syndromes, organ dysfunction and mortality in emergency department patients with sepsis. Crit. Care. 2011;15:R223. doi: 10.1186/cc10463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10463</ArticleId><ArticleId IdType="pmc">PMC3334769</ArticleId><ArticleId IdType="pubmed">21939529</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandjbakhche AH, Bonner RF, Arai AE, Balaban RS. Visible-light photon migration through myocardium in vivo. Am. J. Physiol. 1999;277:H698&#x2013;704. doi: 10.1152/ajpheart.1999.277.2.H698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1999.277.2.H698</ArticleId><ArticleId IdType="pubmed">10444496</ArticleId></ArticleIdList></Reference><Reference><Citation>Parlato M, et al. Circulating biomarkers may be unable to detect infection at the early phase of sepsis in ICU patients: The CAPTAIN prospective multicenter cohort study. Intens. Care Med. 2018;44:1061&#x2013;1070. doi: 10.1007/s00134-018-5228-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-018-5228-3</ArticleId><ArticleId IdType="pubmed">29959455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapalain X, et al. Does chloride intake at the early phase of septic shock resuscitation impact on renal outcome? Shock. 2021;56:425&#x2013;432. doi: 10.1097/SHK.0000000000001757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000001757</ArticleId><ArticleId IdType="pubmed">33606477</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel-Frausto MS, et al. The natural history of the systemic inflammatory response syndrome (SIRS) A prospective study. JAMA. 1995;273:117&#x2013;123. doi: 10.1001/jama.1995.03520260039030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1995.03520260039030</ArticleId><ArticleId IdType="pubmed">7799491</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos JJ, Ellermann SF, Scheeren TWL. Journal of clinical monitoring and computing 2017/2018 end of year summary: Monitoring-and provocation-of the microcirculation and tissue oxygenation. J. Clin. Monit. Comput. 2019;33:201&#x2013;209. doi: 10.1007/s10877-019-00270-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00270-7</ArticleId><ArticleId IdType="pmc">PMC6420417</ArticleId><ArticleId IdType="pubmed">30796643</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruartmoner G, Mesquida J, Ince C. Fluid therapy and the hypovolemic microcirculation. Curr. Opin. Crit. Care. 2015;21:276&#x2013;284. doi: 10.1097/MCC.0000000000000220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCC.0000000000000220</ArticleId><ArticleId IdType="pubmed">26103148</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JP, Dyson A, Singer M, Fraser J. Microcirculatory dysfunction and resuscitation: Why, when, and how. Br. J. Anaesth. 2015;115:366&#x2013;375. doi: 10.1093/bja/aev163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aev163</ArticleId><ArticleId IdType="pubmed">26269467</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 2002;166:98&#x2013;104. doi: 10.1164/rccm.200109-016oc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200109-016oc</ArticleId><ArticleId IdType="pubmed">12091178</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerschug KC, Delsing AS, Schmidt GA, Haynes WG. Impairments in microvascular reactivity are related to organ failure in human sepsis. Am. J. Physiol. Heart Circ. Physiol. 2007;293:H1065&#x2013;1071. doi: 10.1152/ajpheart.01237.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01237.2006</ArticleId><ArticleId IdType="pubmed">17483235</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhanji S, et al. Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit. Care. 2010;14:R151. doi: 10.1186/cc9220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9220</ArticleId><ArticleId IdType="pmc">PMC2945135</ArticleId><ArticleId IdType="pubmed">20698956</ArticleId></ArticleIdList></Reference><Reference><Citation>De Backer D, Donadello K, Cortes DO. Monitoring the microcirculation. J. Clin. Monit. Comput. 2012;26:361&#x2013;366. doi: 10.1007/s10877-012-9383-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-012-9383-8</ArticleId><ArticleId IdType="pubmed">22833180</ArticleId></ArticleIdList></Reference><Reference><Citation>Filho RR, et al. Assessment of the peripheral microcirculation in patients with and without shock: A pilot study on different methods. J. Clin. Monit. Comput. 2020;34:1167&#x2013;1176. doi: 10.1007/s10877-019-00423-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-019-00423-8</ArticleId><ArticleId IdType="pmc">PMC7548274</ArticleId><ArticleId IdType="pubmed">31754965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubbink R, Wefers Bettink MA, van Weteringen W, Mik EG. Mitochondrial oxygen monitoring with COMET: Verification of calibration in man and comparison with vascular occlusion tests in healthy volunteers. J. Clin. Monit. Comput. 2020 doi: 10.1007/s10877-020-00602-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10877-020-00602-y</ArticleId><ArticleId IdType="pmc">PMC8542534</ArticleId><ArticleId IdType="pubmed">33085071</ArticleId></ArticleIdList></Reference><Reference><Citation>Saugel B, Trepte CJ, Heckel K, Wagner JY, Reuter DA. Hemodynamic management of septic shock: Is it time for "individualized goal-directed hemodynamic therapy" and for specifically targeting the microcirculation? Shock. 2015;43:522&#x2013;529. doi: 10.1097/SHK.0000000000000345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000000345</ArticleId><ArticleId IdType="pubmed">25643016</ArticleId></ArticleIdList></Reference><Reference><Citation>Dilken O, Ergin B, Ince C. Assessment of sublingual microcirculation in critically ill patients: Consensus and debate. Ann. Transl. Med. 2020;8:793. doi: 10.21037/atm.2020.03.222.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.03.222</ArticleId><ArticleId IdType="pmc">PMC7333125</ArticleId><ArticleId IdType="pubmed">32647718</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Angus DC. A review of therapeutic attempts to recruit the microcirculation in patients with sepsis. Minerva Anestesiol. 2014;80:225&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">24002463</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Voort PH, et al. Testing a conceptual model on early opening of the microcirculation in severe sepsis and septic shock: A randomised controlled pilot study. Eur. J. Anaesthesiol. 2015;32:189&#x2013;198. doi: 10.1097/EJA.0000000000000126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EJA.0000000000000126</ArticleId><ArticleId IdType="pubmed">25032942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gyldenlove T, Jorgensen LP, Schroeder TV. Micro-lightguide spectrophotometry (O2C) for lower limb perfusion: Effects of exercise walking in claudicants. Int. J. Angiol. 2019;28:161&#x2013;166. doi: 10.1055/s-0039-1692661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0039-1692661</ArticleId><ArticleId IdType="pmc">PMC6707791</ArticleId><ArticleId IdType="pubmed">31452583</ArticleId></ArticleIdList></Reference><Reference><Citation>Benko T, et al. Analysis of data from the oxygen persufflation in liver transplantation (OPAL) study to determine the role of factors affecting the hepatic microcirculation and early allograft dysfunction. Ann. Transplant. 2019;24:481&#x2013;488. doi: 10.12659/AOT.915214.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AOT.915214</ArticleId><ArticleId IdType="pmc">PMC6708281</ArticleId><ArticleId IdType="pubmed">31417074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mucke T, et al. Identification of perioperative risk factor by laser-doppler spectroscopy after free flap perfusion in the head and neck: A prospective clinical study. Microsurgery. 2014;34:345&#x2013;351. doi: 10.1002/micr.22206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/micr.22206</ArticleId><ArticleId IdType="pubmed">24995717</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein KU, et al. Intraoperative monitoring of cerebral microcirculation and oxygenation&#x2013;a feasibility study using a novel photo-spectrometric laser-Doppler flowmetry. J. Neurosurg. Anesthesiol. 2010;22:38&#x2013;45. doi: 10.1097/ANA.0b013e3181bea439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ANA.0b013e3181bea439</ArticleId><ArticleId IdType="pubmed">19816204</ArticleId></ArticleIdList></Reference><Reference><Citation>Bludau M, Vallbohmer D, Gutschow C, Holscher AH, Schroder W. Quantitative measurement of gastric mucosal microcirculation using a combined laser Doppler flowmeter and spectrophotometer. Dis. Esophagus. 2008;21:668&#x2013;672. doi: 10.1111/j.1442-2050.2008.00856.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1442-2050.2008.00856.x</ArticleId><ArticleId IdType="pubmed">18564159</ArticleId></ArticleIdList></Reference><Reference><Citation>Eley KA, Young JD, Watt-Smith SR. Epinephrine, norepinephrine, dobutamine, and dopexamine effects on free flap skin blood flow. Plast. Reconstr. Surg. 2012;130:564&#x2013;570. doi: 10.1097/PRS.0b013e31825dbf73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PRS.0b013e31825dbf73</ArticleId><ArticleId IdType="pubmed">22929242</ArticleId></ArticleIdList></Reference><Reference><Citation>Engoren M, et al. A comparison of sepsis-2 (systemic inflammatory response syndrome based) to Sepsis-3 (sequential organ failure assessment based) definitions-a multicenter retrospective study. Crit. Care Med. 2020;48:1258&#x2013;1264. doi: 10.1097/CCM.0000000000004449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004449</ArticleId><ArticleId IdType="pmc">PMC7484263</ArticleId><ArticleId IdType="pubmed">32618690</ArticleId></ArticleIdList></Reference><Reference><Citation>Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br. J. Anaesth. 2017;119:626&#x2013;636. doi: 10.1093/bja/aex234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bja/aex234</ArticleId><ArticleId IdType="pubmed">29121281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill AVL. Muscular exercise, lactic acid, and the supply and utilization of oxygen. Q. J. Med. 1923;16:135&#x2013;171. doi: 10.1093/qjmed/os-16.62.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/os-16.62.135</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter B, et al. Simultaneous measurement of local cortical blood flow and tissue oxygen saturation by Near infra-red Laser Doppler flowmetry and remission spectroscopy in the pig brain. Acta Neurochir. Suppl. 2002;81:197&#x2013;199. doi: 10.1007/978-3-7091-6738-0_51.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-7091-6738-0_51</ArticleId><ArticleId IdType="pubmed">12168303</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein KU, et al. The effects of arterial carbon dioxide partial pressure and sevoflurane on capillary venous cerebral blood flow and oxygen saturation during craniotomy. Anesth Analg. 2009;109:199&#x2013;204. doi: 10.1213/ane.0b013e3181a800e5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ane.0b013e3181a800e5</ArticleId><ArticleId IdType="pubmed">19535711</ArticleId></ArticleIdList></Reference><Reference><Citation>Roustit M, Cracowski JL. Non-invasive assessment of skin microvascular function in humans: an insight into methods. Microcirculation. 2012;19:47&#x2013;64. doi: 10.1111/j.1549-8719.2011.00129.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1549-8719.2011.00129.x</ArticleId><ArticleId IdType="pubmed">21883640</ArticleId></ArticleIdList></Reference><Reference><Citation>Keymel S, et al. Characterization of the non-invasive assessment of the cutaneous microcirculation by laser Doppler perfusion scanner. Microcirculation. 2010;17:358&#x2013;366. doi: 10.1111/j.1549-8719.2010.00037.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1549-8719.2010.00037.x</ArticleId><ArticleId IdType="pubmed">20618693</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkas K, Kolossvary E, Jarai Z, Nemcsik J, Farsang C. Non-invasive assessment of microvascular endothelial function by laser Doppler flowmetry in patients with essential hypertension. Atherosclerosis. 2004;173:97&#x2013;102. doi: 10.1016/j.atherosclerosis.2003.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2003.11.015</ArticleId><ArticleId IdType="pubmed">15177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A, et al. Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int. 2006;70:157&#x2013;164. doi: 10.1038/sj.ki.5001511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5001511</ArticleId><ArticleId IdType="pubmed">16710351</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglin B, Pries AR. Metabolic control of microvascular networks: Oxygen sensing and beyond. J. Vasc. Res. 2014;51:376&#x2013;392. doi: 10.1159/000369460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369460</ArticleId><ArticleId IdType="pubmed">25531863</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DT, Harding K. Healing responses of skin and muscle in critical illness. Crit. Care Med. 2003;31:S547&#x2013;557. doi: 10.1097/01.CCM.0000081430.34066.1D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000081430.34066.1D</ArticleId><ArticleId IdType="pubmed">12907885</ArticleId></ArticleIdList></Reference><Reference><Citation>Uth N, Sorensen H, Overgaard K, Pedersen PK. Estimation of VO2max from the ratio between HRmax and HRrest&#x2013;the heart rate ratio method. Eur. J. Appl. Physiol. 2004;91:111&#x2013;115. doi: 10.1007/s00421-003-0988-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-003-0988-y</ArticleId><ArticleId IdType="pubmed">14624296</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M. The role of mitochondrial dysfunction in sepsis-induced multi-organ failure. Virulence. 2014;5:66&#x2013;72. doi: 10.4161/viru.26907.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/viru.26907</ArticleId><ArticleId IdType="pmc">PMC3916385</ArticleId><ArticleId IdType="pubmed">24185508</ArticleId></ArticleIdList></Reference><Reference><Citation>Pranskunas A, Koopmans M, Koetsier PM, Pilvinis V, Boerma EC. Microcirculatory blood flow as a tool to select ICU patients eligible for fluid therapy. Intens. Care Med. 2013;39:612&#x2013;619. doi: 10.1007/s00134-012-2793-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2793-8</ArticleId><ArticleId IdType="pmc">PMC3607718</ArticleId><ArticleId IdType="pubmed">23263029</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottecher J, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intens. Care Med. 2010;36:1867&#x2013;1874. doi: 10.1007/s00134-010-1966-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-010-1966-6</ArticleId><ArticleId IdType="pubmed">20725823</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32:1825&#x2013;1831. doi: 10.1097/01.ccm.0000138558.16257.3f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ccm.0000138558.16257.3f</ArticleId><ArticleId IdType="pubmed">15343008</ArticleId></ArticleIdList></Reference><Reference><Citation>Leone M, et al. Oxygen tissue saturation is lower in nonsurvivors than in survivors after early resuscitation of septic shock. Anesthesiology. 2009;111:366&#x2013;371. doi: 10.1097/ALN.0b013e3181aae72d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ALN.0b013e3181aae72d</ArticleId><ArticleId IdType="pubmed">19602965</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr Y, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit. Care Med. 2007;35:1639&#x2013;1644. doi: 10.1097/01.CCM.0000269936.73788.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000269936.73788.32</ArticleId><ArticleId IdType="pubmed">17522571</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadaka F, et al. The effect of red blood cell transfusion on tissue oxygenation and microcirculation in severe septic patients. Ann. Intens. Care. 2011;1:46. doi: 10.1186/2110-5820-1-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2110-5820-1-46</ArticleId><ArticleId IdType="pmc">PMC3256106</ArticleId><ArticleId IdType="pubmed">22067279</ArticleId></ArticleIdList></Reference><Reference><Citation>Meybohm P, Shander A, Zacharowski K. Should we restrict erythrocyte transfusion in early goal directed protocols? BMC Anesthesiol. 2015;15:75. doi: 10.1186/s12871-015-0054-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-015-0054-4</ArticleId><ArticleId IdType="pmc">PMC4428088</ArticleId><ArticleId IdType="pubmed">25956725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27163951</PMID><DateCompleted><Year>2017</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1140</ISSN><JournalIssue CitedMedium="Internet"><Volume>265</Volume><Issue>4</Issue><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Annals of surgery</Title><ISOAbbreviation>Ann Surg</ISOAbbreviation></Journal><ArticleTitle>Human Myeloid-derived Suppressor Cells are Associated With Chronic Immune Suppression After Severe Sepsis/Septic Shock.</ArticleTitle><Pagination><StartPage>827</StartPage><EndPage>834</EndPage><MedlinePgn>827-834</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SLA.0000000000001783</ELocationID><Abstract><AbstractText Label="OBJECTIVE">We hypothesized that after sepsis in humans, MDSCs will be persistently increased, functionally immunosuppressive, and associated with adverse clinical outcomes.</AbstractText><AbstractText Label="BACKGROUND">Cancer and sepsis have surprisingly similar immunologic responses and equally dismal long term consequences. In cancer, increased myeloid-derived suppressor cells (MDSCs) induce detrimental immunosuppression, but little is known about the role of MDSCs after sepsis.</AbstractText><AbstractText Label="METHODS">Blood was obtained from 74 patients within 12&#x200a;hours of severe sepsis/septic shock (SS/SS), and at set intervals out to 28 days, and also in 18 healthy controls. MDSCs were phenotyped for cell surface receptor expression and enriched by cell sorting. Functional and genome-wide expression analyses were performed. Multiple logistic regression analysis was conducted to determine if increased MDSC appearance was associated with in-hospital and long-term outcomes.</AbstractText><AbstractText Label="RESULTS">After SS/SS, CD33CD11bHLA-DR MDSCs were dramatically increased out to 28 days (P &lt; 0.05). When co-cultured with MDSCs from SS/SS patients, antigen-driven T-cell proliferation and TH1/TH2 cytokine production were suppressed (P &lt; 0.05). Additionally, septic MDSCs had suppressed HLA gene expression and up-regulated ARG1 expression (P &lt; 0.05). Finally, SS/SS patients with persistent increased percentages of blood MDSCs had increased nosocomial infections, prolonged intensive care unit stays, and poor functional status at discharge (P &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSIONS">After SS/SS in humans, circulating MDSCs are persistently increased, functionally immunosuppressive, and associated with adverse outcomes. This novel observation warrants further studies. As observed in cancer immunotherapy, MDSCs could be a novel component in multimodality immunotherapy targeting detrimental inflammation and immunosuppression after SS/SS to improve currently observed dismal long-term outcomes.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mathias</LastName><ForeName>Brittany</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>*Department of Surgery, University of Florida College of Medicine, Gainesville, FL &#x2020;Department of Anesthesia, University of Florida College of Medicine, Gainesville, FL &#x2021;Department of Biostatistics, University of Florida College of Medicine, Gainesville, FL &#xa7;The Sepsis and Critical Illness Research Center, University of Florida College of Medicine, Gainesville, FL.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Delmas</LastName><ForeName>Amber L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Ozrazgat-Baslanti</LastName><ForeName>Tezcan</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Vanzant</LastName><ForeName>Erin L</ForeName><Initials>EL</Initials></Author><Author ValidYN="Y"><LastName>Szpila</LastName><ForeName>Benjamin E</ForeName><Initials>BE</Initials></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Alicia M</ForeName><Initials>AM</Initials></Author><Author ValidYN="Y"><LastName>Moore</LastName><ForeName>Frederick A</ForeName><Initials>FA</Initials></Author><Author ValidYN="Y"><LastName>Brakenridge</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials></Author><Author ValidYN="Y"><LastName>Brumback</LastName><ForeName>Babette A</ForeName><Initials>BA</Initials></Author><Author ValidYN="Y"><LastName>Moldawer</LastName><ForeName>Lyle L</ForeName><Initials>LL</Initials></Author><Author ValidYN="Y"><LastName>Efron</LastName><ForeName>Philip A</ForeName><Initials>PA</Initials></Author><Author ValidYN="Y"><CollectiveName>the Sepsis, Critical Illness Research Center Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM113945</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008721</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG028740</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001427</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 GM111152</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM040586</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM105893</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Surg</MedlineTA><NlmUniqueID>0372354</NlmUniqueID><ISSNLinking>0003-4932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003428" MajorTopicYN="N">Cross Infection</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007165" MajorTopicYN="N">Immunosuppression Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072737" MajorTopicYN="N">Myeloid-Derived Suppressor Cells</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010351" MajorTopicYN="N">Patient Discharge</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of Interest and Financial Disclosure Statement: No conflict of or competing interests have been declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27163951</ArticleId><ArticleId IdType="mid">NIHMS802191</ArticleId><ArticleId IdType="pmc">PMC5102824</ArticleId><ArticleId IdType="doi">10.1097/SLA.0000000000001783</ArticleId></ArticleIdList><ReferenceList><Reference><Citation> [Accessed Feb. 17, 2016];National Inpatient Hospital Costs: The Most Expensive Conditions by Payer, 2011. 2011  Available at:  http://www.hcup-us.ahrq.gov/reports/statbriefs/sb160.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">24199255</ArticleId></ArticleIdList></Reference><Reference><Citation>Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. Jama. 1997;278(3):234&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">9218672</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimmele T, Payen D, Cantaluppi V, et al. Immune Cell Phenotype and Function in Sepsis. Shock. 2016;45(3):282&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752878</ArticleId><ArticleId IdType="pubmed">26529661</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JE, Cox CE, Hope AA, et al. Chronic critical illness. Am J Respir Crit Care Med. 2010;182(4):446&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2937238</ArticleId><ArticleId IdType="pubmed">20448093</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile LF, Cuenca AG, Efron PA, et al. Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg. 2012;72(6):1491&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3705923</ArticleId><ArticleId IdType="pubmed">22695412</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenca AG, Delano MJ, Kelly-Scumpia KM, et al. A paradoxical role for myeloid-derived suppressor cells in sepsis and trauma. Mol Med. 2011;17(3&#x2013;4):281&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3060988</ArticleId><ArticleId IdType="pubmed">21085745</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanzant EL, Lopez CM, Ozrazgat-Baslanti T, et al. Persistent inflammation, immunosuppression, and catabolism syndrome after severe blunt trauma. J Trauma Acute Care Surg. 2014;76(1):21&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4310749</ArticleId><ArticleId IdType="pubmed">24368353</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Moldawer LL. Parallels between cancer and infectious disease. N Engl J Med. 2014;371(4):380&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">25054723</ArticleId></ArticleIdList></Reference><Reference><Citation>Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol. 2010;40(11):2969&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3277452</ArticleId><ArticleId IdType="pubmed">21061430</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues JC, Gonzalez GC, Zhang L, et al. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol. 2010;12(4):351&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2940603</ArticleId><ArticleId IdType="pubmed">20308313</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipazzi P, Valenti R, Huber V, et al. Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor-based antitumor vaccine. J Clin Oncol. 2007;25(18):2546&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">17577033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9(3):162&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2828349</ArticleId><ArticleId IdType="pubmed">19197294</ArticleId></ArticleIdList></Reference><Reference><Citation>Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. J Clin Invest. 2015:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4588239</ArticleId><ArticleId IdType="pubmed">26168215</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuenca AG, Moldawer LL. Myeloid-derived suppressor cells in sepsis: friend or foe? Intensive Care Med. 2012;38(6):928&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4001989</ArticleId><ArticleId IdType="pubmed">22552587</ArticleId></ArticleIdList></Reference><Reference><Citation>Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med. 2007;204(6):1463&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2118626</ArticleId><ArticleId IdType="pubmed">17548519</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcy CJ, Minigo G, Piera KA, et al. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients. Crit Care. 2014;18(4):R163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4261583</ArticleId><ArticleId IdType="pubmed">25084831</ArticleId></ArticleIdList></Reference><Reference><Citation>Janols H, Bergenfelz C, Allaoui R, et al. A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram-positive cases. J Leukoc Biol. 2014;96(5):685&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">24929004</ArticleId></ArticleIdList></Reference><Reference><Citation>Muckart DJ, Bhagwanjee S. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit Care Med. 1997;25(11):1789&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">9366759</ArticleId></ArticleIdList></Reference><Reference><Citation>Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood. 2008;111(8):4233&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18272812</ArticleId></ArticleIdList></Reference><Reference><Citation>Damuzzo V, Pinton L, Desantis G, et al. Complexity and challenges in defining myeloid- derived suppressor cells. Cytometry B Clin Cytom. 2015;88(2):77&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4405078</ArticleId><ArticleId IdType="pubmed">25504825</ArticleId></ArticleIdList></Reference><Reference><Citation>Scumpia PO, Delano MJ, Kelly-Scumpia KM, et al. Treatment with GITR agonistic antibody corrects adaptive immune dysfunction in sepsis. Blood. 2007;110(10):3673&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2077315</ArticleId><ArticleId IdType="pubmed">17690255</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Pribis JP, Rodriguez PC, et al. The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury. Ann Surg. 2014;259(1):171&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23470573</ArticleId></ArticleIdList></Reference><Reference><Citation>Clermont G, Angus DC, Kalassian KG, et al. Reassessing the value of short-term mortality in sepsis: comparing conventional approaches to modeling. Crit Care Med. 2003;31(11):2627&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14605534</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, Sun Q, Dubois MJ. Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis. 2002;34(8):1084&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">11914997</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr ME, Ueda J, Yamamoto S, et al. The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation. Free Radic Biol Med. 50(2):371&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3340560</ArticleId><ArticleId IdType="pubmed">21092756</ArticleId></ArticleIdList></Reference><Reference><Citation>Dombrovskiy VY, Martin AA, Sunderram J, et al. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med. 2007;35(5):1244&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">17414736</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao W, Mindrinos MN, Seok J, et al. A genomic storm in critically injured humans. J Exp Med. 2011;208(13):2581&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3244029</ArticleId><ArticleId IdType="pubmed">22110166</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst C, Pape HC, Hildebrand F, et al. 30 years of polytrauma care: An analysis of the change in strategies and results of 4849 cases treated at a single institution. Injury. 2009;40(1):77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">19117558</ArticleId></ArticleIdList></Reference><Reference><Citation>Probst C, Zelle BA, Sittaro NA, et al. Late death after multiple severe trauma: when does it occur and what are the causes? J Trauma. 2009;66(4):1212&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">19359940</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasser SM, Varghese M, Joshipura M, et al. Preventing death and disability through the timely provision of prehospital trauma care. Bull World Health Organ. 2006;84(7):507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2627394</ArticleId><ArticleId IdType="pubmed">16878215</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang DW, Tseng CH, Shapiro MF. Rehospitalizations Following Sepsis: Common and Costly. Crit Care Med. 2015;43(10):2085&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5044864</ArticleId><ArticleId IdType="pubmed">26131597</ArticleId></ArticleIdList></Reference><Reference><Citation>Bueno V, Sant'Anna OA, Lord JM. Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease. Age (Dordr) 2014;36(6):9729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4233024</ArticleId><ArticleId IdType="pubmed">25399072</ArticleId></ArticleIdList></Reference><Reference><Citation>Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13(10):739&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4358792</ArticleId><ArticleId IdType="pubmed">24060865</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacionales DC, Szpila B, Ungaro R, et al. A Detailed Characterization of the Dysfunctional Immunity and Abnormal Myelopoiesis Induced by Severe Shock and Trauma in the Aged. J Immunol. 2015;195(5):2396&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4546902</ArticleId><ArticleId IdType="pubmed">26246141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacionales DC, Gentile LF, Vanzant E, et al. Aged mice are unable to mount an effective myeloid response to sepsis. J Immunol. 2014;192(2):612&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3884685</ArticleId><ArticleId IdType="pubmed">24337739</ArticleId></ArticleIdList></Reference><Reference><Citation>Meirow Y, Kanterman J, Baniyash M. Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate. Front Immunol. 2015;6:523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4601280</ArticleId><ArticleId IdType="pubmed">26528286</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjili MH. Phenotypic plasticity of MDSC in cancers. Immunol Invest. 2012;41(6&#x2013;7):711&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">23017142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">30234819</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>16</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>8</Issue><PubDate><Year>2019</Year><Month>Apr</Month><Day>15</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>30-day Mortality Following Surgery for Spinal Epidural Abscess: Incidence, Risk Factors, Predictive Algorithm, and Associated Complications.</ArticleTitle><Pagination><StartPage>E500</StartPage><EndPage>E509</EndPage><MedlinePgn>E500-E509</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000002875</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Retrospective case-control study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine incidence and timing of mortality following surgery for spinal epidural abscess (SEA), identify risk factors for mortality, and identify complications associated with mortality.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA" NlmCategory="BACKGROUND">SEA is a serious condition with potentially devastating sequelae. There is a paucity of literature characterizing mortality following surgery for SEA.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The National Surgical Quality Improvement Program (NSQIP) database was used. Patients with a diagnosis of SEA were included. A Cox proportional hazards model identified independent risk factors for 30-day mortality. A predictive model for mortality was created. Multivariate models identified postoperative complications associated with mortality.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 1094 patients included, with 40 cases of mortality (3.7%), the majority of which occurred within 2 weeks postoperatively (70%). Independent risk factors for 30-day mortality were age&gt;60 years (hazard ratio [HR]: 2.147, P&#x200a;=&#x200a;0.027), diabetes (HR: 2.242, P&#x200a;=&#x200a;0.015), respiratory comorbidities (HR: 2.416, P&#x200a;=&#x200a;0.037), renal comorbidities (HR: 2.556, P&#x200a;=&#x200a;0.022), disseminated cancer (HR: 5.219, P&#x200a;=&#x200a;0.001), and preoperative thrombocytopenia (HR: 3.276, P&#x200a;=&#x200a;0.001). A predictive algorithm predicts a 0.3% mortality for zero risk factors up to 37.5% for 4 or more risk factors. A ROC area under curve (AUC) was 0.761, signifying a fair predictor (95% CI: 0.683-0.839, P&#x200a;&lt;&#x200a;0.001). Cardiac arrest (adjusted odds ratio [aOR]: 72.240, 95% confidence interval [CI]: 27.8-187.721, P&#x200a;&lt;&#x200a;0.001), septic shock (aOR: 15.382, 95% CI: 7.604-31.115, P&#x200a;&lt;&#x200a;0.001), and pneumonia (aOR: 2.84, 95% CI: 1.109-7.275, P&#x200a;=&#x200a;0.03) were independently associated with mortality.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The 30-day mortality rate following surgery for SEA was 3.7%. Of the mortalities that occurred within 30 days of surgery, the majority occurred within 2 weeks. Independent risk factors for mortality included older age, diabetes, hypertension, respiratory comorbidities, renal comorbidities, metastatic cancer, and thrombocytopenia. Risk for mortality ranged from 0.3% to 37.5% based on number of risk factors. Septic shock, cardiac arrest, and pneumonia were associated with mortality.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Du</LastName><ForeName>Jerry Y</ForeName><Initials>JY</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, University Hospitals Cleveland Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MetroHealth Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schell</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, University Hospitals Cleveland Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Chang-Yeon</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, University Hospitals Cleveland Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trivedi</LastName><ForeName>Nikunj N</ForeName><Initials>NN</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, University Hospitals Cleveland Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Uri M</ForeName><Initials>UM</Initials><AffiliationInfo><Affiliation>New Hampshire NeuroSpine Institute, Bedford, NH.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahn</LastName><ForeName>Nicholas U</ForeName><Initials>NU</Initials><AffiliationInfo><Affiliation>Department of Orthopedics, University Hospitals Cleveland Medical Center, Cleveland, OH.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003920" MajorTopicYN="N">Diabetes Mellitus</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="N">Epidural Abscess</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006323" MajorTopicYN="N">Heart Arrest</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007674" MajorTopicYN="N">Kidney Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012140" MajorTopicYN="N">Respiratory Tract Diseases</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30234819</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000002875</ArticleId><ArticleId IdType="pii">00007632-201904150-00018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vakili M, Crum-Cianflone NF. Spinal epidural abscess: a series of 101 cases. Am J Med 2017; 130:1458&#x2013;1463.</Citation></Reference><Reference><Citation>Darouiche RO. Spinal epidural abscess. N Engl J Med 2006; 355:2012&#x2013;2020.</Citation></Reference><Reference><Citation>Akalan N, Ozgen T. Infection as a cause of spinal cord compression: a review of 36 spinal epidural abscess cases. Acta Neurochir 2000; 142:17&#x2013;23.</Citation></Reference><Reference><Citation>Dandy WE. Abscesses and inflammatory tumors in the spinal epidural space (so-called pachymeningitis externa). Arch Surg 1926; 13:477&#x2013;494.</Citation></Reference><Reference><Citation>Davis DP, Wold RM, Patel RJ, et al. The clinical presentation and impact of diagnostic delays on emergency department patients with spinal epidural abscess. J Emerg Med 2004; 26:285&#x2013;291.</Citation></Reference><Reference><Citation>Tang HJ, Lin HJ, Liu YC, et al. Spinal epidural abscess&#x2014;experience with 46 patients and evaluation of prognostic factors. J Infect 2002; 45:76&#x2013;81.</Citation></Reference><Reference><Citation>Shah AA, Ogink PT, Nelson SB, et al. Nonoperative management of spinal epidural abscess: development of a predictive algorithm for failure. J Bone Joint Surg Am 2018; 100:546&#x2013;555.</Citation></Reference><Reference><Citation>Curry WT Jr, Hoh BL, Amin-Hanjani S, et al. Spinal epidural abscess: clinical presentation, management, and outcome. Surg Neurol 2005; 63:364&#x2013;371.</Citation></Reference><Reference><Citation>Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189&#x2013;196.</Citation></Reference><Reference><Citation>Patel AR, Alton TB, Bransford RJ, et al. Spinal epidural abscesses: risk factors, medical versus surgical management, a retrospective review of 128 cases. Spine J 2014; 14:326&#x2013;330.</Citation></Reference><Reference><Citation>ACS NSQIP participant use data file. Available at: https://www.facs.org/quality-programs/acs-nsqip/program-specifics/participant-use. Accessed March 2, 2018.</Citation></Reference><Reference><Citation>Fuchshuber PR, Greif W, Tidwell CR, et al. The power of the National Surgical Quality Improvement Program&#x2014;achieving a zero pneumonia rate in general surgery patients. Perm J 2012; 16:39&#x2013;45.</Citation></Reference><Reference><Citation>Noureldin M, Habermann EB, Ubl DS, et al. Unplanned readmissions following outpatient hand and elbow surgery. J Bone Joint Surg Am 2017; 99:541&#x2013;549.</Citation></Reference><Reference><Citation>Braun MM, Barstow CH, Pyzocha NJ. Diagnosis and management of sodium disorders: hyponatremia and hypernatremia. Am Fam Physician 2015; 91:299&#x2013;307.</Citation></Reference><Reference><Citation>Costa RT, Nassar AP Jr, Caruso P. Accuracy of SOFA, qSOFA, and SIRS scores for mortality in cancer patients admitted to an intensive care unit with suspected infection. J Crit Care 2018; 45:52&#x2013;57.</Citation></Reference><Reference><Citation>Williamson DR, Albert M, Heels-Ansdell D, et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 2013; 144:1207&#x2013;1215.</Citation></Reference><Reference><Citation>Schoenfeld AJ, Carey PA, Cleveland AW 3rd, et al. Patient factors, comorbidities, and surgical characteristics that increase mortality and complication risk after spinal arthrodesis: a prognostic study based on 5,887 patients. Spine J 2013; 13:1171&#x2013;1179.</Citation></Reference><Reference><Citation>Darouiche RO, Hamill RJ, Greenberg SB, et al. Bacterial spinal epidural abscess. Review of 43 cases and literature survey. Medicine (Baltimore) 1992; 71:369&#x2013;385.</Citation></Reference><Reference><Citation>Salmenkivi J, Sund R, Paavola M, et al. Mortality caused by surgery for degenerative lumbar spine. Spine (Phila Pa 1976) 2017; 42:1080&#x2013;1087.</Citation></Reference><Reference><Citation>Bohl DD, Mayo BC, Massel DH, et al. Incidence and risk factors for pneumonia after posterior lumbar fusion procedures: an ACS-NSQIP study. Spine (Phila Pa 1976) 2016; 41:1058&#x2013;1063.</Citation></Reference><Reference><Citation>Bohl DD, Ahn J, Rossi VJ, et al. Incidence and risk factors for pneumonia following anterior cervical decompression and fusion procedures: an ACS-NSQIP study. Spine J 2016; 16:335&#x2013;342.</Citation></Reference><Reference><Citation>Chung AS, Campbell DH, Hustedt JW, et al. Inpatient outcomes in dialysis-dependent patients undergoing elective lumbar surgery for degenerative lumbar disease. Spine (Phila Pa 1976) 2017; 42:1494&#x2013;1501.</Citation></Reference><Reference><Citation>De la Garza Ramos R, Jain A, Nakhla J, et al. Postoperative morbidity and mortality after elective anterior cervical fusion in patients with chronic and end-stage renal disease. World Neurosurg 2016; 95:480&#x2013;485.</Citation></Reference><Reference><Citation>Piper K, DeAndrea-Lazarus I, Algattas H, et al. Risk factors associated with readmission and reoperation in patients undergoing spine surgery. World Neurosurg 2018; 110:e627&#x2013;e635.</Citation></Reference><Reference><Citation>De la Garza Ramos R, Goodwin CR, Jain A, et al. Development of a Metastatic Spinal Tumor Frailty Index (MSTFI) using a nationwide database and its association with inpatient morbidity, mortality, and length of stay after spine surgery. World Neurosurg 2016; 95:548&#x2013;555.</Citation></Reference><Reference><Citation>Bronheim RS, Oermann EK, Cho SK, et al. Coagulation profile as a risk factor for 30-day morbidity and mortality following posterior lumbar fusion. Spine (Phila Pa 1976) 2017; 42:950&#x2013;957.</Citation></Reference><Reference><Citation>Pumberger M, Chiu YL, Ma Y, et al. Perioperative mortality after lumbar spinal fusion surgery: an analysis of epidemiology and risk factors. Eur Spine J 2012; 21:1633&#x2013;1639.</Citation></Reference><Reference><Citation>Worley N, Marascalchi B, Jalai CM, et al. Predictors of inpatient morbidity and mortality in adult spinal deformity surgery. Eur Spine J 2016; 25:819&#x2013;827.</Citation></Reference><Reference><Citation>Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus 2011; 9:19&#x2013;40.</Citation></Reference><Reference><Citation>el-Solh AA, Grant BJ. A comparison of severity of illness scoring systems for critically ill obstetric patients. Chest 1996; 110:1299&#x2013;1304.</Citation></Reference><Reference><Citation>Chen YC, Tsai MH, Ho YP, et al. Comparison of the severity of illness scoring systems for critically ill cirrhotic patients with renal failure. Clin Nephrol 2004; 61:111&#x2013;118.</Citation></Reference><Reference><Citation>Breslow MJ, Badawi O. Severity scoring in the critically ill: part 1&#x2014;interpretation and accuracy of outcome prediction scoring systems. Chest 2012; 141:245&#x2013;252.</Citation></Reference><Reference><Citation>Breslow MJ, Badawi O. Severity scoring in the critically ill: part 2: maximizing value from outcome prediction scoring systems. Chest 2012; 141:518&#x2013;527.</Citation></Reference><Reference><Citation>30-day death (mortality) rates. Available at: https://www.medicare.gov/hospitalcompare/Data/Death-rates.html, 2018. Accessed May 20, 2018.</Citation></Reference><Reference><Citation>Ashley EA, Vagelos RH. Preoperative cardiac evaluation: mechanisms, assessment, and reduction of risk. Thorac Surg Clin 2005; 15:263&#x2013;275.</Citation></Reference><Reference><Citation>Hollenberg SM. Preoperative cardiac risk assessment. Chest 1999; 115 (5 suppl):51S&#x2013;57S.</Citation></Reference><Reference><Citation>Leppo JA. Preoperative cardiac risk assessment for noncardiac surgery. J Nucl Cardiol 1995; 2:461&#x2013;465.</Citation></Reference><Reference><Citation>Chughtai M, Gwam CU, Mohamed N, et al. The epidemiology and risk factors for postoperative pneumonia. J Clin Med Res 2017; 9:466&#x2013;475.</Citation></Reference><Reference><Citation>Rustagi T, Drazin D, Oner C, et al. Fractures in spinal ankylosing disorders: a narrative review of disease and injury types, treatment techniques, and outcomes. J Orthop Trauma 2017; 31 (suppl 4):S57&#x2013;S74.</Citation></Reference><Reference><Citation>Epstein NE. Multidisciplinary in-hospital teams improve patient outcomes: a review. Surg Neurol Int 2014; 5 (suppl 7):S295&#x2013;S303.</Citation></Reference><Reference><Citation>Alton TB, Patel AR, Bransford RJ, et al. Is there a difference in neurologic outcome in medical versus early operative management of cervical epidural abscesses? Spine J 2015; 15:10&#x2013;17.</Citation></Reference><Reference><Citation>Hlavin ML, Kaminski HJ, Ross JS, et al. Spinal epidural abscess: a ten-year perspective. Neurosurgery 1990; 27:177&#x2013;184.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">29343086</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2019</Year><Month>03</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1557-900X</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>3</Issue><PubDate><Year>2018</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of endourology</Title><ISOAbbreviation>J Endourol</ISOAbbreviation></Journal><ArticleTitle>Percutaneous Nephrolithotomy and Spina Bifida: Complex Major Stone Surgery?</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>212</EndPage><MedlinePgn>205-212</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1089/end.2017.0775</ELocationID><Abstract><AbstractText Label="BACKGROUND">The incidence of spina bifida (SB) is &#x223c;1:1000, and risk of stone disease is substantially raised in SB. This is the unique published study of the outcome of patients with SB undergoing percutaneous nephrolithotomy (PCNL) compared to a neurologically intact historically matched control group at the same institution.</AbstractText><AbstractText Label="PATIENTS AND METHOD">A series of 96 PCNLs in 13 SB and 50 non-SB patients was analyzed. The following measurements were recorded: (1) Comorbidities; (2) Preoperative: (renal function, American Society of Anesthesiologists [ASA] score); (3) Intraoperative: (anesthesia time, number of tracks, stone-free rate); and (4) Postoperative: (sepsis, intensive therapy unit and total length of stay, transfusion rate, stone composition, rate of stone disease-related nephrectomy).</AbstractText><AbstractText Label="RESULTS">Retrograde access to the ureter was impossible in all cases of SB. The median ASA grade (OR 10.5, 95% confidence interval [CI] 2.6-42.7) and operative time (median difference 30 minutes, 95% CI 20-40) were both higher in the SB cohort. Surgeon's estimate of stone-free rate was significantly lower in the SB cohort (46% vs 82%). Intensive care requirement (0.29 days/PCNL vs 0.1 days/PCNL); total hospital stay (7 days vs 4 days); postoperative transfusion rate (11.8% vs 1.6%); and sepsis rate (38% vs 1.6%) were all significantly higher in the SB group. Repeat PCNL and nephrectomy for recurrent stone disease were both significantly increased in SB cohort compared to control group.</AbstractText><AbstractText Label="CONCLUSIONS">PCNL in patients with SB is associated with multiple parameters of poor outcome. Patients with SB should be counseled about increased peri-operative risk and likelihood of stone recurrence. In an era where hospitals are judged according to comparative outcomes, a case may be made for comparing PCNL in this cohort of patients separately because of the significantly increased peri- and postoperative morbidity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Stephen</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>1 Department of Urology, Barnsley and Mid Yorkshire NHS Foundation Hospital Trusts , London, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gurung</LastName><ForeName>Pratik M S</ForeName><Initials>PMS</Initials><AffiliationInfo><Affiliation>2 Health Education West Midlands , Birmingham, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choong</LastName><ForeName>Simon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>3 Department of Urology, University College London Hospital NHS Foundation Trust , London, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morris</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>4 Department of Medical Statistics, MRC Clinical Trials Unit , London, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Daron</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>3 Department of Urology, University College London Hospital NHS Foundation Trust , London, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woodhouse</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>3 Department of Urology, University College London Hospital NHS Foundation Trust , London, United Kingdom .</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Philp</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>3 Department of Urology, University College London Hospital NHS Foundation Trust , London, United Kingdom .</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Endourol</MedlineTA><NlmUniqueID>8807503</NlmUniqueID><ISSNLinking>0892-7790</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Endourol. 2018 Mar;32(3):213. doi: 10.1089/end.2018.0064.</RefSource><PMID Version="1">29439606</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000758" MajorTopicYN="N">Anesthesia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000776" MajorTopicYN="N">Anesthesiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006761" MajorTopicYN="N">Hospitals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="N">Kidney Calculi</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009392" MajorTopicYN="N">Nephrectomy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="N">Nephrolithotomy, Percutaneous</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009403" MajorTopicYN="N">Nephrostomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061646" MajorTopicYN="N">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016135" MajorTopicYN="N">Spinal Dysraphism</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">percutaneous nephrolithotomy</Keyword><Keyword MajorTopicYN="N">spina bifida</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29343086</ArticleId><ArticleId IdType="doi">10.1089/end.2017.0775</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27661863</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Quality Improvement Initiative for Severe Sepsis and Septic Shock Reduces 90-Day Mortality: A 7.5-Year Observational Study.</ArticleTitle><Pagination><StartPage>241</StartPage><EndPage>252</EndPage><MedlinePgn>241-252</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000002069</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To investigate the impact of a quality improvement initiative for severe sepsis and septic shock focused on the resuscitation bundle on 90-day mortality. Furthermore, effects on compliance rates for antiinfective therapy within the recommended 1-hour interval are evaluated.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Prospective observational before-after cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Tertiary university hospital in Germany.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All adult medical and surgical ICU patients with severe sepsis and septic shock.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Implementation of a quality improvement program over 7.5 years.</AbstractText><AbstractText Label="MEASUREMENTS" NlmCategory="METHODS">The primary endpoint was 90-day mortality. Secondary endpoints included ICU and hospital mortality rates and length of stay, time to broad-spectrum antiinfective therapy, and compliance with resuscitation bundle elements.</AbstractText><AbstractText Label="MAIN RESULTS" NlmCategory="RESULTS">A total of 14,115 patients were screened. The incidence of severe sepsis and septic shock was 9.7%. Ninety-day mortality decreased from 64.2% to 45.0% (p &lt; 0.001). Hospital length of stay decreased from 44 to 36 days (p &lt; 0.05). Compliance with resuscitation bundle elements was significantly improved. Antibiotic therapy within the first hour after sepsis onset increased from 48.5% to 74.3% (p &lt; 0.001). Multivariate analysis revealed blood cultures before antibiotic therapy (hazard ratio, 0.60-0.84; p &lt; 0.001), adequate calculated antibiotic therapy (hazard ratio, 0.53-0.75; p &lt; 0.001), 1-2&#x2009;L crystalloids within the first 6 hours (hazard ratio 0.67-0.97; p = 0.025), and greater than or equal to 6&#x2009;L during the first 24 hours (hazard ratio, 0.64-0.95; p = 0.012) as predictors for improved survival.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The continuous quality improvement initiative focused on the resuscitation bundle was associated with increased compliance and a persistent reduction in 90-day mortality over a 7.5-year period. Based on the observational study design, a causal relationship cannot be proven, and respective limitations need to be considered.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scheer</LastName><ForeName>Christian S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>1Department of Anesthesiology, University Hospital of Greifswald, Greifswald, Germany. 2Department of Mathematics and Computer Science, University of Greifswald, Greifswald, Germany. 3Department of Internal Medicine, University Hospital of Greifswald, Greifswald, Germany. 4Department of Microbiology, University Hospital of Greifswald, Greifswald, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Kuhn</LastName><ForeName>Sven-Olaf</ForeName><Initials>SO</Initials></Author><Author ValidYN="Y"><LastName>Vollmer</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Rehberg</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Friesecke</LastName><ForeName>Sigrun</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Abel</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Balau</LastName><ForeName>Veronika</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Bandt</LastName><ForeName>Christoph</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Konrad</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Hahnenkamp</LastName><ForeName>Klaus</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Gr&#xfc;ndling</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2017 Feb;45(2):374-375. doi: 10.1097/CCM.0000000000002110.</RefSource><PMID Version="1">28098640</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064872" MajorTopicYN="N">Patient Care Bundles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="Y">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27661863</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000002069</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32195922</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>10</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1540-0514</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>5</Issue><PubDate><Year>2020</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Shock (Augusta, Ga.)</Title><ISOAbbreviation>Shock</ISOAbbreviation></Journal><ArticleTitle>Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.</ArticleTitle><Pagination><StartPage>667</StartPage><EndPage>674</EndPage><MedlinePgn>667-674</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/SHK.0000000000001533</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Polymyxin B hemoperfusion (PMX-HP) is an adjuvant therapy for sepsis or septic shock that removes circulating endotoxin. However, PMX-HP has seldom achieved expectations in randomized trials targeting nonspecific overall sepsis patients. If used in an optimal population, PMX-HP may be beneficial. This study aimed to identify the optimal population for PMX-HP in patients with septic shock.</AbstractText><AbstractText Label="METHODS">We used a prospective nationwide cohort targeting consecutive adult patients with severe sepsis (Sepsis-2) in 59 intensive care units in Japan. Associations between PMX-HP therapy and in-hospital mortality were assessed using multivariable Cox proportional hazard regression models. To identify best targets for PMX-HP, we developed a non-linear restricted cubic spline model including two-way interaction term (treatment&#x200a;&#xd7;&#x200a;Acute Physiology and Chronic Health Evaluation [APACHE] II score/Sequential Organ Failure Assessment [SOFA] score) and three-way interaction term (treatment&#x200a;&#xd7;&#x200a;age&#x200a;&#xd7;&#x200a;each score).</AbstractText><AbstractText Label="RESULTS">The final study cohort comprised 741 sepsis patients (92 received PMX-HP, 625 did not). Cox proportional hazards regression model adjusted for the covariates suggested no association between PMX-HP therapy and improved mortality overall. Effect modification of PMX-HP by APACHE II score was statistically significant (P for interaction = 0.189) but non-significant for SOFA score (P for interaction = 0.413). Three-way interaction analysis revealed suppressed risk hazard in the PMX-HP group versus control group only in septic shock patients with high age and in the most severe subset of both scores, whereas increased risk hazard was observed in those with high age but in the lower severity subset of both scores.</AbstractText><AbstractText Label="CONCLUSIONS">Our results suggested that although PMX-HP did not reduce in-hospital mortality among overall septic shock patients, it may benefit a limited population with high age and higher disease severity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nakata</LastName><ForeName>Hidekazu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabata</LastName><ForeName>Daijiro</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Advanced Interdisciplinary Studies, The University of Tokyo Graduate School of Engineering, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Umemura</LastName><ForeName>Yutaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ogura</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gando</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Critical Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Acute and Critical Care Center, Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shintani</LastName><ForeName>Ayumi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Atsushi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency and Trauma Center, Kameda Medical Center, Kamogawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saitoh</LastName><ForeName>Daizoh</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Traumatology, Research Institute, National Defense Medical College, Tokorozawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujishima</LastName><ForeName>Seitaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Center for General Medicine Education, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayumi</LastName><ForeName>Toshihiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kushimoto</LastName><ForeName>Shigeki</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Toshikazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Juntendo University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Services Research and Development Center, University of Tsukuba, Tsukuba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiino</LastName><ForeName>Yasukazu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Acute Medicine, Kawasaki Medical School, Kurashiki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakada</LastName><ForeName>Taka-Aki</ForeName><Initials>TA</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine Chiba University Graduate School of Medicine, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarui</LastName><ForeName>Takehiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Trauma and Critical Care Medicine, Kyorin University School of Medicine, Mitaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hifumi</LastName><ForeName>Toru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Otomo</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Trauma and Acute Critical Care Center, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okamoto</LastName><ForeName>Kohji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Center for Gastroenterology and Liver Disease, Kitakyushu City Yahata Hospital, Kitakyushu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotani</LastName><ForeName>Joji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Disaster and Emergency Medicine, Department of Surgery Related, Kobe University Graduate School of Medicine, Kobe, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakamoto</LastName><ForeName>Yuichiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Medicine, Saga University Hospital, Saga, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasaki</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Keio University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shiraishi</LastName><ForeName>Shin-Ichiro</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Aizu Chuo Hospital, Aizuwakamatsu, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takuma</LastName><ForeName>Kiyotsugu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Emergency and Critical Care Center, Kawasaki Municipal Kawasaki Hospital, Kawasaki, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsuruta</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Advanced Medical Emergency and Critical Care Center, Yamaguchi University Hospital, Yamaguchi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagiwara</LastName><ForeName>Akiyoshi</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masuno</LastName><ForeName>Tomohiko</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Emergency and Critical Care Medicine, Nippon Medical School, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takeyama</LastName><ForeName>Naoshi</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Advanced Critical Care Center, Aichi Medical University Hospital, Nagakute, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamashita</LastName><ForeName>Norio</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Advanced Emergency Medical Service Center Kurume University Hospital, Kurume, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ikeda</LastName><ForeName>Hiroto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Teikyo University School of Medicine, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueyama</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Trauma, Critical Care Medicine, and Burn Center, Japan Community Healthcare Organization, Chukyo Hospital, Nagoya, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fujimi</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Trauma and Surgical Critical Care, Osaka General Medical Center, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Japanese Association for Acute Medicine (JAAM) Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis and Trauma (FORECAST) Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Shock</MedlineTA><NlmUniqueID>9421564</NlmUniqueID><ISSNLinking>1073-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>J2VZ07J96K</RegistryNumber><NameOfSubstance UI="D011112">Polymyxin B</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018572" MajorTopicYN="N">Disease-Free Survival</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006464" MajorTopicYN="Y">Hemoperfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007564" MajorTopicYN="N" Type="Geographic">Japan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011112" MajorTopicYN="Y">Polymyxin B</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32195922</ArticleId><ArticleId IdType="doi">10.1097/SHK.0000000000001533</ArticleId><ArticleId IdType="pii">00024382-202011000-00013</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rhee C, Dantes R, Epstein L, Murphy DJ, Seymour CW, Iwashyna TJ, Kadri SS, Angus DC, Danner RL, Fiore AE, et al. CDC Prevention Epicenter Program: Incidence and trends of sepsis in us hospitals using clinical vs claims data, 2009-2014. JAMA 318 (13):1241&#x2013;1249, 2017.</Citation></Reference><Reference><Citation>Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and costs of sepsis in the United States: an analysis based on timing of diagnosis and severity level. Crit Care Med 46 (12):1889&#x2013;1897, 2018.</Citation></Reference><Reference><Citation>Fleischmann C, Scherag A, Adhikari NK, Hartog CS, Tsaganos T, Schlattmann P, Angus DC, Reinhart K. International forum of acute care trial: assessment of global incidence and mortality of hospital-treated sepsis. Current estimates and limitations. Am J Respir Crit Care Med 193 (3):259&#x2013;272, 2016.</Citation></Reference><Reference><Citation>Hajj J, Blaine N, Salavaci J, Jacoby D. The &#x201c;Centrality of Sepsis&#x201d;: a review on incidence, mortality, and cost of care. Healthcare (Basel) 6 (3):90, 2018.</Citation></Reference><Reference><Citation>&#xc1;lvaro-Meca A, Jim&#xe9;nez-Sousa MA, Micheloud D, S&#xe1;nchez-Lopez A, Heredia-Rodr&#xed;guez M, Tamayo E, Resino S5. Group of Biomedical Research in Critical Care Medicine (BioCritic): epidemiological trends of sepsis in the twenty-first century (2000-2013): an analysis of incidence, mortality, and associated costs in Spain. Popul Health Metr 16 (1):4, 2018.</Citation></Reference><Reference><Citation>Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, Cho RJ, Chen RO, Brownstein BH, Cobb JP, Tschoeke SK, et al. Inflamm and host response to Injury Large Scale Collab. Res. Program: a network-based analysis of systemic inflammation in humans. Nature 437 (7061):1032&#x2013;1037, 2005.</Citation></Reference><Reference><Citation>Lord JM, Midwinter MJ, Chen YF, Belli A, Brohi K, Kovacs EJ, Koenderman L, Kubes P, Lilford RJ. The systemic immune response to trauma: an overview of pathophysiology and treatment. Lancet 384 (9952):1455&#x2013;1465, 2014.</Citation></Reference><Reference><Citation>Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, Opal S, Abraham E, Brett SJ, Smith T, et al. MEDIC study: Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 190 (3):527&#x2013;534, 2004.</Citation></Reference><Reference><Citation>Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 7 (1):108&#x2013;114, 2003.</Citation></Reference><Reference><Citation>Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 167 (4):412&#x2013;417, 1994.</Citation></Reference><Reference><Citation>Nakamura Y, Kitamura T, Kiyomi F, Hayakawa M, Hoshino K, Kawano Y, Yamasaki R, Nishida T, Mizunuma M, Ishikura H. Japan Septic Disseminated Intravascular Coagulation (JSEPTIC DIC) study group: potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study. Crit Care 21 (1):134, 2017.</Citation></Reference><Reference><Citation>Kawazoe Y, Sato T, Miyagawa N, Yokokawa Y, Kushimoto S, Miyamoto K, Ohta Y, Morimoto T, Yamamura H. Mortality effects of prolonged hemoperfusion therapy using a polymyxin B-immobilized fiber column for patients with septic shock: a sub-analysis of the DESIRE trial. Blood Purif 46 (4):309&#x2013;314, 2018.</Citation></Reference><Reference><Citation>Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Bobbio Pallavicini FM, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301 (23):2445&#x2013;2452, 2009.</Citation></Reference><Reference><Citation>Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, Pottecher J, Joannes-Boyau O, Martin-Lefevre L, Jabaudon M, et al. ABDOMIX Group: early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med 41 (6):975&#x2013;984, 2015.</Citation></Reference><Reference><Citation>Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, Palevsky PM, Weisberg LS, Schorr CA, Trzeciak S, et al. EUPHRATES Trial Investigators: effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA 320 (14):1455&#x2013;1463, 2018.</Citation></Reference><Reference><Citation>Terayama T, Yamakawa K, Umemura Y, Aihara M, Fujimi S. Polymyxin B hemoperfusion for sepsis and septic shock: a systematic review and meta-analysis. Surg Infect (Larchmt) 18 (3):225&#x2013;233, 2017.</Citation></Reference><Reference><Citation>Fujii T, Ganeko R, Kataoka Y, Furukawa TA, Featherstone R, Doi K, Vincent JL, Pasero D, Robert R, Ronco C, et al. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44 (2):167&#x2013;178, 2018.</Citation></Reference><Reference><Citation>Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 372 (9):793&#x2013;795, 2015.</Citation></Reference><Reference><Citation>Jameson JL, Longo DL. Precision medicine&#x2014;personalized, problematic, and promising. N Engl J Med 372 (23):2229&#x2013;2234, 2015.</Citation></Reference><Reference><Citation>Vincent JL. The coming era of precision medicine for intensive care. Crit Care 21: (suppl 3): 314, 2017.</Citation></Reference><Reference><Citation>Seymour CW, Gomez H, Chang CH, Clermont G, Kellum JA, Kennedy J, Yende S, Angus DC. Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness. Crit Care 21 (1):257, 2017.</Citation></Reference><Reference><Citation>Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med 44 (12):2205&#x2013;2212, 2018.</Citation></Reference><Reference><Citation>Abe T, Ogura H, Shiraishi A, Kushimoto S, Saitoh D, Fujishima S, Mayumi T, Shiino Y, Nakada TA, Tarui T, et al. JAAM FORECAST group: characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care 22 (1):322, 2018.</Citation></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. SCCM/ESICM/ACCP/ATS/SI: 2001&#x200a;SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (4):1250&#x2013;1256, 2003.</Citation></Reference><Reference><Citation>Yang Y, Yang KS, Hsann YM, Lim V, Ong BC. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care 25 (3):398&#x2013;405, 2010.</Citation></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 13 (10):818&#x2013;829, 1985.</Citation></Reference><Reference><Citation>Vincent JL, Moreno R, Takala J, Willatts S, De Mendon&#xe7;a A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22 (7):707&#x2013;710, 1996.</Citation></Reference><Reference><Citation>Harell FE Jr. Package &#x2018;rms&#x2019; Regression Modeling Strategies. 2019. Available at: https://cran.r-project.org/web/packages/rms/rms.pdf. Accessed December 18, 2018.</Citation></Reference><Reference><Citation>Chernozhukov V, Chetverikov D, Demirer M, Duflo E, Hansen C, Newey W, Robins J. Double/debiased machine learning for treatment and structural parameters. Econom J 21 (1):C1&#x2013;C68, 2018.</Citation></Reference><Reference><Citation>Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol 19 (3):593&#x2013;599, 2008.</Citation></Reference><Reference><Citation>Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 23 (5):400&#x2013;405, 2005.</Citation></Reference><Reference><Citation>Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 369 (9):840&#x2013;851, 2013.</Citation></Reference><Reference><Citation>Kinoshita M, Nakashima M, Nakashima H, Seki S. Immune mechanisms underlying susceptibility to endotoxin shock in aged hosts: implication in age-augmented generalized Shwartzman reaction. Int J Mol Sci 20 (13):E3260, 2019.</Citation></Reference><Reference><Citation>Ronco C, Klein DJ. Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care 18 (3):309, 2014.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27993631</PMID><DateCompleted><Year>2017</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2018</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-1570</ISSN><JournalIssue CitedMedium="Internet"><Volume>113</Volume><PubDate><Year>2017</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Resuscitation</Title><ISOAbbreviation>Resuscitation</ISOAbbreviation></Journal><ArticleTitle>Infectious complications after out-of-hospital cardiac arrest-A comparison between two target temperatures.</ArticleTitle><Pagination><StartPage>70</StartPage><EndPage>76</EndPage><MedlinePgn>70-76</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.resuscitation.2016.12.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0300-9572(16)30586-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">It has been suggested that target temperature management (TTM) increases the probability of infectious complications after cardiac arrest. We aimed to compare the incidence of pneumonia, severe sepsis and septic shock after out-of-hospital cardiac arrest (OHCA) in patients with two target temperatures and to describe changes in biomarkers and possible mortality associated with these infectious complications.</AbstractText><AbstractText Label="METHODS">Post-hoc analysis of the TTM-trial which randomized patients resuscitated from OHCA to a target temperature of 33&#xb0;C or 36&#xb0;C. Prospective data on infectious complications were recorded daily during the ICU-stay. Pneumonia, severe sepsis and septic shock were considered infectious complications. Procalcitonin (PCT) and C-reactive-protein (CRP) levels were measured at 24h, 48h and 72h after cardiac arrest.</AbstractText><AbstractText Label="RESULTS">There were 939 patients in the modified intention-to-treat population. Five-hundred patients (53%) developed pneumonia, severe sepsis or septic shock which was associated with mortality in multivariate analysis (Hazard ratio [HR] 1.39; 95%CI 1.13-1.70; p=0.001). There was no statistically significant difference in the incidence of infectious complications between temperature groups (sub-distribution hazard ratio [SHR] 0.88; 95%CI 0.75-1.03; p=0.12). PCT and CRP were significantly higher for patients with infections at all times (p&lt;0.001), but there was considerable overlap.</AbstractText><AbstractText Label="CONCLUSIONS">Patients who develop pneumonia, severe sepsis or septic shock after OHCA might have an increased mortality. A target temperature of 33&#xb0;C after OHCA was not associated with an increased risk of infectious complications compared to a target temperature of 36&#xb0;C. PCT and CRP are of limited value for diagnosing infectious complications after cardiac arrest.</AbstractText><CopyrightInformation>Copyright &#xa9; 2016 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dankiewicz</LastName><ForeName>Josef</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Lund, Sweden; Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden. Electronic address: Josef.dankiewicz@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden; Department of Anaesthesiology and Intensive Care, Helsingborg Hospital, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linder</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden; Division of Infection Medicine, Lund University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuiper</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Leeuwarden Hospital, Leeuwarden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wise</LastName><ForeName>Matthew P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Adult Critical Care, University Hospital of Wales, Cardiff, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cronberg</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden; Department of Neurology, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erlinge</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden; Department of Cardiology, Sk&#xe5;ne University Hospital, Lund Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gasche</LastName><ForeName>Yvan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Geneva University Hospital, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harmon</LastName><ForeName>Matthew B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassager</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Janneke</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Academic Medical Centre, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kjaergaard</LastName><ForeName>Jesper</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellis</LastName><ForeName>Tommaso</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Santa Maria degli &#xc1;ngeli, Pordenone, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stammet</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology and Intensive Care, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Und&#xe9;n</LastName><ForeName>Johan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden; Department of Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Malm&#xf6;, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wanscher</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wetterslev</LastName><ForeName>J&#xf8;rn</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Copenhagen Trial Unit, Centre of Clinical Intervention Research, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc5;neman</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Liverpool Hospital, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ull&#xe9;n</LastName><ForeName>Susann</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>R&amp;D Centre Sk&#xe5;ne, Sk&#xe5;ne University Hospital, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juffermans</LastName><ForeName>Nicole P</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Academic Medical Center, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friberg</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Intensive and Perioperative Care, Sk&#xe5;ne University Hospital, Lund, Sweden; Department of Clinical Sciences, Lund University, Getingev&#xe4;gen, 22185 Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>TTM trial investigators</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Resuscitation</MedlineTA><NlmUniqueID>0332173</NlmUniqueID><ISSNLinking>0300-9572</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001831" MajorTopicYN="Y">Body Temperature</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016887" MajorTopicYN="N">Cardiopulmonary Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007036" MajorTopicYN="Y">Hypothermia, Induced</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058687" MajorTopicYN="Y">Out-of-Hospital Cardiac Arrest</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="Y">Pneumonia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Hypothermia</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Out-of-hospital cardiac arrest</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">c-Reactive protein</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>12</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>12</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27993631</ArticleId><ArticleId IdType="doi">10.1016/j.resuscitation.2016.12.008</ArticleId><ArticleId IdType="pii">S0300-9572(16)30586-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31529483</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>11</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Long-term survival after intensive care: A retrospective cohort study.</ArticleTitle><Pagination><StartPage>75</StartPage><EndPage>84</EndPage><MedlinePgn>75-84</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13475</ELocationID><Abstract><AbstractText>Background Limited data exist on long-term survival of patients requiring admission to intensive care units (ICUs). The aim of this study was to investigate long-term survival of ICU patients in Iceland and assess changes over a 15-year period. Methods Data were collected on age, gender, admission cause, length of stay, comorbidities, mechanical ventilation and survival of patients 18&#xa0;years and older admitted to the ICUs in Landspitali during 2002-2016. Long-term survival of patients surviving more than 30&#xa0;days from admission was estimated and its predictors assessed with Cox regression analysis. Long-term survival was compared to the survival of an age- and gender-matched reference group from the general population. Results Of 15&#xa0;832 ICU admissions, 55% was medical, 38% was surgical and 7% was due to trauma. The 5-year survival of medical, surgical and trauma patients was 66%, 76% and 92% respectively. Significant survival differences were found between admission subgroups. Higher age and comorbidity burden was related to decreased survival in all patient groups. After correcting for age, gender, comorbidities, length of ICU stay and mechanical ventilation, patient survival improved during the study period only for patients admitted for infections. There was a high variability in the estimated time point where the ICU admission had no residual effect on survival. Conclusions Long-term survival of ICU patients is substantially decreased compared to the general population, but varies based on admission causes. Improved long-term survival of patients admitted with infections could be explained by earlier detection and improved treatment of septic shock.</AbstractText><CopyrightInformation>&#xa9; 2019 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kristinsdottir</LastName><ForeName>Eyrun A</ForeName><Initials>EA</Initials><Identifier Source="ORCID">0000-0002-5206-3615</Identifier><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Perioperative Services at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Long</LastName><ForeName>Thorir E</ForeName><Initials>TE</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigvaldason</LastName><ForeName>Kristinn</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Perioperative Services at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karason</LastName><ForeName>Sigurbergur</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0726-4378</Identifier><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Perioperative Services at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Gisli H</ForeName><Initials>GH</Initials><Identifier Source="ORCID">0000-0003-4171-9153</Identifier><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Perioperative Services at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sigurdsson</LastName><ForeName>Martin I</ForeName><Initials>MI</Initials><Identifier Source="ORCID">0000-0001-7054-0844</Identifier><AffiliationInfo><Affiliation>Division of Anaesthesia and Intensive Care, Perioperative Services at Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Medicine, University of Iceland, Reykjavik, Iceland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Agency>Landspitali University Hospital Research Fund</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007055" MajorTopicYN="N" Type="Geographic">Iceland</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="Y">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31529483</ArticleId><ArticleId IdType="doi">10.1111/aas.13475</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Garland A, Olafson K, Ramsey CD, Yogendran M, Fransoo R. Distinct determinants of long-term and short-term survival in critical illness. Intensive Care Med. 2014;40:1097-1105.</Citation></Reference><Reference><Citation>Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Mortality after hospital discharge in ICU patients. Crit Care Med. 2013;41:1229-1236.</Citation></Reference><Reference><Citation>Niskanen M, Kari A, Halonen P. Five-year survival after intensive care-comparison of 12,180 patients with the general population. Finnish ICU Study Group. Crit Care Med. 1996;24:1962-1967.</Citation></Reference><Reference><Citation>Flaatten H, Kvale R. Survival and quality of life 12 years after ICU. A comparison with the general Norwegian population. Intensive Care Med. 2001;27:1005-1011.</Citation></Reference><Reference><Citation>Pandharipande PP, Girard TD, Jackson JC, et al. Long-term cognitive impairment after critical illness. N Engl J Med. 2014;370:185-186.</Citation></Reference><Reference><Citation>Herridge MS, Tansey CM, Matte A, et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011;364:1293-1304.</Citation></Reference><Reference><Citation>Hill AD, Fowler RA, Pinto R, Herridge MS, Cuthbertson BH, Scales DC. Long-term outcomes and healthcare utilization following critical illness-a population-based study. Crit Care. 2016;20:76.</Citation></Reference><Reference><Citation>Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care. 2010;14:R6.</Citation></Reference><Reference><Citation>Oeyen SG, Vandijck DM, Benoit DD, Annemans L, Decruyenaere JM. Quality of life after intensive care: a systematic review of the literature. Crit Care Med. 2010;38:2386-2400.</Citation></Reference><Reference><Citation>Soliman IW, de Lange DW, Peelen LM, et al. Single-center large-cohort study into quality of life in Dutch intensive care unit subgroups, 1 year after admission, using EuroQoL EQ-6D-3L. J Crit Care. 2015;30:181-186.</Citation></Reference><Reference><Citation>Williams TA, Dobb GJ, Finn JC, Webb SA. Long-term survival from intensive care: a review. Intensive Care Med. 2005;31:1306-1315.</Citation></Reference><Reference><Citation>van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ. A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care. 2009;47:626-633.</Citation></Reference><Reference><Citation>Statistics Iceland, Reykjavik, Iceland. Deaths and crude death rate by sex and age 1841-2017. Latest update: 6/18/2018. https://statice.is/.</Citation></Reference><Reference><Citation>Iwashyna TJ, Hodgson CL, Pilcher D, et al. Timing of onset and burden of persistent critical illness in Australia and New Zealand: a retrospective, population-based, observational study. Lancet Respir Med. 2016;4:566-573.</Citation></Reference><Reference><Citation>Meynaar IA, Van Den Boogaard M, Tangkau PL, Dawson L, Sleeswijk Visser S, Bakker J. Long-term survival after ICU treatment. Minerva Anestesiol. 2012;78:1324-1332.</Citation></Reference><Reference><Citation>Wright JC, Plenderleith L, Ridley SA. Long-term survival following intensive care: subgroup analysis and comparison with the general population. Anaesthesia. 2003;58:637-642.</Citation></Reference><Reference><Citation>Williams TA, Dobb GJ, Finn JC, et al. Determinants of long-term survival after intensive care. Crit Care Med. 2008;36:1523-1530.</Citation></Reference><Reference><Citation>Keenan SP, Dodek P, Chan K, et al. Intensive care unit admission has minimal impact on long-term mortality. Crit Care Med. 2002;30:501-507.</Citation></Reference><Reference><Citation>Szakmany T, Walters AM, Pugh R, Battle C, Berridge DM, Lyons RA. Risk factors for 1-year mortality and hospital utilization patterns in critical care survivors: a retrospective, observational, population-based data linkage study. Crit Care Med. 2018.</Citation></Reference><Reference><Citation>Iribarren-Diarasarri S, Aizpuru-Barandiaran F, Munoz-Martinez T, et al. Health-related quality of life as a prognostic factor of survival in critically ill patients. Intensive Care Med. 2009;35:833-839.</Citation></Reference><Reference><Citation>Dragsted L. Outcome from intensive care. A five year study of 1,308 patients. Dan Med Bull. 1991;38:365-374.</Citation></Reference><Reference><Citation>Thoner J. Outcome and costs of intensive care. A follow-up study on patients requiring prolonged mechanical ventilation. Acta Anaesthesiol Scand. 1987;31:693-698.</Citation></Reference><Reference><Citation>Seneff MG, Wagner DP, Wagner RP, Zimmerman JE, Knaus WA. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995;274:1852-1857.</Citation></Reference><Reference><Citation>Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med. 2015;372:2185-2196.</Citation></Reference><Reference><Citation>Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 1995;333:817-822.</Citation></Reference><Reference><Citation>Johannesdottir H, Arnadottir LO, Adalsteinsson JA, et al. Favourable long-term outcome after coronary artery bypass grafting in a nationwide cohort. Scand Cardiovasc J. 2017;51:327-333.</Citation></Reference><Reference><Citation>Viktorsson SA, Helgason D, Orrason AW, et al. Favorable survival after aortic valve replacement compared to the general population. J Heart Valve Dis. 2016;25:8-13.</Citation></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486-552.</Citation></Reference><Reference><Citation>Mukherjee V, Evans L. Implementation of the Surviving Sepsis Campaign guidelines. Curr Opin Crit Care. 2017;23:412-416.</Citation></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38:367-374.</Citation></Reference><Reference><Citation>Levy MM, Rhodes A, Phillips GS, et al. Surviving Sepsis Campaign: association between performance metrics and outcomes in a 7.5-year study. Intensive Care Med. 2014;40:1623-1633.</Citation></Reference><Reference><Citation>Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study). Intensive Care Med. 2015;41:1620-1628.</Citation></Reference><Reference><Citation>Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749-1755.</Citation></Reference><Reference><Citation>Damiani E, Donati A, Serafini G, et al. Effect of performance improvement programs on compliance with sepsis bundles and mortality: a systematic review and meta-analysis of observational studies. PLoS One. 2015;10:e0125827.</Citation></Reference><Reference><Citation>Jonsdottir GM, Lund SH, Snorradottir B, et al. A population-based study on epidemiology of intensive care unit treated traumatic brain injury in Iceland. Acta Anaesthesiol Scand. 2017;61:408-417.</Citation></Reference><Reference><Citation>Sigurdsson MI, Sigvaldason K, Gunnarsson TS, Moller A, Sigurdsson GH. Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand. 2013;57:37-45.</Citation></Reference><Reference><Citation>Sverrisson KO, Palsson SP, Sigvaldason K, Karason S. Clinical aspects and follow up of suicide attempts treated in a general intensive care unit at Landspitali University Hospital in Iceland 2000-2004. Laeknabladid. 2010;96:101-107.</Citation></Reference><Reference><Citation>Sigurdsson MI, Vesteinsdottir IO, Sigvaldason K, Helgadottir S, Indridason OS, Sigurdsson GH. Acute kidney injury in intensive care units according to RIFLE classification: a population-based study. Acta Anaesthesiol Scand. 2012;56:1291-1297.</Citation></Reference><Reference><Citation>Vesteinsdottir E, Karason S, Sigurdsson SE, Gottfredsson M, Sigurdsson GH. Severe sepsis and septic shock: a prospective population-based study in Icelandic intensive care units. Acta Anaesthesiol Scand. 2011;55:722-731.</Citation></Reference><Reference><Citation>Sigvaldason K, Ingvarsson T, Thordardottir S, Kristinsson J, Karason S. Injecting drug abuse: survival after intensive care admission and forensic toxicology reports at death. Laeknabladid. 2014;100:515-519.</Citation></Reference><Reference><Citation>Rhodes A, Ferdinande P, Flaatten H, Guidet B, Metnitz PG, Moreno RP. The variability of critical care bed numbers in Europe. Intensive Care Med. 2012;38:1647-1653.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27504630</PMID><DateCompleted><Year>2017</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study.</ArticleTitle><Pagination><StartPage>e0160907</StartPage><MedlinePgn>e0160907</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0160907</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0160907</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Sepsis remains associated with a high mortality rate. Endotoxin has been shown to influence viscoelastic coagulation parameters, thus suggesting a link between endotoxin levels and the altered coagulation phenotype in septic patients. This study evaluated the effects of systemic polyspecific IgM-enriched immunoglobulin (IgM-IVIg) (Pentaglobin&#xae; [Biotest, Dreieich, Germany]) on endotoxin activity (EA), inflammatory markers, viscoelastic and conventional coagulation parameters.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients with severe sepsis were identified by daily screening in a tertiary, academic, surgical ICU. After the inclusion of 15 patients, the application of IgM-IVIg (5 mg/kg/d over three days) was integrated into the unit's standard operation procedure (SOP) to treat patients with severe sepsis, thereby generating "control" and "IgM-IVIg" groups. EA assays, thrombelastometry (ROTEM&#xae;) and impedance aggregometry (Multiplate&#xae;) were performed on whole blood. Furthermore, routine laboratory parameters were determined according to unit's standards.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Data from 26 patients were included. On day 1, EA was significantly decreased in the IgM-IVIg group following 6 and 12 hours of treatment (0.51 &#xb1;0.06 vs. 0.26 &#xb1;0.07, p&lt;0.05 and 0.51 &#xb1;0.06 vs. 0.25 &#xb1;0.04, p&lt;0.05) and differed significantly compared with the control group following 6 hours of treatment (0.26 &#xb1;0.07 vs. 0.43 &#xb1;0.07, p&lt;0.05). The platelet count was significantly higher in the IgM-IVIg group following four days of IgM-IVIg treatment (200/nl &#xb1;43 vs. 87/nl &#xb1;20, p&lt;0.05). The fibrinogen concentration was significantly lower in the control group on day 2 (311 mg/dl &#xb1;37 vs. 475 mg/dl &#xb1;47 (p = 0.015)) and day 4 (307 mg/dl &#xb1;35 vs. 420 mg/dl &#xb1;16 (p = 0.017)). No differences in thrombelastometric or aggregometric measurements, or inflammatory markers (interleukin-6 (IL-6), leukocyte, lipopolysaccharide binding protein (LBP)) were observed.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Treatment with IgM-enriched immunoglobulin attenuates the EA levels in patients with severe sepsis and might have an effect on septic thrombocytopenia and fibrinogen depletion. Viscoelastic, aggregometric or inflammatory parameters were not influenced.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">clinicaltrials.gov NCT02444871.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wand</LastName><ForeName>Saskia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinic for Anaesthesiology, University Hospital Goettingen, Goettingen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klages</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirbach</LastName><ForeName>Christin</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warszawska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meybohm</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacharowski</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt am Main, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT02444871</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>08</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004731">Endotoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007075">Immunoglobulin M</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004731" MajorTopicYN="N">Endotoxins</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007075" MajorTopicYN="N">Immunoglobulin M</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>3</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27504630</ArticleId><ArticleId IdType="pmc">PMC4978476</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0160907</ArticleId><ArticleId IdType="pii">PONE-D-16-07587</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, et al. The cardiovascular response of normal humans to the administration of endotoxin. The New England journal of medicine. 1989;321(5):280&#x2013;7. Epub 1989/08/03. 10.1056/nejm198908033210503 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejm198908033210503</ArticleId><ArticleId IdType="pubmed">2664516</ArticleId></ArticleIdList></Reference><Reference><Citation>Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, et al. Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. The Journal of experimental medicine. 1989;169(3):823&#x2013;32. Epub 1989/03/01.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2189288</ArticleId><ArticleId IdType="pubmed">2647895</ArticleId></ArticleIdList></Reference><Reference><Citation>Puleo F A M, Van Gossum A, Preiser JC. Gut failure in the ICU. Semin Respir Crit Care Med. 2011;32(5):626&#x2013;38. Epub 2011 Oct 11. 10.1055/s-0031-1287871</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0031-1287871</ArticleId><ArticleId IdType="pubmed">21989698</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaishnavi C. Translocation of gut flora and its role in sepsis. Indian J Med Microbiol. 2013;31(4):334&#x2013;42. Epub 2013/09/26. 10.4103/0255-0857.118870 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0255-0857.118870</ArticleId><ArticleId IdType="pubmed">24064638</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Foster D, Vincent JL, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. The Journal of infectious diseases. 2004;190(3):527&#x2013;34. Epub 2004/07/10. 10.1086/422254 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/422254</ArticleId><ArticleId IdType="pubmed">15243928</ArticleId></ArticleIdList></Reference><Reference><Citation>Schedel I, Dreikhausen U, Nentwig B, Hockenschnieder M, Rauthmann D, Balikcioglu S, et al. Treatment of gram-negative septic shock with an immunoglobulin preparation: a prospective, randomized clinical trial. Critical care medicine. 1991;19(9):1104&#x2013;13. Epub 1991/09/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">1884609</ArticleId></ArticleIdList></Reference><Reference><Citation>Oesser S, Schulze C, Seifert J. Protective capacity of a IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Research in experimental medicine Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie. 1999;198(6):325&#x2013;39. Epub 1999/06/16. .</Citation><ArticleIdList><ArticleId IdType="pubmed">10369088</ArticleId></ArticleIdList></Reference><Reference><Citation>Behre G, Schedel I, Nentwig B, Wormann B, Essink M, Hiddemann W. Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins. Antimicrobial agents and chemotherapy. 1992;36(10):2139&#x2013;46. Epub 1992/10/01. ; PubMed Central PMCID: PMCPmc245468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC245468</ArticleId><ArticleId IdType="pubmed">1444293</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall JC, Walker PM, Foster DM, Harris D, Ribeiro M, Paice J, et al. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Critical care (London, England). 2002;6(4):342&#x2013;8. Epub 2002/09/13. ; PubMed Central PMCID: PMCPmc125316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC125316</ArticleId><ArticleId IdType="pubmed">12225611</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient. Journal of critical care. 2001;16(4):167&#x2013;77. Epub 2002/01/30. 10.1053/jcrc.2001.30666 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/jcrc.2001.30666</ArticleId><ArticleId IdType="pubmed">11815902</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons J, Pittet JF. The coagulopathy of acute sepsis. Current opinion in anaesthesiology. 2015;28(2):227&#x2013;36. Epub 2015/01/16. 10.1097/aco.0000000000000163 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/aco.0000000000000163</ArticleId><ArticleId IdType="pmc">PMC4407200</ArticleId><ArticleId IdType="pubmed">25590467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa A, Hafter R, Graeff H. [Disseminated intravascular coagulation (DIC) after endotoxin infusion into the common bile duct of rabbits (author's transl)]. Research in experimental medicine Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie. 1979;175(3):233&#x2013;8. Epub 1979/07/20. .</Citation><ArticleIdList><ArticleId IdType="pubmed">384487</ArticleId></ArticleIdList></Reference><Reference><Citation>Milbrandt EB, Reade MC, Lee M, Shook SL, Angus DC, Kong L, et al. Prevalence and significance of coagulation abnormalities in community-acquired pneumonia. Molecular medicine (Cambridge, Mass). 2009;15(11&#x2013;12):438&#x2013;45. Epub 2009/09/16. 10.2119/molmed.2009.00091</Citation><ArticleIdList><ArticleId IdType="doi">10.2119/molmed.2009.00091</ArticleId><ArticleId IdType="pmc">PMC2743205</ArticleId><ArticleId IdType="pubmed">19753144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai K, Hiramatsu T, Kobayashi R, Takabayashi N, Ishihara Y, Ohata K, et al. Coagulation disorder as a prognostic factor for patients with colorectal perforation. Journal of gastroenterology. 2007;42(6):450&#x2013;5. Epub 2007/08/03. 10.1007/s00535-007-2027-y .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00535-007-2027-y</ArticleId><ArticleId IdType="pubmed">17671759</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamzik M, Langemeier T, Frey UH, Gorlinger K, Saner F, Eggebrecht H, et al. Comparison of thrombelastometry with simplified acute physiology score II and sequential organ failure assessment scores for the prediction of 30-day survival: a cohort study. Shock (Augusta, Ga). 2011;35(4):339&#x2013;42. Epub 2010/11/12. 10.1097/SHK.0b013e318204bff6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318204bff6</ArticleId><ArticleId IdType="pubmed">21068699</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. Journal of thrombosis and haemostasis: JTH. 2006;4(2):411&#x2013;6. Epub 2006/01/20. 10.1111/j.1538-7836.2006.01715.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2006.01715.x</ArticleId><ArticleId IdType="pubmed">16420574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharowski K, Sucker C, Zacharowski P, Hartmann M. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thrombosis and haemostasis. 2006;95(3):557&#x2013;61. Epub 2006/03/10. .</Citation><ArticleIdList><ArticleId IdType="pubmed">16525587</ArticleId></ArticleIdList></Reference><Reference><Citation>Koch A, Meesters MI, Scheller B, Boer C, Zacharowski K. Systemic endotoxin activity correlates with clot formation: an observational study in patients with early systemic inflammation and sepsis. Critical care (London, England). 2013;17(5):R198 Epub 2013/09/13. 10.1186/cc12892 ; PubMed Central PMCID: PMCPmc4057518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12892</ArticleId><ArticleId IdType="pmc">PMC4057518</ArticleId><ArticleId IdType="pubmed">24025340</ArticleId></ArticleIdList></Reference><Reference><Citation>Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644&#x2013;55. Epub 1992/06/01. .</Citation><ArticleIdList><ArticleId IdType="pubmed">1303622</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardinal DC, Flower RJ. The study of platelet aggregation in whole blood [proceedings]. British journal of pharmacology. 1979;66(1):94p&#x2013;5p. Epub 1979/05/01. ; PubMed Central PMCID: PMCPmc2043811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2043811</ArticleId><ArticleId IdType="pubmed">454976</ArticleId></ArticleIdList></Reference><Reference><Citation>Barratt-Due A, Sokolov A, Gustavsen A, Hellerud BC, Egge K, Pischke SE, et al. Polyvalent immunoglobulin significantly attenuated the formation of IL-1beta in Escherichia coli-induced sepsis in pigs. Immunobiology. 2013;218(5):683&#x2013;9. Epub 2012/09/06. 10.1016/j.imbio.2012.08.268 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.08.268</ArticleId><ArticleId IdType="pubmed">22947599</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD. Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock (Augusta, Ga). 2008;29(1):133&#x2013;9. Epub 2008/02/05. .</Citation><ArticleIdList><ArticleId IdType="pubmed">18246604</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Nawawy A, El-Kinany H, Hamdy El-Sayed M, Boshra N. Intravenous polyclonal immunoglobulin administration to sepsis syndrome patients: a prospective study in a pediatric intensive care unit. Journal of tropical pediatrics. 2005;51(5):271&#x2013;8. Epub 2005/05/27. 10.1093/tropej/fmi011 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/tropej/fmi011</ArticleId><ArticleId IdType="pubmed">15917261</ArticleId></ArticleIdList></Reference><Reference><Citation>Capasso L, Borrelli AC, Parrella C, Lama S, Ferrara T, Coppola C, et al. Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants? Italian journal of pediatrics. 2013;39:63 Epub 2013/10/09. 10.1186/1824-7288-39-63 ; PubMed Central PMCID: PMCPmc3851812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1824-7288-39-63</ArticleId><ArticleId IdType="pmc">PMC3851812</ArticleId><ArticleId IdType="pubmed">24098953</ArticleId></ArticleIdList></Reference><Reference><Citation>Buda S, Riefolo A, Biscione R, Goretti E, Cattabriga I, Grillone G, et al. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery. Journal of cardiothoracic and vascular anesthesia. 2005;19(4):440&#x2013;5. Epub 2005/08/09. 10.1053/j.jvca.2005.05.003 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.jvca.2005.05.003</ArticleId><ArticleId IdType="pubmed">16085247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez A, Rello J, Neira J, Maskin B, Ceraso D, Vasta L, et al. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock (Augusta, Ga). 2005;23(4):298&#x2013;304. Epub 2005/04/02. .</Citation><ArticleIdList><ArticleId IdType="pubmed">15803051</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman M, Monroe DM 3rd. A cell-based model of hemostasis. Thrombosis and haemostasis. 2001;85(6):958&#x2013;65. Epub 2001/07/04. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11434702</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner T, Schmidt K, Delang M, Mehrabi A, Bruckner T, Lichtenstern C, et al. Viscoelastic and aggregometric point-of-care testing in patients with septic shock&#x2014;cross-links between inflammation and haemostasis. Acta anaesthesiologica Scandinavica. 2012;56(10):1277&#x2013;90. Epub 2012/08/18. 10.1111/j.1399-6576.2012.02750.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-6576.2012.02750.x</ArticleId><ArticleId IdType="pubmed">22897591</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivula M, Pettila V, Niemi TT, Varpula M, Kuitunen AH. Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation. Blood coagulation &amp; fibrinolysis: an international journal in haemostasis and thrombosis. 2009;20(6):419&#x2013;26. Epub 2009/07/08. 10.1097/MBC.0b013e32832a76e1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e32832a76e1</ArticleId><ArticleId IdType="pubmed">19581801</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Nakarai E, Takayama T, Nakajima K, Sasaoka T, Ohno Y. Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model. Critical care (London, England). 2009;13(6):R203 Epub 2009/12/17. 10.1186/cc8210 ; PubMed Central PMCID: PMCPmc2811901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8210</ArticleId><ArticleId IdType="pmc">PMC2811901</ArticleId><ArticleId IdType="pubmed">20003418</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau D, Timsit JF, Vesin A, Garrouste-Orgeas M, de Lassence A, Zahar JR, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest. 2007;131(6):1735&#x2013;41. Epub 2007/05/04. 10.1378/chest.06-2233 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2233</ArticleId><ArticleId IdType="pubmed">17475637</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Schultz M. Coagulopathy and platelet disorders in critically ill patients. Minerva anestesiologica. 2010;76(10):851&#x2013;9. Epub 2010/10/12. .</Citation><ArticleIdList><ArticleId IdType="pubmed">20935621</ArticleId></ArticleIdList></Reference><Reference><Citation>Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Current opinion in hematology. 2009;16(5):329&#x2013;33. Epub 2009/06/25. 10.1097/MOH.0b013e32832e9dc6 ; PubMed Central PMCID: PMCPmc2883290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e32832e9dc6</ArticleId><ArticleId IdType="pmc">PMC2883290</ArticleId><ArticleId IdType="pubmed">19550320</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: their role in host defense responses and sepsis. Thrombosis research. 2011;127(3):184&#x2013;8. Epub 2010/11/16. 10.1016/j.thromres.2010.10.010 ; PubMed Central PMCID: PMCPmc3042496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2010.10.010</ArticleId><ArticleId IdType="pmc">PMC3042496</ArticleId><ArticleId IdType="pubmed">21075430</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">30335177</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2393</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>2</Issue><PubDate><Year>2019</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>QJM : monthly journal of the Association of Physicians</Title><ISOAbbreviation>QJM</ISOAbbreviation></Journal><ArticleTitle>Defining risk of general surgery in patients with chronic obstructive pulmonary diseases.</ArticleTitle><Pagination><StartPage>107</StartPage><EndPage>113</EndPage><MedlinePgn>107-113</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/qjmed/hcy240</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The relationship between chronic obstructive pulmonary disease (COPD) and perioperative outcomes remains incompletely understood. Our purpose is to evaluate the features of postoperative adverse outcomes for geriatric surgical patients with COPD receiving non-thoracic surgeries.</AbstractText><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the potential impact of COPD history on the outcome after general surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A retrospective cohort study with matching procedure by propensity score.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a nationwide study of 15 359 COPD patients aged 65 years and older who received major non-thoracic surgeries in 2008-2013 from the Taiwan National Health Insurance Research Database. Comprehensive matching procedure with propensity score were used to select 15 359 surgical patients without COPD for comparison. Major postoperative complications and 30-day in-hospital mortality were evaluated among patients with and without COPD by calculating adjusted odds ratios (ORs) and 95% CIs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with COPD had significantly increased risk for postoperative complications, including pneumonia (OR = 90.3; 95% CI: 60.3-135), septicemia (OR = 3.11; 95% CI: 2.82-3.43), acute renal failure (OR = 2.53; 95% CI: 2.11-3.02), pulmonary embolism (OR = 2.74; 95% CI: 1.52-4.96), and 30-day postoperative mortality (adjusted OR = 2.09; 95% CI: 1.76-2.50), compared with surgical patients without COPD. Longer length of hospital stay and higher medical expenditures were also noted in COPD patients than those without COPD.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Geriatric patients with COPD showed significantly higher postoperative adverse outcome rates with risk of 30-day mortality nearly twofold when compared with patients without COPD. Our findings remind surgical care team pay more attention to this specific population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chao-Shun</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chien-Yu</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>Chun-Chieh</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Surgery, China Medical University Hospital, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, University of Illinois, Chicago, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Chi-Li</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Ta-Liang</ForeName><Initials>TL</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chien-Chang</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Anesthesiology and Health Policy Research Center, Taipei Medical University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology, Shuan Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>QJM</MedlineTA><NlmUniqueID>9438285</NlmUniqueID><ISSNLinking>1460-2393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>QJM. 2019 Feb 1;112(2):157. doi: 10.1093/qjmed/hcy256.</RefSource><PMID Version="1">30380123</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D058186" MajorTopicYN="N">Acute Kidney Injury</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016208" MajorTopicYN="N">Databases, Factual</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005102" MajorTopicYN="N">Health Expenditures</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="Y">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015999" MajorTopicYN="N">Multivariate Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011014" MajorTopicYN="N">Pneumonia</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30335177</ArticleId><ArticleId IdType="doi">10.1093/qjmed/hcy240</ArticleId><ArticleId IdType="pii">5136375</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28607467</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>12</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Changes in novel haematological parameters following thermal injury: A prospective observational cohort study.</ArticleTitle><Pagination><StartPage>3211</StartPage><MedlinePgn>3211</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3211</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-017-03222-w</ELocationID><Abstract><AbstractText>The mortality caused by sepsis is high following thermal injury. Diagnosis is difficult due to the ongoing systemic inflammatory response. Previous studies suggest that cellular parameters may show promise as diagnostic markers of sepsis. The aim of this study was to evaluate the effect of thermal injury on novel haematological parameters and to study their association with clinical outcomes. Haematological analysis was performed using a Sysmex XN-1000 analyser on blood samples acquired on the day of the thermal injury to 12 months post-injury in 39 patients (15-95% TBSA). Platelet counts had a nadir at day 3 followed by a rebound thrombocytosis at day 21, with nadir values significantly lower in septic patients. Measurements of extended neutrophil parameters (NEUT-Y and NEUT-RI) demonstrated that septic patients had significantly higher levels of neutrophil nucleic acid content. A combination of platelet impedance count (PLT-I) and NEUT-Y at day 3 post-injury exhibited good discriminatory power for the identifying septic patients (AUROC&#x2009;=&#x2009;0.915, 95% CI [0.827, 1.000]). Importantly, the model had improved performance when adjusted for mortality with an AUROC of 0.974 (0.931, 1.000). A combination of PLT-I and NEUT-Y show potential for the early diagnosis of sepsis post-burn injury. Importantly, these tests can be performed rapidly and require a small volume of whole blood highlighting their potential utility in clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dinsdale</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK. RXD325@bham.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK. RXD325@bham.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hampson</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wearn</LastName><ForeName>C M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bamford</LastName><ForeName>A L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hazeldine</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bishop</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1789-5886</Identifier><AffiliationInfo><Affiliation>NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Haematology, Queen Elizabeth Hospital, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>J M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Surgical Reconstruction and Microbiology Research Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moiemen</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harrison</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>The Scar Free Foundation Birmingham Centre for Burns Research, Birmingham, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>06</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013922" MajorTopicYN="N">Thrombocytosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Sysmex UK performed comprehensive analysis of extended neutrophil parameters (NEUT-RI and NUET-GI) whilst blinded to clinical data.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28607467</ArticleId><ArticleId IdType="pmc">PMC5468303</ArticleId><ArticleId IdType="doi">10.1038/s41598-017-03222-w</ArticleId><ArticleId IdType="pii">10.1038/s41598-017-03222-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14:R188. doi: 10.1186/cc9300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc9300</ArticleId><ArticleId IdType="pmc">PMC3219295</ArticleId><ArticleId IdType="pubmed">20958968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeschke MG, et al. Pathophysiologic Response to Burns in the Elderly. EBioMedicine. 2015;2:1536&#x2013;1548. doi: 10.1016/j.ebiom.2015.07.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2015.07.040</ArticleId><ArticleId IdType="pmc">PMC4634201</ArticleId><ArticleId IdType="pubmed">26629550</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson PC, et al. Revised estimates of mortality from the Birmingham Burn Centre, 2001&#x2013;2010: a continuing analysis over 65 years. Ann Surg. 2014;259:979&#x2013;984. doi: 10.1097/SLA.0b013e31829160ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e31829160ca</ArticleId><ArticleId IdType="pubmed">23598383</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann EA, Baun MM, Meininger JC, Wade CE. Comparison of mortality associated with sepsis in the burn, trauma, and general intensive care unit patient: a systematic review of the literature. Shock. 2012;37:4&#x2013;16. doi: 10.1097/SHK.0b013e318237d6bf.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e318237d6bf</ArticleId><ArticleId IdType="pubmed">21941222</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530&#x2013;538. doi: 10.1007/s00134-003-1662-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-003-1662-x</ArticleId><ArticleId IdType="pubmed">12664219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampson, P. et al. Neutrophil Dysfunction, Immature Granulocytes, and Cell-free DNA are Early Biomarkers of Sepsis in Burn-injured Patients: A Prospective Observational Cohort Study. Ann Surg, doi:10.1097/SLA.0000000000001807 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27232244</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha SO, et al. Fraction of immature granulocytes reflects severity but not mortality in sepsis. Scand J Clin Lab Invest. 2015;75:36&#x2013;43. doi: 10.3109/00365513.2014.965736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365513.2014.965736</ArticleId><ArticleId IdType="pubmed">25342241</ArticleId></ArticleIdList></Reference><Reference><Citation>Mare TA, et al. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation. Crit Care. 2015;19:57. doi: 10.1186/s13054-015-0778-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-0778-z</ArticleId><ArticleId IdType="pmc">PMC4355545</ArticleId><ArticleId IdType="pubmed">25887201</ArticleId></ArticleIdList></Reference><Reference><Citation>Marck RE, Montagne HL, Tuinebreijer WE, Breederveld RS. Time course of thrombocytes in burn patients and its predictive value for outcome. Burns. 2013;39:714&#x2013;722. doi: 10.1016/j.burns.2013.01.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.burns.2013.01.015</ArticleId><ArticleId IdType="pubmed">23490002</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouel-Cheron A, et al. Early interleukin-6 and slope of monocyte human leukocyte antigen-DR: a powerful association to predict the development of sepsis after major trauma. PLoS One. 2012;7:e33095. doi: 10.1371/journal.pone.0033095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0033095</ArticleId><ArticleId IdType="pmc">PMC3303782</ArticleId><ArticleId IdType="pubmed">22431998</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs C, Harrison P, Machin SJ. Continuing developments with the automated platelet count. Int J Lab Hematol. 2007;29:77&#x2013;91. doi: 10.1111/j.1751-553X.2007.00909.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-553X.2007.00909.x</ArticleId><ArticleId IdType="pubmed">17474881</ArticleId></ArticleIdList></Reference><Reference><Citation>Nierhaus A, et al. Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis&#x2013;a prospective, observational study. BMC Immunol. 2013;14:8. doi: 10.1186/1471-2172-14-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-14-8</ArticleId><ArticleId IdType="pmc">PMC3575223</ArticleId><ArticleId IdType="pubmed">23398965</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada A, Takagi Y, Kono M, Morikawa T. Accuracy of a New Platelet Count System (PLT-F) Depends on the Staining Property of Its Reagents. PLoS One. 2015;10:e0141311. doi: 10.1371/journal.pone.0141311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141311</ArticleId><ArticleId IdType="pmc">PMC4619826</ArticleId><ArticleId IdType="pubmed">26496387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, et al. Performance evaluation of platelet counting by novel fluorescent dye staining in the XN-series automated hematology analyzers. J Clin Lab Anal. 2014;28:341&#x2013;348. doi: 10.1002/jcla.21691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.21691</ArticleId><ArticleId IdType="pmc">PMC6807536</ArticleId><ArticleId IdType="pubmed">24648166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergt K. Blood levels of thrombocytes in burned patients: observations on their behavior in relation to the clinical condition of the patient. J Trauma. 1972;12:599&#x2013;607. doi: 10.1097/00005373-197207000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-197207000-00008</ArticleId><ArticleId IdType="pubmed">4557924</ArticleId></ArticleIdList></Reference><Reference><Citation>Housinger, T. A., Brinkerhoff, C. &amp; Warden, G. D. The relationship between platelet count, sepsis, and survival in pediatric burn patients. Arch Surg128, 65&#x2013;66; discussion 66&#x2013;67 (1993).</Citation><ArticleIdList><ArticleId IdType="pubmed">8418782</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegenthaler M, Spertini O. Images in clinical medicine. Spurious platelet count. N Engl J Med. 2006;354:1936. doi: 10.1056/NEJMicm050107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMicm050107</ArticleId><ArticleId IdType="pubmed">16672705</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence C, Atac B. Hematologic changes in massive burn injury. Crit Care Med. 1992;20:1284&#x2013;1288. doi: 10.1097/00003246-199209000-00015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199209000-00015</ArticleId><ArticleId IdType="pubmed">1521443</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison P, et al. An interlaboratory study of a candidate reference method for platelet counting. Am J Clin Pathol. 2001;115:448&#x2013;459. doi: 10.1309/91PR-E4G6-XBAF-N8DY.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/91PR-E4G6-XBAF-N8DY</ArticleId><ArticleId IdType="pubmed">11242802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zini G, et al. ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol. 2012;34:107&#x2013;116. doi: 10.1111/j.1751-553X.2011.01380.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-553X.2011.01380.x</ArticleId><ArticleId IdType="pubmed">22081912</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesesve JF, et al. Schistocytes in disseminated intravascular coagulation. Int J Lab Hematol. 2014;36:439&#x2013;443. doi: 10.1111/ijlh.12168.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.12168</ArticleId><ArticleId IdType="pubmed">24261329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lesesve JF, Salignac S, Lecompte T. Laboratory measurement of schistocytes. Int J Lab Hematol. 2007;29:149&#x2013;151. doi: 10.1111/j.1751-553X.2006.00829.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-553X.2006.00829.x</ArticleId><ArticleId IdType="pubmed">17474889</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessman JD. Red blood cell fragmentation. Improved detection and identification of causes. Am J Clin Pathol. 1988;90:268&#x2013;273. doi: 10.1093/ajcp/90.3.268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ajcp/90.3.268</ArticleId><ArticleId IdType="pubmed">2458032</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono M, et al. Heme-related molecules induce rapid production of neutrophil extracellular traps. Transfusion. 2014;54:2811&#x2013;2819. doi: 10.1111/trf.12700.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/trf.12700</ArticleId><ArticleId IdType="pubmed">24865940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, et al. Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood. 2014;123:3818&#x2013;3827. doi: 10.1182/blood-2013-10-529982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-10-529982</ArticleId><ArticleId IdType="pmc">PMC4055928</ArticleId><ArticleId IdType="pubmed">24620350</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander JW, Ogle CK, Stinnett JD, Macmillan BG. A sequential, prospective analysis of immunologic abnormalities and infection following severe thermal injury. Ann Surg. 1978;188:809&#x2013;816. doi: 10.1097/00000658-197812000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-197812000-00016</ArticleId><ArticleId IdType="pmc">PMC1397007</ArticleId><ArticleId IdType="pubmed">736659</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng ZY, Tung YL. Neutrophil chemiluminescence in burned patients. J Trauma. 1987;27:587&#x2013;595. doi: 10.1097/00005373-198706000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-198706000-00001</ArticleId><ArticleId IdType="pubmed">3599105</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones CN, et al. Spontaneous neutrophil migration patterns during sepsis after major burns. PLoS One. 2014;9:e114509. doi: 10.1371/journal.pone.0114509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0114509</ArticleId><ArticleId IdType="pmc">PMC4260850</ArticleId><ArticleId IdType="pubmed">25489947</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y, et al. Utility of neut-X, neut-Y and neut-Z parameters for rapidly assessing sepsis in tumor patients. Clin Chim Acta. 2013;422:5&#x2013;9. doi: 10.1016/j.cca.2013.03.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2013.03.026</ArticleId><ArticleId IdType="pubmed">23545278</ArticleId></ArticleIdList></Reference><Reference><Citation>Stiel L, et al. Neutrophil Fluorescence: A New Indicator of Cell Activation During Septic Shock-Induced Disseminated Intravascular Coagulation. Crit Care Med. 2016</Citation><ArticleIdList><ArticleId IdType="pubmed">27441905</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornet E, Boubaya M, Troussard X. Contribution of the new XN-1000 parameters NEUT-RI and NEUT-WY for managing patients with immature granulocytes. Int J Lab Hematol. 2015;37:e123&#x2013;126. doi: 10.1111/ijlh.12372.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.12372</ArticleId><ArticleId IdType="pubmed">25923650</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh DG, et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res. 2007;28:776&#x2013;790. doi: 10.1097/BCR.0b013e3181599bc9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BCR.0b013e3181599bc9</ArticleId><ArticleId IdType="pubmed">17925660</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">15884127</PMID><DateCompleted><Year>2005</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2019</Year><Month>04</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1007-9327</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>18</Issue><PubDate><Year>2005</Year><Month>May</Month><Day>14</Day></PubDate></JournalIssue><Title>World journal of gastroenterology</Title><ISOAbbreviation>World J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Effect of water-soluble contrast in colorectal surgery: a prospective randomized trial.</ArticleTitle><Pagination><StartPage>2802</StartPage><EndPage>2805</EndPage><MedlinePgn>2802-5</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">Postoperative gastrointestinal-tract motility is normally delayed. Early feeding after colorectal surgery has been reported recently, but late feeding is common. Gastrografin not only enhances bowel peristalsis, but also decreases bowel-wall edema. Whether contrast medium allows early oral feeding and reduces the duration of hospitalization requires clarification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Fifty patients underwent elective colorectal surgery in a regional medical center. Patients were prospectively randomized into a Gastrografin group or control group (n = 25 each). Patients in the Gastrografin group began their feeding schedule with 100 mL of 5% dextrose water with 100 mL of Gastrografin on postoperative d 3 and were advanced to a full liquid diet when the contrast reached the colon in 4 h. Patients in the control group began their feeding schedule with 200 mL of 5% dextrose water on postoperative d 3 and were advanced to a full liquid diet after the passage of flatus and stool. Nasogastric tubes were inserted for persistent postoperative vomiting. Fullness, nausea, vomiting, complications, time of anesthesia, time of operation, time of mobilization, time of oral feeding, and duration of hospital stay were recorded and analyzed with Student's t-test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In the Gastrografin group, one patient had aspiration pneumonia and one patient had anastomotic leakage resulting in sepsis and eventual death. This mortality was excluded from the subsequent statistical analysis. In the control group, two patients had wound infections. There was no significant difference between the two groups at the time of anesthesia, time of operation, or time of mobilization. There were significant differences between the two groups in the time of oral feeding (3.3+/-0.3 d in the Gastrografin group vs 4.8+/-0.4 d in the control group; P = odds ratio--, 95%CI [-0.5 to +0.7 d]) and in the length of hospital stay (7.6+/-1.1 d in the Gastrografin group vs 10.2+/-1.3 d in the control group; P = odds ratio--, 95% CI [-1.2 to +1.4 d]).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Gastrografin not only allowed early oral feeding but also reduced the duration of hospitalization after elective colorectal surgery.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jia-Hui</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Division of General Surgery, Tri-Service General Hospital, #325 Sec. 2 Chen-Kung Road, Neihu 114, Taipei, Taiwan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsieh</LastName><ForeName>Chung-Bao</ForeName><Initials>CB</Initials></Author><Author ValidYN="Y"><LastName>Chao</LastName><ForeName>Pei-Chieh</ForeName><Initials>PC</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Hsiao-Dung</ForeName><Initials>HD</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chung-Jueng</ForeName><Initials>CJ</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yao-Chi</ForeName><Initials>YC</Initials></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jyh-Cherng</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Gastroenterol</MedlineTA><NlmUniqueID>100883448</NlmUniqueID><ISSNLinking>1007-9327</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>059QF0KO0R</RegistryNumber><NameOfSubstance UI="D014867">Water</NameOfSubstance></Chemical><Chemical><RegistryNumber>3X9MR4N98U</RegistryNumber><NameOfSubstance UI="D003974">Diatrizoate Meglumine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003107" MajorTopicYN="Y">Colorectal Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003974" MajorTopicYN="Y">Diatrizoate Meglumine</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014867" MajorTopicYN="N">Water</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year><Month>5</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2005</Year><Month>7</Month><Day>22</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2005</Year><Month>5</Month><Day>11</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2005</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15884127</ArticleId><ArticleId IdType="pmc">PMC4305921</ArticleId><ArticleId IdType="doi">10.3748/wjg.v11.i18.2802</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Condon RE, Sarna SK. Motility after abdominal surgery. Clin Gastroenterol. 1982;11:609&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pubmed">6754173</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Kelly KA, Weinshilboum RM. Pathophysiology of postoperative ileus. Arch Surg. 1977;112:203&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">836154</ArticleId></ArticleIdList></Reference><Reference><Citation>Reissman P, Teoh TA, Cohen SM, Weiss EG, Nogueras JJ, Wexner SD. Is early oral feeding safe after elective colorectal surgery? A prospective randomized trial. Ann Surg. 1995;222:73&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1234758</ArticleId><ArticleId IdType="pubmed">7618972</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackmon S, Lucius C, Wilson JP, Duncan T, Wilson R, Mason EM, Ramshaw B. The use of water-soluble contrast in evaluating clinically equivocal small bowel obstruction. Am Surg. 2000;66:238&#x2013;42; discussion 242-4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10759192</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Chang KJ, Lee PH, Wang SM, Chen KM, Lin FY. Oral urografin in postoperative small bowel obstruction. World J Surg. 1999;23:1051&#x2013;1054.</Citation><ArticleIdList><ArticleId IdType="pubmed">10512946</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen SC, Lin FY, Lee PH, Yu SC, Wang SM, Chang KJ. Water-soluble contrast study predicts the need for early surgery in adhesive small bowel obstruction. Br J Surg. 1998;85:1692&#x2013;1694.</Citation><ArticleIdList><ArticleId IdType="pubmed">9876076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson MS, Ellis H, Menzies D, Moran BJ, Parker MC, Thompson JN. A review of the management of small bowel obstruction. Members of the Surgical and Clinical Adhesions Research Study (SCAR) Ann R Coll Surg Engl. 1999;81:320&#x2013;328.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2503289</ArticleId><ArticleId IdType="pubmed">10645174</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi HK, Chu KW, Law WL. Therapeutic value of gastrografin in adhesive small bowel obstruction after unsuccessful conservative treatment: a prospective randomized trial. Ann Surg. 2002;236:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1422541</ArticleId><ArticleId IdType="pubmed">12131078</ArticleId></ArticleIdList></Reference><Reference><Citation>Assalia A, Schein M, Kopelman D, Hirshberg A, Hashmonai M. Therapeutic effect of oral Gastrografin in adhesive, partial small-bowel obstruction: a prospective randomized trial. Surgery. 1994;115:433&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">8165534</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigin E, Seror D, Szold A, Carmon M, Allweis TM, Nissan A, Gross E, Vromen A, Freund HR. Water-soluble contrast material has no therapeutic effect on postoperative small-bowel obstruction: results of a prospective, randomized clinical trial. Am J Surg. 1996;171:227&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">8619455</ArticleId></ArticleIdList></Reference><Reference><Citation>Fevang BT, Jensen D, Fevang J, S&#xf8;ndenaa K, Ovreb&#xf8; K, R&#xf8;kke O, Gislasson H, Svanes K, Viste A. Upper gastrointestinal contrast study in the management of small bowel obstruction--a prospective randomised study. Eur J Surg. 2000;166:39&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">10688215</ArticleId></ArticleIdList></Reference><Reference><Citation>Watkins DT, Robertson CL. Water-soluble radiocontrast material in the treatment of postoperative ileus. Am J Obstet Gynecol. 1985;152:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">4014338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartsell PA, Frazee RC, Harrison JB, Smith RW. Early postoperative feeding after elective colorectal surgery. Arch Surg. 1997;132:518&#x2013;20; discussion 520-1.</Citation><ArticleIdList><ArticleId IdType="pubmed">9161395</ArticleId></ArticleIdList></Reference><Reference><Citation>Stordahl A, Laerum F, Gj&#xf8;lberg T, Enge I. Water-soluble contrast media in radiography of small bowel obstruction. Comparison of ionic and non-ionic contrast media. Acta Radiol. 1988;29:53&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">2964845</ArticleId></ArticleIdList></Reference><Reference><Citation>Skucas J. Anaphylactoid reactions with gastrointestinal contrast media. AJR Am J Roentgenol. 1997;168:962&#x2013;964.</Citation><ArticleIdList><ArticleId IdType="pubmed">9124150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridley LJ. Allergic reactions to oral iodinated contrast agents: reactions to oral contrast. Australas Radiol. 1998;42:114&#x2013;117.</Citation><ArticleIdList><ArticleId IdType="pubmed">9599824</ArticleId></ArticleIdList></Reference><Reference><Citation>Trulzsch DV, Penmetsa A, Karim A, Evans DA. Gastrografin-induced aspiration pneumonia: a lethal complication of computed tomography. South Med J. 1992;85:1255&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">1470976</ArticleId></ArticleIdList></Reference><Reference><Citation>Delaney CP, Fazio VW, Senagore AJ, Robinson B, Halverson AL, Remzi FH. 'Fast track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg. 2001;88:1533&#x2013;1538.</Citation><ArticleIdList><ArticleId IdType="pubmed">11683754</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw BG, Liu SS, Thirlby RC. Standardized perioperative care protocols and reduced length of stay after colon surgery. J Am Coll Surg. 1998;186:501&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">9583689</ArticleId></ArticleIdList></Reference><Reference><Citation>Carli F, Trudel JL, Belliveau P. The effect of intraoperative thoracic epidural anesthesia and postoperative analgesia on bowel function after colorectal surgery: a prospective, randomized trial. Dis Colon Rectum. 2001;44:1083&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">11535845</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27611977</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>25</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Rural Patients With Severe Sepsis or Septic Shock Who Bypass Rural Hospitals Have Increased Mortality: An Instrumental Variables Approach.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>93</EndPage><MedlinePgn>85-93</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify factors associated with rural sepsis patients' bypassing rural emergency departments to seek emergency care in larger hospitals, and to measure the association between rural hospital bypass and sepsis survival.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Observational cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Emergency departments of a rural Midwestern state.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All adults treated with severe sepsis or septic shock between 2005 and 2014, using administrative claims data.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients bypassing local rural hospitals to seek care in larger hospitals.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">A total of 13,461 patients were included, and only 5.4% (n = 731) bypassed a rural hospital for their emergency department care. Patients who initially chose a top-decile sepsis volume hospital were younger (64.7 vs 72.7 yr; p &lt; 0.001) and were more likely to have commercial insurance (19.6% vs 10.6%; p &lt; 0.001) than those who were seen initially at a local rural hospital. They were also more likely to have significant medical comorbidities, such as liver failure (9.9% vs 4.2%; p &lt; 0.001), metastatic cancer (5.9% vs 3.2%; p &lt; 0.001), and diabetes with complications (25.2% vs 21.6%; p = 0.024). Using an instrumental variables approach, rural hospital bypass was associated with a 5.6% increase (95% CI, 2.2-8.9%) in mortality.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most rural patients with sepsis seek care in local emergency departments, but demographic and disease-oriented factors are associated with rural hospital bypass. Rural hospital bypass is independently associated with increased mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>1Department of Emergency Medicine, University of Iowa College of Medicine, Iowa City, IA. 2Division of Critical Care, Department of Anesthesia, University of Iowa Carver College of Medicine, Iowa City, IA. 3Department of Health Management and Policy, University of Iowa College of Public Health, Iowa City, IA. 4Division of Emergency Medicine, Washington University School of Medicine, St. Louis, MO. 5Division of Critical Care, Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO. 6Department of Epidemiology, University of Iowa College of Public Health, Iowa City, IA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harland</LastName><ForeName>Karisa K</ForeName><Initials>KK</Initials></Author><Author ValidYN="Y"><LastName>Shane</LastName><ForeName>Dan M</ForeName><Initials>DM</Initials></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Azeemuddin</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Brian M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Ward</LastName><ForeName>Marcia M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Torner</LastName><ForeName>James C</ForeName><Initials>JC</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR000450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L60 MD009764</GrantID><Acronym>MD</Acronym><Agency>NIMHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 TR001356</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000448</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2017 Jan;45(1):138-139. doi: 10.1097/CCM.0000000000002107.</RefSource><PMID Version="1">27984284</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D048909" MajorTopicYN="N">Diabetes Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007348" MajorTopicYN="N">Insurance, Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017093" MajorTopicYN="N">Liver Failure</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015146" MajorTopicYN="N">Midwestern United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010360" MajorTopicYN="Y">Patient Transfer</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012424" MajorTopicYN="Y">Rural Population</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>No conflicts of interest were declared. The authors have no financial or nonfinancial conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27611977</ArticleId><ArticleId IdType="mid">NIHMS827355</ArticleId><ArticleId IdType="pmc">PMC5161646</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000002026</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Filbin MR, Arias SA, Camargo CA, Jr, et al. Sepsis visits and antibiotic utilization in U.S. emergency departments*. Crit Care Med. 2014;42(3):528&#x2013;535.</Citation><ArticleIdList><ArticleId IdType="pubmed">24201179</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Phillips G, Beale R, et al. The Surviving Sepsis Campaign bundles and outcome: results from the International Multicentre Prevalence Study on Sepsis (the IMPreSS study) Intensive Care Med. 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26109396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers EP. Point: adherence to early goal-directed therapy: does it really matter? Yes. After a decade, the scientific proof speaks for itself. Chest. 2010;138(3):476&#x2013;480. discussion 484&#x2013;475.</Citation><ArticleIdList><ArticleId IdType="pubmed">20822986</ArticleId></ArticleIdList></Reference><Reference><Citation>Faine BA, Noack JM, Wong T, et al. Interhospital Transfer Delays Appropriate Treatment for Patients With Severe Sepsis and Septic Shock: A Retrospective Cohort Study. Crit Care Med. 2015;43(12):2589&#x2013;2596.</Citation><ArticleIdList><ArticleId IdType="pubmed">26491865</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy M, Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Kocher KE, Haggins AN, Sabbatini AK, et al. Emergency Department Hospitalization Volume and Mortality in the United States. Ann Emerg Med. 2014</Citation><ArticleIdList><ArticleId IdType="pubmed">25041705</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr NM, Harland KK, Shane D, et al. Inter-Hospital Transfer is Associated with Increased Mortality on Severe Sepsis: An Instrumental Variables Approach [oral conference presentation]. American College of Emergency Physicians Research Forum; 26 Oct 2015; Boston, Massachusetts.</Citation></Reference><Reference><Citation>Feazel L, Schlichting AB, Bell GR, et al. Achieving regionalization through rural interhospital transfer. Am J Emerg Med. 2015;33(9):1288&#x2013;1296.</Citation><ArticleIdList><ArticleId IdType="pubmed">26087707</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr N, Wong T, Faine B, et al. Divergence between patient and clinician priorities in rural inter-hospital transfer: A mixed methods study [in press] J Rural Health. 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26174410</ArticleId></ArticleIdList></Reference><Reference><Citation>Dranove D, White WD, Wu L. Segmentation in local hospital markets. Med Care. 1993;31(1):52&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">8417270</ArticleId></ArticleIdList></Reference><Reference><Citation>Phibbs CS, Mark DH, Luft HS, et al. Choice of hospital for delivery: a comparison of high-risk and low-risk women. Health Serv Res. 1993;28(2):201&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069930</ArticleId><ArticleId IdType="pubmed">8514500</ArticleId></ArticleIdList></Reference><Reference><Citation>Exworthy M, Peckham S. Access, Choice and Travel: Implications for Health Policy. Social Policy &amp; Administration. 2006;40(3):267&#x2013;287.</Citation></Reference><Reference><Citation>Tai W-TC, Porell FW, Adams EK. Hospital Choice of Rural Medicare Beneficiaries: Patient, Hospital Attributes, and the Patient&#x2013;Physician Relationship. Health Serv Res. 2004;39(6p1):1903&#x2013;1922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1361104</ArticleId><ArticleId IdType="pubmed">15533193</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson DA, Yarnold PR, Williams DR, et al. Effects of Actual Waiting Time, Perceived Waiting Time, Information Delivery, and Expressive Quality on Patient Satisfaction in the Emergency Department. Ann Emerg Med. 1996;28(6):657&#x2013;665.</Citation><ArticleIdList><ArticleId IdType="pubmed">8953956</ArticleId></ArticleIdList></Reference><Reference><Citation>Varkevisser M, Geest SA. Why do patients bypass the nearest hospital? An empirical analysis for orthopaedic care and neurosurgery in the Netherlands. The European Journal of Health Economics. 2007;8(3):287&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">17256180</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams EK, Houchens R, Wright GE, et al. Predicting hospital choice for rural Medicare beneficiaries: the role of severity of illness. Health Serv Res. 1991;26(5):583&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1069844</ArticleId><ArticleId IdType="pubmed">1743970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettengill J, Vertrees J. Reliability and Validity in Hospital Case-Mix Measurement. Health Care Financ Rev. 1982;4(2):101&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4191289</ArticleId><ArticleId IdType="pubmed">10309909</ArticleId></ArticleIdList></Reference><Reference><Citation>Garber AM, Fuchs VR, Silverman JF. Case Mix, Costs, and Outcomes. New England Journal of Medicine. 1984;310(19):1231&#x2013;1237.</Citation><ArticleIdList><ArticleId IdType="pubmed">6424018</ArticleId></ArticleIdList></Reference><Reference><Citation>Radcliff TA, Brasure M, Moscovice IS, et al. Understanding Rural Hospital Bypass Behavior. The Journal of Rural Health. 2003;19(3):252&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">12839133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders SR, Erickson LD, Call VR, et al. Rural health care bypass behavior: how community and spatial characteristics affect primary health care selection. J Rural Health. 2015;31(2):146&#x2013;156.</Citation><ArticleIdList><ArticleId IdType="pubmed">25219792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders SR, Erickson LD, Call VR, et al. Middle-Aged and Older Adult Health Care Selection: Health Care Bypass Behavior in Rural Communities in Montana. J Appl Gerontol. 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26316268</ArticleId></ArticleIdList></Reference><Reference><Citation>Buczko W. Rural Medicare beneficiaries' use of rural and urban hospitals. J Rural Health. 2001;17(1):53&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">11354722</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu J, Mobley LR. Illness severity and propensity to travel along the urban-rural continuum. Health Place. 2007;13(2):381&#x2013;399.</Citation><ArticleIdList><ArticleId IdType="pubmed">16697689</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel PA, Ullrich F, Finegan CN, et al. Rural Bypass for Elective Surgeries. J Rural Health. 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26625274</ArticleId></ArticleIdList></Reference><Reference><Citation>Escarce JJ, Kapur K. Do patients bypass rural hospitals? Determinants of inpatient hospital choice in rural California. J Health Care Poor Underserved. 2009;20(3):625&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pubmed">19648694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589&#x2013;1596.</Citation><ArticleIdList><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalfin DB, Trzeciak S, Likourezos A, et al. Impact of delayed transfer of critically ill patients from the emergency department to the intensive care unit*. Crit Care Med. 2007;35(6):1477&#x2013;1483.</Citation><ArticleIdList><ArticleId IdType="pubmed">17440421</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta HB, Dimou F, Adhikari D, et al. Comparison of Comorbidity Scores in Predicting Surgical Outcomes. Med Care. 2015</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713334</ArticleId><ArticleId IdType="pubmed">26595225</ArticleId></ArticleIdList></Reference><Reference><Citation>Elixhauser A, Elixhauser A, McCarthy EM. Clinical Classifications Software (CCS) for ICD-9-CM.  [[cited 2015 June]];Agency for Healthcare Research and Quality. 2015  Available from:  http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp.</Citation></Reference><Reference><Citation>WWAMI Rural Health Research Center. RUCA data.  [Accessed November 7, 2012];Code definitions, v. 2.0.  [cited Available from:  http://depts.washington.edu/uwruca/ruca-codes.php.</Citation></Reference><Reference><Citation>Cromartie J. Rural-Urban Commuting Area Codes. 2014 Jun 2; 2014 [cited 2015 Available from:  http://www.ers.usda.gov/data-products/rural-urban-commuting-area-codes.aspx.</Citation></Reference><Reference><Citation>Google Maps APIs.  [cited February 2015];2014  Available from:  https://developers.google.com/maps/?hl=en.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453&#x2013;1457.</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechtold D, Salvatierra GG, Bulley E, et al. Geographic Variation in Treatment and Outcomes Among Patients With AMI: Investigating Urban-Rural Differences Among Hospitalized Patients. J Rural Health. 2015</Citation><ArticleIdList><ArticleId IdType="pubmed">26633577</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu J. Severity of illness, race, and choice of local versus distant hospitals among the elderly. J Health Care Poor Underserved. 2005;16(2):391&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pubmed">15937400</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu J, Mobley LR. Impact of local resources on hospitalization patterns of Medicare beneficiaries and propensity to travel outside local markets. J Rural Health. 2010;26(1):20&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">20105264</ArticleId></ArticleIdList></Reference><Reference><Citation>Buczko W. Nonuse of local hospitals by rural Medicare beneficiaries. J Health Hum Serv Adm. 1997;19(3):319&#x2013;340.</Citation><ArticleIdList><ArticleId IdType="pubmed">10168171</ArticleId></ArticleIdList></Reference><Reference><Citation>Buczko W. Bypassing of local hospitals by rural Medicare beneficiaries. J Rural Health. 1994;10(4):237&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">10139173</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronstein JM, Morrisey MA. Bypassing rural hospitals for obstetrics care. J Health Polit Policy Law. 1991;16(1):87&#x2013;118.</Citation><ArticleIdList><ArticleId IdType="pubmed">2066540</ArticleId></ArticleIdList></Reference><Reference><Citation>Dy SM, Rubin HR, Lehmann HP. Why do patients and families request transfers to tertiary care? a qualitative study. Soc Sci Med. 2005;61(8):1846&#x2013;1853.</Citation><ArticleIdList><ArticleId IdType="pubmed">15919143</ArticleId></ArticleIdList></Reference><Reference><Citation>Langland-Orban B, Gapenski LC, Vogel WB. Differences in characteristics of hospitals with sustained high and sustained low profitability. Hospital &amp; Health Services Administration. 1996;41(3):385.</Citation><ArticleIdList><ArticleId IdType="pubmed">10159998</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel WB, Langland-Orban B, Gapenski LC. Factors influencing high and low profitability among hospitals. Health Care Management Review. 1993;18(2):15&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">8320103</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullner RM, McNeil D. Rural and urban hospital closures: a comparison. Health Aff (Millwood) 1986;5(3):131&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pubmed">3792986</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider AH, Chang DC, Efron DT, et al. Race and insurance status as risk factors for trauma mortality. Arch Surg. 2008;143(10):945&#x2013;949.</Citation><ArticleIdList><ArticleId IdType="pubmed">18936372</ArticleId></ArticleIdList></Reference><Reference><Citation>Durairaj L, Will JG, Torner JC, et al. Prognostic factors for mortality following interhospital transfers to the medical intensive care unit of a tertiary referral center. Crit Care Med. 2003;31(7):1981&#x2013;1986.</Citation><ArticleIdList><ArticleId IdType="pubmed">12847392</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado M, Yokell MA, Staudenmayer KL, et al. Factors associated with the disposition of severely injured patients initially seen at non&#x2013;trauma center emergency departments: Disparities by insurance status. JAMA Surg. 2014</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4422057</ArticleId><ArticleId IdType="pubmed">24554059</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosbol EL, Granger CB, Jollis JG, et al. The impact of a statewide pre-hospital STEMI strategy to bypass hospitals without percutaneous coronary intervention capability on treatment times. Circulation. 2013;127(5):604&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pubmed">23275382</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathens AB, Jurkovich GJ, Cummings P, et al. The effect of organized systems of trauma care on motor vehicle crash mortality. JAMA. 2000;283(15):1990&#x2013;1994.</Citation><ArticleIdList><ArticleId IdType="pubmed">10789667</ArticleId></ArticleIdList></Reference><Reference><Citation>Surgery Flag Software.  [cited June 2015];Agency for Healthcare Research and Quality. 2015  Available from:  http://www.hcup-us.ahrq.gov/toolssoftware/surgflags/surgeryflags.jsp.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27820718</PMID><DateCompleted><Year>2017</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1529-7535</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>2</Issue><PubDate><Year>2017</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies</Title><ISOAbbreviation>Pediatr Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Mannose-Binding Lectin Levels in Critically Ill Children With Severe Infections.</ArticleTitle><Pagination><StartPage>103</StartPage><EndPage>111</EndPage><MedlinePgn>103-111</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/PCC.0000000000001000</ELocationID><Abstract><AbstractText Label="OBJECTIVES">Low mannose-binding lectin levels and haplotypes associated with low mannose-binding lectin production have been associated with infection and severe sepsis. We tested the hypothesis that mannose-binding lectin levels would be associated with severe infection in a large cohort of critically ill children.</AbstractText><AbstractText Label="DESIGN">Prospective cohort study.</AbstractText><AbstractText Label="SETTING">Medical and Surgical PICUs, Boston Children's Hospital.</AbstractText><AbstractText Label="PATIENTS">Children less than 21 years old admitted to the ICUs from November 2009 to November 2010.</AbstractText><AbstractText Label="INTERVENTIONS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS">We measured mannose-binding lectin levels in 479 of 520 consecutively admitted children (92%) with severe or life-threatening illness. We genotyped 213 Caucasian children for mannose-binding lectin haplotype tagging variants and assigned haplotypes. In the univariate analyses of mannose-binding lectin levels with preadmission characteristics, levels were higher in patients with preexisting renal disease. Patients who received greater than 100&#x2009;mL/kg of fluids in the first 24 hours after admission had markedly lower mannose-binding lectin, as did patients who underwent spinal fusion surgery. Mannose-binding lectin levels had no association with infection status at admission, or with progression from systemic inflammatory response syndrome to sepsis or septic shock. Although mannose-binding lectin haplotypes strongly influenced mannose-binding lectin levels in the predicted relationship, low mannose-binding lectin-producing haplotypes were not associated with increased risk of infection.</AbstractText><AbstractText Label="CONCLUSIONS">Mannose-binding lectin levels are largely genetically determined. This relationship was preserved in children during critical illness, despite the effect of large-volume fluid administration on mannose-binding lectin levels. Previous literature evaluating an association between mannose-binding lectin levels and severe infection is inconsistent; we found no relationship in our PICU cohort. We found that mannose-binding lectin levels were lower after aggressive fluid resuscitation and suggest that studies of mannose-binding lectin in critically ill patients should assess mannose-binding lectin haplotypes to reflect preillness levels.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Erik C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>1Division of Critical Care Medicine, Department of Anesthesia, Perioperative and Pain Medicine, Boston, MA. 2Division of Critical Care Medicine, Department of Pediatrics, Duke University, Durham, NC. 3Department of Anesthesia, Harvard Medical School, Boston, MA. 4Department of Pediatrics, Harvard Medical School, Boston, MA. 5Department of Pediatrics, Center for Patient Safety and Quality Research, Boston Children's Hospital, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Emily R</ForeName><Initials>ER</Initials></Author><Author ValidYN="Y"><LastName>Madden</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Agan</LastName><ForeName>Anna A</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Sullivan</LastName><ForeName>Ryan M</ForeName><Initials>RM</Initials></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Dionne A</ForeName><Initials>DA</Initials></Author><Author ValidYN="Y"><LastName>Randolph</LastName><ForeName>Adrienne G</ForeName><Initials>AG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI084011</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 AI084011</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR025758</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Crit Care Med</MedlineTA><NlmUniqueID>100954653</NlmUniqueID><ISSNLinking>1529-7535</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005819">Genetic Markers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C445619">MBL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D037601">Mannose-Binding Lectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Pediatr Crit Care Med. 2017 Feb;18(2):190-191. doi: 10.1097/PCC.0000000000001006.</RefSource><PMID Version="1">28157794</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005819" MajorTopicYN="N">Genetic Markers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060005" MajorTopicYN="N">Genotyping Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="Y">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="Y">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D037601" MajorTopicYN="N">Mannose-Binding Lectin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="Y">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>11</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27820718</ArticleId><ArticleId IdType="mid">NIHMS821508</ArticleId><ArticleId IdType="pmc">PMC5366242</ArticleId><ArticleId IdType="doi">10.1097/PCC.0000000000001000</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med. 2002;12(6):335&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">12473150</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita T, Matsushita M, Endo Y. The lectin-complement pathway&#x2013;its role in innate immunity and evolution. Immunol Rev. 2004;198:185&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pubmed">15199963</ArticleId></ArticleIdList></Reference><Reference><Citation>Auriti C, Prencipe G, Inglese R, et al. Role of mannose-binding lectin in nosocomial sepsis in critically ill neonates. Hum Immunol. 2010;71(11):1084&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20732365</ArticleId></ArticleIdList></Reference><Reference><Citation>Fidler KJ, Wilson P, Davies JC, et al. Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med. 2004;30(7):1438&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">15127191</ArticleId></ArticleIdList></Reference><Reference><Citation>Darton TC, Jack DL, Johnson M, et al. MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children. Clin Microbiol Infect. 2014;20(12):1337&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">24977653</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pascale G, Cutuli SL, Pennisi MA, et al. The role of mannose-binding lectin in severe sepsis and septic shock. Mediators Inflamm. 2013;2013:625803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3808714</ArticleId><ArticleId IdType="pubmed">24223476</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Dean MM, Thomas P, et al. Low mannose-binding lectin function is associated with sepsis in adult patients. FEMS Immunol Med Microbiol. 2006;48(2):274&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">17064281</ArticleId></ArticleIdList></Reference><Reference><Citation>Minchinton RM, Dean MM, Clark TR, et al. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol. 2002;56(6):630&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">12472676</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronkhorst MW, Lomax MA, Vossen RH, et al. Risk of infection and sepsis in severely injured patients related to single nucleotide polymorphisms in the lectin pathway. Br J Surg. 2013;100(13):1818&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">24227370</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Dean MM, Boermeester MA, et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis. 2008;47(4):510&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107952</ArticleId><ArticleId IdType="pubmed">18611155</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakking FN, Brouwer N, van Eijkelenburg NK, et al. Low mannose-binding lectin (MBL) levels in neonates with pneumonia and sepsis. Clin Exp Immunol. 2007;150(2):255&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2219357</ArticleId><ArticleId IdType="pubmed">17711490</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakking FN, van de Wetering MD, Brouwer N, et al. The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia. Eur J Cancer. 2006;42(7):909&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">16517152</ArticleId></ArticleIdList></Reference><Reference><Citation>van Till JW, Modderman PW, de Boer M, et al. Mannose-binding lectin deficiency facilitates abdominal Candida infections in patients with secondary peritonitis. Clin Vaccine Immunol. 2008;15(1):65&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2223851</ArticleId><ArticleId IdType="pubmed">17978009</ArticleId></ArticleIdList></Reference><Reference><Citation>de Benedetti F, Auriti C, D&#x2019;Urbano LE, et al. Low serum levels of mannose binding lectin are a risk factor for neonatal sepsis. Pediatr Res. 2007;61(3):325&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17314691</ArticleId></ArticleIdList></Reference><Reference><Citation>Broeders EN, Wissing KM, Hazzan M, et al. Evolution of immunoglobulin and mannose binding protein levels after renal transplantation: association with infectious complications. Transpl Int. 2008;21(1):57&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">17883369</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Shang S, Zhang C, et al. Lower mannose-binding lectin contributes to deleterious H1N1 2009 infection in children. Apmis. 2014;122(2):136&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23755909</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig KF, Potlukova E, Mueller B, et al. MBL serum levels in patients with sepsis correlate with thyroid function but not with outcome. Clin Immunol. 2012;144(1):80&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">22673492</ArticleId></ArticleIdList></Reference><Reference><Citation>Liman P, Babel N, Schachtner T, et al. Mannose-binding lectin deficiency is not associated with increased risk for polyomavirus nephropathy. Transpl Immunol. 2012;26(2&#x2013;3):123&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22198424</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterslund NA, Koch C, Jensenius JC, et al. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet. 2001;358(9282):637&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">11530153</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang AQ, Yue CL, Pan W, et al. Mannose-binding lectin polymorphisms and the risk of sepsis: evidence from a meta-analysis. Epidemiol Infect. 2014;142(10):2195&#x2013;206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9151319</ArticleId><ArticleId IdType="pubmed">24398289</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao DN, Zhang Y, Ren YB, et al. Relationship of serum mannose-binding lectin levels with the development of sepsis: a meta-analysis. Inflammation. 2015;38(1):338&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">25323207</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakking FN, Brouwer N, van de Wetering MD, et al. Safety and pharmacokinetics of plasma-derived mannose-binding lectin (MBL) substitution in children with chemotherapy-induced neutropaenia. Eur J Cancer. 2009;45(4):505&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">19121580</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdimarsson H. Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humans. Biochem Soc Trans. 2003;31(Pt 4):768&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12887300</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdimarsson H, Vikingsdottir T, Bang P, et al. Human plasma-derived mannose-binding lectin: a phase I safety and pharmacokinetic study. Scand J Immunol. 2004;59(1):97&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">14723627</ArticleId></ArticleIdList></Reference><Reference><Citation>Madden K, Feldman HA, Smith EM, et al. Vitamin D deficiency in critically ill children. Pediatrics. 2012;130(3):421&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4074622</ArticleId><ArticleId IdType="pubmed">22869836</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med. 1996;24(5):743&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pubmed">8706448</ArticleId></ArticleIdList></Reference><Reference><Citation>Minne L, Abu-Hanna A, de Jonge E. Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review. Crit Care. 2008;12(6):R161.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2646326</ArticleId><ArticleId IdType="pubmed">19091120</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7107838</ArticleId><ArticleId IdType="pubmed">21880587</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">15636651</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams DJ, Edwards KM, Self WH, et al. Antibiotic Choice for Children Hospitalized With Pneumonia and Adherence to National Guidelines. Pediatrics. 2015;136(1):44&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4485005</ArticleId><ArticleId IdType="pubmed">26101356</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito H, Ikeda A, Hasegawa K, et al. Characterization of human serum mannan-binding protein promoter. J Biochem. 1999;126(6):1004&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10578050</ArticleId></ArticleIdList></Reference><Reference><Citation>Madsen HO, Garred P, Thiel S, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol. 1995;155(6):3013&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">7673719</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Ning B. The role of MBL2 gene polymorphism in sepsis incidence. Int J Clin Exp Pathol. 2015;8(11):15123&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4713640</ArticleId><ArticleId IdType="pubmed">26823854</ArticleId></ArticleIdList></Reference><Reference><Citation>Huh JW, Song K, Yum JS, et al. Association of mannose-binding lectin-2 genotype and serum levels with prognosis of sepsis. Crit Care. 2009;13(6):R176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811900</ArticleId><ArticleId IdType="pubmed">19891773</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Laorden MI, Sole-Violan J, Rodriguez de Castro F, et al. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J Allergy Clin Immunol. 2008;122(2):368&#x2013;74. 74.e1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582923</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon AC, Waheed U, Hansen TK, et al. Mannose-binding lectin polymorphisms in severe sepsis: relationship to levels, incidence, and outcome. Shock. 2006;25(1):88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">16369192</ArticleId></ArticleIdList></Reference><Reference><Citation>Garred P, J JS, Quist L, et al. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis. 2003;188(9):1394&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">14593599</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakking FN, Israels J, Kremer LC, et al. Mannose-binding lectin (MBL) and the risk for febrile neutropenia and infection in pediatric oncology patients with chemotherapy. Pediatr Blood Cancer. 2011;57(1):89&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">21557458</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills TC, Chapman S, Hutton P, et al. Variants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European Cohort. Clin Infect Dis. 2015;61(5):695&#x2013;703.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530723</ArticleId><ArticleId IdType="pubmed">25969530</ArticleId></ArticleIdList></Reference><Reference><Citation>Osthoff M, Au Yong HM, Dean MM, et al. Significance of mannose-binding lectin deficiency and nucleotide-binding oligomerization domain 2 polymorphisms in Staphylococcus aureus bloodstream infections: a case-control study. PLoS One. 2013;8(9):e76218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3785435</ArticleId><ArticleId IdType="pubmed">24086711</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Ramos E, Lopez-Rodriguez M, Ruiz-Hernandez JJ, et al. Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection. Crit Care. 2014;18(3):R127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229788</ArticleId><ArticleId IdType="pubmed">24950659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellemann D, Larsson A, Madsen HO, et al. Heterozygosity of mannose-binding lectin (MBL2) genotypes predicts advantage (heterosis) in relation to fatal outcome in intensive care patients. Hum Mol Genet. 2007;16(24):3071&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872904</ArticleId></ArticleIdList></Reference><Reference><Citation>Smithson A, Perello R, Aibar J, et al. Genotypes coding for low serum levels of mannose-binding lectin are underrepresented among individuals suffering from noninfectious systemic inflammatory response syndrome. Clin Vaccine Immunol. 2010;17(3):447&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837953</ArticleId><ArticleId IdType="pubmed">20042521</ArticleId></ArticleIdList></Reference><Reference><Citation>Agbeko RS, Fidler KJ, Allen ML, et al. Genetic variability in complement activation modulates the systemic inflammatory response syndrome in children. Pediatr Crit Care Med. 2010;11(5):561&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20351616</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakking FN, Brouwer N, Dolman KM, et al. Mannose-binding lectin (MBL) as prognostic factor in paediatric oncology patients. Clin Exp Immunol. 2011;165(1):51&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3110321</ArticleId><ArticleId IdType="pubmed">21488869</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingels C, Vanhorebeek I, Steffensen R, et al. Lectin pathway of complement activation and relation with clinical complications in critically ill children. Pediatr Res. 2014;75(1&#x2013;1):99&#x2013;108.</Citation><ArticleIdList><ArticleId IdType="pubmed">24129551</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann RA, Bodmer N, Simon A, et al. Serum Concentrations of Mannan-Binding Lectin (MBL) and MBL-Associated Serine Protease-2 and the Risk of Adverse Events in Pediatric Patients With Cancer and Fever in Neutropenia. J Pediatric Infect Dis Soc. 2013;2(2):155&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">26619462</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehrnbecher T, Venzon D, de Haas M, et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29(2):414&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10476751</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian YC, Della-Negra M, Rutz R, et al. Immunological analysis in paediatric HIV patients at different stages of the disease. Scand J Immunol. 2004;60(6):615&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">15584973</ArticleId></ArticleIdList></Reference><Reference><Citation>Lausen B, Schmiegelow K, Andreassen B, et al. Infections during induction therapy of childhood acute lymphoblastic leukemia&#x2013;no association to mannose-binding lectin deficiency. Eur J Haematol. 2006;76(6):481&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">16494622</ArticleId></ArticleIdList></Reference><Reference><Citation>Sprong T, Mollnes TE, Neeleman C, et al. Mannose-binding lectin is a critical factor in systemic complement activation during meningococcal septic shock. Clin Infect Dis. 2009;49(9):1380&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19793001</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouwer N, Dolman KM, van Zwieten R, et al. Mannan-binding lectin (MBL)-mediated opsonization is enhanced by the alternative pathway amplification loop. Mol Immunol. 2006;43(13):2051&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">16499969</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin Infect Dis. 2003;37(11):1496&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pubmed">14614673</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll KE, Dean MM, Heatley SL, et al. High levels of mannose-binding lectin are associated with poor outcomes after lung transplantation. Transplantation. 2011;91(9):1044&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21394075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling MT, Tu W, Han Y, et al. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis. 2012;205(1):44&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3242741</ArticleId><ArticleId IdType="pubmed">22080095</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilgin YM, Brand A, Berger SP, et al. Mannose-binding lectin is involved in multiple organ dysfunction syndrome after cardiac surgery: effects of blood transfusions. Transfusion. 2008;48(4):601&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18194386</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28694665</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2219-2840</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>23</Issue><PubDate><Year>2017</Year><Month>Jun</Month><Day>21</Day></PubDate></JournalIssue><Title>World journal of gastroenterology</Title><ISOAbbreviation>World J Gastroenterol</ISOAbbreviation></Journal><ArticleTitle>Pancreas preserving distal duodenectomy: A versatile operation for a range of infra-papillary pathologies.</ArticleTitle><Pagination><StartPage>4252</StartPage><EndPage>4261</EndPage><MedlinePgn>4252-4261</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3748/wjg.v23.i23.4252</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To investigate the range of pathologies treated by pancreas preserving distal duodenectomy (PPDD) and present the outcome of follow-up.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Neoplastic lesions of the duodenum are treated conventionally by pancreaticoduodenectomy. Lesions distal to the major papilla may be suitable for a pancreas-preserving distal duodenectomy, potentially reducing morbidity and mortality. We present our experience with this procedure. Selective intraoperative duodenoscopy assessed the relationship of the papilla to the lesion. After duodenal mobilisation and confirmation of the site of the lesion, the duodenum was transected distal to the papilla and beyond the duodenojejunal flexure and a side-to-side duodeno-jejunal anastomosis was formed. Patients were identified from a prospectively maintained database and outcomes determined from digital health records with a dataset including demographics, co-morbidities, mode of presentation, preoperative imaging and assessment, nutritional support needs, technical operative details, blood transfusion requirements, length of stay, pathology including lymph node yield and lymph node involvement, length of follow-up, complications and outcomes. Related published literature was also reviewed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-four patients had surgery with the intent of performing PPDD from 2003 to 2016. Nineteen underwent PPDD successfully. Two patients planned for PPDD proceeded to formal pancreaticoduodenectomy (PD) while three had unresectable disease. Median post-operative follow-up was 32 mo. Pathologies resected included duodenal adenocarcinoma (<i>n</i> = 6), adenomas (<i>n</i> = 5), gastrointestinal stromal tumours (<i>n</i> = 4) and lipoma, bleeding duodenal diverticulum, locally advanced colonic adenocarcinoma and extrinsic compression (<i>n</i> = 1 each). Median postoperative length of stay (LOS) was 8 d and morbidity was low [pain and nausea/vomiting (<i>n</i> = 2), anastomotic stricture (<i>n</i> = 1), pneumonia (<i>n</i> = 1), and overwhelming post-splenectomy sepsis (<i>n</i> = 1, asplenic patient)]. PPDD was associated with a significantly shorter LOS than a contemporaneous PD series [PPDD 8 (6-14) d <i>vs</i> PD 11 (10-16) d, median (IQR), <i>P</i> = 0.026]. The 30-d mortality was zero and 16 of 19 patients are alive to date. One patient died of recurrent duodenal adenocarcinoma 18 mo postoperatively and two died of unrelated disease (at 2 mo and at 8 years respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">PPDD is a versatile operation that can provide definitive treatment for a range of duodenal pathologies including adenocarcinoma.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>W Kyle</ForeName><Initials>WK</Initials><AffiliationInfo><Affiliation>W Kyle Mitchell, Pradeep F Thomas, Adam J Brooks, Dileep N Lobo, Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>Pradeep F</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>W Kyle Mitchell, Pradeep F Thomas, Adam J Brooks, Dileep N Lobo, Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaitoun</LastName><ForeName>Abed M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>W Kyle Mitchell, Pradeep F Thomas, Adam J Brooks, Dileep N Lobo, Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>W Kyle Mitchell, Pradeep F Thomas, Adam J Brooks, Dileep N Lobo, Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lobo</LastName><ForeName>Dileep N</ForeName><Initials>DN</Initials><AffiliationInfo><Affiliation>W Kyle Mitchell, Pradeep F Thomas, Adam J Brooks, Dileep N Lobo, Gastrointestinal Surgery, Nottingham Digestive Diseases Centre, National Institute for Health Research Nottingham Biomedical Research Centre, Nottingham University Hospitals and University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>World J Gastroenterol</MedlineTA><NlmUniqueID>100883448</NlmUniqueID><ISSNLinking>1007-9327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014670" MajorTopicYN="N">Ampulla of Vater</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000714" MajorTopicYN="N">Anastomosis, Surgical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001803" MajorTopicYN="N">Blood Transfusion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002404" MajorTopicYN="N">Catheterization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004379" MajorTopicYN="N">Duodenal Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004384" MajorTopicYN="N">Duodenoscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004386" MajorTopicYN="N">Duodenum</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D046152" MajorTopicYN="N">Gastrointestinal Stromal Tumors</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059351" MajorTopicYN="Y">Organ Sparing Treatments</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016577" MajorTopicYN="N">Pancreaticoduodenectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011184" MajorTopicYN="N">Postoperative Period</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Adults</Keyword><Keyword MajorTopicYN="N">Duodenal disease</Keyword><Keyword MajorTopicYN="N">Duodenojejunostomy</Keyword><Keyword MajorTopicYN="N">Indications</Keyword><Keyword MajorTopicYN="N">Outcome</Keyword><Keyword MajorTopicYN="N">Pancreas preserving distal duodenectomy</Keyword><Keyword MajorTopicYN="N">Surgical technique</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList><CoiStatement>Conflict-of-interest statement: No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2017</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28694665</ArticleId><ArticleId IdType="pmc">PMC5483499</ArticleId><ArticleId IdType="doi">10.3748/wjg.v23.i23.4252</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Perey B. Neoplasms of the duodenum. In: Scott H, Sawyers JL, editor Surgery of the Stomach, Duodenum and Small Intestine. Boston: Blackwell Scientific Publications, 1987: 571-584</Citation></Reference><Reference><Citation>Jefferson G. Carcinoma of suprapapillary duodenum casually associated with pre-existing simple ulcer. Br J Surg. 1916;4:209.</Citation></Reference><Reference><Citation>Stauffer JA, Raimondo M, Woodward TA, Goldberg RF, Bowers SP, Asbun HJ. Laparoscopic partial sleeve duodenectomy (PSD) for nonampullary duodenal neoplasms: avoiding a whipple by separating the duodenum from the pancreatic head. Pancreas. 2013;42:461&#x2013;466.</Citation><ArticleIdList><ArticleId IdType="pubmed">23462322</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1570590</ArticleId><ArticleId IdType="pubmed">16794383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimptsch U, Krautz C, Weber GF, Mansky T, Gr&#xfc;tzmann R. Nationwide in-hospital mortality following pancreatic surgery in Germany is higher than anticipated. Ann Surg. 2016;264:1082&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pubmed">26978570</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung RS, Church JM, vanStolk R. Pancreas-sparing duodenectomy: indications, surgical technique, and results. Surgery. 1995;117:254&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">7878529</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarireh B, Ghaneh P, Gardner-Thorpe J, Raraty M, Hartley M, Sutton R, Neoptolemos JP. Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps. Br J Surg. 2008;95:1506&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">18991295</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerremans RP, Lerut J, Penninckx FM. Primary malignant duodenal tumors. Ann Surg. 1979;190:179&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1344485</ArticleId><ArticleId IdType="pubmed">464691</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawano N, Ryu M, Kinoshita T, Konishi M, Iwasaki M, Furuse J, Yoshino M, Hasebe T. Segmental resection of the duodenum for treating leiomyosarcoma associated with von Recklinghausen&#x2019;s disease: a case report. Jpn J Clin Oncol. 1995;25:109&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">7596048</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattell RB, Braasch JW. A technique for the exposure of the third and fourth portions of the duodenum. Surg Gynecol Obstet. 1960;111:378&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">13808480</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassen K, Coolsen MM, Slim K, Carli F, de Aguilar-Nascimento JE, Sch&#xe4;fer M, Parks RW, Fearon KC, Lobo DN, Demartines N, et al. Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS&#xae;) Society recommendations. Clin Nutr. 2012;31:817&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">23079762</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher MM, Yeo CJ, Lillemoe KD, Roberts JR, Cameron JL. Pancreas-sparing duodenectomy for infra-ampullary duodenal pathology. Am J Surg. 1996;171:62&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">8554153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn TA, Lillemoe KD, Cameron JL, Pitt HA, Kaufman HS, Hruban RH, Yeo CJ. Adenocarcinoma of the duodenum: factors influencing long-term survival. J Gastrointest Surg. 1998;2:79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">9841972</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Yasui A. Pancreas-sparing duodenectomy for a huge leiomyosarcoma in the third portion of the duodenum. J Hepatobiliary Pancreat Surg. 1999;6:414&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pubmed">10664293</ArticleId></ArticleIdList></Reference><Reference><Citation>Orda R, Sayfan J, Wasserman I. Surgical treatment of leiomyosarcoma of the distal duodenum. Dig Surg. 2000;17:410&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">11053954</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammori BJ. Laparoscopic pancreas-preserving distal duodenectomy for duodenal stricture related to nonsteroidal antiinflammatory drugs (NSAIDs) Surg Endosc. 2002;16:1362&#x2013;1363.</Citation><ArticleIdList><ArticleId IdType="pubmed">12072993</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenberger CF, Knoefel WT, Peiper M, Yekebas EF, Hosch SB, Busch C, Izbicki JR. Pancreas-sparing duodenectomy in duodenal pathology: indications and results. Hepatogastroenterology. 2004;51:727&#x2013;731.</Citation><ArticleIdList><ArticleId IdType="pubmed">15143902</ArticleId></ArticleIdList></Reference><Reference><Citation>Spalding DR, Isla AM, Thompson JN, Williamson RC. Pancreas-sparing distal duodenectomy for infrapapillary neoplasms. Ann R Coll Surg Engl. 2007;89:130&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1964558</ArticleId><ArticleId IdType="pubmed">17346405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaniglia D, Petrucciani N, Lorenzon L, Caterino S, Cavallini M. Partial duodenectomy with end-to-end anastomosis for duodenal gastrointestinal stromal tumor. Am Surg. 2012;78:E273&#x2013;E275.</Citation><ArticleIdList><ArticleId IdType="pubmed">22691326</ArticleId></ArticleIdList></Reference><Reference><Citation>Waisberg J, Joppert-Netto G, Vasconcellos C, Sartini GH, Miranda LS, Franco MI. Carcinoid tumor of the duodenum: a rare tumor at an unusual site. Case series from a single institution. Arq Gastroenterol. 2013;50:3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23657299</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu K, Hashimoto D, Abe S, Chikamoto A, Baba H. Pancreas-preserving partial duodenectomy of the distal region for large duodenal adenoma: report of a case. Surg Today. 2015;45:390&#x2013;393.</Citation><ArticleIdList><ArticleId IdType="pubmed">24549473</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Molina FJ, Mateo-Vallejo F, Franco-Osorio Jde D, Esteban-Ramos JL, Rivero-Hen&#xe1;ndez I. Surgical approach for tumours of the third and fourth part of the duodenum. Distal pancreas-sparing duodenectomy. Int J Surg. 2015;18:143&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">25917202</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe N, Hashimoto Y, Kawaguchi S, Shimoyama H, Kojima Y, Yoshimoto E, Kondo E, Ohki A, Takeuchi H, Nagao G, et al. Successful treatment of large adenoma extending close to the papilla in the duodenum by laparoscopy-assisted pancreas-sparing duodenectomy. Asian J Endosc Surg. 2016;9:52&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">26781527</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">26362864</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>6</Issue><PubDate><Year>2015</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Sepsis-associated pulmonary complications in emergency department patients monitored with serial lactate: An observational cohort study.</ArticleTitle><Pagination><StartPage>1163</StartPage><EndPage>1168</EndPage><MedlinePgn>1163-8</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2015.07.031</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(15)00429-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Patients with severe sepsis and septic shock are at high risk for development of pulmonary complications, including acute respiratory distress syndrome (ARDS). Serial lactate monitoring is a useful tool to gauge global tissue hypoxia in emergency department (ED) patients with sepsis. We hypothesized that patients undergoing serial lactate monitoring (SL) would demonstrate a decreased incidence of pulmonary complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This is a retrospective observational cohort study of adult severe sepsis and septic shock patients with elevated lactate presenting to a large academic ED. A total of 243 patients were assigned to SL (n=132) or no serial lactate monitoring (NL; n=111). The primary outcome was a composite of pulmonary complications: (1) ARDS development and (2) respiratory failure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-eight patients (21%) in the SL group and 37 patients (33%) in the NL group developed the primary outcome (P=.03). Multivariate analysis demonstrated an association between the NL group and development of pulmonary complications (adjusted odds ratio [aOR], 2.1; confidence interval [CI], 1.15-3.78). Emergency department mechanical ventilation was independently associated with development of ARDS (aOR, 3.5; 1.8-7.0). In the a priori subgroup of patients mechanically ventilated in the ED (n=97), those who developed ARDS received higher tidal volumes compared to patients who did not develop ARDS (8.7 mL/kg predicted body weight [interquartile range, 7.6-9.5] vs 7.6 [interquartile range, 6.8-9.0]; P&lt;.01).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Serial lactate monitoring is associated with a decrease in major pulmonary complications in severe sepsis and septic shock. Acute respiratory distress syndrome incidence is also influenced by ED-based mechanical ventilation. These results provide 2 potentially modifiable variables to be targeted in future studies to prevent pulmonary complications in this patient subset.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dettmer</LastName><ForeName>Matthew R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Division of Critical Care Medicine, Department of Medicine, Cooper Medical School of Rowan University, Cooper University Hospital, Camden, NJ 08103. Electronic address: dettmer-matthew@cooperhealth.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohr</LastName><ForeName>Nicholas M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Roy J. Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242; Division of Critical Care, Department of Anesthesia, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242. Electronic address: nicholas-mohr@uiowa.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuller</LastName><ForeName>Brian M</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Division of Emergency Medicine, Washington University School of Medicine in St Louis, St Louis, MO 63110; Division of Critical Care, Department of Anesthesiology, Washington University School of Medicine in St Louis, St Louis, MO 63110. Electronic address: fullerb@wusm.wustl.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KL2 TR000450</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL115663</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR000448</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2015</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>33X04XA5AT</RegistryNumber><NameOfSubstance UI="D019344">Lactic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004635" MajorTopicYN="N">Emergency Medicine</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004636" MajorTopicYN="N">Emergency Service, Hospital</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019344" MajorTopicYN="N">Lactic Acid</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008991" MajorTopicYN="N">Monitoring, Physiologic</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012128" MajorTopicYN="N">Respiratory Distress Syndrome</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013990" MajorTopicYN="N">Tidal Volume</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ARDS</Keyword><Keyword MajorTopicYN="N">Emergency department</Keyword><Keyword MajorTopicYN="N">Lactate</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2015</Year><Month>7</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>7</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26362864</ArticleId><ArticleId IdType="mid">NIHMS736668</ArticleId><ArticleId IdType="pmc">PMC4648355</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2015.07.031</ArticleId><ArticleId IdType="pii">S0883-9441(15)00429-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson ND, Frutos-Vivar F, Esteban A, et al. Clinical risk conditions for acute lung injury in the intensive care unit and hospital ward: a prospective observational study. Crit Care. 2007;11(5):R96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2556739</ArticleId><ArticleId IdType="pubmed">17784960</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16):1685&#x2013;1693.</Citation><ArticleIdList><ArticleId IdType="pubmed">16236739</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller B, Mohr NM, Dettmer M, et al. Mechanical ventilation and acute lung injury in emergency department patients with severe sepsis and septic shock: an observational study. Acad Emerg Med. 2013;20(7):659&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3718493</ArticleId><ArticleId IdType="pubmed">23859579</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller BM, Mohr NM, Miller CN, et al. Mechanical ventilation and acute respiratory distress syndrome in the emergency department: a multi-center, observational, prospective, cross-sectional study. Chest. 2015 Mar 5; Epub ahead of print.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4524326</ArticleId><ArticleId IdType="pubmed">25742126</ArticleId></ArticleIdList></Reference><Reference><Citation>Spragg RG, Bernard GR, Checkley W, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med. 2010;181(10):1121&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2874454</ArticleId><ArticleId IdType="pubmed">20224063</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-P&#xe9;rez ER, Sprung J, Afessa B, et al. Intraoperative ventilator settings and acute lung injury after elective surgery: a nested case control study. Thorax. 2009;64(2):121&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">18988659</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes CG, Weavind L, Banerjee A, Mercaldo ND, Schildcrout JS, Pandharipande PP. Intraoperative risk factors for acute respiratory distress syndrome in critically ill patients. Anesth Analg. 2010;111(2):464&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">20418537</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Malhotra A, Saeed M, Mark RG, Talmor D. Risk Factors for ARDS in Patients Receiving Mechanical Ventilation for&gt; 48 h. Chest. 2008;133(4):853&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2628459</ArticleId><ArticleId IdType="pubmed">18263691</ArticleId></ArticleIdList></Reference><Reference><Citation>Licker M, de Perrot M, Spiliopoulos A, et al. Risk factors for acute lung injury after thoracic surgery for lung cancer. Anesth Analg. 2003;97(6):1558&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">14633519</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Brown MD, Trzeciak S, et al. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med. 2008;36(10):2734&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2737059</ArticleId><ArticleId IdType="pubmed">18766093</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest. 2009;136(1):102&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">19318675</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Loomba M, Yang JJ, et al. Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock. J Inflamm (Lond) 2010;7(6)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2837000</ArticleId><ArticleId IdType="pubmed">20181046</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368&#x2013;1377.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikkelsen ME, Shah CV, Meyer NJ, et al. The epidemiology of acute respiratory distress syndrome in patients presenting to the emergency department with severe sepsis. Shock. 2013;40(5):375&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3800497</ArticleId><ArticleId IdType="pubmed">23903852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">20463176</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA Investigators EMSRN. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739&#x2013;746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Puskarich MA, Trzeciak S, Shapiro NI, et al. Whole blood lactate kinetics in patients undergoing quantitative resuscittyion for severe sepsis and septic shock. Chest. 2013;143(6):1548&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3673659</ArticleId><ArticleId IdType="pubmed">23740148</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettmer M, Holthaus CV, Fuller BM. The impact of serial lactate monitoring on emergency department resuscitation interventions and clinical outcomes in severe sepsis and septic shock: an observational cohort study. Shock. 2015;43(1):55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4269567</ArticleId><ArticleId IdType="pubmed">25186838</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. Ann Intern Med. 2007;147(8):573&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">17938396</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Trzeciak S, Kline JA. The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med. 2009;37(5):1649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2703722</ArticleId><ArticleId IdType="pubmed">19325482</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer M, R&#xfc;egg S, Czaplinski A, et al. Inter-rater reliability of the Full Outline of Unresponsiveness score and the Glasgow Coma Scale in critically ill patients: a prospective study. Crit Care. 2010;14(2):R64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2887186</ArticleId><ArticleId IdType="pubmed">20398274</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526&#x2013;2533.</Citation><ArticleIdList><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Gajic O, Dabbagh O, Park PK, et al. Early Identification of patients at risk of acute lung injury. Am J Respir Crit Care Med. 2011;183(4):462&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056224</ArticleId><ArticleId IdType="pubmed">20802164</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573&#x2013;1582.</Citation><ArticleIdList><ArticleId IdType="pubmed">22926653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiedemann H, Wheeler A, Bernard G, et al. National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med. 2006;354(24):2564&#x2013;2575.</Citation><ArticleIdList><ArticleId IdType="pubmed">16714767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1334&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">10793167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348(2):138&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">12519925</ArticleId></ArticleIdList></Reference><Reference><Citation>Determann RM, Royakkers A, Wolthuis EK, et al. Ventilation with lower tidal volumes as compared with conventional tidal volumes for patients without acute lung injury: a preventive randomized controlled trial. Crit Care. 2010;14(1):R1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2875503</ArticleId><ArticleId IdType="pubmed">20055989</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32(8):1637&#x2013;1642.</Citation><ArticleIdList><ArticleId IdType="pubmed">15286537</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreyfuss D, Saumon G. Ventilator-induced lung injury. Lessons from experimental studies. Am J Respir Crit Care Med. 1998;157(1):294.</Citation><ArticleIdList><ArticleId IdType="pubmed">9445314</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuller BM, Mohr NM, Drewry AM, Carpenter CR. Lower tidal volume at initiation of mechanical ventilation may reduce progression to acute respiratory distress syndrome-a systematic review. Crit Care. 2013;17(1):R11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983656</ArticleId><ArticleId IdType="pubmed">23331507</ArticleId></ArticleIdList></Reference><Reference><Citation>Neto AS, Cardoso SO, Manetta JA, et al. Association Between Use of Lung-Protective Ventilation With Lower Tidal Volumes and Clinical Outcomes Among Patients Without Acute Respiratory Distress SyndromeA Meta-analysisProtective Ventilation and Lower Tidal Volumes. JAMA. 2012;308(16):1651&#x2013;1659.</Citation><ArticleIdList><ArticleId IdType="pubmed">23093163</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27416064</PMID><DateCompleted><Year>2017</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2016</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>High Mortality in Severe Sepsis and Septic Shock Patients with Do-Not-Resuscitate Orders in East Asia.</ArticleTitle><Pagination><StartPage>e0159501</StartPage><MedlinePgn>e0159501</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0159501</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0159501</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe sepsis is a potentially deadly illness and always requires intensive care. Do-not-resuscitate (DNR) orders remain a debated issue in critical care and limited data exist about its impact on care of septic patients, particularly in East Asia. We sought to assess outcome of severe sepsis patients with regard to DNR status in Taiwan.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective cohort study was conducted in intensive care units (ICUs) between 2008 and 2010. All severe sepsis patients were included for analysis. Primary outcome was association between DNR orders and ICU mortality. Volume of interventions was used as proxy indicator to indicate aggressiveness of care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-seven (9.4%) of 712 patients had DNR orders on ICU admission, and these patients were older and had higher disease severity compared with patients without DNR orders. Notably, DNR patients experienced high ICU mortality (90%). Multivariate analysis revealed that the presence of DNR orders was independently associated with ICU mortality (odds ratio: 6.13; 95% confidence interval: 2.66-14.10). In propensity score-matched cohort, ICU mortality rate (91%) in the DNR group was statistically higher than that (62%) in the non-DNR group (p &lt;0.001). Regarding ICU interventions, arterial and central venous catheterization were more commonly used in DNR patients than in non-DNR patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">From the Asian perspective, septic patients placed on DNR orders on ICU admission had exceptionally high mortality. In contrast to Western reports, DNR patients received more ICU interventions, reflecting more aggressive approach to dealing with this patient population. The findings in some ways reflect differences between East and West cultures and suggest that DNR status is an important confounder in ICU studies involving severely septic patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Chun-Ta</ForeName><Initials>CT</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Traumatology, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chuang</LastName><ForeName>Yu-Chung</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Yi-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Graduate Institute of Biomedical and Pharmaceutical Science, College of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ko</LastName><ForeName>Wen-Je</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Chong-Jen</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>07</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005202" MajorTopicYN="N">Asia, Eastern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057216" MajorTopicYN="N">Propensity Score</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016414" MajorTopicYN="Y">Resuscitation Orders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>7</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>7</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>7</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27416064</ArticleId><ArticleId IdType="pmc">PMC4944975</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0159501</ArticleId><ArticleId IdType="pii">PONE-D-16-15560</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Payne JK, Thornlow DK. Clinical perspectives on portable do-not-resuscitate orders. J Gerontol Nurs. 2008;34(10):11&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18942535</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines for the appropriate use of do-not-resuscitate orders. Council on Ethical and Judicial Affairs, American Medical Association. JAMA. 1991;265(14):1868&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">2005737</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin MT, Gillerman G, Rice NR. Orders not to resuscitate. N Engl J Med. 1976;295(7):364&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">934225</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach MC, Morrison RS. The effect of do-not-resuscitate orders on physician decision-making. J Am Geriatr Soc. 2002;50(12):2057&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">12473020</ArticleId></ArticleIdList></Reference><Reference><Citation>Holtzman J, Pheley AM, Lurie N. Changes in orders limiting care and the use of less aggressive care in a nursing home population. J Am Geriatr Soc. 1994;42(3):275&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">8120312</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedell SE, Pelle D, Maher PL, Cleary PD. Do-not-resuscitate orders for critically ill patients in the hospital. How are they used and what is their impact? JAMA. 1986;256(2):233&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">3723709</ArticleId></ArticleIdList></Reference><Reference><Citation>Santonocito C, Ristagno G, Gullo A, Weil MH. Do-not-resuscitate order: a view throughout the world. J Crit Care. 2013;28(1):14&#x2013;21. 10.1016/j.jcrc.2012.07.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2012.07.005</ArticleId><ArticleId IdType="pubmed">22981534</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzeng E, Colaianni A, Roland M, Chander G, Smith TJ, Kelly MP, et al. Influence of institutional culture and policies on do-not-resuscitate decision making at the end of life. JAMA Intern Med. 2015;175(5):812&#x2013;9. 10.1001/jamainternmed.2015.0295</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2015.0295</ArticleId><ArticleId IdType="pubmed">25845020</ArticleId></ArticleIdList></Reference><Reference><Citation>Zingmond DS, Wenger NS. Regional and institutional variation in the initiation of early do-not-resuscitate orders. Arch Intern Med. 2005;165(15):1705&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">16087817</ArticleId></ArticleIdList></Reference><Reference><Citation>Quill CM, Ratcliffe SJ, Harhay MO, Halpern SD. Variation in decisions to forgo life-sustaining therapies in US ICUs. Chest. 2014;146(3):573&#x2013;82. 10.1378/chest.13-2529</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.13-2529</ArticleId><ArticleId IdType="pmc">PMC4151359</ArticleId><ArticleId IdType="pubmed">24522751</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165&#x2013;228. 10.1007/s00134-012-2769-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-012-2769-8</ArticleId><ArticleId IdType="pmc">PMC7095153</ArticleId><ArticleId IdType="pubmed">23361625</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 1995;274(12):968&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pubmed">7674528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol. 2003;14(4):1022&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">12660337</ArticleId></ArticleIdList></Reference><Reference><Citation>Powell ES, Sauser K, Cheema N, Pirotte MJ, Quattromani E, Avula U, et al. Severe sepsis in do-not-resuscitate patients: intervention and mortality rates. J Emerg Med. 2013;44(4):742&#x2013;9. 10.1016/j.jemermed.2012.09.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jemermed.2012.09.034</ArticleId><ArticleId IdType="pubmed">23260467</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradford MA, Lindenauer PK, Wiener RS, Walkey AJ. Do-not-resuscitate status and observational comparative effectiveness research in patients with septic shock*. Crit Care Med. 2014;42(9):2042&#x2013;7. 10.1097/CCM.0000000000000403</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000403</ArticleId><ArticleId IdType="pmc">PMC4266548</ArticleId><ArticleId IdType="pubmed">24810532</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Yang KS, Hsann YM, Lim V, Ong BC. The effect of comorbidity and age on hospital mortality and length of stay in patients with sepsis. J Crit Care. 2010;25(3):398&#x2013;405. 10.1016/j.jcrc.2009.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2009.09.001</ArticleId><ArticleId IdType="pubmed">19836195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000&#x2013;2012. JAMA. 2014;311(13):1308&#x2013;16. 10.1001/jama.2014.2637</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.2637</ArticleId><ArticleId IdType="pubmed">24638143</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent JL. Characteristics and outcomes of cancer patients in European ICUs. Crit Care. 2009;13(1):R15 10.1186/cc7713</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc7713</ArticleId><ArticleId IdType="pmc">PMC2688132</ArticleId><ArticleId IdType="pubmed">19200368</ArticleId></ArticleIdList></Reference><Reference><Citation>Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">3928249</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Med. Crit Care Med. 1998;26(11):1793&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">9824069</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32(3):858&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">15090974</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Z, Gardiner JC, Bradley CJ. Applying propensity score methods in medical research: pitfalls and prospects. Med Care Res Rev. 2010;67(5):528&#x2013;54. 10.1177/1077558710361486</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1077558710361486</ArticleId><ArticleId IdType="pmc">PMC3268514</ArticleId><ArticleId IdType="pubmed">20442340</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs L, Chronaki CE, Park S, Novack V, Baumfeld Y, Scott D, et al. ICU admission characteristics and mortality rates among elderly and very elderly patients. Intensive Care Med. 2012;38(10):1654&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718912</ArticleId><ArticleId IdType="pubmed">22797350</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazaure H, Roman S, Sosa JA. High mortality in surgical patients with do-not-resuscitate orders: analysis of 8256 patients. Arch Surg. 2011;146(8):922&#x2013;8. 10.1001/archsurg.2011.69</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archsurg.2011.69</ArticleId><ArticleId IdType="pubmed">21502441</ArticleId></ArticleIdList></Reference><Reference><Citation>Shepardson LB, Youngner SJ, Speroff T, Rosenthal GE. Increased risk of death in patients with do-not-resuscitate orders. Med Care. 1999;37(8):727&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">10448716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemphill JC 3rd, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004;35(5):1130&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">15044768</ArticleId></ArticleIdList></Reference><Reference><Citation>Stapleton RD, Wang BM, Hudson LD, Rubenfeld GD, Caldwell ES, Steinberg KP. Causes and timing of death in patients with ARDS. Chest. 2005;128(2):525&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">16100134</ArticleId></ArticleIdList></Reference><Reference><Citation>McLean RF, Tarshis J, Mazer CD, Szalai JP. Death in two Canadian intensive care units: institutional difference and changes over time. Crit Care Med. 2000;28(1):100&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">10667506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenger NS, Pearson ML, Desmond KA, Brook RH, Kahn KL. Outcomes of patients with do-not-resuscitate orders. Toward an understanding of what do-not-resuscitate orders mean and how they affect patients. Arch Intern Med. 1995;155(19):2063&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7575065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakim RB, Teno JM, Harrell FE Jr., Knaus WA, Wenger N, Phillips RS, et al. Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgments. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med. 1996;125(4):284&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">8678391</ArticleId></ArticleIdList></Reference><Reference><Citation>Wachter RM, Luce JM, Hearst N, Lo B. Decisions about resuscitation: inequities among patients with different diseases but similar prognoses. Ann Intern Med. 1989;111(6):525&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">2549825</ArticleId></ArticleIdList></Reference><Reference><Citation>Azoulay E, Metnitz B, Sprung CL, Timsit JF, Lemaire F, Bauer P, et al. End-of-life practices in 282 intensive care units: data from the SAPS 3 database. Intensive Care Med. 2009;35(4):623&#x2013;30. 10.1007/s00134-008-1310-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-008-1310-6</ArticleId><ArticleId IdType="pubmed">18850088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehter HM, Wiener RS, Walkey AJ. "Do not resuscitate" decisions in acute respiratory distress syndrome. A secondary analysis of clinical trial data. Ann Am Thorac Soc. 2014;11(10):1592&#x2013;6. 10.1513/AnnalsATS.201406-244BC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201406-244BC</ArticleId><ArticleId IdType="pmc">PMC4298982</ArticleId><ArticleId IdType="pubmed">25386717</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J, Joynt GM, Nishimura M, Deng Y, Myatra SN, Chan YH, et al. Withholding and withdrawal of life-sustaining treatments in intensive care units in Asia. JAMA Intern Med. 2015;175(3):363&#x2013;71. 10.1001/jamainternmed.2014.7386</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2014.7386</ArticleId><ArticleId IdType="pubmed">25581712</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner A, Genga KR, Studart FS, Settmacher U, Hofmann G, Reinhart K, et al. Epidemiology of and factors associated with end-of-life decisions in a surgical intensive care unit. Crit Care Med. 2010;38(4):1060&#x2013;8. 10.1097/CCM.0b013e3181cd1110</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181cd1110</ArticleId><ArticleId IdType="pubmed">20068464</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang DW, Brass EP. Patient and hospital-level characteristics associated with the use of do-not-resuscitate orders in patients hospitalized for sepsis. J Gen Intern Med. 2014;29(9):1256&#x2013;62. 10.1007/s11606-014-2906-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-014-2906-x</ArticleId><ArticleId IdType="pmc">PMC4139525</ArticleId><ArticleId IdType="pubmed">24928264</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, et al. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17(2):R72 10.1186/cc12680</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12680</ArticleId><ArticleId IdType="pmc">PMC3672731</ArticleId><ArticleId IdType="pubmed">23594407</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, Aldabo-Pallas T, Cayuela-Dominguez A, Marquez-Vacaro JA, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother. 2008;61(2):436&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">18056733</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnacho-Montero J, Gutierrez-Pizarraya A, Escoresca-Ortega A, Fernandez-Delgado E, Lopez-Sanchez JM. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality. Crit Care. 2015;19:302 10.1186/s13054-015-1000-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1000-z</ArticleId><ArticleId IdType="pmc">PMC4549859</ArticleId><ArticleId IdType="pubmed">26307060</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">27543527</PMID><DateCompleted><Year>2018</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>3</Issue><PubDate><Year>2016</Year><Month>Sep</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Baroreflex impairment and morbidity after major surgery.</ArticleTitle><Pagination><StartPage>324</StartPage><EndPage>331</EndPage><MedlinePgn>324-31</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/bja/aew257</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Baroreflex dysfunction is a common feature of established cardiometabolic diseases that are most frequently associated with the development of critical illness. Laboratory models show that baroreflex dysfunction impairs cardiac contractility and cardiovascular performance, thereby increasing the risk of morbidity after trauma and sepsis. We hypothesized that baroreflex dysfunction contributes to excess postoperative morbidity after major surgery as a consequence of the inability to achieve adequate perioperative tissue oxygen delivery.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">In a randomized controlled trial of goal-directed haemodynamic therapy (GDT) in higher-risk surgical patients, baroreflex function was assessed using the spontaneous baroreflex sensitivity (BRS) method via an arterial line placed before surgery, using a validated sequence method technique (one beat lag). The BRS was calculated during the 6 h postoperative GDT intervention. Analyses of BRS were done by investigators blinded to clinical outcomes. The primary outcome was the association between postoperative baroreflex dysfunction (BRS &lt;6 mm Hg s(-1), a negative prognostic threshold in cardiovascular pathology) and early postoperative morbidity. The relationship between baroreflex dysfunction and postoperative attainment of preoperative indexed oxygen delivery was also assessed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Patients with postoperative baroreflex dysfunction were more likely to sustain infectious {relative risk (RR) 1.75 [95% confidence interval (CI): 1.07-2.85], P=0.02} and cardiovascular morbidity [RR 2.39 (95% CI: 1.22-4.71), P=0.008]. Prolonged hospital stay was more likely in patients with baroreflex dysfunction [unadjusted hazard ratio 1.62 (95% CI: 1.14-2.32), log-rank P=0.004]. Postoperative O2 delivery was 36% (95% CI: 7-65) lower in patients with baroreflex dysfunction in those not randomly assigned to GDT (P=0.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Baroreflex dysfunction is associated with excess morbidity, impaired cardiovascular performance, and delayed hospital discharge, suggesting a mechanistic role for autonomic dysfunction in determining perioperative outcome.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION" NlmCategory="BACKGROUND">ISCRTN76894700.</AbstractText><CopyrightInformation>&#xa9; The Author 2016. Published by Oxford University Press on behalf of the British Journal of Anaesthesia. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Toner</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Royal Perth Hospital, Perth, WA, Australia Clinical Physiology, Department of Medicine, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Royal Free Hospital, Pond Street, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>G L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Clinical Physiology, Department of Medicine, University College London, London, UK William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, London, UK Centre for Cardiovascular and Metabolic Neuroscience, Neuroscience, Physiology and Pharmacology, University College London, London, UK g.ackland@qmul.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>POM-O Study Investigators</CollectiveName></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RP_2014-04-022</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017704" MajorTopicYN="N">Baroreflex</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006439" MajorTopicYN="N">Hemodynamics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009017" MajorTopicYN="N">Morbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autonomic nervous system</Keyword><Keyword MajorTopicYN="N">baroreflex</Keyword><Keyword MajorTopicYN="N">postoperative complications</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gallego Paredes</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Toner</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lyness</LastName><ForeName>Craig</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bodger</LastName><ForeName>Phoebe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reyes</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Whittle</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sciusco</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cone</LastName><ForeName>Steven</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Karmali</LastName><ForeName>Shamir</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ackland</LastName><ForeName>Gareth</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Omar</LastName><ForeName>Rumana</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Singer</LastName><ForeName>Mervyn</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Del Arroyo</LastName><ForeName>Ana Gutierrez</ForeName><Initials>AG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hamilton</LastName><ForeName>Mark</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mallett</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Malago</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Imber</LastName><ForeName>Charles</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Windsor</LastName><ForeName>Alastair</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hinchliffe</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mughal</LastName><ForeName>Muntzer</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dawas</LastName><ForeName>Khaled</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mould</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Everingham</LastName><ForeName>Kirsty</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lees</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shulman</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>8</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27543527</ArticleId><ArticleId IdType="doi">10.1093/bja/aew257</ArticleId><ArticleId IdType="pii">S0007-0912(17)33792-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29315332</PMID><DateCompleted><Year>2018</Year><Month>02</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2018</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Clinical profile and outcomes of acute cardiorenal syndrome type-5 in sepsis: An eight-year cohort study.</ArticleTitle><Pagination><StartPage>e0190965</StartPage><MedlinePgn>e0190965</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0190965</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0190965</ELocationID><Abstract><AbstractText Label="BACKGROUND">To evaluate the clinical features and outcomes of acute cardiorenal syndrome type-5 in patients with severe sepsis and septic shock.</AbstractText><AbstractText Label="METHODS">Historical cohort study of all adult patients with severe sepsis and septic shock admitted to the intensive care units (ICU) at Mayo Clinic Rochester from January 1, 2007 through December 31, 2014. Patients with prior renal or cardiac dysfunction were excluded. Patients were divided into groups with and without cardiorenal syndrome type-5. Acute Kidney Injury (AKI) was defined by both serum creatinine and urine output criteria of the AKI Network and the cardiac injury was determined by troponin-T levels. Outcomes included in-hospital mortality, ICU and hospital length of stay, and one-year survival.</AbstractText><AbstractText Label="RESULTS">Of 602 patients meeting the study inclusion criteria, 430 (71.4%) met criteria for acute cardiorenal syndrome type-5. Patients with cardiorenal syndrome type-5 had higher severity of illness, greater vasopressor and mechanical ventilation use. Cardiorenal syndrome type-5 was associated higher unadjusted in-hospital mortality, ICU and hospital lengths of stay, and lower one-year survival. When adjusted for age, gender, severity of illness and mechanical ventilation, cardiorenal syndrome type-5 was independently associated with 1.7-times greater odds of in-hospital mortality (p = .03), but did not predict one-year survival (p = .06) compared to patients without cardiorenal syndrome.</AbstractText><AbstractText Label="CONCLUSIONS">In sepsis, acute cardiorenal syndrome type-5 is associated with worse in-hospital mortality compared to patients without cardiorenal syndrome.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vallabhajosyula</LastName><ForeName>Saraschandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1631-8238</Identifier><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakhuja</LastName><ForeName>Ankit</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geske</LastName><ForeName>Jeffrey B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Mukesh</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashyap</LastName><ForeName>Rahul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kashani</LastName><ForeName>Kianoush</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Multidisciplinary Epidemiology and Translational Research in Intensive Care (METRIC) Laboratory, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jentzer</LastName><ForeName>Jacob C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR000135</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059347" MajorTopicYN="N">Cardio-Renal Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012121" MajorTopicYN="N">Respiration, Artificial</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Competing Interests: </b>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29315332</ArticleId><ArticleId IdType="pmc">PMC5760054</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0190965</ArticleId><ArticleId IdType="pii">PONE-D-17-39030</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527&#x2013;39. Epub 2008/11/15. doi: 10.1016/j.jacc.2008.07.051 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2008.07.051</ArticleId><ArticleId IdType="pubmed">19007588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronco C, McCullough PA, Anker SD, Anand I, Aspromonte N, Bagshaw SM, et al.
Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2010;165:54&#x2013;67. Epub 2010/04/30. doi: 10.1159/000313745 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000313745</ArticleId><ArticleId IdType="pubmed">20427956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Rabb H, Shaw AD, Singbartl K, Ronco C, McCullough PA, et al.
Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:174&#x2013;94. Epub 2013/05/22. doi: 10.1159/000349970 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000349970</ArticleId><ArticleId IdType="pubmed">23689662</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha A, Vallabhajosyula S, Coville HH, Kashani K. Cardiorenal syndrome in sepsis: A narrative review. Journal of Critical Care. 43:122&#x2013;7. doi: 10.1016/j.jcrc.2017.08.044
</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2017.08.044</ArticleId><ArticleId IdType="pubmed">28881261</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonucci E, Fiaccadori E, Donadello K, Taccone FS, Franchi F, Scolletta S. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment. J Crit Care. 2014;29(4):500&#x2013;11. Epub 2014/05/06. doi: 10.1016/j.jcrc.2014.03.028 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2014.03.028</ArticleId><ArticleId IdType="pubmed">24794044</ArticleId></ArticleIdList></Reference><Reference><Citation>Virzi GM, Clementi A, Brocca A, de Cal M, Marcante S, Ronco C. Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation. Kidney Blood Press Res. 2016;41(6):1008&#x2013;15. Epub 2016/12/23. doi: 10.1159/000452602 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000452602</ArticleId><ArticleId IdType="pubmed">28006779</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula S, Sakhuja A, Geske JB, Kumar M, Poterucha JT, Kashyap R, et al.
Role of Admission Troponin-T and Serial Troponin-T Testing in Predicting Outcomes in Severe Sepsis and Septic Shock. J Am Heart Assoc. 2017;6(9). Epub 2017/09/11. doi: 10.1161/jaha.117.005930 ; PubMed Central PMCID: PMCPMC5634261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/jaha.117.005930</ArticleId><ArticleId IdType="pmc">PMC5634261</ArticleId><ArticleId IdType="pubmed">28889100</ArticleId></ArticleIdList></Reference><Reference><Citation>Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, et al.
Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation*. Crit Care Med. 2014;42(4):790&#x2013;800. Epub 2013/12/25. doi: 10.1097/CCM.0000000000000107 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000107</ArticleId><ArticleId IdType="pubmed">24365861</ArticleId></ArticleIdList></Reference><Reference><Citation>Plataki M, Kashani K, Cabello-Garza J, Maldonado F, Kashyap R, Kor DJ, et al.
Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol. 2011;6(7):1744&#x2013;51. Epub 2011/07/08. doi: 10.2215/CJN.05480610 .</Citation><ArticleIdList><ArticleId IdType="doi">10.2215/CJN.05480610</ArticleId><ArticleId IdType="pubmed">21734090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al.
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31 Epub 2007/03/03. doi: 10.1186/cc5713 ; PubMed Central PMCID: PMCPMC2206446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc5713</ArticleId><ArticleId IdType="pmc">PMC2206446</ArticleId><ArticleId IdType="pubmed">17331245</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessiere F, Khenifer S, Dubourg J, Durieu I, Lega JC. Prognostic value of troponins in sepsis: a meta-analysis. Intensive Care Med. 2013;39(7):1181&#x2013;9. Epub 2013/04/19. doi: 10.1007/s00134-013-2902-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-013-2902-3</ArticleId><ArticleId IdType="pubmed">23595497</ArticleId></ArticleIdList></Reference><Reference><Citation>Sturgess DJ, Marwick TH, Joyce C, Jenkins C, Jones M, Masci P, et al.
Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers. Crit Care. 2010;14(2):R44 Epub 2010/03/25. doi: 10.1186/cc8931 ; PubMed Central PMCID: PMCPMC2887156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc8931</ArticleId><ArticleId IdType="pmc">PMC2887156</ArticleId><ArticleId IdType="pubmed">20331902</ArticleId></ArticleIdList></Reference><Reference><Citation>Herasevich V, Pickering BW, Dong Y, Peters SG, Gajic O. Informatics infrastructure for syndrome surveillance, decision support, reporting, and modeling of critical illness. Mayo Clin Proc. 2010;85(3):247&#x2013;54. Epub 2010/03/03. doi: 10.4065/mcp.2009.0479 ; PubMed Central PMCID: PMCPMC2843116.</Citation><ArticleIdList><ArticleId IdType="doi">10.4065/mcp.2009.0479</ArticleId><ArticleId IdType="pmc">PMC2843116</ArticleId><ArticleId IdType="pubmed">20194152</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al.
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31(4):1250&#x2013;6. Epub 2003/04/12. doi: 10.1097/01.CCM.0000050454.01978.3B .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000050454.01978.3B</ArticleId><ArticleId IdType="pubmed">12682500</ArticleId></ArticleIdList></Reference><Reference><Citation>Herasevich V, Pieper MS, Pulido J, Gajic O. Enrollment into a time sensitive clinical study in the critical care setting: results from computerized septic shock sniffer implementation. J Am Med Inform Assoc. 2011;18(5):639&#x2013;44. Epub 2011/04/22. doi: 10.1136/amiajnl-2011-000228 ; PubMed Central PMCID: PMCPMC3168322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/amiajnl-2011-000228</ArticleId><ArticleId IdType="pmc">PMC3168322</ArticleId><ArticleId IdType="pubmed">21508415</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison AM, Thongprayoon C, Kashyap R, Chute CG, Gajic O, Pickering BW, et al.
Developing the surveillance algorithm for detection of failure to recognize and treat severe sepsis. Mayo Clin Proc. 2015;90(2):166&#x2013;75. Epub 2015/01/13. doi: 10.1016/j.mayocp.2014.11.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2014.11.014</ArticleId><ArticleId IdType="pmc">PMC6571011</ArticleId><ArticleId IdType="pubmed">25576199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A, Vairavan S, Akhoundi A, Wilson G, Chiofolo C, Chbat N, et al.
Development and validation of electronic surveillance tool for acute kidney injury: A retrospective analysis. J Crit Care. 2015;30(5):988&#x2013;93. Epub 2015/06/14. doi: 10.1016/j.jcrc.2015.05.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2015.05.007</ArticleId><ArticleId IdType="pubmed">26070247</ArticleId></ArticleIdList></Reference><Reference><Citation>Walkey AJ, Hammill BG, Curtis LH, Benjamin EJ. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014;146(5):1187&#x2013;95. Epub 2014/04/12. doi: 10.1378/chest.14-0003 ; PubMed Central PMCID: PMCPMC4219336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.14-0003</ArticleId><ArticleId IdType="pmc">PMC4219336</ArticleId><ArticleId IdType="pubmed">24723004</ArticleId></ArticleIdList></Reference><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303&#x2013;10. Epub 2001/07/11. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al.
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304&#x2013;77. Epub 2017/01/20. doi: 10.1007/s00134-017-4683-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-017-4683-6</ArticleId><ArticleId IdType="pubmed">28101605</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, et al.
Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013;17(1):R25 Epub 2013/02/08. doi: 10.1186/cc12503 ; PubMed Central PMCID: PMCPMC4057242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12503</ArticleId><ArticleId IdType="pmc">PMC4057242</ArticleId><ArticleId IdType="pubmed">23388612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadav H, Harrison AM, Hanson AC, Gajic O, Kor DJ, Cartin-Ceba R. Improving the Accuracy of Cardiovascular Component of the Sequential Organ Failure Assessment Score. Crit Care Med. 2015;43(7):1449&#x2013;57. Epub 2015/03/19. doi: 10.1097/CCM.0000000000000929 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000000929</ArticleId><ArticleId IdType="pubmed">25785522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, et al.
Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med. 2009;35(5):871&#x2013;81. Epub 2008/12/11. doi: 10.1007/s00134-008-1367-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-008-1367-2</ArticleId><ArticleId IdType="pubmed">19066848</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula S, Kumar M, Pandompatam G, Sakhuja A, Kashyap R, Kashani K, et al.
Prognostic impact of isolated right ventricular dysfunction in sepsis and septic shock: an 8-year historical cohort study. Ann Intensive Care. 2017;7(1):94 Epub 2017/09/09. doi: 10.1186/s13613-017-0319-9 ; PubMed Central PMCID: PMCPMC5589718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-017-0319-9</ArticleId><ArticleId IdType="pmc">PMC5589718</ArticleId><ArticleId IdType="pubmed">28884343</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabhajosyula S, Jentzer JC, Geske JB, Kumar M, Sakhuja A, Singhal A, et al.
New-Onset Heart Failure and Mortality in Hospital Survivors of Sepsis-Related Left Ventricular Dysfunction. Shock. 2017.  Epub 2017/07/21. doi: 10.1097/shk.0000000000000952 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/shk.0000000000000952</ArticleId><ArticleId IdType="pmc">PMC5766383</ArticleId><ArticleId IdType="pubmed">28727607</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SJ, Nalos M, McLean AS. Is early ventricular dysfunction or dilatation associated with lower mortality rate in adult severe sepsis and septic shock? A meta-analysis. Crit Care. 2013;17(3):R96
doi: 10.1186/cc12741 ; PubMed Central PMCID: PMC4056117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc12741</ArticleId><ArticleId IdType="pmc">PMC4056117</ArticleId><ArticleId IdType="pubmed">23706109</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevilla Berrios RA, O'Horo JC, Velagapudi V, Pulido JN. Correlation of left ventricular systolic dysfunction determined by low ejection fraction and 30-day mortality in patients with severe sepsis and septic shock: a systematic review and meta-analysis. J Crit Care. 2014;29(4):495&#x2013;9. Epub 2014/04/22. doi: 10.1016/j.jcrc.2014.03.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2014.03.007</ArticleId><ArticleId IdType="pubmed">24746109</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanspa MJ, Gutsche AR, Wilson EL, Olsen TD, Hirshberg EL, Knox DB, et al.
Application of a simplified definition of diastolic function in severe sepsis and septic shock. Crit Care. 2016;20(1):243 Epub 2016/08/05. doi: 10.1186/s13054-016-1421-3 ; PubMed Central PMCID: PMCPMC4973099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1421-3</ArticleId><ArticleId IdType="pmc">PMC4973099</ArticleId><ArticleId IdType="pubmed">27487776</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlati S, Brenna S, Prencipe L, Marocchi A, Casella GP, Lanzani M, et al. Myocardial necrosis in ICU patients with acute non-cardiac disease: a prospective study. Intensive Care Med. 2000;26(1):31&#x2013;7. Epub 2000/02/09. .</Citation><ArticleIdList><ArticleId IdType="pubmed">10663277</ArticleId></ArticleIdList></Reference><Reference><Citation>Ammann P, Fehr T, Minder EI, Gunter C, Bertel O. Elevation of troponin I in sepsis and septic shock. Intensive Care Med. 2001;27(6):965&#x2013;9. Epub 2001/08/11. .</Citation><ArticleIdList><ArticleId IdType="pubmed">11497154</ArticleId></ArticleIdList></Reference><Reference><Citation>McCullough PA, Kellum JA, Haase M, Muller C, Damman K, Murray PT, et al.
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol. 2013;182:82&#x2013;98. Epub 2013/05/22. doi: 10.1159/000349966 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000349966</ArticleId><ArticleId IdType="pubmed">23689658</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, et al.
Initiation Strategies for Renal-Replacement Therapy in the Intensive Care Unit. New England Journal of Medicine. 2016;375(2):122&#x2013;33. doi: 10.1056/NEJMoa1603017 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1603017</ArticleId><ArticleId IdType="pubmed">27181456</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">21220270</PMID><DateCompleted><Year>2015</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0885-0666</ISSN><JournalIssue CitedMedium="Print"><Volume>26</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Journal of intensive care medicine</Title><ISOAbbreviation>J Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Resuscitation bundle compliance in severe sepsis and septic shock: improves survival, is better late than never.</ArticleTitle><Pagination><StartPage>304</StartPage><EndPage>313</EndPage><MedlinePgn>304-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/0885066610392499</ELocationID><Abstract><AbstractText Label="UNLABELLED">While clinicians' management of severe sepsis and septic shock has been positively influenced by a number of clinical research studies in the last decade, challenges remain regarding early hemodynamic optimization as envisioned in the Surviving Sepsis Campaign's (SSC) resuscitation bundle (RB). We examined the impact of a hospital-wide continuous quality improvement (CQI) initiative on patients presenting with severe sepsis and septic shock, and the impact of the sepsis RB on patient outcomes when completed beyond the 6-hour recommendation period. The study was an 18-month, prospective cohort study enrolling patients who met the definition of severe sepsis or septic shock. Compliance with the hemodynamic components of the sepsis RB was defined as achieving goal mean arterial pressure (MAP) &#x2265; 65 mm Hg, central venous pressure (CVP) &#x2265; 8 mm Hg, and central venous oxygen saturation (ScvO&#x2082;) &#x2265; 70%. Compliance was assessed at 6 hours and 18 hours after diagnosis of severe sepsis or septic shock. In all, 498 patients with severe sepsis and/or septic shock were evaluated to determine the upper limit of the range of hours that compliance with the RB would still improve outcomes. Using 18 hours as a marker, Compliers at 18 hrs and Non-Compliers at 18 hrs were compared. There were 202 patients who had the RB completed in less than or equal to 18 hours. There were 296 patients who did not complete the RB at 18 hours. The Compliers at 18 hrs had a significant 10.2% lower hospital mortality 37.1% (22% relative reduction) compared to the Non-Compliers at 18 hrs hospital mortality of 47.3% (P &lt; .03). When the two groups were adjusted for differences in baseline illness severity, the Compliers at 18 hrs had a greater reduction in predicted mortality of 26.8% versus 9.4%, P &lt; 0.01.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Initiating the sepsis RB for patients with severe sepsis and/or septic shock decreased mortality. A CQI initiative that monitored the implementation in real-time allowed for improvement in compliance and efficacy of the bundle on outcomes. Multiple studies have shown that compliance to the RB within 6 hours lowers hospital mortality. This study uniquely shows that when bundle completion is extended to 18 hours, the mortality reduction remains significant.</AbstractText><CopyrightInformation>&#xa9; SAGE Publications 2011.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Coba</LastName><ForeName>Victor</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Emergency Medicine, Detroit, MI, USA Department of Surgery, Trauma and Surgical Critical Care, Detroit, MI, USA. vcoba1@hfhs.org</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitmill</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma and Surgical Critical Care, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooney</LastName><ForeName>Roberta</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Quality and Safety, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horst</LastName><ForeName>H Mathilda</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma and Surgical Critical Care, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandt</LastName><ForeName>Mary-Margaret</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma and Surgical Critical Care, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Digiovine</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Medicine, Pulmonary Critical Care and Allergy, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mlynarek</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Trauma and Surgical Critical Care, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McLellan</LastName><ForeName>Beth</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Nursing, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boleski</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Nursing, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Epidemiology, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conway</LastName><ForeName>William</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Quality and Safety, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Quality and Safety, Detroit, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>(The Henry Ford Hospital Sepsis Collaborative Group)</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Intensive Care Med</MedlineTA><NlmUniqueID>8610344</NlmUniqueID><ISSNLinking>0885-0666</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014662">Vasoconstrictor Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D018806" MajorTopicYN="N">APACHE</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000140" MajorTopicYN="N">Acidosis, Lactic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005440" MajorTopicYN="N">Fluid Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007022" MajorTopicYN="N">Hypotension</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010092" MajorTopicYN="N">Oximetry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058996" MajorTopicYN="N">Quality Improvement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012151" MajorTopicYN="N">Resuscitation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061665" MajorTopicYN="N">Time-to-Treatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014662" MajorTopicYN="N">Vasoconstrictor Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bundles</Keyword><Keyword MajorTopicYN="N">infection</Keyword><Keyword MajorTopicYN="N">quality improvement</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">septic shock</Keyword><Keyword MajorTopicYN="N">severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>6</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21220270</ArticleId><ArticleId IdType="doi">10.1177/0885066610392499</ArticleId><ArticleId IdType="pii">0885066610392499</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39470561</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1536-5964</ISSN><JournalIssue CitedMedium="Internet"><Volume>103</Volume><Issue>43</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Medicine</Title><ISOAbbreviation>Medicine (Baltimore)</ISOAbbreviation></Journal><ArticleTitle>Mortality of patients with sepsis in intensive care units at tertiary hospitals in Jordan: Prospective cohort study.</ArticleTitle><Pagination><StartPage>e40169</StartPage><MedlinePgn>e40169</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e40169</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1097/MD.0000000000040169</ELocationID><Abstract><AbstractText>The aim of this study was to describe the 30-day mortality rate of adult patients with sepsis and septic shock in 6 intensive care units of 2 tertiary hospitals in Jordan. A prospective cohort design was used. Patients with sepsis and septic shock admitted to the medical and surgical intensive care units at 2 tertiary hospitals were followed up during the period between February 2022 and June 2022 (N&#x2005;=&#x2005;148). Data were analyzed using SPSS, version 23. Moreover, descriptive statistics, chi-square, and binary logistic regression were used. Notably, 52.7% of patients with sepsis and septic shock died within 30 days of diagnosis of sepsis and septic shock. Sequential Organ Failure Assessment score and the history of having solid tumors significantly predicted the 30-day mortality rate. Moreover, 43 (29.0%) patients with sepsis and septic shock had positive blood cultures, and 46 (31.0%) had positive urine cultures. Patients with sepsis and septic shock have a notable mortality rate that can be predicted from total Sequential Organ Failure Assessment scores and from the history of having solid tumors. Early assessment and initiation of treatment for sepsis essentially would reduce the likelihood of progression of sepsis to septic shock and would reduce associated patients' mortality.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Al Omar</LastName><ForeName>Saleh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Al-Balqa Applied University, Salt, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alshraideh</LastName><ForeName>Jafar Alasad</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Acute and Critical Care, University of Jordan, Amman, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oweidat</LastName><ForeName>Islam</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Community and Mental Health Nursing Department, Faculty of Nursing, Zarqa University, Zarqa, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al Qadire</LastName><ForeName>Mohammad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>College of Nursing, Sultan Qaboos University, Muscat, Oman.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Nursing, Al Al-Bayt University, Mafraq, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khalaf</LastName><ForeName>Atika</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>The PRO-CARE Group, Faculty of Health Science, Kristianstad University, Kristianstad, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Nursing, Fatima College of Heath Sciences, Ajman, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abu Sumaqa</LastName><ForeName>Yasmeen</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Faculty of Nursing, Al-Balqa Applied University, Salt, Jordan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Mugheed</LastName><ForeName>Khalid</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-9727-7804</Identifier><AffiliationInfo><Affiliation>College of Nursing, Riyadh Elm University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saeed Alabdullah</LastName><ForeName>Amany Anwar</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Department of Maternity and Pediatric Nursing College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farghaly Abdelaliem</LastName><ForeName>Sally Mohammed</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Nursing Management and Education, College of Nursing, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Medicine (Baltimore)</MedlineTA><NlmUniqueID>2985248R</NlmUniqueID><ISSNLinking>0025-7974</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007597" MajorTopicYN="N" Type="Geographic">Jordan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="Y">Intensive Care Units</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062606" MajorTopicYN="Y">Tertiary Care Centers</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="Y">Shock, Septic</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="N">Organ Dysfunction Scores</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no conflicts of interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>16</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>16</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>10</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39470561</ArticleId><ArticleId IdType="pmc">PMC11521002</ArticleId><ArticleId IdType="doi">10.1097/MD.0000000000040169</ArticleId><ArticleId IdType="pii">00005792-202410250-00089</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. . The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J-L, Sakr Y, Singer M, et al. .; EPIC III Investigators. Prevalence and outcomes of infection among patients in intensive care units in 2017. JAMA. 2020;323:1478&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7093816</ArticleId><ArticleId IdType="pubmed">32207816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleischmann-Struzek C, Mellhammar L, Rose N, et al. . Incidence and mortality of hospital-and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46:1552&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381468</ArticleId><ArticleId IdType="pubmed">32572531</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor SP, Anderson WE, Beam K, Taylor B, Ellerman J, Kowalkowski MA. The association between antibiotic delay intervals and hospital mortality among patients treated in the emergency department for suspected sepsis. Crit Care Med. 2021;49:741&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33591002</ArticleId></ArticleIdList></Reference><Reference><Citation>Berr&#xed;os-Torres SI, Umscheid CA, Bratzler DW, et al. .; Healthcare Infection Control Practices Advisory Committee. Centers for disease control and prevention guideline for the prevention of surgical site infection. JAMA Surg. 2017;152:784&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28467526</ArticleId></ArticleIdList></Reference><Reference><Citation>Neviere R, Parsons PE, Finlay G. Sepsis syndromes in adults: epidemiology, definitions, clinical presentation, diagnosis, and prognosis. In: Connor RF. (Ed), UpToDate. Wolters Kluwer; 2022. https://www.uptodate.com/contents/sepsis-syndromes-in-adults-epidemiology-definitions-clinical-presentation-diagnosis-and-prognosis.</Citation></Reference><Reference><Citation>Grozdanovski K, Milenkovikj Z, Demiri I, et al. . Epidemiology of community-acquired sepsis in adult patients: a six year observational study. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2018;39:59&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">30110265</ArticleId></ArticleIdList></Reference><Reference><Citation>Heldens M, Schout M, Hammond NE, Bass F, Delaney A, Finfer SR. Sepsis incidence and mortality are underestimated in Australian intensive care unit administrative data. Med J Aust. 2018;209:255&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30176790</ArticleId></ArticleIdList></Reference><Reference><Citation>Hantrakun V, Somayaji R, Teparrukkul P, et al. . Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalised patients in a resource limited setting in Northeast Thailand: a prospective observational study (Ubon-sepsis). PLoS One. 2018;13:e0204509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6157894</ArticleId><ArticleId IdType="pubmed">30256845</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Liang S, Geng J, et al. . Development of a nomogram to predict 30-day mortality of patients with sepsis-associated encephalopathy: a retrospective cohort study. J Intensive Care. 2020;8:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7331133</ArticleId><ArticleId IdType="pubmed">32637121</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson A, Tyd&#xe9;n J, Johansson J, et al. . Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scand J Clin Lab Invest. 2020;80:156&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">31841042</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleakley G, Cole M. Recognition and management of sepsis: the nurse&#x2019;s role. Br J Nurs. 2020;29:1248&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">33242267</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson A, Coates DE, Osborn S, Blackmore CC, Williams B. Early, nurse-directed sepsis care. Am J Nurs. 2019;119:52&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30589710</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Humaidan AH, Ahmad FM, Al-Binni MA, Bani Hani A, Abu Abeeleh M. Characteristics of adult sepsis patients in the intensive care units in a tertiary hospital in Jordan: an observational study. Crit Care Res Pract. 2021;2:2741271.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8736695</ArticleId><ArticleId IdType="pubmed">35003804</ArticleId></ArticleIdList></Reference><Reference><Citation>Adam MA, Turner MC, Sun Z, et al. . The appropriateness of 30-day mortality as a quality metric in colorectal cancer surgery. Am J Surg. 2018;215:66&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28599835</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima T, Yamamoto H, Marubashi S, et al. . Validity and significance of 30-day mortality rate as a quality indicator for gastrointestinal cancer surgeries. Ann Gastroenterol Surg. 2018;2:231&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5980515</ArticleId><ArticleId IdType="pubmed">29863181</ArticleId></ArticleIdList></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2021;57:323&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">12725876</ArticleId></ArticleIdList></Reference><Reference><Citation>Jouffroy R, Parfait PA, Gilbert B, et al. . Relationship between prehospital modified Charlson Comorbidity Index and septic shock 30-day mortality. Am J Emerg Med. 2022;60:128&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">35961123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y, Wang J, Lei Z, Zhang Y, Wang W. Sentiment analysis for necessary preview of 30-day mortality in sepsis patients and the control strategies. J Healthc Eng. 2021;2021:1713363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8560239</ArticleId><ArticleId IdType="pubmed">34733452</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva EP, Duarte VD, Soares MM, et al. . Survival analysis of patients with sepsis in Brazil. Rev Soc Bras Med Trop. 2019;52:e20180121.</Citation><ArticleIdList><ArticleId IdType="pubmed">30994793</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang CT, Tsai YJ, Tsai PR, Yu CJ, Ko WJ. Epidemiology and outcome of severe sepsis and septic shock in surgical intensive care units in Northern Taiwan. Medicine (Baltimore). 2015;94:e2136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5059006</ArticleId><ArticleId IdType="pubmed">26632737</ArticleId></ArticleIdList></Reference><Reference><Citation>Baykara N, Akalin H, Arslanta&#x15f; MK, et al. . Epidemiology of sepsis in intensive care units in Turkey: a multicenter, point-prevalence study. Crit Care. 2018;22:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901868</ArticleId><ArticleId IdType="pubmed">29656714</ArticleId></ArticleIdList></Reference><Reference><Citation>Szakmany T, Pugh R, Kopczynska M, et al. .; Welsh Digital Data Collection Platform Collaborators. Defining sepsis on the wards: results of a multi-centre point-prevalence study comparing two sepsis definitions. Anaesthesia. 2018;73:195&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">29150856</ArticleId></ArticleIdList></Reference><Reference><Citation>Abou Dagher G, El Khuri C, Chehadeh AA, et al. . Are patients with cancer with sepsis and bacteraemia at a higher risk of mortality? A retrospective chart review of patients presenting to a tertiary care centre in Lebanon. BMJ Open. 2017;7:e013502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5353271</ArticleId><ArticleId IdType="pubmed">28289047</ArticleId></ArticleIdList></Reference><Reference><Citation>Van de Louw A, Cohrs A, Leslie D. Incidence of sepsis and associated mortality within the first year after cancer diagnosis in middle aged adults: a US population based study. PLoS One. 2020;15:e0243449.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769272</ArticleId><ArticleId IdType="pubmed">33370330</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres VB, Azevedo LC, Silva UV, et al. . Sepsis-associated outcomes in critically ill patients with malignancies. Ann Am Thorac Soc. 2015;12:1185&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">26086679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper AJ, Keller SP, Chan C, et al. . Improvements in sepsis-associated mortality in hospitalised patients with cancer versus those without cancer. A 12-year analysis using clinical data. Ann Am Thorac Soc. 2020;17:466&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7175974</ArticleId><ArticleId IdType="pubmed">31800299</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcan B, Olgun S, Torlak F, Sa&#x11f;men SB, Ery&#xfc;ksel E, Karakurt S. Determination of factors affecting mortality of patients with sepsis in a tertiary intensive care unit. Turk Thorac J. 2015;16:128&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793766</ArticleId><ArticleId IdType="pubmed">29404090</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson M, Chikhani M, Blyth E, et al. . Predicting 30-day mortality in patients with sepsis: an exploratory analysis of process of care and patient characteristics. J Intensive Care Soc. 2018;19:299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6259088</ArticleId><ArticleId IdType="pubmed">30515239</ArticleId></ArticleIdList></Reference><Reference><Citation>Suh JW, Kim MJ, Kim JH. Risk factors of septic shock development and thirty-day mortality with a predictive model in adult candidemia patients in intensive care units. Infect Dis (Lond). 2021;53:908&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">34330205</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerken S, Mandel M, Zingg W, Wolkewitz M. Use of prevalence data to study sepsis incidence and mortality in intensive care units. Lancet Infect Dis. 2018;18:252.</Citation><ArticleIdList><ArticleId IdType="pubmed">29485090</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel Mawla MA, Mostafa EA, Hasanin RM, Salah MM. Assessment of seasonal variation on neonatal sepsis. Bull Natl Res Cent. 2021;45:1&#x2013;6.</Citation></Reference><Reference><Citation>Rababa M, Bani-Hamad D, Hayajneh AA, Al Mugheed K. Nurses&#x2019; knowledge, attitudes, practice, and decision-making skills related to sepsis assessment and management. Electron J Gen Med. 2022;19:em420.</Citation><ArticleIdList><ArticleId IdType="pubmed">35051870</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">28858182</PMID><DateCompleted><Year>2018</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1528-1159</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>9</Issue><PubDate><Year>2018</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Spine</Title><ISOAbbreviation>Spine (Phila Pa 1976)</ISOAbbreviation></Journal><ArticleTitle>Metabolic Syndrome and 30-Day Outcomes in Elective Lumbar Spinal Fusion.</ArticleTitle><Pagination><StartPage>661</StartPage><EndPage>666</EndPage><MedlinePgn>661-666</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/BRS.0000000000002397</ELocationID><Abstract><AbstractText Label="STUDY DESIGN">A retrospective cohort study.</AbstractText><AbstractText Label="OBJECTIVE">The aim of this study was to evaluate the effect of metabolic syndrome (MetS) on 30-day morbidity and mortality following elective lumbar spinal fusion.</AbstractText><AbstractText Label="SUMMARY OF BACKGROUND DATA">MetS is a variable combination of hypertension, obesity, elevated fasting plasma glucose, and dyslipidemia.MetS has been associated with an increased risk of postoperative morbidity and mortality in multiple surgical settings. To our knowledge, the effect of MetS on 30-day outcomes following elective lumbar spinal fusion has not been well studied.</AbstractText><AbstractText Label="METHODS">An analysis of ACS-NSQIP data was performed between 2006 and 2013. Patients undergoing elective posterior lumbar fusion were identified. Emergency procedures, infections, tumor cases, and revision surgeries were excluded. Patients were defined as having MetS if they had a history of hypertension requiring medication, diabetes, and a body mass index (BMI) &#x2265;30&#x200a;kg/m.</AbstractText><AbstractText Label="RESULTS">One thousand five hundred ninety (10.2%) patients with MetS were identified. A mild increase in major (P&#x200a;=&#x200a;0.040) and minor complications (P&#x200a;=&#x200a;0.003) in patients with MetS was noted. MetS was associated with increased rates of pulmonary complications (1.9% compared with 1.0%; P&#x200a;=&#x200a;0.001), sepsis (1.7% compared with 0.9%; P&#x200a;=&#x200a;0.005), and acute post-op renal failure (0.4% compared with 0%; P&#x200a;&lt;&#x200a;0.001). Multivariate analysis confirmed MetS to be an independent predictor of pulmonary complications [odds ratio (OR) 1.51; 95% confidence interval (95% CI 1.00-2.27); P&#x200a;=&#x200a;0.048], sepsis (OR 1.56; 95% CI 1.01-2.42; P&#x200a;=&#x200a;0.039), and acute postoperative renal failure (OR 6.95; 95% CI 2.23-21.67; P&#x200a;=&#x200a;0.001). MetS status was associated with a mild increase in total hospital length of stay (4.38 compared with 3.81 days; P&#x200a;&lt;&#x200a;0.001).</AbstractText><AbstractText Label="CONCLUSION">While MetS is a predictor of postoperative acute renal failure, it only slightly increases the risk of overall complications and is not associated with increased rates of 30-day reoperations or readmissions following elective lumbar fusion.</AbstractText><AbstractText Label="LEVEL OF EVIDENCE">3.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chung</LastName><ForeName>Andrew S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Mayo Clinic-Arizona, Department of Orthopedic Surgery, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campbell</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Arizona College of Medicine-Phoenix, Orthopedic Surgery Residency, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waldrop</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Sonoran Spine, Phoenix, AZ.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crandall</LastName><ForeName>Dennis</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Mayo Clinic-Arizona, Department of Orthopedic Surgery, Phoenix, AZ.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sonoran Spine, Phoenix, AZ.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine (Phila Pa 1976)</MedlineTA><NlmUniqueID>7610646</NlmUniqueID><ISSNLinking>0362-2436</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="N">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013123" MajorTopicYN="N">Spinal Fusion</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28858182</ArticleId><ArticleId IdType="doi">10.1097/BRS.0000000000002397</ArticleId><ArticleId IdType="pii">00007632-201805010-00015</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356&#x2013;359.</Citation></Reference><Reference><Citation>Aguilar M, Bhuket T, Torres S, et al. Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015; 313:1973&#x2013;1974.</Citation></Reference><Reference><Citation>Selph JP, Whited WM, Smith AB, et al. Metabolic syndrome as a predictor for postoperative complications after urologic surgery. Urology 2014; 83:1051&#x2013;1059.</Citation></Reference><Reference><Citation>Ao H, Xu F, Wang X, et al. Effects of metabolic syndrome with or without obesity on outcomes after coronary artery bypass graft. A cohort and 5-year study. PLoS One 2015; 10:e0117671.</Citation></Reference><Reference><Citation>Bhayani NH, Hyder O, Frederick W, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 2012; 152:218&#x2013;226.</Citation></Reference><Reference><Citation>Glance LG, Wissler R, Mukamel DB, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology 2010; 113:859&#x2013;872.</Citation></Reference><Reference><Citation>Gonzalez A, Valle D, Chiu YL, et al. The metabolic syndrome in patients undergoing knee and hip arthroplasty trends and in-hospital outcomes in the United States. J Arthroplasty 2012; 27:1743&#x2013;1749. e1.</Citation></Reference><Reference><Citation>Bae HW, Rajaee SS, Kanim LE. Nationwide trends in the surgical management of lumbar spinal stenosis. Spine (Phila Pa 1976) 2013; 38:916&#x2013;926.</Citation></Reference><Reference><Citation>Memtsoudis SG, Kirksey M, Ma Y, et al. Metabolic syndrome and lumbar spine fusion surgery. Spine (Phila Pa 1976) 2012; 37:989&#x2013;995.</Citation></Reference><Reference><Citation>Weiss A, Anderson JE, Chang DC, et al. Comparing the national surgical quality improvement program with the nationwide inpatient sample database. JAMA Surg 2015; 150:815.</Citation></Reference><Reference><Citation>Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894:I&#x2013;xii. 1&#x2013;253.</Citation></Reference><Reference><Citation>Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21:1&#x2013;6.</Citation></Reference><Reference><Citation>Belmont PJ, Goodman GP, Hamilton W, et al. Morbidity and mortality in the thirty-day period following total hip arthroplasty: risk factors and incidence. J Arthroplasty 2014; 29:2025&#x2013;2030.</Citation></Reference><Reference><Citation>Saleh A, Thirukumaran C, Mesfin A, et al. Complications and readmission after lumbar spine surgery in elderly patients: an analysis of 2,320 patients. Spine J 2017; 17:1106&#x2013;1112.</Citation></Reference><Reference><Citation>Gandhi R, Woo KM, Zywiel MG, et al. Metabolic syndrome increases the prevalence of spine osteoarthritis. Orthop Surg 2014; 6:23&#x2013;27.</Citation></Reference><Reference><Citation>Golinvaux NS, Varthi AG, Bohl DD, et al. Complication rates following elective lumbar fusion in patients with diabetes. Spine (Phila Pa 1976) 2014; 39:1809&#x2013;1816.</Citation></Reference><Reference><Citation>Bluth T, Pelosi P, de Abreu MG. The obese patient undergoing nonbariatric surgery. Curr Opin Anaesthesiol 2016; 29:421&#x2013;429.</Citation></Reference><Reference><Citation>Pugely AJ, Martin CT, Harwood J, et al. Database and registry research in orthopaedic surgery: part i: claims-based data. J Bone Joint Surg Am 2015; 97:1278&#x2013;1287.</Citation></Reference><Reference><Citation>Pugely AJ, Martin CT, Harwood J, et al. Database and registry research in orthopaedic surgery: part 2: clinical registry data. J Bone Joint Surg Am 2015; 97:1799&#x2013;1808.</Citation></Reference><Reference><Citation>Bohl DD, Basques BA, Golinvaux NS, et al. Nationwide Inpatient Sample and National Surgical Quality Improvement Program give different results in hip fracture studies. Clin Orthop 2014; 472:1672&#x2013;1680.</Citation></Reference><Reference><Citation>Bohl DD, Russo GS, Basques BA, et al. Variations in data collection methods between national databases affect study results: a comparison of the nationwide inpatient sample and national surgical quality improvement program databases for lumbar spine fusion procedures. J Bone Joint Surg Am 2014; 96:e193.</Citation></Reference><Reference><Citation>Lawson EH, Louie R, Zingmond DS, et al. A comparison of clinical registry versus administrative claims data for reporting of 30-day surgical complications. Ann Surg 2012; 256:973&#x2013;981.</Citation></Reference><Reference><Citation>Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24:683&#x2013;689.</Citation></Reference><Reference><Citation>Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient's sex. Am J Crit Care 2009; 18:468&#x2013;473.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31127197</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>30</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5624</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>11</Issue><PubDate><Year>2019</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Spinal cord</Title><ISOAbbreviation>Spinal Cord</ISOAbbreviation></Journal><ArticleTitle>A prospective study of health behaviors and risk of all-cause and cause-specific mortality after spinal cord injury.</ArticleTitle><Pagination><StartPage>933</StartPage><EndPage>941</EndPage><MedlinePgn>933-941</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41393-019-0298-9</ELocationID><Abstract><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Prospective cohort study OBJECTIVES: Identify the association between health behaviors and risk of all-cause and cause-specific mortality in adults with chronic spinal cord injury (SCI) SETTING: A large rehabilitation hospital in the Southeastern United States.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Participants included 3070 adults (&gt;18 years old) with chronic (&gt;1-year) traumatic SCI. Behavioral data were collected by mail-in self report assessment between 1997-1998 and 2007-2010. Mortality status was determined using the National Death Index as of December 2016. We examined the associations between six behavioral domains (prescription medication usage, alcohol use, smoking, two nutrition factors, and fitness) and risk of all-cause and cause-specific mortality, including deaths due to sepsis (ICD-10-CM A40-A41), pneumonia and influenza (J09-J18), cancer (C00-D49), heart and blood vessel diseases (I00-I99), unintentional injuries (V01-X59, Y40-Y84, Y88), and all other causes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">All health behaviors, except one nutrition factor, were associated with risk of all-cause mortality. Prescription medication usage was related to an increase in the risk of deaths caused by sepsis, unintentional injuries, and other causes of death. Alcohol usage was associated with an increased hazard of deaths due to unintentional injuries. Smoking was associated with increased risk of deaths due to cancer, heart and blood vessel diseases, and all other causes. Fitness level was protective from deaths due to heart and blood vessel diseases and other causes, as was the other nutrition factor.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The results identify relationships between health behaviors and specific causes of death and affirm their importance as targets for SCI rehabilitation research and intervention.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>DiPiro</LastName><ForeName>Nicole D</ForeName><Initials>ND</Initials><AffiliationInfo><Affiliation>College of Health Professions, Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>College of Health Professions, Medical University of South Carolina, Charleston, SC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krause</LastName><ForeName>James S</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>College of Health Professions, Medical University of South Carolina, Charleston, SC, USA. krause@musc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>90IF0066</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>90SI5016</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>H133G090059</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant><Grant><GrantID>H133N50022</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant><Grant><GrantID>90IF0066</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>90SI5016</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>H133G090059</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant><Grant><GrantID>H133N50022</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant><Grant><GrantID>90IF0066</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>90SI5016</GrantID><Acronym>ACL</Acronym><Agency>ACL HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>H133G090059</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant><Grant><GrantID>H133N50022</GrantID><Agency>U.S. Department of Health &amp; Human Services | ACL | National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>05</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Spinal Cord</MedlineTA><NlmUniqueID>9609749</NlmUniqueID><ISSNLinking>1362-4393</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002423" MajorTopicYN="N">Cause of Death</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015438" MajorTopicYN="N">Health Behavior</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073599" MajorTopicYN="N">Health Risk Behaviors</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013119" MajorTopicYN="N">Spinal Cord Injuries</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31127197</ArticleId><ArticleId IdType="doi">10.1038/s41393-019-0298-9</ArticleId><ArticleId IdType="pii">10.1038/s41393-019-0298-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Spinal Cord. 2012 Aug;50(8):609-13</Citation><ArticleIdList><ArticleId IdType="pubmed">22410844</ArticleId></ArticleIdList></Reference><Reference><Citation>J Spinal Cord Med. 2014 Nov;37(6):662-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24090450</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2013 May;51(5):413-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23380680</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2009 Oct;90(10):1708-15</Citation><ArticleIdList><ArticleId IdType="pubmed">19801060</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2006 Aug;87(8):1079-85</Citation><ArticleIdList><ArticleId IdType="pubmed">16876553</ArticleId></ArticleIdList></Reference><Reference><Citation>J Spinal Cord Med. 2009;32(2):162-74</Citation><ArticleIdList><ArticleId IdType="pubmed">19569464</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2017 Jun;55(6):553-558</Citation><ArticleIdList><ArticleId IdType="pubmed">28169293</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2008 Aug;89(8):1482-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18674984</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2018 Mar;56(3):265-273</Citation><ArticleIdList><ArticleId IdType="pubmed">29187745</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2019 Jul;57(7):594-602</Citation><ArticleIdList><ArticleId IdType="pubmed">30804424</ArticleId></ArticleIdList></Reference><Reference><Citation>J Spinal Cord Med. 2019 Jul;42(4):444-452</Citation><ArticleIdList><ArticleId IdType="pubmed">30124389</ArticleId></ArticleIdList></Reference><Reference><Citation>Top Spinal Cord Inj Rehabil. 2010 Fall;16(2):53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">21960734</ArticleId></ArticleIdList></Reference><Reference><Citation>Soc Sci Med. 2010 May;70(10):1558-66</Citation><ArticleIdList><ArticleId IdType="pubmed">20226579</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2015 Apr;96(4):645-51</Citation><ArticleIdList><ArticleId IdType="pubmed">25616394</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2005 Jul;43(7):408-16</Citation><ArticleIdList><ArticleId IdType="pubmed">15711609</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1984 Oct 12;252(14):1905-7</Citation><ArticleIdList><ArticleId IdType="pubmed">6471323</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2018 Oct;56(10):920-930</Citation><ArticleIdList><ArticleId IdType="pubmed">29895883</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 1996 May;34(5):255-63</Citation><ArticleIdList><ArticleId IdType="pubmed">8963971</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2018 Oct;99(10):1941-1948</Citation><ArticleIdList><ArticleId IdType="pubmed">29908137</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2017 Feb;55(2):135-140</Citation><ArticleIdList><ArticleId IdType="pubmed">27897187</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10569435</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2009 Jan;90(1):95-101</Citation><ArticleIdList><ArticleId IdType="pubmed">19154835</ArticleId></ArticleIdList></Reference><Reference><Citation>Top Spinal Cord Inj Rehabil. 2013 Winter;19(1):15-24</Citation><ArticleIdList><ArticleId IdType="pubmed">23459002</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2018 Jan 2;13(1):e0190362</Citation><ArticleIdList><ArticleId IdType="pubmed">29293575</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2018 Jul;56(7):680-686</Citation><ArticleIdList><ArticleId IdType="pubmed">29483586</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Phys Med Rehabil. 2016 Oct;97(10):1669-78</Citation><ArticleIdList><ArticleId IdType="pubmed">27449321</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuroepidemiology. 2015;44(3):182-98</Citation><ArticleIdList><ArticleId IdType="pubmed">25997873</ArticleId></ArticleIdList></Reference><Reference><Citation>Top Spinal Cord Inj Rehabil. 2012 Spring;18(2):113-117</Citation><ArticleIdList><ArticleId IdType="pubmed">23074361</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinal Cord. 2007 Nov;45(11):713-21</Citation><ArticleIdList><ArticleId IdType="pubmed">17279098</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">16909250</PMID><DateCompleted><Year>2008</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0341-2695</ISSN><JournalIssue CitedMedium="Print"><Volume>31</Volume><Issue>4</Issue><PubDate><Year>2007</Year><Month>Aug</Month></PubDate></JournalIssue><Title>International orthopaedics</Title><ISOAbbreviation>Int Orthop</ISOAbbreviation></Journal><ArticleTitle>Urinary catheterisation and deep wound infection after hip fracture surgery.</ArticleTitle><Pagination><StartPage>483</StartPage><EndPage>485</EndPage><MedlinePgn>483-5</MedlinePgn></Pagination><Abstract><AbstractText>We have studied the incidence of deep wound infection after hip fracture surgery and its relationship to urinary catheterisation. Infection after hemiarthroplasty occurred in 16/949 cases and 10/1,143 sliding hip screw fixations. No cases of deep sepsis were seen for the 203 patients treated with an intramedullary nail or the 816 patients treated with parallel screws. The use of urinary catheterisation was compared with a control group of patients. In the sepsis group, 12/18 patients had been catheterised peri-operatively or within 24 h, as opposed to 18/36 patients in the control group; the difference between these two groups was not statistically significant (P=0.38). There was a statistically significant increase in the proportion of patients who had more than two urinary catheterisations (6/18 versus 3/36, P=0.05) or who had a long-term catheter (7/16 versus 3/36, P=0.01) in the sepsis group.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cumming</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department Orthopaedic Surgery, Peterborough District Hospital, Thorpe Road, Peterborough, UK. jdcumming1@aol.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>Martyn J</ForeName><Initials>MJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2006</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Int Orthop</MedlineTA><NlmUniqueID>7705431</NlmUniqueID><ISSNLinking>0341-2695</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001178" MajorTopicYN="N">Arthroplasty</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001863" MajorTopicYN="N">Bone Screws</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005592" MajorTopicYN="Y">Fracture Fixation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006620" MajorTopicYN="N">Hip Fractures</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="Y">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013203" MajorTopicYN="N">Staphylococcal Infections</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013530" MajorTopicYN="N">Surgical Wound Infection</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014546" MajorTopicYN="N">Urinary Catheterization</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Le but de cette &#xe9;tude est de d&#xe9;terminer la fr&#xe9;quence des infections profondes apr&#xe8;s traitement chirurgical sur fracture de hanche et la relation de ces infections avec le sondage urinaire. Les infections apr&#xe8;s h&#xe9;mi arthroplastie sont survenues dans 16/949 cas et dans 10/1,143 cas de vis plaques en compression. Aucun cas d&#x2019;infections profondes n&#x2019;est survenu chez 203 patients trait&#xe9;s par clous intra m&#xe9;dullaires ni sur les 816 patients trait&#xe9;s par vissage simple. L&#x2019;utilisation du sondage urinaire a &#xe9;galement &#xe9;t&#xe9; compar&#xe9;e chez un groupe de patients contr&#xf4;le. Dans le groupe des patients infect&#xe9;s, 12/18 ont &#xe9;t&#xe9; sond&#xe9;s dans les 24 h p&#xe9;ri op&#xe9;ratoires en opposition aux 18/36 patients du groupe contr&#xf4;le, la diff&#xe9;rence entre ces deux groupes n&#x2019;&#xe9;tant pas significative (P=0.38). Par contre, il existe une diff&#xe9;rence significative chez les patients qui ont eu deux, ou plus de deux sondages urinaires (6/18 versus 3/36, P=0.05) ou qui ont eu un sondage de longue dur&#xe9;e (7/16, versus 3/36, P=0.01) dans le groupe des septiques.</AbstractText></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2006</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2006</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2006</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>1</Month><Day>18</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2008</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16909250</ArticleId><ArticleId IdType="pmc">PMC2267643</ArticleId><ArticleId IdType="doi">10.1007/s00264-006-0227-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation/><ArticleIdList><ArticleId IdType="pubmed">9827278</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbari EF, Hanssen AD, Duffy MC et al (1998) Risk factors for prosthetic joint infection: case-control study. Clin Infect Dis 27:1247&#x2013;1254</Citation><ArticleIdList><ArticleId IdType="pubmed">9827278</ArticleId></ArticleIdList></Reference><Reference><Citation/><ArticleIdList><ArticleId IdType="pubmed">1570138</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald RH Jr (1992) Total hip arthroplasty sepsis. Prevention and diagnosis. Orthop Clin North Am 23:259&#x2013;264</Citation><ArticleIdList><ArticleId IdType="pubmed">1570138</ArticleId></ArticleIdList></Reference><Reference><Citation/><ArticleIdList><ArticleId IdType="doi">10.1016/S0196-6553(99)70088-X</ArticleId><ArticleId IdType="pubmed">10196487</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for the prevention of surgical site infection. Am J Infect Control 27:97&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pubmed">10196487</ArticleId></ArticleIdList></Reference><Reference><Citation/><ArticleIdList><ArticleId IdType="pubmed">15911671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R (2005) Infection of the surgical site after arthroplasty of the hip. JBJS (Br) 87-B:844&#x2013;850</Citation><ArticleIdList><ArticleId IdType="pubmed">15911671</ArticleId></ArticleIdList></Reference><Reference><Citation/><ArticleIdList><ArticleId IdType="pubmed">7371252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wroblewski BM, Del Sel HJ (1980) Urethral instrumentation and deep sepsis in total hip replacement. Clin Orthop 146:209&#x2013;212</Citation><ArticleIdList><ArticleId IdType="pubmed">7371252</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33744918</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1468-2834</ISSN><JournalIssue CitedMedium="Internet"><Volume>50</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Sep</Month><Day>11</Day></PubDate></JournalIssue><Title>Age and ageing</Title><ISOAbbreviation>Age Ageing</ISOAbbreviation></Journal><ArticleTitle>Frailty is associated with long-term outcome in patients with sepsis who are over 80&#xa0;years old: results from an observational study in 241 European ICUs.</ArticleTitle><Pagination><StartPage>1719</StartPage><EndPage>1727</EndPage><MedlinePgn>1719-1727</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ageing/afab036</ELocationID><Abstract><AbstractText Label="BACKGROUND">Sepsis is one of the most frequent reasons for acute intensive care unit (ICU) admission of very old patients and mortality rates are high. However, the impact of pre-existing physical and cognitive function on long-term outcome of ICU patients&#x2009;&#x2265;&#x2009;80&#xa0;years old (very old intensive care patients (VIPs)) with sepsis is unclear.</AbstractText><AbstractText Label="OBJECTIVE">To investigate both the short- and long-term mortality of VIPs admitted with sepsis and assess the relation of mortality with pre-existing physical and cognitive function.</AbstractText><AbstractText Label="DESIGN">Prospective cohort study.</AbstractText><AbstractText Label="SETTING">241 ICUs from 22 European countries in a six-month period between May 2018 and May 2019.</AbstractText><AbstractText Label="SUBJECTS">Acutely admitted ICU patients aged &#x2265;80&#xa0;years with sequential organ failure assessment (SOFA) score&#x2009;&#x2265;&#x2009;2.</AbstractText><AbstractText Label="METHODS">Sepsis was defined according to the sepsis 3.0 criteria. Patients with sepsis as an admission diagnosis were compared with other acutely admitted patients. In addition to patients' characteristics, disease severity, information about comorbidity and polypharmacy and pre-existing physical and cognitive function were collected.</AbstractText><AbstractText Label="RESULTS">Out of 3,596 acutely admitted VIPs with SOFA score&#x2009;&#x2265;&#x2009;2, a group of 532 patients with sepsis were compared to other admissions. Predictors for 6-month mortality were age (per 5&#xa0;years): Hazard ratio (HR, 1.16 (95% confidence interval (CI), 1.09-1.25, P&#x2009;&lt;&#x2009;0.0001), SOFA (per one-point): HR, 1.16 (95% CI, 1.14-1.17, P&#x2009;&lt;&#x2009;0.0001) and frailty (CFS&#x2009;&gt;&#x2009;4): HR, 1.34 (95% CI, 1.18-1.51, P&#x2009;&lt;&#x2009;0.0001).</AbstractText><AbstractText Label="CONCLUSIONS">There is substantial long-term mortality in VIPs admitted with sepsis. Frailty, age and disease severity were identified as predictors of long-term mortality in VIPs admitted with sepsis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Haas</LastName><ForeName>Lenneke E M</ForeName><Initials>LEM</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Diakonessenhuis Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boumendil</LastName><ForeName>Ariane</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Assistance Publique-H&#xf4;pital de Paris, H&#xf4;pital Saint-Antoine, Service de R&#xe9;animation M&#xe9;dicale. Paris F-75012, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flaatten</LastName><ForeName>Hans</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Bergen, Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guidet</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Institut Pierre Louis d'Epid&#xe9;miologie et de Sant&#xe9; Publique, AP-HP, H&#xf4;pital Saint-Antoine, Service de R&#xe9;animation, Sorbonne Universit&#xe9;, INSERM, F75012 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibarz</LastName><ForeName>Mercedes</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Universitary Hospital Sagrat Cor Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jung</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Cardiology, Pulmonology and Vascular Medicine, University Hospital D&#xfc;sseldorf, Heinrich-Heine-University, D&#xfc;sseldorf, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Unidade de Cuidados Intensivos Neurocr&#xed;ticos e Trauma. Hospital de S&#xe3;o Jos&#xe9;, Centro Hospitalar, Faculdade de Ci&#xea;ncias M&#xe9;dicas de Lisboa (Nova Medical School), Universit&#xe1;rio de Lisboa Central, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morandi</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation and Aged Care, Hospital Ancelle, Cremona, Italy. Parc Sanitari Pere Virgili and Vall d'Hebr&#xf3;n Institute of Research, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Finn H</ForeName><Initials>FH</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, &#xc5;lesund Hospital, &#xc5;lesund, Norway, Department of Circulation and Medical Imaging, NTNU, Trondheim, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zafeiridis</LastName><ForeName>Tilemachos</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, General Hospital of Larissa, Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walther</LastName><ForeName>Sten</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic and Vascular Surgery, Heart Centre, Link&#xf6;ping University Hospital, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oeyen</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Intensive Care 1K12IC, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leaver</LastName><ForeName>Susannah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research Lead Critical Care Directorate St George's University Hospital, NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Watson</LastName><ForeName>Ximena</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>St George's University Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boulanger</LastName><ForeName>Carole</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chair NAHP Section ESICM, Intensive Care Unit, Royal Devon &amp; Exeter NHS Foundation Trust, Exeter, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Intensive Care and Perioperative Medicine Division, Jagiellonian University Medical College, Krak&#xf3;w, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, Inselspital, Universit&#xe4;tsspital, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cecconi</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Humanitas Clinical and Research Center - IRCCS, Via Alessandro Manzoni 56, 20089, Rozzano, MI, Italy. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Rozzano, MI, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mater Misericordiae University Hospital, Dublin, Ireland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joannidis</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Intensive Care and Emergency Medicine, Department of Internal Medicine, Medical University Innsbruck, Innsbruck, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nalapko</LastName><ForeName>Yuriy</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>European Wellness International, ICU, Luhansk, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elhadi</LastName><ForeName>Muhammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, University of Tripoli, Tripoli, Libya.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fj&#xf8;lner</LastName><ForeName>Jesper</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Intensive Care, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artigas</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, CIBER Enfermedades Respiratorias, Corporacion Sanitaria Universitaria Parc Tauli, Autonomous University of Barcelona. Sabadell, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lange</LastName><ForeName>Dylan W</ForeName><Initials>DW</Initials><AffiliationInfo><Affiliation>Department of Intensive Care Medicine, University Medical Center, University Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>VIP2 study group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Age Ageing</MedlineTA><NlmUniqueID>0375655</NlmUniqueID><ISSNLinking>0002-0729</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="Y">Frailty</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">frailty</Keyword><Keyword MajorTopicYN="N">intensive care unit (ICU)</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">very old people</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Joannidis</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eller</LastName><ForeName>Philipp</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Helbok</LastName><ForeName>Raimund</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schmutz</LastName><ForeName>Ren&#xe9;</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nollet</LastName><ForeName>Joke</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Neve</LastName><ForeName>Nikolaas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Buysscher</LastName><ForeName>Pieter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oeyen</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Swinnen</LastName><ForeName>Walter</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mika&#x10d;i&#x107;</LastName><ForeName>Marijana</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bastiansen</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Husted</LastName><ForeName>Andreas</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dahle</LastName><ForeName>B&#xe5;rd E S</ForeName><Initials>BES</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cramer</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xf8;lling</LastName><ForeName>Christoffer</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>&#xd8;rsnes</LastName><ForeName>Dorthe</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomsen</LastName><ForeName>Jakob Edelberg</ForeName><Initials>JE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Jonas Juul</ForeName><Initials>JJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Enevoldsen</LastName><ForeName>Mathilde Hummelmose</ForeName><Initials>MH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elkmann</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kubisz-Pudelko</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pope</LastName><ForeName>Alan</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Collins</LastName><ForeName>Amy</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raj</LastName><ForeName>Ashok S</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boulanger</LastName><ForeName>Carole</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frey</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hart</LastName><ForeName>Ciaran</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bolger</LastName><ForeName>Clare</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spray</LastName><ForeName>Dominic</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Randell</LastName><ForeName>Georgina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Filipe</LastName><ForeName>Helder</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Welters</LastName><ForeName>Ingeborg D</ForeName><Initials>ID</Initials></Investigator><Investigator ValidYN="Y"><LastName>Grecu</LastName><ForeName>Irina</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cupitt</LastName><ForeName>Jason</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lord</LastName><ForeName>Jenny</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Henning</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jones</LastName><ForeName>Joanne</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ball</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>North</LastName><ForeName>Julie</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Salaunkey</LastName><ForeName>Kiran</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Gordoa</LastName><ForeName>Laura Ortiz-Ruiz</ForeName><Initials>LO</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bell</LastName><ForeName>Louise</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Balasubramaniam</LastName><ForeName>Madhu</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vizcaychipi</LastName><ForeName>Marcela</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Faulkner</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mupudzi</LastName><ForeName>McDonald</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lea-Hagerty</LastName><ForeName>Megan</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Reay</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spivey</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Love</LastName><ForeName>Nicholas</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Spittle</LastName><ForeName>Nick Spittle Nick</ForeName><Initials>NSN</Initials></Investigator><Investigator ValidYN="Y"><LastName>White</LastName><ForeName>Nigel</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Patricia</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morgan</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wakefield</LastName><ForeName>Phillipa</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savine</LastName><ForeName>Rachel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jacob</LastName><ForeName>Reni</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Innes</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kapoor</LastName><ForeName>Ritoo</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Sally</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rose</LastName><ForeName>Steve</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dowling</LastName><ForeName>Susan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Leaver</LastName><ForeName>Susannah</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mane</LastName><ForeName>Tarkeshwari</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lawton</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ogbeide</LastName><ForeName>Vongayi</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khaliq</LastName><ForeName>Waqas</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baird</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romen</LastName><ForeName>Antoine</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galbois</LastName><ForeName>Arnaud</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guidet</LastName><ForeName>Bertrand</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vinsonneau</LastName><ForeName>Christophe</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Charron</LastName><ForeName>Cyril</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thevenin</LastName><ForeName>Didier</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guerot</LastName><ForeName>Emmanuel</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Besch</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savary</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mentec</LastName><ForeName>Herv&#xe9;</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chagnon</LastName><ForeName>Jean-Luc</ForeName><Initials>JL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rigaud</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Quenot</LastName><ForeName>Jean-Pierre</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castaneray</LastName><ForeName>Jeremy</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosman</LastName><ForeName>J&#xe9;r&#xe9;my</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maizel</LastName><ForeName>Julien</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tiercelet</LastName><ForeName>Kelly</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vettoretti</LastName><ForeName>Lucie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hovaere</LastName><ForeName>Maud Mousset</ForeName><Initials>MM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Messika</LastName><ForeName>Messika</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Djibr&#xe9;</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rolin</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Burtin</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcon</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nseir</LastName><ForeName>Saad</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valette</LastName><ForeName>Xavier</ForeName><Initials>X</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rabe</LastName><ForeName>Christian</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barth</LastName><ForeName>Eberhard</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ebelt</LastName><ForeName>Henning</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fuest</LastName><ForeName>Kristina</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Franz</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Horacek</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuster</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meybohm</LastName><ForeName>Patrick</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bruno</LastName><ForeName>Raphael Romano</ForeName><Initials>RR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Allg&#xe4;uer</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dubler</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schaller</LastName><ForeName>Stefan J</ForeName><Initials>SJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schering</LastName><ForeName>Stefan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Steiner</LastName><ForeName>Stephan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieck</LastName><ForeName>Thorben</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rahmel</LastName><ForeName>Tim</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Graf</LastName><ForeName>Tobias</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koutsikou</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Vakalos</LastName><ForeName>Aristeidis</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Raitsiou</LastName><ForeName>Bogdan</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Flioni</LastName><ForeName>Elli Niki</ForeName><Initials>EN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neou</LastName><ForeName>Evangelia</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tsimpoukas</LastName><ForeName>Fotios</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Papathanakos</LastName><ForeName>Georgios</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marinakis</LastName><ForeName>Giorgos</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Koutsodimitropoulos</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aikaterini</LastName><ForeName>Kounougeri</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rovina</LastName><ForeName>Nikoletta</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kourelea</LastName><ForeName>Stylliani</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Polychronis</LastName><ForeName>Tasioudis</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zidianakis</LastName><ForeName>Vasiiios</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Konstantinia</LastName><ForeName>Vryza</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aidoni</LastName><ForeName>Zoi</ForeName><Initials>Z</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marsh</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Motherway</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Read</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Martin-Loeches</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cracchiolo</LastName><ForeName>Andrea Neville</ForeName><Initials>AN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morigi</LastName><ForeName>Aristide</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Calamai</LastName><ForeName>Italo</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brusa</LastName><ForeName>Stefania</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Elhadi</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tarek</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Khaled</LastName><ForeName>Ala</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Hazem</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belkhair</LastName><ForeName>Wesal Ali</ForeName><Initials>WA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cornet</LastName><ForeName>Alexander D</ForeName><Initials>AD</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gommers</LastName><ForeName>Diederik</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Lange</LastName><ForeName>Dylan</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Boven</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haringman</LastName><ForeName>Jasper</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Haas</LastName><ForeName>Lenneke</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>van den Berg</LastName><ForeName>Lettie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hoiting</LastName><ForeName>Oscar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>de Jager</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gerritsen</LastName><ForeName>Rik T</ForeName><Initials>RT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dormans</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dieperink</LastName><ForeName>Willem</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Breidablik</LastName><ForeName>Alena Breidablik Alena</ForeName><Initials>ABA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Slapgard</LastName><ForeName>Anita</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rime</LastName><ForeName>Anne-Karin</ForeName><Initials>AK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jannestad</LastName><ForeName>Bente</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sj&#xf8;b&#xf8;e</LastName><ForeName>Britt</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rice</LastName><ForeName>Eva</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Andersen</LastName><ForeName>Finn H</ForeName><Initials>FH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strietzel</LastName><ForeName>Hans Frank</ForeName><Initials>HF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jensen</LastName><ForeName>Jan Peter</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lang&#xf8;rgen</LastName><ForeName>J&#xf8;rund</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>T&#xf8;ien</LastName><ForeName>Kirsti</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Strand</LastName><ForeName>Kristian</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hahn</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Klepstad</LastName><ForeName>P&#xe5;l</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Biernacka</LastName><ForeName>Aleksandra</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kluzik</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kudlinski</LastName><ForeName>Bartosz</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maciejewski</LastName><ForeName>Dariusz</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Studzi&#x144;ska</LastName><ForeName>Dorota</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hymczak</LastName><ForeName>Hubert</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stefaniak</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Solek-Pastuszka</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zorska</LastName><ForeName>Joanna</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cwyl</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Krzych</LastName><ForeName>Lukasz J</ForeName><Initials>LJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zukowski</LastName><ForeName>Maciej</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lipi&#x144;ska-Gediga</LastName><ForeName>Ma&#x142;gorzata</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pietruszko</LastName><ForeName>Marek</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Piechota</LastName><ForeName>Mariusz</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Serwa</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Czuczwar</LastName><ForeName>Miroslaw</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zi&#x119;tkiewicz</LastName><ForeName>Miros&#x142;aw</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kozera</LastName><ForeName>Natalia</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nasi&#x142;owski</LastName><ForeName>Pawe&#x142;</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sendur</LastName><ForeName>Pawe&#x142;</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Zatorski</LastName><ForeName>Pawe&#x142;</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Galkin</LastName><ForeName>Piotr</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gawda</LastName><ForeName>Ryszard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ko&#x15b;ciuczuk</LastName><ForeName>Urszula</ForeName><Initials>U</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cyrankiewicz</LastName><ForeName>Waldemar</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gola</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pinto</LastName><ForeName>Alexandre Fernandes</ForeName><Initials>AF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fernandes</LastName><ForeName>Ana Margarida</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Santos</LastName><ForeName>Ana Rita</ForeName><Initials>AR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sousa</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Barros</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Isabel Amorim</ForeName><Initials>IA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Blanco</LastName><ForeName>Jacobo Bacariza</ForeName><Initials>JB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Carvalho</LastName><ForeName>Jo&#xe3;o Teles</ForeName><Initials>JT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maia</LastName><ForeName>Jose</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Candeias</LastName><ForeName>Nuno</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Catorze</LastName><ForeName>Nuno</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Belskiy</LastName><ForeName>Vladislav</ForeName><Initials>V</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lores</LastName><ForeName>Africa</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mira</LastName><ForeName>Angela Prado</ForeName><Initials>AP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cilloniz</LastName><ForeName>Catia</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Perez-Torres</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Maseda</LastName><ForeName>Emilio</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Enver</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prol-Silva</LastName><ForeName>Estefania</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eixarch</LastName><ForeName>Gaspar</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gom&#xe0;</LastName><ForeName>Gemma</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aguilar</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Velasco</LastName><ForeName>Gonzalo Navarro</ForeName><Initials>GN</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jaimes</LastName><ForeName>Mari&#xe1;n Iraz&#xe1;bal</ForeName><Initials>MI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Villamayor</LastName><ForeName>Mercedes Ibarz</ForeName><Initials>MI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fern&#xe1;ndez</LastName><ForeName>Noem&#xed; Llamas</ForeName><Initials>NL</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cubero</LastName><ForeName>Patricia Jimeno</ForeName><Initials>PJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf3;pez-Cuenca</LastName><ForeName>Sonia</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomasa</LastName><ForeName>Teresa</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sj&#xf6;qvist</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brorsson</LastName><ForeName>Camilla</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schi&#xf6;ler</LastName><ForeName>Fredrik</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Westberg</LastName><ForeName>Henrik</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nauska</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Sivik</LastName><ForeName>Joakim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berkius</LastName><ForeName>Johan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thiringer</LastName><ForeName>Karin Kleiven</ForeName><Initials>KK</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Geer</LastName><ForeName>Lina</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Walther</LastName><ForeName>Sten</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Boroli</LastName><ForeName>Filippo</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schefold</LastName><ForeName>Joerg C</ForeName><Initials>JC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hergafi</LastName><ForeName>Leila</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eckert</LastName><ForeName>Philippe</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Y&#x131;ld&#x131;z</LastName><ForeName>Ismail</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Yovenko</LastName><ForeName>Ihor</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nalapko</LastName><ForeName>Yuriy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nalapko</LastName><ForeName>Yuriy</ForeName><Initials>Y</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pugh</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>21</Day><Hour>21</Hour><Minute>18</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33744918</ArticleId><ArticleId IdType="doi">10.1093/ageing/afab036</ArticleId><ArticleId IdType="pii">6178974</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">34238546</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-6771</ISSN><JournalIssue CitedMedium="Internet"><Volume>127</Volume><Issue>4</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>British journal of anaesthesia</Title><ISOAbbreviation>Br J Anaesth</ISOAbbreviation></Journal><ArticleTitle>Proteomic signatures for perioperative oxygen delivery in skin after major elective surgery: mechanistic sub-study of a randomised controlled trial.</ArticleTitle><Pagination><StartPage>511</StartPage><EndPage>520</EndPage><MedlinePgn>511-520</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bja.2021.06.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0007-0912(21)00355-X</ELocationID><Abstract><AbstractText Label="BACKGROUND">Maintaining adequate oxygen delivery (DO<sub>2</sub>) after major surgery is associated with minimising organ dysfunction. Skin is particularly vulnerable to reduced DO<sub>2</sub>. We tested the hypothesis that reduced perioperative DO<sub>2</sub> fuels inflammation in metabolically compromised skin after major surgery.</AbstractText><AbstractText Label="METHODS">Participants undergoing elective oesophagectomy were randomised immediately after surgery to standard of care or haemodynamic therapy to achieve their individualised preoperative DO<sub>2</sub>. Abdominal punch skin biopsies were snap-frozen before and 48 h after surgery. On-line two-dimensional liquid chromatography and ultra-high-definition label-free mass spectrometry was used to characterise the skin proteome. The primary outcome was proteomic changes compared between normal (&#x2265;preoperative value before induction of anaesthesia) and low DO<sub>2</sub> (&lt;preoperative value before induction of anaesthesia) after surgery. Secondary outcomes were functional enrichment analysis of up/down-regulated proteins (Ingenuity pathway analysis; STRING Protein-Protein Interaction Networks). Immunohistochemistry and immunoblotting confirmed selected proteomic findings in skin biopsies obtained from patients after hepatic resection.</AbstractText><AbstractText Label="RESULTS">Paired punch skin biopsies were obtained from 35 participants (mean age: 68 yr; 31% female), of whom 17 underwent oesophagectomy. There were 14/2096 proteins associated with normal (n=10) vs low (n=7) DO<sub>2</sub> after oesophagectomy. Failure to maintain preoperative DO<sub>2</sub> was associated with upregulation of proteins counteracting oxidative stress. Normal DO<sub>2</sub> after surgery was associated with pathways involving leucocyte recruitment and upregulation of an antimicrobial peptidoglycan recognition protein. Immunohistochemistry (n=6 patients) and immunoblots after liver resection (n=12 patients) supported the proteomic findings.</AbstractText><AbstractText Label="CONCLUSIONS">Proteomic profiles in serial skin biopsies identified organ-protective mechanisms associated with normal DO<sub>2</sub> after major surgery.</AbstractText><AbstractText Label="CLINICAL TRIAL REGISTRATION">ISRCTN76894700.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 British Journal of Anaesthesia. Published by Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heywood</LastName><ForeName>Wendy E</ForeName><Initials>WE</Initials><AffiliationInfo><Affiliation>Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bliss</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahelil</LastName><ForeName>Fatima</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Translational Medicine &amp; Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cyrus</LastName><ForeName>Trinda</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Medicine &amp; Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crescente</LastName><ForeName>Marilena</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Manchester Metropolitan University Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Translational Medicine &amp; Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iqbal</LastName><ForeName>Sadaf</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>University College London NHS Hospitals Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paredes</LastName><ForeName>Laura G</ForeName><Initials>LG</Initials><AffiliationInfo><Affiliation>University College London NHS Hospitals Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toner</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, Royal Perth Hospital, Perth, Western Australia, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Del Arroyo</LastName><ForeName>Ana G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Translational Medicine &amp; Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Toole</LastName><ForeName>Edel A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Translational Mass Spectrometry Research Group, UCL Institute of Child Health, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>Gareth L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Translational Medicine &amp; Therapeutics, William Harvey Research Institute, Queen Mary University of London, London, UK. Electronic address: g.ackland@qmul.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Br J Anaesth</MedlineTA><NlmUniqueID>0372541</NlmUniqueID><ISSNLinking>0007-0912</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011506">Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016629" MajorTopicYN="N">Esophagectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019990" MajorTopicYN="N">Perioperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011506" MajorTopicYN="N">Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D040901" MajorTopicYN="Y">Proteomics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012867" MajorTopicYN="N">Skin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">oxygen delivery</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword><Keyword MajorTopicYN="N">randomised controlled trial</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">skin</Keyword><Keyword MajorTopicYN="N">surgery</Keyword><Keyword MajorTopicYN="N">wound infection</Keyword></KeywordList><CoiStatement>Declarations of interest GLA is an Editor of British Journal of Anaesthesia; and declares consultancy work for GlaxoSmithKline, unrelated to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>9</Day><Hour>5</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34238546</ArticleId><ArticleId IdType="pmc">PMC8524389</ArticleId><ArticleId IdType="doi">10.1016/j.bja.2021.06.003</ArticleId><ArticleId IdType="pii">S0007-0912(21)00355-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang B., Whiteaker J.R., Hoofnagle A.N., Baird G.S., Rodland K.D., Paulovich A.G. Clinical potential of mass spectrometry-based proteogenomics. Nat Rev Clin Oncol. 2019;16:256&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6448780</ArticleId><ArticleId IdType="pubmed">30487530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bantscheff M., Lemeer S., Savitski M.M., Kuster B. Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present. Anal Bioanal Chem. 2012;404:939&#x2013;965.</Citation><ArticleIdList><ArticleId IdType="pubmed">22772140</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong T.G., Chan N.Y., Dillon S.T. Identification of plasma proteome signatures associated with surgery using SOMAscan. Ann Surg. 2021;273:732&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6832727</ArticleId><ArticleId IdType="pubmed">30946084</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukai A., Suehiro K., Watanabe R. Impact of intraoperative goal-directed fluid therapy on major morbidity and mortality after transthoracic oesophagectomy: a multicentre, randomised controlled trial. Br J Anaesth. 2020;125:953&#x2013;961.</Citation><ArticleIdList><ArticleId IdType="pubmed">33092805</ArticleId></ArticleIdList></Reference><Reference><Citation>Khuri S.F., Henderson W.G., DePalma R.G., Mosca C., Healey N.A., Kumbhani D.J. Determinants of long-term survival after major surgery and the adverse effect of&#xa0;postoperative complications. Ann Surg. 2005;242:326&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1357741</ArticleId><ArticleId IdType="pubmed">16135919</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W.C., Smith T.S., Henderson W.G. Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg. 2010;252:11&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">20505504</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse R.M., Harrison D.A., MacDonald N. Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery: a randomized clinical trial and systematic review. JAMA. 2014;311:2181&#x2013;2190.</Citation><ArticleIdList><ArticleId IdType="pubmed">24842135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackland G.L., Iqbal S., Paredes L.G. Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trial. Lancet Respir Med. 2015;3:33&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">25523407</ArticleId></ArticleIdList></Reference><Reference><Citation>Peerless J.R., Alexander J.J., Pinchak A.C., Piotrowski J.J., Malangoni M.A. Oxygen delivery is an important predictor&#xa0;of outcome in patients with ruptured abdominal aortic aneurysms. Ann Surg. 1998;227:726&#x2013;732. ; discussion 32&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1191355</ArticleId><ArticleId IdType="pubmed">9605664</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil G.S. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542:177&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">28179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson K., Jensen J.A., Goodson W.H., 3rd Tissue oxygenation, anemia, and perfusion in relation to wound&#xa0;healing in surgical patients. Ann Surg. 1991;214:605&#x2013;613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1358617</ArticleId><ArticleId IdType="pubmed">1953114</ArticleId></ArticleIdList></Reference><Reference><Citation>Catania R.A., Schwacha M.G., Cioffi W.G., Bland K.I., Chaudry I.H. Does uninjured skin release proinflammatory cytokines following trauma and hemorrhage? Arch Surg. 1999;134:368&#x2013;373. ; discussion 73&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">10199308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bos J.D. The skin as an organ of immunity. Clin Exp Immunol. 1997;107(Suppl 1):3&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9020927</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashima K., Honda T., Ginhoux F., Egawa G. The immunological anatomy of the skin. Nat Rev Immunol. 2019;19:19&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">30429578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope J.C., Dearman R.J., Kimber I., Hopkins S.J. The kinetics of cytokine production by draining lymph node cells following primary exposure of mice to chemical allergens. Immunology. 1994;83:250&#x2013;255.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1414935</ArticleId><ArticleId IdType="pubmed">7835943</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien P.A., Strasberg S.M. Severity grading of surgical complications. Ann Surg. 2009;250:197&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638901</ArticleId></ArticleIdList></Reference><Reference><Citation>Bliss E., Heywood W.E., Benatti M., Sebire N.J., Mills K. An optimised method for the proteomic profiling of full thickness human skin. Biol Proced Online. 2016;18:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4955162</ArticleId><ArticleId IdType="pubmed">27445641</ArticleId></ArticleIdList></Reference><Reference><Citation>Distler U., Kuharev J., Navarro P., Levin Y., Schild H., Tenzer S. Drift time-specific collision energies enable deep-coverage data-independent acquisition proteomics. Nat Methods. 2014;11:167&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pubmed">24336358</ArticleId></ArticleIdList></Reference><Reference><Citation>Geromanos S.J., Vissers J.P., Silva J.C. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC-MS with data dependant LC-MS/MS. Proteomics. 2009;9:1683&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType="pubmed">19294628</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y., Csordas A., Bai J. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442&#x2013;D450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Szklarczyk D., Gable A.L., Lyon D. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607&#x2013;D613.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323986</ArticleId><ArticleId IdType="pubmed">30476243</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology Consortium The gene Ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47:D330&#x2013;D338.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6323945</ArticleId><ArticleId IdType="pubmed">30395331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa M., Sato Y., Furumichi M., Morishima K., Tanabe M. New approach for understanding genome variations in KEGG. Nucleic Acids Res. 2019;47:D590&#x2013;D595.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6324070</ArticleId><ArticleId IdType="pubmed">30321428</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">19131956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer A., Green J., Pollard J., Jr., Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30:523&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J.H., Fraser I.P., Fukase K. Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity. Blood. 2005;106:2551&#x2013;2558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1895263</ArticleId><ArticleId IdType="pubmed">15956276</ArticleId></ArticleIdList></Reference><Reference><Citation>Dziarski R., Kashyap D.R., Gupta D. Mammalian peptidoglycan recognition proteins kill bacteria by activating two-component systems and modulate microbiome and inflammation. Microb Drug Resist. 2012;18:280&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412580</ArticleId><ArticleId IdType="pubmed">22432705</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpenter S. Skin biopsy for diagnosis of hereditary neurologic metabolic disease. Arch Dermatol. 1987;123:1618&#x2013;1621.</Citation><ArticleIdList><ArticleId IdType="pubmed">3120649</ArticleId></ArticleIdList></Reference><Reference><Citation>de Veer S.J., Furio L., Harris J.M., Hovnanian A. Proteases and proteomics: cutting to the core of human skin pathologies. Proteomics Clin Appl. 2014;8:389&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">24677727</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature. 2008;453:314&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">18480812</ArticleId></ArticleIdList></Reference><Reference><Citation>Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">12843410</ArticleId></ArticleIdList></Reference><Reference><Citation>Spallotta F., Cencioni C., Straino S. A&#xa0;nitric oxide-dependent cross-talk between class I and III histone deacetylases accelerates skin repair. J&#xa0;Biol Chem. 2013;288:11004&#x2013;11012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3630901</ArticleId><ArticleId IdType="pubmed">23463510</ArticleId></ArticleIdList></Reference><Reference><Citation>Shatirishvili M., Burk A.S., Franz C.M. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress. Cell Death Dis. 2016;7:e2461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5260879</ArticleId><ArticleId IdType="pubmed">27831556</ArticleId></ArticleIdList></Reference><Reference><Citation>Jhanji S., Vivian-Smith A., Lucena-Amaro S., Watson D., Hinds C.J., Pearse R.M. Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: a randomised controlled trial. Crit Care. 2010;14:R151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2945135</ArticleId><ArticleId IdType="pubmed">20698956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger E., Kloetzel P.M. Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme. Curr Opin Immunol. 2012;24:77&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">22296715</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C., Tampe R. MHC I chaperone complexes shaping immunity. Curr Opin Immunol. 2019;58:9&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">30771631</ArticleId></ArticleIdList></Reference><Reference><Citation>Agah A., Kyriakides T.R., Lawler J., Bornstein P. The lack of thrombospondin-1 (TSP1) dictates the course of wound healing in double-TSP1/TSP2-null mice. Am J Pathol. 2002;161:831&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1867266</ArticleId><ArticleId IdType="pubmed">12213711</ArticleId></ArticleIdList></Reference><Reference><Citation>Isenberg J.S., Pappan L.K., Romeo M.J. Blockade of&#xa0;thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg. 2008;247:180&#x2013;190.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2432017</ArticleId><ArticleId IdType="pubmed">18156939</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulniute R., Shen Y., Guo Y.Z. Plasminogen is a critical regulator of cutaneous wound healing. Thromb Haemost. 2016;115:1001&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pubmed">26791370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao J., Shen B., Gao L., Xia C.F., Bledsoe G., Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biol Chem. 2010;391:345&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">20180644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lisboa F.A., Dente C.J., Schobel S.A. Utilizing precision medicine to estimate timing for surgical closure of traumatic extremity wounds. Ann Surg. 2019;270:535&#x2013;543.</Citation><ArticleIdList><ArticleId IdType="pubmed">31348045</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">25867906</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>8</Issue><PubDate><Year>2015</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>An Electronic Tool for the Evaluation and Treatment of Sepsis in the ICU: A Randomized Controlled Trial.</ArticleTitle><Pagination><StartPage>1595</StartPage><EndPage>1602</EndPage><MedlinePgn>1595-602</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000001020</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To determine whether addition of an electronic sepsis evaluation and management tool to electronic sepsis alerting improves compliance with treatment guidelines and clinical outcomes in septic ICU patients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A pragmatic randomized trial.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Medical and surgical ICUs of an academic, tertiary care medical center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Four hundred and seven patients admitted during a 4-month period to the medical or surgical ICU with a diagnosis of sepsis established at the time of admission or in response to an electronic sepsis alert.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">Patients were randomized to usual care or the availability of an electronic tool capable of importing, synthesizing, and displaying sepsis-related data from the medical record, using logic rules to offer individualized evaluations of sepsis severity and response to therapy, informing users about evidence-based guidelines, and facilitating rapid order entry.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">There was no difference between the electronic tool (218 patients) and usual care (189 patients) with regard to the primary outcome of time to completion of all indicated Surviving Sepsis Campaign 6-hour Sepsis Resuscitation Bundle elements (hazard ratio, 1.98; 95% CI, 0.75-5.20; p = 0.159) or time to completion of each element individually. ICU mortality, ICU-free days, and ventilator-free days did not differ between intervention and control. Providers used the tool to enter orders in only 28% of available cases.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A comprehensive electronic sepsis evaluation and management tool is feasible and safe but did not influence guideline compliance or clinical outcomes, perhaps due to low utilization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Semler</LastName><ForeName>Matthew W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>1Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN. 2Division of Anesthesiology Critical Care Medicine, Vanderbilt University, Nashville, TN. 3Department of Internal Medicine, Eastern Virginia Medical School, Norfolk, VA. 4Division of Critical Care, Christian Medical College Hospital, Vellore, Tamil Nadu, India. 5Institute for Software Integrated Systems, Vanderbilt University School of Engineering, Nashville, TN. 6Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN. 7Department of Internal Medicine, Meharry Medical College, Nashville, TN.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weavind</LastName><ForeName>Liza</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Hooper</LastName><ForeName>Michael H</ForeName><Initials>MH</Initials></Author><Author ValidYN="Y"><LastName>Rice</LastName><ForeName>Todd W</ForeName><Initials>TW</Initials></Author><Author ValidYN="Y"><LastName>Gowda</LastName><ForeName>Supriya Srinivasa</ForeName><Initials>SS</Initials></Author><Author ValidYN="Y"><LastName>Nadas</LastName><ForeName>Andras</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Yanna</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Jason B</ForeName><Initials>JB</Initials></Author><Author ValidYN="Y"><LastName>Bernard</LastName><ForeName>Gordon R</ForeName><Initials>GR</Initials></Author><Author ValidYN="Y"><LastName>Wheeler</LastName><ForeName>Arthur P</ForeName><Initials>AP</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1 UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1RC1LM010310-01</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC1 LM010310</GrantID><Acronym>LM</Acronym><Agency>NLM NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 HL087738</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 RR024975</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Crit Care Med. 2015 Aug;43(8):1776-7. doi: 10.1097/CCM.0000000000001099.</RefSource><PMID Version="1">26181117</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000046" MajorTopicYN="N">Academic Medical Centers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020000" MajorTopicYN="Y">Decision Support Systems, Clinical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017052" MajorTopicYN="N">Hospital Mortality</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007902" MajorTopicYN="N">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010043" MajorTopicYN="N">Outcome and Process Assessment, Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflicts of Interest and Source of Funding: Study supported by grants 1RC1LM010310-01 from NIH, 1 UL1 RR024975 from NCRR/NIH, and CCF- 0424422 from NSF. All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. M.H.H. reported prior consulting for Biomereux and T.W.R. reported serving on an advisory board for Avisa Pharma, LLC and as a DSMB member for GlaxoSmithKline. Otherwise, the authors declare no potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2016</Year><Month>8</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25867906</ArticleId><ArticleId IdType="mid">NIHMS690789</ArticleId><ArticleId IdType="pmc">PMC4506222</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000001020</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303&#x2013;1310.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445675</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA J Am Med Assoc. 1995;273(2):117&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">7799491</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulm&#xe9; R, Lepage E, Le Gall R. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002;28(2):108&#x2013;121. doi: 10.1007/s00134-001-1143-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-001-1143-z</ArticleId><ArticleId IdType="pubmed">11907653</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368&#x2013;1377. doi: 10.1056/NEJMoa010307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa010307</ArticleId><ArticleId IdType="pubmed">11794169</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Brown MD, Trzeciak S, Shapiro NI, Garrett JS, Heffner AC, Kline JA Emergency Medicine Shock Research Network investigators. The effect of a quantitative resuscitation strategy on mortality in patients with sepsis: a meta-analysis. Crit Care Med. 2008;36(10):2734&#x2013;2739. doi: 10.1097/CCM.0b013e318186f839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318186f839</ArticleId><ArticleId IdType="pmc">PMC2737059</ArticleId><ArticleId IdType="pubmed">18766093</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589&#x2013;1596. doi: 10.1097/01.CCM.0000217961.75225.E9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000217961.75225.E9</ArticleId><ArticleId IdType="pubmed">16625125</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med. 2003;31(12):2742&#x2013;2751. doi: 10.1097/01.CCM.0000098031.24329.10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000098031.24329.10</ArticleId><ArticleId IdType="pubmed">14668610</ArticleId></ArticleIdList></Reference><Reference><Citation>MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clin Infect Dis Off Publ Infect Dis Soc Am. 2004;38(2):284&#x2013;288. doi: 10.1086/379825.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/379825</ArticleId><ArticleId IdType="pubmed">14699463</ArticleId></ArticleIdList></Reference><Reference><Citation>Severe sepsis bundles.  [Accessed December 15, 2009];Resuscitation bundle.  Available at:  http://www.survivingsepsis.org/Bundles/Pages/default.aspx.</Citation></Reference><Reference><Citation>Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC Surviving Sepsis Campaign. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med. 2010;38(2):367&#x2013;374. doi: 10.1097/CCM.0b013e3181cb0cdc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3181cb0cdc</ArticleId><ArticleId IdType="pubmed">20035219</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro NI, Howell MD, Talmor D, Lahey D, Ngo L, Buras J, Wolfe RE, Weiss JW, Lisbon A. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med. 2006;34(4):1025&#x2013;1032. doi: 10.1097/01.CCM.0000206104.18647.A8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000206104.18647.A8</ArticleId><ArticleId IdType="pubmed">16484890</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest. 2007;132(2):425&#x2013;432. doi: 10.1378/chest.07-0234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-0234</ArticleId><ArticleId IdType="pmc">PMC2703721</ArticleId><ArticleId IdType="pubmed">17573521</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, Edwards J, Cho TW, Wittlake WA. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35(4):1105&#x2013;1112. doi: 10.1097/01.CCM.0000259463.33848.3D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.CCM.0000259463.33848.3D</ArticleId><ArticleId IdType="pubmed">17334251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S-M, Huang C-D, Lin H-C, Liu C-Y, Wang C-H, Kuo H-P. A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial. Shock Augusta Ga. 2006;26(6):551&#x2013;557. doi: 10.1097/01.shk.0000232271.09440.8f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.shk.0000232271.09440.8f</ArticleId><ArticleId IdType="pubmed">17117128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer R, Artigas A, Levy MM, Blanco J, Gonz&#xe1;lez-D&#xed;az G, Garnacho-Montero J, Ib&#xe1;&#xf1;ez J, Palencia E, Quintana M, de la Torre-Prados MV Edusepsis Study Group. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA J Am Med Assoc. 2008;299(19):2294&#x2013;2303. doi: 10.1001/jama.299.19.2294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.299.19.2294</ArticleId><ArticleId IdType="pubmed">18492971</ArticleId></ArticleIdList></Reference><Reference><Citation>Lellouche F, Mancebo J, Jolliet P, Roeseler J, Schortgen F, Dojat M, Cabello B, Bouadma L, Rodriguez P, Maggiore S, Reynaert M, Mersmann S, Brochard L. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med. 2006;174(8):894&#x2013;900. doi: 10.1164/rccm.200511-1780OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200511-1780OC</ArticleId><ArticleId IdType="pmc">PMC4788698</ArticleId><ArticleId IdType="pubmed">16840741</ArticleId></ArticleIdList></Reference><Reference><Citation>Herasevich V, Yilmaz M, Khan H, Hubmayr RD, Gajic O. Validation of an electronic surveillance system for acute lung injury. Intensive Care Med. 2009;35(6):1018&#x2013;1023. doi: 10.1007/s00134-009-1460-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-009-1460-1</ArticleId><ArticleId IdType="pmc">PMC2730460</ArticleId><ArticleId IdType="pubmed">19280175</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinley BA, Moore LJ, Sucher JF, Todd SR, Turner KL, Valdivia A, Sailors RM, Moore FA. Computer protocol facilitates evidence-based care of sepsis in the surgical intensive care unit. J Trauma. 2011;70(5):1153&#x2013;1166. doi: 10.1097/TA.0b013e31821598e9. discussion 1166&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e31821598e9</ArticleId><ArticleId IdType="pubmed">21610430</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper MH, Weavind L, Wheeler AP, Martin JB, Gowda SS, Semler MW, Hayes RM, Albert DW, Deane NB, Nian H, Mathe JL, Nadas A, Sztipanovits J, Miller A, Bernard GR, Rice TW. Randomized trial of automated, electronic monitoring to facilitate early detection of sepsis in the intensive care unit*. Crit Care Med. 2012;40(7):2096&#x2013;2101. doi: 10.1097/CCM.0b013e318250a887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318250a887</ArticleId><ArticleId IdType="pmc">PMC4451061</ArticleId><ArticleId IdType="pubmed">22584763</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JB, Mathe JL, Miller P, Ledeczi A, Weavind L, Miller A, Maron D, Nadas A, Sztipanovits J. A Model-Integrated Approach to Implementing Individualized Patient Care Plans Based on Guideline-Driven Clinical Decision Support and Process Management - A Progress Report. 2008.</Citation></Reference><Reference><Citation>Mathe JL, Ledeczi A, Nadas A, Sztipanovits J, Martin JB, Weavind LM, Miller A, Miller P, Maron DJ. A Model-Integrated, Guideline-Driven, Clinical Decision-Support System. IEEE Softw. 2009;26(4):54&#x2013;61. doi: 10.1109/MS.2009.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/MS.2009.84</ArticleId></ArticleIdList></Reference><Reference><Citation>Nadas A, Mathe J, Weavind L, Semler M, Sztipanovits J. Lessons Learned from the Development of aModel-integrated Decision-support Application for Sepsis. Washington (DC): 2014.</Citation></Reference><Reference><Citation>Miller A. Alerts and reminders: Is this all there is to clinical decision support? 2011 Available at:  www.cs.umd.edu/hcil/sharp/workshop2011/files/Miller,Anne-EHR-HCILseminar.pdf#sthash.fY1CVR4W.dpuf.</Citation></Reference><Reference><Citation>Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA Emergency Medicine Shock Research Network (EMShockNet) Investigators. . Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA J Am Med Assoc. 2010;303(8):739&#x2013;746. doi: 10.1001/jama.2010.158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2010.158</ArticleId><ArticleId IdType="pmc">PMC2918907</ArticleId><ArticleId IdType="pubmed">20179283</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330(7494):765. doi: 10.1136/bmj.38398.500764.8F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38398.500764.8F</ArticleId><ArticleId IdType="pmc">PMC555881</ArticleId><ArticleId IdType="pubmed">15767266</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg AX, Adhikari NKJ, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J, Sam J, Haynes RB. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005;293(10):1223&#x2013;1238. doi: 10.1001/jama.293.10.1223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.293.10.1223</ArticleId><ArticleId IdType="pubmed">15755945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni&#xe8;s J, Colombet I, Degoulet P, Durieux P. Determinants of success for computerized clinical decision support systems integrated in CPOE systems: a systematic review. AMIA Annu Symp Proc AMIA Symp AMIA Symp. 2006:594&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1839370</ArticleId><ArticleId IdType="pubmed">17238410</ArticleId></ArticleIdList></Reference><Reference><Citation>Durieux P. Electronic medical alerts--so simple, so complex. N Engl J Med. 2005;352(10):1034&#x2013;1036. doi: 10.1056/NEJMe058016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe058016</ArticleId><ArticleId IdType="pubmed">15758015</ArticleId></ArticleIdList></Reference><Reference><Citation>MacRedmond R, Hollohan K, Stenstrom R, Nebre R, Jaswal D, Dodek P. Introduction of a comprehensive management protocol for severe sepsis is associated with sustained improvements in timeliness of care and survival. Qual Saf Health Care. 2010;19(5):e46. doi: 10.1136/qshc.2009.033407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/qshc.2009.033407</ArticleId><ArticleId IdType="pubmed">20671074</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawyer AM, Deal EN, Labelle AJ, Witt C, Thiel SW, Heard K, Reichley RM, Micek ST, Kollef MH. Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med. 2011;39(3):469&#x2013;473. doi: 10.1097/CCM.0b013e318205df85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e318205df85</ArticleId><ArticleId IdType="pubmed">21169824</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurnani PK, Patel GP, Crank CW, Vais D, Lateef O, Akimov S, Balk R, Simon D. Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after study. Clin Ther. 2010;32(7):1285&#x2013;1293. doi: 10.1016/j.clinthera.2010.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2010.07.003</ArticleId><ArticleId IdType="pubmed">20678676</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent J-L, Moreno R Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. . Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580&#x2013;637. doi: 10.1097/CCM.0b013e31827e83af.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e31827e83af</ArticleId><ArticleId IdType="pubmed">23353941</ArticleId></ArticleIdList></Reference><Reference><Citation>ProCESS Investigators. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, Terndrup T, Wang HE, Hou PC, LoVecchio F, Filbin MR, Shapiro NI, Angus DC. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370(18):1683&#x2013;1693. doi: 10.1056/NEJMoa1401602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1401602</ArticleId><ArticleId IdType="pmc">PMC4101700</ArticleId><ArticleId IdType="pubmed">24635773</ArticleId></ArticleIdList></Reference><Reference><Citation>The ARISE Investigators and the ANZICS Clinical Trials Group. Goal-Directed Resuscitation for Patients with Early Septic Shock. N Engl J Med. 2014 doi: 10.1056/NEJMoa1404380.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1404380</ArticleId><ArticleId IdType="pubmed">25272316</ArticleId></ArticleIdList></Reference><Reference><Citation>Esteban A, Frutos-Vivar F, Muriel A, Ferguson ND, Pe&#xf1;uelas O, Abraira V, Raymondos K, Rios F, Nin N, Apeztegu&#xed;a C, Violi DA, Thille AW, Brochard L, Gonz&#xe1;lez M, Villagomez AJ, Hurtado J, Davies AR, Du B, Maggiore SM, Pelosi P, Soto L, Tomicic V, D&#x2019;Empaire G, Matamis D, Abroug F, Moreno RP, Soares MA, Arabi Y, Sandi F, Jibaja M, Amin P, Koh Y, Kuiper MA, B&#xfc;low H-H, Zeggwagh AA, Anzueto A. Evolution of mortality over time in patients receiving mechanical ventilation. Am J Respir Crit Care Med. 2013;188(2):220&#x2013;230. doi: 10.1164/rccm.201212-2169OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201212-2169OC</ArticleId><ArticleId IdType="pubmed">23631814</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumenthal D, Tavenner M. The &#x201c;meaningful use&#x201d; regulation for electronic health records. N Engl J Med. 2010;363(6):501&#x2013;504. doi: 10.1056/NEJMp1006114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1006114</ArticleId><ArticleId IdType="pubmed">20647183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29981649</PMID><DateCompleted><Year>2018</Year><Month>07</Month><Day>16</Day></DateCompleted><DateRevised><Year>2018</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1555-9823</ISSN><JournalIssue CitedMedium="Internet"><Volume>84</Volume><Issue>6</Issue><PubDate><Year>2018</Year><Month>Jun</Month><Day>01</Day></PubDate></JournalIssue><Title>The American surgeon</Title><ISOAbbreviation>Am Surg</ISOAbbreviation></Journal><ArticleTitle>Importance of Markers of Sepsis in Surgical Patients.</ArticleTitle><Pagination><StartPage>1058</StartPage><EndPage>1063</EndPage><MedlinePgn>1058-1063</MedlinePgn></Pagination><Abstract><AbstractText>Sepsis, severe sepsis, and septic shock represent a serious medicinal and general social problem and still maintain an important position among the present issues in the basic and clinical research. In the prospective analysis of patients satisfying the criteria of septic condition, we determined serum levels of bioparameters in three consecutive days from the first signs of sepsis depending on the stage or advancement of the septic condition. We determined the most significant parameter/parameters which are able to determine the stage of sepsis or to predict patient's death. In the group of 68 patients, all monitored biomarkers showed significant difference in serum concentrations versus the control group (P = 0.001). The strongest positive connection between the seriousness of sepsis and serum level is in case of procalcitonin. Predictor of mortality (r = -0.468; P = 0.001), transferrin (r = -0.506; P = 0.003), and tumor necrosis factor-&#x3b1; (r = 0.939; P = 0.001). Our results show that the monitored parameters (procalcitonin, C-reactive protein, tumor necrosis factor-&#x3b1;, and interleukin 6) have strong correlations between the serum levels and the stage of disease. Examination of at least one cytokine in normal clinical practice might lead to better interpretation of the patient's condition, determining the risk of death.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Smol&#xe1;r</LastName><ForeName>Marek</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Dedinsk&#xe1;</LastName><ForeName>Ivana</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Ho&#x161;ala</LastName><ForeName>Michal</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Maz&#xfa;ch</LastName><ForeName>J&#xfa;lius</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Laca</LastName><ForeName>L'udovit</ForeName><Initials>L</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am Surg</MedlineTA><NlmUniqueID>0370522</NlmUniqueID><ISSNLinking>0003-1348</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014168">Transferrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014409">Tumor Necrosis Factor-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014168" MajorTopicYN="N">Transferrin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014409" MajorTopicYN="N">Tumor Necrosis Factor-alpha</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>7</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29981649</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">29684391</PMID><DateCompleted><Year>2019</Year><Month>05</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3792</ISSN><JournalIssue CitedMedium="Internet"><Volume>200</Volume><Issue>4</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>The Journal of urology</Title><ISOAbbreviation>J Urol</ISOAbbreviation></Journal><ArticleTitle>A Randomized Controlled Trial of Preoperative Prophylactic Antibiotics Prior to Percutaneous Nephrolithotomy in a Low Infectious Risk Population: A Report from the EDGE Consortium.</ArticleTitle><Pagination><StartPage>801</StartPage><EndPage>808</EndPage><MedlinePgn>801-808</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.juro.2018.04.062</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-5347(18)43035-2</ELocationID><Abstract><AbstractText Label="PURPOSE">Single institution studies suggest a benefit of a week of preoperative antibiotics prior to percutaneous nephrolithotomy. These studies are limited by lower quality methodology, such as the inclusion of heterogeneous populations or nonstandard definitions of sepsis. The AUA (American Urological Association) Best Practice Statement recommends less than 24 hours of intravenous antibiotics but to our knowledge no other data exist on the duration or benefit of preoperative antibiotics. Using CONSORT (Consolidated Reporting of Trials) guidelines we sought to perform a rigorous multi-institutional trial to assess preoperative antibiotics in patients in whom percutaneous nephrolithotomy was planned and who were at low risk for infection.</AbstractText><AbstractText Label="MATERIALS AND METHODS">This randomized controlled trial enrolled patients undergoing percutaneous nephrolithotomy who were at low risk, defined as negative preoperative urine cultures and no urinary drain. Of the subjects 43 were randomized to nitrofurantoin 100 mg twice daily for 7 days preoperatively while a control arm of 43 received no oral antibiotics. All subjects received perioperative doses of ampicillin and gentamicin. Prone percutaneous nephrolithotomy was performed by urologists blinded to randomization. The primary outcome was the development of sepsis.</AbstractText><AbstractText Label="RESULTS">A total of 86 subjects were enrolled. Preoperative patient characteristics were similar in the treatment and control cohorts with a stone size of 19 and 17 mm, respectively (p = 0.47). Intraoperative characteristics also did not differ. The sepsis rate was not statistically different between the treatment and control groups (12% and 14%, respectively, 95% CI -0.163-0.122, p = 1.0). Other infectious parameters and complications were similar, including intensive care admission, fever, hypotension and leukocytosis.</AbstractText><AbstractText Label="CONCLUSIONS">Our study demonstrated no advantage to providing 1 week of preoperative oral antibiotics in patients at low risk for infectious complications who undergo percutaneous nephrolithotomy. Perioperative antibiotics according to the AUA Best Practice Statement appear sufficient.</AbstractText><CopyrightInformation>Copyright &#xa9; 2018 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chew</LastName><ForeName>Ben H</ForeName><Initials>BH</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Nicole L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>Vanderbilt University, Nashville, Tennessee.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abbott</LastName><ForeName>Joel E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Chesapeake Urology Associates, Hanover, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lange</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of British Columbia, Vancouver, British Columbia, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Humphreys</LastName><ForeName>Mitchell R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Mayo Clinic Arizona, Phoenix, Arizona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pais</LastName><ForeName>Vernon M</ForeName><Initials>VM</Initials><Suffix>Jr</Suffix><AffiliationInfo><Affiliation>Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monga</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cleveland Clinic, Cleveland, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krambeck</LastName><ForeName>Amy E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Indiana University, Indianapolis, Indiana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sur</LastName><ForeName>Roger L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>University of California-San Diego, San Diego, California. Electronic address: RLsur@ucsd.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Urol</MedlineTA><NlmUniqueID>0376374</NlmUniqueID><ISSNLinking>0022-5347</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>927AH8112L</RegistryNumber><NameOfSubstance UI="D009582">Nitrofurantoin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019072" MajorTopicYN="N">Antibiotic Prophylaxis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016001" MajorTopicYN="N">Confidence Intervals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D032921" MajorTopicYN="N">Consensus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007669" MajorTopicYN="N">Kidney Calculi</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074642" MajorTopicYN="N">Nephrolithotomy, Percutaneous</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009582" MajorTopicYN="N">Nitrofurantoin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016482" MajorTopicYN="N">Urinalysis</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antibiotic prophylaxis</Keyword><Keyword MajorTopicYN="N">kidney calculi</Keyword><Keyword MajorTopicYN="N">nephrolithotomy</Keyword><Keyword MajorTopicYN="N">percutaneous</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">systemic inflammatory response syndrome</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>5</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">29684391</ArticleId><ArticleId IdType="doi">10.1016/j.juro.2018.04.062</ArticleId><ArticleId IdType="pii">S0022-5347(18)43035-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">24524473</PMID><DateCompleted><Year>2014</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2015</Year><Month>11</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1221-9118</ISSN><JournalIssue CitedMedium="Print"><Volume>109</Volume><Issue>1</Issue><PubDate><Year>2014</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Chirurgia (Bucharest, Romania : 1990)</Title><ISOAbbreviation>Chirurgia (Bucur)</ISOAbbreviation></Journal><ArticleTitle>Early dynamics of leptin plasma level in surgical critically ill patients. a prospective comparative study.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>72</EndPage><MedlinePgn>66-72</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">10</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Leptin (LPT), a hormone secreted by adipocytes,plays a role in inflammation and infection. Our study aimed to characterize the early dynamics of LPT in comparison with CRP and IL-6 during systemic inflammatory response syndrome(SIRS) and sepsis in surgical patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Sixty patients were assigned into 3 equal groups:SIRS (SI) group with major abdominal elective surgery;sepsis (SE) group with community-acquired complicated intra-abdominal infection and controls (C). LPT, CRP and IL-6 were measured initially in all groups and repeated in groups SI and SE within 5 days after surgery (9 samples - 4 day 1, 2 day 2, 1 next 3 days).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">LPT increased at 12-24 hours in SI group, but stayed within normal range in SE group. CRP and IL-6 had higher values in SE group versus SI group with an early peak for IL-6 and a late peak for CRP.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">LPT has a different early dynamics during SIRS and sepsis. LPT measurement in association with CRP or IL-6 may be useful in the differential diagnosis and prognosis of surgical critical illness at different time courses.</AbstractText><CopyrightInformation>Celsius.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Grigora&#x15f;</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Branisteanu</LastName><ForeName>D D</ForeName><Initials>DD</Initials></Author><Author ValidYN="Y"><LastName>Ungureanu</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Rusu</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Ristescu</LastName><ForeName>I</ForeName><Initials>I</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Romania</Country><MedlineTA>Chirurgia (Bucur)</MedlineTA><NlmUniqueID>9213031</NlmUniqueID><ISSNLinking>1221-9118</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020738">Leptin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016638" MajorTopicYN="Y">Critical Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="N">Elective Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059413" MajorTopicYN="N">Intraabdominal Infections</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020738" MajorTopicYN="N">Leptin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24524473</ArticleId><ArticleId IdType="pii">10</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31440795</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1238</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>9</Issue><PubDate><Year>2019</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Intensive care medicine</Title><ISOAbbreviation>Intensive Care Med</ISOAbbreviation></Journal><ArticleTitle>Patient's characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study.</ArticleTitle><Pagination><StartPage>1241</StartPage><EndPage>1251</EndPage><MedlinePgn>1241-1251</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00134-019-05730-x</ELocationID><Abstract><AbstractText Label="PURPOSE">Necrotising soft-tissue infections (NSTI) are characterised by necrosis, fast progression, and high rates of morbidity and mortality, but our knowledge is primarily derived from small prospective studies and retrospective studies.</AbstractText><AbstractText Label="METHODS">We performed an international, multicentre, prospective cohort study of adults with NSTI describing patient's characteristics and associations between baseline variables and microbiological findings, amputation, and 90-day mortality.</AbstractText><AbstractText Label="RESULTS">We included 409 patients with NSTI; 402 were admitted to the ICU. Cardiovascular disease [169 patients (41%)] and diabetes [98 (24%)] were the most common comorbidities; 122 patients (30%) had no comorbidity. Before surgery, bruising of the skin [210 patients (51%)] and pain requiring opioids [172 (42%)] were common. The sites most commonly affected were the abdomen/ano-genital area [140 patients (34%)] and lower extremities [126 (31%)]. Monomicrobial infection was seen in 179 patients (44%). NSTI of the upper or lower extremities was associated with monomicrobial group A streptococcus (GAS) infection, and NSTI located to the abdomen/ano-genital area was associated with polymicrobial infection. Septic shock [202 patients (50%)] and acute kidney injury [82 (20%)] were common. Amputation occurred in 22% of patients with NSTI of an extremity and was associated with higher lactate level. All-cause 90-day mortality was 18% (95% CI 14-22); age and higher lactate levels were associated with increased mortality and GAS aetiology with decreased mortality.</AbstractText><AbstractText Label="CONCLUSIONS">Patients with NSTI were heterogeneous regarding co-morbidities, initial symptoms, infectious localisation, and microbiological findings. Higher age and lactate levels were associated with increased mortality, and GAS infection with decreased mortality.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Madsen</LastName><ForeName>Martin Bruun</ForeName><Initials>MB</Initials><Identifier Source="ORCID">0000-0001-5832-2262</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. martin.bruun.madsen.01@regionh.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skrede</LastName><ForeName>Steinar</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1615-4453</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Science, University of Bergen, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perner</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-4668-0123</Identifier><AffiliationInfo><Affiliation>Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnell</LastName><ForeName>Per</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nekludov</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Surgical Services and Intensive Care, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruun</LastName><ForeName>Trond</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-7441-8413</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Haukeland University Hospital, Bergen, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karlsson</LastName><ForeName>Ylva</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Blekinge County Hospital, Karlskrona, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansen</LastName><ForeName>Marco Bo</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polzik</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hedetoft</LastName><ForeName>Morten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ros&#xe9;n</LastName><ForeName>Anders</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6739-6730</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saccenti</LastName><ForeName>Edoardo</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8284-4829</Identifier><AffiliationInfo><Affiliation>Laboratory of Systems and Synthetic Biology, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bergey</LastName><ForeName>Fran&#xe7;ois</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>LifeGlimmer GmBH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins Dos Santos</LastName><ForeName>Vitor A P</ForeName><Initials>VAP</Initials><AffiliationInfo><Affiliation>Laboratory of Systems and Synthetic Biology, Wageningen University and Research, Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LifeGlimmer GmBH, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>INFECT study group</CollectiveName></Author><Author ValidYN="Y"><LastName>Norrby-Teglund</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Infectious Medicine, Karolinska Institute, Karolinska University Hospital, Huddinge, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyldegaard</LastName><ForeName>Ole</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-1147-379X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthesia, Centre of Head and Orthopaedics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>305340</GrantID><Agency>FP7 Health</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Intensive Care Med</MedlineTA><NlmUniqueID>7704851</NlmUniqueID><ISSNLinking>0342-4642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019115" MajorTopicYN="N">Fasciitis, Necrotizing</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017063" MajorTopicYN="N">Outcome Assessment, Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018461" MajorTopicYN="N">Soft Tissue Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Critical care</Keyword><Keyword MajorTopicYN="N">Fournier&#x2019;s gangrene</Keyword><Keyword MajorTopicYN="N">Group A streptococcus</Keyword><Keyword MajorTopicYN="N">Necrotising fasciitis</Keyword><Keyword MajorTopicYN="N">Sepsis</Keyword></KeywordList><InvestigatorList><Investigator ValidYN="Y"><LastName>Bidstrup</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xe6;rnthsen</LastName><ForeName>Nina F</ForeName><Initials>NF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Frend&#xf8;</LastName><ForeName>Gladis H</ForeName><Initials>GH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Jansen</LastName><ForeName>Erik C</ForeName><Initials>EC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Madsen</LastName><ForeName>L&#xe6;rke B</ForeName><Initials>LB</Initials></Investigator><Investigator ValidYN="Y"><LastName>M&#xfc;ller</LastName><ForeName>Rasmus B</ForeName><Initials>RB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pedersen</LastName><ForeName>Emilie M J</ForeName><Initials>EMJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Petersen</LastName><ForeName>Marie W</ForeName><Initials>MW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ravn</LastName><ForeName>Frederikke</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smidt-Nielsen</LastName><ForeName>Isabel F G</ForeName><Initials>IFG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wahl</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wulffeld</LastName><ForeName>Sandra</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aronsson</LastName><ForeName>Sara</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rosemar</LastName><ForeName>Anders</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Trogen</LastName><ForeName>Joakim</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nedreb&#xf8;</LastName><ForeName>Torbj&#xf8;rn</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Oppegaard</LastName><ForeName>Oddvar</ForeName><Initials>O</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rath</LastName><ForeName>Eivind</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>S&#xe6;vik</LastName><ForeName>Marianne</ForeName><Initials>M</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31440795</ArticleId><ArticleId IdType="doi">10.1007/s00134-019-05730-x</ArticleId><ArticleId IdType="pii">10.1007/s00134-019-05730-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sci Rep. 2016 Nov 04;6:36624</Citation><ArticleIdList><ArticleId IdType="pubmed">27812043</ArticleId></ArticleIdList></Reference><Reference><Citation>Surg Clin North Am. 2009 Apr;89(2):403-20, viii</Citation><ArticleIdList><ArticleId IdType="pubmed">19281891</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2016 Feb 23;315(8):801-10</Citation><ArticleIdList><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Surg. 2014 Jun;149(6):528-36</Citation><ArticleIdList><ArticleId IdType="pubmed">24740134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Surg. 2019 Jan;269(1):58-65</Citation><ArticleIdList><ArticleId IdType="pubmed">29672405</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1951 Mar 3;1(6653):501-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14805109</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Surg. 2011 Aug;202(2):139-45</Citation><ArticleIdList><ArticleId IdType="pubmed">21545997</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2014 Jul 15;59(2):147-59</Citation><ArticleIdList><ArticleId IdType="pubmed">24947530</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1993 Dec 22-29;270(24):2957-63</Citation><ArticleIdList><ArticleId IdType="pubmed">8254858</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Microbiol Infect. 2013 Dec;19(12):E545-50</Citation><ArticleIdList><ArticleId IdType="pubmed">23795951</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Surg. 2005 Feb;140(2):151-7; discussion 158</Citation><ArticleIdList><ArticleId IdType="pubmed">15723996</ArticleId></ArticleIdList></Reference><Reference><Citation>ANZ J Surg. 2014 Jun;84(6):468-72</Citation><ArticleIdList><ArticleId IdType="pubmed">24164901</ArticleId></ArticleIdList></Reference><Reference><Citation>World J Emerg Surg. 2018 Dec 14;13:58</Citation><ArticleIdList><ArticleId IdType="pubmed">30564282</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2017 Nov;43(11):1585-1593</Citation><ArticleIdList><ArticleId IdType="pubmed">28421246</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2009 May;35(5):847-53</Citation><ArticleIdList><ArticleId IdType="pubmed">19099288</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2007 Aug 15;45(4):450-8</Citation><ArticleIdList><ArticleId IdType="pubmed">17638193</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2013 Feb 04;17(1):204</Citation><ArticleIdList><ArticleId IdType="pubmed">23394211</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2007 Oct 20;370(9596):1453-7</Citation><ArticleIdList><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2011 Jun 21;15(3):R152</Citation><ArticleIdList><ArticleId IdType="pubmed">21693053</ArticleId></ArticleIdList></Reference><Reference><Citation>BMC Infect Dis. 2012 Dec 12;12:348</Citation><ArticleIdList><ArticleId IdType="pubmed">23234429</ArticleId></ArticleIdList></Reference><Reference><Citation>J Burn Care Res. 2014 Sep-Oct;35(5):449-54</Citation><ArticleIdList><ArticleId IdType="pubmed">25144805</ArticleId></ArticleIdList></Reference><Reference><Citation>J Emerg Med. 2013 Nov;45(5):781-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23937806</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Anaesthesiol Scand. 2018 Feb;62(2):272-279</Citation><ArticleIdList><ArticleId IdType="pubmed">29082520</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care Med. 2004 Jul;32(7):1535-41</Citation><ArticleIdList><ArticleId IdType="pubmed">15241098</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2017 Dec 7;377(23):2253-2265</Citation><ArticleIdList><ArticleId IdType="pubmed">29211672</ArticleId></ArticleIdList></Reference><Reference><Citation>Epidemiol Infect. 2016 Apr;144(6):1338-44</Citation><ArticleIdList><ArticleId IdType="pubmed">26548496</ArticleId></ArticleIdList></Reference><Reference><Citation>Trials. 2018 Mar 27;19(1):198</Citation><ArticleIdList><ArticleId IdType="pubmed">29587803</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2015 Aug;41(8):1506-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26109399</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Acad Dermatol. 2015 Dec;73(6):1006-12.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">26412163</ArticleId></ArticleIdList></Reference><Reference><Citation>J Surg Res. 2014 Nov;192(1):143-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24923631</ArticleId></ArticleIdList></Reference><Reference><Citation>Crit Care. 2004 Aug;8(4):R204-12</Citation><ArticleIdList><ArticleId IdType="pubmed">15312219</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 1996 Jul;22(7):707-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8844239</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann R Coll Surg Engl. 2017 May;99(5):341-346</Citation><ArticleIdList><ArticleId IdType="pubmed">28462647</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">24953159</PMID><DateCompleted><Year>2015</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-1632</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Jan</Month><Day>01</Day></PubDate></JournalIssue><Title>The spine journal : official journal of the North American Spine Society</Title><ISOAbbreviation>Spine J</ISOAbbreviation></Journal><ArticleTitle>Predicting patients with concurrent noncontiguous spinal epidural abscess lesions.</ArticleTitle><Pagination><StartPage>95</StartPage><EndPage>101</EndPage><MedlinePgn>95-101</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.spinee.2014.06.008</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1529-9430(14)00571-3</ELocationID><Abstract><AbstractText Label="BACKGROUND CONTEXT" NlmCategory="BACKGROUND">Spinal epidural abscess (SEA) is a serious condition that can lead to significant morbidity and mortality if not expeditiously diagnosed and appropriately treated. However, the nonspecific findings that accompany SEAs often make its diagnosis difficult. Concurrent noncontiguous SEAs are even more challenging to diagnose because whole-spine imaging is not routinely performed unless the patient demonstrates neurologic findings that are inconsistent with the identified lesion. Failure to recognize a separate SEA can subject patients to a second operation, continued sepsis, paralysis, or even death.</AbstractText><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To formulate a set of clinical and laboratory predictors for identifying patients with concurrent noncontiguous SEAs.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A retrospective, case-control study.</AbstractText><AbstractText Label="PATIENT SAMPLE" NlmCategory="METHODS">Patients aged 18 years or older admitted to our institution during the study period who underwent entire spinal imaging and were diagnosed with one or more SEAs.</AbstractText><AbstractText Label="OUTCOME MEASURES" NlmCategory="METHODS">The presence or absence of concurrent noncontiguous SEAs on magnetic resonance imaging or computed tomography (CT)-myelogram.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective review was performed on 233 adults with SEAs who presented to our health-care system from 1993 to 2011 and underwent entire spinal imaging. The clinical and radiographic features of patients with concurrent noncontiguous SEAs, defined as at least two lesions in different anatomical regions of the spine (ie, cervical, thoracic, or lumbar), were compared with those with a single SEA. Multivariate logistic regression identified independent predictors for the presence of a skip SEA, and a prediction algorithm based on these independent predictors was constructed. Institutional review board committee approval was obtained before initiating the study.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Univariate and multivariate analyses comparing patients with skip SEA lesions (n=22) with those with single lesions (n=211) demonstrated significant differences in three factors: delay in presentation (defined as symptoms for &#x2265;7 days), a concomitant area of infection outside the spine and paraspinal region, and an erythrocyte sedimentation rate of &gt;95 mm/h at presentation. The predicted probability for the presence of a skip lesion was 73% for patients possessing all three predictors, 13% for two, 2% for one, and 0% for zero predictors. Receiver operating characteristic curve analysis, used to evaluate the predictive accuracy of the model, revealed a steep shoulder with an area under the curve of 0.936 (p&lt;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The proposed set of three predictors may be a useful tool in predicting the risk of a skip SEA lesion and, consequently, which patients would benefit from entire spinal imaging.</AbstractText><CopyrightInformation>Copyright &#xa9; 2015 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ju</LastName><ForeName>Kevin L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA. Electronic address: kju@partners.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Sang Do</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melikian</LastName><ForeName>Rojeh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bono</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Mitchel B</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Department of Orthopaedic Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Spine J</MedlineTA><NlmUniqueID>101130732</NlmUniqueID><ISSNLinking>1529-9430</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Spine J. 2015 Jan 1;15(1):102-4. doi: 10.1016/j.spinee.2014.09.029.</RefSource><PMID Version="1">25511671</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020802" MajorTopicYN="N">Epidural Abscess</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013131" MajorTopicYN="N">Spine</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Algorithm</Keyword><Keyword MajorTopicYN="N">Concurrent</Keyword><Keyword MajorTopicYN="N">Epidural abscess</Keyword><Keyword MajorTopicYN="N">Noncontiguous</Keyword><Keyword MajorTopicYN="N">Prediction</Keyword><Keyword MajorTopicYN="N">Skip lesion</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>6</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24953159</ArticleId><ArticleId IdType="doi">10.1016/j.spinee.2014.06.008</ArticleId><ArticleId IdType="pii">S1529-9430(14)00571-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">26958751</PMID><DateCompleted><Year>2017</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2017</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1530-0293</ISSN><JournalIssue CitedMedium="Internet"><Volume>44</Volume><Issue>6</Issue><PubDate><Year>2016</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Critical care medicine</Title><ISOAbbreviation>Crit Care Med</ISOAbbreviation></Journal><ArticleTitle>Prevalence and Characteristics of Chronic Intensive Care-Related Pain: The Role of Severe Sepsis and Septic Shock.</ArticleTitle><Pagination><StartPage>1129</StartPage><EndPage>1137</EndPage><MedlinePgn>1129-37</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/CCM.0000000000001635</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">There is only limited knowledge about chronic pain conditions resulting from critical care. Experimental and clinical data suggest a close relationship between inflammation and pain perception. Since sepsis is the most severe form of systemic inflammation, the primary objective was to evaluate chronic pain states and functional impairment of septic and nonseptic patients 6 months after discharge from ICU. Second, we aimed to obtain the total prevalence and characteristics of chronic ICU-related pain.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Case-control study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Observational study in long-term survivors of mixed surgical and medical ICUs.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Septic and nonseptic survivors of critical care (n = 207) and healthy controls (n = 46).</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">None.</AbstractText><AbstractText Label="MEASUREMENTS AND MAIN RESULTS" NlmCategory="RESULTS">We collected comprehensive information on patients' past and present pain 6 months after ICU discharge by means of the German pain questionnaire. Pain intensity levels and pain interference ratings were compared between septic and nonseptic patients and healthy controls. We found no differences in prevalence, severity, and interference of pain between septic and nonseptic patients. However, both patient groups differed significantly from controls. In secondary analysis, a third of all patients reported chronic clinically relevant pain associated with the ICU stay 6 months after ICU discharge. Half of these patients experienced chronic pain conditions before ICU admission and reported additional sources of pain. Most important, 16% of all patients had no preexisting pain condition and now experience chronic ICU-related pain. The majority of patients with chronic ICU-related pain reported a high degree of disabling pain, limiting daily activities.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">A high percentage of former ICU patients develop chronic pain conditions associated with critical care. These patients differ significantly from control data in terms of pain intensity and show high levels of interference with pain. The presence of sepsis per se seems to play a marginal role for the development of chronic ICU-related pain.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Baumbach</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>1Integrated Research and Treatment Center, Center for Sepsis Control and Care (CSCC), Jena University Hospital, Germany. 2Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany. 3Biomagnetic Center, Hans-Berger-Klinik for Neurology, Jena University Hospital, Jena, Germany. 4Department of Biological and Clinical Psychology, Friedrich Schiller University of Jena, Jena, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;tz</LastName><ForeName>Theresa</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Albrecht</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Weiss</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Meissner</LastName><ForeName>Winfried</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Crit Care Med</MedlineTA><NlmUniqueID>0355501</NlmUniqueID><ISSNLinking>0090-3493</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059350" MajorTopicYN="N">Chronic Pain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="Y">Critical Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064368" MajorTopicYN="N">Healthy Volunteers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>3</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26958751</ArticleId><ArticleId IdType="doi">10.1097/CCM.0000000000001635</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38131396</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1445-2197</ISSN><JournalIssue CitedMedium="Internet"><Volume>94</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>ANZ journal of surgery</Title><ISOAbbreviation>ANZ J Surg</ISOAbbreviation></Journal><ArticleTitle>Management of acute perianal abscess: is surgeon specialization associated with improved outcomes?</ArticleTitle><Pagination><StartPage>938</StartPage><EndPage>944</EndPage><MedlinePgn>938-944</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ans.18836</ELocationID><Abstract><AbstractText Label="BACKGROUND">Acute surgical units (ASU) are increasingly being adopted and in our system are staffed by colorectal and non-colorectal general surgeons. This study aims to evaluate whether surgeon specialization was associated with improved outcomes in perianal abscess.</AbstractText><AbstractText Label="METHODS">Patients with perianal abscess admitted to the ASU between 2016 and 2020 were identified from a prospective database and their medical records reviewed. Patients with IBD, treatment for fistula-in-ano within the preceding year, or perianal sepsis of non-cryptoglandular origin were excluded. Patients admitted under an ASU colorectal (CR) consultant were compared with those under a non-CR general surgeon in a retrospective cohort study. Primary outcome was perianal abscess recurrence. For those without initial fistula, hazard of recurrent abscess or fistula was analysed. Multivariable Cox PH regression analysis was performed.</AbstractText><AbstractText Label="RESULTS">Four-hundred and eight patients were included (150 CR, 258 non-CR). The CR group more frequently had a fistula identified at index operation (34.0% versus 10.9%, P&#x2009;&lt;&#x2009;0.0001). However, Cox multivariable analysis found no difference in hazard of recurrent abscess between groups (HR 1.12, 95% CI 0.65-1.95, P&#x2009;=&#x2009;0.681)). Abscess recurred in 18.7% CR and 15.5% non-CR. Subsequent fistula developed in 14.7% in both groups. For patients without initial fistula, there was no difference between groups in hazard of recurrent abscess or fistula (HR 1.18, 95% CI 0.69-2.01, P&#x2009;=&#x2009;0.539).</AbstractText><AbstractText Label="CONCLUSION">Surgeon specialization was not associated with improved outcomes for ASU patients with perianal abscess, albeit with potential selection bias. CR surgeons were more proactive identifying fistulas; this raises the possibility that drainage alone may be adequate treatment.</AbstractText><CopyrightInformation>&#xa9; 2023 Royal Australasian College of Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Gregory A</ForeName><Initials>GA</Initials><Identifier Source="ORCID">0000-0003-3817-173X</Identifier><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tham</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-2866-8841</Identifier><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandra</LastName><ForeName>Raaj</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Read</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-6555-7358</Identifier><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chittleborough</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCormick</LastName><ForeName>Jacob J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayes</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of Surgical Specialties, Royal Melbourne Hospital, Melbourne, Victoria, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Australia</Country><MedlineTA>ANZ J Surg</MedlineTA><NlmUniqueID>101086634</NlmUniqueID><ISSNLinking>1445-1433</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000038" MajorTopicYN="Y">Abscess</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001004" MajorTopicYN="Y">Anus Diseases</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012008" MajorTopicYN="N">Recurrence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012003" MajorTopicYN="N">Rectal Fistula</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066231" MajorTopicYN="N">Surgeons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000208" MajorTopicYN="N">Acute Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013038" MajorTopicYN="N">Specialization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">abscess</Keyword><Keyword MajorTopicYN="N">cryptoglandular</Keyword><Keyword MajorTopicYN="N">fistula</Keyword><Keyword MajorTopicYN="N">perianal</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>22</Day><Hour>7</Hour><Minute>45</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38131396</ArticleId><ArticleId IdType="doi">10.1111/ans.18836</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Abcarian H. Anorectal infection: abscess&#x2010;fistula. Clin. Colon Rectal Surg. 2011; 24: 14&#x2013;21.</Citation></Reference><Reference><Citation>Vogel JD, Johnson EK, Morris AM et al. Clinical practice guideline for the management of anorectal abscess, fistula&#x2010;in&#x2010;ano, and rectovaginal fistula. Dis. Colon Rectum 2016; 59: 1117&#x2013;1133.</Citation></Reference><Reference><Citation>Parks AG. Pathogenesis and treatment of fistula&#x2010;in&#x2010;ano. Br. Med. J. 1961; 18: 460&#x2013;463.</Citation></Reference><Reference><Citation>Cox SW, Senagore AJ, Luchtefeld MA, Mazier WP. Outcome after incision and drainage with fistulotomy for ischiorectal abscess. Am. Surg. 1997; 63: 686&#x2013;689.</Citation></Reference><Reference><Citation>Ramanujam PS, Prasad ML, Abcarian H, Tan A. Perianal abscesses and fistulas. A study of 1023 patients. Dis. Colon Rectum 1984; 27: 593&#x2013;597.</Citation></Reference><Reference><Citation>Read DR, Abcarian H. A prospective survey of 474 patients with anorectal abscess. Dis. Colon Rectum 1979; 22: 566&#x2013;568.</Citation></Reference><Reference><Citation>Vasilevsky CA, Gordon PH. The incidence of recurrent abscesses or fistula&#x2010;in&#x2010;ano following anorectal suppuration. Dis. Colon Rectum 1984; 27: 126&#x2013;130.</Citation></Reference><Reference><Citation>H&#xe4;m&#xe4;l&#xe4;inen KP, Sainio AP. Incidence of fistulas after drainage of acute anorectal abscesses. Dis. Colon Rectum 1998; 41: 1357&#x2013;1361; discussion 1361&#x2010;2.</Citation></Reference><Reference><Citation>Hamadani A, Haigh PI, Liu IL, Abbas MA. Who is at risk for developing chronic anal fistula or recurrent anal sepsis after initial perianal abscess? Dis. Colon Rectum 2009; 52: 217&#x2013;221.</Citation></Reference><Reference><Citation>Lohsiriwat V, Yodying H, Lohsiriwat D. Incidence and factors influencing the development of fistula&#x2010;in&#x2010;ano after incision and drainage of perianal abscesses. J. Med. Assoc. Thai. 2010; 93: 61&#x2013;65.</Citation></Reference><Reference><Citation>S&#xf6;zener U, Gedik E, Kessaf Aslar A et al. Does adjuvant antibiotic treatment after drainage of anorectal abscess prevent development of anal fistulas? A randomized, placebo&#x2010;controlled, double&#x2010;blind, multicenter study. Dis. Colon Rectum 2011; 54: 923&#x2013;929.</Citation></Reference><Reference><Citation>Schlichtemeier S, Tou S. Treatment for complex anal fistula, are we any wiser? Colorectal Dis. 2018; 20: 1067&#x2013;1068.</Citation></Reference><Reference><Citation>Cadeddu F, Salis F, Lisi G, Ciangola I, Milito G. Complex anal fistula remains a challenge for colorectal surgeon. Int. J. Colorectal Dis. 2015; 30: 595&#x2013;603.</Citation></Reference><Reference><Citation>Malik AI, Nelson RL, Tou S. Incision and drainage of perianal abscess with or without treatment of anal fistula. Cochrane Database Syst. Rev. 2010; 7: CD006827. https://doi.org/10.1002/14651858.CD006827.pub2.</Citation></Reference><Reference><Citation>Tarasconi A, Perrone G, Davies J et al. Anorectal emergencies: WSES&#x2010;AAST guidelines. World J. Emerg. Surg. 2021; 16: 48.</Citation></Reference><Reference><Citation>Page DE, Dooreemeah D, Thiruchelvam D. Acute surgical unit: the Australasian experience. ANZ J. Surg. 2014; 84: 25&#x2013;30.</Citation></Reference><Reference><Citation>Shakerian R, Thomson BN, Gorelik A, Hayes IP, Skandarajah AR. Outcomes in emergency general surgery following the introduction of a consultant&#x2010;led unit. Br. J. Surg. 2015; 102: 1726&#x2013;1732.</Citation></Reference><Reference><Citation>Chana P, Burns EM, Arora S, Darzi AW, Faiz OD. A systematic review of the impact of dedicated emergency surgical services on patient outcomes. Ann. Surg. 2016; 263: 20&#x2013;27.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. STROBE initiative (2007), the strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453&#x2013;1457.</Citation></Reference><Reference><Citation>Kinnear N, Jolly S, Herath M et al. The acute surgical unit: an updated systematic review and meta&#x2010;analysis. Int. J. Surg. 2021; 94: 106109.</Citation></Reference><Reference><Citation>Amato A, Bottini C, de Nardi P et al. Evaluation and management of perianal abscess and anal fistula: SICCR position statement. Tech. Coloproctol. 2020; 24: 127&#x2013;143.</Citation></Reference><Reference><Citation>Williams G, Williams A, Tozer P et al. The treatment of anal fistula: second ACPGBI position statement. Colorectal Dis. 2018; 20: 5&#x2013;31.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">32319686</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-6576</ISSN><JournalIssue CitedMedium="Internet"><Volume>64</Volume><Issue>7</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Acta anaesthesiologica Scandinavica</Title><ISOAbbreviation>Acta Anaesthesiol Scand</ISOAbbreviation></Journal><ArticleTitle>Causes of late mortality among ICU-treated patients with sepsis.</ArticleTitle><Pagination><StartPage>961</StartPage><EndPage>966</EndPage><MedlinePgn>961-966</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/aas.13592</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with sepsis may have an increased risk of late mortality, but the causes of late death are unclear. This retrospective matched cohort study aimed to determine the causes of late death (&#x2265;1&#xa0;year) among patients with sepsis compared to patients without sepsis.</AbstractText><AbstractText Label="METHODS">8760 patients with severe sepsis or septic shock (2001 consensus criteria) registered in the Swedish Intensive Care Registry (2008-2013) were compared with a 1:1 matched (gender, age, SAPS3 probability for death, ICU length of stay) control group consisting of non-septic ICU patients. Causes of death (International Classification of Diseases codes) were obtained from the Swedish Cause of Death Register (2008-2014).</AbstractText><AbstractText Label="RESULTS">During 2008-2014, 903 patients with sepsis died at&#xa0;&#x2265;365&#xa0;days after their initial septic event, compared to 884 patients in the control group. Median time of follow-up was 313&#xa0;days (sepsis group, interquartile range 11-838&#xa0;days) vs 288&#xa0;days (control group, 9-836&#xa0;days). The most common causes of death were heart diseases (sepsis: 50.2%, non-septic: 48.6%) and cancer (sepsis: 33.7%, non-septic: 31.7%). Infectious diseases were significantly more common cause of death in the sepsis group (24.3% vs 19.6%, respectively; P&#xa0;&lt;&#xa0;.05). Pneumonia was a common infectious cause of death in both groups, whereas sepsis was more common in the sepsis group.</AbstractText><AbstractText Label="CONCLUSIONS">The most common causes of late death after ICU admission among patients with and without sepsis were heart diseases and cancer. However, patients with sepsis more frequently had infectious diseases as a cause of late death, compared to non-septic patients.</AbstractText><CopyrightInformation>&#xa9; 2020 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley &amp; Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wilhelms</LastName><ForeName>Susanne B</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0002-7265-5706</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care and Department of Clinical and Experimental Medicine, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walther</LastName><ForeName>Sten M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Cardiothoracic Anaesthesia and Intensive Care and Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sj&#xf6;berg</LastName><ForeName>Folke</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care and Department of Clinical and Experimental Medicine, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Geer</LastName><ForeName>Lina</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9201-5282</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care and Department of Medical and Health Sciences, Link&#xf6;ping University, Link&#xf6;ping, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Acta Anaesthesiol Scand</MedlineTA><NlmUniqueID>0370270</NlmUniqueID><ISSNLinking>0001-5172</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003141" MajorTopicYN="N">Communicable Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="N">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003422" MajorTopicYN="N">Critical Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="N">Heart Diseases</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012042" MajorTopicYN="N">Registries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013548" MajorTopicYN="N" Type="Geographic">Sweden</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013995" MajorTopicYN="N">Time</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">late mortality</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>11</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32319686</ArticleId><ArticleId IdType="doi">10.1111/aas.13592</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.</Citation></Reference><Reference><Citation>Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530-538.</Citation></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions For Sepsis And Septic Shock (Sepsis-3). JAMA. 2016;315:801-810.</Citation></Reference><Reference><Citation>Kadri SS, Rhee C, Strich JR, et al. Estimating ten-year trends in septic shock incidence and mortality in United States Academic Medical Centers Using Clinical Data. Chest. 2017;151:278-285.</Citation></Reference><Reference><Citation>Rhee C, Dantes R, Epstein L, et al. Incidence and trends of sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014. JAMA. 2017;318:1241-1249.</Citation></Reference><Reference><Citation>Shankar-Hari M, Ambler M, Mahalingasivam V, Jones A, Rowan K, Rubenfeld GD. Evidence for a causal link between sepsis and long-term mortality: a systematic review of epidemiologic studies. Crit Care. 2016;20:101.</Citation></Reference><Reference><Citation>Winters BD, Eberlein M, Leung J, Needham DM, Pronovost PJ, Sevransky JE. Long-term mortality and quality of life in sepsis: a systematic review. Crit Care Med. 2010;38:1276-1283.</Citation></Reference><Reference><Citation>Prescott HC, Osterholzer JJ, Langa KM, Angus DC, Iwashyna TJ. Late mortality after sepsis: propensity matched cohort study. BMJ. 2016;353:i2375.</Citation></Reference><Reference><Citation>DeGeer L, Oscarsson Tibblin A, Fredrikson M, Walther SM. No association with cardiac death after sepsis: A nationwide observational cohort study. Acta Anaesthesiol Scand. 2019;63:344-351.</Citation></Reference><Reference><Citation>Ludvigsson JF, Almqvist C, Bonamy AK, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31:125-136.</Citation></Reference><Reference><Citation>Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659-667.</Citation></Reference><Reference><Citation>Brooke HL, Talback M, Hornblad J, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765-773.</Citation></Reference><Reference><Citation>The National Board of Health and Welfare. Statistics about causes of death 2016 (Swedish: Statistik om d&#xf6;dorsaker 2016); 2017. Available at http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/20668/2017-9-10.pdf, Accessed 19 September 2017 .</Citation></Reference><Reference><Citation>Karlsson S, Varpula M, Ruokonen E, et al. Incidence, treatment, and outcome of severe sepsis in ICU-treated adults in Finland: the Finnsepsis study. Intensive Care Med. 2007;33:435-443.</Citation></Reference><Reference><Citation>Mullerova H, Chigbo C, Hagan GW, et al. The natural history of community-acquired pneumonia in COPD patients: a population database analysis. Respir Med. 2012;106:1124-1133.</Citation></Reference><Reference><Citation>Williams NP, Coombs NA, Johnson MJ, et al. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records. Int J Chron Obstruct Pulmon Dis. 2017;12:313-322.</Citation></Reference><Reference><Citation>Sun A, Netzer G, Small DS, et al. Association between index hospitalization and hospital readmission in sepsis survivors. Crit Care Med. 2016;44:478-487.</Citation></Reference><Reference><Citation>The Swedish Intensive Care Registry. Report of year 2013 (Swedish: &#xc5;rsrapport 2013); 2013. Available at http://www.icuregswe.org/globalassets/arsrapporter/analyserande_2013.pdf, Accessed October 6, 2018.</Citation></Reference><Reference><Citation>Engerstrom L, Kramer AA, Nolin T, et al. Comparing time-fixed mortality prediction models and their effect on ICU performance metrics using the simplified acute physiology score 3. Crit Care Med. 2016;44:e1038-e1044.</Citation></Reference><Reference><Citation>Nielsen GP, Bj&#xf6;rnsson J, Jonasson JG. The accuracy of death certificates. Implications for health statistics. Virchows Arch A Pathol Anat Histopathol. 1991;419:143-146.</Citation></Reference><Reference><Citation>Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol. 2000;29:495-502.</Citation></Reference><Reference><Citation>The National Board of Health and Welfare. Causes of death 2014 (Swedish: D&#xf6;dsorsaker 2014); 2015. Available at http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19909/2015-8-1.pdf, Accessed October 6, 2018.</Citation></Reference><Reference><Citation>Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.</Citation></Reference><Reference><Citation>Wilhelms SB, Walther SM, Huss F, Sj&#xf6;berg F. Severe sepsis in the ICU is often missing in hospital discharge codes. Acta Anaesthesiol Scand. 2017;61:186-193.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31358597</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1488-2329</ISSN><JournalIssue CitedMedium="Internet"><Volume>191</Volume><Issue>30</Issue><PubDate><Year>2019</Year><Month>Jul</Month><Day>29</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Association between complications and death within 30 days after noncardiac surgery.</ArticleTitle><Pagination><StartPage>E830</StartPage><EndPage>E837</EndPage><MedlinePgn>E830-E837</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1503/cmaj.190221</ELocationID><Abstract><AbstractText Label="BACKGROUND">Among adults undergoing contemporary noncardiac surgery, little is known about the frequency and timing of death and the associations between perioperative complications and mortality. We aimed to establish the frequency and timing of death and its association with perioperative complications.</AbstractText><AbstractText Label="METHODS">We conducted a prospective cohort study of patients aged 45 years and older who underwent inpatient noncardiac surgery at 28 centres in 14 countries. We monitored patients for complications until 30 days after surgery and determined the relation between these complications and 30-day mortality using a Cox proportional hazards model.</AbstractText><AbstractText Label="RESULTS">We included 40 004 patients. Of those, 715 patients (1.8%) died within 30 days of surgery. Five deaths (0.7%) occurred in the operating room, 500 deaths (69.9%) occurred after surgery during the index admission to hospital and 210 deaths (29.4%) occurred after discharge from the hospital. Eight complications were independently associated with 30-day mortality. The 3 complications with the largest attributable fractions (AF; i.e., potential proportion of deaths attributable to these complications) were major bleeding (6238 patients, 15.6%; adjusted hazard ratio [HR] 2.6, 95% confidence interval [CI] 2.2-3.1; AF 17.0%); myocardial injury after noncardiac surgery [MINS] (5191 patients, 13.0%; adjusted HR 2.2, 95% CI 1.9-2.6; AF 15.9%); and sepsis (1783 patients, 4.5%; adjusted HR 5.6, 95% CI 4.6-6.8; AF 12.0%).</AbstractText><AbstractText Label="INTERPRETATION">Among adults undergoing noncardiac surgery, 99.3% of deaths occurred after the procedure and 44.9% of deaths were associated with 3 complications: major bleeding, MINS and sepsis. Given these findings, focusing on the prevention, early identification and management of these 3 complications holds promise for reducing perioperative mortality. <b>Study registration:</b> ClinicalTrials.gov, no. NCT00512109.</AbstractText><CopyrightInformation>&#xa9; 2019 Joule Inc. or its licensors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><CollectiveName>Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators</CollectiveName></Author><Author ValidYN="Y"><LastName>Spence</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>LeManach</LastName><ForeName>Yannick</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Matthew TV</ForeName><Initials>MTV</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>C Y</ForeName><Initials>CY</Initials></Author><Author ValidYN="Y"><LastName>Sigamani</LastName><ForeName>Alben</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Xavier</LastName><ForeName>Denis</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Pearse</LastName><ForeName>Rupert</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Alonso-Coello</LastName><ForeName>Pablo</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Garutti</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Srinathan</LastName><ForeName>Sadeesh K</ForeName><Initials>SK</Initials></Author><Author ValidYN="Y"><LastName>Duceppe</LastName><ForeName>Emmanuelle</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Walsh</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Borges</LastName><ForeName>Flavia Kessler</ForeName><Initials>FK</Initials></Author><Author ValidYN="Y"><LastName>Malaga</LastName><ForeName>German</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>Valsa</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Faruqui</LastName><ForeName>Atiya</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Berwanger</LastName><ForeName>Otavio</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Biccard</LastName><ForeName>Bruce M</ForeName><Initials>BM</Initials></Author><Author ValidYN="Y"><LastName>Villar</LastName><ForeName>Juan Carlos</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Sessler</LastName><ForeName>Daniel I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Kurz</LastName><ForeName>Andrea</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Chow</LastName><ForeName>Clara K</ForeName><Initials>CK</Initials></Author><Author ValidYN="Y"><LastName>Polanczyk</LastName><ForeName>Carisi A</ForeName><Initials>CA</Initials></Author><Author ValidYN="Y"><LastName>Szczeklik</LastName><ForeName>Wojciech</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Ackland</LastName><ForeName>Gareth</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>X</LastName><ForeName>Garg Amit</ForeName><Initials>GA</Initials></Author><Author ValidYN="Y"><LastName>Jacka</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Guyatt</LastName><ForeName>Gordon H</ForeName><Initials>GH</Initials></Author><Author ValidYN="Y"><LastName>Sapsford</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Colin</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Cortes</LastName><ForeName>Olga Lucia</ForeName><Initials>OL</Initials></Author><Author ValidYN="Y"><LastName>Coriat</LastName><ForeName>Pierre</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Ameen</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Tiboni</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Belley-C&#xf4;t&#xe9;</LastName><ForeName>Emilie P</ForeName><Initials>EP</Initials></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Stephen</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Heels-Ansdell</LastName><ForeName>Diane</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>McGillion</LastName><ForeName>Michael</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Parlow</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Matthew</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Pettit</LastName><ForeName>Shirley</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Yusuf</LastName><ForeName>Salim</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Devereaux</LastName><ForeName>P J</ForeName><Initials>PJ</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00512109</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>CMAJ. 2019 Jul 29;191(30):E828-E829. doi: 10.1503/cmaj.190882.</RefSource><PMID Version="1">31809258</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019106" MajorTopicYN="N">Postoperative Hemorrhage</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013514" MajorTopicYN="N">Surgical Procedures, Operative</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: Clara Chow received support from the National Health and Medical Research Council of Australia and The Heart Foundation (Australia) for a career development fellowship. Robert Sapsford received nonfinancial support in the form of a research nurse funded by the National Institutes of Health Research, and lecture fees from Eli Lilly, MSD and Novo Nordisk. Denis Xavier received grants from Cadila Pharmaceuticals, Boehringer Ingelheim, Astra Zeneca India, Sanofi Aventis, Pfizer, Bristol&#x2013;Myers Squibb, Medical Research Council (United Kingdom) and Wellcome Trust outside the submitted work. Emmanuelle Duceppe received a grant as a coapplicant on an investigator-initiated study and lecture fees from Roche Diagnostics. Philip J. Devereaux is a member of a research group with a policy of not accepting honorariums or other payments from industry for their own personal financial gain. They do accept honorariums or payments from industry to support research endeavours and costs to participate in meetings. Based on study questions Dr. Devereaux has originated and grants he has written, he has received grants from Abbott Diagnostics, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers-Squibb, Coviden, Octapharma, Philips Healthcare, Roche Diagnostics, Siemens and Stryker. Dr Devereaux has participated in advisory board meetings for GlaxoSmithKline and Boehringer Ingelheim. He also attended an expert panel meeting with AstraZeneca and Boehringer Ingelheim. Roche Diagnostics provided Troponin T assays and financial support for the Vascular Events in Noncardiac Surgery Patients Cohort Evaluation (VISION) Study. No other competing interests were declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31358597</ArticleId><ArticleId IdType="pmc">PMC6663503</ArticleId><ArticleId IdType="doi">10.1503/cmaj.190221</ArticleId><ArticleId IdType="pii">191/30/E830</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372:139&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18582931</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Sessler DI. Cardiac complications in patients undergoing major noncardiac surgery. N Engl J Med 2015;373:2258&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26630144</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui NF, Coca SG, Devereaux PJ, et al. Secular trends in acute dialysis after elective major surgery &#x2014;1995 to 2009. CMAJ 2012;184:1237&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3414596</ArticleId><ArticleId IdType="pubmed">22733671</ArticleId></ArticleIdList></Reference><Reference><Citation>Smilowitz NR, Gupta N, Guo Y, et al. Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery. Heart 2018;104:1180&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6102124</ArticleId><ArticleId IdType="pubmed">29305561</ArticleId></ArticleIdList></Reference><Reference><Citation>Botto F, Alonso-Coello P, Chan MT, et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 2014;120:564&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">24534856</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Biccard BM, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2017;317:1642&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">28444280</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu N, Misra D, Neogi T, et al. Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score&#x2013;matched cohort study. Arthritis Rheumatol 2015;67:2771&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581914</ArticleId><ArticleId IdType="pubmed">26331443</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">18479744</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1494&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">24679062</ArticleId></ArticleIdList></Reference><Reference><Citation>Myles PS, Leslie K, Chan MT, et al. The safety of addition of nitrous oxide to general anaesthesia in at-risk patients having major non-cardiac surgery (ENIGMA-II): a randomised, single-blind trial. Lancet 2014;384:1446&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25142708</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012;307:2295&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">22706835</ArticleId></ArticleIdList></Reference><Reference><Citation>Peduzzi P, Concato J, Feinstein AR, et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 1995;48:1503&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">8543964</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xfc;ckinger S, von Kries R, Toschke AM. An illustration of and programs estimating attributable fractions in large scale surveys considering multiple risk factors. BMC Med Res Methodol 2009;9:7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2636839</ArticleId><ArticleId IdType="pubmed">19166593</ArticleId></ArticleIdList></Reference><Reference><Citation>Biccard BM, Madiba TE, Kluyts HL, et al. Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study. Lancet 2018;391:1589&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">29306587</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: a 7-day cohort study. Lancet 2012;380:1059&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3493988</ArticleId><ArticleId IdType="pubmed">22998715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P, Chang DC, Osen HB, et al. NSQIP reveals significant incidence of death following discharge. J Surg Res 2011;170:e217&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">21816434</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelacher C, Lurati Buse G, Seeberger D, et al. Perioperative myocardial injury after noncardiac surgery: incidence, mortality, and characterization. Circulation 2018;137:1221&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">29203498</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Warner M, Lang BH, et al. Epidemiology of anesthesia-related mortality in the United States, 1999&#x2013;2005. Anesthesiology 2009;110:759&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2697561</ArticleId><ArticleId IdType="pubmed">19322941</ArticleId></ArticleIdList></Reference><Reference><Citation>Eichhorn JH. Practical current issues in perioperative patient safety. Can J Anaesth 2013;60:111&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23263979</ArticleId></ArticleIdList></Reference><Reference><Citation>John Doyle D, Dahaba AA, LeManach Y. Advances in anesthesia technology are improving patient care, but many challenges remain. BMC Anesthesiol 2018;18:39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899388</ArticleId><ArticleId IdType="pubmed">29653517</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuvan CH, Mitchell I. Missed opportunities? An observational study of vital sign measurements. Crit Care Resusc 2008;10:111&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">18522524</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z, Sessler DI, Dalton JE, et al. Postoperative hypoxemia is common and persistent: a prospective blinded observational study. Anesth Analg 2015;121:709&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4825673</ArticleId><ArticleId IdType="pubmed">26287299</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan A, Chang C, Cohen B, et al. Incidence, severity, and detection of blood pressure perturbations after abdominal surgery: a prospective blinded observational study. Anesthesiology 2019;130:550&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">30875354</ArticleId></ArticleIdList></Reference><Reference><Citation>Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014;370:1504&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">24679061</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill NP, Wright B, Reilly CS. Relationship between hypoxaemic and cardiac ischaemic events in the perioperative period. Br J Anaesth 1992;68:471&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">1642934</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">31489646</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-3083</ISSN><JournalIssue CitedMedium="Internet"><Volume>90</Volume><Issue>6</Issue><PubDate><Year>2019</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Scandinavian journal of immunology</Title><ISOAbbreviation>Scand J Immunol</ISOAbbreviation></Journal><ArticleTitle>Plasma PTX3, MCP1 and Ang2 are early biomarkers to evaluate the severity of sepsis and septic shock.</ArticleTitle><Pagination><StartPage>e12823</StartPage><MedlinePgn>e12823</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e12823</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/sji.12823</ELocationID><Abstract><AbstractText>Sepsis is associated with significant mortality. Early diagnosis and prognosis of patients with sepsis is still a difficult clinical challenge. In this study, the ability of plasma PTX3 (pentraxin 3), MCP1 (monocyte chemoattractant protein 1) and Ang (angiopoietin)1/2 was investigated to evaluate the severity of sepsis. Blood samples were obtained from 43 patients with sepsis. A total of 33 post-surgery patients with infections and 25 healthy individuals served as controls. The results showed that plasma PTX3, MCP1 and Ang2 significantly increased in patients on the first day of septic shock onset, while sepsis patients had significantly higher Ang2 level, compared with controls. Furthermore, PTX3, MCP1 and Ang2 had high AUROC values in patients with septic shock on the first day of sepsis onset. The findings suggest that PTX3, MCP1 and Ang2 maybe early predictors to evaluate the severity of sepsis and septic shock with the latest Sepsis 3.0 definitions.</AbstractText><CopyrightInformation>&#xa9; 2019 The Authors. Scandinavian Journal of Immunology published by John Wiley &amp; Sons Ltd on behalf of The Scandinavian Foundation for Immunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xiaoli</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ranran</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jiahui</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhaojun</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Erzhen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-7197-3385</Identifier><AffiliationInfo><Affiliation>Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Enqiang</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Emergency, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ruoming</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-0417-9784</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jialin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qu</LastName><ForeName>Hongping</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-2116-5125</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>184119500900</GrantID><Agency>Shanghai Science and Technology Innovation Fund</Agency><Country/></Grant><Grant><GrantID>2016ZB0206</GrantID><Agency>Key Discipline Construction of Shanghai Municipal Commission of Health and Family Planning</Agency><Country/></Grant><Grant><GrantID>81772040</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>ZY(2018-2020)-FWTX-1108</GrantID><Agency>Project of Shanghai Municipal Commission of Health and Family Planning</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Scand J Immunol</MedlineTA><NlmUniqueID>0323767</NlmUniqueID><ISSNLinking>0300-9475</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C586513">ANGPT2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D042702">Angiopoietin-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C111835">CCL2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000683">Serum Amyloid P-Component</NameOfSubstance></Chemical><Chemical><RegistryNumber>148591-49-5</RegistryNumber><NameOfSubstance UI="C077657">PTX3 protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042702" MajorTopicYN="N">Angiopoietin-2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="Y">C-Reactive Protein</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000683" MajorTopicYN="Y">Serum Amyloid P-Component</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Ang2</Keyword><Keyword MajorTopicYN="N">MCP1</Keyword><Keyword MajorTopicYN="N">PTX3</Keyword><Keyword MajorTopicYN="N">pro-inflammatory cytokine</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>12</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31489646</ArticleId><ArticleId IdType="pmc">PMC6900011</ArticleId><ArticleId IdType="doi">10.1111/sji.12823</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sagy M, Al&#x2010;Qaqaa Y, Kim P. Definitions and pathophysiology of sepsis. Curr Probl Pediatr Adolesc Health Care. 2013;43:260&#x2010;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">24295606</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med. 1999;21(340):207&#x2010;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">9895401</ArticleId></ArticleIdList></Reference><Reference><Citation>Koskela M, Ala&#x2010;Kokko TI, Gaddnas F, et al. Blister fluid and serum cytokine levels in severe sepsis in humans reflect skin dysfunction. Acta Anaesthesiol Scand. 2017;61:53&#x2010;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">27514616</ArticleId></ArticleIdList></Reference><Reference><Citation>Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517&#x2010;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">28555385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AP, Liu J, Yue LH, Wang HQ, Yang WJ, Yang GH. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis. Clin Chem Lab Med. 2016;54:345&#x2010;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">26351925</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestre J, Povoa P, Coelho L, et al. Is C&#x2010;reactive protein a good prognostic marker in septic patients? Intensive Care Med. 2009;35:909&#x2010;913.</Citation><ArticleIdList><ArticleId IdType="pubmed">19169668</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Grady NP, Barie PS, Bartlett JG, et al. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American college of critical care medicine and the infectious diseases society of America. Crit Care Med. 2008;36:1330&#x2010;1349.</Citation><ArticleIdList><ArticleId IdType="pubmed">18379262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino M, Kunderfranco P, Basso G, et al. Epigenetic regulation of the extrinsic oncosuppressor PTX3 gene in inflammation and cancer. Oncoimmunology. 2017;6:e1333215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5543905</ArticleId><ArticleId IdType="pubmed">28811977</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottazzi B, Doni A, Garlanda C, Mantovani A. An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol. 2010;28:157&#x2010;183.</Citation><ArticleIdList><ArticleId IdType="pubmed">19968561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottazzi B, Garlanda C, Cotena A, et al. The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity. Immunol Rev. 2009;227:9&#x2010;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">19120471</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonavita E, Gentile S, Rubino M, et al. PTX3 is an extrinsic oncosuppressor regulating complement&#x2010;dependent inflammation in cancer. Cell. 2015;12(160):700&#x2010;714.</Citation><ArticleIdList><ArticleId IdType="pubmed">25679762</ArticleId></ArticleIdList></Reference><Reference><Citation>Doni A, Garlanda C, Mantovani A. Innate immunity, hemostasis and matrix remodeling: PTX3 as a link. Semin Immunol. 2016;28:570&#x2010;577.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5414833</ArticleId><ArticleId IdType="pubmed">27881292</ArticleId></ArticleIdList></Reference><Reference><Citation>Shalova IN, Lim JY, Chittezhath M, et al. Human monocytes undergo functional re&#x2010;programming during sepsis mediated by hypoxia&#x2010;inducible factor&#x2010;1alpha. Immunity. 2015;17(42):484&#x2010;498.</Citation><ArticleIdList><ArticleId IdType="pubmed">25746953</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein&#x2010;1 (MCP&#x2010;1): an overview. J Interferon Cytokine Res. 2009;29:313&#x2010;326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2755091</ArticleId><ArticleId IdType="pubmed">19441883</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen TL, Ransohoff RM, Strieter RM, Sellebjerg F. Chemokine CCL2 and chemokine receptor CCR2 in early active multiple sclerosis. Eur J Neurol. 2004;11:445&#x2010;449.</Citation><ArticleIdList><ArticleId IdType="pubmed">15257681</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Wang W, Zou Z, et al. Monocyte chemoattractant protein 1 released from macrophages induced by hepatitis C virus promotes monocytes migration. Virus Res. 2017;15(240):190&#x2010;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">28860098</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsukawa A, Hogaboam CM, Lukacs NW, Lincoln PM, Strieter RM, Kunkel SL. Endogenous MCP&#x2010;1 influences systemic cytokine balance in a murine model of acute septic peritonitis. Exp Mol Pathol. 2000;68:77&#x2010;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">10716911</ArticleId></ArticleIdList></Reference><Reference><Citation>Leligdowicz A, Richard&#x2010;Greenblatt M, Wright J, Crowley VM, Kain KC. Endothelial activation: the Ang/Tie Axis in sepsis. Front Immunol. 2018;9:838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5928262</ArticleId><ArticleId IdType="pubmed">29740443</ArticleId></ArticleIdList></Reference><Reference><Citation>Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin&#x2010;TIE pathway. Nat Rev Drug Discov. 2017;16:635&#x2010;661.</Citation><ArticleIdList><ArticleId IdType="pubmed">28529319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie&#x2010;2 ligand angiopoietin&#x2010;2 is stored in and rapidly released upon stimulation from endothelial cell Weibel&#x2010;Palade bodies. Blood. 2004;1(103):4150&#x2010;4156.</Citation><ArticleIdList><ArticleId IdType="pubmed">14976056</ArticleId></ArticleIdList></Reference><Reference><Citation>Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis&#x2010;3). JAMA. 2016;23(315):801&#x2010;810.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4968574</ArticleId><ArticleId IdType="pubmed">26903338</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med. 2001;29:1404&#x2010;1407.</Citation><ArticleIdList><ArticleId IdType="pubmed">11445697</ArticleId></ArticleIdList></Reference><Reference><Citation>Han B, Mura M, Andrade CF, et al. TNFalpha&#x2010;induced long pentraxin PTX3 expression in human lung epithelial cells via JNK. J Immunol. 2005;15(175):8303&#x2010;8311.</Citation><ArticleIdList><ArticleId IdType="pubmed">16339571</ArticleId></ArticleIdList></Reference><Reference><Citation>He X, Han B, Bai X, et al. PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation. Intensive Care Med. 2010;36:356&#x2010;364.</Citation><ArticleIdList><ArticleId IdType="pubmed">19921147</ArticleId></ArticleIdList></Reference><Reference><Citation>Dias AA, Goodman AR, Dos Santos JL, et al. TSG&#x2010;14 transgenic mice have improved survival to endotoxemia and to CLP&#x2010;induced sepsis. J Leukoc Biol. 2001;69:928&#x2010;936.</Citation><ArticleIdList><ArticleId IdType="pubmed">11404378</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamed S, Behnes M, Pauly D, et al. Diagnostic value of Pentraxin&#x2010;3 in patients with sepsis and septic shock in accordance with latest sepsis&#x2010;3 definitions. BMC Infect Dis. 2017;9(17):554.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5550951</ArticleId><ArticleId IdType="pubmed">28793880</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornai F, Carrizzo A, Forte M, et al. The inflammatory protein Pentraxin 3 in cardiovascular disease. Immun Ageing. 2016;13:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4995820</ArticleId><ArticleId IdType="pubmed">27559355</ArticleId></ArticleIdList></Reference><Reference><Citation>Slusher AL, Mischo AB, Acevedo EO. Pentraxin 3 is an anti&#x2010;inflammatory protein associated with lipid&#x2010;induced interleukin 10 in vitro. Cytokine. 2016;86:36&#x2010;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">27450429</ArticleId></ArticleIdList></Reference><Reference><Citation>Caironi P, Masson S, Mauri T, et al. Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial. Eur J Clin Invest. 2017;47:73&#x2010;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5414835</ArticleId><ArticleId IdType="pubmed">27864924</ArticleId></ArticleIdList></Reference><Reference><Citation>Gesta S, Guntur K, Majumdar ID, et al. Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation&#x2010;induced MCP1 expression in adipocytes. Obesity (Silver Spring). 2016;24:1695&#x2010;1703.</Citation><ArticleIdList><ArticleId IdType="pubmed">27312141</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Z, Wang P, Li J, et al. MCP1 triggers monocyte dysfunctions during abnormal osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis. J Mol Med (Berl). 2017;95:143&#x2010;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">27921117</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CC, Ho HC, Su YC, Lee MS, Hung SK, Lin CH. MCP1&#x2010;induced epithelial&#x2010;mesenchymal transition in head and neck cancer by AKT activation. Anticancer Res. 2015;35:3299&#x2010;3306.</Citation><ArticleIdList><ArticleId IdType="pubmed">26026089</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu T, Liao X, Feng T, et al. Plasma monocyte chemoattractant protein 1 as a predictive marker for sepsis prognosis: a prospective cohort study. Tohoku J Exp Med. 2017;241:139&#x2010;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">28202856</ArticleId></ArticleIdList></Reference><Reference><Citation>Barre M, Behnes M, Hamed S, et al. Revisiting the prognostic value of monocyte chemotactic protein 1 and interleukin&#x2010;6 in the sepsis&#x2010;3 era. J Crit Care. 2018;43:21&#x2010;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">28834779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Liu Q, Liu T, et al. Early plasma monocyte chemoattractant protein 1 predicts the development of sepsis in trauma patients: a prospective observational study. Medicine (Baltimore). 2018;97:e0356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5902265</ArticleId><ArticleId IdType="pubmed">29620667</ArticleId></ArticleIdList></Reference><Reference><Citation>Isidori AM, Venneri MA, Fiore D. Angiopoietin&#x2010;1 and Angiopoietin&#x2010;2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes. J Endocrinol Invest. 2016;39:1235&#x2010;1246.</Citation><ArticleIdList><ArticleId IdType="pubmed">27344309</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong GM, Slager JJ, Verbon A, van Hellemond JJ, van Genderen PJ. Systematic review of the role of angiopoietin&#x2010;1 and angiopoietin&#x2010;2 in Plasmodium species infections: biomarkers or therapeutic targets? Malar J. 2016;1(15):581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5134107</ArticleId><ArticleId IdType="pubmed">27905921</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing LY, Yin J, Shao M, et al. Clinical characteristics and prognosis of serous body cavity effusions in patients with sepsis: a retrospective observational study. BMC Anesthesiol. 2018;14(18):169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6237031</ArticleId><ArticleId IdType="pubmed">30428838</ArticleId></ArticleIdList></Reference><Reference><Citation>Scholz A, Plate KH, Reiss Y. Angiopoietin&#x2010;2: a multifaceted cytokine that functions in both angiogenesis and inflammation. Ann N Y Acad Sci. 2015;1347:45&#x2010;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">25773744</ArticleId></ArticleIdList></Reference><Reference><Citation>Roviezzo F, Tsigkos S, Kotanidou A, et al. Angiopoietin&#x2010;2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther. 2005;314:738&#x2010;744.</Citation><ArticleIdList><ArticleId IdType="pubmed">15870388</ArticleId></ArticleIdList></Reference><Reference><Citation>David S, Park JK, Meurs M, et al. Acute administration of recombinant Angiopoietin&#x2010;1 ameliorates multiple&#x2010;organ dysfunction syndrome and improves survival in murine sepsis. Cytokine. 2011;55:251&#x2010;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">21531574</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">25241933</PMID><DateCompleted><Year>2015</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1557-8615</ISSN><JournalIssue CitedMedium="Internet"><Volume>30</Volume><Issue>1</Issue><PubDate><Year>2015</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of critical care</Title><ISOAbbreviation>J Crit Care</ISOAbbreviation></Journal><ArticleTitle>Prognostic evaluation of severe sepsis and septic shock: procalcitonin clearance vs &#x394; Sequential Organ Failure Assessment.</ArticleTitle><Pagination><StartPage>219.e9</StartPage><EndPage>219.e2.19E12</EndPage><MedlinePgn>219.e9-12</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jcrc.2014.08.018</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0883-9441(14)00349-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The purpose of the study is to compare the clearance of procalcitonin (PCT-c) in the first 24 and 48 hours of treatment of severe sepsis and septic shock with another early prognostic marker represented by the 48-hour &#x394; Sequential Organ Failure Assessment (SOFA).</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Prospective, observational cohort study conducted in a general intensive care unit including patients with severe sepsis and septic shock. The PCT-c was determined at the diagnosis of sepsis and after 24 and 48 hours. The SOFA score was determined at the time of intensive care unit admission and after 48 hours.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred thirty adult patients with severe sepsis and septic shock were studied over an 18-month period. The 24- and 48-hour PTC-c scores were significantly higher in survivors (P &lt; .0001). In nonsurvivors, the initial SOFA was significantly higher, and the 48-hour &#x394; SOFA was significantly smaller (P = .01). The area under the receiver operating characteristic curve was 0.68 for &#x394; SOFA and 0.76 for 24- and 48-hour PCT-c.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The 48-hour &#x394; SOFA score and the clearance of 24- and 48-hour PCT are useful markers of prognosis in patients with severe sepsis and septic shock. A decrease in PCT-c in the first 24 hours of treatment should prompt the reassessment of the appropriateness and adequacy of treatment.</AbstractText><CopyrightInformation>Copyright &#xa9; 2014 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Azevedo</LastName><ForeName>Jos&#xe9; R A</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, S&#xe3;o Domingos Hospital, Maranhao, Brazil. Electronic address: jrazevedo47@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres</LastName><ForeName>Orlando J M</ForeName><Initials>OJ</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, S&#xe3;o Domingos Hospital, Maranhao, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beraldi</LastName><ForeName>Rafael A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Department of Surgery, Evangelic University Hospital of Curitiba, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ribas</LastName><ForeName>Carmen A P M</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Evangelic University Hospital of Curitiba, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malafaia</LastName><ForeName>Osvaldo</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Surgery, Evangelic University Hospital of Curitiba, Curitiba, PR, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT01841190</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Crit Care</MedlineTA><NlmUniqueID>8610642</NlmUniqueID><ISSNLinking>0883-9441</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606589">CALCA protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011498">Protein Precursors</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-12-9</RegistryNumber><NameOfSubstance UI="D002116">Calcitonin</NameOfSubstance></Chemical><Chemical><RegistryNumber>JHB2QIZ69Z</RegistryNumber><NameOfSubstance UI="D015740">Calcitonin Gene-Related Peptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019540" MajorTopicYN="N">Area Under Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002116" MajorTopicYN="N">Calcitonin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015740" MajorTopicYN="N">Calcitonin Gene-Related Peptide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007362" MajorTopicYN="N">Intensive Care Units</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063305" MajorTopicYN="Y">Organ Dysfunction Scores</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011498" MajorTopicYN="N">Protein Precursors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018805" MajorTopicYN="N">Sepsis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012772" MajorTopicYN="N">Shock, Septic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Biomarker</Keyword><Keyword MajorTopicYN="N">Procalcitonin</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword><Keyword MajorTopicYN="N">SOFA score</Keyword><Keyword MajorTopicYN="N">Septic shock</Keyword><Keyword MajorTopicYN="N">Severe sepsis</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>6</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2014</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>8</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>9</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25241933</ArticleId><ArticleId IdType="doi">10.1016/j.jcrc.2014.08.018</ArticleId><ArticleId IdType="pii">S0883-9441(14)00349-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>